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Abstracts of Papers to be Presented at the 38th Annual Scientific
Session of the American College of Cardiology, Anaheim, California,
March 19-23, 1989
This year 4,008 abstracts (original contributions) were
submitted for evaluation. Each was graded by eight
recognized authorities in a special area of interest.
Acceptance for presentation was based on the relative
grade ranking in each of the 29 categories.
Ample meeting space combined with the inclusion of
poster sessions again this year permitted the 1989 Annu-
al Scientific Session Program Committee to accept 1,007
abstracts,,,approximately 25 % of the number submitted.
Many exceUent contributions were received for this
Monday, March 20,1989
10:30AM-12:00NOON, California Room A
Anaheim Convention Center
Young Investigators' Awards Competition
The following five abstracts are from the win-
ning entries in the Young Investigators' Awards
Competition, 38th Annual Scientific Session.
MYOCARDIAL STIFFNESS AND REPARATIVE FIBROSIS FOLLOWING
CORONARY EMBOLIZATION IN THE RAT.
Eugenia Carroll M 0 , Joseph S. Janicki, Ph.D., Ruth
Pick, M.D., Karl T. Weber, M.D., F.A.C.C., Cardiovascular
Institute, Michael Reese Hospital, University of Chicago
Pritzker School of Medicine, Chicago, Illinois
The structural nature of fibrillar collagen involved in
the replacement fibrosis that accompanies myocyte
necrosis remains uncertain, as does its influence on the
passive diastolic (OS) and active systolic (AS) stiffness
(g/cm2) of the myocardium. This study utilized 15 micron
diameter microsphere embolization of Wistar rat hearts to
address these issues. Collagen volume fraction (CVF),
fibrillar collagens (picrosirius-polarization technique)
and systolic and diastolic stress-strain relations of the
myocardium (isolated heart technique) were determined in
control rats (C, n-9) and 30 days after embolization (S,
n-14). Differences included:
ill ill .w.
Systolic BP (mm Hg) 126 ± 15 153 ± 26 <.02
LV/RV weight 3.9 ± 0.2 4.0 ± 0.4 NS
CVF 6.4±1.7 15.9 ± 5.5 <.001
AS (g/cm2) 268.0 ± 8.6 449.4 ± 10.4 <.001
OS (strain 5') 63.2 ± 12.3 96.7 ± 43.8 <.05
No correlation was found between CVF and AS or OS. The
reparative fibrosis consisted of a meshwork of short,
taut, thick and thin collagen fibers that was situated
in-series with muscle. Thus, not because of its
cQUcentration, but rather its fibrillar structure,
alignment, and location, a reparative fibrosis will have
a marked influence on myocardial stiffness.
year's competition, and we appreciate your support and
interest.
Arthur E. Weyman, MD, FACC
Chairman, 1989 Annual Scientific Session
Program Committee
Steven E. Nissen, MD, FACC
Co-Chairman, 1989 Annual Scientific Session
Program Committee
PLATELET PLASMINOGEN ACTIVATOR INHIBITOR: PURIFICATION
AND CHARACTERIZATION OF INTERACTION WITH PLASMINOGEN
ACTIVATORS AND ACTIVATED PROTEIN c. William P. Fay,
M.D., and Whyte G. Owen, Ph.D. Kayo Clinic/Foundation,
Section of Hematology Research, Rochester, KN 55905
The interaction of Plasminogen Activator Inhibitor
(PAl) and activated Protein C (APC) has been implicated
to play a role in the regulation of fibrinolysis by
altering the ratio of plasminogen activators to their
rapid inhibitor. We have isolated PAl from platelets
and quantitatively studied its interaction with APC,
tissue-type plasminogen activator (t-PA), and urokinase
(UK) in a purified porcine system. Incubation of PAl
with APC, UK, and t-PA yielded not only SDS-stable
complex formation, but also a modified inhibitor of
slightly reduced molecular weight. The second order
rate constants for the inhibition of t-PA, UK, and APC
by PAl were 3.5 x 10', 3.4 x 10', and 1.1 x 10' K-lsec l ,
respectively. Activated Protein C inhibited PAl with a
second order rate constant of 1.1 x 10' K-lsec- l This
rate was not accelerated by the addition of Protein S,
phospholipid, and calcium. Platelet PAl inhibited the
functional activity of APC in plasma in a heparin-
independent fashion. These results indicate that: 1)
PAl can function as both inhibitor and substrate of its
target proteasBs, 2) if APC promotes fibrinolysis via
inactivation of PAl, then APC must be present in
concentrations several orders of magnitude greater than
t-PA, or the interaction of APC and PAl must be
accelerated by presently unknown mechanisms, and 3)
Platelet PAl is the most rapid heparin-independent
inhibitor of APC yet described. Hence, it may promote
clot stability not only via inhibition of fibrinolysis,
but also by inhibiting the inactivation of Factors Va
and VIlla by APC.
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VASCULAR RESPONSES TO LEUKOCYTE PRODUCTS IN
ATHEROSCLEROTIC PRIMATES.
J. Antonio G. Lopez. M.D •• Donald D. Heistad. M.D •• VA
Medic.i Center and University of low•• low. City. low••
Little is known about the possible role of leukocytes in
the pathogenesis of vasosp.... We hypothesized that
v.eo.ctive products released by leukocytes might produce
constriction of .therosclerotic .rteries. To test this
hypothesis, we infused f-met-leu-phe (fMLP) , • peptide
which .ctiv.tes leukocytes to rele.se their v.so.ctive
products, into the perfused hind limb of normal .nd
atherosclerotic cynomolgus monkeys. Infusion of fMLP
did not change resistance of l.rge arteries in normal
monkeys. In contr.st. fMLP produced pronounced
constriction of l.rge .rteries in .therosclerotic
monkeys. To determine whether leukotrienes. platelet
.ctiv.ting f.ctor (PAF) or prostagl.ndin E2 (PGE2).which .re released by leukocytes. may contribute to
leukocyte-induced vasoconstriction in .therosclerotic
monkeys. we injected leukotriene D~ (LTD~). PAF. and
PGE2 intra-arterially into the perfused hind limb.LTD and PAF had minimal effect. on large arteries in
botA normal and atherosclerotic mOnkeys. In contrast.
PGE2 produced gre.ter than ten-fold more constrictionof I.rge arteries in atherosclerotic than normal
monkeys. Thus 1) pronounced constriction in
.therosclerotic. but not normal ••rteries during
infu.ion of fMLP suggests that products rele.sed by
leukocyte. may mediate v.soconstriction in
.thero.clerotic vessel. and 2) vasoconstrictor response.
to PGE2 are profoundly potenti.ted by atherosclerosis.which iugge.ts th.t PGE2 may contribute toleukocyte-induced v.soconstriction.
SELECTIVE INHIBITION OF a2-ANTIPLASMIN AUGMENTS THE
POTENCY AND SPECIFICITY OF PLASMINOGEN ACTIVATORS.
Guy L. Reed MD, G.ry R. M.tsueda PhD, Edg.r Haber MD.
cardi.c Unit, Massachusetts Gener.l Hospit.l, Boston,
MA.
Clinical trials h.ve shovn th.t plasminogen
.ctivator ther.py significantly reduces the mort.lity
from myocardial infarction. Yet, for • number of
patients this ther.py fails to lyse the coronary
thrombus, or is associated vith bleeding or
rethro.bosis. In part these failures are due to the
effects of a2-antiplasmin, the protein that protects
the clot from lysis by plasmin. To investigate the
hypothesis that selective inhibition of a2-antiplasmin
would i.prove the potency .nd specificity of
plasminogen activators, ve used a monoclonal antibody
vhich specifically inhibits human a2-antiplasmin. This
inhibitory antibody RVR, functions as a reversible
inhibitor causing 50% inhibition of a2-antiplasain at
a molar r.tio of 0.7:1 (RVRIa2-antiplasmin). In a
quantitative assay of clot lysis in plasma, RVR
draaatically incre.ses tha potency of tissue
plasminogen .ctiv.tor (27-fold) .nd urokin.sa
(SO-fold). At tha .... tias RVR preserves tha
fibrinolytic specificity of tha.e .ctiv.tors and doss
not increase the nonspecific consumption of
fibrinogen.
Fro. these results we conclude that the co.bined
use of a plas.inolen .ctivator and an a2-antiplasmin
inhibitor viII increase the potency and specificity of
thro.bolytic ther.py.
CARDIOTOXIC EFFECI'S OF ANGIOTENSIN U
Lip-Bun Tan M BBCbir 0 Phi!. Jorge E. J.IiI. M.D.• Joseph
S. Janicki. Ph.D., Karl T. Weber. M.D., F.A.C.C.• William A.
Clark, Ph.D., Cardiovuc:ular Institllte, Michael Reese Hospital.
Univ. of Chicago, Chicago, Illinois.
The role of angiotensin U(AU) in the pathogenesis and pro-
gression of heart failure is unknown. However. we have shown
that All infusion into rats (19O-300g) produces substantial
cardiac myocytolysis. All was sdministered via Alzet minipumps
at a dose (200 ng/min. i.p.) which did not cause acute hyper-
tension. We induced elevated endogenous All by abdominal aortic
banding with renal artery constriction. Necrotic cardiac
myocytes were identified by in vivo administration of monoclo-
nal antibodies against cardiac myosin and by immunofluorescence
labelling. The healing process following injury was monitored
by determining rep.rative (sHlthymidine incorporation into
fibroblast DNA. Exogenous All produced scattered labelling of
cardiac myocytes, indicative of necrosis, which was maximal on
day I of infusion. Subsequently. DNA synthesis rates were
increased. and reached peak level on day 2 (DNA specific acti-
vity: All 9O.Ot18.6. Controls 11.4;1:2.3 cpm/"g, p<O.OS). Prior
to day 3 of infusion. systemic blood pressure was not
significantly elevated from control. Concurrent treatment with
propranolol (30 mllkg/day s.c.) and phenoxybenzamine (S
mllkg/day s.c.) did not attenuate the necrotic effect of AU.
Increased endo-genous All produced similar myocyte necrosis and
increased DNA synthesis rate. each of which were prevented by
captopril (SO-SO mllday p.o.). Aortic banding without renal'
artery involve-ment produced hypertension but no myocardial
necrosis. We con-clude that pathophysiological levels of
endogenous and exoge-nous All was capable of inducing
myocardial necrosis. which was unrelated to the hypertensive
effect of All and not secondary to adrenergic activation.
Captopril was effective in preventing myocyte necrosis in our
model of renovascular hypertension.
Monday, March 20, 1989
10:30AM-12:00NOON, California Room D
Anaheim Convention Center
Detection and Treatment of Silent Myocardial
Ischemia
DISCORDANCE BETVEEN RADIONUCLIDE, DOPPLER ECHO, ANGI0-
GRAPHIC AND AMBULATORY ECG 1lAUIR5 OF ISCBBMIA.
D.vid C. Reed, M.D., Petar B. Stone, M.D.,PACC, Thomas
L. Shook, M.D.,PACC, Lorena A. Shav, BSM, Phillip YoUDi,
Phar••D., Robert S. Gibson, M.D., PACC and the ASIS
Group. Univ of Vir,inia, Charlottesville, Virginia.
To deter.ine the relationship betveen the mass of
ischemic myocardium and silant ische.ia, ve proapective-
ly ev.luated 20 consecutive pts (mean ega 60+5 yrs) vith
chronic stable angina vitbdravn. fra- anti-aniinal medi-
cation and placed on placabo. After one vaeIt of placabo
tharapy, e.ch pt undervant graded treedaill exarcisa
(GTX) testiAi, quantitativa TL-20l scintigraphy, supra-
sternal doppler echo of eacendiAi aortic blood flov
velocity (v) and acceleration (dv/dt) duri.. GTX,ancI 48
hra of post GTX ambulatory BeG (AECG). All 20 pta had
angina and >1 _ ST sel • duriAi GTI; 11 p~. (60%) had
silent ischiaia (SI) by AECG critaria (~l _ ST • for ~l
.in) and 8 pts (40%) did not. compari.on of the tvo
AECG defined groups shoved si.ilar GTI duration and
rate-pressure products, treadJdll 1ST••cor.. , prior KI
and LVEF. Pts vith SI vere youocar (p..05), hadlasa LV
asynargy (p••07), fever perd.tant TL-201 ~faet.
(p••07) and • lover prevalaqca of ~o~ luaa fL-201
upteke (p..04) duriAi GTI i-.illl. bportalltly, tbere
vere no betveen group diffarancaa in doppl.r-derived LV
ejection phase indices durilll GTI or· tbe nu-bar of scin-
tiscan seg. or vascular r..tou UOriIll fL-201 bch_ia,
d••pite hisber &niio jeopardy .cot~.~ pt. vith SI
(p••05). Pt. vitb SI VB. tboM·Yit_\C·1I nr. IIOr.
likely to have an RCA .t_.iI(••IU, p;o:.OI) and in-
feropoatarior isch_ia by '1'1.-20.1 (.,..121;,,'.....02).
Thu., the prea.nea of 51 on All» ~'eorre1at. vith
ex.rcis. TL-201 _ured ischeU~ ,01' doppl.r .cbo
indic•• of LV contractU. r..... 1Iut;4a:.... pt. is
relatad to the sit. of isch..t":..-alJtbelCl.
lACC Vol. 13, No.2
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SILENT ISCHEMIA DURIIC DAILY LIFE IS All INDEPENDENT
PRmICTOR OF SURVIVAl IN STABLE ANGINA
prakash Deedwania, M,p,. f,A.C.C., Enrique Carbajal,
M.D., John Nelson, M,D., Lawrence Linn, VAMC/UCSf School
of Medicine, fresno, CA
, •• , , i.:. .:. .:.
Silent ischellia (51) on ambulatory ECG IIOnitoring (AEH)"
predicts poor prognosis in pts with MI and unstable
angina. However the significance of 51 in stable angina
(SA) is not established. In this prospective blinded
study, we evaluated 118 pts (.can age 63) with proved CAD
and SA undergoing 24 hr AEM with validated fM systl!ll,'
All pts continued prescribed antianginal drugs and were
followed at 3-4 month intervals. Silent ischemic events
(SIEs) were defined as ST + ~ 1 1I'Ill, 80 msec- frail J,
lasting ~ 60 sec, and without symptoms. Of the 118 pts,
107 had analyzable AEM data and were divided into two
groups (gr): gr-l, 46 pts with 51, and gr- II, 61 pts
without SI. During a mean follow-up period of 23±8 mas,
Kaplan-Meier actuarial -ethods for the tiMe-dependent
probability of survival revealed significantly worse
prognosis for gr I (p-0.023). The stepwise Cox hazard
analysis of 11 variables including age, risk factors,
prior MI,exercise para.cters, ECG and angiographic
findings revealed the presence
of SI as an independent and ·IlIOSt --'
powerful predictor of IIOrtality -~ ,.,-
(p-0,0025) in these patients. r ~
Conclusion:The presence of silent I
ischemia during daily life is a
marker of unfavorable outcome and' j
poor surviva1 in pat ients wi th· •.•._
stable angina,
The relatiol1$hips between exercise teating results and
occurrence of silent ischemia (SI) during ambulatory monitoring
were evaluated in 21 pta with coronary disease and ST depression
(STU during exercise. Symptom-limited exercise was performed on
a supine bicycle ergometer, with gated blood pool scans at rest and
during peak exercise. Each pt was monitored for a mean of 41 ± 8
hours during daily activities.
Nine pts had a total of 47 episodes of SI during the
ambulatory monitoring period, and 12 pta had no SL Pts in both
groups were similar in their use of anti-anginal medications (4 of 9
with SI, 6 of 12 with no SI), in the frequency with which they
reported angina during the exercise test (2 of 9 with SI,4 of 12 with
no SI), and in maximal HR and HRxBP product achieved during
exercise. Pts with SI developed STl significantly earUer in exercise
(412 ± 160 vs 902 ± 314 sec, p<.01) than those with no SL There was
no significant difference between the 2 groups, however, in change
in ejection fraction (~EF) with exercise (+5.0 ± 7.7% VI +6.3 ± 99%~
Duration of exercise at onset of STl was an accurate
predictor of SI; development of STl in the first 2 stagei of exercise
was 89% sensitive and 92% specific in identifying pts with ischemia
during daily activities. The 8 pta with STl in Stages 1 or 2
accounted for 89% of the episodes and 73% of the total duration of
SI for the entire group. In contrast, there was no value for ~EF
which helped distinguish pts with SI from those without SL
In summary, pts with a high probability of ·having SI during
ambulatory monitoring can be identified by the time at which
significant STl occurs during exercise, but not by symptoms or by
~EF. These results suggest that SI is more closely related to the
early onset of ischemia with exercise than to the magnitude of
ischemia at peak exercise.
EXERCISE TEST RESULTS PREDICT SILENT ISCHEMIA ON
AMBULATORY MONITORING
Alan HjnderUtcr. M D Margaret Herbst, M.S.N, Edith Bragdon,
MA, Martha Ballenger, David Sheps, MD, FAe.e.
University of North Carolina, Chapel Hill, N.e.
mATIOO BE'lWEm IscmJ!IA~ EXERCISE AND NeCLA'lURY
ISClII1JtIC~ IN CDR:H\RY ARTER! DISFASE
Arshed A. QuyylJni, M.D., Julio A. Panza, M.D., TiJoothy s.
callahl11i, Kevin E. McCarthy, M. D., RJbert O. BoOOW, M. D. ,
P.A.C.C., st:e);nen E. Epstein, M.D., F.A.C.C, RnaI,
Bethesda, II)
Exercise (ex) irdJoed LV e¥sfunction and sr depression
are 1D{lortant indices of prognosis in pta with ooronatY
disease (CAD). 1IID1l.atory 1sc:bem1c episodes CAIE) have
been proposed as additional indices of progoosis: however,
their relation to ex 1ndJoed isdleiD1a 18 llI'Iknown. we
performed ex radionuclide angiography, treadtLill ex, and
48 hr stbJlatory srJOOnitoring free of antianginal drugs
in 80 pta with CAD. AlE prevalence and du'ation (min/48
hrs) was evaluated in 1) pta with atnotmal ejection
fraction (EF) response to ex (~2' increase) (EF~) and
oormal ex EF response (~3t increase) (EFt) and 2) pts with
and without 5'U during treadn1.l.1 ex.
Bdl't Bdl'l BIl8I'J. RIBIS'!' 4.
All pta Nt.Ittler of pta 57 23 56 24
AIE prevalence 67\* 3~ 80\** 13\
AIE d1ration (m) 111+20* 45+23 129+20** 2.5+1
3 VI) tlJdler of pta 21- 5 - 10- 16 -
(n-26) AIE prevalence 62' 20\ 88\** 0\
AIE cbration (m) 109+32 13+12 148,t38 0
*-p<.05 **-p<.001 lllB/IJ1 ±SB vii· vessel. disease
Although the prevalence and cbration of AlE were greater
in pta with J.EF with ex, there was no relation between
the lIIII!J1itude of EF change and the dlration of AIE. In
contrast, AIE cbration oorrelated with dlration of
treadn1ll ex to sr4> (r-.4, p<.004). AlE were absent in
38\ of pta with 3 VI) and ex LV e¥sfl.l\Ction. 'lbls, AIE
prevalence does not identify DW¥ pts with severe disease
and ex LV e¥sfunction, therefore, silent ischemia detec-
don may not provide as precise prognostic inf011llation as
tbatobta1ned fran coronary arteriography and ex tests.
THERAPY OF PAINFUL AND PAINLESS HYOCARDIAL ISCHEHIA IN
348 PATIENT5:RESULTS OF THE NIFEDIPINE TOTAL ISCHEHIA
AWARENESS PROGRAH,
Peter F. Cohn, H.D" F.A,C.C" George W. Vetrovec, H.D.,
F.A.C,C., Richard Nesto, H.D., F.A.C,C. and Total
Ischemia Awareness Program Investigators, SUNY Health
Sciences Center, Stony Brook, New York,
The Total Ischemia Awareness Program (TIAP), a national
multicenter study, assessed clinical and Holter moni-
toring (HH) data In 2 groups of pts, a study group (312
pts) and a ~ontrol group (36 pts). All pts completed 96
hrs of HH. Of the 312 pts In the study group, 136 (44%)
had at least I episode of myocardial Ischemia. The total
number of episodes WaS 372: 84% were painless. During
Phase 1 (baseline therapy) most pts were either on long
acting nitrates (LAN) or on beta blockers (BB) with or
without LAN. In Phase 2, nifediplne (N) was added to
study group patients only. Number of episodes of ST seg-
ment depression per pt per 48 hrs HH In Phase 1 was 2.7+
0,3 (mean+SEH) and fell to 2.1+0.2 during Phase 2 -
(p<.005):-total duration per pt fell from 49,0 min+6 to
40.7+5 (p<.Ol). Effect on number of ischemic episodes of
adding N to LAN and/or BB as follows:
LAN BB(+LAN)
Phase 1 4.0+1,3 01 2,6+0,3 05
Phase 2 2.2+1,2 p<. 2.3+0.3 p<.
Treatment with N-was most beneficial in the 38 pts with
>6Omln of Ischemia per 48 hrs: mean duration fell from
l27+8mln to 68+15 (p<,OOI) and the mean number of epi-
sodes fell from 5,8+0,7 to 3,8+0,5 (p<.OOI), In contrast
to the study group,-the controT group showed no differ-
ences between Phase 1 and 2, Thus, addition of N to
baseline therapy was very effective In reducing total
ischemic activity, especially in pts with more severe
Ischemia.
4A ABSTRACTS JACC Vol. 13, No.2
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PAINLESS MYOCARDIAL ISCHEMIA IN DIABETIC PATIENTS
WlTII CORONARY ARTERY DISEASE
Hideo Mitamura M.D., Susumu Nakagawa M.D., Hisashi Katayama M.D.,
Susumu Ui M.D., Mitsuru Kimura M.D., Saiseikai Central Hospital,
Tokyo, Japan.
Painless myocardial ischemia (PMI) has been said to develop often in
diabetic Pts (DP) whereas its exact incidence and characteristics have not
been systematically evaluated. We therefore studied occunence of chest
pain with regard to electrocardiographic ST segment depression during
exercise in 44 consecutive Pts with angiographically proven coronary
artery disease and a positive treadmill test. There were 26 DP and 18
nondiabetic Pts (NP). The two groups were comparable in age, sex,
history of MI, indices of LV function, number of coronary vessels dis-
eased. Chest pain was absent during a positive exercise test in 18/26
(69%) DP vs 3/18 (17%) NP (p<0.005) despite both showing similar
exercise time, peak heart rate, peak blood pressure, and the degree of
maximum ST depression. At Imm ST depression, 25/26 (96%) DP and
10/18 (56%) NP were pain-free (p<0.005). At 2.5mm, 11/12 (92%) DP
remained pain-free as compared to 2/8 (25%) NP (p<O.OI). When the
incidence of treadmill-induced chest pain was compared with that of
clinically occurring chest pain, NP exhibited 12/18 (67%) concordance
whereas DP showed discordance (P<O.OOS) such that 13/18 (72%) DP
with PMI during a treadmill test had a history of angina. Although
statistically not significant, DP with PMI tended to have a higher fasting
plasma glucose level (170 vs 133 mgfdl), a higher HbAlc (9.3 vs 7.7%),
and a longer diabetic history (12 vs 9 years) than DP with painful
ischemia. Notably, DP with PMI had either neuropathy, nephropathy,
or retinopathy more frequently (15/18 or 83%) than DP with painful
ischemia (2/8 or 25%, p<0.025). We conclude that in Pts with diabetes,
particularly in the advanced stage, PMI during exercise is common and
can be seen even at severe ischemia or in Pts with a history of clinical
angina.
Monday. March 20. 1989
10:30AM-12:00NOON. California Room D
Anaheim Convention Center
Catheter Athersclerotic
ULTRASONIC ANGIOPLASTY USING A NEW FLEXIBLE WIRE
SYSTEM.
Israel Freeman, M.D., Jeffrey M. Isner, M.D., F.A.C.C.,
Dov Gal, D.V.M., Gary H. Friedman, M.D., Howard
Alliger, B.A., Andrew M. Grunwald, M.D., F.A.C.C., Long
Island Jewish Medical Center, New Hyde Park, NY and St.
Elizabeth's Hospital, Tufts University School 0 f
Medicine, Boston, MA
We investigated the use of transarterial ultrasonic
angioplasty to recanalize totally occluded
atherosclerotic arteries in vivo. Vascular obstructions
were created experimentally in Yucatan microswine fed
an atherogenic diet for 2 weeks before and 8-10 weeks
following balloon endothelial denudation of the iliac
arteries. A total of 5 arteries in these 4 animals were
then selected for transarterial recanalization,
performed via the surgically exposed internal carotid
artery. An angiographic catheter was used to deliver a
flexible 0.2-0.3 in. -diameter ultrasonic wire (Sonic
Needle Corpl, Farmingdale, NY) to the site of the iliac
occlusion. Sonication was performed at a frequency of
22 KHz, using 20-sec exposures for a total of k2-6 min.
In one artery, subtotally (99\) occluded for 2.7 em in
length, the wire could not be advanced without
ultrasound .With sonication, the entire length of the
total occlusion was recanjllized producing a residual
stenosis of only 20'. In· the remaining 4 arteries,
ultrasonic angioplasty was used to partially recanalize
total occlusions of 0.5-2.3 cm in length, producing
~30' luminal patency. None of the arteries were
perforated during the sonication process, although 3 of
5 arteries were perforated while maneuvering the
guiding catheter or the wire-catheter delivery system.
These preliminary findings indicate the feasibility of
employing transarterial ultrasound angioplasty to
recanalize atherosclerotic vascular occlusions.
INTRAVASCULAR REAL-TIHE. HIGH RESOLUTION TWO-
DIMENSIONAL ECHOCARDIOGaAPHY.
Jos R. Roelandt. Patrick W. Serruys. Nicolaas
Bo., El.a J. Gussenhoven. Frans C. van Eg.ond,
Charles T. Lancee, Har. ten Hoff. Wille. J. van
Alphen. Thoraxcenter, Rotterda. and
Interuniversity Cardiology Institute of the
Netherlands.
Direct assess.ent of atherosclerotic involve-
ment of the arterial wall is a major research
goal. To assess lu.en morphology and the
details of arterial wall disease under the
endothelial surface we developed a 2 m.
catheter with a 40HHz single element transducer
mounted at its tip providing a 360-degree
display of the vesset interrogated at 25
images/second. In vitro studies of normal and
diseased arteries accurately demonstrated lumen
geometry and wall tissue characteristics
including atheroma. These images show extre.ely
good correlation with the histopathologic
findings. Subsequent in vivo studies both in
pigs and humans showed excellent clinico-
pathologic correlation of arterial
atherosclerotic disease and wall dyna.ica.
This imaging syste. haa great potential for the
accurate localisation. characterisation and
quantification of atherosclerotic disease aa
well as the evaluation of the acute and long-
ter. effects of pharmacological and catheter
based intravascular interventions.
INTRAVASCULAR ULTRASOUND IMAGING OF ATHEROSCLEROTIC
CORONARY ARTCRIES: No4IN VJmO VAUDATION STUDY
Antonio l BartoreUI MD. Benjamin N. Polkln M.D., Yaron Almagor
M.D., James C. Gessert B.S., William C. Roberts M.D., FA.C.C., Martin
B. Leon M.D., FA.C.C. NHLBI, Bathesda, MD
Safe and effective clinical application of new Interventlonal therapies
may require more precise Imaging of atherosclerotic coronary
arteries (CA). To determine the reliability of catheter-based
Intravascular ultrasound (US) as an Imaging modality, a miniature
prototype US system (1 mm transducer, 25 MHz frequency, 0.1 mm
axial resolution, and 0.4 mm lateral resolution) was used to acquire
real-time 20 vessel wall Images In 32 necropsy CA segments (54
sites) with moderate or severe atherosclerosis from 13 patients.
Comparable 360· US images and transverse histology (H) sections
were analyzed using a computer video planlmetry system. US and H
measurements correlated significantly (all p<.OOO1) for total cross-
sectional area (r•.94), lumen area (r•.85), % cross-sectional
narrowing (r•.84), and linear plaque thickness dimensions measured
at 0·, 90·, 180·, and 270· (r•.92). Moreover, predominant H
plaque composition was accurately predicted by US Images In 98% of
examined sites. CA anatomic features easily discernable were the
media-adventitia Interf~ce, the plaque-lumen Interface, and plaque
composition subtypes including 1) calcified lesions-bright echoes
casting an acoustic shadow, 2) fibrous leslons-<lense, homogeneous
echoes, and 3) lipid-filled lesions-zones of relative echo lucency.
From these data, we conclude that Intravascular US imaging of
atherosclerotic CA 1) precisely defines cross-sectional and linear
vessel dimensions and 2) accurately determines plaque distribution
and composition. Thus, catheter-based Intravascular US of
atherosclerotic CA has great potential both as a diagnostic modalily and
for real-time guidance of interventlonal procedures.
JACC Vol. 13. No.2
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INTRALUMINAL TWO-DIMENSIONAL ULTRASOUND
ANGIOSCOPIC QUANTITATION OF ARTERIAL STENOSIS:
COMPARISON WITH EXTERNAL HIGH·FREQUENCY ULTRASOUND
IMAGING AND ANATOMY
Natesa pandjan Mp FACC, Andreas Kreis MD, Thomas O'Donnell
MD, Alex Sacharoff PhD, Edward Boleza PhD, Richard Caro PhD.
Tufts-New England Medical Center, Boston, Massachusetts.
Extemal high frequency ultrasound imaging (ExHFU) has been
shown to be capable of defining peripheral and coronary arterial
stenosis (St). Recently a new, catheter-based, intraluminal
ultrasound angloscopic imaging method has been developed. We
evaluated, in this study, the accuracy of ultrasound angioscopy (UA)
In quantifying In arterial St. The prototype device (Summit
Technology) we used has a 20 MHz transducer rotating at 1800 rpm
within the tip of a 6 Fr catheter. Arterial segments (n-20) of
various size (5-59 mm2 lumen area by anatomy) were imaged in
control and after experimental St both by ExHFU and by UA. Lumen
areas were measured from calibrated ultrasound images in control
and after St, and % cross-sectional area St calculated. These data
were compared to % area St derived from calibrated anatomic
photographs of the arteries taken in control and after St. Both UA
and ExHFU yielded high-resolution, two-dimensional,
circumferential images of the arteries. Alterations In vessel area
and shape were apparent after creation of St. The correlations for
quantifying arterial % area ST were:
ExHFU (y) vs Anatomy (x) y-0.69x+22 r-0.82 p<0.001
UA (y) vs Anatomy (x): y-0.65x+21 r-0.92 p<0.001
UA (y) vs ExHFU (x) y-0.72x+14 r-0.86 p<0.001
Thus, intraluminal UA provides a reliable new imaging approach to
quantify arterial stenosis. Catheter-based ultrasound angioscopy,
with its ability ot image arteries inaccessible to ExHFU, has a
significant potential in guiding and gauging Interventional therapy
for coronary and other arterial stenosis.
EVALUATION OF MIXED ATHEROSCLEROTIC PLAQUES BY
QUANTITATIVE ULTRASONIC METHODS.
P.A.N. Chandraratna, M.D., F.A.C.C., Joie P. Jones,
Ph.D., Shahbudin H. Rahimtoola, M.D., F.A.C.C., Steve
Kaiser, LAC-USC Medical Center, Los Angeles, CA.
We have preViously shown that quantitative ultra-
sonic methods (QUS) can differentiate between fatty
(FAP) , fibrous (FIP) and calcific plaques (CP). To
assess the role of QUS in evaluating mixed athero-
sclerotic plaques, 2000 freshly excised specimens of
human abdominal aorta were suspended in a water tank
and scanned using a rectilinear ultrasound scanner. A
data acquisition system based on the TRW 8-bit 20 mHz
AID board and IBM AT computer was used. A matrix of
A-lines was taken over a specified region of interest
and the RF waveforms associated with each A-line
recorded. The acoustic impedance (Ac Imp, CGS Rayl
10-~) and attenuation coefficient (At Coef,
db/cm/mHz)of 2000 areas of normal aorta (NL), 550 FIP,
480 FAP, 610 CP, 320 partly fibrous and partly fatty,
230 partly fatty and partly CP and ·124 partly fibrous
and partly CP were determined.
NL FiP FAP CP
Ac Imp 1.5±0.04 1.6±0.02 1.7±0.03 1.8±0.02
At Coef 0.6±O.05 0.7±0.06 1.8±0.2 5.3±0.4
The Ac Imp and At Coef of partly fibrous and partly
fatty plaques were between FIP and FAP, in proportion
to the amount of fibrous and fatty tissue determined
histologically. The Ac Imp and At Coef of partly fatty
and partly CP, were between FAP and CP, in proportion
to the amount of fat and calcium. In partly fibrous
and partly CP the Ac Imp was between fibrous and CP
(Le. in the range of FAP); however, the At Coef was
much higher than FAP. CONCLUSION: QUS is useful in
evaluating mixed plaques, and the AC Imp and At Coef
values depend on their histological compositon.
ABSTRACTS
DETECTION OF INTRAVASCULAR THROMBUS BY HIGH
FREQUENCY INTRALUMINAL ULTRASOUND ANGIOSCOPY:
IN VITRO AND IN VIVO STUDIES
Natesa pandjan Mp FACC Andreas Kreis MD, Barbara Brockway
BS, Alex Sacharoff PhD, Edward Bolaza PhD, Richard Caro PhD.
New England Medical Center Hospitals, Tufts University School of
Medicine. Boston, Massachusetts.
Detection of intravascular thrombus currently requires
angiography. To assess whether ultrasound angioscopy, a new
technique which can provide intraluminal two-dimensional
ultrasound images, would be of value in the detection of
intravascular thrombi, we used a catheter-based 20 MHz ultrasound
probe (Summit Technology) in vitro in 10 arterial segments with
experimental thrombi of various size. Ultrasound angioscopy
provided circumferential, high resolution images of all vessls and
detected the intraluminal thrombi In all. In the ultrasound
angloscopic images, thrombi appeared as granular echo-dense
masses with various greylevel shades. We measured the maximum
thrombus width and area from calibrated ultrasound angioscopic
images and compared them to similar measurements made from
calibrated anatomic photographs of the thrombus in the vessel. The
correlations between anatomic (x) and ultrasound angioscopic
measurements (y) were excellent both in assessing the luminal area
occupied by the thrombus (y_0.9x+0.53, r-0.98, p<0.001) and
for maximum thrombus width (y-0.69x+0.95, rz O.87, p<0.01).
When intraluminal thrombi was produced in carotid arteries In vivo
in 11 dogs and the vessels imaged, ultrasound angioscopy displayed
real-time, two-dimensional images of the blood vesssls, detected Ihe
thrombi in all, and also allowed visualization of the dynamics and
evolution of thrombus formation. This new technique thus offers a
valuable approach in the evaluation and stUdy of vascular diseases
with associated intraluminal thrombosis.
Monday, March 20,1989
10:30AM-12:00NOON, Garden Grove Room
Anaheim Convention Center
Non-Q Wave Myocardial Infarction
1lIE PROGNOSTIC SIGNIFICANCE OF FIRST
MYOCARDIAL INFARCrION TYPE (Q-WAVE
VS NON-Q-WAVE)
Jesaia Benhorin M.D., Anhur 1. Moss M.D., F.A.C.C., David
Oakes Ph.D., Frank: Marcus M.D., F.A.C.C., Elizabeth Hahn
M.A., Stephen Algeo M.D., and the Multicenter Diltiazem
Post-infarction Research Group, University of Rochester,
Rochester, NY.
The prognostic significance of first mlocardial infarction (M!)
type (Q-wave [QMI] vs non Q-wave LNQMI] MI) was
determined from our multicenter data-base of 777 placebo
treated pts, followed for 1-4 years after their first acute MI.
Two hundred twenty four pts had NQMI and 553 pts had QMI.
Pts with NQMI were more likely to be females (p=O.05), to be
treated with beta blockers at randomization (p<O.OOl), and to
have significantly higher post-MI LVEF than pts with QMI
(53±12% vs 46±13%, respectively, p=O.OOOI). Cardiac
mortality and non-fatal reinfarction rates were similar in both
groups at one year (4% vs 5.2%, and 7.6% vs 5%, respectively,
p=ns), and at total follow-up (6.3% vs 7.6%, and 10.3% vs
7.8%, respectively, p=ns). Cox survivorship analyses, using
stepwise selection from 8 peninent baseline clinical variables
other than MI type revealed that frequent VPCs, lack of beta
blocker therapy, advanced NYHA cfass, and pulmonary
congestion were those that carried significant and independent
risk for subsequent cardiac monality (hazard ratio (HR): 2.5,
2.3, 2.2, 1.6, respectively). Adding MI type to this optimal
model did not demonstrate that it carries an independent risk for
subsequent cardiac mortality (HR 1.3, p=ns).
Conclusion: MI type (QMI vs NQMO does not significantly
change the risk ofpost-MI cardiac mortality after adjustment
for peninent baseline clinical variables in pts with first ML
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FAVORABLE EFFECT OF DILTIAZEM ON LATE MORTALITY AND
REINFARCTION AFTER NON-Q-WAVE MYOCARDIAL INFARCT!ON:
MULTICENTER DILTIAZEM POST-INFARCTION TRIAL (MDPIT).
William E. Boden MD, FACC; Robert E. Kleiger MD, FACC; J.
Philip Miller, Henry Greenberg MO, FACC; Ronald J. Krone,
MD, FACC; W. David Hager MO, FACC; Jonathan Abrams MD,
FACC; Arthur J. Moss MD, FACC; MOPIT Research Group,
Harper Hospital, Wayne State University, Detroit, MI.
One of the principal prespecified findings from MOPIT,
a large prospective study of prophylactic diltiazem (DTZ)
240 mg/day vs. placebo (PLC) in post-MI pts followed for
up to 4 1/2 years (mean c 25 mo; range - 12-52 mol, was a
significant 34% reduction in cumulative first recurrent
cardiac events (cardiac death [CD] or non-fatal
reinfarction [MI]) in 634 non-Q wave (NQ) MI pts who
received DTZ; Cox hazard ratio -*0.66 (0.44-0.98).
Because a prior short-term multicenter trial of DTZ in
NQMI showed a cumulative 51% reduction in early «14 day)
reinfarction, but not mortality, we sought to determine
within the MOPIT NQMI cohort whether: a) late MI and CD
were concordantly reduced byDTZ during followup, and; b)
there was evidence that the significant post-MI treatment
effect attenuated over time. Within the NQMI cohort,
there was a total of 46 cardiac deaths (CD) and 62
non-fatal MI during the 52 mo followup, of which 67
occurred on PLC and 41 on DTZ. Comparative cumulative
cardiac events (CD and MI) for PLC vs DTZ subgroups,
using the Cox proportional hazards model, revealed:
6moCD;MI lyrCDiMI 2yrCDiMI ~ 3yrCDiMI TOTAL
PLC(n-338) 13;23 21;29 24;34 30;37 67
DTZ(n-296) 8; 6 12;13 13;20 16;25 *41
CONCLUSION: 1) Diltiazem was associated with a parallel
reduction in both mortality and reinfarction after NQMI;
2) This significant overall beneficial effect was evident
early in the post-infarction period and was sustained
throughout the duration of followup.
CORONARY ANATOMY PRECEDING NON-Q WAVE
MYOCARDIAL INFARCTION.
Wmjam C. Little M 0 FA C C, Raymond Workman, Mark
Burrows, P.A., Frederic R. Kahl, M.D., F.A.C.C.. Michael A.
Kutcher, M.D., F.A.C.C.• Wmiam P. Santamore, Ph.D., Robf!rt
Applegate, M.D. Bowman Gray School of Medicine, Wake Forest
University. Winston-Salem, North Carolina.
A recent report suggests that the pre-existing stenosis in the
infarct related artery is frequently more severe in patients with
non-Q wave myocardial infarction (MI) than with Q wave MI. To
study this possibility, we evaluated 58 patients (21 with non-Q
wave MI, 37 with Q wave MI) who had undergone coronary
angiography 819;t813 days (mean±SD) prior to suffering MI.
Coronary angiography 12±10 days after MI was used to identify the
infarct related vessel. The most severe lesion in the infarct related
vessel at the initial angiogram (prior to infarct) was measured using
a computerized quantitative coronary angiographic system. The
infarct related artery frequently did not contain a high grade
stenosis at the fint angiogram. The most severe diameter stenosis
of the infarct-related artery prior to MI was 44±19% in the non-Q
MI and 47±20% in the Q wave MI (p-NS). Furthermore, only 7 of
21 (33%) patients with non-Q wave and IS of 58 (29%) patients
with Q wave MI initially had greater than 50'lb stenosis in the
infarct related vessel. The artery initially containing the most
severe stenosis was subsequently responsible for the MI in only 9
of 21 patients (43%) with non-Q wave and 13 of 37 patients (35%)
with Q wave MIs (p-NS). No relation existed between the initial
severity of the lesion, in the infarct vessel and the time to develop
MI in either group (r<O.OI, p-NS).
Conclusion: There is no difference in the coronary stenosis in
the infarct related artery that precedes Q and non-Q wave MI.
Both frequently develop from nonobstructive (s50% stenosis)
coronary artery lesions. It is difficult to predict the time or
location of a subsequent Q or non-Q MI from analysis of the fint
coronary angiogram.
ROLE OF ELECTROCARDIOGRAPHIC LOCATION ON DILTIAZEM
TREATMENT EFFECT IN NON-Q WAVE MYOCARDIAL INFARCTION:
MULTICENTER DILTIAZEM POST-INFARCTION TRIAL (MDPIT).
William E. Boden MD, FACC; Henry Greenberg MD, FACC;
Robert E. Kleiger MO, FACC; John Gillespie MD, FACC;
Edward M. Dwyer, Jr. MD, FACC; Ronald J. Krone MD, FACC;
MDPIT Research Group; Harper Hospital, Detroit, MI.
A prespecified subgroup analysis of MDPIT showed that
diltiazem (DTZ) therapy reduced first recurrent cardiac
events (RCE) (cardiac death or non fatal reinfarction),
the primary MDPIT endpoint, in 634 non-Q wave (NQ) MI pts
during a 25 + 8 mo followup. To assess whether DTZ
benefit was related to electrocardiographic (ECG) site
(anterior [ANT], inferior [INF], combined [ANT+INF+LAT])
or !IE! of (first [1st] acute vs. prior [P] MI + acute)
NQMI, we compared RCE at 1 yr of followup, using the Cox
model, among various subgroups of NQMI patients randomly
assigned t02DTZ or placebo (PLC). Event rates (1 yr) andp values (X :2-tail, Fisher Exact Test) based on type of
NQMI, of which 511/634 (81%) were 1st NQMI, revealed:
RCE/All NQM~ RCE/lst NQMI RCE/PMI+NQMI
PLC 51/338 (15%)p= 055 37/278 (13%)p_ 066 14/60 (23%)N S
DTZ 29/296 (10%)' 19/233 (8%) • 10/63 (16%) ••
For site of MI, 409/634 (65%) NQMI were localizable (LOC)
by ECG (ANT· 33%; INF - 41%; combined - 26%), while
225/634 (35%) NQMI were non-localizable (NL) by ECG ST/T
waves. Among specific ECG sUbgrou~s of LOC-NQMI, there
were no treatment differences by X ,but overall:
RCE/LOC-NQMI RCE/NL-NQMI RCE/NL-lstNQMI
PLC.32/219 (15%)N.S. 22/119 (18%)p_ 009 17/92 (18%)p_ 010
DTZ 22/190 (12%) 7/106 (7%)' 4/76 (5%) •
CONCLUSION: 1) Among all NQMI, DTZ was more beneficial in
1st NQMI pts; 2) the overall prevalence of non-
localizable NQMI was 35%; 3) in this subgroup, DTZ
resulted in a significant 3-fold decrease in 1 yr RCE,
i.rrespective of prior ECG evidence for MI.
LACK OF ASSOCIATION BETWEEN EARLY ADMINISTRATION
OF THROMBOLYTIC THERAPY AND THE DEVELOPMENT OF
NON-Q WAVE MYOCARDIAL INFARCTION.
Michael McKinney MD. David C Booth MD FACC. John Gurley
MD, Cindy Grines MD, Marcelo Branco MD, Anthony DeMaria
MD FACC. The University of Kentucky. Lexington, Ky.
Recent reports have suggested an association between early
reperlusion and development of non-Q wave myocardial
infarction (MI). To test this hypothesis, we evaluated data from
~ 08 patients enrolled in three thrombolysis protocols employing
tissue plasminogen activator. Entry criteria included ST segment
elevation of ~1 mm in two or more contiguous limb leads or ~ 2
mm in precordial leads on ECG, ~ 30 minutes chest pain
unrelieved by nitroglycerin, and no contraindications to lytic
therapy. Thirty patients (28%) were excluded due to failure to
achieve reperfusion (TIMI Flow 0-1) at the 90-minute
catheterization. 5 of whom (16%) had non-Q wave MI. Twenty
two of 78 recanalized patients (39%) sustained non Q-wave MI ,
while 56 (61 %) evolved Q-wave MI. Patients with non-Q wave
MI were significantly more likely to have a patent infarct vessel
than patients with Q-wave MI (p < .0001 by Chi square). Time
from pain onset to lytic drug administration did not differ between
non-Q and Q wave MI, 202±.78 min vs 201 ±. 64 min. Peak
creatine kinase was significantly less for non-Q compared to Q
wave MI, 1936 IU ±. 2903 vs 3010 ±. 2268, P < .05, as was
maximal ST elevation on the presenting electrocardiogram, 2.4 ±
1.3 mm vs 4.3 ±. 2.6, P < .0016. Conclusions: Compared to a
wave MI, non-Q wave MI is associated with less ST elevation
and myocardial necrosis. A patent ve~el is more likely to be
associated with non-Q wave MI. Evolution of non-Q wave MI is
largely independent of time of institution of thrombolytic therapy,
suggesting that a degree of spontaneous reperfusion may be
necessary to preclude evolution to Q wave MI.
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Conclusion: The significant Increase In global ejection fraction
was primarily due to a significant Improvement In the regional
myocardial function of the Infarct zone. The results suggest that
regional myocardial dysfunction. due to stunning of the
myocardium In patients with angina earty after a non.Q-wave MI.
may be Improved after successful PTCA.
RECOVERY OF REGIONAL MYOCARDIALFUNCTION AFTER SUCCESSFUL
CORONARY ANGIOPLASTY EARLY AFTER A NON.Q-WAVE MYOCARDIAL
INFARCTION
Harry SUryapranala. MO Kevin Beall, MRCP, Pim J. de Feyter, MO.
Ron van Oomburg. MSc. Patrick W. Serruys, MO. FACC.
Thoraxce/lter. University Hospital Rotterdam. The Netherlands.
Repeated Ischemic attacks earty after a non.Q-wave myocardial
infarction (MI) may lead to prolonged regional myocardial
dysfunction. The aim of this study was to determine whether In
patients with angina earty after a non.Q-wave MI, the regional
myocardial dysfunction due to stunning C'I the myocardium might
be Improved by coronary angioplasty (PTCA). The study population
consisted C'I 36 patients undergoing successful PTCA within 30
days after a non.Q-Wave MI. In whom sequential left ventricular
angiography C'I adequate quality was pertormed before the InItlaI
procedure and at a follow-up at 6 months.
Global and regional left ventricular function was studied from
the 30· right anterior oblique projection using an automated
hardwired endocardial contour detector. Regional contrIIUIon
to the global ejection fraction (CREF) was determined along a
system of 20 coordinates on the pattem C'I actual endocardial waI
motion. The systolic segmental volume change was considered as a
parameter of regional pump function.
global EF ('ll.)
Sum C'I abnormal CREF ('ll.)
Sum C'I normaJ CREF ('ll.)









A New Approach to In Vivo Measurement of Conorary
Blood Flow Utilizing High-Speed Coronary Angiography:
Steven E. Nissen MD FACC, John C. Gurley MD, David Haynie MD
Kevin Sublett MD, Joyce Evans, and Anthony N. DeMaria MD FACC
University of Kentucky and Lexington VA, Lexington, Ky.
Although previous efforts have attempted to measun: coronary blood
flow (CBF) from cineangiographic (cine) transit-time, this approach
has been hindered by limitations in framing rate and inability to pre-
cisely calculate distance. Therefore, we devised a technique which em-
ployed high-speed cine and a calibrated coronary guidewire to measun:
distance in order to calculate CBF and coronary flow reserve (CFR)
from transit-time. Anesthesized open-chest dogs were instrumented
with an ultrasonic flow probe and a pneumatic occluder on the Circum-
flex (LCx). A 0.018 inch guide wire with radiopaque markings at 1cm
intervals was placed in the Lex through as Fr catheter. Boluses of 1-3
ml contrast were injected and cine performed at 60 or 120 FPS under
basal conditions and after induction of reactive hyperemia by brief cor-
onary occlusion. Twenty-five injections were performed at varying
levels of CBF. Transit-time from a proximal to distal marker was deter-
mined by counting the number ofcine frames during passage of the
contrast wavefront The distance between markers was divided by the
transit-time to yield flow velocity in cms/sec. Cross-sectional area
(CSA) was calculated from the coronary diameter. CBF was computed
as CSA x flow velocity. CFR was calculated as the ratio of flow during
hyperemia divided by basal flow. Lex flow by ultrasonic probe varied
from 13.4 to 100.6 mlJmin. Flow velocity from 120 FPS cine ranged
from 7.4 to 22.2 cms/sec and calculated CBF varied from 21.8 to 84.2
mlJmin. There was a close correlation for measun:s of CBF by cine and
ultrasonic probe, r=O.8S. CFR by ultrasonic probe ranged from 1.7 to
7.S: 1 and was somewhat lower by cine, 1.2 to 3.86. The correlation
for CFR by flow probe and high-speed cine was close, r=O.82. Fram-
ing rates <120 FPS lacked sufficient temporal resolution to accurately
measun: CBF, r=O.47. Thus, these data demonstrate that high-speed
cine combined with a calibrated guidewire can accurately measun: CBF
and CFR from coronary transit-time in an animal model. Framing rates
below 120 FPS were inadequte to perfonn these calculations.
Monday, March 20,1989
10:30AM-12:00NOON, California Room C
Anaheim Convention Center
Digital Cardiovascular Imaging and Ultrafast CT
EFFECT OF X-RAY DOSE ON ACCURACY AND PRECISION OF
QUANTITATIVE DIGITAL CORONARY ANGIOGRAPHY
Kenneth G. Morris, MD, Jack T. Cusma, Ph.D., Thomas M.
Bashore, MD, Duke and VA Medical Centers, Durham, NC
The x-ray dose required for optimum quantitative digital
coronary angiography (QDCA) has significant importance to
digital imaging equipment design and selection. To assess
the effect of x-ray dose on the accuracy and precision of
QDCA, 12 coronary stenoses were created in 7 dogs using
plastiC clips of varying diameters. ECG gated QDCA were
acquired in a 5122 x 10 bit matrix and a 5" image inten-
sifier mode. Each QDCA was acquired at x-ray doses of 25,
50, 250 and 750 pH. The hearts were fixed in situ by per-
fusion with iced 10% formalin and the coronary arteries
were th~n casted by perfusion with RTV sUicone gel at
100 mm Hg. Each stenosis was then analyzed by projection
microscopy of cast cross-sections from stenotic and
reference segments. Regression coefficients (r) and stan-
dard errors (SEE) for reference and stenosis diameters
(RefD and StD) and % area stenosis for both geometric
(%GEO) and videodensitometric (%VID) techniques at each
of the x-ray doses are summarized below, r (SEE).
750 pH 250 pH 50 pH 25 pH
RefD .84(.171 .85(.17) .88(.15) .95(.10)
StD .75(.23) .75(.23) .79(.21) .82(.20)
%GEO .77(6.2) .66(12.6) .88(8.0) .86(8.6)
%VID .75(11.0) .73(11.5) .76(10.9) .80(10.1)
Precision was assessed by comparison of regression anal-
ysis of paired data from the 2 lower doses with those of
the 2 higher doses (r=.93, SEE 5.4 and r=.92, SEE 4.7
respecti vely). Despite obvious differences in subtracted
image quality, the accuracy and precision of QDCA with
higher x-ray doses was not superior to that with standard
cine doses. This suggests that a lObi t pixel depth is
nOt needed in the design of equipment for QDCA. Adequate
QDCA can be obtained at a lower x-ray dose.
EFFECT OF SUBCRITICAL STENOSIS ON CORONARY AND
MYOCARDIAL FLOW RESERVE IN TERRITORY SUPPLIED BY OTHER
NON-STENOTIC ARTERIES
Helmut Schuhlen M.D., Neal Eigler M.D., J Martin Pfaff
Ph.D., James Whiting Ph.D. Cedars-Sinai Medical Center,
Los Angeles, California
Coronary artery flow reserve (CFR) and regional
myocardial flow reserve (MFR) may be different if
stenosis enlarges the territory supplied by non-stenotic
arteries. An index of MFR may be the contrast media mean
transit time (distribution volume/flow) assuming that
the resting volume inversely reflects the vasodilatory
capacity of the microcirculation. MFR was calculated by
digital angiographic impulse response analysis of 73
left coronary injections in 11 open-chest dogs with
flowmeters on the left anterior descending and
circumflex arteries. Under resting conditions in the
absence of contralateral stenosis, regional MFR
correlated with CFR (MFR = 2.2 CFR + 2.4; r~O.7S).
Although subcritical contralateral stenosis (contra-
lateral CFR = I.B±O.S) did not affect ipsilateral
resting flow (24±4 to 24±3 ml/min; p-NS) or CFR (3.3±O.6
to 3.S±O.7; p-NS), MFR was reduced (II.3±2.3 to 9.4±3.0
min-I; p<O.02). Conclusions: (1) Myocardial perfusion
reserve refl ectscoronary flow reserve in the absence of
contralateral stenosis. (2) Coronary flow reserve is not
altered by contralateral stenosis. (3) Myocardial
perfus i on reserve is reduced by contra1atera1 stenosi s
because the distribution volume of the ipsilateral
artery increases.
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RIGHT VENTRICULAR MASS CAN BE ACCURATELY ASSESSED BY
ULTRAFAST COMPUTED TOMOGRAPHY. Zina D. Hajduczok, M.D.,
Robert M. Weiss, M.D. and Melvin L. Ksrcus, M.D., FACC;
Dept. of Med., CV CTR, U of Iowa, Iowa City, Iowa
There is currently no clinical approach to precisely
measure RV mass, We postulated that the radiologic mode
of ultrafast computed tomography (Cine CT) {3 mm thick
slices, 0.7 mm resolution] would allow sufficient
resolution to accurately estimate RV mass. Using this
radiologic mode we serially imaged the entire RV from
apex-to-base gated to end-diastole, and applied
Simpson's rule to calculate mass of the RV free wall.
Thirteen mongrel dogs (weight 6-30 kg) were studied.
The free wall maaa of the RV 'ranged from 12.0 to 47.5 g
and averaged 35.4 ± 3.7 g (x±SE). The correlation
between RV mass estimated by Cine CT and actual RV mass
was r a O.85, SEE-5.5g, slope-0.99, intercepta -l.8,
accuracy -±6%. Intra- and interobserver variability
(r-0.99 and r-0.98 respectively) was excellent. Seven
normal young healthy males were also studied. The free
wall mass of the RV ran&ed from 48.3 to 67.4 g and
averaged 54.6 ± 2.8 g (x±SE). The LV/RV ratio
averaged 3.2 ± 0.2/1. These results are in agreement
with human autopsy data in healthy males reporting mean
RV mass - 46 g and LV/RV ratio - 3.4/1. Because imaging
every 3 mm slice from apex-to-base requires two contrast
injections, we determined the accuracy of RV mass
measurements if only every fourth 3 mm slice with
interpolation was employed. RV mass meaaurements using
every slice or every fourth slice with interpolation
were nearly identical (dogs r-0.99, humans r-0.98).
Conclusions: High resolution CT imaging of every fourth
3 mm tomogram allows accurate measurements of RV mass
using only one contrast injection (40-60 cc), thus
permitting the study of progression and regression of RV
mass in patients with various diseases.
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NONINVASIVE LOCALIZATION OF ACCESSORY PATHWAYS
Joseph A Abbott M D FA C C , Elias H, Botvinick,M,D.,F.A.C.C.,
Elan D. Scheinman, J. William O'Connell, Melvin M.Scheinman,
M.D, F.A.C.C., University of California san Francisco. CA.
We attempted to localize accessory pathways (AP's), by
obtaining dynamic computerized tomograms (CT's) in 19 pts.
with pre-excitation and in 10 normals. Contrast enhanced
dynamic CT's were acquired when pts. were minimally (sinus
rhythm) and maximally pre-excitated (atrial pacing). CT images
were mathematically transformed using a first harmonic Fourier
phase analysis technique. Phase images were color encoded
allowing objective analysis of ventricular contraction patterns.
CT phase images were interpreted blindly by 2 experienced
readers. All 19 pts. also had AP's located during
eleetrophysiologic study by endocardial mapping (EM), and AP's
were verified in 16/19 at surgery (8) or by successful
transvenous ablation \8). AP's were left free wall in 9, left
paraseptal In 1, septal n 7, rl~ht free wall in 1. and both septal
and left fee wall in 1. In all 7 With septal AP's, initial contraction of
the septum was followed by near simultaneous contraction of
both ventricles and lastly by late rightward septal motion. In 7/9
with left lateral AP's, maximal pre-excitation consistently induced
a uniform CT pattern which originated in the lateral LV wall and
moved to the septum and finally to right ventricle. Two pIS. with
left lateral AP's were not correctly diagnosed. One was
misdiagnosed a dual pathway (left free wan and septal) while
the other had a major wall motion abnormality (due to infarction)
in the region of the AP. Discrepant findings also occurred in the
left paraseptal AP. AP location correlated with EM, in 16/19
(84%), and could be corroborated at surgery (8) or catheter
ablation (8) in 14/16 (88%). Cooclysions' We found excellent
agreement between C'r and EM (or surgery-ablative
techolques) for AP localization. This study documents a unique
non-Invasive method of AP localization. Inaccurate findings
occurred in 3 pts. with left sided pathways and 1/3 had an
associated with wall motion abnormality. A unique pattern of late
septal motion seen only in septal AP's is described.
Monday, March 20, 1989
10:30AM-12:00NOON, Santa Ana Room 1
Anaheim Convention Center
Atrial Naturetic Factor in Congestive Heart
Failure
ATRIAL NATRIURETIC FACTOR INHIBITION OF RENIN DURING
RENAL HYPOPERFUSION: ROLE FOR THE MACULA DENSA.
Patricia G. Cavero, M.D., Lawrence L. AarhUS, Wayne L.
Miller, M.D., Margaret M. Redfield, M.D., John C.
Burnett, Jr., M.D., Mayo Clinic, Rochester, Minnesota
We have reported that elevated endogenous atrial
natriuretic factor (ANF) inhibits increases in plasma
renin activity (PRA) in acute congestive heart failure
(CHF) despite decreases in renal perfusion pressure
(RPP). We tested the hypothesLs that the mechanism of
ANF inhibition of PRA during decreased RPP is linked to
ANF maintenance of sodium delivery from the proximal
tubule (PT) to the macula densa. Therefore, RPP was
decreased 15% by supra-renal aortic clamping in anesthe-
tized dogs with (n-4) and without (n-4) infusion of ANF
(10 ng/kg/min, i.v.) to mimic plasma concentrations in
acute CHF. Without ANF, decreased RPP increased PRA
from 2.04±0.60 to 4.07±0.69 ngAI/ml/hr (p<.OS). PRA
activation was associated with a decrease in sodium
delivery from the PT as determined by the fractional
excretion of lithium (FELi), a marker for PT sodium
reabsorption, during the initiation of decreased RPP
(36.0±4.1 to 30.9±3.8%, p<.OS). In contrast, physiologic
increases in plasma ANF (37.8±6.0 to 170.8±36.0 pg/ml,
p<.OS) prevented activation of PRA (3.24±1.4 to 4.65±1.3
ngAI/ml/hr, NS) and the decrease of sodium delivery to
the macula densa by maintaining sodium delivery from the
PT (FELi 40.1±7.2 to 42.6±18.0%, NS). These studies
support the. hypothesis that physiologic concentrations
of ANF may inhibit increases in proximal tubule sodium
reabsorption. ANF may, therefore, prevent activation of
PRA during reductions in RPP in acute CHF by maintaining
sodium delivery to the macula densa.







N-TERMINAL (1-25) ATRIAL NATRIURETIC FACTOR IN HUMANS
WITH CONGESTIVE HEART FAILURE: A MARKER FOR ENDOGENOUS
SECRETION.
Denise M. Heublein, Don W. Heser, Brooks S. Edwards, M.D.,
Margaret M. Redfield, M.D., Wayne L. Miller, M.D.,
Pai Kao, M.D., John C. Burnett, Jr., M.D., Mayo Clinic,
Rochester, Minnesota
Atrial natriuretic factor (ANF) may be co-secreted as
a biologically active C-terminal peptide (99-126) and a
non-biologically active N-terminal peptide (1-25). While
the C-terminal 99-126 peptide is established to be
increased in congestive heart failure (CHF) due to
increased cardiac filling pressures (CFP), it is unclear
if N-terminal peptide is elevated in parallel. Employing
specific RIAs with no cross-reactivity, we investigated
N-terminal (1-25, C-8 Bond-elut extraction) and C-
terminal (99-126, c-18 Bond-elut extration) fragments in
normals (n-59) and in subjects with CHF (n-11). Secondly,
in CHF, we determined the response of C- and N-terminal
ANF to a non-hypotensive dose of ANF with the objective
of determining if N-terminal 1-25 would parallel CFP and
thus serve as a marker for endogenous ANF secretion
during exogenous administration of biologically active
ANF. In normals, C-terminal (99-126) was 27±1 pg/ml and
N-terminal (1-25) was 556±28 pg/ml. In CHF, both forms
were comparably increased: C-terminal, 341±42 pg/ml, and
N-terminal, 8123±1377 pg/ml. Exogenous ANF significantly
increased C-terminal (99-126) to 483±62 pg/ml. N-
terminal (1-25) remained unchanged at 7737±1541 pg/ml as
did atrial pressures. These studies demonstrate eleva-
tion of both C- and N-terminal ANF in CHF. Further,
N-terminal ANF (1-25) parallels CFP in CHF during
exogenous ANF infusion and may thus serve as an impor-
tant marker for endogenous ANF secretion during
administration of biologically active ANF.
VENTRICULAR LEVELS OF THE ATRIAL NATRIURETIC FACTOR
AND OF ITS MESSENGER RIBONUCLEIC ACID AT THE TIME OF
HEART TRANSPLANTATION
Jean-Jacqyes Mercadjer M P Ph P . Marie-Alphonse Zonguo M.D.,
R~ml Urbain M.S., Yves L8p1ne M.D., Paul KI~ro de Rosbo M.D., Paul
D. Allen M.D., Michel Komajda M.D., Alain Carayon M.D., Kelty
Schwartz Ph.D. INSERM Unit~ 127, H6pital Lariboisi~re, Paris,
France.
Recent data have shown In animal models of heart failure and in the
falling human heart that, beside the atria, the ventricles could
contribute to the Increased plasma ANF levels reported during cardiac
failure. In order to precisely quantify the capacity of the falling LV to
contribute to this Increase, the levels of Atrial Natriuretic Factor
(ANF) and of its messenger ribonucleic acid (mRNA) were measured
In LV samples from 7 patients free of heart disease maintained under
life support whose hearts had been ultimately rejected for trans-
plantation (CI), and from 21 transplanted hearts (8 coronary artery
disease, CAD; 8 dilated cardiomyopathy, DC; 5 miscellanous). Ven-
tricular levels of ANF mRNA and of immunoreactive ANF (IR-ANF)
were assayed by dot blot hybridization with a synthetic oligonu-
cleotide probe and by radioimmunoassay, respectively. ANF mRNA
level in control ventricles was 1.5±1.4"1o (mean±SD) that in the
right atrium of one of the control hearts used as a standard. It In-
creased to 16.2±23.8"1o in the transplanted hearts (range: 1-103"10,
p<0.01 vs. CI). IR-ANF in control ventricles was 12.5±4.6 pg/mg of
wet tissue and Increased to 23.3±19.2 pg/mg in the transplanted
hearts (range: 4-98 pglmg, p<0.025 vs. CI). ANF mRNA and IR-ANF
levels did not differ between DC and CAD.
We conclYde' 1. that at the time of transplantation some ventricles
contain increased levels of ANF and ANF mRNA and thus might
contribute to increased plasma ANF levels; 2. that the ventricular
levels of ANF and ANF mRNA are highly variable from one heart to
another, ranging from normal to markedly elevated values Indicating
various levels of ventricular ANF gene recruitement at the stage of
heart transplantation.
DOES TOLERANCE TO ATRIAL NATRIURETIC FACTOR
(ANF) DEVELOP DURING 24 HOUR-INFUSION IN PA-
TIENTS WITH CONGESTIVE HEART FAILURE?
Thomas Munzel, M.D., Helmut Drexler, M.D., Jurg.n Holtz,
M.D., Thomas Meinertz, M.D., Hanjorg Just, M.D., Medizi-
nische Klinik III, University of Freiburg, West Germany
ANFmay improve cardiac performance in patients with
congestive heart failure by reducing pre- and afterload.
However, long-term effects may be limited by down-regu-
lation of responsiveness. Therefore, we studied the
effect of 20 to 24 hour-infusion of ANF in patients
with chronic heart failure (n=8) on hemodynamics. ANF
was titrated to produce a 30n reduction in pulmonary
wedge pressure (PCW) or 20n increase in CO. The maximal
titration dose fullfilling these criteria (average 0.08
jig/kg/min) was then maintained for 20 to 24 hours. Urine
volume, sodium and potassium were measured every four
hours and SUbsequently replaced. Initially, ANF signifi-
cantly reduced POW by 30±12n, total peripheral resistan-
ce (TPR) by 21±8n and increased CO by 17±6n (p<0.05).
During 24-hour infusion POW, CI , and TPR returned to-
wards preinfusion values despite the fact, that pharma-
cological plasma ANF levels were maintained during the
24 hour ANF-infusion. Patients with high filling pres-
sures at baseline (above 25 mm Hg) did not change hema-
tocrit in contrast to patients with low filling pressu-
res. After discontinuation of ANF infusion, two patients
experienced dramatic increases in heart rate, mean arte-
rial pressure and POW along with severe angina pectoris.
Conclusions: 1. The hemodynamic effects ofANF are dimi-
nished during 24 hour-infusion; 2. Extravasation of
fluid due to ANF may depend on preexisting filling pres-
sures; 3. The applicability for long-term intravenous
application might be hampered by the development of par-
tial tolerance and adverse effects during withdrawal.
LACK OF INOTROPIC EFFECf OF ATRIAL NATRIURETIC FACfOR IN
HUMANS VITB HEART FAILURE: DEKONSTRATION BY LEFT
VENTRICULAR END-SYSTOLIC PRESSURE-VOLUME ANALYSI~
Hare J. Semigran KD, Constantine N. Aroney KBBS,
G. ViIIiam Dec HD FACC, Howard C. Herrmann KD, Charles A.
Boucher KD FACC, Kichael A. Fifer KD FACC. Kassachusetts
General Hospital and Harvard Kedical School, Boston, KA
To assess the inotropic effect of atrial natriuretic
factor (ANF) independent of its effect on ventricular .
loading conditions, we employed LV end-systolic pressure-
volume (ESPV) analysis in 9 pts with heart failure (NYHA
class II-IV, LV ejection fraction 14±1% mean±SEH)
undergoing cardiac catheterization. The baseline LV ESPV
relation (solid line in figure) was constructed from
micromanometer LV pressure and simultaneous LV volume
(gated scan), before (0-0) and during (I-I) nitroprusside
infusion. During ANF infusion (6-6, dose 0.43±0.OS
~g/kg/min), mean arterial pressure (89±3 to 80±2 mmHg,
p<.Ol) and LVEDP (24±2





~ 60 during ANF infusion
:::> 40 (2.0±0.~ to 2.4±0.2,
en L/min/m p<. 01) . Seven
IDe: 20 I__~~~~~~~~_--. of nine pts had no shift0+ in the ESPV relation,
Q. 340 360 380 400 420 440 4600ne had a slight
UME ( I) rightward shift, one had\'OL m a slight leftward shift.
Conclusions: (1) ANF has no inotropic effect in humans
with heart failure. (2) ANF increases cardiac index by
afterload reduction.
lOA ABSTRACTS lACC Vol. 13, No.2
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V-ANF was Qbserved in 88% Qf DCM and 75% of RCM subjects.
V-ANF was assQciated with elevated LVEDP but not LVEDVI.
The data demQnstrate the high prevalence Qf V-ANF
expressiQn in humans with systQ1ic Qr diastQ1ic
dysfunctiQn and indicate that ventricular inductiQn of
ANF Qccurs independent Qf di1atatiQn.
We conclude that in HCIt, Q waves are 1- determined by
the ratio of the UAS to RV thickne•• , and 2- are absent
in the presence of RVH.
The detel"lllinant. for tha pre.ence of Q wave. in hyper-
trophic cardiomyopathy (HCIt) are uncl.ar. we correlated
localization of Q wave. in HCK with the site of riSht
and left ventricular hypertrophy (RVH, LVH) .. deter-
mined by echocardiolraphy. The .tudy sroup con.bts of
73 consecutive patients (pts) with HCIt, 39 male. and 3.
females, ased 17-67 years (..an .0) .. RVH was seen in
••1.; LVH was asytlllletrical in 561., sylD8trical in 351.,
and dbtal in 9t.. Localization of LVH did not differ
sisnificantly accordins to the presence of RVH. Q wave.
were present in 19 pts, overlapped between site., and
were located either inferiorly (13 pt.>, anteriorly (9
pts), or laterally (. pt.). In the•• pt., Q wave loca-
lization was correlated with the ratios of tha
thickn.ss of: upper and lower seSll8nts of the sept_,
posterior and fr•• wall of tha LV and of av.
AnalyziDl .0 cOlllbinations of LV and RV wall thickness,
by stepwise discriminant analy.is, Q wav.. were
silnificantly related to the ratio of the thickness of
the uppar anterior septWl (UAS) to the _ RV
(p<.OOl). The .ensitivity and specificity of UAS/RV for
localiziDl Q waves were respectively 79t. and 951..
Q WAVES III HYPERTROPHIC CAROIOKYOPAM: PRISEIiCIl AIID
LOCALIzATIOIiACCORDIIiG TO THE SITI AIID BlTIIIT OF RIGHT
AIID LIFT VEIITRICULAR HYPERTROPHY.
Robert L_q. lID, Shaulhan Dicki., Vic Aber, MSc,
AnS.lilta Kleinebenna, lID, Petro. WihoYannopulo., lID,
Willi.. J. KcKenna, lID. St-Geo£lea, London, n, and




IN THE HUMAN, EXPRESSION OF VENTRICULAR ANF IS
INDEPENDENT OF VENTRICULAR DILATATION.
BrQQks Edwards. M.D .• Peggy Puetz, Lester WQ1d,
Reeder, M.D., Richard RQdeheffer, M.D., JQhn C.
Jr, M.D., MaYQ Clinic, RQchester, Minnesota.
Under physiQlogic cQnditions, atrial natriuretic factor
(ANF) is 1Qca1ized Qn1y tQ atrial cardiocytes and
released by atrial stretch. We have reported the presence
Qf ventricular ANF (V-ANF) in states Qf cQngestive heart
failure with cardiac di1atatiQn. Therefore, we
hypQthesize that ventricular di1atatiQn is required for
the expression Qf V-ANF. 'The presence Qf
V-ANF was assessed by immunQhistQchemica1 analysis Qf
ventricular tissue Qbtained by endQmYQcardia1 biQpsy.
Studies were perfQrmed in 17 humans with dilated (DCM)
and 8 with restrictive (RCM) physiQ1Qgy. Additionally,
we determined plasma ANF, ejection fractiQn (EF), left
ventricular end diastQ1ic volume index (LVEDVI, nQrma1
<100 m1/mZ) and pressure (LVEDP nQrma1 <14 mmHg). Plasma
ANF was elevated but not different between the tWQ
grQups (151:39 vs 169:35 pg/m1 ns, NQrma1 range 20-77
pg/m1) (*p<.05)
EF% LVEDVIm1/m2 LVEDP mmHg
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The Electrocardiograph as a Diagnostic
Predictive Technology
RAND S WAVE AMPLITUDE CHANGES WITH ACUTE TRANSMURAL
ISCHEMIA.
ShlQmo CharJap MDn FA C C, Jacob Shani, M.b., FAC.C.,
Nancy Schulhoff, B.S.N., Alvin Greengart, M.D., F.A.C.C.,
Subbarao Mylavarapu, M.D.,Gerald Hollander, M.D., F.A.C.C.,
Brad Herman, M.D., Edgar Licbstein, M.D., F.A.C.C.
Maimonides Medical Center, SUNY, Health Science Center at
Brooklyn, Brooklyn, N.Y.
Increases in Rand S wave amplitudes (amp) have been proposed as
additional ECG marlrers ofmyocardial ischemia, but these changes
have been primarily described during exercise testing associated
with ST segment depression. PTCA serves as a model ofacute
transmural iscbemia with corresponding ST segment elevation
(STe). To investigate the partem of RandS wave amp cbanges
with transmural iscbemia, hemodynamic data and precordial ECG
leads V 1-V4 were recorded at baseline and during inflation in 31 pts
with LAD PTCA and STe of 21 rom in at least one precordial lead.
Results: The sum of R wave amp increased in 18 pts, was
unchanged in 8, and decreased in 4. The sum of S wave amp
decreased in 27 pts (including 2 with complete loss of S wave), was
unchanged in 3, and increased in 1. Mean R wave amp change was
+4.65 ±8.1 rom (range -6 to +28 rom), mean S wave amp change
was - 12.5 ± 9.2 (-35 to +3) and mean precordial STe was + 13.8
± 11.2 (+2 to +35). Absolute R wave amp change correlated
direcdy with STe ( p<.OO7), while S wave amp change correlated
inversely (pdlOI). Only changes in STe correlated with changes
in pulmonary wedge pressure(PW)( p<.OO6). Fifteen pts who
demonstrated both increases in R wave and decreases in S wave
amp did not differ from the rest in extent of LV dysfunction with
inflation (PW:24.6 vs 22.9 rom Hg, p=ns).
Conclusions' Decreases in S wave amplitude and less commonly,
increases in R wave amplitude are seen with diagnostic STe.
However, the independent value of these amplitude changes as
markers of myocardial ischemia appears to be limited.
100% SPECIFICITY IN LOCALIZING VENTRICULAR PREEXCITATION
SITE IN WPW SYNDROME WITH THE ECG.
Robert Frank M.D., Eric Chandon M.D., Guy FQntaine
M.D., FACC. Hapita1 Jean Rostand - Ivry - France.
The low specificity of the usual criteria to lQca1ize
the preexcitatiQn site has been reevaluated on 62 pts
with a single accessQry pathway (AP), submitted to epi-
cardial mapping: 28 left free wall (LL), 11 left (LPS)
and 11 right (RPS) posterQsepta1, 8 right lateral (RL)
and 4 right anterosepta1 AP (RAS). An a1gorythm was
built giving 100% specificity in this series using delta
wave and QRS orientatiQns in right precordial leads
(DV1,DV2,QV1,QV2,+,-,-) and in the frontal plane (AD,
AQ), combined with the presence of right or left ventri-
cular hypertrophy (RVH,LVH) Qr nQt (N). Each criteria
is applied to the remaining population:
1- QV1+ Qr QV1= and N: LL (19/28)
2- QV1+,QV1= and AD>-30° and AQ>-15°: LL (J/28) (LVH)
3- AO>-75°: LL (5/28)
4- AD>=60° and QV2- and LVH: LL (1/28) (LVH)
5- AD>-60° and AQ>-75° and N: RAS (1/4)
6- DV2-: RAS (2/4)
7- QV2+ and AD<--45°: LPS (8/11)
8- and DV1+: LPS (2/11)
g- and AQ<=-45° and RVH: LPS (1/11)
10- and AQ>-45°: RPS (J/11)
11- Heart Nand AQ<-Oo: RPS (J/11)
12- and AQ>Oo: RL (4/8)
13- AD>-30° and AQ>-JOo: RAS (1/4) (LVH)
14- AD<--60o: RPS (2/11) (LVH)
15- AQ<-·15° and LVH: RPS (J/11)
16- and RVH: RL (3/8)
17- AQ<-O° and AD<-Oo: RL (1/8) (LVH)
The high degree of specificity was demonstrated on
another series Qf 55 LL, 9 LPS, 17 RPS, 10 RL and 5 RAS
AP. Only 2 LPS were identified as LL, and 1 RPS as RL.
JACC Vol. 13, No.2
February 1989: lIA
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RIGHT VBWTRICULAR BLBCTROCARDIOGIAPBIC AI.OlMALITY I.
ORTHOTOPIC HEART T~SP~T PATIBItS
Jas.inder Sandhu MD, Bdward Curtiss MD, PACC, Villiaa
Follansbee, MD, FACC, Tony Zerbe, MD, Robert lorao., MD
Uni.er.ity of Pitt.burlh, Pitt.burlh, Penn.yl.ania
The pre-di.charae 12 lead BCG of 191 recent heart
tran.plant pt. were re.iewed. The pre.alence of ri,ht
bundle branch block Q1S aorphololY, either riabt bundle
branch block (lBBB, Q1S~120 as, n-20) or incoaplete ri,ht
bundle branch block (IRBBB, Q1S<120 as, n-67),
collecti.ely teraed RV BCG abnoraa1ity (IVlCGA), wa. 46%.
The Q1S duration in 11BBB pt. wa. lonler than in pt.
without RVBCGA (95ill •• 86i8 a.; p-O.OOO). Of the 64
RVBCGA pts who had an BCG on the· first po.t-tran.plant
day, 77% had already de.eloped lVECGA. RVBCGA pre.alence
was siMilar in pts with a prior definite epi.ode of
rejection (29/63) coapared to pts who definitely did not
ha.e rejection (31/70). For pt. with and without RVBCGA,
donor ischeaic tiae (172!43 .s 18l!42 ain, reapacti.ely)
and pre-operati.e pulaonary .ascular re.i.tance (2.1i1.7
.s 2.4+1.9 Vood unit., respecti.ely) were .iailar.
A ;ublroup of 46 consecuti.e pt. were studied with
rilht heart catheteri.ation and radionuclide an,iolraphy
pre-discharle. RVECGA (n-21) wa. only related to a
Ireater left anterior oblique anile raquired to best
separate the .entricle. (69±11 vs 59!9 delrees; paO.019),
and to the pre.ence of IV dy.function (13/21 •• 6/25 pt.;
p.0.009), both troa the radionuclide .tudy. Ixc1udinl the
7 RBBB pts in this .ublroup, QIS duration wa. lonler in
tho.e with IV dysfunction (97i12 .s 84i10 as; p-0.008).
The hilh pre.alence of RVECGA appear. to be related
to the posterior rotation of the transplanted heart in
the thorax resulting froa surlical technique, and to IV
dysfunction, the lattar probably account in. for the
lonler QRS duration seen with IRBBB.
IMPROVED ELECfROCARDIOGRAPIllC
IDENTIFICATION OF PATIENTS WI1H
THE LONG QT SYNDROME (LQTS)
Jesaia Benhorin M.D., Mario Merri M.S., Michela Alberti M.S.•
Emanuela LOCati M.D., W Jackson Hall Ph.D., Arthur J Moss
M.D., F.A.C.C., Peter J Schwanz M.D., F.A.C.C., University
of Rochester, Rochester, NY. and University of Milan, Milan,
Italy
The conventional ECG criterion for LQTS diagnosis is a
prolonged heart-rate corrected QT interval (QTc). In order to
Improve the ECG diagnostic accuracy of LQTS, logistic
regression models were applied to a database of 7 inde~ndent
ECG repolarization variables (REPV) measured on digitized
l2-lead ECG recordings of 315 normals and 37 LQTS pts
(QTc>O.44 sec), age 17-60 rears. REPV which independently
identified LQTS (p<o.OOl) mc1uded the heart-rate corrected S
offset to T max (SoTm) interval (T1), which is highly
correlated to the QTc, as well as the time to accumulate 25-75%
of total ~olarization area [TRA] (T2), %TRA accumulated at
T offset (T3), T wave area symmetry ratio (T4), and the
standard deviation of SoTm in leads V1-V6 (T5). The
performances of selected models in identifying pts with LQTS
In the combined study population were:
Variables Misclassification Rate (%)
in Model· LQTS Normal All Sens. Spec.
-..- ...-........-------------------------------------..._----- ...--
Tl 18.9 5.1 6.5 81 95
T2" T5 18.9 4.8 6.3 81 95
Tl - T5 5.4 3.8 4.0 95 96
• Measured in lead V5 except T5; cutoff probability = 0.2
Conclusion: The quantitation of five inde~ndent repolarization
variables significantly enhances the identification of pts with
I:.QTS.
ABNORMAL QT/QS2 RATIO AT REST AND EXERCISE IN
ROMANO-WARD LONG QT PATIENTS. NORMALIZED BY
BETA-BLOCKER 1HERAPY.
G Michael vincent M P Deepak Jaiswal M.D., Katherine Timothy
B.S.• LOS Hospital, University ofUtah. Salt Lake City. UT
The QTI<2S2 ratio has been reported to refIcct sympathetic cardiac tone
in normals (NIs). Romano-Ward Long QT syndrome (LQTS) patients
are thought to have an abnormality of right cardiac sympathetic effect.
Exercise (Elt) modifies sympathetic tone. We. therefore, proposed that
the QTIQS2. as a marker for sympathetic lone, would be different
during Ex in LQTS than in Nls. We compared QT/QS2 at rest and
during bicycle exercise in 5 familial LQTS, mean QTc 0.48±.04 sec.•
and 8 age matched Nls. mean QTc O.4O±.03. The subjects were on no
medications. A phonocardiogram and Eoo were simultaneously
recorded at a paper speed of 100 mm/s. Records were obtained while
unmedicated, after 1'1 Esrnolo1 (Es) and after Es plus Atropine (At). At
rest, LQTSQT/QS2 was longer than Nls. 1.16±O.14 vs 0.9St.04.
P<.OOS. With Ex, LQTS QT/QS2 increased from rest 1.16±.14 to Ex
l.S8±.Ol. a significantly greater increase than in Ms. O.9St.04 to
1.16±.13. P<.OOI. Nls QT shortened from 0.39±.03 to 0.31t.02.
and QS2 even more, O.41±'03 to 0.26±.04. and thus QTIQS2 ratio
increased (rest O.9S to Ex 1.16±.13). In LQTS. QS2 decreased.
OA1t.01 to O.26±.01. similar to Nls. but QT shortened less,
0.46±.06 to O.42±.OS. than in NIl, and thus QTIQS2 increased more
than Ms. IV Es abolished the exaggerated response of LQTS, so
QTIQS2 before and after Ex were similar to Ms, 1.l0±.10 to U)6±.07
vs O.99±.OS to l.03±.09. respectively. P=NS. Es and At produced
results similar to Es alone. These results support the concept of
abnonnal sympathetic tone in LQTS. manifested by abnonnal QTIQS2
at rest and Ex. and blocked by Es. The QT/QS2 ratio may serve as.a
diagnostic marker for LQTS and also as an indicator of therapeutic
efflClC)'.
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Coronary Risk Interventions
RISK FAcroRS AND KORTALITY IN THE KULTIPLE RISK FACTOR
INTERVENTION TRIAL AFTER 10. 5 YEARS OF FOum·UP.
The KRFIT Research Group
The MRFlT clinicel trial provides one of the largest
prospective analy.es of lipoproteins, other risk
factors and mortality. The baseline LDL cholesterol
was strongly related to CHD death at 10.5 years,
relative risk (RR) - 2.2 (highest quintile/lowest
quintile) but only weakly associated with total
mortality (RR - 1.3). Regression coefficients
corresponding to LDL cholesterol indicated that a
10 mg/dl lowering was associated with a 7.4% reduction
in CUD and a 2.3% reduction in all cause mortality.
The UDL cholesterol was inversely associated with CHD
death (RR for highest vs. ·lowest quintUe - 0.45) and
weakly associated with all cause mortality (RR - 0.89).
Regression coefficients corresponding to HDL
cholesterol indicated that a 5 mg/dl increase was
associated with an 11.2% reduction in CHD and a 2.1%
reduction in all cause mortality. Neither LDL or HDL
cholesterol was associated with death frOM stroke. The
body mass index (8MI) was inversely associated with CHD
death in both univariate and multivariate analyses
(P < 0.01). This inverse association was evident in
both normotensive and hypertensive men. Only cigarette
smoking was a significant risk factor for all major
causes of death (CHD, stroke and cancer) and total
mortality.
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EFFECT OF ESTROGEN REPLACEMENT AND CORONARY
ARTERY DISEASE ON SURVIVAL IN POSTMENOPAUSAL
WOMEN.
Jay M Sul!jyan M.D FA C Cn Roger Vander Zwaag, Ph.D., Jeff
P. Hughes M.A., Frank W. Kroetz M.D., Kodangudi B.
Ramanathan M.D. F.A.C.C., Edgar C. Schick M.D. F.A.C.C.,
David M. Mirvis M.D., University of Tennessee, Memphis, IN.
The relationship between postmenopausal estrogen use, coronary
stenosis and survival was examined in 2268 women undergoing
coronary angiography. The patients were selected for study if their
age was 55 years or older at the time of angiography or if they had
previously undergone bilateral oophorectory. Postmenopausal
estrogen use for 1178 cases of coronary artery disease (>70%
stenosis) and 644 cases of mild to moderate coronary artery disease
(35 to 69% stenosis) was compared with 446 control subjects (0%
stenosis) using life-table analysis. Over 10 years of follow-up, there
was no significant difference in survival among patients initially free
of coronary lesions on arteriography who had either never used (377)
or ever used (69) estrogens. Among patients with mild to moderate
coronary stenosis, 10 year survival of those who never used
estrogens was 85.0% and was 95.6% among 99 ever users (p<O.03).
Survival was 60.0% among those with >70% coronary stenosis who
never used estrogen and 97.0% among 70 ever users. Never users
were older (65 vs 59 yrs), had a lower proportion of cigarette
smokers (40% vs. 57.1%), a higher proportion of diabetics (21.7%
vs. 12.9%) and hyperlipidemics (58% vs 44%) and approximately
equal numbers of hypertensives (56.0% vs 54.3%). We conclude
that estrogen replacement after menopause prolongs survival when
coronary artery disease is present but has less effect in the absence of
coronary artery disease.
PRIOR BETA BLOCKER THERAPY IMPROVES 28 DAY POST
INFARCTION SURVIVAL.
SM Nidorf. R Parsons. PL Thompson. K Jamrozik. MST Hobbs.
Departments of Cardiovascular Medicine and Clinical
Epidemiology. Queen Elizabeth II Medical Centre. Perth.
Western Australia.
We evaluated the influence of the prior use of a Beta
Blocker (BB) on 28 day survival follOWing acute
myocardial infarction (AMI). All patients hospitalized
with a diagnosis of AMI in Perth between 1984-86 had
clinical data recorded prospectively in the MONICA
project. Of 1.824 patients. 23% were on a BB at the time
of AMI. Although this group was older (poCO.OOl) and more
likely to have a past history of AMI. angina and/or
hypertension (poCO.OOl) than patients not on a BB. 28 day
mortality was similar in both groups (13.0% vs 13.5%).
A logistic regression model used to adjust for factors
predictive of cardiac death at 28 days. including age.
past AMI and the development of pulmonary oedema or
cardiac arrhythmias. showed that patients on BBs had an
independent benefit (Relative Risk 0.45 p <0.001). This
beneficial effect was most evident in patients surviving
>24 hours (RR 0.33 p<.0.003) and in patients with a
past AMI (RR 0.50 p<O.OOl). Whilst the incidence of
heart block and ventricular fibrillation was similar in
both groups. the mean peak creatine kinase was lower in
the BB group (p<0.03). These data suggest that patients
taking a BB prior to the onset of AMI had a significant
early survival advantage.
I>IEmRY INmI<E OF SA'lURMm PM AND~L IN FARLY
QIIUHlOO: IMPLICATICH3 RR mEVENl'ICIl OF~IS
Katrina Holt. II> RD, Audrey Hay, HID RD, O:nttance Kies,
HID, Janet Wi!sal Ml' (ASCP), Bruce M::ManJs, MD, HID,
~, University of NebrasIca Medical center, Qnaha, NE.
Pri:amy preventiat, Degun in early d1i1dhood, may be the
best: approach to further reduce or delay llDXbidity am
DDrtality fran ClO%allIZY heart disease (am). J\s
participlmts in the statewide NebrasIca oiet-fleart study,
363 l-to-5 year-olds umerwent ClCIIprElhensive historical,
physical, am laboratory sb.dy. Macra'I1trients in the
diet, as jlXlged by a 24-hcur dietary recall am
food frecpeR::y cpesticnnaire, were analyzed with respect
to the blood lipid dlolesterol, triglycericles, HDL-C,
IDIt-C, am apolipoproteins A-I am B. CorrelatialS of
variable magnitude oca.u:Ted bet:toieen dietary cart:ent am
blood parameters. Notably, eatin] patterns were clearly
established by 1 year of age am intakes cxxrt:i.nued
0CI1St:ant through age 5 for both boys am girls. In
CXIJllBr:isa'1 with AHA dietary l"aXIimetdatialS, a majority
of the presdlool d1i1dren were ClClI'ISUIIIin1 excesses. Mean
dietazy intakes were higher in total fat (32-37%) than
prudent quiclel.ines, l~ in c:artxt1ydrate (49-54%),
similar in protein (14-16%), am were dlaracterized by a
very low PIS ratio (0.22-0.35). Mean dlolesterol intake
was 127-212 Dqlday, am 105-153 DqldaY/1,OOO kcal. By
wrrent quiclel.ines of the National QIolesterol aJucaticn
Program, presdlool Nebraskan girls by age two am .boys by
age five have a mean total plasma cholesterol of 170
Dqldl which is ocnsidered "high-risk". Farly d1i1dhood
dietary intakes of Nebraskan children~ unhealthy
intakes of fat, saturated fat, am dlolesterol, am these
are reflected in ''high-risk'' lipid profiles. M:xIificaj:icn
of undesirable natural histories of at:herosc1erotic
disease IIIJSt be cd:lressed beqi.nnirq in preschool.
ABSORPTION AND EFFECT ON PLATELET FUNCTION FROM SINGLE
DOSE CONCENTRATED FISH OIL COMPARED WITH TUNAFISH
DI Silverman, JA Ware, FM Sacks and RC Pasternak, FACC
Harvard-Thorndike Lab and Beth Israel Hospital, Boston MA.
Fish oil supplements(FOS) have recently been employed
as an alternative to fish for various indications. To
compare the absorption and effect on platelet aggregation
(PL-AGG) of n-3 fatty acids(n-3FA) in FOS vs. fish, we
gave a fatty meal containing n·3FA either as 12 gms
FOS(35' total n3-FA) or 182 gm tuna (10.9 gm total fat,
22' total n3-FA) to 8 subjects in a crossover trial and
measured plasma triglyceride(TR), eicosapentaenoic acid
(EPA) and docosshexaenoic acid(DHA) content in TR over
24hr. We also measured bleeding time (BT) and PL-AGG at 0
and 4 houl'fl. The graph shows absorption data for meal) EPA
levels over 24 hr during both EPAAISORPTION:FlSHon.VSTUNA
phase.s of the trial. Results are,AO
aimilar for DHA and TR. There
was no significant difference ,AI
between FOS and tuna in peak i
absorption or time to peak for r .."
EPA or DRA. PL-AGG to the ;'
thromboxane A2 mimetic U4666l9~
was inhibited at 4 hours after
FOS (69 vs 25mm/min, p<0.05') and
tuna (69 vs 45 mm/min, p<0.05). 0.00. 0 , I I. • • u (h
BT was mildly prolonged after FOS (4.4min at Ohr vs 5.3min
at 4hr, p.O.l). PL-AGG induced by epinephrine, ADP. or
collagen was mildly reduced after both FOS or TUNA. We
conclude l)EPA appears rapidly in plasma after a single
dose of n-3FA as either FO or TUNA, in eqUivalent amounts
at similar times. 2)This is associated with reducedPL-AGG
soon after ingestion. The decrease in PL-AGG from n3-FA
suggests that the anti-aggregatory effect of n3-FA on
platelets cannot be due solely to its incorporation into
megakaryocytes.
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tllB MAJORITY (6 PHYSICIANS USE DRUG TIIBIW'I FOR ISOLAtED
SYSTOLIC HYPERTENSION.
John B. Kostis. M.D., F.A.C.C., Mary B. Breckenridge,
Ph.D., UMDNJ-Robert Wood Johnson Medical School, New
Brunawick, New Jersey.
the advisability ot treating isolated systolic
hypertenaion (ISH) in the elderly is a matter ot debate.
We surveyed ourrent olinioal practioes tor ISH among
IIlI!IlIbers ot the Alll!lrican College of Physioians - New
Jersey Chapter and the New Jersey loade., ot Faaily
Physioians (N=1514). The response rate was 87J.
For ISH in patients aged 60 and older, 88J of the 1317
respondents use drug therapy, with small variations by
speoialty, type ot praotioe, and physician's age. the
first line drug is a diuretic tor 65J, and a beta blooker
tor 11J. The most co~n second line drug ohoioes are a
beta blocker (28J), a central alpha agonist (19J), and a
diuretic (18J). the lowest systolic pressure considered
tor drug use varied more within specialties than between
specialties.
The patient's age appears to enter strongly into
decisiona on drug use. While 811J ot those who use drug
therapy tor ISH conaider doing so at systolic pressures
ot 170 or less tor persons aged 60-69, only 76J would do
so tor persons aged 70-79, and 55J tor those aged 80+.
llthough proot ot a benefioial ettect on morbidity and
-ertality is not available, a majority ot physicians
surveyed use pharIBcologic therapy, usually diuretics,
tor ISH.
Monday, March 20, 1989
2:00PM-3:30PM, Anaheim Room
Anaheim Convention Center
Peripheral Vascular Disease: Technics for
Revascularization
GUIDED PERCUTANEOUS PULSED LASER ANGIOPLASTY : RESULTS
AND FOLLOW-UP.
~He~rub~e~r-.lt,::-~J7' ---"GilleiL!s~c~h!!wul.IJD'lojd ...=MIl.oJ'DIL.':".......~F,....D.A....C~.C...... , JeaD-Luc
Dubols-RaDd~. M.D., G~rard Polrot, M.D., Georges
Boussl gDac , M.D., UDlverslty Hospital HeDrl MODdor,
Cr~tell, FraDce.
From July 1987 to July 1988, laser aDgloplasty (LA) was
performed ID 31 patleDts (pts) wIth total occlusloDs of
the superficial femoral artery or the iliac artery (4
to 25cm leDgth). The system (MCM Smart Laser ~ )
jDcluded: 1/ a treatmeDt pulsed dye laser operatlDg at
480 om, 15-49 mJ/pulse. 2 sec: 2/ a diagDostlc HeCd
laser operating at 325 Dm, 5 mW, 50 msec ; 3/ a siDgle
500 ~m or 200 ~m optical fiber that traDsmltted
excitatioD light, fluoresceDce emlssioD from the tissue
iD cODtact with the distal flbertlp aDd the tissue
ablatioD dye laser. The treatmeDt laser was
cODtiDuously guided by a computerIzed logic system
which allowed the treatmeDt laser Ilghl to be emitted
oDly OD atheroma targets. The procedure was completed
by ballooD aDgioplasty. Laser recaDallzatioD was
obtalDed ID 28 patleDts. The three failures were due to
iDablllty to mechaDlcally direct the laser beam toward
the occlusioD. ID 1 patleDt subsequeDt ballooD
aDgloplasty could Dot be performed. There were
perforatioDs aDd dissectloDs due to mechaDicai
maDlpulatloDs of the guidewire or the fiber with DO
appareDt cliDical sequelae. Follow-up was assessed by
Doppler (28 pts) aDd aDglograms (11 pts). Five pts had
short-term reocclusloDS which were successfully treated
by thrombolysIs. At 1 to 12 mODths (meaD 5.8)
follow-up, pateDcy was demoDstrated ID 23 patleDts.
CODclusloDS: 1/ pulsed dye laser is effective ID
recaDallzlDg 10Dg occlusloDS, 2/ UDder spectroscopic
guldaDce, laser aDgloplasty Is safe, 3/ techDlcal
failures may be avoided by Improved deflectable
catheters, 4/ the rate of pateDcy (82 %) Is acceptable,
cODslderlDg the severity of lesloDs.
ABSTRACTS
FACTORS ASSOCIATED WITH RESTENOSIS FOLLOWING
SUCCESSFUL PERIPHERAL ATRERI!X:TOMY.
~ Selmon, MD; Gregory Robertson, MO; TOlIDaki
Hinohara, MO, FACC; Neil White, MO; Michael Rowe, MO;
John Simpson, MD, FACC; Sequoia Hospital, Redwood
City, CA.
Periphera 1 a therec tomy (PA) has been shown to be an
effective procedure for the treat..,nt of occlusive
peripheral vascular disease. Ibwever, restenosis (RS)
in th e c onv ale sc ent phese has been ob se rv ed. The
purpose of this study' is to evaluate RS following
successful PA am identify the factors associated with
RS. One humred am seven patients (pts) umerwent
successful PA, Six IIDnth follow up IoillS available for
90 pts (angiographic in 51, Doppler in 32, and
clinical symptotlll in 7). Clinical RS was observed in
28 (angiographic evidence of RS in 25, Doppler
evidence of RS in 3). Univariate analyses were
performed on the following variables: lesion location,
pre PA stenosis (total or subtotal stenosis), post PA
s tenos is (res idua 1 s tenos is < 0 r ~ 30%), les ion le ng th
( < or ~4 .Ocm), diabetes, smoking, hypertension,
hyperlipidemia, sex, age. Factors associated with RS
were residual stenosis >30% (p"0.005) and lesion
length ,L4.0em (p" 0.05). -RS was observed in 47% of
PR with >30% residual stenosis but 23% of PR with <30%
residual-stenosis. RS was 73% in lesions> 4.0 cm am
24% in lesions < 4 cm. RS was 16% in lesions < 4 em
which had < 30% residual stenosis. In conclusion, RS
occurs following successful PA, however, the incidence
of RS was significantly lower when less than 30%
residual angiographic stenosis was achieved. This
preliminary report suggests that the goal of the PA
procedure should be aimed at aChieving the least
residual stenosis to prevent RS.
COHBIIlED LASn/TIIDIW. UCAJIAl,IZATION OP PU.IPIIUAL
Al.TnY OCCLUSIOJ(S.
David C. Cumberland H.D., Anna H. Belli H.D .• Richard
K. Hyler H.D .• F.A.C.C., Simon H. Stertzer H.D.,
P.A.C.C., John C. Crew H.D., Northern General Hospital,
Sheffield, England and San Francisco Heart Institute,
Seton Hedical Center, Daly City, CA
The "hot tip" probe, a purely thermal device powered by
laser energy, has been found to be a useful adjunct to
balloon angioplasty (BA) by recanalizing peripheral
arterial occlusions not passable with a conventional
guidewire (and therefore, impossible to treat with BA
alone). Success has been achieved in 56% of such cases
and there is a patency rate of 73% at one year.
A new device, the Spectraprobe PLR, has a distal
portal that allows 20% of the laser light to escape;
thus, this device combines both thermal and direct
laser energy. A 2.5 mm diameter tip Spectraprobe was
used to traverse 32 peripheral artery occlusions: 9
iliac occlusions of 5-7 (mean 5.8) cm long and 23
femoral/popliteal occlusions 5-32 (mean 14) cm long.
25 of these 32 (78%) were successful. There were two
minor perforations, both without sequelae. The mean
luminal diameter channel produce~by this device was
2.45 mm ± 0.75 (SD), which is 50% larger than that
achieved with the thermal probe alone.
The combination of direct laser and thermal energy
appears to be more effective and provides a larger
channel than by thermal means alone. Greater tissue
ablation may explain these results. The Spectraprobe
may be an important device for improving long-term
patency of occlusions ~ollowing peripheral ballooD
angiopiasty.
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RADIOFREQUENCY THERMAL ANGIOPLASTY FOR THE TREATMENT OF
PERIPHERAL VASCULAR OCCLUSIVE DISEASE: PRELIMINARY
RESULTS OF ACLINICAL TRIAL
Warren Grundfest, M,D.. Frank Litvack, M.D" F,A,C,C"
Ann Hickey, M.D" Louis Adler, M.D" Robert Foran, M,D.,
Phillip Levin, M,D" Jacob Segalowitz, M.D" Lisa
Hestrin, M,P.H., James Forrester, M,D., F.A,C,C., Cedars-
Sinai Medical Center, Los Angeles, California.
We report the first results of radio frequency (RF)
thermal angioplasty for the treatment of peripheral
vascular occlusive disease in 12 patients, mean age 70.3
yrs" (range 53-79). All were candidates for peri'pheral
bypass surgery. There were 13 lesions in the SFA and
proximal popliteal distribution: 8 occlusions with mean
length of 12 em (range 4-17 em), ankle brachial index
(ABI) mean 0.47 (range 0.38-0.91) and 5 stenoses, 87%
mean diameter, mean ABI 0,70 (range 0.35-0.94). We used a
2.3 mm gold tipped RF thermal angioplasty catheter at 20
watts. Primary recanalization followed by balloon
angioplasty was achieved in 9 of 12 (75%) with residual
stenosis less than 20% in successful cases. The 3
failures occurred in heavily calcified vessels; in two
the diameter was less than 4 mm. There were no
complications secondary to the RF thermal angioplasty.
Post-procedure mean ABI for occlusions was 1.05 (range
0.81-1.40): a mean improvement of 0.47, For stenoses ASI
was 0.96 (range 0.87-1.05): mean improvement of 0.24. All
successful patients became asymptomatic and remained so
at mean of 1 month follow up. In unsuccessful cases 1 of
the 3 patients went on to elective bypass surgery.
Conclusion: In selected cases, radiofrequency thermal
angioplasty is effective in recanalizing occluded
peripheral vessels, providing a practical, low cost
alternative to laser thermal angioplasty or bypass
surgery.
CONTRASTING EFFECTS OF CONTINUOUS WAVE AND PULSED LASER
IRRADIATION ON VASOREACTIVITY OF ATHEROSCLEROTIC
VESSELS IN VITRO
Anthqny J Rgogippo. B A , Dov Gal, D.V.M., Stephen T.
DeJesus, B.A., Saurabh K. Chokshi, M.D., Richard H.
Clarke, Ph.D., Jeffrey M. Isner, M.D., Tufts University
School of Medicine, Boston, MA
Previous studies from our laboratory have demonstrated
that continuous wave (CW) and pulsed (P) laser (L)
irradiation (I) have qualitatively different effects on
the vasomotor reactivity of non-atherosclerotic
vascular segments: heating associated with CW LI
produces contraction (CON); lack of similar heating
with P LI produces relaxation (RELAX). Because response
of atherosclerotic (Ath) segments is more relevant to
use of LI for revascularization, we studied effects of
CW vs. P LIon rings of Ath aorta from rabbits fed an
Ath diet pre- and post-balloon endothelial (Endo)
denudation. Rings were mounted in Krebs bicarbonate
buffer (95% 02-5% C02' pH-7.4, 370 C); ring tension and
temperature (temp) were simultaneously recorded during
fiber-mediated CW or P LI. CW LI (argon (488, 514 nml
20-sec exposures, n-57) at all powers >1.0 watt
consistently produced Endo-independent contraction
(807±.140mg (m±.SEM)) associated with increased ring
temp up to 60 0 C. In contrast, P LI (excimer {351nm},
10-100 Hz, 20-60-sec exposures, n-133) in no case
caused contraction, but instead produced Endo-
independent relaxation (360mg±23) at all fluences (up
to 5 J/cm2); ring temp never exceeded 100 C. These
results are neither qualitatively nor quantitatively
different from responses to CW and P LI reported
previously using non-Ath vessels. Cgoclu3]PPS: CW and P
LI produce directionally opposite changes in vascular
tone in Ath, as well as normal, vessels. Lack 0 f
increased vascular tone in Ath segments treated with P
LI suggests that clinical applications of P LI may be
less likely to provoke spasm.
PERCUTANEOUS LASER ANGIOPLASTY OF PERIPHERAL ATHERO-
SCLEROTIC OBSTRUCTIONS BY THE UNICORN-CAP (Tm) PROBE
SYSTEM: A MULTICENTER STUDY.
Garrett Lee, M.D., F.A.C.C., Ronald R. Masden, M.D.,
F.A.C.C., Daniel Scharf, M.D., F.A.C.C., Jeffrey A. Weiss,
M.D., Robert L. Falk, M.D., Gerald D. Temes, M.D., George
E. Pool, Hal Coons, M.D, Agustin J. Argenal, M.D.,
F.A.C.C., David Wixson, M.D., Dean T. Mason, M.D.,
F.A.C.C., Northern California Heart and Lung Institute,
Concord, California.
Since arterial perforation is the major limitation of
current laser delivery systems, we studied a new laser
probe (Unicorn-Cap, Xintec Corporation, Oakland, CA) to
percutaneously recanalize peripheral arteries in 26
patients (13 males, 13 females, age range 55-85 years).
The catheter comprises a leading steerable 0.035" coaxial
guidewire attached to the metal cap which is connected to
a portable Nd:YAG laser system (Model XT-IO, Xintec
Corporation). Thirty-three atherosclerotic lesions (16
stenoses and 17 occlusions <10 em) in iliac, femoral or
popliteal vessels were successfully recanalized without
complications (no perforations, spasm or significant
adhesiveness). Laser therapy was the sole intervention
in three; the remainder were followed by balloon angio-
plasty. Symptom relief and/or leg salvage was achieved
with improved ankle/arm index. Thus this novel coaxial-
guided laser probe system provides effective and safe





Thrombolytic Therapy in.Acute Coronary
Syndromes
ANGIOSCOPIC ENDOTHELIAL MACROPATHOLOGY IN PATIENTS WITH
ACUTE CORONARY SYNDROMES.
Kyoichi Mizuno M.D., Akira Miyamoto M.D., Kimio Satomura
M.D., Toshio Shibuya M.D., Yasuhiro Okamoto M.D.,
Hidetaka Seguchi M.D., Kazushige Isojima M.D., Akira
Kurita M.D., Tsunenori Arai Ph.D., Haruo Nakamura M.D.
National Defense Medical College, Saitama, Japan.
To investigate the pathophysiology of acute coronary
syndromes including unstable angina and acute myocardial
infarction, we performed percutaneous transluminal
coronary angioscopy in 63 patients [acute «6h)
myocardial infarction (AMI) 9, unstable angina 7, recent
(3 days to 4 weeks) myocardial infarction (RMI) 13,
stable angina 13, old (>4 weeks) myocardial infarction
(OMI) 211 using a new angioscope which has an inflatable
balloon and angulation mechanism. Good visualization was
obtained in 50 patients. The main observations were a1'l
follows.
Thrombi Ragged surface Yellow plaque
AMI 100% 03%) (17%)
Unstable angina 50% (50%) (25%)
RMI 13% 88% 75%
Stable angina 0% 17% 25%
OMI 0% 0% 10%
( ): exact number might be masked by overlying thrombi
White or mixed white and red thrombi were observed in
cases of acute coronary syndromes. NecrOSis-ridden
matured xanthomatous ulcerated plaque with or without-
tipped thrombi, ragged, irregular surface were observed
in patients with acute coronary syndromes and those
within one month after AMI attack. Conclusions: (1)
Thrombi overlying a rupture in the lining of the plaque
may playa major role in acute coronary syndromes. (;2)
Lipid-rich gruel atheroma and thinning fibrous caps may
precede its rupture. 0) Angioscopy may provide a new
understanding of endothelial pathology in living man.
lACC Vol. 13, No.2
February 1989:J5A
PATIENTS wrrn ST SEGMENT DEVIATION AND UNSTABLE
ANGINA HAVE CONSISTENT INCREASES IN TIlROMBIN
ACTIVITY.
Paul R. Eisenberg M.D. F.A.C.C., Joseph L. Kenzora M.D.
F.A.C.C., Colleen Schaab, R.N. and Allan S. Jaffe M.D. F.A.C.C.,
Washington University, SI. Louis MO.
Reversible ST segment and/or T wave changes in patients with unstable
angina are associated with increased cardiovascular morbidity. Because
it is felt that many of these patients harbor nonocclusive coronary
thrombi, administration of antithrombotic and/or fibrinolytic agents has
been advocated. However, prospective noninvasive criteria for
identifying patients with thrombi are not available. To define the
incidence of thrombosis and the sensitivity and specificity of specific
electrocardiographic (ECG) patterns for its detection in patients with
unstable angina, we measured plasma levels of fibrinopeptide A (FPA),
a sensitive marker of thrombin activity in 26 patients with unstable
ischemic symptoms and ECG changes. FPA was measured by
radioimmunoassay from samples obtained a mean of9.1±1.4 (SE) hrs
after chest pain. Elevated FPA (~ 2.0 ng/mI) occurred in 65% (17/26)
of patients. FPA was normal in 9 patients and moderately elevated in 5
others (SS ng/mI) with T wave changes alone (mean = 2.3±O.3 ng/mI,
range = 2.0-4.6 ng/mI). In contrast, all 12 patients with reversible ST
segment shifts had elevations of FPA (mean = 19.0±1O.0 ng/mI, p<
0.01 compared to those with T wave changes only). In 9 of 12,
elevations were greater than the maximal elevation observed in patients
with T wave changes alone. Four of the five patients (including the 2
with ST segment elevation) with marked elevations of FPA (~ 8.0
ng/mI) had findings consistent with thrombus by angiography. Thus,
evidence of active thrombosis is common in patients with unstable
angina. In contrast to patients with T wave changes and unstable angina
in whom increased thrombin activity is infrequent, and if present is at
most modes!, patients with unstable angina and ST segment deviation
manifest consistent and frequently marked increases in thrombin
activity. Accordingly, they are more suitable for treatment with
anticoagulants and/or fibrinolytic agents.
INABILITY OF THROMBOSIS RELATED MARKERS TO DISTINGUISH
BETWEEN UNSTABLE AND STABLE ANGINA PECTORIS.
Dimitrios Alexopoulos MD, David Stump MD, Pramod Deshmukh
MD, Susan Borrico BS, Richard Gorlin MD, FACC, Valentin
Fuster MD, FACC, John A. Ambrose MD, FACC. The Mount
Sinai Medical Center, New York, NY
Angiographic and pathologic data indicate a role for
thrombus formation in the pathogenesis of unstable angina
(USAP). The value of thrombosis related markers in
peripheral blood like fibrin D-dimer and plasminogen
activator inhibitor (PAl) -an index of endogenous
fibrinolytic activity- in distinguishing between USAP and
stable angina pectoris (SAP) is unclear. We prospectively
analyzed D-dimer (ELISA, ~g/ml) and PAl (enzymatic assay
using chromogenic substrate, IU/ml) in the peripheral
blood of 53 pts (34 with USAP and 19 with SAP). For each
patient with USAP a baseline sample prior to any heparin
treatment was drawn 0 to 6 hrs after rest pain (median
2.5) and 24-48 hrs later. Samples were analyzed blindly
to the clinical data (SAP vs USAP, recurrent chest pain
within 72 hrs) or coronary angiographic findings.
RESULTS: (median, range)
SAP USAP(baseline) USAP(24-48hrs)
D-dimer .05(.03-.39) .07(.03-.30) .05(.02-.33)
PAl 5(3.9-11) 5.9(3.9-40) 5.4(3.9-11)
There were no significant differences between groups.
Baseline samples in pts with USAP drawn 0 to 1 hour after
rest pain were similar to samples 4 to 6 hours after rest
pain. Coronary anatomy (acute lesions or presence of
thrombus) and recurrent chest pain (n-18 of 34) could not
be differentiated by the studied markers or their change
over 24-48 hrs. Thus, peripheral markers of thrombosis
appear unable to distinguish USAP from SAP. Although
coronary thrombus formation is important in USAP, the
amount may be too small for detection in the periphery.
ABSTRACTS
EFFECTS OF UROKINASE AND HEPARIN ON LESION
GEOMETRY IN UNSTABLE ANGINA.
Mara Sansa M.D., Carmelo Cernigliaro M.D.,Ignazio Simonetti M.D.,
Ospedale Maggiore, Novara, Italy, and University of Pisa, Italy.
The effects of urokinase (UK) and heparin (H) on the geometry of a
<100% ischemia-producing lesion were investigated in 43 PIS with
unstable angina (UA) on maximal medical therapy with Ca-blockers, B-
blockers and nitrateS. After baseline coronary angiography, PIS were
randomized to UK (10' U bolus followed by H infusion at 800 to 1200
U/hr), H alone (10 3 U bolus + 800 to 1200U/hr infusion, or placebo (P).
Angiography was repeated at 1hrand 8 days oftreatment. EightPts were
excluded after the fIrSt study (1 in the H group and 7 in the P group)
because of non Q-wave MI and/or need for emergency
revascularization. In the remaining 3S PIS, lesion minimum cross-
sectional area (MCSA; BrownIDodge method) was blindly measured
on orthogonal pairs of angiograms taken in the same view at baseline,
1 hr and 8 days of treatment. Changes in MCSA (mm2) were
(mean±SEM; *=p<O.OS vs Control):
Control 1 hr • (%) 8 days - (%)
UK(n=12) .84±'16 .94±.17(l6±6)* 1.0±.18(25±12)*
H (n=12) .64±.14 .66±.13 (6±6) .79±.17 (27±8)*
P (n... l1) .65±.15 .69±.16 ( 6±6) .71±.20 (7±15)
Lesion MCSA in the excluded PIS (.70±.15) was not different from that
measured in the included ones. In conclusion: 1) either UK or H can
improve the geometry of the ischemia-producing lesion in UA; 2) UK
is provided by a faster effect than H; 3) both drugs provide a better
prognosis for UA than standard medical therapy.
THROMBOLYTIC THERAPY IN UNSTABLE ANGINA
AND NON Q-WAVE MYOCARDIAL INFARCTION: A RAN-
DOMIZED TRIAL OF UROKINASE VERSUS ASPIRIN.
Theodore L Schreiber MD.. F A C C: Gregory Macina M.D.,
F.A.C.C.; Paul Bunnelt, B.S.; Ann McNulty, R.N.; David H.
Milter MD., F.A.C.C.; Richard B. Devereux MD., F.A.C.C.;
Barbara Gerling, MD.; Richard Tenney, MD., F.A.C.C.; Ben-
jamin Zola MD., Cornelt Medical Coltege, New York, NY
The pivotal role of thrombosis in unstable angina (UA) and
non Q-wave myocardial infarction has recenlly been estab-
lished. To assess whelher thrombolytic therapy is superior 10
conventional aspirin therapy (ASA) in arresting progression to
recurrent ischemic endpoints -- intractable ischemia (II) or
transmural infarction (MI) -- 25 patients presenting with a
typical clinical history of UA, and abnormal ECGs with sub-
endocardial ischemia, were randomized to receive either
urokinase (UK) 3.0 mill U/30 min intravenouslyfoltowed by
heparin (12 pts), or ASA 325 mg. daily (13 pts). Morphologic
severity of the culprit tesion was graded by coronary
arteriography at 24-48 hrs: 4+, definite thrombus; 3+, ulcera-
tion/probable thrombus; 2+, ulceration/possible thrombus; 1+,
ulceration alone; and 0, chronic tesion. AI 7 days. 8/13 ASA
piS vs 3/12 UK pts (62% vs 25%, p s .07) had progressed 10 a
primary ischemic endpoint (ASA, 5 Mis, 3 II vs UK, one
death, 2 II). Mean morphologic severily score was equal in
both groups (3+). We conclude thai UK appears superior to
ASA in arresting progression of UA to major ischemic end-
points without major amelioration of culprit lesion morphol-
ogy. Large scale randomized trials to assess this therapy are
warranted.
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INTERMIlTENT UROKINASE THERAPY AS A NEW
STRATEGY CONCEPT IN UNTRACTABLE ANGINA PECTORIS
Matthias Leschke M.D.. Helmut HOffken M.D., Martin Vogt
M.D., Wolfgang Motz M.D., Bodo E. Strauer M.D. F.A.C.C.
Dept. of Medicine, University of DUsseldorf, W. Germany
Patients with severe diffuse coronary artery disease can
benefit from an optimized blood fluidity. Accordingly, 16
patients with end-stage coronary artery disease and angina
pectoris (AP) refractory to conventional medical treatment
(nitrates, calciumchannel-blockers, betablockers) were
treated with 250 000-500 000 Urokinase (UK)/day for 4
months. UK-therapy aimed at an improvement in blood fluidity
and myocardial microcirculation due to fibrinogenolysis.
Under UK the fibrinogen level (345:1:98 mg/dl) decreased to 201±
59mg/dl (p<O.OOI). Plasma viscosity and erythrocyte aggregation
decreased from 1.42±0.08 to 1.31:1:0.06 m Pas (p<O.OOI) and from
14.6:1:4.4 to 12.3:1:3.6 (p<O.OJ) ,respectively. As early as after
3 weeks of therapy the daily episodes of AP were reduced
(1.9:1:0.6 vs. rj±1.4, p<0.02) with a consecutively reduced
nitrate consumption. The maximum working capacity (bicycle)
increased significantly from 15104±6648 Joule to 24010:1:13790
Joule by 59%. In 10 of 12 patients exercise thallium perfusion
scan improved. Cardiac index sligthly rose from 2.6:1:0.4 to 2.9
±OOS l/min/m2 and ejection fraction from 45.8:1:19.2% to 50.8±16.8%.
Conclusions' (i) Patients with end-stage coronary artery disease
can show symptomatic improvement under a chronic urokinase
therapy. (ii) The increased exercise tolerance is induced by
fibrinogenolysis and improved blood fluidity as indicated by
decreased plasma viscosity and erythrocyte aggregation. (iii)
Due to therapeutical increase of myocardial perfusion left
ventricular pump function is slightly improved.
Monday, March 20,1989
2:00PM-3:30PM, California Pavilion D
Anaheim Hilton Hotel
Balloon Valvuloplasty in Aortic Stenosis
FOLLOW-UP OF BALLOON AORTIC VALVULOPlASTY: RESULTS IN 192
CASES.
Richard E. Kuntz MD. Bradley H. Leonard, MD, Raymond E.
Erny, MD, Hare J. Levine, MD, Patricia C. Come, MD, FACC,
Daniel J. Diver, MD, Robert D. Safian, MD, William
Grossman, MD, FACC, Raymond G. McKay, MD. Harvard-
Thorndike Laboratory, Beth Israel Hospital, Boston, MA.
Percutaneous balloon aortic valvuloplasty (BAV) for the
treatment of calcific aortic stenosis (AS) was performed
in 192 patients (pts) with a mean age of 77 ye~rs (range
35-93), resulting in the reduction of the peak aortic
valve gradient from 7l±28 to 36±14 (mm Hg*) , improvement
of the aortic valve area (AVA) from .6+.2 to .9+.3
(cm'*), and improvement of the cardiac- output from
4.5+1.4 to 4.9+1.5 (L/min*). Post-BAV, but prior to
hospital discharge, there were 7 early deaths and an
additional 5 pts who required aortic valve replacement.
Of the 180 pts successfully dischaged (mean follow-up
l4±4 months, range 3-29), 49 (27%) have developed recur-
rent symptoms and 30 (17%) have died. The remaining 101
pts (56%) are asymptomatic or improved. Improvement in
left ventricular ejection fraction (EF) was seen in pts
with an initial low EF, from 37% pre-BAV to 44% post-BAV,
to 55% at 5 months mean follow-up. Repeat catheteriza-
tion has been performed in 36 pts (6 months mean follow-
up time) including 22 symptomatic and 14 asymptomatic
pts. Late restenosis (defined as a loss of >50% of the
initial improved increase in AVA post-BAV) was demon-
strated in 20/22 (91%) of the asymptomatic and 8/14 of
the symptomatic pts.
Conclusion: BAV can provide effective short-term pallia-
tion of symptoms in the majority of pts referred with
calcific AS, however late restenosis and mortaltiy rates
remain high. *p<.Ol
ONE - TWO YEAR FOLLOW-UP AFTER PR IMAR IL Y SUCCESS·
FUL VALVULOPLASTY FOR CALCIFIED AORTIC STENOSIS.
Christoth SpielberH M.D. Irmtraud Kruck M.D"
Ihomaslnderer M•• ,Rolf Schr~der M.D.,F.A.C.C.
Klinikum Steglitz, Free University Berlin,FRG
From June 1986 to September 1987, balloon valvu-
loplasty (VP) of aortic stenosis was performed
in 33 patients(mean age 74 years)with repeat-VP
in 6 cases. Overa 11 reduction of peak gradient
was -53% and increase in valve area was +90%.
Immediately after VP, 76% of the patients were
asymptomatic or significantly improved. 4 pa-
tients remained symptomatic, There was 1 early
valve replacement because of VP-induced aortic
insufficiency and 3 early deaths occurred with-
in 4 weeks after VP, Follow-up included 23 in-
vasive controls and repeat Doppler-echocardio-
graphy (DE) every 2-3 months in all patients.
Restenosis (loss of initial gain in valve area
and/or loss of gradient reduction ,50%) was seen
in over 80% of the patients. DE showed progres-
sive loss of achieved gradient reduction at
each control: 1-3 days after VP -28%, after 3
months -48%, after 4-6 months -60%, ? 7 months
-74%.
After a mean follow-up of 17 months (11-26 mo.),
10 patients were deceased, 12 had valve replace-
ment, and to 4 surgery had been strongly suggest-
ed. Only 7 patients (21%) were still clinically
improved. Conclusions: VP of calcified aortic
stenosis is a solely palliative procedure with
an unacceptably high restenosis-rate and a poor
clinical outcome after :>12 months. It seems no
realistic alternative to valve replacement.
cmml ULLOOI mmorusn OF IEClOPst miOTIC AOITIC mm:
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SECOND DILATATION FOR RESTENOSIS FOLLOWING SUCCESSFUL
BAllOON AORTIC VALVULOPLASTY: RESULTS, PATHOLOGY AND
MECHANISM.
Ted Feldman MD FACC, Seymour Glagov MD, Y. Christopher
Chiu MD, John D. Carroll MD. The University of
Chicago, Chicago, Illinois.
Restenosis after balloon aortic valvuloplasty
(BAY) is common, occurring in as many as half of pts in
the first year. For many pts, redilation is the
preferred therapy for restenosis. We examined results
of second dilations and the histology of restenosed
valves excised during valve replacement for restenosis.
Six of an initial 50 patients with calcific aortic
stenosis underwent second BAV for restenosis. The mean
age was 81±7 years. The interval between 1st and 2nd
dilatations was 9.7±2.5 months (range 6-12 mos).
AREA PRE AREA POST CHANGE
1st BAV .53±.14 .95±.18 .42±.12
2nd BAV .59±.15 . 79±. 22 .20±.1l*
The change in valve area after second BAV was only
half as great as first BAV (p<O.Ol). Second BAV was
done at a time when our overall results were greatly
improved (post BAV area 1.08 vs .86 cm2, p<O.Ol).
Multiple histologic sections from excised,
restenosed valves from 5 pts showed zones of active
capillary and cellular proliferation in crevices
between calcific nodules in 3 cases. Associated foci
of ossification were seen in 2 of these. Stenotic (non
BAV) control valves (n-9) showed no ossifications.
CONCLUSIONS: 1) Histologic changes in restenosed
valves differ from those seen initially in calcific
aortic stenosis, with granulation, fibrosis and
ossification being present. 2) These findings may help
to explain the limited results of second dilations for
restenosis.
FAILURE OF BALLOON AORTIC VALVULOPLASTY TO RESULT IN
SUSTAINED CLINICAL IMPROVEMENT IN PATIENTS WITH DEPRESSED
LEFT VENTRICULAR FUNCTION.
Charles J. Davidson, M.D., Thomas N. Skelton, M.D., Mark
Leithe, M.D., Katherine B. Kisslo, R.D.M.S., Thomas M.
Bashore, M.D., F.A.r..C., Duke Medical Center, Durham, NC
Return of symptoms (sx) after balloon aortic valvulo-
plasty (BAV) occurs variably within 3 to 6 months. To
determine whether invasive hemodynamic parameters are
predictive of early return of symptoms, 50 consecutive
pts were evaluated pr~ and post BAV using high-fidelity
pressure and digital imaging methods. Stroke work was
defined from pressure-volume loops. The acute hemodynam-
ic changes observed in pts with improved symptoms at 3
months were compared to those in whom recurrent sx oc-
curred.
Acute C~anses: Improved Symptoms Recurrent Svmntoms
n - 38 n 12
AVA Pre-BAY 0.5 ± 0.2 0.5 ± 0.1
(cm2) Post BAY 0.7 ± 0.2 0.8 ± 0.2
LVEF Pre-BAV 51 ± 17 31 ± 18*
(\) Post BAV 53 ± 16 34 ± 18*
Stroke Wo~k Pre-BAY 14.6 ± 6.1 8;8 ± 4.3*
(erg x 10) Post BAV 12.4 ± 5.5 8.4 ± 4.2
Peak + dp/dt Pre-BAY 1778 ± 423 1325 ± 469*
(mmHg/sec) Post BAV 1584 ± 380 1241 ± 450*
*p < 0.005 recurrent symptoms vs. improved symptoms
The final aortic valve area (AVA) did not predict
which pts developed recurrent sx. Early return of sx oc·
curredin pts with baseline depressed LV function (as
evidenced by a low EF, SW and peak + dP/dt).
Thus, aortic valvuloplasty in pts with intrinsically
depressed LV performance does not appear to result in
sustained clinical improvement at 3 months compared to
pts with preserved LV function.
NEW DEVELOPMENTS IN AORTIC BALLOON VALVULOPLASTY
Alain Cribier M.D. , F.A.C.C., Fernando Grigera M.D.,
Helene Eltchaninoff M.D., Eric Lefebvre M.D., Jacques
Berland, M.D. and Brice Letac M.D, F.A.C.C.
University of Rouen, France.
In our initial experience (GrouyA) of 182 patients (Pts)aortic balloon valvuloplaty (BY was performed with non -
specific catheters (NSC) designed for dilatation of
pulmonic valves and peripheral arteries; maximal balloon
size used was > 20 mm in only 9 % of the cases; no
arterial sheath (ASh) were used for NSC femoral inser-
tion. In the 146 following Pts (Group B), advances in BV
consisted in the use of: 1) a double size balloon cathe-
ter specifically designed for BV of the aortic valve in
all Pts, 2) larger balloon sizes : > 20 mm in 52 % of the
cases (23 mm or 25 mm), 3) a 14 F ASh in the last 69 Pts.
Pre-BY clinical and hemodynamic data were similar in the
two groups. Results and complications were compared in
Group A and B : mean duration of BV : 120 + 32 mn vs
35 + 16 mn (p<.05), post-BY mean gradient (111III Kg) and
valve area (cm2 ) : 29 + 14 vs 26 + 12 (p<.05) and
.92 + .3 vs 1.05 + .3-(p<.001), increased valve area to
>- l-cm2 : 36 % VB 52 % (p<.Ol); in-hospital mortality:
5 % vs 3 %, stroke: 2 % vs .7 %, pericardial tamponade:
2 %vs .7 %, severe aortic regurgitation: .6 % vs .7 %.
Vascular complications and need for surgical repair were
unchanged in the two groups when ASh was not used: 14.8 %
and 5.5 % vs 14.2 % and 5 % but decreased to 4.9 % and
o % with the use of ASh in Group B.
Conclusions : with these new developments, aortic balloon
valvuloplasty has become a simpler, faster and more
effective procedure. The rate of major complications
tends to decrease. The use of a 14 F arterial sheath has
markedly reduced the number of vascular complications and
the need for femoral artery surgical repair.
Monday, March 20,1989




SIX MOIITH FOLLOW-UP OF HITRAL BALLOOII VALVULOPLASTY
Raoul Bonan. H.D., F.A.C.C. for the IIHLBI Balloon
Valvuloplasty Registry, Coordinating Center, university
of Washington, Seattle, WA.
Twenty-three centers entered 223 pts undergoing mitral
balloon valvuloplasty (HBV) into the Balloon Valvulo-
plasty Registry (BVR) between 11/87 and 9/88. Of the
first 47 pts having HBV >6 mo. ago there were 4 early
(3 cardiac. 1 noncardiac) deaths (~). To determine the
early clinical course of pts following HBV we have com-
pared the functional status of the 30 surviving pts at
baseline, 5 Wks and 6 mo. There were 7 men 60+21 yrs of
age and 23 women ags 54%21 yrs. Hitral stenosis was
severe in 43'- and moderate in 43'-. Hi Id mitral regurgi-
tation was present in 27'- and moderate in 7'-. At base-
line congestive heart failure (CHF) was present in all
pts but was severe (class III or IV) in 73'-. At 5 Wks
CHF was still present in 53'- but was severe in only
23'-. By 6 mo. CHF was present in 57'- but was severe in
only 17'-. A history of syncope was present in 17'- at
baseline, 7'- at 5 Wks and in lot. between 5 Wks and 6
mo. Angina was infrequent both before and following
HBV. At 5 wk follow-uP. 73'- of pts ware improved. 2Ot.
were unchanged and 7'- were worse. At 6 mo.. 8ot. were
reported improved, 13'- unchanged and 7'- were worse.
Rehospitalization had been required in 17'- by 5 Wks and
in 33'- between 5 wks and 6 mo.
Thus HBV results in substantial clinical improvement by
5 Wks with further clinical improvement over the next 5
mo. Early mortality was high (9'-) and late mortality
occurred in 1/43 pts (2'-) HBV may be a suitable alter-
native to mitral valve surgery in selected pts Who are
at increased risk for surgery.
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LONG-TERM FOLLOW-UP Of PATIENTS UNDERGOING CLOSED
TRAHSVENTRICULAR MITRAL VALVE COMMISSUROTOMY
David R. Holmes Jr. M.O., F.A.C.C •• Robert L. Frye M.D.,
F.X.C.C., Rick A. Nishi~ura M.D., F.A.C.C., Duane M.
Ilstrup, LaVon N. Hammes. Hartzell V. Schaff M.D ••
F.A.C.C., John W. Kirklin M.D., F.A.C.C., Mayo Clinic,
Rochester, Minnesota.
Surgical transventricular mitral valve dilatation
(TVMVD) as perfonaed in the 1960's and percutaneous
mitral balloon valvuloplasty ~f the 1980's both involve
nonvisually-directed dilatation of the mitral valve.
Long-term follow-up of the fonwer may allow a comparison
cohort for the latter. Two hundred sixty seven pts
underwent TVMVD for significant mitral stenosis at Mayo
Clinic from 1960-1964; 207 females, 60 males, mean age
43.6 years (yrs). Sixty-one percent were NYHA
functional class III or IV. In these pts, 24.1% had LA
thrombus at surgery. Thirty-day perioperative
complications included death, 2.6%; cerebrovascular
accident (CVA), 1.9%; non-central nervous system
embolus, 1.1%; and new or worsened mitral insufficiency
in 22.5%. Following surgery, 92% were sygptomatically
improved; improvement lasted 1 - 2 years in 12.4%, 3 - 4
yrs in 24.4%, 5 - 10 yrs in 28.8%, and 10 - 20 yrs in
24.4%. During a mean follow-up of 15.5 yrs, actuarial
survival free of death. mitral valve replacement (MVR)
and CVA were:
1 Yr 5 Yrs 10 Yrs 15 Yrs 20 Yrs 25 Yrs
Death 94.3% 89.91 79.7% 70.3% 60.4% 46.0%
MVR 98.3% 91.0% 74.7% 53.7% 41.4%
CVA 98.4% 97.5% 93.1% 88.a 85.5% 82.4%
Conclusion: Symptomatic improvement from TYMVD (and
possibly mitral balloon valvuloplasty) is maintained at
least 3 - 4 yrs in approximately 75% of pts. At the end
of 10 yrs, approximately 75% remain free of mitral valve
rep lacement.
LONG-TERM FOLLOW-UP IN 105 PATIENTS UNDERGOING
PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY.
Marc J Levine MD.. Raymond E Erny, MD.. Bradley M. Leonard, MlJ,
ROMld D. Jenkins. M.D.• Greg;) J. Reis, M.D., Daniel.), Diver. M.D.. Robert D.
Safldn, M.D., Patricia C. Come. M.D., FAC.C.. Raymond G. McKay, M.D.
Harvard- Thorndike Laboratory, Beth Israel Hospital, Boston, MA
Smgle or liJuOle balloon mitral valvuloplasty (BMV) wet> sUI.'CeSSfully
periormaJ m97 of 105 pts With critIcal mitral stenosIs (~1S1 (cqe 27 to 83
years), IIlcluding 5I~ with significant valvular calcification. 5"1% were
considered nlgll surgical rlsl'. due to advaoced age. severe pulmonary hyper-
tension or heart failure, or need for coroMry artery bypass grafting or aor-
tiC valve replacement. Post BMV. there was Improvement In mitral valve
area (MVA; 1.0:t0.4 to 1.9:t0. 7cm2*), mean mitral gradient ( 14:t5 to 7:t3
mmHg* l. CO (42:t 1.2 to 5.0:t 1.6 L/mm* l, pulmonary capIllary wE!O;le
pressure (24:t 7 to 16:t6 mmHg*), mean PA pressure (39:t 15 to 31:t 12
mmHgl, and pulmonary vascular resistance (335:t35 1to 277:t232 t1ynes-
sec-cm-5*). ComplicatIOns included I death, 2 left atrial perforations. 1
stroke, one TlA. one myocardial infarction. and 21 small atrial septal defects
': mean Op/Os= 1.4:t0.4). There have been 8 late deaths unrelated to the pro-
cedure, Two pts underwent valve replacement due to SubOPtimal symptom
relief and 4 other pts developed recurrent sYmptoms 16 months after BMV; 2
of these responded to repeat BMV (9 and 13 months after Initial BMV, re-
spect lVely) ,one underwent valve rep lacement. and one IS bemg mangage<l
mediC8l1y, All other pts (88%) remain symptomatically improved' 4:t8
(rilnlJ9 I to 30) montns post BMV. Serial echo/doppler stUdies at 3.6, and
12 months after 6MV demonstrate persistent improvement in MVA. Fo!-
low-'Jp (F /1J1 catheterIZatIOn was performed 1n 20 pts 11:t6 months after
BMV. only 4 of whom were symptomatic:
Pre-BtW Dost-BMV F/V
MVA 08:t03 cm2 18%08 cm:" 15:t0 6 em:"
ConclusIon' BMV in adult pts with MS results in longterm improvement in
valve function and sYmptoms. (it P( .0 I)
ADVANTAGES OF INOUE-BALLooN(SELF-POSITIONING BALLOON) IN
PERCUTANEOUS TRANSVENOUS MITRAL COMMISSUROTOMY(PTMC) AND
AORTIC VALVULOPLASTY(PTAV).
Kanji Inoue, M.D., Masakiyo Nobuyoshi, M.D., F.A.C.C.,
Chanrong Chen, M.D., Jui Song Hung, M.D., Kochi Municipal
Hospital, Kochi, Japan and 60 Collaborating Institutions
in Japan, China and Taiwan
Clinical application of non-surgical mitral
commissurotomy was firstly success in 1982 by using the
Inoue-Balloon, and recently its clinical use has been
rapidly increased, 713 patients (pts). The technical
success rate was 97%. PTMC resulted in a decrease in
mitral valve gradient from 12.0 ± 5.9 to 5.4 : 3.0 mmHg
and in an increase of mitral valve area from 1.22 ± 0.44
to 2.13 ± 0.76 cm2. No patients died due to PTMC.
Complication included 2 (0.3%) cerebral embolisms, and 10
(1.4%) severe mitral regurgitations. The Inoue-Balloon
has also been used in the antegrade aortic valvuloplasty
in 58 pts. The technical success rate was 96%. PTAV
resulted in a decrease in aortic valve gradient from 87 ~
29 mmHg to 44 ± 16 mmHg, and in an increase of aortic
valve area from 0.50 ± 0.20 to 0.87 ~ 0.39 cm2. One
patient died due to a severe aortic regurgitation. Three
patients underwent a subsequent aortic valve replacement
for an increase of regurgitation. The advantages of the
Inoue-Balloon are as follows. It has a large diameter
(25 - 31 mm in mitral, 18 - 25 mm in aortic) with a low
profile (4.5 mm in mitral, 4.0 mm in aortic). The
balloon is easily placed at the right position. The
balloon does not slip out of the valve during dilatation.
Inflation and deflation can be totally completed within 5
seconds. These advantages allow a high success fate,
~ood efficacy and low risk in PTMC and PTAV.
EARLY AND LONGTERM RESULTS AFTER MITRAL VALVULOPLASTY AS
COMPARED WITH VALVE REPLACEMENT
Felicitas Kraus MD, Serban Dacian MD' Caroline Rudolph MD.
Donald Hall MD, FACC. Werner Rudolph MD, FACC.
German Heart Center, Munich, FRG.
To compare the results of successful valvuloplasty (VP)
with those of valve replacement (VR) for severe mitral
stenosis, studies were performed in 63 pats with pre-
existing valve orifice area <1.0 qcm/qm (I. 1~0.4 qcm prior
to VP and 1.1+0.4 qcm prior to VR). Before, I week(w) and
1/2 year(y) after VP as well as before, 2-3 wand 1/2 y
after VR resting (R) and exercise (EX) hemOdynamics as
well as O,-saturation in the pulmonary artery (PA) were
determined.
PAPm SV PA-O, HR
(1IIIIIIIg) (m» (sat%) (b/min)
R Ex R Ex R Ex R Ex
pre VP 30 63 57 54 61 37 72 128
post VP (Iw) 23 51 67 67 64 41 69 126
post VP( 1/2y) 22 51 64 64 66 40 65 126
pre VR 27 61 70 67 65 40 70 123
post VR(2-3w) 19 43 66 79 64 39 81 118
post VR(1/2y) 17 42 65 75 67 4\ 74 115
P values
pre VP vs VR ns ns .01 .005 .025 .01 ns ns
postVPvsVR(1/2-3w).05 .005 ns .05 ns ns .005 ns
postVPvsvR(1/2y) .005 .005 ns .05 ns ns .025 ns
Both early and during longterm follow-up after VP, at R
and during EX. PA-pressure was higher than after YR. As
it had been prior to the procedure, during EX after VP.
stroke volume was also lower.
Thus, VP leads to improvement in hemodynamics at Rand
during EX which are not, however, comparable to those
obtained by YR.
19AJACC Vol. 13, No.2
February 1989:19A
ABSTRACTS
COKPARISOB OF LOBG-TERM HEKODYVAKIC EVALUATIOB BITWEEB
PIRCUTAilEOUS KITRAL VALWLOPLASTY AIlD KITRAL VALWLAR
UPLACIlKEBT FOil SEVEIlE KITRAL STlIIOSIS.
Christian Spauldina. K.D .• houl Bonan, K.D., F.A.C.C.,
Antonio Serra, M.D., Jacque. Crepeau, M.D., Ihor Dyrda,
M.D., F.A.C.C., Conr.d Pelletier, M.D., Montreal Heart
In.titute, Montreal, Canada.
ROLE OF ELECTROPHYSIOLOGIC TESTING IN PATIENTS WITH
ASYMPTOMATIC NONSUSTAINED VENTRICULAR TACHYCARDIA:
RELATIONSHIP TO VENTRICULAR FUNCTION AND THE PRESENCE OR
ABSENCE OF CORONARY ARTERY DISEASE.
Stephen Hammill~ Jane Trusty R.N., Bernard Gersh
M.D., Michael Osborn M.D., Douglas Wood M.D., David
Holmes M.D., Mayo Clinic, Rochester, MN
105 pts with asymptomatic nonsustained ventricular
tachycardia (VT) were evaluated prospectively to assess
the value of electrophysiologic testing (EP) in pt sub-
groups which included normal or abnormal ejection frac-
tion and the presence or absence of coronary artery
disease. EP consisted of 3 extrastimuli delivered during
sinus rhythm and right ventricular pacing at 100 and 150
bpm from 2 sites. A positive test (EP+) was defined as
monomorphic VT lasting >30 see or requiring cardiover-
sion. EP+ pts were treated using serial drug testing
including amiodarone. An event during follow-up waa
defined as sustained VI requiring physieian intervention
for termination or out-ot-hoapital cardiac arreat.
Results. (Mean follow-up 15 months). Group 1: In 55
pts with an ejection fraction(EF) >40% there were no
events and 4 were EP+. Group 2: In 50 pts with EF <40%,
Group 2A had 26 with coronary artery disease (CAD) (mean
EF 28%) ot whom 12 were EP+ with 1 event and 14 EP- with
3 events; and Group 2B had 24 with nonCAD (dilated cardi-
omyopathy in 23) (mean EF 24%), of whom 2 were EP+ with
no events and 22 EP- with 8 events.
Conclusions: 1) Pts with EF >40% had low inducibility
(7%~0 events and do not require EP; 2) Pts with EF
<40% and nonCAD had low indueibility (8%), a 33% event
rate and did not benefit from EP; and 3) Pts with EF <40%
and CAD had high inducibility (46%), a negative study was













We compared Ions-term h8lllOdynamic evolution after
percutaneous mitral valvulopla.ty (PKY) and mitral
valve replacement (KVIl) for severe mitral .tenosi•. PKY
was performed in 33 pt. (aroup 1) and KVIl in 21 (sroup
2) uains porcine in 13 and _chanical valve. in 8.
Cardiac catheterization was done before the procadures
and 6. 28:t1. 3. IICI. after PKY and 17. 3:t19.. 110. after
KYIl. Initial clinical .tatu. and h8lllOdyn..ic
measurements at re.t were .imilar in both Iroup.. The
followinS variation. in _an mitral valve area (KYA)













durins exercise 5.00:tl.46 5.25:tl .•5 BS
In conclusion, PKY may not be a. efficient as KVIl in
incre••ins KYA and CI, but durins exercise this
difference disappears, sussestins that similar valve
performanee is obtained after PKY.
Monday, March 20,1989
2:00PM-3:30PM, Marriott Hall North
Anaheim Marriott Hotel
Electrophysiologic Testing of Ventricular
Tachycardia
RELATICfi (R nuJCIBn..ITY OF vmnu<IlLAR ARHIYmMIAS TO
~ IN PATIEm'S WITH !M'ER'lKJlHIC CARDICIM>PAmY -
m.awa: OF INIXJ(E) PCL»QUlHIC VEN1'RI<IlLAR T1\QIYCARDIA.·
Lameh Fananap!!zir, M.D., Qinthia Tracy, M.D., Judith B.
Winkler, B. s., Martin Leon, M. D., Richard ClInoon, M. D. ,
SteFben E. EPltein, M.D., F.A-C.C., lIRaI, Bethesda, K)
Progrllllllled ventricular stimulation (PITS) using >2 prema-
ture st1nll1i (PS) in pta with i¥Pertropuc cardiaDyopathy
allegedLy inaJces non-specific polYlOOrphic ventricular
tachycardia (VT). We studied the relation of inaJcibil-
ity of polYlOOrphic and toonaOOrphic VT to synptans, >3
beat VT on 48-bJur Holter monitor and aggressiveness of
PITS (nUlltler and prematurity of PS and ntmiler of ventricu-
lar sites tested>, in 106 pts. PITS of up to 3 PS, 3 drive
pacing rates (600, 500 and 400 l::.pn), and 2 W and an LV
site, .inllIced sustained (>30 beat or requiring cardiOl7er-
sian> ventricular arri'¥tbnia in U (42" pts. '1tle
arrhytlJnia was polYlOOrphic VT in 32 (73" pta, JIDllCllIOr-
puc VT in 10 (23') pts and ventricular fibrillation in
2 (5%) pta. '1tle relation between presenting syDIltans and
irdlcibility of ventricular arrhythnias, including
polYlOOrphic VT was significant (P<0.02):
No. All arrhytllnias Polymorphic
Presentation pta '2 PS >2 PS VT
BLIlCftOPHYSIOLOGIC TllSTIBG III PATIDTS WITIl ASYHPTOKlTIC
1I0llSUSTAlIIED V1lII'11ICULAR TACHYCAl.DU Pl.EDICTS !UBI: or
SUDDEII DUTIl 01 SUSTAIIIED VEIIDICULAR TACHYCAl.DU WITaIII
TIlIl FIRST YEAR BUT IIOT TBIlIlIlAFTIlIl.
IWxt ,L. Loughery. Llh, Willi.. K. Kil.. , M.D., FACC,
lIaami S. Fineberg, Ph.D., Jaae. J. Heger, K.D., rACC,
Lawrenee S. Uein, M.D. ,FACC, Dougl.. P. Zip.. , K.D.,
FACC, Erie N. Pry.tov.ky K.D., rACC, Indiana Univ Sehool
of Ked, ~raDDert In.t of Cardiol, VAKC, Indpl., III
We pro.pectively perforaed drug-free electrophy.iologic
.tudie. (EPS) on 79 patient. (pt.) (age 57.1 ~ 13.3 yr.)
vith a.yaptcaatie non.u.tain.d ventrieular taehycardia
(VTBS). Pta had coronary artery di....e (CAD)(n-55),
cardiomyop.thy or valvular heart di.ea.e (BD)(n-16) or DO
structural BD (n-e). U.ill& up to 3 extr..tilll1li (84),
group (gp) I (54/79, 68%) had either DO VT (n-21), VTHS
(n-25) or ventricular fibrillation (VP) vith S4 (n-8)
induced .t EPS. Gp II (25/79, 32%) had either au.tained
.onoaorphic VT (VTS)(n-20) or VF vith < S4 (n-5) induced
at EPS. 110 gp I pt va. treated, and only 16/25 IP II pt.
reeeived therapy (guided by .erial IPS in 11/16 pta).
Surviv.l eurve analy.i. .hoved that .urvival vithout VTS
or .udden death (SD) in IP I pt. va. almoat tvice a. lonl
a. in gp II pt. (41.6 ~ 2.5 v. 23.9 ~ 3.5 mo: p-0.013).
Of note, the greate.t differenee in VTS/SD-free .urvival
occurred in the fir.t 13 me of follovup (47/54 IP I v.
17/25 gp II pt., P <0.05). In eontra.t, at the end of the
follovup period (.ean 22.5 mo, range 0.4 to 50.5) there
vaa DO difference in VTS/SD-free aurvival (42/54 gp I v.
16/25 gp II). We conelude: 1) in pt. with a.yaptamatie
VtNS, induction of VF vith < S4 or VTS at EPS predict. a
.horter VTS/SD-free .urvival time than induction of DO VT,
VTHS, or vr requiring S4: 2) reevaluation of ri.k may be
appropriate at 1 yr, po••ibly becau.e of di.e••e
progreuion.
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SHOULD THE INDUCTION OF NONSUSTAINED
VENTRICULAR TACHYCARDIA DURING BASELINE
ELECTROPHYSIOLOGIC TESTING CONSTITUTE A POSI-
TIVE STUDY?
Christooher A. Bonnet MD James J. Elson, MD., Ph.D., Susan
B. Fiedler, R.N., Richard N. Fogoros, MD., F.A.C.c', Allegheny
General Hospital, Pittsburgh, Pennsylvania.
The induction of nonsustained ventricular tachycardia (NSVT)
during baseline electrophysiologic study (EPS) is often con-
sidered a nonspecific finding, and such patients arc often
regarded as being non-inducible. Of J48 consecutive patients
presenting with sustained ventricular tachycardia or cardiac
arrest, 33 (Group A) had> 10 beats of NSVT (J 7±8 beats) as
the only inducible arrhythmia at baseline EPS. Twenty-four
(Group B) were considered noninducible « 10 beats of
ventricular tachycardia). Between groups there were no sig-
nificant differences in age or sex distribution, or in severity of
underlying cardiac disease. Patients in Group A received ag-
gressive therapy guided by serial EPS, which included implan-
tation of the automatic implantable cardioverter-defibrillator
in 10. Patients in Group B received no antiarrhythmic therapy.
The mean follow-up was 3S±16 (±SD) months for Group A and
2S±17 months for Group B. The actuarial incidence of recur-
rent sustained ventricular tachycardia or cardiac arrest (±SE)
was:
Months Group A (n-33) Group B (n-24) P
6 6±4% 0% < .01
12 IS±6% 0% < .01
24 24±8% 6±6% < .os
Conclusions: Patients in whom NSVT of at least JO beats in
duration is the only arrhythmia inducible at baseline arc at a
significantly higher risk of arrhythmia recurrence (despite ag-
gressive therapy) than patients who arc noninducible. Our
data suggests that the induction of NSVT at baseline EPS
should be considered a positive study.
FAVORABLE OUTCOME OF PATIENTS WITH VENTRICULAR TACHYCARDIA
OR FIBRILLATION AND A NORMAL ELECTROPHYSIOLOGIC STUDY
Soo G. Kim M.D., F.A.C.C., Alan P. Aboaf B.S., Anthony D.
Mercando M.D., John D. Fisher M.D., F.A.C.C., Montefiore
Medical Center, Bronx, NY
A slbset of patients with ventricular tachycardia (VT) or
ventricular fibrillation (VF) is not inducible at baseline
by programmed stimulation (PES) and thus does not qualify
for PES guided antiarrhythmic drug therapy (Rx). The
prognosis of these pts is unclear. We studied 25 pts
(coronary artery disease in 11, cardiomyopathy in 9,
others in 5) who had sustained (>30 seconds or required
cardioversion) VT (0=16) or VF (n=9) not associated with
remediable causes or an acute myocardial infarction. Mean
ejection fraction was 54 +15~. PES protocol included 3
extrastimuli and rapid pacing at 2 sites. All pts were
noninducible «10 beats) by PES at baseline before Rx. All
had Holter monitors before and after drug Rx. In 1B pts
frequent (>10/hour) ventricular ectopy was noted. Infre-
quent ventricular ectopy was noted in 7 pts. Anti-
arrhythmia Rx was guided by Holter monitoring or chosen
empirically (beta-blockers in 4), One pt received an
implantable defibrillator while none had coronary bypass
or angioplasty. No pts had exercise induced arrhythmias
at discharge. During follow up (28+18 months), 2 pts had
nonfatal VT, 2 had sudden death (6 and 20 months), and 2
died of congestive heart failure. Actuarial survival rates
at 1, 2, 3 and 4 years were 95~, 90~, 90~ and 90~ for
sudden death, 95~, 85~, 79~ and 79~ for total cardiac
death and 90~, 85~, 76~ and 76~ for arrhythmia free
survival, respectively. Conclusion: Pts with sudden death
and a normal PES study have a very good prognosis at 4
years - 90~ had no sudden death. This favorable outcCJ1le
may be due to the relatively good ventricular function or
the antiarrhythmic Rx in this study.
MULTIPLE MORPHOLOGIES OF INDUCED VENTRICULAR TACHYCAR-
DIA: ROLE OF ANTIARRHYTHMIC DRUGS AND CLINICAL IMPLICA-
TIONS.
Marc Dubuc, M.D., Teresa Kus, M.D., Ph.D., Wilhelm Kal-
tenbrunner, M.D., Dominique Lacroix, M.D., Mohammad
Shenasa, M. D., Ph. D., F.A.C.C.. Sacr6-Coeur Hospital,
University of Montreal, Montreal, Canada.
Different morphologies of ventricular tachycardia (VT)
are believed to represent different sites of origin
and/or different epicardial breakthroughs of cardiac
activation. It implies also a different sequence of
activation that may interfere with recognition of VT by
devices using morphology criteria for termination. We
studied the effect of antiarrhythmic drugs (MD) on VT
morphology as defined by frontal and horizontal axis
criteria. Twenty-three coronary artery disease Pts with
a mean age of 63 ± 6 yrs had serial programmed electri-
cal stimulation (PES) using right ventricular (RV) drive
at 2 basic cycle lengths and 1 to 3 extrastimuli at 2 RV
sites were done without and on drug. All Pts had
several inductions of VT at every study. In the drug-
free state, all 23 Pts manifested only one induced VT
morphology that was identical to the spontaneous
"clinical VT" morphology. Subsequently, all Pts had 1-4
PES on MD. In 8 Pts (35~), at least one new morphology
appeared on AAD and, in 6 of these, the morphology
induced at the drug-free study was no longer inducible.
In the remaining 15 Pts, VT morphologies on MD werE!
unchanged. Therefore, in 35~ of Pts on AAD, new VT mor-
phologies appeared and in 75~ of these, the original
"clinical VT" was no longer inducible. We conclude that
new VT morphologies may be caused by the use of MD pnd
this will have major clinical impact in the use of AAD
in Pts with implantable devices that use morphology
criteria for recognition and termination of VT.
Monday, March 20,1989




THE LONG QT SYNDROME INTERNATIONAL PROSPECTIVE REGISTRY
Peter J. Schwartz, MD.FACC*. Arthur J. Moss. MD.FACC**,
Emanuela Locati.MD*. Richard S. Crampton.MD.FACC***.
Daniel Tzivoni.MD.·. Arthur Garson.MD.FACC··. G.Michael
Vincent.MD.FACC···. *Univ. of Milan. **Univ. of Roches-
ter. ***Univ. of Virginia. ·Univ. of Jerusalem. ··Texas
Children's Hospital. ···Univ. of Utah
The international prospective registry for the idiopa-
thic long QT syndrome (LQTS). established in 1979. has
enrolled 1766 subjects as of July 1988. Besides specific
projects. the main objectives of this study include defi-
nition of the natural history of LQTS. risk stratificati-
on particularly for the as~ptomatic family members with
a prolonged QT interval. and long term assessment of the-
rapy. The population includes 2S0 probands (first patient
diagnosed as affected by LQTS in a family) and 1516 first
and second degree family members. For 617 family members
the ECG analysis and clinical history is not yet comple-
te. Among the probands 67% are females. 7% have congeni-
tal deafness. 84% have history of syncope and/or cardiac
arrest. 63% had their first episode below age 15. 92% are
treated. and 20% had left stellectomy. Pharmacologic and
surgical antiadrenergic interventions confirm high long
term therapeutic efficacy. Among the 646 patients with
prolonged QT interval (QTc>440 msec). 46% were symptoma-
tic. A significant finding is the fact that among the 503
family members with normal QT interval. 30 (6%) had syn-
cope. This confirms the concept that LQTS has a wide
spectrum and that. among affected families. the disease
may become fully manifest even in t~e absence of a pro-
longed QT interval of the surface ECG.
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DURATlON OF VT (sec)
ETIOLOGY OF POLYMORPHIC VENTRICULAR TACHYCARDIA IN THE
ABSENCE OF PROLONGED QT
Patrick Tchou, M,D" Keith Atassi, M,D" Mohammad
Jazayeri, M,D,. James McKinnie, M,D,. Boaz Avitall,
M,D" Ph.D,. Kasood Akhtar. M,D., F,A,C,C. Sinai
Samaritan Medical Center, Milwaukee. Wisconsin,
Polymorphic ventriclar tachycardia (Poly-VT) is known
to be associated with QT prolongation, either
congenital or secondary to drug therapy or electrolyte
imbalances. The clinical correlates of Poly-VT with
normal QT interval are unclear, Data from 18 patients
presenting with Poly-VT unassociated with QT
prolongation are reported here, There were 14 males and
4 females, QT interval averaged 390 ± 40 msec, Mean
age was 63 ± 11 years, Mean left ventricular ejection
fraction was 36 ± 9\. Sixteen of the 18 patients had
severe coronary disease while 14 had prior myocardial
infarctions. In 13 patients. a high grade stenosis
(>90\) could be identified in at least one artery which
supplied viable myocardium, Poly-VT was abolished in
all patients who underwent successful revascularization
surgery, One patient, who had 99\ stenosis of the
right coronary artery supplying an infarcted inferior
wall, had exercise induced Poly-VT which persisted even
after Amiodarone therapy, Poly-VT was abolished after
successful agioplasty (PTCA) of the stenotic vessel.
Two patients also responded to Amiodarone treatment.
Three patients died from medically refractory
arrhythmias prior to surigical intervention.
Conclusions: Clinical Poly-VT without QT prolongation
is most likely assocciated with high grade coronary
artery stenoses, Revascularization surgery (or PTCA)
appears to be an effective therapy to abolish Poly-VT
and should be considered urgently in patients who
present with this entity.
HIS-PURKINJE ACHVA HON DURING VENTRICUlAR TACHYCARDIA:
A DETERMINANT OF QRS DURATION.
John M. Miller M.D., F.A.C.C., Charles D. Gottlieb
M.D., Michael D. Lesh M.D., Francis E. Marchlinski
M.D., F.A.C.C., Alfred E. Buxton M.D., LA.C.C., Mark E.
Josephson M.D., F.A.C.C., University of Pennsylvania,
Philadelphia, PA.
Patients with ventricular tachycardia (VT) may have
several VT morphologies with differing QRS durations. To
test if the timing of His-purkinje activation may
determine QRS duration, we recorded His bundle potentials
(quadripolar catheters) and measured VH intervals (onset
QRS-His potential) during 59 VTs in 24 patients (1-7
VTs/patient). His potentials were visible in 55 VTs
(93'.1\) and in each patient during at least 1 VT. VH
intervals ranged from -38 to 246 ms (mean 67~55 ms).
The mean cycle length of 45 (76'.1\) VT showing a 1:1 QRS:H
relationship was longer than the 14 (24'.1\) VT without a
1:1 QRS:H ratio (349+70 ms vs 310+55 ms, p<0.05). In
8 patients having >3-VTs with measurable VH intervals,
regression analysis showed a close correlation between
QRS duration and VH (mean r=0.878), but not between QRS
duration and VT rate (mean r=0.455). Catheter mapping
dur ing 23 VTs showed 14 VTs from the basal 1/2 of the
heart had shorter VH intervals than 9 VTs from the apical
1/2 (22+32 ms vs 87+67 ms, p<.02) but there was no
difference in VH during VT of septal origin (63+65 ms)
vs free wall origin (63+73 ms). In sum: 1) His-poten-
tials are visible during VT in >90'.1\ of VTs and associated
with the QRS, rather than dissociated, in the majority of
these; (2) the close correlation between VH and QRS
duration in VT suggests that the His-purkinje system is
important in ventricular activation during VT but (3)
more work is needed to determine if there is His-purkinje
participation in the VT circuit.
NEW CRITERION FOR DIAGNOSIS OF SUSTAINED BUNDLE BRANCH
REENTRY TACHYCARDIA.
Jose Caceres, H.D., Patrick Tchou, H.D., Hohammad
Jazayeri, H.D., James HcKinnie, H.D., Boaz Avitall, H.D.,
Hasood Akhtar, H.D., F.A.C.C., Sinai-Samaritan Hedical
Center, Hilwaukee, Wisconsin.
The distinction of sustained bundle branch reentry
tachycardia (SBBRT) from ventricular (V) tachycardia
originating from V muscle with secondary His bundle (H)
activation can pose a problem. We postulated that in
SBBRT, variations in H-H intervals (delta HH) should
precede similar V-V intervals changes (delta VV).
Whereas, in tachycardia of V origin with incidental
activation of the H, delta HH will be expected to follow
delta VV.
Electrophysiologic data was analyzed in 20 consecutive
patients in whom 23 SBBRT's were induced in the
laboratory. When delta HH during the second, third, and
fourth tachycardia beats were plotted against succeeding
delta VV, the correlation coefficients were 0.98 and
1.00. In contrast, when delta HH of the same beats were
compared to delta VV of the preceding beats, the
correlation coefficients were -0.29 and -0.46.
Conclusions: (1) Spontaneous H-H cycle length (CL)
variations producing corresponding V-V CL changes in
subsequent complexes with no relation to the preceding
V-V CL's may be the most reliable diagnostic criterion of
SBBRT as the mechanism. (2) Such data would strongly
argue against ventricular myocardial origin of these
tachycardias.
USE-DEPENDENT PROLONGATION OF VENTRICULAR
TACHYCARDIA CYCLE LENGTH BY TYPE IA AND IC DRUGS.
Gregorv A Kidwell M D.• Arnold J. Greenspon M.D.• FACC. Richard M.
Greenberg M.D, FACC. Kent J. Volosln M.D.• FACC. Lynn Jefferies RN.
Jefferson Medical College, Philadelphia, Pennsylvania.
The In vitro time course of use-dependent sodium channel blockade by
Type IA and IC antiarrhythmic drugs differs markedly. We studied 29
sustained monomorphic ventricular tachycardias (VT) In 27 patients.
Identical control (C) and drug VT morphologies (Leads I, aVF, V1) were
induced before and after either procainamlde (P) or flecalnlde (F)
therapy. VT cycle length (Cl) at onset was not significantly different for
Pand Fcontrols (263±9 vs, 249±10 ms) and did nat change over 20 sec of
observation (see Inset), Following P(n=15). VT CL at onset Increased to
311±11 ms (p <0.001, vs. C) and did not changethereafter<VTCL= 320±10
ms after 30 sec). Although F(n=14) also produced a prolongation of VT
CL at onset (324±12 ms: p <0.001.vs, C). VT CL continued to increase over
time to a steady state value of 408±14 ms. The mean change between
onset and steady state VT CL following F (83±9 ms) was significantly
greater than that following P(9±4 ms) (p <0,005), The time constant for
this ·use-dependent· prolongation of VT CL by Fwas 13.2±1.3 sec. Beat-
to-beat mean arterial pressure. measured In 5 VT's during therapy with F.
increased from an onset value of 62±2 to 97±7 mm Hg. The time course
of the observed hemodynamic response was similar to the use-depend-
ent VT CL prolongation.
10 conclusjon: Pand Fproduce
similar changes in VT CL at
onset. but only F was assocI- !
ated with additional use-de- S
pendent changes In VTCL. Use-
dependent prolongation of VT
CL by F may be an impartant
determinant of clinical hemo-
dynamic tolerance of VT dur-
Ing therapy with Type IC drugs.
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TIME-DEPENDENT ELECTROPHYSIOLOGIC CHANGES AFTER
EXPERIMENTAL MYOCARDIAL INFARCTION: PARALLEL
CHANGES IN INDUCIBILITY OF VENTRICULAR ARRHYTHMIAS
AND THE SIGNAL-AVERAGED ELECI'ROCARDIOGRAM
D Kuchar MD FRACP. D Rosenbaum MD. P Albrecht PhD. J
Smith MD PhD, H Garan MD FACC. J Ruskin MD FACC. R Cohen
MD PhD. Harvard-MIT Division of Health Sciences.
Cambridge, MA.
This study sought to identify the relationship between late
potentials (LPs) detected on the body surface in a canine
model of post-infarction ventricular tachycardia (VT) with
the results of programmed cardiac stimulation (PCS) at
different stages after anteroapical myocardial infarction
(MI). Signal-averaged ECG was performed in II dogs
immediately prior to PCS at 5 day intervals during the first 3
weeks after MI. PCS was performed from 3 ventricular sites
with ~3 extrastimuli. VT was defined as >10 nonstimulated
monomorphic ventricular beats. LPs were defined as QRS
duration >58ms. voltage in the last 20 ms of the QRS <20uV
and late potential duration >18ms. using a bidirectional 4
pole Butterworth filter (40·250 Hz).
Results: During~ (0-3 days), 5 dogs were studied:
none had LPs and no VT was induced. During~ (4-10
days). 18 studies were performed. In 5, LPs were present: 4
had VT and I had VF induced. Two additional dogs without LP
had VF induced. During £1iG.Jll (>10 days). 10 studies were
performed. Two dogs had LPs and each had VT; an additional
3 dogs without LP had VF and no arrhythmia was induced in
the remainder. In all cases where a LP appeared. VT or VF
was induced at that day's study. In 2 dogs. disappearance of
LPs coincided with failure to induce VT.
Conclusion: There is a close relationship between
temporal changes in signal-averaged ECG and response to
PCS after canine MI. suggesting that inducibility of VT is
dependent on changes in cardiac conduction.
Monday, March 20,1989
2:00PM-3:30PM, California Room D
Anaheim Convention Center
Color-Flow Doppler: Relationship of Flow
Maps to Jet Dynamics
LIMI'IM'IOOS OF CDIm DJPPIm IN ANALYSIS OF VALVUIAR
~Ql'.
Dg.plas 1D"9"'P, M.D., JctIn Pastore, M.D. ,F2\lX:, Jeffrey
Isner, M.D. ,F2\lX:, st. Elizabeth's Hospital, Bostal, MA.
Attellpts haVe been made to cpantif'y regurgitatien based
en color tq:p1er(CD) i.III!Iqing. To test the ability of (CD)
to distinquish volUllle(VOL) from velocity (VEL) , we
ocnstnx::ted an ~tus that allowed us to dJseIve the
CD pattern :..:;Jlerent VOIs flowin:J at different VErs.
A bath of was fitted with a CD transducer and
the tube of a pa>'II!I" injector so that flow was d.irected at
the transdUcer. '!be injector was used to deliver a
precise VOL(ml) at identical rates(ml/sec). '!be actual
VEL of flow was altered in:i3peudently, acx:xmiirg to the
BemcW.li theorem, by chang'ing the orifi08 diameter(OP) (1
VB. 2II1II). 'nlllS the relative effects of c:tlan:}es in VOL VB.
VEL en the CD flow pattern eeuld be ClCJIIl'Ulld. '!be CD
pattern was graded, in a blinded fash1tn, en a scale fran
1+ to 4+, and the _ erYX'IIP"sseci in the color flow
pattern was pl.animatered. Ead1 IIIElaSUr&DI!I1 was repeated
eight times. REI. CD AREA
VOL(ml) 00(II1II) VEL GlWE (~ ± mn
A) 3 2 Ie;> 1+ 22.0 ± l.~.OOOI
B) 3 1 hi 3+ 44.9 ± 1. p<.OOOI
C) 6 2 l~ 2+ 32.4 ± 1.3 p<.OOOI
D) 6 1 hi 4+ 66.7 ± 3.2
E)pll. VOIs injecl::ed at higher VErs r&ceived a higher CD
grade(A VB 8, C VB D)-(3+ VB 1+, 4+ VB 2+) and resulted
in a~ CD area(44.9 VB 22 ail, p<.OOOl; 66.7 VB
32.4 em, p<. 0001). Furtherlll:lr8, a lesser VOL(3 VB
~ (B VB C) aweared. greater(3+ VB 2+, 44.9 VB 32.4
em, p<.OOOI) ~ flowing at higher VEL(Le t:hro.Jgb
the smaller 00). 'lhese data indicate that CD flow pattern
is principally a func:tien of VEL rather than VOL. CD
analysis may under or overestimate regurgitant VOL
~ upcn VEL of regurgitant jet.
CONSISTENCY OF COLOR FLOW DOPPLER ESTIMATION OF REGURG-
ITANT FLOW RATE ACROSS VARYING SIZE ORIFICES AND MULTI-
PLE ORIFICE COMMUNICATIONS USING FLOW CONVERGENCE CON~
CEPTS: STUDIES IN AN "IN-VITRO" MODEL. Valdir Moises,
M.D., Robin Shandas, B.S., Benedito Maciel, Miguel
Beltran, M.D., Franco Recusani, M.D., David J. Sahn,
M.D., FAce. Univ Calif, San Diego, CA.
We previously showed that regurgitant flow rate (FR)
can be estimated using color flow Doppler (CFD) measure-
ments of the flow convergence (FC) region proximal to a
regurgitant (REG) orifice (ie., on the LV side of the MV
for MV REG). FC is imaged as concentric aliasing towards
the orifice. If the first alias is a hemispheric isovel-
ocity boundary of flow going into the orifice, FR can be
estimated using the radius (R) from the alias to the
orifice and the known Nyquist limit (NL). In a constant
flow model, we imaged the Fe region for flow through 7,
16, 19.6, and 28.2mm' orifices and for flow simultane-
ously through 2 adjacent orifices (9.6 and 19.6 mm') for
FR from 1.04 to 5.8 L/min using a Toshiba SSH65A, 3.75
MHz and 4kHz pulse repetition frequency (NL=54 an/sec).
FR by CFD was calculated from the hemisphere surface
area 2wR' X NL. R was independent of gain and of the
angle from which the FC was imaged. CFD FR calculated
across the individual orifices correlated well to the
measured FR (r=0.80, r=0.92, r=O.93, and r-0.9l, res-
pectively for each orifice) and the regression relat-
ionships had similar slopes and intercepts. For the
flow crossing 2 orifices, FR calculated from the Fe for
each, separately, and summed, also correlated well with
measured FR (r=0.9l). Identification of flow velocity
isopleths from the laminar FC region imaged by CFD can
be used to estimate FR across a wide range of REG ori-
fices, as well as across multiple orifice regurgitant'
lesions.
HOW TURBULENT IS A TURBULENT JET? AN IN VITRO COLOR FLOW
DOPPLER STUDY
James D. Thomas. MD, Chun-ming Liu, MD, John P. O'Shea,
MB BS, Ravin Davidoff, MB BS, Shawn McGlew, Arthur E.
Weyman, MD, FACC. Noninvasive Cardiac Laboratory,
Massachusetts General Hospital, Boston, MA.
Accurate quantification of valvular regurgitation by
color flow Doppler echocardiography demands an under-
standing of the the natural velocity variation inherent
in turbul ent jet flow. In order to defi ne the statist i-
cal characteristics of turbulent jets, we examined pulsed
Doppler and color Doppler M-mode recordings from an in
vitro model of valvular regurgitation. Jets resulting
from blood flow through circular orifices of 0.1 to 0.5
Cmf with flow rates from 10 to 100 c~/sec were digitized
at 1 mm spatial by 4 msec temporal resolution. RESULTS:
Mean axial velocity was observed to decay inversely with
distance from the ori fi ce, and to have an approxi mate1y
Gaussian profile at any given depth. With flow held
constant, however, instantaneous velocity throughout the
jet fluctuated 28 to 35% about the local mean velocity,
with distinct 'rippling' apparent in the M-mode display,
consistent with propagation of turbulent eddies. Fourier
analysis revealed power spectrum peaks between 12 and 30
Hertz, with higher frequencies occurring closer to
the orifice. The random variation in velocity caused the
jet axis to swing chaotically ±.2· cm from its mean.
Conversion to laminar flow in this model occurred at jet
Reynolds numbers between 200 and 300 at which time
variations in both velocity and axis position abruptly
decreased (p<.OOI). CONCLUSION: Turbulent jets have
predictable average velocity profiles but significant
instantaneous variance both in velocity and shape.
Quantitative color flow analysis must use careful data
averaging techniques to overcome this random variability.
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EFFECT OF RECEIVING CHAMBER COMPLIANCE ON THE SPATIAL
DISTRIBUTION OF REGURGITANT JETS AS IMAGED BY COLOR
DOPPLER FLOW MAPPING, AN IN-VITRO STUDY. Benedito
Maciel, M.D., Valdir Moises, M.D., Robin Shandas, B.S.,
lain Simpson, M.D., Miguel Beltran, M.D., Lilliam
Valdes-Cruz, M.D., FACC, David J. Sahn, M.D., FACC, Univ
Calif, San Diego, CA.
In order to study the effect of atrial compliance on
color Doppler (CD) imaging of regurgitant jet areas
(RJA), we varied regurgitant flow rate (RFR) from 80 to
400 ml/min through a 1.5rnm' orifice into receiving
chambers (RC) of different compliances (Cz 1,2,4.5 and 9
ml/mmHg) using a closed, constant flow system. Color
RJA obtained using a Toshiba SSH65A, at constant gain,
3.75MHz and 4kHz pulse repetition frequency and
continuous wave maximal jet velocities for calculation
of RFR (Irex IIIB) were recorded from an atrial-viewing
window. For each chamber at a constant residual volume
(15Oml), RJA correlated linearly with RFR (r=0.97,
0.98,0.98, 0.99) and with pressure gradient across the
orifice (rz O.98,0.97,O.98, 0.99) for the 4 differing
compliance RCs respectively. At the same RFR, color RJA
increased with increasing chamber compliance up to C-4.5
m1/mmHg, but at very high compliance no further increase
in RJA was observed. When residual RC volumes were
increased stepwise (110,130, & 15Oml) at constant RC
compliance (2 ml/mmHg) with constant RFR, the RJA
decreased with increasing volume and pressure in the RC.
Our results showed that RJA has a nonlinear relationship
with compliance at constant RFR and suggest that in a
pulsatile system the pressure/volume relationship inside
the RC should be a major determinant of RJA as imaged by
CD. Even at constant compliance, changes in volume and
ambient pressure of the RC can result in significant
changes in RJA, independent of modifications in
regurgitant volume.
ABSTRACTS
THE PROFILE OF A REGURGITANT COLOR JET IS
INDEPENDENT OF ORIFICE SHAPE.
John P. O'Shea, M.B.B.S., F,R,A.C.P.. James D.Thomas.
M.D., A1eksandar D. POPOVIC, M,D., tracy Svizzero, Arthur E.
Weyman, M.D., F.A.C.C. Massachusetts General Hospital,
Boston, MA.
The quantitative evaluation of color flow jets using two-
dimensional Doppler echocardiography (2DDE) frequently
assumes that such jets are circularly symmetrical or conical in
shape. However. valvular orifices are frequently irregular in shape
and it remains uncertain whether such an assumption of circular
symmetry applies with validity to orifices of varying eccentricity.
To explore this assumption. we analyzed the size and shape of
color flow jets in an in-vitro model of valvular regurgitation.
using a constant driving pressure. Color jet profiles were digitized
for each of the following combinations: 3 orifice sizes (0.1, 0.3
and 0.5 cm2); 4 degrees of eccentricity. for each orifice size, with
the major/minor axis ratio of each orifice varying from 1:1
(circular) to 5: I (elliptical) and laminar vs turbulent jets. for each
combination. The width of each jet was measured in two
orthogonal planes at 1 cm intervals from the orifice to a distance
of 5 em downstream and their ratio of eccentricity (ER)
calculated. RESULTS: Taking all elliptical orifices together. jet
profile was distinctly elliptical from the orifice (ER = 1.75, P <
0,01 vs circularity) to 2 cm downstream (ER = 1.3, p < 0.05).
but thereafter became more circular until by 5 em downstream,
all jets were circular (ER = 1.0, P = ns). Multilinear analysis
revealed that larger and more eccentric orifices preserved their
elliptical profile longer (p < 0.02). While laminar flow tended to
preserve shape longer than turbulent flow. this did not reach
statistical significance. CONCLUSION: In this in-vitro model of
valvular regurgitation, color jet profile rapidly becomes
independent of orifice shape. Quantitative color flow Doppler
analysis, which assumes axial jet symmetry, therefore appears
valid.
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VALIDATION OF A KETHOD TO ESTIMATE REGURGITANT
FRACTIONS USING THE POWER MODE IN A DOG MODEL
David D Kandath, M D" Frederick Helmcke, M,D"
Elizabeth F. Philpot, M.S., Adelino Parro, Jr" M.D.,
William G. Tracy, Swav Lobodzinski, Ph,D., Ajit P.
Yoganathan, Ph.D., Navin C. Nanda, M.D., F.A.C.C.,
University of Alabama at Birmingham, Alabama
Power mode in color Doppler, which emphasizes display
of signal intensity, was used to estimate regurgitant
fractions (RF) resulting from induced pulmonic and
aortic regurgitations in open chest dogs. The degrees
of regurgitation were varied by banding the distal
artery, punching multiple holes in the valves or volume
loading. Using a computer algorithm, the strength of
the color intensities (I) were scaled from 0 to 8. The
numbers of pixels with the specific I grades were
counted in delineated regurgitant and forward flow
areas recorded using power mode, Each grade was scaled
assuming that maximum intensity corresponded to maximum
number of moving red blood cells (RBC) in a pixel. The
relative number of RBC/_ was then estimated for each
area by multiplying number of pixels with specific I by
number of RBC represented by that I. Readings were
taken at early, mid, and late systole and diastole for
forward and regurgitant flows respectively and averaged
to determine the number of RBC/mm. Because they
represented only one instance in time, the numbers were
multiplied by the cycle time to obtain the final rela·
tive number of RBC/mm, The ratio of numbers obtained
for regurgitant and forward flows were calculated to
determine RF. The pulmonic RF (n-9) ranged from 4·92'
(mean 42') and correlated very well with RF calculated
by comparing forward and reverse flows measured in the
PA using an electromagnetic flowmeter (r-0.94). The
aortic RF (n-8) ranged from 42·100' (mean 74') and also
correlated well (r-o.86).
Monday, March 20, 1989
4:00PM-5:30PM, California Room D
Anaheim Convention Center
Color Flow Doppler: Clinical and Experimental
Studies
IMPACT OF INTRAOPERATIVE ECHOCARDIClGRAPHY: TIlE FIRST
1,000 PATIENTS.
Martin E. Goldman, M.D.,F .A.C.C., Theresa Guarino RN,
Scott Lazar, John Fotlades, Andrew Rothschild, Laura
Andreae, M. Hasan Jethabhai, Bruce P. Mindich, M.D.,
F.A.C.C., Mount Sinai Hospital, New York, New York.
Intraoperative Echocardioqraphy (IOE) is a new method to
evaluate ventricular and valvular function, which
requires technical expertise and may prolong the
procedure. Therefore, to determine the potential
benefits of IOE, we reviewed 1,000 consecutive operations
performed with IOE between 1982 and 1988 by a single
surgeon, for "new" information provided, alteration (alt.)
of operation (Le. valve procedure performed or not) and
therapeutic interventions (therap) dictated by IOE.
There were 570 men, 430 women, mean age 63 years, who
had: 409 valve operations; 230 coronary bypasses (CAD);
286 CAD and valve; 77 other procedures.
1982-83 '84 '85 '86 '87 '88
UOE ~ 2II 178 1~ 2~ In
valve 29 60 73 72 93 76
CAD + valve 5 23 39 54 83 31
CAD 30 116 56 44 39 16
% new 1 6 12 26 29 19
%alt 6 9 17 31 30 21
% therap 0 2.4 5.1 6 12.3 10
Of the 1,000 pts studied with IOE monitoring, the
operation was altered in 206 pts, new information
obtained in 174, and a therapeutic intervention was
instituted in 61 based on the IOE. IOE had significantly
greater impact on valvular than CAD cases (22.6% vs.
2.3%). Importantly, 35 pts needed re-institution of
bypass due to problems detected by IOE. Therefore, lOE
has a major impact on open heart surgery and can
significantly alter surgical and therapeutic approaches ...
24A ABSTRACTS lACC Vol. 13, No.2
February 1989:24A
CAN COLOR DOPPLER/TWO DIMENSIONAL ECHOCARDIOGRAPHY
IDENTIFY THE NEED FOR TRICUSPID VALVE REPAIR?
HirdaY K Chopra MD .• PoHoey Fan, M.D., Dinyar
Daruwa1a, M.D., Kanwa1 K. Kapur, M.D .• Raj Ba11a1,
M.D., Sally Moos, Navin C. Nanda, M.D., F.A.C.C.,
Albert D. Pacifico, M.D., F.A.C.C. University of
A1ab....a at BirJIingh..... A1ab....a
Tricuspid regurgitation (TR) severity was assessed
preoperatively by color Doppler in 94 Pts who subse·
quent1y underwent mitral and/or aortic valve replace'
ment. Of these, 56 Pts (Group A) also required tricus·
pid valve (TV) annu10p1asty because TR was judged to be
severe intraoperatively. In the remaining 38 Pts
(Group B) TV annu10p1asty was not done because TR was
judged not severe during surgery. Using apical 4 cham-
ber and parasternal short axis views, the severity of
TR was assessed by color Doppler by taking a ratio of
maximum area of TR signals to right atrial area. This
ratio was found to be >34' (mean 50.55±11.65') in 54/56
Pts (94') in Group A, and <34' (mean 27.53±6.96'.
p<.OOl) in 36/38 Pts (95') in Group B. Maximum dia-
stolic tricuspid annulus di....eter (using same 2D echo
planes) was >38mm (mean 44.79±7.03 mm) in 50/56 (89')
in Group A and <38mm (mean 28±5.67 mm) in 37/38 (97')
in Group B (p<.OOl). Percentage shortening of tricus-
pid annulus diameter (maximum minus minimum/maximum
diameter x 100) was <25' (mean 17.78±6.62') in 51/56
(97') in Group A, and >25' (mean 32.47±6.6') in 35/38
(92') in Group B (p<.001). Doppler derived pulmonary
artery systolic pressure and 2D echo RV ejection frac-
tion did not distinguish the two groups. Both color
Doppler and 2D echo are useful in identifying Pts who
would require TV repair for severe TR during mitral
and/or aortic valve replacement.
DIAGNOSIS OF LEFT VENTRICULAR PSEUDOANEURYSM BY COLOUR
DOPPLER FLOW MAPPING.
John Smyllie M.D., George Sutherland M.D., Jos Roe1andt
M.D., F.A.C.C., Thoraxcenter, Erasmus University,
Rotterdam, the Netherlands.
Left ventricular pseudoaneurysm (LVPA) is defined as a
cardiac rupture contained by adherent pericardium. It is
an unusual complication of myocardial infarction,
cardiac surgery and chest trauma. Due to the tendency
for LVPAs to rupture, early recognition is of paramount
importance, as surgical repair may be curative. Eleven
consecutive patients with cardiac rupture forming LVPAs
have been studied using colour flow mapping (CFM), 5
with acute rupture following myocardial infarction, 2
following stab wounds, 1 late rupture of a calcified
"true LV aneurysm", 1 post surgical resection of an LV
aneurysm and 2 resulting from LV venting. Recurrent
rupture following repair of LVPA occurred in 2 pts. The
study group therefore consisted of 13 cases. In all 13
~ases the diagnosis was confirmed by angiographic and
surgical information. The diagnosis was suspected
clinically in only 6/13. 2-D echo alone confirmed the
diagnosis in 7/13. In all 13 CFM demonstrated turbulent
trans-myocardial flow in and out of the LVPA cavity at
the rupture site as well as the abnormal flow pattern
within the pseudoaneurysm. Pulsed Doppler at the defect
site revealed a characteristic multiphasic "to and fro·
flow pattern whose peak velocity demonstrated a
consistent respiratory variation. This intracardiac flow
pattern is diagnostic of a LVPA. We conclude that in
view of the above findings CFM is a valuable addition to
2-D echo with integrated Doppler in the diagnosis of
cardiac rupture with LVPA.
QUANTITATIVE EVALUATION Of VENTRICULAR SEPTAL DEfECTS BY
COLOR DOPPLER fLOW IMAGING
Edward Har1amert, M.D.; Michael Harrison, M.D., fACC;
Hikel Smith, H.D., fACC; David Booth, M.D., fACC;
Claudine Moffett; Oi Ling Kwan, B.S.; Anthony DeMaria,
M.D., fACC; University of Kentucky, Lexington, Kentucky
Preliminary data have suggested that the severity of con-
genital ventricular septal defect(VSD) may be estimated
by color Doppler flow imaging(CDfl). However, no data re-
garding the usefulness of CDfl to predict the severity of
acquired VSD accompanying acute myocardial infarction
(AMI) has been reported. Accordingly, we performed CDfI
and cardiac catheterization in 13 VSD pts (7 with AMI and
6 children with congenital VSD). The interventricular
septum was interrogated in the standard parasternal, api-
cal and subcostal views to depict the largest flow dis-
turbance(jet) from the LV to RV through the VSD. Maximal
jet area(MJA) was measured as the outer border of the
largest clearly defineable jet during frame-by-frame
analysis. MJA was corrected for body surface area, as
MJA/BSA·maxima1 jet area index(MJAI), to standardize the
pediatric and adult populations. Cardiac catheterization
was performed to obtain hemodynamic and 0, saturation
information. MJA and MJAI were compared to shunt flow
ratio (QP/QS), RV to LV systolic pressure ratio
(RVP/LVP), and mean pulmonary artery pressure(MPAP). Re-
sults: MJA and MJAI correlates with QP/QS (r. 0.76 and
0.72 respectively) in adults with VSD secondary to AMI.
MJAI also correlates with QP/QS in congenital VSD and in
the combined population (r·0.71 and 0.70 respectively).
MJAI exhibits no correlation with MPAP (r·0.50) nor with
RVP/LVP (r·.55). finally, we observed that significant
(>2:1) s~Uniing through the VSD occurred on1Y2when ~I
was >4cm /m and in adults when MJA was >6 em . Thus,
these data indicate that the area of flow disturbance by
CDfI may be used to estimate the severity of VSD in pts
with AMI, as well as, pts with congenital lesions.
TWO DIMENSIONAL/COLOR DOPPLER ASSESSMENT OF VENTRICULAR
SEPTAL DEFECTS.
Albino de Souza M D Frederick He1mcke M.D .• Edward V.
Colvin, M.D., F.A.C.C., Benigno Soto M.D., F.A.C.C.,
Navin C. Nanda M.D., F.A.C.C., Robert P. Gatewood, Jr.,
M.D. University of Alabama at Birmingham, AL.
Color Doppler (CD) examinations were performed in 54
Pts with 58 ventricular septal defects (VSD) proven
surgically/anatomically. All Pts also had angiocardio-
grams. CD examination detected all VSDs and correctly
categorized the site and extension of VSDs in 49/58
(84'). All perimembranous (PM) VSDs were diagnosed in
the LVO short axis plane as an area of discontinuity
adjacent to septal tricuspid valve leaflet attachment.
Of 15 Pts with inlet extension, 13 showed color flow
signals only along the septal tricuspid leaflet. Of 23
PM VSD with outlet extension, 19 had flow signals mov-
ing directly towards the RV outflow tract. One PM VSD
with trabecular extension showed flow signals directed
toward RV anterior wall. Muscular VSDs were similarly
categorized correctly by CD as inlet, outlet and tra-
becular in 12/15 Pts. All 4 doubly committed VSDs were
correctly diagnosed as an area of discontinuity adja-
cent to the pulmonary valve in the short axis view with
flow signals directly moving through VSD into RV out-
flow and PA. CD misc1assified 2/15 PM inlet VSD, and
4/23 PM outlet VSDs probably because the VSD jet was
deflected by a fibrous tag (PM inlet) and aneurysm/pro-
lapse of aortic valve into VSD (4 PM outlet). Angiog-
raphy correctly detected all VSDs and correctly classi-
fied their site and extension in 46/58 (79'). It mis-
classified 3/15 PM inlet and 4/23 PM outlet VSD. It
also missed 3/15 muscular VSD and 1/4 doubly committed
VSD. The accuracy of CD approaches that of angiocardi-
ography in detection, location and extension of VSD.
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DEMONSTRATION OF JET ENTRAINMENT - AN INTERACTION WHICH
CAUSES PARALLEL JETS TO MERGE AND CROSS, IN-VITRO
EXPERIMENTS USING COLOR DOPPLER FLOW MAPPING AND OPTICAL
VISUALIZATION. Robin Shandas, B.S., Valdir Moises, M.D.,
Benedito Maciel, M.D., David J. Sahn, M.D., Dorian
Liepmann, M.S. Univ Calif, San Diego, CA.
The imaging of multiple jets within a single cavity,
such as in combined AO insuffiency (AI) and mitral sten-
osis (MS), has at times been confusing as the jets often
appear to merge and their velocities (VELs) are some-
times difficult to interrogate separately on continuous
wave (CW) Doppler studies. We studied the behavior of
dual parallel jets into a modeled LV chamber, by both
color Doppler flow mapping (CDFM) (Toshiba SSH65A, 3.75
MHz, 4kHz), and by optical visualization using india ink
and a high resolution video camera. When a medium to
low VEL (1-2.5 m/sec) jet entered the chamber through a
19mm' orifice parallel to a high VEL (4-7m/sec) laminar
jet flowing through orifices 0.05 to 1.5 mm' in the same
direction, the CDFM studies showed consistently that the
larger jet deviated toward the smaller jet, and rather
than repel each other away, the flow streams appeared to
meet and cross each other, resulting in a turbulent,
swirlinq flow towards the apex. With optical visualiza-
tion it was clear that VEL recruitment in the reqion
between the 2 jets draws the larger jet towards and
across the smaller jet, resultinq in their merging into
a turbulent deceleratinq flow. The resultinq anqu-
lar deviation for the larger jet towards the smaller jet
was as much as 45', sometimes resultinq in their
crossinq within 2cm of their oriqin. Our studies lend
insight into the behavior of multiple parallel jets,
such as the co-minqlinq of AI and MS jets which often
merge, regardless of the valve morphology, provided they
enter the ventricle in close proximity.
ABSTRACTS
CHRONIC REDUCTION OF LEFT VENTRICULAR VOLUMES
AT REST AND EXERCISE IN PATIENTS TREATED WITH
NITROGLYCERIN FOLLOWING ANTERIOR MI
Dennis P. Humen M.D., Lillian McConnick RTNM, and Bodh I.
Jugdult M.D. University of Alberta, Edmonton, Canada
Treatment with nitrogylcerin (NTG) has been shown to modify left
ventricular shape distortion following anterior wall MI (AMD.. In
order to detennine whether these anatomic changes affect function at
rest and exercise, a series of patients (pts) were studied in the post-
infarct period. All pts were treated with IV NTG for the first 48 hrs.
of hospitalization and then randomized to double-blind treatment
groups consisting of buccal NTG (1 to 3 mg) TID (19pts), or placebo
(14 pts). Patients were studied a mean of 10 months following
myocardial infarction. Study medication had been discontinued 6
weeks following admission for AMI.
Gated radionuclide ventriculograms were obtained at rest and at each
stage of a symptom-limited semi-recumbent exercise cycle protocol
consisting of 3 min stages and 25 W increments. Images were
analysed to obtain ejection fraction and left ventricular volumes using a
calibrated non-geometric method.
At rest there was no significant difference between groups in age,
heart rate, blood pressure, or ejection fraction. The NTG treated group
however, had significantly smaller hearts in systole and diastole at rest
which was maintained at submaximal exercise and at maximal stress.
EDy rest EDy ex ESy rest ESy ex
NTG 121±9* 139±H** 74±9* 80tH
PLACEBO 146±10 165±1 U 93±9 99±H
*p<.05 vs PLACEBO, *p<.05 vs rest values: mean±SD (mls)
We conclude that treatment with NTG for 6 weeks following AMI
modifies healing to provide smaller cardiac volumes at rest and
exercise. This beneficial effect is present long after withdrawal of the
interventional agent (NTG) and is considered to be secondary to
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Left Ventricular Function After Myocardial
Infarction
NATURAL BIS'l'OlfY or LIn' VDlTJUCULAR. PUlfCTIOlI CIWIGIS
An'IR MYOCARDIAL DIlARCTIOlI. Sidney O. Gottlieb,
H.D.,FACC, Lewis C. Becker, M.D., FACC, Alan D. Guerci,
M.D., E. David Mellits, Sc.D., Gary Gerstenblith, M.D.,
FACC. Johns Hopkins Med. Inst., Baltimore, Maryland.
The impact of strategies designed to decrease infarct
(MI) size is often assessed by serial non-invasive
measures of LV function. The natural history of global
and regional LV ejection fraction (El) changes was
therefore studied in 83 pts with acute MI (62 Q wave, 21
non-Q) who had not received thrombolytic therapy by
serial gated blood pool studies performed on days I, 10,
and 42. (Data are presented as mean ± SO):
Global EF(%) Q wave(62) Non-Q (21)
Day 1 52 + 12 61 + 12
Day 10 51 :+: 12 61 +10
Day 42 49 +11 60 :+: 9
REMOTE ZONE EF(%) - -
Day 1 62 ± 11 65 + 10
Day 10 58 ± 13 64 + 12
Day 42 54 ± 13 62 ± 12
INFARCT ZONE EF(X)
Oily 1 34 + 12 44 + 13
Day 10 41 + 16 51 +11
Day 42 38 ± 15 51 +11
Thus, during the first 6 weeks post Hi, global EF
remained constant while infarct zone El increased and
remote zone EF decreased in both Q and non-Q wave MI
(p<.Ol for regional EF changes ANOVA over time for both Q
and non-Q groups). The spontaneous improvement in infarct
zone EF appeared to be complete by 10 days, suggesting
that resolution of myocardial stunning occurs within this
time frame. This natural history data must be considered
when evaluating the impact of interventions designed to
preserve regional LV function.
TIKI COURSE OF IMPROVED ruICTIOI rOLLOVIIG POST-
I1P.&ICmII BGIOI'LlSl'I: 15VIDI!ICB POI "RD!IlRJm(Jl" B9JII
IX -DlPAIlC'l'IlD" MrocuDIlII.
Michael Drossner, M,D" JllII8S L, Weiss, M,D" F,A,C,C"
Gary Gerstenblitb, M,D" F,A,C.C., Jean Cadden, Harlan F,
Weisman, M.D., F.A,C,C" Jeffrey A. Brinker, M.D.,
F,A.C.C" Johns Hopkins Hospital, Baltimore, Maryland,
There has been considerable interest in the role of
"hibernation" in dysfunctional regions early post-
infarction, We examined the effect of coronary
angioplasty (PTCA) of flow-limiting lesions serving
infarct zones, The time course of the change in regional
myocardial function following PTeA of the infarct related
artery performed a mean of 8 days post-infarction in 15
stable patients was studied by two d1llenaional echoes
(2DE) obtained before, and then one day and four weeks
following PTCA, 2DEB were read in a blinded randomized
fashion by 2 observers, Wall motion was scored for 7
segments: -1-dysldnetic, D-akinetic, I-bypokinetic,
2-normal, Results over time were analyzed by ANOVA,
Average infarct score increased from 0,96+,16 before PTeA
to 1.26;t,14 one day following PTeA and-to 1.32±,16 at
four weeks (p-,OOI), Global EF, by the bullet formula,
increased from 4Q±2% before PTCA to 51~% at one day and
to 5~3% at a mean of four weeks (p-,OI), Thus, most of
the improvement in infarct zone function after PTCA was
iDDediate as evidenced by a 31% improvement in infsrct
score at one day and only an additional 5% improvement at
four weeks, Patients with the most severe wall motion
abnormalities before PTCA evidenced the most improvement
in infarct zone function, The early benefit in
hypokinetic, akinetic and dyskinetic areas indicates that
viable, reversibly depressed (i,e, "hibernating") regions
are present even in presumably "infarcted" myocardium and
that revascu1ar1zation results in functional improvement,
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LONG-TERM IMPROVEMENT OF LEFT VENTRICULAR FUNCTION
AFTER MYOCARDIAL INFARCTION WITH AND WITHOUT THROMBO-
LYTIC THERAPY BY LATE PTCA OF THE INFARCT-RELATED ARTERY.
Thomas L1nderer M.D.. Bellina GUhl, Julia Norlng, Thomas Brugge-
mann, Lulse Schnitzer M.D., Christoph Spielberg M.D.,Rol! Schroder
M.D.,F.A.C.C., Opt. of Cardiology, Kllnlkum Steglltz, Free University
Berlin, FRG
Low grade residual stenosis of the Infarct-related artery alter thrombo-
lytic (LYS) treatment of myocardial Infarction (Mil results In long-term
Improvement of LV function, as we showed In a previous stUdy. The
aim of this stUdy was to evaluate the ellect of treatment of a hlgh-
grade residual stenosis by elective PTCA on LV function alter MI. We
compared ejection fraction (EF) and regional wall motion abnormal-
Ities (asynergy Index) from Lvanglograms before and 7 months alter
successful PTCA In 145 pts with previous MI. Data were analyzed
with regard to time between MI and PTCA (~30 days, mean 14 days
or ,.30 days, mean 9 months), thrombolytic therapy (LYS or no LYS)
and baseline EF (~55% or,. 55%).
Results:
Ejection fraction Asynergy Index
N before 7 mo p before 7 mo p
"0 days 75 63 66 0.013 113 69 0.005
'30 days 70 57 61 0.002 193 117 0.000
LYS 72 62 65 n. s. 118 75 0.012
no LYS 73 58 63 0.000 185 109 0.000
EF >55% 101 67 68 n. s. 64 47 n. s.
EF 5055% 44 44 54 0.000 352 197 0.000
Sustained left ventricular function benefit one year
after thrombolytic therapy.
Harvey White M.B•• F.A.C.C •• John Rivers M.B•• M:>rimasa
Takayana M.D•• Michael Brown M.B•• Robin No=is M.D••
John OIllliston M.B••
Green Lane Hospital. Auckland. New Zealand.
Early Presexvation of left ventricular function has been
well shown following thrartlolytic therapy. However. it
is not known whether this benefit is maintained long-
teDII. In a randanised doub6e-blind trial ofStreptokinase (sk) 1.5 X 10 u infused CNer 30 min vs
placebo 155 patients had biplane cineangiogrClllS at 3
weeks after a first myocardial infarction. At 12 months
119 patients (77%) had repeat cineangiogralll3. Analysis
of cineangiogralll3 was blinded and ejection fractions
(EF) and end-systolic voll.ll1eS (ESV) were measured.
Placebo Streptokinase £
3 weeks (n = 61) (n = 58)
~ 52 ± 12 59 ± 10 <: 0.05
ESV(ML) 72 ± 40 51 ± 22 < 0.05
12 llDnths
EF (%) 53 ± 13 60 ± 12 <0.05
ESV (ML) 72 ± 42 59 ± 35 * <:0.05
Concluslgns:
Restoration of sufficient flow through an Infarct-related coronary
artery Improves LV global and regional function Independent of
former thrombolytic therapy, even when PTCA Is performed late
alter MI. Patients with severely depressed LV function seem to
benefit most.
* A ESV in sk group fran 3 weeks to 12 lICI1ths. P = 0.01
CXN:WSlOO After thrartlolysis the left ventricular
ejection fraction benefit is maintained at one year. In
addition end-systolic volunes are smaller than in
placebo-treated patients rot left ventricular dilatation
occurs in the Streptokinase-treated patients.
Early infusion of APSAC in AMI is safe, produces a high
short-term patency rate and a significant preservation of
LV function especially in ant. MI.
J. Machecourt, J. Cassagnes, J. P. Bassand, J.E. Wolf, J.R.
Lusson, T. Anguenot, D. Vacher, E. Borel, F. Schiele.
University Hospital 38000 GRENOBLE FRANCE
IMPROVEMENT OF GLOBAL AND REGIONAL LEFT VENTRI-
CULAR FUNCTION WITH INTRAVENOUS APSAC IN ACUTE
MYOCARDIAL INFARCTION. RESULTS OF A MULTICENTER
DOUBLE BLIND TRIAL.
231 pta were randomly allocated within 5 hours after
the onset of a first myocardial infarction (MI) either to
anisolated streptokinase plasminogen activator complex
(APSAC) 30 mg over 5 minutes or to heparin (5000 IU bolus).
A RAO left ventricular (LV) angio was performed under
nitroglycerin infusion (l mg/hour), II±.I.I days later and
blindly analyzed : LVEF were measured by the Simpson
method ; regional wall motion by the Leighton method :
according to the shortening of each LV herniaxis, a dysynergic
score was ca1culated for each pt. The coronary patency
rate was 7796 in APSAC and 3796 in Heparin** :
**
Monday, March 20, 1989
4:00PM-5:30PM, Garden Grove Room
Anaheim Convention Center
Prognosis After Myocardial Infarction
IS COMPLETE HEART BLOCK IN INFERIOR MYOCARDIAL INFARC-
TION A BENIGN PHENOMENON FOLLOWING REPERFUSION THERAPY?
P Clemmensen M.D., ER Bates M.D. F.A.C.C., RM Califf
M.D. F.A.C.C., MHlatky M.D. F.A.C.C., BS George M.D ..
OJ Kereiakes M.D. F.A.C.C., L Aronson B.S., E Berrios
R.N., EJ Topol M.D. F.A.C.C. Duke University Medical
Center, Division of Cardiology, Durham, North Carolina
and the TAMI Study Group.
In the pre-thrombolytic era it was established that com-
plete heart block (CHB) in Pts with inferior myocardial
infarction (IMI) was associated with increased mortali-
ty. To assess the outcome of Pts with CHB after reper-
fusion therapy, 372 consecutive Pts entered into the
TAMI Trials with IMI and the infarct related artery (IA)
angiographically identified as the right coronary artery
were studied. In the 54 (15%) Pts who developed CHB the
majority of the episodes originated on the first day
(87%). The table displays acute and follow up findings
in the 2 groups. (Mean + I standard deviation (SO»).
- NO CHB CHB
N 3W M
Age 56 ! 10 59 ! 10
LV Ejection Fraction (%) 55 + 10 54 + 9
Delta EF day 7 (%) 0 +" 8 .4 +" 6 *
Infarct zone (SO/chord) -2.37 +" 1.1 -2.88 +" 1.0
Multivessel disease 661 57%
Reocclusion 16% 27%
IA patency 91% 89%
Mortality 4% 19%
* p =0.025, ** P < 0.001.
Conclusion:
The occurrence of CHB during IMI treated with reperfu-
sion therapy is an ominous sign and should not be igno-



















** P <.002 - *p
lACC Vol. 13. No.2
February 1989:27A
ABSTRACTS 27A
EARLY INTERVENTION WITH LOW DOSE ASPIRIN IN FIRST ACUTE
TRANSMURAL ANTERIOR MYOCARDIAL INFARCTION : INFARCT SIZE,
CLINICAL OUTCOME AND FOLLOW-UP
Thus, early intervention with low dose ASA in first
transmural anterior AMI does not seem to influence infarct
size. However, early ASA reduces the incidence of rein-
farction. Prevention of reinfarction rather than reduction
of infarct size might be the basis for the excellent re-
sults of early intervention with ASA in pts with AMI.
MYOCARDIAL INFARCTION WITH MINIMAL CORONARY ATHEROSCLERO-
SIS: A SYNDROME OF YOUNG WOMEN WITH GUARDED LONG TERM
PROGNOSIS.
D.J. Kereiakes. M.D. F.A.C.C., E.J. Topol, M.D. F.A.C.C.,
B.S. George, M.D., C.W. Abbottsmith. M.D. F.A.C.C., R.J.
Candela, M.D. F.A.C.C., L. Anderson, R.N. B.S.N., L. Aron-
son, B.S., R.M. Califf, M.D. F.A.C.C., The Christ Hospital
Cincinnati, Ohio.
Myocardial infarction (MI) usually follows coronary throm-
bosis in patients with severe coronary stenosis. We found
a residual coronary stenosis (RS) of < 50% documented
angiographically at 90 min of therapy-in 43 of 777 (5.5%)
patients enrolled in The Thrombolysis and Angioplasty in
Myocardial Infarction (TAMI) Trials of intravenous throm-
bolytic therapy with tissue plasminogen activator (t-PA),
Urokinase (UK) or combination t-PA/UK therapy for MI.
Compared to patients with:> 50% RS at 90 min, patients with
minimal RS were younger (median 49 vs 57 yrs; p-~OOl),
more often women (28% vs 19%; p-.026), had fewer diseased
vessels (100% < 1 vessel disease vs 50%; p-<.OOl) and had
better resting-LV function (median LVEF 57% vs 51%; p-
.018). History of angina, smoking and infarct artery
location were similar in both groups. Hospital mortality
was 7% in RS >50% and 2% RS ~50%. At mean follow-up> 1.5
yrs. non-fatal reinfarction and death were similar for
both groups (8% and 5% RS < 50% vs 5% and 3% RS >50%J
Minimal coronary atherosclerosis after thrombolysis pre-
dominately affects young women and is likely due to throm-
bosis and/or spasm. Although minimal RS patients are
younger, have better LV function and less extensive coron-
ary disease, they remain at substantial risk for reinfarc-
tion or death despite empiric therapy with aspirin, cal-





















Freek W.A. Verheugt, M.D., F.A.C.C., Arnoud van der Laar-
se, M.D., Albert J. Funke Kupper, M.D., Luc G.W. Sterkman,
M.D., Jan P. Roos, M.D •• Department of Cardiology, Free
University Hospital, Amsterdam, The Netherlands
Recent reports indicate, that low dose aspirin (ASA) gi-
ven early to patients (pts) with acute myocardial infarc-
tion (AMI) improves short-term survival. However, the me-
chanism of mortality reduction with early ASA is unclear.
In a prospective double-blind trial we randomised 100
consecutive pts with first transmural anterior AMI within
12 hours after first symptoms to 100 mg ASA qd (n=50) or
placebo (PLBO, n-50). Intravenous thrombolytic therapy «
4 hours after symptom onset) was given to 50 pts (24 ASA,
26 PLBO). as was 50 mg subcutaneous heparin to all pts bid
till mobilisation. Infarct size was measured as cumulative
plasma release of lactate dehydrogenase within the first
72 hours after admission (LDH72). Study medication was
continued during the first 3 months and follow-up is com-








ea entr cu ar
100 Pts. Tachycardia(ll)
WMI-l ~ 2.0 9 <0 01 7 N SWMI-l < 2.0 3 P • 4 ••
WMI-2 ~ 2.0 111 p<O.OOl 9 <0 02WMI-2 < 2.0 2 P •
ASSESSING INFARCT EXPANSION IN AN ECHOCARDIOGRAPHIC WALL
MOTION INDEX IMPROVES PREDICTION OF OUTCOME AFTER
MYOCARDIAL INFARCTION.
Jay H. Chap~, M.D., Louis A. Nassef, M.D., F.A.C.C.,
R1chard J. Butcher, M.D., F.A.C.C., Francis J. Menapace,
M.D., F.A.C.C., Geisinger Medical Center, Danville, Pa,
To test if measuring infarct expansion (IE) improves the
echocardiographic prediction of in-hospital complications
after myocardial infarction, an established 14 segment
wall motion index (WMI-l) was modified to include a bias
for IE (WMI-2). Echocardiograms from within 72 hours of
admission were analyzed blinded to outcome in 100 pts.
with a first myocardial infarction not treated by reper-
fusion. Criteria for IE were abnormal LV diastolic con-
tour with regional cavity enlargement (defined if apical
long axiS/LV long axis length ~ 0.5 or if basal abnormal/
normal short axis length ~ 1.2). Criteria for aneurysm
were as above plus discrete demarcation of normal from
abnormal segments and suitability for surgical resection.
Segments were scored in WMI-l as I-normal, 2=moderate
hypokinesis, 3-akinesis, 4-dyskinesis, 5-aneurysm, and in
WMI-2 as I-normal, 2-moderate hYPOkinesis, 3-akinesis,
4-dyskinesis plus 1 for IE and 2 for aneurysm. Mean
scores er se ent were re orted.
Sens1t1v1ty' .75 vs .92 .64 vs .82
Specificity* .68 vs .64 .66 vs .62
*Results are WMS-l vs WMS-2.
CONCLUSION: Ameasure of infarct expansion improves the
echocard10graphic prediction of in-hospital complications
after first ~oc~rdial infarction.
AGE RELATED RISK FACTORS AND MECHANISM OF DEATH
FOLLO WING MYOCARDIAL INFARCTION. EXPERIENCE FR()I THE
MULTICENTER DILTIAZEM POSTINFARCTION TRIAL.
Frank I. Marcus, MD, FACC, Karen Friday, MD, FACC, John
Me Cans, MO, 'Thomas E. Moon, Ph.D., Elizabeth Hahn, MA,
Leonard Cobb, MD, FACC, Jesse Edwards, MD, FACC, and
Lewis Kuller, MD, FACC. University of Arizona Health
Sciences Center, Tucson, Arizona.
The basis for the excess mortality with age after acute
myocardial infarction (AMI) is not clear, nor is it
known whether the mode of death is altered with age. We
examined age related factors predictive of mortality and
age related mechanisms of the 333 deaths in 2466
patients after AMI. There were 3 age groups with
increasing mortality rates, ages 25-49 {N=499}, 50-64
(N=1228) and 65-75 (N=739).There was a significant age
related increase in the proportion of patients with the
following baseline characteristics: NYHA functional
class II-IV one month before AMI, pulmonary congestion
by chest xray, VPCs > lO/hr, BUN>35 mg/dl, and a
decrease in the use of beta blockers at randomization
(all p=.OOOl) as well as an increase in the proportion
of pts with prior MI and LVEF < 40% (p=.OO7 and .047
respectively). These baseline characteristics did not
differ by treatment (placebo vs diltiazem}.However,
multivariate Cox proportional hazard regression still
identified age as an independent risk factor for cardiac
death.The proportion of arrhythmic and myocardial
failure deaths did not vary by treatment or age group
(p=1.0 and pz.70 respectively).Conclusion: There is an
increased proportion of baseline riSk factors after AMI
with increasing age; however, age itself is an
independent risk factor for cardiac death.The mechanism
of death does not di ffer wi th age.
28A ABSTRACTS JACC Vol. 13, No.2
February 1989:28A
ANTECEDENT ANGINA: A CLINICAL HARKER FOR PATIENTS AT
RIGH RISK FOLLOVINGTBROHBOLYTIC THERAPY.
Nicholas A. Ruocco, Jr., H.D., FACC, Bruce Bergelson,
H.D., David P. Faxon, H.D., FACC, Thomas J. Ryan, H.D.,
FACC, for the TIHI Investigators, Boston University
Hedical Center, Boston, MA.
To determine whether a history of angina prior to myo-
cardial infarction (HI) identifies patients (pts) at
higher risk for subsequent ischemic events following
thrombolytic therapy we analyzed data available as of
6/5/88 from the TIHI II B Trial. Among the 1629 pts who
received rt-PA and were randomly assigned to No-PTCA,
842 had antecedent angina (AA). Compared to those
without AA, they had significantly more hypertension
(42.7% vs 32.9%, p<.OOl), a greater incidence of prior
HI (23.4% vs 3.6%, p<.OOl) and experienced more post
infarction angina (30.3% vs 21.3%, p<.OOl), and re-
current infarctions while hospitalized (4.8% vs 2.5%,
p<.02). The need for emergency catheterization and CABG
prior to discharge was significantly higher in the group
with AA (14.0% vs 8.6% and 11.4% vs 5.5%, respectively,
p<.OOl). Exercise tests at discharge were positive more
frequently in the AA group (25.5% vs 18.9%, p<.OO5).
Angiography data from 1435 pts undergoing routine cath-
eterization per protocol from the 1634 similar pts ran-
domly assigned to 18-48 hr PTCA showed a more signifi-
cant residual stenosis among the 752 pts from that
cohort who had AA compared to those without AA (80.9% +
0.7 vs 76.3% + 0.9, p<.OOl). These data suggest AA -
identifies a high risk subgroup of pts following throm-
bolytic therapy. The influence of routine coronary
arteriography followed by appropriate revascularization
in this clinically identifiable group will be discussed.
Monday, March 20,1989
2:00PM-3:30PM, California Room C
Anaheim Convention Center
Assessment of Myocardial Viability by Nuclear
Methods
EAKLY POST-TIIROMBOLYSIS ASSBSSMIlIT OF RECaOSIS All])
VIABILITY WITH UST-REDISTRIBUTIOIi TllALLI1JK SCIlITIGIlAPBY,
COIlllBLATIOIi WITH POSITROIi BKISSIOIi T<HlGRAPBY (PET).
Todd S. Kotler MD, Christoph Nienaber MD, Allan S. Lew
MD, FACC, Jamshid Haddahi MD, FACC, Heinrich Schelbert
MD, FACC, Daniel S. Berman MD, FACC, Cedars-Sinai Medical
Center and UCLA School of Medicine, Los Angeles, CA.
The ability of day-l rest-redistribution planar thallium-
201 myocardial scintigraphy (Tl) to distinguish between
viable and necrotic myocardium following thrombolysis was
studied in 11 pts with first anterior MI and documented
reperfusion. Nine segments comprising the LAD territory
on rest, 4 and 24 hr planar Tl images were scored visu-
ally (O-normal to 3-severe defect). Redistribution scores
were summed to yield indices of necrosis based on 4 and
24 hr images. These results were correlated with N-13-
ammonia and F-18-deoxyglucose PET images on day 33±15.
Necrosis and viability by PET were based on circumferen-
tial profile analysis. The percent necro~is by both 4 and
24 hr Tl correlated with PET (r-.74, p-.009), but Tl
overestimated necrosis relative to PET (alope of regres-
sion-3.4). Tl and PET images were also compared for seg-
mental agreement in 3 composite segments in the LAD ter-
ritory. PET showed criteria for viability in 5/6 normal
Tl segments, 6/7 segments with reversible Tl defects and
10/20 segments with non-reversible Tl defects at 4 hrs.
There were similar results at 24 hrs.
Conclusions. 1) A visual index of necrosis derived from
early post-thrombOlysis Tl correlates with the extent of
necrosis by PET; 2) a normal or reversible pattern of Tl-
201 uptake is predictive of viability; but 3) 50: of
segments with nonreversible Tl defects also showviabil-
ity by PET. These results suggest that Tl-201 myocardial
uptake is a specific but insensitive marker of viability
in the early period following thrombolysis.
RECOVERY OF MYOCARDIAL METABOLISM BY PET
PRECEDES IMPROVEMENT OF ISCHEMIC WALL MOTION
AFTER PTCA.
CbrtslAAb Nlenabtr M P Richard Brunken M.D., F.A.C.C., Todd Shennan
M.D., Lawrence Yeatman M.D., Sanjlv S. Gambhlr M.S., Janlne Krivokapich
M.D., F.A.C.C., linda Derner M.D., Ph.D., John Child M.D., F.A.C.C.,
Heinrich SChelbert M.D., F.A.C.C., UCLA School of Medicine. Los Angeles,
Calfomlr
To evaluate the temporal relationship between recovery of regional
function, blood flow and glucose metabolism in post-ischemic myo-
cardium, we studied 11 pts with 2-D echo and PET using N-13
ammonia and F-18 deoxyglucose before and within 48 hours of
PTCA (Group I). Five pts (Group II) were re-studied at 63±17 days.
Wall motion abnormalities (WMA) as independently graded on a
scale from -1 (dyskinetic) to 3 (normal), were present in all areas
supplied by the target vessel (9 LAD, 2 CFX) and displayed
metabolism-perfusion mismatch (MM) prior to PTCA. Pre· and post-
PTCA area stenosis was evaluated by quantllative coronary
angiography. Circumferential profile analysis was used to quantify
MM extent as % myocardium affected and MM score as the product of
MM extent and devIation from normal.
Results: Pre-PTCA Post·PTCA FIU-PTCA
% area stenosis 90 ± 9.6 53 ± 24'"
MMExtent t 24.7 ±13 9.8 ±9.1**
Ii: 26.1 ± 16 5.3 ± 5.5** 3.35 ± 3.3"
MM Score I 202 ± 291 53.7 ± 121**
II: 256 ±368 15.4 ±25** 8.2 ±7.7*"
WMScore t 0.84 ±.82 1.22 ±1.14
Ii: 0.61 ± .87 0.94 ± 1.04 1.1 ± 1.0*
Segments w WMA: 5.5 ±4.3 4.7 ±3.3 2.6 ±2.1*
.05; ** <.02; *.. <.001 vs re-PTCA
ocuments success u y Improvement 0
myocardial blood flow/metabolism mismatch and predicts delayed
recovery of wall mOlion. 2, Improvement in blood flow and metabo-
lism precedes recovery of function in post-ischemic myocardium.
FREQUENCY OF LATB DBFECT UVBRSIBILITY IN SPBCT TL-201
STRESS REDISTRIBUTION STUDIBS. L. de Yang, H.D., D.
Berman, H.D., FACC, H. Kiat, H.D., K. Resser, J.
Friedll8ll, H.D., L. Roy, A. Rozanski, M.D., FACC.,
J.Haddahi, H.D., FACC. Cedars-Sinai Hedical Center, Los
Angeles, CA
To determine the frequency of late (18-72 hr)
reversibility (LR), we assessed 118 consecutive pts who
had multiple non-reversible (NR) defects at 4 hr on Tl-
201 stress-redistribution SPBCT and underwent 24 hr
imaging. On SPBCT, 20 segments were scored visually.
Fifty-three % (62/118) of pts and 22% (164/762) of 4 hr
NR segments deaonstrated LR. Of 1047 segments
demonstrating stress defects, 27% (285) demonstrated R by
4 hrs, significantly less than the 43% (449)
demonstrating R by combined 4 hr and late imaging
(p(.OOOI). Hare pts with LR had BeG ST depression (57% vs
25%, p<.OOO5) , chest pain (23% vs 14% p-NS), and fewer
had prior HI (53% vs 66% p-NS) than pts with only late NR
defects. To evaluate if selection bias for late imaging
influenced our results, pts haVing late studies were
compared to 98 randomly selected pts with 4 hr NR defects
but without late imaging. Clinical and EOG indices of
ischemia and frequency of prior HI were comparable, and
Tl-20l defects were only slightly more extensive and
severe in the late imaging group vs the group imaged at 4
hr only.
Conclusion: LR is common, occurring in approximately 1/2
of pts and 1/5 of regions with 4 hr NR stress defects.
Late imaging significantly increases the detection of
reversible defects by Tl-20l SPECT. The much higher
as.ociation of BOG evidence of i.cheaia in pt. with La
compared to pts with only late NR defects suggests that
LR reflects myocardium that is still viable but highly
jeopardized. Thus, our results suggest that pts with NR
defects at 4 hr should undergo late imaging.
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RIBOSE INFUSION POST-ISCHEMIA ALTERS THALLIUM-20l
MYOCARDIAL CLEARANCE IN PATIENTS WITH CORONARY DISEASE.
Neal Perlmutter M.D., Richard Wilson M.D., F.A.C.C.,
Debra Angello M.D., Robert Palac M.D., F.A.C.C. Oregon
Health Sciences University, Portland, Oregon.
We have previously shown that ribose infusion post-
ischemia accelerates thallium-20l (Tl-20l) redistribu-
tion in pts with coronary artery disease (CAD). In or·
der to investigate the mechanism of this effect, 17 pts
underwent two exercise Tl-20l stress tests, performed 1-
2 weeks apart. After immediate post-exercise planar
imaging, pts received either intravenous ribose (3.3
mgjkg/min x 30 min) or saline. Imaging was then per-
formed one and four hours post-exercise. Pts exercised
to the same double product on the second test and re-
ceived the opposite infusion. Blood thallium levels
were drawn before, during, and at the end of infusion,
as well as at 30, 60, 120, and 180 minutes post infu-
sion. Reversible defects (by count profile analysis)
identified 55 ischemic regions; corresponding non-
ischemic regions contained the maximum Tl·20l activity
in that projection. Tl-20l clearance rates for both
regions were calculated as t washout. At one hour post-
exercise, Tl·20l clearance in nonischemic regions was
higher after ribose infusion, as compared to saline
(24.3±3.9 vs. 19.8±3.4t, p-O.OOl). Simultaneously, in
ischemic regions, Tl·20l clearance was lower after ri-
bose infusion (11.0+3.2 vs. l3.5±3.lt, p-0.02). At four
hours post·exercise, nonischemic regional Tl·20l clear-
ance remained higher after ribose infusion (48.6±3.l vs.
40.2±4.2t, p-0.00004), although no differences were seen
in ischemic regional clearance. Tl-20l blood levels
were not significantly different between the two tests.
Ribose appears to accelerate Tl-20l redistribution in
pts with CAD by altering Tl-20l myocardial clearance,
mostly by accelerating nonischemic Tl-20l washout.
RELATION OF MODIFIED FATTY ACID UPTAKE TO WALL MOTION
AND CORONARY ANATOMY. ,
Vasken Dilsizian M D , Thomas P. Rocco, M.D., Alan J.
Fischman, M.D., Charles A. Boucher, M.D., F.A.C.C., H.
William Strauss, M.D., F.A.C.C. Massachusetts General
Hospital, Boston, Massachusetts.
To assess modified fatty acids (MFA) as an imaging
approach for coronary artery disease (CAD), we studied
10 such pts who underwent symptom-limited maximal
exercise and cardiac catheterization (CATH). The
regional distribution of 1-123 labeled 9-methyl-
pentadecanoic acid (MFA) at peak exercise (initial)
was compared to segmental wall motion (WM) and percent
coronary stenosis by CATH. No pts with unstable
angina or acute-phase myocardial infarction were
included. Images were acquired in the 3 standard
projections and segmental MFA uptake score was
assigned as either abnormal (reduced/ absent) or
normal. CATH WM was scored as normal (NL) , hypo-
kinetic (HK) or akinetic (AK). WM data were available
in 77 segments. The MFA correlation data follow;
MFA Uptake Segmental Wall Motion
Initial NL HK AK
Normal 35 12 1
Abnormal 8 12 9
p<.OOl by Chi-square analysis
Thus, in viable segments, as evidenced by preserved
wall motion (NL or HK), initial MFA uptake is normal
in 47/67 (70%), in contrast to only 1/10 (10%)
segments with akinesis. Of the 9 AK segments with
abnormal MFA, 5 had total coronary occlusion, and 4
had critical but subtotal stenosis.
In conclusion, MFA uptake correlates with regional
wall motion and coronary anatomy in CAD pts.
NON-INVASIVE IDENTIFICATION OF VIABLE VERSUS INFARCTED
MYOCARDIUM BY AUTOMATED THREE-DIMENSIONAL CARDIAC
POSITRON EMISSION TOMOGRAPHY WITH GENERATOR PRODUCED
RUBIDIUM -82.
Dahlia Garza.M.D., David R. Sease,M.D., Michael E.Merhige,
M.D.,FACC, Keri Hicks,M.S., Nizar Mullani,B.S., K. Lance
Gould,M.D.,FACC. The University of Texas Medical School,
Houston, Texas.
In order to determine whether transmural myocardial infarc-
tion vs viable myocardium can be determined by positron
emission tomography (PET) perfusion imaging of generator
produced rubidium-82 (Rb-82), seven acutely instrumented
dogs had cardiac PET using intravenous Rb-82 and intra-
atrial radiolabelled microspheres before, during, and
after snare occlusion of the left anterior descending
artery. Animals were sacrificed, heart slices soaked in
triphenyltetrazolium chloride (TTC), and, at the center of
the infarction, percent of transmural wall thickness that
was TTC - was measured visually by ruler. Heart slices
were then cut into one gram samples, labelled as TTC +, -,
or +/- and microsphere perfusion in cc/g/min determined.
PET images were automatically processed to provide
short axis tomograph. Relative perfusion as percent of
normal in tissue samples by microspheres closely paralelled
absolute perfusion in cc/min/g and predicted normal,
critically ischemic, mixed infarcted/viable, and infarcted
myocardium from relative perfusion distribution rather
than absolute flow. Minimum activity of Rb-82 at the center
of image defects, expressed as percent of normal by PET,
correlated linearly (r-.95) with percent wall thickness
that was infarcted (TTC -) at the center of the infarct.
CONCLUSION: The presence of transmural myocardial infarc-
tion vs ischemic viable myocardium can be non-invasively
determined by automated three-dimensional cardiac PET with
generator produced Rb-82.
Monday, March 20,1989
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TC-99m Isonitriles in the Evaluation of
Perfusion
THE ASSESSMENT OF ISCHEMIA DURING OCCLUSION AND REPERFU-
SION USING METHOXY-ISOBUTYL ISONITRILE.
Albert Sinusas M.D.
t
Kimberly Weber B.S., Denny Watson
Ph.D., Todd Greenwa d M.D., Mirta Ruiz M.D., William
Smith M.S., George Beller M.D. F.A.C.C., University of
Virginia, Charlottesville, Virginia.
Methoxy-Isobutyl Isonitrile (MIBI) lends i tseH to the
evaluation of myocardial salvage following reperfusion
(RP), since it does not redistribute. To define MIBI
uptake before and after RP, 11 open chest dogs underwent
3 hrs of LAD occlusion (OCC) and 3 hrs of RP. MIBI was
injected either during OCC (5 dogs; Group I), or after 90
min of RP (6 dogs; Group II). An in vivo risk area (IRA)
was planimetered from MIBI autoradiographs of myocardial
slices. Anatomic Risk Area (ARA) and infarct areas were
defined by dual injection of monastral blue and TTC post-
mortem. ARA (34 ± 7% LV; n-ll) and infarct areas (15 ±
5% LV) were comparable in both groups. Flow was assessed
by microspheres. The LV was divided into 96 segments for
gamma well counting, and resulting flows and MIBI activ-
ity were normalized to non-ischemic values. In Group I,
MIBI endocardial uptake following injection during OCC
correlated linearly with OCC flow (r=0.79). In Group I,
IRA by MIBI was consistently smaller (IRA _ 0.68 x ARA +
0.9; r=0.89), than the ARA reflecting the contribution of
collateral flow. In Group II, MI8I uptake in the central
ischemic zone 90 min after RP, was 25 ± 21% of nonisch-
emic uptake, whereas flow was restored to 86 ± 61% of
nonischemic flow. Endocardial HI81 uptake during RP
correlated better with the OCC flow (r=0.88) in these
dogs.
Thus, 1) MI8I uptake during OCC defines an in vivo
risk area which is smaller than the anatomic risk area,
and 2) MI8I uptake at 90 min of RP following 3 hrs of
OCC appears to be reflective of ischemic conditions, and
not just flow restoration.
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SERIAL afANGES IN MYOCARDIAL PERroSICN USING 'lUollGRAPHIC
TrolNE:l'IUM-99M METHOXY lSOBl1lYL ISCNITRIIE (Tc-MIBI)
FOLI.OmlG REPERroSICN 'lHERAPY OF MYOCARDIAL INFARCTICN
Patricia A. Pellikka, M.D., 'Ib:ltas Behrenbeck, M.D.,
Mario s. Verani, M.D., FAf:(;, Jd'ln J. Mahrrarian, M.D.,
Frans J. Wackers, M.D., FACe, Raynond J. Gibbons, M.D.,
FAf:(;, Mayo Clinic, Rochester, Mirmesota.
Resting myocardial perfusion iIrages using Tc-MIBI were
obtained in 19 patients during their first acute myocar-
dial infarction. Tc-MIBI was injected intravenously
BEFORE acute treatment with thratix>lytic therapy or
coronary angioplasty at 18 to 48 hours (FARLY), and at 7
to 14 days (LATE). '!he absence of redistribution of
Tc-MIBI penni.tted tarographic iIraging up to 8 hours
after administration to deteImine the extent of hypoper-
fused myocardiun (% LVHYPO) at the time of administra-
tion. % LVHYPO was quantita,ted by a technique validated
in phantans (r=O.99 VB true defect). Reperfusion was
successful in 14 patients; 5 patients had persistent
occlusion of the infarct-related artery. In the patients
with reperfusion, there was a significant (p<.03) decrease
in % LVHYPO between the BEFORE and FARLY studies (-8%*13%)
oansistent with myocardial salvage, and a further decrease
(p<.OOO3) between the BEFORE and LATE studies (-16%:1:12%).
In the 5 patients with persistent occlusion, there was
an insignificant increase in % LVHYPO in the oantrol
patients FARLY (2%:1:6%) and lATE (1%:1:7%). % LVHYPO
measured LATE correlated significantly (r=-O.82) with
resting ejection fraction and with regional wall llOtion
score in the infarct segrrent (r=-O.80 for anterior,
r=-O.78 for inferior). Conclusions: 1) TarDgraphic
Tc-MIBI is an excellent quantitative tool for assessing
the efficacy of reperfusion therapy in acute myocardial
infarction. 2) IIlproverrent in myocardial perfusion is
detectable by 18-48 hours, and substantial additional
improvement occurs LATE.
~~~=~~~;:~~:.~?:- ~Fi~g::<f~~e&~~i
Jose R. Amiri. M.D" Fayez Dawood, B.Sc., Charles Lefkowitz,
M.D., Ray Mey, B.Pharm., Peter Uu, M.D. FAe.e. Toronto
General Hospital, Toronto, Canada.
Coronary reperfusion (REP) can be associated with the "no
reflow" phenomenon, limiting the efficacy of reperfusion. To
define "no reflow", particulate tracers such as microspheres (MS)
have been used, which are of considerable size. Therefore it is not
clear whether diffusion of micromolecules to the "no reflow" area is
also impaired during reperfusion, and whether metabolic substrates
such as glucose can continue to reach these cells.
We studied 9 do~ using a 2 hr occlusion (OC)/1 hr reeerfusion
mO<Jel with M~ injected durin~ Oc, f~ediate~ after (IM~and
agam at 45 mm post-reperfusIOn. C-deoxygIucose (DG was
irifused during REP to assess metabolic activity; and Tc-M I, a
soluble small perfusion tracer was given at 55 min post-REP to
assess molecular diffusion. The heart was sliced and counted for
Tc-MIBI, DG and MS from infarcted (INF), border (BORD) and
normal (NML) zones as defined by TIC staining. Results are as
follows (mean.±. SD):
MicroiUREllOOd Flows hoca il 45mREfil IkMIlll OO~
INF .14.±..1 1.5.±.1.9 1.05.±.1.0* 2.58.±.2.3** 9.2.±.6.6
BORD .86.±..4 1.4.±..6 1.5.±..76 4.51.±.2.0 15.1.±.6.7
NML 1.2.±..5 1.5.±..58 1.7.±..91 5,.35.±.1.6 15.4.±.8.2,
a = flow in ml/min/gm; b = cpm/2IIl x 10:'; c = cpm/gm x 10";
* p <.03 INF vs NML; ** p< .01 INF vs NML
The correlation between Tc-MlBI activity and 45 min REP
microsphere flowwas excellent at r=O.92 (p < 0.001).
Conclusions: (1) Tc-MIBI and microspheres show similar
p~tterns of "no reflow", suggesting impairment of micromolecular
d~~ion: (2) D.e.oxyglucose uptake suggests fersistin~ metabolic
actiVity m the mfarct zone at 3 hours. (3 Combmed use of
Tc-MlBI and DG has the potential to monitor "no reflow" in man.
TOMOGRAPHIC MYOCARDIAL PERFUSION IMAGING VITH
TECHNETIUM-99m 2-METHOXY ISOBUTYL ISONITRILE (MIBI) AND
THALLIUM-20l: TIlE SENSITIVITY AND REPRODUCIBILITY OF
SEMI-QUANTITATIVE ASSESSMENTS OF MYOCAIUlIAL PEllFUSION
AND REGIONAL SYSTOLIC FUNCTION
A. lain KeGhie. MD, Joel K. Kahn, MD, Marvin S. Akers,
BS, Tracy L. Faber, PhD, James R. Corbett, MD, FACC.
U.T. Southwestern Medical Center, Dallas, TX.
Simultaneous assessments of segmental myocardial
perfusion and systolic function are possible with gated
tomography and technetium-99m 2-methoxy isobutyl isoni-
trile (Tc-99m MIBI). Thirty one patients were studied
following symptom limited exercise stress. Two blinded
observers assessed semi-quantitatively segmental per-
fusion (0-3) and systolic thickening (0-2); maximal
scores indicating normal perfusion or thickening,
snd scores of 0 indicating absence of perfusion or
thickening. Twenty-eight segments from four representa-
tive sectional images were scored for each study. Gated
MIBI tomography identified abnormalities of perfusion
in 84% of the 62 stenosed distribution whereas ungated
MIBI tomography identified 66% and thallium-20l (Tl-
201) tomography identified 52% (P<0.05). Abnormalities
of thickening were present in 60% of stenosed coronary
distributions, and retained thickening was present in
90' of the coronary distributions with reversible
defects. The mean kappa statistic for the interrater
agreement of segmental assessments of myocardial
perfusion were: gated MIBI .67±.1l (SD)(range 0.48-
0.87), ungated MIBI .72±.14 (range 0.46-1.0), and Tl-
201 .6l±.11 (range 0.31-0.74). The mean kappa statistic
for assessment of systolic thickening was .70±,15
(range 0.35-0.93). Thus, in comparison to Tl-20l tomo-
graphy, Tc-99m MIBI tomography (gated and ungated)
provides improved sensitivity and reproducibility.
CLINICAL COMPARISON BETWEEN THALLIUM-20l AND Tc-99m
METHOXY ISOBUTYL ISONITRILE (MIBI) MYOCARDIAL PERFUSION
IMAGING FOR DETECTION OF CORONARY ARTERY DISEASE.
Raymond Taillefer M.D., Denis-C. Phaneuf M.D.! F.A.C.C.,
Raymond Lambert M.D., Georges Dupras M.D., Jean Gregoire
M.D., Jean Leveille M.D. Hotel-Dieu de Montreal Hospital,
Montreal, Quebec, Canada.
Tc-99m-MIBI (methoxy isobutyl isonitrile) is a new Tc-99m-
hexakis analog that can be used as a myocardial perfusion
imaging agent. The purposes of this study were to compare
MIBI to Tl-20l thallous chloride myocardial stress scinti-
graphy in patients referred for investigation of chest
pain and to evaluate the sensitivity of MIBI in detection
of coronary artery disease. One hundred patients were
prospectively studied with both Tl-20l and MIBI planar
imaging. Sixty-five patients had a current coronary angio-
graphy. There was a total of 97 significantly (y70%) ste-
nosed major coronary arteries. MIBI (25mCi) study was done
within a week of the Tl-201 scan with reach of identical
double products upon standard treadmill stress testing.
Rest studies with MIBI were obtained 24-48 hours after the
stress test using the same acquisition parameters and same
dose. Analysis was performed by 3 blinded observers. The
left ventricle was divided into five segments in each ima-
ge. Analysis of Tl-20l and MIBI results in 1500 left ven-
tricle segments showed an overall agreement in 1326/1500
(88.4%) segments. Correlation between the patient diagno-
sis on the Tl-201 and MIBI studies showed an agreement in
89 patients (89%). Tl-201 revealed myocardial uptake de-
fects in 526 segments detecting 72 out of 97 (74.2%) signi-
ficantly stenosed coronary arteries and MIBI detected 513
segments corresponding to 68 (70.1%) stenosed arteries
(no significant statistical difference). In conclusion,
these results show a good correlation between Tl-201 and
MIBI myocardial imaging in detection of significant coro-
nary artery disease.
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ASSESSMENT OF MYOCARDIAL VIABILITY WITH TECHNETIUK-99m
2-METHOXY ISOBUTYL ISONITRILE (KIBI) AND GATED TOKO-
GRAPHY IN PATIENTS WITH CORONARY ARTERY DISEASE.
Joel K Kahn. MD, lain HcGhie, MD, Tracy L. Faber, PhD,
Hichael N. Sills, MD, Harvin S. Akers, liS, James T.
Willerson, MD, FACC, James R. Corbett, MD, FACC.
U. of Texas Southwestern Hedical Center, Dallas, TX.
Gated tomography with the technetium-99m labeled
c~gdiac perfusion agent 2-methoxy isobutyl isonitrile
( mrc HIIlI) , allowing simultaneous assessments of LV
perfusion and segmental function following exercise and
rest, may allow enhanced differentiation of ischemic
(ISC) and infarcted myocardium. Twenty-nine patients
with documented coronary disease were studied. Perf-
usion defect (PD) severity and reversibility determined
quantitatively with computer generated circumferential
profiles were compared to regional systolic thickening
scored semi-quantitatively: 2 normal, 1 hypokinetic, 0
akinetic. There were 48 PDs. By ECG and contrast left
ventriculography 18 PDs were in regions of prior HI (11
Q-wave,7 non-Q). Defect severity was greater in
infarcted than ISC regions (45±3% uptake vs. 58±3%,
p<.05), and in Q than non-Q wave HI (37±4% uptake vs.
58±3%, p<.Ol). Systolic thickening was less in
infarcted (Q-wave 0.4±.l, non-Q 0.8±.3) than in ISC
regions (1.8±.l,p<.01). Infarcted and ischemic regions
were better separated by abnormal systolic thickening
(16/18 HI, 6/30 ISC) than by severely reduced uptake
«50% uptake) (9/18 HI, 7/30 ISC,p<.05) or PD irre-
versibility (9/18 ~I, 5/30 ISC,p<.05). Thus, gated
tomography with 9 mrc HIBI, permitting simultaneous
assessments of LV segmental perfusion and systolic
thickening, enhances the differentiation of ischemic
and infarcted myocardium.
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Cellular and Subcellular Aspects of Coronary
Pathophysiology
IMMUNOHISTOCHEMICAL DETECTION AND LOCALIZATION OF TUMOR
NECROSIS FACTOR IN HUMAN VASCULATURE
Peter Barath. M.D .• Ph.D, Michael C. Fishbein, M.D.,
FACC, Jin Cao, M.D., James Fagin, M.D., James Forrester,
M.D., FACC, Cedars-Sinai Medical Center, Los Angeles, CA
Since several aspects of the histologic sequence of athe-
roma evolution (neovascularization, central hemorrhagic
necrosis, endothelial erosion/disruption) parallel tumor
evolution, we hypothesized that similar cytokines might
drive both processes. As tumor necrosis factor (TNF), a
product of activated macrophages, has the capability of
producing all these histologic changes, we developed an
immunohistochemical staining using monoclonal TNF anti-
body against rTNF. We used formalin fixed, paraffin
embedded sections from 8 normal human coronary arteries,
6 normal femoral arteries, 14 coronary arteries with
different stages of atherosclerotic disease, 6 tibial
arteries from amputation, and 4 specimens from carotid
endarterectomy. We also stained 5 necrotizing colon can-
cer as positive controls. TNF was positive in 10 of 14
atherosclerotic coronary arteries, and all tibial
arteries and endarterectomy specimens. TNF is localized
in smooth muscle cells (SMC), endothelial cells and
macrophages within the human arteries. The most inten-
sive staining was found in the SMC (media, vasa vasora
and newly formed vessel). Macrophages revealed intracell-
ular staining, while the staining of SMC's and endothe-
lial cells was localized to the cell surface. In the
colon tumors the TNF was localized in both tumor and in-
flammatory cells.
CONCLUSION: We reported the first detection of tumor
necrosis factor in human arteries. The difference in
frequency distribution between normal and atherosclerotic
arteries suggest its possible role in the evolution of
atheroma, particularly since the known effects of this
cytokine paralell that of atheroma evolution.
ABSTRACTS
ANGIOGRAPHIC DEMONSTRATION OF HYPERCONSTRICTION INDUCED
BY SEROTONIN AND AGGREGATING PLATELETS IN PORCINE
CORONARY ARTERIES WITH REGENERATED ENDOTHELIUM.
Hiroaki Shimokawa H D , Paul H. Vanhoutte H.D., Hayo
Clinic and Mayo Foundation, Rochester, Minnesota
In isolated coronary arteries, the endothelium inhibits
the contractions induced by serotonin and aggregating
platelets. This effect is reduced after regeneration.
The present study was designed to examine whether those
in vitro observations could be reproduced in vivo.
Sixteen male Yorkshire pigs underwent balloon
endothelium-removal for either left anterior descending
(n-9) or left circumflex (n-7) coronary arteries. After
4 weeks an angiographic study was performed; at this
time the presence of a full endothelial lining was
confi rmed histologically. The control coronary
angiogram showed no stenotic lesions in the previously
denuded artery. Intracoronary inj ection of serotonin
(10 I'g/kg) caused hyperconstriction in the previously
denuded artery (55 ± 4%) compared with control coronary
artery (13 ± 2%). This hyperconstriction was
associated with ischemic ECG changes (7/16 cases) and
could be repeatedly induced. Intracoronary injection of
aggregating platelets (obtained from 300 ml autologous
blood with recovery rate 30-40% and stimulated by 5 mg
collagen) caused constriction in the previously denuded
(32 ± 5%) but not in the control artery (4 ± 2%) (n-6).
The hyperconstrictions induced by serotonin and
aggregating platelets were inhibited by intravenous
treatment with ketanserin (a 5HT2 -serotonergic blocker;
1 mg/kg). Conclusions: I, The normal endothelium
reduces the vasoconstriction induced by serotonin and
aggregating platelets in vivo: 2, The inhibitory effect
of the endothelium is reduced after regeneration,
allowing hyperconstriction and/or vasospasm.
ENDOTHELIUM-DEPENDENT INHIBITION OR ERGONOVINE-INDUCED
CONTRACTION IS IHPAIRED IN PORCINE CORONARY ARTERIES
WITH REGENERATED ENDOTHELIUM
Hiroaki Shimokawa H.D., Nicholas A. Flavahan Ph.D.,
John T. Shepherd H.D., F.A.C.C., Paul H. Vanhoutte H.D.,
Ph.D., Mayo Clinic and Hayo Foundation, Rochester,
Hinnesota
The inhibitory effects of the endothelium on ergonovine-
induced contraction was examined in porcine coronary
arteries under normal conditions and after endothelial
regeneration. Endothelium-dependent responses were
examined in vitro in normal Yorkshire pigs (n-16) and in
pigs which had undergone coronary balloon endothelium-
removal 4 weeks before the study (n-lO). The presence
of a complete endothelial lining was confirmed histo-
logically. In rings from normal coronary arteries
contracted with prostaglandin F2a' ergonovine caused
endothelium-dependent relaxations, which were inhibited
by pertussis toxin (inhibitor of the Gi protein linked
to adenylate cyclase), and abolished by hemoglobin
(inactivator of endothelium-derived relaxing factor).
In quiescent rings, ergonovine caused contractions,
which were inhibited by the endothelium or ketanserin
(5HT2-serotonergic blocker); this endothelium-dependent
inhibition was abolished by hemoglobin. In rings from
arteries with regenerated endothelium, relaxations to
ergonovine were reduced significantly and the inhibition
by pertussis toxin was virtually absent. The
endothelium-dependent inhibition of the ergonovine-
induced contractions and the endothelium-dependent
contraction to hemoglobin were reduced. Conclusions: I,
The endothelium inhibits the contractions evoked by
ergonovine; 2, The inhibitory effects of the endothelium
is impaired after regeneration, in part because of
dysfunction of endothelial Gi protein.
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ANTIPLATELET ANTIBODY [7E3 F(ab')2) PREVENTS RETHROMBOSIS
ATER TISSUE-TYPE PLASMINOGEN ACTIVATOR INDUCED CORO-
NARY ARTERY THROMBOLYSIS IN A CANINE MODEL.
Judith K Mickelson M D FACC, Paul J, Simpson Ph.D., Megan Cronin,
Eric D. Laywell B.S., Jon W. Hameister B.S., Jan M. Kijzen Ph.D., Benedict
R. Lucchesi M.D., Ph.D., The Universijy of Michigan, Ann Arbor, MI
Rethrombosis (RT) may complicate initially effective thrombolytic therapy.
Platelets interacting wijh injured vascular endothelium in a region along the
coronary artery with reduced luminal cross sectional area contribute to RT.
Antibody (AB) that inhibits platelet aggregation was tested in animals wijh a
critical stenosis, electrically induced thrombosis and rt-PA (25 mg) induced
reper/usion of the left circumflex coronary artery (LCCA) to determine if AB
(0.8 mglkg bolus at the time of lysis) could prevent RT. Time required for
thrombosis, thrombolysis and rethrombosis (if ij occurred) was similar withA. (n=9) or saline (CT, n=10). Baseline LCCA blood flow (CBF) was similar
in both groups but fell in the CT group (25±3 to O±O mllmin) as RT oc-
curred in each case (50±9 min after lysis). With AB only 2/9 had RT and
CBF stabilized (24±4 to10±2mVmin, n=9). Oscillations in CBF preceded
RT in CT animals but seldom occurred in AB treated animals (5.2±0.9 vs
0.7±0.4 oscillations, p<0.05). Thrombus mass in the LCCA after 3 h was
greater in CT than AB group (7.0±2.3 vs 1.5±0.7mg, p<0.05). Area of LV
at risk (AR) for infarction (IN) was similar (CT:35±3%, AB:34±4%) butlNJAR
was larger in CT animals (35±9% vs 6±4%, p<0.05). Platelets aggregated
(AG) similarly at baseline. ADP, but not arachidonic acid (AA) induced AG
diminished 50% after rt-PA. The limited AG with ADP correlated with de-
creased fibrinogen in both groups (p<0.05). ADP and AA induced AG was
further inhibited after AB administration (p<O.OOl). In this canine model,
antibody to platelet GPllblllla receptors prevented rethrombosis and stabi-
lized reper/usion CBF, thus reducing infarct size. Since rethrombosis was
not entirely eliminated, components in addition to platelets and non-
occlusive thrombi must effect coronary vasomotor tone in the damaged ar-
tery after rt-PA induced thrombolysis.
MEMBRANE INCORPORATION OF UNSATURATED FATTY ACIDS
INCREASES IJ>L KETABOLISK BY U937 KONOCYTES. Paul \{yo.
~ Hark Weinfeld, B.A., K.Audrey Rudd, Ph.D., Joseph
Loscalzo, K.D.,Ph.D.,FACC. Harvard Kedical School,
Brigham and Women's Hospital, Boston, KA 02115.
While the link between dietary unsaturated fatty acids
(UFA) and reduction in IJ>L cholesterol is firmly
established, the aolecular mechanism by which this occurs
remains unknown. Since the degree of membrane fatty acid
saturation can affect membrane dependent cell functions
and fluidity, we measured IJ>L binding at 4·C, uptake at
37·C and degradation at 37·C in U937 monocytes that were
unmodified (C) or aodif1ed by plasma membrane enrichment
with oleate (0)- a mono-UFA, linoleate (L)- a poly-UFA,
and stearate (5)- a saturated fatty acid.
Bioting UIlGake Degsadation
(ugllO cells/4·) (ugllO cells/4·) (ug/lO cella/4·)
C 0 .17±(1. 04 1. 21,±0 .18 1. 32±0. 18
S 0.15±0.04* 0.92±0.14** 1. 53±0. 21*
o 0.25;tO.06** 2.43±0.27*** 2.94±0.2l***
L 0.36;tO.04*** 2.63±0.18*** 3.90±1.0***
[*, pooNS; **, p<0.05; ***, p<0.001]
Compared to C, O-enriched cells had an 11.8 ± 2.7 mole
i increase in membrane 0 while L-enriched cells had a 9.7
± 1.8 mole i increase in membrane L. 5-enriched cells
had a 4.0 ± 0.4 mole i increase in membrane S. Plasma
membrane fluidity measurements showed the following order
of fluidity: L > 0 > C - S enriched cells. UFA
incorporation into cell membranes increases LDL binding,
uptake, and degradation. Poly-UFA incorporation results
in augmented LDL binding (p<0.02) in comparison to
mono-UFA incorporation, while uptake and degradation were
not statistically different. These data suggest a
possible mechanism for the role of dietary UFA, in
general, and the equivalency of mono-UFA and poly-UFA, in
particular, in lowering IJ>L cholesterol.
GEm:l'I0ULY-INWCED AlliEOOSCIEROSIS
ATI'EMJATES ENOOIHELIALLY MEDIATED REIAXATIOO
CJ Haugh, JB Atkinson M.D. ,Rl.D. RF Bluth M.D., LL SWift
Rl.D, RM ROOertson M.D. ,FACe. Van:lerl:lilt university
Medical center, NashVille, Tennessee.
we studied eniothelial fUrx:tion in watanabe Heritable
Hyperlipidemic (WHHL) rabbits, whim at 20 weeks on a
nonnal diet develcp spontaneoos aortic atherosclerosis
(A'IH) IOOl:];hologically similar to human A'IH. Aortic
Be:Jl1leIlts (n=100) with am withoot ernothelium (+/-EN)
fran 8 age-matched (27-30 wk) WHHL am 8 New zealam
White (NZW) rabbits were studied usin] stamard tissue
bath ted1niques (Krebs-RiIYJer-bicartx:mate ooffer gassed
with 95%02-5%C02; 37OC). Concentration response curves
[10-9-10-4Ml were perfonned to histam:ine(H), to
noradrenaline (NA), am (after preoontraction) to
acetylcholine (ACh) , both with am withoot l50Ujml.
superoxicle dismutase (SOD). Responses were nonnalized to
am expressed as a percentage of the response to
supramaximal I<Cl for contraction (%K+), or to 10-4M 3-
isobutyl-l-n-ethylxanthine for relaxation (%R).
AC1unaX(%R) ACh ECSO Hmax(%K+) H ECSO
NZW-EN 90±9 1.2E-SM
NZWi-EN 54±2 3.7E-7 89±8++ 1.2E-5M++
WHIlLI-EN 29±1* 3.6E-7+ 141±11++,* 6.2E-6M++,*
WHHIr-EN l50±12* 5.5E-6M*
*=p<0.005 VB. NZW; -+=NS VB. NZW; +!<'NS VB. same-EN
'1he contractile response to NA was similar in all groops.
Neither NA- nor H-irouced contraction was significantly
altered by EN rerocwal in NZW or WHHL. 'Ihese data suggest
that endothelium-dependent relaxation does not
:ilrportantly mdify either H- or NA-in:luced contraction in
this mdel. SOD did not enhance relaxation to ACh. we
conclude that the spontaneoos A'IH in WHHL attenuates
receptor-nedi.ated, ernothelil.lIlHiepenjent relaxation in a
manner not oxidation-rate limited.
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Arrhythmia Induction and Remission
CAFFEINE IS PROARRHYTHMIC IN PATIENTS WITH ORGANIC HEART
DISEASE.
Scott L. Harris M.D.. Rita D. Hill R.N., Abraham
Varaghese Ph.D, Addlson A. Taylor M.D., Cathy Rosene
R.N., Marilyn J. Francis R.N, Craig M. Pratt M.D. FACC,
Baylor College of Medicine, Houston, Texas.
Caffeine (CAF) has been implicated as a cause of
excessive cardiovascular mortality. One mechanism might
be the provocation of ventricular tachycardia (VT).
In two recent studies CAF has failed to provoke
ventricular arrhythmia (VA) in normal subjects. By
studying a higher risk population. we conclude that CAF
is frequently proarrhythmic. We report on 24 patients
(pts) with VA enrolled in a double blind placebo
contro 11 ed 8 week study with ambu1atory e 1ectro-
cardiographic (48 hour baseline) recording, using a
specialized kitchen serving a CAF free diet; comparing
placebo to CAF dose 1 (450 mgt day), or CAF dose 2 (900
mg/day); with peak/trough CAF levels. Study group: 24
pts, 16 ~, 8 i, mean age 58 yrs, mean 1eft ventri cul ar
ejection fraction (LVEF) 44X. 14/24 had LVEF <SOX, 10
pts had coronary artery disease. Results:
Pl acebo CAF 1 CAF 2
VPB/hr 23~ 324:TIIT2.7 299-:ID03.1
Pairs/day 6.8±3.6 8.3±4.7 11.5±6.2*
VT runs/day 4.4±2.5 8.9±4.5 21.6±13.7*
*p=O.Ol vs placebo; VPB=ventrlcular premature beat.
10/14 pts with no VT at baseline developed VT on CAF.
All pts with VT at baseline continued to have VT on CAF.
Three pts (mean LVEF=33X) with no VT at baseline
developed sustained VT on CAF. (Lengths 24, 23 and 52
beats; rates 181, 158 and 205 respectively). Conclusion:
Patients with organic heart disease and VA should avold
caffeine because of the demonstrated proarrhythmic
effect.
JACC Vol. 13. No.2
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COMBINED AMBULATORY EEG AND ECG MONITORING FOR EVALUATION
OF SYNCOPE. Lou-Anne M. Beauregard, M.D., F.A.C.C.,
Rosemary Rudderow, B.S.N., Caprice H. Rogers, B.A.,
Barbara Lightfoot, A.B., Paul L. Schraeder, M.D., Travis
Toly, M.D., Harvey L. Waxman, M.D., F.A.C.C. Robert Wood
Johnson Medical School, Camden, New Jersey.
Patients who have syncope frequently undergo both a car-
diac and neurologic evaluation to determine the cause.
Recently the 24 hr EEG has proven highly sensitive in
detecting pts with epilepsy in whom the diagnosis was not
made on routine EEG monitoring. The ambulatory EEG
includes 8 EEG channels and 1 ECG channel. The purpose
of this study was to evaluate combined EEG/ECG monitoring
in pts with suspected neurologic syncope(NS) or non-
neurologic syncope(NNS). A simultaneous Holter monitor
was applied to provide two additional ECG leads.
A total of 25 pts underwent combined EEG/ECG monitoring
using the Oxford Medilog 9000 EEG monitor and standard
Holter recorders. Pts included 14 males and 11 females,
aged 11-87 yrs, 13 with NS and 12 with NNS. Of 13 pts
with NS, 6 had ECG abnormalities, 3 had seizure activity
on EEG and 1 had both ECG and EEG abnormalities. ECG
abnormalities included sinus bradycardia, ectopic atrial
rhythm and atrial tachycardia. In 12 pts with NNS, 5 had
ECG abnormalities, e.g. sinus bradycardia, atrial fibril-
lation or pauses, 1 had EEG slowing and 1 had bradycardia
and abnormal EEG activity. Three pts had ECG abnormali-
ties not detected on the ECG channel of the ambulatory
EEG. Of 13 pts with NS, combined EEG/ECG revealed an
abnormality in 10(77%), and in 12 pts with NNS, an abnor-
mality was found in 7(58%). In pts with NNS, the EEG was
abnormal in only 2(17%).
CONCLUSIONS: Noninvasive evaluation of syncope includes
both EEG and ambulatory ECG monitoring. Combined ambula-
tory EEG/ECG monitoring may increase yield and detect
episodic abnormalities more efficiently.
INCREASED VENTRICULAR ECTOPIC ACTIVITY DURING ISCHEMIC
EPISODES IN AMBULATORY PATIENTS
Shmuel Banai H.D" Shlomo Stern H.D., F.A.C.C., Andre
Keren M.D., Dan Tzivoni M.D., F.A.C.C.
Bikur Cholim Hospital, Jerusalem, Israel
In order to investigate an association between
increased ventricular ectopic activity (VEA) and
ischemic episodes during everyday activities, we studied
prospectively 75 consecutive patients with proven
coronary disease, hchemic episodes on Holter monito-
ring, positive treadmill tests, known ventricular
arrhythmias and no antiarrhythmic therapy. In these 75
patients 719 ischemic episodes were recorded during 127
24-hour monitoring periods. Among 43 pts with no
baseline VPB's or with <14 VPB's/24 hours, none had
increased VEA during ischemia. Of 32 patients who had
basel ine VPB's >14/24h (average 243/VPB' s/24h), in 11
pts increased VEA was observed in 47 episodes (out of a
total of 174); during 40 episodes the number of single
VPB's increased 30 fold on the average; during 4
episodes trigeminy appeared and during another 3
bigeminy was observed. More complex ventricular ectopy
was not observed. There was no correlation between the
severity of the episode (degree of ST depression and
duration of ischemia) and the increased VEA. The
increased VEA appeared during the recovery (reperfusion)
phase of the episodes in 8~. Among the 11 pts with
increased VEA, only 4 developed VPB's during treadmill
testing. No corre1at ion was found between arrhythmi as
during the episodes and symptoms or lack of symptoms of
the patients.
8RNrANEXXlS VARIABILl'lY m vnmuC1lIAR ARRH1!'IHMIA'3 IXJRIN3
OIlQlIC "~,, ANI'IARRH1l'IHMC 'IlIERAI'Y.
Maria t. Anastasiou-Nana M.D., Ra1ald L. Menlave Rl.D.,
John N. Nanas M.D., Jeffrey L. Anderson M.D. F.A.C.C.,
university of utah, res Hospital, salt lake City, utah.
Spont:.aneoos variability (V) has previo.lSly been detennined
for reoordi.r¥;ls (R) of untrea1:e;i but rot trea1:e;i ventricular
arrhythmias (VA). '!bus, we assessed heM frequently clinic-
ally noteworthy in:::reases in VA occur in trea1:e;i pts with
c:hrcnic, CXIIplex VA in order to discriminate true loss of
drug efficacy fran V. V in percent 5UJ:Pression (8) of total
VA ('IVA) an:i repetitive VA (RITA) was detennined in 23 con-
secutive cases with dlronic VA an:i III.l1tiple R duriJ'v;J chronic
therapy with initially "effective" antiarrhythmic drugs.
Effective 8 was defined as ~70% reduction in 'IVA an:l/or
~90% in RITA. V in 8 was substantial, the overall (group)
stamard deviaticn averagiJ'v;J 29+60% for 'IVA an:i 25+53% for
RITA. TreOOs (NS) emerged ~Ch suggested greater V for
those with idiopathic disease, higher ejection fraction,
leM initial arrtlyt:hmia frequency, an:i no beta-blocker
therapy. Each of the 23 cases was then assigned to 1 of 5
cate:;lories accordin;J to the 8 of 'IVA an:i RITA duriJ'v;J folleM-
up. '!be categories 'Nere (A) always 5UJ:Pressed, (B) sup-
pressed duriJ'v;J all except ale day an:i then within 10% of
=iteria, (C) 8 interspersed with "loss of 8," (D) never
5UJ:Pressed, an:i (E) VA rate above baseline. '!he J'UIII'i:ler
(percentage) of cases in each category was:
ABC D E
'IVA 10 (43%) 2 (9%) 7 (30%) 2 (9%) 2 (9%)
RITA 10 (43%) 2 (9%) 8 (35%) 0 (0%) 3 (13%)
'!bus, V on a siJ'v;Jle R is high duriJ'v;J therapy an:i may rot
indicate loss of drug efficacy; loss of 8 on III.l1tiple R
(D) an:i V above baseline (E) may form a better basis for
adjustiJ'v;J therapy.
HIGH INCIDENCE OF REMISSION IN PATIENTS WITH INCES-
SANT VENTRICULAR TACHYCARDIA DISCONTINUED FROM
ANTIARRHYTHMIC DRUGS
Robert J. Hariman, M.D., F.A.C.C.. Jose L. GalIastegui, M.D.,
F.A.C.C., Dayi Hu, M.D., Karen J. Beckman, M.D., Jerry L.
Bauman, Pharm.D., University of Illinois, O1icago Illinois
Prognosis of patients (pts) with incessant (INC) ventricular
tachycardia (VI) not due to acute myocardial infarction (AM!),
acute myocarditis or drug toxicity is unknown. We studied and
followed 17 pts with INC VT, ages 52.91:.20.6 years, for 591:.35
months (mos) since the diagnosis (OX) of incessant VT. INC VT
was defined as episodes of sustained VT, rate> 120 bpm,
symptomatic, lasting >24 hours, and upon 24 hour ECG recording
showed VT beats >5096 of total beats. Nine pts had coronary
artery disease (CAD), 4 cardiomyopathy (CM) and 4 no organic
heart disease (OHD). The pts were divided into 2 groups (GR):
GR I (4 pts) had left ventricular (LV) ejection fraction (EF) <4096
(range 17-3496) and GR II (13 pts) had LV EF> 4096 (range 41-
6796). Of GR I, 2/4 pts (5096) had sudden cardiac deaths (SCD)
while on antiarrhythmic drugs (AAD) and 1 additional pt died of
LV failure within 22 mos after OX. Of GR II pts, 1/13 (896) had
SCD while on AAD, and 1 additional pt died of AMI within 26
mos after DX. Of the surviving GR II pts, AAD were stopped in
4 pts because of drug side effects 1 week to 61 mos after DX;
none of these 4 pts had VT recurrence (follow-up off AAD 671:.14
mos). On the basis of the above results, attempts were made to
stop AAD in 6/7 asymptomatic pts on AAD, who consented. No
VT recurrence occurred in 5/6 pts during these attempts (follow-
up off AAD 151:.4 mos), one pt had VT recurrence within 2 weeks
off AAD and was put back on AAD. Thus, of all 11 surviving GR
II pts, 9/11 pts (8296) had remission off AAD. These pts had CAD
(4), CM (2) and no OHD (3). Conclusions: 1) Prognosis of pts with
INC VT and good LV EF is good, 2) High remission rate in these
pts warrants trials of stopping AAD, when pts become totally
asymptomatic on AAD.
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P < 0.01
EFFECT OF BETA-BLOCADE ON THE CIRCADIAN VARIATION
OF VENTRICULAR ARRHYTHMIAS.
Koonlawee Nademapee M 0 F A C C Adeoye Y. Olukotun. M.D.•
Helen A. Robertson. B.S., Bryna J. Harwood. Bramah N. Singh. M.D.•
F.A.C.C.• VA Medical Center. Los Angeles. California.
Although the mechanism responsible for the circadian variation in
the incidence of sudden death is unknown. the possibility exists that it
may be related to the diurnal increase in frequency of PVCs and VT.
Thus. we studied the circadian variation of PVCs and VT beats and
its response to beta-blockade in 33 patients with malignant ventricular
arrhythmias. All patients underwent a single-blind placebo controlled
protocol and were treated with nadolol (N) in an incremental dose
(20-160 mg/day). Holter recordings were obtained at least twice
during the placebo treatment and serially during N therapy.
Using the cosiner method to analyze the circadian rhythms of
PVCs and VT. we found that during baseline 26 patients had a
significant diurnal increase in PVCs. This was qUite reproducible in
its peak time (between IPM-6PM. rc .67; p < 0.001) and amplitude
(Amp - maximum frequency. rc .93). N suppressed the Amp of the
PVC rhythm and had marked effects on VT (see Figure).
Conclusions:
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HOLTER-MONI'l'ORING AND PROGIlANotIID VENTRICULAR STIMULATION
TO PRKDICT CLINICAL OUTCOM1l IN PATIENTS WITH MALIGNANT
'lh1lTRICULAR TACHYAIlRHYTIIoIIAS
Dietr~c::l1_.A!tdresen,.~.D" Gerhard Steinbeck, M.D., Ralph
Haberl, M.D •• Rolf Schroder, M.D., F.A.C.C., University
of Berlin and Munich, FRG
Little is known about the clinical course of patients
(pts) left untreated after documented sustained ventri-
cular tachycardia (VT) or priaBry ventricular fibrilla-
tion without acute MI (VF). In a prospective study, we
followed 70 Pts (38 with VT, 32 with VF), who underwent
progr~ ventricular stiaulation (PVS) and 24-h Hol-
termonitoring (BM) before being discharged without anti-
arrhythmic drug therapy. (Mean follow up was 12.6 mos).
Results:
PVS: + +
8M : + +
Pts (n): 70 29 11 16 +
Follow uP:! 1 IIItotal:
recurrences: 23 14 4 3 2
rec. VT: 17 8 4 3 2
SD: 6 6 0 0 0
(Definitions: PVS + inducibility of sustained VT or
VF. HM + = detection of frequent ventricular extrasysto-
les/ frequent ventricular pairs/ventricular tachycar-
dia, rec. VT = pts with recurrences of VT, SD= pts with
sudden death). Conc::lusio:'l: A discordant PVS and BM fin-
ding cannot distinguish VT/VF-patients who will have re-
currences from those who will not. Concordant PVS fin-
dings are more predictive of good and poor outca.e. In
all pts who died suddenly, both PVS and 8M were positiv.
Thus, only by combining HM and PVS it is possible to
identify a subgroup of VT/VF-Pts as candidates for al-
ternative antiarrhythmic therapy.
DOES AMBULATORY ST SEGMENT MONITORING CONFER
ADDED INFORMAnON TO THAT OF EXERCISE TESTING
IN THE INVESTIGATION OF PATIENTS WITH CORONARY
ARTERY DISEASE· A STUDY OF 277 PATIENTS
David Mulcahy MRCPI, Jennifer Keegan MSc, Jane Sparrow BEd.
Amanda Park SRN. Christine Wright SRN. Kim Fox MD.
National Heart Hospital. London, England.
It has been reported that ischaemia in the ambulatory setting
may result from differing mechanisms to those in the formal
exercise setting. Thus one might expect ambulatory ST
monitoring (AM) to be a complementary investigation to that of
exercise testing (Ex Test) in the detection of ischaemia in pts
with coronary artery disease (CAD).
We investigated 277 pts (231 males) aged 30-77 yrs (mean 55.5
yrs) with proven CAD (78 single. 89 two, 110 three vessel
disease). All pts underwent treadmill Ex Tests and 48 hrs of
AM (total-I 1.964 hrs). 146 pts (53%) were studied off all
routine therapy. Of the Ex Tests performed 187 (67%) were
positive for ischaemia. During 11,964 hrs of AM 881 ischaemic
episodes ~Imm ST depression persisting for >Imin) were
recorded (645 (73%) silent). 808 ischaemic episodes (92%)
occurred in pts with a positive Ex Test, and only 73 (8%) in
those with a negative test. The frequency and total duration
of ischaemia were strongly related to a positive Ex Test
(p<O.OOI, and p<O.OOI) both in groups off and on therapy. Only
one pt with a negative Ex Test had frequent daily k.5/day)
episodes of iSChaemia, and had documented coronary artery
spasm.
In summary, AM contributes little further to the results of Ex
Test in terms of the detection of ischaemia, and is indicated
only in those with a history suggestive of coronary spasm or
when a meaningful Ex Test cannot be performed. The strong
relationship between ischaemia.in the ambulatory and formal
exercise setting suggests that the underlying mechanisms of
ischaemia are similar. .
ENHANCING PREDICTION OF INDUCED VENTRICULAR
TACHYCARDIA IN PATIENTS WITH NON-SUSTAINED RUNS
BY THE SIGNAL AVERAGED ELECTROCARDIOGRAM
EfwJ~ 't Caref B.S., Gioia Turitto M.D., Nabil
E - er1 M.D.,F.A.C.C., SUNY Health Science
and VA Medical Centers, Brooklyn, New York
A systematic analysis of the value of the
signal averaged BCG (SAECGl in predicting the
induction of sustained VT 1n pts with non-
sustained VT was conducted in 75 pts. Twenty-
two pts (29') had induced VT on programmed
stimulat10n and 53 (71') did not. Each SAECG
was analyzed at 11 high pass filter settings,
10 to 100 Hz and the low pass was fixed at 250
Hz. QRS duration, low amplitude signal <40~V
(LAS), and root mean square voltage of the last
40 me of the 9RS (RMS) were grouped alone and
in every poss1ble paired combination and
analyzea for sensitivity (Sens), specificity
(Spec), positive (Pos), negative (Heg) and
total predictive accuracy (PA) to predict
inducibility. Normal values were based on data
from 100 normal subiects. RESULTS: 561 colllbin-
ations were analyzea. Statistical parameters
and selected combinations are shown below:
~inatioP/(il SiPS Sire PosPA Ni~PA TotalPA
H1g est 1 89 91
Lowest 59 68 53 84 73
RMS(25Hz L 40HZ) 82 94 86 93 91LAS-RMSi~5HZ) 82 89 75 92 87
LAS-RMS 40Hz) 82 89 75 92 87
LAS-RMS 80Hz) 73 91 76 89 85
CONCLUSIONS: 1) The total ~redictive accuracy
of the SAECG for inducibil1ty of sustained VT
in pts with non-sustained VT was as high as
911. 2) combinations of parameters paired at
different filter settings were superior to
those at same setting, with optimal prediction
observed using RMS(25Hz) paired with RMS(40Hz).
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FACTORS PREDICTING SURVIVAL FROM PREllOSPITAL CARDIAC
ARREST
Donald D.Brown, M.D., F.A.C.C., Kenneth R. Stults,
M.S., Younghae Chung, M.S., Richard E. Kerber, H.D.,
F.A.C.C., University of Iowa, Iowa City, Iowa.
Iaproving cardiac arrest survival requires
understanding the relative importance of several
factors which might be amenable to modification either
directly or indirectly. Using multivariate techniques
we analyzed data from 444 ventricular fibrillation (VF)
cases (300 witnessed) to assess the relative impact on
survival of age, witnessed srrest (W). citizen CPR
(CCPR). initial VF amplitude (VFA), time in arrest
(TA). and rhythm resulting from the firat shock (RRI).
RRI waa a strong (p<.OOI) predictor of survival; the
survival rate was 24% when RRl was organized, 8% when
it was VF, and 6% when it was asystole. VFA and TA
were each strong (p<.OOl) determinants of RRl, but
were only weakly correlated with one another (r=-.17).
Wwas a strong (p<.OOl) predictor and CCPR a weak
(p<.lO) predictor of survival, but neither was
significantly associated with RRI. Thus, the following
model is hypothesized:
W~TA
CCPR ~ RRl ~ Survival
VFA---'
VFA appears to be an independent predictor of outcome
through RRl and may be dependent on myocardial diaease
and drugs. The mechanism for the associations of Wand
CCPR with survival probably result ~hiefly from their
association with shorter TA's.
PROGNOSTIC VALUE OF LATE POTENTIALS IN HYPERTROPHIC
CARDIOMYOPATHY.
Tim CriQlls MD. John Camm, F.A.C.C., William McKenna. F.A.C.C.,
St George's Hospital Medical School, London, England.
The value 01 late potentials (LP) In predicting arrhythmias was
assessed in 31 patients (pts.) with hypertrophic cardiomyopathy
(HCM). Maximum echocardlographic wall thickness was 15-29mm.
median 22mm; 15 patients were on amiodarone (median dose, 200
mglday); 12 01 the patients were young «25 years), and 01 these 3
had been resuscitated Irom out-ol-hospital ventricular fibrillation
(VF). All 31 patients had 48 hour Holter monitoring; 8 had non-
sustained ventricular tachycardia (VT) and one had sustained VT.
None 01 the 3 young patients with a history 01 VF had arrhythmias on
Holter. LP were detected using Simson's method; patients with bundle
branch block were excluded and a prolonged filte~ed ORS was not
considered positive lor LP if the surface ORS was >120ms. LP were
present In 7/31 (23%). There was no difference between the
Incidence 01 LP in those with and without amlodarone therapy and
there was no correlation with the degree 01 echocardiographic left
ventricular hypertrophy. 01 the 4 patients with a history 01 life-
threatening arrhythmias 3 (the one with sustained VT and 2 of the 3
with VF) had late potentials. The sensitivity lor the prediction 01
life-threatening arrhythmias by lP was thus 75%, the specificity
85% and the positive predictive accuracy 43%. 01 the 9 patients
with non-sustained VT, 4 had lP compared with 3122 without VT
(p<0.05). All 8 patients with non-sustained VT have had a benign
course. Conclusions: the presence 01 lP in patients with HCM
correlates both with 1) the occurrence 01 Iile-threatening
arrhythmias and 2) non-sustained VT, a known prognostic marker in
HCM. Signal averaged electrocardiography may be 01 value in the
assessment 01 the risk 01 sudden death in HCM, especially in the
younger age group, where currently no prognostic indicator exists.
VARIABILITY OF N&;ATIVE T WAVE IN LEFT VENTRICUIAR HYPER-
TROPHY, THE POSSIBLE RESULT OF CONTRACTION-EXCITATION
FEEDBACK.
Yasuro Sugishita, M.D.. F.A.C.C.. Keiji Iida. H.D.,
Takashi Miyauchi, M.D•• lwao Ito. H.D•• Katsutoshi Goto,
Ph.D., Dept. of Med •• Univ. of Tsukuba. Tsukuba, lbaraki,
Japan
Studies have revealed that changes in ventricular short-
ening lead to changes in action potential duration via
contraction-excitation feedback in man. We studied the
influence of the changes in LV contraction on the varia-
bili ty of negative T wave (NT) in 18 Pts with hypertro-
phic cardiomyopathy (HCM) and 9 Pts with aortic regurgi-
tation. ECG and echocardiograms were studied by symptan-
limited ergometer exercise test, isoproterenol (0.02
\.Ig/kg/min for S min) infus ion and the depression of sys-
tolic blood pressure by 30 mmHg by sodium nitroprusside
infusion. No Pt had coronary artery disease. By exer-
cise, in HCH, fractional shortening (FS) obtained from
echocardiography increased (40±7 + 47±7%*) and NT became
less deep (-1.3±0.5 + -0.8±0.4 mV*); but in aortic regur-
gitation, FS and NT did not cnange significantly. The
changes of T wave (liT) correlated significantly with the
changes of FS (LiFS) in all patients (r~0.80*). By iso-
proterenol in HCH, FS increased (4HS + 54±8%*) and NT
became less deep (-1.3±0.4 + -0.5±0.4 mV*) , and liT corre-
lated with LiFS significantly (LiT-0.055LiFS+0.15, r-O.72*).
By nitroprusside (measurements were performed before
heart rate increased), FS increased (44±5 + 46± 7%*) and
NT became less deep (-l.O±O.S+ -0. 7±0.5 mV*), and the re-
lation between LiFS and liT were on the regression line ob-
tained by isoproterenol, as mentioned above. With nitro-
prusside, R amplitude/T depth became smaller. Conclusion:
These data suggest that tne changes in LV shortening in
human LV hypertrophy produce the changes in the depth of
NT via contraction-excitation feedback. *p<O.OOl
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nmEE DECADE TRENDS IN IlCIDENCE OF CORONARY DISEASE AND
RISK FACTORS IN 1llE FRAMINGIAM SnJDY.
W.B. Kannel M.D.; R.G. D'Agostino Ph.D.; A. Belanger M.A.
Substantial declines :in U.S. Coronary Heart Disease
(CHD) IOOrtality are well docunented, but secular trends in
incidence and associated risk factors based on uniform
assessment are unavailable. Trends in CHD prevalence, in-
cidence and case fatality rates are examined in the
Framingham study over the 1950's, 1960's and 1970's
(biennial exams 3-12). Significant increases in CHD
(peOl) and myocardial infarction (MI) prevalence were
noted in men and for MI in wanen. CHD prevalence increas-
ed 1.6 fold in men and 1.3 fold in wanen. Men also showed
increases in MI and MI-by electrocardiogram (ECG) in both
sexes, although this was significant only in wanen
(p<.05).
Modest but significant decline in CHD mortality was
noted in wanen (p< .05). Sudden death IOOrtality showed no
obvious trends, even excluding those with prior overt am.
CIID case fatality rates declined from 26 to 20% in men;
no significant trends were noted in waren.
Hypertension and cholesterol values have declined over
the three decades. Left ventricular hypertrophy as shown
on ECG is dramatically reduced. Cigarette smoking
declined substantially in men but increased slightly in
women. Obesity increased in men but not women, and
diabetes increased sharply in prevalence in both sexes.
The data suggest that we may be seeing milder cases of
CIID lately and that medical care may be prolonging lifE'
in those with established disease.
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SURVIVAL AND QUAUTY OF LIFE IN CIGARETI'E SMOKERS
VERSUS QUITI'ERS RANDOMIZED TO MEDICINE OR CABG IN
THE CORONARY ARTERY SURGERY STUDY (CASS): 10 YEAR
FOLLOW-UP. J. Bradley Cavender MD. William J. Rogers MD.
FACC. Uoyd D. Fisher PhD. FACC. Bernard J. Gersh MD. FACC.
C. Joan Coggin MD. FACC, William O. Myers MD FACC for the
CASS Investigators. UAB Medical Center, Birmingham. AL.
To determine the effects of continued cigarette smoking on
patients with coronary artery disease, we examined the clinical
outcome after 10 years' follow-up in patients randomized to
medical therapy (N .. 390) or surgery (CABG)(N .. 390) in the
NHLBI Coronary Artery Surgery Study (CASS). Patients smoking
at entry were classified at the 6 month follow-up as Quitters (N
= 97) if they had quit smoking or as Non-Quitters (N .. 187) if
they had continued smoking.
Among all randomized patients, survival at 10 years was 83%
in patients not smoking at baseline, 84% in Quitters, and 72% in
Non-Quitters (p ...004). Of smokers randomized to CABG, 10
year survival was 90% in Quitters and 73% in Non-Quitters (p =
.02); whereas. among smokers randomized to medicine, 10 year
survival was 76% in Quitters and 71% in Non-Quitters (PNS).
Overall, patients smoking throughout the followup period had a
relative risk of death of 1.99 (p = .0001) that of non-smokers
after adjustment for baseline covariates (Cox).
Additionally, at 10 years Quitters had significantly less angina
(Quitters--no angina: 53%, Non·Quitters-·no angina: 34%, p ..
.003) and significantly less activity limitation (Quitters--no
limitation: 36%, Non-Quitters--no limitation: 20%, p .. .006).
Furthermore, among patients having CABG and who smoked at
any time during followup, there was a trend toward more repeat
CABG's than among non-smokers (13% vs 8.5%, p = .10).
Thus, continued or incomplete cessation of cigarette smoking
among randomized CASS patients resulted in decreased survival
(especially among CABG patients). more angina. greater
impairment of physical activity and a trend toward more repeat
CABGs.
CHRONIC IMPAIRMENT OF PARASYMPATHETIC CARDIAC CONTROL IN
HEAVY SMOKERS.
Junichiro Hayano M.D •• Masami Yamada M.D •• Yusaku
Sakakibara M.D •• Takao Fujinami M.D., Kazuyuki Takata
Ph.D., Third Dept. of Internal Medicine, Nagoya City
University Medical School, Nagoya, Japan.
From Framingham study. relative risk of sudden coronary
death (SCD) in men has been reported to be ten times
higher in smokers than in non-smokers. Smoking seems to
increase the vulnerability to ventricular fibrillation
(VF) through altering autonomic functions. Therefore, in
this study. we investigated the chronic effects of
cigarette smoking on autonomic functions by analyzing the
heart rate variability in 56 male smokers (31 moderate (1-
24 per day) and 25 heavy (>=25 per day) smokers) more than
12hr after the last smoking and in 25 healthy male non-
smokers. The autoregressive spectral analysis was used to
determine the power spectral density (PSD) of R-R interval
variability. The PSD contains two major components
reflecting respiratory sinus arrhythmia (RSA) and 0.04-
a.15Hz fluctuation of cardiovascular system. that provide
quantitative indices of parasympathetic cardiac control
and sympathetic activity with vagal modulation.
respectively. The RSA component was significantly smaller
in magnitude in heavy smokers than in moderate and non-
smokers. The difference was especially marked in younger
subjects. Whereas the other component was not different
between three groups. Conclusions: 1. parasympathetic
cardiac control is chronically reduced by heavy smoking
especially in younger subjects; 2, since increased
incidence of SCD and VF has been demonstrated in patients
with decreased parasympathetic cardiac control. the
finding of this study explains a mechanism of increased
coronary mortali ty in smokers. especially. in young
smokers; 3. much more attention should be paid on SCD and
VF in young heavy smokers.
FAMILY HISTORY PREDICTORS OF HIGH BLOOD
CHOLESTEROL LEVELS IN 4TH GRADE SCHOOL CHILDREN.
DennIs M. pavldson M.p •• Cynthia A. Iftner R.D.,
Beverly J. Bradley Ph.D., Sandra M. Landry P.N.P.,
Madalene Y. Rose R.N., Nathan D. Wong Ph.D.,
UniversIty of California, Irvine, California
To examine the predIctive value of a family
history (FHx) of cardiovascular rIsk Indlcactors In
the determInatIon of chi Idren with high levels of
blood cholesterol, we studIed 625 fourth-graders
whose parents provided parental and grandparental
history of: myocardial infarction (MI), coronary
bypass surgery, high blood pressure, high blood
cholesterol, dIabetes, and smoking. Of the 625, 113
were Spanish-surnamed (SS) and 136 were Vletnamese-
American (VN). Mean total blood cholesterol (TC)
(by flngerstick) for all children = 171.40 mg/dl
with SS= 167.5 and VN= 175.1 (p<.05). Children wIth a
reported FHx of high blood cholesterol had TC=179.0;
37% had TC >= 190 and 25% had TC >= 200. These levels
contrasted significantly (p<.001) with chIldren with
no FHx of hIgh blood cholesterol (mean TC= 168.5).
WIthin this group, TC levels were similar In those
ch I Idren w,lth a FHx of MI at age 55 or younger
(TC= 168.1) and all others (TC= 168.6). Of the 625
ch II dren tested, 123 had TC >= 200 mg/o I. However,
only 42 of the 123 had reported either a) a FHx of
hIgh blood cholesterol or b) a FHx of MI at age 55
or younger. Thus, adherence to the current pol Icy
recommending TC screening of only children wIth a
positive family hIstory would have faIled to detect·
nearly 2/3 of chIldren In this study whose TC levels
were above current adult guidelines of 200 mg/dl.
COFFEE USE AND ACUTE MYOCARDIAL INFARCTION.
Arthur L. Klatsky M.D •• F.A.C.C•• Mary Anne Armstrong
M.A•• Gary D. Friedman M.D., Kaiser Permanente Medical
Center. Oakland, California.
Evidence that coffee use may increase risk of coronary
artery disease (CAD) has been conflicting. but reports of
an aSSOCiation of blood cholesterol levels with coffee
strengthen the plausibility of a coffee-CAD link. We did
a new prospective study of these relationships among
129.672 persons. In the years 1978-1986. 740 persons
were hospitalized for an acute myocardial infarction
(AMI) and 1,174 persons were hospitalized for other CAD
diagnoses. Analysis was controlled for age. sex, race.
smoking, alcohol use. tea use, and education. Coffee use
was associated with increased risk of AMI. Using non-
drinkers of coffee as the reference, the relative risks
(95% confidence intervals) for AMI follow: 1-3 cups per
daY"1.14 (0.91-1.42); 4-6 cups/daY"1.36 (1.05-1.75), p_
0.02; 6+ cups/day-l.45 (1.03-2.04). p-0.03. The coffee-
AMI relationship remained significant when controlled for
blood cholesterol. blood glucose. Quetelet index, or
baseline heart disease. singly. or combined. A signifi-
cant coffee-AMI relationship was found in men. women,
whites. blacks. never smokers, and current smokers. but
not in exsmokers. In the earlier study years (1978-1982)
the relationship was stronger (relstive risk of AMI for
4+ vs. no cups/daY"1.85 [1.26-~.74]. p-0.002). which
raises the possibility of a short-term effect. Tea use
was not related to AMI; neither coffee nor tea use was
related to other CAD diagnoses. We conclude that: 1.
these data suggest a weak independent relationship of
coffee use to AMI. not explained by the coffee-cholester-
ol link; 2. persons at risk of AMI who drink 4+ cups of
coffee per day should consider reduction of intake.
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HOUSESTAFF PRACTICE OF PREVENTIVE CARDIOLOGY: WHO I S NOT
DOING WHAT? Marian Limacher, M.D., FACC, Yvonne Brinson,
R.N., Nancy Norvell, Ph.D., A. Daniel Martin, Ph.D., C.
Richard Conti, M.D., FACC. The University of Florida and
Gainesville VAKC, Gainesville, FL.
To determine how completely house officers on different
services evaluate pts at risk for coronary heart disease
(CHD), 30 randomly chosen GVAKC discharge records were
reviewed from each of three in-patient services: Cardio-
logy (Card), General Medicine (Med), and General Surgery
(Surg). Twenty-eight Card pts had diagnoses of existing
CHD, no Med pts had CHD and 8 Surg pts had peripheral
vascular disease. Documentation of historical and meas-
urable risk factors was noted. Interns invariably docu-
mented family history, age of CHD onset, blood pressure,
cigarette, cholesterol (chol), diabetes and alcohol his-
tory more frequently than residents on all services. Diet
and physical activity were documented in less than 10% of
all charts. Family history and onset age of family heart
disease were more frequently obtained by Card (93% and
50%) than Med (63%** and 10%*) or Surg (7%*** and 0***).
Chol history was documented for 50% of Card pts, but only
3%*** of Med and 7%*** of Surg pts. However, Card and
Surg pts were more likely to have a chol level drawn: 57%
Card and Surg vs 23%* Med. In contrast, the majority of
pts on all services had cigarette and alcohol history
documented: Card 100% and 87%, Med 90% and 73%, and Surg
77% and 77% (p=NS). {*p<.05, **p<.Ol, ***p<.OOl by chi
square} Conclusions: The chart survey method indicates
that most preventive screening occurs in pts who already
have a diagnosis of CHD. However, chol, diet, activity
and onset age of family CHD are still not routinely
addressed. Educational efforts for housestaff must be
expanded to increase screening effectiveness for all
pts at risk.
ABSTRACTS
SILENT CORONARY ARTERY DISEASE IN ELDERLY MEN:
LOW EXERCISE TOLERANCE IS STRONGLY ASSOCIATED
WITH MULTIVESSEL DISEASE.
~!:..K..itmwlMJ2., Miriam C. Morey M.A., Robert J. Sullivan
M.D., Gail M. Crowley R.N., Robert C. DiPasquale M.S., Michael B.
Higginbotham M.B., Duke and V.A. Medical Centers, Durham, North
Carolina.
In symptomatic elderly men, exercise duration and ST segment
depression during exercise treadmill testing (ETT) have additive
predictive value for coronary artery disease (CAD). However, in
asymptomatic elderly men, little information is available
regarding the diagnostic utility of ETT. We performed fatigue
limited ETT on 64 consecutive men entering a geriatric (~ age 6S)
fitness program who had no prior clinical manifestation of CAD.
Prospectively, all entrants (n-16) with a +ETT were offered
coronary angiography. Of the 12 who accepted, 10 had ~ 2mm flat
ST segment depression and 2 had ~ Imm ST segment depression
during the ETT. At angiography, 7 patients (5g%) had significant
CAD (~ 7S% narrowing), 2 had insignificant CAD «7S% narrowing)
and 3 had normal coronary arteries. Multivessel CAD was present
in 4 patients (33%). No subject developed ischemic symptoms or
had complications during the ETT. Fifty-eight (91%) of the
entrants exercised beyond the end of Bruce stage I equivalent (5
MEl'S). Four (67%) of the 6 entrants who did not complete stage I
had a +ETT, and all 4 had multivessel disease at angiography
(p.O.OO2, Fisher's exact test). For entrants with a +ETT, the
association between multivessel CAD and low exercise tolerance
was confirmed by logistic analysis (p-o.OOOI). Thus,
asymptomatic elderly men can safely perform fatigue limited ETT
and Dlost will complete Bruce stage I equivalent. The majority of
those who develop ST segment changes will have significant CAD,
particularly if they demonstrate low exercise tolerance.
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Cardiovascular Disease in the Elderly
RISK FACTORS FOR CORONARY MORTALITY IN ELDERLY SURVIVORS
OF MYOCARDIAL INFARCTION: THE FRAMINGHAM STUDY.
Nathan D. Wong Ph.D., Kara L. Kerns, William B. Kannel
M.D., University of California, Irvine, California.
Recognized standard and clinical risk factors for coro-
nary heart disease were evaluated in relation to long-
term prognosis following initial myocardial infarction
(MI) in elderly participants of the Framingham Heart
Study. 140 men and women aged 65 to 88 years (mean age-
71.3 years) returned for a scheduled biennial examination
following HI where risk factors were measured, and a res-
ting electrocardiogram (ECG) and chest x-ray were per-
formed. Hean follow-up wss 8.2 years and 39 subjects
subsequently died of coronary disease. Cox regression
demonstrated age to be positively associated (p<O,Ol)
with coronary mortality, and males were at more than four
times the risk than females (p(O.Ol). A 50 mgldl incre-
ment in serum cholesterol level was associated with s 67%
incresse in risk of coronary death (p<O.05). Reported
smoking in the past year, or the presence of diabetes,
hypertension, or obesity did not emerge as prognostic
indicators. Of clinical factors, the risk of coronary
mortality was 12.7 times greater in those with left ven-
tricular hypertrophy by ECG (p<O.OOl), 2.9 times greater
in those with non-specific T-wave abnormalities (p<O.Ol),
and 4.3 times higher in those experiencing an interim re-
infarction (P<O.Ol). These associations were adjusted
for the effects of age, sex, and cholesterol. Cardio-
meagaly on x-ray, diuretic usage, functional class level,
and other ECG indicators did not add prognostic informa-
tion. These results argue for close monitoring of older
individuals with left ventricular hypertrophy and T-wave
abnormalities on follow-up ECG, and suggest that efforts
to control elevated serum cholesterol levels may be
beneficial in this population.
CARDIOVASaJIAR RISl< OF HYPERIDffiICN IN 'IllE OID OlD: 'IllE
BKNX u:NGITtlDINAL J\GING S'roDY.
steven Greenberg M.D., lbiard Qlzik M.D., Willian
Frishman M.D., FNr., wee I.ocX Ck>i Rl.D., Mirian Aronson
Ed.D., Albert Einstein Ck>ll.ege of M:!di.cire, Bronx, N.Y.
In order to assess the risk of systemic hypertensien in
the extre!le elderly and the efficacy of tl:eatments. we
studied prospectively an elderly subject (Doort of 488
ncninstituticnalized individuals (aged 75-85 years at
entxy) for eight years. Hypertension was defined by
history and auscultatory blood pressure values above
140/90 1lIlfIg, off or on therapy. Sixty-three F&"oent of
the sWjects (n=312) were hypertensi~ at the tirre of
initial study or were receiving antihypertensi~drug
treatIrent: 37% were oomlOtensive off drug tl:eatIrent.
'Ihe hypertensive patients showed a precbninant elevation
of systolic blood pressure. Only 30% of the hypertensive
subjects were well controlled on drug treatment. Sub-
jects with hypertension dancnstrated a higher incidence
of cardiovascular IIOrbid and IIOrtal eVlSl'lts oatpared to
the oon-hypertensive subjects, Subjects with hyper-
tension had a 15.4% incidence of new stroke versus a
3.9% incidence in nen-hypertensives (poo(l.004), hyper-
tensive subjects had a 23.5% incidence of silent and
painful IlI}'OCardi.al infarcticns versus 13.9% in rxn-
hypertensives (p=O. 04). PoorlY-CDI1trolled hypertensives,
especially those with LVH en E:CX;, had the highest
incidence of new myocardi.al infarction (30%), a signif-
icant difference fran the well-a:ntrolled patients
(p=O.006). Hypertensien, especially systolic hyper-
tensien, is an extrarely CXlII1lOl finding in the old old.
It is associated with an increased risk. of stroke and
myocardial infarction wen may be rrodified by anti-
hypertensive drug treatIrent.
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DECREASED REJECTION IN OLDER CARDIAC TRANSPLANT PATIENTS
Steven K. Rowe, M.D., James B. Young, M.D., F.A.C.C.,
George P. Noon, M.D., F.A.C.C., Michael E. DeBakey, M.D.,
F.A.C.C., Baylor College of Medicine, Houston, Texas
There may be a survival advantage in older heart
transplant (HT) patients (pt) (55-68 years). These Pts
may experience less rejection compared to younger Pts,
but this is controversial. To study the effect of age on
rejection in heart transplantation, we analyzed 90 consec-
utive orthotopic HT in 89 Pts. 30 Pts >55 years (range
13-68), 13>60 years (including the oT'ilest Pt in the
International Registry, 68 years). Follow-up was 13.5±13
(mean±SD) months. Overall mean agec 46.5±14 years. Men/
women=76/13; mean EF=20%±4; previous heart surgery=38;
inotropic support=32; intraaortic balloon pump-10;
etiology: coronary artery disease=SO; dilated cardio-
myopathy=26; other=13. Results: Initial hospital stay -
31±49 days; readmissions/ Pt·year=1.35±2; total days
readmissions/Pt'year=13±28; rejection/Pt·year=1.8±4.5;
infection/Pt·year=3.6±10. Rejection was diagnosed by
McAllister grade (0-10). Moderate (5) or above was
defined as significant rejection requiring treatment.
Linear covariant analysis demonstrated decrease in
rejection epi sodes/Pt wi th advancing age (p=0.02,
r=-0.27). Older Pts tended to experience rejection later.
This occurred without any difference in infection (p>.05,
rs -0.03), length of hospital sta¥ (p>.05, r=-O .01), or
readmission days (p>.05, r--0.023). Overall actuarial one
year survival was 72% with age not adversely affecting
outcome (psO.86). Conclusions: Older Pts can undergo
cardiac transplantabon successfully and expect no
survival penalty, increased infection or requirement for
readmission. The incidence of rejection appears to
decrease with advancing age. This may allow modulation of
immunosuppressive regimens resulting in reduced incidence
of related morbidity and mortality.
THE POTENTIAL ROLE OF TRANSESOPIIAGEAL ECHO IN THE
DEFINITION OF INTRACARDIAC SOURCES OF EMBOLI IN
TRANSIENT ISCHEMIC ATTACKS.
Gheorge Pop M.D., George Sutherland M.D., Jos Roelandt
F.A.C.C., Thoraxcenter, Erasmus University, Rotterdam,
the Netherlands.
To compare and contrast the role of precordial (PE) and
transesophageal echo (TEE) in the definition of
potential intracardiac sources of emboli, 70 patients
with a recent unequivocal transient ischemic attack
(TIA) were studied. The patients studied were subdivided
into 2 Groups. Group 1 (52 pts) with no clinical cardiac
abnormality and Group 2 (18 pts) with one or more
abnormal cardiac findings on clinical examination. In
Group 1, PE appeared normal in all S2 pts but TEE
defined significant clinically unsuspected abnormalities
in 4 pts which could predispose to a TIA (1 left atrial
appendix thrombus; 1 aortic dissection, 1 thrombus on
posterior mitral leaflet and 1 mitral valve prolapse in
a young patient). In Group 2 13/18 had both normal PE
and TEE studies while 5 had both abnormal PE and TEE
studies. The latter 5 had either left atrial and/or left
ventricular dilatation visualised on both PE and TEE
studies but only TEE clearly defined significant left
atrial appendix thrombus in 2 pts. In addition, in 29 of
the 70 pts TEE identified widespread ascending and
descending aortic atherosclerotic placques not
visualised from the precordial approach. We conclude
that TEE does significantly increase the yield of
potential intracardiac sources for emboli in patients
with transient ischemic attacks.
AORT1C STENOSIS IN THE ELDERLY: AORTIC BALLOON
VALVULOPLASTY VS. AORTIC VALVE REPLACEMENT
James Srebro MD, Sergio Manubens MD, Paul Yock, MD.
FACC, Thomas Ports, MD, FACC, University of California,
San Francisco
Critical aortic stenosis is a therapeutic dilemma in the elderly
(>80). In order to study the risks and benefits of aortic
balloon valvUloplasty (ABV) as compared to aortic valve
replacement (AVR), we reviewed the clinical course of
patients who underwent these procedures in our institution
since 1980 In demographically similar groups of patients
(age, sex, symptoms and hemodynamics at presentation). the
in-hospital mortality was significantly lower in 29 patients
who underwent ABV (4%) compared to 29 who had AVR
(17%). Morbidity, including myocardial infarction,
cerebrovascular accident and transient ischemia attacks was
also substantially lower for ABV (7% vs. 30%). Only 20% of
patients undergoing ABV required blood transfusion whereas
all who underwent AVR required blood products (mean 10
units). The duration of hospitalization for ABV was much
shorter than AVR (3 vs. 17 days) at an average cost of $9,500
compared to $32,000 for AVA. Long-term follow-up suggests
that patients who undergo ABV more frequently (33% vs. 0%)
experience deterioration of functional class over a mean
follow-up period of 9 months. We conclude that ABV can be
performed with low morbidity in the very elderly. but with less
sustained benefit than AVR which has substantially higher
morbidity and mortality in this population
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Peripheral Changes in Congestive Heart
Failure
CAPILLARY DENSITY. FIBER TYPE AND ENZYME COMPOSITION OF
SKELETAL MUSCLE IN CONGESTIVE HEART FAILURE.
Clyde W. Yancy. Jr. M.D •• Dorabeth Parsons. Ph.D., Lynda
Lane M.S•• R.N., Melissa Carry. H.D •• Brian G. Firth,
M.D •• F.A.C.C •• C. Gunnar Blomqvist. M.D •• F.A.C.C. UT
Southwestern Medical Center. Dallas. Texas.
Patients with congestive heart fail ure (CHFl may have
impaired maximal oxygen uptake partly because of
peripheral maladaptations to skeletal muscle hypo-
perfusion. To evaluate structural and functional changes
in skeletal muscle in CHF. we perforllled needle biopsies
of the vastus lateralis muscle in six patien~ (5 men. 1
woman: age 50.3) with CHF rrm 0.26: VO.,max 13.5
ml/kg/min) and compared these data with refehnce data
frolll sedentary control s (CON) and highly fit SUbjects
(HF). IlIIIlUnocytochemistry using biotinylated lectin and
computerized image analysis was used to identify and
quantitate capillaries and skeletal muscle fibers.
Skeletal muscle capi~lary (cap) density was markedly
reduced (251.5 cap/mm + 37.7 Lx + S.L]. CON 334.96 +
87.86: HF 414.4:!:. 40.3):-Capillary-to muscle fiber rat10
was decreased (1.15 cap/fiber + 0.28. CON 1.39 + 0.3: HF
·4.15 :!:. 0.6). Fiber type analysTs revealed high-per cent
type II fiber (71.31 :!:. 7.4, normal 55S). ~ut reduced type
II fiber cross-sectional area (3510.5 u + 496.5: HF )
6000), EnzYll1e assays yi el ded normal phosphofructok Inase
activity but lIIarkedly Impaired succinate dehydrogenase
activity (1.18 umol/gm/min :!:. 0.19. CON 5.6-8.0). In
summary. skeletal muscle in CHF demonstrates: 1) impaired
vascularity that may limit perfusion: and 2) important
alterations in muscle fiber type and function that may
limit oxidative and favor anerobic metabolism. These data
suggest that peripheral maladaptatiQns may contribute
significantly to illlPaired exercise capacity and reduced
maximal oxygen uptake in congestive heart failure.
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SKELETAL MUSCLE METABOLIC ABNORMALITIES IN HEART FAILURE
ARE IN PART DUE TO INTRINSIC SKELETAL MUSCLE CHANGES ..
Donna Mancini M D , E. Coyle Ph.D., N. Ferraro R.N., R.
Seestedt B.S., Britton Chance Ph.D., John R. Wilson M.D.,
University of Pennsylvania, Philadelphia, Pennsylvania.
Patients with heart failure exhibit abnormal skeletal
muscle P-3l NKR metabolic responses to exercise. To in-
vestigate whether these abnormalities are related to in-
trinsic skeletal muscle changes, we performed gastrocne-
mius biopsies and obtained P-3l.NKR spectra during sub-
maximal calf exercise in 21 patients with heart failure
(Peak V02-l5.6±5.l ml/kg/min; EF-19.7±7%). Biopsies
were analyzed for fiber type and area, capillarity, cit-
rate synthase (CS), phosphofructokinase, lactate dehydro-
genase, and p-dehydroxyacyl Co dehydrogenase (BOAC). P-
31 NKR spectra and systemic V02 were obtained during
plantarflexion performed at 3 workloads. The slope of
the relationship between V02 and the inorganic phos-
phorus/phosphocreatine ratio was used to assess muscle
metabolism. Patients were divided into those with 3l-P
NKR slopes below (Group I) vs. above (Group II) the mean
slope for the entire group. Patients with the least ab-
normal spectra (Group I) exhibited higher peak V02 (I:
19.4±5.S; II: l3.3±2.5 ml/kg/min; p<0.05), larger calf
circumferences (I: 35.3±2.2; II: 32.l±1.3 cm; p<O.Ol),
significantly greater BOAC (I: 5.l0±1.69; II: 2.97±0.66
mol/kg-protein/hr; p<0.005) and CS (I: 5.S±2.0; II:
3.59±1.06 mol/kg-protein/hr) concentrations and tended to
have more type I fibers (I: 57.5±16.5; II: 45.l±lS.7%;
NS). No difference was found in capillarity or fiber
area. These data suggest that abnormal skeletal muscle
metabolic responses in heart failure are in part due to
intrinsic muscle changes. These intrinsic changes may be
due to deconditioning as the state of conditioning influ-
ences oxidative and lipolytic enzymatic activity, fiber
type, and muscle mass.
DECREASED AEROBIC OXIDATIVE CAPACITY IN SKELETAL MUSCLE
IN CHRONIC HEART FAILURE
Martin J. Sullivan, MD, Michael B. Higginbotham, MB.
Howard J. Green, MD, Frederick R. CObb. MD, Duke and VA
Medical Centers. Durham, NC
In order tc determine if an abnormality in skeletal
muscle metabolic function exists in chronic heart failure
(HF). 11 pts with HF (ejection fraction 17±9%. lleak V02
1316 ml/kg/min) and 8 normal sUbjects (NL)(peak V02 29±9
ml/kg/min) underwent biopsy of the vastus lateral is
skeletal muscle. Enzymatic analysis included: phospho-
fructokinase (PFK). phosphorylase (PHOS). lactate
dehydrogenase (LDH), citrate synthetase (CS). succinate
dehydrogenase (SDH). and 3-hydroxyacl CoA dehydrogenase
(3HAD). Results are expressed as ~ moles/mg protein/min:
TEMPORAL DISSOCIATICN BE."IWEm INVASIVE lIND NCN-INVASIVE
lE'l'EmINATICN OF J\NAEKBIC 'llIRESHOID IN am::NIC HEARl'
FAILURE.
Stuart D. Katz M.D., Rlbert Berkowitz M.D., Peter
Keller M.D., 'fiiierry H. LeJemtel M.D., EdrnJnd H.
5onnenblick, M.D., F1VX, Albert Einstein Q:lllege of
M:!dicine, Bronx, N.Y•
'Thielve patients with chronic heart failure (~ max 9.0-
14.4 ml/kg/min) eJercised 00 a bicycle using a 5 watt/
min ranp protOCXl1. Lactate anaerci>ic thresOOld (!AT)
was derived from a log-log plot of arterial lactate
obtained very minute during eJercise. Ventilatory
anaerci>ic threshold (VAT) was rreasw:ed by standard (std)
rrethods (~' va:l:!, lQ, VE, Pet ~, Pet CD:2, VE/VO:l:2,
VE~) and a CXIIpUterized v-slope rrethod. R!sults wem:
Tine to Nr %~ Max Arterial Lactate
(sec) at Nr at Nr (rnrol/L)
!AT 252 80 1.6
VAT std--rrethod 340* 83* 2.6*
VAT V'"'slope rrethod 377* 87* 2.7*
* =p<0.05 VB !AT
VNr by std--rrethod and v-slope rrethod did not correlate
(r = 0.24 for ~ at VAT; r = -.02 for tine to VAT).
Lactate anaerobic threshold could not be detected in
patients with V02 max <11 ml/kg/min as arterial lactate
rose linearly within 120 seconds of exercise, while ~
was already >70% of ~ max. In remai.nin:J patients,
lactate anaerobic threshold occurred earlier during
exercise, at lower V02 and arterial lactate than VAT
by either rrethod. 'nlus, lactate anaerobic threshold
does oot coincide with VAT in patients with severely
iItpaimd aerobic capacity. SUCh tellp:>ral dissociatioo
queStiCX1S the physiologic basis of anaerobic threshold
detetminatioo in chralic heart failure.
PREDICTORS OF MORTAUTY CHANGE AS THE DISEASE
PROGRESSES IN PATIENTS WITH CHRONIC HEART FAILURE.
S1ephen S. Gottlieb MD, Lowrence Baruch MD. Morrick L Kukin
MD. Jonine L Bernstein MS, Gerold W. Neuberg MD, Milton
Packer MD, FACe. Mt. Sinoi School of Medicine, New York, NY
Long-term follow-~ studies in chronic heart failure (CHF)
h()fe disagreed strongly as to which pretreatment variables are
the principal determinants of survival. The reasons for such dif-
fering views ere unknown, but it is possible that prognastic
variables may change in importance as CHF progresses. To eval-
uate this hypothesis. we measured plasma renin activity (PRA,
ng/ml/hr) & norepinephrine (PNE, pg/ml), LV ejection fraction by
nuclear ventriculography (EF. %). and the freq.Jency of ventric-
ular premature beats (VPB/day) and ventricular tachycardia
(vr /day) on 24-hour Holter monitoring in 119 pts with class II, III
and N CHF before treatment with vasodilators; * =p <0.05.
These data indicate that enzymatic pathways involved in
glycogenolysis and glycolysis are intact in patients with
HF while the metabolic capacities for aerobic oxidation
and fatty acid utilization are markedly reduced. These
results suggest that intrinsic abnormalities in aerobic
skeletal muscle function may contribute to decreased
exercise tolerance due to early lactate production in pts
























CHF class PRA pl\E EF vt VPB
II (n=34) 2.5 451 20 6 3046
III-IV (n=8S) 7.1 * 815* 19 109* 4506
As CHF increased in severity (from class II to 11I-1Vl. EF did not
+. but neurohormonal systems (PI\E end PRA) became activated
and vr events + in freq.Jency. Despite a similer EF in the 2
groups, class III-IV pts hod a less favorable long-term survival
thon class II pts (64% vs 82% I-yeer survival~ p <0.05.
The determinants of mortality were assessed in each function-
al group by Cox analysis. In class II pts, EF end vr were the only
independent predictors of survival, and mortality was not related
to the degree of neurohormonal activation. In contrast, in class
III-IV pts, PI\E and VT were the only independent predictors of
survival, and EF provided no additional prognostic information.
In conclusion, the determinants of sIXvival change as CHF
progresses. Neurohormonal variables are important predictors of
survival only in severe CHF. when neurohormones are most
activated. In this advanced stoge, cordiac function (as assessed
by EF) is no longer the principal determinant of mortality.
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REXXJVERY OF SMAIL AND IAR;E ARI'I!RY VASOCXl'SIRICl'ICfi IN
SE.VERE HEARl' D.IlllRE POI.U:MIN:; HEARl' 'IRANSP.UlNl'ATCfi.
J. KWplm O. AIIp1d MO, Jctln R. Imrie MO, Gorden E.
Mardliori R1D, F. Neil M:::Kenzie MO, Peter W. Pflugfelder
MO, william J. Kcstuk MO, l'2\CX:, University of western
ontario, I.aldal, ontario, canada.
Marked peripleral vasoca'lStrictim of small am large
arteries ocx:urs in severe c:hra1i.c heart failure (OfF),
bIt it is rot known if these~ iJtprove unifOJ:lll1y
after heart transplantatim (TXP). we oc:upared 11
patients with severe OfF before, 10 days am 30 days
following TXP with 6 nonnal subjects of similar age.
Foreal1II blood fla.r (FBF) was measured by venous
plethysmograply at rest am after 10 min of arterial
ooclusim (peak reactive hyperemia - mi). Foreaxm
vascular resi.staIx:le (FVR) = mean BPt-FBF. Brad1ia1 artery
diameter (D) was measured~ am at 30 days post-
TXP with a zero-crossi.!'J1 p.J1sed Ikg>ler system
incoIpOrati.!'J1 an adjustable ~ted time system am a
double transducer prdJe. Arterial p.Use wave velocity
(FWV) was measured with paired transducers over the
brad1ia1 am radial arteries am bradli.al artery
CCllpliance (IW:) was calculated as "'/4(D/FWV)2 loilere P is
blood density. Mean ± s.e. *1><0.02 vs. nonnal
FVR mi 0 IW:
(units) (ml/100nljmin) (mn) (an4/dyne/107)
~ 22.6±2.9 36.9±2.1 4.7±0.1 2.2±0.4
OfF 70.5±8.2* 17.1±1.5* 3.8±0.3* 1.2±0.2*
10 ~YS 51.4±4.4* 17.o±2.3*
30 ~S 61.6±4.5* 27.o±2.7* 4.9±0.2 2.3±0.4
These results demonstrate that the significant
<XtlStrictim seen in small am large arteries in severe
OfF is rot unifOJ:lll1y inproved post-'l'XP. '!his owld be
due to different medlanisms oontrib.Iti.n1 to the
<XtlStrictim in small am large arteries duri.!'J1 OfF or
possible vascular effects of cyclosporin m arterioles.
Monday, March 20,1989
4:00PM-5:30PM, California Room A
Anaheim Convention Center
Hormonal and Metabolic Effects of Exercise
RELATIONSHIP OF LEFT AND RIGHT ATRIAL PRESSURES
TO ATRIAL NATRIURETIC FACTOR ELABORATION DURING
EXERCISE IN NORMAL MAN
l2IIw~KiWIwlMJ2.., John C. Burnett M.D., Martin J. Sullivan
M.D., Frederick R. Cobb M.D., Michael B. Higginbotham M.B., Duke
University and V.A. Medical Centers, Durham, North Carolina.
From studies using volume loading maneuvers. it is known that
increases in right atrial pressure (RAP) are related to atrial
natriuretic factor (ANF) release. Although the left atrium also
contains ANF granules, the contribution of left atrial pressure to
ANF release is unclear. We examined the effect of progressive
exercise on arterial plasma ANF concentration and right and left
atrial pressures in 20 normal male subjects performing maximal
(MAX) upright bicycle exercise during right heart and brachial
arterial catheterization. Measurements included mean RAP (mmHg),
balloon occluded pulmonary capillary'wedge pressure (PWP,mmHG),
heart rate (HR), mean arterial pressure (MAP,mmHg), and arterial
lactate (LAC,mmol/l). Plasma ANF concentration (pg/dl) was
measured following extraction by radioimmunoassay for alpha human
ANF. Displayed below are the means for rest and MAX (*p<o.OOOI,
rest vs. MAX) and the regression correlation coefficients for
~ rest to MAX vs A ANF rest to MAX.
REST MAX
ANP 37.4±14.S 62.4±3S.6*
RAP -2.2± 2.0 1.8± 2.S* 0.24 (p.0.32)
PWP 1.2± 3.3 8.8± 4.9* 0.63 (p-o.OOI)
HR 77.8±18.9 162.7±23.7* 0.43 (p-o.07)
MAP 102.2± 13.3 131.8±17.1* -0.10 (p.0.69)
LAC 0.6± 0.4 8.8± 2.4* -0.11 (p.0.6S)
Thus, in normal man, intense dynamic exercise is a potent stimulus
for ANF release, and this correlates best with the rise in PWP.
These data indicate that during exercise, left atrial pressure is
an important mediator of ANF release.
EXERCISE ALTERS GUANINE NUCLEOTIDE BINDING PROTEINS
Evelyn M. Horn M.D., F.A.C.C., Gerald W. Neuberg M.D.,
Bruce Morrow, Won Chaeltal, Rafael E. Pajaro M.D., Alex
deCholnoky, Melvin B. Weiss M.D., F.A.C.C., John P.
Bilezikian M.D., ColUlllbia University, College of
Physicians & Surgeons, New York, N.Y.
Exercise has been shown to be associated with an
increase in lymphocyte (lymph) beta-adrenergic receptor
density (BAR) and adenylate cyclase activity. Since
physiological modulation of the BAR complex lD8y also
sffect post-receptor elements, we studied lymph BAR,
cAMP and stimulatory and inhibitory G proteins (Gs snd
Gi) at rest and at peak exercise in normal and athletic
subjects. Seven subjects exercised 11 ~ 0.8 min.
Heart rate increased from 56.4 + 4 to 184 + 4.2 on a
flexible 1 min incremental protocol and va; achieved
was 47 + 6.9 DIl/min/kg. In response to exe~cise, BAR
increased (23.1 to 48.8 fmol/mg, p(.Ol), Gi increased
(2 + 0.3 to 3.5 + 0.6 compared to a standardized me_
brane preparation, p(.OS), Iso stiDl/basal cAMP
increased (2.45 + 0.5 to 5.1 + 0.8, p(.02); Gs remained
unchanged. - -
Thus, exercise-enhanced beta-adrenergic receptor
function is not due to an increase in Gs. It relD8ins
possible that coupling between BAR and Gs is enhanced
after exercise. In addition, pertussis toxin substrate
is increased with exercise and this may further affect
signal-transduction at the level of the BAR.
ABNORMAL TISSUE GLYCOGEN DEPLETION PATTERNS DURING
SUBMAXIMAL EXEROSE IN RATS Wl1H A CHRONIC
MYOCARDIAL INFARcnON AND HEART FAILURE.
Hans Groth M D Russell Moore Ph.D., Robert Zelis M.D. (PAC.C.),
Timothy Musch Ph.D. The Pennsylvania State University, Division of
Cardiology, College ofMcdicinc ,Hershey, PA.
RaIS lhat have received sham operations (SH) will excrdsc for longer
periods of time at a given absolurc level of submaximal exercise than rats
with a c:bronic myocardial intlIn:tion (MI) and mcxIerate compensated 1Icart
failure. The reascn for the early 0IISCt offatigue found in the MI tat remains
IItIClcar, but may be related to abnormal JaICS ofglycogen (glyc) utilization
in the tissues since the point of fatigue coicides with deplctioo of these glyc
stores. In the present study glyc COI1CCIIIrlItions were measured in the liver,
diapIuagm, and different skeletal muscles of the hindlimb (soleus, plantaris,
and wbiie gastI'OCI1CIDius) ofSH and MI I'alS at JeSt and following 15 and 30
min of submaximal tmadmill excJclse. Patterns ofglyc utilizaticn for these
diffelent tissues were compared in animals exercising at the same AllmW
and lClaEiD worldOlds. Rcsu1Is demonstrated that when SH and MI I'alS
excrciscd at the same &I!.ID.IIIm workloads (lSI{, grade, 28 mImin) that the
glyc coocentratiOllS found in the liver, diaphragm and the different skeletal
muscIcs were significantly reduced after 15 and 30 min ofexen:isc when
compared to those found at rest. However, the patterns of glyc depletion
folllld in the diaphragm and white gast:rocncmius muscle of me Mi tat were
significantly different (p<O.OS, 2-way ANOVA) than those found in the SH
tat as me glyc concentrations found in mesc tissues appeared to be lower in
the MI tat after 15 and 30 min of exercise. When SH and MI rats exercised
at me same~ worldoads (-70% ofmaximal oxygen uprakc) again me
glyc coocentratiOllS folllld in the liver, diaphragm and the diffelent skeletal
muscIcs were significantly reduced after IS and 30 min ofexen:isc when
compared to those found at rest. However. the patterns ofglyc depletion
folllld in all the tissues were similar in the SH and MI tat as were the
magnitude of the responses. These results suggest that abnormalities in
glyc utilization may be associated with the early ODSCt ofmuscular fatigue
folllld post-MI when performing at a given iIl.saIJ& level of submaximal
wort. In addition, abnonnal patterns ofglyc depletion in the diaphragm
may be contributing to the feeling of breathlessness commonly folllld during
submaximal work in heart failure through respiratory fatigue.
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1HE EFFECf OF COMBINED DYNAMIC EXERCISE AND HEAD-
OUT WATER IMMERSION ON ATRIAL NATRIURETIC PEPTIDE.
lAi' M Sheldahl Ph D. Felix E. Tristani, M.D.,F.A.C.C., Terence
Connelly, M.D., Scot G. Levandoski, B.S., Meredith M. Skelton,
M.S., Allen W. Cowley, Jr, Ph.D, and Ronald K. Kalkhoff, M.D. VA
Medical Center and Medical College of Wisconsin, Milwaukee, WI.
An increase in RA pressure and sympathetic neural activity are
considered possible mechanisms for release of atrial natriuretic peptide
(ANP) during exercise. During head-out water immersion (WO, we
previously showed that RA pressure increases immediately upon rest WI
but remains unchanged from rest to peak exercise. To evaluate the effect
of exercise combined with WI on ANP release, 9 young men underwent
45· min rest seated WI and cycle exercise tests on land and WI at work
loads (5 min) correspopding to about 40, 60, 80, and 100% maximal
oxygen consumption (V02max). Results: V02max did not differ in WI
and land (35.7±2.6 vs 36.4±3.0 mllkg/min). During the rest session,
ANP averaged 16±4 pglml on land and increased to 24±4, 32±IO, 37±9
and 63±26 pglml with 5, IS, 30 and 45 min WI, respectively (P<0.05).
During the exercise sessions, ANP responses (pg/ml) on land, WI, and
WI-adjusted for WI time effect (based on rest session) were:
l.iInl1 M WI-adjusted
Sit . 25±4 20±S 14±3
40% VQ2max 23±4 52±17¥ 36±10
60% VQ2max 28±S 98±27Y 59±15
80% VQ2max 48±3S* 173±64*V 155±6IV
VOlmax 68±13* I83±69*Y l66±66*
(Means±SE; *P=<O.05 compared to sit within each environment;
V=P<O.05 compared to land at same stage)
Plasma norepinephrine at peak exercise was significantly (p<O.05) lower
in water (l885±393 pg/ml) compared to land (3532±S70 pglml). The
results indicate that ANP progressively rises with increased exercise
intensity in WI as on land. In addition, both exercise and WI contribute
to a rise in ANP. We conclude that I) increases in plasma
norepinephrine and ANP during exercise are not tightly coupled and 2) a
rise In RA pressure from rest to exercise is not required for release of
ANP with exercise.
BLOCKADE OF ADENOSINE RECEPTORS WITH AMINOPHYllINE.
EFFECTS ON EXERCISE CAPN:ITY IN STABLE ANGINA
Filippo erea H D Alfredo Galassi M.D .. Giu.eppe
Pupita M.D , Hassan EI-Tami.mi. M.D., Margarita J Vejar
M.D.. Juan-Carlos Kaskl M.D.. Graham Davles
M.D .. Hammersmith Hospital, London, U.K.
It lS well recoqnlsed that the adenoslne IAI released
in the coronary circulation during exercise is respon-
slble for the metabollc vasodilatlon of small vessels.
In atherosclerotic epicardial arteries the decrease in
post-stenotlc pressure oonsequent to A-lnduoed vasodl-
lation might result in llubendooardial underperfusion
and lnorease the .everlty of lsohelDla. To test thlS
hypotheSls. we performed a single-blind, plaoebo-con-
trolled randomlzed study ln 10 patlents (ptsl wlth
stable angina pectoris and documented ooronary artery
dlsease uSlng the A antagonlst amlnophyillne lAm).
Immediately follOWing intravenous administration of Am
(7 mglkg over 10 IDlnl or plaoebo. pts underwent tread-
mill exeroise testing (modified Bruoe) on :: consecu-
tlve days. Am lnoreased exerOlse duratlon from 8.5%2.9
min to 11. ::%2.:: min, p<O. 00::. Furthermore, with Am,
compared to plaoebo. all pts developed 111III ST depres-
sion at a higher heart rate (HR, bpml (130%::1 v~
108%16. p<V.OOll and at a hlqher rate-pressure product
(RPP,bplllXllllliigx10-2 ) (205%41 vs 165%26, p<0.001). In 5
pts Ylth anqlographlcally dOCUlllSnted collaterals the
improvement in HR and in RPP at 1mm ST depression was
greater than ln the remalnlng 5 pts wlthout oollater-
als (6Im 27%6 VB 15%10. respeotively, 6RPP 55%28 vs
25%17. respeotlvely) Thus. blookade of A reoeptors
with Am improves exeroise oapacity indioating that A-
lnduoed vasodllatlon can be detrlmental. The more pro-
nounoed benefioial effeot of Am in patients with 001-
laterals could be explalned by an lnorease 1n perfu-
sion pressure from oollateral donor arteries.
EXERCISE TRAINING ALTERS CATECHOLAMINE METABOLISM IN
HEALTHY OLDER MEN
Todd D. Miller M.D., Ray W. Squires Ph.D •• Paul J.
Rogers M.D •• Bruce Banwart. Ann Knobbe. Alfred A. Bove
M.D •• Ph.D •• F.A.C.C., Gertrude Tyee Ph.D •• Mayo Clinic.
Rochester. Minnesota
Prior studies examining the effects of exercise training
on autonomic regulation have focused on changes in plasma
levels of free norepinephrine (NE) and epinephrine (E)
and have reported conflicting results. Catecholamine
synthesis and degradation is considerably more complex
and involves the NE and E precursor dopamine (DA) and
numerous metabolites. Our goal was to determine if
exercise training alters catecholamine metabolism in an
older population by additionally measuring 24-hour urine
levels of these 3 catecholamines and their major metabo-
lites (normetanephrine. metanephrine. vanillylmandelic
acid for NE and E; 3-methoxytyramine and homovanillic
acid for DA). reasoning that these values might reflect
daily sympathetic activity more accurately than isolated
plasma values. Seventeen healthy men ages 52-75 under-
went 16 weeks of exercise training. Peak oxygen uptake
increased 21% from 21.3 to 25.7 ml 02/k9/min (p<0.OO5).
Urine values ([mean ± SO] ug/24 hrs) before and after
training were:
Before
[DA + metabolites] 4980-r-T007
[NE + E + metabolites] 7386 ± 2227
After p ~a~5e626~916 <.
6712 ± 1690 NS
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Poster Displayed: 2:00PM-5:00PM
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Pacific Room. Anaheim Convention Center
Coronary Atherosclerosis and Angioplasty
EFFECTS OF CYCLOSPORINE ON SERUM LIPOPROTEINS
Ethan J. Podet. M.D.. Christie M. Ballantyne, M.D.,
Wolfgang P. Patsch. M.D.. Vadollah Rarab, M.D •• Vlcki
Appel. R.N., Charlotte Payton-Ross. B.A •• Antonio M.
Gotto, Jr •• M.D •• Ph.D., F.A.C.C •• James B. Young, M.D.,
F.A.C.C .. Baylor College of Medicine. Houston. TX
Accelerated atherosclerosis is a leading cause of death
in long-term survivors of heart and renal transplant (TP)
and may be exacerbated by the frequent occurrence of post
TP hyperlipidemia(HPL). Attempts to define the mechanism
for HPL in TP patients are confounded by dramatic changes
in metabolism and nutritional status post TP as well as
multiple immunosuppressive and antihypertensive drugs. To
avoid these pitfalls and determine if cyclosporine alone
adversely affects lipids. we measured lipoprotein levels
in a prospective. double-blinded, randomized. placebo-
controlled trial of cyclosporine(CS) in 36 men with
amyotrophic lateral sclerosis. Mean (±SD)(mg/dl) serum
total cholesterol (TC). LDL cholesterol. triglycerides
(TG). apolipoprotein B (ApoB) are shown below.
Thus exercise training increased urine metabolites of DA
(a catecholamine with unique selective renal vasodilatory
properties in low concentrations) without altering



























Significant increases in TC. LDL and ApoB occurred only
in the CS group. This study conclusively shows that
cyclosporine therapy alone adversely affects serum
lipoproteins by increasing total cholesterol due
primarily to an increase in LD~· cholesterol.
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James N. Karneqis, M.D., Ph.D., John P. Matts, Ph.D., Kurt
Amplatz. M.D., POSCH Group. U of Nebraska. Omaha, NE
It is well established that patients with peripheral
atherosclerosis (ASCL) have a high risk of also having
coronary ASCL, but a possible converse relationship has
not been comprehensively investigated. We studied the
coronary and aortic-iliac-femoral CAlF) arteriograms of
SUbjects enrolled in the Program on Surgical Control of
the Hyperlipidemias (POSCH). POSCH is a randomized,
controlled. secondary intervention clinical trial of
hyperlipidemic subjects, ages 30-64 years with 1
myocardial infarction and angiographically demonstrable
coronary ASCL, Of the 838 enrolled subjects. 436 had
diagnostic visualization of all parts of the coronary and
AIF systems. Indices were used to score the severity of
the ASCL. The AIF index was the sum of stenosis in the
aorta and its 6 major branches, the coronary index the
weighted sum of stenosis of the left main coronary artery
and the 13 segments of its branches.
AIF Coronary Index (\ of, subjects)
Index 1-99 100-199 200-299 > 300 n
o 57 45 32 25 194
1-80 35 42 49 42 184
> 80 8 13 19 33 58
n 104 231 89 12 436
The p-value was 0,0083. Conclusions: 1) Peripheral ASCL
frequently may be absent even when coronary ASCL is
severe, 2) Nevertheless. the severity of peripheral ASCL,
if present, strongly correlates with that of coronary
ASCL.
PROGRESSION OF CORONARY ATHEROSCLEROSIS AND EIlHAIICED
THROMBIN-INDUCED PLATELET AGGREGABILITY.
Jules Y.T. Lam, H.D., F.A.C.C., Jean-Gilles Latour,
Ph.D., Jacques Lesperance, M.D .• Martha Reitman, H.D.,
David Waters, M.D., F.A.C.C., Montreal Heart Institute,
Montreal, Canada.
Platelets may play a role in coronary artery disease
(CAD) progression and anti-platelet therapy has been
shown to prevent the sequellae of CAD progression. The
relatlonship between platelet function and CAD progres-
sion was studied in S3 pts who underwent repeat coro-
nary arteriography after 2 yrs in a prospective study
(Contr Clin Trials 8: 216, 1987). Selection criteria
inclUded a high risk of CAD progression based upon
young age and diffuseness of CAD. No pt was taking
anti-platelet drugs. CAD progression was defined as a
decrease ~O." mm in arterial diameter measured quan-
titatively using the Coronary Angiographic Analysis
system of Reiber et al. The platelet aggregation
response (change in optical ....ensity. 4 O.D. and area
under the aggregation curve) to ADP, collagen and epi-
nephrine in platelet rich plasma was similar in pts
with and without progression, as were indices of plate-
let function including platelet factor ", a-thrombo-
globulin and TxB2 levels. Clinical features of the 2
groups were also similar. However, aggregation to
thrombin was greater in those who progressed:
Group n 4 o. D. Surface area(cm2)
progression 22 1.12±.22 1.6S±.22
p~.016 p~.019
No progression 31 O.S±.l1 l.09±.1l
Thus, progression of CAD is associated with a selective
enhancement of thrombin-induced platelet aggregation.
This may be a useful marker for CAD progression. Whe-
ther inhibition of thrombin activity prevents CAD pro-
gression needs further evaluation.
CORRELATION OF
ATHEROSCLEROSIS.
CORONARY ARTERIAL WITH SYSTEMIC
New CytoBab were noted in only 1/7 (14%) of heart
transplant patients with documented CAD, We conclude
that cytotoxic B cell antibodies infrequently develop
after heart transplant il" patients treated with cyclo-
sporine and prednisone and are an insensitive predictor
for the development of coronary artery disease.
CYTOTOXIC B CELL ANTIBOOIES: INSENSITIVE PREDICTOR OF
CORONARY DISEASE POST HEART TRANSPLANT
Christie M. Ballantyne, M.D. Marilyn 5, Pollock, Ph.D.,
John Farmer, M.D., E. Clinton Lawrence, M.D" George P.
Noon, M.D., F.A,C.C., James B. Young, M.D., F,A.C,C.,
Baylor College of Medicine, Houston, TX
The development of coronary artery disease (CAD) after
heart transplant (HTP) is a silent progressive process
that is felt to be a form of chronic rejection. Circu-
lating cytotoxic B cell antibodies (CytoBab) have been
demonstrated during chronic renal allograft rejection and
previously reported in one study to be a useful predictor
for the development of CAD and myocardial infarction (MI)
after HTP. Although this study has been frequently cited
(Circ 68[sup 2]:94, 1983), it was done prior to the use
of cyclosporine and has not been corroborated. We
prospectively followed the development of CytoBab in 25
patients (pt) who underwent orthotopic HTP and had
followup (FlU) catheterization (cath) or autopsy (mean
FlU 20 mos), Four pts had cath evidence of CAD and 3 pts
had MI at autopsy with CAD present (7125; 28%), All pts
had basel ine CytoBab measured prior to HTP and 6 months
post HTP or at the time of catheterization.
CXR:tlARY~IS IMPAIRS cctnR:lL OF SHFAR S'mESS
Josedl A. Vita MD, Peter Ganz MD F'1\t::C, D!vid A. 0Jx MD,
R. Dlvid Fish MD, Clarles B. Treasure MD, Amrew P.
Selwyn MD F'1\t::C. Brigham & WCInen's Hospital, Bost:a1, MA
In experimental studies, aI:n:mDal wall shear stress (Tau)
:iJIpairs erdothelial func:ticn am may lead to CXlI"CI'IlU:Y
atherosclerosis (CAD). We tested the hypJthesis that 1)
increas1n;J shear stress is associated with dilaticn of
lIOZ1Ilil1 arteries un:ier cx:nii.tioos of increased flai, am
2) in CAD, loss of this reactive dilaticn leads to
aI:n:mDal in::reases in Tau. Adenosine 0.22 to 2.2 III}Imin
was infused via a 2.5 F Ilc:gller flow catheter positiooed
in the~ segment of the left anterior c:lesoerxtin;J
arteJ:y (IAO) in 8 patients with mild aID, bIt no flow
limit1n;J stenoses, am in 10 patients with entirely
SIIDJth ClOI'CI'IaZY arteries. QUantitative angiOt)Z'aP1Y am
ClOI'CI'IaZY flow velocity cozrect:ed for cross-sectiooal area
(CBF) were used to estiJnate Tau in a pmximl IAO segment
exposed to~ in flow bIt nat to ademsine. Peak
in:::rease in CBF was the same in SIIDJth (371±65%) am
irregular segments (377±50%). However, at peak flow,
SIIDJth segments dilated DDre (l6.3±2.7% fran 2.77±.lS DIll)
than irregular segments (2.<>±1.5% fran 3.05j;O.19 DIll)
(p<.OOl) am Tau increased by atly l89±23% in SIIDJth
segments, bIt increased lIDre in irregular segments,
365±52% (P<.01). In eaen patient, SIIDJth segments showed
linear dilation with in::reas1n;J Tau (slcpe 7 .4±O.9%),
lIIhereas irregular segments dilated less am showed
greater in::reases in Tau (slcpe 0.!l±O.6%) (P<.01). 'lhus,
SIIDJth ClClralaries tern to dilate with, am thereby limit,
in::reases in Tau. At equal in::reases in CBF, lack of
dilaticn in irregular oorooaries leads to a cbJbl1n;J of
Tau 0CIIpared to SIIIXJt:h segments. Failure to limit Tau in
aID my pexpetuate both func:tiooal disturtlanoes of
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CLINIaL SAFElY AND FARIN CXXlRSE rou.amt:; PR:lUHim
INFIATICH3 m EUX:l'IVE 'mANSIlJmlAL~ AM;I0PtASTY
Mitchell w. XI:ucoff. M.p., James B. Reese, BlD, Mary K.
Kehoe, R.N., Yvette R. JaclaJcn, R.N., Qlarlene W.
WisdaII, BlD, Kenlsth M. Kent, M.D., F.A,C.C. D.IIte
university Medical oent:er, D.u:ham, North carolina.
Prolon;,ed balloal inflatiaB dJrinq arqioplasty (Plt7.)
were previOl,!Sly avoided, I:ut um:e recently have been
suggested as a means of 1IIBdllInically stabiliziJ¥j a
dilatatien site and E!II'8I'I of reduciJ¥j rate of restemsis.
To assess the early respaee to prolon;,ed inflaticns, 28
patients for elective Plt7. wre prospectively ran:kbized
to shorter (60-90 SElCC.1Ds) or lager (4-5 minrt:es)
inflaticns. CCI1tin.lcus digital U-lead ST segment
monitoriJ¥j (~ ELI-ST) was perfmmed overnight
(mean 19 haml) followi.r¥j SUlXlIlSSful. Plt7., and serial
CPt< isoenzymas were drawn qBh. OXygenated Flucsol- Dll
20% was infused distal to the inflated balloal in both
groops. Ischemic episodes (ST) after PD::A wre defined
as > 1 DIn ST deViatien in 2 leads or 2 DIn ST deViaticn
in 1 lead lastiJ¥j > 60 secx:n:is: infarctien (MI) was
defined as > 3X ncn:mal CPt<-MB. A total of 7 en::Jpoints
(ST, MI) were seen in 4 patients, as:
m sr HI
4 (27%) 4 (27%) 3 (20%)




Mean final stenosis was 27% in the SIDn' gr<:ql and 21%
in the UH; group (NS). nms, len} balloal inflaticns
tilriJ¥j elective Plt7. do not~ to have an adverse
effect en early patient art:oaDe. In altiitien, there
"RJElllrB to be a treni toiiard a possible protective or
stabiliziJ¥j effect, reduciJ¥j episodes of isc:tIemia and
infactien with prolon;,ed balloal inflaticn.
DETAll.S OF CORONARY STENOSIS MORPHOLOGY
INFLUENCE ITS HEMODYNAMIC SEVERITY AND DISTAL
FLOW RESERVE Frank A Fedele MD. Barry Sharaf, MD,
Alben S. Most, MD, FACC, HeJUy Gewirtz, MD, RI Hospital,
Providence, RI
Diff~nces in coronary flow n:serve wilh aoatomically similar
coronary artery stenoses (CAS) have been attribuled to 1) non-
standard physiological conditions, 2) inadequacies of measumnents
of CAS dimension and/or ceronary blood flow (CBF), 3) inade-
quate hyperemic stimulus. This study tesled die hypothesis that
details of CAS geometry also may contribute importantly to such
diff~nces. A simple (SMPL) and complex (CMPX) CAS, each of
which reduced vessel cross-sectional area by 84%, was introduced
in random order into the left anterior descending coronary artery of
nine closed chest, sedated pigs. The SMPL CAS had a single lwnen
while lhe CMPX CAS had five smalliumena whose combined area
equalled that of the SMPL CAS. Measurements of hemodynamics
and regional myocardial blood flow (microspheres)w~ made at
conb'Ol and after 10 min of adenosine infused at 400 ~g/min and
then at 800 ~g/min distal to each stenosis. Both heart rate and aortic
mean pressure did not change versus initial conb'Ol (129 ± 4 min and
120 ± 10 mmHg, mean ± SO, respectively) during the study.
Baseline trans-stenosis flow (mVs) was similaf at each conb'Ol (1.05
± 0.35 versus 0.92 ± 0.34, SMPL versus CMPX, respectively, p =
ns). At maximal adenosine, total flow with SMPL was 3.44 ±0.92
versus 2.77 ±0.51 for CMPX CAS (P < .05). Distal zone
maximal endocardial flow with the SMPL CAS (3.83 ± 1.17;
mlImin/g) also was greater (P < .01) than that with the CMPX CAS
(2.76 ±0.83). Although flow with CMPX CAS was similar at
baseline and lower at maximal hyperemia versus SMPL CAS,
resistance was greater (P < .01) for CMPX CAS both at baseline
(13.2 ±3.9 vs 7.1 ±2.0 mmHg/mVs) and at maximal flow (19.7 ±
4.5 vs 13.4 ± 3.0). Thus, diff~nces in details of CAS geometry
may contribute importantly to diff~nces in coronary flow resetVe,
especially in the endocardium, despite comparable reduction in
vessel cross-sectional area.
IN VIVO PHOTOSENSITIZER ENHANCED LASER
ANGIOPLASTY IN ATHEROSCLEROTIC YUCATAN
MlNISWINE
SEISMOCARDIOGRAPHY FOR DETECTION OF CORONARY
ARTERY OCCLUSION DURING CORONARY ANGIOPLASTY: A
PRELIMINARY REPC:'!.T
G Michael vincent M.D.. R. William Mackie M.D., Eric Orme M.D.,
Jolene Fox R.N., Michael Johnson B.S., LOS Hospital, Salt Lake
City, UT.
Photosensitization of atherosclerotic (Ath) plaque with exogenous
chromophores may confme laser irradiation (LI) injury to Ath plaque
and allow safer and more efficacious laser angioplasty.
Dihematoporphyrin ether (DHE) accumulates pref~ntially in plaque,
and previous in vitro U studies have shown confinement of U injury
to plaque. To further evaluate DHE enhanced laser angioplasty, 5 Ath
Yucatan miniswine with 8 iliofemoral stenOSeS (Sten)w~ treated with
2.5mg/kg of DHE IV. 24 hrs later, 632nm continuous wave U was
delivered to Sten using a 2001l core optical fiber with a 582~ x lcm
diffusing tip. Angiograms w~ performed before, immediately after
and 2 weeks following LI. 618 vessels showed improvemenL Conb'Ol
mean Sten was 71%, immediate post U was 55% and 2 weeks post U
was 19% Sten. In 4/6 responding vessels, there was 0% Sten at 2
weeks post U and lhe previously stenotic segments appeared normal.
2/6 responders showed only modest improvement, from control mean
Sten of 83% to 55% Sten at 2 weeks. 2/8 vessels showed no
improvemenLTh~ w~ no perforations or dissections. The excellent
results in some vessels demonstrate the potential of photosensitizer
enhanced U as very effective primary therapy of Ath. The time course
of improvement indicates that both immediate thermal and delayed
photochemical (photodynamic therapy) effects are operative. Further
studies are required to identify reasons for failure in some vessels.
Dayjd M Salerno. M 0 Ph 0 F A C C , John Zanetti, MS.,
Michael R. Mooney, M.D., James Madison, M.D., F.A.C.C., Robert
A. Van Tassel, M.D., F.A.C.C., Hennepin County Medical Center,
University of Minnesota, \Ifill the Minneapolis Hearl Institute,
Minneapolis, Minnesota
Seismocardiography is a new noninvasive test for the deteotion of
myocardial ischemia. Based on techniques from the field of
seismology, the method analyzes compression waves transmitted from
the heart during its movemenL We hypothesized that obstruction of
coronary artery blood flow by balloon inflation during angioplasty
would produce a change in left ventricular function that would alter the
compression waves recorded by the seismocardiograph. To test this
hypothesis, we recorded the seismocardiogram before, during, and after
coronary angioplasty of 13 arteries in 11 patients with coronary artery
stenosis. The recordings w~ made during the first balloon inflation.
The balloon was inflaled for one minute in each case. During inflation
of the balloon in 12 of the 13 arteries, the seismocardiographic waves
developed a change in morphology. Changes were usually apparent by
30 seconds after inflation. The changes returned to baselin~ by 5
minutes after inflation. For the left anterior descending artery, 1 of 1
had changes; for the circumflex, 3 of 3; and for the right coronary, 8 of
9 had changes.
We conclude that reversible changes consistently occurred in the
seismocardiogram in lhese patients during occlusion of a coronary artery
by an angioplasty balloon catheter. These changes may have baen due
to changes in left ventricular function induced by myocardial ischemia.
Seismocardiography may be useful for monitoring patients during
angioplasty and during clinical syndromes associaled with occlusion of
a coronary artery, such as acute myocardial infarction. Because of the
reversibility of the abnormalities on the seismocardiogram, it may be
useful for monitoring thrombolytic therapy during infarction.
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OXIDATION OF SULFHYDRYL GROOPS OF SERUM ALBUMIN IN
OORONARY ARTERY DISEASES
Kazushige Kadota M.D., Yoshiki Yui M.D., Yoshiharu
Murohara M.D., Yoshiki Takstsu M.D., Mamoru Takahashi
M.D., Takeshi Aoyama M.D., Manabu Shirotani M.D., Hiroshi
Morishita M.D., Keiji Sakaguchi M.D., Chuichi Kawai M.D.,
F.A.C.C., Kyoto University Hospital, Kyoto, Japan.
No. of cases %MA
15 {i 64.7:3.2]*
AMI; acute phase 10 i59.4:4.7]*
(2.7:0.8 hrs from the onset)
AMI; subacute phase 10 49.8±5.9
(70.1:8.1 hrs from the onset) ] *
NORMAL CONTROLS 15 69.7±4.2
MA decreased in pts with EAP and AMI as compared with
normal controls. Decrease of MA in AMI was greater than
that in EAP. In AMI, further decrease of MA was obser~ed
in subacute phase as compared with acute phase.
In conclusion, myocardial ischemia seems to induce the
oxidation of SH groups of serum Alb.
Oxygen free radicals have been implicated in the
pathogenesis of myocardial ischemic-reperfusion injury.
Sulfhydryl(SH) groups are known to be OXidized by free
radicals. Albumin(Alb) is a major protein of the SH
contents in serum. Alb with SH group is mercaptalbumin
(MA), a reduced form, and Alb with mixed disulfide(-SS-)
is nonmercaptalbumin(NA), an oxidized form. We studied
the effects of myocardial ischemia on the SH groups of
serum Alb in patients(pts) with effort angina pectoris
(EAP) and acute myocardial infarction(AMI) and normal
controls. MA and NA were determined by high performance
liquid chromatography using Asahipack GS-520 column.
%MA[ = MA/(MA+NA) x 100] was evaluated by elution profile
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Myocardial Ischemia: Consequences and
Treatment
KETANSERIN PREVENTS ACUTE OCCLUSION BUT NOT
RESTENOSIS AFTER PTCA.
Werner Klein, M.D., F.A.C.C., Bernd Eber M.D.,
Norbert Fluch M.D., Johann Dusleag M.D.,
Med.Univ.Klinik Graz, Austria.
Restenosis remains the major problem following
successful PTCA, ocurring in about 25-35%
within six months. In ischemic heart disease,
platelet serotonin efflux is increased
triggering platelet activation. In 21 patients
(pts) with coronary heart disease and PTCA the
influence of the S -serotonergic receptor
antagonist k~tanserin ~O,lmg/min for 24 hours)
on early (24 ) and late (4 months) restenosis
was investigated with quantitative angiography.
22 pts treated with conventional therapy served
as a control group. 24 hours after PTCA 3 pts
in the control group, but no pt in the ketan-
serin group developed restenosis or occlusion
(p<O.05) Diameter stenosis was unchanged in the
ketanserin group, but increased by 12% in the
controls (p<O. 05). After 4-6 months follow up
the restenosis rate in the control group was
29%, in the ketanserin group 33% (ns).
Thus, ketanserin infused over 24 hours after
PTCA prevents occlusion and early restenosis,
but does not influence the incidence of reste-
nosis after 4-6 months.
NEUTROPHIL FUNCTION IN ISCHEMIC HEART DISEASE.
Jay Djnerrnan. M.D.. Jawahar Mehta. M.D.• F.A.C.C., Paulette
Mehta, M.D., Tom Saldeen, Ph.D., M.D., Daniel Lawson, B.S.,
William Donnelly. M.D.• University of Florida. Gainesville,
Florida.
Neutrqphils are involved in the remodeling of myocardium
following ischemia and contribute to reperfusion injury and
extemiion of ischemic damage. To further characterize
neutrophil function in ischemic heart disease (IHD), neutrophil
chemotaxis, leukotriene B4 (LTB4) generation, and plasma
elastase levels were measured in 20 patients (pts) with stable
angina pectoris (SAP), 17 pts with unstable angina pectoris
(UAP) or acute myocardial infarction (AMI). and in 20 age-
matched control subjects. Neutrophils from pts with SAP
exhibited markedly increased chemotactic activity (48%) and
LTB4 generation (103%) as compared to age-matched
controls (both P<O.01). These cells had normal morphologic
appearance by electron microscopy and did not clump
spontaneously ex vivo. In contrast. neutrophils of pts with UAP
or AMI appeared highly activated by electron microscopy wittl
pseudopod formation and extrusion of granules and clumped
spontaneously ex vivo in 50% of pts. Chemotactic activity and
LTB4 generation by neutrophils from these pts were in the
normal range suggesting prior in vivo activation.. Plasma levels
of peptide BB, a product of fibrin degradation by neutrophil
elastase. were 15·fold higher (P<O.OO1) in pts with UAP or AMI
(5881171 pmolesJL. n:12) than in pts with SAP (37±25
pmolesIL. n=10) or control subjects (40122 pmolesIL. n=14).
confirming in vivo neutrophil activation. This study identifies
enhanced neutrophil function in pts with SAP. Intense
neutrophil activity and subsequent elastase release may relate
to fibrin degredation, reperfusion injury, and myocardial tissue
remodeling following coronary thrombotic events.
EXTENT OF JEOPARDIZED MYOCARDIUM: IMPORTANCE OF
LOCATION, SEVERITY AND EXTENT OF CORONARY STENOSIS.
John J. Mahmarian M.D., Terri M. Boyce B.S., Ronald K.
Goldberg, M.D., MarlO S. Verani, M.D., F.A.C.C., Baylor
College of Medicine, Houston, Texas.
Left main, multivessel, and prOXimal left anterior de-
scending (LAD) coronary artery disease (CAD) identify
pts at an increased risk for cardiac events, presumably
because of the large extent of jeopardized myocardium
(EJM). This pathophysiologic assumption, however, has
not been proven. Accordingly, we evaluated the EJM in
221 consecutive pts with significant (>50% stenosis)
CAD. EJM (% LV) was estimated from exercise thallium-
201 tomographic images using a computer algorithm
validated in our laboratory. EJM (mean ± SD) was sig-
nificantly greater in pts with double (23.2±16.1%,
p<.05) or triple (28.3±13.4%, p<.Ol) vessel CAD than in
those with single (18.6±15.4%) vessel CAD. In pts with
single vessel CAD (N=53). EJM was affected by stenosis
severity and location as follows:
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Identification of transient regional myocardial
metabolic abnormalities in patients with chronic stable
angina using positron emission tomography (PET)
Luis I Araujo MD,Edward McFalls MD,Christopher G Rhodes
MSc,Victor Pike PhD,Terry Jones PhD and Attilio Maseri
MD FACC. MRC Cyclotron and Cardiovascular
Units, Hammersmith Hospital, London, UK
To evaluate metabolic changes associated with transient
myocardial ischemia we studied 5 patients with severe
single vessel CAD and chronic stable angina.All pts had
no clinical or angiographic evidences of myocardial
infarction. Measurements of myocardial glucose uptake
were performed during baseline (B) and following the
infusion of 0.6 mg/kg of dipyrid'amole (D) in each
patient using 15 slice PET and F-18 deoxyglucose
(FDG) .In both studies all pts underwent 12 to 15 hours
fasting.3 pts had chest discomfort during D but only one
of them showed >1 mm ST depression in the EKG. Over 60
regions of interest were drawn on an average of 10
cross-sectional images of the heart in each study and
grouped into myocardium supplied by normal (N) and
stenosed vessels (5) .Myocardial FOG concentration was
then normalised to the integral of the arterial FDG from
the time of the tracer injection to mid-scantime
(FDGm) . Baseline FDGm in Nand S was 1.02+/-.24 and
1.34+/-.21 resp(NS). Following D FDGm in N was not
different than baseline (1.41+/-.4) whereas in S
increased to 6.64 +/-3.4. FGDm in S was significantly
higher when compared with that performed during Band
with FDGm in N following D (p S.Ol and S.005 resp.
Student t test). Thus, PET showed a marked increase in
glucose uptake in the territory of stenosed arteries
following (D) even in the absence of EKG changes .This
metabolic signal may be used as a noninivasive tool to
localise transient myocardial ischemia.
BDIXli\L TIME CXXJRSE OF CXlLI.ATERAL 1EVEIDiMENl' m AC1JIE
MYClC1\RDIAL INFARCl'ICN.
P. Rentrcp M.p. F.A.C.C•• Frederick Felt M.D. F.A.C.C.,
warren Shennan M.D. F.A.C.C., Jdm ihornton Fh.D., ihe
!bmt 5inai-New York university REperfusioo study Groop,
N.Y., N.Y.
ihe prevalence of oollat:eral.s to the infarct artery was
asse ed in 267 patients who had aI¥Jiograpty within 14
hours ot ooset of infarctioo. COllat:eral.s were
significantly Jll)re cxmDal in patients with ocmplete (33\;
64/196) than in those with subtotal. cilstrUctioo of the
infarct vessel. (11\; 8/71) (p<O.OOl). In patients with
ocmplete d:Jst.roctioo, the relatioo between oollaterals
and tiJIIe i.nteIva1 fran ooset of pain to aI¥Jiograpty was:
T.ilIle to Arqio (Mrs.) ~ i::§ 6-8 8-14 m.
Patients (n) 40 56 48 52 196
COllaterals (\) 33 30 29 38 33
Repeat a:n:Jiograpty 10-14 days later in 98 patients with
ocmplete d:Jst.roctioo at baseline aI¥Jiograpty showed:
1. In those patients with persistent total occlusioo
(n=42) an in::rease in the prevalence of oollaterals frau
33\ to 9ot. 2. In those patients who experieooed sus-
tained recanalizatioo durin} thraIix>lytic therapy (n=56)
a decrease of oollaterals frau 38\ to 7\.
o:n::l.usioos:
1. within 4 hours of acute total cora»ry occlusion
collat:eral.s can be visualized in 1/3 of patients. It is
li.ltely that these patients had deve1qled collateral
dlanne1s prior to the infarct web were recrui.ted as a
result of the abrupt drcp in pressure distal to the total
corooary artery occlusioo.
2. Delayed appearance of collaterals in a1Joost all
remainin;J patients with persistent total occlusion after
more than 14 hours and before aI¥Jiography on day 10 to
14, probably involves cell proliferatioo in the walls of
mi.rute collateral dlannels web are a::njellitally present.
ABSTRACTS
FUNCTIONAL LEFT VENTRICULAR ANEURYS" AFTER ANTERIOR
O-WAVE "YOCARDIAL INPARCTION: INCIDENCE, CONTRIBUTING
FACTORS AND NATURAL HISTORY.
John C. Lystash, ".D., David E. Haines, ".0., FACC,
Lorene N. Shaw, BSN and Robert S. Gibson, ".0., PACC.
University of Virginia, Charlottesville. Virginia
Sixty-two consecutive pts with CKKB-confirmed anterior
O-wave HI underwent 24-hour holter, radionuclide ventri-
culography (RVG) , exercise TL-201 and coronary angio at
10+3 days. A functional aneurysm (i.e., diastolic
delormity with akinesis or dyskinesis) was present on
RVG in 19 patients (31%). The presence vs absence of
aneurysm did not identify differences in Norris index,
Lown >3 grade ectopy, presence or extent of TL-201
ischemia, or angio jeopardy scores. Pts with aneurysm
had lower LVEP (34vs42%; p<. 01) .larj~er myocardial scar
areas by RVG (p _ .004) and by TL-201 (p - .0001), and a
lower LAD patency rate (11vs37%; p_.038).
At one year, aneurysm pts had a higher rate of CHP
(37vs9%; p<.05) but total mortality (11vs5%). sudden
cardiac death ([SCD),5vs5%) and incidence of sustained
VT (5vs2%) were similar in the two groups. Lona-term
outcome (mean 4.5 yrs) revealed more CHP (42vs21%); how-
ever, SCD (11vs7%) and incidence of VT (11vs2%) re.ained
low (p NS). Overall, mortality was higher in aneurysm
pts (32vs14%; p<.05) secondary to recurrent HI and pump
failure. Using Kaplan-Heier life table analysis, there
were no between group differences in survival fro. SCD
(.95vs.95) or in event-free survival fro. all arrhythmic
events (SCD and VT; .83vs.95).
Thus. aneurysm formation after uncomplicated anterior
O-wave HI is common (31%) and is associated with greater
global and regional LV dysfunction resulting in a higher
incidence of early CHF. However, the I-year mortality
rate is not significantly increased and the incidence of
VT and SCD is low both at 1 and 4.5 years of follow-up.
FACl'OBS 'l'HAT INFI1lEIfCB '1'IIE REPIlOWCIBI:L1. OF
VFNlRIaJIM~ "
Alan Wlfih MD, Iauri ToiVa1ell MD, Jetfrey 10Jshnet MD,
JaU. SUllmi.tt 00, steve Sdlmaltz MPH, Fred M:Jrady MIl
FNX, university of Mic:hi.gan, Ann Arbor, HI
ihe degree of variability in the deteminatioo of
ventricular refractoriness and the factors affectin;J
such variability are 1.IllIcncM1. 'lhus, we measured IN
effective refractozy periods (ERP) in 4 grc:ups ot 10
pts. each usin} 8 51'S, 3 sec. pause and 2 ~.
da:LemE!uts. In each group, ale variable was altered and
VRP's detennined 10 t.ilIles durin} o:niitioos A and B.
o:niitioo A's were 1) outplt-2 x threshold 2) no atrial
pacin} (pts. with AV dissociation) 3) 51 de1ay-oft 4) 1
min. pause between trials to vary the IUIiler of trains.
o:niitioo B's were 1) outplt-l0 ~ 2) AV sinultaneoos
pacin} 3) 51 delay - 500 :msec. 4) no pause~
trials. coefficients of variance (ev) were calculate:i
in eaeb pt. and carpared by paired t-tests. ihe mean
maxinum differen:::e between shortest and lcn:JE!St VRP's in
each pt (MDif) was also aatp.tted. Mean Results:
anlitic:rl A Qniitim B
~ ERP cv HOif ERP CV MOit
1 247.3 1.16\ 8.6 219.8* .94' 6.2
2 232.6 1.78\ 12.2 231.6 .96\+ 6.8
3 235.7 1.01\ 7.0 237.7 .75% 5.6
4 232.5 1.51\ 10.8 231.5 .74\* 4.8
*p<0.01 vs o:niition A; +p<0.05 vs o:niitioo A
we <XR:1\de: 1) Mean differences of 5-12 :msec. my be
foom 00 repeated determinatioos of ERP. 2) ihe IUIi:ler
of trains prior to readlirg VRP and the ocrrt:rol ot AV
syrdu:t:ny significantly affect the reproducibility of
refractoriness. 3) Of the variables tested atly
stinulation current affects the a1l6olute value of ERP.
45A
46A ABSTRACTS lACC Vol. 13, NO.2
February 1989:46A
PRBSfllVATIQI CI VDmUCllUlR PlllU'OIlI'WD!: IIl'lB RIDx:B>
ISaH!lIC ~CIi BY IlflRAVl'XUJ MUODIPDe IUUI«;
RAPID A11UAL PACDl; .
Brian Kirilall M.D., K. Randal Wilt80n M.D., V~ctor
UPret~ B.se., Oriiversitv of To-ronto, Toronto, Ontar:j.o.
To evaluate the effeet.a of nJ.80ldip.me,. on~c
~cs, ventricular-Performance and ischeiiri.
56
c LV
~ion we studied l\lsubjects. mean age yrs(r~ 45-7~ yrs~to di.a9nostic CQ!'OI)il(YI'art:ei'~oqraphy. c measurenenta lllCII»ed
arterial prea~, I; end~licp~ and.carl;li.ac
out:p.It (t:lIeznDtilutil?ll!' w~th ~zedquant~tat~ve
LV !lIl9iQgramv. ut~hzP:l9 non-~~c contrast:: media
(Johexol-35tl)~ at baseline (B1 ), and after rapid atrial
p;lCing. tc;> lOOderate. typical ang~ (P1 ). Intravenousni80ld~1.Ile (3.5 U9/~I.5 nu.n) WillI aciuin~stered,
with ~t !ilYstemic 'cs and ~rd r,.V
angiqgrilP:ty before (8:.) after (Pa ) an ~dent1C\11
rapid pacing protocol. Absolute LV vollm!S, ei~t1on
fractions. ana regional wall motion analys~s lfractional
radial shortening. FRS) were determined using an image
~sing CCl!Plfer (Kontron Cardio-200). road-
t glQbaI and regional contractility indices
were calculated via peak Systolic pressure/ei'ld-systolic
voltne (PSP/ESV) and-peak !ilYstolic pressure/end-Systolic
radial len¢l:l (PSP/SRL) rat10B • resPectively.
Heroodynami.c data is presented below (mean, ±SO):
Experimental stages
B" P1 B:. Pa
mBP(mmHg) Il2(tI6) 123(t12) 94(tlO)* 101(tI2)
CI(L/min/m3) 3.3(tO.7) 3.5(tO.6) 4.3(tO.8). 4.8(tl.3)
LVEDP(mmHg) 13(t6.0) 21(tlO)' 17(±7.0) 15(tlO)@
EF(\) 72(t9.0) 67(tl6) 78(t9.0)*78(:I:10)
*p(0.05. fp<O.OI. Ba VB B,,; @p<O.05. p... VB P1
POtentially ischemic LV sec:JIlNlts, 1,Q.IR?11ed bv.
signif~cantly stenosed co~ artenes 050\ ~ter
stenolUs, n=12), dem::lnstrated reduced FRS after~1J\9,
with subsecluent reversal by ni90ldipine Ipre-6.:Htl4)ll;.
~+3.8(tI4!\~.P<O.lJ. Load-i.ndeceildent global
contractile inaices were !Jtprovecf' following nisoldipine
Ipre-0.82(tl.O). post+0.2S(tl.4) ~ p<0.05!, with reg~onal
iildices revealing amelioration or ~schemic ~tal LV
dvsftmetion Ipre-;-lS.3(t:?4), .PQBt+8.?(t24), p<0,051" .
COnclus~ons: D1r¥tg PilClllg-iixhJ::ed ~schemia~ nJ.80 dip.me
mnntal.nB IN peJ::fo~ IJy a oc::rilination or systemic;:
vasodilation and reduction in pacillg-induced~l
ischemia, as detennined by loaa-i.ndependent glObal and
regional contractile indices.
SURVIVAL A/'tOl'IG PATIENTS WITH FLASH PUUtONARY EDEMA:
A RETROSPECTIVE REVIEW OF SURGICAL AND MEDICAL
MANAGEMENT. Forrester A. Lee, M.D •• Harry J. Bigham.
M.D •• Henry S. Cabin. M.D •• F.A.C.C. Yale University.
New Haven. CT.
We recently reported a retrospective analysis of
angiographic and clinical findings in patients (pts)
with sudden onset of acute pulmonary edema without
preceding history of progressive congestive symptoms -
"flash" pulmonary edema (FPE). Here we report
follow-up and survival data for a cohort of 54 pts
hospitalized with FPE without transmural infarction
who were SUbsequently catheterized. Mean age was 68.5
years. Coronary disease was present in 51 pts (94%).
The majority of pts had preserved ventricular function
with mean LV ejection fraction of 42% ± 17%. Pts were
managed surgically (36) and medically (18) at the
discretion of attending physicians. Surgical
management included coronary artery bypass (26), valve
replacement/repair (4), combined bypass/valve
replacement (4). and other (2). Among medically
managed patients. 8 (44%) had non-surgical disease and
10 (56%) were considered inoperable because of anatomy
or co-morbid disease.
Of the 54 FPE pts, 46 (83%) survived acute
hospitalization. In-hospital deaths occured in 5
surgical and 3 medical pts. Follow-up data were
obtained on 44 of 46 hospital survivors with a mean
follow-up period of 15.4 months. Deaths occurred in 6
surgical pts (19%) and 11 medical pts (53%). Among
all pts who survived hospitalization. 81 ± 5% and 74 ±
6% were alive at one and two years by life table
analysis. Among surgical pts. survival was 89 ± 6%
and 84 ± 7% for the same time period.
We conclude that the majority of pts with FPE can
be managed surgically with a good prognosis at 2 years.
EPIDURAL SPINAL STIMULATION IN PATIENTS SUFFERING FROM
INTRACTABLE ANGINA.
John Sanderson MD MRCP. Dennis Waterhouse FFARCS. Kyra
Neubauer MRCP. Richard Palmer, Taunton & Somerset
Hospital. Musgrove Park, Taunton, Somerset, England TAl
SDA
Epidural spinal cord stimulation (ESCS) is a recognised
technique in Europe for the treatment of severe peripheral
vascular disease and it has been established that it
relieves pain and increases blood flow. However, it has
not been used to any extent in patients with angina.
Recently we have implanted ESCS units in seven patients
with intractable angina, mean age 61 (range 47 to 72
years). Six patients had had coronary artery bypass
surgery (x 2 in two patients and x 3 in one patient). one
inoperable. and all were on full medical treatment. The
technique involves implanting under local anaesthetic a
stimulating electrode (Medtronic Sigma) in the epidural
space at the level of T1-T2. positioned to produce
parasthesia across the chest and into the left arm (i.e,
the area of angina pain) and connected to the stimulator
(Medtronic Itre1) which was implanted in the axilla.
There were no complications with implantation.
Post-operatively all patients noted a significant
improvement in symptoms. exercise duration was increased
and pain intensity was reduced. GTN consumption was
reduced from average 8.S/day (4-20) pre-operatively to nil
in S patients and average of 3/day in 2 patients post-
operatively. Right atrial pacing showed an increase in
the threshold of angina pain. However, the reduction in
ischaemic ECG changes was small and did not correlate with
symptomatic relief. ESCS appears to relieve angina but it
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Cardiovascular X-Ray, NMR and CT
A RANDOMIZED TRIAL OF IONIC VERSUS NON-IONIC CON-
TRAST FOR CARDIAC ANGIOGRAPHY: EFFECT ON COM-
PLICAnONS AND COSTS.
Mark A. Watky MD FACC, Kenneth G. Morris MD, Karen S. Pieper
MS, Charles J. Davidson MD, Steve J. Schwab MD. Thomas M.
Bashore MD FACC. Duke University Medical Center and Durham
VeteraRJ Administration Medical Center, Durham, NC.
In order to examine the relative efficacy and cost of ionic and
non-ionic contrast media for cardiac catheterization, we randomized
443 patients to receive either iopamidol or cliatrizoate for cardiac
angiography. All complications acutely and within 24 hours of the
procedure were recorded prospectively by study personnel and clas-
sified according to previously determined criteria. Major complica-
tions were def'med as life threateninl, requiring a procedure to treat,
or both (e.l. ventricular fibrillation, pulmonary edema, bradycardia
requirinl a pacemaker, or prolonled chest pain). Minor complica-
tions were non-life threateninl (e.l. bradycardia respondinl to coulh,
angina. or vomiting). Costs were assigned to medications and proce-
dures used to treat complications based on estimated marginal costs.
A total of 22 patients (S%) had major and 141 (32%) had minor
complications after catheterization with diatriwate, while 10 patients
(2%) had major and S3 had minor (12%) complicatioRJ after
iopamidol (p • 0.07 for major complications; p <0.0001 for total com-
plications). Laboratory complications occurred in 148 patients given
diatrizoate (II major, 137 minor) as compared with 31 patients liven
iopamidoJ (2 major, 36 minor). Most complications were treated fair-
ly easily. however, and median cost of catheterization and treatment
of complications was $190 higher with non-ionic contrast than with
ionic contrast (p < 0.002).
Thus. non-ionic contrast substantially reduces the rate of com-
plications after cardiac anliography. This reduced morbidity is asso-
ciated with a significantly higher cost, primarily due to the cost of
non-ionic contrast.
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SURGICALLY RESECTABLE LEFT VENTRICULAR ANEURYSM: SPECI-
FIC CHARACTERISTICS BY ULTRAFAST COMPUTERIZED TOMOGRAPHY.
Ehud Grenadier, M.D., Robert M. Weiss, M.D., John H.
Lemmer, M.D., Michael D. Winniford, M.D., FACC, William
Stanford, M.D., Melvin L. Marcus, M.D., FACC, Dept. of
Medicine and Surgery, Univ. of lA, Iowa City, IA
Conventional diagnostic criteria.(regional dyskinesis by
contrast ventriculography (CLV» do not reliably identify
pts with a surgically resectable LV aneurysm (SRLVA). To
determine if SRLVA could be identified preoperatively by
ultrafast computerized tomography (UCT), we retrospec-
tively reviewed UCT and CLV studies of B pts who had SRLVA
confirmed by pathological findings of dense myocardial
scar tissue. LV volume measurements with UCT in pts with
SRLVA showed decreased LV EF (20+7% [x+SE]); increased LV
end-diastolic volume (273!82 ml); and an increase in LV
mass (178~53 gm/M2). The aneurysms were located antero-
laterally and involved the anterior septum. In 6/8 pts a
large thrombus was demonstrated by UCT and confirmed in
5/6 at surgery. Quantitative segmental analysis of the
UCT data revealed that pts with SRLVA demonstrated pre-
dominantly regional akinesis, involving 21+7% of the LV
surface area. The abnormal area had a very thin wall
(aneurysm end-diastolic wall thickness (EDWT): 4+1 mm,
remote EDWl: 11+1 mm). CLV revealed evidence of diastolic
distortion in 578 pts and predominant akinesis in 8/8.
Retrospective analysis of UCT studies of 2 pts who did
not have SRLVA at surgery despite a definite diagnosis of
aneurysm by CLV revealed a restricted mainly hypokinetic
segment involving 8+2% of LV surface area, with only a
mild decrease in EDWl (8+0.2 mm) of the abnormal segment.
In conclusion, although SRLVA cannot be reliably identi-
fied by conventional angiographic criteria, they can be
detected with UCT by the presence of a large akinetic,
thin-walled segment and a high incidence of thrombus.
REPHROTOXICITY OF ROnORIC CORTB.AST MEDIA: IMPORTANCE OF
DOSAGE IR BlGH I.lSK PATlERTS.
Scott H. McCallia~er M.D., Ronald E. Vlietatra M.D.,
F.A.C.C., David I.. Holaea M.D., F.A.C.C., Kria K.
Menke R.R., Duane M. Ilatrup M.S., Charlea P.
Taliercio M.D., F.A.C.C., Mayo Clinic, Rocheater,
Minneaota.
Ronionic radiocontraet agenta vith low oaealality have
been recently introduc@d and are now extenaively uaed in
cardiac catheterization. The prevalence of and riak
factora for contraat nephropathy (CR) due to nonionic
contraat .edia are not eatabliahed. We atudied the
nephrotoxicity of iohexol (Oanipaque 350) over a 2o-.onth
period froa 5/86 to 12/87. Sixty pta at higher riak for
CR becauae of baaeline aerua creatinine (Cr) > 2.0 aa/dL
underwent cardiac angiography vith aubaequent-follow-up of
renal atatua. Mean pt age vaa 68 yeara (range 29-94) vith
65% aale and a .edian bueline Cr of 2.5 aa/dL (range
2.0-9.4). There vaa Clasa III or IV heart failure in 32%.
Mean doaage of iohexol vaa 110 aL (range 40-235). CR,
defined aa a riae in Cr ~ 1.0 aa/dL over baaeline,
occurred in 9 (15%) pts vith 3 pts requiring dialyaia.
Median baaeline aerua creatinine vaa 2.6 aa/dL in thoae
developing CR. Iohexol doaage vaa aignificantly aaso-
ciated vith CR. Mean doae vaa 148 aL in pta developing CR
coapared to 104 aL in those vithout CR (p • 0.008). CR
developed in 3% of pta (1 of 34) receiving < 125 aL ca.-
pared to 32% (8 of 25) receiving> 125 aLI Other factora,
including diabetea .ellitua, coexIstent heart failure,
aurgery following angiography, and treataent vith calciua
channel blockera, did not influence the occurrence of CR
in thia pt cohort.
In auaaary, nephrotoxicity occurred in 15% of high risk
pts following cardiac angiography vith iohexol and vaa
directly related to dosage adalnistered.
IMPROVED DIASTOLIC FUNCTION AFTER AORTIC VALVE REPLACE-
MENT ASSESSED BY ULTRAFAST COMPUTED TOMOGRAPHY (UFCT).
Ian C. Gilchrist M.D., Peter B. Kurnik M.S., M.D.,
F.A.C.C., Elaine M. Christelis M.S., Harvey L. Waxman
M.D., F.A.C.C. UMDNJ/Robert Wood Johnson Medical
School, Camden, New Jersey.
The pts with regression demonstrated serial normalization
of LV wall mass over the 4 and 8 month periods, although
PFR only normalized during the later 4 months. Time to
PFR and heart rate did not change, while EDV decreased
and ejection fraction increased. Pts without regression
had no improvement in PFR.
Conclusions: 1, UFCT provides an accurate method to
assess changes in LV maSSi 2, improvement in OF occurs
after intervention for aortic valve disease and appears
to follow rather than parallel LV mass regression.
Improvement in diastolic function(DFI is expected to
accompany regression in ventricular mass after successful
aortic valve replacement (AVRI in aortic stenosis and/or
insufficiency. Using UFCT we assessed the LV mass and
concurrent peak diastolic filling rate(PFRI in 16 Pts
before AVR(n=lS) or valvuloplasty(n=ll, and post-
operatively at 4 and 8 months. The PFR was normalized
for end-diastolic volume (EDV) and derived during early
diastole using a third order polynomial curve fit(17
frames/sec,r>0.9S). The Pts were grouped into those






Mass(g/m'l PFR(EDV/sl Mass(g/m') PFR(EDV/s)
l60±11 2.10±O.18 164±18 2.38±0.70
I07±S* 1.93±O.2l lS9±18 1.72±O.7S
97±6* 2.62±O.24* lS4±18 2.26±O.63
mean±SEM, * p<O.OS vs baseline
CAN IN-PATIENT CARDIAC CATHETERIZATION BE ELIMINATED BY
OUT-PATIENT PROCEDURES?
James R. Bengtson. MO.MPH, Jennifer Lee, Joseph Lipscomb,
PhD, Thomas Bashore, MD, FACC, Daniel B. Mark, MD, MPH,
Robert M. Califf, MD, FACC, David B. Pryor, MD, FACC, and
Mark A. Hlatky, MD, FACC. Duke University Medical Cen-
ter, Durham, NC.
To determine the potential of out-pt cardiac
catheterization to replace in-pt procedures, we studied
986 consecutive pts undergoing cardiac cath in a 3 month
period. pts were stratified by eligibility for out-pt
cath, using published guidelines. Group I consisted of
240 pts who underwent an out-pt cath, group Ila was 279
in-pts who were eligible for out-pt cath, and group lIb
was 467 in-pts who were ineligible for out-pt cath. Among
all pts catheterized, 519 (531) had out-pt cath or were
eligible for out-pt cath. Among group lIb pts, 221 (471)
had congestive heart failure, 150 (321) had unstable
angina, 105 (221) had recent infarction, 139 (301) had
other cardiac disease, and 85 (181) had severe non-
cardiac disease. Among all in-pts, one exclusion
criterion was present in 269 pts (361), 2 in 163 (221),
and 3 in 35 (51). Eligible in-pts (Group Ila) appeared
to have more severe illness than out-pts in that they
were older (p•. 002), had lower ejection fractions
(p•. 009), and were more likely to have 3-vessel disease
(p<.OOOI). The cost of the procedure was not different
between in-pts and out-pts.
We conclude that out-pt cath is feasible in approxi-
mately half of all pts who undergo this procedure. Using
currently accepted guidelines, in-pt procedures will con-
tinue to be needed for a substantial number of patients.
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LONG TERM CHARACIERIZAnON OF LEFT VENTRICULAR
DIASTOUC COLLAPSE DYNAMICS POST INFARCTION
Joseph I McInerney. Ph.D.. Roben D. Aronoff, M.D., Gary L.
Copenhaver, B.S., Michael D. Herr, M.S., Penn State University,
Depart1Jlents of Medicine and Bioengineering, Hershey, PA.
High resolution analysis of left ventricular (LV) confonnational
changes during the cardiac cycle reveal that the anterolateral LV wall
undergoes a brief (50-70 msec) inward displacement (0) or diastolic
collapse (DC) during early diastole. Using a closed-chest canine
model, high resolution cardiac surface velocity and displacement maps
(CMAP) are constructed by a non-invasive technique analyzing
scattered x-rays off the heart surface. These maps show that DC
occurs after systolic ejection and prior to surface expansion in the
normal heart. Fourier analysis of D over time permits calculation ofa
maximum (Max) and average (Avg) inward velocity (Y, mm1sec)
during DC. Serial measurements of D, MaxV, AvgV were made over
30 days in 9 dogs with infarction induced via closed-chest
embolization of an epicardial artery. (%Infarct=16.4.±6.0 SD).
Results (mean+SEM):
DETECTION OF MYOCARDIAL HEMORRHAGE USING IH NMR
IMAGING AT 1.5 T
Chaim Lotan MD, Sandra K Miller PhD, Alain Bouchard MD FACC,
Russell C Reeves MD FACe, Sanford P Bishop DVM PhD, Gabriel A
Elgavish PhD, Gerald M Pohost MD FACe, University of Alabama at
Birmingham.
Proton eH) NMR imaging appears to be a useful approach for
identifying zones of myocardial infarction (MI) due to increase in T1
and T2 resulting in increased signal intensity (SI). In the present
study, ex-vivo IH NMR imaging at 1.5Twas performed in 14 dogs: 24
hours (6 dogs) and 72 hours (8 dogs) after coronary occlusion. In 7
dogs zones of decreased 51 (zone I) were seen adjacent to or within
the central zone of increased 51 (zone II). Gross inspection of sliced
myocardium disclosed hemorrhage in the zones with decrease 51,
which was later confirmed by histology. Image-derived relaxation
times (T1 and T2) for the different zones revealed that the decrease
in 81 resulted from enhancement of T2 and not T1 relaxation rates:
controllcl zQnelil zone/Ill c vs.l I vS.1I
T2 msec 54:4.8 44:8.4 63:2.8 p< .01 p< .01
T1 msec 969+50 918=49 962:99 p=ns p=ns
Such a selective enhancement is consistent with the paramagnetic
effect of deoxyhemoglobin (DHb), and becomes apparent only at
high magnetic fields. In 5 of the remaining 7 dogs. very small
hemorrhages were observed, with no apparent effect on 51. This can
be attributed to opposing effects of edema and hemorrhage on T2•
In conclusion, hemorrhagic zones associated with MI, demonstrate
significantly reduced 51 caused exclusively by T2 reduction. This
observation should help to diagnose and further characterize the
pathological process associated with MI.
BLOOD-VELOCITY IMAGING BY MAGNETIC RESONANCE
PHASE-DIFFERENCE TECHNIQUES FOR QUANTITATIVE MEASUREMENT
OF STROKE VOLUME, CARDIAC OUTPUT AND VENOUS RETURN:
COMPARISON WITH DOPPLER ULTRASOUND.
Albert ~ !!!!!. Rossum M.D., Michiel Sprenger Ph.D,
Kathinka H. Peels M.D., Frans C. Visser M.D., Jaap
Valk M.D., Free University Hospital, Amsterdam, The
Netherlands.
As the phase of the magnetic resonance (MR) signal is
very sensitive to flow, special pulssequences have been
designed to induce phase-shifts that are directly
related to blood velocity (V). Measurement of these
shifts allows non invasive quantification of V on a
pixel-by-pixel base at multiple intervals in the cardiac
cycle (RR). We used such a technique in 17 subjects to
measure V in a plane perpendicular to the ascending
aorta and superior vena cava (SVC), and to the inferior
vena cava (IVC) on 16 velocity images acqUired at equal
intervals (dt) over RR. The transverse area (A) of the
vessels was determined on anatomic images and mean V
over this area on corresponding velocity maps.
Calculations: volume per interval (Qi) = A x mean V x
dt: volume per RR = sum of the 16 Qi values. Aortic
measurements yield LV stroke volume (SV) and CO (LVSV x
heartrate). Measurements in SVC + IVC yield venous
return per RR. LVSV and CO were compared to
measurements made by Doppler echocardiography (D).
~ obtained by regression analysis are:
LVSV (ml) MR = -7.5 + 1.1 D r = 0.76 (n=17)
CO (L/min) MR = 0.3 + 0.9 D r = 0.86 (n=17)
MR venous return = 1.3 + 1.0 MR LVSV r = 0.91 (n-13)
Conclusion: I)Non invasive determination of blood flow
by MR is reliable, as a good correlation was found
between LVSV and venous return. 2) MR velocity imaging
shows a good correlation with Doppler ultrasound for
assessment of LVSV and CO.
control stenosis dipyr+sten QiQyr
LAD 47±3 33±8 29±6 62±5
REMOTE 30+4 42±5 54±6 52±3
p<0.05 NS p<0.05 NS
Conclusion: We have demonstrated that high speed NMR
imaging with Dy-DTPA and dipyr, is capable of detecting the
effect of a coronary stenoses.
DETECTION OF CORONARY STENOSES BY HIGH SPEED
NMR IMAGING:THE UTILITY OF DYSPROSIUM-DTPA
Howard L. Kantor M.D.,Ph.D.,F.A.C.C, Richard R.Rzedzian
Ph.D., Elise Berliner, Paul Beaulieu, Thomas J. Brady M.D.,
Ian L. Pykett Ph.D., Mass. General. Hospital., Boston, MA.
Dysprosium-DTPA (Dy) has a low relaxivity but is a potent
myocardial T2 contrast a~ent by virtue of its high magnetic
moment. Its usefullness In detecting coronary stenoses has
been examined with a prototype NMR imager(Advanced NMR
Systems Inc, Woburn, MA), generating each image in less
than 40ms. Using a canine model of LAD coronary stenosis,
seven animals were examined with the following protocol:1)
control, 2)stenosis, 3)dipyridamole(dipyr), 4)dipyrHelease of
stenosis. Images were obtained every 1.2~1.8s (set of 80)
using a spin echo sequence with TE of 30ms. A rapid
intravenous contrast injection (0.19 mmollkg) was performed
after the 10th image. The results shown below demonstrate a
significant difference in signal reduction between two cardiac
zones in the control and dipyr&stenosis studies. The coronary
stenosis reduced the Dy effect on the LAD zone(NS), and the
addition of d~yr accentuated the perfusion difference.
% ignal reduction after Dy-DTPA
lACC Vol. 13, No.2
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IMPROVED ASSESSMENT OF ACUTE MYOCARDIAL INFARCTION BY
MAGNETIC RESONANCE IMAGING AND GADOLINIUM-DTPA
Paul R.M. van Dijkman M.D., Ernst E. van der Wall M.D.,
Joost Doornbos Ph.D., Arnoud van der Laarse Ph.D.,
Sandra Postema M.D., Albert de Roos M.D.,
Ad E. van Voorthuisen M.D., Albert V.G. Bruschke M.D.
University Hospital Leiden, The Netherlands.
To assess the usefulness of Gadolinium(Gd)-DTPA in Magne-
tic Resonance Imaging (MRI) of acute myocardial infarc-
tion (AMI), we studied 25 Pts after a first AMI (13 ante-
rior, 12 inferior) by ECG-gated MRI and Gd-DTPA after
93±49 hrs from the onset of symptoms. MRI was performed
using a Philips Gyroscan (0.5 Tesla) and spin-echo mea-
surements (echo-time 30 msec) were made before and 20 min
after intravenous injection of 0.15 DDIlol/kg Gd-DTPA. In
all Pts contrast enhancement of the infarcted areas was
observed after Gd-DTPA. Signal intensities were deter-
mined from 10 regions of interest in adjacent myocardial
areas of the optimal LV slice. The signal intensities of
the infarcted versus normal areas were used for calcula-
tion of intensity ratios. Intensity ratios before Gd-DTPA
were 1.15±0.18 and after Gd-DTPA 1.54±O.30 (P<O.OOI).
When Pts were stratified according to early MRI studies
«72 hrs, 10 Pts, Group I) and late MRI studies (>72 hrs,
15 Pts, Group II), the intensity ratios before Gd-DTPA
were 1.05±0.12 (Group I) and 1.21±0.19 (Group II)
(P<0.05). After Gd-DTPA the intensity ratios were
1.37±0.12 (Group I) and 1.65±0.34 (Group II) (P<0.02).
Conclusions: I, Gd-DTPA improves visualization of acutely
infarcted myocardial areas by MRI; 2, infarcted areas
show increased signal intensity compared to non-infarcted
areas; 3, maximal contrast enhancement is obtained
>72 hrs after onset of AMI indicating increased uptake of





Pacific Room, Anaheim Convention Center
Echo Doppler: General I
DOPPLER HARMONIC SPECTRAL SIGNALS ("STRIPES"): IN VIVO
AND IN VITRO EVIDENCE OF AN ARTIFACT DUE TO LEAFLET
REVERBERATIONS
Mikel D. Smith, M.D., F.A.C.C., Edward A. Har1amert,
M.D., Kevln L. sUblett, M.D., Helga Miles, Oi Ling Kwan,
B.S., Annette Cater, Charles Knapp, Ph.D., Michael R.
Harrison, M.D., F.A.C.C., Anthony N. DeMaria, M.D.,
F.A.C.C., University of Kentucky Medical Center,
Lexington, Kentucky.
Although high-frequency striated Doppler signals thought
to be due to leaflet vibrations have been described in
torn prosthetic valves, few reports exist with native
valve lesions. We studied 24 patients with 25 lesions in
whom pulsed (PW) and continuous (CW) Doppler of
regurgitant native lesions without evidence of
degeneration or tears (15 MR, 7 AR, 3 TR) revealed dense
parallel bands above and below the zero line throughout
regurgitation. The bands were spaced at multiples of the
fundamental velocity, which ranged from 30-80 cm/s; were
recorded only with PW sampling directly on or adjacent to
the leaflet; and disappeared with catheters across the
valves in 2 cases. Color flow imaging done in all
patients showed a homogeneous bright green turbulent
signal localized to the leaflet. The severity of
regurgitation ranged from mild (13), moderate (5), to
severe (7). Identical audio and spectral signals were
reproduced in vitro by movement of a specular reflector
perpendicular to the transducer. Thus, parallel Doppler
harmonic signals appearing as horizontal "stripes" may
rarely be seen in native valvular disease. These signals
do not appear to be related to the etiology or severity
of the lesion. Localization of these signals to the
valve leaflets and in vitro simulation by target motion
suggest that "stripes" are an artifact related to
reverberation.
INTRAVASCULAR ULTRASOUND IMAGING CATHETER ACCURATELY MEA-
SURES AREA OF STENOTIC AORTIC VALVES IN VITRO
Debra Heldman. M.D.; John Mallery, M.D.; Gerald Spear,
M.D.; James Gessert; James Griffith, Ph.D.; Jonathan
Tobis, M.D., F.A.C.C.; Walter L. Henry, M.D., F.A.C.C.;
University of California, Irvine, CA.
The measurement of aortic valve area in aortic stenosis
~ has been difficult. The limitations of the Gor-
lin technique are well recognized. Likewise, the use of
external 2-D echo is limited because shadowing and rever-
beration caused by calcification prevents adequate visu-
alization of the orifice. An ultrasound imaging tech-
nique that permits visualizing the aortic valve orifice
from inside the orifice would overcome these difficul-
ties. In this study, we evaluated a 1.2 mm diameter
intravascular ultrasound imaging catheter with a single
20 mHz transducer which is hand-rotated to paint a cross-
sectional image on a computer screen. To assess the use-
fulness of this device, 3 calcific, stenotic intact human
aortic valves were imaged by both external 2-D echo and
the intravascular ultrasound imaging catheter. The aor-
tic valve orifice could not be visualized adequately by
external 2-0 echo. In contrast, acceptable images of the
valve orifice were obtained by the ultrasound catheter in
all 3 specimens and were planimetered. The smallest
lumen area was compared with valve area determined by
planimetering photographs of the gross tissue.




Thus, intravascular ultrasound imaging provides a poten-
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Echo Doppler II
QUANTITATION OF ACUTE AORTIC INSUFFICIENCY WITH COLOR
DOPPLER FLOW MAPPING: IN VITRO STUDIES IN A FLEXIBLE
MODEL OF THE LEFT VENTRICLE
Byron F. Vandenberg, MD, FACC, Kevin C. Dellsperger, MD,
PhD, Ian Law, BS, Krishnan B. Chandran, DSc and Richard
E. Kerber, MD, FACC, University of Iowa, Iowa City, IA
Previous in vitro studies of the quantitation of aortic
insufficiency (AI) with color Doppler flow imaging (CD)
have been limited to pulsatile studies in an
axi-symmetric (tube) aortic valve chamber. Our purpose
was to evaluate the quantitation of acute AI with CD in
a compliant left ventricular (LV) chamber mounted in a
pulse duplication system. The compliant LV chamber was
made of polyurethane permitting adjustment of LV end
diastolic pressure (EDP). Two bioprosthetic Hancock
valves were used in the "mitral" and "aortic"
positions. CD was performed with an Aloka 880 CD System
and a 2.5 mHz transducer oriented at the apex of the LV
chamber, parallel to outflow through the aortic valve.
Transvalvular defects were created in the aortic
bioprostheses. Jet area was measured from frames that
did not include contamination of the AI jet by mitral
inflow. Regurgitant volume and fraction were measured
with an electromagnetic flow probe.
RESULTS: (n-27) EDP ranged from 23-37 mmHg (mean±SD,
26±3), regurgitant volume ranged from 0.3-9.6 ml/beat
(mean, 2.7±2.3), and regurgitant fraction ranged from
0.5-24.5% (mean, 9.3±7.6). Jet area measurements were
compared to actual regurgitant volumes. Actual
regurgitant volume-0.85 (CD jet area) + 0.6; R-0.90,
SEE-l.06 ml, p<O.OOOI.
CONCLUSION: Color Doppler flow mapping and jet area
measurement may provide an accurate estimation of
regurgitant volume in the presence of acute aortic
insufficiency.





VARIABILITY IN MITRAL REGURGITANT JET AREA SIZE DURING
SYSTOLE AND ITS RELATION TO MITRAL REGURGITATION SEVERITY
Steven J. Lavine, MD, F.A.C.C., Luis Tami, MD, Rom Reddy,
MD, Daniel Dubay, MD, Vicki Johnson. Harper Hospital,
Wayne State University, Detroit, MI.
Although good correlations have been noted between
maximal mitral regurgitation (MR) jet area (JA) size
indexed to LA size and MR severity, there is overlap among
the grades of MR and variability in the timing of maximal
JA/LA. To determine whether the variability in JA size
during systole (S) was related to MR severity, we obtained
2-D echo's, pulsed and continuous wave Doppler and color
flow mapping on 12 pts with mild MR, 21 pts with moderate
MR, and 12 pts with severe MR (none with mitral valve
prolapse). MR severity was assessed by pulsed Doppler
regurgitant fraction (RF): RF<20% in mild MR, RF- 20-40%
in moderate MR, and RF>40% in severe MR. JA/LA's were
obtained on a frame by frame basis during S from para-
sternal long axis and apical 4 chamber views and averaged.
JA/LA were then determined at 2S%, SO% and 7S% S.
Mild MR Moderate MR Severe MR
2S% S 0.17 + 0.09 0.24 + 0.13 0.38 + 0.12""
SO% S 0.17 +0.11 0.39 + 0.18" 0.49 +0.17"
7S% S 0.07 +0.06 0.28 +0.19" 0.4S +0.17""
"p < •OS vs mild MR "p < •05-moderate vs severe MR
In mild MR, JA/LA was smallest at 7S% S as compared to 25%
and 50% S (p<.OS). In moderate MR, JA/LA at SO% of S was
greater than 2S% or SO% S (p<.05). In severe MR, JA/LA at
SO% S was greater than 2S% S (p<.OS). JA/LA during 75% S
best differentiated among MR groups. 10 of 12 pts with
mild MR had JA/LA < 13.2% and 18 of 21 pts with moderate
MR had JA/LA > 13.2% (p<.05). 17 of 21 pts with moderate
MR had JA/LA < 26.7% and 10 of 12 pts with severe MR had
JA/LA> 26.7% (p<.OS). Conclusion: (1) Extent of MR
throughout S is related to severity and (2) JA/LA during
late S can differentiate MR severity.
EFFECT OF AGE ON PULMONARY VENOUS FLOW VELOCITIES IN
NORMAL SUBJECTS.
Allan Klein M.D., Darryl J. Burstow M.D., Charles P.
Taliercio M.D., F.A.C.C., Prince K. Zachariah M.D.,
Ph.D., Kent R. Bailey Ph.D., James B. Seward M.D.,
F.A.C.C., A. Jamil Tajik M.D., F.A.C.C., Mayo Clinic,
Rochester, Minnesota.
Pulmonary venous (PV) flow velocity (VEL) profiles are
being frequently utilized for assessment of left
ventricular (LV) diastolic function; however, the effect
of age on PV VEL in normal subjects is unknown. We
performed pulsed-wave Doppler studies of PV VEL and of
the mitral inflow (MY) with respiratory monitoring in 40
normals (age, 47z17 yr; 31 women). PV peak systolic (S),
diastolic (D), and atrial reversal (AR) VEL, i systolic
forward flow velocity integral (i FFVI syst) and MY (E)
and (A) VEL, deceleration time (DT) were measured during
inspiration, expiration, and apnea. The patients were
divided into 2 groups: age < 50 yr (n = 21) and ~ 50 yr
(.!! = 19).
PV VEL, cm/s i FFVI MY
Age S D AR srst E/A OT, ms
<50 48 52 19 56 1.99 172
>50 62 37 23 65 1.19 196
E 0.0001 0.0001 0.03 0.0001 0.001 0.001
Normals ~50 yr have increased PV S, decreased 0,
increased AR VEL, and increased i FFVI syst. Analogous
changes seen in the MY in normals >50 yr were decreased
E/A and prolonged DT. There was no signifioant ohange in
PV VEL and MV VEL during inspiration, expiration, and
apnea. Conclusions: 1, Signifioant changes in PV VEL
oocur with aging: 2, these factors must be considered in
the assessment of LV diastolic funotion; 3, respiratory
changes in PV and MY VEL profiles are negligible.
Three-DimensionalEchocardlography :
A Feasible, Non-Invasive Method to Measure Cardiac Volume
Hugh A. McCann. M.D.. K.Chandrasekaran, M.D., Eric A. Hoffman,
Ph.D., Lawrence J. Sinak, M.D., James B. Seward, M.D.• FACe and
James F. Greenleaf, Ph.D., Mayo Clinic, Rochester, MN,
Hahnemann Univ. and University of PelUlsylvania, Philadelphia PA.
The detailed evaluation of cardiac anatomy in three-dimensions (3D)
without using gross geometric assumptions remains a major
challenge in medical imaging. In this study we utilized a conventional ,
sector scanner. We incrementally rotated the transducer around its
central beam axis to obtain 50 angles of view 3.6 degrees apart, thus
overcoming the limited acoustic access which has frustrated 3D
echocardiography. We insened the images into a 3D matrix at their
respective angles of view, preserving the original myocardial
backscatter data. To establish the accuracy of the method we
scanned 6 balloons and 4 excised heans in a water bath. The
reconstructed volumes of the balloons matched the estimated
volumes [y = 0.998X + 1.575; r = 0.99; S.E.E. = 1.67 mls] and a
simi1arly good correlation was found for the excised heart study [y=
0.919X + 3.187; r= 0.92; S.E.E. = 1.548 mIsl. We then estimated the
left ventricular (Iv) volume from a healthy volunteer in the same
manner and compared the volumes to those estimated utilizing 3D
magnetic resonance imaging.
Ved Ves SV
3D ECHO 107 ml 47 ml 59 mI
3D MRl 109 ml 46 ml 58 ml
Ved: end-diastolic Iv volume: Yes: end-systolic Iv volume
SV: stroke volume; EF: ejection fraction
We conclude that 3D echocardiography is a feasible method to obtain
information on cardiac volume.
SERIAL ASSESSMENT OF MITRAL REGURGITATION IN PATIENTS
UNDERGOING AORTIC VALWLOPLASTY. Patricia C Come. M.D.,
Marilyn F. Riley, B.S., Carol A. Waksmonski, M.D.,
Harvard-Thorndike Laboratory, Beth Israel Hospital and
Harvard Medical School, Boston, MA.
Mitral regurgitation (MR) was serially assessed by pulsed
Doppler echocardiography in 144 patients undergoing
balloon aortic valvuloplasty (BAV) for symptomatic aortic
stenosis. Scores of 0, I, 2 and 3 were assigned to pulsed
Doppler patterns corresponding to no, mild, moderate, and
severe MR. Before BAV, MR score correlated significantly
(p < O.OOS), but weakly, with aortic valve area (r -
-0.24) and with left ventricular ejection fraction (r -
-0.34). There was no significant correlation between MR
score and either mean catheterization or mean Doppler
aortic valve gradient. BAV produced decreases in both
catheterization and Doppler mean transvalvular aortic
gradients (56±19 to 31±12 and 60±19 to 48±16 mm Hg,
respectively; both p < 0.0001) and an increase (p < 2
0.0001) in aortic valve area (0.6±0.2 to 0.9± 0.3 em ).
Left ventricular ejection fraction did not change. Pulsed
Doppler findings of MR were present pre-BAV in 102 of the
144 patients. Eighty-eight patients had scores compatible
with at least mild MR, and 49 had scores indicative of
moderate or severe MR. In the 88 patients with mild or
greater HR, MR score decreased from 1.8±0.7 to 1.S±0.8 (p
< 0.0001). In the 49 patients with Doppler patterns of
moderate or severe MR before dilatation, regurgitant
score decreased in 38, remained unchanged in 8 and
increased (by only O.S grade) in 3. Conclusions: 1) MR is
commonly present in adult patients undergoing BAV; 2) it
is weakly and inversely correlated with left ventricular
ejection fraction and aortic valve area; 3) its severity
improves following BAV; 4) a decrease in the severity of
MR may be an important mechanism for symptomatic
improvement follOWing BAV.
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EFFECT OF DECREASED AFTElUA\D ON DOPPLU. INDICES OF
LEn VENTRICUUJl FILLING IN PRESSURE OVERLOAD
HYPERTROPHY.
lIarren J !lanning MD, Carol A lIaltslDOnaki MD. !larllyn F
Riley as, Patricia C Coae MD, FACC. Beth Israel
Hospital, Harvard-Thorndike Laboratory. Boston, MA.
Pressure overload hypertrophy (POR) is frequently
associated with an impairment of LV relaxation and
early diastolic filling. To deteraine if excessive
after10ad is a aajor contributor to this diastolic
iapairaent in patients with POH due to aortic stenosis,
we analyzed transmitra1 pulsed Doppler inflow patterns
1-2 days pre and post balloon aortic valvuloplasty
(BAV) . Of 190 consecutive patients undergoing BAV, 163
were excluded from analysis because of other factors
known to influence transmitra1 Doppler signals (CAD,
mitral/aortic regurgitation, irregular rhythms). Eight
patients did not have serial Doppler studies. The 19
reaaining patients (10K/9F, age 75±14 years) had a mean
LV wall thickness of 18±.3 _. Baseline radionuclide
LVEF was 0.73~.15. Following BAV. peak LV systolic
pressure fell from 212±)2 to 185~2 ~g (P<.OOOl) and
mean aortic gradient fell from 65±l3 to 50±14 mmHg
(P<.OOl). Peak E and A wava velocities, , atrial
contribution to LV filling, time for 50' LV filling.
and , filling in the first 1/3 of diastole did not
significantly change, nor was there any correlation
between changes in Doppler indices and mean aortic
gradient or LV systolic pressure. Analysis of a
subgroup of 12 patients with the same inter-study hesrt
rate (~10') was similar.
Conclusion: In the aortic stenosis model of POH,
an acute decrease in afterload following balloon aortic
valvuloplasty is not associated with early improvement
in Doppler indices of LV diastolic filling.
ABSTRACTS
IMPROVED DOPPLER ASSESSMENT OF NORMAL ST. JUDE'S
PROSTHETIC AORTIC VALVES USING THE CONTINUITY EQUATION.
Edward R. Chafizadeh, B.A., Wllliam A. Zoghbi, M.ll.,
F.A.C.C., Baylor College of Medicine, Houston, Texas.
Doppler echocardiography (DE) has provided accurate
measurements of stenotic aortic valve area using the
continuity equation. We postulated that the continuity
equation is superior to gradients in the evaluation of
prosthetic aortic valves (PrV). Accordingly, DE was
performed on 67 pts (41 M, 26F, mean age 58:14 yrs)
within 1 month following aortic valve replacement with
St. Jude's valves (mean 10 ± 6 days). All pts were
clinically stable and without evidence of valve
dysfunction. Valve size ranged from 19 to 31nm, mean
23.6 1lIl1. LV ejection fraction ranged from 30 to 751.
Using the parasternal long axis view, the LV outflow
diameter was measured just proximal to the PrV. A good
correlation was observed between valve size and LV out-
flow diameter measurements (r=0.92). Doppler-derived
maximal PrV gradients ranged from 9-71 mmHg (mean 29),
mean gradients from 5-30 IlIl1Hg (mean 14) and cardiac
output from 2.8-12.3 l/min (mean 5.3). Effective PrV
area by the continuity equation averaged 1.63 cmZ (range
0.73 cmZ for a 19 IlIl1 valve to 4.23 for a 31 nm valve).
Using analysis of variance, PrV area differentiated
better the various valve sizes (p<O.OOOOOl) than did
gradients (p=0.003). Furthennore, PrV area correlated
better with valve size (r=0.82) than did either maximal
or mean gradients (rE -0.46 and -0.4, respectively).
In conclusion, the calculation of effective valve area
using the continuity equation is superior to the use of
grad~ents in assessing normal St. Jude's prosthetic
aortlc valves. These data warrant the application of the
continuity equation to the evaluation of prosthetic
aortic valve stenosis.
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I. ."Ilu.ttd tb. UI.fu1n... of tr.....o'la.f••1
tclaoear4iorr.pb, (TIl) in 10 plti.nt. in wboa tla.
tr...tbor.cic .cboelrdiogrl,b, (TTl) ,ro"id14
in.uffici.nt infor••tion for o,ti'11 ,.ti.nt (,t)
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TD. 111 tla••• ,t. w,[I IWlt. durinf TIl. TIl ,lly14 •
• ituific..t ro1. in ,t aaD&ftatDt in 32 of 3~ ,.ti.nt.
witb lortic di.ord.r. (inc1"iDf ~ aortic root
ab.c••• , 2 l.ft w.ntricullr outflow trlct to l.ft
Itri.l fi.tul., ... 3 .ortic di.atetion). 21 of 33 ,t.
.itb aitr.l disord.r. (inc1udiDf 11 ptri,roatb.tic
r'fUrfit.tion. 2 eDdocarditi.) 5 ,t. witla eonf.nit.l
di.ord.r. (inc1udinf ,.rti.1 'Ddoe.rdill cu.bion
d.f.ct witla H.ur,•• of tla. cl.ft, w.ntricu1.r ••,t.l
d.f.ct) ..d 7 of 1 intr.c.rdi.c ...... (inc1udinf 3
iat.rltri.l ••,t.1 •••• , ~ 1.ft .trill I,,.nd.f'
tbroaba.) •••••d on .dditioD.l TIl i,fora.tion in 3
.ortic di•••ction. ~ .ortic ab.c••• , 9 .itr.l
regurfit.tioe .urfic.l tr'ltatDt WI' p1.DD.d. In tb.
r••t, TIl prowi4.. n.c•••ary inforaatioa to ....f.
.14ically, ola"ilt.. c.tb.t.ril.tion. or in4iclt.d D.14
for c.tla.t.ril.tion. I. conclud. tblt 11tbODfb III i.
.d!(Q.t. in 'Ijoritr of p.ti.Dt., tb.r. i. I •••11
froup in wbo. it i. Dot ..d III i. n.c••••ry. Thi.
grou, iDClud. pt. witb .11 for.. of b••rt di•••••
••,.ci.lly tbo•• witb .ortic root di 4 aitr.1
,rOltb.Ii••
THE CONTRIBUTION OF TRANSOESOPHAGEAL ECHOCARDIOGRAPHY IN
THE ULTRASOUND ASSESSMENT OF PERCUTANEOUS MITRAL
VALVULOPLASTY.
Bertrand CORMIER MD, Alec VAHANIAN MD. Pierre-Louis MICHEL
MD, Bernard VITOUX MD, Charles STARKMAN MD, Lionel ENRIQUEZ
MD, Alain KULAS MD. Jean ACAR MD.
Tenon Hospital, Paris, FRANCE.
The aim of this study is to assess the interest of trans-
oesophageal echocardiography (TEE) compared with that of
transthoracic (TTE) in selecting candidates and evaluating
results of percutaneous mitral valvuloplasty (PMV). Between
June and September 1988, 31 patients (pts) were examined by
TEE and TTE before PMV .
PMV was not performed in 3 pts in whom a thrombus in the
left atrial appendage was detected by TEE but not by TTE .
Before PMV, TEE was also better than TT£ in showing spon-
taneous contrast of the left atrium (20 vs 0, p," .001), in
assessing subvalvular lesions (correct visualisation in all
patients vs 26 by TTE, p( .02) and in detecting mild mitral
regurgitation (MR) (18 vs 10, p ~ .05). On the contrary pla-
nimetry of valvular area was only possible with TTE. This
technique was also superior in visualising the commissural
area. During PMV. TEE enabled the puncture of the intera-
trial septum to be made in one pt. Echocardiographic study
was repeated 24 to 48 hours after PMV in 28 pts. MR) 2+ was
observed in 2 pts where only TEE was able to show the causal
mechanism : rupture of chordae in one and valvular mutila-
tion in one. Color Doppler showed a trivial shunt at the
atrial level in 16 cases with TEE vs 5 cases with TTE
(p, .01). In the same way a small atrial septal defect was
directly found in 10 cases only by TEE.
From this preliminary study we conclude that TEE provides
additional information in echocardiographic assessroent of
PMV in : - detecting the presence of left atrial thrombi
- determining the degree and mechanism of MR
- assessing small atrial septal defects.




CARDIAC CYCLE-DEPENDENT VARIATION OF INTEGRATED
BACKSCATTER: AN INDEX OF CONTRACTILE
PERFORMANCE THAT IS NOT DISTORTED BY
PARADOXICAL SEPTAL MOTION.
Mark R MilunsJci. M 0" Charles E. Canter, M.D., Samuel A.
Wickline, M.D., Burton E. Sobel, M.D., James G. Miller, Ph.D.,
Julio E. Perez, MD., Washington University, St. Louis, Missouri.
We have previously shown that canine and human myocardium
exhibit a cardiac cycle-dependent variation of integrated backscatter
(CV) that depends on regional myocardial contractile performance and
that is altered promptly by ischemia and by reperfusion.To determine
whether CV provides an index of regional contractile performance that
is not distorted by altered wall motion per se, we studied 8 children
(age 10.6 ± 4 yrs) with congenital cardiac lesions including 5 with
surgically corrected defects who exhibited paradoxical septal motion
evident with conventional 2-D and M-mode echocardiography.
Controls were 6 healthy children (age 9 ± 0.6 yrs) with normal
echocardiograms. CV was measured in parasternal long-axis views
from multiple septal sites (2.5 ± 1 in the study group; 2.8 ± 0.8 in
controls) for each subject. The average magnitude of septal CV was
8.3 ± 0.8 dB (SO) compared with 5.7 ± 1.0 dB in the study and
control groups (P = 0.05) consistent with right ventricular volume
overload in the study group. Systolic septal thickening was 46 ±
12.7% and 42 ± 14.5% in the study and control groups (P =NS).
Regional CV was in phase with electromechanical events of the
cardiac cycle in both groups. These results indicate that CV quantifies
regional contractile performance manifest also by physiologic wall
thickening. Furthermore, CV remains in phase with physiologic
regional systolic wall thickening despite paradoxical wall motion and
may therefore be less prone to error in detecting regional tissue
viability compared with analysis of the phase of wall motion alone.
Thus, ultrasonic tissue characterization appears to provide a sensitive
and quantitative index of regional tissue viability regardless of the
presence of altered wall motion that may be seen in transiently
ischemic but still viable myocardium.
THE ECHO-DOPPLER EYALUATIOI OF PERCUTAHEOUS IIITRAL YAL-
VULOPLASTY CORRELATES POORLY WITH IWASIY! KEASUREKEHTS
BUT IS PREDICTIYE OF SUCCESS
Thierry Muller, 11.0., Raoul Bonan, 11.0., F.A.C.C.,
Robert Petitclerc, 11.0., Antonio Serra, 11.0., lIartine
Dethy, 11.0., Angel Cequier, 11.0., Jacques Crepeau,
11.0., Jacques Lesperance, 11.0., David Waters, 11.0.,
F.A.C.C., lIontreal Heart Institute, lIontreal, Canada.
The utility of echO-Doppler measurements pre and post
percutaneous mitral valVUloplasty (PIIV) were assessed
in 76 pts. Their mean age was 52:1:14 years and 66 were
women. Poor correlations with invasive measurements
were found:
Ecbo-Doppler Catbeterization! 2
lIitral area: pre 1.1:1:0.. 1.07:1:0.3 0.1 VS
(nun2) post 2.0:1:0.6 2.2:1:0.9 0.1 VS
6 mo. 1.8:1:0.3 1.8:1:0.3 0.1 IS
pre 10:1:2 16:1:5 0.5 <.001
post 5.H2 6:1:2.7 0.3 <.001
6 mo. 5.2:1:2.1 6.5:1:2 0.6 <.01
lIitral regurg. .5 ~ 57 pts 35 ~ .5 pts 0.6 <.01
Success was classified by catbeterization criteria as
optimal (valve area >1.5 and gain >25'1.: 53 pts) and
SUboptimal (area '1.5 and gain '25'1.: 15 pts). The
echocardiograpbic factors predictive of optimal success
by univariate analysis were left atrial diameter (50:1:8
vs 56:1:7 nun, p=.OOl), leaflet thickness (p=.002), leaf-
let mobility (p=.002) and ecbocardiograpbic mitral
valve score (p=.009). By multivariate analysis with
bemodynamic parameters, left atrial size and pulmonary
vascular resistance were selected as independent pre-
dictors of optimal success.
Thus, althougb ecbocardiograpbic parameters correlate
poorly with invasive measurements, tbey are useful botb
to select optimal candidates for PKV and as a baseline
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PRESERVATION OF MYOCARDIAL FUNCTION BY A CORONARY
PERFUSION CATHETER.
Abel E. Moreyra, M.D., F.A.C.C., Peter M. Scholz, M,D.,
Angelo Macds, John B. Kostis, M.D., F.A.C.C., UMDNJ-
Robert Wood Johnson Medical School, New Brunswick, NJ.
We studied the effectiveness of a coronary perfusion
catheter (CPC) in an animal model of acute coronary
occlusion (Occ). Hemodynamic variablea, regional myocar-
dial blood flow (RMBF) in the subepicardium (epi) and
subendocardium (endo) and regional systolic function (by
ultrasonic crystals) of the circumflex (Cx) perfused
area were measured in 7 anesthesized dogs. After base-
line measurements, the Cx artery was occluded with a
silk snare and measurements repeated after 5 minutes of
ischemia (Occ 111). The snare was released and 1 hour
later the snare occlusion was repeated after placement








ESTIMATION OF PULMONARY PRESSURE IN VENTRICULAR SEPTAL
DEFECT: OOPPLER AND COLOR FLOW APPLICATION.
Samuel B. Ritter, M.D., Karen R. Segal, Ph.D., Diana
Kawai ROMS, William A. Rothe, M.D., Rica Arnon, M.D.,
Richard J. Golinko, M.D., Mount Sinai School of Medicine,
New York, NY
Quantification of pulmonary artery pressure (PAp) in
children with ventricular septal defect (VSD) is essen-
tial in clinical management. Continuous wave Doppler
(CWO) can estimate the pressure drop (~P) across the
VSD. Eccentricity of VSD jets may allow CWO interroga-
tion to underestimate true gradients and thereby
overestimate PAp. Color flow Doppler (CFD), however,
accurately displays the area of maximal transseptal flow
and allows for direction of the CWO beam through the VSD
jet. Thirty-seven patients, aged 5 wks to 6 yr (Mean 3.2
yr) with VSD were studied by 20 echo/CWD/CFD at the time
of cardiac catheterization (CC). Maximal trans-VSD velo·
cities were identified by directing the CWO beam across
the VSD both without and subsequently with CFD display.
Velocities (V) were converted to gradients (4!lP LV-RV) by
a modified Bernoulli equation (AP=4V2). LV pressure
was assumed equal to systolic right brachial artery
pressure. PAp's measured during CC were regressed on the
values obtained from both "black and white" and CFD CWO
examinations. Estimation of PAp (no CFD) correlated well
with CC-measured PAp (r=0.96, p< .001). The best-fitting
regression line differed significantly from the line of
identity. Use of CFD to "angle-correct" CWO provided a
better prediction of PAp (r=0.99) which did not differ
significantly from the line of identity. Estimation of
PAp by trans-VSD CWO is accurate: CFD improves CWO mea-
surements by allowing visualization of trans-VSD flow.
SBP-systolic blood pressure; LVEDP-left ventricular
end-diastolic pressure; I:!.L%-percent systolic segmental
shortening; *p <0.01 from baseline;tP <0.05 from Occ #1.
Conclusions: In anesthesized dogs CPC returned values of
epi RMBF to 63% and endo RMBF to 44% of baseline.
Although both values were significantly lower (P<O.Ol)
from baseline levels, flow was ad1!quate to preserve
re~ional systolic function (I:!.L%).
JACC Vol. 13, No.2
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PERCUTANEOUS LEFT ATRIAL -FEMORAL ARTERY BYPASS
WITH APULSATILE PUMP: INITIAL HUMAN EXPERIENCE IN
CARDlCGENlC SHOCK.
Jacob Shanj MD FACe Gerald Hollander, MD. FACC. Ira
Nathan, PhD, Alvin Greengart, MD, FACC, Bruce Toporoff, MD,
Israel Jacobowitz, MD, Ephraim Glassman, MD, Joseph
Cunningham, MD, Edgar Lichstein, MD, FACC, Maimonides
Medical Center, SUNY. Health Science Center at BrOOklyn,
BrOOklyn, NY.
Experimental data suggests that prompt unloading of the left
ventricle prevents ongoing myocardial damage during acute
infarction and reperfusion. We inserted a percutaneous left
atrial-femoral artery (LA-FA) bypass device into 6 pts in
cardlogenic shock. undergoing CPR. Acannula was inserted
through the femoral vein transseptally into the left atrium.
Blood drained from the left atrium was ejected by a pulsatile
pump into the femoral artery, thus, bypassing and completely
unloading the left ventricle while maintaining systemic
circulation. Coronary angiography and angioplasly were
performed SUbsequently. Two pts lived for 2 days; both were
alert until the time of expiration. One patient in cardiac
standstill was maintained 4 hours with adequate systemic
pressures on the pulsatile pump. LVEDP and wedge pressure
decreased, systemic pressures were normalized and lactate
levels decreased in all pts while on the pump. Conclysions' The
LA-FA bypass can be inserted percutaneously. The pulsatile
pump is effective in supporting the systemic circulation and
unloading the left ventricle.
ABSTRACTS
INCREASE IN MYOCARDIAL SALVAGE BY COMBINING CORONARY
SINUS OCCLUSION AND RETROPERPUSION.
Alice K. Jacobs M.D., F.A.C.C., Paul Simon H.D.,
Victoria Hogfeldt, David P. Faxon H.D., F.A.C.C.,
Alyson Oven M.D., Tho.as J. Ryan M.D., F.A.C.C. Boston
University Medical Center, Boston, HA.
Both synchronized retroperfusion of arterial blood
(SRP) and pressure-controlled interaittent coronary
sinus occlusion (PICSO) are known to reduce experimen-
tal infarct size. To test whether their effects are
additive, 49 open-chest anesthetized dogs were randomly
assigned 30 min. after LAD occlusion to Group I
(CONTROL, n~14), Group II (PICSO, n.14), Group III
(SRP, n.8) or Group IV (PICSO+SRP, n.13). PICSO was
achieved by the timed inflation of a balloon-tipped
catheter (~10 sec inflation, ~4 sec deflation) and SRP
by the retroperfusion of femoral artery blood into the
coronary sinus in diastole. In group IV, PleSO was
coabined with SRP so that SRP was performed during each
10 sec balloon inflation. Infarct size was measured by
triphenyltetrazolium chloride staining and risk region
was determined by Rhodamine B perfusion after 6 hours.
Infarct size/risk region (%) (mean + SE)
CONTROL PICSO SRP PICSO+SRP
54.7+3.9 38.0+5.7* 39.0.7.6* 21.5+4.2**
- -* p< 0.05-vs Group I -
** p< 0.02 vs Group II + III, p< 0.001 vs Group I
In conclusion, both PICSO and SRP significantly reduced
infarct size equally. Combining PICSO with SRP reduced
infarct size more than either technique alone, salvag-
ing approximately 80% of the region at risk. This
enhanced salvage is likely due to improved delivery
of oxygenated blood to the ischemic territory.
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CARDIOPOLKlNARY BYPASS SUPPORTED CORONARY AllGIOH.ASTY IN
INOPERABLE PATIENr.!
FaylZ A,Shavl.MD.FACC;M1OOael J. Domanski, MD, FACC, Sudbakar
Punja, MD, FACC, TOII18 J. Herlllndez, MD, Wallhinaton Adventist
Hospi tal, TaIeOlla Parle, MD.
S<:ae pts with _ere llJmptClllatio ooroaary artery
di_ae(CAD) are not surgl.oal OIndidates. or 48 pts who
\lIlderwent PrCA uaina percutaneoua oardiopulllOnary bypallll
support(PCPS),12(ages 117-79 yra) were relt to be
inoperable beOluae or poor LV r\lllotion, only one target
vesael sUPplyill8 the raainill8 viable 1DJ00lrdi~(H)
and/or associated nonoardiao diaeaaes. 11 had prior
myooardial infarotion; 8 had prior oorolllrJ bypass
surgery. I!;jeotion rraotionranpd rrOll 11-35,l(man 26).
All pts had oritioal 3 veaael CAD and one had lert .ain
CAD. In 6, the target artery was the only r_ainina
veaael aervina viable H. 8 pta had oongelltive hart
railure. Nonoardiao di__ inoluded savere OOroaio l\lllg
diaeaae(II); renal railure(2); diabetea(3); history or
eternal dehisoence(1) and bilateral oarotid atenoais(II).
20F cannulae were placed in the r_oral artery and vein
and PCPS was initiated. nov rates or 2.8-11.0 LllDin(_an
3.5) were obtained. Pulmonary wedge pressures were 0-5 _
1Ig. PrCA or all 22 lellions attempted were suoesarully
dilated. PCPS was discontinued without inaident in all
pts. 'DIere were no deaths. Six pta required tranaruaion
or 1 to 3 units(_n 1.8). other OCllIplioationa: transient
isOOaio attacle(l), deep vellOuathr<:abollia(l), OInnula
lIi te infeotion( 1l and raoral nerve wealmesa( 1l. Follovup
1-3 1IOIlthS atter disOOarge: 9 pta were allJmptc.atio, 1 pt
had Class I and 1 had Clallll II angl.lII. In oonoluaion: (1)
PCPS makes PrCA rasible in pts in wh<:a ooroaary bypallll
is not rallible and(2) PCPS oan be perrol'lled sarely in
hilll1 risle patients. Further study or this extended
applioation or PrCA 111 needed to olearly elltabUm ita
role in the therapy or CAD.
AN IN VITRO COMPARISON OF EXCIMER LASER AND AN ARGON
LASER HEATED PROBE
Jonathan M. Tobis. H.D •• fACCi John A. Hallery, H.D.;
Lachlan Hacleay, H.D.; Michael Hcrae, H.D.; Hichael
Berns, Ph.D.; Walter L. Henry, H.D., fACC; University of
Cal ifornia, Irvine, CA
Recent studies have reported that excimer laser vaporiza-
tion has a high degree of success in recanalizing com-
plete occlusions in the femoral artery and that the inci-
dence of arterial perforation may be less with the
excimer laser than with a thermal probe. To understand
the mechanism of action during recanalization of com-
pletely occluded human arteries, an in vitro study was
performed with 19 arterial segments (2 to IOcm long). An
Argon laser assisted thermal probe recanalized 3 segments
but perforated 8 (73%) others. Histologic sections
showed that the thermal probe was deflected by dense
fibrocalcific plaque and dissected mechanically between
the intima and media prior to perforation. An excimer
laser With a ~OO micron quartz fiber was pulsed at 20 Hz
with 50 mj/mm of energy. The excimer stimulated quartz
fiber penetrated dense plaque in all 8 arterial segments,
but perforated 4 (50%) due to deflection from calcified
sections. In the arterial sections without calcifica-
tion, the excimer laser cut cleanly through the intimal
plaque without mechanical deflection or evidence of ther-
mal damage on histologic section. In vitro excimer laser
or thermal recanalization of dense fibrocalcific atheroma
is associated with a high incidence of mechanical deflec-
tion of the delivery devices. Better gUidance systems
need to be developed to lower the risk of arterial perfo-
ration.
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ENHANCED RECOGNITION OF PLAQUE COMPOSITION IN VIVO USING
lASER-EXCITED FWORESCB-CESPECTf03COPY
Antonio L Bectoral!! M 0 , Roben Bonner Ph.D., Varon Almagor M.D.,
Richard Neville M.D., Charles Mcintosh M.D., F.A.C.C., Julie Swain
M.D., FA.C.C., Martin B. Leon M.D., F.A.C.C. NHLBI, Bethesda, MD
Although we used laser-excited fluorescence spectra (FS) to
successfully direct clinical laser ablation of plaque (P), recognition of
P composition should improve the effectiveness of laser angioplasty.
Using a nitrogen laser (337 nm @ 40"w per pUlse) for excitation and
improved broadband optics, we obtained 708 FS from 177 sites,
through a 200 IJ.IT1 optical fiber, In 25 patients (57±15 yrs.), 9
during catheterization and 16 in a bloodless field during cardiac
surgery. Four highly distinct FS types were observed (see Figure): 1)
normal (92 sites), 2) white fibrous plaque (34 sites), 3) yellow
fatty plaque (39 sites) and 4) thrombus (15 sites). These In vivo data
were compared to FS from normal and •
variable composition P necropsy ..~
specimens (100 sites). FS from normal I
aorta exhibited similar maximal i..
intensity (.8 ± .3) and emission peaks
(410 ±2 nm) whether in the cath lab,
during surgery or in vitro. Compared :....... ..
with normal aona, FS from normal .A-"'",
coronaries showed similar peak position and shape, but reduced
maximal intensity (.5±.3, p<.OOl). Tissue composition was
reproducibly and accurately determined by FS shape and peak position,
both in patients and In vitro for white P (peak @ 399±3nm), yellow
P (peak@406±2nm) and thrombus (valley @ 431±1 nm which
corresponds to Hb absorption). We conclude: using this Improved
laser-excited FS system, that normal and variable composition P
tissue sites manifest distinct FS patterns which are eqUivalent in
clinical studies and in vitro. Imponantly, the enhanced recognition of
P composition by FS may permit ablation of specific targets (eg.
thrombus in total occlusions) with optimized laser pulse energies,
which should Improve safety and efficacy of laser angioplast)'.
rTPA VERSUS rTPA PLUS PTCA IN ACUTE MYOCARDIAL
INFARCTION:gUANTITATIVE RESULTS OF EARLY AND LATEORONARY ARTERIOGRAPHY
Rainer lJebis M 0 Alfred E.R. Arnold M.D., Martin H. Sigmund
M.D., Rolf Doerr M.I~:l.MaartenL. Simoons M.Q;I David P. de
Bono M.D., Patrick w. Serruys M.D., Peter nanrath M.D.
FAC.C.
Medical Clinic I, RWIH Aachen, West Germany _
for the European Cooperative Study Group for ffPA
A p'rospective randomized stu~was carried out to assess whether
an invasive strategy with Lv. ffPA, acetylic salicylic acid, heparin
plus immediate angiography and PTCA (~oup 2) woufd be
superior to a nonmvasive treatment with thrombolysis alone
(~oup 1). Coronary angiograms were obtained before and after
PTCA in group 2 and W-22 days after admission in both groups'
for quantitative analysis of at least 2 views per patient and
investi,gation, a computerized system with automatic edge
detectIOn, developed at the Thorax Center in Rotterdam, was
used. Medians and 90% confidence intervals ar~given.
In group 2, acute angioplasty before and after PTCA revealed an
improvement in diameter stenosis from 57.2 (36.4-73.1) to 38.3
U
9.4.59.9)% and in obstruction diameter from 1.2 (0.8-1.9) to 1.8
1.2-2.5) mm.
esults 10-22 days later:
Conclusions' Immediate PTCA when combined with thrombolysis
with rTPA is able to improve residual stenosis in the infarct
related artery. The difference is still present prior to discharge
10-22 days after the acute intervention. However, this does not
result in a better clinical course of these patients.
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Balloon Valvuloplasty: Acute Hemodynamic
Changes and Long Term Follow-up
BALLOON AORTIC VALVULOPLASTY: ACUTE AND CHRONIC ASSESS-
MENT OF LEFT VENTRICULAR HEHODYlWfICS AND PRESSURE-VOLUME
RELATIONSHIPS.
Charles J. Dayidson, H.D., Thomas N. Skelton, H.D.,
Katherine B. Kisslo, R.D.H.S., Hark Leithe, H.D., Thomas
H. Bashore, H.D., F.A.C.C., Duke University Hedical Cen-
ter, Durham, N.C.
The acute and chronic changes in left ventricular (LV)
performance have yet to be vell defined after balloon
aortic valvuloplasty (BAV). Sixty-five patients (pts)
vere studied before and immediately after BAV using dual
sensor micromanometer catheters, digital ventriculography
and aortography and Fick cardiac output. TWenty pts with
similar acute changes returned for repeat catheterization
at 6 Z 1.7 months (9 due to recurrent symptoms). Pres-
sure-volume (PV) loops defined stroke work (SW).
Results: In.:.W Post-BAY FQLLOWP
n - 65 65 2Q
LVEDP(mmHg) 18 + 8 14 ± 6A 2Q + 9B
LVEDV(ml) 148 ±6Q 146 ± 59 112 ±43AB
+ dP/dt (max) 1624 ± 452 1495 + 473A 1710 + 479
- dP/dt (max) -1449 ± 427 -1253 ±442A -1563 ; 373
Hean Gradient (mmHg) 59 + 22 32 + llA 51 ; 15AB
AVA (cm2) Q.5 ±Q.l Q.8 ±Q.2A Q.6 ±Ot2AB
Ejection Fraction(') 47 ± 20 51 ± 19A 52 ± 17
SW (erg x 106) 16.0 ± 7.1 14.3 ± 5.7A 12.2 ± 5.6A
C.O. (L/min) 4.2 ± 1.0 4.0 ± 0.9 4.2 ± 1.2.
A - P < 0.01 vs pre; B - P < 0.01 vs post
Initially, BAV results in complex hemodynamic changes
vith a shift in the PV loop to the left, a fall in both
peak + and peak - dP/dt, a reduction in SV and an in-
crease in the £F. At 6 months, despite rescenosis, the
PV loop shifts further to the left, and SW oontinues to
decline, yet C.O. is preserved. This suggests ventri-
cular remodelling has occurred that allows for mainten-
ance of LV performance at a lower energy expenditure.
elr.~If78P§lvJFAOJW<:Gs&IS~Ie:Bi\orIVHftr
9 ~ Bfol I~, JoIIIIlI. Allea lI.p., FraDCis u. Lau II.D•. !be Bept .D1(ru~,~OIlPI of tile Good SoantaD aDd II.II.II.C - Lou Linda universIty.
Los Anqe 5, ca.
Fron August 1985 to August 1988 Percutaneous Double Balloon Valvuloplasty (PDBV)
was perforJed in 52 patients witb severe aortic steaosis (A.S). In tbe overall
group the transvalvular gradient (AVG) decreased frol n±34 nBq. to 25±15 nBq.
(p<.OOOl) and the valve area (AVA) increased frol .48±.16 CI.' to L14±.49 CI.'
(p<.OOO5). Group I consisted of 34 calcific deqenerative A.S, all older than 70
years of aqe in whon tbe AVG decreased frol 80±36 DIIq. to 26±13 nBq. (p<.OOI)
and tbe AVA increased frol .46±.14 CI.' to .89±.35 CI.' (p<.OOOl). Group II
consisted of 13 conqenital A.S younqer tban 35 years of aqe, in Whol the AVG
decreased fron 85±30 nBq. to 28±19 nBq. (p<.OOl) witb an increase in AVA frol
.5H.15 CI.' to L21±.64 CI.' (p<.OI). Group III consisted of 5 rheuJatic A.S,
4 younqer than 35 years of aqe and 1 of 74 years old. The AVG in tbis last
group decreased frol 79±22 nBq. to 14±9 nBq. (p<.OOOI) and the AVA increased
fron .62±.17 CI.' to 2.36±.64 CI.' (p<.OOOI). There were 3 procedure related
deatbs, and all occurred in group r. At 3 years follow-up, in group I there were
2 deatbs witbin 3 nontbs of PDBV, 5 deatbs witbin 1 year. One patient underwent
repeat PDBV at 2 years. 7 have relained IYRA-rc HI but the doppler AVG is the
salle as pre-dilatation in all but one. 3 have sylptolatically (IYRA-rc III-IV)
restenosed and refuse further intervention. 6 relain aSyiptolatic witb doppler
AVG under 45 IIIlq. 7 were lost to follow-up. In group II, 4 underwent valve
replacelent (3 for restenosis and 1 for severe aortic requrqitation) witbin one
year, 6 relain IYRA-FC I, 3 witb doppler AVG UJKIer 25 nBq. and 3 under 45 nBq.
3 are lost to follow-up. In group III all-renain IYRA-FC I, 4 witb doppler AVG
under 15 nBq. and one patient had a doppler at 6 IOntbs but refused further
stUdies. Therefore we conclude tbat: 1.- PDBV does not alter tile outCOIe of
deqenerative aortic stenosis and should only be recooended to ilprove
conditions for an inediate valve replacelent. 2.- PDBV could be offered to
younq conqenital A.S to qain tile for a valve replaceJellt. 3.- PDBV &eelS to be
an effective procedure up to 2 years follow-up for rheulatic A.S, however lonqer
follow-up is needed before tbe procedure can be offered as a first choice
alternative.
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LEFT VENTRICULAR RELAXATION IN MITRAL STENOSIS BEFORE
AND AFTER VALVULOPLASTY,
Mjchel F, Rousseau M.D" F,A.C,C" Walter J, Paulus
M.D" Philippe Mengeot M.D" Claude Hanet M.D" Erwin
Schroeder M,D" Guy R. Heyndrickx M.D., Hubert Pouleur
M,D" F.A.C,C., University of Louvain, Brussel sand
Cardiovascular Center, Aalst, Belgium,
Left ventricular (LV) relaxation was analyzed in II
patients (pts) in sinus rhythm with mitral stenosis.
The 6 pts with normal end- diastolic (ED) volumes
(91±IS ml/m2 ; Group A) had normal LV end-diastolic
pressure and time-constant T of isovolumic pressure
fall (8±4 mmHg and 40±4 ms, respectively). In contrast,
S pts (Group B) had increased end-diastolic volumes
(137±11* ml/m2 ), increased LV end-diastolic pressure
(17±4* mmHg) and prolonged T (72±21* ms) when compared
to normal subjects or to group A. They also had
slightly reduced ejection fractions (64±10 vs 70±9% in
groupe A; NS). No correlation was found between
impaired relaxation and mitral valve area, After
balloon valvuloplasty, mitral valve area increased from
0,8 to 1.6* cm2 and valvular gradient dropped in all
pts, Heart rate was lower at the end of the procedure
(91 to 83* bpm) but no significant changes in LV
end-diastolic pressure, (dP/dt)Max, (dP/dt)Min or T
were noted in group A or B, Thus, LV diastolic function
is abnormal in a large subset of pts with mitral
stenosis and this appears related more to myocardial
factors than to the degree of stenosis, Such
abnormalities may impair LV function during atrial
fibrillation and exercise or limit the functional
benefit after dilatation. *P<O,OS Group A vs B
PERCUTANEOUS MITRAL VALVULOPLASTY IN PATIENTS
WITH PREVIOUS SURGICAL COMMISSUROTOMY.
Jean P. Bassand, Fr8ll\;0is Schiele, Yvette Bernard, Patrick
Jacoulet, Jean P, Maurat.
University Hospital 25000 BESANCON FRANCE.
Fibrous lesions and calcifications of mitral valve and
chordae tendinae are often extensive in patients with recur-
rent mitral stenosis after surgical commissurotomy, In order
to assess whether percutaneous mitral valvuloplasty (PMV)
may be a valuable alternative to mitral valve replacement
in such patients we compared among 70 patients submitted
to PMV the results of those with previous surgical commissu-
rotomy (group A = 15 patients) to those without (group
B = 55 patients). On average, group A patients were signifi-
cantly older (61+11 vs 5CH-82 P <. 0.05), had more severe
mitral stenosis 'ind more - severe cardiac enlargement than
group B patients.
MV A group A MVA group B
PrePAY 0.79+0.33 I.O~0.34**
PostPAY 1.67+0.40* 2.08+0.35* &: **
* P <. 0.05 betweenpre and post PAY viIues
**p <. 0.05 between group A and group B
Mitral regurgitation (MR) worsening was more frequent
in group A pts (4 out of I j) than in group B pts (4 out
of 55 pts). Full commissural opening was less frequent in
group A than in group B pts. Mitral valve area (MVA) remai-
ned below 1.5 em' in 3 group A pts and 5 group B pts.
Functionnai improvement of at least I functionnai class
ocurred in 9 out of 15 group A pts.
These results demonstrate that PMV is feasible in patients
with recurrent mitral stenosis after closed heart commissu-
rotomy but produces less favorable results than in patients
without previous surgical commissurotomy.
EARLY AND LONGTERM RESULTS AFTER MITRAL VALVULOPLASTY AS
COMPARED WITH OPEN COMMISSUROTOMY
Felicitas Kraus MD, Serban Dacian MD. Caroline Rudolph MD.
Donald Hall MD, FACC, Werner Rudolph MD, FACC,


































Jo compare the results of successful valvuloplasty (VP)
with those of open commissurotomy (COM) for severe mitral
stenosis, studies were performed in 52 pats with pre-
existing valve orifice area <1,Oqcm/qm (I, 1~0.4qcm prior
to VP and 1.1+0.3 qcm prior to COM), Before, I week (W)
and 1/2 yearlY) after VP as well as before, 2-3 Wand 1/2
Y after COM resting (R) and exercise (EX) hemodynamics as
well as O,-saturation in the pulmonary artery (PA) were
determined, Newly incurred regurgitation or increase were
assessed after VP with angiography and after COM by aus-
cultation and Doppler echo; the incidence was 33% in VP














pre VP vs COM ns ns ,05 .05 ,005,005 ns ns
postVPvsCOM(I/2-3w)ns ns ns ns ns ns ,005 ns
postVPvsCOM{ 1/2y).005.005 ns ns ns ns ,01 ns
Thus, early after VP the hemodynamic results achieved are
comparable with those of COM, 1/2 Y after the respective
interventions, there are clearly more markedly pathologic
changes in PA pressure after VP than COM such that after
VP longterm results appear less favorable.
FEATURES OF SEVERE MITRAL REGURGITATION
FOLLOWING PERCUTANEOUS BALLOON COMMISSUROTOMY.
Alec Vahanian MD, Pierre-Louis Michel MD, Xavier Michel MD
Eric Dadez MD, Bernard Vitoux MD, Jean Gu~rinon MD, Chris-
tian Cabrol MD, Jean Acar MD, Tenon Hospital; Paris, France.
The characteristics of severe mitral regurgitation (MR) follo-
wing percutaneous commissurotomy (PC) were reviewed from a
series of 250 PC, in which 9 severe MR, angiographic grade
3+/4 (Sellers criteria), occurred after the procedure.
Six patients (pts) were female and 3 male, their mean age
was 48 + 13 Yrs (22 - 64); 2 pts had had previous surgical
commissurotomy, all were in NYHA Class III and mitral calci-
fications were present in 4 (valvular I, commissural 3),
Echocardiographic examination showed extensive subvalvular
disease in all 9 and valve thickening in 6. Mitral regurgitation
was present in 6 : angiographic grade 1+ in 5, 2+ in I. PC was
performed using I balloon in 2 pts and 2 balloons in 7.
Two patients were subsequently not operated on : one impro-
ved to NYHA Class II while the degree of MR decreased to 2+
on repeated catheterization 3 months later, while in the other,
who remained in Class III, surgery was contra-indicated becau-
se of cancer. Surgery was carried out in the remalning seven,
29 • 15 days (10 - 50) after PC due to persistent or increa-
sed-functional disability. The intra-operative findings confir-
med the echo predictions in all as regards the extent of valvu-
lar impairment. MR was related to para-commissural tearing of
the posterior leaflet in 6 out of 7 and to rupture of chordae
in the seventh. Complete commissural splitting was only obser-
ved in this last case, Valve replacement was performed in 6
and repair in I with moderate residual MR. No further compli-
cation occurred.
Conclusions : I. Severe post PC mitral regurgitation though
infrequent (4%) may occur in cases of unfavourable anatomy
2. Valvular tearing is the major mechanism 3. Delayed surgery
appears necessary in most cases.
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REGRESSION OF INFUNDIBULAR PULMONARY STENOSIS AFTER
SUCCESSFUL BALLOON PULMONARY VALVULOPLASTY IN ADULTS.
Mohamed Eid Fawzy, MRCP, FACC; Edward N. Mercer, MD,
FRCP(C) , Bruce Dunn, MD; Ranganatha Sriram, MD, King
Faisal Specialist Hospital, Riyadh, Saudi Arabia
Between July 1985 and March 1988, 22 consecutive adult
patients with congenital pulmonary stenosis underwent
pulmonary balloon valvuloplasty (PBV). There were 10
males and 12 females, age 15-45 (mean 25) years. A
double balloon technique was used in 17 patients and
single balloon in 5. Fifteen paients were studied 6-30
(mean 9) months later. Student's t test was used for
comparison of data. Results RV systolic pressure before
dilatation was 84-200 (mean 127 + 33.4) mmHg and the
peak pulmonary gradient (PPG) was 60-176 (mean 110 +
34.2) mmHg. Immediately after dilatation the RV systolic
pressure dropped to 32 to 110 (mean 56 + 18) mmHg (p<
0.001) and PPG dropped to 10-80 (mean 34.5 + 17.3) mmHg
(P( 0.001). At repeat catheterization the RV systolic
pressure dropped to 33-66 (mean 45.5 + 11.6) mmHg
(P(0.05) and PPG dropped to 0 to 48 (mean 22 + 13.5)
mmHg (P <O. 001). The infundibular gradient ranged from
14-80 (mean 35.6 + 16.7) mmHg before PBV. This regressed
at repeat catheterization to 0 to 25 (mean 15 + 6.4)
P (.05. Conclusion. (1) PBV is safe, effective-and long
lasting for the treatment of pulmonary valve stenosis in
adults, (2) severe to moderate infundibular stenosis






RESPONSE OF ATRIAL UTRIURETIC FACTOR TO PERCUTAlIEOUS
MITRAL VALVULOPLASTY.
Anlel cequier, M.D., Raoul Bonan, M.D., P.A.C.C., Ihor
Dyrda, M.D., F.A.C.C., Jacques Crepeau, M.D., Antonio
Serra, M.D., Gaetan Thibault, Ph.D., Marc Cantin, M.D.,
Ph.D., David Waters, II.D., P.A.C.C., 1I0ntreal Heart
Institute, 1I0ntreal, Canada.
In 23 pts undersoing percutaneous mitral valvuloplasty
(PlIV), atrial natriuretic factor (AJIP) levels in f8llO-
ral vein, pulmonary artery and aorta were sitlUltane-
ously measured at baseline, 1 min after the first in-
flation and 20 min after the last inflation. AJIP was
also measured in a peripheral vein 1 day before and 3,
24 and 48 hI'S after PIIV.
AJIP (pl/ml) Basal First Inflation
Femoral vein 78±9 112i:10'"
Pul. artery 116i:ll 164i:13"'''''''
Aorta 108%12 168i:14""""
"'pa.05, "''''p<.Ol, "''''''p<.OOl vs basal values
In 9 pts in whom pulmonary artery samples were obtained
1 min before the first inflation, AlIP levels had al-
ready increased (148%19 to 201%32 pg/ml, p<.OOl) with
no further increase after the first inflation (217H8
pg/ml, p=NS). Peripheral AlIP levels returned to base-
line 3 hrs after the procedure (87HO vs 84i:10 n/ml,
paNS), with no subsequent change: 93i:10 at 24 hrs and
92%10 pg/ml at 48 hI'S (p=NS). In 9 pts restUdied 6
months after PIIV, hemodynamic improveaent persisted but
AlIP levels in femoral vein, pulmonary artery and aorta
remained elevated.
thus, during PIIV technical manoeuvres before balloon
inflation transiently increase AMP. Despite a decrease
in intracardiac pressures AMP levels remain abnormal up
to 6 months post-PMV.
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AGE-RELATED CHANGES IN LEFT VENTRICULAR PERFORMANCE
DURING ISOMETRIC EXERCISE
Chrintian Jr Swinner H D., Jerome L. Fleg, M,D"
p.A,e,e., Joao A,e, Lima, M,D" Sandra D, L1IIla, Edward
P, Shapiro, M,D" F,A,C,e, Francb Scott Itey Medical
Center, A Johns Hopkins Medical Institution,
Gerontology Research Center, NIA, Baltimore, MD
Whether advancing age altera left ventricular (LV)
performance during illOlllOtric exercbe is unknown, We
performed echo-Doppler during isometric bandgrip (lUG),
at 30J of IUIX1JInm strength for 3 II1n in 25 bealtby,
normotenllive volunteers ages 23-84 from tbe BaltiJlore
Longi tudinal Study of Aging, At rest, systolic blood
prellllure (SBP), and LV end diastolic dillenaion (EnD)
were unrelated to age, end systolic d1lllension (ESD)
decreaaed witb age (1' ..-,110, p(,05) and fractional
lIbortening (F8) increased witb age (1'=,119, pa,on, The
Doppler diastolic filling ratio (AlE) and plan1lletric
atrial filling fraction (AFF) were botb correlated witb
age at rest (1'= ,92, p(,0001 and 1'=,89, p(,0001
respectively), lUG induced tbe following age-related
cbanges fro. baseline:






Warren Shennan MD, FACC, Charles Lazzam MD, Howard B,
Eison MD, Matthew Schwinger MD, Ronnie Hershman MD,
Lawrence Krakoff MD, FACC, Mount Sinai Hospital, New
York, NY.
THE CLINICAL VALUE OF MEASURlr«l ATRlOOATIUURETIC FACTOR
ArI'ER BALLC:lOO AORTIC VALVULOPLASTY
We measured atrionatriuretic factor (ANF) and
hemodynalllics (right heart pressures and flow) before
(pre) and after (at 1/4, I, 4 and 12-24 hr) balloon
aortic valvuloplasty (BAV) in 16 pts (age 81+8, mean+SD)
with aortic stenosis (AS). Pre- to post.:aAv chaDges
included: mean aortic gradient 46+20 to 24+15 DIll Hg
(p<O.OOl) and valve area 0.5+0.1 to ~.7+ cm2 (p<0.001).
ANF (pg/JIIl; mean+SD) Clecreased -over time: pre-
345+244, 1/4 hr- 331+2'00, 1 hr- 276+159, 4 hr- 242+112
and-12-24 hr- 278+l9l-(normal- 37+7).- These changes Were
not significant bY paired analysis. While ANF was weakly
correlated with baseline right atrial pressure (p-O.06.
r-O. 53) , neither ANF nor the \change in ANF (\dANFr
change in ANF!baselinq ANF) ~orrelated with any pre- ':),
post-BAY hemodynamic variable.
\dl\NF at 24 hrs strongly correlated with adverse
clinical outcome (return or persistence of SYBPtoms) at 2
(p<0.005), 8 (p<0.05) and 26 (p<0.05) weeks. A %dANF at
24 hrs of >10% (increase in ANF) identified all patients
who remained symptomatic at 2 weeks, 75% of those
symptomatic at 8 weeks and all patients symptomatic at 25
weeks.
c:et«:LUSI~: 'l1le very high levels of ANF in pta with
AS teild to decline following BAV. A rise in ANF of > lal
after MV 18 a strong predictor of poor early eUnical
outca..
Thus, witb advancing age IIIG induces an exaggerated
rise in afterload, associated witb d1llliniahed systolic
performance, mild LV dilatation and a greater dependence
on the already aupented atrial contribution to LV tilling,
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DOES ACE MODIFY TI-£ t-EMODYNAMIC AND QINICAL
RESPONSE TO CONVERTING-ENZY!'IE. INHBITORS IN
PATIENTS WITH CHRONIC t-EART FAILURE? Dorid J.
Pinsky MD, Marrick L. Kukin MD, Milton Pa:ker MD, FAce.
Mount Sinai School of Medicine, New York, NY
Elderly pts show a diminished therapeutic response to
converting-enzyme irtlibitors (CEO when these drugs are used in
the treatment of hypertension, but it is unknown whether age
modifies the effects of CEI in pts with heart failure (CHF). We
measured cardia: index (I/mirv'm2~ mean arterial, pulmonary
wedge and right atrial pressures (MAP, PWP & RA, mm Hg),
heart rate (HR, bpm), systemic vascular resistance (SVR, d-s-C>,
blood urea nitrogen (BUN, mg/dl) and serum creatinine (Cr,
mg/dl) in 104 CHF pts before (pre) and after treatment with
captopril or enalapril for 1-3 months. Pts were grouped
a:cording to their median o/S yrs.,e * =~<.05Jt[e vs CEO
cl MAp WP R R SV BeN Cr
<65 Pre 1.7 84 26 12 87 2012 35 1.5
(n=51) CEI 2.0* 68* 16* 8* 78* 1441* 44* 1.6*
>65 Pre 1.8 84 27 II 80 2035 47 1.9
Tn=53) CEI 2.0* 67* 16* 6* 74* 1518* 60* 2.1 *
Pretreatment hemCXlynamic variables in elderly pts were
similar to younger pts. Although PRA was slightly lower in
elderly pts (4.9 vs 6.7 ng/ml/hr), both groups showed similar
hemodynamic responses to CEI after 1-3 months. Thirty-four of
the 51 pts (67%) <65 years and 32 of the 53 pts (60%) >65 years
improved clinically after 1-3 months of CEI, p=NS. -
Although elderly pts had worse renal function before CEI than
younger pts (p <.05), the + in BUN and Cr following CEI in both
groups was similar. A similar fraction of pts <65 yrs (12 of 51
pts) and~65 yrs (20 of 53 pts) had worsening azotemia dJring
CEL Elderly pts were less likely than younger pts to experierce
early symptomatic hypotension (9% vs 20%), p=NS.
In conclusion, in contrast to hypertensi-..e pta, age does not +
the benefits or + the risks of CEI in pts with CHF. CEI should
not be avoided in elderly CI-F pts who require these drugs.
Aging is associated with a reduction in the diastolic
function of the heart. Because calcium channel blockers
have been reported to improve diastolic function, we stu-
died the effect of two calcium blockers (nisoldipine and
nifedipine) on the diastolic performance of isolated per-
fused ventricular septa from 5 young (age 1-1 1/2 years)
and 6 old (3-4 years) rabbits. Septa were perfused at 3
ml/min with oxygenated Ringers and paced at 48 beats/min.
Haximum relaxation velocity (-dT/dt) and time of relax-
ation (tR) were measured before and during drugs. At
baseline, -dT/dt was reduced and tR lengthened by 2~ in
old compared to young rabbits (p<0.05). When either Cal-
cium blocke( was introduced into the perfusate at high
doses (>lO-OH), all systolic and diastolic parameters
were
1
gepressed. However, at ~ower doses of nifedipine
(10- H) and nisoldipine (10- H), tR shortened by 2~ and
-dT/dt increased by 2~ (p<O.OI) in old but was unchanged
in young rabbits. As a result of this differential
effect, tR and -dt/dt were similar in old and young rab-
bits at these lower drug doses. Systolic parameters such
as max tension (T), time to max tension (tm) and contrac-
tion velocity (+dT/dt) were not changed by these lower
drug doses in either age group. These beneficial concen-
trations of thB drugs arawithin or below the therapeuticrange of 5xlO- to 4xlO- H of plasma free drug. These
data suggest that calcium blockers could potentially
improve relaxation in the aging myocardium at therapeutic
doses.
IMPROVEMENT OF RElAXATION VELOCITY BY CALCIUM BLOCKER IN
AGING RABBIT MYOCARDIUM
N. Charle Horcos. H.D.! Ph.D; Julius H. Gardin, H.D.,
FACCi Walter L. Henry, H.D., FACC; University of Califor-
nia, Irvine, CA
AGING-RELATED DECREASE IN VASODILATORY CAPACITY IN
CORONARY MICROCIRCULATION ESTIMATED BY CORONARY DOPPLER
CATHETER
Yasushi Matsumura M.D•• Kazuhisa Kodama M.D., Masayoshi
Mishima M.D., Shinsuke Nanto M.D., Masaaki Uematsu M.D.,
Hiroshi Sato M.D., Tohru Masuyama M.D.,
Osaka Police Hospital, Osaka, Japan
Coronary flow reserve in patients with effort angina was
demonstrated not necessarily to coincide with coronary
stenosis. There may be great difference in the reserve
capacity in coronary microcirculation level in each
individual. To estimate the effect of aging on reserve
capacity for vasodilation in coronary microcirculation,
30 patients without epicardial coronary lesion in the
left coronary artery were studied. Peak coronary flow
velocity during maximal vasodilation by intracoronary
papaverine was measured by coronary Doppler catheter,
and reserve capacity was calculated as the quotient of
the peak coronary flow velocity and the resting
coronary flow velocity. The Doppler catheter was located
in the proximal left coronary arteries. The patients
with hypertrophic heart and/or left ventricular asynergy
as well as the patients with diabetes mellitus were
excluded in this study. The average age of the patients
was 6O~10 (mean~SD), ranged from 33 to 78 years. And the
average of reserve capacity for vasodilation in these
patients was 3.6~1.2, ranged from 2.2 to 8.0. The
vasodilatory reserve were less in the elder patients
than in the younger, revealing a significant correlation
between the vasodilatory reserve and the age (r=0.68).
Thus, these results suggest that the vasodilatory
capacity in coronary microcirculation are decreased with
age.
SITE OF AGE-RELATED PR INTERVAL PROLONGATION IN NORMAL
SUBJECTS.
Jerome L. Fle9. M.D •• F.A.C.C., Dhirendra N. Das, M.D.,
Gerontology Research Center, NIA, NIH, Baltimore, MD.
The mechanism for the PR interval prolongation seen
with aging is unclear. Using a high resolution ECG
(Harquette MAC-I) to signal average 512 cardiac cycles,
we recorded His bundle potentials from the bod1 surface
of 50 young (x s 30 yr) and 64 old (x s 72 yr) healthy
vol unteers from the Bal t imare Longi tud i nal Study of
Aging. All subjects were free of cl inical heart
disease and had normal rest and exerc1se ECG and a PR
interval < 210 msec. The following intervals in msec
were measured or derived: PR (PR), P wave duration (P),
HV (HV), PR - HV (PH), and PH - P (Prox PRJ segment.
Values are mean + S.D.
Hen Women
(oung - Old..e tOU2~--0Id..e
n=25) (n-25) n- ) (~)
PR 159+16 175+22 .01 156+17 165+15 .05
PH 121+13 136+"18 .01 117+16 127+15 .02
Prox PR 22+11 33+15 .01 24+12 30+15 .07
HV 38+ 6 40+ 9 NS 40+ 6 39+ 9 NS
Neither heart rate- nor P were age-reTated in either
sex. In a separate group of 7 older men (x s 71 yr)
with PR > 220 msec (x = 238 + 14), the PH (193 + 21)
and ProxPR (B~ !. 19) but noCHV (45 ~ 11) were longer
(p<.OOI) than 1n the 25 old men with normal PRo Thus,
a modest and similar age-related prolongation of PR
interval is found in both sexes, and is localized to
the Prox PR segment, probably reflecting delay within
the atrioventricular junction. A similar but more
stri king delay in the Prox PR segment is present in
older men with first degree heart block.
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Coronary Angioplasty Technique I
PA'ITERNS OF DILATATION DURING CORONARY ANGIOPLASTY
Craig Honsen, MD. John A. Ambrose. HD.FACC. Susan
Borrico. BS. Hare Cohen. HD.FACC. Warren Sherman.
HD.FACC. Richard Gerlin. HD.FACC,Valentin Fuster.
HD.FACC. Haunt Sinai Hospital. New York. NY.
There are little in-vivo data concerning the mechanisms
of balloon inflation during angioplasty (TCA). To
characterize how lesions dilate we used videodensitometry
to measure the diameter (D) of the inflated balloon
across 27 coronary lesions in 25 patients. Pressure-
diameter (P-D) curves for each lesion were derived
utilizing a standardized incremental inflation protocol
between 2 and 6 BAR with 3mm low profile.bal100ns that
approximated normal vessel D. D of coronary stenoses pre
and post TCA were also measured.
poD curves showed that the most improvement in lumen
caliber occurred at low inflation P. A distensibility
factor (dis) defined as the ratio of D at 2 BAR compared
to D at 6 BAR showed that eccentric-irregular lesions
(n-ll) had greater dis (.49±.17) than lesions (n-16)
without this morphology (.33±.14) p<.02. The former were
soft presumably due to thrombus in these lesions. Also P-
D curves often showed a loss of lumen calibre when
balloon D at 6 BAR was compared to D post TCA. This was
defined as elasticity or recoil and we found a
significant direct correlation between the amount of
elasticity and the extent of balloon inflation at 6 BAR.
That is. lesions more fully dilated at 6 BAR showed more
elasticity. This relationship was most striking for
eccentric irregular lesions (r-0.8.p<.001) and was
unchanged by nitroglyerine. Thus. poD curves analyzing
distensibility and elasticity prOVide information about
mechanisms of TCA that 'probably reflect lesion
composition and geometry. This approach may have clinical
relevance.
SINGLE VERSUS MULTIPLE BALLOON INFLATIONS IN
CORONARY ANGIOPLASTY:
LATE ANGIOGRAPHIC RESULTS AND RECURRENCE
lai~sM~EBbert Schmitz M.D.Juergenvom Dahl M.D.•
et ome. amer von Essen M.u., Peter Hanrath M.D.
FAC.C.
Medical Clinic I, RwnI Aachen, West Germany
A pros~ve study was carried out to assess wether multiple in
com-parison to stngle balloon inflations during the same
PTCA-procedure could decrease recurrence rate. In 300
consecutive patients (pt5., 258 m, 42f, 45 ±8 yrs.) 325
PTCA-procedures randomly were asstg!1ed to either a single
balloon inflation (infl.• gr.A) or 3 infl. (gr~). In 97 ptsof gr.A and
47 pts. ingr.B the initiil randomization could not be mamtained
because ola residual stenosis > 50%. apressure,gradient remaining
> 15 mm of mercury, or because a complication occured. Initial
success rate was slightly higher in group Bt94 vs. 88%, p < .05) and
complication rate was comparable In both groups. In 272/325
PTCA-case5 (80,4%), an anglOgraphic follow-up 6months after the
procedure is availabte.i,.recurrence rate was anitlysed according to
the definition of the l'u1LBI.
no. of inflations PTCA Control recurrence
random. fllllll n n n %
1 0 2 0 0 -
A 1 1 70 61 9 14,7
1 >1 95 79 1:7 34,2
3 <3 19 14 2 14,3
B 3 3 111 94 29 30,8
3 >3 28 24 8 33,3
};: A 167 140 36 'J,j,7
1: B lS8 132 39 29,5
};: A+B 325 m 75 V,6
~QncJusjQn'Multiple inflations cannot be recommended ingene'ral,
ecause recurrence rate even tended to be higher WIth this
approach.
Both group. were .eparat.d by'th. v.lu. of ) 6 pg/l (••n-
sitivity 100', .pecitity 92.8'. p ( 0.011. Ve conclude
th.t in the aajority of ca.e. only t.aporary patency can
be .chieved by TT atter PTC1. Thi. is due to .trongly
incr••••d throabin reI•••• in p.tient. experiencing
reocclusion. TAT level. ) 6 pg/l .pecific.lly predict
r.occlu.ion, therefor. p.tient. with T1T ) 6 pg/l 2b
.ft.r TT .ft.r PTC1 .hou1d under,o ea.rgency byp•••
grafting.
1ctITB TRROKB01'IC RIOCCLtJSIOI lFTD PDCUTllI'EOtJS TR1JSLtJ-
MIH1L COROI1RY 11GIOPL1STY - SHOULD THROMBOLYSIS BE
1TTBl!PTED?
Dietrich C. GUlba, M.D., H.Sc.; RQdiger Siaon, H.D.;
Verner G. Daniel. M.D.; G.rt-H. Reil, M.D.; Monika
Barthe1s, M.D.; Paul R. Lichtlen, M.D., r.l.C.C. Hannov.r
Medical School, Hannover, rRG
One a.jor coaplic.tion of percut.neou. transluain.l coro-
nary .ngiopluty (PTC1) is throabotic occlu.ion ot the
ves••l. In • series of 441 pt. undergoing PTCl tro.
february 1981 to july 1988, 21 experienced acute throabo-
tic occlusion (6') .nd und.rwent throaboly.is with either
rt-Pl (14) or • coabination ot urokin.se and pro-urokina-
•• (13). Pria.ry r •• toration of antegr.de blood tlow
could be achiev.d in 22 pts 181'), however, control
.ngiogr.phy 24h later in 12 pt. r.ve'led reocclu.ion
(54.5'). Only 31' of all pati.nt. undergoing throabo1y.i.
had .n peraitant op.n venel. Throabin-.ntithroabin III
coaplex (UT) levels were aeuured in 21 pts (1 with
per.i.tant open ve•••l/group 1; 14 with reocclu.ion (10)
or non reopening (4)/group B).
Re.u1t.: T1T pg/1
DOES BALLOON INFLATION DURATION INFLUENCE THE ANGIOGRAPHIC
RESULT OF CORONARY ANGIOPLASTY?
Paul J Garrahy MBBS, Hrudaya Nath MD, Joan C Anderson RN,
Thomas MBulle MD, FACC, Larry S Dean MD, FACC. University
of Alabama, Birmingham, Alabama.
The i~portance of the duration of balloon inflation during
coronary angioplasty (CA) is undefined. We performed a
randomized trial c~paring 30 second (Gpl) with 60 second
(Gp2) inflations in 165 patients. with 224 lesions. The
stu~y required up to 3 inflations at the randomized
duration with angiographic assessment prior to alteration
of inflation duration. Chest pain (duration and severity)
and ST alteration was noted. Stenosis severity was measured
with digital calipers from orthogonal views. Lesion and
vessel characteristics were documented. ~: GpI
comprised 107 lesions, Gp2 117. There was no significant
difference between the two groups in pre-CA angiographic
variables, number of protocol inflations (2.8vs2.7 p-NS),
residual post-protocol stenosis (35%vs34% p-NS). total
number of inflations (3.4vs3.1 p-NS). final residual
stenosis (34%vs33% p-NS) , incidence of dissection (l4%vsl8%
p-NS). side branch occlusion. or vessel appearance post-
CA. Total inflation time was significantly less in Gpl
(123vs184 seconds p<.OOI) as was pain duration (105vs203
sees p<.05) and average ST alteration (74vs135 secs
p<.OOI). 49 lesions received additional inflations (mean
2.2) following protocol for a mean stenosis improvement of
6.8%. Only 7 of 13 with a post-protocol stenosis >50%
improved to a stenosis <50% with additional inflations.
Conclusions: 1. There is no difference in the acute
angiographic result of 30 as opposed to 60 second
inflations 2. Short inflations are much better tolerated
3. The improvement prOVided by inflations in excess of the




o 60 120 ain .ign.
8.5 t 11.4 6.4 t 3.6 3.5 ± 1.5 n•••
5.5 t 2.8 14.0 ± 14.1 15.4 t 13.8 p( 0.05
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CONCLUSION: Acute LV thrombua is characterized by:
(1) an increaae in backscatter compared to blood and
ischemic tissue, and (2) no cyclic backscatter
variability. This approach may provide a method for
rapid, objective identification of LV thrombi.
IDENTIFICATION OF ACUTE EXPERIMENTAL LEFT VENTRICULAR
THROMBI USING A REAL-TIME BACKSCATTER IMAGING SYSTEM
Byron F. Vandenberg. MD, FACC. Hewlett E. Melton. Jr.
PhD. Robert A. Kieso. MS. Karen Fox-Eastham. BLS.
Richard E. Kerber, MD. FACC. Steve M. Collins. PhD.
David J. Skorton, MD. FACC. Univ. of Iowa, Iowa City. IA
2D echo is an excellent technique for detecting LV mural
thrombi (LVT) but LVT may be difficult to differentiate
from extraneous echoes. We have previously demonstrated
that acute LVT can be distingUished from surrounding
blood and myocardium by off-line computer analysis of
ultrasound gray level statistics. Our purpose was to
study acute LVT with a recently developed real-time
integrated backscatter (IBS) imaging system which
provides on-line. immediate analysis of IBS.
Transthoracic imaging was performed in 7 dogs in the
presence of LVT produced by injecting thrombin into the
LV apex after coronary occlusion. IBS was measured in
the cavity (blood), LVT and myocardium (apex).
RESULTS (mean:!:SD): Data are expressed in relative units
(dB). ED-end-diastole, ~-diastolic-systolicIBS.
LVT
INTRAVENOUS NITROGLYCERIN PREVENTS CORONARY
ARTERY VASOCONSTRICTION AFTER PTCA
]m A Aschel. Geraidne Derby. 1M Tse. Micbael L. Stadius, FACC.
Stanford University Medical Center, Stanford, CA.
It has recently been observed that spontaneous coronary artery
vasoconstriction occurs routinely in the dilated coronary artery segment alter
PTCA, despite the use of aspirin and calcium channel blockers. To
determine whether or not this vasoconstriction could be prevented by
intravenous (IV) nitroglycerin (NTG) given during and alter PTCA we
analyzed the spontaneous, and then intracoronary (IC) NTG induced
changes in segmental coronary artery diameters following PTCA in patients
randomly assigned to receive (+IV NTG. n-5) or not receive (- IV NTG, n=10)
IV NTG. Exclusion crileria Included concurrent NTG therapy, IC NTG during
the PTCA. and inadequate coronary arteriography. All 15 patients were
maintained on dlltiazem and aspirin at the time of the stUdy. Coronary
arteriograrns were obtained as follows; 1) pre-PTCA (Pre), 2) < 5 minutes
alter PTCA (Post). 3) 30 minutes alter PTCA (30 min). 4) and then. 3
minutes alter 300 IiQ of IC NTG (IC NTG). Serial quantitative measurements
were performed at each time, in 5 rom long segments centered In the dilated
segment (PTCA). and in a nonmanipulated vessel (Control). The diameters
alter IC NTG were defined as the maximally vasodilated state. The minimal
diameter (mean, in mm) for the PTCA segment at each time is shown below
for the' and + IV NTG groups: (SE) - standard error of the mean. The %
vasoconstrtclion. VS. IC NTG diameter Is shown to right (%).
• IV NTO .79.08 - 1.73.16 -3 1.12 .11 33 1.68 .27 0
+ IV NTO .83.24 - 1.78.10 0 1.61 .17 6 1.79 .21 0
Significant vasoconstriction (vs.lC NTG) was seen in the PTCA segment
In the - IV NTG group (p< 0.01) but not in the + IV NTG patients at 30 min
alter PTCA. The difference in % vasoconstriction between the - and + IV
NTG groups at 30 minutes was significant (p<0.01, t-test).
Concluslons:1) Spontaneous post-PTCA coronary artery vasoconstrict-
ion at the site of dilatation can be prevented by the administration of IV NTG
during and alter PTCA. 2) These findings have implications conceming the
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DIASTOLIC ABNORMALITIES IN HYPERTENSION ARE NOT
EXPLAINED BY LVH ALONE.
Jadwiga Szlachcic. M.D •• Julio F. Tubau.M.D. Brian
O'Kelly. M.D., Barry M. Massie. M.D .• F.A.C.C. VAMC and
University of California, San Francisco. California
Hypertension (HTN) and aging are both associated with
abnormalities of LV diastolic filling (DF) and increased
LV mass index (LVMI). To determine whether DF
abnormalties in HTN are due to aging, LV hypertrophy or
other factors. we studied 19 HTN patients following 4
weeks off therapy and 18 normotensives (NLS) matched for
age and LVMI. All subjects had normal systolic function
by echo and ejection fraction by radionuclide
angiography. We measured: peak velocity of early filling
(E). late filling (A) and their ratio (E/A) using
pulsed Doppler echocardiography.
NLS (n-18) HTN (n-19)
112±20 119±22
126±12/79±6 150±11*/101±4*
0.96 ± 0.30 0.87 ± 0.20
0.72 ± 0.18 0.91 ± 0.20*
1.44 ± 0.64 1.00 ± 0.20*
(* - p<.Ol vs NLS)
Diastolic filling indices were significantly different
,in HTN compared to NLS. None of DF indices were related
to LVMI. E/A was inversely related to age in both NLS
(r--0.75) and HTN (r-O.-55. both p<O.Ol). A was related
to systolic BP ( r-O.48. p<O.05) only in HTN. These
findings indicate that DF abnormalities in HTN are not
solely caused by either LVMI or older age and therefore
must be in part related to altered myocardial or chamber
properties.
GRADUAL INCREASE IN LEFT VENTRICULAR DIMENSION WITH
DECREASE IN PRESSURE HALF-TIME OF TRANSMITRAL FLOW
FOLLOWING BALLOON MITRAL VALVULOPLASTY.
Tadashi Tamura M.D.. Seiki Nagata M.D., Fuminobu Ishikura
M.D., Masakazu Yamagishi M.D., Satoshi Nakatani M.D.,
Kunio Miyatake M.D., Yasuharu Nimura M.D.
National Cardiovascular Center, Suita, Osaka, Japan.
To investigate the serial changes in cardiac dimension
and pressure half-time (PHT) of transmitral flow
follOWing balloon mitral valvuloplasty (BMV), we measured
mitral val ve area (MVA), left atrial (LAD), left
ventricular diastolic (LVDd) and systolic dimensions
(LVDs) by two dimensional and M-mode echocardiography.
PHT was determined by continuous wave Doppler technique.
These examinations were performed pre- and post-BMV in 12
patients with mitral stenosis.
Results: Values are mean±S.D.
MVA(cm2)
~ post-2hrs -10hrs -24hrs -7days
l.1±0.5 1.9±0.6* 1.9±0.S 1.9±0.5 1.9±0.S
LAD(mm) S2±7 47±7* 46±7 46±7 46±7
LVDd(mm) SO±4 SO±4 51±4# 53±4## S3±4##
LVDs(mm) 3S±4 34±4 34±4 35±4 3S±S
PHT(msec) 290±80 190±50* 160±60## 150±SO## lS0±50##
*=p<O.Ol vs pre. #=p<O.OS and ##=p<O.Ol vs post-2hrs.
BMV decreased PHT and LAD at post-2hrs. Although LVDd was
unchanged in these periods. thereafter it tended to
increase until post-24hrs. PHT also showed further
decrease although MVA was constant. These results suggest
that improvement of transmitral flow gradually increased
LV dimension, which may affect the pressure half-time of
transmitral flow following balloon mitral val vuloplasty.
One should take a caution when mitral val ve area is
determined from PHT during these periods.
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ISOLATED QUADRICUSPID AORTIC VALVES; INCIDENCE,
DESCRIPTION, AND FUNCTIONAL ASSESSMENT.
Barr~ Feldman, M.D., Carole Warnes, M.D., Bijoy
Khan heria, M.D., James Seward, M.D., F.A.C.C., A. Jamil
Tajik, M.D., F.A.C.C., Mayo Clinic, Rochester, Minnesota.
Necropsy incidence of isolated quadricuspid aortic valves
(QAV) has varied from .00D8t to .033t. To determine inci-
dence in living pts, we reviewed archival data from the
Mayo Clinic Echocardiographic Laboratory. Of 60,447 pts
between June 1982 to May 1988 who had a 20 echocardiogram
there were 8 cases of QAV with an incidence of 0.013t. In
the latter 10 months 6 of these pts were noted from 13,805
pts giving an incidence of D.044t. Ages ranged from 28-71
with a mean of 45. There were 3 males and 5 females. The
diagnosis of QAV was based on a characteristic 20 echo
appearance of the letter "X" configuration in diastole
and a "squared" opening in systole. This is in contra-
distinction to the "Y" configuration in diastole and
"triangular" opening in systole observed in trileaflet
aortic valves. In 3 pts the 4 cusps were of near equal
size and in 5 pts the accessory cusp was considerably
smaller than the other 3. A QAV with a small accessory
cusp was confirmed in 2 pts; one at the time of valve
replacement for bacterial endocarditis (BE) and the other
at necropsy. Doppler interrogation revealed AR in 6/8
pts (75t); mild in 4, moderate in 1, and severe in the pt
with BE. One pt (the oldest) had mild aortic stenosis.
Conclusions: 1. The incidence of QAV is higher than
most published necropsy data and recent improved ultra-
sound technology suggests an incidence of D.D44t.
2. There is a high incidence of AR possibly reflecting
referral bias. 3. Significant premature aortic stenosis
does not occur. 4. Diagnosis is important because of the
possible risk of BE. 5. High resolution ultrasound per-
mits accurate diagnosis and functional assessment of QAV.
USE OF DOPPLER tCHOCARDIOGRAPHV iN DETERMINATION OF LEFT
VENTRICULI\R Op/Ot MAX. ANTHONY HUNT MRCP. RAPHAEL I'ERRY
MRCP., ASHOK SETH MRCP, PATRICA LOWRy MO. MRCI'. MAN FA!
SHIU MO. FRCI'. QUEEN cLIZA~EIH HO~PlTAL, DiRMINC~. UK
DoODler echocardlOQraphy IS emer~in~ as a powerfUl tOO!
In measuring Indices of left ventricular contractility. In
human sUbjec'5 peak "celeration been shown to be correlat-
ed closely to eJection fractions and In dogs peak aortiC
flOW velor.lty has bgen shown to be correlated closely to
maximum Dp/Dt. Our study verifieS the correlation of peak
velocity with Op/Dt max 'jn l1ulllan subjectS ar:a valtdatQs
our tneoretlcally derived formula Which showed a better
correlation witn OP/ot max. USing the concept for conser-
vation ot energy, by assuming sinusoidal aortic flow and
pressur~ patterns and a constant of proportionality betwe-
en the area of LV outflow and ascending aorta, the tOllow-
Ing is derived:
~ max. K~· + pulse pressure (pulse p)
Te
K = constant T = time to peak velocity
VP = peak v~locity TC = corrected ejection time
The valldty of this equation was t~sted In II patients
undergoing diagnostic catheterlsation using a catheter tip
micromanometer In the LV for Op/Ot max and a 2MHz contin-
uous wave Doppler transducer for aortic flow signals.
WhllttVp and mean acc~l~ratlon (MA) correlated wlt~ Up/Ot
max (r=u.765 and 0.66 respectively) d better correlation
(r=O.B82 p<O.OOl) was found for KVP'/T + pulse p/Te an~ a
correlation of (r=U.85 p 0.001) fo~nct for Vp~/T against
Dp/ut max, This method may prove useful 111 the non-Invas-
ive estimation of Dp/ot max ill t!lfferlng cl inical sltuat-
iUII~. P,H'Ucullll'ly ii' conditions of l'apidly changing
(beat to bellt) variation In corrlractllity.




'LASEI WIlE' FOI PRCUTAlIBOUS AIlGIOPLASTY COHPLETE
PBUPBnAL AJlD COIOKUY AJ.TnIAL OCCLUSIONS - IIfITIAL
CLINICAL RESULTS.
Robert J. Bowes M.D., David C. Cumberland M.D •• Anna M.
Belli M.D., G.D.G. Oakley M.D., Richard K. Myler M.D.,
F.A.C.C., Simon H. Stertzer H.D .• F.A.C.C., John C.
Crew H.D., Thomas J. Linnemeier H.D., Northern General
Hospital, Sheffield. England and San Francisco Heart
Institute, Seton Medical Center, Daly City, CA
A percutaneously introduced 2.0mm diameter thermal
probe powered by laser energy has been shown to
recanalize some complete peripheral artery occlusions
not amenable to conventional techniques, with a low
incidence of complications. A new device, the 'laser
wire', consisting of a metal-tipped laser fiber
contained in a 0.018 inch diameter steerable gUide wire
which is coupled to a continuous wave argon laser
generator at 3 watts power, was used to traverse 7
tibial artery and 4 coronary artery occlusions not
associated with acute ischemia/infarction, all of which
could not be traversed with a conventional guidewire.
Five of seven (71%) tibial arteries and 3 of 4 (75%)
coronary arteries were successfUlly recanalized prior
to balloon dilation. There were no complications.
The laser wire shows promise in ~roving the
results of angioplasty in chronic, smaller artery
occlusions, and thus possibly extending the applica-
bility of the angioplasty technique in peripheral and
coronary arteries.
DIJm:T~ IASm IRRADIATIQI OF HIQI-GWE S'niJD>ES
AND 'IOl7\L cx:x::r.mICRS IN NATIVE IIIWl CXR:'NARY ARmRIlS
AND BYPASS GRAFl'S: INITIAL CLINIC7U. EXFmmiNCE.
A.E. Fosc:hi. M.p., C.A. zapala, R.N., st.Francis H0sp-
ital, Evllnstal, II.
A clinical trial ot an argon laser de1ivm:y syStoI
(USIN!' SystEa, GV Medical) for treatin:J atheJ:aiclerot-
ic oortnUy arteries an:! bypsss grafts is undeniay. By
usinq a JUlti-lumen balloat catheter to oomdally align
an optical tiber an:! lElllS llSSE!IItUy, llIU.cn diverged the
laser beam to 40', an:! by infusinq Ringer's solution an:!
IIDlitorinq lens flUOl:-.liIl1oe, laser delivmy without
tissue CXI1tac:t WlIS possible despite systaltic JIlOtion.
st.aR:Ilmi P1'CA tecilnique was used un:ier fluorose:x:pic
~ to treat 9 lesions in 8 pta. (7 mIe, 1 ttlllll1e;
41-73 yrs. old), 1Oho all gave WODlIIC! consent. 'l\«)
native right oortnUy arteries (R::A), 3 native left
anterior cIesoen:linq (IAO) arteries an:! 4~ vein
by-pass grafts were treated. Ead1 nativa vessel an:! one
gratt were totally oocluded; all stenoses exr:lIIR'W' 9ot.
'lhe mean fillin} defect WlIS of 18.7 11II (range 10-30 DID).
Exposures consisted of 1 to 2 S8CXI'ld exposures; total
enel9Y delivered ranged frail 30 to 510'JOJ1es. 'lhe
laser allowed ...~ penetration of the lesion with
a gui.dswire(previously iJIp:lssible) , tollowed by balloat
dilation. All lesions were reclJoBd to 1_ th!1n sot
stenosis; no perfCll1ltions, arterial .., VW1triQ1lar
fibrill.ati.on, post-treatment JDY'OCardiAl Warction or
_g8iq surgery occurred. All pta. naained hemody-
lIiIIIlically stable, without elevata:l a<: (MB) enzyIIlIIS: pain
did not .increase upon lasin}. Clinical iJIproII_rt:
(relief fraI syupt:.aIB, lIUAXlrted by post-treatment an-
qiogJ:'ali1y)WlIS evident in each case. Iaser enezgy _y
t:b.Is augment ooronary &n1icplasty, wt more follow-up
an:! further ncn-invasive lIBsesF"'Rlt ot pat:&1cy are
dNialS1y MBied.
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PERCUTANEOUS CORONARY EXCIMER LASER ANGIOPLASTY IN
ANIMALS AND HUMANS
Frank Litvack. MD. FACC, Warren Grundfest, MD, Ann
Hickey, MD, Andrew Jakubowski, MD, Fred Mohr, MD, Jacob
Segalowitz, MD, Lisa Hestrin, MPH, Tsvi Goldenberg, PhD,
James Laudenslauger, PhD, Hugh Narciso, MS, James
Forrester, MD, FACC. Cedars-Sinai Medical Center, Los
Angeles, California.
We report animal testing and the first human experience
with a percutaneous coronary excimer laser angioplasty
system. The system operates at 308 nm, 35-45 mJ/mm2, 150
nsec, 20 Hz. The catheter has twelve 200 micron fibers
concentrically arranged around a moveable .018 inch PTCA
guidewire. In 8 pigs, a guide catheter was placed in the
coronary ostium via the carotid artery. The guidewire was
advanced to the distal portion of an epicardial artery.
During multiple passes, 1,000 to 10,000 pulses were
delivered to 2-3 arteries per pig. In all cases, the
catheter advanced easily through tortuosities into distal
vessels. With the catheter in motion, no perforation,
spasm or occlusion occurred. Occlusion without
perforation occured when the catheter was placed in a 1
mm obtuse marginal. To test tolerance to perforation the
catheter was left stationary for 5 minutes in 1 pig. This
caused no angiographic effect after 3,000 pulses,
however, after 5,005 pulses (4.2 minutes) dye extra-
vasation was seen. Histology revealed medial ablation
and slight periadventitial hemorrhage but no perforation.
Subsequently, percutaneous coronary excimer laser
angioplasty was used in our first patient, reducing the
stenosis from 95% to 30% with the laser alone.
CONCLUSIONS: I. The "over-the-wire" percutaneous excimer
laser angioplasty catheter tracks effectively through
tortuous coronary arteries without vascular injury. 2.
This system permits percutaneous angioplasty of
obstructed human coronary arteries.
ABSTRACTS
EARLY CLIHICAL EXPERIEHCE WITH PERCUTANEOUS TRAMSLUMIHAL
ARGOH LASER COROHARY ANGIOPLASTY.
Gilles cate. ltD, Simon H. Stertzer, ltD, FACC, Richard
K. Kyler, ltD, FACC, Raoul Bonan, ltD, FACC, W. Scott
Andrus, PhD, Lary Roth, KEng, John Lane, BSc, Kike
Dumont, BSc, Kike Kaden, BSc, Benito O. Hidalgo,
Kontreal Heart Institute, Kontreal, Canada and
San Francisco Heart Institute, Daly City, CA.
The purpose of this study was to evaluate the feasibi-
lity and safety of percutaneous trans luminal coronary
recanalization using argon laser energy (454.5-528.7
nm). All lesions attempted were first crossed with a
0.014 inch guide wire to assure coaxial delivery of la-
ser energy. A specially designed laser recanalization
catheter (LRC) was subsequently advanced, over the wi-
re, at the obstruction. Pulsed argon laser energy (15
Watts) was delivered percutaneously at 0.1 sec pulses,
through 4 flexible optical fibers mounted inside a 1. 5
mm in diameter (4.5 French) catheter. A total of 5 pa-
tients, with 5 lesions localized in the 3 major corona-
ry arteries (3 RCA, 1 LAD, 1 LCx) were irradiated. The
targeted lesions, range 95-l0~ diameter narrowing,
were discrete (~1.5 cm in length) and non-calcified.
Significant residual stenoses (~5~) remained after
laser angioplasty in all cases. Additional balloon an-
gioplasty was subsequently performed reducing the resi-
dual stenosis (range 0-3~ diameter narrowing). Initial
hemodynamic, angiographic and clinical success was
achieved in all cases attempted. Ho arterial perfora-
tion, thrombosis, spasm or embolization occurred. Ho
other il11ll\Qdiate or delayed complication were seen and
all patients were discharged 24 to 48 hours post laser
angioplasty. This study would suggest that percutaneous
transluminal coronary laser angioplasty can be perform-
ed safely and pulsed argon laser energy delivered
effectively in selected patients.
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Hr.MAN PFRaJTANEDUS LASER-ASSIS'IFD a:Ra1ARY AtK;Ia>LASTY:
EFFt:RTS 10 Rl!DOC'E SPASM AND 'I'lMMIn)IS
Thonns J. Linnemeler, M.D., F.A.C.C., DavId C. Omrberland,
M.D. ,Donald A. Rothbaum, M.D., F.A.C.C. ,Ronald J. Landin,
M.D., F.A.C.C., Michael W. Ball, M.D., St. VIncent
Hospital, Indiana Heart InstItute, IndIanapolis, Indiana
The initial case reports of percutaneous laser-assisted
coronary angioplasty (P~) suggested frequent complica-
tions of spasm and/or thrombosis. Me present a larger
pilot study of 19 patients (22 vessels), aged 47-75 years
(mean 62) treated with P~. Fifteen saphenous vein bypass
grafts and 7 native (6 restenosed) coronary arteries were
treated. All patients were pretreated with ASA, Di-
pyridamole, calcium antagonists, IV Nitroglycerin, IV Dex-
tran and intra-arterial Heparin. P~ was performed using
tllU 8-12 watt bursts of argon laser energy (Trimedyne
Laserpro~). The probe crossed 21/22 vessels (95%),
and lll:IS followed by successful balloon angioplasty (Pn:A.l
in 21/22 vessels (95%). IV Nitroglycerin lll:IS continued for
24 hours, IV Heparin drip for 24-48 hours and ASA, Dipyri-
damole and calcium antagonists as an outpatient. ProblemB
related to spasm 01' thrombosis occurred in three vessels
(14%) including one distal embolization (successfully
treated with P~), closure of a side branch vessel in the
native left circumflex during P~, and late closure of an
LAD graft 6 days post P~ (stenosis unable to be reduced
to <50% by Pn:A.l. The rerooining 19 vessels (86%) showed no
evidence for laser-related spasm 01' thrombosis, suggesting
a lower incidence of these complications than the initial
case reports. Coopllcations related to this protocol
included one femoral artery heroo tonn (4.5%). In slDlJllClry, we
feel that with the use of this regimen, thrombosis and
spasm can be minimized with P~ and that other important
issues such as restenosis and efficacy of P~ as compared
to conventional P~ rooy be addressed.
PERCUTANEOUS CORONARY LASER BALLOON ANGIOPLASTY:
PRELIMINARY RESULTS OF A MULTICENTER TRIAL.
J.Richard Spears,Me,FACC, Vincent Reyes,MD, I. Nigel
Sinclair,FRACP, Barry Hopkins,MD, Leonard Schwartz,MD,
Harold Aldridge,MD, H.W.Thijs Plokker,MD,PhD. Harper
HospitaliWayne State University, Detroit, HI
Laser balloon angioplasty(LBA), wherein the arterial
wall surrounding an inflated balloon is heated to a tis-
sue subvaporization threshold with laser energy, has been
shown experimentally to have utility in the treatment of
potential causes(dissection, recoil, thrombus) of compli-
cations following PTCA. To test the hypothesis that LBA
may be similarly effective clinically, 25pts in 4 centers
were treated with a LBA balloon identical in size(3.0mm x
20mm) to a balloon used for PTCA performed immediately
prior to LBA. Coronary angiography was repeated at 1 day
(n-23) and 1 month(n-13) after the procedure, and compu-
terized processing was used to quantitate lumen diameter
(D). 1-3 laser doses of either 450 or 380 joules of 1.06~
cw Nd:YAG laser radiation were given over 20 sec/exposure
under brief anesthesia. High risk lesions treated included
3 ostial RCA stenoses, 3 long recurrent restenoses and 5
proximal LAD stenoses. Results :Acutely and 1 day after
LBA, no significant adverse effects on the arterial lumen
or on angiographic LV function was noted. Suboptimal PTCA
results from suspected thrombus (n-2) , recoil (n-3) , and
dissection(n-2) were all successfully reversed with LBA.
Hean minimum D increased from 1.28±48mm pre PTCA to
2.l9±48mm post PTCA (p<O.OS) with further improvement to
2.44±.50 acutely post LBA(p<O.OS). No change in D at 1 day
(2.S3±56mm) or at 1 month (2.S4± 4Smm) was found. However,
restenosis has occurred in 3 patients with proximal LAD
lesions ca 4 months post high dose LBA. Conclusions: LBA
is effective in the acute treatment of common causes of a
poor PTCA result. Optimal laser dosimetry needs to be
defined to prevent late recurrence.
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Tuesday, March 21, 1989
8:30AM-I0:00AM, California Pavilion D
Anaheim Hilton Hotel
Cardiac Transplantation
CYCLOSPORINE AND CONCOMITANT KETOCONAZOLE AFTER
CARDIAC TRANSPLANTATION: INTERMEDIATE TERM FINDINGS
AND POTENTIAL SAVINGS
Samyel M Bytman M 0 FACC, Joan Wild, ARTC, Paul Nolan, D.
Pharrn., Tim Fagan, M. D., Mary Mackie, RN, Paul Finley, M. D., Jack
G. Copeland, M. D., FACC, University of Arizona, Tucson, Arizona













DIAGNOST1C APPUCATIONS OF LYMPHOCYTE CULTURES FROM HEART
AI.l.OGRAFT BIOPSIES.
John Cadqu;st ph.D.. Jeffrey Anderson M.D., F.A.C.C., Elizabeth
Hammond M.D., John O'Connell M.D., F.A.C.C. LOS Hospital and
University of Utah, Salt Lake City,Utah.
Despite advances in cardiac transplantation, acute rejection still
remains the principal cause of graft failure. In an effort to assist in
this problem, we evaluated the diagnostic and prognostic utility of
culturing endomyocardial biopsy specimens in medium containing
interleukin-2 (IL-2). This technique allows the in.....lillm
proliferation of activated lymphocytes present in the myocardium at
the time of biopsy (i.e. alloactivated lymphocytes). A comparison of
the culture results (positive or negative lymphocyte growth) of
234 specimens with the histological grading of the specimen (l_no
rejection; 2-can't rule out rejection; 2.S- focal mild rejection;3-
mild rejectlon;4-moderate-severe rejection) employing a 2xS
contingency table revealed a highly significant correlation
(p<O.OOOS) between the methods. The predictive value of IL-2
cultures was examined by comparing culture results for a specimen
with the histological and culture results of a subsequent specimen
obtained by biopsy within 21 days. A significant correlation was
noted between culture results for a given specimen and the
histological grade of the subsequent biopsy specimen (n-150;
p<0.02, ANOVA). Similarly, culture results were observed to be
significantly predictive of the culture results of the next biopsy
(n_110; p<0.004, ANOVA). Cultures were of particular value when
initial culture results and histology were in disagreement. A follow
up of 4S patients with culture positive/histologically negative
(sgrade 2) specimens, revealed that 24 (S3.3%) experienced
worsening rejection by one or more histological grades within 21
days, 18(40%) had no change, and 3 (6.6%) had a reduction in
histological grade. Of the 24 patients showing increased rejection
grade, 16 (66.6%) required treatment for acute rejection. thus,
IL-2 lymphocyte cultures can be of value in the diagnosis and
prognosis of acute rejection in cardiac allograft recipients.
PROPHYLACTIC ANTI-REJECTION THERAPY EARLY AFTER CARDIAC
TRANSPLANTATION: RATG VERSUS OKT3.
James K. Kirklin MD,FACC, Robert C. Bourge MO,FACC,
Connie White-Williams RN, David C. Naftel PhD, Michael
G. Phillips PA, Unlv of Alabama at Birmingham, AL.
The value of prophylactic monoclonal or polyclonal
antibody therapy early after cardiac transplantation Is
controversial. Between t/I/87 and 7/1/88, 32
consecutive patients (pts) underwent cardiac
transplantation (C Tx) (cyclosporlne, azathioprine, and
prednisone maintenance therapy) utilizing either early
prophylactic rabbit anti thymocyte gtobulln (RATG)
(n-17) or monoclonal OKT3 (to days) (n-15), with
follow-up through 9/1/88.
Data: All pts (100%) survived throughout the study
period (follow-up 2-20 months). The efficacy of RATG
and OKT3 prophylaxis was similar regarding median time
(days) to first rejection (16 vs 21, p-0.5), number of
rejection episodes during first 2 months (1.5 vs 1.3,
p(chl-square)-0.8), and persisting or severe rejection
In first 2 months (0.5 vs 0.5 episodes, p(chl-square)
-0.4). Infections were similar In the RATG and OKT3
groups (infections In first 2 months: 0.3 vs 0.5/pt,
p-.08; median time to first Infection: 318 vs 250
days, p-0.5). CMV syndrome was cOf1lllOn, with one CMV
pneumonia. T-cel I markers during OKT3 did not predict
subsequent rejection (within 2 weeks following OKT3) as
assessed by mean T3 lymphocyte count (T3-L) during OKT3
(p-0.3) or T3-L during last 3 days of OKT3 (p-0.4).
Inferences: (1) Prophylactic RATG or OKT3 with 3-drug
Immunosuppression yields excellent Intermediate
survival after C Tx. (2) These protocols for RATG and
OKT3 provide similar protection against early rejection
with the same low risk of early Infection. (J) T-cell










a n.s. vs group I; b <.0001 vs group I; C < .01 vs group II; pHTN:
pulmonary hypertension; EGF: early graft failure.
Conclusion;. In contrast to baseline PYR, the response of PYR
to N is of value in predicting early post-transplant morta-
lity. High risk pts include those whose PYR cannot be re-
duced below 2.5 as well as those whose PYR can be reduced
below 2.5 only at the expense of systemic hypotension.
RESPONSE TO NITROPRUSSIDE - PREDIcroR OF EARLY POST
TRANSPLANT MORTALITY
Anielika Costard M D Irene Hill Ph. D., John Schroeder M.D.,
F.A.C.C., Michael Fowler M.B., M.R.C.P., F.A.C.C., Stanford
University Hospital, California.
Screening of potential cardiac transplant candidates at
Stanford includes demonstration of reactivity of pulmonary
vascular resistance (PYR) to nitroprusside (N) with the
attempt to achieve a PYR S 2.5. To test the validity of this
concept we analyzed the pre-transplant right heart
catheterization data, available in 291 of 301 pts who
underwent cardiac transplantation between December 1980
and July 1988. The 3-month mortality (3-MM) did not
differ significantly between pts with a baseline PYR S 2.5
(n=149; 3-MM 8,7%) and those with a PYR > 2.5 (n=142; 3-
MM 16,9%). 135 pts with baseline PYR > 2.5 received N. The
response to Nand subsequc'1t 3-MM is shown in the table:
Response to N total 3-MM Cause of death
n= n= % pHTN EGF
31 13 41.9 2 I
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HIBERNATION INDUCTION TRIGGER EXTENDED EFFEC-
TIVE ORGAN PRESERVATION TIME IN A NEW AUTOPER-
FUSION MULTIORGAN PREPARATION.
Snfan Chien. MD. Peter R. Oeltgen, PhD, John N. Diana, PhD, Edward
P. Todd, MD, PhD, FACC, William N. O'Connor, MD, W. Randolph
Chitwood, Jr. MD, FACC. University of Kentucky Medical Center,
Lexington, KY.
Plasma from hibernating woodchucks containing a hibernation induc-
tion trigger (HI11 was aoded to a new autoP.erfusion preparation. The
animal was anesthetized and the heart, lungs,liver, pancreas, duodenum
and kidneys were removed, while still bemg perfused by the ~art and
oxygenated by the lungs. The system was thenplaced m a 32 C solu-
tionbath. A respirator with a gas mixture of50% 02 and 3% CO2 was
used to maintain ventilation. Blood and a dextrose solution containing:
KO, insulin, Ca02, mannitol, penicillin and flagyl, were given via the
portal vein. Soyacal2 ml and Diednisolone 30 mg were infused through
the portal vein every~ hours. Six dogs (G 1) were injected intravenous-
ly with 10 ml of HIT containing plasma 2 hours before the operation
and 5mlevery 4hours during the preservation. Seven dogs (G2) without
HIT were used as controls.The survival time in GI ranged from 33 to
56 hours with an average of 43.4 hours. The survival ume varied be-
tween 9 to 26 hours With an average. of 14.8 hours for G 2. In G I,
average urine output was 45.6 mllhour, bile output 5.2 mllhour,
pancreatic and duodenal outputs 5.8 mllhour. AOSP 65-9OmmHg, free
plasma hemoglobin ghanged from 38.3 to 167 mg/dL at 44 hours. RBC
varied 6.25-8.12 (I0 ~uL) and WBC reduced from 10.4 to 0.3 (10"'luL)
at 44 hours (p<.OO1). Arterial blood pH was between 7.28-7.42, Pa02
164-290 mniHg, PaC02 22-34 mmHg. Serum SGOT increased from 40
to 200 (uIL) anil SGPT increased from 45 to 362 (uIL) within 44 hours.
Serum amylase scaled between 750-673 uIL; BUN reduced from 15.58
to 6.60 (ai2ldL)(p<.0025), and Creatinine also reduced from 0.80 to
0.25 (mg/dL) by 44 hours (p<.ool). In G 2, severe liver congestion,
premature renal failure and pulmonary edema reduced the survival.
These were not evident in G1 within 44 hours of the preservation time.
Lung wet/dry weight ratio in G 1was 4.85 at the beginning and changed
to 5.34 by the 44th hour. Although the exact mechanisms are not clear,
the use of HIT in the newautooenusion preparation seems to extend
organ preservation time signiffcantaly.
A DIRECT ADMIlfISTRATION OF RECOKBIHAHT SUPEROIIDK
DISKOTASE SIGlfIFlCAm.Y PRESERVES KYOCARDIAL FmlCTIOH AID
MITOCHONDRIAL STRUC'l'VRES AFl'ER 30 KDfl1l'ES lfORtIl'l'IIEIlC
GLOBAL ISCIIFHIA
Nobuo HatorikMD. , Yozo Uriuda,MD. ,Eriya Okuda,MD.1.Hiroshi
I osnJ.zu ,flV., Kira Seno~MD. ,Susumu Tanaka ,M!). ,National
Defense Medical College,!okorozawa, Japan
To determine the efficacy of direct vs. systemic
administration of human recom6inant superoxide dismutase
(rt-SOD) in acute myocardial ischemia and reperfusion, the
following experimental model was applied. 21 dogs were
subjected to 30 min. global ischemia at 370 C by the
occlusion of the ascendJ.ng aorta followed by 60 min.
reperfusion. T", eliminate the collateral blood flows.
during ischemia, bipulmonary hilus were clamped. The dogs
were rando~'y assigned to three groups: group A(n=7) ,rt-
SOD (lOOOOIu'/kg) was administered by Iiolus injection
through the aortic root into the coronary artery 1 min.
~rior to re~erfusion ~in addttion to a 30 min. continuous
J.nfusion of rt-SOD (-,OOOOIU/kg) into the cardiopulmonary
bypass circuit beginning just after reperfusion; group
B(n=7) , the treatment was similar except the bolus
injection was into the cardio,Pulmonary bypass circuit;
group C(n=7), saline was adminJ.stered as in grou,P A. Left
ventricular stroke work index(LVSWI) was determJ.ned by a
right heart bypass technique and expressed as a % recovery
of pre-occlusion state. Morphologic structures were
observed by electron microsco~e. Coronary sinus blood was
assessed for malondialdehyde MDA) measured by TBA method
and creatine phosl1hokinase(CP ) .J(esults for a % recovery
of LVSWI after 00 min. reperfusion are tabulated.
(*p<O.OS)
~og~e~sure l~~f%* l~~%* l~~~%*
Group B Sz.l=21% 62+.39%* S2+18%
Groujl C 24+38% 22+14% 3s:F23%
In group A, myocardial structure had a normal ap~earance
in most areas. However, swollen mitochondrias
d
dJ.srupted
myofibrills, decreased glycogen particles an capillary
endothelial alterations were observed in groups B and C.
Serum MDA levels did not change in all gro!!ps, although
CPK levels were less in group A. Conclusion:These results
show that the direct infusion of rt-SOD J.S more effective
than systemic one.It may also suggest that rt-SOD is need
to be adequate concentrations in the interstitial fluid at
the time of reflow.
Tuesday, March 21, 1989
10:30AM-12:00NOON, California Pavilion D
Anaheim Hilton Hotel
PET and Receptor Imaging
QUANTITATIVE POSITRON TOMOGRAPHY
DEMONSTRATES ACCELERATED GLUCOSE
UTILIZATION RELATIVE TO FLOW IN ISCHEMIC
HUMAN MYOCARDIUM.
Richard Brunken M pEA C C , Freny Vaghaiwalla Mody M.D.,
Sanjiv S. Gambhir M.S., Christoph Nienaber M.D., Lynne
Warner Stevenson M.D., FAC.C., S. C. Huang DSc., Heinrich
Schelbert M.D., F.A.C.C., UCLA School of Medicine, Los
Angeles. California.
Laboratory studies have indicated that glucose utilization is
augmented relative to flow in ischemic myocardium. To
determine the relationship between absolute myocardial blood
flow (MBF) and glucose utilization (GU) measurements in
human myocardium, 11 pts with ischemic cardiomyopathy
were studied with dynamic positron tomography (PET) utilizing
N-13 ammonia (NH3) and F-18 deoxyglucose as tracers of flow
and metabolism respectively. Tissue time-activity curves and
arterial input function were obtained by drawing 8 ROI's on 3
simultaneously acquired cross-sectional planes and LV cavity
respectively. Quantitative MBF measurements were derived
utilizing a two compartment NH3 model while quantitative GU
rates were calculated using a modified Patlak approach. In 50
segments with flows ranging from 0.09 to 1.15 ml/min/gm, GU
rates ranged from 0.068 to 1.21 Ilmol/min/100 gm. Ratios (R) of
GUiMBF were inversely related to MBF according to the
exponential formula: R=4.39*(exp( ·3. 13'lIow)) [r2=O.58, corr
coeff-O.76]. For flows greater than 0.45 ml/min/gm, there was
little variation in R with increasing flows. In contrast, for flows
less than 0.45 ml/min/gm, R increased rapidly to a maximum of
4.2 at 0.12 ml/min/gm. We conclude that GU is accelerated
relative to MBF in ischemic human myocardium, consistent with
increased substrate flux in glycolytic pathways.
IMPAIRED FATTY ACID METABOLISM IN POSTISCHEMIC CANINE
MYOCARDIUM : A TIME COURSE STUDY WITH POSITRON EMISSION
TOMOGRAPHY. .
D. Vogelaers, W. Wijns, J.A. Melin, A. Bol, C. Michel,
D. Labar, M. Cogneau, A. Keyeux, G.R. Heyndrickx. Univ.
of Louvain, Brussels and State Univ.of Gent, Brussels.
Prolonged post ischemic dysfunction was induced in 9
chronically instrumented dogs by a single 1 hr episode
of graded circumflex coronary(C) artery(A) stenosis(S).
Blood flow(F) was measured by microspheres and by
Doppler probes. Regional left ventricular thickening was
measured by transmural ultrasonic crystals (% systolic
wall thickening, SWT). CAS reduced transmural F to 47±8%
of baseline such that regional akinesia was obtained
(SWT ranging from 27 to ·15% of control). Fatty acid
metabolism was studied with C-ll palmitate (CPA) and
dynamic PET imaging 4-8hr after ischemia and reperfusion
in 2 dogs as well as serially 24 hr and 1 week after
ischemia in 7 dogs. CPA tissue wash-out curves were ob·
tained from regions of interest in the stunned(SA) and
normal areas(NA). Biexponential curve fitting yields the
halftime of the early rapid phase (t~), which is related
to CPA oxidation and the size of the late slow turnover
pool (LSP) related to deposition of CPA in neutral
lipids. In the dogs studied 4 and 8 hr after ischemia,
t~ in SA was respectively 175 and 115% of NA; LSP was
103 and 141% of NA. In 3 dogs showing normal CPA
washout at 24 hr, SWT had returned to 90% of control.
In 4 dogs showing abnormal CPA washout at 24 hr, SlIT was
only 65% of control. In SA, t~ was prolonged by 21%
from 4.9±1.3 min in NA; LSP in SA was increased by 44%
from 28±8X of peak activity in NA. At 1 week, SWT was
93X of control and CPA washout was normalized. Thus,
stunning is associated with altered CPA handling i.e.
decreased oxidation and increased storage. Recovery of
SWT is paralleled by normalization of CPA metabolism.
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QUANTITATION OF CRITICALLY ISCHEMIC MYOCARDIAL MASS
DURING ACUTE CORONARY OCCLUSION IN VIVO: MEASUREMENT WITH
POSITRON EMISSION TOMOGRAPHY. Michael E. Merhige~ M.D'dF.A.C.C., Dahlia Garza, M.D., David Sease, M.D., • Wan a
Rowe, Ph.D., Jonathan Maclean, M.S., K. Lance Gould,
M.D., F.A.C.C., Positron Research Center, University of
Texas at Houston, Houston, TX
"Critical" myocardial ischemia (CIl during acute
coronary occlusion has been defined as myocardial per-
fusion < 50% of normal because tissue AlP content and
regional wall motion decline with this level of flow
reduction. To determine if CI LV mass can be measured in
vivo with Positron Emission Tomography (PET), we obtained
myocardial perfusion images in 9 open chest dogs with IV
N-13 Ammonia, during LAD coronary ligation. Left atrial
injection of radiolabelled microspheres was performed
during image acquisition and perfusion was subsequently
calculated in each 0.5 g myocardial section of the
trimmed LV.
LV mass with microsphere perfusion ~ 50% of peak mid-
wall flow was expressed as a fraction of total LV weight
while the CI LV mass was measured from PET perfusion
images after 50% background subtraction which defined the
LV edges. The number of pixels with ~ 50% of peak
myocardial N-13 ammonia uptake was determined using
computer assisted regions of interest. There was a linear
correlation between the CI LV mass measured with
microspheres in vitro and that measured in vivo with PET
which approximated the line of identity TY = O.90x + 2.7;
r· 0.88). Conclusion: noninvasive myocardial perfusion
imaging with N-13 Ammonia and PET permits quantitation
of critically ischemic LV mass during acute coronary
occlusion ~ vivo.
1'-18 METARAMINOL UPTAKE AS HARDR FOR NEURONAL FUNCTION
IN POST-ISCHEMIC CANINE MYOCARDIUM.
Markus Schwaiger, M.D., Haydee Guibourg, M.D., Karen
Rosenspire, Ph.D, Thomas McClanahan, Kim Gallagher, Ph.D.,
Gary Hutchins, Ph.D., Donald Wieland, Ph.D., University of
Michigan Medical Center, Ann Arbor, Michigan.
Myocardial ischemia has been shown to cause sustained de-
pletion of tissue norepinephrine (NE). To study neuronal
function in reperfused myocardiua (REP) following 30 min
(Grp 1) and 60 min (Grp 2) ischemia, regional uptake of
the new catecholaine analog 1'-18 IIM!tarmnol (FME) was
determined in 11 intervention and 6 control dogs (She).
Myocardial blood flow (MBF) was meaaured using micro-
spheres during LAD occlusion (OCL) and prior to i.v. FME
injection 30 min after reperfuaion. The animals were sac-
rificed 30 min after FME injection. Tissue 1'-18 activity
was deterldned by well counting and normalized to the ar-
terial input function of FKR yielding absolute FKR uptake
in control (CONT) and center of REP. Tissue HE levels
were determined in CONT and REP using HPLC electrochell1cal
methods.
MBFOCL MEFREp FKRcONT PKRup NEcONT NEREp
Sh_ 1.1+.3 3O:t5 28.~ 431+99 441-+84
Grp 1 0.2+2* 1.0+.4 28+21 21+17* 363+100 297+84
Grp 2 0.3+2* l.o!.5 2~ l8!5* 340!88 27J!40
*p (0.05; KBF-al!min!g; FME-arbitrary units; NE-pg!g
Thirty aDd 60 min IS resulted in significantly decreased
FME uptake in REP. 30 min IS resulted in decreaaed FME
in REP only, while 60 min produced also decreased 1'KR up-
t*e in CONT (1'(0.05). FKR paralleled changes in regional
NE tissue content. Thus, 1'-18 metarainol allows sensi-
tive assessment of catechol_ine uptake in ischemically
injured myocardium and may be clinically useful in COm-
bination with PET for the noninvasive evaluation of neu-
ronal function in patients with ischemic heart disease.
DIFFERENCES IN DISTRIBUTION OF BETA-BLOCKERS
IN INFARCTED PORCINE HEARTS. A STUDY WITH
POSITRON EMISSION TOMOGRAPHY (PET).
A. Waldenstrlim, J.-A. Bjtirkman, P. Hartwig, J. Hultman,
P.-O. Sjl}quist, G. Wikstrtim, G. Antoni, J. Ulin, B. LAng-
strlSm, and H. Lundqvist. Uppsala University, Uppsala,
Sweden.
The aim of the present study was to compare the dynamics
of tissue distribution within the ischemic heart of two beta-
blockers with different physicochemical properties; meto-
prolol (M) being more lipophilic than atenolol (A). Atenolol
(A) and metoprolol (M) were both synthesized and labelled
with positron emitting HC (t1l2 = 20 min). 30 min after LAD
occlusion, equipotent doses (0.3 mglkg) of either of the drugs
were injected into anaesthetized pigs positioned in the PET
camera. Myocardial flow before and during ischemia was
measured by injection of radiolabelled microspheres, and
blood flows close to zero in the ischemic region were confir-
med. Normal and ischemic areas of PET pictures were deli-
neated and drug concenterations over time estimated.
Results; In the ischemic region of M pigs (n = 3) a conti-
nuous increase in drug concentration was seen which was
not observed in the A group (n =6). Average drug concen-
treations in the ischemic area at the end of experiment (60
min after drug administration) was for A = 57 pmoJlg tissue
and for M = 136 pmoJlg tissue. This study demonstrates that
a) a lipophilic drug (M) penetrates more easily into an
ischemic area than a hydrophilic one (A) as described by the
significantly different slopes of the activity curves, M being
0.017 and A being 0.005, and b) that the PET technique is
suitable for studying drug distribution continuously within
ischemic hearts during in vivo conditions.
PORTRAYAL OF CARDIAC BETA RECEPTORS IN LIVING ANIMALS.
James Sisson, M.D., Donald Wieland, Ph.D., Jon Johnson,
B.S., Gersld Bolgos, B.S., Terese Malak, B.S. Marcian
Van Dort, Ph.D., David Gildersleeve, Ph.D., Markus
Schwaiger, M.D, Gary Hutchins, Ph.D., University of
Michigan Medical Center, Ann Arbor, Michigan.
To aid in determining the roles of beta cardiac adre-
nergic receptors in the develop.ent of arrhythmias and
heart failure, we have developed a method to portray and
quantify beta receptor binding in living animals. 125-
I-iodocyanopindolol (125-ICYp), a beta antagonist,
bound with high affinity to the heart in rats. Bind-
ing was inhibited by a nOD-selective antagonist, pro-
pranolol, to give non-specific binding (45%). Binding of
125-I-ICYP to lung was inhibited by a beta-2 selective
antagonist, ICI 118,551, in doses that did not affect
binding to the predollinately beta-1 heart receptors.
In dogs, about 90% of l23-ICYP injected into coronary
arteries was extracted. Early release from the heart
was biexponential: relatively rapid over a few II1nutes
and unaffected by propranolol; then slower over an hour
and accelerated by propranolol. 123-ICYP given IV
enabled scintigraphic portrayal of the dog left ven-
tricle in planar and tomographic views. There was no
gradient in the binding of 123-ICYP frOll base to apex
which contrasts with the gradient known for adrenergic
neurons. Specific binding was estimated at 2 hours after
which total binding decreased slowly (Tl!2: 9.8 h), and
non-specific binding in the presence of propranolol only
slightly faster (Tl!2: 7.8 h).
Scintigraphy of 123-ICYP may enable portrayal and
quantifying of beta receptors in man. The method
combined with scintigraphy of the neurons by a neuron-
specific agent could define the major components of the
adrenergic nervous system in the heart.
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Implantable Defibrillators I
A Flesible and Effective 3 Electrode Non-Thoracotomy
Defibrillation System In Man.
Gust H. Bard~ M.D.~F.A.C.C~ Margaret D. Allen M.D.,
Rahul MehrabD.,orge Jo nson B.S.E.E., H. Leon Greene
M.D., F.A.C.C., Tom D. Ivey M.D., University of
Washington, Seattle, Washington.
Thus, a coronary sinus--right ventricular--subcutsneous
patch lead system coupled to a flesible waveform pulse
generator should allow non-thoracotomy defibrillator
implantation in the majority of pts.
It is unlikely that any single pulsing method or
electrode system will result in a uniformly superior
defibrillation technique when used with non-thoracotomy
lead systems for automatic antiarrhythmia devices. The
purpose of this study, therefore, waS to develop a
non-thoracotomy lead system that would.lend itself to a
large number of alternative defibrillation methods.
Using a coronary sinus coil, right ventricular coil, and
a thoracic patch, we were able to test monophasic,
biphasic, sequential, and/or simultaneous pulses over a
variety of current pathways. In 12 sudden death
survivors, defibrillation thresholds (DFT) were measured
with the non-thoracotomy lead system described above and
subsequently compared to DFT values obtained with 2 large
epicardial patch electrodes used at the time of automatic
defibrillator implantation. The multiple options
available for improving defibrillation efficacy enabled
defibrillation of each pt within the voltage and energy
limits of presently available pulse generators.
Comparison of epicardial and non-thoracotomy DFT's
follow:
nm AUfOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
AND PATIENT SURVIVAL: A CASE CONTROL STUDY
Dayjd Newman MD John Herre MD FACC. Mary Jane Sauve RN,
Jay Franklin MD. Melvin Scheinman MD FACC, Jerry Griffin
MD FACC. University of California, San Francisco. California.
An automatic implantable cardioverter defibrillator (AICD) was
implanted in 40 patients (pts) with ventricular tachycardia
(VT) or cardiac arrest. Each AICD patient was matched to 2
controls according to age. ejection fraction (EF). heart disease,
presenting arrhythmia. continuing amiodarone (Amio) usc,
Amio intolerance or clinical recurrence on drug therapy.
Thirty four pts received amiodarone (Amio) prior to AICD and
17 after. In both groups the EF was (31±1I.S%,mean ±SD). age
(S9±13 yr). and 7S% had ischemic heart disease. The AICD pts
and controls were followed for 19.9±12 months (range 0-S2)
and 17.S±10 months (range 1-92) respectively. In the first 2S
mos there were no AICD sudden deaths and 4 in the control
group. There have been a total of 10 and 20 deaths in the AICD
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By interval analysis AICD improved survival between 8-21
months (p <.OS). Overall by Cox proportional hazard model
analysis there were no differences between the two
survivorships. Subgroup analysis suggest that most of the AICD
survival gain was seen in the group unable to take Amio.
Conclusion: AICD improves survival in pts treated for life
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INITIAL CLlNICAL~: ENOOrAK'" - :tI1PlP.NrA8IE 'lllANS\IENlJS
IEFIBRIIlA1tR SYSnH.
Stanley M. llach, Jr., MD; Janice Barstad, BS; Narey Harper, RN, 1lII';
David !layer, BS; Suzan Koser, RN, BSN; Mark Snutka, BS; Rita Theis,
RN, BSN; Jill IJollins, Ih.D.; Cardiac Pacanakers, Ire., St. Paul, !'tl
Between Karch 24, 1988 IIIll1 AujyJst 31, 1988, 28 pta received the CPI
ENXJrAK'" TrarllM!RlUS Defibrillation lead Systsn. The lead systsn,
COllSis~of a transven:lUS defibrillation catheter, ,dm",c'Ilar or
Slix:utaneous patch _ iDp1.anted in 23 males IIIll1 5 females, mean age
63 yrs (range 46-78 yrs). Primal:y di.agp>ses for pt groop "",re:
coronary arteIy disease 86%, nonischemic ~t:hy 4%, other
caxdi.ac diseases (idiopatirl.c vent:ri.cular anhytbnia IIIll1 other valvular
disease) 10%. Mean UJ ejection fraction _ 29% (range 12-57%).
Primal:y clinical anhytbnia _ ventricular fibrillation (VF) in 4
pta, ventricular taehy<:ardi.a IIIll1 fibrillation r,yr/'lF} in 11 pta am
vent:ri.cular taehy<:ardi.a (Yr) in 13 pta. 1\00 of four possible lead
systsn confiiJ.xrations (confit;;)~ randaDly selected for iDplant
tes~. Additional config9 "",re tested at inIIestigator discretion.
At core1usion of testing the lead config detennined to be DOst
efficacious _ chronically iDplanted: 1 pt received config #1 (pos
patch, nlg proximsl IIIll1 distal sp~ electrodes); 23 pta received
config #2 (pos proximsl sp~ IIIll1 patch, nlg distal spriIlg); 1 pt
received config #3 (pos proximsl sp~, nlg distal spriIlg); IIIll1 2 pta
received config 114 (pos patch, nlg distal spring) IIIll1 1 pt received a
cali>ination ENOOrAK/2 large patch leads (pos patches, nlg distal
spring). furing 1Dplant, pre-lxlspital discharge, IIIll1 8-12-1Oeek post-
1Dplant~ Aim'" canIiaverter/ defibrillator ar:rhytbni.a
COIMlrSion tes~, the p.J1se getBrator sensed IIIll1 COllIIerted iIrlxed
vr/VF. To date, 5 pta have received awroPriate card1aversion,l
defibrillation of vr/VF episodes.
Cog;lusiaJs' 1) Transverous defibrillation lead systsn 1Dplantstions
us~ the m:xJrAK lead Systsn have occurred with good early results;
2) Use of a d1Iooi.ca1l.y iDplanted t:ransvernlS lead systsn for
iDpl.anb!ble card1aversion,l defibrillation is feasible in lunans.
Does Poor Cardiac Function Preclude Benefit fl'OlD an
Automatic Implantable Cardioverter Defibrillator?
Joseph H. Levine, Adrienne Richards, David Mellits,
Rosemary Baumgartner, Enrico P. Veltri, Lyle A. Siddoway,
Louise Grunwald, Jean Lisek, Diana Aarons, Levi Watkins,
Morton Mower, M.Mirowski, N.A.M. Estes, Lawrence S.C.
Griffith. The Johns Hopkins Hospital, Baltimore, MD.
The utility of the Automatic Implantable Cardioverter
Defibrillator (AICD) in patients with severe left
ventricular dysfunction (LVD) is unknown; some suggest
that although the device may reduce arrhythmic mortality,
patients with severe LVD may succumb to other
complications of heart failure. To determine whether
survival in patients with AICD is dependent upon
severity of LVD, we evaluated outcome as a function of
ejection fraction (EF) in 199 patients with AICD. The
incremental benefit of survival added by AICD was
defined as the time from first appropriate firing
(symptomatic. documented VT. etc) to death.
Results:
Ejection Fraction <15% 16-25% >26%
Patient Number -17 45 137
Median Survival (months) 27.7 35.5 64.9 p<O.OI
Median Time to First
AICD Firingor Death 4.8 5.2 15.8 p=O.OI
i\ledian Time from First
AICD Firing !Q Death 14.5 22.9 30.2 p=.05
Conclusions: 1. Patients with severe LVD (EF<15%) have
earlier appropriate AICD discharges but worse overall
prognosis. 2.All groups had benefit from AICD as indexed
as the time from first AICD firing !Q death. 3. The degree
of benefit was dependent, in part, on ejection fraction.
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PACI!IfADI/DIPL&II'l'ABLB DIFIBIILL&1'OR IlI'I'ERACl'IClIS: AlB
'l'BBI OF CLIlICAL IMPOITAIICB?
Hush Calkins, K.D., Jeffrey A. Brinker, K.D., F.A.C.C.,
Lyle Siddowar, K.D" Robert Hanich, K.D., Thomas
Guarnieri, K.D.. Joseph H. Levine, K.D., Johns Hopkins
Medicsl Institution, Baltimore, Haryland.
Since its introduction in 1980, 176 patients have had
an implantable defibrillator (AICD) placed at the Johns
Hopkins Hospital, Thirty of these patients (17%) also
had a pac~er implanted either prior to (N-I6), during
(N-2) or followins (N-I2) !lCD placsent. To determine
the incidence and clinical illportance of interactions
between these two devices, we reviewed our experience.
Twenty-five had sinsle chamber pacellakers (22 VVI, 1
VVIR, 2 anti tach) and 5 patients had dual chamber
pacemakers (1 DDDR), The 4 patients with unipolar
pacemakers were revised to bipolar. Pacemaker/AICD
interactiona occurred in one patient whose AICD double
counted the pacer stimulus and evoked QRS but did not
cause false firinss. No!lCD inhibition durinR VF was
seen. !lCD/Pacemaker interactions occurred frequently,
DurinR AICD testinR, 7 patients demonstrated transient«60 sec) failure to capture and/or sense post discharRe,
Three patients dellonstrated pacemaker reprogramming
following an !lCD discharge (2 to backup mode, 1 to off).
Conclusions: 1) Pacemaker/AICD interactions includinR
double counting and !lCD inhibition are extrellely
uncommon with bipolar pace.akers, 2) AICD/Pacemaker
interactions occur frequently and may result in transient
failure to sense snd capture as well as pacemaker
reprogramminR which may be clinically significant. With
careful screenlnR, the clinical importance of these
interactions can be minimized.
AUTOMATIC IMPLANrABLE CARDIOVERrEB. DEFIBRILLATOR:
ANALYSIS OP SPONTANEOUS SHOCKS
Hugh P McAlister MD, Jay Gross MD, Lon W Csstle MD,
PACC, John D Pisher MD, PACC, Victor A Morant MD,
Anthony Hercando MD, Tony W S1Julons MD, PACC, Bruce L
Wilkoff MD, PACC, Seyaour Puraan MD, PACC, Jalles D
Maloney MD, PACC
The Cleveland Clinic Poundation; Cleveland, Ohio and
Montefiore Medical Center; Bronx, New York
We analyzed the occurrence of shocks and its effect on
prognosis in 125 pts implanted or followed with an
auta.atic implantable cardioverter defibrillator (AlCD)
between 1982 and 1988 at 2 centers, There vere 106 aa1es,
19 feaalea, aged 58+11 yrs; 99 bad coronary disease, 20
cardia.yopathy, 6- other; ejection fraction (EP) was
33+13%, 38 (30%) were in NYHA cluse8 III-IV. Shocks
were assumed appropriate unlesa documented or stroDgly
clinically suspected otherwise. At a follow-up of 20+17
mos. 66 pu (53%) had received;>l shock, of wbCllll-22
(33%) bad received;>10. Pirst shock occurred at 8+10
IIOS. Cumulative discharge occurrence rate at 6.12,
18,24,36 and 48 1I0S vas 38%.53%. 61%,75%, 90% and 92%
respectively. Of 18 pta witbout sbocks at 18 IIOS. and
followed to 36 1I0S, 11 (61%) received shocks duriDg that
tille. Pts with shocks (Gp!) and those without (GpB) had
siadlar aean EP (33% vs 34%). no. in NYHA classes III-IV
(30% vs. 31%), no. with coronary disease (79% vs. 80%).
and no. initially presenting with sudden death (45% va
43%). 1'!lere were 22 deatba, 18 in Gp! and 4 in GpB
(p-O.005), at a .ean of 12 80S after iap1ant. Po11ow-up
vas 23+19 IIOS in GP!. 16+15 IIOS 10. GpB. One and 2 yr
survival vas 77% (n-53) and 67% (n-43) in gp!. and 91%
(n-33) and 76% (n-17) in gpB (P"Da).
CONCLUSIONS: 1) Despite AlCD efficacy, pta receiving
shocks have a poorer prognosis. 2) 90% of pts followed 3
yrs had AlCD shocks.
Tuesday, March 21, 1989
10:30AM-12:00NOON, Marriott Hall North
Anaheim Marriott Hotel
Implantable Defibrillators II
USE OF GRADIENT MAPS TO CREATE AN ELECTRODE CON.
FIGURATION WITH A MORE EVEN DEFIBRILLATION FIELD
Anthony S L Tang, M 0 , Patrick D. Wolf, M.S., William M.
Smith, Ph.D., Raymond E. Ideker, M.D., Ph.D., Duke Universi·
ty Medical Center, Durham, NC
The potential gradient field produced through the ventricles by
a shock is thought to be an important determinant for
defibrillation efficacy. This study used potential mapping to
determine the shock fields produced by three catheter and patch
defibrillation electrode configurations. In 6 dogs, a catheter was
inserted with RV apical (V) (2.8 sq cm) and RA (A) electrodes
(1.4 sq cm). In the last 3 of the dogs, a second catheter was
inserted with its distal electrode (2.8 sq cm) in the RV outflow
tract (0). A cutaneous R2 patch (P) was placed on the left
lateral thorax. Shock potentials were recorded simultaneously
from 128 electrodes in the LV and RV subepicardium and
subendocardium, the ventricular septum and the atria. After
closing the chest, 50 rnA shocks were given during diastole via
V-A (V, cathode and A, anode); V_P; and V+O-P. Poten-
tial gradients were calculated at the subepicardium and suben-
docardium in mV/cm per volt of shock. The highest(H) and
10west(L) gradients (mean±SD) were:
V-+A V-P V+O-+P
H (mV/cm/V) 101.3±5.7 82.7±34.2 57.2±5.7
L (mV/cm/V) 5.2±O.9 5.7±2.8 7.2±O.9.
I'atio H:L 20±8 17±8 8±1
V-A was most uneven, with low gradients at the LV apex.
V-P was also uneven, with low gradients anteriorly. We
attempted to raise the gradient anteriorly by adding 0 in the
last 3 dogs. V+O-P created a more even field, decreasing the
high gradient by furnishing an alternate current path and rais-
ing the low gradient by O's anterior location. This study sug-
gests that mapping the shock potentials can guide the develop-
ment of defibrillation electrode configurations which produce a
more even potential gradient field.
~ OF stXX:ESSFUL lEFIBRILtATIal al~
tm'IElRIU.ATIal 'IIIRmII:lIJ) IN A CANINE !DEL OF RAPIDLY
RPJaJRRIN:; CARDIAC ARREST.
sajlld H. Mir B.S., Mictlael H. I4lhm!!nn M.p., F.A.C.C.,
Da1qlu I.lm11h.D., RllS8el.l staiDDan M.D., ClAuiio
sc:tJuger M.D., Harper Hcsp./Wayne state univ., Iletroit, HI
nJring iJIplantatim ot the autaaatic cardioverter
detihrillAtor (AICD), detibrillatiat thresholds (I:F1'B)
are ..MMSed ue.iD1 .ild.lced episcidee ot wntriallar
t:1hrillatiat (VF) eeparatacll:Jy -....raJ. 1Iimtee. HcwiIII8r,
AICDe IIIlIY be nqJired to tunc:tiat in settings ot~
rapidly l'8O.Il:'ring VF, Wen I:F1'B might be altered. To
investiqate this pose.ibility we studied. 10 cpeaH:Dllet,
anesthetized and ventilated lDC:Ilgr81 dogs. An extemal
det:1hrillator _ attacmd to 2 ~.icardial patch
elecb::cdee. In the liml. arrest CYlxl) protocol, V't was
in:1uced via III}'CCaX'dial pl\.llYil8 electrcdee; 15 sec later, a
test shock was delivered aet'CSS the patch elecbooc:Jlls.
'D1e "!'!INe arrest M'x2l protocollllOd81.ci a SCBIlarlo in
104lid1 VF recurs shortly after SUCClllltul cletibrillatial
(SIF) with a 300' AICD shocJc. 'lhis was mimicked l:Jy tirst
in:Iuc.iD1 V't and, 15 sec later, det.ibrillatinq with a 300'
shoc:It; then, tOUadn;J CZlly a 15 sec recaII8XY periocl, VF
was aqain in:tlced tar 15 sec before the test shoc:It. Test
E!nIlX9Y barDdclths tar ead1 protocol ware oent:erecl al the
initially deteJ:minIld ccnventicml "DFl'" (beq1nnin; with
200' shocks, and d8c:nIDBntinq l:Jy 2J). Eac:b ehccIc enarqy
was then randaIIly tested tour Dm'8 times (with 5 IIIin rest
l:let:W8In protocols). Data relatinq pet'C81t SIF to energy
ware used to ocnstruc:t sigDX)idal "doee-%espa1I8" CU%Y8I.
Mean (±SE) energies t1ClI%eepaldinq to 504 (ESO) and 80t
(EBO) sri ware: 8.4 ± 1.2.1 and 10.4 ± 1.5J far VFxl va.
8.7 ± 1.2.1 and 10.2 ± 1.3.1 far VFx2, nspec:tively
(pooHS) • F~ in this canine~ suggest that with
prc:mpt.ly tem!nated V't, theJ:e is nQ Om..1lativa riM in
IF!' (EBO) dur.iD1 rapidly recutr.iD1 episodes.
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The total energy required for defibrillation using this SCBW was one
third of that required for the DCBW. The use of the SCBW unex-
pectedly resulted in a significant reduction not only of energy, but
also of VII required for defibrillation when compared to the DCBW.
In conclusion, the SCBW requires only a small amount of energy for
successful defibrillation and is significantly more energy efficient than
the DCBW.
A COMPARISON OF SINGLE AND DOUBLE CAPACITOR
BIPHASIC WAVEFORMS FOR INTERNAL DEFIBRILLATION
Kathetine M Kayanagh M 0 Anthony S.L. Tang, M.D., Dennis L.
Rollins, M.S., William M. Smith, PhD., Raymond E. Ideker, M.D.,
PhD., Duke University Medical Center, Durham, NC
Truncated exponential biphasic waveforms have been shown to
reduce energy requirements for internal defibrillation. The use of a
single output capacitor for defibrillation would reduce the size of
implantable devices. For double capacitor biphasic waveforms
(DCBW's), the leading edge voltage of the second phase (V21) usually
equals the negative of the leading edge voltage of the first phase
(Vll). For single capacitor biphasic waveforms (SCBW's), V2l equals
the negative of the trailing edge of the first phase of the waveform.
This study compared the defibrillation energy requirements of
SCBW's and DCBW's. The cathode consisted of two 3.25 cm long
transvenous catheter electrodes, one in the RV apex, the other in the
RV outflow tract. The anode consisted of a 113.0 sq cm cutaneous left
chest wall electrode patch. Defibrillation thresholds were established
within 40 volts using a modified Bourland technique in 8 anesthetized
dogs (25.6 ± 2.6 kg). All biphasic waveforms were 6/6 msec duration.
DEFIBRILLATION THRESHOLD
INCREASED DEFIBRILLATION THRESHOLD AND CARDIAC
HYPERTROPHY IN A RAPID PACING MODEL OF CONGESTIVE HEART
FAILURE IN THE DOG
S. Deborah Lucy M.Sc., Douglas L. Jones Ph.D., George
J. Klein M.D., F.A.C.C., University of Western Ontario
and J.P. Robarts Research Institute, London, Ontario,
Canada
Patients with idiopathic congestive cardiomyopathy,
prone to arrhythmia and sudden death, are candidates
for an implantable automatic defibrillator. It is
unknown if the progressive hypertrophy in these patients
influences the energy necessary for defibrillation. We
evaluated this influence of hypertrophy using a rapid
ventricular pacing model of heart failure in the dog.
Following electrophysiological and hemodynamic
assessment, adult mongrel dogs were randomly assigned
to one of two groups: 1) control, those having standard
transvenous pacemaker implants set to demand pacing at
70 beats per minute (bpm), (n=6) or 2) rapidly paced,
those having a custom modified pacemaker (Medtronics
Inc.) set to pace at 240 bpm, (n=6). Seventeen days
post implant, three evenly spaced epicardial mesh
electrodes (Medtronic, TX-7) were sutured onto the basal
ventricular surface for sequential pulse defibrillation.
Three replicate defibrillation thresholds were obtained
from each animal. Average defibrillation threshold was
five times higher in the rapidly paced group, 13.3 ± 4.4
joules (mean ± SO), than the control group, 2.9 ± 1.4
joules (p <.01). Ventricular weight corrected for body
weight was significantly higher in the rapidly paced
dogs, 15.5 ± 1.4 g/kgO• 75 , versus 12.5 ± 1.4 g/kgO•75
of the control dogs (p <.01). We conclude that
ventricular hypertrophy may profoundly increase the












Thus, conduction block can follow either B or M shocks, but the
PG causing block is greater for B than M shocks. This effect
may partially explain the increased defibrillation efficacy of B
shocks, if reentry circuits can form around regions of block and
lead to the resumption of fibrillation.
THE STRENGTH OF MONOPHASIC AND BIPHASIC
SHOCKS THAT CAUSE CONDUCTION BLOCK
Sejtaro Yahe, M 0 , William M Smith, PhD., James P. Dau-
bert, M.D, Patrick D. Wolf, M.S., Raymond E Ideker, M.D.,
PhD., Duke University Medical Center, Durham, NC
Biphasic (B) shocks defibrillate at lower energy than monophasic
(M) shocks. Potential gradients (PGs) > 100 V/cm are created
near cardiac defibrillation electrodes during shocks. We deter-
mined if such PGs cause conduction block and if conduction is
impaired less with B than M shocks. In 6 dogs, simultaneous
recordings were made on the upper anterior RV from 117 epicar-
dial electrodes over a 32 x 30 mm area. Sl pacing (350 ms cycle
length) from a long narrow electrode on the right side of the
mapped area generated parallel activation isochrones. At 300
ms after the last Sl, a 10 ms M or 5-5 ms B shock of 70 to 850
V was delivered via a mesh titanium electrode cathode on the
left side of the mapped area with the anode on the RA. Eighty
shocks created PGs of 1.4 to 190.3 V/cm with high PGs on the
left and low PGs on the right side of the mapped area. Sl pac-
ing from the right side was reinitiated 0.2 sec after the shock.
The first post shock activation propagated as before the shock
where PG was weak, but blocked without conducting into areas
where PG was >64±7 V/cm for M and >72±6 V/cm for B
shocks. These values are significantly different (p<O.Ol). As
shown below for both M and B shocks, the higher the PG, the
longer was the duration of block before conduction returned.
DOES ELECTRODE POLARITY INFLUENCE DEFIBRILLATION EFFICACY
FOR THORACOTOMY AND NON - THORACOTOMY INTERNAL DEFIBRILLA-
TION?
Ranjan Thakur M.D., Joseph Souza, Paul Troup M.D.,
F.A.C.C., Jule Wetherbee M.D., Peter Chapman M.D.,
F.A.C.C., Medical College of Wisconsin, Milwaukee,
Wisconsin.
To assess the effect of electrode polarity upon defibril-
lation efficacy for thoracotomy (N=6) and non-thoracotomy
(N=6) lead systems, 12 dogs (23.9 .!. 1.9 kg) underwent
defibrillation trials using monophasic (M) and single
capacitor biphasic (B) shocks of 10 msec total duration.
B shocks had a 5 msec positive phase followed by a
5 msec negative phase. The thoracotomy defibrillation
pathway consisted of two 13.9 cm2 patch electrodes
placed on the epicardium anteriorly and posteriorly
while the non-thoracotomy defibrillation pathway consisted
of a 4 cm2 right ventricular catheter electrode paired
with a 13.9 cm2 subcutaneous chest wall patch electrode.
Each polarity configuration was tested 4 times against
AC induced ventricular fibrillation at 5 different
voltage levels and efficacy curves were constructed
using logistic regression analysis. Energies associated
with 80% probability of defibrilation (E80) were compared:
THORACOTOMY NON-THORACOTOMY
Mono E80 BI E80 Mono E80 BI E80
LV Post(-) 14.1 ~ Cath(-) 24.9----rrJi
Ant(-) 14.4 9.8 Patch(-) 25.0 14.9
For all lead configurations, B waves were superior
to M waves (p<O.OOI). Change in polarity did not affect
defibrillation energy requirements for either thoracotomy
or non-thoracotomy model. Conclusion: Polarity does
not significantly affect defibrillation energy require-
ment of normal canine hearts for M or B waveforms
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Anaheim Convention Center
Transesophageal Echocardiography
~ 2D CQ..CR-CCIEl lXA'l.ER EO-D:MDI~
r:l.RI~ PERCllTA/£Cl.S TlW6.lJ'1INItL. CCRNliRY AN:iICf'lASTY.
,JacqUft KaqJ.!.!L.!1J:1..... , C... Vi ...r 1'1.0 •• F.A.C.C., c;.ar9R
Da.,id 1'1.0., Harry ven W.z.1 1'1.0., HIt,. Ba't Ph.D., Ar-..d
Dunning 1'1.0., F.A.C.C., o.,.'t. of l:.rdiolagy, ~ic
"'-ctical c.nUr, A1K't.r"'" n-. "''t'''rl.nds.
A. tr.,...DPh;I~1 -.:hocardiagr.phy providn .tabl. r..-
c:ording pOSitions and hi~1 i'ty i_9ft, 1M ~.r.i.-d
.'t LV papi Ilary -uscl .. I_I, in 9 ....'t...'tizltd p't.,
b.for. and dur ing ~rl:U'ta~ trans I.. i nal coronary
angiapl••'ty (FTCA), t'" " inc:r /d-.:ra•• (.1) of' per-
~ta9R .ra r~'tion (PM). r iDnllI arM .jection
tr.ction (RlAEF") at ara .t ri.k••nd ~ystD'ic ..,. i-
dional ... 11 .'tr... (!"loS; cf>onlt/Clltl. In .dcli'tion...rly
(E)/a'tri.1 (A) tr.nsllitral peak tlow velocity and ti..-
..-loci'tY int.sr.1 (TVI; CII) w.r. obtai.-d .t annul.r
1..... 1; lIS ~II a... itral r .....rsitation (I'R) d_IQpIIltn't.
All pt. had nor_' LV tunction.nd no l'R.t ba•• ,i .. ; 26
i.ch.. ic ~riods ..r. IIOnitored, 18 I.tt ant.riDr O-Sc.nd-
ing art.ry (LAD) and 8 at risht COronary artery (RCA).
LAD RCA
contrDI PTCA L\ control FTCA L\
PM 60 to * 48t5 Z3 ~ t5 ** 50 t4 11
RlIeF 57 to * 3tl0 96 51 t9 * Z1 t4 17
EtA 1.2t.3 * .9t.3 37 1.2t.2 ns 1.lt.2 18
TVI 12 tl.9 * 10tl.5 16 11 tl.7 ns 11 t 1.2 2
!"loS 7Z t17 * Hlt17 56 75 tID * 98 t16 3D* p(.ODI; ** p<.OI
During FTCA L\ot all veriabl .. IMr•• ignificantly (p<.OI)
ditt.r.nt bat~n LAD and RCA P't•. I'R during PTCA ....
only ...n durins RCA occlu.iDn.
Conc Ius iDns: 1) E!ath sl Dba I and r ... ianal LV tunc:t ion ar.
IIQr. aU-.:t.d by LAD than by RCA Dcclu.iDn. 2) RHrra~
...,t at LV inflow and dft:r.... at TVI durins PTCA i. only



















'lbere was a high concordance between TEE and operative
findings. Mitral valve repair was successful in all pta.
Conclusions: 1) TEE was highly accurate in delineation
of IIDqilological alnJrmalities of the mitral apparatus.
2) TEE was superior to Tl'E in the diagnosis of ruptured
chordae tendinae and flail segrents. 3) There was a
high concordance between Tl'E and TEE in determining the
severity of mitral regurgitation.
TAANS'ffiORACIC VERSUS TIWlSEOOPHl\GFA 'nP-DIMEmICNAL
EOD/OOPPIER FIJ:Jtl IMAGINi IN SUR:;ICAL PATIFNrS WI'll!
MITRAL RE73UR3ITATICN.
Tillet J. Mills. M.D•• Charles P. Taliercio. M.D•• Kent
R. Bailey. Ph.D.• Hartzell V. SChaff. M.D•• Tharas A.
orszulak. M.D•• Martin D. Abel. M.D., A. Jamil Tajik.
M.D. Mayo Clinic, Rochester. Minnesota.
Precise determination of alnJrmalities of the mitral
apparatus is necessary in planning mitral valve recon-
struction. To date the ClCIlPU'ison of transt}x)racic
(Tl'E) to transesofhageal(TEE) in assessing the mitral
support apparatus has not been reported. Therefore. we
ClCIlPU'ed Tl'E with intraoperative TEE echocardiography in
16 patients (pts) undergoing mitral valve repair. 'lbe
mean age was 64 yrs (42-87), 15 patients were nal.e. Tl'E
transducer frequency was 2.5 Ilflz and TEE was 5 Ilflz. The
ed1ocardiographic findings were eatpared with surgical
observations •
TRANSESOPHAGEAL ECHO COMPUTER TOMOGRAPHY:
A NEW METIIOD FOR DYNAMIC 3-D IMAGING OF TIlE
HEART
Helmut Wollschliil:er. MD, Andreas M. Zeiher, MD, Hans-Peter
Klein, Wolfgang Kasper, MD, Susanna Wollschlager, MD,
Hanjorg Just, MD. Medical Clinic, University of Freiburg, F.R.G.
The limited acoustic windows of the chest wall \?revent imaging of
a sufficient number of parallel sections to permit complete spatial
reconstruction of thebeart. Transesophageal echocardiography
provides unrestricted access for ultrasonic imaging of the heart,
but is limited by varying transducer positions and thus different
imaging planes. Therefore, we developed a new device for the
acquisition of standardized parallel echocardiographic imaging
planes covering the entire heart and the great vessels.
This device consists of a conventional transesophageaJ probe with
an additional fully flexible distal portion serving as housing for the
ultrasonic transducer, which is mounted on a sliding carriage.
After insertion of the probe into the distal esophagus and visuali-
zation of a cross sectIOnal view of the left ventricular apex, the
housing (extending over 20 cm) is mechanically straightened to
form a ngid tube, thus allowing the transducer to slide in axial
direction. Thereafter, the transducer is pulled back in 05 rom
increments by means of an ECG gated, computer controlled step
motor providing exact parallel and equidistant imaging planes. At
each level, a complete cardiac cycle is recorded with ECG
triggering and stored in the memory of an image processing
computer. 256*256·256·8 bit cubic data sets are generated in 30
msec intervals corresponding to the echocardiographic frame
rate. A dedicated softWare for dynamic 3-D reconstruction allows
the computation of any desired tomographic view of the beating
heart and the great vessels.
Initial clinical application of transesophageal echo computer
tomogra(lhy demonstrated the applicability of this technique and
resulted tn high quality computed tomographic echo images of the
dynamic cardiac anatomy, providing unique new views of the
beating heart.
OVERESTIMATION OF REGURGITANT JET AREA BY TRANSESOPHAGEAL
AS COMPARED TO TRANSTHORACIC COLOR DOPPLER
Mikel D. Smith, M.D., F.A.C.C., Michael R. Harrison, M.D.,
F.A.C.C., Rossam Kanall, M.D., W. Randolph Chitwood, Jr.
F..A.C.C., M.D., Robert Salley, M.D., Oi Ling Kwan, B.S.,
and Anthony N. DeMaria, M.D., F.A.C.C. University of
Kentucky and VA Medical Centers, LeXington, Kentucky.
Transesophageal echocardiography(TEE) with color Doppler
flow imaging(CDFI) has been widely applied for the
quantitative estimation of valvular regurgitation(REGI.
However, because of differences in depth, transmitting
frequencies and attenuation, the existing criteria .
~ployed for estimating severity of REG by transthoracic
echo{TTX) ~~y not apply. We compared TTX and TEE for 16
regurgitant lesions. The r.~ximal jet areas for 7 MR, 5 AR
and 4 TR lesions were traced from 4 and 5-chamber views ~y
TEE and compared with equivalent views by TTX. For TTX,
imaging was performed using 2.5 MHz transducers at an
average scale of 16.0 cm while a 5 MHz probe was used for
all TEE studies and at average scale of 12.4 cm. Two
observers traced the largest definable REG jet area for
each lesion from 3 cardiac cycles and results were
average~. Jet areas for TTX st~dies ranged from 0.8 to
14.4 cm (mean =4.5 + 3.6 cm I. The same lesio2s from
comparable T~E stUdies-ranged from 1.4 - 12.3 em (mean =
6.2 + 3.6 em ). TEE jet areas were larger (p = .025) than
TT~ areas in 14/16 lesions, with a n~an difference of 1.6
~ . There was a fair correlation for jet areas by the two
techniques with r = .74 ~ut a systematic overestimation by
TEE; TTX = .74TEE + .04. Thus, TEE REG jet areas are
larger than those obta ined from TTX i,.~ges using CDFI.
This finding is important in the quantitative estimation
of valvular REG, especially during intraoperative
~onitoring. A baseline TEE study, performed intra-
operatively prior to sternotomy, is indicated for
comparison in patients undergoing valve surgery.
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TRANSESOPHAGEAL ECHO IN MITRAL PROSTHETIC
DYSFUNCTION: ECHO· SURGICAL CORRELATION
Philip J Currie MBBS, FACC, Paul Calafiore MBBS, William J.
Stewart MD, FACC, Helga Lombardo, Laurel Burgess, RN,
William A. Schiavone MD, FACC, Delos Cosgrove MD, FACC,
Bruce M. Lytle MD, FACC Cleveland Clinic, Cleveland, OH.
Due to shielding of the LA, diagnosis of mitral prosthetic
dysfunction by precordial echo is difficult. We compared
transesphageal echo and color flow Doppler (TEE) to surgical
findings in determination of the mechanism of mitral dysfunction
in 60 consecutive pts who underwent TEE and subsequently
had reoperation for mitral valve replacement. There were 37
bioprosthetic valves and 23 mechanical valves. All 30 pts with
central prosthetic mitral regurgitation (M R) by TEE we re
confirmed at surgery. All 27 pts with periprosthetic MR by TEE
were confirmed at operation. The sites of periprosthetic MR by
TEE were correctly predicted in 25/27 of these pts. The most
common lesion for bioprostheses was central prosthetic MR
(26/37 pts) and for mechanical was periprosthetic MR (16/23
pts). 10/11 pts with predominant prosthetic stenosis by TEE
were confirmed at surgery; 1 pt with mild stenosis by TEE and
moderate stenosis by catheterization, had no stenosis at
surgery. All 4 pts with definite vegetations by TEE were
confirmed at operation. In 2 pts small echodensities on the
prosthesis were diagnosed as possible vegetations by TEE, but
were not confirmed as vegetations at operation. In 9 pts, LA
thrombus detected by TEE were confirmed in all pts at
operation. Only 1 pt was falsely negative for thrombus by TEE,
however this was very small intraprosthetic laminated thrombus
at surgery.
Conclusions: TEE for mitral prosthetic dysfunction is
extremely accurate and reliable. TEE is the new diagnostic
standard of accuracy in this disorder.
MITRAL PROSTHESIS MALFUNCTION: UTILITY OF
TRANSESOPHAGEAL ECHOCARDIOGRAPHY.
BijObKhandheria, M.D., James Seward, M.D., F.A.C.C.,Jae h, M.D., F.A.C.C., William Freeman, M.D., and A.
Jami1 Tajik, M.D., F.A.C.C., Mayo Clinic, Rochester,
Minnesota.
Ultrasonic shadowing by prosthetic material reduces the
usefulness of standard transthoracic 2-D/Dopp1er echo
(2DE) in the assessment of mitral prosthesis (MP).
Transesophagea1 echocardiography (TEE) allows an un-
obstructed window for imaging left atrium and posterior
MP. We performed TEE in 55 Pt (39 females), mean age
62 yrs (range 16-86 yrs) with suspected MP dysfunction
(mechanical MP 40 Pt, bioprosthetic MP 15 Pt). Indi-
cation for 2DE: abnormal clinical examination 26,
thromboembolism 12, endocarditis 7, miscellaneous 10.
Standard transthoracic 2DE detected MP regurgitation in
13/55 (24') Pt. TEE, however, detected abnormal MP in
28/55 (51') including: vegetation/abscess (4 Pt), sig-
nificant regurgitation (20 Pt) [11 peri valvular, 9
valve dysfunction, (7 torn cusp, 3 partial dehiscence)],
obstructed valve (2 Pt) and thrombus (2 Pt). TEE more
accurately delineated the site of regurgitation in the
13 Pt identified as abnormal by standard 2DE. Operation
in 23 Pt showed findings concordant with TEE in 21
(91'); 2 Pt had small thrombus [sewi ng ri ng (l Pt),
ventricular surface of ball (1 Pt)], 15/23 Pt (66')
had operation without catheterization •. Conclusion:
TEE is superior to standard 2DE for the assessment of
MP dysfunction and is particularly suited for the
diagnosis of vegetations/abscess, and for
semiquantitation and accurate localization of the site
of MP regurgitation.
Tuesday, March 21, 1989
10:30AM-12:00NOON, California Room D
Anaheim Convention Center
Balloon Mitral Valvuloplasty Hemodynamic
Effects
RAPID REDUCTION OF PLASMA ATRIAL NATRIURETIC PEPTIDE
AFTER BALLOON MITRAL VALVULOPLASTY IN PATIENTS WITH
MITRAL STENOSIS.
Fuminobu Ishikura M.D., Seiki Nagata M.D., Yukio Hirata
M.D., Koji Kimura M.D., Jun Tarnai M.D., Masashi Akaike
M.D., Fumio Ohmori M.D., Makoto Takamiya M.D., Kunio
Miyatake M.D. and Yasuharu Nimura M.D..
National Cardiovascular Center, Suita, Osaka, Japan
To demonstrate the direct effect of the left atrial
pressure (LAP) on secretion of human atrial natriuretic
peptide (hANP), we studied the relationships between
plasma hANP levels, neurohumonal factors and hemodynamic
changes in 16 patients with mitral stenosis undergoing
balloon mitral valvuloplasty (BMV). Thirty minutes after
BMV, LAP fell in all patients significantly, while there
were no remarkable changes in either right atrial
pressure, mean arterial pressure and heart rate.
Plasma hANP levels in the pulmonaly artery
significantly decrease and plasma aldosterone
concentration (PAC) increased 30 minutes after BMV.
However there were no remarkable changes in plasma renin
activity and plasma norepinephrine concentration. There
was a significant correlation between the decrement of
hANP levels and that of LAP (r=0.73, p<O.OOS). However,
there was no significant correlation between the
decrement of hANP and the increment of PAC.
pre post (mean±SE)
LAP (mmHg) 13.6±1.6 6.2±0.6 p<O.OOOS
hANP (pg/ml) 262±43 129±2S p<O.OOOS
PAC (p~/ml) 11.0±1.3 IS.S±2.3 p<O.OS
These data suggest that the rapid reduction of LAP
directly influenced hANP secretion. And the reduction of
hANP had no influence to other neurohumoral factor. So
left atrial pressure as well as right atrial pressure had
importante role in the secretion of hANP.
PERClJTANEXXJS MITRAL VALve:trr:Mi USIliG THE DOUBLE BALIroN
TOCHNIQUE: DETERMINANT FACI'ORS OF MITRAL RmJRGITATION.
seung-Jung Park M.D. ,Woong-Ku Lee M.D. ,Won Heum Shim M.D.,
seung Yun Cho M.D. ,seung Jea Tahk M.D. ,Sung Soon Kim M.D.,
F.A.C.C.,Yonsei University,Medical center,8eoul,Korea.
Percutaneous mitral valvotomy(PMV) was successfully per-
formed in 62 (9S%) out of 6S pts (18M, 44F, mean age: 38
flO yrs) with mitral stenosis. There was an increase in
mitral valve area(MVA) (0.9±0.2 to 2.0±0.7 cm2,p<0.OOOl),
a decrease in mean mitral gradient (17±7 to 6±3 nmHg,
p<O.OOOl) and a rise in CO (4.3±0.8 to 4.8±1.2 Llmin, p<
0.01) .Mitral regurgitation(MR) developed or increased in
severity in 26(42%). Complications included embolic epi-
sode in 2, cardiac tamponade in 2 and creation of ASD(Qp
/Qs>l.S) in 12. The morphologic features of the stenotic
mitral valve was evaluated using echocardiographic score
(1-4 represent the severity of valve IOObility,thickening,
calcification and subvalvular lesions). pts with low-
score (~8) had IOOre effective dilation in MVA after PMV
compared with Fts with high-score ()8) (0.9 to 2.2 vs '0.8
to 1.4 cm2,p<O.OOl) despite of the similar EBDA/BSA(eff-
ective balloon dilating area/body surface area, 4.02 vs
4.03). Fts with an incease in MR had relatively larger
EBDA/BSA,more thickened and stiffer leaflets, and higher
total score. (. * p<O.OS, ** p<O.Ol VB group A )
GROUP A.OO MR B. INCREASE IN MH=l+ C. MR ~ 2+
No. of pts 36 14 12
EBDA/BSA 3.8 ±0.4 4.1 ±0.4 * 4.3 ±0.6
Thickening 1.9 to.S ** 2.4 ±O.S * 2.3 to.S
Mobility 1.4 to.S * 1.7 ±O.S 1.7 ±O.S
Total score 7.3 ±1.4 * 8.4 ±1.6 8.2 ±1.2
Conclusion:l) P1'1V using double-balloon technique is safe
and effective procedure in selected pts; 2)MVA after PM\!
was IOOre effectively dilated in Fts with low-score; 3)
An increase in ~m might be related to EBDA!BSA, valvular
thickening and mobility, and echocardiographic score.
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BALLOON MITRAL VALVULOPLASTY : A MULTICEM'l'llE STUDY
P Manga M.D.. R Chun M.D.. It. Horak M.D.. P Sareli
M.D•• L Disler M.D.
Department of Cardiology. University of the
Witwatersrand Johannesburg. and University of Cape
Town. South Africa.
Eighty patients (pts) with tight mitral stenosis
who were symptomatic despite medical therapy underwent
percutaneous balloon mitral valwloplasty (PBMV).
There were 57 females and 23 males. The mean age was
31 years. All pts were in NYRA fu~ctional c~ass III or
IV. Six pts had previous closed m~tral c~mm~ssurotomy.
PBMV was performed trans-se.ptally us~ng a s~ngle
catheter (Trefoil or BHoil) ~n 48 pts and 2 nngle
balloon (2x20mm) catheters in 27 pta. PBMY was
successful in 74 pts (92%). The results were as
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There was no difference in the results obtained.with
the single catheter vs the double cathet~r t~chn~que.
Complications included 2+ m~tral regurl1~anon ~!1 7
pts. Atrial septal defect ~th shunt r~nos < 1. ~. 5
were detected in 13 pta. One pt dud. Card~ac
tamponade developed in 2 pts. Three pts underwen,t KVR
for persistent symptoms related to m~tral
refurfitation. Two pts underwent successful repeat
va vu oplast_y for recurrent Sympt,OIDS dU~ to. v1l1ve
restenosis. The remaining pts rema~n chn~capy well
at a mean follow-up of 6 JI10nths and senal echo
studies have not shown restenos~s ~n th~s group.
Conclusion: PBMV is an effective therapy for ~he
relief of symptomatic tight pliable .mitral ~tel1o)s~.
The use of a single catheter (Trefo~l or B~fo~l or
the double balloon catheter appears to be equally
effective in relieving the stenosis.
HEMODYNAMIC RESULTS AND FOu.oW-UP OF PATIENTS WITH IATRO-
GENIC ATRIAL SEPTAL DEFECT FOu.oWING BALLOON MITRAL
VALWLOPIASTY
Raymond E Erny, MD PhD, Daniel J, Diver, MD, Robert 0,
Safian, MD, Patricia C, Come, MD. William Grossman, MD,
FACC, and Raymond G, McKay, MD, Harvard-Thorndike Labora-
tory. Beth Israel Hospital, Boston, KA
21 of 85 pts undergoing balloon mitral valvuloplasty
demonstrated significant post-procedure atrial septal
defects (ASD) by oximetry. with a mean Qp/Qs ratio of 1.4
(range 1,1 to 2.3). Compared with the other pts, those
pts with an ASD had lower post-procedure systemic blood
flow (SBF) (p<.Ol), less of an increase in calculated
mitral valve area (MYA) (p<.Ol), and higher post-proce-
dure right atrial and mean pulmonary artery pressures
(p<.05). Mitral valve gradient (MYG) was identical in
the two groups. Pre- and post-valvuloplasty hemodynsmic
data are summarized below (mean ± standard error).
Patients with ASD Patients without ASD
pre post pre post
SBF (l/min) 3.7:1:.2 4.0:1:.2 4,4:1:.2 5.3:1:.2
MYA (cm2 ) 0.9:1:.07 1.5:1:,07 1.0:1:.04 2.0:1:.1
MYG (mmHg) 14.2:1:1.3 6,6:1:,6 13.8:1:.6 6,6:1:,4
RA (mmHg) 9,8:1:.9 11.2:1:1.1 7.7:1:.8 6.6:1:.8
PA (mmHg) 45:1:5 36:1:3 37:1:2 30±1
Development of an ASD tended to correlate with use
of a large single balloon ~ primary use of two smaller
balloons (P<,lO). Late follow-up (mean of 14 months.
range 1-33 months) revealed no difference in mortality or
symptom recurrence in the two groups. One patient with
ASD (Qp/Qs of 1. 5) and pre-existing tricuspid regurgita-
tion has developed worsening right sided congestive heart
failure, Conclusion; Iatrogenic ASD after balloon
mitral valvuloplasty is associated with less initial
hemodynsmic improvement but no significant difference in
clinical outcome at an average follow-up of 14 months.
PERCUTANEOUS MITRAL VALVOTOMY INCREASES LEFT ATRIAL
COMPLIANCE WITHOUT AFFECTING ITS PRESSURE-VOLUME CURVE
James D. Thomas. MD, John P. O'Shea, MB BS, Vivian M.
Abascal, MD, Frank A. Flachskampf, MD, Igor F. Palacios,
MD FACC, Peter C. Block, MD, FACC, Arthur E. Weyman, MD,
FACC, Massachusetts General Hospital, Boston, HA.
In order to investigate the changes in atrial (LAC) and
ventricular (LVC) compliance caused by percutaneous
mitral valvotomy (PMV) , we studied 10 patients prospec-
tively immediately before and after PMV. Compliance is
taken to be the instantaneous ratio of volume change to
pressure change. Pressures were obtained transseptally
and cardiac output by thermodilution, Mean LAC was
defined as (stroke volume)/(magnitude of atrial V-wave),
and thus is considered to include the pulmonary veins in
a common elastic chamber; mean LVC was defined as (stroke
volume)/(ventricular end-diastolic pressure). RESULTS:
LAC increased by 130% immediately after PHV, from
3.19:1:1.97 cm 3 /mmHg (mean:l:S.D.) to 7.34:1:3.95, p<0.005,
whereas LVC was unchanged, 4.84:1:3.66 cm3/mmHg pre-PMV to
5.01:1:4.08 post-PHV (p - NS). Mean LAC and atrial
pressure data were then used to construct postulated
exponential pressure-volume relationships. The data for
individual patients were well fit by the same set of
curves pre- and post-PMV (r - 0.89). Even the pooled
atrial data from all patients could be fit by a single
pressure-volume curve that held equally well before and
after PMV: PRESSURE· exp(VOLUME/91.9), r-0.62, p<0.01.
The left ventricular data was similarly fit best by a
single relationship pre- and post-PMV: PRESSURE·
exp(VOLUME/35.5). CONCLUSION: PMV causes a significant
increase in mean LAC and insignificant changes in LVC.
These changes appear to result from shifts along a given
pressure-volume curve, rather than any significant change
in the material properties of the chambers.
RESULTS AND FOLLOW-UP OF A MULTICENTER REGISTRY FOR
BALLClCN MI'l'RAL VALVVUlPLASTY Howard C. Herrmann, MD,
J. Patrick Kleaveland, MD, FAcr:., James A. Hill, MD, FAcr:.,
Michael Cowley, MD, FACC, Sheldon Goldberg, MD, FACC,
James Margolis, MD, FAcr:., Andrew Taussig, MD, FACe, George
Vetrovec, MD, FACC, Hall Whitworth, MD, FACC and carl
Pepine, MD, FACe for the M-Heart Study Group.
Philadelphia, PA and Gainesville, FL.
The M-Heart registry for percutaneous balloon mitral
valVUloplasty (PMV) has entered 50 pts in 7 centers with a
mean (~EM) age of 53 + 2 years (range 14-85). All
pts had-heart failure: NtHA class II (n=15), III (n=27),
or IV (n=9). Hem:xlynamic results of PMV'follow (*p<O.OOl,
MVA = mitral valve area):
MVA Gradient CO LA PA
(an2) (!tI11Hg) 1!L'!!!!!!1. l!!!!!!!9l.~
pre-PMV 0.9 + 0.04 15 + 1 4.1 + 0.1, 26! 1 37+2
post-PMV 2.0:! 0.1* 7:! 1* 4.7:! 0.2* l7! 1* 32! 2*
A successful procedure defined as a final MVA ~ 1.2
cm2 and final gradient < 10 nmHg was obtained in 78' of
attempted PMV. Fifteen pts (30') experienc,d complica-
tions including: LV perforation and death (1), cardiac
tamponade (1), cardiac arrest (2), systemic embolisn (4).
Mitral regurgitation grade increased in 7/30 pts (23').
Follow-up was obtained in 39 pts at 6.4 ! 0.7 II'OI'lths.
Restel105is occurred in 5 pts (13'), and was treated wi th
mitral valve replacement (3 pts) or ~ilation. Thirty-
three pts (85') felt improved, including 23 pts who becane
asymptomatic. Mean NYHA class improved fran 2.9 ! 0.1
to 1.5 + 0.1 (p<O.OOOl).
Conelu.iona: 1) PMV can be successfully perfotllled in
the majority of pts, and results in marked clinical
improvement by 6 II'OI'lths of follCM-up. 2) 78' of attEllpted
procedures were successful, but oanplications occurred in
30' of pts and may limit widespread application.
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SUPPRESSION OF CARDIAC PROTEIN DEGRADATION CONTRIBUTES
TO PROGRESSIVE HYPERTROPHY DUE TO AORTIC REGURGITATION.
Norman Magid M.D., Mason Young M.D., Donald Wallerson
M.D., Richard Goldweit M.D., Rebecca Hahn M.D., John
Carter Ph.D., Karen Patrusky B.A., Maribeth Shea M.S.,
Jeffrey Borer M.D., F.A.C.C., Cornell Medical Center,
New York, New York.
Tuesday, March 21, 1989
8:30AM-IO:OOAM, Garden Grove Room
Anaheim Convention Center
Valvular Regurgitation: Factors Affecting
Outcome
We conclude that an increase in total cardiac protein
s)-nthesis occurs only during the early phase of
hypertrophy follOWing acute AR induction, accounting for
the more rapid hypertrophic response during this period.
However, a reduction in cardiac protein degradation also
occurs acutely and appears to be the primary cause of
the slower, progressive hypertrophy occurring one month
following AR induction.
To determine in vivo the contributions of protein
synthesis and degradation to the progressive hypertrophy
occurring after surgical induction of aortic
regurgitation (AR), infusions of 3-H leucine were
performed in 24 rabbits 3 days(3D) and 1 month(1M)
folloWing AR induction, in 12 sham-operated controls,
and in 7 normal rabbits. Total cardiac protein
fractional synthesis(Ka) and degradation(Kd) rates per
day [obtained from subtraction of growth rates(Kg) from
Ka) were calculated from plasma and total cardiac
protein hydrolysate data. Results are expressed as mean
% per day t SO:
RIGHT AND LEFT VENTRICULAR RESPONSE EARLY AND LATE AFTER
SURGICAL RELIEF OF MITRAL REGURGITATION.
Jeffrey Borer M.D.,FACC, Clare Hochreiter M.D., FACC,
Nathaniel Niles M.D., FACC, Mary Roman M.D., Richard
Devereux M.D., FACC, Paul Kligfield M.D., FACC, Cornell
Medical Center, New York, NY.
Previous observations indicate that left(L) ventricular
(V) ejection fraction(EF) falls early after complete sur-
gical relief (MVR) of mitral regurgitation(MR). However,
late responae of LVEF to MVR, and its course of develop-
ment, have not been determined, while response of righteR)
VEF (recently shown by us to be prognostically important
in unoperated MR) is unknown. Therefore, among 21 pts
with successful MVR, we used radionuclide angiography to
prospectively assess LV and RVEF at rester) and exercise
(ex) pre-op, <lyr post-op and annually thereafter for up
to 7 yrs. While LVEFr decreased from pre-op to 5-12 mos
post-op(50% to 47%, p-.057), by end of yr 2 this early
value had increased (+5%,p<.05). Though later improvement
occurred in some pts (particularly with subnormal LVEFr
pre-op), av LVEFr did not vary significantly and at last
follow-up was 52% (p-.3 vs pre-op). In contrast, pre-op
RVEFr rose markedly by 5-12 mos post-op(38% to 46%,p<.01)
and 3% further (p<.05) at later follow-up; RVEFr normal-
ized in all 4 pts who were subnormal pre-op. Late ex res-
ponse to MVR was even more striking: LVEFex-50% pre to
55% post (p<.02); RVEFex-32% pre to 45% post(p~1). We
conclude: MVR for MR can cause early deterioration in LV
performance, but gradual improvement then csn be expec-
ted, with normalization in most patients·by 2 yrs post-
op; in contrast, RV performance improves dramatically
early post-op, with modest later improvement. These
findings may help explain the excellent long term survi-
val we recently reported post MVR even among pts with
























IMRm'AIICB OF 00II1'IACl'ILIT D DB'.i1lItM1II1IG IWr
VBI'l'IICOLAI SIZE AID PBImIIIIWIZ D PATIEIITS Wl'l'B AORTIC
UGOIGITATIOII.
Mark R. Starling, M.D., F.A.C.C., University of Michigan
and VA Medical Centers, Ann Arbor, Michigan.
To deteradne the importance of contractility in
determining LV size and performance before and following
aortic valve replacement (AVR) in Pts with aortic
regurgitation (AR), we studied 26 Pts with AR using
micromanometer LV pressures and radionuc1ide LV volumes
(V) during right atrial pacing. Depressed LV
contractility was defined as 2 standard deviations below
the mean D1BximwD time-varying elastance slope (Emax) of
5.0601.54I111lHg/ml obtained in 25 normal Pts. Prior to
AVR, Pta with AR and preserved LV contractility had
higher LV systolic pressures (p<0.05), _ller LV end-
diastolic and end-systolic Vs (p<0.01 for both), and
higher LV ejection fractiona (58*9%, p<0.05) compared to
Pts with AR and depreased LV contractility (LV ejection
fraction 48012%). In 6 Pts with AR and preserved and 9
Pts with AR and depressed LV contractility, AVR was
performed. In those with preserved LV contractility, LV
end-diastolic and end-systolic Vs and ejection fraction
did not change. In contrast, in the Pts with AR and
depressed LV contractility, LV end-cliastolic and end-
systolic Vs decreased (p<O.Ol for both) and the LV
ejection fraction increased modestly from 49 to 55%.
These data suggest chat, in contrast to Pts with AR and
preserved LV contractility, Pts with AR and depressed LV
contractility may have increased LV size and reduced LV
performance becauae of a contractile-dependent afterload
miSDl8tch. Following AVR, the afterload miSDl8tch is
alleviated and, thus, LV size and performance are no
different at 3 to:6 months following AVR in Pta with AR
and preoperative preserved or depressed LV contractility.
l1l'IL1TY OF IWr VIlII'l'IICQLAR BLAS'l'AlI:B 1U PlEDICTI1IG
SlIICICAL (J(JT(DIB D PATIIlN'l'S Wl'l'B MlDAL 11DIIlG1TA1'IOI.
Mark R. Starling. M.D~, F.A.C.C.. University of Michigan
and VA Medical Centers, Ann Arbor, Michigan.
To determine whether calculating LV e1aatance is useful
for predicting surgical outcome in Pts with mitral
regurgitation (MR), we studied 16 Pts with MR using
micromanometer LV pressures (P) and radionuc1ide LV
volumes (V) during right atrial pacing. LV contractility
was assessed as the D1Bx1DIum slope (Emax) of the linear
regression of multiple, isochronal P-V data points.
Depressed LV contractility was defined as 2 standard
deviations below the mean Emax slope of 5.06~1.54mmHg/ml
obtained in 25 normal Pts. LV contractility was
depressed in 12 Pts with MR and preserved in 4 Pts with
MR. The Pts with MR and preserved LV contractility had
higher LV syatolic P (p<0.05) and _Her LV end-
diastolic and end-systolic Vs (p<0.01 and 0.05) compared
to Pts with MR and depreased LV contractility. In
contrast, they had LV ejection fractions (60*9%) and
(+)dP/dtDIBX (1441t405mmHg/sec) values which were
comparable to those in Pts with MR and depressed LV
contractility (55d2% and 1077~337I111lHg/sec). In 7 Pta
with MR and depressed and 2 Pts with MR and preserved LV
contractility, mitral valve replacement was performed.
In those with preserved LV contractility there was no
significant change in LV end-cliastolic and end-systolic
Va or LV ejection fraction (63 vs. 63%). In contraat, in
those with depressed LV contractility, LV end-cliastolic
and end-systolic Vs increaaed IIIOdestly and LV ejection
fraction decreased (55 to 42%, p<O .01). These data
suggest, therefore, chat using the e1astance concept to
assess LV contractility will be useful for predicting the
LV functional response to mitral valve replacement in Pts
with MR.
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PREDICTION OF RISK FOR COMPLICATIONS IN PATIENTS WITH
LEFT SIDED INFECTIOUS ENDOCARDITIS.
AnthQny J SanfilippQ MD, Michael H Picard MD, Ravin
DavidQff MD, James 0 ThQmas MD, Arthur E Weyman MD FACC.
Massachusetts General HQspital, BQstQn MA.
DetectiQn Qf valvular vegetatiQns (VEGS) by echQcard-
iQgraphy (echQ) has becQme impQrtant in the diagnQsis
and management of infectious endQcarditis (IE). Although
the size of such VEGS has been reported to relate to
prognos is. 1itt1e is known abQut the sign i ficance of
Qther structural characteristics.
To study the relative importance of a number of VEG
characteristics a 5 year computer search was carried Qut
tQ identify patients with the clinical diagnQsis IE who
had an echQ study carried out during their hospital-
izatiQn. These studies were reviewed by experienced
Qbservers blinded tQ the clinical data. The fQllQwing
mQrphologic features were assessed and graded; VEG size,
mobility, extra-valvular extent (EVX) and texture. The
occurence of the following clinical events was deter-
mined by chart review; peripheral and central emboliz-
atiQn, heart failure, necessity Qf valve surgery, and
death. The results of the first 53 patients (34H:19F;
mean age-54.0 yrs) with left-sided native endocarditis
were analysed using lQgistic regressiQn analysis.
RESULTS: VegetatiQn ill and mobil ity were significant
predictors of compl icat ions (p-0.0019 and 0.0113 resp-
ectively) but~ and~ (p - 0.15 and 0.41) were
nQt. An echQ SCQre based on EVX and mobil i ty predi cted
cQmpl icatiQns with even greater pQwer (p-O.OOO7) and
cQrrectly predicted outcome in 7~ Qf cases.
CONCLUSIONS: The mobility and extra-valvylar extent of
vegetatiQns as assessed by echo predict the Qccurence of
cQmplications in patients with IE, but vegetation lin
and~ do not. A score can be derived which is
highly effective in predicting complications.
ECHO-DOPPLER VS CARDIAC CATHETERIZATION IN THE
DECISION TO OPERATE ON MITRAL VALVES
~ ~ Gindea, M.D., James Slater, M.D.,
F.A.C.C., Larry A. Chinitz, M.D., F.A.C.C.,
Robin S. Freedberg, M.D., F.A.C.C., Ephraim
Glassman, M.D., F.A.C.C., Andrew Goldfarb, M.D.,
Barry P. Rosenzweig, M.D., F.A.C.C., Paul A.
Tunick, M.D., F.A.C.C. Howard E. Winer, M.D.,
F.A.C.C., Itzhak Kronzon, M.D •• F.A.C.C. New
York University Medical Center, New York, New
York.
One hundred and forty nine consecutive pts
referred for cardiac catheterization (C) for
mitral and/or aortic valvular disease underwent
Doppler-echocardiography (DE). The decision
concerning operating on the mitral valve (MV)
was made twice for each pt by blinded,
clinically experienced cardiologists: once
using clinical plUS DE data (Method A), and once
using the same clinical data plus C data (method
B). Using Method A, a decision was reached in
139/149 pts (93%) which agreed with the decision
by Method B in 119/149 (80%). This included the
decision to operate on 32 and not to operate on
84 valves. Decisions differed in 20/149 (13%) •
In 10 pts (7%) a decision could not be made by
Method A. Estimation of the degree of mitral
regurgitation (MR) in 17 pts was the major cause
of differences between the two methods (DE>C in
7, C>DE in 10).
CONCLUSION: In 139/149 (93%) of pts, decisions
could be made using clinical and DE data alone
Which was unchanged by C data in 119/149 (80%)
of these pts. Grading of MR appears to be the
main reason for differences in the decision.
Tuesday, March 21, 1989
10:30AM-12:00NOON, Garden Grove Room
Anaheim Convention Center
Valvular Heart Disease: Diagnostic Methods
'IlIE: stmGlCAL FATE 'or MI'I1lAL RmJRGlTATI~ ASSOCIATED WI'IIf
SEVERE J\ORTIC STl!H>SIS: AN INl'RAOPERATIVE ECH) S'!UDY.
Bruce P. ltindich, M.D'ia!.A.C.C., '1heresa Guarino, 11N,
Scott Lazar, JOhn Fot! 5, Alldr_ Rothschild, Laura
Andreae, M. Hasan Jethabhai, Martin E. Goldlllan,
M.D.,F.A.C.C., St. Luke'5 Hospital, New York, New York.
Frequently, severe aortic stenosis (AS) is accompanied
by significant mitral regurgitation (MR) which may be
primary or functional due to markedly elevated systolic
intracavitary pressure or LV dysfunction. Though
preoperative assesSlllent cannot determine the severity of
residual fIR once the AS is relieved, potentially
intraoperative 2-D echo (IO!!:) could better define
valvular pathology and assess MR at lower afterload
conditions. 'l1lerefore, we performed epicardial IO!!: with
contrast and/or color flow i-aging i..ediately prior to
the aortic valve procedure (valve replacement or
decalcification), following the procedure (pt off bypass)
and at 6 month follow up to detemne degree of residual
MR. Baseline IO!!: (Interspec and A'l'L, tJII-6) MR was graded
based on contrast or color filling of left atrium in long
and short axis vi-a. Fifty-five pts had both
significant AS and MR; all underwent aortic surgery.
40/55 (73') required initial aitral surgery. However,
9/55 (16') who had miltH1x!erate MR and 6/55 (1n~ who
had IIIOderate-severe MR by catheterization but only
mild-moderate MR by lOE, did not undergo aitral surgery
because of no praary pathology of the IIitral valve
and,Ilesa MR by lOE than by preop catheterization. At 6
month follow up, only 1/15 pts had developed -are
significant MR. 'l1lerefore, intraoperative 2-D echo with
color or contrast can significantly alter the operative
outcc.e of COIIbined aortic stenosis and Mitral
regurgitation reducing surgical duration, risk and
postoperative complications.
ALTERED LEFI VENTRICUIAR DIASTOLIC FILLING DUE TO ACUTE
RIGHT VENTRICUIAR VOUlKE OVElW>AD FOLLOVING TRICUSPID
VALVULECTOKY. A PULSED DOPPLER. ECHOCARDIOGRAPHIC STUDY.
Eric K. Louie. M,D . F.A C C , Teresa Bieniarz, B,S"
Anna Marie Moore, B,A., Sidney Levitsky. M.D.,F.A.C.C,.
Loyola U" Maywood IL & U of IL, Chicago IL.
Tricuspid valvulectomy (TVV) for isolated tricuspid
endocarditis provides the opportunity to study the
effects of acute RV volume overload (RVVO) on LV
filling in pts with intrinsically normal LV function.
Using pulsed Doppler and 2D echo we assessed
transmitral filling and LV geometry in 11 TVV pts (mean
age 33±8y) and 11 age matched controls (CTRL). RVVO in
~ resulted in progressive leftward shift of the
ventricular septum throughout diastole such that the
eccentricity index of the LV (minor axis parallel to
the septum/minor axis perpendicular to the septum)
increased from 1.07±0.09 at end-systole to 1.30±0.22 at
mid-diastole (p < 0.01) and remained significantly
deformed at end-diastole (1.35+0.13). In contrast CTRL
had no significant change in e~centricity index from
end-systole (1,00±0.05) to mid-diastole (1.03±0.09) and
at end-diastole the short axis profile of the LV
remained circular in shape with an eccentricity index
(1.03±0.10) significantly less than that found in TVV
(1.35± 0.13, p < 0.001). The late diastolic compression
of the LV which occured in TVV pts resulted in a
significant reduction in the LV late diastolic filling
fraction (0.22±0.11) when compared to CTRL (0,32±0.09 p
< 0,05) and a redistribution of LV filling to early
diastole (LV early diastolic filling fraction: TVV
0.78±0.11 v. CTRL 0,68±0.09, p < 0.05). Thus RVVO due
to TVV results in late diastolic ventricular septal
deformation and impaired late filling of the LV with
atrial systole.
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TIlE GORLIR FORIIILA FOR AORTIC VALVE ORIFICE AREA
VALIDATED IR VIno
Duid Spridnp IIICP. lohn CbaJlbers IIICP, '"'-.-
Cochrane PhD, lohn Allen IIICPatb, Martin Blecll PhD,
Grahaa 1acllllOl1 FReP. Cardiac Dept, I1OS' s Colles-
Hospital, London SE5 9RS, UK.
Calculation of orifice area (QA) using tbe Garlin
fora&1a is regarded as the SOld standard for
quantifyiOS the severity of aortic stenosi.. However,
the foraula has rarely been tasted against direct
_ur_t of 01.. ... therefore studied 9 h_ aortic
val"es obtained at necropsy (rangina frc. noc.al to
.."erely stenotic) and 4 bioprosthetic valYeS in a
cosputer-controlled, positive-displac..-nt pulse-
duplicator. Maxi_ 01. __ plani_tered frOil
si_Uanaous video recordings. Each "alve __ studied
at 3-5 systolic flow rat_ rangina frOil 130-340 Ills/sec
at a cycle rate of 70 bpa givios 57 data points. QA
(rense 0.3-2.8 c~) end ..an systolic pressure drop
<JI'D) (rangs 3-84 ..as) "aried directly witb flow (Q),
For individual "alves, the incr_ in QA frc. l~t
to bighest flow rensed frOll 11-10n. QA correlated
_11 witb Q/11I'D (r =0.93, P (0.00000. 1be
espirical Garlin constant, calculated frOll the fonsula
(Q/J MPD)/(44.3 x QA), for each set of observations NaS
1. 2 ~ 0.3 (_en t SO) and __ only waIIly correlated
witb flow (r =0.3), NeD (r =0.4) and 01. (r =-0.3).
we conclude thet orifice area is accurately
predicted by the Gorlin foraula over a wide range of
systolic flows in aortic valves in "itro. The
correction factor in c~ use is too low and this .y
explain why tbe Garlin fonsula o"eresti.t.. relati98
to the continui ty equation.
ABSTRACTS
VALIDATION IN PHYSIOLOGIC PULSATILE FLOW OF A
NEW METHOD FOR NONINVASIVE QUANTIFICATION OF
VALVULAR REGURGITATION BASED ON CONSERVATION
OF MOMENTUM .
Edward G. Cape. BSChE. Ajit P. Yoganathan, PhD, Elias G.
Skoufis, BSChE, Liisa Rihko. Robert A. Levine, MD, FACC.
Massachusetts General Hospital, Boston, MA
The assessment of regurgitant volume (RVOL) from Doppler (D)
flow maps is limited because visualized jet volume (NOL) ;&
RVOL+entrained fluid, and NOL critically varies with driving
pressure and instrument settings. An equation has therefore been
derived from the principles of turbulent jet flow to quantL
RVOL from velocities VEL directl measurable 6 D. use
momentum IS conserv or Tee Jets, as more mass IS entrained,
VEL fiills. This pnnclple yields an equation for RVOL in tenns
of maximum jet VEL. a distal centerline VEL and the intervening
distance. This equation was derived most properly for~t~y
flow. The purpose of this study was to detennine its~1It in
pliYsiologic pulsatile flows and its ability to calculate ow
rale (Qpeak) and total RVOL. by correcting Qpeak for t tlme-
course of orifice VEL. A physiologic pulse duplicator was used
to drive flow through .08-.2 sq em orifices at peak rates of
1.2-4.5 t/min (7-169 mm Hg gradients). Peak orifice and
downstream VELs were measured by continuous (CW) and pulsed
o to calculate Qpeak; RVOL was obtained from Qpeak and the
time-velocity integral of orifice VEL by CWO. These were
compared with electromagnetic flow probe data. RESULTS: By
linear regression. calculated and actual flows agreed well (Qpeak:
y = 1.02x+.03. r = .98. SEE = .2 I/min: RVOL: y =
1.02x+.58, r = .95. SEE = .8 ml: n = 42). Results were not
significantly different at various downstream sites (p > .O~i).
CONCLUSIONS: For free turbulent jet resemblin~many cardiac
lesions. despite the presence of PR~tre physiologiC flows and
pressures. both ap?k and total can be calculated from 0
VELs without p anlmetry of let area.
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THE GORUN FORMULA: IS THE TRADmONAL METHOD OF
CALCULATING TIlE PRESSURE GRADIENT ACCURATE?
John P. O·Shea. M.B.B.S .• F.R.A.C.P.. James D. Thomas. M.D.• Vivian
M. AbascaI. M.D., Frank A. Flachsk8mpf, M.D.. Igor F. Palacios. M.D.•
F.A.C.C., Peter C. Block. M.D.. F.A.C.C.• Arthur E. Weyman. M.D.,
F.A.C.C. Massachuselt5 General HO'pital. BoslOn. MA.
The Oornn equation. the standard method for calCUlating mitral valve area
(MVA) at cardiac catheterization. typically uses the square root of tbe mean
pressure gradient in ib denominator (Method A). However. basic principles
of nuid dynamics suggest that the mean of the square roob of multiple
instantaneous pressure gradienb (Method B) is more accurate and tbat any
discrepancy will be mO't marked wben the end-diastolic gradient (EOG) is
low. Tbis prediction has been confirmed in an in-vitro model of mitral
stenosis: when the EOG is close to zero. Method A underestimates a given
orifice area by up to 14%. whereas in the event of the EOG being 50% of
the peak gradient. this error reduces to only 2%. To investigate the practical
significance of Ihis observation. we prO'pectively studied 10 consecutive
petienb undergoing percutaneous mitral valvuloplasty (PM¥). by the
anterograde trans!eptal approach. recordln, simultaneou! LA and LV
pressure tracings immediately before and after PMV. together with cardiac
oulpub at each stage. The pressure tracings were digitized. the trans-mitral
gradient was calculated. at 5 msec intervals and the mean gradient calculated
by both Method A and Method B. Five cycles. pre- and post-PMV. were
analyzed for patienb in sinus rhythm and ten for those in atrial fibrillation
and the resulting mitral valve areas. calculated using the Oorlin formula.
were compared. RESULTS: Method B resulted In a significantly larger
Oorlin mitral valve area Ihan Method A, the discrepancy being more marked
immediately post-PMV (mean MVA: 2.21 + 0.21 cml vs. 1.85,± 0.18. P
< 0.0008) than pre-PMV (0.97 .± 0.07 c~ vs. 0.93.± 0.9. p < 0.003).
This discrepancy resulted in a significantly greater increase in MVA PO't-
PMV by Method B (1.24 + 0.25 cm2 vs. 0.92.± 0.22. p < 0.002). and
appeared to be related to lbe lower EOG in the post-PMV group.
CONCLUSIONS: Mitral valve area may be significandy underestimated if
calculated by the traditional Method A. This has Important implications for
procedures, such as PMV, where estimation of mitral valve area is critical in
guiding clinical declsion-maldng.
HYPERLIPIDEMIC VALVULOPATHY: AORTIC REGURGITATION IN
FAMILIAL HYPERCHOLESTEROLEMIA STUDIED BY COLOR DOPPLER
ECHOCARDIOGRAPHY
Akito Kawaguchi M.D, Kunio Miyatake M.D, Shintaro Beppu
M.D, Fumio Omori M.D, Masakazu Yamagishi M.D, Chikao
Yutani M.D, Shinji Yokoyama M.D, Akira Yamamoto M.D,
Yasuharu Nimura M.D.
National Cardiovascular Center, Suita Osaka, Japan
Homozygous familial hypercholesterolemia (FH) frequently
showed significant valvular regurgitation associated
with cholesterol infiltration to the valve leaflets. To
study this "hyperlipidemic valvulopathy", 38 patients
(pts) with FH, including 3 homozygotes (serum LDL level
>1000 mg/ d 1) and 35 heterozygotes (500<LDL< 700 mg/dl),
ranging from 9 to 58 years, were examined by color flow
imaging technique (Toshiba SSH-65 A). Clinically healthy
30 subjects were also examined as a control. Aortic
regurgitation (AR) was demonstrated in 10 pts (26.3%), 2
of homozygotes and 8 of heterozygotes. Only a homozygote
who was treated by plasmaexchange to maintain the
cholesterol low level (<300 mg/dl) did not show AR. In
contrast, AR was found in 1 of 30 controls (3.3%,
p<0.05). Two-dimensional echocardiography showed mor-
phological abnormalities in only 4 pts who showed slight
enhancement of valvular echo images. Severity of AR was
moderate in 6 and mild in 4 pts, and it was related to
the serum LDL levels. None of pts with AR have any other
factor resulting in AR. Mitral regurgitation was found in
15 of 38 pts (40%) and 8 of 30 controls (27%, N.S.).
Conclusions: (1) The higher incidence of AR in FH was
documented by color flow imaging technique. (2) Severity
of hyperlipidemic valvulopathy is correlated with the
serum LDL levels. (3) Color flow imaging is sensitive
method to detect valve involvement in FH which was not
detected by conventional 2-dimensional echocardiography.
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Surgery for Congenital Heart Disease
CORONARY BLOOD FLOW AND HEMODYNAMICS DURING EXERCISE
AFTER THE CORONARY ARTERY BYPASS GRAFTING WITH THE
INTERNAL MAMMARY ARTERY FOR KAWASAKI DISEASE
Kawachi K M.D., Kitamura S M.D., Seki T M.D., Kobayashi
H M.D., Morita R M.D., Nishii T M.D., Taniguchi S M.D.,
Inoue K M.D., Nara Medical College, Kashihara, Japan.
The subjects of the present study were 12 pediatric
pts with Kawasaki disease(avg. age 8.7±3.0) who underwent
coronary bypass surgery(CBS) employing the internal
mammary artery(IMA). Hemodynamics during exercise(Ex)
were measured with a bicycle ergometer, and coronary
sinus flow(CSF) was measured by the continuous thermo-
dilution method. The average number of coronary bypass
grafts was 2.3±0.7 per pt. For all pts, the left IMA
was anastomosed to the left anterior descending artery;
for 5 pts, right IMA was also anastomosed to the right
coronary artery. In addition, 10 saphenous vein grafts
(SVG) were used. The postoperative patency rates after
one month were 100% with IMA and 91% with SVG. One
year after the operation, the patency rates showed 100%
with IMA and 50% with SVG(p(O.05). The results of hemo-
dynamic measurements showed no significant differences
between preoperative stroke volume index(SVI) at resteR)
and during Ex. However, postoperatively, SVI during
Ex increased. The relationship between 6LVEDP( the dif-
ference between LVEDP at R and during Ex) and lISWI(the
difference between the stroke work index at R and during
Ex) was analysed. Four pts out of 6 showed reduced
cardiac function preoperatively(lILVEDP~plus,lISWI-minus).
However, after the operation, 5 pts out of 6 demonstrated
improvements in cardiac function during Ex( lILVEDP=plus,
lISWI=plus). CSF per unit LV mass increased postopera-
tively from 70±46 to 87±56 ml/min at R, and 139±118 to
l83±150 ml/min during Ex. Conclusion: The results of
this study revealed improvements in both hemodynami~s and
CSF during Ex after CBS with lMA for Kawasaki disease.
BIDrmcrrCNALCA~ ANAS'II:'M:SIS.
Antario CoIn> M.D., F.A.C.C., &nio lobzzera M.D., Bnn:> Milrino M.D.,
Sergio Picard:>, M.D.. Carlo !>tlrcelletti, M.D.; Q;pedal.e Bartlino ClEsJ,
TbTa, Italy.
Fran February 86 to Mm:tl ffi 22 J:9.tients (pts), mean "fi!!'3 yrs 8 mas
(4 rroe-13 yrs), mean ..eiglt 14.3 Kg (5-36 Kg), l.I'Xlenoe1t bidirectic:nal
cavo-p.Wrcnary emstarosis for carplex cy;nrt;ic oc:ngenital heart disease
The ~is _ in 4 pts left isaneri3ll with p.iliralary sta'x:6is (PS),
in 4 rigpt iscmerisn with PS, in 4 p.iliralary atresia (PA) with intact
ventrio..Uar sepu.m, in 4 llliventrio..Uar heart with !'S, in 3 oc:ngenitally
oarreeted transpositim of the great arteries with PA, in 2 cbJble wt>-
let EN with !'S, in me tricuspid atresia with !'S. Nine pts had persi-
stent left superior vena cava ard 2 pts azyp ccntinuatim. The croice
for this J:e.l1iative~ _ clIe in 8 pts to the "fi!!' (less tha1 2
yrs), in 5 anooalcos VEl1COS rewm, in 4 distarticrt of the p.iliralary
arteries, in 3 a,JV valve reg.Jrgit8ticrt, in 2 failure or a Fcrtta'l proce-
cilre. In 15 pts a bidirectic:nal cavo-p.Wrcnary a'laStarosis _ perfor-
med, in 7 pta the anastomosis _ bilateral bidirecticrtal. There ..ere
ro h:Jspital deaths ard 2 late deaths (2/22 = 9.1%) in a mean follCl\\'-l4l
of 15.7 mas (4-28 mas). All survivors are clinicaJ..1,y inproved, with a
mean arterial CQ saturatim :in::reased fran 75.2i6 to 85.Jl': 11/19 (= !:$)
pts are taking digDdn cnl/or diuretics. Img scin~ _ perfOI'-
med in 13 pts ard carcIia= catheterizatioo in 9, in all of them showing
bilateral lu1g pe!'fusioo. Cax:lusi.a1s: in pts reQ.Ji.ring increase of the
effective p.iliralary blood f104' with red.lCtioo of the cardiac volune 0IIe£
load, the bidirectic:nal cavo-p..Unr.mry anastomosis, with 1.cM martality
a1d m::>ri)idity, waI'f'a'lts clinical irrproverra1t avoiding distartioo of the
p.iliralary arteries ard al.l.o...mg oornal vernJS pressure in the corcrtary,
hepatic a1d renal sysb!m, a1d maintains the possibility for f\Jrttler
surgical~.
DOUBLY-COMMITTED SUBARTERIAL VENTRICULAR SEPTAL DEFECT:
AN ELEVEN-YEAR EXPERIENCE
Merrick, S.H., Verrier, E.D., Hanley, F.A., Turley, K.T.,
Ebert, P.A., University of California, San Francisco
From 1977 to 1988, 36 patients underwent surgical repair
of a doubly-committed subarterial ventricular septal de-
fect(DCS VSD); this group represented 5.2% of 689 VSD re-
pairs performed at our institution during that interval,
(23 males and 13 females, aged 2 months to 46 years).
Eight patients(22%) were repaired during the first year of
life due to progressive congestive heart failure and pul-
monary hypertension, secondary to significant left-to-
right shunting. After age 1 year, pulmonary hypertension
was uncommon, but aortic insufficiency(AI) was present in
18 patients(50%) and cusp prolapse in 13 patients(36%). A
significantly wider pulse pressure and severity of AI was
seen in the second decade of life. Two-dimensional echo-
cardiography correctly identified the pathophysiology in
all but 1 patient. The DCS VSD was repaired with a Teflon
patch in 32 patients(89%); other procedures were primary
repair(I), aortic valvuloplasty(I), valve replacement(l)
and palliative PA band(I). Two patients required a patch
and aortic annuloplasty to restore aortic competence. No
operative or late deaths occurred. Postoperatively, there
was 1 residual VSD and 2 patients had mild AI. Our results
confirm the DCS VSD is unlikely to close spontaneously.
Echocardiography has replaced catheterization at our in-
stitution for diagnosis and follow-up of these patients.
Surgical repair can be done safely in infants to prevent
failure and irreversible pulmonary hypertension. In older
children and adults, correction is justified to prevent
valvular damage and progressive AI. Simple patching o~ the
VSD with or without annuloplasty, will give excellentres~lts in the majority of patients and valve replacement
is rarely required.
NEOIlATAL REPAIR OF FALLOT'S TETRALOGY WITH AND WITHOUT
PULMONARY ATRESIA
Roberto DiDonato M D" Richard A. Jonas M.D., Peter Lang
M.D., Jonathan J. Rome M.D .• John E. Mayer M.D., Aldo R.
Castaneda M.D., Children's Hospital. Boston, MA
Neonatal repair is the logical extension of the
trend to earlier corrective surgery for congenital heart
disease and is already practised routinely for d-
transposition of the great arteries at our institution.
We have previously demonstrated that early repair of
Tetralogy of Fallot minimizes secondary organ damage and
late ventricular ectopy and particularly in the case of
pulmonary atresia, may improve pulmonary angiogenesis.
We examined the results of surgery among 26 symptomatic
neonates who underwent repair of tetralogy with (12) or
without (14) pulmonary atresia between 1973 and 1987.
Mean age was 8.2 days and mean weight 2.9 kg (1.3 - 4.2
kg). Unsatisfactory palliative shunts had been placed
previously elsewhere in 4 patients. Twenty-four
transannular patches and two conduits were placed. There
were 5 hospital deaths (2 with pulmonary atresia)
including two avoidable technical problems. All d~at2s
occurred with pulmonary artery area index < 150 mm 1m .
One premature child weighing 2.3 kg developed an absent
pulmonary valve-like syndrome and died late from
respiratory complications caused by aneurysmal branch
pulmonary arteries. Late catheterization in 16 of 20
survivors showed RV pressure less than half systemic in
12. All patients are symptomatically well and in sinus
rhythm I-IS years after repair. We infer from this
selected group of sick neonates that satisfactory short
and longterm results may be achieved by neonatal repair
of tetralogy of Fallot
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EXPERIENCE WITH THE FONTAN PROCEDURE
Hillel Laks, M,D., Jeffrey Pearl, M.D., Barbara George,
H.D., Alex Wu, B.S., Thomas Santulli, H.D., Roberta
Williams, M.D., UCLA Medical Center, Los Angeles, CA.
From 11/78 to 9/88, 143 patients underwent a Fontan
procedure for a variety of congenital cardiac defects.
There were 50 patients with tricuspid atresia (TA), 86
patients with univentricular heart, 6 patients with
pulmonary atresia and intact ventricular septum, and one
patient with hypoplastic left heart syndrome who had
preViously undergone a Norwood Stage I procedure. The
mean age was 8.7 years (8 mos- 463 mos). The mean
pulmonary artery pressure was 1St 7NmHg (5-72mmHg) pre-
operatively with a Qp/Qs of 1.5t 0.7. The pulmonary
vascular resistance was 2.0t 1.5 Wood units (0.17- 7.9
Wood units) preoperatively and mean LVEDP was 9t 311111lHg
(3- 20mmHg). The early mortality, deaths less than 30
days and all hospital deaths, was 9% overall. In the TA
group there were 3 early deaths among 50 patients
(mortality· 6%). There were 8 early deaths (mortality.
9%) in the 86 patients with univentricular heart. In the
130 hospital survivors there have been 3 late deaths
(mortality. 2.3%) in a mean follow-up of 40 months (2-
117 months). Hence, the combined early and late mort-
ality for the Fontan operation is 11%. Twenty-six pts.
required the use of a venous assist device postoper-
atively and 3 required intra-aortic balloon pumps; the
mortality among this group was 31%. Conclusions: 1, the
Fontan procedure can be performed with a relatively low
operative mortality; 2, late results are excellent with
a late mortality of only 2.3%; 3, the use of a venous
assist device can be beneficial in the early postoper-
ative period in patients with RA hypertension and low
cardiac output.
COLOUR FLOW IMAGING AS INTRA-OPERATIVE ANGIOGRAPHY IN
VENTRICULAR SEPTAL DEFECTS - ADVANTAGES AND PITFALLS?
George Sutherland M.D., John Smyllie M.D., Jos Roelandt
F.A.C.C., Marc van Oaele M.D., Jan Quaegebeur M.D.,
Thoraxcenter, Rotterdam, Netherlands.
51 patients undergoing surgical repair of one or more
ventricular septal defects (VSO) were studied by
epicardial echo both immediately pre and post
cardiopulmonary bypass. 2-D echo, contrast echo and
colour flow imaging (CFI) were performed to determine
,whether a combination of these techniques could reliably
predict 1) successful VSO closure, 2) further
unsuspected VSOs, or 3) any resultant complications. 2-D
echo alone detected a patch dehiscence in 1 pt. Post
bypass CFI demonstrated, well localised trans or
peri-patch VSO jets in 26/51 pts (multiple jets 16/26).
In none did contrast echo suggest a significant shunt.
Early and late post op studies demonstrated the
disappearance of 'the narrow jets in 24/26 pts. This
invariably occurred by 6 hours post bypass. In a
further 4 pts broad extensive CFI VSO jets were
immediately identified in all of whom contrast
echocardiography suggested an interventricular shunt. In
none of these cases was bypass recommenced as the defect
appeared small. Post-bypass, further significant distal
VSOs (undetected by pre-op angio) were noted in 2 pts
and bypass was recommenced to effect closure. Late patch
dehiscence was clearly defined in a further 3 pts. We
conclude that a combination of 2-D echo, contrast echo
and CFM can provide the surgeon with an accurate intra
operative monitoring technique which can both confirm
defect closure and exclude the presence of singificant
and residual VSOs.
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Atrial Naturetic Factor and Inhibitors
ATRIOPEPTIDASE INHIBITORS, A NOVEL CLASS OF
DRUO 'mAT RAISES LEVELS OF ENDOGENOUS
ATRIAL NATRIURETIC FACTOR· nm PRECLINICAL
PHARMACOLOGY OF UK-69,578
OM.R. Smnuels BSc PhD, P.L. BlJ'clay BSc PhD,
CJ. Peters BSc PhD, P.EIIia BSC PhD
Pf1Ze1' Central Research, Sandwich, U.K.
UK-69,578 (Cis-4·11.[2-elll'boxy-3-(2-methoxyethoxy)
propyl)-l-eyclopentaneclll'boxamido}-l-eyclohexanec~xylic
acid), (UK), is a potent, selective inhibitor (Ki 3.6 x 10- M) of
atriopeptidue (Be 3.4.24.11), thetlte limitinI enzyme in the
breakdown of atrial natriuretic factor (ANP) by renal
homo,enates. We describe here some biochemical and
physiological consequences of atriopeptidue inhibition in viro.
UK (3 mgI!t, LV.) prolonp the half=liIe ofexo'erlous APm m
nonnal (0.72 min to 1.02 min) and in nephrectomised (0.96 min
to 2.52 min) anaesthetised rats, indicating important extra-renal
locations of this enzyme. The compound (0.3 milk, i.v.)
potentiates the diuretic and natriuretic responses (lt4) to APm
(50 ng/JcJ/min i.v. for 10 min) in anaesthetised rats, and (at 10
milk, iv.) to endogenous ANP released by an acute saline load
(20 m1/hIrat iv.). In the latter model, this enhanced natriuresis,
unlike that induced by hydrochlorodliazide, is substantially
reduced by ANP antibodies, clearly indicating a different
mec:hanism ofaction of the two &lenI3. In conscious
spontaneously hypertensive rats maintained on a high salt
intake, UK (10 rng.tkg/day via a minipump) causes an enhanced
diuresis and natriuresis over the 7 day study, with a
concomitant increase in plasma ANP levels (x6) and a decrease
in plasma aldosterone levels (50%). Thus UK clearly illustrates
the physiological impact of modest elevations ofendogenous
ANF.
nm EFFECT OF UK-69,578, AN ATRIOPEPTIDASE
INHIBITOR, IN A CONSCIOUS DOG MODEL
OF CARDIAC INSUFFICIENCY
C.T.~ BSc PhD, I. Machin BSc,
P.L. B8lC&YSc PhD, a.MR. Samuels BSc PhD
Pfizer Central Research, Sandwich, U.K.
UK-69,578 (Cis-4-II-[2-el1l'boxy-3-(2-methoxyethoxy)
propyl)-l-cyclopentanecarboxamido}-l-eyclohexaneclll'boxylic
acid) (UK) is a potent, selective inhibitor of~ (BC
3.4.24.11) thereby reducina the breakdown ofatrial natriuretic
factor (ANP) both in vitro and in vivo (Smnuela !!..!l, this
meetinJ). This stu~besthe renal and hormona1 effects
of UK administration to cooscious dogs with atrioventricular
helrt block. a model of low output cudiac insufficiency with
circulatin, ANP levels higher than those found in nonnal dop.
UK, over the dose range of 0.5 to 3 mgIItg (iv.) produced dose
related natriuretic and diuretic responses peakinJ at I to 2 h and
still evident 4 h after dose. At 3 mg/kg (n=5) there was a
doublinJ of circulating ANP, and a ten fold increase in urinary
excretion of ANP. both effec:tl beina maximal 1 h after dose.
There wu DO change in plaama renin activity (PRA). In
conaut, hydrochlorothiazide (0013), at an equinatriuretic dose
level, caused DO change in ANP levels whereas PRA increased.
The enhanced excretion of sodiwn and water, without
activation of the renin axis, u demonstrated with UK, sugeats
therapeutic potential for this clus of &lent in bean failure.
75r.
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THE AClITE AND CHRONIC ANTIHYPERTENSIVE
EPPICACY OF ATRIOPEPTIDASB INHIBmON IN RATS
O.M.R. Samuels BSc PhD, P.L. Barclay BSc PhD,
NoB. SheppelllOl1 BSc PhD, I.A. Bennett BSc PhD.
Pfizer Central Research, Sandwich, UK.
UK-69,578 (Cis+l1-[2-carboxy-3-(2-methoxyethoxy)
propyl]-l-cyclopentaneearboxamido)-l-cyclohexll1eCalboxylic
acid) is a potent, selective inhibitor ofatriopeptid.- (BC
3.4.24.11). It raises circulatina atrial natriuretic flCtor (ANF)
levels in vivo, II1d potentiates the diuretic II1d natriuretic
responses to exogenous II1d endogenous ANF in rats and dogs
(Samuels et ai, this meeting). We describe here its
antihypertensive efficacy in I-kidney DOCA-salt rats (DOCA-
R). UK-69,578 (10 mgIkg i.v.) significantly reduced blood
pressure by some 30 mm Mg, the effect being well maintained
through 4 h (n-9 animals). At 3 ma:/ki Lv., the effect wu less
pronounced II1d of shorter duration. Using UK·74,816 (an
orally active indanyl ester of UK-69,578) we investiglUed the
effect ofchronic atriopeptidue inhibition on the development
of hypertension in DOCA-R. UK-74,816 (3 mi/kg p.o. once
daily, first administered 24 h post surgery) substantially
reduced the rate of development of hypertension, II1d
significantly reduced the blood pressure reached 29 clays post-
surgery (mean increue 51 ±7 mm Hg 0-9) in comparison with
vehicle treIUed control animals (mean increase 79 ±8 mm Hg
n-10). All blood pressures were meuwed 18 h post-dose.
This antihypertensive effect wu assocWed with an increase in
plumaANFlevels (1038 ±364 pg/ml vs 542 ±190pg/ml), but
evidence ofdependence on ANF awaits completion of further
studies. Thus administration of an atriopeptidase inhibitor not
only decreases blood pressure acutely, but on chronic
administration markedly reduces the development of
hypertension in DOCA-R, suggesting therapeutic potentisl for
this clus of .,em.
Aa11'E EF'F!D'S OF A'DUOPEPTIDIlSE Il'lHIBITUJf (I(~
A'.nUAL NM1UURE'1'IC FACl'CR IN amaac HEARl' FAILURE.
David B Northridge foB MRCP, lain N Findlay foB MRCP,
Alan Jardine foB MRCP, Stephen G Dilly foB and Henry J
Dargie foB FRO'.
Deparbnent of cardiology, western Infizmary, Glasgow.
Inhibitial of atricpept:idase raises plasna levels of
atrial natriuretic factor (ANF) in animals and rormal
tunan volunteers causing diuresis and natriuresis. we
report the first study of a new atriqJeptidase
inhibitor (UK 69,578; Pfizer central Research) in
chrt:n1c heart failure (0iF).
UK 69,578 was adnini.stered as an intravenous infusicn
in a place1:x> ocntrolled, cross-over fashicn to 6 male
patients with stable LV dysfuncticn (mean [~] LV
end-diastolic dimensicn 65 [57-73] JIIlI). Plasna ANF was
elevated at baseline, mean (SO) 84 (53) pg/ml, and
:rose further to a peak of 275 (322) pg/ml, 1 00ur
after active drug adninistraticn (P<O. 05) • This was
accarpanied by a fall in plasna active renin fran 61
(48) to 35 (21) uU/ml (P<0.01), and a dose dependent
diuresis and natriuresis. Nc:n-invasive haem:xiynamic
nr:nitoring revealed ro~ in heart rate, arterial
blood pressure or echx:ardiograpuc LV dimensicns.
K:Jwever, invasive measurements using a Swan Ganz
catheter da'Cllstrated falls in right atrial pressure
f:ron 6.1 10 4.2 1IIlflg, and pulm:nary artery wedge
pressure f:ron 9.3 to 6.9 nnag following UK 69,578,
with ro ~ in CO. No such~ occured
following placebo.
'Itlus in mild 0iF, UK 69,578 elevates plasna ANF with
associated diuretic, natriuretic and vencdilator
effects, l::ut wittnlt stinulating renin secreticn.
Atricpept:idase inhibitors therefore represent a
potential therapeutic advance.
PHARMACOLOGICAL ELEVATION OF ENDOGENOUS ATRIAL
NATRIURETIC FACTOR IN MAN USING THE ATRIDPEPTIDASE
INHIBITOR (UK 69578).
Alan Jardine MB MRCP, John MC Connell MD MRCP. Stephen G
Dilly MB PhD. David Northridge MB MRCP. Brenda Leckie PhD.
N.J. Cussans PhD. Anthony F Lever MB MRCP, MRC Blood
Pressure Unit. Western Infirmary, Glasgow, UK.
Atrial natriuretic factor (ANF) is a peptide hormone with
vasorelaxant, natriuretic and diuretic properties. UK
69578 (C20,H33.N07) is a novel compound developed by
Pfizer Central Research (UK) which inhibits breakdown of
ANF by the endopeptidase EC3.4.24.ll ('atriopeptidase')
and elevates plasma ANF in experimental animals. In this
first administration in man, 16 normal male volunteers
received 3 doses of intravenous UK 69578 plus placebo in
a study covering the dose range 0.025-10.0 mg/kg. UK
69578 was well tolerated in all subjects, with no
adverse effects. Blood pressure, plasma electrolytes and
haematocrit were unchanged. The plasma half life of UK
69578 was 1.1 hours. volume of distribution O.25L/Kg.
clearance 2.7 ml/Kg/min. There was a dose dependent
increase in plasma ANF with a peak of 2-3 times basal
values by 2 hours post dose returning to normal by 8
hours. After 2mg/Kg UK 69578 ANF rose from 23.4 (3;1) to
45.8 (6.2) pg/ml at 2 hours [mean(SE).P<O.Oll. Plasma
levels were unchanged following placebo. There was an
associated diuresis and natriuresis with 8 hour urinary
Na excretion rising from 88.0(8.0)mmoles after placebo to
133.6(5.3) after 2 mg/Kg[P<O.Oll. Urinary K was unchanged
and the natriuresis was not accompanied by a rise in
renin angiotensin II or aldosterone, UK 69578 is a new
class of agent which. through elevation of endogenous ANF
produces diuresis and natriuresis without stimulation'of
the renin angiotensin system and may have a therapeutic
role in a variety of conditions in man inclUding
hypertension and heart failure.
Atrial natriuretic factor in atrial flutter and fibrilla-
tion: Role of atrial rate and cardioversion.
Sakti Mookhern, M.D., F.A.C.C., James Longo, M.D.,
F.A.C.C., Harot Smulyan, M.D., F.A.C.C., Sunan Varden,
M.D., Gunner Anderson, M.D., VA Medical Center and Health
Science Center, Syracuse, N.Y.
To examine whether faster atrial frequency and/or
associated congestive heart failure (CHF) contribute to
elevated atrial natriuretic factor (ANF) in the setting
of atrial flutter (AFWT) and fibrillation (AFIB), 24
patients (pts), 16 with AFLUT and 8 with AFIB were
studied. Clinical and electrocardiographic evaluation
was performed and venous ANF level detennined by radio-
inmunoassay 1 hour before and 1 hour after cardioversion
(cv). Control ANF level was unrelated to atrial fre-
quency, arterial pressure, ventriuclar rate, arrhythmia
duration or left atrial size (echocardiography). Seven
pts (5 AFUJT and 2 AFIB) had clinical indices of CHF with
ANF values of 172.2 ± 45.7 (SE) pg/ml vs 110.6 ± 17.5
pg/ml in 17 without GHF (p-NS). AFIB pts had ANF levels
of 161.6 ± 37.8 pg/ml vs 112.1 ± 20.1 pg/ml in AFWT pts
(p-NS). Two AFWT and 1 AFIB pts converted to sinus
rhythm without D.C. countershock (1 spontaneously and 2
pharmacologically). Remaining 21 pts recieved D.C.
countershock (14 AFUJT and 7 AFIB) under intravenous
methohexital anesthesia. Regardless of energy used or the
mode of cv the ANF fell post cv in the entire group from
128.6 ± 18.5 pg/ml to 55.7 ± 9.2 pg/ml (P<O.Ol). The
post cv fall in ANF correlated with control ANF level
(r =0.83, P<O.01) but not with fall in heart rate. Thus,
(1) ANF level in AFIB with more frequent atrial electrical
impulses may not be significantly higher than that in
AFWT, (2) presence of CHF seems non contributory to ANF
levels in this setting, (3) the ANF is pranptly lowered
with dysrrhythmia termination and (4) its post cv reduc-
tion is independent of the mode of cv or anesthesia use.
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Thrombosis and Thrombolysis: Mechanisms
PREVENTION OF THROMBOSIS BY RECOMBINANT HIRUDIN DURING
ARTERIAL ANGIOPLASTY 'IN PIGS: COMPARISON WITH HEPARIN
Magda Heras. MD, James H. Chesebro, MD, FACC, Mark
We ster, MB, Jozef Mruk, MD, Diane Grill, MS, Lina
Badimon, PhD, Valentin Fuster, MD, FACC, Mayo Clinic,
Rochester, Minnesota
The effects of heparin and 3 dosages of recombinant hiru-
din, a specific thrombin inhibitor, were compared for
reducing 111In-platelet and 12SI-fibrinogen deposition
(PD,FD) and mural thrombus (TH) in arteries with deep
injury during angioplasty. Hirudin, heparin or placebo
was given as a bolus plus an infusion started 10 minutes
before angiop1asty. Dosages (mg/kg + mg/kg/h) of hirudin
were 1.0, 0.7 and 0.3 and of heparin was SO U/kg +SO
U/kg/h. Pigs underwent bilateral carotid angiop1asty (S
inflations for 30 sec to 6-8 atm, 60 sec apart) and were
sacrificed 60 minutes later. Activated partial throm-
boplastin time (APTT) at angioplasty is reported in
multiples of the basal value PD and FD (mean ± SD) are
reported as log p1ate1ets/cm~ and log of molecules/cm2,
respectively. The proportion of TH in arteries with deep
injury is also assessed.
Rx Control 0.3 mg/kg 0.7 mg/kg 1.0 mg/kg SO U/kg
(n=8) (ns8) (n=4) (".14) (n"6)
APTT 1,02 1,64 1,97 3.2S 1.94
PD 3.7±0.9*,o 2.9±0.6* 1.8±0.S 1.7tO.S 3.2tO.B*,o
FD 3.S±0.8* 3.2tO.6* 2.4tO.3 3.0tO.S
TH 7~ S4' ~ ~ 6~
*p<O.OS compared with 1 mg/kg; °p<O.OS compared with 0.7
mg/kg. There was also a significant inverse relationship
between hirudin dosage and PD (r=-0.8; paO.OOO1).
In conclusion, at similar APTTs hirudin significantly
decreased thrombosis compared with heparin. The two
higher dosages of hirudin totally prevented thrombosis at
therapeutic APTTs.
ABSTRACTS
THE AJlTITHROIlBOTIC EFFECT OF ASPIRI. IS IIIDEPE.DEKT OF
STE.OSIS SEVERITY.
Jules Y.T. Lam, M.D .• F.A.C.C., Michael Johnstone,
M.D .• Garth Linton, Chantal Lachapelle, Jean-Gilles
Latour, Ph.D., David Waters, M.D .....A.C.C., Montraal
Heart Institute, Montreal, Canada.
Hemorrheolosic disturbances at sites of arterial steno-
se. prOlllOte localized platelet deposition; more severe
steno.es cause more extensive platelet thrombus deposi-
tion. Whether the anti thrombotic efficacy of aspirin is
influenced by these rheolosic disturbances is not
mown. Platelet deposition (xID6) onto normal pOl:'eine
aortic media placed in cylindrical flow chambers and
exposed ex vivo to flowins, non-anticoasuiated blood
from control (n=8) or aspirin treated (1 ms/ks/day for
3 days, n=8) piss was quantitated. The flow ehambers
were specially desisned to provide 0, 50, 66 or 75~
stenoses. Femoral arterial blood was circulated ex vivo
throush the flow chambers for 5 min. by means of a
peristaltic pump set at a flow rate of 20 ml/.in. Pla-
telet deposition was evalusted usins autolo&ous
lllIndium labeled platelets injected 18-24 hrs before
the experiment. The follDWin& differences in platelet
deposition were observed:
Stenosis n Control Aspirin p (vs control)
M 8 55 . 5til .6 26 . 2:t5 •3 0 .005
5M 8 75.1~14.7 29.5:t5.8 0.005
66~ 8 95.0~19.2 30.2:t5.0 0.015
75" 8 108.0%18.0 36.5:t5.9 0.005
Thus, aspirin (1 ms/kS) si&nificantly decreases plate-
let deposition onto aortic media exposed to flovins
blood. This antithrombotic effect persists resardless
of the severity of stenoses. Flow alterations caused by
stenoses do not appear to modify the antithrombotie
effect of aspirin.
77A
BLEEDIl-C COMPLICATIONS AFTER DOUBLE-CHAIN tPA:
INFLUENCE OF DOSE AND DURATION OF lNEUSION,
Udho Thadani. M,D•• FACC for the Burroughs WellcOllle tPA
Study Group. OUHSC. Oklahoma City. Oklshoma,
No significant relationship between KDR and serious BC
was found(P=O.S). When TO and DI vere examined separate-
ly. both demonstrated a significant relationship to
serious BC(P<O,OOOl). After adjustment for TO in a lo-
gistic model. DI added additional independent informa-
tion for predicting the occurrence of serious BC. These
data suggest that a prolonged maintenance dose following
a lytic dose is associated with high risk of serious BC.
We examined the relationship of serious bleeding compli-
cations(BC) to maintenance dose rate(KDR). duration of
infusion(DI). and total dose(TO) of tPA administered to
223 patients(pts) vit~myocardial infarction. Burroughs
WellcOllle tPA(PROLYSI~ vas administered 3.41;1.1 hours
after symptom onset in an initial dose of 0,641;0.16 mega-
units/kg(KU/kg) aver 90 .in. Responders at 90 min [65%
(134/207).TIMI grade 2-3] then received 1/3 the initial
dose aver 1.5 brs. followed by one of several I1DRs(range:
0,01-0.13 KU/kg/hr for 0.6-22.4 hrs). Repeat angiography
vas performed 11-26 hrs after initiation of tPA. During
the 96-bour study period.40 pts(l8%) experienced serious
BC. primarily at catheterization sites(13%). No CNS or
fatal BC were reported. Other serious BC were: GI. 2%:
hematuria ~ 1%: retroperitoneal • .£.1%. Transfusions were
required in 34 pts(15%). Serious BC occurred vith the
following frequency :
ASPIRIN IlJT ;m STPHlIRD f£PARIN ffiEVENTS nRMlUS FHRIN OCFOSITIC'
IN IWlBITS "TREATED WITH TlS9JE PLA9HtmN ICTIVATffi.
GiiflCarlo ~~, Claudia Pascucci, Benilde C09l1i M.D.,
Giuseppe G. Nenci M.D., Istituto di Serreiotica f/edica, \..i1iversity of
R"rugia, ~lOD R"rugia, Italy.
Rethrorrosis after thrombolytic trea1JlBlt is a crucial problem and
tte value of acijunctive tterapy is not defined. The aim of this
stuqy was to evaluate the effectiveness of st<mard tEparin (91) and
aspirin (ASA) in preventing fibrin dep;lsition onto experimental
thrortJi partially lysed by tissue plasminogen activator (HA). To
evaluate the fibrin deposition, standard sized non radioactive
thrrnt>i were produced in the jugJlar veins of New Zealand rallbits
(weight: 2.S Kg). Ths1 125I-fitrinogen \oilS injected via left carotid
artery, its accumulation onto the thrart>i being considered as an
expression of potential rethrorrosis. Single chain recartJinant t-PA
(I\cti lyse, Boehringer Ingelheim, Florence, Italy), 0.5 IT!J, \>iIS in-
fused over three hours in each rabbit. This cbse \oilS selected be-
cause it produces 35% thrombolysis in this animal rrodel. In addition
to t-PA rabbits received l)salire or 2)91 20 and 60 I.U./i<I]/hour for
three hours or 3)sal ire or ASA 20 IT!J/i<I] as a bolus cbse. The infu-
sion of 9i and t-PA started at the sare time, the lCX of the cbses
being injected as a bolus. The salire and ASA bolus was injected
irrmediately prior to the start of t-PA infusion. The accretion of
l25I-fibrinogen was evaluated at the end of t-PA infusion. At the
end of the infusion the accreted 12SI-fitrinogen was 34i:lil'g in tte
salire treated rabbits (both bolus and infusion), 3~ and 33lSi 1'9
in tte rabbits treated with tte lCl'l and hi~ cbse of 9i, respective-
ly and 81:11'9 in tte ASA treated rabbits. Thus when anpared with
sal ire, ASA significantly reduced tte accumulation of radioactive
fibrin onto preformed thrart>i (p<O.05), while 91 had no effect. In
tte standard tEparin treated rabbits tte anti-Xa level was about 0.4
U./ml and 0.9 U./ml in the low and high dose, respectively. l<e
conclude that in this animal rrodel ASA inhibits thrarlJus growth
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STREPTOKINASE INHIBITS PLATELET THROMBUS FORMATION IN
STENOSED DOG CORONARY ARTERIES: POSSIBLE MECHANISMS.
John D. Folts, Ph.D.,F.A.C.C., Bradford S. Schwartz, M.D.,
Michael Kroll, M.D., Andrew I Schafer, M.D., Univ. of
Wisconsin Medical School, Cardiology Section, Madison, WI
and Dept. of Medicine, Harvard Medical School, Boston, MA.
Tuesday, March 21, 1989
8:30AM-I0:00AM, Santa Ana Room 2
Anaheim Convention Center
Cardiovascular Effects of Cocaine
!~ ~=.# / -
G., ., 0' ., ." .1 ·1
We have shown that IV streptokinase (SK) inhibits
periodic acute platelet thrombus formation (APTF) in our
open chest dog model with mechanically stenosed coronary
arteries (MSCA), and intimal damage. These thrombi are
primarily platelet aggregates with very little fibrin.
In 22 dogs with MSCA, (coronary blood flow measured with
EMF probe) APTF periodically occurred producing cyclical
coronary blood flow reductions (CFRs) as the thrombi
formed and then embolized distally. SK 68,OOOt13,OOO
U/kg was given IV to generate plasmin (P) and CFRs were
abolished in 20 and diminished in 2 dogs. Plasma fibrino-
gen levels decreased from 227t41 to 132t19 mg/dl (pc.OOl)
while template bleeding time increased from 3.2tO.6 to
14t4 min (pc.OOl) after SK. Platelet thromboxane A
production (n-7) and platelet rich plasma C-AMP lev~ls
f2s5) were not significantly changed, nor was binding of
I antibody to the platelet GPIIb-IIIa receptor altered
(n-5), after SK. Ex vivo platelet aggregation induced by
ADP (n-l0) or Botrecetin (n-4) was not changed but col-
lagen induced aggregation was decreased by 34tll% (n-6,
pc.05). We postulate that P was generated by SK and that
the P inhibited APTF and thus abolished or diminished
CFRs in these dogs. If SK and generated P inhibit colla-
gen induced platelet aggregation this may account in part
for abolishing CFRs, since exposed collagen, due to inti-
mal damage, is thought to be the primary stimulus for APTF
in this model. P inhibits human platelets in vitro and
if it occurs in vivo in man it may enhance thrombolysis
by inhibiting further platelet accumulation on the clot.
COCAINE-INDUCED CONTRACTION OF VASCULAR SMOOTH MUSCLE
IS INHIBITED BY CALCIUM CHANNEL BLOCKADE.
Anthony J RQogiope B A , JeffrEiy M. Isner, M.D.,
F.A.C.C., St. Elizabeth's Hospital, Tufts University
School of Medicine, Boston, MA
Recent in vitro studies have documented that cocaine
(C) may provoke endothelium-independent contraction
(CON) of rabbit and human vascular smooth muscle (VSH)
in vitro, thus providing a basis for clinical reports
of C-induced myocardial infarction. To investigate the
mechanisms responsible for the vasoconstrictor effects
of C on VSH, the potential antagonism of alpha blockers
and calcium channel blockers on C-induced CON of VSH
were studied in 78 ring segments of rabbit thoracic
aorta mounted isometrically with 1-2 gIllS tension in
Krebs bicarbonate buffer (370 C and pH-7.4, 95\ 02 - 5\
C02). In 43 segments challenged with either 10-7 to 10-
4 H prazosin or phentolamine prior to C (10-7 through
10-3 H) (n-14S), no consistent effect on C-induced CON
of VSH was observed. In contrast, pre-treatment with
diltiazem (D) markedly inhibited C-induced CON
according to the dose response curve shown below:values
are presented as means±'SEM (for C, n-14; for D+C,
n-21). Similar results were obtained with verapamil
(10-7 H) and nifedipine (10-4 H). C-induced CON with or
without antagonists was again endothelium-independent.
Cgncluojon' C has a potent vasoconstrictor effect an
VSH in vitro which is calcium-dependent and
endothelium-independent. These findings suggest that
in contrast to the
conventional view of C as
potentiator of response to
norepinephrine, C-induced CON
of VSH is more directly a
result of enhancement by C of
calcium influx across the
cell membrane.
Heart Rate (bpm)
LV pressure (mm Hg)
LV dP/dt (mm Hg/sec)
LVEDP (mm Hg)
CARDIODEPRESSANT EFFECTS OF COCAINE
Sharon L, Hale, B.S., Kevin J. Alker, Shereif Rezkalla,
M.D., Gerald Figures, Robert A. Kloner, M.D, Ph.D., FACC.
Hospital of the Good Samaritan, Los Angeles, California
Cocaine produces diverse effects depending on such factors
as the dosage and race of administration. Smoking ·crack·
is currently popular in certain populations. This results
in rapidly peaking, high blood levels of cocaine. Our
objective was to study the effeccs of rapid cocaine
administration. We measured hemodynamics, myocardial blood
flow (MBF) , and LV cavity end-systolic area (ESA) and end-
diastolic area (EDA), by 2-D echocardiography, before and
15 min after a bolus injection of cocaine (10 mg/kg) in







*p<.OS. **p<.006 vs baseline
Cocaine also caused dilation of the LV: ESA increased from
2.7±.2 to 3.2±.3 cm2 (p<.03) and EDA increased from 3.4+.4
to 4.3±.4 cm2 (p<.04). Subepicardial MBF fell from .82±~09
to .60±.11 ml/min/g (p<.04). In 7 other dogs, angiograph-
ically estimated proximal circumflex artery diameter (CXO)
and KBF were measured before and 3-S minutes after the same
dose of cocaine. In these animals cocaine-induced coronary
artery vasoconstriction was observed: CxD was reduced lS+4%
(range 2-29%, p<.01 vs baseline) after cocaine. Epicardial
RMBF was reduced from 1. 07±. 23 to .83±.16 ml/min/g. We
conclude that in this model, rapid administration of
cocaine depresses LV function, causes LV dilation and is
associated with coronary artery vasoconstriction and





















Conclusion: More rapid administration of a given dose of
t-PA results in a significantly lesser degree of lysis of
older clots and may therefore be safer.
TIlE EFFECT OF TIlE LEIIG7II OF TISSUE PLASflIMOGIIf ACTIVA'IOIl
ADIIINIS'l'IlATIOIi ON LYSIS OF FRESH AND OLD TDOIIIII.
Ken Kanamasa, MD, Ikuyoshi Watanabe, MD, Bojan Cercek,
MD, Juliana Yano, Michael C. Fishbein, MD, FACC, William
Ganz, MD, FACC, Cedars-Sinai Medical Center and Univ. of
California, Los Angeles, CA.
Serious bleeding may occur during coronary
thrombolysis when a hemostatic thrombus is also lysed. On
the assumption that hemostatic thrombi are likely to be
older than the coronary thrombi, we explored the effect
of the length of t-PA administration on lysis of I-hr and
24-hr old clots (CL). In dogs, clots were produced with
the copper coil technique in the left or right jugular
and femoral vein and 23 hours later in the contralateral
jugular and femoral vein. One hour later all 4 coils were
removed from the veins, weighed and inserted into the
adjacent carotid and femoral arteries. A 1 mg/kg dose of
t-PA was given either over 30 min and 180 min. The coils
were removed from the arteries and weighed to determine
the degree of lys is, ei ther upon termina tion of the
infusion (groups I-A and II) or 45 minutes later (group
I-B). The results were expressed as the ratio of lysis of
I-hr and 24-hr old clots.
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ERGONOVINE TESTING IN COCAINE INDUCED MYOCARDIAL
ISCHEMIA
Auatin A. Halle III M.D., Jerald Inael M.D., Michael
B. McDonald M.D., ICodangudi B. Ramanathan M.D.
F.A.C.C., Univeraity of TeDDeaaee, Memphia,
Tenneaaee
Coronary apaa. appeara to be the underlying
mechania. reaponaible for cocaine induced coronary
iache.ia. To determine propenaity for apaa.,
provocative teating with ergonovine maleate waa
carried out during catheterization in 7 male cocaine
abuaera (26-37 yeara). Four had angina and 3 had
auatained myocardial infarction(MI). All 7 had
patent coronariea with ventricular aaynergy in 3
patienta. Two of 7 however, demonatrated
inaignificant coronary atheroacleroaia in the
involved veaael. Intravenoua ergonovine waa
adminiatered in incre..ntal doaea until there waa
reproduction of cheat pain, ERG changea, preaaor
reaponae and/or total doae of O.5mg. Focal apaa.
with ergonovine waa preaent only in the two that had
pre-exiating coronary diaeaae. In contraat, 5
patienta including one who reqUired thrombolyeia for
MI and two othera with cocaine induced ST elevation
had negative ergonovine teat. Thua, in the abaence
of underlying coronary diaeaae, ergonovine teating
ia negative and in addition to apae. there may be
other mechania.a reaponaible for cocaine induced
myocardial iechemia.
COCAINE MEDIATED IMPAIRMENT OF CARDIAC
CONDUCTION IN THE CONSCIOUS DOG
J. Scott Kabas. M.D.. Susan M. Blanchard, Ph.D.,
Yuzuru Matsuyama, M.D., Samir Gupta, Ph.D., Everett H.
Ellinwood, M.D., Peter K. Smith, M.D., Harold C. Strauss, M.D.
Duke University Medical Center, Durham, NC
Previous studies of the physiologic effects of cocaine (C) have focused
on variables likely to be affected by changes in autonomic tone includ.
ing blood pressure (BP), heart rate (HR), cardiac output, and coronary
blood flow. However, cocaine also produces a local anesthetic effect
which may slow cardiac conduction. To assess this possibility, 10
conscious mongrel dogs were randomly assigned to receive either 3 or 5
mg/kg cocaine HCI intravenously over 30 sec. His bundle electro-
grams and serum cocaine levels were obtained in the control state and
at 0.5, 1.0, 1.5, 5, and 15 min following cocaine administration. At
both doses, significant prolongation of His to ventricle (HY) intervals
occurred as early as 0.5 min (15% and 17% increases) and progressed
to maximal delays of 40% and 52%. HV prologation followed the rise
in serum cocaine and persisted for 5 min. Mean BP and HR also
increased with cocaine infusion by 2-40% and 2-57%, respectively, and
remained elevated throughout the study. While arterial pOZ and
pCO stayed within physiologic limits, mild metabolic acIdosis
deveroped at both doses (minimum pH: 7.27 for 3 mg/kg and 7.26 for
5 mg/kg). Despite marked cardiac effects, only one animal experienced
seizures. Time: 0.5 min 1.0 min 1.5 mill 5 min 15 min
9 mg/kg: [CI ng/!,) 30±6 14H HI HO O±O
%6HV 15±4" 40H" 32±3" 14±4" HI
%ABP 10±7 5H 4O±l2" 29±11" 15±9
%t.HR 18±l3 32±l2" 57±36 49±27 26±l4
5 mg/kg: [CI ng/!,I 47±9 17±7 6±2 2H O±O
%6HV 17±1" 49±9" 52±6" 23±3" 3±3
%6BP 2±2 13±7 19±9 31±7" 30;±5"
%t.HR 2H2 29±l6 33H7 29±12 17±11
Mean±SEM; " p<0.05 from control (paired t-test on raw data)
These data indicate that cocaine significantly prolongs cardiac conduc-
tion which may contribute to cocaine-induced mortality.
EVIDENCE 'mAT COCAINE SLOWS CARDIAC CCNlUCTICl'l 8Y AN
ACTICl'l Cl'l BOTH AV 00DlU. AND HIS-PURKINJE TISSUE
IN THE OOG.
iIIthia Tracy M.D. F.A.C.C., Lisa sachenheimer M.D.,
en SOlomon M.D., JUlie Rothstein, Richard Gillis Ph.D.
Georgetown university Hospital, Washington, D.C.
'1be effects of intravenous (IV) cocaine (2 IIICJIkg) were
tested on several indices of electrical activity in
conscious, sedated dogs. These included sinus rate, AH
interval (paced and unpaced), HV interval (paced and
unpaced), AV nodal effective refractory period (AVNERP),
ventricular effective refractory period, OIlS duration and
the r;:r interval (during sinus rhythm and at a constant
pacing rate ). No significant effects were observed in IS
control animals after IV cocaine. However, after
blockade of sympathetic nervous system effects on the
heart with propranolol (0.5 1IICJIk9 IV), cocaine increased
the PR interval (+15 ~ 4 msec, p<0.05). The effect on the
PR interval was related to slowing at the AV node level
as AH prolongation was observed at a constant paced rate
(+23.3 + 8.71 IDSec, P<0.05). No significant change in HV
interval was noted either during sinus rhythm or during
constant pacing. There was a significant increase in the
r;:r interval (+56 + 18 msec, p<0.05). Cocaine administered
to 6 animals subjected to pharmacological blockade of
both divisions of the autonomic nervous system (with IV
propranolol plus propantheline) resulted in siudlar
significant increases in PR and AH intervals. In
addition, there were significant increases in AVNERP
(+29 + 5.9 msec, p<0.05) and HV interval (+6.7 + 1.7
msec,-p<0.05) during constant pacing. '1bese dati suggest
that cocaine iDqlairs cardiac conduction by acting
directly on the AV node and His-Purkinje system,
presumably by blocking the entry of calciUDI and sodiuel
into these cells, respectively.
COCAINE INDUCED DELETERIOUS EFFECTS ON THE CANINE
CORONARY CIRCULATION
Frederick E. Kuhn, MD, Richard A. Gillis, PhD, Svea K.
Wahlstrom, Marc S. Visner, MD, FACC, Gary L. Schaer, MD,
FACC, Georgetown University, Washington, D.C.
Cocaine abuse has been associated with cardiovascular
complications (myocardial infarction, sudden death), but
its effects on the coronary circulation have not been
well characterized. Accordingly, the coronary vascular
effects of cocaine were assessed in 7 sufentanil sedated
dogs. Cocaine (2 mglkg IV) produced a decrease in the
diameter of the left anterior descending (LAD, coronary
angiography) of 19±3% p<0.05; and an increase in coron-
ary vascular resistance (microspheres) of 55±20% p<0.05.
These effects were noted 2 min after cocaine and were
associated wi~h significant (p<0.05) increases in heart
rate (from 76~9 to 100±14 beats/min), mean arterial
pressure (from 106±6 to l28±10 mm Hg), and cardiac
output (from 3.7±D.7 to 5.4±1.7 L/min). In 2 other
groups of dogs (n=5 each), lower doses of cocaine (0.5
and 1.0 mg/kg) produced similar changes but of lesser
magnitude. Dogs (n=5) pretreated with the alpha-
adrenoceptor antagonist phentolamine, did not exhibit
the deleterious effect of cocaine (2 mg/kg IV) on either
LAD diameter (+1±8%), or coronary resistance (-11±30%),
(both p=NS vs pre-cocaine baseline).
Conclusions: 1) Despite marked augmentation of myo-
cardial oxygen demand, cocaine produces constriction of
both epicardial and coronary resistance vessels; 2)
These deleterious effects are mediated by alpha-adreno-
ceptor stimulation; 3) These data suggest that an
imbalance between myocardial oxygen supply and demand
may play a role in the cardiovascular complications
associated with cocaine abuse.
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Coronary Artery Disease/Myocardial Ischemia
and Infarction
POSTOPERATIVE MONITORING OF REGIONAL LEFT VENTRICULAR
FUNCTION IN MAN. Craig J. Hartley, PhD; Raphael S.
Rabinovitz. PhD; Hee Shlk Lee. BS; Luc J. Suignard, MS;
Bharat S. Patel, HO; Jacques E. Che11y, HO, PhD; George P.
Noon, MO, FACC; Roberto Bolli, MO, FACC; Baylor College of
Medicine, Houston, TX.
To monitor the recovery of regional ventricular function
after cardiac surgery, we developed an ultrasonic sensor
which can be sutured loosely to the epicardium during
surgery to measure LV thickening (LVT). The si1astic
sheathed leads are exteriorized near the chest tube. and
when measurements are no longer needed. the sensor is
removed by pulling on the leads. LVT is sensed by tracking
the phase of echoes from a sample volume (SV) range-gated
to any depth in the myocardium. Thickening fraction (TF)
is determined by dividing systolic LVT by the SV depth.
Sensors have been implanted on the anterior LV wall in 23
coronary bypass patients with normal pre-op LV function
(EF>35%) for 24 to 48 hours. No data was obtained from 6
patients because the sensor failed (2) or detached from
the LV (4). All sensors were removed successfully in the
intensive care unit. Two patients developed sustained
systolic thinning (-10%) during the recovery period (one
confirmed by echo), but neither had ECG changes or other
symptoms of ischemia. In one patient placed on an
intra-aortic balloon pump, TF improved progressively from
5% to 18% in 48 hours. In the other patients TF averaged
26% (range 2-48) before bypass, 30% before chest closure.
22% after chest closure, 27% after 24 hours. and 34%
(range 12-55) after 48 hours. In general, regional TF is
highly variable, is depressed after surgery (p<.01), but
recovers to pre-op control levels by 24 hours. We conclude
that the epicardial thickening sensor can follow the
recovery of regional myocardial function and is valuable
for detecting ischemia and for assessing the effects of
therapeutic interventions during the postoperative period.
ENDOCARDIAL TRABECULATION:
MYOCARDIUM
A HARKER FOR HIBERNATING
RELATION BETWEEN LEFT VENTRICULAR HYPERTROPHY, FILLING,
AND PERFUSION IN ASYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY.
James E. Udelson MD, Barry J. Maron MD, FACC, Patrick T.
O'Gara MD, Robert O. Bonow MD, FACC, NHLBI, Bethesda, Hd.
Ronnie A. Hershman, MD, Warren Sherman, MD, FACC, Richard
Charney, MD, Harc Cohen, MD, FACC, and John A. Ambrose,
MD, FACC. Hount Sinai Hospital, New York, NY
Detection of hypocontractile yet viable myocardium is
important in coronary disease. We evaluated a new easily
derived angiographic parameter: endocardial
trabeculation (T) as an index of hibernating (H)
myocardium. 75 consecutive pts with wall motion
abnormalities (WHA) in the anteroapical segments on LV
grams were evaluated. T was graded O-none or minimal and
1 = moderate or normal, and WHA was graded 0-4; 0 =
normal or mild hypokinesis, 1= moderate, 2. severe, 3 •
akinesis and 4 = dyskinesis. T, WHA and precordial R
wave sum on ECG were compared to post PVC potentiation as
an index of H myocardium.
T grade was inversely related to WHA (R = -0.6, pS.Ol)
and positively related to the sum of R waves (R =.4,
pS.OI). The correlation between WHA grade and R wave sum
was less significant (R =.2, pS.05).
In pts with WHA grade ~l (n = 54), a T grade - 1 was
predictive of post PVC potentiation (chi2 • 9.9, p-.002).
Even in pts with reduced R wave sum S40 mV and WHA grade
~1, TG • 1 predicted post PVC potentiation (chi2 = 4.0, P
S.05). In contrast, neither WHA grade nor R wave sum
correlated with post PVC potentiation.
In conclusion, preservation of endocardial
trabeculation appears to predict viable myocardium in pts
with wall motion abnormalities.
Previous studies in our laboratory have shown that exer-
cise-induced thallium perfusion defects are common in
asymptomatic or mildly symptomatic pts with hypertrophic
cardiomyopathy. To assess the relation of these perfusion
defects to LV hypertrophy (LVH) and LV filling parameters,
we studied 29 such pts with 2-D echocardiography, exer-
cise and rest thallium tomography, ana radionuclide angio-
graphy. Maximum wall thickness and an LVH index were used
to score the magnitude and extent of LVH by echocardio-
graphy. Reversible perfusion defects developed in 14 pts
with exercise. Pts with inducible perfusion defects had
a higher LVH index (94±14 vs 60±10, p-.OOl), lower peak
filling rate at rest by radionuclide angiography, normal-
ized either to end-diastolic volume (3.3+0.9 vs 4.2+1.0
EDV/s, pe.04) or to stroke volume (4.2+1~2 vs 5.7+1~3
SV/s, pe.Ol), and longer time to peak filling rat; (241±
a7 vs I85±26 ma, pe.04) compared to pts with normal per-
fusion. Ejection fraction and heart rate did not differ
between the two groups. In addition, maximum wall thick-
ness correlated with peak filling rate (r-.4, pc.05), and
LVH index correlated with both peak filling rate (r-.58,
pe.002) and time to peak filling rate (r-.48, pe.02).
Thus, the rate and timing of rapid LV filling are influ-
enced by the magnitude and extent of LVH in asymptomatic
or mildly symptomatic pts with hypertrophic cardiomyopa-
thy, and both LVH and impaired LV filling are related to
inducible myocardial ischemia. These data suggest that
LVH, impaired LV filling, and myocardial ischemia (even
when clinically silent) are interrelated pathophysiologic
features of hypertrophic cardiomyopathy.
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~ ARreRY DISEASE IS ASSOCIATED WITH INAD~
lEFT VENTRICULAR HYPER'mOPHY IN 1\ORTIC STEOOSIS.
vladimir ye!<shtein M), R wayne Alexander M) FNX,
Theodore Pla~rt, Martin G St John Sutton M) FNX,
Peter Ganz M) FNX, Andrew selwyn M) FNX, and John A
Bittl M) FNX, Brigham & Waren' s Hospital, Boston, MA.
Pts with severe aortic stenosis (AS) develcp widely
variable patterns of left ventricular hypertrcphy (LVH).
We postulated that limitations in coronary flow inp:>sed
by atherosclerosis (OlD) may lead to ineffective LVH in
pts with AS and no previous HI. LV mass and volurres were
quantitated fran the 2-D echo using the 5/6 short axis
area x length method and correlated with coronary angio-
graphy in 41 pts with severe AS (0 .3-0.8 an2), no IIOre
than mild (1+) insufficiency, and no regional wall
IIOtion abnormalities. 8 pts (Group I) had SIIOOth coro-
nary arteries, 15 pts (Group II) had <50% atheranatous
irregularities, and 18 pts (Group III) had obstructive
CAD with ~50% stenoses. The magnitude of hypertrcphy in
relation to cavity size, given by the mass:systolic
volurre ratio (M!Vsys), and ejection fraction (EF) were
higher in pts with no OlD carpared to pts with OlD
(ANOVA). pt age, sex, or degree of AS did not influence
the M!Vsys.
CAD Score' ~ II III R
LV mass 252 ± 35 274 ± 23 312 ± 22 NS
M!Vsys 10.0 ± 1.7 6.0 ± 0.9 5.6 ± 0.6 0.01
EF (%) 67 ± 4 55 ± 5 49 ± 4 0.03
'lhese data indicate that angiographically normal
coronary arteries in AS are associated with concentric
LVIi, better LV function and normal cavity size, whereas
early and particularly obstructive OlD is associated
with inadequate LVH with chant>er dilatation and abnormal
function. Coronary blood flow may playa permissive role
in effective LVH develcpnent in AS.
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Hormonal Influences in Hypertension
ATRIAL NATRIURETIC PEPTIDE AND ELEVATED RIGHT HEART
PRESSURES IN ESSENTIAL HYPERTENSION.
Ludwig Neyses M.D .• Jobst Nitsch M.D .• Berndt
Luderltz M.D. F.A.C,C., Dept. of Cardiology, Univer-
sity Hospital, Bonn. Federal Republic of Germany
High, normal. and low levels of atrial natriuretic pep-
tide have been reported in human essential hypertensio~
To explain these apparent contradictions we studied the
relationship of atrial natriuretic peptide (ANP) and
right heart pressures in 40 essential hypertensives
(HT) and in 60 normotensives (NT). ANP was 42(3) pg/ml
in NT and 59(5) pg/ml in HT (peo.05). The regression
line between mean right atrial pressure and ANP was
significantly steeper in HT than in NT. Therefore, at
low atrial pressures no significant differences were
observed in ANP levels in HT versus NT whereas at high
right atrial pressures HT had significantly higher
ANP values. To eliminate the possibility that raised
LVEDP in HT influenced ANP via raised pulmonary and
right heart pressures, HT and NT with identical LVEDP
in the normal range «13 rom Hg) were matched. For each
level of lVEDP mean pulmonary and right atrial pressure
were higher in HT than in NT. The same applied to ANP
levels. For all matched patients mean right atrial
pressure was 3.1(0.2) ver~us 4.5(0.3) rom Hg in NT and
HT, respectively (peJ.05). ANP was 40.2(4.3) pg/ml in
NT and 57,9(5.8) pg/ml in HT after matching for LVEDP.
Conclusion: The elevation of ANP is best explained by
raised right atrial and pulmonary pressures indepen-
dent of left heart involvement. Differences in ANP be-
come apparent only at high levels of pulmonary and
right atrial pressures in HT.
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IMPROVEMENT IN LEFT VENTRICULAR EJECTION FRACTION DURIH6
THE FIRST POST-INFARCTION YEAR IN PATIENTS WITH INFERiOR
AND NOH Q-NAVE INFARCTS.
Shmyel Gottl ieb M.D" Menahem Gordin M.D., Andre Keren
M.D., Dan Tzivoni M.D., F.A.C.C
Bikur Cholim Hospital, Jerusalem, Israel.
Radionuclide ventriculography (RNV) was performed in
164 consecutive pts recovering from acute myocardial
infarction (MI) prior to discharge and 6~12 months (mean
8.7) later. No pt received streptokinase during the
acute MI. No pt had new cardiac event between the two
studies. Pts were divided according to infarct site and
predischarge lVEF (lVEF1). 57 pts had anterior, 48
inferior, 32 non-Q wave and 27 had previous MI. 72 pts
had lVEFl ~ 51';, 64 LVEFl-30-5OS and 28 lVEFl i 29'.
Repeated RNV revealed improvement of ~ 1~ (relative to
baseline value) in lVEF in 57 (35,;) pts, worsening in 42
(26';) and no change in 65 (4~) pts. Improvement was
more marked in pts with lVEFl 30-5~, 47'; (30 pts) of
them improved their lVEF by more than 1~, and 31'; (20
pts) by more than 2~, during the first post MI year,
In the whole group LVEF did not change between the two
studies (47.6'; vs 48.g,;, p-NS). However, when the pts
were divided into subgroups, a significant improvement
was noticed in those with lVEFl 30-50', from 40,2' to
43.3'; (p<0.02). In this subgroup, of 64 pts, the
improvement was mainly observed in those who had either
inferior or non-Q wave MI (20 pts), frOM 43.7'; to 51.4';
(p<O.Ol). On the other hand, LVEF did not change between
the two studies in pts with lVEFl ~51'; or i29'. LVEFI
was higher in 42 pts whose lVEF deteriorated as compared
to 57 pts whose lVEFl improved (50.6% vs 41.5';,
respectively, p<0.02). Conclysion: Improvement in lVEF
during the first po~t infarction year is seen mainly in
pts with lVEFl 30-5~, with inferior or non-Q wave MI.
INFLUENCE OF ANTIHYPERTENSIVE THERAPY ON PLASMA HORMONES
IN CARDIAC TRANSPLANT RECIPIENTS: MEASUREMENTS AT REST
AND DURING EXERCISE
Christiane E, Angermann MD, Christoph H. Spes MD, Stephan
Willems, Peter Dominiak MD, Jochen Weil MD, Ruppert Gerzer
MD, Bernhard M. Kemkes MD, Karl Theisen MD
Medizinische Klinik Innenstadt, University of Munich, FRG
After cardiac transplantation (HTX) systemic hypertension
develops in most patients on cyclosporine A and steroids.
To investigate the influence of an antihypertensive regi-
men(T) with enalapril (2Omg/d) and furosemide (20-40 mg/d)
alone or combined with verapamil (120-360 mg/d) on resting
and exercise blood pressure (BP,mmH9) and plasma hormones,
14 hypertensive patients after HTX (44+9 yrs.,12+11 months
pop.) were evaluated. Systolic and diastolic BP, plasma
renin activity (PRA,ng AI/ml/h), atrial natriuretic factor
(ANF,P9/ml)and its 2nd messenger cyclic guanosin monophos-
phate (cGMP, pmol/ml), adrenaline and noradrenaline (A,NA,
pg/ml) were determined. Blood was taken at rest (control)
and during supine bicycle exercise (25 and 50 W). Measure-
ments before and during antihypertensive T were compared.
Results (mean values, **/*: p(0.05/0,001 before T vs. T):
BPs BPd PRA ANF cGMP E NE
Control 160 105 2.9 128 7.42 20 195
25 W 163 104 3.2 165 8.10 24 331
50 W 175 101 3.4 244 9.34 28 542
Control (T) 129** 84** 9.8* 107 5.98* 23 275
25 W(T) 144* 89* 10.2* 132* 6.84 32 380
50 W(T) 161* 93* 11.8* 171* 7.96 46 612
Conclusion: T normalizes resting and exercise BP in hyper-
tensive HTX-patients, but causes marked changes in plasma
hormones: PRA increases during T; ANF and cGMP, which are
elevated at rest and during exercise after HTX, decrease
under T, possibly as a consequence of lower peripheral and
probably intraatrial pressures.E and NE do not change sig-
nificantly, but there is a trend to higher levels under T.
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DECREASED ADRENERGIC RESPONSE IN HYPERTENSIVE PATIENTS
WITHOUT LEFT VENTRICULAR HYPERTROPHY.
Yasuro Sugishita. M.D., F.A.C.C., Keiji Iida, M.D.,
Kimihiko Yukisada, M.D., Iwao Ito, M.D., Dept. of Med.,
Univ. of Tsukuba, Tsukuba, Ibraki, Japan
LV mass fractional shortening (FS) and end-systolic wall
stress (ESS) measured by echocardiography and the re-
sponse of FS and ESS to the infusion of isoproterenol
(ISP) (0.02 IIg/kg/min for 5 min) were studied in 84
patients who had essential hypertension for 5 years, and
13 age-matched normal volunteers (N). Twenty-seven
hypertensive patients had no LV hypertrophy (LV mass <240
g) (H(-», and 57 patients had LV hypertrophy (H(+».
Blood pressure was no~ different between H(-) and H(+).
When ESS was >12 g/cm , this variable showed a signifi-
cant inverse linear relation with FS in all the subjects
before ISP. The inotropic response to ISP was measured
as the increase of FS corrected for the decrease of ESS
(A FS/-AESS). The M:!:SD change in AFS/-llESS was signifi-
cantly smaller in H(-) (0.52±0.16 cm 2/g) than in normal
(0.65±0.17 cm 2/g) (p<0.05), and than in H(+) (0.95±0.54
cm2/g) (p<O.Ol). The response to ISP was decreased in
the patients with severe LV hypertrophy in H(+), too.
Conclusions: In the hypertensive patients without LV
hypertrophy (H(-», adrenergic response is depressed,
compared to normal control and H( +). This depression
might be etiologically related to the phenanenon that LV
hypertrophy did not develop in H(-) in spite of the same
level of pressure overload as in H(+).
BLOOD PRESSURE, LEFT VENTRICULAR MASS AND INTRACELLULAR
CALCIUM IN PRIMARY HYPERPARATHYROIDISM.
Anna Dominiczak M.D., M.R.C.P., Henry Dargie, M.B.,
F.R.C.P., Peter Semple M.B., F.R.C.P. MaC Blood Pressure
Unit and Department of Cardiology, Western Infirmary,
Glasgow, Scotland.
Primary hyperparathyroidism is associated with left ven-
tricular hypertrophy which is said to be out of propor-
tion to mild hypertension. The mechanisms are not well
understood but intracellular free calcium may affect
vascular tone and cell growth. We measured blood pres-
sure, left ~~ntricular mass and platelet cytosolic free
calcium (Ca )i, using Quin 2 in 23 patients with
untreated primary hyperparathyroidism and in 30 normal
controls. 13 out of 23 patients underwent parathyroid-
ectomy and all measurements were repeated 6 months
later. Blood pressure was higher in the hyperpara-
thyroid patients than in controls (141±5(SE)/85±2mmHg
vs l25±2/78±2mmHg, p <0.01) and parathyroidectomy had no
effect on blood pressure. LV mass index was a~so higher
in hyperparathyroid patients (123±9 vs 99±5g/m , p-0.02)
and surgical t~eatment did not lower it signi~~cantly
(133 vs 144g/m ,p-O.l). Median platelet (Ca )i was
slightly but not significantly lower in patients than
in controls (820M vs 880M; 95% CI (-0'1+ 17.7), p-0.07).
FollOWing parathyroidectomy median (Ca )i tended to
increase (77oM vs 880M; 95% CI (-2.1, 20.1)'2~-0.07).
There was a negative correlation between (Ca )i and dia-
stolic pressure in the hyperparathyroid group (n-23,
r--0.46, p<0.05). Conclusions: I, In primary hyperpara-
thyroidism LV mass is consistent with mildly raised
blood pressure. 2, In contrast to essential hyperten;
sion, patients with high blood P2~ssure and hyperpara-
thyrOidism show low levels of (Ca )i and this cellular
abnormality seems to be at least partially corrected by
surgical removal of parathyrOid adenoma.
(mean ± SO, c*p<O .01 between groups)
PNE did not correlate in either group with PFR or PER.
However, PNE correlated with time to PFR in pheochromo-
cytoma (r- -0.92, p-o.OOl) but not in essential hyper-
tension.We conclude that although mean values of LV
functional indices were similar in pheochromocytoma and
essential hypertension, the relationship of PNE to
indices of diastolic LV function differed in the two
groups; in pheochromocytoma but not in essential
hypertension PNE influenced time to PFR. The lack of
correlation of PNE with PFR may be related to factors
other than adrenergic activity influencing LV filling.
LEFT VENTRICULAR DIASTOLIC FUNCTION IN PHEOCHROMOCYTOMA:
RELATION TO PLASMA CATECHOLAMINES.
FetQ4t FOUAd·Tarazi M D, FACC, Hassan Nagi, M.D.,
Manoel Saragoca, M.D., Emmanuel Bravo, M.D., Cleveland
Clinic, Cleveland, Ohio.
Plasma catecholamines may reflect adrenergic activity
and therefore influence LV systolic function and relax-
ation indices. To evaluate this question, we studied 11
pheochromocytoma pts and 11 essential hypertensive pts
matched for age, sex, BSA, and blood pressure. LV func-
tion was evaluated by gated blood pool scanning with
derivation of LV ejection fraction, peak ejection rate
(PER), peak filling rate (PFR) , time to PER and time to
PFR. Despite differences in plasma norepinephrine
(PNE) , LV functional indices were not significantly dif-




Ejection fraction (t) 65±12
PER (Hz) 2. 86±0. 75
PFR (Hz) 2.47±O.72
PFR/PER O. 86±0. 09
Time to PER (msec) l38±32










CAPTOPRIL PRETREATMENT AND MYOCARDIAL FIBROSIS AND
STIFFNESS IN RENOVASCULAR HYPERTENSIVE RATS.
JorKe E Jalil M p , Joseph S. Janicki Ph.D., Sanjeev G.
Shroff Ph.D., Ruth Pick M.D., Karl T. Weber M.D.,
F.A.C.C., Michael Reese Hosp., Cardiovascular Institute,
Univ. of Chicago Pritzker Sch. of Med., Chicago, Illinois
Although converting enzyme inhibition (CEI) has been
shown to induce regression of LVH in different models of
hypertension, its effects on myocardial stiffness and
collagen concentration in renovascular hypertension (RH)
have not been examined. We tested the hypothesis that in
rats with RH, CEI pretreatment would prevent collagen
accumulation, or fibrosis, and alter systolic and
diastolic stiffness. Three groups were studied: control
(CTRL); RH created by abdominal aorta and right renal
artery constriction for 8 weeks (H); and rats treated
with oral captopril (0.5 giL) 2 days before RH and 8
weeks thereafter (H-CAP). At sacrifice, systolic blood
pressure (SBP, mmHg); LV to RV weight ratio (LVW/RVW~; LV
collagen volume fraction (CVF, t); and slopes (gm/cm ) of
LV systolic (m-Sys) and diastolic (m-Dia) stress-strain
relations in isolated, perfused hearts were measured.
(Data: meantSD, * p<O.05 versus CTRL; @p<0.05 versus H)
CIRL (n-11) H (n-lOl H-CAP (n-8)
SBP l32±8 l85±2l* l28±20
LVW/RVW 3.75±0.26 4.75±0.7l* 3.95±0.47
CVF 2. 97±0. 50 6.57£2.20* 4. 79±1. 20* @
m-Sys 359±7 533±16* 5l7±6*
m-Dia l30±17 2l5±53* 200±33*
Ihus, in this model of RH, pretreatment with captopril
prevented hypertension and LVH and attenuated, but did
not abolish, myocardial collagen accumulation. These
effects were not associated with significant modifica-
tions in LV myocardial stiffness given that fibrosis
occurred in the absence of LVH.
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Vascular Reactivity in Hypertension
POTENT PRESSOR EFFECTS OF ENDOTHELIN IN SPONTANEOUSLY
HYPERTENSIVE RATS AND WISTAR KYOTO RATS
Takashi Miyauchi, M.D" Tomohisa Ishikawa Ph.D" Masashi Yanagisawa M.D"
Sadao Kimura Ph.D., Yasuro Sugishita M.D., F.A.C.C" Iwao Ito M.D" Katsu-
toshi Goto Ph.D. Tomah Masaki M.D" Ph.D" University of Tsukuba, Tsukuba.
Ibaraki. Japan
Endothelin (ET) is a potent vasoconstrictor peptide produced by vascular en·
dothelial cells. To investigate its involvement in the pathogenesis of hyper-
tension, pressor effects of ET were studied in spontaneously hypertensive
(SHR) and Wistar Kyoto rats (WKY) (12 wold) after treatment with auto-
nomic blockade (atenolol I, bunazosin 1, atropine 0.25 mg/kg), under ure·
thane anesthesia. The blood pressure (BP) was measured from the carotid
artery and drugs were injected intravenously. ET showed dose·dependent
(0.125 - 2 nmol/kg) pressor actions. ET·induced pressor responses can·
sisted of the first (transient) and the second (long·lasting, continued about 3
hours at 2 nmol/kg) phases. The maximum increase in BP (2 nmol/kg) was
significantly greater in SHR than WKY in both the first (76.5 ± 6.2 vs
60.8 ± 3.1 mmHg, n=6, p<0.05) and the second (70.8 ± 6.2 vs 60.8
± 3.1 mmHg, N=6. p<0.05) phases. From the pharmacological analysis in
WKY, nicardipine (CaH antagonist. 0.1 mg/kg) attenuated largely the second
phase (37.0 ± 5.8 mmHg at 2 nmol/kg, n=5, P<O.OOI) but only slightly
the first phase. However. a higher dose of nicardipine (1 mg/kg) inhibited
greatly both phases (n=6). Neither saralasin (angiotensin n blocker) nor in·
domethacin (PG synthesis inhibitor) attenuated the pressor effects of ET.
Conclusions: 1. ET produced potent pressor effects. The maximum responses
were significantly larger in SHR. 2. Pressor effects of ET were blocked by
Ca2 + antagonist. 3. These results suggest that ET may contribute to the
pathogenesis of hypertension in SHR.
EFFECT OF ORAL ADMINISTRATION OF ANTIHYPERTENSIVE AGENTS
ON ENDOTHELIUM DEPENDENT AND ENDOTHELIUM INDEPENDENT
VASCULAR RELAXATION.
Pamela Shultz. M.D., Jon Tolins, M.D., Leopoldo Raij,
M.D., VAMC and U. of Minnesota, Minneapolis, Minnesota.
We have shown that in hypertension (HPN) both endothelium
dependent (EN-D) as well as independent (EN-I) responses
to vascular relaxants are depressed. In these studies we
investigated whether anti-HPN agents affect EN-D and/or
EN-I responses to agonists of vascular relaxation. Normo-
tensive Sprague-Dawley rats were given for 2 weeks either
tap water (W) or W containing captopril (CAP) enalapril
(EPL) or hydralazine (HYZ) in concentrations shown to be
equihypotensive in hypertensive rats; these concentrations
did not significantly lower BP of normotensive rats.
Aortic rings (with and without EN) were suspended in organ
chambers for isometric tension recording. The % relaxa-
tion induced by the EN-I agent Na nitroprusside (10-8M)
was significantly but similarly enhanced in rats given
CAP, EPL and HYZ compared with rats given W (75+8%, 81+6%
and 80+6% vs 50+5%, respectively, p < 0.05). In all rats
acetylcholine (Ach) , 10-9_10-4M, caused relaxations in
rings with, but not in those without EN. EN-D relaxations
were significantly enhanced in CAP rats but not in W, EPL
or HYZ rats: the concentration of Ach (-log M) required to
evoke 50% relaxation (IC50) was reduced in rats given CAP
(7.9+0.1) vs W (6.2+0.2), HYZ (7.1+0.2) or EPL (6.8+0.2)
p<O .05. Indomethacin lO-5M did not prevent the effect of
Ach while both pyrogallol 10-4M and Hb lO-5M, inhibitors
of the endothelium derived relaxing factor NO, inhibited
Ach induced relaxations. These studies suggest that anti-
HPN agents differentially affect vascular relaxations in
response to EN-D and EN-I agonists. This may influence
the overall beneficial effect of anti-HPN agents in
cardiovascular pathology.
ANI' BLUNTS FiJREAAI'I VASOCllNSTRICTl~ TO LOWER BODY NEGATIVE PRESSURE IN ESS£N-
TlAl. HyPERTENSIVE PATIENTS
RDBERTO P£DRlNELLI,I1D,STEFAl(J TADDEI,I1D,STEFANIA FAVILLA,MD, AlHDtUD SALVETTI,i'ID
HYPERTENSION UNIT, I CLINlCA tEDlCA,UNlVERSITY OF PlSA, ITALY
Contrasting huaan data eXist about the oodulatlon of sYllf'athetic outflOll by
ANI',partlcularly at 1011 coocentratlons. Therefore, the Interference by a syn-
thetic hUllan AlE analogueIWY,476b3)on sYllpathetlc foreara vasocoostrIctlon WiS
studied In 5 male patients with essential hypertension. Non hypotensive l_r
body negative pressureILBNP,-lO IIIIHg X5a1n) was used to stllDUlate sYlIlf'athetlc
tooe reflexogenicaIlYi forearm blood flow IFBF,straln gauge venous
plethysaography,ml/dl/llnl, IntraarterIal IIAP and HR Wfr'l! monltored,and venous
illllllUl10reactive IIRI ANF ,PRA, aldosterone(ALD(Jland NorepinephrinelNEI eeasured
at the end of each experimental perIod.ANF was given at either il low or high
concentratlon,preceded and follOlled by vehicle infuslonlHal!llilCell x 30
.inlel the,- systemically or locally at at least 8 hrs intervals.
Graded systemic lnfusionl.OO5 and .05 \lg/kg/ain x 60tllnl incr'l!ased IR-AI-F
from 37,818. to 1I2.6120,and 044,4165 pg/al,while basal IIAP,FBF,tIl,PRA,NE did
not change and ALDO dropped IfrOll 2015 to 1214 and 1012 ng/II l'eSflectively
p<O. OS), LBNP decreased FBF dUring prelnfusion ilnd recovery periods by 3814 and
46:5% respectively,but it was ineffective in presence of rtF at either ratel-4
+2.and -2.7:4 I.), To dissect a peripheral fl'llftl a lOre central site of
acllon,ANF was also infused into the brachial artery at rates I. 005 and .05
pg/dl tissuelmln X30 mlO each)raising local lfroa 32.4,t7 to 184t:i1 and 470i89
pg/ml "espectivelyi but not systemic venous IR-ANF, The analogue increased FBF
dose-I-elatedly, from 3.2:.3 to 3.8±.S and 6.21.4 al/dl/lin on the infused
sldelp(.OJ) Without changes in systl!llllC MAP and til or contralateral FBF.Under
these .xperl_tal conditions, LBti' vasoconstrlcted forearm arterioles to a
similar extent,lrrespective of the presencei.005:-n;tS, .05:-42.8.!:6%1 or ab-
sence of ANFlpreinfusion:-54;t4i recove,-y:-40,1;7%, NS vs ANFI.
Therefore, exogenous ANF, even at 1011 doses, counteracts' sYllf'athetic-
lediated vasoconstriction 10 man,an effect exerted at a site othe,' than the
neurovascular junctioo,at least In the foreara vasculatur'l!,SYllf'athetic oodula-
tion may be relevant to the physiological and pharaacologlcal action of AIf'.
CYCLOSPORIN THERAPY IMPAIRS ENDOTHELIUM-DEPENDENT RELA-
XATIONS IN THE RENAL CIRCULATION.
Dennis Diederich M.D., Zhihong Yang M.D., Fritz R.
Buhler M.D. and Thomas F. Luscher M.D., Dept. of Research
and Medicine, University Hospital, Basel/Switzerland.
Cyclosporin A (CyA) is an i11Ullunosuppressive substance
which causes structural and functional changes of endo-
thelial cells. The endothelium can modulate vascular tone
by the release of endothelium-derived relaxing (EDRF) and
constricting factors (EDCF). Functional changes of the
endothelium could contribute to hypertension, arteriolo-
pathy and premature atherosclerosis occurring during
chronic CyA therapy. Male Wistar Kyoto rats (20-24 weeks)
were treated with CyA 50 mg or 30 mg s.c./day, the
solvent or saline for 1 or 2 weeks, respectively. CyA did
not cause significant increases in blood pressure. Renal
artery rings were suspended in organ chambers filled with
physiological salt solution (37°C; 95\ 0 /5\ CO2);isometric tension was recorded. In saline ~reated rats,
acetylcholine (ACh) induced relaxations in rings with
(7lt7\, n=9} , but not in those without endothelium. The
sensitivity and maximal response to ACh was impaired in
rats receiving either 30 mg CyA for 2 weeks or 50 mg for
1 week (13tlO\ and 3ltll\; p<0.05, n=9 and 22, respecti-
vely). The solvent also tended to reduce the relaxations.
Inhibition of cyc!~xygenasewith either indomethacin or
meclofenamate (10 M) augmented the response in CyA rats.
Thus, (l) ACh releases EDRF in the rat renal artery, (2)
chronic CyA therapy blunts endothelium-dependent relaxa-
tions in the renal circulation and (3) an endothelium-
derived cyclooxygenase product interferes with the action
of EDRF in CyA treated rats.
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TRANSIENT MYOCARDIAL ISCHEMIA IN HYPERTENSIVE
CORONARY MICROANGIOPATHY.
Wojfgang Mot; M.D.. Sibylle Scheler M.D.•Martin Vogt M.D.,
Bodo E. Strauer M.D.• F.A.C.C.•Dept. of Medicine. University of
Duesseldorf, W.Germany.
In hypertensive patients with a normal coronary angiogram coronary
regulating capacity is usually impaired due to coronary microangio-
pathy. To determine whether episodes of transient myocardial
ischemia can be documented in patients with coronary microangio-
pathy.coronary reserve was measured and ST-Holter-analyses were
performed in 20 pts (age: 55.6 :t 8.1 years) with essential arterial
hypertension (systolic/diastolic blood pressure: 170:t II /95:t I5mmHg).
Coronary reserve (Rcor/Rmin) was determined by measuring the
coronary resistance before (Rcor) and after dipyridamole (O.5mg/kg
body weight intravenously:Rmin).Coronary blood flow was measured
by the gaschromatographic Argon method. ST-segment changes were
evaluated by Holter-monitoring (Marquette-Holter) over 24 hours.
Horizontal or downsloping ST-segment depressions ( ~1.0 mm,
duration ~1.0min) were considered to be of pathological value.
~In 75% (15/20) of the patients studied ST-segment depressions
were detected by Holter-monitoring.ln patients with ST-segment
depressions Rmin was 46% higher than in patients without ST-
segment depressions (O.50:t 0.18 vs 0.23 ± 0.02mmHg·min·100g/ml.
p < 0.01). Coronary reserve (Rcor/Rmin) was markedly impaired in
patients with ST-segment depressions (2.60:t1.l5 vs 4.68:t0.18, p<
0.01). Maximum coronary blood flow per weight unit myocardium
after dipyridamole was significantly lower in patients with (245
:t 25 ml/min.IOOg) than in those without ST-segment depressions
(344:t 36 ml/min·IOOg; p<0.05) Conclusions: (i) Hypertensive
patients with a normal coronary angiogram have coronary micro-
angiopathy as shown by an impaired coronary vasodilator reserve.
(ii) The frequent episodes of ST-segment depressions in these
patients indicate that hypertensive coronary microangiopathy
implies a chronic ischemic risk inspite of the abscence of
coronary macroangiopathy.
INDUCTION BY LDL OF GROWTH RELATED METABOLISM IN VASCULAR
SMOOTH MUSCLE CELLS.
Tim Scott-Burden Ph.D., Th~r~se J. Resink Ph.D., Alfred
Hahn Ph.D., Fritz R. BQh1er M.D., Department of Research,
University Hospital, Basel, Switzerland.
The implication of LDL in the pathophysiology of athero-
sclerosis has been long recognized but its direct effects
on vascular smooth muscle cell (VSMC) metabolism are less
clear. We have shown that LDL stimulates a number of
intracellular metabolic events normally associated with
proliferation in cultured human and rat VSMC. When
quiescent (serum-deprived) VSMC ar!:I.(~xpo!1d to LDL there
is a time- and dose-dependent (10 -10 M) stimulation
of S -kinase and ornithine decarboxylase activation,
phospEboinositide breakdown, elevation of intracellular pH
and the induction of the nuclear proto-oncogenes c-fos
and c-myc. Under the serum-free conditions employed we
did not see growth stimulation by LDL alone, however, in
the presence of EGF (5 ng/ml) both growth and DNA synthe-
sis were enhanced significantly. Similar studies with
VSMC from spontaneously hypertensive rats (SHR) and their
normotensive Wistar Kyoto (WKY) counterparts yielded
essentially the same date as that obtained with human
VSMC except that cells from SHR sources showed an enhan-
ced responsiveness to LDL in combination with EGF.
prolonged (48 hrs) preincubation o..~ VSMC from the two
speicies (rat/human) with TPA (10 M) obliterated all
subsequent stimulatory effects of LDL by itself. A direct
effect of LDL on human VSMC 'proliferative' responses may
be relevant to atherogenesis.
Tuesday, March 21, 1989
8:30AM-I0:00AM, California Room A
Anaheim Convention Center
Coronary Vasoconstrictor Substances
~ EMIX7.IHEL1N :nmsICN :INIXX1!S 'DWl!HlRAL
ISCHAEXIA IN 'IHE ra;
s. Iarkin BSc. J. Clarke MRCPI, B. Keogh FRCS,
L. Araujo MD, c. Rhodes RID, J. Brannan, K. Taylor FRCS,
G.OWies MD, ani A. Maseri FACe.
cardiovascular Unit, Royal Post-qraduate Medical SChool,
Hammersmith Hospital, IXIcane Road, Il:ltUxl W12 OON, UK.
A 21 residue en:Jat:hel.ium-derived vasoconstrictor peptide,
etX:lothelin (E1'), has recently been isolated ani studied
in vascular preparations in vitro. We have investigated
the effects of locally infused E1' in the dog~
circulation in vivo. six anaesthetised, cpan d1est
greyhoI.1n:l. dogs were studied. ReCXlrdi.rgs were taken fran
electranagneti.c flow prd:les awlied to the praxillIal left
anterior <:lesoerxtin;J (IAO) ani circumflex (CX) arteries,
IA an::l 1lD pressure lines, an::l the epicardial Em. Nonnal
saline vehicle or incremental doses of E1' (3 to 100
poc>ljmin) were infused via a fine cannula positioned in
the proximal IAO. In three animals radiolabelled
mi~ were also given to deteJ:mine reqional
myocardial blood flow, an::l in avo coronary arteriogr'aI:hy
was perfoIlllBd to assess c:han1es of epicardial coronaIy
(Ee) calibre at the maxiJmml dose of E1'. E1' :in:1uoed a
significant~ reduction of IAD~
blood flow (CBF) reducinJ it by 70% fran 60±8 to 1.9±7
ml/min (mean± SEM, p<0.005) at 100ptW:>l/min. Reductions of
IAO CBF below 50% of basal ¥.'ere associated with the onset
of gross ischaemic Em c:han1es ani raised IA pressure.
Mi~ distr.ib.rt:ion shewed transrrural. flow reduction
in the IAD territoty. No significant c.han:Jes of 1lD
pressure, heart rate, or CX CBF were seen until severe
ischaemia persisted, an::l no Ee constrictiQ'l was seen
durinJ ~iogr'aI:hy. In con::lusion INa have shown piOCl1Dlar
doses of a novel errlothelil.llll-derived peptide can in:luce
~ :isctlaBnia p:ed::minantJ.Y 1:¥ SlBl1 veseel. cxn.;t::rid:im.
ENDOTHELIN IS A POTENT CONSTRIcrOR OF FOREARM
RESISTANCE VESSELS AND VEINS IN MAN
John Clarke MRCPI, Nigel Benjamin MRCP. Simon
Larkin BSc, David Webb MRCP. Graham Davies MD.
Attilio Maseri FACe. Royal Postgraduate Medical
School, London, U.K
Endothelin (ET) is a 21 amino acid peptide
synthesized by cultured mammalian endothelial
cells. Studies in vitro suggest that it is a potent
constrictor of vascular smooth muscle and may act as
a final mediator for a number of constrictor agents.
We have studied the effect of brachial artery infusion
of ET (5pmollmin) on forearm blood flow (FBF) using
strain gauge plethysmography, and of local infusion
on dorsal hand vein diameter in normal volunteers.
ET produced a progressive reduction in FBF in the
infused arm over 60 mins to a maximum 39±7% (n=9)
similar to that with the same molar dose of
angiotensin II (40±7%; n=8). The effect of ET was
prolonged on stopping the infusion (t1 /2 = 50min) and
was rapidly reversed by co-infusion of nicardipine
(10~g/min). No effect was seen in the non-infused
arm. ET similarly produ~ed a progressive
constriction in veins over 60 mins (53±l2%; n=9).
again with delayed offset but here nicardipine failed
to reverse the effect. The kinetics of ET-induced
constriction in human vessels make it unlikely that
the effects of other recognised constrictor agents are
mediated by this peptide. However it may have an
important role in long-term modulation of peripheral
resistance and venous capacitance in man.
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JiNOOlHEUN IS A KIlDll' aHmUCR:R OF IDWI <XlUWN
ARDIm!S llf Vl.'lK)
1\dri.an 0Jester ESc. Jam Clarke MRCPI, Sham Kauser,
SinDn I.arIdn ESc, Graham Dlvies MD, Magdi. Yacoob fl'CS.
'Ihe ca:rdi.othoracic Institute, Harefield Hospital, U.K.
Erx:lot:helin (El') is a 21 amioo acid peptide derived fran
vascular erdothelial cells in culture an:i is a potent
CQlStrictor of JDalI1IIa1ian vascular tissue in vitro. It
has been suggested that El' may be an en:logetnls
antagonist of voltage-deperxient calciUIII dlannels. we
have investigated the dose-respoose relatialShip of El'
in isolated human epicardial oorallll:Y arteries. B.Iman
epicardial coronary arterial rirq segments of 2-3nm
diameter from 4 patients undergoing cardiac
transplantatiCBl were suspen:led en Irshaped hooks an:i
studied in 5m1 organ baths at 370C in a IlIXii.fied tyrode
solutiCBl gassed with a 95% ~~ mix. lin initial
tensiCBl of 5011N was at:Plied to each segment which
resulted in a restirq tensiCBl of 5-25nN at CBle ha.1r.
All segments were challen:]ed with 90Dft K'" to assess
viability. After~ an:i~, cunul.ative log
doses of El' (3xlO-lO to 3xlO-7 ) were added. El' i.niuoed
a oorrentratiCBl deperoent constrictien of rapid onset
00t with a protracted develqment of maximJm tension of
67.7nN ± 9.9. 'Ihe maximJm oontractiCBl was oonsistently
greater than that i.rxiuoed by 90Dft K'" (163%). 'Ihe dose
respoose curve was shifted to the right by 1llg
nicardipine while the oonstrictiCBl was reversed by
substaooe P (10-7 M), adenosine (10-6 M) an:!.
i.sqlrenal.ine (10-6 M), 00t not by acetylcholine or
indaDethacin. we have shawn that an erdotheliUIII derived
peptide is a potent constrictor of human ClOrorlillY
artery iniucirq a maxi.nmI oontractiCBl greater than that
iniucible with serotonin (JOlIN) or K" (3011N) an:i that
the effect is irhibite:l by a calciun dlame1 I:llodcin:J agent.
ACB'fILClIOLIU IS A POTDT VASOCOISTRICTOIl U IIUIWI
COIlOIAIlY AIl'l'BIlIBS lWILY ArrBIl CAIIDIAC TlWISPLAIIUTIOI.
Tommy C. Lee M.D., Ulrich Nellessen M.D., Tim A. Fis-
chell M.D., Tohru Masuyama M.D., Edwin L. Alderman M.D.
FACC, John S. Schroeder M.D. FACC, Stanford Universi-
ty, Stanford, CA.
The reliability of intracoronary (IC) acetylcholine
(ACh) to monitor the accelerated atherosclerosis seen
in cardiac transplant patients (pts) is controversial.
We have previously shown that IC ACh consistently
constricts coronary arteries of pts 1 to 8 years after
transplantation. In order to determine early respon-
ses, we infused IC ACh in increasing log doses (10-6 M
to 10-2 M) in 6 pts soon after transplantation (mean +
SD = 18 + 8 days). All had angiographically normal
coronary arteries and were free of rejection at the
time of study. ACh was infused via a 3 Fr catheter
placed into the mid-portion of the left anterior des-
cending coronary artery through a guiding catheter.
Angiograms after 4 minute infusion periods at each ACh
dose were obtained to assess coronary vasomotion.
Analysis of the angiograms was performed by a computer-
assisted quantitation system. No vasodilation was ob-
served in any pt. Five of 6 pts had significant
vasoconstriction at 10-3 MACh with mean diameter re-
duction of 34 + 7% (p < 0.001). No change was observed
in the sixth pt. There were no changes in blood pres-
sure or heart rate with the drug infusion. Sublingual
nitroglycerine caused significant vasodilation in all
pts. We conclude that ACh is a potent vasoconstrictor
in coronary arteries of pts even very early after
transplantation and that ACh mediated vasomotion is not
a useful assay for accelerated atherosclerosis in
transplant pts.
EFFEcrS OF ENDOTHELIN. A NOVEL VASOCONSTRICTOR PEPTIDE.
ON THE ISOLATED HUMAN MESENTERIC ARTERIES
Takashi Miyauchi M.D.. Yoko Tomobe B.S.. Masashi
Ysnagisawa M.D•• Yasuro Sugishita M.D., F.A.C.C., Iwao
Ito M.D., Sadao Kimura Ph.D., Ka tsutoshi Goto Ph.D.,
Tomoh Masaki M.D., Ph.D., University of Tsukuba. Tsukuba,
Ibaraki, Japan
Endothelin (ET) is a novel potent vasoconstrictor
peptide, which consists of 21 amino acids and is produced
by vascular endothelial cells. To investigate the
physiological significance of ET in the regulation of
human vascular tone, we studied the effect of ET on the
isolated human mesenteric arteries (RMA), and compared
wi th that of noradrenaline (NA). RMA were ob tained from
patients undergoing segmental resection of the intestine.
Ring segments (4 mm long) of RMA were lWunted in· a Kreb9-
Ringer's solution (37°C, bubbled with 95%02 + 5%C02), and
contractile tension was measured. Both ET and NE
produced dose-dependent contractions. The maximum
response to ET was 85.9±4. 2% (n-7) of that to NA.
However the ED50 value of ET (2.8 X 10-9 M, n-7) was
about two orders of magnitude less than that of NA (3.8 X
10-7 M, n=7, p<O.OOl). Vasoconstrictor effects of ET
were not affected by a-adrenergic. a-adrenergic,
muscarinic and serotonergic antagonists but were
significantly reduced by nicardipine (3 X 10-9 M), a Ca2+
antagonist, thereby the ED50 value of ET being 1.7 X 10-8
M. n-4, p<0.05). Conclusions: 1. ET showed potent
vasocostrictor effects (about 100 times mre potent than
NA) on the isola ted human mesenteric arteries. 2. The
effects of ET ','lare specifically blocked by Ca2+
antagonist. 3. These results suggest that ET may
participate in regulation of the human vascular tone and
is implicated in certain types of hypertension as well as
vasospasm.
ACB'fILClIOLIn CAUSBS YASOCOISTRICTIOI II PIlB-COftllACTBD
IIUIWI COROIAllY ARTBIlIBS U VIVO.
Tommy C. Lee M.D., Ulrich Nellessen M.D., Tohru Masuya-
ma M.D., Edwin L. Alderman M.D. FACC, John S. Schroeder
M.D. FACC, Tim A. Fischell M.D., Stanford University,
Stanford, CA.
The role of acetylcholine (ACh) on coronary vasomotion
is controversial. Although ACh causes endothelial
dependent vasodilation in organ baths, results from
human studies are mixed. To optimize the detection of
vasodilation mediated by ACh, we studied the dose
response of normal coronary arteries to ACh after phen-
ylephrine (PE) induced contraction in 6 patients (pts).
All had normal coronary arteries angiographically.
Increasing doses of PE (10-6 M to 10-4 M) was infused
over 4 minute periods via a 3 Fr catheter placed into
the mid-portion of the left anterior descending coro-
nary artery through a guiding catheter. These in-
cremental infusions produced a 19 + 10% reduction (p <
0.001) in coronary diameter without-causing significant
changes in blood pressure or heart rate. Incremental
log doses of intracoronary ACh (10-6 M to 10-2 M) were
then infused simultaneously with PE. Angiograms after
4 minute infusion periods at each ACh dose were made to
assess coronary vasomotion. Analysis of the angiograms
was performed by a computer-assisted quantitation sys-
tem. No vasodilation was observed in any of the pts.
Five of the 6 pts had vasoconstriction beyond the pre-
constricted diameters at 10-4 MACh with further mean
diameter reduction of 27 + 21% (p < 0.01). No change
was observed in the sixth patient. All 6 pts had a
negative ergonovine provocation test following the ACh
drug studies. We conclude that ACh is a potent
vasoconstrictor in angiographically normal coronary
arteries despite a pre-contracted state produced by PE.
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Systolic Function: Left Ventricular Mechanics
A Geometric View of Cardiac: "Etrk:Jeocy"
Eric A. Hoffman Ph D.• John Rumberger M.D., Larry Dougherty,
Nathaniel Reichelt M.D.• and Leon Axel M.D., Ph.D.. Univ. of
Pennsylvania, Philadelphia., PA. and Mayo Clinic, Rochester, MN.
It has been previously demonstrated (AJP 249: H883-8890. 1985)
thal the total heart volume (THY: pericardial sac contents) in dogs
remains within 5% of the end-diastolic volume throughout the cardiac
cycle. We have hypothesized that this constancy of mv minimizes
the wolk load particularly for the right heart and that. the
maintenance of a constant center of mass would further minimize
cardiac wolk load. To evaluate this hypothesis in humans, we have
volumetrically scanned 6 volunteers via cine-CT and 4 volunteers via
a new magnetic resonance (MR) myocardial tagging technique.
Change in TIIV between end-diastole ED and end-systole ES as per
cine-CT scans was 8±O.76% (SEM) while the % change in total
chamber volume was 20±2.4 %. Data closely parallel previous dog
stUdies which suggested possible intra-cardiac cycle alterations of
myocardial blood aiding the maintenance of a constant TIIV. Shift of
the TIIV center of mass between ED and ES was only 3±0.8 rom
along the LV long axis with no change along orthogonal axes. MR
tagging, whereby "stripes" are added to the myocardium via spatial
modulation of magnetization (SPAMM>, has allowed for evaluation of
the contribution of segmental myocardial contraction to the intel3Ction
between the four chambers leading to a constant TIIV. Stripe motion
parallel to the mitral valve plane demonstrate a tethering of atrial
dome and epicardial apex. Transmural warping of stripes demonstrate
regional inhomogeneities of myofibril contributions to wall dlicltening
and motion. Motion of the mycatdial stripes relative to pericardial sac
stripes demonstrate the strong role of the pericardial sac in
facilitating low resistance to cardiac positional and shape changes.
Supported in port by NIH HL-29886; Dr. Hoffman is an established
investtgalOr oithe American Heart Association.
COMPARISON OF THREE INDICES OF LEFT VENTRICULAR
PERFORMANCE DERIVED FROM PRESSURE-VOLUME
LOOPS IN CONSCIOUS DOGS.
Micbael Mymma M 0, Che-Pina Cbeng, M.D., Ph.D.• Jakob
Vinten-Johansen, Ph.D., William E. Johnston, M.D., William C.
Little, M.D., F.A.C.C. BoWD1311 Gray Scbool of Medicine, Wake
Forest University, Winston-Salem, NC.
Three load-insensitive indices of left ventricular (LV)
performance derived from pressure (P)-volume (V) loops have been
proposed; the end-systolic P-V (PES-VES) relation, the stroke
work-end-diastolic V (SW-V~D) relation and the maximum dP/dt-
VED (dP/dtma.-VED) relation. We evaluated the variability and
inolropic senslUvity of the slopes of these relations in 9 conscious
dogs. LV V was determined from three orthogonal LV diameters
measured by sonomicromelry. Three to five sets of variably loaded
P-V loops were generated by transient caval occlusions before and
after inotropic stimulation with dobutamine (6±1 meg/kg/min,
meantSD). The variability of the slopes were assessed at constant
inotropic state using the coefficient of variation. The SW- V1::D
relation was less variable (S±3%) than either the P.ES-'YES relation
(9±6%, p<O.05) or the dP/dtmu-VED relation (1I±9'lll,- p<O.OS).
The SW-VED relation had a smalier increase with dobutamine
(12S±29% or control. p<o.OS) and the dP/dr.nax-VES relation a
greater increase (233±57%, P<O.OS) than the slOpe of tile PES-VESrelati~n (187;t6O%). The position of the P -VES relation,
quantitated by V100' the VES at PES-IOO, Show~ Jess variability
(4±S%) than the slope of the PES';VES relation (9j;6%, p<O.OS).
V100 consistently decreased with llobuwnine (88±7% of control,
p<O.OS).
Conclusion: In conscious dogs, the slope of the SW- VED
relation is less variable but also less sensitive to changes ID
inotropic state than the slope of the PES- V:ES relation, while the
slope of the of the dP/dt ax-VED relitIon IS more sensitive and
more variable. V100 has ~ vanability than the slope of the PES-VES relation and responds consistently to inotropic stimulation.
DELETERIOUS EFFECTS OF VOLUME LOADING AFTER ACUTE
PULMONARY EMBOLISM.
Israel Belenkie MD, FACC, Rosa Dani MD, Eldon R. Smith
MD, John V. Tyberg MD, PhD, FACC. University of Calgary,
Calgary, Alberta, Canada.
Volume loading (VL) is used to treat hypotenaion due
to pulmonary eabolism (PE). We studied 10 closed chest,
anesthetized and ventilated dogs to test the hypothesis
that VL after PE would decrease LV stroke work (SW) by
cauaing a leftward septal shift and fecreased LV
trsnsmural pressure (P). PLV, PRV (Millar ), PRA and P
pericardi.... (balloon) plus septum-to-RV free wall,
septum-to-LV free wall (DSLV) and LV anteroposterior
(DAP) diameters (sonomicrometry) were measured. Repeated
PE (RPE) was produced with autologous clot. VL was done
before PE, after one PE and after RPE. LV area (ALV -
DAP x DSLV) was used as an index of LV volume. SW was
calculated as the area of the LVP x ALV loop.
ALV (111III2 ) SW(1Im Hg X 1102 )
C VL C VL
Before PE 2870~430 3080t520* 188~85 260tlOl*
After 1 PE 2850t470 2870t500 l88t39 203t 52
After RPE 2760t440 2660t420* 133t64 45t 27*
* P <.05 vs C (ANOVA).
VL after RPE decreased the tranaaeptal gradient (-3c2
to -5tO _ Hg; p<.OOl) with a leftward septal ahUt.
Preload, aa reflected by LV tr.namural P, alao decreased
(lt2 to -lt2 111III Bg; p<.Ol). Thus, despite similar
increases in LVEDP with each VL, the response after RPE
was quite different from before PE and after 1 PE.
We conclude that volume loading in this model of
pulmonary embolism can cause a marked reduction in LV
stroke work by decreasing diastolic filling secondary to
ventricular interaction. This suggests that the
reaponses to VL in patients with PE may also be variable
and potentially deleterious in some circumstances.60LV VOLUME Iml)
ON IMPORTANT VOLUMES IN THE LEFT VENTRICLE
Srdjan Nikolic, MS, Micluiel P. Feneley, MD, Octavio
Pajaro, MS, Robert W.M. Frater, MD, FACC, J. Scott
Rankin, MD, FACC, Edward L. Yellin, PhD
Albert Einstein College of Medicine, Bronx, N. Y., and
Duke University Medical Center, Durham, N.C.
In 7 anesthetized dogs, LV pressure (P) was
measured with micromanometers, and LV volume (V)
was calculated from 3 orthogonal ultrasonic diameters.
Relationships were investigsted between 3 important
ventricular parameters: volume intercept of the end~
systolic P-V relationship (Vd), "unstressed" end
diastolic volume determined at maximal vena caval oc-
clusion (Vvco) , and "equilibrium" volume (Vo) obtained
by end-systolic occlusion of an implanted Bjork mitral
valve (MVO). Single beat MVO's were performed every
13-8 cycles during VCO to transiently prevent filling,
and minimal LVP and V during MVO determined the
non-filling P-V relationship (dashed line) with volume
intercept Yo. The end-diastolic P-V relationship also
was computed (solid line) with volume intercept Vvco.
E~;§:~E~!I'--~..ia.-.,~..~.-•.;.:'~.i,.-'...;,•.•-'-'·'-·'·-"-:.--.
different physiologic pheno- ~! e."",,
mena. The conceptual rela- :::ll
tionship between these volume g:
parameters, especially as to ::;
which represents true myo-
cardial "slack length," needs
to be assessed in further
studies.
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Myocardial and PericardiaI Disease
CAN PRE-OPERATIVE PEAK CX»OlARY PLCW PRmICI' SYMPIaf Am
METABCLIC BmEFIT AFrER OPERATIVE RE1.IEF OF c:J3S'm)CI'ICfi IN
HYPERl1VPHlC CAIDICJM>PATHY?
Richard O. cannon, M.D., F.A.C.C., Cllarles L. McIntosh,














~rative relief of left ventriaJIar (LVi outflow
obstruction improves symptans in most, but not all,
patients with hypertrophic cardiOll!{Opathy (HOO. we have
hypothesized that small vessel ooronaI}' disease may
oontribute to sytI'fll:ans in ROh this aI:l1oIllla1ity would
inpair peak ooronaI}' flow, and would not be improved by
surgeI}'. To ascertain whether pre-op peak ooronary flow
predicts operative benefit, we measured great cardiac
vein mev} flow during rapid atrial pacing in 20 R(}IJ
patients with LV outflow obstruction. Group A includes 6
patients with peak 001 flow >175 ml/min during pre-op




G~ A Pre-op 216+18 -32.8+30.5
Post-op 151+46* 28+23.9*
Group B Pre-op 138+19 -10.4+52.8
Post-op 123±43 -6.0±26.2
*p<.05 VB pre-op: Lactate=llfol·ml/min.
All Group A patients had a 10 beat/min or greater
ilrprovement in pacing angina threshold with no lactate
prodJctioo, whereas 5/14 Group B patients had no
improvement. 'IhLs, a higher peak flow response to stress
pre-op oonsistently predicts post-op sytI'fll:an and metabolic
ilrprovenent to pacing stress. Results in patients with
lower peak flow responses are variable, suggesting
mechanisms other than obstruction, such as small veasel
disease, may contribute to synptans.
LEPT VENTRICULAR SYSTOLIC PRESSURE-VOLUME AREA AND OXYGEN
CONSUMPTION OP HYPER-AND HYPOTHYROID RABBITS.
Yoichi Goto, M.D., Bryan K. Slinker, D.V.M., Ph.D.,
Martin M. LeWinter, M.D., P.A.C.C. University of
Vermont, Burlington, VT.
o consumption per beat (VO ) in isolated left ventri-
cle tLV} is linearly correlate3 with pressure-volume
sres (PVA). The reciprocal of the slope (m) of the VOZ-PVA relationship indicates the mechanical efficiency
of the contractile machinery, while the VOz-intercept
(Int) reflects the energy cost of EC couplIng and bssal
metabolism. A variety of acutely administered inotropic
drugs have been shown to alter the VOZ-Int, but none
has had any effect on mechanical efficiency. In rabbits,
hyperthyroidism increases the V1/V3 ratio of myosin iso-forms, thereby altering the kinetics of the actin-myosin
interaction. To determine what effect this has on the
VOZ-PVA relation, we quantified contractility by Emax
(slope of the end-systolic PV relation) and mechanical
energy output by PVA in blood perfused hearts isolated
from normal (N, nz 7), hyperthyroid (Hr, n~5), and hypo-
thyroid (Ho, n~7) rabbits. LV weight and normalized
Emax were similar among the groups. However, both m
and VOZ-Int of the_~02-PVA'relationwere greater (p<.05)
in Hr {m, 3.1 x 10 ml 0z/[mmHg'm!~; Int, 0.051 ml 0Z/
beat/100 g} tha~5in N (m, Z.l x 10 ; Int, 0.040) and
Ho (m, Z.1 x 10 ; Int, O.035). Isoproterenol increased
rnt but not m in each group, indicating that m changes
in Hr are not due to increased beta-receptors. We con-
clude that in Hr the LV has both decreased contractile
efficiency (due to increased V1/V3 ratio) and increasedenergy cost of E-C coupling + oasal metabolism. Both
contribute to higher VOZ in Hr.
MYOCARDIAL METABOLIC TO MECHANICAL ENERGY
TRANSFER CHARACTERISTICS FROM SINGLE
VENA CAVAL OCCLUSIONS IN CONSCIOUS DOGS
Joseph R. Elbeery, MD, Clarence H. Owen, BS, Michael
A. Savitt, MS, George W. Maier, MD, J. Scott Rankin,
MD, FACC, Peter VanTrigt, MD
Duke University Medical Center, Durham, NC
Myocardial energetics have been quantified by
linear energy transfer (ET) curves relating steady-state
total LV oxygen consumption per beat (coronary blood
flow x AV02 difference) on the abscissa to total mecha-nical energy expenditure (stroke work plus the product
of end-diastolic LV volume and mean ejection LV pres-
sure) on the ordinate. ET characteristics have been
shown to be insensitive to alterations in afterload and
inotropism, and link. myocardial metabolism to mechanical
function. However, a clinically applicable method for
determining ET relationships has not been available.
Accordingly, dynamic ET curves obtained during rapid
vena caval occlusion (VCO) were compared with those
from steady state preload reduction in 8 autonomically
blocked conscious dogs . LV volume was measured with
ultrasonic transducers, LV pl'9ssure with micromano-
meters, coronary blood flow with Doppler probes, and
coronary AV0.2. .difference with high fidelity fiberoptic
catheters. Higruy linear (mean R=.95±.03) ET curves
were observed both for rapid VCO and for multiple
steady state preloads. The slopes and intercepts of the
dynamic ET curves (1.32 ± .24; .14 ± .07) were not
significantly different from steady state coefficients
(1.34 ± .20; .13 ±.06) by analysis of covariance (p>.6).
Thus, metabolic adjustments to changing LV energy
demand occur rapidly, and transient vena caval occlu-
sion may be a simple, practical, and clinically useful
technique for examining myocardial energetics in
patients undergoing cardiac catheterization.
ENHANCED CARDIAC ADRENERGIC RESPONSE IN CARDIOMYOPATHIC
HAMSTER AT A PRE-CONGESTIVE FAILURE STAGE.
Osamu Hano, M.D., Edward G. Lakatta, M.D., Laboratory of
Cardiovascular Science, Gerontology Research Center, NIH,
NIA, 8altimore, Maryland
Prev lous stw ies suggest that the pathogenesi s of the
Syrian hamster cardiomyopathy{CMH) may be related to an
exaggerated responsiveness to catechol ami nes. In order
to differentiate the response to ~~nergic stimulation
from that due to increased cell Ca per se, we used
35-60 day old male CMH (filled symbols) and age-matched
FIB strain control (C; open symbols) hearts. Isolated,
Isovol umlc and AV blocked hearts were perfused with Hepes
buffer at constant pressure and stimul ated at 2 Hz at
37°h to investigate the effect of changes in bathing
[Ca ] (I-10 RIM; n z 6 of each; .,A), II-adrenergic (iso-
proterenol, 0.001-0.5 11M; n = 6 of each; e,o) and Cl-~re­
nergic (phenylephrine, 0.05-10 11M plus propranolol,S 11M;
n • 6 of each; _ ,0) agonists on developed. pressure (IP).
Results (Figure~ofllre ~ of DP(%Control) 10g[Ca2+)
DP in 2 mM [Ca ] prior -) -2
to drug, which were 61.2~ 250 ~1""'''I "ii'., "ii"
5.5 and 81.2~.2 nmHg 13" ,
(mean ~ SEM) in CMH and C200 - I \,- or (l
respectively. In CHH i"~,
both a- and II-adrenergic " .., '~
responsiveness is mark- 150 I' ..
ed1y enhanced (Figure);' ...~
this is not due to !.\! 100 ~~
enhanced response to Ca
per se (Figure), but may 50
be2jl ue to greater ce 11 _9w..UJ_Wl8~J.J._7 -6 -5
Ca. lo~ing by catechol- log[isoproterenol]
amIne stImulation. or log[phenylephrin]
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PATHOGENESIS OF SYSTOLIC ANTERIOR MOTION OF
THE MITRAL VALVE - CAN THE PAPILLARY-MITRAL
APPARATUS PLAY A PRIMARY ROLE CLINICALLY?
John P. O'Shea, M.B.B.S., F.R.A.C.P., Nicolas Oanchin,
M.D., Arthur E. Weyman. M.D., F.A.C.C., Robert A. Levine,
M.D.• F.A.C.C. Massachusetts General Hospital, Boston, MA
The patho~enesis of systolic anterior motion (SAM) of the mitral
valve remams controversial, as patients with hypertrophic
cardiomyopathy have two potential primary causes of SAM:
asymmetric septal hypertrophy (ASH) and abnormalities of the
papillary-mitral apparatus (PMA). In order to exelore whether
SAM can occur clinically due to PMA abnormabtles m the
absence of ASH, we searched the records of our labOratory and
referrals tor 811 patients (PTS) with 2-dimensional echo studies
(20E) demonstrating leaflet SAM. RESULTS: 9.5 PTS with SAM
were identified. of whom 90 had septal hypertrophy. Of the
remainder, in addition to 2 pts with tumors of the PMA
prolapsing into the LV outflow tract (LVOT). there were 3
distinct mechanisms evident for SAM: I)tumor of the posterobasal
myocardium displacing the papillary muscles (PMs) and mitral
leaflets anteriorly into LVOT flow (n= I), 2)anomalous fusion of
redundant chordae (n = I) and 3)anomalous PM position (n = I).
In this series, the ratio of septal to posterior wall thickness was
normal (1.01 + 0.15) asr'as the LVOT diameter (2.3 + 0.4 em)
and area (6.40+ 0.7 em ). Nevertheless, SAM in thisseries was
accompanied byelevated LVOT velocities (up to 3.2 mts),
abnormal LVOT gradients at catheterization (up to 4.5mm Hg at
rest) and clinical evidence of pre-syncope. CONCLUSION: In
the absence of ASH, SAM can occur clinically as a result of PMA
abnormalities. These spontaneous experiments of nature illustrate
the primary role that abnormalities of the PMA can play in
generating LVOT obstruction, by alterations in leaflet redundancy
and chordal tension.
ELECTROCARDIOGRAPHIC CHANGES DURING DIPYRIDAMOLE STRESS AS
POTENTIAL MARKERS OF ACUTE CARDIAC REJECTION.
Eugenio Picano, MD, Gabriella De Pieri, MD, Jorge A. Salerno, MD, ElOIsa
Arbustini, MD, Alessandro Distante, MD, LUigi Martinelli. MD. Carlo
Montemartini, MD, Mario Vigano', MD. Cardiology and Cardiosurgery Div.,
University of Pavia, Clinical Physiology Institute, Pisa, Italy
It has been hypothesized that ocute cardioc rejection, Syndrome X and
arterial hypertension can induce small vessel damage and therefore
restrIctiOn of coronary reserve in the presence of normal epicardial
coronary arteries. We have previously described in Syndrome Xand arterial
hypertension a charocteristic response pattern to dipyridamole (DIP)
Infusion: ST segment depression without any measurable systolic
dysfunction. Aim of this study was to establish whether ocute cardioc
rejection might induce electrocardiographic alterations during DIP infusion.
Changes in 12 lead electrocardiogram and 2-0 echocardiogram during higll
dose DIP infusion (up to 0.84 mg/kg in 10') were evaluated within 24 hrs
of endomyocardial biopsy in 11 transplanted Pts: a total of 40 biopsy
controlled DIP studies were performed within 5 weeks after cardioc
transplantation. For eoch Pt, at least 7 days elapsed between 2 consecutive
studies. Electrocardiographic and echocardiographic trocings were analyzed
without prior knowledge of endomyocardial biopsy findings. No remarkable
side effects occurred in any case, so that the DIP study could be completed in
all Pts. In all studies a synergic controction pattern of all ventricular walls
was detected in resting conditions and after DIP Adiagnostic () 0.1 mVolt)
ST segment depression was found in 13 studies. The sensitlvity and
specificity of DIP-induced ST segment depression for the detection of biopsy
proven ocute rejection was 72l and 90l respectively. These data show that
DIP stress is feasible and safe in transplanted Pts. and that ocute cardioc
rejection can be occompanied by DIP induced ST segment depression, without
detectable impairment in systolic function These Changes might provide I)On















T mlPHOCYTE SUBSETS AS THE NONINVASIVE IIARKER OF
GARDTOIIYOPATIlY
Tsugiyasu Kar~ II.D., Tomoyuki Yokoya.a II.D.,
Tadashi Suzuki II. D., Kuzuhiko lIurata II. D., Gunlla
Univers ity, Gunl1la, Japan.
Eighty-five patients with unexpained congestive heart
failure were examined T lymphocyte subset in the periphe-
ral blood as the noninvasive diagnosis by two-color laser
flow cytometry. The final dianosis was perfoued cathete-
rization and endOllYocardial biopsy. The patients were diag-
nosed as dilated cardioll'ioP"athY (OCII) , (n=24), 1IY0carditis
(IIC) by Dallas criteria(nc ll), Coronary heart disease(CHD)
(n=I7). The results were as fol!ows:CD8'CDU-(cytotoxic T)
subset was significantly lower,CD4'2H4+(suppressor!inducer
T) subset was higher in patients with DCII than IIC and CHD.
CD4/COB and CD4 '204' /COB'CDll - ratios were eXaJIined and
co_pared with nor~1 control(NC).
DCII IIC
47±lO 43i9
13. 4i5. 7' 22. 5i9. 2
26.9i9.3· 20. 6i7. 9
2. 2i l. 3" 1. 2iO. 7 O. 6iO. 4 O. 8±0. 6
2. 4±1. 7' 1. 5iO. 8 1. 5±0. 7 1. 6±0. 7
·p<.05, ·'P(.OI, +P<.02 co_pared with NC.
A ratio of CD4'2H4'/CD8+CDll-)1. 6 was defined as a 831
spe~ificity and 7~ sensitivity for the diagnosis of di-
I~t~.cardiomyopathy, although CD4/CD8>1.8 was a 671 spe-
CifICity and 651 sensitivity. There were no significance
in the ratio bP.tween IIC and CHD,however,CD8+Leu7' (natural
suppressor)subset in IIC was statistically higher(19.2±8.31
p<.02) than DeN.CHD and NC. Conclusion: An elevated ratio
of CD4'2H4+/CD8+CDI1- in tr.e-TY~hocytes of peripheral
blood gay be a useful diagnostic I8rker of dilated cardio-
.yopathy versus myor~rditis and coronary heart disease.
NOVEL CARDIAC-SPECIFIC CIRCULATING AUTOANTIBODIES
IN DILATED CARDIOMYOPATHY
Alida Caforio MD. William J. McKenna, M.D., F.A.C.C.,
Ezio Bonifacio, M.B., Michael P. Frenneaux, M.B.,
Emanuele Bosi, M.D., Gian Franco Bottazzo, M.D. St.
George's and Middlesex Hospitals, London, U.K.
Organ-specific autoimmunity is characterized by
circulating autoantibodies (Abs) which are specific to
the diseased target organ and do not cross react with
other tissues. Organ-specific cardiac Abs have not been
reported. To determine whether organ-specific cardiac
Abs are present in dilated cardiomyopathy (DCK) we
tested 55 sera from patients (pts) with DCM, 249 with
other cardiac disease (OCD) and 200 normals by indirect
immunofluorescence (IFL) on human atrium (HA) and human
skeletal muscle (HSM). Positive sera were then titrated
by IFL before and after absorption with homogenates of
HA, HSM and rat liver as control tissue. Sera were
classified as cross-reactive when Ab titer dropped
Significantly (~ 2 doubling dilutions) after absorption
with both HA and HSM and as organ-specific when the Ab
titer fell only with HA absorption. Organ-specific
cardiac Abs were more frequent in DCM (13/55, 24'), than
in pts with OCD (2/249, I') and normals (3/200, 1.5'.
p<O.OOl). Organ-specific cardiac Abs were IgG (titer
range pre-absorption: 1/10 - 1/40) and gave a
cytoplasmic IFL staining on atrial myocytes only.
Conversely. cross-reactive sera were similarly detected
in DCM (4/55. 7'), OCD (15/249, 6') and normals (15/200.
7.5'. p-NS) and gave the previously described striated
and/or sarcolemmal IFL pattern both on HA and HSM. These
results provide novel evidence for the existence of
organ-specific cardiac Abs in DCM and suggest an
autoimmune pathogenesis in some pts with this condition.
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PREVALENCE AND DIRECTION OF MITRAL REGURGITATION IN
HYPERTROPHIC CARDIOMYOPATHY.
Ian C. Darcel M.D., Zion Sasson M.D., John Fulop M.D.,
Gregory Mlshkel M.D., E. Douglas Wigle M.D., Harry
Rakowski M.D. Toronto General Hospital, Toronto,
Canada.
To study the presence and direction of mitral
regurgitation (MR) and Its relationship to LV outflow
tract obstruction we performed 77 color flow Imaging
studies In patients with Hypertrophic Cardiomyopathy.
Obstruction (OBS) was present In 18, no obstruction at
rest (NO) In 30 and 29 were studied post-myectomy (M).
The prevalence and direction of mitral regurgitation
were as follows:
In the CBS patients with at least mild MR, 93" had
jets originating from the anterior portion of the mitral
valve plane. These jets were directed posterIorly In an
eccentric fashion and often were layered against the
posterior left atrial wall. ThIs was due to the
anterior direction of both mitral leaflets. Following
myectomy only 34" had at least mild MR with 63" of jets
being centrally directed. Patients without obstruction
and post myectomy behaved similarly.
In most patients, MR Is related to the presence and
degree of obstruction. The posterior direction of the
MR jet appears due to the funnel effect of systolic





























RELATIONSHIP BETWEEN THE EXTENT OF MUSCULAR HYPERTROPHY
AND DIASTOLIC FUNCTION IN PATIENTS WITH HYPERTROPHIC
CARDIOMYOPATHY WITHOUT LEFT VENTRICULAR OUTFLOW GRADIENTS
OR MITRAL REGURGITATION.
Toshinori Utsunomiya, MDi Jylius M. Gardin. MO. FACC;
Walter L. Henry, MD, FACC; University of California,
Irvine, CA.
Multiple factors have been postulated to cause diastolic
dysfunction in patients with hypertrophic cardiomyopathy
(HCM), including the extent of ~ocardial thickening pro-
duced by the myopathic process. We evaluated the rela-
tionship between the extent of myocardial thickening and
diastolic function in 16 pts with HCM (aged 15-75 yrs)
using M-mode, 2-D and Doppler echo. Six of 16 pts had LV
outflow gradients and 8 had mitral regurgitation (MR).
Because of the known influence of MR on early diastolic
filling, the 8 pts with MR were excluded. In the remain-
ing 8 pts without MR or LV outflow gradients, the sever-
ity and extent of muscular hypertrophy were assessed from
2-0 echo by Wigle's index. Diastolic function was evalu-
ated by measuring the ratio of late-to-early diastolic
peak mitral flow velocity from Doppler and maximum early
diastolic velocity of the LV posterior endocardium fro.
M-mode echo. Doppler mitral flow velocity data were
adjusted for age using previously derived regression
equations. In HCM pts without HR, Wigle's index corre-
lated directly with the ratio of late-to-early diastolic
peak mitral flow velocity (r-O.69, p<O.05) and inversely
with the maximum early diastolic velocity of the LV post-
erior endocardium (r--O.79, P<O.05). These data suggest
that the extent of myocardial thickening reflected by
Wigle's index and the degree of LV diastolic dysfunction
are significantly associated in pts with HCH who do not
have LV outflow gradients or HR.
ANTIBODY MEDIATED DISTURBANCE OF MYOCARDIAL
FUNCTION - A MODEL FOR DILATED CARDIOMYOPATHY.
~ Schulthei•• , ~. Schulze, R. Schauer, and
B.F. B.ck.r; M.d. ~linik I, Univ. Munich, FRG.
R.c.ntly, autoantibodi... (AB) against the
ADP/ATP carri.r, which inhibit the nucleotide
tran.port in vitro w.re demon.trat.d in DCM.
To ••tabli.h wh.ther AB again.t the ADP/ATP
carri.r might b. of pathophy.iological
r.l.vanc. by alt.ring myocardial function,
guin.. pig. were iaaunized with the i.ol.t.d
carri.r protein. After 24-30 week. the ha••o-
dynamic function of the heart. was ••••ur.d by
i.olated perfu.ed working heart pr.paration.,
the metabolic .tatu. by non-aqueou. fractiona-
tion. In immuniz.d animal. mean aortic
pr•••ur. (53%12 vs. 93%8 mmHg) ••troke work
(0.4%0.3 v.. 1.7%0.3 mJ/g) and ext.rnal h.art
work (62%82 v•• 375%58 mJ/g/min) w.r. signifi-
cantly d.cr••••d, the lactate relea.e (4.4%1.9
v.. 1.7%0.4 pM/g/min) increased. Parallel the
ADP/ATP ratio a. w.ll a. the pho.phorylation
.tate of ATP were .ignificantly low.r in the
cyto.ol. while in the mitochondria a
.ub.tantial increa.e vas obs.rv.d. Con••qu.nt-
ly the differ.nc. b.twe.n the mitochondrial
and the cyto.olic phosphorylation potential
of ATP (AG) was only 0.7 kJ/mol (controls: 4.6
kJ/mol) (p<O.OOll. Th••e finding. prove the
.u.picion that AB again.t the ADP/ATP carrier,
cau.ing an imbalanc. betveen energy deliv.ry
and d••and, might b. an essential component of
the pathophy.iological mechani.m involved in
dilat.d cardio.yopathy.
PREVALENCE OF CARDIAC ABNORMALITIES IN A LARGE KINDRED
WITH MYOTONIC DYSTROPHY.
William A. Zoghbi, M.D., F.A.C.C., Antonio Pacifico,
M.D., F.A.C.C., Henry F. Epstein, M.D., Tetsuo Ashizawa,
M.D., Richard Armstrong, M.D., M. Benjamin Perryman,
Ph.D., Miguel A. Quinones, H.D., F.A.C.C., Baylor
College of Medicine, Houston, Texas.
Myotonic dystrophy is the most common muscular dystrophy
affecting adults. Clinical manifestations may not become
evident until late adulthood. The incidence of cardiac
involvement in large families with myotonic dystrophy
has not been determined. We prospectively performed
echocardiographic studies as well as neurologic and
opththalmologic examinations on 85 blood line members of
a single large kindred with myotonic dystrophy (43 M,
42 F; mean age 31 ± 18 yrs). Sixteen individuals were
clinically affected with myotonic dystrophy; of these, 6
had mitral valve prolapse (MVP) by both M-mode and 20
echo, 2 had diffuse LV hypokinesis (ejection fraction
40% and 45%) and 3 had segmental wall motion
abnormality. In contrast, in the 69 unaffected members
who are still at risk for developing ~otonic dystrophy,
MVP was present in 12 and no other cardiac abnormality
was observed. Overall. the presence of any cardiac
abnormality of MVP and/or cardiac function was
significantly more prevalent in affected (11/16 or 69~)
than in unaffected members (12/69 or 17~; p 000.0001).
Conclusions: Cardiac abnormalities are prevalent in a
large Idndred with myotonic dystrophy, predominantly
involving affected individuals. Of interest is the high
incidence of mitral valve prolapse (17%) in individuals
at risk for developing myotonic dystrophy, compared to
the general population. This raises the possibility of
subclinical involvement with myotonic dystrophy and
warrants a prospective follow-up of these patients.
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New Aspects of Experimental Myocardial
Infarction
P08'l'-BYPOPBDU8IOII UPBDUBIOII: ORCBB8TRA'l'BD
UCOVBRY PROM MYOCARDIAL 8UPPLY/DBKAIID
IXBALAlfCB IlA%IKIlIB8 BBAll'l' PUBCTIOII.
~ Pelikan. 812... ~, Jay Sharma, BA, and
James Niemann, MD, Harbor-UCLA Medical Center
and Saint John's Heart Institute, Torrance, CA.
To determine whether hypopertusion-induced
augmentation of mitochondrial function is an
adaptive response to myocardial supply/demand
imbalance, 19 experimental isolated perfused
rat hearts were sUbjected to 30 min
hypoperfusion (coronary perfusion pressure
[CPPJ decreased to 20 mm Hg) followed by
reperfusion (CPP returned to 80). ouring early
reperfusion LV pressure increased to 88 ± 2 lIIlII
Hg, greater than baseline pre-hypoperfusion
pressure (78 ± 2; p<0.005). Mitochondria
isolated from 5 hearts in early reperfusion
during LV functional augmentation showed an
increase in state 3 respiration (470 ± 49 ngram
atoms O/min/mg) compared to 5 time-matched non-
hypoperfused controls (327 ± 33; p<0.05). In 14
experimental hearts mitochondria were isolated
after 30 min reperfusion when LV pressure had
returned to baseline levels. State 3 was 321 ±
32, equivalent to that found in 7 time-matched
control non-hypoperfused hearts (380 ± 47;
p=NS). Thus, hypoperfusion-induced augmentation
of mitochondrial function persisted during
increased LV function in early reperfusion but
not into late reperfusion, after the period of
increased LV function. The simultaneous
enhancement of LV and mitochondrial functions
therefore may be components of an orchestrated
response to supply/demand imbalance which
maximizes post-hypoperfusion recovery.
ISCHIMIC VlHfRICULAR FIBRILLATION IS DISTINGUISHED BY
PRESIRVID HISTAMINE-STIMULATID ADBHYL CYCLASE ACTIVITY
Andrew ¥plff. MD. FACC, Dawn Hines, Joel Karliner, HD,
rACC, VAHC and CYRI, ucsr, San rrancisco, CA.
we have shown that adenyl cyclase activity (ACA) .ediated
bye-adrenergic receptors is preserved during ische.ia by
enhanced coupling of 8-receptors to the stiaulatory
guanine nucleotide binding protein, Ga. To see i£
ischeaic hista.ine (Hst) H2 receptors behave siailarly,
we coapared net ACA (i ••• , lCA in the presence of agonist
and 10 ~H GpplHp .inus activity due to 10 ~ GpplHp
alone; paul cAKP/-.J prot/aln) sU_lated by Hat or (-1-
isoproterenol (Isol In ..abranes froa non-ische.ic (NI)
vs ische.ic (II .yocardiu. fro. rabbits surviving 30 .in
of coronary occlusion, and fro. rabbits which succuabed
to ventricular fibrillation (¥P) within 30 .in of coro-
nary occlusion. Net Iso-sti.ulated ACA (5 conc.ntra-
tions, 10 nH through 10 ~) was not different in NI vs I
fro. non-fibrillating rabbits, ~or was the Iso dose-
response curve shifted (1C50s: 9 vs 20 nK; nE 61. In
contraat, net Hat-stlaulated ACA at both .1 and 1 aM was
depressed by 30 .in iacheala (33 t 17 ISO/ VB 9 t 17,
p•• Ol and 35 t 26 va 14 t 12, p-.05, relpectively; n-81;
1C50 rose after 30 .in ische.ia fro. 12 to >80 ~H (n-81.
Reaarkably, this divergent ische.ie response between Iao-
and Hat-sti.ulated ACA was not aeen with ¥P; ACA was
preserved durinq iseheaia with ¥P, whether stiaulated by
Iso or by Hst, each over 4 logs of agonist concentration.
(Iso 1C501: 27 vs 50 nH; Hst IC50s: 3 va 8 ~; n-3). Ie
conclude that 8-receptor. and Hst H2 r.ceptor. respond
differently to ischeaia without Yr, but relpond .i.ilarly
when vr COIIpl1eates i.chema. The pathog.nesis of ¥P aay
involve the dichotoay between the Hat re.ponaes of adenyl
cyclaae in ische.ie ..abranes fro. fibrillating VB
non-fibrillatinq hearta.
PROTECTIVE EFFECTS OF GLUTATHIONE ON COMPLIANCE AND
CORONARY RESISTANCE
Alvin S Blaustein MD,. auth I. Stolz M.D., Nancy A.
Healey B.S., Deborah Baxter B.S., Susan M. Deneke
Ph.D .• VA Medical Center. Boston. MA.
We hypothesized that glutathione (G) is an important
defense against ischemia (I)/reperfusion (R) radical
injury within the vasculature. Isovolumic buffer-
perfused (constant flow) rat hearts underwent 20 or 40
min I and were reperfused for 30 min with standard (B)
or 2mH G-enriched (8+) buffer. We compared changes in
G levels, compliance (k values). and coronary
perfusion pressure (pr, maNg). G levels were
1.42±0.65 umol/heart after 20 min equilibrium (EQ).
With B, there were no changes in G levels after I/R.
With B+, levels increased to 4.66±0.50 (20 min I/R)
and 3.72±0.67 (40 min I/R) (p<0,05 vs EQ); after 5 min
washout, levels fell to 1.54±0.39. G levels in
bovine pulmonary artery endothelial cells incubated 2h
with 6mM G increased from 1.97+0.07 to l5.2±1.67
nmol/l06 cells. -
EO 20 IIR EO 40 ItR
B k 2. 4±0. 6 2. 4±1. 0 1. 6±0. 3 6. 5±2. 5*
PP 77±8.3 102±22.4* 87±6.1 116±16.3*
B+ k 1.3±O.4 1.2±O.3 1.4±0.6 2.2±0.6
PP 82±6.3 88±18.7 80±7.1 86±13.4
*p<0.05 vs EQ; data are mean ± SD, n-5-10.
Reperfusion with B+ prevented increases in myocardial
stiffness and coronary resistance. Although most of
the increase in G represented extracellular trapping, _
protection of coronary vasculature may also represent
endothelial G uptake resulting in only small increases
in myocardial levels.
STUNNED MYOCARDIUM: A FORM FRUSTE OF ELECTROMECHANICAL
DISSOCIATION?
R2bir1 iL~~, Joseph H. Levine, M.D., Charles
Prood, Ph.D, Joseph F. Spear, Ph.D., F.A.C.C., E. Nell
Moore, D.V.M., Ph.D., F.A.C.C. The Johns Hopkins
University School of Medicine, Baltiaore, NO
8rief periods of ische-ia (J) and reperfusion (R) lead
to prolonged mechanical dysfunction, the
electrophysiologic (EP) correlates of which are
uncertain. Eighteen dogs anesthetized with
pentobarbitol (30 mg/kg IV) underwent thoracotOllY, 15
.in proximal anterior descending occlusion, and 20 Min R.
At baseline (B), peak I, and 20 Min R, electrogrill
durations (0), refractory periods (ERP) and conduction
velocity (CV) were measured frOll 12 standardized sites
spanning the border zone between ischemic (IZ) and less
or nonischemic (LIZ) myocardium. Echocardiographic
percent thickening (T) confirmed normal preischemic and
markedly reduced postische.ic function.
B 1 Z2m1nB
lZ 37.2±12.1 110.0±35.9** 39.2±11.5
LlZ 38.4±12.0 42.0±14.2 37.8±11.0
lZ 0.68±0.15 0.19±O.31** 0.65±O.15
LlZ 0.64±0.18 0.74±0.18* 0.73±0.19
1ZlL1Z 132±6 134±11
1ZlL1Z 42±21 -13±8**
**p<0.001 versus Bi *p<0.05 versus 8)
With R, return of CV toward normal in JZ versus LIZ is
slightly blunted. Nonetheless the EP of SM has largely
renormalized (p>0.05: 20 min R versus 8), despite
ongoing hemodynamic compromise. SM thus appears to
represent a forme fruste of electromechanical
dissociation.
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E:Ff'EO'S OF ASPIRIN rn IN vrmo LYSIS wrrn UROKINASE OF
a:MBINED PIATELEI' AND FIBRIN TIlR(MlI
~ Terres, M.D., Christian 8eythien, Christian W.
Han1II, M.D., Wolfram Kupper, M.D., walter Bleifeld, M.D.,
F.A.C.C., Department of cardiology, EWendorl University
fbspital, Hamb.1rg, West-Gmnany.
we coold recently shoN that the addition of platelet
deaggregating prostaglaOOin E1 to urokinase (UK)
improved the in vitro lysis of CCIltlined platelet am
fibrin thrarbi. To further evaluate the possible role of
platelets in thranbolysis, we studied the effects of
pretreating plasma with aspirin before thranbJs
formation, am of adding aspirin to UK after canpletion
of thranbJs formation. 'Ihranbi (n 2 144, mean weight 20
mg) were produced in vitro by adding CaC12 and collagen
(1 pg/ml) to citrated platelet rich plasma (PRP, 250,000
platelets per pl). After 10 min, thranbolysis with UK
(2000 U/ml for 30 min) was started. '!he addition of
aspirin (10 - 200 pg/ml) to PRP prior to thranbJs
formation resulted in a dose depen:ient improvement of
thrartJolysis. '!his effect was optimal at a concentration
of 20 pg/ml of aspirin. After pretreatrrent of the PRP
with aspirin 20 pg/ml, thranbJ,s weight after 30 min of
thranbolysis was by a mean of 47 % lower than in the
control experiments (p<O.OOOl). lboIever, when aspirin
(10 - 200 pg/ml) was added to PRP after canpletion of
thranl:us formation, no significant effect on thranbo-
lysis with UK was noted. 'Ihus, the in vitro lysis with
UK of canbined platelet am fibrin thranbi was fourrl to
be enhanced when the thranbi were produced urrler the
influence of aspirin, rot not when aspirin was added to
UK after canpletion of thranl:us formation.
EFFECT OF THE CHOLINERGIC AGONIST CARBACHOL AND CYCLIC
GUANOSINE HONOPHOSPHATE ON SUDDEN CARDIAC DEATH:
PROTECTION FROM VENTRICULAR FIBRILLATION
George E. Billman, Ph.D., The Ohio State University,
Columbus, Ohio,
Previous studies have demonstrated that a reduced cardiac
vagal tone correlates with a greater susceptibility to
ventricular fibrillation (VF). If reductions in vagal
tone contribute to VF, one would predict that interven-
tions that increase vagal tone should protect against
these lethal arrhythmias. To test this hypothesis, VF
was induced in 11 mongrel dogs with healed myocardial in-
farctions by a 2 min. coronary occlusion during exercise.
This exercise plus ischemia test consistently elicited VF
on each placebo (normal saline) presentation. On a sub-
sequent day, the cholinergic agonist carbachol (20 ug/kg,
i.v.) was injected 3 minutes before the coronary occlu-
sion (i.e., while the animal was running). Carbachol
elicited significant (analysis of variance, P < 0.001)
reductions in heart rate (control 227,6 ± 9.3 versus car-
bachol 150.9 ± 9.3 beats/min.) and prevented VF in 9 of
11 dogs. This protection was still present even when
heart rate decline was prevented by ventricular pacing
(n-3). Cyclic guanosine monophosphate (cyclic GMP) is
believed to act as an intracellular messenger of cholin-
ergic activation; therefore, 8-Bromo-cyclic GMP, a com-
pound that enters the cell and resists breakdown by phos-
phodiesterases, was infused (100 ug/kg/min., i.v.)
throughout the exercise plus ischemia test, beginning 30
minutes before exercise (to allow time to enter the car-
diac cells). This dose of 8-Bromo-cyclic GHP did not
affect heart rate (control 232.9 ± 13.3 versus cyclic GHP
234.5 ± 9.7 beats/min.) yet prevented VF in 5 of 5 dogs
tested. These data suggest that cholinergic agonists and
cyclic GMP can prevent VF independent of heart rate change.
RANDOMIZED CONTROLLED TRIAL OF NEUROLEPTANALGESIA INFUSION
IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL INFARCTION.
Alfredo Balvanera M.D. FACC., Victor Alvarez M.D., Omar
Fuentes M.D., Alberto Zamora M.D., Humana Hospital and La
Salle University, Mexico City, Mexico.
Forty patients (Pts) with acute myocardial infarction (MI)
were admitted to the hospital within 4 hours of symptoms.
Pts were randomly assigned, 20 to the control (C) group,
and 20 to the Neuroleptanalgesia (NLA) group 10 inferior
and 10 anterior in each group. The C group received 5%
dextrose solution in water and meperidine. The NLA group
received 1 amp of 10 ml of fentanyl and 1 amp of 10 ml of
droperidol dissolved in water to be administered within 8
hours. In both groups all Pts registered 3+ or 4+ of chest
pain score, Killip Class I-II and important ST segment
elevation. In the NLA group all Pts were completely re-
lieved of chest pain within 10 + 4 min after infusion
(P 0.001) vs 120 + 72 min in 3 +1 divided doses for the
C group. In the NLA group the mean pulmonary capillary
wedge pressure decreased 36% for the group with anterior
MI and 26% for the inferior MI group (P 0.001) vs 10% or
less reduction in this parameter for the C group. The ra-
dionuclide ejection fraction improved 10% for the group of
Pts with anterior MI and 12% for the group with inferior
MI, one week after NLA administration (P 0.05). In con-
trast Pts in the C group showed a consistent decrease in
radionuclide ejection fraction. Angiography was performed
in 5 of 20 Pts on the NLA group as well as the C group.
In the NLA group we could observe in 3 cases the reopening
and reperfusion of infarct related artery vs no change in
the C group. Overall mortality for the C group was 15%
and 5% for the NLA group (P 0.05). Conclusions: NLA
possess an action of augmenting blood flow in ischemic
myocardium, releasing the spasm, and thus it may improve
chest pain, myocardial energetics, ST segment elevation
and decrease myocardial damage and mortality rate.
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Myocardial Infarction Clinical Studies
OBSERVER VARIABILITY IN TIMI FLOW GRADING:
COMPARISON TO A NEW COMPUTER METHOD FOR
MEASUREMENT OF REPERFUSION KINETICS
Steven E. Nissen MD FACC, John C. Gurley MD, Cindy Grines MD
David Booth MD, Marc Branco MD, and Anthony N. DeMaria MD
FACC University of Kentucky &: VA Hospital, Lexington, Ky
The Thrombolysis in Acute Myocardial Infarction (TIMI) study utilized
a subjective scale for grading reperfusion following acute MI which is
now widely employed to assess the results of thrombolysis and to
guide therapy. However, the TIMI flow scale is subjective and may be
compromised by variability in interpretation. Therefore, we designed
this study to evaluate the inlerObserver variability ofTlMI flow grading
and to compare the subjective TlMI scale of reperfusion to an objective
method based upon computer analysis of the contrast decay rate in the
infarct vessel in comparisioo to a non-involved artery. Films from 21
successfully reperfused patients (4 patients-TIMI grade I, 9 patients-II,
8 patients-Ill) were assigned TlMI flow grades by three other
experienced angiographers (total = 4 observers). The films were
digitized using a 512 x 512 x 8 bit pixel matrix. A region of interest
(ROn was pIaccd over the infarct artery (IA) and a non-involved
adjacent vessel (NIA) and time-density curves generated. The lime
from peak opacification until decay to 112 peak density was detennined
for the IA and NIA and the ratio lAINIA was computed. A difference
of at least 1TIMI grade among the 4 observers was present for 214
ar1tries originally graded TlMI I, 619 for TIMI n, and 318 TlMI m.
Decay half-times ranged from 1.07·2.03 sec for TIMI m (mean-1.5),
1.67-2.67 sec for TlMI n(mean-2.14) and 1.83 to 3.13 sec for TIMI
1 (mean-2.76). Ratios ofNIAIIA ranged from 1.8-4.5:1 (mean-2.7),
1.1-3.0:1 mean-1.6S), and .8-1.6:1 (mean 1.18) for TIMI I,II, and m
respectively. These data demonstrated that there is considerable
interobserver variability in TlMI grading and actual contrast decay rates
overlap substantially between grades. This phenomenon must be
considered in evaluating the results of thrombolytic studies. Contrast
decay rates obtained by digital image processing provide a more
objective means for evaluating reperfusion.
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SELECI1VE NEUROHUMORAL AcnvAnON IN 1HE
RECOVERY PHASE OF ANTERIOR MYOCARDIAL IN-
FARcnON IN MAN.
Douilas E. VauKhan. M DH Gervasio A. lamas, M.D., FAC.C.,
Marc A. Pfeffer, M.D., Ph.D., FAC.C., Brigham and Women's
Hospital, Boston, MA.
Neurohumoral activation is readily apparent in patients with
symptomatic CHF and in the acute phase following myocardial
infarction (MI), but its profile in asymptomatic patients in the
early convalescent phase post-MI is less clear. We measured
plasma catecholamines, renin (PRA), aldosterone (ALDO), and
angiotensin II (A2) levels and performed hemodynamic measure-
ments, coronary angiography, and biplane left ventriculography
in 35 patients with LV dysfunction but no clinical evidence of
CHF 18±4 days post-anterior MI. Plasma catecholamines were
not significantly elevated and did not correlate with hemodynamic
or angiographic variables. The renin-angiotensin-aldosterone
system was activated, as anticipated, in patients on diuretics. As
well, however, in the 27 patients not on diuretics plasma A2
levels were elevated in correlation with the extent of systolic wall
motion abnormality [% Akinesis, Dysldnesis (AD»).
n HE EPI A2 PRA
AD<3~ 19 266tll0 43t25 21t8 1.6tl.0
AD>3~ 8 211t132 42t30 30t7* 2.5tO.8*
Patients not on diuretics. mean±SD, ·p<O.05.
Thus, in these asymptomatic patients in whom catecholamines
were not significantly elevated 3 weeks post-AMI we found that
not only in the presence of diuretics, but even in the absence of
diuretics or hemodynamic imbalance, that the renin-angiotensin-
aldosterone system was activated, the extent of which was related
to the degree of myocardial damage.
DBTERKINANTS OF DIPROVED GLOIlAL LEFt' VEN'IlUCULAII.
FUNCTION AFTER. tPA AND DEFERRED PTCA FOR ACUTE !II
Alan p Guerd M.p, Sidney O. Gottlieb, M.D. FACC,
Gary D. Walford, M.D. FACC, Thomas R. Aversano, M.D.
FACC, Jeffrey A. Brinker, M.D. FACC, Cynthia Siu,
M.D., Myron L. Weisfeldt, M.D. FACC, Nisha C. Chandra,
H.D. Johns Hopkins Hospital, Baltimore, MD.
To detemine variables predictive of improved rest
and exercise LV function in patients receiving tPA
and/or deferred PTCA, multiple regression analysis was
applied to 138 patients vith acute HI randomly
assigned to tPA or placebo, and from these, 85
angioplasty candidates randomly assigned to PTCA on
day 3 or no PTCA during the 10 days of the study.
Treatment with tPA increased resting EF by 3.6
percentage points (P<O.Ol). This increase vas
inversely related to day I EF (r--.31.P<.02) but
independent of age, infarct location, initial heart
rate or BP, Q waves on entry ECG. or PTCA.
Although deferred PTCA had no effeet on resting EF,
it was associated with an increase in EF from 53' to
61' during exercise (P<O.OI). This increase in
exercise EF was directly related to an angiographic
estimate of the' LV distal to ~90' stenoses (P<.05).
Response to PTCA was not dependent on resting EF.
treatment with tPA, peak CPK or Q waves on day 2 ECG.
These data support treatment of large and inter-
mediate sized MI' s with tPA. Benefit from PTCA is
related to extent and severity of CAD and cannot be
predicated by ECG.
THE PIVOTAL ROLE OF MULTIVESSEL CORONARY ARTERY DISEASE
AND THE REMOTE ZONE IN THE REPERFUSION ERA.
EJ Topol MD, FACC, sa Ellis MD, FACC, BS George HD, OJ
Kereiakes MD, FACC, RJ Candela MD, FACC, RS Stack MD,
FACC, CW Abbottsmith MO, FACC, K SiglllOn, K Lee PhD, B
Pitt MD. FACC, RM Califf MD, FACC and the TAMI Study
Group, Univ. of Michigan Medical center, Ann Arbor, MI.
The role of multivessel diaease (MYO) in pts receiv-
ing reperfusion therapy has not been amply studied. Of
855 consecutive pts enrolled in the TAMI trials, all
received i.v. thrombolysis, had emergency cardiac cath
to ang iopl sa ty, and 7 day repeat cath; 92S achieved
reperfuaion. Using a 75S non-infarct vessel stenosis
criterion, 233 (27.3S) pts had MVD and 622 (72.7S) pts
had aingle vessel (SVD). Age, sex, time to reperfu-
sion, 141 location and intervention were similar for the
2 groups. Results for ejection fraction (EF), infarct











Using a atepwise logistic regression model, non-
infarct zone wall motion, was the most powe-rful
predictor of in-hospital survival (p=O.0057); no. of
diseased vessels was second (p=0.04). In conclusign:
,) perfusion and function of the contralateral wall is
critical; 2) methods to rapidly detect and rectify the
condition need scrutiny.
INTRACORONARY THROMBOLYTIC THERAPY IN PATIENTS
WITH REFRACTORY THROMBUS AFTER INTRAVENOUS
TREATMENT
JK Samaha, M D, P Quigley, M.D.• DJ Kereiakes, M.D., FACC, B
Griffin, RS Stack, M.D., FACC, K Sigmon, R Candela, M.D.• FACC,
RM Califf, M.D., FACC, EJ Topol, M.D., FACC, Baptist Memorial
Hospital, Memphis, Tennessee
Although the majority of patients (pts) achieve adequate
reperfusion with intravenous (iv) thrombolytic therapy (IT), some
pts bave resistant inttalumilla1 thrombus. In the TAMI 2 and 3 tri-
als we prospectively applied intracoronary (IC) IT in 21 pts with
angiographically documented penisten-t thrombus. IC t-PA in a
dose of 30 mg was used in I I pts, IC urokinase was used in 3 pts in
a dose of 7SO.000 units and 7 pts received both agents IC. Specific
indications for Ie therapy were visible thrombus alone in 7 pIS, in-
termittent reocclusion in 3 pIS, poor flow despite patency in 2 pts,
distal emboli in 2 pIS, both visualized thrombus and distal emboli in
4 PIS and other reasons in 3. Pts treated with IC theraPy had worse
LV ejection fractions (46.2 vs 49.4%) and required more balloon in-
flations with angiopJasty (6.& vs 3.9 inflations). prior to IC therapy,
9 PIS had TIM! Grade 0 or I perfusion, while after IC therapy only
3 had TlMI Grade 0 or I flow. Visible filling defects eleared in 13
pIS. At one week followup, 13 pts had TIMI Grade 3 flow; I had
TlMI Grade 2 flow and 2 had TlMI Grade 0 flow (5 pts did not
bave followup ansiography, 3 becaUse of death). Durins the hospi-
talization 3 reocclusions occurred, 4 pIS required ursent bypass
sursery and 2 required repeat emersency ansioplasty. Bleeding
complications were not sisnificantly different in pts with IC
therapy despite the hisher total thrombolytic therapy dose. In con-
clusion. while pts requirins adjunctive IC thrombolytic therapy
remained at high risk for reocclusion or recurrent ischemia, direct
administration led to improvement in acute phase patency without
apparent incremental bleeding risle.
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We have previously documented the importance of post
infarction angina with ECG changes (PIA) and of
admission and/or discharge ST + in risk stratification
of patients with non Q-wave MI. Analysis of admission
and discharge ECG's in 484 patients with non Q-wave HI
yields the following mortality rates.
IN-HOSPITAL ANGINA WITH TRANSIENT ECG CHANGES PREDICTS
POOR ONE-YEAR SURVIVAL ONLY IN PATIENTS WITH ST
DEPRESSION
Kenneth B. Schechtman, Ph.D. William E. Boden, M.D.,
F.A.C.C., Robert E. Kleiger, M.D., F.A.C.C., Robert S.
Gibson, M.D., F.A.C.C., Robert J. Capone, M.D.,
F.A.C.C., David J. Schwartz, M.D., F.A.C.C., Robert
Roberts, M.D., F.A.C.C., and the Diltiazem
Reinfarction Research Group. Washington University,
St. Louis, MO.
Among patients without ST +, mortality is non-
significantly higher in those without PIA. However,
in non Q-wave HI patients with ST + at both admission
and discharge, mortality is lower in patients without
~ (16.7%) than in those with PIA (36.4%, p-.021).
When all patients with ST + at one or at both time
points are analyzed, mortality without PIA is 11.8%
(27/229) vs 28.6% (16/56) with PIA (p-.002). We
conclude that PIA after non Q-wave HI is a risk factor
for l-year mortality only in the presence of ST +.
With ST + at both admission and discharge, PIA is
associated with 36.4% l-year~rtality.
No ST +
ST + -one ECG













cx::MPARISCfi OF '!HE EFftrl' OF UPRIQfI' R'BroRE AND EXm¥:ISE
Ctf PIMmEl'~ AND~c ACI'IVl'IY
KA1 Winther. M.p., Geoffrey H. Tofler, M.B., Alfredo
Jimenez, M.D., D!Imi.an BrezinsJd., JOIleP1 I.cecalzo, M.D.,
Fb.D., James E. MJ11er, M.D., P.A.C.C., HaJ:Vllrd Medical
Sdlool, Bosta1, MassachJsetts
'!here is increas~ evic1eme that daily activities may
trigger the alSElt of carallU'Y thraIiJosis. 'Ihis t:.ri.cpr-
~ CDlld be :mediated in part by alteratialS in the
balance ~ the thraIi:xlgenic an:! t:hraJiJolytic
eXlIIlClIIlnts of the blood. we CXIIpll:'ed the effects of
ass.mptial of the upright pcst:uxe (JIVP) an:! exercise 00
platelet ~ility (19.) ani fibrinolytic activity
(t-a antic}en, p].asni.nogen activator inhibitor [PAI], ani
EUJlol::W.in clot: lysis time [ECllr]) in 11 male volunteers.
19. was assessed as the miniJua cxllulnuatioo of epi.ne-
P1rine nqrl.red for biplasic platelet aggregatioo in
~. Values are IIEliU1 ± SPX.
SUPINE UPRIQfI' EXm¥:ISE
10 min 90 min pre post
t-a antigen 3.8 5.8* 4.6 4.0 13.5**
(rqIml) ±O.3 ±O.5 ±O.4 ±O.3 ±1.5
ECllr 136 98* 120 100 41**
(mi.raJt:es) ±4 ±10 ±11 ±11 ±4
Platelet agq. 3.5 1.8* 1.5* 1.0 1.1
(IlM epi) ±O.4 ±O.3 ±O.3 ±O.3 ±O.3
WilCXlXl:ll1 *P < .05 VB supine~ **P < .01 VB pre-exercise
PAI did not: ctIanJe significantly at a:trj time.
JIVP inc:rellSed 19. ani caused ally a mderat:e increase
in fibrinolysis ~d1 did not: persist at 90 min 104len 19.
remained inc:rellSed. In ca1l:rast, dur~ exercise 19. did
not: increase ani t-a levels increased DDre than 3-fold.
'Ihus, c:.ban)es in t-a an:! 19., major det:e1:minant:s of the
thtUlixxjE!idc pat:ential. of blood, are 1_ favorable
dur~ JIVP than~ exercise.
ATRIAL NATRIURETIC FACTOR IN PATIENTS WTIH RIGHT
VENTRICULAR INFARCTION
Beniamin Robalino M.D., Richard Petrella M.D., Emmanuel
Bravo M.D., Fuad Jubran M.D., Bernadine Healy M.D.,
F.A.C.C., Patrick Whitlow M.D., F.A.C.C., The Cleveland
Clinic Foundation, Cleveland, Ohio
Right ventricular infarction (RVI) is often associated
with inappropriate diuresis and protracted hypotension
in the setting of normal left ventricular function. To
determine the possible role of atrial natriuretic factor
(ANF) in this syndrome, we performed serial measurements
of peripheral plasma ANF in pts with inferior myocardial
infarction with associated RVI (Group I, n-8) and with-
out associated RVI (Group II, n-13). All pts underwent
enzymatic, ECG, echocardiographic, and coronary arterio-
graphic studies, and diagnosis of RVI was made by at
least 2 of the following: ECG changes, echocardiograms,
and coronary arteriography. Ten pts had right heart
hemodynamic measurements. Enzymatically measured
infarct size, presence of left heart failure and
arrhythmias were simi lar in both groups. Group I had
evidence of RV dysfunction by echocardiography and
elevated RV pressures. ANF results (mean±SEM in pg/ml):
JID....l Qll..l Dll..1 I2iLl
Group I 152±30)* 165±48) t 199±27)** 189±32) **
Group II 55± 9 55±1l 61±13 77±20
*p < 0.05, **p < 0.01, t - not significant
ANF levels above 100 on day I were seen exclusively with
RVI. Conclysions: The data shows that (1) pronounced
ANF e1evat ion is part of the neurohumoral response to
RVIj (2) ANF is also elevated in inferior infarction
without RVI at a markedly less extent. These findings
suggest that elevated ANF may play a pathophysiologic
role in the right ventricular infarct syndrome.
MECHANISM OF MYOCARDIAL INFARCTION IN PATIENTS WITH PRIOR
CORONARY BYPASS SURGERY: THERAPEUTIC IMPLICATIONS
Cindy Grines, M.D., Steven Nissen, M.D., F.A.C.C., David
Booth, M.D., F.A.e.C., Marcelo Branco, M.D., F.A.C.C.,
John Gurley, M.D., Kim Bennett, R.N., Antnony DeMaria,
M.D., F.A.C.C., University of Kentucky and VA Medical
Centers, Lexington, Kentucky.
Although acute myocardial infarction (AMI) is usually due
to thrombotic occlusion when involving a native coronary
artery, the mechanism responsible for ~j~ in pts with
previous bypass surgery (CABG) is not clear. Since know-
ledge of pathophysiology of AMI may alter subsequent
management, we reviewed angiograrns obtained within 1 hr -
7 days of AMI (median = 1 day) in 43 pts at least 1 year
after CABG. The culprit lesion was identified by the
presence of residual stenosis and/or thrombus in the
vessel supplying the infarct zone or by reviewing previous
angiograms. Infarction was produced by a recent occlusion
of a vein graft in 27 (63%), critical graft stenosis in 5
(12%), recent occlusion of a native vessel in 8 (19%), and
could not be accurately determined in 3 (7%). Among the 32
vein grafts suspected as the culprit vessel, unequivocal
angiographic evidence of residual thrombus (filling
defect/persistant staining) was present in 24 (75%) and
was >3 Cr.1 in length in 10 pts. Successful thrombolytic
reperfusion occurred in only 3/9 (33%) grafts after IV
and/or intragraft drug administration. Angioplasty was
successful at restoring flow in 3 grafts after failed
thror.mo1ysis. Thus, in pts who have undergone previous
CABG: 1) acute myocardial infarction is usually caused by
recent graft throroibosis, 2) conventional thrombolytic
approaches may be inadequate to restore flow and 3) the
1arge mass of thrombus and absent flow in the graft rolay
require subse1ective drug infusion, a higher thrombolytic
dose, or a mechanical means of recanalization.
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Thrombolysis and PTCA in Acute Myocardial
Infarction
THE WESTERN WASHINGTON TISSUE PLASMINOGEN
ACTIVATOR EMERGENCY ROOM STUDY
Ralph Althouse MD. MPH. Charles Maynard PhD, Michele Olsutka
RN, James Ritchie MD FACC, J. Ward Kennedy MD, FACC and their
clinical colleagues, University ofWasmngton, Seattle, WA.
To evaluate starting IV tissue plasminogen activator (tPA) in the
emergency room (ER), we prospectively screened 1028 consecutive MI
pts admitted to 8 hospitals. 160 pts s; 75 yrs old with ST elevation and
chest pain for S; 6 hrs were treated with 150 mg (10 pts.) or 100 mg (150
pts) of tPA over 6 hrs: all received IV heparin. Pts had nuclear studies
of ejection fraction (EF) and thallium infarct size. 98% had documented
MI. Although not a randomized control group, we compare outcome
with control and treated pts from our previous trial of IV streptokinase
(SK), which had the same entry criteria and core labs as the present
study. The groups were nearly identical in age, sex, MI location, Killip
class, peak CPK and number of diseased vessels. Time to treatment was
shorter in the ER group (141±69 vs 209±84 mins; p=O.OOOI).
tPA % en) SK % en) Control % en)
Number 160 191 177
Mortality 5.0 (8) 6.3 (12)t 9.6 (17)
EF-anterior 43±17 (38)* 43±19 (31)t 37±15 (33)
EF-inferior 56±10 (62)" 54±12 (79)t 52±12 (62)
Infarct size-anterior 19±12 (37)t 23±15 (31)t 27±13 (34)
Infarct size-inferior 10±9 (62)* 12±1l (79)t 14±12 (63)
Complications 1 9 (3) 0 5 en:!: 0 (0)
*p<o.05 tPA vs Control, f p<o.OI tPA vs Control,:rtPA vs SK all n.s.
We conclude that starting tPA in the ER reduces time to thrombolysis.
Furthermore, within the limits of using historical controls, early tPA is
as effective as later IV SK in decreasing mortality, preserving LV
function and reducing infarct size. There was a slight although not
statistically significant (p=O.33) increase in ICH in tPA pts compared to
those given SK.
AaJl'E~ AND laIC TERM FOLLOW-UP OF PATIENTS WI'm
AaJl'E MYOCARDIAL INFARCl'ION AND SINGLE VESSEL DISEASE
TREATED WI'm AOOIOPLASTY WI'IlKXJl' THR<:JomOLYTIC THERAPY
Gregg W. Stone MD, Barry D. Rutherford MD, FAce, David R.
M::Conahay MD, FACe, Warren L. Johnson MD, FACC, Lee V.
Giorgi MD, FACe, Robert W. Ligon MA, Geoffrey O. HartZler
MIl, FAce, Mid-America Heart Institute, Kansas City, MJ.
we studied 211 consecutive pts (age 57;t11 yrs, 75% male)
with acute myocardial infarction (AMI) and single vessel
disease who underwent Pl'CA as primary therapy. The
infarct related vessel was identified as the LAD in 89
pts (42.2%), the LCX in 26 pts (12.3%), the RCA in 92 pts
(43.6%), the IMain in 1 pt (.5%), and a saphenous vein
graft in 3 pts (1.4%) resulting in 92 anterior (43.6%)
and 119 inferior (56.4%) MIs.
Pl'CA was successful ill 208 pts (98.6%). There were no
procedural deaths, though 2 pts (.9.1') died prior to
discharge. Two pts (.9.1') required bypass surgery (CAm)
after failed Pl'CA. Follow-up data was available in 210
pts (99.5%) at a mean interval of 21.7+14.3 months. There
were 12 late deaths (survival 93.3%), '3 of which were
non-cardiac. The actuarial 3-year survival was 95.0J'.
Univariate correlates of cardiac death were anterior MI,
shock and peak CPK. Six pts (2.9.1') sustained a late
nonfatal MI, and 8 pts (3.8%) underwent subsequent CAm.
Considering cardiac death, MI and CAm as events, the
actuarial 3-year event free survival was 94.4%. Repeat
PI'CA was performed in 69 pts (32.9.1'), before discharge in
20 pts (9.5%) and after discharge in 49 pts (23.3%). At
late follow-up, 174 pts (82.9.1') were free of angina.
conclusions: 1) In pts with AMI and single vessel
disease, PI'CA without thrClllbolysis can be performed with
a very high success rate and few procedural
caIIllications. 2) '!his approach results in an excellent
early and late (3-year) event free survival.
PIUMAU AllGIOPLASTr 'DIBJlAPY IN PA1'IBIITS EXCLUDED FROH
TIIJUlMIOLITIC TllKRAPY OF AaJTIl MYOCAIlDIAL U1FAICTIOII.
Anil Bansal, M.D., Gerald C. Timmis, M.D., F.A.C.C.,
William O'Neill, M.D., DART & AGED Study Group, William
Beaumont Hospital, Royal Oak, Michigan.
Conclusive evidence now exists that timely reperfusion
significantly reduces mortality during acute transmural
myocardial infarction (MI). Nevertheless, reperfusion
therapy is withheld from some patients (pts) admitted
with MI due to advanced age or late presentation after
onset of chest pain (CP). We therefore determined the
number of pts excluded from the TIMI II-B study for the
above reasons; from October 1987 through April 1988 54
MI pts were considered for inclusion in this trial.
Only 36 pts (66%) were eligible «76 years of age,
presenting 0 to 4 hrs after chest pain); ten pts were
excluded due to age and 8 pts due to late presentation.
Therefore, two new acute PTCA protocols were initiated.
Thirteen pts were prospectively enrolled in the Delayed
Arterial Recanalization Trial (DART; <76 yrs and
presenting 3 to 24 hrs after CP with high risk MI, e.g.,
anterior MI, inferior MI with reciprocal changes or
second HI); 11/13 underwent successful PTCA (defined as
residual stenosis of 50% or less); 2/13 had urgent
bypass due to left main or equivalent disease. There
was no in-hospital mortality. Five pts were enrolled in
the Aged trial (i.e., age >76 yrs presenting with CP
from 0 to 12 hrs); all 5 underwent successful
angioplasty. One pt with a MUGA EF of 11% died within
24 hrs due to progressive heart failure. Conclusion:
Reperfusion is withheld from fully 34% of MI pts due to
age or delayed presentation. Our initial experience
indicates that over 80% of these pts (16/18) can be
successfully treated with PTCA.
MYOCAIlDIAL IlIIPTUU CClIIPLlCATUIG TISSUB PLASJlIWlGU
ACTIV.uoI. 'DIBJlAPY OF AaJTIl MYOCAIlDIAL U1FAICTIOII.
Karin L. Loukinen, M.D., William O'Neill, H.D., Nathan
Laufer, M.D., F.A.C.C., Alan Lew, M.D., F.A.C.C., Gerald
C. Timmis, H.D., F.A.C.C., William Beaumont Hospital,
Royal Oak, Michigan.
To characterize the incidence and clinical predictors of
myocardial rupture following thrombolytic reperfusion
therapy for acute myocardial infarction, 198 patients
receiving tissue plasminogen activator (t-PA) between
January 1986 and April 1988 were studied. Among this
group, there were three cases of myocardial rupture
(HR). For purposes of comparison with survivors of
thrombolytic therapy, these cases were added to three HR
cases collected from other institutions. Rupture was
documented by necropsy (4) or ventriculography (2; one
early death and one delayed beyond 30 days). Clinical
differences between patients with and without HR follow:
HR No HR 1!.
Number '6" ~
Age 68.2+6 57.5+10 0.01
Sex H:P 2:4 - 159:39 0.02
HI Area Ant/inf 3:3 85:110 NS
Initial B/P 106/67 130/82 NS
Prior HI 1 15 NS
CPK peak 1415 2399 NS
t-PA dose 103.5mg- 110.5mg NS
Time to t-PA 40+41 hrs 2.9+0.9 hrs <0.001
Hospital 1I0rtality 8373% 5.5% <0.001
CONCLUSIONS: The incidence of HR following t-PA therapy
of myocardial infarction is 1.5% at this institution.
Predictors of myocardial rupture include advanced age,
female sex, and delayed initiation of t-PA therapy.
Rupture must be added to the list of concerns in
designing delayed reperfusion protocols.








OVERRIDING HEIGHTENED RISK, PRIOR ANGINA DENOTES A
FAVORABLE RESPONSE TO MYOCARDIAL REPERFUSION.
EJ Topol MD, FACC, RM Califf MD, FACC, BS George MD, OJ
Kereiakes MD, FACC, RJ Candela MD, FACC, K Sigmon, SG
Ellis MD, FACC and the Thrombolysis and Angioplasty in
Myocardial Infarction (TAMI) Study Group, University of
Michigan Medical Center, Ann Arbor, Michigan.
To examine the importance of previous angina in pts
with acute MI who receive reperfusion therapy, we
analyzed 727 pts in the TAMI trials who had prior
angina> 7 days (n=196) or no prior angina (n=531).
All pts -received Lv. thrombolysis, emergency cardiac
catheterization + angioplasty, and follow-up cath. The
age, sex, race, -infarct vessel, frequency of reperfu-
sion and thrombolytic and angioplasty intervention were
similar for the 2 groups. But, pts with prior angina
had a substantially higher risk profile (hypertension
53.6 vs. 37.2J, p<O.OOOl; diabetes 22.5 vs. 12.1J,
p<O.OOOl; hyperlipidemia 19.4 vs. 9.8J, p=O.OOl,
cerebrovascular disease 4.6 vs. 1. 5J, p=O. 015; multi-
vessel coronary disease 57.8 vs. 39.n; p<O.OOOl, and
longer time to reperfusion, 190 vs. 174 min; p<O.Ol).
+ Angina - Angina __P__
No. Pts. 196 531
Reocclusion 16 (8.2J) 72 (13.6J) 0.048
Death 9 (4.6J) 38 (7.2J) 0.21
Ejection fx (acute J) 48.8+11.9 51.3+11.3 0.02
Ejection fx (7 day J) 51.2:t:ll.0 52.0:t:ll.3 NS
This benefit may relate to preconditioning or an
adaptive endothelial response, but was not correlated
with l' collaterals. Thus, despite a multiplicity of
increased risk factors, more multivessel disease, and
worse baseline ventricular function, pts with previous
angina demonstrated more recovery of ventricular
function, less reocclusion and lower mortality.
REDUCTION OF INFARCT SIZE BY INTRAVENOUS APSAC
IN MYOCARDIAL INFARCTION (MULTICENTER RANDOMI-
ZED TRIAL VS HEPARIN).
J. cassagnes, J.R. Lusson, P. Peycelon, T. Anguenot, J.E.
Wolf, E. Borel, F. Schiele, J. Machecourt, J.P. Bassand.
CHU Clermont Ferrand, Grenoble, BeSilll\;on, FRANCE
In a series of 231 patients with a first myocardial infarct
(MI) who were randomly treated by heparin (hep) or acyl
plasminogen streptokinase activator complex (APSAC) within
5 hours following the onset of symptoms, the infarct size
(IS) was measured by a thallium 201 myocardial single photon
emission tomography (SPECT).
Coronary arteriography and LV angiography were perfor-
med between day I and day 7 ; radionuclide (RN) angiography
and T1 201-SPECT were performed between day 14 and
day 21. The tomographic defect was measured by 2 indepen-
dant blinded observers : the inter and intra observer reproduc-
tibility was excellent () 0.95). The defect size was expressed





Occluded Vessel 4~14 36+13
Patent Vessel 53+14*** 4~1I***
*p <0.05 **p (0.01 ***p (0.001
Beside value in detecting and localizing a defect, Tl
201 SPECT is a reproductible method to quantify IS, that
can be used to evaluate the efficacy of drugs.
A significant. limitation of IS was observed in APSAC
patients, resulting in a significant improvement of the LV
function.
BIPHASIC RELEASE OF CARDIAC MYOSIN LIGHT CHAINS IN
PATIENTS WITH SUCCESSFUL THROMBOLYSIS IN ACUTE MYOCARDIAL
INFARCTION
Atsushi Hirayama M.D., Kazuhisa Kodama M.D., Masayoshi
Mishima M.D., Shinsuke Nanto M.D., Kazuo Komamura M.D.,
Osaka Police Hospital, Osaka, Japan.
It has been shown that serum cardiac myosin light chain
(MLC) levels are useful to estimate the infarct size more
accurately than cardiac enzymes, however, the
intracellular source and release kinetics of MLC from
irreversible injured myocardium are not known with
certainly. We measured the serum MLC levels by enzyme
linked immunoadsarbent assay (ELISA) using monoclonal
antibodies (mAb), then studied the serial changes of serum
MLC levels in 17 patients with succeSSful thrombolysis in
acute myocardial infarction. The MLC release showed the
biphasic pattern; that is, the early rapid release reaches
the peak concentration of 32±18 nglml at 18-24 hr. and the
subsequent release reaches the peak concentration of
47+24 nglml at 3-5 days after the onset. The peak
concentrations of the first and second released MLC have
significant correlations with not only % abnormally
contracting segment calculated by left ventriculography
(r:O.72,p<O.05 and r:O.81,p<O.Ol, respectively) but also
peak creatinine kinase activity (r:O.69 ,P<O.05 and
r:O.67,p<O.05, respectively). MLC 1&11 complexes measured
by ELISA utiliZing two monoclonal antibodies specific to
MLC I and II respectively in a sandwich assay were
detected at both peaks. Thus there were no different
characteristics and meanings between MLCs at both peaks.
These results showed that MLCs at both peaks released from
the degradation of myofibrils itself and biphasic release
of MLC represent the process of myocardial cell necrosis
in myocardial infarct zone . The measurement of the MLC
release may be useful to monitor the cell necrosis as well
as to estimate the infarct size.
THROMBOLYSIS-INDUCED LIMITATION OF INFARCT SIZE IN RELAnON
TO TIME FROM PAIN ONSET AND INFARCT LOCALIZATION: RESULTS
FROM THE I.S.A.M. STUDY.
Rolf Schroder M.D..F.A.C.C•• Karl-Ludwig NeUhaus M.D., Thomas
L1nderer M.D., Ulrich Tebbe M.D., Thomas Bruggemann MSc, Karl
Wegschelder PhD, Kllnlkum Steglltz, Free University Berlin, FRG
The ISAM stUdy was a double-blind, placebo-(PLA)controlled trial, In
which within 6 h of AMI in 1741 pts aged ~ 75 Y the effect of 1.5 M
STK on limitation of Infarct size was tested by 3 different parameters:
1) QRS score (QRS)(93 pts with BBB:5.8% and 64 pts =4% without the
reqUired amount of STelevatlon on the prerandomlzatlon ECG were ex-
clUded). 2) Cumulative CK-MB release(CK) (80 Pts=5.3% with Insuffi-
cient samples and 34=2.2% early deaths were excluded). 3) Global and
regional EF (R EF) from contrast angiography 3 weeks after AMI In 52%
of pts (It was a subset of younger pts who had angiography without
any selection as to whether treated with STK or PLA). For all 3 para-
meters there was a significant limitation of Infarct size as compared
with PLA for the total group and for pts treated within J h of symptom
onset.
Subgroup analyses revealed a significant limitation of Infarct size for
anterior MI (ANT) for the first 4h after onset of paln:QRS 25% (peO.002),
CK 14%(p< 0.02), EF 57.7 vs 52.1 (p <0.005), REF 23% (p<O.O 1). (First
hour 38 to 46%, similar effects 2nd to 4th h).Inferior MI (INF) similar for
the first 2 h: CK 28% (p<0.003), EF 61.4 vs 56.8 (p= 0.06), REF 31%
(p<0.03). According to the Ischemic area at risk at baseline limitation
of Infarct size was significant In pts with moderate or large Infarction
but also substantial In pts with a small Ischemic area (sum of ST eleva-
tions on the prerandomlzatlon ECG 1-6 mm). Angiography at 3 weeks
revealed Improved LV function also In pts treated later,l.e.who had
no effect In QRS or CK.
Concluslon:Thrombolysls limits Infarct size within 4 h of symptom onset
In ANT MI and within 2 h In INF MI. limitation of Infarct size Is signif-
Icant In pts with moderate or large Ischemic areas but may be worth-
while also in pts with smaller Infarcts. pts may benefit by a subse-
quent Improvement In LV functlon,even If limitation of Infarct size could
not be assessed In the acute phase.







NO DIFFERENCE IN LONG TERM LEFT VENTRICULAR FUNCTION
AFTER STREPTOKINASE AND TISSUE PLASHlNOGEN ACTIVATOR
THERAPY IN ACUTE HYOCARDIAL INFARCTION.
HyltQn I. Hiller MS, Arie RQth HD, Avrahaa Parades HD,
Boris Shalarodsky HD, Gabriel Barabash HD and ShlQaQ
LaniadQ HD. Tel-Aviv Medical Center, Tel-Aviv, Israel.
In a sequential nQn-randoaised study usina siailar
prQtocQls, 76 patients (pts) were were treated with SK
(Grll and 96 with tPA (GrII) within 4 hrs Qf the Qnset
Qf HI. There was DO difference between Iroups relardina
tiae tQ therapy, peak creatine kinase,coronary anatQay,
aortality, bypass surcery and non-Q wave infarction. In
Gp.I, 701 of infarct arteries (IA) were patent, 831 in
Gp.II. 721 of pts in Gp I underwent PTCA, and 541 in
Gp. II. Hean IA stenosis was 92±141 in Gr.I and 82±101
in Gr.II (p<.01). Pts with inferiQr (inf) HI and ant-
eriQr (ant) HI were analysed separately and glQbal LVEF
(Il serially aeasured.
IlJulla. 24 hours
inf HI SK • 47±9 NS
inf HI tPA ......... 53±13 NS
ant HI SK NS ::::38±10 •
ant HI tP 39t15 •
KS : p non-significant • - p<0.01
CQnclusiQns: Both SK and tPA are effective and safe
throabolytic agents. Pts with inf HI did not shQW a
silnificant late iaprQveaent in LYEF, recardless Qf
type Qf throabolytic therapy. HQwever, in pts with ant
HI, there was a silnificant LVEF iaproveaent in both
groups but nQ difference between both alents. Despite
evidence Qf apparant iaprQved thrQabolytic efficacy
with tPA, lQng ter. Ilobal LVEF is nQt different frQa
SK treated pts.
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AUGMENTATION OF EJECTION FRACTION DURING AMBULATORY
MONITORING IN THROMBOLYSIS PATIENTS WITH CONCOMITANT
SILENT VENTRICULAR DYSFUNCTION: MECHANISTIC IMPLICATIONS
David S Kayden M p , Frans J. Wackers, M.D., F.A.C.C.,
Barry L. Zaret, M.D., F.A.C.C., and TIMI. Yale University,
New Haven l CT.
We have shown that silent left ventricular dysfunction
(LV dys) detected by ambulatory radionuclide LV function
monitoring (VEST) during routine clinical activity
following thrombolysis predicts adverse cardiac events.
The mechanisms underlying this LV dys are not known and
the ability of these pts with transient LV dys to augment
LV function in response to increased demand is unclear.
Consequently, we studied 27 HI pts following thrombolysis
with VEST monitoring and submaximal supine bicycle
exercise equilibrium radionuclide ventriculography (ExT)
at hospital discharge. Pts were monitored with the VEST
for an average of 184±59 mins during routine hospital
activity. 11/27 pts demonstrated transient falls in LV
ejection fraction (EF) >5%, lasting ~l min, occurring
without increase in heart rate (HR). 8/11 of these pts and
11/16 pts without LV dys also had episodes of tLVEF ~lO%
with tHR during the same monitoring period. There was no
difference between the 2 groups in number of episodes
tLVEF/pt (2.8±2.3 vs 2.5±2.7), ALVEF (+13±4% vs +12±3%),
4HR with tLVEF (+14±11 vs +lO±10 b/min) or duration of
episodes (5.7±4.1 vs 7.1±4.3 mins). In contrast, during
ExT at ~same HR as VEST activity only 4 pts had tLVEF ~10%
(p<O.OOOl) .
Thus, following thrombolysis, transient LV dys occurs
during routine activity in the apparent absence of
increased myocardial demand. Many of these pts can augment
LVEF at other times, suggesting that the mechanism of
silent LV dys following thrombolysis is a decrease in
myocardial supply. In addition, changes in LVEF during
supine ExT do not necessarily parallel relevant LVEF
augmentation during routine activity. Ambulatory
monitoring of LVEF during routine activity may provide
additional important functional clinical information.
AMBULATORY LBFT VBNTRICULAR FUNCTION HONITORING: ARB TBI
EJICTION FRACTION HBASURBMBNTS REPRODUCIBLB?
Ling de Yang, M.D., C. Noel Bairey, M.D., Daniel Berman,
M.D., FACC, Ken Resser, B.S., Ken NichQls, PH.D. Alan
RQzanski, M.D., FACC, Cedars-Sinai Hed Ctr., LA, CA
Ve previously repQrted a validation of the ambulatory
left ventricular (LV) functiQn monitor (VlST) by
comparing exercise (IX) LV ejection fraction (IF) tQ
gaama caaera (C) aeasurements (J Nucl Med
29(5):741,1988), but the reproducibility of LViF by VlST
measureaents during serial activity is not known. Bence,
Tc-99m RBC BX LViF responses vere coapared for VlST vs
VlST (V-V) in 9 vQlunteers vho exercised 3 times, tvice
vearing the VlST and once during gamma camera (C)
imaging. V vs C IFs during repeat IX vere alsQ cQapared
in 27 other subjects vho exercised tvice. V vs V
measurements fQr IF vere compared at matched heart rates
for 2 minute and 30 second intervals for each level Qf
exercise (N-36) as veIl as fQr peak IX only (N-9):
Duration IF 4 IF
V-V comParisons (seconds) ICC Diff ~ Q11t
All IX levels l20s 0.88 1.921.5 0.88 1.821.4
All IX levels 30s 0.94 1.721.3 0.94 1.821.5
Peak IX only 30s 0.88 1.821.2 0.94 1.320.9
ICC-intra-class cQrrelatiQn coefficient. Diff-average
absolute difference in IF (2SD). By coaparisQn, the
correlation coefficient for IF fQr V vs C vas 0.85
(SRB-3.98) and for ~ IF vas 0.73 (SII-3.95) for 138
matched EX stages in the total Qf 36 subjects.
Conclusion: Measureaents Qf LViF during repeat EX are
highly reproducible by VlST measurements, even fQr
measurements obtained Qver brief 30 second intervals
during peak exercise. These results underscor. the
usefulness of the VEST fQr assessing continuQus LV
functiQn during ambulatory activities, short tiae periods
and strenUQUS exercise.
IHITIAL ~IDATIOH or A ... PATIBHT-BORNB
MINIATURJI DBVICB POR COHTIIlUOUS MONITORING or
LBrr VBJlTRICULAIl PUJlC'l'IOB AIlD ST-SBGKBB'l'
Avjiit LAhjrj MB FACC, Peter Cashman PhD, Paul
Broadhurst MRCP, John CraWley BSc, Edward
Raftery MD FACC. Northwick Park Hospital and
Clinical Research Centre, Harrow, UK.
A new portable bedside monitoring system has
been developed for continuous monitoring of
left ventricular (LV) function using a minia-
ture CsI/photodiode scintillation detector
(45x40mm) and an Olivetti M24 computer (CsD).
Special purpose modules inside the computer
perform signal processing and gated or beat-to-
beat LV activity curves are continuously dis-
played together with an averaged ECG from which
ST-seqment values are obtained. At the end of
each acquisition the ejection fraction (EF),
relative volumes, diastolic filling parameters
and ST level are displayed, can be trended
and/or stored on disc. Validation was per-
formed on 15 patients undergoing gamma camera
(G) radionuclide ventriCUlography within 20 min
and 6 hours later. The mean ±SD difference
between CsD and G was 5. 6±7 •9% (early) and
4.5±7.3% (late), (range of EF: 20%-78%). The
small size and low cost of-this system make it
suitable for longo-term monitoring and rapid
response time allows accurate LV function
assessment following acute interventions.
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NITROGEN-13 AMMONIA MYOCARDIAL OPTAlCB AT
Rl:ST AND WITH EXERCISB IN NORMAL VOLUN-
TEERS: QOANTII'ICATION 01' CORONARY I'LOW WITH
DYNAMIC POSITRON BMISSION TOMOGRAPHY
,Janine Krivokapich M D , F ACe, Gary T. Smith
M,D., Sung-Cheng Huang D.SC., Osman Ratib M.D.,
Heinrich R. Schelbert M.D., F.A.C.C. UCLA School of
Medicine, Los Angeles, CA
To assess the utility of using the flow tracer
nitrogen-13 ammonia (NH3) with dynamic positron
emission tomography (PET) to quantitate coronary
flow, we injected NH3 at rest and during supine
exercise into 11 normal volunteers and obtained
dynamic PET images for 10 min. The net extraction
of NH3 was calculated as the myocardial uptake of
NH3 at 10 min divided by the input function
obtained from a left ventricular blood pool region
of interest. Net extractions of NH3 were .35±.02
for rest and .40±.02 for exercise. The ratio of
exercise/rest extractions was 1.14±.06. Average
flows obtained from application of a 2 compartment
model fit to the initial 90 sec of PET data were
. 8l±.43 and 1.53±.69 ml/min/g for rest and
exercise. The ratio of exercise/rest flows was
2.06±.68 which correlated with a 280% increase in
double product. The lack of significant increase
in net extraction of NH3 with exercise is due to a
decrease in extraction fraction with increasing
flow and limits the usefulness of net extractions
to quantitate flow changes. We, however, conclude
that coronary blood flow can be quantitated using
dynamic PET images and a 2 compartmental model.
Predictive value oi' In-Ill Antimyosin uptake i'or
i~rovement oi' left ventrio.Jlar wall motion aTter
thrombolysis in aO-lte myocardial inTarction.
Bob van Vlies M.D., Jim Baas M.D., Cees Visser M.D.
F .A.C.C.. Eric van Royen M. 0., Arend funning M.D. F .A.C.C.
Depts aT Cardiology and III...lclear Medicine,
Academic Medical Center, Ansterdam, The Netherlands.
In 19 patients (pts.). who were treated with thrombolysis
-I'or transrrural ao..tte myocardial inTarct (AMI), the degree
aT myocardial uptake (MJ) aT Indium-Ill I"broclonal
Antimyosin (IMA), injected wi thin 24 hours aTter onset aT
AMI, was ~red with the degree and extent aT regional
asynergy (RA) on admission and discharge as assessed by
2D-echo. 2mCi IMA was injected on day 1 oT AMI and planar
images were made 24 hours later. I~ was evaluated i'or
CC>..lnt density index (CDI=CC>..lnt density aT inTarct
zone/leTt lung count density) in the leTt anterior
oblique projection, which optimally displayed inTarct
zone in all patients. Using 2D-echo, LV was divided in 13
segn-ents and evaluated i'or RA. RA was considered severe
(akinesis or dyskinesis) or mild (hypokinesis). RA extent
was measured by the number aT asynergic segments •
All 19 pts. had severe RA on admission; 7/19 showed only
mi Id RA on discharge, 12/19 had persistent degree aT RA.
RA CIII DIa::l-M:£
MILO SE\ta<E
COl 1.71:9.25 * 2.50:9.47 * P<O.Ol
In 13 pts. a decrease in the number aT akinetic segments
was seen between admiSSion and discharge. In 6 this
number was unchanged.
EXTENT CF SE\ta<E RA
IECREASED t..J\O-¥lNE)
COl 1.93:9.37 * 2.72:9.40 * P<O.Ol
Thus, early COl predicts wall motion improvement in AMI
treated with thrombolysis.
Quantitative measurement of myocardial blood flow and
coronary flow reserve in patients with CAD employing 0-15
water and positron emission tomography (PET)
Luis I Araujo MD,Edward 0 McFalls MD,Adriaan Lammertsma
PhD,Terry Jones D5c,Giuseppe Pupita MD and Attilio Haseri
MD,FACC. HaC Cycloton and Cardiovascular Units,Hammersmith
Hospital,London UK
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Myocardial Perfusion Imaging
PROGNOSTIC IMPLICATIONS OF NUCLEAR EXERCI SE TESTS IN AN
UN5ELECTED OUTPATIEm' POPULATION.
Richard M. 5teingart M.D •• Sylvia Wassertheil-Smoller
Ph.D •• Jonathan Tobin Ph.D •• John Wexler M.D •• Ph.D ••
Winthrop-University Hospital & Albert Einstein College of
Medicine. Mineola and Bronx. NY.
To assess the efficacy of nuclear exercise tests in
predicting mortality (M). 235 pts with suspected or proven
coronary disease (CAD) were prospectively enrolled and
followed for 5 yrs. 121 pts were referred for exercise
thallium scintigraphy and 114 for radionuclide ventriculo-
graphy. Since there were no significant differences in
clinical characteristics or survival of patients sent for
exercise thallium scintigraphy or radionuc1ide ventriculo-
graphy. combined results are presented below. There were
192 men. 43 women. median age 55 years. Pretest probabil-
ity of CAD was <.10•• 10-.90. and ~.90 in 15%. 39%. and
14% of pts respectively. The remaining 32% had known CAD
(prior infarction or CAD at angiography). Only 4% had
heart failure. and 6% had rest ejection fractions <50%.
Fo1lowup for M was complete. Overall survival was 94.5%
at 5 years. M rates were as follows: Men 8%. women 1% (p<
0.04); anginal symptoms present 8%. absent 1% (peO.03);
probability for CAD ~.90 9%. =<.90 3% (p=0.05): ST segment
depression during exercise present 8%. absent 3% (p=NS).
Ischemia on either exercise thallium scintigraphy (defined
as a transient exercise related perfusion defect) or
radionuclide ventriculography (defined as an exercise
related regional wall motion abnormality) was highly
predictive of an increased M (10%) when compared with the
absence of ischemia (1.6%) (p<0.007). Conclusions: Five
year survival was good among unse1ected outpatients refer-
red for nuclear exercise tests. Nuclear exercise test
results further identified low and higher risk subgroups.





We previously validated a method to measure HBF with a
continuous inhalation of 0-15 C02 and dynamic PET scanning
in a dog model performing simultaneous measurements of HBF
with gamma labelled microsphers (r=0.98) .In the present
study we studied 6 patients with severe single vessel
disease ,positive exercise test and no evidence of
myocardial infarction (MI) (group1) and 4 patients with
q-wave MI (group2) .Measurements of MBF were performed
during baseline (B)in all pts and following the
administration of 0.6 mg/kg of dipyridamole (D) in
group1. Over 60 regions of interest were drawn on an
average of 10 cross-sectional images of the heart to
generate time /activity curves of the myocardium and left
ventricular chambers (arterial input function). HBF was
obtained by fitteing to a 2 compartment model.HBF results
were then grouped in regions of myocardium supplied by
normal arteries (N) and those supplied by stenosed






(group1:B N vs D N p:S;.05,B 5 vs D 5 N5;group2:N VS 5
p:S;.OOl).Coronary flow reserve in the distribution of 5 was
57+/-12% of that of N in patients of group1(p<.001 one way
ANOVA). Thus, PET measurment of MBF was found to be
consistent with the presence of MI and an impaired flow
reserve in those pts with single CAD and no HI.
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SUPBRXORXTY OF To-". KBTHOXYXSOBUTYL XSORXTRXLB
COMPARBD TO THALLXUM-201 FOR THB TOMOGRAPHXC
A8SBSSKBRT OF COItODRY ARTBRY STBROSBS.
Joel K. Kahn, M.D., lain McGhie, M.D., Michael
N. Sills, M.D., Tracy L. Faber, Ph.D.,Marvin S.
Akers, B.S., James T. Willerson, M.D., F.A.C.C.,
James R. Corbett, M.D. I F.A.C.C. University of
Texas Southwestern Medical Center, Dallas, TX.
To test the hypothesis that tomography (SPECT)
with Tc-99m 2-methoxyisobutyl isonitrile (MIBI)
accurately identifies coronary stenoses, we
compared stress-rest Tc-99m MIBI with stress-
redistribution thallium (Tl-201) imaging in 38
pts with coronary artery disease documented by
angiography (~50% diameter stenoses). Tracer
distributions were quantified and compared to
lower limits (mean - 2.5 S.D.) from 12 healthy
volunteers. Tc-99m MIBI images were visually
superior to Tl-201 in 84% of pts. Heart/lung and
heart/liver ratios were similar for MIBI and Tl-
201. Tc-99m MIBI identified 36 pts compared to
32 pts with Tl-201 (p=0.2). Compared to Tl-20l,
Tc-99m MIBI identified more stenoses (59 vs. 45
of 75,p<.05), a similar number of uninvolved
vessels (28 vs. 27 of 39,p=NS), and had greater
accuracy (76% vs. 63%,p<.05). More non-infarct
related stenoses were detected with Tc-99m MIBI
(38/54 vs. 25/54,p<.05). Quantitative perfusion
defect severity was equivalent for MIBI and Tl-
201. Tc-99m MIBI identified 134 reversibly
ischemic segments in 33 pts compared to 104
segments in 28 pts with Tl-201 imaging (p<.05).
Thus, Tc-99m MIBI SPECT myocardial perfusion
imaging provides superior detection of stenoses
and reversible ischemia compared to Tl-201.
QUANTITATIVE ANALYSIS OF STRESS TC-99M KETROn ISOBUTYL
ISONITRILB(MIBI) SPECT: PRELIMINARY DEVELOPMENT AND
VALIDATION OF AN OPTIMIZED COMPUTERIZED KETROD.
It van Train, B.S., R Kiat, M.D., J Maddahi, M.D., FACC, C
Vong B.S., L Roy, B.S., J Friedman. M.D., FACC, 0 Berman,
M.D., FACC. Cedars-Sinai Medical Center, LA, CA.
A method was developed to objectively quantitate MIBI
based on our quantitative SPECT Tl-201(bl) method. SPECT
MIBI imaging used 32 projections over 180 • After low-pass
filtering and reconstruction, maximum count
circumferential profiles were generated and normalized to
each short- and vertical long-axis slice. Short-axis and
the apical portion of long axis profiles were plotted on a
2-dimensional polar display. Using 10 pts(5 male(M) and 5
female(F» with <5% likelihood of coronary artery
disease(CAD), average counts of Tl and MIBI in 4
myocardial regions were:
Anterior ~ Inferior ~
Tl/MIBI Tl/MIBI Tl/MIBI Tl/MIBI
M: 84/84 91/93 74/76 78/81
F: 86/87 93/93 83/86 81/85
Relative increase in counts observed in the inferior and
septal regions in F was presumably due to breast
attenuation of opposite walls. Normal limits for MIBI were
then developed from 14 M with <5% likelihood of CAD.
Sensitivities and specificities for overall CAD detection
and identification of diseased vessels (~50% stenosis) in
12 Mpts were:
~ ~ 1&1 .BkA
Sensitivity: 8/8(100%) 5/6(83%) 6/6(100%) 4/5(80%)
Specificity: 3/4( 75%) 4/6(68%) 4/6( 68%) 5/7(71%)
Ve conclude: 1) gender aatched normal li.it. are
required for SPECT MIBI, 2) this objective quantitative
method for SPECT MIBI offers promise for the overall
detection of CAD and identification of disease in
individual coronary arteries.
PlANAR AND 'lQoI:lGRAfH[C MYOCARDIAL IMl\GIN:; WI'lH SQ
30217, A NE.W TEQlNEI'IUM I.ABEI.ED AGENl'
william R. Herzog. M.D., 1Inna Nys, R.N., Midlael L.
Cianci, Richard J. Katz, M.D., F.A.C.C., Richard C.
Reba, M.D., Alan G. WasseITl1ilD, M.D., F.A.C.C. George
WashinJton University, washi.n;Jton, oc.
In evaluation of SQ 30217 (SQ), a new neutral lipo-
IiUlic technetium labeled myocardial perfusion agent
with rapid clearaooe, _ studied 22 patients referred
for coronazy arteriograp,y. Treadmill exercise was
performed to 80% of maximal predicted heart rate or
synptans am SQ (12-2011C1) was injected at peak exer-
cise. Planar bnagin1 was performed in the first 15
patients in three views startin1 in 2 minutes in the
anterior (3 min), 45 lAO (6 min), am left lateral (9
min) views. A dose of SQ was repeated 120 minutes
later at rest. Images -re evaluated by 3 observers
blimed to the cath results. Eight patients had
significant coronary disease (~50% stenosis). SQ scans
identified 5/8 (63%) patients with CAD am 5/11 (45%)
abnoJ:lnal vessels with no false positives. 'lWo patients
with sin1le vessel circumflex am one with only right
coronary disease -re not detected possibly because SQ
hepatic activity abscured the inferior wall on the
lateral view. All but one abnonnal region (100%
ooc:lusion) , in a non-infarct location, nonnalized at
rest. In order to inprove accuracy, SQ SPEC!' was
performed post exercise am at rest in the final 7
patients, 6 of whan had CAD. SQ SPEC!' identified all 6
patients with CAD am 8/11 (72%) abnonnal vessels with
no false positives. COoolusion: SQ is a pranisin1
iJnagin1 agent for the identification am localizadon
of CAD, particularly usin1 SPEC!'. '!he rapid myocardial
washart: of SQ allows for the sequential perfQI'lllal'X:le of
both rest am exercise studies.
KINETICS OF THE NEW Tc-99m LABELED BLOOD FLOW HARKER
(SQ30217) IN CANINE MYOCARDIUM.
Richard E. Stewart, M.D., Gary D. Hutchins, Ph.D., Eileen
Bour, Thomas B. McClanahan, Kim D. Gallagher, Ph.D., Neil
A. Petry, M.S., Markus Schwaiger, M.D., University of
Michigan Medical Center, Ann Arbor, Michigan.
SQ30217 (SQ), a boronic acid adduct of technetium oxime
complex, 18 a neutral lipophilic myocardial blood flow
(MBF) tracer introduced for cardiac imaging. To charac-
terize myocardial retention and clearance, a a..ll bolua
of SQ was injected into the LAO in 5 open cheated doga (8
experimental runa). Kyocardial time activity curvea vere
recorded using aNal (Tl) probe placed over the left ven-
tricle. Myocardial activity cleared in a biezponential
pattern following i.c. injection. Curve fitting waa em-
ployed, yielding first paas retention fractiona (RF),
clearance halftimes (T 1/2) and relative proportiona (RP)
of each ezponential to the iF. Prior to each injection,
radiolabeled microspherea were injected to determine KBF.
SQ It1netica vere asaeased over a vide KBF range utilizing
i.v. dipyridamole (0). At baaeline, (GI) KBr averaged .43
+ .17 .l/min/g, while MBF increased (GIl) to 3.1 + 1.5 all
'i1n/g following 0 (0.3-0.5 Jlg/kg). -
n iF T 1/2(1) T 1/2(2) RP(l) RP(2)
(min) (min) % %
GI 3 .80 + .07 2.5 +.7 20 + 11 70 + 2 30 + 2
GIl 5 .84 +.06 1.8 +.2 37 +8 78 + 1 22 + 1
SQ haa a high first pass retention fraction, which 18
stable over a wide flow range. Myocardial tracer kinetica
are characterized by biexponential clearance. The rate
and proportion of the fast component, which repreaenta
approxiaately 75% of total clearance, is related to blood
flow. Thus, the high 1lF favors SQ 88 a auitable OF
tracer, but the faat clearance seen in canine heart chal-
lenges conventional SPECT imaging procedures.





REVERSE REDISTRIBUTION FOLLOWING MYOCARDIAL INFARCTION
IS RELATED TO SEVERITY OF CORONARY STENOSIS.
Aoatoly LanRer M.D., Michael Freeman M.D., Robert Burns
M.D., Peter Liu M,D., Ronald Baigrie M.D., Paul Daly
M.D., Aminul Haq M.D" Christopher Morgan M.D., Paul
Armstrong M.D, Toronto, Canada.
We evaluated the infarct-related territory (IRT) and
artery (IRA) to test the hypothesis that, in comparison
to reversible defect (RD), apparent worsening (reverse
redistribution, RR) on exercise thallium single photon
emission computerized tomography (SPECT) may be due to
rapid washout (WO) of thallium in segments supplied by
IRA with less severe flow limiting stenosis. Accordingly
we studied 58 pts (age 54±1 yrs, i±SEK) who were part of
a randomized, double-blind, placebo controlled trial of
IV tPA for myocardial infarction (MI, 34 pts received
tPA and 24 placebo). All pts had an open (TIMI grade II
or III) IRA at lO±.3 days and underwent symptom-limited,
Bruce protocol exercise with SPECT at 9±.4 days
following admission. Quantitative coronary angiography
(QCA) was used to calculate minimal cross-sectional area
(MCSA) of IRA. Presence of normal perfusion (N), fixed
defect (FD) , RD, and RR in IRT was determined by two
independent observers blinded to the results of QCA.
~ l!2 RR ~
2 9 23 24
1 5 14 14 *p<.Ol
.8±.6 .9±.4 ,7±.1 1.6±.3* vs RD
The WO rates in IRT were assessed by quantitative
analysis and were more frequently above normal in pts
with RR than in those with RD (17/24 vs 3/23, p<.005).
We conclude that reverse redistribution is frequently
seen in pts with patent IRA following MI. RR is associ-
ated with faster thallium washout and a lesser degree of
luminal obstruction and may be useful in identifying
vessels with less severe flow limiting stenosis.
IODINE-l23-PIIENYLPBlI'rADECAHOIC ACID 'l'OIIIOGRAPHY FOLLOIIING
DIPYRIDAMOLE DlFUSION FOR THE DETECTION OF CORONARY
ARTERY DISEASE.
Terrence Ruddy, MD, FACC, Michel White, MD, Ross Davies,
MD, FACC, Lyne Vigus, RN, Paula Spencer, RNMT, Elaine
Cooper, RNMT, Michael Baird, MD, FACC, Jean-Francois
Marquis, MD, FACC, James Ballinger, PhD, University of
Ottawa Heart Institute, Ottawa, Canada.
Myocardial uptake of iodine-123-phenylpentadecanoic acid
(IPPA), a synthetic fatty acid, is directly related to
blood flow and aerobic metabolism. Dipyridamole results
in flow differences and often ischemia (anaerobic
metabolism) in pts with coronary artery disease (CAD).
Thus, myocardial uptake of IPPA after dipyridamole
should be reduced in myocardial regions supplied by
stenosed coronary arteries and permit localization of
CAD. The diagnostic accuracy of dipyridamole IPPA
imaging for the detection of CAD was evaluated in 55 pts
with chest pain (35 with and 20 without CAD defined as
~70% diameter stenosis by quantitative coronary
angiography). pts were imaged tomographica11y (3 serial
16 minute studies) after dipyridamole and IPPA
injection. Rapid IPPA clearance permits redistribution
imaging immediately after initial imaging. Results for
detection of CAD by decreased uptake of IPPA are below.
SENSITIVITY SPECIFICITY DIllGHOSTIC ACCORACY
CAD 0.94 0.80 0.89
LAD 0.82 0.82 0.82
LCX 0.60 0.94 0.82
RCA 0.87 0.70 0.75
Dipyridamole IPPA tomographic imaging has high
sensitivity, specificity and diagnostic accuracy for
detection of CAD. Redistribution imaging immediately
after initial imaging results in greater patient and
laboratory convenience. Dipyridamole IPPA imaging may be
a superior alternative to stress thallium imaging.
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Cardiac Function: General
LEFT VENTRICULAR DIASTOLIC FUNCTION - DOPPLER
CHANGES IN EARLY POST CARDIAC TRANSPLANT
RECIPIENTS.
Frederick G. St.Goar. M.D" Rebecca Gibbons. ROMS, Ingela
Schnittger, M.D.,F.A.C.C., Hannah A.Valantine,M.D., Richard L.
Popp, M.D., F.A.C.C., Stanford University, Stanford, CA.
Left ventricular diastolic function is altered in acute cardiac transplant
rejection and a restrictive ventricular filling pattern QCCures. Doppler
echocardiographic indices have been proposed as sensitive markers of
the rejection process. As rejection progresses the restrictive ventricular
filling pattern is reflected by a shortening of the isovolumic relaxation
time (lVR1) and mitral valve pressure half time (PHl) and an increase in
the early transmittal filling velocity (MI). It is also known that left
ventricular filling undergoes characteristic changes suggestive of
improving diastolic function in the early post operative period in non
transplant cardiac surgery patients. We examined the progression in
Doppler derived mitral filling indicies in a group of cardiac transplant
recipients (10 patients) who demonstrated no histological evidence of
transplant rejection. IVRT, PHT and MI were measured on a weekly
basis for the first post operative month on the day that surveillance right
ventricular endomyocardial biopsies were performed. A gradual
improvement over time in LV diastolic function and a decrease in the
restrictive filling pattern was demonstrated by all three measured Doppler
parameters.
CIlARACTElUZATION OF PATIENTS WITH ABNORMAL STRESS
REDISTRIBUTION TL-201 SPBCT AND NORMAL CORONARY ARTERIBS.
H Kiat, H.D., J Haddahi, H.D., FACC, A Rozanski, H.D.,
FACC, J Friedman, H.D., FACC, D Bellil, H.D., R Siegel,
H.D" FACC, R Bachur, H.D., P. Kimsey, D Berman, H.D.,
FACC, Cedars Sinai Hedical Center, Los Angeles, CA,
To assess the potential causes of abnormal(abnl) stress
redistribution Tl-201(Tl) SPBCT in patients(pts) with
normal(nl) coronary arteriograms(NCA), 46 pts with these
findings tested from 1983-1988 were identified. Their
SPBCT studies and those of 27 randomly selected additional
pts - 17 with coronary disease ~50% stenosis(CAD) and 10
with low likelihood of CAD(LL) - were reinterpreted
blindly by 3 experienced observers as nl, equivocal or
abnl. Excellent agreement was found between the original(1
expert) and consensus reading for LL(90%) and CAD(94%)
pts. Agreement was lower for NCA pts with 10/46(22%) being
reclassified as equivocal(N-7) or nl(N-3), attributed to
experience in identification of nl variant Tl SPBCT
patterns(eg" breast and inferior wall attenuation). An
additional 9/46(20%) pts had technical artifacts
explaining positive Tl SPBCT: 5 had motion or "upward
creep", 2 had "hot spots" and 2 had "vertical heart", the
latter causing nonreversible septal defects. Of the other
27 pts, definite cardiac abnl was present in 18: LBBB with
septal reversible defects(N-4), marked(~ 20 mmHg)
elevation of LV end-diastolic pressure(LVBDP) and/or
moderate to severely abnl wall motion(N-13), and severe
mitral regurgitation(N-l). The remaining 9 NCA pts had
possible occult cardiac pathology with ST depression
(N-7), and/or moderate elevation of LVEDP(N-6),
In conclusion, pts with abnl Tl and NCA can be
categorized into 2 groups: 1) over-reading and technical
errors(solved by experience and quality control), and 2)





















Conclusions: This Doppler data confirms the improvement in LV
diastolic filling in the early post operative period in the~ of
rejection. Knowledge of these characteristic changes is important for the
application of these indices for rejection surveillance.
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RESTING AND SUPINE EXERCISE HEMODYNAMICS IMPROVE
1 AND 3 YEARS AFTER ORTHOTOPIC CARDIAC
TRANSPLANTATION
Peter W, Pflugfelder MD. Blair J, O'Neill, MD. Alan H, Menkis,
MD, F, Neil McKenzie, MD, William J. Kostuk, MD, FACC,
University Hospital, London, Ontario, Canada,
To assess the changes in resting and exercise central
hemodynamics that occur with time, 74 heart transplant
recipients have had serial resting hemodynamic studies at 1
wk, 3 mo. and 1 yr, and 12 patients have also had studies at 3
yr, Hemodynamic measurements during symptom limited
graded supine exercise were obtained serially in all patients at
3 mo, 1 yr, and 3 yr, R.sults:
Reiling Hemodynamic.
HR CO PCWP RAP
1wk 87±14 5.3±1.3 16±6 9±6
3mo 95±12* 6,2±1.2* 14±4 6±2*
1 yr 92±11* 6.0±1.2* 12±4* 5±2*
3 yr (",,12) 86±12 6.5±1.3· 11±3§ 5±2*
means ± SO; ·p<.01 VI 1 wk, §p<.01 VI 1 wk and 3 mo.
Exerel.. Hemodynamic.
PCWP RAP
3mo 1yr 3yr 3mo lyr 3yr
EX 1 23±6 21±6 20±6 l4±5 10±4' 9±2'
PEAK 27±7 25±7 27±6 17±4 14±4' 12±4§
means ± SO; ·p<.01 VI 3mo. §p<.01 VI 3 mo and 1 yr; EX1.25 W supine
exen:lse. PEAK.rnaxklun exen:lse.
At 1 and 3 yr, exercise heart rate response became more
physiologic as did deceleration post exercise. Peak exercise
cardiac output (970/0 increase) was maintained to 3 yr, Thus.
although ventricular filling pressures increase strikingly during
exercise from 3 rna on, there is no evidence of progressive LV
dysfunction with time, RV performance during exercise
con~~~.~esto improve to 3 yr.
RIGHT VENTRICULAR RESTRICTIVE/CONSTRICTIVE PHYSIOLOGY
ACCOMPANIES HEART TRANSPLANT REJECTION. B.Jaski M.D••
FACC. M.McDaniel. P.Hoagland H.D •• FACC. S.Smith M.D ••
FACe. T.Widman H.D•• R.Adamson H.D•• K.Peterson H.D ••
FACC. Sharp Memorial Hospital. University of California.
San Diego. CA.
Conflic;ting reports have evaluated changes in indices
of both systolic and diastolic LV function with heart
transplant (TX) rejection (RJN):--Therefore. in 10 TX
Pts. intravenous digital subtraction RV angiograms based
on densitometric analysis and micromanometer RV pressure
were prospectively assessed at endomyocardial biopsy. 13
episodes of RJN (myocyte necrosis) were compared to
preceding negative biopsies. Heart rate (HR.bpm). RV
systolic (SYS). minimum (MIN) and end-diastolic (ED)
pressures (mm Hg). ejection fraction (EF%). peak filling
rate (PFR. ED vol/s) and time to PFR (tPFR. ms) were
(mean:t SEM):
IIR SYS MIN ED .E PFR ~
- RJN 83+2 28+2 O+f 7+1 58+2 2.45+.10 132+5
+ RJN 86±3 34±3* 4±1* lo±2* 62±2 2.82±.19* 14o±5
*p< .05 vs. - RJN
Dip and plateau changes in RV diastolic volume and pres-
sure curves were noted with RJN. No significant changes
in stroke volume. pulmonary capillary wedge pressure.
pulmonary vascular resistance or RV peak positive dP/dt
occurred. Thus TX RJN may effect RV diastolic performance
secondary to either changes in myocardial mechanics or
loading. RV diastolic function may be a better index of
graft viability than systolic function.
BETA ADRENERGIC BLOCKADE BLUNTS COIPENSA'l'ORY HYPBRlClNESIS
DURING ACUTE INFARCTION.
Richard M. Steina&rt M.D •• JaDice DiBiaae. Anthony
GAIlino M.D •• N:Ilti Kantroviu M.D •• Steven Zeldia H.D.
FACC. StaDley Kau M.D. FACC. Winthrop-Univer.ity
Ho.pit.l. Mineola NY aDd SUNY Stony Brook.
Coap_.tory hyperkinesia (Cft) in .cute HI ha. been
.ttributed to .drenergic .tLauI.tion. th. Frank-St.rling
mechanis.. and intr.ventricul.r inter.ctions that unlo.d
the normal .ea-ent.. To •••••• the role of adrenergic
.t~l.tion in CR. nin. un••ge 52+13 yre were given 15
as IV utoprolol (MET) <1.5 hour••fter PTCA for .cute
MI. All had 1 v••••l CAD. He••ur_ta were obt.in.d
before IV MET (PRE). iamediat.ly.fter (POST). and .fter
9.1=1.2 d.y. of lOOms MET PO BID (LATE). Regional motion
(RWN) w.s .cored in • ma.ked f••hion: O=dy.kinetic;
l=eltinetic; 2=hypokinetic; 3=normal; 4=hyperkinetic.
He.rt Rate Blood Pre••ure EI!'
PRE POST LATE PRE POST LATE PRE POST LATE
MEAN 88 71* 62* 125 125 111 55 45* 54+
S.D. 14 13 12 10 15 16 14 15 10
*=pcO.005 v. PRE. +=p<0.05 v. POST IV MET.
In a control population. IV MET produced no change in
RWN. Among pt•• IV MET did not chang. infarct zone RWK.
1.6+0.7 to 1.3+0.7. but norwal zone RWM declined frca
3.6~.5 (hyperkinetic) to 2.7!O.5. (normal) (peO.05).
This r••ult.d in • 10 unit f.ll in the glob.l !I!'. At
LATE .tudy. normal zone RWM r_inad normal. while
inf.rct zone RWH illprov.d to 2.4+0.7. p< 0.02. Thia
improved inf.rct zona RWH resulted in • 9 unit ri.e in
the glob.l EI!' fro. POST to LATE. or only • I unit fall
froa PRE to LATE. Conclu.ions:Adrenergic sd_l.tion'
cau.es CH in .cute HI. By blocking noraal zone Cft. IV
MET can influence the direction.l change in glob.l Er.
independent of ita effecl: on intarct zone recovery.
QUANTITATIVE REGIONAL CURVATURE ANALYSIS: DETERMINATION
OF ABNORMAL SYSTOLIC AND DIASTOLIC FUNCTION BY ASSESSING
SHAPE THROUGHOUT THE CARDIAC CYCLE.
G B John Mancjni. M.D" F.A.C.C. Scott F DeBoe, B.S.,
Edward Anselmo. B.S .• Michael T LeFree, Sandra BSimon,
M.A., Joseph Sitomer, M.S.B.E. University of Michigan
& VA Medical Centers. Ann Arbor, HI
Quantitative Regional Curvature Analysis (QRCA) was
developed to lIleasure left ventricular (LV) regional
function independent of volUlle and reference, coordinate
or indexing syste.s. QRCA was based on calculation of
shape (curvature) from LV cines at end-diastole and end-
systole. Curvature was nonaallzed to dimensionless
units by incorporating perimeter length thereby allOWing
comparison of ventricles of different sizes. QRCA was
enhanced so that systolic and diastolic shape
abnormalities could be quantitated throughout the full
cardiac cycle. Frame-by-frUle outlines of 30 nonaal and
40 abnormal patients were analyzed. To account for
differences in cycle length. interpolation was used to
create 100 ·frames· per cardiac cycle such that frame
I and frame 100 corresponded to end-diastole and frame
50 corresponded to end-systole. Results were displayed
in a color-lIIOdulated graph 1:ontaining 100xlOO pixels
(color. deviation from nonaal curvature values. Xaxis
• perimeter location, y axis -. phase of the cardiac
cycle). Percentage of pixels with abnonaal deViations,
mean deviation per pixel and total deviation per region
were worse in areas of dysfunction compared to normal
zones (44 ± 2 vs 55 ± 3, 0.14 ± 0.05 vs -0.11 ± .08, and
594 ± 200 vs -598 ± 296. respectively, all p < .004).
QRCA is an innovative technique for comprehensively
measuring both systolic and diastolic function
independent of volume and reference frames.
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ACUTE AND OIRONIC RESPONSE TO ORAL ENOXIMONE IN SEVERE
CONGESTIVE HEART FAILURE: SUSTAINED HEMODYNAMIC
IMPROVEMENT AND PREFERENTIAL EFFECT ON RIGHT
VENfRICULAR SYSTOLIC PERFORMANCE
pavid M arm Mp. Marvin A. Konstam MD FACC, Jeanne Metherall
CNMT, Cindy Lane RN, Patricia Lyman RN, Noreen Dolan RN, Susan
Kelly RN, Tufts University-New England Medical Center, Boston, MA
We examined acute and chronic responses to oral enoximone to
determine 1) effect of chronic therapy on baseline hemodynamics and
ventricular pertormance; 2) effect of chronic therapy on acute drug
effect; 3) relative acute and chronic effects on RV and LV
pertormance. Eleven patients with severe congestive heart failure
(LV ejection Iraction (EF) 0.17 ±. 0.02, mean ±. SE) underwent
hemodynamic and radionuclide ventriculographic study before and 2
hours alter a single oral dose (mean 1.2 mglkg). All patients were
restudied alter an average 01 7 weeks of enoximone therapy, with
enoximone discontinued 24 hours belore study. Enoximone increased
CI and reduced PA wedg!! pressure (PAWP). Enoximone improv!!d
RVEF, but not LVEF. At follow-up study, pre-drug parameters were
unchanged from the initial study. Response of all parameters to
enoximone was similar to the response observed at the initial stUdy.
("p<O.OS vs. rest.)
Initjal Stydy Follow-yp Stydy
Best EllOxjmone Best Enoxjrnone
LVEF .17 ±. 02 .17 ±. .02 .16 ±. .02 .17 ±. .03
RVEF .33 ±. .02 .40 ±. .04" .32 ±. .02 .41 .±. 04"
CI(lImin/m2) 2.0 ±..2 2.3 ±. .2" 2.0 ±. .2 2.2 ±. .2"
PAWP(mmHg) 21 ±. 2 17 ±. 3" 20 ±. 3 17 ±. 3"
Conclysions: In patients with severe congestive heart failure: 1)
Enoxlmone preferentially augments RV systolic pertormance, with no
detectable effect on LVEF. 2) Chronic enoximone therapy does not alter
bas!!lin!! (off !!noximone) hemodynamics or ventricular pertormanc!!.
3) Effects of enoxlmon!! on h!!modynamics and on RV pertormance are
maintained alter chronic th!!rapy.
HETEROGENEITY OF REGIONAL MOTION AND SHAPE IN RESPONSE
TO ALTERED LOAD.
G B JQhn Mancini. M.D" E,A.C.C., Mark R Starling, M.D.,
F.A.C.C. University Qf Michigan &VA Medical Centers,
Ann Arbor, MI.
Left ventricular (LV) regional wall motion (RWM) has
been used to evaluate interventiQns despite the fact
that such measures are load-dependent. To assess
whether LV shape, an important aspect of IIll!chanica1
functiQn, is also 1Qad-dependent, 10 noma1 patients and
12 patients with either aortic or Mitral regurgitation
were studied with ventriculography and high-fidelity
pressures during control and infusiQns of methoxamine
(M) and nitroprusside (N) at a constant heart rate. RWM
and regional shape (RS) were derived using the
"centerline" and "quantitative regional curvature"
methods, respect ive1y. In normal subjects, LV end-
diastQ1ic and systolic pressures ranged between 12-20
and 102-179 mmHg, respectively and LV end-diastolic
volumes ranged between 102-179 m1. In valve patients,
the respective ranges were 4-38 and 87-208 MmHg and 134-
408 m1. RWM in nQrma1 subjects showed load-dependency
that was greatest in the inferior wall (-.19 ± .9 during
N vs -1.06 ± 1.22 standard deviations per chord during
M, p< .05). RS of the anterior and inferiQr Wills
showed no load-dependency. In valve patients, RWM of
both the anterior and inferior walls showed a SiMilar
degree of load dependency whereas RS showed no load
dependency. Thus, in patients with nO"'11 LVs, load
dependency of RWM is greatest in the i nferi or wall
whereas in valve patients both the anterior and inferio~
walls show similar load dependency. RS is independent




IN VIVO ASSESSMENT OF THE INDEPENDENT EFFECTS OF
HEART RATE, CONTRACTILITY AND SYSTOLIC LOADING
CONDITIONS ON MYOCARDIAL OXYGEN CONSUMPTION.
Roberto M. Lang, M.D., F.A.C.C., Daniel David, M.D., F.A.C.C.,
Alex Neumann, B.S., Lynn Weinert, B.S., Kenneth M. Borow,
M.D., F.A.C.C., The University of Chicago, Chicago, Illinois.
The dependence of myocardial oxygen consumption (MV02) on
HR, contractile state and LV fiber load (I.e., integral of wall
stress during ejection (1a)] Is well recognized. However, a method
for determining the relative importance of each factor In vivo
does not exist. A.,ocordlngly, 7 atrlally paced closed chest dogs
were Imaged with 20 targeted M-mode echo and instrumented
with coronary sinus and Ao/LV mlcrotlp catheters. Data were
acquired during: 1) load (L) manipUlation with nipride and/or
volume at HR90, 2) Increued contractlIlty (dobutamlne (Dob), 5
Ilg/kg/mln, HR90) and 3) Increued HR (90 + 120 bpm). For each
dog, a reference Une of MV02 vs fa/beat (r = 0.92) wu generated
at a HR of 90 under bual contractlIlty conditions using 4 points
(Ll + L4) acquired over a 7396 change In I/beat. The independent
effects of +HR and +contractlIlty on t>MV02 were assessed using
the vertical deviation from this reference I1ne, thereby
eUmlnating changes In systolic load u a confounding variable.
t> LOAD t> DOB t> HR
t>MV02 2996 596 3296
The Isolated change in systoIlc load
(L1+L4) resulted in a 2996 change in
MV02• The + in contractlIlty resulted in 1M""
only a minimal change In MV02 when HR wu maintained
constant and Io/beat wu normaUzed to the reference Une. In
contrut, the + In HR resulted in a marked + in MV02 relative to
the Ia/beat reference Une. Thus, (1) a method for usesslng the
importance of each of the major determinants of MV02 now
exists, (2) in the normal LV, a moderate Increue in contractlIlty
alone does not significantly alter MV02•
PROPAGATION OF TURBULENCE IN AORTIC STENOSIS
John D Carroll MD, Y. Christopher Chiu MD, Ted Feldman
HD FACC, Petrit Alibali, Patricia Wirth PhD, Sanjeev
Shroff PhD, University of Chicago, Chicago, IL.
Turbulence produces high-frequency oscillations of
pressure and velocity waveforms immediately above the
stenotic aortic valve (AS). While turbulence is key to
the physical findings of AS, in YiY2 data are scant to
understand it'5 origin and propagation. The speed and
extent of distal propagation of turbulence in the aorta
were studied in 23 pts with AS (valve area 0.6 + .2 cm2)
using multisensor catheters (3 pressure, I v;locity).
The onset of turbulence (fall in pressure, arrows in
figure) was timed at 2 sensors 5 cm apart. Turbulence
velocity (TV) was calculated and contrasted to the
velocity of pressure wave transmission (PWV).
Turbulence was progressively delayed and attenuated
at more distal sensors. TV was 0.8 ± 0.3 m/sec and PWV
was 7.8 ± 4.2 m/sec. In pts with valve area <0.5 cm2
turbulence persisted further downstream. No ;igns of
turbulence were present in any patient at 25 cm
downstream. The blood velocity waveform was turbulent
in the ascending aorta, but laminar in the descending
aorta. Conclusions: 1) Turbulence is propagated
downstream at a veloeity typical of blood, thus
distinguishing its physical basis from pulse wave
transmission. 2) Turbulenee is transient during systole
and the extent of propagation is variable and dependent
on the severity of AS.
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N:I'l-INVASIVE Df.'l'E»IINATIGl OF Cl\RDIAC CVI'l'UT OORIID
Aa1l'E MYOCARDIAL INFARCI'IGl US:m:; ELECTRICAL
BIOl:MPEl:WCE Cl\RDlOORAPHY.
lain N Firolay MRCP, David l'brthridge MRCP, John T
Wilsc:n, EstheJ:' Henderson, Janes Olrlstie, Heru:y J
Dargie, FRCP. cardiac Department western Infirmaxy
GlasgcM Sootland.
A reliable rxn-invasive technique for measuring cardiac
oot:pxt in acute myocardial infarctien is described. We
measured CO in 26 patients, within 12 b::m'S of the
cnset of chest pain, us:UYJ the technique of electrical
bicllIr{ledanoe. CO determined by the ~ in
t:ranst:roraoic inpldarx:e (TTI) was CXXIpllred with Swan-
Ganz thermodiluticn (TO). Mean (SO) CO by TO was 4.1
(1.1), range 2.1-6.2 l/min and by TTl was 4.1 (1.2),
r~ 1.1-6.2 l/min (p=NS), r-=O.86, p<0. 0005 , y=1.06x-
0.4, SEE = 0.7 l/min. Mean strcKe volUllll by TO was 50
(18) VB 48 (20) mls by TTl (p=NS) , r-=O.93, p<0.0005,
TTl = 1.06TO-4, SEE = 8mls. Since st:rcke VOll.llle
deteDnined by TTl makes asstmpticns en thoracic voll.llle
and body surface area this was cxnI.....-ted for; st:rcke
volume index shewed a sjrnilar close relatiooshiP2
st:rcke volune index by 'lD was 27 (9) VB 26 (11) mls/m
by TTl, p=NS, r-=O.93, p<O. 0001 , TTl = 1.05TO-2,
SEE=4mls/m. Repr:oducibility of CO by TTl was
determined in 10 patients with repeat assessnent after
30 minutes. CO was 4.2(1.5) VB 4.1(1.4) l/min, mean
difference = 0.13 l/min, 95% ccnfidence limits 0.24
l/min, oo-efficient of variaticn 2.7%, r = 0.99, Y =
0.96x+O.l, SEE = 0.14 l/min.
Thus CO by electrical bio~ is highly
reproducible, cx:uparable with thermodiluticn and offers
the possibility of rapid ncn-invasive deteIminatien of
cardiac functicn during acute myocardial infarcticn.
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Metabolism or Ischemia and Reperfusion
OXIDATIVE METABOLISM DURING CARDIAC ALLOGRAFT REJECTION
STUDIED BY NADH LASER FLUORIMETRY.
Denis Duboc M.D., Martine MUffat-Joly Eng., Patrick
Perrier M.D., Philippe Abastado M.D .. Marcel Toussalnt
M.D., Thomas Lavergne M.D., Fran90is Gu~rin M.D., Michel
Degeorges M.D., Alain Carpentier M.D., Universit~ Ren~
Descartes, H6pital Cochin, Paris, France.
Using NMR spectroscopy, decrease in high energy phosphate
compounds has been described during early phase of car-
diac graft rejection. To investigate the behaviour of
myocardial oxidation-reduction states during rej ection,
we studied NADH fluorescence (FO) on 12 non rejecting
(NR: Lewis donnor/Lewis recipient) and 19 rejecting (R:
Fisher donnor/Lewis recipient) heterotopically transplan-
ted rat hearts. Six days after transplantation, FO (arbi-
trary uni ts) was recorded, at base-line, during 30 s of
complete ischemia (I,donnor aorta transiently occluded),
and during reperfusion. At base-line Fo was not signifi-
cantly different in both groups (NR : O. 45±0. 04,
R:0.45±0.05). During I, no significant difference was
evidenced between both groups (NR: 1.11±0.05, R:
0.87±0.10, p#0.06). However in 7 R presenting myocardial
necrosis and fibrosis histologically evidenced, FO l~vel
during I was signicantly lower than in NR (0.49±0.09,
p<10-3), reflecting a lower content of NAD to be reduced
prObably due to the myocardial tissue loss in these ca-
ses. For the other 12 R, with moderate histological re-
jection score, FO level during I was 1.08±0.10 (NS versus
NR). The rate of FO decrease after I was significantly
lower in the overall R group than in NR (0.024±0.001 vs
0.038±0.002 FO.S-1 , p<10-3) reflecting a lower rate of
NADH reoxidation in rejecting myocardium. This suggests a
mitochondrial impairment during rejection process. Ener-
getic metabolism disturbancies may contribute to myocar-
dial dysfunction during cardiac allograft rejection.
In intense EX (PK EX), OFT falls to 1/3 and LVET to 2/3
their resting levels (RL). If 10 responds as LVET, PRO
should drop to 2/9 its RL. LVP at MC should then rise
to 4.5 its RL, i,e. to 70-80 mm Hg. Diastolic BP in PK
EX was 75:. 10 mm Hg. 8eats were identified in three
instances where AD clearly preceded MC. Thus, our
finding of ICP v- 0 ms in intense EX is consistent with
the model prediction and has important physiological
and clinical implications.
LEFT VENTR ICULAR ISOVOLUMIC CONTRACT ION PERIOD V"'f,; SHES
DURING INTENSE EXERCISE
Joe M. Moody, Jr., M.D.! F.A.C.C., Ares PasiDoularld~s,
M.D .• Ph.D., F.A.C.C .• Joseph P. Johns, M.D. Brooke
Army Medical Center, Fort Sam Houston, TX.
There is an inertial delay (10) between atrioventricu-
lar (A-V) pressure crossover and mitral closure (MC).
Mathematical modeling of this 10 showed that LV pressure
(LVP) at MC should be inversely related to the product
(PRO) of diastolic filling time (OFT) and 10. If PRO
falls sharply in exercise, LVP at MC could match/exceed
levels inducing aortic opening (AD), phasing out iso-
volumlc contraction (ICP=MC-AD). To test this, 9 NL
adults were studied during graded bicycle exercise (EX)
with dual M-mode for simultaneous echo of MC and AD.





















GLUCOSE METABOLISM IN STUNNED REPERFUSED MYOCARDIUM.
Britta Renstrom, Ph.D., A. James Liedtke, M.D., F.A.C.C.,
Stephen H. Nellis, Ph.D., Section of Cardiology, Univ. of
Wisconsin, Madison, WI
We have previously determined that oxidation of fatty
acids (FA) recovered to at least aerobic values during
early myocardial ref low while pyruvate metabolism was
suppressed. To further characterize use of carbohydrates
during this condition, rates of glucose oxidation were
measured in two groups of hearts (n-18), one of which
(n-9) received treatment with the FA blocker, oxfenicine.
Experiments were performed using extracorporeally per-
fused, intact swine hearts infused with Intralipid and
hep~~in (average serum FA levels: 1.1±0.1 ~mol/ml),
[6- C)-glucose, and unlabeled glucose as needed (average
serum levels 6.3±1.2 ~mol/ml). All hearts were perfused
aerobically for 30 min (average anterior coronary flow
7.6±0.4 ml/min/g dry), rendered regionally ischemic (-606
% in anterior flow) for 45 min, and reperfused for 50
min. Appreciable mechanical stunning was evident during
recovery in both groups (-506% in systolic shortening, p<
0.05 from aerobic values in control hearts; -326%, p<
0.05 in treated hearts) and was associated with compar-
able reductions in myocardial oxygen consumption (-186%,
p < 0.02 from aer~bic values). ~ Glucose oxidation as
estimated from CO 2 production from labeled glucose wasno different in recovery than during ischemia in control
hearts (14 ~mol/hr/g dry)but doubled (p< 0.01) in hearts
treated with oxfenicine which blocked access to FA
utilization. Tissue glycogen recovered to 55% of aerobic
levels in reperfused hearts in both groups. Thus early
myocardial reperfusion is characterized by preference for
FA oxidation as a primary energy source without any
evidence of accelerated use or need of carbohydrates.
Indeed, glycogen i~ preserved in this condition.
JACC Vol. 13, No.2
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Left Ventricular Maximal Positive dp/dt
Administration of inosine was very useful for
increasing myocardial gross energy product and improving
cardiac function.
Reperfusion 20 minutes 1 hour 4 hours
Control 100.0f2.7% 84.4£2.4% 78.8±5.9%
A Inosine 102.8£7.4% 90.0£3.7% 81.8±4.7%
B Control 95.7±9.2% 77.6£6.5% 51.1±4.7%
Inosine 93.7±3.5% 76.8£7.3% 80.9±7.3%*
(A:30 minute ischemia, B:60 minute ischemia)
IMPROVEMENT OF POST-ISCHEMIC MYOCARDIAL METABOLISM AND
FUNCTION BY INOSINE IN 31 P-MRS STUDY.
Minoru Yoshiyama, Hirozumi Sakai, Masakazu Teragaki,
Kazuhide Takeuchi, Tadanao Takeda. Osaka City University,
Mari Ikata, Makoto Ishikawa, Iwao Miura. Otsuka
Pharmaceutical co. ltd., Tokushima, Japan.
VALIDATION OF A TRACER ANALOGUE METHOD FOR THE ASSESSMENT
OF GLUCOSE METABOLISM IN ISOLATED WORKING RAT HEART.
Van T.B. N~ufen B.A.
t
Donna Shaffer, Heinrich Taegtmeyer,
M.D., D. pi., F.A••C., University of Texas Medical
School at Houston, Houston, Texas.
In order to assess whether the tracer analogs, 2-deoxy-
D-glucose (2-DG) and 2-fluoro-2-deoxy-D-glucose (2-FDG)
are valid markers of glucose metabolism, we perfused
working rat hearts for specified time periods and at dif-
ferent work loads (WL) with either 2-DG or 2-FDG. To
determine the time dependence of tracer accumulation,
hearts were perfused for 30' or 90' at intermediate WL
(10 mM glucose) with 2-DG. To determine the work depen-
dence of tracer accumulation, hearts were perfuse4 for
60' at either low or high WL (5 mM glucose) with 2-DG.
Rates of glucose utilization were 365, 813 and 965
(umol/hr/g dry) for low, intermediate and high WL, res-
pectively and correlated well with the accumulation of
radioactivity in the tissue. Concentrations of intra-
cellular free and phosphorylated tracer were also mea-
sured. Although 2-DG accumulated as a function of
perfusion time and work load, the percent of nonphos-
phorylated tracer remained constant (12±2%). To deter-
mine the uptake and retention of 2-FDG, hearts were per-
fused at intermediate WL (10 mM glucose) with 2-FDG for
60' followed by a 40' washout period with non-radioactive
perfusate. 2-FDG activity in the heart rose linearly
with time. Conclusions: 2-DG and 2-FDG appear to be valid
markers of glucose metabolism. Superior temporal reso-
lution resulting from external detection of 2-FDG permits
more accurate assessment of changes in glucose uptake
induced by metabolic perturbations. In contrast to pre-
vious observations, there was a detectable pool of intra-
cellular, non-phosphorylated 2-DG supporting the counter-







A Control 63.3*3.3% 69.0*4.2%
Inosine 63.1~3.2% 73.7~1.7%
B Control 41.1£4.7% 45.7f4.9%
Inosine 43.0~2.1% 54.1±3.6%
ATP
Reperfusion 5 minutes 1 hour
Perfused guinea-pig hearts, which were analyzed, by
31P-MRS, were subjected to 30 and 60 minute ischemia and
reperfused using two perfusates, one containing 200 pM
inosine, and the other without inosine (Control). Inasine,
hypoxanthine, xanthine, and uric acid were detected in the
coronary effluents of post-ischemic hearts by HPLC,
however, adenosine was not found.
POSSIBLE DIFFERENCE OF METABOLICAL CONDITION IN PATIENTS
WITH DILATED CARDIOMYOPATHY AND SEVERE CORONARY ARTERY
DISEASE: EVALUATION BY POSITRON EMISSION TOMOGRAPHY.
Tetsuro Fudo, M.D., Hirofumi Kambara M.D., F.A.C.C.,
Masataka Hayashi M.D., Tetsuo Hashimoto, M.D., Ryuji
Nohara M.D., Nagara Tamaki M.D., Keiji Yamashita M.D.,
Junji Konishi M.D., Chuichi Kawai M.D., F.A.C.C., Kyoto
University, Kyoto, Japan.
To examine the alteration of metabolism and perfusion in
patients with dilated cardiomyopathy (DCM) and severe
coronary artery disease (CAD), positron emission
tomography (PET) was performed with N-13 ammonia and F-
18 deoxyglucose as an indicator of blood flow and
exogenous glucose utilization, respectively. Eighteen
patients with DCM and 20 patients with CAD, who had
multivessel disease and reduced left ventricular
ejection fraction (~40%), ,were selected for the study.
Discrete perfusion defects were observed in 19 of 20
patients with CAD, whereas DCM showed imhomogenous
distribution of flow tracer and only 3 discrete
perfusion defects (p<0.01). In CAD, FOG imaging showed
increased uptake in hypoperfused area ("mismatch") in 14
of 20, and concordant decrease in 5. On the other hand,
in DCM, concordant increase of F-18 deoxyglucose and N-
13 ammonia was observed in 10 of 18 patients. The
remaining 8 showed increased F-18 deoxyglucose uptake
with normal NH3 distribution (6: lateral, 2: antero-
septal), suggesting the regional alterations of
metabolism with no relation to myocardial blood flow.
Thus, PET findings with N-13 ammonia and FOG shows
different metabolical and flow pattern between DCM and
CAD and would give us new insights into the
pathophysiology of the two disease entities.
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Hypertension
HIGH OOSE DIPYRIDAM:>LE·ECHOCARDIOGRAPHY TEST IN
HYPERTENSIVES: CORRELAIDN WITH EXERCISE·ELECTRO-
CARDIOGRAPHY TEST AND CORONARY ARTERIOGRAPHY.
Alessan<ta R. Lycarjnj MP Eugenio Picano, MD, Fabio LalIaozl,
MD, Artonio Salvetti, MD, Alessancto Dislarte, MD. Universly of
Pisa, Pisa, laly.
The value of ellertlsHledrocardlog'aphy test (EEl) In the detection
of coronary artery disease (CAD) In hypertensives is li'nted.
Recertly, the hlgh-dose dlpyrldamOle-echocardlogaphy test (DET:
2-D echo mont«tng dlling i.v. dIpyrIdamOle iltUsion, 14> to 0.84
mglKg 0'1« 101 has been proposed as an aternatlve to exercise tor
the diagnosis of CAD. In order to establish the relative diagnostic
usetulness of EETand DET rorthe detection of CAD, the 2tesls were
performed In 114 conseclilve hypertensive pts evaluated ror chest
pain syn<tome. a these 114, 41 had echocardlogaphlc evidence
of LV hypertrophy; 22 had ST segnert and T wave changes on
resting ECG; 40 had a previous myocardial irtar<:tion. Postlvly of
DET was based on detection of a lransiert asynergy of coma<:tlon,
absertor ofa lesserdeg'ee In resting condtlons; an EET (by l4>flgtt
cycloergornelw) was considered postlve In case of ST segnert shit
>0.1 mVot, 0.08 sec. aItM the Jpolrt. Coronary angiogaphy shoVt'td
slgnficart CAD (>70% diameter reduction of at least 1 major
coronary vesseQ In 84 pts. (*. p<0.05)
.fEr QEI
Senstlvly 68% 71%
Spe<:l'i<:ly S2% * 90%
Acctra<:y 62% * 79%
PredId:iVe value of aposiive test 79% * 96%
Predld:iVe value of a negatlve test 34% * S8%
Thus, DET appears to be of g-eater diagnostic value than EET tor
non-Invasive detection of CAD In hypertensives wth chest pain.




COUPLING OF LEIT VENTRICUlAR LOAD AND HYPERTROPHY IN
HYPERTENSION.
Antonello Ganou M.D., Mary J. Roman, M.D., Thomas G.
Pickering, M.D., Ph.D., Peter L. Schnall, M.D., Richard
B. Devereux, M.D., FACC. Cornell Medical College, New
York, N.Y.
The weak relation of systolic blood pressure (SBP) to
LV mass in hypertensive pts suggests a mismatch between
pressure load and muscle growth. To analyze this dis-
crepancy we studied 50 untreated Hand 50 normal adults
by independently read M-mode and 2-D echocardiograms.
Theoretical optimal LV mass (LVHt) was calculated as a
function of SBP and M-mode LV diastolic diameter, to
allow each subject to achieve a constant normal peak LV
wall stress; 2-D echo was used to calculate LV end-
diastolic volume (EDV) and stroke volume (SV); the
end-systolic stress/volume index ratio (ESS/ESVI) was
calculated from M-mode measurements and SBP as an index
of contractile performance; and observed LV mass was
measured by the Penn method. In spite of the adequacy by
design of LVMt to hemodynamic load, relation of SBP to
LVHt was not close (r-.46; p<O.OOl) , and was similar to
that with observed LV mass (r-.4S; p<.OOl). On the other
hand, LVHt was more closely related to 2-D echo LVEDV
(r-.72; p<.OOl). Observed LV mass was more closely
related to SV (r-0.60, p<O.OOl) and ESS/ESVI (r--0.48,
p<O.OOl) than to SBP; all 3 contributed independently
(p<O.OOl) to prediction of LV mass (multiple R-0.8l,
p<O.OOOl). Multiple regression equation showed equiva-
lence of 10ml of LV volumes and 10mmHg of SBP in inducing
a change of about 20g in LVHt.
Thus, the lack of close relation of SBP to LV mass is
due to concomitant effects of LV chamber size on optimal
LV load-mass coupling, rather than reflecting the effect
of non-hemodynamic factors; chamber size in turn is
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Lynn S. Taska, B.A., Alan K. Tannenbaum, M.D., Liz
Brondolo, M.S., Delia Smith. M.S •• UMDNJ-Robert Wood
Johnson Medical School. New Brunswick. New Jersey,
Although it is known that nonpharmacological therapy (NP)
is effective in lowering blood pressure in some patients.
well-controlled studies comparing this therapy with
pharmacological treatment are not available.
In a randomized placebo controlled study 86 male patients
age S7.1t8.9 with mild hypertension (DBP 95-105 mm Hg)
were randomly assigned to NP (n-:34) and double blind
pharmacological therapy (n-S2) consisting of 3 months
administration of propranolol titrated to 80 mg bid in a
randomized cross-over design.
Nonpharmacological therapy consisting of dietary modifi-
cation (calorie, sodium. alcohol). exercise training and
stress management resulted in blood pressure reduction
(-12.7/-7.4 mm Hg) similar to PR (-8.2/-7.0 mm Hg) mono-
therapy and significantly more pronounced than placebo
(-4.5/+0.2 mm Hg) (p-0.0001). NP. however. was associated
with a greater improvement (p-O.OOS) in exercise
tolerance (+1.2±1.4 METS) than PR (0.0±1.1 METS) or PL
(+O.3±1.4 HETS). In addition. NP decreased LDL
cholesterol (-10.8±19.3), triglycerides (-3S.6±6S.6) and
body weight (-13.4±10.9) while PR increased these
variables (+5 .0±29.0 ,+11. S±70.0 .+1. 2±S. S. p-O .0001) •
Conversely. HDL increased on NP (+1.9t6.3) and decreased
on PR (-0.1t7.9).
The data of this randomized trial indicate that appropri-
ately structured NP is superior to propranolol
monotherapy in treating mild hypertension.
Risk of CV Events by Hypertensive and Obesity Status
CV Risk Ratios (Def. HBP/Norma1)
Hypertension is dangerous in both lean and obese. Only
when diagnosed cardiovascular disease at baseline is
included do leaner persons appear to have a higher
hypertension-associated relative risk (1.7 vs. 1.1).
PROGNOSIS OF OBESITY-RELATED HYPERTENSION: FRAMINGHAt1 STUDY
William B. Kannel M.D .• Robert J. Garrison M.S .• Tingjie
Zhang M.D .• Boston University Medical Center. Boston.
Massachusetts and National Heart. Lung and Blood
Institute. Bethesda. Maryland
It has been claimed that obesity-related hypertension
is relatively innocuous. To explore this. cardiovascular
events over 32 years were examined in relation-to biennial
weights and blood pressures using time-dependent covariate
proportional hazards analysis. Participants were also
classified by age. cigarette smoking and antihypertensive
treatment at each of four basel ine exams. with B year
follow-up. Age and smoking-adjusted risks of
cardiovascular events were uniformly high in hypertensives
of all ages when subjects with prior cardiovascular
disease were excluded at baseline.
TREATMENT OF HYPERTENSION ALTERS THE RELATIONSHIP BETWEEN
PLATELET CALCIUM AND SENSITIVITY TO AGGREGATORY AGENTS.
J.Wilson MB, M.W Baig MB, A.D Lees, M.A Orchard PhD, E.J
Perrins MD FACC, J.A Davies MD, and C.R.M Prentice MD.
Univ.Dept Medicine,The General InfirmarY,Leeds,Engl.UK
Previous investigators have reported that platelet intra-
cellular calcium (ICa2+li and platelet aggregation are
increased in hypertension. In a study with severely
hypertensive patients, we have investigated the relation-
ship between these two platelet parameters and have
compared the effect of two different dihydropyridine
calcium antagonists. 10 patients, whose blood pressures
were poorly controlled with metoprolol, were blindly
randomized to receive either nifedipine (Nif.) or
felodipine (Fel.) as second line agents.At each treatment
phase, venous blood samples were collected for whole
blood aggregation to ADP and collagen and measurement of
ICa2+li using fura 2. Dose response curves to ADP and
collagen were constructed and the concentrations required
to produce 70t aggregation (ED70) calculated. Control of
blood pressure induced a decrease (Wilcoxon, p<O.OS) in
median ICa2+li from 122 to 81 PM with Nif. and from 112
to 67 PM with Fel. such that after treatment, ICa2+li for
both groups was within 2 standard deviations of the mean
value obtained from 14 normotensive subjects. Overall
ICa2+li correlated with mean blood pressure (r=0.4S,
p<0.03). Neither Nif. nor Fel. affected the ED70 to
collagen, but Fel. selectively desensitized the platelets
to ADP such that ED70 to ADP increased from a mean(sd) of
2.0 (1.4)uM to 4.7 (2.2)uM, p<O.OS. These results confirm
that effective treatment of hypertension significantly
reduces ICa2+li into the normotensive range but question
whether an elevation in basal [Ca2+li modulates the
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ABSTRACTS 105A
The presence of either ischemia or LVH were good
predictors for the development of VA. PTS with both LVH
and ischemia had the highest incidence of VA (6/10 60%)
and of VT (5110 50%). Thus, PTS with HTN and LVH are at
high risk for developing severe VA during stressful
conditions and the presence of ischemia further enhances
their electrical instability.
INCIDENCE OF SERIOUS VENTRICULAR ARRHYTHMIAS DURING
SURGERY IN HYPERTENSIVES WITH LEFT VENTRICULAR
HYPERTROPHY •
Jadwiga Szlachcic, M.D., Martin London, M.D., Julio F.
Tubau, M.D., Brian O'Kelly, M.D., Dennis Mangano, Ph.D.,
M.D. VAMC and University of California, San Francisco,CA
Hypertensives (HTN) with left ventricular hypertrophy
(LVH) are at increased risk for sudden death and are
known to have higher incidence of ventricular
arrhythmias (VA). To assess whether this electrical
instability is further enhanced by the presence of
myocardial ischemia (I), we studied the incidence of VA,
>30 PVCs/hour or VT( ~4beats) dUring non cardiac surgery
in a cohort of HTN patients (PTS) with or without LVH.
All subjects had known or were at high risk for CAD(>2
risk factors) but had no previous myocardial infarction.
I by transesophageal echocardiography was defined as the
development of new segmental wall motion abnormalities
and by continuous ambulatory ECG monitoring using
bipolar leads CC5, CM5 or ML and defined as an ST
segment depressed > 1mm compared to the preceding
baseline lasting at least 1 minute.
vmrRIaJIAR ARRHTYHMIAS IN PATIENTS WITH ESSENTIAL
HYPERl'ENSIal
vasilios Papademetriou M.D •. F.A.C.C., Aldo
Notargi.acc:m::l, M.S., Donald Heine M.D., Ross Fletcher
M.D., F.A.C.C., Edward Freis M.D., F.A.C.C.
Georgetown University and VA Medical Center,
washiIgtal, D.C.
left ventricular hypert:rcp1y (LVH) has been identified
as a bad pt:ogllostic :in:licator in patients (pts) with
essential hypertension (HTN). -Previous studies
:in:licated an iIx:reased incideIx:e of anhybnias in pts
with LVH. In this study the relationship of the
degree of LVH with the severity of ventricular
arrllyt:hmias was assessed in 55 black pts (age 56±lO
years) with Ul'lCCllplicated HTN. After discontinuing
medicatioos for 3 weeks all pts had a 48-hr holter
monitoring, an echocardiogram, an ECG and routine
blood work. Of these pts 33 had LVH by echo and 22
did nJt. In these two groups results were as follows:
LVJ:W LVS LVM PVC,Ihr CXXlPII48hr vr/48hr
LVH 14.7 15.5 371 14.4 3.97 0.30
NPLYH 10.8* 10.9* 229* 2.7** 0.27** 0.09***
*=p<0.001, **=p<0.08, ***=p<0.05
Of the same 55 pts, 28 had evidence of LVH on the
ECG's. However, ECG LVH was not associated with
higher incidence of arrhythInias. Linear regression
analysis revealed no correlation at all of any
anhythmia type and any of the echo parameters, or
with EeX; LVH, age, body weight, plasma potassium, or
re:sti.n;J blood pressure. We conclude that in these
pte: 1) edloca:rdi.ographic LVH predicts arrhythmias
better than EeX; LVH; 2) there is no close association
between the degree of LVH and severity or frequency of
arrllyt:hmias and 3) it appears that other variables
CXXltrib.rt:e to an1lyt:hlrogen.city in these pts.
LVH (n=17)
noLVH(n=l7)
>30 PVCs/hour VT ISCHEMIA
10117(58%)
10/17(58%)
RISK OF VENTRICULAR ARRHYTHMIAS ACCORDING TO
ANATOMICAL CATEGORIES OF LEFT VENTRICULAR
HYPERTROPHY
In men LV dilatation confers increased risk for arrhythmias
(P<0.001), while increased wall thickness does not. These
findings were not observed in women.
LV WALL THICKNESS
NOT THICKENED THICKENED
MEN WOMEN MEN WOMEN
NONDILATED 10.4% 15.2"10 15.2% 13.8%
N-73 N-63 N.154 N=307
Joanne M. Murabito M.D.• Daniel Levy M.D., FAC.C., Keaven
M. Anderson Ph.D., Jane C. Christiansen M.P.H., William P.
Castelli M.D., William B. Kannel M.D., F.A.C.C. Framingham
Heart Study, Framingham, MA.
The Framingham StUdy recently reported a powerfUl associa-
tion between left ventricular hypertrophy (LVH) determined by
echocardiography (echo) and risk for ventricular arrhythmias
(VA). We studied risk for VA on 1-hour Holter recordings in 843
subjects with echo LVH. Subjects were stratified according to
presence of LV dilatation and/or increased LV wall thickness.
Age adjusted rates of complex-or-frequent VA are shown below






MICROPROTEINURIA - AN EARLY MARKER FOR TARGET
ORGAN DAMAGE IN ESSENTIAL HYPERTENSION
Roland E. SChmieder M.D, Heinz Rilddel, M.D., Harald SChle-
busch, Ph.D., Eberhard Grube, M.D.,
Dept. of Medicine and Gynecology, Vniv. of Bonn, FRG
The heart and the kidneys are primary target organs of hy-
pertensive disease. Whereas left ventricular hypertrophy
(LVH) indicates the onset of hypertensive heart disease, si-
milar markers for hypertensive nephropathy are missing. To
investigate the clinical importance of microproteinuria, we
examined the prevalence of microproteinuria and its relation
to cardiac structural adaptation in 80 male, middle-aged pa-
tients with essential hypertension. Patients with secondary
causes of hypertension were ruled out.
14 out of 80 hypertensives (18 percent) were found to have
microproteinuria defined as "negative" for urinary protein
excretion in the conventional test, but "positive" (above the
upper normal limit) in the 24-hour urine samples. Patients
with microproteinuria had a similar age and body weight, but
a higher systolic and diastolic pressure (161 ± 14/104 ± 12 vs
148 ± 14/97 ± 9 mmHg, p < 0.01) than those with normal pro-
tein excretion. Also, hypertensives with microproteinuria had
a greater left ventricular mass (241 ± 57 vs 207 ± 45 g, p <
0.05) and greater cross sectional area (22.2 ± 2.8 vs 20.S ±
2.9 cm2, p < 0.02) evaluated by 2-D guided M-mode echocar-
diography than the control group. A positive Sokolow-index
was more prevalent in patients with microproteinuria than in
those without (x2 = 6.2, p < 0.02).
Patients with essential hypertension and microproteinuria
(prevalence 18 per cent) were characterized by a higher arte-
rial pressure, by a higher degree of echocardiographic and
electrographic evidence of LVH. Thus, microproteinuria might
serve as a marker for early target organ damage in essential
hypertension.





THE SELF-EXPABDIYG PARALLEL WIRE METALLIC STEYT.
Raoul Bonan, K.D., F.A.C.C .• Krishna Bhat. K.D.,
Ki Leung. K.D., Jules Lam. K.D., F.A.C.C.,
Lemarbre, K.D.. Rod Wolff, B.S.. Kontreal
Institute, Kontreal. Canada.
Parallel wire stents were implanted over exchange guide
wires at PTCA sites in 7 canine circumflex coronary
arteries dilated with slightly oversized balloons.
Stents are stainless steel. self-expandable, 3.5 to •. 0
III1l in diameter, 9 to 12 mm in length and are made of 10
wires longitudinally laser welded in a zig-zag design.
The compressible stent is delivered by the withdrawal
of a Teflon outer catheter (4.5 to 5F) and the push of
a polyethylene inner catheter. Aspirin 90 mg/day was
given fr01ll the day prior to, and heparin (150 U/kg)
during implantation. pathologic and quantitative angio-
graphic studies were performed illlllediately and at 2. 5
and 12 wks post-implantation. During a mean of 5.2 wks
of follow-uP the coronary arteriographic diameter at
the stent site remained unaltered: 3 .•0:1:0.08 vs
3.60:1:0.06 III1l (p =YS). with no stent displacement. At
microscopy the wires were oriented perfectly, compres-
sed the media. and by 2 weeks were covered by mucopoly-
saccharide ground substance, myofibroblasts and an
almost complete monolayer of neoendothelial cells.
Scanning electt"on microscopy showed these cells to be
large, immature, ovoid and oriented with the blood
flow. At 5 wks the monolayer was complete with tight
intercellular junctions.
This study demonstrates that a self-expanding parallel
wire stent can easily be implanted with this new deli-
very system. Although it is short, it has good stabi-
lity. tolerability, patency and low thrombogenicitf 3
months post-implantation. The perfect imbedding with
mild neointimal proliferation and a complete monolayer
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EXERCISE TRAINING VERSUS EXERCISE TRAINING WITH OILnAZEM OR
PROPRANOLOL: EFFECTS ON RESTING BLOOD PRESSURE IN MEN WITH
MILD HYPERTENSION
Kerry J stewart Ed 0 Mark B. Effron M.D.• F.A.C.C.. Stephen A. Valenti
M.D.• FAC.C.. and Michael H. Kelemen M.D.• FAC.C. Johns Hopkins
School of Medicine. Baltimore. Maryland.
To determIne whether exercise combIned with drug therapy provides
additive benefits In BP control compared wtth exercise and placebo. 52
sedentarymen.ages 25-59.with DBP of90to 105offdrugs. and negative
stress tests. were randomized In a double blind manner to dlltlazem
SR(OIIJ. propranolol (PRO). or placebo (PtA). SUpine resting BP after a 4
week single blind placebo period. after 2 weeks of drug run-In. and at
weeks 1. 4. and 7 of Intense exercise training are shown below. During
run-In dally dOses were Increased to 240 mg PRO and 360 mg OIL. 51
patients (OIL n=17. PLA n=19. PRO n=15) completed the 1hour. 3 times
per week walking/Jogging and circuit weight training program.
SBP 100 DBP
s••• Run-In Wkl Wk4 Wk7 S... Run-In Wkl Wk4 Wk7
There were serial decreases (p<O.OI) In SBP and OBP after run-In and at
week 4with no further decrease at week 7. At week 1the SBP decrease
from bosellne was greater for exercise with PRO versus exercise with OIL
orPLA(p<O.05). The OBPdecrease at week 1was greaterforOILand PRO
groups versus PLA (p<O.05). No between group differences were seen In
BP decreases at weeks 4 and 7. Thus. there was more Immediate BP
control with exercise combined with active drug. However. exercise and
placebo was as effective for BP control after 4 weeks of training.




CHRONIC ENDOVASCULAR RESPONSES AFTER STENTIMPLANTA~ IN
VEIN GRAFTS
Martin B LeQn M pEA C C , Renu Virmani M.D., E.A.C.C., 5teven O.
Lenhard, YarQn AlmagQr M.D., AntQnlQ L. BartQrelll M.D., louis G.
PrevQsti M.D. NHLBI, Bethesda, MD.
AlthQugh ballQQn expandable stents (5) may reduce restenQsis after
PTCA, the chrQnlc effects Qf 5 In arterialized vein grafts (VG) are
unknQwn. We implanted 13 slQtted tubular steel 5 Qn balloon catheters
(4-8 mm) In 13 femQral Interposition VG (8 mQnths after InsertiQn)
In 11 sheep and analyzed anglQgraphy, light, transmission, and
scanning electron microscopy at 3 wks, 8 wks, and 5 mos. Prior to 5
deployment, the VG were either normal in size (n-5), or contained
regions of aneurysmal dilatation (n-8). Results: 1) In 5 5
placements without dextran treatment, large anglographic thrombi
were present acutely In 3 (60%). By 3 wks, 1 of these VG was
occluded and another had residual thrombus. In contrast, no dextran
treated VG (n-8) had anglographic evidence of thrombus formation.
2) In normal VG, endothelializatlon (E) over 5 progressed from
proximal to distal 5 segments and was completed by 8 wks. There were
remnants of organizing microthrombi beneath E, and platelets with
fibrin were seen Qver 5 with partial E. 3) 5 placed In aneurysmal VG
manifested delayed or absent E In regions of poor 5-vessel wall contact
and more extensive thrombi were found In the 5-vessel wall space. E
over organized thrombi was seen at 5 mos only in aneurysmal VG with
closer 5-vessel wall spaces. 4) By 5 mos, VG media showed reduced
smooth muscle cell density with replacement fibrosis. 5)Neo-intlma
thickness over 5 averaged 140 11m at 3 wks, 280 11m at 8 wks, and
130 11m at 5 mos. We Conclude that 5 placement In VG 1) requires
dextran treatment to prevent early thombosis, 2) manifests delayed or
absent E In areas of poor 5-vessel wall contact, and 3) results in
modified transmural VG architecture Including an overlying neolntima
which becomes thinner with time and media which is replaced by
fibro-collagenous tissue. Thus, chronic in vivo responses to 5
implantation In VG are favorable, but close 5-vessel wall contact in
aneurysmal segments Is fundamental to ensure proper E.
Balloon Expandable Intravascular Stents (SEIS) in
1llm:ln COrt:Ilary Arteries: A Fo:Ll.ai-Up Report
R:i.chard A. SChatz, MD, FlIIX, Julio C. Palmaz, MD, Ian
M. Penn, MB,FRllCP, 8al.ly L. Ievll¥J, RN, Arizalla Heart
Institute FouIXlatian, P!rJen:bl. AZ.
Early reports of BEIS in coronary arteries sb::wed high
short-term paterry rates. Follcw-l4l in this series
rDi i.rr:lwes 28 srz::cessfully delivered stents (20
rigjd, 8 "flexible")in 18 patients. n.enty-fourIVere
placed in t:M right caronary artery (RCA) am 4 in t:M
left anterior desc:emi..Tq (IAD) • The patients IVere
pretreated with aspirin, persantine am calcilRl
channa1. blockers before stentirq am three III1l1ths
after st:ent::1ng, am h3parin and dextran dur:J.n;J t:M
procedure. Percent: sterrJsis dec:reased fran 94% to 0
while gradients IVere retft£'ed frarJ 54 to 3tmHg. O1lly
0Ile patient was discharged QI'l warfarinfor 30 days for
suspected nonocclusive t1lraDbus within t:M stent.
~ was ro abn.pt closure in this group, :ror IVere
there an; ccmplications. Clinically, in 17 patients
am ~aphically in 0Ile patient, there was ro
resteoosis in fol1.ai-l4l (rarqe 1-9 III1l1ths, mean 3
III1l1ths) • Four rigid stents in four patientscouldrot
be delivered to the target site as a result of
inflexibility. ~ IVere ro caJIp1:1cations in the
group of patients that received the "flexible"stent
design.
we carlu:fe that when srz::cessfully delivered, BEIS are
relatively 1X:JI1t1lLwoogeuic and high paterry rates can
be expected short-term. Altlru,Jhdelivery faiJ.ure is
a p;>tentialrroblemwith the orig1nal rigjd prototype,
this appelal'S to be resolved with the rat "flexible"
versiCII'l. WhetMr or rot BEIS will decrease lang-term
resteoosisrates foll.cwiIqP70i raua1ns to be seen.










STENT IMPlANTATION FOR THE TREATMENT OF CORONARY ARTERY
BYPASS GRAFT STENOSIS
patrick W, Serruys. MD. F.A.C C KsvIn J. Beall M.R.C.P. Plm J. de Feyter
M.D. Hany Suryapnmata M.D. MerceI van den Brand M.D. Rene Geuek_
M.D.
Thoraxcentra. EI8III1UI UnIverIIIy. Rotterdam. The Netherlands.
The long term IIlCC*S d bell00n angloplasly In coronary artery bypass
grafts Is Ilmlted by the high recurrence rate d the Initial stenosis.
18 seIf-expand1ng IntravucuIarstentIwara Implanted In 11 patients following
balloon dlatatlon d a coronary artery bypass graft stenosis. and the
immediate rasUts assessed by quantllatJve coronary angiography.
The II18lIIl age d the group was 61.1 (43-75) years and the age d the
bypass grail 90.2 (2·128) months. In 10 patlents the procedure was elective
81 a measure to pr-. rest8l1Cllls and In one the stant was Implanted
followlng dissection and the dlsloca1lon d athet8l'Oll1lltous material In order
to Improve the immediate hemodynamic reUt. and so avoid or delay the
need for bypass surgwy. The mean unconstrained diameter d the stenl was
4.1 (3.5-5.0) mm. Implanted Into grafts with a mean dlameter d 3.3 (2.1 ....7)
mm. The implantation was proximal In 8 CIIM and In the middle d the
bypass graft In 7 cases. In 5 cases the Implanted poeItIon was In the dIslaI
portion elther prior to or distal to the first Jump and In two petlents the device
was posIIJoned so as to Involve the distal anastomoeIs; one straddling an
end·to-slde anastomoIiI and one a sIde-to-side anastomosis. The minimal
lumen diameter was 1.4 (0.9-2.2) mm pra-PTCA, 2.0 (1 ....2.7) mm post-PTCA
and 2.6 (2.1-3.20) mm post·stent implantation.
So f8r there have been more then 38 stents Implanted Into the coronary
artery veln grafts In flve centers In Europe. ThIs has been achieved wIlhlU
technical dllflculty or procedure related complication, and the Implanted
device appears to further Improve the hemodynamic resUt. Detaled follow.
up studies are needed to determine how elfectIve thls device wi! be an In the
long term treatment for coronary bypass stenosis.
IMPLANTATION OF 100 CORONARY ARTERY STENTS: LEARNING
CURVE FOR THE INCIDENCE OF ACUTE EARLY COMPLICATIONS.
Ulrich Sigwart M.D. F.A.C.C., Philip Urban M.D.,
Hoaaein Sadeghi M.D., Lukaa Kappenberger M.D. CHUV,
Lauaanne, Switzerland.
Between april 86 and euguat 88, 100 coronary aelf-
expanding meah atenta were implanted in 78 patienta
during 85 procedurea. The indications were abrupt
post-angioplasty occlusion (20 stents) and prevention
of restenosia or recurrent reatenosia (80 stents). In
72 procedurea 1 stent was implanted, in 11 procedures
2 stents and in 2 procedures 3 atenta. For the first
50 stents (unconatrained diameter 3.5 + 0.5 mm,
implanted length 17.9 + 3.3 mm), the incid;nce of in-
hospital thrombotic -atent occlusion was 7/45
procedurea (161). Of these, 5 (711) were treated by
angioplasty and/or intracoronary thrombolysia and
patency was reatored in all caaea. 3 of the 7 patienta
had an enzyme riae and 2 developped new Q waves on
their ECG. 2 patients had emergency CABG and there waa
1 post-operative death. For the last 50 stents
(diameter 4.1 + 0.8 mm, length 22.6 + 3.4 mm), only 1
of 40 procedur;a (31) was complicat;d by temporary
stent occlusion and pstency wsa restored with
sngioplssty and thrombolysis. There wss a rise in
cardiac enzymes, but no new Q wave developed on the
ECG. No patient died or required emergency CABG.
Early thrombotic stent occlusion has become lesa
frequent with the use of longer and larger stents,
together with increased experience in patient
selection, implantation technique and post-implant
medication. Patency can be reliably restored in most
cases of thrombotic occlusion with a combination of
intracoronary thrombolysis and balloon angioplasty.
RESTENOSIS WITHIN CORONARY STENTS: POSSIBLE EFFECT OF
PREVIOUS ANGIOPLASTY.
Philip Urban M.D., Ulrich Sigwart M.D. F.A.C.C., Urs
Kaufmann M.D., Lukas Kappenberger M.D., CHUV,
Lausanne, Switzerland.
During a 29 montha periOd, 104 self-expanding meah
coronary stenta were implanted during 87 procedures in
80 patients. Until now, S3 (611) procedures have been
controlled angiographically after a median follow-up
of 5 montha (range 2 to 27 months). These 53
procedures were aimed either at a primary lesion (12
casea of abrupt poat-angioplaaty closure + 7 elective
procedures), or at a restenotic lesion after prior
balloon angioplasty (34 elective procedures).
Restenosis within the stented segment(s) was obaerved
in 5 cases (91) and late total occluaion in 4 casea
(81). Conaidering subgroupa, there was 1 case of late
stent occlusion after 19 procedurea for primary
lesiona (51) and 8 casea of reatenosis or occlusion
for 34 procedurea on a res enotic lesion (241). For
restenotic lesions, within-stent restenosia or
occlusion were observed more often when the delay
between previous angioplasty and stent implantation
was ~ 3 montha (7/17 • 411) than > 3 months (1/17 •
61), p<0.05.
These preliminary data would seem to suggest that
elective stenting for reatenosis early after previoua
angioplasty carries an increased risk ot restenosis
within the stent. It could be that the active
fibrocellulsr proliferation associated with the esrly
phase of restenosis sfter balloon angioplasty is
further stimulsted by stent implsntation.
Tuesday, March 21, 1989
2:00PM-3:30PM, California Pavilion D
Anaheim Hilton Hotel
Coronary and Peripheral Arterial Athrectomy
Clinical follow-up in 40 patients treated with
peripheral percutaneous atherectomy
A. von Polnitz M.D., D. Backa B.S •• B. Hofling M.D.,
J.B. Simpson M.D.
Med. Klinik I, Klinikum Gro~haQern. Ludwig-Maximilians-
Universitlt, Munich, W. Germany
40 patients with a total of 72 stenoses (the majority
complicated: 40.3% calcified, 26.4% totally occluded.
25% concentric and 48.6% eccentric) of the superficial
femoral (n=62), popliteal (n=5) and iliac (n=5)
arteries underwent atherectomy with the Simpson
catheter on 45 limbs. fhere was technical success in
91% of stenoses. The mean 5tenosis was reduced from
87.2 ± 13.9% to 16.6 ± 15.5%; at 6 month angiographic
follow-up 35.7 ± 30.9 % (n=43) with angiographic
re-stenosis (>70%) found in 9 stenoses (21%),
coincident ~ith clinical deterioration in 8/9 cases.
Doppler index Walking distance (meters)
0.57 n=45 80.47 ± 65.74 n=40
0.81 n=45 152.80 ± 80.27 n=40
0.80 n=35 165.27 ± 81.62 n=30
0.78 n=27 169.33 ± 80.64 n=25
0.77 n=17 166.22 ± 99.01 n=15
0.74 n=ll 148.50 ± 127.38 n=9
0.76 n=7 135.33 ± 110.21 n=5
7 patients (3 with baseline total occlusions) have
undergone repeat atherectomy and 2 patients surgical
bypass procedures at 6.3 ± 1.8 months after initial
treatment.
Conclusion: Doppler index and walking dist4nce showed a
good correlation with angiographic results. The
majority of patients (84%) treated by atherectomy
required only one procedure in follow-up up to 2 years.









Th. Aoute OUtco•• of Ath.rectoall in Peripheral
Arterial Ol>struotive DiseAse
&era" Jlprnell D~ XaVHn S&ohelev. M.D.. lu!len
IAvin. M.D.• LVnn. Mathiak. I.X .. St. LuM'S Meclic&l
C.nt.r. Milvau... WI
Betw..n 10/87 anel 7/88. 107 pati.nts (ptsl. a.an
Iof' 63 ~ 9 ll.ars, unelerv.nt peripheral atherectoav
vith the Siapson Atherooath elu. to clauelication (86"1,
ranrren. (•.S"I. rest pain (S.S"I or non-h.alinr ulc.rs
(3.7"1. P.riph.ral atherectoall vas su_sful in
IM/I07 (97"1 st.n_ (3/S illiac, 70/70 f.aoral. 27/27
poplit'eal. &nel ./. tillial arteries), &nel .7/U occlusions
(3/3 iliac, 38/38 f.aoral. S/S poplit.al). Failures v.n
elu. to too saall a cath.t.r (21, &nel a tortuous iliac
vess.l lll. Anriorraphv !lefon anel after ath.rectoall
oonfiratcl that the lesions v.re successfully opentcl
Ist.noses: 86 ~ 10" to 11 ~ a", p<O.05, anel occlusions:
100" to IS ~ 10", p<0.051. A a.an of 66 ~ .1 puses
v.n requirtcl to aelequat.lll reaove suffici.nt plaqu•.
Ath.rectoav vas ustcl in coallination With anfioplastll
in IS/U (M"I of oooluelecl v.sselS. Coapli"tions
inolucltcl insipificant contrast atravantion in 7
(S.5"1, elistal .a!lolilation in • (3.7"1. anel (roin
h.aatoaa in 2 pes (l.9"1. Within ~ hours, 102/107 pts
("AI w.re iaprovecl anel elisoharrtcl clinioallll iaprovecl.
Anlll.-!lrachial inelioes sirnificantlv inoreastcl froa 0.59
~ 0.13 !lefore to 0.73 ~ 0.18 after (P< 0.0011. Thus
periph.ral ath.rectoav oan !Ie saf.lv anel .fficaoiouslV
utiliJtcl to relieve arterial ollstructions (st.n_ anel
occlusions) vith _11.nt anfiorraphio &nel iaatcliat.
clinioal su_s. anel a lov inoiel.nc. of ooaplioabons.
GREATER IMPROVEMENT IN CORONARY FLOW VELOCITY
WITH ATHERECTOMY COMPARED TO ANGIOPLASTY
N White Jr M D , 5 Denardo M.D., E Johnson M.D., P Yock
M.D, FACC, V Hargrave B.S., P Hui, M.D., J Srebro MD., M
Selmon M.D., G Robertson M.D., B McAuley M.D.,FACC, T
Hinohara M.D.,FACC, J Simpson M.D., FACC. University of
California, San Francisco and Sequoia Hospital, Redwood
City, California
We have previf/usly validated a new Doppler catheter
method for accuc,ite assessment of flow restriction in a
coronary stenosis based on the ratio of the velocity in the
stenosis to the velocity in a normal proximal segment (the
coronary stenosis velocity ratio, CSVR). In a canine model
the CSVR predicted the true cross-sectional area (CSA) of
the implanted stenoses with accuracy exceeding results of
prior studies with quantitative angiography. A
stenosis:proximal ratio 1:1 indicates no narrowing; larger
ratios indicate formation of a stenosis jet, and correlate
precisely with the ratio of stenosis to proximal CSA.
We compared CSVR in 5 patients undergoing PTCA with 5
patients undergoing coronary atherectomy (C-ATH). Pre-
procedure all patients had CSVR indicative of a severe
stenosis (CSVR greater than 5:1). Post-procedure, PTCA
patients had a CSVR of 1.67:1 to.5 while C-ATH patients had
a CSVR of O.95:1±O.1 (pSO.01). Post-procedure angiographic
estimates of area corroborated the CSVR measurements,
with less residual CSA for C-ATH versus PTCA.
Conclusion: CSVR, previously shown to be an accurate
measurement of relative CSA, is useful in monitoring the
success of catheter interventions. Based upon CSVR
determinations, coronary athereetomy appears to be more
effective than PTCA in completely removing obstruction to
coronary flow.
PERCUTANEOUS CORONARY ATHERECTOMY: EARLY EXPERIENCES
OF MULTICENTER TRIAL
Cass Pinkerton,!!Q, FACC; John Simpaon, MD, FACC;
Matthew Selmon, MD; Gregory Robertaon, MD; TOlIDaki
Hinohara, MD, FACC; Jay Hollman, MD, FACC; Donald
Baim, MD, FACC; St. vincent lbapital,' Ind ianapolis,
IN.
To evaluate the efficacy aId safety of percutaneoos
coronary atherectomy (PCA), a 1DJ1ticenter trial is
currently underway. Since June 1988, PCAa were
attempted in 80 lesions in 71 patients (pt) at 4
centers. Lesion distribution was as follows; left
main (3%), left anterior descending (46%), right
coronary (28%), left circumflex (2%) aId vein graft
(21%). The device was successfully Placed in 94% of
the lesions aId tissue was rellDved in 98% of stenoses
with median sample number of 9 (range 0-30). A
successful result ( < 50% residual stenosis) was
obtained in 68 lesions (success rate of 8"%). Median
stenosis was reduced from 90% to 10%. Eleven patients
with failed PCA uIder'lent attempted coronary balloon
angioplasty (PTCA) "ith a success rate of 36%.
Emergency bypass surgery was performed for acute
occlusion in 4 patients (5%), 2 of which had recent
thrombolytic therapy. Other complications included
myocardial infarction in 3 pts (4%), angiographic
evidence of distal embolization in 2 pts (3%), loss of
small side branch in 5 pts (7%) aId repair of fellDral
access site in 2 pts (3%). There 'lere no perforations
and no deaths. Conclusion: This multicenter trial
confirms that PCA can be used to remove coronary
atheroma "ith a high success ra te aId an occ lusive
comp licat ion ra te simi lar to PTCA.
COMPARISON OF EARLY AND RECENT EXPERIENCE IN
PERCUTANEOOS CORONARY AmERECTOMY
~ Simpson, ~ FACC; TOlIDaki Hinohara, MD, FACC;
Matthew Selmon, MD; Gregory Robertson, MD; Neil White,
MD; Michael Ro'le, MD; Lissa Braden, Sequoia Hospital,
Red"ood City, CA.
Percutaneous Coronary Atherectomy (PCA) is a ne"
investigational procedure wich is evolving rapidly in
both equipment aId operator's experience. This study
compares our early and IIDre recent experiences with
PCA. Since October 1986, 83 patients (pt-) uIderwent
PCA. The pts were divided into two groups: Group A
coosists of initial 41 pts and Group B consists of the
latest 42 pts. PCAs were performed between October
1986 and May 1988 in Group A and between May and
August 1988 in Group B. The lesion distributions for
groups A aId B respectively 'lere 16% aId 8% for left
main, 33% and 43% for the anterior desceIding, 21% aId
27% for the right coronary, 7% and 0% for the
circumflex aId 23% aId 22% for the vein graft s. Mean
pre PCA stenosis "as 89% in Group A aId 84% in Group
B. Resu It s 'Ie re as fo llo"s.
Group A Group B
Lesions attempted n'" 44 n- 49
Successful pr1mary crossing 66% 92%
Successful placement 86% 94%
Successful tissue removal 68% 94%
Specimens per lesions 4.9 8.8
Success rate ( 50% stenosis) 52% 90%
Post peA stenosis 22% 12%
Emergency bypass surgery 2% 0%
In conclusion, comparison of early vs. recent
experience reveals significantly improved outcomes of
PCA, presumably due to advances in equipment and
ope ra tor 's exper ie nc e.







<.02 vs-: 40.8 min; CL in
CL Basal CL Ischemia CL
5 min 200+11 134+8
11.5 min 220+11 142+7
40.8 min 206+11 100+7
en p <.. 01 vs. T1.5 min; -. p
counts per second (mean + SE).
The finding of higher CL-with 11.5 vs. 5 min ischemia may
be due to depletion of cellular protective mechanisms
during longer periods of ischemia. Lower CL after 40.8
min may reflect cell damage and decreased ability to
produce oxygen radicals. We conclude oxygen radical
generation measured by CL varies with duration of
ischemia. The level of oxygen radical production may not
correlate with the severity of meChanical dysfunction.
POST -ISCHEMIC OXYGEN RADICAL PRODUCTION DETECTED BY
CHEMILUMINESCENCE VARIES WITH DURATION OF ISCHEMIA.
Timothy D. Henry M.D., Stephen L. Archer M.D., Daniel P.
Nelson B.S., E. Kenneth Weir M.D.,F.A.C.C., Kamil Ugurbil
Ph.D., Arthur H.L. From M.D., Minneapolis VAMC and
University of Minnesota, Minneapolis, Minnesota.
Chemiluminescence (CL) is a sensitive continuous, indica-
tor of oxygen radical generation. We have previously
found CL decreases during ischemia and increases with
reperfusion We studied the effect of duration of
ischemia on oxygen radical generation and mechanical
dysfunction. CL was measured during 38"C global ischemic
periods of 5, 11.5, or 40.8 + 4 min (10 min post ischemic
contracture) and during a 20 min reperfusion period in
three groups of five Langendorff perfused isovolumetric
rat hearts. Lucigenin (10-5M), a CL enhancer specific
for 02~, was added to lOmM pyruvate/gl ucose perfusate.
Hearts were paced at 300 beats/min. Mechanical
dysfunction was assessed by the change in systolic blood
pressure from basel ine to end of reperfusion (% /::, SBP).
CORONARY ATHERECTOMY FOR 'IRE TREATMENT OF UNFAVORABLE
PTCA LESIONS
~ Robertson, ~; Tom:>aki Hinohara, MD; Matthew
Selmon, MD; John Simpson, MD, FACC; Sequoia Ik>spital,
Redwood City, CA.
Despite an overall high primary success rate with
percutaneous transluminal coronary angioplasty (PTCA) ,
many lesions are not ideal for PTCA because of the
higher complication rate and lower success rate. The
newly developed procedure, percutaneous coronary
atherectomy (PCA), is designed to overcome some of
these limitations. Since March 1988, with availability
of currently designed equipment, PCA was attempted in
48 lesions thought to be unfavorable for PTCA in 43
patients. The lesion characteristics were marked
eccentricity (22), heavy calcification (14),
ul~eration (l), bifurcation lesions (l), aorto-ostial
(6), ostial LAD (2), post-PTCA intimal flap (1), graft
stenosis (15), marked ly long lesions (1), and
previously failed PTCA (5). Successful results,
defined as <50% residual restenosis, were obtained in
38 lesions (79%). In 8 patients, PTCA was attempted
following unsuccessful PCA crossing, with a success
rate of 25%. Complications include PTCA related abrupt
closure requiring emergency CABG (}), a coronary
occlusion requiring surgery (1 pt), distal
embolization (l pt) and side branch occlusion (2 pt),
and transient thrombosis resolving with lytic therapy
(l pt). In conclusion, early experience suggests that
l) PCA is a favorable approach for the treatment of
selected unfavorable PTCA lesions, and 2) PTCA
following failed PCA has a low success rate.
Tuesday, March 21, 1989
4:00PM-5:30PM, California Pavilion D
Anaheim Hilton Hotel
Reperfusion Injury: Cases and Consequences
TIME COURSE OF REPERFUSION INDUCED REVERSAL OF EARLY
MYOCARDIAL EXPANSION.
Edward J. Brown, Jr., M.D., F.A.C.C., John A. Mannisi,
I'1.D., F.A.e.e., Oneida i. [Ii I,s, a.s .. Peter F. Cohn,







PRESERVATION OF 'MYOCARDIAL FUNCTION AND TOPOGRAPHY BY
LATE REPERFUSION AND SUPEROXIDE DISKUTASE TIlERAPY.
Bodb Jugdutt M 0 F Ace, Shi..in Yang M.D., Jack
Demare, Terry Liu, John Henriksen, Moh8llllllad Ibrahim
M.B.B.S., Karc Poznanslcy Ph.D., University of Alberta,
Edmonton, Canada.
Salvage of ischemic myocardium and preservation of
function by reperfusion (RP) within 2 hours is
frequently not possible in the clinical setting. To
determine whether late RP and therapy with the
free-radical scavenger superoxide dismutase (SOD) after
2 hours of mid left anterior descending coronary artery
ligation in instrumented dogs can preserve left
ventricular function and topography, 24 dogs were
randomized to permanent ligation (controls. C), RP and
RP + SOD. SOD was given at the beginning of
reperfusion (300.000 IU left atrial bolus and 300,000 IU
by intravenous infusion over 2 hours). Infarct size
relative to left ventricular mass and risk region
(coronary arteriography), expansion index (ratio of
infarct to non-infarct containing segment length) and
left ventricular ejection fraction (LVEF by Simpson's
rule on echocardiography) were measured at 5 days.
Results (mean ± SO) were:
C{n-8) RP{n-8)
Infarct as 'LV 38±3 25±3 §
Infarct as 'risk 65±6 50±6 §
Expansion index 2.52±0.29 1.74±0.2l
LVEF (,) 43±2 52±2 §
§p<O.OOl vs C; tp<O.Ol vs RP (MANOVA)
Thus. RP and SOD after 2 hours coronary ligation Can
decrease infarct expansion and improve function more
than RP alone. Late RP+SOD might prolong the period for
salvage of ischemic myocardium. topography and function.
Reperfusion of ischemic myocardium can reverse early
infarct expansion. Our purpose was to establish the
time course and quantify the degree of reperfusion's
effect on infarct expansion. Twenty-one dogs underwent
left anterior descending coronary occlusion. Infarct
size was measured with triphenyltetrazolium chloride
incubation and expressed as a percent of the area-at-
risk. Early myocardial expansion was measured as end-
diastolic separation of ultrasonic crystals implanted in
the midmyocardium of the infarct zone. Dogs were reper-
fused for 60 minutes after 3 (n=9), 5! (nmS) or 9 (n=7)
hours of ischemia. The table shows expansion expressed
as a percent change over baseline. Results are
mean+SEM:
3 hrs. S! hrs. 9 hrs.
I s chem i a i1l'+2" 21i+5"" 2'i+'3
Reperfusion () Hr) -9+6* 2+5* 14+'3+*
*significant compared to ischemia-(p<o.OOl)
+significant compared to S! hrs. (p<O.OOl)
Infarct size was reduced in the 3 hr. reperfusion group
but not in the S! or 9 hr. groups. Thus, expansion can
be completely reversed by reperfusion after up to 5! hrs.
of ischemia. Reperfusion following 5! to 9 hrs. of
ischemia wi II partially reve.rse expansion. However,
some infarct expansion persists.
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DETECTION OF HYDROXYL RADICALS IN THE REPERFUSED iSOLATED
MONKEY HEART.
Daniel R. Margulies M.D., Steven M. Schwartz M.D.,
Whitney M. Limm M.D., Lawrence Piette Ph.D. and J. Judson
McNamara M.D., F.A.C.C., Cardiovascular Research Lab,
University of Hawaii School of Medicine, Queen's Medical
Center, Honolulu, Hawaii.
Oxygen Free radicals have been indirectly implicated
in myocardial reperfusion injury. Using EPR analysis,
investigators have recently demonstrated oxygen radical
proliferation in the reperfused isolated rabbit and rat
heart. In this study, a primate isolated heart model was
used to demonstrate the production of hydroxyl radicals
in the postischemic period. Macaque monkey hearts were
excised and immediately perfused with warmed Krebs-
Hensleits solution of p02 between 140 and 160 mmHg. The
spin trap 5,5-dimethyl-l-pyroline-n-oxide (DMPO) was
circulated at 100 roM prior to sampling. The LAD artery
was isolated and its corresponding vein cannulated.
Regional ischemia was induced for 20 minutes, and serial
samples were obtained from the right ventricle and the
coronary vein. EPR studies of the coronary effluent
demonstrate the formation of DMPO-OH, a n=aH=14.9 G, peak-
ing at 30 seconds and disappearing after 2 minutes. No
radicals were detected from the right ventricular efflu-
ent. Hydroxyl radicals were demonstrated in primates in
the regional postischemic myocardium. Maximal production
was noted within the first minute of reperfusion. This
finding in primates lends further support to the possibi-
lity that free radical generation may play a part in
reperfusion injury in man.
EFFEX:l' OF REPERFUSION ON POST-MYOCARDIAL INFARCl'ION
ANEURYSM FORMATION AT ONE WEEK
carolyn M.COnnelly,Ph.D. Soeun Ngoy, Scott Davis, carl
S.Apstein, M.D., F.A.C.C., Boston University School of
Medicine and Boston City Hospital, Boston, MA.
To cause post-myocardial infarction aneurysms, aortic
insufficiency (AI) was induced in rabbits at the time of
coronary occlusion. The effect of reperfusion (R) was
assessed by releasing the coronary occlusion after one
hour or three hours. Aneurysm formation was assessed in
these R groups and in non-reperfused coopletely occluded
groups by measuring infarct thickness and the regional
short axis diameter of the infarcted apex. At one week
post-infarction AI caused significant aneurysm formation
in animal~ without reperfusion. For AI (n=17) vs. no-AI
(n=15), thickness was 1.2+0.1 vs. 2.2+0.1 rom (P=.001)
and diameter was 6.2+0.3- vs 3.9+0.3 rom (P=.001),
respectively. Both the-R and the non-reperfused groups
had transmural infarcts as determined by TTC staining. R
protected against AI induced aneurysm formation as
indicated:
Thickness (rom) Diameter (rom)
no R (n=17) 1.2+0.1 6.2+0.3**
Rat 1 hr (n=15) 1.9+0.2 * 5.03:0.4
Rat 3 hr (n=8) 1.4+0.1 5.0+0.3
Mean + SEM. * P=.01 vs no R, **P=.03 vs R groups
COnclusion: Reperfusion at one hour although too late
to prevent trallSlWral infarction may reduce aneurysm
formation by reducing wall thinning and dilatation while
reperfusion at three hours rray not prevent wall thinning
but will nonetheless resist aneurysmal expansion.
SUPEROXIDE DISMUTASE (SOD) PREVENTS
REPERFUSION-INDUCED DETERIORATION IN CORONARY
VASODILATOR RESERVE (CVR) AND REGIONAL
MYOCARDIAL FUNCTION.
Jawahar Mehta. M.D. F.A.C..C" Wilmer Nichols, Ph.D.,
F.A.C.C., Menno ter Riet. B.S., Linda Thompson, B.S., Dan
Lawson, B.S., Tom Saldeen, M.D., Ph.D., University of Florida,
Gainesville, Florida.
CVR and regional myocardial function deteriorate following
coronary artery occlusion and reperfusion (O-R), due to release
of superoxide radicals. To determine the effects of a
superoxide scavanger SOD, 10 dogs underwent circumflex
(Cx) coronary artery occlusion for 1 hr. and reperfusion for 1
hr.; 5 dogs were given saline (Group A) and the other 5 SOD
(2mg/kg bolus followed by 4mg/kg i.v.. beginning just before
reperfusion and continuing for 20 min. (Group B). ex blood
flow (CBF) response to acetylcholine (ACh) and regional
segmental myocardial function (ultrasonic crystals) were
measured before and after O-R. In all animals. CBF increased
prior to O-R (ACh 0.5~g-132±13%, 1.0~g·151±24%).
Following O-R, increase in CBF was reduced (ACh 0.5~g­
53±13%, 1.0~g-55±10%, both P<0.01) and myocardial
segment length change was paradoxical (-6±2% vs. +10±2%
before O-R, P<0.01) in Group A animals. In contrast, in Group
B animals. CBF following O-R was preserved (ACh 0.5~g­
118±18%, 1.0~g-149±21%, poNS, compared to before O-R)
and myocardial function was reduced (segment length change:
5±1% vs. 10±1%, P<0.05) but was not paradoxical. Thus SOD
given before reperfusion prevents deterioration in CVR' and
myocardial function.
Tuesday, March 21, 1989
2:00PM-3:00PM, Marriott Hall North
Anaheim Marriott Hotel
Cardiac Pacing and Defibrillation
ELECTROPHYSIOLOGIC AND HISTOPATHOLOGIC COMPARISON BETWEEN
APICAL AND TRANSEPICARDIAL SEPTAL VENTRICULAR PACING IN
THE IMMATURE CANINE MYOCARDIUM: EVALUATION OF A NEW METHOD
Peter Karpawich M.O., Chung-Ho Chang, M.D., Lawrence
Kuhns M.D., Chl1dren's Hospital of Michigan, Detroit, MI
Ventricular (V) pacing (VVI) originating from an apical
(Ap) implanted electrode (E) alters normal V stress
vectors and depolarization (DP) patterns producing
histopathologic changes (HC) of myofibrillar disarray,
calcium deposits (CD) and mitochondrial changes (MC) in
the immature myocardium. To determine if HC can be
prevented, more normal V DP and contraction (C) patterns
were attempted using a transepicardial septal (TS)
approach and compared with standard epicardial Ap V
pacing. In 13 beagle puppies (age 3 mos), V DP and C
sequences were determined using epicardial Velectrodes
and mu1tigated acquisition nuclear imaging. Ten
unaerwent complete atrioventricular block. In 5, a
Medtronic model 6917A-35T E was attached to the right V
apex. In 5, a modified model 4951 E was inserted into
the aortoatrial groove and positioned in the proximal V
septum (S). After 4 mos VVI pacing, V DP and C pattern
studies were repeated and matched tissue samples were
obtained from the paced and remaining 3 control puppies
and studied using light and electron microscopy. The Ap
paced group demonstrated left bundle branch DP and C
patterns with cellular disarray, CO and MC. The TS paced
group showed nearly normal QRS, intracardiac DP and C
sequences and normal cellular arrangements without CD or
MC. Conclusions: Although VVI pacing per se remains
non-physlo1ogic, the HC observed with typical Ap pacing
can be prevented by maintaining relatively normal V DP
and C patterns achievable with the new TS approach to V
pacing.
lACC Vol. 13. No.2
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PACEMAKER SYNDROME IS ASSOCIATED WITH VERY
HIGH PLASMA CONCENTRATIONS OF ATRIAL
NATRIURETIC PEPTIDE (ANP)
ChristQPhe~ M T~aYill MRCP. T 0 MeurigWillia~s M CP,anQs Vardas MD. Ann Ingram,
Julie Chal~ers HNC~ StaffQrd Light~an FRCP,
Richard SuttQn FRC~ FACC~ Westminster
HQspita1. LQndQn SW1P 2A~. UK.
Pace~aker syndrQa. (PHS) Qccurs in soae
patients with intact retrQgrade atriQ-
ventricular cQnductiQn (RAVC) when paced in
the ventricle. It is assQciated with reduced
cardiac Qutput and systeMic pressure due tQ
lQSS Qf atrial cQntributiQn tQ ventricular
filling. Contraction of the atria against
clQsed atriQventricu1ar valves causes elevated
atrial pressures and ANP release. The latter
causes vasodilatation and reduction in
intravascular volu~e both of which WQuid tend
to WQrsen the hae~odynamics seen in PHS.
We investigated 5 patients aged 77t3 (mean t
SE) years with a history of pacemaker upgrade
for PHS complicating VVI pacing. Diagnoses
were intermittent A-V block (1), Sick Sinus
Syndrome (1), Carotid Sinus Syndrome (2) and
Vasovagal Syndrome (1). Pacini was switched
from DOD to VVI at time 0 for 120 ains at 10
ppm abQve the intrinsic atrial rate and plasma
ANP and bloQd pressure were ~easured at
intervals before, during and after this
procedure. Results. *p<0.05, **p<O.Ol
f~~ta(:1n)i~~C¥~GeHgDEBP (m~Hg) ANP (pmol/l)
-15 DDDISR 101t 5 79t 2
o * 98t 7 73~15ii vVI1+RAvc Iii i** i~i!il~:
120 83t 7* 235t53*
150 DDD/SR 73t12 188=23*
180 J. 94t6 13h 10*
CQnclusion: Patients with pacemaker syndrQme
have very high circulating ANP concentrations
which return tQ normal with dual chamber
pacing. ANP may contribute tQ the
pathQphysiQlogy of the cQndition.
IS ATRIAL ACTIVATION BENEFICIAL IN HEART TRANSPLANT
RECIPIENTS?
Mark £:. ~ide1, MD, Christopher Leggett, MD, Kenneth L.
Baughman, MD, FACC, William Baumgartner, MD, Gary D.
Walford, MD, FACC, Jeffrey A. Brinker, MD, FACC, The
Johns Hopkins Hospital, Baltimore, MD.
The unique architechture of the transplanted heart
has led to speculation that atrial contraction does not
contribute significantly to ventricular (V) pump
performance. To study the effect of atrial activation
on LV function in such pts, we compared cardiac output
(CO) and mean arterial pressure (MAP) in five cardiac
transplant recipients during both AAI and VVI pacing.
All pts received temporary epicardial donor atrial
and V pacing wire. at the time of their
transplantation. At the time of their first biopsy (9
± 1 d post transplantation), an arterial cannula and a
PA catheter were placed; CO was measured using
thermodilution. In random order, pts were paced from
either the atrium or the V at a rate at least 10'
faster than their sinus rate, but not slower than
100/min (mean - 105 ± 5). CO and MAP were recorded
following two minutes of equilibration. Next, the
pacing mode was changed to the alternate pacing site at
the same heart rate, and measurements were repeated.
CO and HAP averaged 5.4 ± 1.5 l/min and 101 + 20
mmHg respectively during atrial pacing while these
values were significantly lower during V pacing at the
same rate (4.1 ± 1.8 l/min, p<0.03; and 89 !: 15 IIlmHg,
p<0.03). Changes were present despi te the absence of
demonstrable LV dysfunction, elevated EDP. or
rejection. and no evidence of hypertrophy at the time
of study. We conclude that atrial activation
contributes to V pump performance in the transplanted
heart. It is possible that this role lIlight be
magnified later if rejection and LV dysfunction occur.
Finally, we believe that atrial pacing is superior to V
pacing in heart transplant recipients who require
subsequent permanent pacemaker implantation.
SPONTANEOUS CHANGES IN VENTRICULAR TACHYCARDIA CYCLE
LENGTH: RELEVANCE TO ANTITACHYCARDIA DEVICE DEVELOPMENT.
Kent J. Volosin, M.D., Lou-Anne M. Beauregard, M.D.
F.A.C.C., Rosemary Rudderow, B.S.N., Howard Mattingly,
and Harvey L. Waxman, M.D., F.A.C.C. Robert Wood Johnson
Medical School, Camden, NJ.
Understanding spontaneous fluctuations in ventricular
tachycardia (VT) cycle length (CL) is required to develop
VT detection and pacemaker termination algorithms. We
analyzed variations in VTCL, time to stable VTCL, and
range of VTCL. Seventy-four episodes of sustained mono-
morphic VT induced on no antiarrhythmic agents were
studied. VTCL variability (VAR) was calculated as one
standard deviation of the mean VTCL for every 10 beats for
each episode. VTCL was considered stable when it varied
<10 msec. Fifty beats were analyzed for each episode.
RESULTS:
1. VAR: Linear regression revealed VTCL VAR to decrease
over time (41+24 msec to 17+19 maec, p<.OOI), slower
VT had more VICL VAR than faster VT (p<.OOl) and VT
which started out more variable tended to remain more
variable (p <.001) •
2. STABILITY: Fifty-four percent of episodes were stable
after 15 beats, 75% by the 30th beat, and 93% by the
50th beat. The number of beats to stable VTCL was
independent of VTeL (p-ns).
3. RANGE: The average range in VTCL per episode was 127+
72 msec. Twelve percent of VT varied by less than 50
maec, 45% by less than 100 msec, and 70% by less than
150 maec. The maximum range in VTCL for any given
episode was 290 maec.
CONCLUSIONS: 1. VT demonstrates a wide range of cycle
lengths and has time dependent changes in variability and
stability. 2. These cycle length changes must be
considered in the algorithms for VT detection and
termination by automatic antitachycardia devices.
PROTOCOL FOR EVALUATION OF IHTERHAL DEFIBRILLATION
SAFETY MARGINS.
Dougla. J. Ling. Ph.p.: Elizabeth L. Cato; Debra S. Echt.
M.D. Cardiac Pacemaker., Inc., st. Paul. Minnesota.
The satety margin (SM) ot an autoaatic iaplantable car-
diovereer-detibrillator (AICO) is the ditterence between
the AICO output and the ainiaum energy tor consistent
detibrillation (OF). Determination ot a .ingle OF
threshold (OFT) by testing decre.sing energy levels aay
overe.tiaste the SM tor OF, .ince the relationship be-
tween percent succe.stul detibrillation (' SOF) and
energy i. a OF curve. We evaluate4 whether a single
OFT protocol followed by 2 extra shocks at the OFT would
Clarity the SM. An expande4 OFT protocol was perf01'llled
in 154 doqs uaing spring lead/LV patch electrode. to
construct OF curves and to deteraine .ingle OFTa and the
.ucce.s (+) or tailure (-) of 2 extra shocks at the OFT
energy. The di.tribution ot , SOF tor the single OFT
(Figure A) was ditterent (p < 0.01) troa those ot the
extra-shock OFTs: OFT++ (Figure B, n-79): OFT+- (n-54);
OFT-- (n-21).
il~J k OFT alone ..:s,oo• B: OFT++is 50
• D
D 211 40 eo 50 '00
~SDF
One-third ot the orrs lay below 60' SOF, overestiasting
the SM by ~ 40' ot the OF curve width. The OFT+- and
OFT-- were distributed to aiddle and lower' SDF, indi-
cating a possible overestimation or the SM. With aU
ot the OFT++ above ao, SOF. the OFT++ were distributed
higher on the OF curve than the OFT .lone. ThUS, a OFT
that yields successtul converaions tor 2 extra trials
results in a more accurate determination ot the satety
margin.
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EFFECT OF PERICARDIAL EFFUSION ON ENERGY REQUIREMENTS
FOR DEFIBRILLATION USING EXTRAPERICARDIAL PATCH ELECTRODES.
Joseph Souza, Ranjan Thakur M.D., Paul Troup M.D.,
F.A.C.C., Jule Wetherbee M.D., Peter Chapman M.D.,
F.A.C.C., Medical College of Wisconsin, Milwaukee,
Wisconsin.
To determine if pericardial effusion (PE) influences
defibrillation energy requirements with extrapericardial
patch electrodes placed via median sternotomy, 6 anesthe-
tized mongrel dogs (24.5 + 2.2 kg) underwent defibrilla-
tion trials comparing monophasic (M) and single-capacitor
biphasic (B) shocks with and without PE. A median sternot-
omy was performed and two 13.9 cm2 patch electrodes
were sewn onto the outside of the pericardium. Three
cclkg of .9% NaCI was instilled through an intrapericardial
catheter used to create a hemodynamically insignificant
pericardial effusion. Four trials of 5 leading edge
voltages (200, 300, 400, 500 and 600 volts) were performed
for M and B shocks of 10 msec total duration (capacitance
150 uF) and defibrillation efficacy curves were determined
by logistic regression analysis. Baseline impedance
declined from 67 + 9 ohms to 51 + S ohms with PE (p
<0.000 I). Energies associated with 80% probability
of successful defibrillation were compared:
BASELINE* WITH PE*
M 13 .4 J 19 . 5 J * p-O. 18
ESO B 9.7 J 11.7 J
Although there was a tendency for higher defibrillation
energy requirements for both M and B shocks with PE,
this did not achieve statistical significance. Conclusion:
Pericardial effusion is associated with a decline in
impedance and a trend for higher defibrillation energy
requirements, which conceivably could result in reduction
in the margin of safety for defibrillation in the clinical
setting.
Tuesday, March 21, 1989
4:00PM-5:30PM, Marriott Hall North
Anaheim Marriott Hotel
Cardiac Pacing
ACUTE CLINICAL TESTING AND FOLLOW-UP OF A RATE-VARIABlE
PACEMAKER CONTROLLED BY CENTRAL VENOUS OXYGEN
SATURATION.
SVejn Emrestrand MP Britt T. Skadberg, M.D., Ken Anderson. M.Sc.•
Ole-Jergen Ohm, M.D., E.A.C.C., University Schoolot Medicine. Bergen,
Norway and Bakken ReselllCh Center, Maastricht, The Netherlands.
We studied a new rate-variable pacemaker (PM), that uses central venous
oxygen saturation (02Sat) to control PM rate during rest and tollowing 3
minutes supine arm exercise periods in 7 patients (mean age, 76 years) with
atrioventricular block and bradycardia. The sensor. which is incorporated In
the PM lead, emits red and infrared light in the RV and measures the
refleclion, from which 02Sat is derived. The calculated 02Sat, which can be
transferred via telemetry to the PM programmer, Is translated into a pacing
rate using I of 20 programmable response settings (RI to R20). The 02Sat,
heart rate (bpm) and CO (I/min; thermodilution) were measured during
bradycardia and for three reponse settings (R5, RIO and R15) In an 02Sat-
controlled pacing mode (Table below). Blood samples were obtained from
the RV to verify 02Sal. Heart rate response to changes in 02Sat was rapid
and increased the cardiac output with increasing work loads. The 02Sat
measured by the PM correlaled closely with 02Sat obtained from RV
safT1lling (n = 165, r= 0.95, P < .001).
Parameler Rest 'mean ±semI Exercise 'mean + semI
02Saturation, % 62 ± I 47 ±1
Heart rate, bpm (baseline) 39 ± 2 53 ±7
Heart rate, bpm (R5) 74 ±5 97 ±2
Heart rate. bpm (RIO) 84 ±7 112±9
Heart rate, bpm (RI5) lOO±6 136±2
CO, Voln (baseline) 4.3 ± .2 4.9 ±.7
CO, Voln (R5) 4.9 ± .2 6.5 ±.9
CO,Voln(Rl0) 5.1±.6 6.9±12
CO VnjolR151 49+ S 72± 6
Based on the favorable resuhs obtained during acute studies, two patients
have received permanent PMs implanted for 3 and 2 months, thus far. Initial
results assessed by exercise testing and Holter recordings at dillerent R
suggest that 02Sat can be measured by the PM on a long-term basis.
Furthermore. the heart rate can be physiologically adapted from central
venous 02Sat when the optimal Ris selected in an incividual patient
IIITIAL CLIIICAL UPDIDCE VITB .l DUAL ClWtBD lATE
1IDJL.l'l'lD P.lCl!tllIBl.
Jeffrey Brinker. M.D. F.A.C.C •• Roy Jutzy, M.D.,
F.A.C.C., David Hayes, M.D., F.A.C.C., Richard Gentzler,
M.D., F.A.C.C.,Kenneth Austin, M.D., F.A.C.C•• Tom Hee,
M.D., F.A.C.C., Paul Levine, H.D" F.A.C.C., James
Higgins, H.D., F.A.C.C., Charles Byrd, H.D., Stephen
Schaal, H.D" F.A.C.C., Bryant HcElroy, B.H.E., Johns
Hopkins Hedical Institute, Baltimore, Haryland.
We report the early experience liith the first dusl
chamber activity based rate modulated pacemaker.
Pacesetter model 2020T (Synchrony) vas implanted in 64
patients (pts) age 61+16 yrs (23-88) for sino-atrial
disease (46) and/or A-V block (18). Paired exercise tests
(DDDR vs ODD) were performed in a single blind randomized
fashion within a month of implant in 33 pts. Haximum
heart rate (MHR) and exercise duration vas increased liith
DOOR pacing (125+3.7/min vs 110+4.1/min, P<.002; 10.2+.7
minutes vS 9.6+.7 minutes, P<.03 repectively). During
ODOR MHR was sensor driven in 23/33 (70%). Nine patients
(27%) failed to increase their sinus rate > 100 during
treadmill testing. These chronotropic impaired (Cl) pta
had a MHR in ODD of only 8S/min compared with 12S/min
achieved by the other 24 pta (P<.OOOl). The Cl patients
increased their MHR to 109+6.1/min when progrlllllllH!d to
DDDR (P<.OO6). Follow-up data on the entire group of 64
pts is 110 +40 days. All but 9 remain in DDDR (6 DDlR and
1 DVlR because of atrial tachyarrhythmia, 2 VVlR because
of lead dysfunction). Thus DDDR pacing appears beneficial
in prolonging exercise effort by allowing a greater MHR.
For the CI patient the sensor driven MHR is significantly
increased but does not equal the sinus response of the
non CI patient. The ability to progru the device. to
non-tracking rate-modulated modes is beneficial in
selected patients.
INVESTIGATION OF A NEW ACTIVITY SENSING RATE RESPONSIVE
DUAL CHAMBER PACEMAKER
Stuart T. Higano M.D. and David L. Hayes M.D., F.A.C.C.,
Mayo Clinic, ROChester, MN
The importance of atrial contraction to resting and
exercise hemodynamics remains controversial. This is of
clinical importance in pacemaker selection, as either
rate responsiveness (VVIR) or AV synchrony (DOD) may be
selected. A new device incorporates activity sensing
rate responsiveness with AV synchrony (DOOR).
This device is ideally suited for Pts with AV block
and sinus node dysfunction. To assess the functional
advantage of AV synchrony vs. rate responsiveness, we
performed 1 month post-implant cardiopulmonary exercise
tests in 7 Pts in each of 3 modes (VVIR, DOD, DOOR).
Each Pt performs 3 separate randomized tests and thereby
acts as their own control. In addition to the usual
exercise parameters (HR, BP, ECG, Duration), oxygen con-
sumption and cardiac output are determined by respira-
tory gases and acetylene rebreathing techniques:
VV IR DOD DOOR
Res~eak Res--t--Peak Res~eak
HR bl!'20 --,.;r- "'TIS --rr"'ill
V02, mllmin 271 1413 313 1454t 282 1485*
CI, l/min/m2 2.2 3.9 2.3 4.3t 2.1 4.4*
SVI, ml/m2 36 33 32 37 28 35
02 Pulse ml 4.4 11.8 4.4 12.8 4.0 11.7
AV-02oiff ml II 70 196 80 184 83 184t
Duration, min 10:31 11:00t 11:03*
Versus Peak VVIR: * P<0.05, t P<O.lO
Conclusion: Compared to VVIR, DOOR exhibited enhanced
exercise cardiac index, oxygen consumption, and duration,
with smaller AV-02 differences. Although DOD did not
exhibit chronotropic incompetence, DOOR did improve
function at peak exercise, due to atrtal contribution to
exercise stroke volume and slightly' increased peak HR.
JACC Vol. 13, NO.2
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INITIAL EXPERIENCE WITH AUTO"ATIC SLOPE SETTINGS FOR "ETA
"V AND RHYTH"YX RATE RESPONSIVE PACE"AKERS
".W. hig "S, R. Sutclifh, A. Srlln, J. Perrin. "D, FACC
Th. e.n.r.l Inflr ••ry .t L••d., L••d., Engl.nd.
p.tl.nt. with flr.t g.n.r.tian r.t. r ••pan.iv. p.c •••k.r.
aft.n r.quir. r.p •• t.d .x.rci •• t ••t. to .n.ur. opti ••1
•• ttlng. of th. r.t. r ••pon•••lgarlth•• Th. ".t. "V .nd
Rhyth.yx unit. Incorpor.t. ..ch.nl... for .uta••tic
.lgarith•••tting. Th••1. of thl ••tudy 01" to .v.lu.t.
th. p.rfar ••nc. of th... n.w f•• tur ••. Th. ".t•••n•••
• inut. valu•• by ••••uring ch.ng•• in thar.cic i.p.d.nc.
(Til with. tr.n.v.nau. blpal.r p.cing .l.ctrad•• To ••t
th•• lgorith" th. TI ••••ur.d .t r •• t i. ca.p.r.d with
th.t .t p••k .x.rci •••nd th••dvl ••d .Iop. I. co.put.d
.utas.ticslly. Th. reproducibility of th. .dvi ••d .Iap.
wh.n ••••ur.d .ft.r int.rv.l, gr••t.r th.n 24h 01" high
in S aut of 6 pt., th.t i., th. v'lu. .ft.r th•••cand
t ••t v.ried by 1." th.n 2 .tep. fro. th. flr.t. Th.
••nsar used by Rhyth.yx i, the endac.rdi.l p.c.d QT
int.rv.l. Th. differenc. in th. QT int.rv.l. of
succ.,.iv. b•• t. d.t.r.in•• the pieing r.t. Iccarding to
th. .lop. ..tting of the .Igorith.. Th. plc•••k.r
ca.put •• thl v.lu. of the ,lap. It the b.,. rlt••v.ry
24h Ind IdJu,t. it. vllu. I' n.c ••••ry. 10 Rhythy.x unit.
h.v. be.n I.pllnt.d. Int.rrag.tion of th••lap•••tting.
WI' dane It 4Sh interv.l. for 14 d.y. Ifter .nlbling th •
•uta'ltic 'lope to r.co~d Initlll ch.ng•••nd to check
it, ,ub.equent .tlbillty. Th. • ••n ti.e for .lop.
,t.blll ••tlon Wi' 20 d.y. (r.ng. S-321 .nd inlti.l poor T
w.ve ,en,lng in 1 pt. .ccaunt. for the wide r.nge.
Sub.equ.nt .t.bility of th. 'lope h•• b••n confir••d
(ux. fallaN·up till I, e .anth,l. Canclu.lonl bath
.y.te•• hive Ichieved luto'ltic .Iape Id.ptltion le.dlng
to •••ti.f.ctory rate rise an Ix.rci.e. Thi. repre••nt.
• n I.port.nt dev.lap.ent in rite r ••pansive plcing.
A DOUBLE BLIND CROSS-OVER STUDY ON THE SYMPTOMATOLOGY AND
QUALITY OF LIFE IN PATIENTS WITH RATE RESPONSIVE PACEMAKERS
Chy-Pak Loy. MS. Julio Rushby, BSc, Michelle Leigh-Jones,
Carven YF Tom, Jon Polonlecki, Ann Ingram+, Richard Sutton+,
MD, FACC, A John Camm, MD, FACC
·Depllrtment of Cardiology, St. George's Hospital; +Westminster
Hospital, London
The hemodynamic advantages of rate responsive pacing
(RRP) are well establ!shed, but the symptomatic benefit on
patients (Pts) receiving RRP remains controversial and the
effects on the quality of life have not been assessed. 16 Pts
(6 Meta, 4 5ensolog 703, 3 Blorate, 2 dp/dt sensing and I
Actlvitrax) with RRP and a mean age of 56 (range 22-77) yrs
were Involved in a double blind cross-over study designed to
assess their exercise capacity (treadmill testing). symptoms
and quality of life (structured questionnaires). During the
trial. the pacemakers were randomly programmed into the RRP
or constant rate pacing (VVI) modes for four-week study
periods. All pts exercised longer in the RRP mode (570i29 s
vs 437il7 s, P<O.OOll. Symptoms were assessed in the pts and
also reported by their close relatives using a 10-point scale:
PATIENT SCORE RELATIVE SCORE
VVI RRP P WI RRP P
Dyspnea 6.9iO.9 B.2iO.7 0.02 6.BiO.B B.OiO.5 0.01
Energy 6.9iO.5 7.BiO.5 0.02 7.1iO.5 7.9±,0.4 0.03
Preference 7.3±.0.4 B.OiO.2 0.03 7.7iO.4 8.2±.0.2 0.08
Well being 7.6iO.5 8.1±.0.3 0.3 7.4±,0.5 8.0iO.4 0.17
Non-disease specific 'quality of life' was studied in II Pts
using the Nottingham Health Profile which showed a trend for
a better quality of life in 5 of the I) dimensions of
perceived health <pain. sleep, emotional reaction, sodal
isolation and physical mobility) during RRP compared to VVI,
although none of the changes was statistically significant.
CONCLUSION: RRP improves symptomatolgy of Pts but the
differences are not large enough to affect the general well
being nor a non-disease specific quality of life measure.
UNIQUE UPPER RATE BEHAVIORS IN DUAL CHAMBER, RATE
MODULATED PACEMAKERS
Stuart T. Higano M.D., David L. Hayes M.D., F.A.C.C.,
Mayo Clinic, Rochester, Minnesota.
The dual chamber, rate modulated pacemaker (DOOR) is
ideally suited for those with combined sinus node and AV
node dysfunction. In combining dual chamber with single
chamber, rate modulated technologies, DOOR developed a
hybrid of upper rate behaviors (URB) utilizing intrinsic
atrial activity and sensor driven pacing. We sought to
analyze the observed DOOR URB in 12 Pts during one month
post-implant exercise tests .
Three new URB, unique to DOOR, were observed:
1. "Pseudo-Rate-Smoothi ng"--A lthough standard dual
chamber modes may have large cycle length variations at
the maximum tracking rate (MTR) because of 2:1 or
Wenckebach-type block, DOOR displays "pseudo-rate-
smoothing" during this time. This occurs because the
Wenckebach interval is not a~lowed to exceed the sensor
driven rate interval. Like true rate-smoothing, marked
cycle length variations are prevented during exercise.
Pseudo-rate-smoothing will only occur at the MTR, or
after ectopics, during exercise. 2. Discrepant Upper
Rate Limits--The maximum sensor rate and MfR, must both
be programmed in a DOOR. Programming discrepant MTR and
maximum sensor rate is useful in pts with supraventricu-
lar tachycardias because rapid tracking of the taChycar-
dia is thus prevented while sensor driven rate
responsiveness is maintained. 3. P-Wave Trackina Above
The MTR--At atrial and sensor rates above the MT ,
appropriately timed P-waves can result in A-spike inhi-
bition and runs of apparent P-wave tracking. This
should not be mistaken for malfunction.
Conclusions: Analysis of URB in DOOR in 12 Pts has
led to 3 unique responses. These will be widely seen as
DOOR comes into widespread clinical use •
Tuesday, March 21, 1989
2:00PM-3:30PM, California Room D
Anaheim Convention Center
Echocardiography in the Evaluation of Balloon
Valvuloplasty
DOPPLER-ECHOCARDIOGRAPHIC EVALUATION OF THE RESULTS OF
SURGICAL ULTRASONIC DECALCIFICATION OF THE AORTIC VALVE.
David Nlgelhout, M.D., Anthony C. Pearson, M.D., FACC,
Vallee t. Willman, M.D., Hendrick B. Barner, M.D., FACC,
Arthur J. Labovitz, M.D., FACC, St. Louis University
Medical Center, St. Louis, Missouri.
Surgical decalcification of the aortic valve (AV) using
Cavitron Ultrasonic Surgical Aspirator (CUSA) has recent-
ly been introduced as an alternative to AV replacement
for severe calcific AV stenosis. We studied 17 patients
before and 7-10 days after AV (CUSA) decalcification
using M-mode (KM), tvo-dimensional (2D) and Doppler-echo-
cardiography. Pressure gradient (PC) aeroas the AV Vis
measured by continuous vave Doppler using the modified
Bernoulli equation. AV area vaa calculated using the
continuity equation. Aortic inaufficiency (AI) and mitr.l
regurgitation (MR) were quantitated using conventional
and color flov Doppler. KM and 2D studiea revealed
marked decrease in AV calcification and increase in leaf-
let mobility folloving the procedure. All patients had a
significant reduction in peak and Dean gr.dient (63+17 to
20+7mmHg and 37+12 to 9+4mmRg p<.OOOl). There vas arso a
siini~icant improve~nt-of lortic va!~e area (AVA) from
0.7cm +0.2 to 1.5cm +0.5 (p<.OOOl). LV systolic function
measured by MM shortening fraction (SF) vas not signifi-
cantly changed (34+7 to 32+7%). Mild AI vas initially
present in 7 patients vith-one pltient baying moderate AI.
AI vas unchanged in 9 patients, improved in 3 (by 1
grade) and vorsened in 5 p.tients (by 1 grade). MR vas
present in 8 patients and improved in 7 by 1 grlde. Two
patients developed .ild MR after the procedure. We
conclude that CUSA effectively decalcifies and mobilizes
AV leaflets in patients vith senile calcific AS result-
ing in a doubling of AVA. MR improved in 7/8 patientl
folloving the procedure probably as function of decreased
afterload. AI is improved or not changed in the majoricy
of patienta.
1l4A ABSTRACTS JACC Vol. 13, No.2
February 1989: 114A
ECHO EVALUATION OF IMMEDIATE AND lATE
FAilED MITRAL VALVE REPAIR
Thomas Marwick MBBS, Philip J. Currie MBBS, FACC, William
J. Stewart MD, FACC, Paul Calafiore MBSS, Ernesto Salcedo
MD, FACC, Floyd D. Loop MD, FACC, Bruce Lytle MD, FACC,
Delos Cosgrove MD, FACC, Cleveland Clinic, Cleveland, OH
Mitral repair has distinct advantages over replacement in pts
with mitral regurgitation (MR). Intraoperative echo (IOE)
provides immediate assessment of integrity of repair. The aim
of this study was to identify by echo the mechanism of failed
mitral repair. Mitral repair for MR was performed in 270 pts
over a 26 month period. Immediate failure (IF) of the mitral
repair was diagnosed by IOE in 15 pts during the initial repair
allowing a second pump run for further surgery. Late failure
elF) occured in 11 pts requiring a second thoracotomy (interval
before reoperation of 1 week to 18 months). Etiology of MR
was prolapse in 14/15 (93%) IF pts and 6111 (55%) of LF pts.
(p .. 0.05). The primary repair included leaflet resection in
12/15 IF pts and 5111 IF pts (p .. 0.01); ring insertion in 10115
IF pts and 11/11 IF pts (p .. 0.05). All IF pts had residual MR;
IOE diagnosed mitral valve systolic anterior motion in 6, suture
line dehiscence in 5 and inadequate leaflet coaptation in 4.
The second pump run consisted predominantly of ring removal
in 5, further leaflet repair in 7 and valve replacement in 3. All
IF pts left the operation with successful surgery documented by
IOE. In LF pts, etiology of failed repair was suture dehiscence
in 2, ring dehiscence in 1 and disease progression in 8.
Reoperation in LF pts was prosthesis insertion in 10 111 IF pts
and repeat repair 1/11 pts.
Conclusions: The causes of failed repair differ between IF
and IF pts. The mechanism of IF is most commonly related to
technical problems that can be identified by IOE and corrected
during the same thoracotomy. IF are most commonly related
to disease progression.
OOPPLER-ECHo EVALUATION OF MITRAL STENoSIS PRE-
AND POST-BALLOoN VALWLOPLASTY
Joseph xisslo, MD, FACe, tor the NHLBI Balloon
Valvuloplasty Registry, Coordinating center,
University ot Washington, Seattle, WA
In a 23 center national registry, 101 pa-
tients underwent Doppler (OOP) and echo pre-
«30 days) and post- (24-72 hours) mitral bal-
loon valVUloplasty (MPLASTY). Mean age was
57±16 years with 24 males and 77 females. Fol-
lowing MPLASTY, OOP mean transmitral gradient
decreased (10±5 to 7±6 mmHg); planimetered echo
mitral va2ve area (MVA) increased (1.2±.3 to1.7±.5 em ); pressur! halt-time MVA increased
(1.1±.4 to 1.8±.5 em ) (all p<.OOl). Invasive-
ly, mean mitral gradient decreased (14±6 to 6±4
~g) and MVA increased (1.0±.4 to 2.0±.8
em ) (both p<.OOl). Mitral requrgitation (MR)
severity assessed by OOP color tlow imaging
increased post-MPLASTY in 31t with an increase
greater than one grade in only 8t. Pulmonary
artery (PA) systolic pressure did not change
signiticantly when estimated trom tricuspid re-
qurgitant jet velocity (47 to 50 mmHg)(p-.IO).
Invasively measured mean PA pressure dropped
slightly immediately pre- and post-MPLASTY
(39±12 to 31±10 mmHg)(p<.OOl).
These data indicate that post-MPLASTY: COP
and echo accurately retlect change. that occur
in MVA and gradient; MR doe. increa.e slightly
in nearly one-third ot patients; PA pressure.
change little in the immediate po.t-MPLASTY
period. Such findings increase the likelihood
that COP and echo may be used to reliably
tollow patients in the long term post-MPLASTY.
DO HEMODYNAMICS OVERESTIMATE THE RESULTS OF BALLOON
MITRAL VALVULOPLASTY ?
Jacques Berland M.D., Eric Lefebvre M.D., Habib Gamra
M.D., Annick Barrier B.S., Paolo Rocha M.D., Alain Cribier
M.D., FACC, Brice Letac M.D., FACC.
Rouen University, France.
Post balloon valvuloplasty (BV), Doppler (DOP ,area-2201
Tl/2) evaluation of mitral valve area(MVA) is estimated
inacurate because large discordances with immediate
hemodynamic (H, Gorlin formula "gold standard") were
published in short series. We studied the correlations
between Hand Dop or 2D Echo (2DE) assessments of MVA in
73 patients (Pts), age 44+18, before and after BV.
Before BV : Significant correlations between Hand 2DE
(r-0.57, p<O.OOl) and Hand DOP (r-0.59,p<0.00l) were
found. The mean values of MVA were similar (H- 1.09+0.3
cm2,2DE- 1.04+ 0.26cm2,DOP- 1.02+O.2c1l\2,NS). All the-Pts
were correctfy diagnosed as having M stenosis (MVA-
<1.8cm2 ) by the 3 methods.
After BV : Immediate H correlated less well with 2DE
(r-0.49,p<0.001) or Dop(r-O.30,p<0.02) performed 24 hours
after BV. Aortic insufficiency (n-12) and increased mitral
regurgitation (n-8) specifically denatured the correlation
between H and DOP. VA was significantly larger with H
(2.26+0.51cm2 ) than with 2DE (1.94+o.44cm2,p<0.001) or DOP
(1.83+O.38c1l\2, p<O.OOl). On the contrary, 2DE and DOP VA
were similar and highly correlated (r-0.70,p<0.001) which
seems to validate the results obtained by these 2 methods.
Moreover, in our 25 Pts with 6 months follow-up 2DE and
DOP VA were unchanged confirming the post-BY results.
Conclusions : As opposed to pre-BY, immediate post BV H
evaluation of MVA oversizes DOP or 2DE MVA and J:hus
overestimates the results of balloon mitral valvulo-
plasty. Therefore, only comparisons with post-BMV non
invasive data have to be taken into consideration for the
evaluation of a possible restenosis.
DOPPLER-ECHO EVALUATION OF AORTIC STENOSIS SEVERITY PRE-
AND POST-BALLOON AORTIC VALVULOPLASTY.
Patricia C Corne M D" for the NHLBI Balloon
Valvuloplasty Registry, Coordinating Center: University
or Washington, Seattle, WA.
In a 23 center national registry, 240 patients, enrolled
over 8 months of a planned 24 month enrollment, underwent
Doppler echocardiography pre- (within 30 days) and post-
(24-72 hrs) aortic balloon valvuloplasty (ABV). Mean age
was 79 ± 9 years, with 104 males and 136 females. Doppler
mean transaortic pressure gradient (dP) decreased from 49
± 19 to 35 ± 15 mmHg. Continuity equation aortic va2vearea (AVA) increased from 0.6 ± 0.3 to 0.8 ± 0.3 cm
(both p < 0.001). Similar directional changes were noted
in invasive measurements immediately pre- and post-ABV
for meanAP (582± 24 to 30 ± 13 mmHg) and AVA (0.5 ± 0.2to 0.8 ± 0.3 cm , both p < 0.001),
Aortic insufficiency (AI) severity, evaluated by Doppler
flow mapping, increased post-ABV in 16% of patients with
an increase by more than one grade in only 2%. LV
systolic function was depressed on 2D echo pre-ABV in 52%
of patients (mildly in 18%, moderately in 15% and
severely in 19%), and improved acutely post-ABV in only
19% of these patients (10% of total group).
We conclude that aortic-BV results in an immediate modest
decrease in mean 6 P and increase in AVA as measured by
both Doppler and catheter techniques. AI severity
usually is unchanged as is LV systolic function.
JACC Vol. 13, No.2
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ONE-YEAR CLINICAL AND DOPPLER ECHOCARDIOGRAPHIC
FOLLOW-UP OF PATIENTS HAVING DOUBLE-BALLOON CATHETER
BALLOON VALVULOPLASTY FOR MITRAL STENOSIS. Cheryl L.
Reid, M.D., F.A.C.C., David T. Kawanishi, M.D.,
F.A.C.C., Shahbudin H. Rahimtoola, M.D., F.A.C.C.
LAC/USC Medical Center, Los Angeles, CA.
Of the first 27 pts, age 43t15 yrs (meantSD) having
successful double-balloon catheter balloon valvuloplasty
(CBV) for mitral stenosis, clinical and Doppler
follow-up have been obtained in 21 pts. Evaluation
including NYHA Functional Class (FC) and Doppler mitral
valve area (MVA) and mitral regurgitation (MR) were made
pre-, immediate post (immed), 3 mos, and 364t50 days (12
mos) post CBV. Based on reproducibility of day-to-day
measurements of MVA in these pts, a change of >22% was
considered significant. -
RESULTS: MVA increased from 1.0t.2cm2 pre-CBV to
2.lt4cm2 immed (pC05). Follow-up at 3 mos MVA was
1.9t.4cm2 , at 12 mos 1.8t.4cm2 (p<.05 Immed vs 3 and 12
mos). At 3 mos, 3 pts (12%) had a decrease in MVA which
was unchanged at 12 mos; an additional 8 pts (38%) had a
decrease at 12 mos. Two pts returned to within 22%-of
pre-CBV MVA at 12 mos. MR decreased by 1 grade in 7
pts, in 5/7 pts (71%) decrease in MR was associated with
decrease in MVA. Pre-CBV, 89% of pts were FC 3-4. At 3
and 12 mos, 92% and 86% of pts were FC 1-2. FC deteri-
orated by 1 class at 12 mos in 3 pts; all had decrease
in MVA.
CONCLUSIONS: 1) 12 mos post CBV, 86% of pts maintain
initial improvement in FC. 2) Decrease in MR is often
associated with decrease in MVA. 3) Although MVA
decreases in 52% of pts, an early decrease may not be
progressive and the decrease from 3 to 12 mos is mini-
mal. Only 10% of pts returned to pre-CBV MVA. In most
pts, decrease in MVA is not of sufficient magnitude to
result in deterioration of FC.
Tuesday, March 21, 1989
4:00PM-5:30PM, California Room D
Anaheim Convention Center
Contrast/Coronaries
MYOCARDIAL CONTRAST ECHO WASHOUT CURVES:
THE INFLUENCE OF ISCHEMIA AND HYPEREMIA.
Shimon A Reisner MD, Ianine R Shapiro MD, Antonio F Amico MD,
Richard SMeltzer MD, PhD, FACC. U. of Rochester, Rochester, NY
To determine the influence of different coronary blood flow levels on
myocardial contrast washout curves, 8 open chest dogs underwent
intracoronary contrast injections of sonicated 5% human albumin.
Regional ischemia was induced by ligation of a coronary artery and
hyperemia by intravenous infusion of 0.75 mg/kg of dipyridamole.
Blood pressure, pulmonary capillary wedge pressure and heart rate were
kept at baseline level with fluids, neosynephrine and pacing. Washout
curves were generated from the area of interest using beat-by-beat
analysis of end-diastolic frames. Background subtracted peak contrast
intensity (PCI, gray scale units/pixel) was defined as the highest value
obtained. Washout half time (1'112) was calculated from the decay phase
of the curve by the equation Tl/2=1n(2/k) (k = exponential decay rate).
Each value of PCI and T1I2 was averaged from 2 successive
injections. High quality contrast time-intensity curves, (r>0.8,
correlation of exponential decay), were obtained in 5 dogs. PCI in the
ischemic area was 44±14 (mean±lSD) at baseline, 43±6 after coronary
artery occlusion and 51±9 during hyperemia. In the nonischemic area,
PCI was 32±11 at baseline and 40±9 during hyperemia. All PCI
changes were statistically insignificant. Tl/2 (in number of cycles) and
percent change in T1I2 from baseline after coronary occlusion and
during hyperemia were:
Baseline Occlusjon Hyperemia
Ischemjc area' 3.8±O.9 4.2±1.1 (+10%) § 4.4±O.S (+16%) *
Nonjschemjc area' 3.2±O.1 3.3±O.9 (+3%) 4.6±0.4 (+43%) *
* Tl/2 was significantly longer (p<O.02, ~y paired Student's t-test ),
during hyperemia compared to baseline for both the ischemic and
nonischemic areas. § Tl/2 was significantly longer (p<O.OS) after
occlusion compared to baseline in the ischemic area. Conclusjons: 1.
Both ischemia and hyperemia prolong washout time, probably by
different mechanisms. 2. The greater prolongation with hyperemia is
partially obscured in the ischemic area. 3. There is no significant change
in PCI with ischemia or hyperemia.
MYOCARDIAL CONTRAST BCBOCARDIOGRAPBY CAN NOT BI USED TO
ASSESS ENDOCARDIAL/EPICARDIAL BLOOD PLOV RATIO. Sanjiv
Kaul H.D., F.A.C.C., Hark II. Keller H.D., lIilliam P.
Glasheen H.E., Dale A. Touchstone H.D., lIilliam 0, Spot-
nitz H.D., F.A.C.C, Howard P. Gutgesell H.D., F.A.C.C.
University of Virginia, Charlottesville, VA
Two preliminary reports have claimed that endocardial/
epicardial blood flow ratio (EER) can be assessed using
myocardial contrast echocardiography (HCE). Based upon
our experience, we postulated that EER can not be deter-
mined with HCE. Accordingly, we studied 2 groups of open-
chest anesthetized dogs. In group I (n • 6) we placed a
hydraulic occluder on the left anterior descending coro-
nary artery (LAD). In group II (n • 6) we produced a cri-
tical stenosis of the left circumflex artery. Sonicated
microbubbles were injected into the left main artery in
all dogs and 20 echo images obtained. In group I dogs,
injections were performed during baseline and following
severe stenosis of the LAD. In group II dogs, injections
were performed following intracoronary injection of 6 mg
of papavarine to enhance endocardial steal. Time-inten-
sity plots were obtained from the endocardium and epicar-
dium of digitized end-di~stolic 20 echo images. A gamma-
variate function (Axe-" ) was fitted to the plots and
curve width (ex), height (A/exz), and areas (Aloe) were
derived. These parameters were correlated with endocar-
dial blood flow and EER obtained using radiolabeled mic-
rospheres. The EER varied in these dogs from 0.08 to 1.4.
In nei ther group of dogs did any HCE parameter derived
from the endocardium correlate wi th endocardial flow or
EER. The best correlations (ratios of areas under the
curves from epicardium and endocardium vs EER) were 0.57
and 0.17, respectively (peNS) in the two groups of dogs.
lie conclude that EER cannot be assessed using HCE. The
inability of HCE to assess the transmural distribution of
blood flow may be related to tissue 'cross-talk' result-
ing from scatter of ultrasound from the microbubbles.
REPRODUCIBILITY OF WASHOUT CURVES DERIVED
FROM MYOCARDIAL CONTRAST ECHO.
Shimon A Reisner MD, Janine R Shapiro MD, Antonio F
Amico MD, Richard SMeltzer MD, PhD, FACC.
University of Rochester, Rochester, NY
To investigate whether peak contrast intensity and washout
half time (T1/2) derived from myocardial contrast time-intensity
curves are reproducible, we performed repeated, paired left
intracoronary injections of contrast in 8 open chest dogs.
Sonicated 5% human albumin (bubble size 5.2±2.6 microns)
was the contrast agent. Pairs of injections were performed 1) at
baseline, 2) after ischemia induced by ligation of a coronary
artery, and 3) during hyperemia produced by intravenous
infusion of 0.75 mg/kg of dipyridamole. Blood pressure,
pulmonary capillary wedge pressure and heart rate were kept
at baseline level with fluids, neosynephrine and pacing. Time-
activity curves were generated for the area of interest by beat
per beat analysis of a frozen end-diastolic frame. Peak contrast
intensity with background subtracted (PCI, gray scale
units/pixel) for each injection was determined as the highest
point of the curve. T1/2 was calculated from the decay phase of
the curve using the least square fit by the equation T1/2=ln(21k)
(k • exponential decay rate). Thirty six paired high quality
contrast washout curves were obtained in 6 dogs. PCI
(mean±1SD), T1/2 (mean±1SD; units of T1/2 are cycles), p (by
paired Student's t-test) , correlation coefficient (r), and
standard error of the estimate (SEE) were:
Iniection 1 Injection 2 p r SEE
PCI 45±8 45±10 0.97 0.80 6.8
T1/2 4.2±0.6 4.0±0.7 0.09 0.86 0.3
Conclusion: Peak contrast intensity and washout half time
derived from high quality myocardial contrast washout curves
are reproducible at different coronary blood flow levels.
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CURRENT MYOCARDIAL PERFUSION ECHO METHODOLOGY
PRECLUDES AN ACCURATE ASSESSMENT OF CORONARY
VASCULAR RESERVE.
Folkert J TenCate M.D, , Patrick W Serruys M.D. ,
Paul R Silverman M.D., Pieter D Verdouw Phd,
Nico de Jong MSc., Thoraxcenter, Erasmus
University, Rotterdam, The Netherlands.
Myocardial contrast echoperfusion (MCE) has
recently been introduced into clinical cardio-
logy. Among its possible applications is deter-
mination of coronary vascular reserve (CVR). To
test this hypothesis we studied MCE and CVR in
10 patients (pts) and experimentally in 12 pigs
(P). MCE was studied using intracoronary (i.e.)
injections of sonicated iopamidol (microbubble
size 9 ± 3)k). For CVR, 0.42 mg/kg papaverine
(i.e.) (Pap) was used and MCE measured after 30
seconds. In pts and P MCE images were digitized
and time intensity parameters (TIP) calculated,
including peak I (%1) from baseline before and
after Pap. In P simultaneous electromagnetic
coronary flow and myocardial wall thickness
(MWT) (by epicardial ultrasound transducer)
were measured. In P MWT increased significantly
(>lmm) after Pap if coronary flow increased by
>30%. However, in pts and P no correlation was
found between %1 or TIP and severity of the
stenosis. Conclusions: In pts and P, MCE was
unable to quantitate changes in bloodflow after
Pap. This may be due to increased myocardial
blood volume (as shown by increased MWT), cur-
rent lack of standarization for TIP measure-
ments and inability of current imaging systems
to determine absolute Rf amplitudes.
TRANSTHORACIC TVO-OI~ENS:ONAL ULTRASONIC HIGH FREQUENCY
(7.5 MHZ) VISUALIZATION OF THE DISTAL LEFT ANTERIOR
CORONARY ARTERY
Jchn J. Ross, Jr., RCP!, Gary S. Mintz, KD FACC, K.
Chandrasekaran, ~D, Likoff Cardiovascular Institute,
Hahnemann University, Philadelphia, PA
Pre~ious transthoracic two-dimensional echocardio-
.rl~hic (2DEi imaging techniques could look only at the
proxi~al coronary artery anatomy within the focal zone of
stl~~ar: i~aging frequencies of 2.5 to 3.5 MHZ. Ve
hypothesized that new higher frequeny (7.5 MHZ) mechanical
20E transducers would not cnly improve nearfield
res~lution, but also allow visualization of the distal
left lnteri~r descending (LAD) artery normally masked by
near field artifacts of standard transducers.
NONINVASIVE EVALUATION OF THE INTERNAL MAMMARY ARTERY
BY ULTRASONIC DUPLEX-SCANNING.
Han A M Spierenburg,MD, Wybren Jaarsma,MD, Cees A.
Visser,MD,FACC, Rob G.A. Ackerstaff,MD,
Carl A. Ascoop,MD. Dept of Cardiology St. Antonius
Hospital and the Interuniversity Cardiology Institute,
Utrecht, the Netherlands.
To evaluate the feasibility of ultrasonic duplex-
scanning (i.e. combined display of a 7.S mHz 2D-echo
and 5.0 mHz pulsed Doppler) of both left and right
internal mammary artery(IHA), we studied 20 normals
(mean age 30 yrs). In all pts both left and right IHA
were imaged, either from the supraclavicular fossa,
the third and fifth intercostal space. Only 2 left
IHA's could not be found in the fifth intercostal
space. At origo level the diameter of both IHA's was
3.ltO.6mm (mean t ISO), and at the fifth intercostal
space 2.ltO.3mm. The peak systolic(S) velocity was
1.ltO.2 m/sec, the diastolic(D) velocity 0.3tO.OS
m/sec. in both IHA's (ratio SID 3.7). In lS
asymptomatic pts post IHA-bypass surgery a peak
systolic velocity of 0.8tO.4 m/sec and a peak
diastolic velocity of 0.7tO.S mlsec was measured
(ratio SiD 1.1).
Conclusions:
(1) Ultrasonic duplex-scanning can be of help to
properly select the internal mammary arteries for
coronary artery bypass grafting and
(2) may provide, as a noninvasive method, useful
information about left and right IHA patency in the •
postoperated patient.
Tuesday, March 21, 1989
4:00PM-5:30PM, Garden Grove Room
Anaheim Convention Center
Hypertrophic, Dilated and Restrictive
Myocardial Disease
SPECTRUM OF RESTRICTIVE CARDIOMYOPATHY: A MULTICENTER
STUDY
Yuzo Hirota, M.D., Gen Shimizu, M.D., Yoshio Kita, M.D.,
Yasuahi Nakayama, M.D., Keiahiro Kawamura, M.D., Seiki
Nagata, M.D., Toshitami Sawayama, M.D., Toru Izumi, M.D.,
Takeshi Nakano, M.D. and Morie Sekiguchi, M.D.
The Third Division, Department of Internal Medicine,
Osaka Medical College, Takatsuki JAPAN
Prospecti~ely , we studied 35 patients (PTS) using a
~odified apical window and visualized the long and short
lxis of tha distal LAD in 28 patients. This was confirmed
by guide wire det.ction during LAD coronary angioplasty.
~ength, diameter and circu~!erence wera measured on line:
1a conclude that the improved nearfield resolution
of high fr.quency (7.S MHZ) 2DE transducers allow visuali-
zation of the ~istal LAD which ~s one of the most anterioc
structures of the heart. In the future it may be pos.ible
to detect distal LAD :isease. flow, and respon•• to
phar=acologic and ::I.chanical intervention. This approach
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This report describes clinical profiles of 23 Pts with
restrictive cardiomyopathy (RCM) from 12 institutes based
on the criteria of 1) congestive heart failure (CHF) due
to stiff LV, 2) normal LV size and systolic function, 3)
absence of LV hypertrophy, and 4) etiology unknown.
There were 7 cardiac deaths; 1 died within 1 year, 1 at
the 5th year, and 5 after 10 years. Three had family
history of RCM and hypertrophic cardiomyopathy (HCM),
respectively. Thromboembolism was observed in 7 Pts.
Echocardiogram showed normal LV wall thickness and
contraction, and pericardial effusion was common in Pts
with severe CHF. The square root sign (SRS) of RV
pressure was seen in 11 whose RA pressure was higher than
those without SRS «+) :13±6 vs (-):6±3mmHg, p<O.OOS).
This sign was seen in LV, and LA pressure was not
different between Pts with and without SRS. RVEDP was
higher in Pts with tricuspid regurgitation (TR) than that
of Pts without TR «+):15±5 vs (-):7±3mmHg, p<0.005), and
equalization of RV and LV filling pressures was seen in
Pts with severe TR. Interstitial fibrosis (19/20) and
endocardial thickening (11/18) were the most common
histological findings. Severe myocardial dysarray
consistent with HCM was seen in 2 cases. Conclusions:
1) the clinical course of RCM is long, 2) RV and LV
filling pressures could be equal with severe TR, 3) SRS
is not diagnostic, and 4) thromboembolism is common.
Some of them may be an atypical manifestation of HCM.
JACC Vol. 13. No.2
February 1989:117A
ABSTRACTS 117A
RmlCIl{; LEF'1' VENmI<lJLAR CXJ'l'F!.Oo1 TRACl' CBSTRUC1'IOO
IN PATIENl'S wrm HYPER'l'ROFHIC CARDIOMYOPATHY BY PACIID-
INOOCED INTERlJENI1U<lJLAR SEPl'AL PR&-EXCITATIOO.
Lameh Fananapazir, M.D., Judith Winkler, B.S., Bill
Schenke, B.A., Deborah Barbour, M.D., Arshed Quyyuni,
M.D., mLBI, Bethesda, MD.
*-p<0.05 compared with atrial pacing.
Conclusion: Ventricular septal pre-excitation during 000
pacing results in significant relief of LV OT obstruction
- an effect that is not associated with hypotension and
is exaggerated at higher heart rates. This intervention
may have clinical utility in some pts with with obstruc-
tive hypertroFhic cardiomyopathy.
EVIDENCE FOR AN ABNORMAL VASODILATOR RESPONSE IN
HYPERTROPHIC CARDIOMYOPATHY.
Micheal P Frenneaux. M B, Peter J. Counihan, M.B., David Webb,
M.D., William J. McKenna, M.D., F.A.C.C. St George's Hospital
Medical School, London, U.K.
Sudden death is common in hypertrophic cardiomyopathy (HCM) but
the mechanism(s) have not yet been established. To identify those at
risk of hemodynamic collapse. 103 pis with HCM, age 12-70 (mean
40) yrs underwent symptom limited treadmill exercise with standard
cuff blood pressure recording (BP) at each minute of exercise and
every 15 seconds during recovery for 3 minutes on at least 2
occasions. The test was repeated in 25 with direct arterial pressure
measurement. Fifty one had a normal and 52 an abnormal BP
response with either hYPOtension during recovery or a fall during
exercise of ~ 20 mm Hg (range 20-100, mean 45 mm Hg) from the
peak value to that recorded immediately before stopping. A family
history of sudden death was more common in those with an abnormal
exercise BP response (24/52 vs 3/51, p<O.OOI). To assess the
mechanism of the hypotensive response 10 with an abnormal and 7
with normal exercise BP response underwent exercise hemodynamic
studies, with continuous direct arterial pressure recording and
measurement of cardiac output each minute. Systolic BP fell by 25-
95 (mean 50) mm Hg in all 10. The rise in cardiac index on exercise
(l/min/m2) was similar in those with normal (2.3tO.5 to 8.8±2.4) and
abnormal BP response (2.ltO.5 to 7.2!1.1). Systemic vascular
resistance in the 2 groups at rest and at 2 mins exercise was similar,
but at peak exercise fell significantly more in the hypotensive vs
normal BP responders (22!6% vs 42t4% of resting values, p<O.OI).
To assess the mechanism of this abnormal vasodilation, forearm
plethysmography was performed during supine bicycle exercise in II
hypotensive pis and 10 normal volunteers. Forearm vascular
resistance fell by 18t45 % in the hypotensive pis, but increased by
131±4S % in the normals (p-o.OO3). In conclusion: Exercise
hypotension is common in HCM, is strongly associated with a family
history of sudden death and is due to an inappropriate vasodilation
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100 105 + 14 99 + 15 99 + 18
120 94 + 17 95 + 18 98 :; 17
150 84+25 89 ± 31 98 ± 26
Heart
Rate
In some pts with hypertroFhic cardiauyopathy, the inward
systolic lOOVement of the thickened interventricular septllll
and anterior lOOVement of the mitral valve (SAM), cause LV
outflOW' tract (OT) obstruction. In these pts., atriovent-
ricular pacing (000) may increase LV ar dimensions by in-
ducing parack>xical septal IOOtion. This would reduce SlIM
and thereby Lvar obstruction, but also maintain the atrial
contribution to cardiac output. We corrplred the effects of
000 pacing on LV ar gradients and aortic pressures with
atrial pacing at identical heart rates, during cardiac
catheterization in 16 pts. The results were:
Pacing Mode (Atrioventricular Delay, ms)
Atrial 000(80) OOOnOO) ooo(20)
(LV ar Gradient, !!I!!Hg)
BEm:FICIAL EFFECI'S OF I.OOGlmot IEm-BIlXI<l\lE Wl'IH BX:INI:OIOL
IN PATImrS wrm IDIOPA'lHIC DIlATED CARDICMYOPATHY.
Jeffrey Amerson. MD. FAce, Edward Gilbert, MD, John
O'connell, MD, FAce, [)lie Rallurd, /01), FN::C, Frank Yan::M1tz,
MD, FAce, Marian Bartholanew, !lS, Marianne Murray, RN,
Patricia Mealey, RN, Kirk Volkman, RN, Michael BristcM,
MD, RlD, University of Utah, salt lake City, Utah.
Beta-blockade represents a pranisiIX] bolt =nt::l:o.msial
therapeutic awroach to idi~thic dilated cardiauyopathy
(DCM) • 8.1cin:lolol (B), a novel new beta-blocker, showed
favorable effects in a shortterm trial in lXM, bJt lcrqt.erm
response is unknown. In order to assess this, 20 stu1y
pt (7/9 placebo, 13/14 B pt) reoeiva:i chronic B am 1IIere
followed for 21 ± 4 mo (~, 15-28). Mean age was 49 y
(rarJ;Je, 29-66), am mean functional class (Fe), 2.6 (2-4);
disease duration averaged 11 100 (1-190); 15 pt were men.
At JOOSt recent follCMlP (9/88), all 20 were alive, 17
continued on B (mean dose, 157 Irg/d, raIl3"e, 25-200), am
2 were transplanted. Paired en;lpoints were (mean ± SO):
&JR\TIVAL OF PATIENl'S WITH HYPERI'RJFHIC CARDI<JoIYOPATHY
&JCCESSFULLY RE&JSCITATED FRQ! SUIDEN CARDIAC ARRFSl'.
Franco cecchi, M.D., Barry J. Maron, M.D., F.A.C.C.,
steFben E. Epstein, M.D., F.A.C.C., NIlLBI, Bethesda,
Maryland.
While sudden death is the IOOst devastating complication
of hypertroFbic cardianyopathy (HOt), the long-term out-
come of that unique subgroup of pts successfully resus-
citated frCl'll cardiac arrest (CA) is not known. This study
describes long-term outcome of 33 such pts with H~.
cardiac arrest occurred at ages 9 to 62 years (mean 32);
5 pts survived multiple arrests (i.e., 2 or 3). A vari-
ety of treatments were acininistered; 18 Fts with outflOW'
obstruction had rnyotany-rnyectauy or mitral valve replace-
ment and also drug therapy, while 15 pts received medical
theraP.i alone. To date, 22 of the 33 Fts (67%) have sur-
vived after CA for 1.5 to 22 years (mean 7); 12 have sur-
vived >5 years. Of the 22 survivors, 16 have remained
asynptanatic or only mildly syrrptanatic; 6 others have
become severely symptanatic with cardiac failure, includ-
ing 3 with LV wall thinning and cavity enlargement.
Eight pts died of cardiac causes (suddenly or progressive
heart failure) 7 IOOnths to 8 years (mean 5 years) after
CA. Actuarial pt survival was 97... , 74+9% and 61+11%
after 1, 5 and 10 years. Event free rate (without
recurrent cardiac arrest or SO death) was 83+7%, 65+9\
and 53:tll%. In conclusion, long-term out~ of pta with
H~ after SO was variable. ~rrent CA or premature
death (sudden or due to congestive failure) occured in
about one-third of pts, IOOst COI1IlIOnly in the first 5
years after initial CA. Conversely, roost pts survived
and remained free of CA and marked synptans. Aborted
episodes of sudden death ck> not necessarily convf!!:l an
omioous prognosis in H~ and in some pts appear to be
isolated events in the natural history of their disease.
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'lhus, longterm B leads to strikiIX] increases in EF am
1nproved Fe while maintainiIX] stable exercise perfonIBlt:e.
Also, similar or better EF (mean, +1.5 percentage points)
am El' (+0.4 min) were observed after lon:Jterrn than sh:lrt-
term (3 100) B. Given this excellent tolerance, survival,
and f'I.1rctional efficacy result, longtecn B therapf deserves
further evaluation in IXM.
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Growth Factors Identified in Myocardium of Patients
with Hypertrophic Cardiomyopathy. Pamela Karasik, M.D.,
S. Ward Casscells, M.D., Charles L. McIntosh, M.D.,Stephen
E. Epstein, M.D. NHLBI, Bethesda, MD.
Acidic and basic fibroblast growth factors (aFGF, bFGF)
have been identified in many tissues of mesenchymal origin
Because both aFGF and bFGF have a strong affinity for
heparin, we applied the technique of heparin-sepharose
chromatography to determine if these factors were pre-
sent in myocardium obtained at the time of left ventricu-
lar myomectomy in pts with hypertrophic cardiomyopathy
(HCM). Fresh tissue was homogenized in phosphate buffered
saline with protease inhibitors, and centrifuged at 48,000
g x 60 minutes. The supernatant was applied to a heparin-
sepharose column, washed, and eluted with 10mM Tris, EnTA,
and increasing concentrations of NaCI. Crude homogenate,
supernatant, and column fractions were tested for mito-
genicity on quiescent Balblc 3T3 cells. The homogenate,
supernatant, and column fractions eluted at 1.0-2.OK NaCl
(which are known to contain aFGF and bFGF, if present)
were potent mitogens, stimulating DNA synthesis two to
six fold. Mitogenicity of the homogenate and of the
column fractions eluted at 1.0-1.5M NaCl were potentiated
50-100% by the addition of heparin, in the 10-20ug/ml
range (a characteristic of aFGF). Thus myocardium de-
rived from pts with HCM contains potent mitogens, most
likely aFGF and bFGF. These data suggest a potential
role of growth factors in the pathophysiology of HCM.
Tuesday, March 21, 1989
2:00PM-3:30PM, California Room C
Anaheim Convention Center
Basic Science and Clinical Advances in
Pediatric Cardiology
NONCARDIAC DEFECTS ASSOCIATED WITH
CONOTRUNCAL ABNORMALITIES·FURTHER IMPLICATIONS
OF NEURAL CREST INFLUENCE
Todd W, Ussery,B.S.. Frederick W. Arensman,M,D"F.A.A.C"
Linda Leatherbury,M,D.,F,A.A.C., David B. Flannery,M.D" John
D. Harmon,M.D" Margaret F, GUill,M.D., Mary S, Lettell,PhD.,
Ronald A. BeIl,D.D,S., William B. Strong,M.D.,F.A.A.C., Medical
College of Georgia,Augusta,Georgia.
Previous animal research has demonstrated that ablation of
chick neural crest (NC) results in bOth a high incidence of
cardiac conotruncal abnormalities and associated noncardiac
malformations. Because the NC influences the development of
many noncardiac structures in humans, we chose to assess the
incidence and severity of abnormalities associated with
Tetralogy of Fallot (TOF) and Persistent Truncus Arteriosus
(PTA). 26 Patients (Pts) were evaluated by otolaryngologic,
audiologic, facial dysmorphism, immunologic and
cephalometric criteria. The mean number of NC abnormalities
was 2.± 1 including those of brow, ptosis, iris and palpebral
fissures. Mean pharyn~eal arch abnormalities numbered 5.± 2
including pinnae, fTlandlble, nasal bridge and alae, nares,
philtrum andm~ flatness. Total cutaneous anergy was
present in 65% of the Pts, while low T cell number was observed
In 75% of the TOF Pts and 100% of the PTA Pts, Even when
%COO was normal, 60% had low %CD4. The incidence of
associated abnormalities was not significantly different between
TOF and PTA groups, but the total group had many more
abnormalities than a normal population (p < .ססOO1). Ib.us
abnormal neural crest influence is implicated in human
conotruncal malformations by the high incidence of associated
noncardiac abnormalities. Pts with conotruncal abnormalities
should undergo multidisciplinary screen to assess their need for
complete noncardiac diagnosis and potential intervention.
ELEVATED RIGHT VENTRICULAR PRESSURE INCREASES
COLLAGEN IN VENTRICULOTOMY SCARS IN CANINES.
Susan W. Oenfield M.D., Debra Kearney, M.D., Kathleen
Sprague, B.S., Art~ur Garson Jr., M.D., F.A.C.C., Baylor
College of Medicine, Texas Children's Hospital, Houston,
Texas.
Ventricular arrhythmias (VA) are a significant problem in
patients who have had repair of tetralogy of Fallot. The VA
may be associated with increased right ventricular systolic
pressure (RVSP) and are mapped in the electrophysiology
laboratory adjacent to large areas of scar. It was our
hypothesis that increased RVSP would alter healing and scar
formation. Eight adult beagles of either sex weighing 9-14 kg
had right ventriculotomy only (N=4) or right ventriculotomy
and pulmonary artery band placement (N=4). RVSP was
initially normal «22 mmHg) in all dogs prior to band place-
ment. The RVS15' averaged 55+24 mmHg (SO) (range 38-90)
after banding. The scars were allowed to mature for a
minimum of 2 months. The hearts were removed and scars
examined by hematoxylin and eosin and Gomori's trichrome
stains for collagen. The amounts of dense and loose collagen
and fat in each scar were estimated by light microscopy
using the following scale: 0 = absent, I = 1-2596, 2 = 26-4496,
3 = 45-5596, 4 " 56-7596, 5 = 76-10096. The scars that healed
with high RVSP had more dense collagen (all had score ~4)
and less fat (all ~2) than those healing with normal RVSP -
dense collagen (all 9), fat ( all ~2) (P <0.03). It is possible
tha t differer,ces in scar composi tion may alter the ar-
rhythmogenic potential of scar and surrounding myocardium
and may contribute to the VA seen in some patients with high
RVSP following repair of tetralogy of Fallot.
Depressed Myocardial Functton and Vanll1cuar Wall Stress In Neural Crest
Ablated Chicle Embryos
David S, Braden M.p , Unda Leatherbury M.D., FAC.C., WDliam F. Jackson
Ph.D., Harold E. Gauldin. Medical College 01 Georgia, Augusta, Georgia
Mlcroclnepholography was used to study a model 01 persistent truncus
arteriosus created In chick embryos by cauterizing premlgratory neural
crest destined for the fourth aortic arches and truncal septum. When
embryogenesis reached the looped cardiac tube stage, 15 experimentals
and 15 control ,.mbryos were evaluated, Previous data demonstrated a
significantly c!o3Creased ventricular shortening fraction (SF'll.) In
axperimenta' embryos wtth similar cardiac outputs, This decreased SF'll.
was hypothesized to be due to Increased ventricular wall stress secondary
to increased resistance In the aortic arch arteries. Peak-systolic meridional
stress (PSSm) and peak-systolic circumferential stress (PSSc) were
calculated using peak-systolic ventricular pressures (PSVP). (Data as
means..:t S.D,)
SF9I> PSVP PSSm PSSc
.!!!:l!.ntkIl !gj,m}l ~l
Controls 76..:t8 1.85..:tO,52 2.93..:t1.47 4.27..:t1.55
Experimantaf 53..:t12 1.85..:tO.48 3.35..:t1.86 4.57..:t1.25
% Change -30% ° +14% 7%pvaJue <:0.001 NS NS NS
ApproXimately 5091> 01 experimental embryos have aortic arch anomalies.
Although both PSSm and PSSc str"- ware greater In experimental
embryos, this difference was not statlstJcaily s1gnMlcanl. likewise. there
was no difference In PSVP between experimental and control embryos.
Therefore, the previously documented decrease In SF9I> In experimental
embIyos Is probably due to myocardial dysfunction and not due to
difference In wall stress from aortle arch artery anomalies.
JACC Vol. 13, No.2
February 1989: 119A
ABSTRACTS 119A
MECHANICAL F~CTION AND PALMITATE OXIDATION IN THE NEO-
NATAL PIGLET HEART DURING NORMOTHERMIC ISCHEMIA AND REPER-
FUSION.
Robert J. Ascuitto. M.D., Ph.D •• Nancy T. Ross-Ascuitto,
M.D •• Kathleen H. McDonough, Ph.D., Tulane and Louisiana
State University Schools of Medicine, New Orleans. LA.
Information is limited regarding substrate utilization by
the neonatal heart during ischemia and reperfusion. Left
ventricular peak systolic pressure (PSP). end-diastolic
pressure (EDP), coronary flow (CF), 02 consumption (MV02)
and palmitate oxidation (Ox) were studied in isolated
hearts from pigs less than 2 days of age. Paced. isovol-
umically-beating hearts were perfused with a non-recirc-
ulating, oxygenated buffer (37°C) containing: erythrocytes,
Hct 15%; glucose. 5mM and 14C palmitate. 0.5mM palmitate
bound to 2% albumin. Ox was determined from 14C02 produc-
tion. Each heart was studied for 30 minutes with the per-
fusion pressure (PP) 60 mmHg (control): 30 minutes with PP
12 mmHg (normothermic ischemia) and 30 minutes with PP
returned to baseline (reperfusion). Control values av-
eraged: PSP, 101±7 mmHg; EDP, 1.3±0.4 mmHg; CF, 3.7±0.2ml/
min/g; MV02. 81.5±8.5 ul/min/g and Ox, 28.8±2.1nmol/min/g.
During ischemia, these parameters decreased to 32±3 mmHg,
0.8±0.1 mmHg, 0.9±0.2 ml/min/g, 29.5±3.4 ul/min/g and 11.4
±1.0 nmol/min/g, respectively. Upon reperfusion, CF in-
creased two-fold and PSP 20% above control values and then
returned to baseline. No significant increased in EDP was
observed. Ox rates increased to control values by the
end of reperfusion. The influence of lactate concentra-
tion on palmitate Ox has also been examined. Thus, the
neonatal pig heart can utilize palmitate during low-flow
ischemia and reperfusion. and recovers mechanical function
following such an insult.
THE IMPORTANCE OF ANALYZING INSPIRATORY GASES
WHEN CALCULATING OXYGEN CONSUMPTION AND CARBON
DIOXIDE PRODUCTION DURING EXERCISE.
Gerald Barber M D. and Charles T. Heise, C.R.T.T. The Children's
Hospital of Philadelphia, Philadelphia, PA.
Accurate breath-by-breath (BBB) determination during
exercise of 02 consumption (V02) and CO2 production (VC02) is
valuable in: I) determination of the anaerobic threshold, 2) non-
steady state exercise (ramp) protocols, and 3) determination of the
time constants of the V02 and VC02 response to rapid changes in
workload. We compared 1161 BBB V02 and veo2 '/alues from 6
normal patients calculated using 3 different algorithms. In I
(reference method), measured inspiratory and expiratory °2, CO2,
and N2 content were used to calculate V02 and VC02. In II, V02
and VC02 were calculated ignoring inspiratory and expiratory N2
contents (which reflect changes in functional residual capacity) and.
in III, V02 and ve02 were calculated ignoring all 3 inspiratorygases. A paired t-test was used to compare II and III to I.
There was no statistical difference in the mean V02 or yeo?
at rest or any workload between the 3 algorithms. Methods II and II C
however, result in significantly greater BBB variability.
% BBB Variability
Workload V02 veo2
I II III I II III
Rest 39 206 3S 37 37 34
1st 17 S4 22 17 22 23
2nd 14 40 18 13 17 17
3rd 9 33 12 9 II II
We conclude that, due to the high BBB variability of methods
II and III, only Method I appears to be acceptable for BBB
determination of V02 or ve02.
The Impact of Medical and Surgical Therapy on the
Cardiovascular Prognosis of the Marfan Syndrome in Early
Childhood. Kenneth G, Zahka, M,D" Cathy Hensley,
Marshall Glesby, Reed E. Pyeritz, M,D, The Johns Hopkins
Hospital, Baltimore, Maryland
We determined the cardiovascular natural history and the
effects of beta blockade and surgery on 53 children
presenting in the first 4 years of life with the Marfan
syndrome, There were 24 sporadic (age 2.l±0,3 yrs) and 29
familial (age 1,9±0,2 yrs) cases, The mean follow-up for
both groups was 4,0±0,9 yrs, Ao root and LV dimensions
measured from M-mode echocardiograms were normalized for
age and body surface area by calculating the Ao ratio
(observed Ao/predicted Ao) and the LV ratio (observed
LV/predicted LV), Data: The Ao ratio at the time of
presentation was greater in the sporadic (1.43±0.33) than
the familial (1,28±0,2l) cases (p<0,025), The Ao ratio
increased during follow-up in both sporadic (1.59 ±0,42
p<0.05, n-22) and familial (1,35±0.14 p<0,025,n-21)
cases, There was no change in the Ao ratIo in the 4
familial and 6 sporadic cases on beta blockers for 3.3
±0,7 yrs (1,36±0,27 to 1.35±0,21). The Ao ratio in those
on no therapy increased (1,30±0,31 to 1,50±0,36, p<O,Ol).
The LV ratio in cases with no / mild mitral regurgitation
(MR) (all the familial and 15/24 sporadic) was 0.99±0,09.
The LV ratio was markedly increased (1. 31±0. 25) in 9/24
sporadic cases with moderate or severe MR. Of these 9, 5
had mitral valve (MV) replacement with one death, 1 had
MV and tricuspid valve (TV) repair and 1 had MV and TV
repair and aortic homograft replacement, The LV ratio in
the 6 survivors decreased to 1,08±0.11, p<0.001.
Conclusions' The cardiovascular complications of the
Karfan syndrome are often more severe in young children
with new mutations. Beta blockade has a preventive role
and cardiovascular surgery can be effective in the
treatment of young children with the Marfan syndrome.
Tuesday, March 21, 1989
4:00PM-5:30PM, California Room C
Anaheim Convention Center
Interventional Cardiology and Cardiac Surgery
in Children
USE OF BALLOON·EXPANDABLE STENTS TO TREAT EX·
PERIMENTAL PERIPHERAL PULMONARY ARTERY AND
SUPERIOR VENA CAVAL STENOSIS:PRELIMINARY EXPE·
RIENCE.
Albert P Rocchini MD, Jon N Meliones MD, Robert H Beekman
MD,FACC,C S Mott Children's Hospital, Univ of Michigan, Ann
Arbor,Mi
Current therapy for congenital or acquired stenoses of the pe-
ripheral pulmonary arteries (PPA) and superior vena cava
(SVC) is frequently ineffective. This report describes our initial
experience with the use of a balloon-expandable stent to treat
experimentally created PPA and SVC stenosis. Seven adult
mongrel dogs had surgically created stenoses of either a PPA
or SVC ( 5 Rt PPA, 1 Lt PPA and I SVC), A balloon-ex-
pandable stainless steel (0.076 mm) 3 cm long, intravascular
stent was used in all animal ( provided by Johnson and
Johnson Inc). Percutaneous placement of the stents was
performed using a 12·16 French 75 cm long sheath and a 8 or
18 mm balloon angioplasty catheter. Stents were successfully
placed in 4/7 animals ( 2 Rt PPA, 1Lt PPA and 1 SVC) with
hemodynamic and angiographic relief of stenoses in all. We
were unable to successfullyplace the stents in 3 animals with
verydistal Rt PPA stenosis due to inability to cross the stenotic
site with either the large sheath or angioplasty catheter.
Repeat catheterization performed six month following
placement of the stents, documented persistent gradient relief
and angiographic evidence of unobstructed flow through the
stent without evidence of thrombus formation. Our preliminary
experience suggests that balloon-expandable stents are a
potential alternative for the treatment of PPA and SVC steno-
ses,
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TRANSCATHETER UNBRELLA CLOSURE OF ATRIAL DEFECTS
James E Lock MD, Jonathan J Rome MD, Stanton B PerryMD,
John F Keane MD. Children's Hospital, Boston Mass,
We have modified the Rashkind double umbrella PDA tech-
nique to attempt closure of atrial defects (ASD) in 14 pts.
All but 1 had had prior surgery (Fontan, TOF repai~ Glenn,
etc); one pt had an ASD 20 and severe LV myopathy. Defects
were ASD 20 (n=5); SVC/RA defects post-Glenn(n=5) and post-
Fontan ASD(n=4). ASD size (Balloon sizing) ranged from 5
to 27mm; umbrellas(17-34mm) were chosen to have a stated
diameter of nearly 2x ASD diameter or larger. Twelve of14
pts were cyanosed, 2 pts had atrial arrhythmias (post-Fon-
tan) and 3 had strokes or brain abscess pre-umbrella.
Two defects(ll, 27mm) were too large to close with the
umbrellas available; the procedure was terminated without
umbrella release. All other ASDs were closed with a single
umbrella: no umbrella became dislodged, no arrhythmias oc-
curred, and no pt had vascular compromise. Angio/echocar-
diography suggested complete closure in 11/12 defects; 1
pt (post-Fontan) appeared to have multiple defects. All
but 1 (immediate postop) pt were discharged within 48 hrs.
Followup ranged from 2-39 months (m=lB mos) for a total
of 18 pt-yrs. No pt has had umbrella migration, umbrella-
induced dysfunction of great vessel or cardiac valve, endo-
carditis, brain abscess, or stroke. Two pts have had late
arrhythmias, both post-Fontan: l(with 2 limited episodes
of flutter) had atrial arrhythmia pre-umbrella, and 1
(with L-loop and an umbrella in the LSVC-LA junction) de-
veloped A-V block 2i years postop. No pt has had evidence
of recanalization. There have been no deaths.
These data suggest that modified double 'umbrellas to
close atrial defects are not associated with frequent
late complications. Trials of modified double umbrellas
in patients with uncomplicated ASD secundum would now
appear warranted.
EARLY EXPERIENCE WITH PULMONARY AUTOGRAFT USE FOR AORTIC
VALVE REPLACEMENT IN PEDIATRIC PATIENTS
Kent E. Ward, M.D., FACC; Edward D. Overholt, M.D., FACC;
Jerry D. Razook, M.D.; Webb M. Thompson, Jr., M.D., FACC:
Pa~l St~lzer, M.D., FACC; Ronald C. Elkins, M.D., FACC,
Unlverslty of Oklahoma, Oklahoma City, Oklahoma.
Initial results with use of pulmonary autografts (PA) for
aortic valve replacement (AVR) have been successful in
adults. We have used PA for AVR with combined homograft
replacement of the pulmonic valve in 15 children (age
range 2.6-17.1 yrs., mean=II.7 yrs.) since 11/86. In-
dications for AVR were severe aortic stenosis (AS)(n=2)~ortic insufficiency (AI)(n=6) or both (n=7). Six pat-'
lents (pts) had undergone one or more previous aortic
valvulotomies and 5 had undergone prior valvuloplasties.
PA's were performed using hypothermic circulatory arrest
with a mean aortic cross-clamp time of 119 min. and a
mean bypass time of 195 min. Most pts were extubated
within 24 hrs. (mean=12 hrs.) and the average hospital
stay was 8 d~ys. There have been no deaths nor early
thromboembollc events. Postoperative echocardiographic
assessment was performed in each pt from 0.1 to 15.4 mos.
after AVR. Aortic obstruction was significantly reduced
from 67±?2 mm Hg (pre-op) to 6±l0 mm Hg (post-op)
(p(O.OOI). One patient had significant residual trans-
pulmonary obstruction. Significant AI was found in 4 of
the first 5 pts and one of the following 10. Significant
pulmonic insufficiency was present in 1. Other major
complications were early cardiac tamponade in 1 and
postoperative complete heart block in 1. Our results
show PA replacement of the aortic valve in children can
be accomplished with a low mortality and morbidity. PA's
~h9wed good function after a short follow-up period. Sign-
lflcant AI may be a long term problem, but appeared to De
related to early surgical technique.
SURGICAL MANAGEMENT OF AORTIC ARCH OBSTRUCTION
AND TRANSPOSITION OF THE GREAT ARTERIES.
John E Mayer. Jr, M On FA C C , Gil Wernovsky, M.D, Richard A.
Jonas, M.D. and Aldo R. Castaneda, M.D., Ph.D., F.A.C.C.
The Children's Hospital, Boston, MA
Aortic arch obstruction (AAO) is an uncommon associated anomaly
in pts with transposition of the great arteries (TGA). Between
1/1/83 and 7/1/88, 14 pts with TGA and AAO underwent surgical
management by an arterial switch operation (ASO) and aortic arch
repair. Two pts had intact ventricular septum (IVS) and 12 had
ventricular septal defect (VSD) or double outlet right ventricle
(DORV). AAO was due to isolated coarctation (CoA) in II, CoA plus
severe transverse arch hypoplasia in 2 and type B interruption (IAA)
in I.
Both pts with IVS and I with small VSD had neonatal CoA repair
and ASO at 6d, 17d and 2 mos of age; I pt died. The two pts with
arch hypoplasia, CoA, and VSD were managed as neonates by one-
stage ASO, VSD closure and arch reconstruction via midline
sternotomy; both survived. Of the remaining 9 pts, 8 had neonatal
CoA or IAA repair with pulmonary artery banding (PAB) and
subsequent ASO at 4-28 mos of age, and I had neonatal PAB CoA
repair at 3 1/2 mos and ASO at 4 mos. All but I (with multi~le
VSD's) of these 9 pts survived.
Seven of 12 survivors have had follow-up cardiac catheterization.
None has significant (>15 mmHg) residual AAO, residual VSD or
"aortic" valve regurgitation. The remaining 5 pts have no clinical or
echocardiographic evidence of residual AAO or VSD.
The combination of TGA and AAO can be successfully managed
by an ASO and aortic arch reconstruction. Recent experience has
shown that ASO and arch reconstruction can be performed as a
single procedure for more severe arch anomalies or by staged
procedures during the same hospitalization for isolated CoA,
Follow-up has shown satisfactory early results up to 5 years
postoperatively.
ISCHEMIC TIME AND GRAFT FUNCTION IN HUMAN INFANT
CARDIAC TRANSPLANTATION
Mark M. Boucek, MD, Mohammad S. Kanakriyeh, MD,
Eugene L. Petry, MD, Leonard L. Bailey, MD, FACC'
The Neonatal Cardiac Transplant Program
Lorna Linda University, Lorna Linda, CA
Donor availability and the sensitivity of neonatal
myocardium to ischemic injury may interact to limit the
supply of infant cardiac allografts. To evaluate graft
function as related to ischemic time, we studied 21
consecutive infants «1 year) using echo indices of LV
f~n~tion post transplantation. All grafts were preserved
slmllarly and all patients were on cyclosporine immuno-
suppression without evidence of rejection. Fifteen grafts
harvested locally with a mean arrest time of 102+8.7 min
w:r: compared to 6 distantly procured grafts with a si9-
nlflcantly longer arrest time 282+57 min (276%, p<0.05).
Grafts were studied 7 and 30 days-after transplantation
and LV shortening fraction (LVSF), ejection phase ratio
(PEP/ET), isovolumic relaxation time (IVRT), mass, and
dimension were determined. In the local grafts the mean
LVSF at 7 days was 39~6%, the mean PEP/ET ratio was .32
~0.6 and the IVRT was 55+18 msec. These values were not
significantly different from the respective distantly
procured graft values of 37~7%, .39+0.5 and 69+48 msec.
At 30 days, graft function was stilT normal in-the local
group with a mean LVSF of 40+6%, a PEP/ET ratio of .28+
.05 and an IVRT of 53+16 msec, and these values were not
significantly different from the data on the distant
organs. There were 4 deaths (19%). Graft fail ure occur-
red with a similar frequency in both groups (13% vs 16%),
but was unrelated to ischemic time. We conclude that the
infant donor myocardium can tolerate an ischemic time as
long as 5 hrs and 40 min and still acutely function
adequately as an allotransplanted organ. These data indi-
cate a potential procurement range of 1500 - 2000 miles.
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VENTRICULAR SEPTAL DEFECT WITH AORTIC REGURGITATION: A 35
YEAR EXPERIENCE
L. Rhodes MD, J.F. Keane MD, J.P. Keane, K.E. Fellows MD
FACC, R.A.Jonas MD FACC. A.R. Castaneda MD FACC: The
Children's Hospital/Harvard Medical School, Boston, MA.
The purpose of this study was to review our experience
with 91 pts (33 females) with ventricular septal defect
(VSD) and audible aortic regurgitation (AR). Median age
of AR onset was 5 years (range 0.5-17). VSD location was
subpulmonary (SP) in 26% and subcristal (SC) in 65%. AO
valve was tricuspid in 88% and bicuspid in 10% (2 pts with
SP). Right coronary cusp (RCC) prolapse alone was present
in 60% (83% of SP, 59% of SC). noncoronary cusp (NCC)
alone in 12% (all with SC), and both RCC and NCC in 15%
(13% of SP, 19% of SC). AR progressed in 28 pts (40% of
SP, 33% of SC). 19 pts (7 with SP) have been followed
medically (median 15 years), degree of AR remaining
unchanged in 71% (including 2 with SP, each followed over
30 years). 72 pts underwent VSD closure, with
valvuloplasty (VP) in 47, valve replacement (AVR) in 15,
and alone in 10. There were 14 perioperative deaths, all
prior to 1973. Following VP, AR was absent in 13%. less
in 30%, unchanged in 21%. and more in 10% (3 pts required
AVR). AR improvement occurred in 58% of those < 10 years
old compared to 31% in those older. In those with AVR. AR
was absent in 60% and less in 27%; reoperation was
required in 3. In 8 survivors of VSD closure alone, AR
was absent in 4, less in 2, unchanged in 1, and more in 1.
Endocarditis (BE) occurred on 14 occasions in 13 pts.
Conclusions: VSD with AR is more common in males, VSD
location SC in most. median age of AR onset 5 years, and
BE is common. NCC prolapse alone is seen only in those
with SC. Degree of AR may remain mild for many years in
some, and complete relief is more common following AVR.
VP is more effective when undertaken in the first decade.
PORTABLE BYPASS DOES NOT IMPROVE SURVIVAL IN CARDIAC
ARREST PATIENTS
Renee~~ Joseph LoCicero, M.D., John Sanders,
M.D., James Frederiksen, M.D., Lawrence Michaelis, M.D.,
Northwestern University Medical School, Chicago,
Illinois .
Technical improvements in portable bypass systems have
led to a rekindling of interest in the use of
cardiopulmonary bypass as a resuscitative tool. In 16
months, 24 pts undergoing in-hospital CPR were placed on
bypass within 9 minutes (mean) from phone request (range
7-35). An average flow of 4.3 liters per minute (3-
5.2), was achieved using right femoral cutdowns and the
Bard (1lI CPS system. Etiology of cardiac arrest was
cardiogenic shock in 15 pts, metabolic in 2, septic shock
in 1, arrhythmogenic in I, iatrogenic in I, pulmonary
or amniotic fluid embolus in 3, and aortic dissection in
1. Of the 24 arrests, 18 occurred in the hospital.
Subsequent diagnostic/therapeutic procedures carried out
in 15 pts were: cardiac catheterization (7), other
supportive devices (5), coronary bypass (4), pUlmonary
artery exploration (4), valve replacement (2),
angioplasty (2), dialysis (1), and rewarming (1).
Although 12 pts pts initially regained brief cardiac
activity, only one (4%) achieved long-term survival.
Five additional pts (20%) were successfully weaned from
bypass and survived 2-10 days. Causes of death in the
remaining 18 pts were biventricular failure, brain death,
or a combination of these factors.
The dismal results in this series of resuscitations using
portable cardiopulmonary bypass indicate that despite
rapid implementation even for witnessed, in-hospital
events, survival is negligible if the technology is
employed after cardiac arrest occurs.
Intraoperative ma~guided laser photoablation (LP) during
ventricular tachycardia (VT) was performed on 72 VT morphologies
in 30 pts. Epicardial presystolic activity was recorded during
VT and epicardial LP was required to ablate at least one VT in
10 pts (33%). The purpose of this stUdy was to define anatomic
variables (infarct vessel and presence of aneurysm) associated
with the necessity of epicardial LP to terminate VT. Only pts
surviving 3 months were included.
Results:
CHARACTERISTICS OF PATIENTS REQUIRING EPICARDIAL VS
ENDOCARDIAL Nd:Y AG LASER PHOTOABLATION FOR
VENTRICULAR TACHYCARDIA - A THREE YEAR STUDY.
Robert H. Svenson MD, FACC, Laszlo Littmann MD, FACC, John
J. Gallagher MD, FACC, Jay G. Selle MD, Samuel H. Zimmern
MD, FACC, John M. Fedor MD. F ACC, Kathleen T. Seifert,
George P. Tatsis, Francis Robicsek MD, FACC, Sanger Clinic,
Carolinas Heart Institute, Heineman Medical Research Center,
Charlotte, NC.
LAD 16
Aneurysm 12 11 1
No aneurysm 4 4 0
LCX/RCA 14
Aneurysm 3 3 0
No aneurysm 11 2 9
TOTAL 30 20 10
Map guided epicardial LP was performed in 10/72 VT's (14%).
However, epicardial LP was required in 9/11 pts (88%) with LCX/
RCA infarction and no aneurysm vs in only 1/16 pts (6%) with
LAD infarct. Conclusions: The data suggest that VT ablation
procedures directed at the endocardium alone will have a high
failure rate curing all VT's in patients with inferior infarction
and no aneurysm.
Tuesday, March 21, 1989
2:00PM-3:30PM, Santa Ana Room 1
Anaheim Convention Center
Cardiac Surgery: Devices and Complications
FIRST HUMl\N USE OF '!HE HEHlRJMP, A CMHElHER-M:xlNl'ED
vmrRIaJI.AR lISSIST IEVICE
O.H. Frazier MD F1lCX:, Ridlard K wanpler MD,
J Midlael D.Jncan MD F1lCX:, wayne E Dear MD F1lCX:,
Midlael P Macris MD, Steplen M Pamis, John M F\lqUa
Texas Heart Institute, st. !JJke's ~i.scq:lal Hospital,
Halstal, TX
'nIe~ is a cathet:er-m:mrt:e, t:e1llorazy
ventricular assist device. It consists of an exten1al
electranedlani.cal drive console and a disposable,
intr.!-aortic axial flow p.mp (21 Frerd1). Pcweris
transmittecl to the p.mp perc:utaneoosly by a flexible
drive shaft within the catheter. 'nIe device is
positiQ'lSd in the left ventricle us~ a fenoral artery
cut-oown or via the ascen:iin;J aorta. Blood is withdrawn
fran the left ventricle~ the transvalvular inlet
canml.a and p.mped into the aorta. As of May, 1988, we
have successfUlly used the HeIncpmp in three cases of
cardiogenic shock. 'nIe first patient was a 61 year old
male cardiac allograft recipient with severe rejectioo1
the seccni patient was a 61 year old male with
hypotensioo and ca'geStive heart failure fol1~ a
myocardial infarctioo; the third patient was a 72 year
old fesnale with past-cardiotany syn:h'ane after~
aorto-ool:a1ary bypass. 'nIese patients were Sl.JRlOr1:ed by
the HeIncpmp for 2, 4, and 2 days, respectively. No
device-related ClCllplicatiCl'lS were en::oontered, incl.ucli.rq
no evidence of heIoolysis, t:hraJixlsis, or endothelial
injury. In the first and third patients, cardiac
functioo reoovered allow~ their eventual di.scharge.
OCIIC1usicaal 'nIe HeIIr.pmp provides effective, t:eqloraxy
ci.raJlatory~ in patients with potentially
reversible cardiac failure. It may be introduced with-
out a major SUl9ical procedure, and was well tolerated
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PREDICTORS OF DEEP STERNAL WOUND INFECflONS AFIl:R
CARDIAC SURGERY
William S Weintraub, M.D., FAC.C., Ellis L Jones, M.D, FAC.C., Joseph
M Craver, M.D., FAC.C. and Robert A Guyton, M.D., FAC.C.
Departments of Medicine and Surgery, Emory University School of Medicine,
Atlanta,GA
Deep sternal wound infections (DSWI) are a serious complication of open
heart surgery leading to further complications. To understand the clinical
characteristics that give rise to DSWI, all 34 patients with DSWI noted
between 9/1/86 and 3/31/S8 were compared with 105 randomly selected
undergoing cardiac surgery during the same time period. Results:
Infection No Infection P Value
Age 58±14 61±12 NS
% Male 85 n .09
%PostOPMI 8.8 3.8 NS
% Re-open for Bleeding 8.8 1.0 .02
% Prior Surgery 20.6 2.9 .0005
%IABP 14.7 1.9 .003
# Grafts 2.6±1.4 2.8±1.6 NS
%IMA 69 69 NS
Cross Clamp 'rime 44 43 NS
% Mortality 21 2.9 .0005
DSWI post-operalJvely represent one of the most setlOUS complicatIOns of
cardiac surgery and are associated with a significant mortality. DSWI is
associated with reoperation for bleeding and the use of the intra-aortic
balloon pump. Of great significance, DSWI are strongly associated with
previous cardiac surgery.
CEN'l'RAL NEUROLOGICAL CQlPLICATIONS AFTER CORONARY ARTERY
BYPASS: INFLUENCE OF MULTIPLE Ac:m'IC CRoss-<::LA/tlPING.
Abel Garibaldi, M.D., Joel Guillory, M.D., Aloysius Chen,
M.D., Zev Davis, M.D. cardiovascular-Renal consultants,
Blue Island, Illinois and Rush Medical College
Chicago, Illinois
A recent increase in the incidence of neurological ~li­
cations after coronary artery bypass (CAB) has been re-
ported and attributed to the increasing age of the patient
population being sUbmitted to this procedure. we randomiz-
ed our patients into two groups to study the influence of
some surgical techniques in the incidence and seriousness
of postoperative neurological conplications. Patients were
c:oaparable as far as sex, age, clinical condition, left
ventricular function and magnitude of the surgical proce-
dure. Patients with cerebrovascular pathology, intracavi-
tary clots and those requiring associated pt"ocedures were
not included. Group I consists of 231 patients operated on
by the traditional technique of multiple intermittent aor-
tic crosa-Clal11?ings (MIACC). Group II consists of 180 pa-
tients operated on with a single aortic crosa-elal11?
(SACC). There were five major and one minor strokes in
Group I (2.59%). Four patients with major strokes died.
Two minor strokes occurred in Group II (l.U%). There were
no deaths. The difference in major stroke.s between the
groups is both statistically (O.05)p)O.02) and clinically
significant. Although the patient population being submit-
~ed to CAB is growing older and, therefore, more suscept-
lble to a neurological complication, we believe that tech-
nical factors are stiU important in the incidence and
severity of this COllplication. The use of a SACC in CAB
has a significantly 8IlIilUer incidence of severe central
~urological COllplications when eatpared to MIACX::. This
dlfference is possibly due to less aortic trauma and to
the easier handling of intra-eavitary air.
OPmATIVE (3<H».Y) M::RrAL1Tl FOLt.CMIlG DIPLANI1d'.ICIf OF
'IHE AI11QlM'IC IMPIANI'ABIE CARDIOIJmIER~.
pooert D. bteJ,lor M.p., Claudio D. SdlI.qer M.D.,
Ancira C. '1haDaS R.N., Russell T. st:eirmlul M.D., Michael
H. I.ehmann M.D., F.A.C.C., Huper Hospital and wayne
state university, Detroit, Michigan.
Of 1545 pta un:lergoirq initial ilIp1antation ot an
autanatic ilIp1antal:l1e cardicnerter defibrUlator (AICD)
at 17 centers, we analyzed peri-eparative (op) deaths
Ioi'lic:h ocx:urred in 35 (2.3\) durirq the tirst 30 days
after surgezy. l\IIa'q cp-<1eath pta, 91\ were male: mean
age was 6O;t12 years; under1yirq heart cU.sease was
atheroeclerotic (ASHD) in 82t, dilated cardicmycpathy
in 12t, and misoel1~ in 6\; mean ejection tn.ction
(EF) was 26±12t (~ 10-5St); and ocncanitant cardiac
surgery (ClOl'ICCIII surg) was pertozmed in only 11t (and
consisUd ot r8vucu1arization [CABG) alane). A group
ot 440 randaD Jl,D-q)-death control pta had similar
characteristics except tor higher EP' (34±lst, p<O.Ol),
and~ ccncaa surg (44\, p<0.OO5, with CABG alone in
29t, anew:yslIl8CtaD alone in 4\, and both in 11t).
Amt:nJ the cp-deaths, 9 (26\) were sud&3rVc:axdillc, 16
(46\) non-sudden,IamUac and 10 (29t) ncn-cardiAc; 30
(86\) ocx:urred durin;r hospitalization. All 8
in-haipital sudden cp-deaths were c:1llIa to ventricular
tachyl::ardiaItibrillation (VI'/VP'), and in 3 (38t) cases
the AIalB were in a deactivated state at the time ot
~. Olnc1ysiqw: 1) 'Iha 3O-day cp-death lIlOrtality
toll~AIa>~ was tairly low (2.3t) in
this large pt p:p.Jlation; 2) cp-death was related to a
lIlOJ:a~ EP' and to 1_ c:x:ncc:a surq (CAM) va'
J'll:I'totqHSIIth cues, despite similar prwvalenca at ASIlD;
and 3)~ ot op-duths were 1IUl:lden, c:1llIa to
vrfVF, and associAt:..s with Utt:entionally deactivated
AICDS in several cases.
Tuesday, March 21, 1989
4:00PM-5:30PM, Santa Ana Room 1
Anaheim Convention Center
Surgery for Valvular Heart Disease
CYSTIC MEDIAL NECROSIS OF THE AORTA: NATURAL HISTORY
AND LONG-TERM FOLLOW-UP
Dominic L. Manalese, MD, Douglas S. Moodie, MD, M.
Goormastic, MPH, A. ~ovacs, BS. Cleveland Clinic
Foundation, Cleveland, Ohio.
Few studies have dealt with the natural history and
long-term follOW-Up of pts with cystic medial necrosis
(CMN). Ninety-three pts were diagnoll8d as CMN at the
Cleveland Clinic from 1963 to 1987 (72' Mles, mean
age 55 yrs, range 26-77 yrsl. All pts had a patholog-
ic diagnosis of CMN and none met the standard criteria
for the Marfan syndrome (MS). Seventy-three percent
of patients presented with a diastolic murmur and CXR
revealed a dUated aortic arch (49') and cardiomegaly
(6"). Eighty-seven· percent underwent cardiac cath-
eterization which del1lOnstrated aor tic root dilatation
(88'), aortic regurgitation (81'), aortic dissection
(4"), and CAD (36'). Ninety pts underwent surgery
Which inclUded aortic reconstruction and/or composite
graft repair (79'), AVR (72'1, and CABG (23').
Follow-Up was obtained on 90 of 93 pts (9") with a
length of fOllOW-UP of 0-137 months (mean 29 months).
Thirty-tour of 90 pts expired (range 29.9-74.9 yrs,
mean age 60.4 yrs). Ninety-tour percent of the known
causes of death were related to the cardiovascular
system. Sixty-five percent were the result at aortic
dissection, rupture, or sudden death. Ninety-six
percent of 55/59 survivors were MYRA punctional Class
I or II. overall estiJlated survival at 5 yrs was
57. U. The presence of a diastolic IIIlrllUr at initial
presentation was associated with a poor progn08is
(p-O .03). BecaU8e these pt8 lack the external
stigmata of the MS and hence identifiable markers for
aortic root disea8e, they present at an older age and
with advanced disease.
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UTILITY OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN
PATIENTS UNDERGOING CARDIAC VALVE SURGERY.
Khalid H. Sheikh MD, Norbert deSruijn MD, J.
Scott Rankin MD, Tom Stanley MD, Fiona Clements
MD, Walter Wolfe MD, Joseph Kisslo MD, FACC,
Duke University Medical Center, Durham, N.C.
The utility of intraoperative transesophaqeal
echocardioqraphy (TEE) was assessed in 154 pts,
out of a total 686 havinq cardiac valve surqery
between October 1985 - July 1988. All had 2-D
TEE imaqinq pre and post cardiopulmonary bypass
(CPS) with 103 also havinq TEE Doppler color
flow (CF) imaqinq. Surqical decisions based on
TEE were cateqorized as: (l)Preoperative unsus-
pected findinqs leadinq to modification of plan-
ned surqery, 18/154(12%); or a different opera-
tion, 11/154(7%); (2)Identification of inade-
quate initial repair resultinq in further opera-
tion, 10/154(7%); (3)Inotropic support for post
CPS LV dysfunction, 12/154(8%). Major surqical
decisions based on TEE were made in 41/154(27%)
cases with qreatest impact seen with TEE+CF in
mitral valve surqery, 27/64(42%). Risk of post-
operative complications (CXS) and death (DTH)
were related to post CPS LV function (LVF) and
residual valvular defects (RVD) noted by TEE:
LyF stable LVF decrease No RYP RYD
cxs 13/131(10%) 17/23(73%)* 17/95(18%) 6/7(86%)*
DTH 7/131(5%) 6/23(26%)* 5/95(5%) 3/7(43%)*
(*p<.05 for LVF decrease v. LVF stable and for
RVD v. No RVD). These data indicate that pre and
post CPS transesophaqeal color flow imaqinq is
useful in formulatinq surqical plan, a.sessinq
surqical results and identifyinq patients at
risk for post operative complications.
THE PULMONIC VALVE AUTOGRAFT: ECHOCARDIOGRAPHIC
FACTORS PREDICTING POSTOPERATIVE VALVE PERFORMANCE
Sunil B Lulla. MD, Steve M. Teague, MD, FACC, Mukesh K.
Sharma, MD, Wyatt F. Voyles, MD, FACC, Paul Stelzer, MD,
FACC, Kent Ward, MD, FACC, and Ronald C. Elkins, MD.
University of Oklahoma School of Medicine, Oklahoma City.
Autologus transplantation of pulmonic valves for
stenotic (AS) or regurgitant (AR) aortic valves is an
attractive alternative to prosthetic or heterograft valve
replacement, but predictors of surgical outcome have not
been explored. We hypothesized that preoperative (PRE)
echocardiographic match between the diameters of aortic
and pulmonic anuli would predict postoperative (POST)
valve performance. Seventeen patients (3 with pure AR)
of age 31±18 years underwent echo Doppler studies PRE
(4±4.days) and POST (62±60 days) to determine AS severity
(peak Doppler gradient), AR grade (Doppler halftime and/
or mapping; 1 to 4+), diameters of aortic (AVAN) and
pulmonary valve (PVAN) anuli, and DELTA (PVAN - AVAN)
("p<.OOl): DELTA
AS AR AVAN PVAN POST AR GRADE
(mmIIg) (+) (MM) (MM) 0,1+ 2,3+
PRE 52+31 1.8±1.3 23±4 26±4 5.5+4 -5+2"
POST 9±4" 1.2±0.8 21±3 26±4 - -
All AS patients had relief of obstruction, but POST AR
was recorded in all but two patients: 1+;11, 2+;2, 3+;2,
4+;0. Significant (2+,3+) POST AR was confined to
patients with significant PRE AR where AVAN»PVAN. Two
patients with acute severe PRE AR (4+) had minimal POST
AR where AVAN«PVAN (delta +10,+7). We conclude that
preoperative echo assessments of aortic and pulmonic
anuli diameters identify patients at risk for significant
postop pulmonary autograft regurgitation.
One CUSA pt had a TIA at 6 weeks, 1 OMNI pt had a
paravalvular leak, and 2 BAV pts required aortic valve
replacement. All other pts are well. At the critical
6 month point at which balloon valvuloplasties fail,
CUSA debridement is successful without increasing
stenosis or regurgitation. If these results extrapolate
to long term followup, CUSA will be an important
alternative to valve replacement for aortic stenosis.
IS ULTRASONIC DEBRIDEMENT OF AORTIC STENOSIS A RELIABLE
ALTERNATIVE TO VALVE REPLACEMENT?
Bruce P. Mindich, M.D., F.A.C.C., Theresa Guarino, B.S.
EdWard A. Fisher, M.D., Reidi K. Krenz, M.D., Enrico
Gonzales, M.D., Warren Sherman, M.D., F.A.C.C., Martin
E. Goldman, M.D., F.A.C.C., St. Luke's Hospital, NY NY
Ultrasonic debridement of stenotic aortic valves with
the Cavitron Ultrasonic Surgical Aspirator (CUSA)
effectively reduces transvalvular gradients and
increases valve area. However, since the longevity of
this procedure is unknown and because balloon aortic
valvuloplasty (BAV) begins to restenose at 6 months,
surgical debridement may also fail. Therefore, we
evaluated 17 pts who had CUSA for severe aortic
stenosis, 15 pts who had aortic valve replacement
(OMNI) and 18 pts who had BAV by clinical and echo
color Doppler exam. 11/18 BVA pts restenosed within
7.7 months. Late (6 month) followup was compared to
early (6 week) followup in the CUSA and OMNI groups for
a change in gradient (GRAD,mmHG), regurgitation on
scale of 0-4+ (REG), valve area (AVA, cmz), and NYHA
Class.
A COMPARISON OF THE GORLIN, CANNON, ANGEL AND HAKKI
EQUATIONS FOR THE DETERMINATION OF PATHOLOGIC STENOSIS
IN PORCINE XENOGRAFTS
Steven Khan, MD, Ray Cheng, Lawrence Czer, MD, FACC,
Richard Gray, MD, FACC, Aurelio Chaux, MD, Jack Matloff,
MD, FACC.
In order to separate normal (N) from stenotic (S)
Hancock and Carpentier-Edwards mitral valves, we
compared the hemodynamics of 131 measurements on 37
patients with Nvalves, evaluated postoperatively, and
16 measurements of 10 patients with S valves, evaluated
at catheterization. Effective orifice areas (EOA's)
were calculated from the Gorlin (G), Cannon (C), Angel
(A), and Hakki (H) equations. Valve resistance (R-mean
dias. pressure (P)/mean dias. flow, was also calculated.
Results: Avg. EOA's (cm2) (normal/stenotic)
Size Gorlin Cannon An,el Hakki Rxl00
27 1.8/.79 1.6/1.3 1.7 .84 1.7/.84 3.6/16
29 2.0/1.1 1.6/1.3 1.9/.99 1.9/1.1 3.1/9.1
31 2.4/.97 1.7/1.3 2.1/.88 2.1/1.0 2.8/14
/I overl p: 3 0 3 6 0
Nand S EOA's were siQnificantly different (P<.008).
Only the Cannon equatl0n and valve R separated the
valves without overlap. The Cannon EOA's, however, were
significantly higher than the other EOA's for stenotic
valves (P<.04). We conclude that parameters using the
simple ratio of flow and P are superior to those based
on the square root of P in separating normal from
stenotic valves. The use of the square root of P in
evaluating EOA (as done in G,H,A equations) diminishes
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PULMONARY HYPERTENSION IN SEVERE AORTIC STENOSIS: SIGNS,
SYMPTOMS AND SURVIVAL.
James Slater M.D. ,F.A.C.C., Evan Sehgal M.D .• James Post
M.D., Alfred Roston B.S., James Albanese B.S., Howard A.
Levite M.D.,F.A.C.C., Larry Chinitz M.D., F.A.C.C., Howa
Winer M.D. ,F.A.C.C., Aubrey Galloway M.D., Frank Spencer
M.D., Ephraim Glassman M.D., F.A.C.C., New York Universi
Medical Center, New York, New York.
To assess the potential adverse effects on operative mor·
tality of pulmonary hypertension (PH) in pts with severe
aortic stenosis (AS), 112 pts with a systolic PA pressun
greater than 50 (Grl) were compared to 112 randomly selec
ted age and sex matched pts with severe AS without PH (Gl
2). The incidence of diabetes, hypertension, renal and
pulmonary disease was similar in both groups.
Group I Group 2 .2
Peak systolic gradient 95±25 82±25 <0.001
LVEDP 30±8 20±7 <0.001
PA systolic pressure 69±16 3217 <0.001
Cardiac index 2.4±0.6 2.7±0.6 <0.001
Heart rate 83±17 72±13 <0.001
Aortic valve area 0.51±0.21 0.57±0.23 0.202
Gr 1 pts had more dyspnea and edema and less angina. LV
function was worse in Gr I. There was no difference in
coronary disease severity or history of prior infarction.
Neither operative mortality nor long-term survival by
life table analysis differed between groups (1 Yr Gr 1 =
69~ Gr 2=74%; 5 Yr Gr 1=52% Gr 2=61%). The presence of
severe PH identifies pts with more severe AS and worse LV
function, though the excellent operative and long-term
survival would encourage surgical intervention.
Tuesday, March 21, 1989
2:00PM-3:30PM, Santa Ana Room 2
Anaheim Convention Center
Cardiac Necrosis: New Insights into
Modulating Factors and Compensatory
Response
ENHANCED e-ADRENERGIC ACTIVITY IN NON-INFARCTED MYOCARDIUM
MAY CAUSE EXERCISE-INDUCED ST-SEGMENT ELEVATION IN OLD
MYOCARDIAL INFARCTION
Keizo Yamashita,M.D., Makoto Ohno,M.D., Yoshihide
Sakaguchi,M.D., Toshio Miyazaki,M.D., Kozo Takada,M.D.,
Hitoshi Kawabata,M.D., Kinji Ishikawa,M.D., Ryo Katori,
M.D., Kinki University School of Medicine, Osaka, Japan.
The exact mechanism behind exercise-induced ST-segment
elevation in old myocardial infarction (OMI) is still
unknown. In 7 closed-chest dogs transmural anterior wall
infarction was induced by inserting a gelatin sponge
embolus into the left anterior descending artery. One
week following recovery, three interventions were per-
formed; right atrial pacing (AP) alone, AP combined with
noradrenaline (NA) infusion and AP with methoxamine (MT)
injection. ECG, LV angiogram and blood pressures were
taken. AP alone did not result in any ST changes, but
AP~NA resulted in marked ST elevations. AP~MT again did
not result in any ST changes in spite of large increases
in LVEDP. AP~NA significantly improved LV ejection
fraction (b12.3%, p<O.Ol), while AP~MT resulted in marked
decreases (b21.6%, p<O.OI). In the analysis of regional
wall motion, AP~NA strongly enchanced radial shortenings
(b19.5%, p<0.05) in the non-infarcted area, but AP~MT
reduced these shortenings (bll.6%, p<O.05). The wall
motion of infarcted area did not show any changes by the
three interventions. Based upon these experimental
results, we performed isoproterenol (ISO) infusion in 5
OMI patients who exhibited exercise-induced 5T elevation
and suffered from single vessel disease. ISO exhibited
marked 5T elevations equivalent to exercise-induced 5T
elevations in all patients. These results suggest that
ST-segment elevation may be a result of hyperkinesia of
the non-infarcted areas, probably due to enhanced
e-adrenergic activity in normal myocardial cells.
Recent Exposure to Cigarette Smoke Increases Myocardial
Infarct Size
Robert C. Prentice M.D., Richard Carroll M.D., Patrick
J. Scanlon M.D., FACC, John X. Thomas Jr., Ph.D. Loyola
University Medical Center, Maywood, IL.
Cigarette smoking has been reported to increase the
incidence of myocardial infarction. To assess the
influence of a recent exposure to cigarette smoke on
infarct size, dogs (CS) were exposed to the smoke of 10
cigarettes in an inhalation chamber 1 Hr daily for 10
days. Mean blood nicotine (N) and carboxyhemoglobin
(CH) levels follOWing 1 Hr exposure to smoke were 45±4
ng/ml (mean±SEK) and 27±3' respectively. After 24 Hrs,
Nand CH levels had decreased significantly to 4±1 and
3±1, respectively. Control (CTRL;n-5) and CS (n-5; 24
Hrs. after the 10th smoke exposure) dogs were
anesthetized with Q·chloralose. Through a left
thoracotomy, the circumflex artery was isolated and
ligated 1.5 cm from its origin. After 6 Hrs, the area at
risk was defined by dye injection and the infarct size
was determined using standard triphenyl tetrazolium
chloride staining techniques. The area at risk (\ LV)
was similar between groups (CTRL:35±2, CS:37±3).
Infarce size (' of area at risk) was 24±5 in CTRL, vs.
46±6 in CS (p<0.025). Conclusions: 1) Recent exposure
to cigarette smoke significantly increases myocardial
infarct size. 2) This effect is present despite the
absence of elevated levels of Nand CH at the time of
infarction. Thus, the increased infarct size in the CS
group was not due to elevated circulating levels of M or
CH. The mechanism by which a recent history of smoke
exposure produces larger infarct size demands further
study.
THE EFFECT OF TPA ON KYOCAlUlIAL CELLS, THE NO-REFLOll
PHENOMENON, AND INTRAHYOCAlUIIAL HEKOlUUlAGE
Robert A Kloner M,D., Ph D FA C C , Kevin Alker,
Andrew Eisenhauer, M.D., F.A.C.C. Colin Campbell, Ph.D.,
Heart Institute, Hospital of The Good Samaritan, L. A., CA
While tissue plasminogen activator (TPA) is being widely
used for the treatment of acute myocardial infarction,
there is little information on the effect of TPA on the
myocardium. Some studies showed that TPA reduced infarct
size independent of its thrombolytic action; others
suggested TPA could worsen intramyocardial hemorrhage. Ye
assessed the effect of TPA in a 2 hour mechanical coronary
occlusion . reperfusion model in the anesthetized dog.
Either high·dose TPA (1.3 mg/kg) or saline was infused for
2 hours starting 30 minutes after coronary occlusion. The
extent of necrosis as a percent of the risk zone was
similar in TPA (44 ± 12%) and control groups (46 ± 12%).
Regional myocardial blood flow assessed with microspheres
remained depressed post reperfusion in both control dogs
(.27 ± .11 ml/min/gm in previously ischemic region versus
.75 ± .08 in nonischemic zones) and TPA-treated animals
(.20 ± .05 vs .. 76 ± .11). Hemorrhage occurred follOWing
reperfusion in both groups. Intramyocardial hemoglobin
levels were 16 ± 5 ug/mg in control and 12 ± 3 ug/mg in
TPA-treated infarcts compared to values of 6.5 - 7.0 in
noninfarcted regions. Microscopic evaluation revealed
intramyocardial hemorrhage in both groups without
extension of hemorrhage beyond zones of contraction band
necrosis. Neutrophil infiltration was prominent in both
groups. These results suggested that TPA does D2t have
any direct beneficial effects on myocardial cells (other
chan its ability to lyse proximal thrombi), does not
improve the no-reflow phenomenon by lysing microthrombi;
but importantly does not exacerbate intramyocardial
hemorrhage compared to mechanical reperfusion.
JACC Vol. 13. No.2
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DEFIBRINOGENATION REDUCES INFARCT SIZE IN A CANINE MODEL
OF ACUTE MYOCARDIAL INFARCTION
Mun Kyung Hong Mp and Thomas Aversano, MD
Johns Hopkins Hospital, Baltimore, MD.
It has been suggested that in the treatment of myocardial
infarction streptokinase (SK) may have beneficial effects
independent of its thrombolytic action. Since SK is also
a fibrinogenolytic agent, we studied the effect of
defibrinogenation (DF) alone on infarct size (ISZ). 18
open-chest dogs were pretreated either with 4 unitsjkg of
Arvin IV (a defibrinogenating extract of Malayan Pit
Viper venom) or with saline IV over one hour (N-9 in each
group). The left anterior descending artery was then
occluded for 4 hours. The fibrinogen level in the Arvin-
pretreated (APT) group was undetectable. Otherwise there
were no differences in heart rate, blood pressure, or the
hemogram between the two groups. Coronary flow was
measured with microspheres. The risk region was defined
as the mass of myocardium whose flow at the onset of
occlusion was < 50' of pretreatment flow and infarct was
defined by lack of triphenyltetrazolium staining. ISZ
expressed as a percent of risk region was 44 ± 9 , in
controls and 14 ± 6 , in APT dogs (P<.02). In the control
group ISZ was related to flow in the most ischemic
regions of the infarct (Qinf) (ISZ - -3.5Qinf+69, P<.05),
while in the APT group infarts were almost uniformally
small. We conclude that preocclusion DF with Arvin
reduces infarct size in this 4 hour occlusion-no
reperfusion model of myocardial infarction. While
improvement in coronary collateral flow in
defibrinogenated animals cannot be completely ruled out
as a contributing mechanism of salvage, it does not fully
account for the profound infarct size reduction observed.
MJRFH}£'IRlC MAPPIN; OF REGIOOAL DIFFEREtaS IN MYOCYlE DIAI£'IERS AF1ER
IlEA'l.IN; OF MYOCARDIAL INFARCITOO. Marilyn Calc !!:Q:.. IIWin I!erman Ph.D.,
Marcel StEts, R.J. Myerlxlrg M.D., FNX, Patricia Kozlovskis, Ph.D.
University of Miami, Miami, FL.
This study \o6S desiglai to measure myocYte ctianeters in 2 healed
myocardial infarct (1tIl) IIIJde1s to test the hypothesis that myocyte
hypertrophy is a fuoction of proximity to the infarct. LV translLlI'al
(T, ,,"3) or noo-translllJl"al (Nr, ,,"2) MI's Itel'e produca:l in cats. At 13-
20 IIKlllths after surgety the LV free ..wJ. \o6S cut into ~tu:Iinal
sections. Myocardial cell ctianeters ~re measured fnm apex to base
through the infarct. No regional differences ~re fan! in control (C)
heartS"~N-4~'1O.7~.9u),._., a. B r
llu .-_11II_ i." ..
j ~ j".lo.Ij
3'0.. 31..._..,........r -"t--rl-o-T........
u. " ...... '" • • t.,~.--;-;,,-:.;--;.::-.::--::.-:.~,.- ~- - ~ ~~ ~
Non-TraIlSlllJl"al (Nr) Transaural. (T)
Fieldll Tissue Cell D1areter (u) Fieldll Tissue O!ll DiaDeter (u)
1 NI 12.5:U.4* 1 I 16.m.7*
13 NI ll.9±1.7* 7 I 16.2j().9*
28 I ll.8:!.O.6* 13 I 14.914.5*
32 I 15.3!:1.8* 15 I 2O.11~.4*
36 I 16.8t1.6* 41 I 14.8:!:l..4*
~ I 13.~O.8* 53 NI 13.8:!:l..5*
50 I 13.2!:1.4* 57 NI l4.3:!:2.3*
59 I 11.3!:1.9 63 NI 14.4:t1.6*
In the Nr preparation (pmel A) cell diameters ~re sf8pificantly
increase:I (P<O.05, Table) in apical noo-infarcted tissues (NI), and in
cells fI'llll infarcted areas (NI) relativ<! to C. Cells in fields tOlmds
the base ~re rot different fI'llll C. In the T preparation (panel B).
all fields had significantly increased cell diameters (Table). It is
cmcluled that T and Nr ItIl create a gradient increase in myocyte
diameter. am that the increase is greatest in tissues adjacent to the
00.
DELAYED SWITCH OF MYOSIN HEAVY CHAIN GENE EXPRESSION IN
THE RIGHT VENTRICLE AFTER EXPERIMENTAL INFARCTION IN THE
RAT
Stanley A. Rubin M,D .. F.A.C.C .• Adele El Kareh M.D.,
Ph,D., Cedars-Sinai Medical Center and UCLA School of
Medicine, Los Angeles, CA.
a II a II
Sham 0.66 0.34 0.80 0.20
1 week 0.37 0.63 0.88 0.12
5 week 0.38 0.62 0,59 0.41
In the LV the switch of MHC gene expression was within 1
week, whereas the switch in the RV was delayed.
Conclusion; There are early shifts in MHC gene expression
after MI that are specific to the LV and only subsequent-
ly involve the RV. This suggests that locally acting fac-
tors (possibly humoral or hemodynamic) are capable of
specific alteration of MHC gene expression after MI.
Tuesday, March 21, 1989
4:00PM-5:30PM, Santa Ana Room 2
Anaheim Convention Center
Non Invasive Diagnosis of Coronary Artery
Disease
LIMITATIONS OF EXERCISE THALLIUM SINGLE PHOTON
TOMOGRAPHY EARLY AFTER MYOCARDIAL INFARCTION
Robert J. Burns, M.D., F.A.C.C., Michael R. Freeman,
M.D., F.A.c.c., Peter [lU, M.D., F.A.C.C .. Firind Cox,
B.Sc., Christopher D. Morgan, M,D., Paul W. Armstrong,
M.D., F.A.C.C., and the TPAT Study Group, University of
Toronto, Toronto, Canada.
Assessment of perfusion after thrombolytic therapy for
myocardial infarction (MI) is key to evaluation of this
and subsequent therapy. We performed symptom-l imi ted
Bruce exercise (time 7.2*2.7 min, peak double product
22.5*6.6xlcrmmHg/min, mean*SD) thallium tomography (Tl-
SPECT) on day 8 and coronary angiography on day 9 in 47
patients randomized to tissue plasminogen activator or
placebo. Tl-SPECT was analyzed visually by 2 blinded
observers and quantitatively by comparison of polar
plots to normal data. Defects were localized to
anterior descending, circumflex and right coronary
distributions. Sensitivity and specificity for
detection of stenoses !o50% in MI and nonMI vessels
(per ECG) were compared to those in 107 an9ina
patients (CONTROL): CONTROL STUDY VESSELS
VESSELS MI nonMI
SENSITIVITY - visual; -:rs--.93--:1I*
- quantitative; .84 .95 .35*
SPECIFICITY - visual; .82 .50 .84
- quantitative; .82 .14 .79
*p~O.005 compared to CONTROL
Early after MI Tl-SPECT has reduced sensitivity for
localization of CAD in nonMI vessels. Possible
mechani sms inc1ude i nadequate exerci se by some
pati ents and that defects ari si ng from nonMI vessels
can be contiguous with MI segments. Reduced specificity
in MI vessels is to be expected when MI's are followed
by clot lysis leaving ~50% residual stenoses.
LVGroup
Infarction imposes an immediate hemodynamic burden on
the LV, but the effects on the pulmonary circulation and
RV are delayed. We examined the effects of myocardial
infarction (MI) on LV and RV cardiac myosin heavy chain
(MHC) gene expression. Mature female rats were sacri-
ficed one week after MI (5 rats) five weeks after MI (5
rats) or after sham procedure (4 rats). Cardiac expres-
sion of the beta and alpha mRNA transcripts of MHC was
examined in the uninfarcted portion of the LV and in the
free wall of the RV by solution hybridization/S1 nucle-
ase protection assay with a radiolabelled DNA rat probe
specific for MHC, electrophoresis in polyacrylamide
gels, autoradiography and densitometry.
Fraction of MHC
RV
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DIPYRIDAMOLE-INDUCED KALPERFUSION MAY NOT INDICATE
ISCHEMIC VENTRICULAR DYSFUNCTION.
Marvin W Kronenberg M D" F.A C C, Christopher U.
Cates, M,D" H, Wade Collins, M,D" Martin P, Sandler,
M,D., Vanderbilt University, Nashville, Tennessee,
Dipyridamole (D) produces myocardial malperfusion, but
malperfusion may not cause ischemia, To evaluate this
disparity we compared signs of ischemia on D-radionuclide
ventriculography (D-RVG) to malperfusion on D-thallium
(D-TL) in 28 patients (pts), 19 with coronary artery
disease (CAD) (;::50% stenosis, no Q waves) and graded
results blindly, Seventeen of these pts had severe CAD
(;::50% left main (LM) or ;::70% other vessel (V) stenosis),
Failure to increase ejection fraction (EF) ;::4%, decrease
in regional wall motion (RWH) (6 point scale) or
reduction in TL score (RTS) by ;:: 1 unit (4 point scale)
were abnormal responses. Sensitivity (sens) and
specificity (spec) for severe CAD were calculated:
ABNORMAL RTS RTS RVG
RESPONSE' ~l 0 ~l 5 EF RWM
;::1V CAD;::70% N
%sens/spec: 17 88/27 41/91 63/91 53/91
3VCAD,LM
%sens/spec: 5 80/17 40174 100173 60170
Markedly abnormal D-TL (RTS;:: had low sensitivity but high
specificity for severe CAD. Definitely abnormal D-TL
(RTS;::l) had high sensitivity, but very low specificity,
Malperfusion was common (23/28 pts) but overestimated
ischemia as defined by RVG: of 23 positive TL, only 13
had abnormal RVG; but 12/13 had CAD. Thus, malperfusion
on D-TL overestimates the frequency of severe CAD, and
reduced perfusion on D-TL does not always indicate
myocardial ischemia, D-RVG can identify severe CAD with
good sensitivity and high specificity using the
principles of ischemic ventricular dysfunction rather
than malperfusion.
EXERCISE RADIONUCLIDE ANGIOGRAPHY YIELDS PROGNOSTIC IN-
FORMATION EQUIVALENT TO CARDIAC CATHETERIZATION
Kerry L Lee. PhD, David B Pryor, MD, FACC, Karen S Pieper,
MS, Frank E Harrell Jr, PhD, Robert MCaliff, MD, FACC,
Daniel B Mark, MD, Mark A Hlatky, MD, FACC, R Edward
Coleman, MD, Frederick R Cobb, MD, Robert HJones, MD,
FACC. Duke University Medical Center, Durham, NC
To determine the prognostic importance of exercise
radionuclide angiography (RNA) testing relative to non-
invasive clinical assessment (Clin) and the results of
cardiac catheterization (Cath), we studied 571 consecutive
medically treated patients (PTS) with coronary artery dis-
ease (~75' stenosis) who had rest and exercise RNA within
three months of Cath. All PTS were followed ~3 years, and
90 PTS have died from cardiac causes. Using the Cox pro-
portional hazards model, 17 RNA variables were examined,
including rest and exercise ejection fraction (EF), heart
rate, wall motion, blood pressure, exercise ECG changes,
exercise induced angina, and exercise time.
The most important RNA predictor of survival was ex-
ercise EF (X2.81, p<.OOOI). Also contributing independent
information were resting end systolic volume index and
change in heart rate with exercise. The relative prog-





Clinical and Cath 121
Clinical and Cath and RNA 134
RNA provided prognostic information equivalent to Cath
alone, and 85' of the combined information provided by
Clin and Cath. In conclusion, descriptors from RNA are
powerful predictors of survival. Furthermore they can'help
define risk even when clinical and Cath variables are
known.
PROGNOSTIC VALUE OF INTRAVENOUS DIPYRIDAMOLE THALLIUM
IMAGING IN ASYMPTOMATIC PATIENTS WITH CORONARY DISEASE
AND NO PREVIOUS MYOCARDIAL INFARCTION.
Liwa T. Younis, M.D., Ph.D., Sheila Byers, R.N., Leslee
Shaw, M.A., Grace Barth, R.N., Henry Goodgold, M.D.,
Robert D. Wiens, M.D., FACC, Bernard R. Chaitman, M.D.,
FACC, St. Louis University Medical Center, St.Louis, MO
Of the 4 group 2 pts who died or had an MI, 3 had a
reversible and 1 a fixed thallium defect.
Thus, a normal I.V, dipyridamole thallium test in an
asymptomatic pt with documented coronary disease is
associated with an excellent prognosis and no need for
revascularization therapy. An abnormal test is
associated with a significantly increased risk of
cardiac events raising the possibility of silent
myocardial ischemia in these otherwise asymptomatic pts.
We studied the prognostic value of I.V. dipyridamole
thallium imaging (DPT) in 60 asymptomatic pts without
previous myocardial infarction who had angiographically
documented coronary disease (>50% narrowing) and who
underwent the test as part of-a preoperative risk
assessment or inability to exercise. The DPT was
normal in 28 pts (group 1) and abnormal in 32 pts
(group 2): 22 and 10 group 2 pts had a reversible and
fixed defect respectively. The average follow-up
duration was 13+10 months. Cardiac events were defined
as death (D), nonfatal myocardial infarction (MI),
angina (A), or a revascularization procedure (R). The




COMPUTER ANALYSIS REDUCES INCIDENCE OF FALSE POSITIVE
EXERCISE TESTS IN MIDDLE AGED WOMEN. Ann D. Walling
~, Michael H. Crawford, M.D., F.A,C.C. University of
Texas Health Science Center, San Antonio, TX.
TE Criteria Specificity
Standard ECG 10/18 (55%)
HTES score 16/18 (89%)*
*p<,02, McNemar test
We conclude that in middle-aged women obesity limits the
applicability of HTES, but in those with valid tests,
HTES reduces the incidence of falsely positive treadmill
exercise tests in comparison to standard ECG criteria.
The frequent occurrence of false positive treadmill
exercise (TE) ECG tests in women limits their value for
the detection of coronary artery disease (CAD). In men,
computer derived ST area measurements [Hollenberg TE
score (HTES)] improve diagnostic accuracy of TE, but
this commercially available analysis program has not
been evaluated in women. Thus, we studied 40 women aged
54±8 (SD) years, without prior myocardial infarction
with suspected CAD because of chest pain syndromes. The
majority (75%) were hispanics with a history of typical
angina (69%) and were menopausal with 2 or more risk
factors for CAD. All underwent Bruce protocol TE and
coronary angiography. The HTES was invalid in 11 (27.5%)
because of insensitive leads due to ECG low voltage.
The mean percent ideal body weight in women with a valid
HTES was 142% compared to 179% in those with insensitive
leads (p<,OOl). In the remaining 29 coronary arterio-
graphy revealed normal coronaries in 14 and stenosis
diameter <50% in 4 (normals, n-18); 1 vessel disease in
2 and 2-3 vessel disease in 9 (CAD pts, n-ll). Below
are the results of HTES versus standard ECG analysis for
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EXERCISE SEISMOCARDIOGRAPHY FOR DETECTION OF
CORONARY ARTERY DISEASE: A PRELIMINARY REPORT
David M Salerno. M D Ph D F A C C . John Zanetti, M.S., Irvin
Goldenberg, MD.• F.A.C.C., Robert A. Van Tassel. M.D.,
F.A.C.C.• Hennepin County Medical Center. University ofMinnesola,
and the Minneapolis Heart Institute, Minneapolis, Minnesota
Seismocardiography is a new noninvasive test for the detection of
myocardial ischemia. Based on techniques from the field of
seismology, the method analyzes the compression waves transmitted
from the heart during its movement. We hypothesized that patients with
significant coronary artery disease would develop a change in left
ventricular function during exercise that would alter the compression
waves recorded by the seismocardiograph. To test this hypothesis, we
recorded the seismocarWograrn befote, immediately after, and 5 minutes
after exercise in 32 patients (age 61 ± 9, 25 males) undergoing graded
treadmill exercise with 12·lead ECGs obtained each minute. The
patients also had coronary angiography, enabling calculation of
sensitivity and specificity for the detection of coronary disease (~ 60%
stenosis). We detected reversible changes in the seismocardiographic
waves in some patients immediately after exercise, defmed as abnonnal.
Abnormal ECGs had ~ I mm horizontal or downward ST depression.
Sensitivity Specificity
NONHOMOGENOUS REDISTRIBUTION OF REGIONAL MYO-
CARDIAL BLOOD FLOW AND POTASSIUM DURING REPER-
FUSION OF ISCHEMIC MYOCARDIUM
Robert J. Hariman, MoD, F.A.C.C., Eric K. Louie, MoD.,
F.A.C.c.. Abe F. Go~m, B.S., Rick L. Krahmer, M.S.,
0BrreU P. Preche1, u.s.. James L. Fergu.m, Ph.D., Ulivenity
of nIlnois, O1icago, nIlnois
To better understand the mechanism of reperfusion (RP)
arrhythmias, we measured left ventricular mid-wall extracellular
potassium concentration (I<+l» using up to 1.5 Hill K-sensitive
electrodes and correlated the data with regional myocardial
blood flow (RMBF) measured using multiple 1.5 JI radioactive
microspheres during control, 20 minutes of left anterior
descending (LAD) coronary artery occlusion, and after I minute
of RP in 9 dogs. RMBF was calculated in up to 30 pieces of 0•.5
to 1•.5g full thickness myocardial tissue in and around the left
ventricular area supplied by the LAD. At the end of 20 minute
LAD occlusion, an area of ischemia (ISCH) with RMBF <.50% of
normal RMBF resulted in an increase in [K+lo from 4•.5 ! 0.7
mEq/1 to 13•.5 ! .5.8 mEq/1 (p < 0.000, with a trend towards
higher (K+lo in the center of ISCH and lower [K+l> in areas
adjacent to the areas with normal RMBF. Electrograms in the
area of ISCH showed diminution of amplitude and fractionation.
After I minute of RP, RMBF map showed islands with various
degrees of increase in RMBF ranging from three to six times of
normal RMBF. The nonhomogenous RMBF during RP caused
different ra~s of normalization in [K +lo resulting in areas of
high [K+l> in juxtaposition with areas of lower (K+lo and an
increase in (I<+l> gradient between adjacent areas. Different
rates of normalization in (1<+] 0 also resulted in different rates
of normalization of fractionated electrograms. Nonhomogenous
reactive hyperemia during RP and the concomitant variability in
clearance of (I<+l> (and other metabolites of ISCH) may be
important in the genesis of RP arrhythmias.
REPERFUSION ASSOCIATED VENTRICULAR FIBRILLATION:
POTENTIATION BY LEFT VENTRICULAR HYPERTROPHY DESPITE
LIDOCAINE PRETREATMENT.
Anne Taylor. M.D •• F.A.C.C .• Robert Winter. M.D •• Sidney
Murphree. M.D •• Robin Eckels. Patricia Pastor. M.S •• Mark
Kremers. M.D •• F.A.C.C. University of Texas Southwestern
Medical Center. Dallas. Texas.
While left ventricular hypertrophy (LVH) has been
associated with an increase in sudden death during
coronary artery occlusion (CAO). an influence of left
ventricular hypertrophy (LVH) on reperfusion (R)
arrhythmias has not been previously noted.
Hypothesis: LVH potentiates reperfusion arrhythmias.
Protocol: Fourteen awake. unsedated dogs with
renovascul ar hypertension LVH and 9 control (C) dogs
underwent 15 min CAO and R. Prior to CAO. all dogs were
pretreated with four lidocaine (L) boluses 0.5. 1.0.
0.8. 0.8 mg/kg) at 15 min intervals followed by
continuous IV infusion (2 mg/min) during CAO.
Hemodynamics and ECG were measured continuously and
regional myocardial blood flows were obtained.
Results: 1. Reperfusion ventricular fibrillation (RVF)
immediately at reflow was increased in LVH versus C (5/14
vs 019. p=0.059). 2. L pretreatment abolished arrhythmias
during ischemia in 9/9 C and 13/14 LVH. and prevented RVF
in C dogs but not in LVH. 3. The ratio of heart weight
(g) to body weight (Kg) was increased in LVH compared to
C (5.0±.0.7 vs 4.2±.O.7. p=0.OI4). 4. Significantly
increased heart rate at 15 min CAD was the only
hemodynamic variable differentiating survivors (LVH or C)
from those with RYF.
Conclusions: 1. LVH potentiates RVF in this model. and.
2. lidocaine pretrea~ent protected all C dogs and 13/14
LVH dogs from VF during CAD. but it did not prevent RVF
in LVH dogs.
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DElAYED VEliTJ.IClJlAJl ARllHYTHKIAS (PHASE 18) RESULTING FROK
KIDKYOCAlUlIAL UE!l'l'RY
Eugene Patterson Ph D, Benjamin J. Scherlag, Ph.D.,
F.A.C.C. University of Oklaholla Health Sciences Center and
Veterans Administration Medical Center, Oklahoma City,
Oklahoma
SUSTAINED REENTRANT ACTIVATION ORIENTS AROUND ARCS OF
ABRUPT FUNCTIONAL CONDUCTION BLOCK IN THE CANINE POST-
INFARCllON HEART.
Nabll EI-Sherif MP FACC. Mark Restivo PhD, Celvin Williams
MD, Raphael Henkin MS,Wiliiam B. Gough PhD. State University
of New York, Health Science and VA Medical Centers, Brooklyn,
New York.
Sustained monomorphic ventricular tachycardia due to circus
movement reentry could be Induced In the surviving epicardial
layer 3-5 days following left anterior coronary artery occlusion
In the dog heart. The reentrant circuit bas a figure 8
configuration In the form of two circulating wavefronts oriented
around two sepearate arcs of functional dlssoclatton. The arcs are
usually aligned parallel to epicardial fiber axis. The arcs has been
ascribed to functional conduction block or to 'pseudo block'
created by very slow conduction across fiber axis relative to
faster conduction along fiber axis, I.e. anisotropic conduction
properties. Both conclusions were based on relatively low density
mapping of epicardial activation (3 to 8mm Interelectrode
distance). We investigated the nature of the arc using high density
recording (1 mm intereleetrode distance) and found evidence of
abrupt (within 1 mm) conduction block across the arc. Two
distinct deflections were seen In electrograms recorded on
opposite sides of the arc; one represented local activation and the
second, an electrotonus corresponding to activation recorded 1 mm
away. Both deflections were separated by a vartable Isoelectrlc
period which correlated wfth the Isochronal dlfferenca across the
arc. In recordings obtained from the center of the arc, local
activation and electrotonus were separated by 90 to 110 msec.
Thls Interval successively decreased towards both ends of the arc.
We conclude that In the canine post-Infarction heart ctrcus.
movement reentry Is sustained around a continuous arc of abrupt





COllposite bipolar electrodes were used to record from
epicardium (EPI) and midmyocardiUli (MID) during ventricular
arrhythmias observed after anterior descending coronary
artery ligation (CAL) in dogs (N-13). Ventricular arrhyth-
mias observed during the first 10 min after CAL were
preceded by progressive activation delays in EPI and were
accompanied by continuous electrical activity in EPI.
Arrhythmias resolved with the loss of late EPI activation.
Delayed ventricular arrhythmias (DVA) observed 15 to 30 min
after CAL were preceded by progressively delayed activation
in ischemic zone KID exceeding delays observed on the
corresponding EPI. Premature ventricular beats, couplets,
and tachycardia during DVA were
accompanied by continuous elec-
trical activity in KID bridging
the preceding diastolic
interval. DVA were observed
only when delays in KID were
_ '0 LCX OELAV greater than 130 msec. DVA
~ $0 lIiHU1f1i11i1l1fiHIUlIlf11i subsided with a partial
5'0 1 f 1reso ution 0 de ayed
activation in KID. Delayed
activation in KID was distinct
from delay in EPI since KID
delay always exceeded delay in
EPI during OVA. The data
suggest that DVA after CAL
result from late activation and localized reentry within
acutely ischemic lIidmyocardiUli.
TIlE REGIONAL ELECIROPHYSIOLOGICAL EFFEcrS OF
STELLATE STIMULATION ON INFARCTED MYOCARDIUM
Dayid Newman MD, Luisa Munoz MD, Michael Chin, John Herre
MD FACC, Michael Franz MD, Elias Botvinick MD FACC, Melvin
M.Scheinman MD FACe, Michael Dae MD. University of
California San Francisco, California.
Denervation due to myocardial infarction (MI) may relate to
the development of post MI arrhythmias. To examine the
effects of coronary occlusion on necrosis and sympathetic
denervation we studied 8 open chest dogs 2 weeks after left
anterior descending artery ligation. The monophasic action
potential (APD) at multiple epicardial sites was recorded
before and after left stellate ganglion stimulation (SS). Heart
slices were imaged after the administration of 1123 _
metaiodobenzylguanidine (MIBG) and Tl201 to detect
denervated but viable myocardium. .~: All had small
sized infarctions (mean 3% of total heart weight). In all cases
denervated regions extended beyond the planimetered infarct
margins, reaching 18% of total area. In the absence of SS
there were no differences in APD between normal and
denervated areas. SS induced shortening of APD at 20% (p<.OS)
but not at 90% repolarization (APD90) in normal areas only. In
denervated areas there was no SS induced change in either
APD measure. There was a trend for ERP shortening to be
greater in normal than denervated areas during SS. 55
induced lengthening of APD90 was frequently due to after-
depolarizations delaying final repolarization. During 55
ventricular ectopy occurred in all dogs and ranged from
single ectopic beats to fibrillation in 2. Conclusions:
t. Myocardial infarction (MI) produces scintigraphic
demonstration of denervation that exceeds the anatomical
area of infarction. 2. The effects of SS on APD heterogeneity
and on induced afterdepolarization may be important in
understanding post MI arrhythmogenesis.
Tuesday, March 21, 1989
4:00PM-5:30PM, California Room B
Anaheim Convention Center
Basic Electrophysiology: Cardiac Conduction
EVIDENCE FOR TWO TYPES OF SODIUM CURRENTS IN ISOLATED
NEONATAL AV NODAL HEART CEllS.
Jeffrey P. Hoak. MD. FACC; Diana l. Kunze, MD.
Texas Children's Hospital, Houston, Texas.
Enhanced AV nodal conduction, observed in newborn
animals, may result from developmental difFerences in the
typea of inward depolarizing currents present. Sodium
(Na) channels have previously been identiFied in AV nodal
cells. Our purpose was to Further characterize the
properties of the sodium current present in isolated AV
nodal cells From the newborn rabbit heart. AV nodal
cells were prepared by enzymatic isolation and cultured
in DME-F12 media. Whole cell voltage clamp was performed
using the gigasea1 technique. Na currents were examined
in a bath solution containing in mM: 107 NaCl, 1
MgCl2' .02 CaCl2' 10 glucose, 10 Hepes, 30 TEA, and 5
4-AP. The pipette contained in RIM: 124 CsCl2' 1
CaCl2' 2 MgCl2' 10 Hepes, and 11 ECTA.
Our results showed: 1) Under these conditions, a rapidly
activating inward current was present in 95' of the
cells. 2) A second component to the Na current was
identiFied after TTX application. The remaining Na
current (TTX-resistant) was 121 of the peak Na current in
10-5M TTX. 3) The TTX-resistant Na current was
suppressed by Cd 0.1 mH, and nimodopine 10-6 to 10-7M.
The reaponse to nimodopine 10-8M was biphaaic, consistent
with a mixed agonist/ sntagonist effect. In 50S of the
cells studied, nimodopine 10-8M incressed the
TTX-resistant Na current, in the other half it decreased
the TTX-resistant Na current.
We conclude thst there are two· components to the Na
current in neonatal AV nodal cells; one TTX sensitive,
and the other resistant.
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IDENTIFICATION OF PUTATIVE INTRAMURAL CONDUCTION CELLS
IN CANINE LEFT VENTRICLE
Robert H. Hoyt, M.D. and Jeffrey E. Saffitz, M.D.,
Ph.D., F.A.C.C., Washington University, St. Louis, MO
We have identified morphologically distinct cardiac
myocytes in canine epicardium and mid-myocardium that
differ markedly from common ventricular myocytes by
light and electron microscopy. These structurally
specialized myocytes were arranged in loose bundles of
long (138±3& ~m vs. 98±53 in common myocytes, p<.Ol),
thin (12±4 ~m vs. 17±5 in common myocytes, p<.Ol)
cells separated by sparse collagenous septae. The most
striking feature of specialized myocytes was frequent
lateral interconnections with small intercalated discs
and gap junctions at 15-20 ~m intervals along the cell
body, a finding never seen in common ventricular
myocytes. The unique distribution of side-to-side
connections between specialized myocytes was associated
with decreased surface density of intercalated discs
(2.8±0.8 x 10-2 ~m/~m2 section area vs. 3.&±1.0 in
common myocytes, p<.04) and gap junctions (5.4±1.2 x 10-3
~m/~m2 vs. &.9±2.& in common myocytes, p=.09).
Although specialized myocytes contained T-tubules, their
structural specializations otherwise resembled those
typical of subendocardial conduction cells. Moreover,
specialized myocyte bundles terminated with extensive
connections to common myocytes. Specialized myocyte
connections with subendocardial Purkinje or transitional
cells have not yet been investigated. However, the
unique morphologic features and distribution of
specialized myocytes suggest that they may be distal,
intramural components of the conduction system which
slow or modulate transmural activation.
CYTOPLASMIC AND JUNCTIONAL COMPONENTS OF ANISOTROPIC
INTERNAL RESISTANCE IN CANINE MYOCARDIUM
Robert H. Hoyt. M.D., Jeffrey E. Saffitz, M.D .• Ph.D.,
F.A.C.C., Washington University. St. Louis, MO
Internal resistance (Ri) is a major determinant of
myocardial conduction velocity. Previous studies of
cytoplasmic and junctional components of Ri' based on
models of myocytes as simple cylinders packed end-to-
end, have ignored important contributions of anisotropic
myocyte shape, packing geometry, and gap junction dis-
tribution. Accordingly, we used morphometry and immuno-
histochemistry to delineate the surface areas and loca-
tions of all gap junctions and thereby construct anatom-
ically accurate two-dimensional maps of canine myo-
cardium. Cytoplasmic and gap junctional components of
Ri were determined in directions longitUdinal (L) and
transverse (T) to the long myocyte axis. Cytoplasmic
resistivity and single channel resistance were assumed
to be 200 Q cm and 2 x 1010 Q, respectively. The
cytoplasmic:junctional resistance ratio was linearly
related to % open channels (slopes-ll.2 and 3.8 in the L
and T directions, respectively). Cytoplasmic resistance
equaled junctional resistance at 8% and 30% open chan-
nels in the Land T directions. respectively. With
physiologic coupling (5% open channels). the anisotropic
resistance ratio (Ri(T)/RlIL» was 9:1, sufficient to
account for directional differences in conduction velo-
city. With improved coupling (100% open channels), the
anisotropic resistance ratio decreased to 4.8:1. Uncou-
pling (0.25% open channels) caused a modest increase in
RiCT)/Ri(L) to 10.7:1 but a l&-fold increase.in Ri (4-
fold slowing of conduction velocity). Thus, both cyto-
plasmic and junctional components of Ri are aniso-
tropic. Ri is determined by gap junction distribution
and elongated myocyte shape. The degree of anisotropy
of Ri is modulated by the extent of myocyte coupling.
Jil' A. JII. B JII C
COllduioll: 1) The presence of a broad activation wavefronl masks underlying
tissue anisotropy. 2) AfIXed, .interrupted barrier allows slow T conduction to be
manifest distal to the barrier. 3) Therefore. in infarcted myocardium the interaction
of fixed barrien and intrinsic tissue anisotropy may be important in allowing slow
conduction, requmd for reentry, to occur.
MASKING OF TISSUE ANISOTROPY· A COMPUTER MODEL OF THE
INTERACTION BETWEEN ACTIVATION WAVEFRONT AND FIXED
BARRIERS: Micbael D. Lesb, M.D. and Josepb F. Spear, PbD.,
F.A.C.C. University of Pennsylvania, Pbiladelpbia, PA
Nonnal myocardium is anisotropic: resistivity is greater transverse (T) than longi-
tUdinal(L) to fiber axis and therefore conduction is faster parallel to fibers. We
hypothesized that the observed pattern of conduction in anisotropic myocardium
depends not only on intrinsic anisotropic propertities but also on how an activation
wavefront encounters the tissue. We constructed acomputer model of 5000 cells in
atwo-dimensiona1 sheet Activation could be initiated by pacing from any point(s)
on the sheeL Activation times for each resting cell were calculated based on the
conduction time from each currently activated cell. We could also specify filled
barriers (scar) through which no activation was possible except at holes in the
barrier. "Intrinsic" LandT conduction velocities(VL.VT) were defined as those
which would occur if conduction w= a plane ....ave in the respective direction.
Resllllr for VL:VT = 0.6:0.3 mls are shown. A.: Pacing from 1 site at the edge
of the sheet yields ellipt.icall0 msec. isochrones with conduction slower T than L
to fiber axis. B: Simultaneous multiple site pacing along one edge produces
activation with parallel isochrones; slow T conduction is masked. C: The
activation wave encounters an interrupted, fixed barrier; isochrones are parallel
proximal to the barrier, but the preaence of a hole in the barrier allows slow T
conduction to again become manifest beyond the bfurier.
- .....
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SYMPATHETIC-INDUCED CHANGES IN ATRIAL EXCITATION
SEQUENCES INFLUENCE AV NODAL CONDUCTION. IQdQr
Maz~alev Ph,D.. Leonard S. Dreifus M.D. F.A.C.C., . Eric L.
Michelson. M.D. F.A.C.C. Lankenau Medical Research Center,
Philadelphia, PA
Recently, it has been reported that the expected shortening of AV
nodal (AVN) conduction time in response to sympathetic stimulation
is attenuated if the degree of sinus node (SN) tachycardia is
restricted. We examined this paradoxical effect and its relationship
to sympathetic·induced changes in SN-atrial activation. In 13 SN·
atrial-AVN preparations superfused with Tyrode solution containing
3xlO"M an-opine, bipolar elecn-ograms were recorded from crista
terminalis (Cr1), interatrial septum OAS) and His (H) along with
action potentials of AVN cells. The intervals CrT-lAS and CrT-H
(AVN conduction time) were monitored on a beat-to-beat basis. In
conuol, the cycle length was 390±33ms and CrT was depolarized
26±8ms before lAS. Postganglionic sympathetic stimulation
(PGSS;20-40Hz,I-3s) was introduced locally in the SN and produced
transient cycle length shortening of 123±33ms. PGSS-induced
tachycardia was consistently accompanied by a transient shortening
of the CrT-lAS interval (by 32±llms). including a reversed
sequence of atrial activation in 10113 preparations. In all cases, the
lAS-input of AVN was depolarized progressively earlier and AVN
conduction time shortened despite the tachycardia. When a
feedback-programmed pacing protocol was utilized to mimic the
exact pattern of tachycardia but without PGSS. the CrT-lAS interval
remained constant and, as expected, AVN conduction time only
prolonged. Propranolol or surgical isolation of the lAS abolished
PGSS-associated changes in AVN engagement and the shortening of
AVN conduction time. Thus, the effect of localized sympathetic-
induced sinus tachycardia can be associated with an unexpected
shortening of AVN conduction time due to a reorientation of the
timing of the atrial inputs to the AVN at the CrT and lAS.
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MECHANISMS OF ELECTROTONIC UNCOUPLING OF MYOCAROIUM
INDUCED BY HYPOXIA
Robert H. Hoyt. M.D., Mark L. Cohen, M.D., Ph.D., Peter
B. Corr, Ph.O., Jeffrey E. Saffitz, M.D., Ph.D.,
F.A.C.C., Washington University, St. Louis, MO
To delineate mechanisms of electrotonic uncoupling
induced by hypoxia, we characterized electrophysio10gic
and ultrastructural alterations in canine left
ventricular myocardium in vitro after selected intervals
of superfusion with hypoxic (p02=28 mmHg) glucose-free
media. Space constants, determined by current
injection, were unchanged after 15 min of hypoxia
(1.1±.3 mm vs 1.8±.4 in paired controls; n=5) but
declined significantly after 30 min of hypoxia (p<.02,
n=8), reflecting a &5% increase in gap junctional
resistance. Uncoupling after 30 min of hypoxia was
irreversible. Quantitative ultrastructural analysis
demonstrated no significant derangements after 15 min of
hypoxia. However, focal disruption of intercalated
discs, resulting in a 22% reduction in gap junction
surface area, and focal irreversible myocyte injury were
observed after 30 min of hypoxia. Gap junction P-face
particle diameters measured in freeze-fracture replicas
were unchanged after 15 min (B.4±1.5 nm vs 8.5± 1.& in
controls). In contrast, particle diameters decreased to
1.3+1.3 nm after 30 min of hypoxia (p<.Ol vs control)
consistent with partial closure of the 1.5 nm junctional
channel. Thus, impaired myocyte coupling induced by
hypoxia is due to both decreased gap junction· surface
area and increased single channel resistance related to
a conformational change in the intramembranous channel.
Tuesday, March 21, 1989
2:00PM-3:30PM, California Room A
Anaheim Convention Center
Diastolic Function: Left Ventricular Mechanics
KITRAL OPENING PRESSURE STRONGLY INFUJENCES LEFt' VENTRI-
CUlAR PEAK RAPID FILLING RATE.
nmma Ii2I.UIL. tL.L, Alan Pearlman, K.D., F.A.C.C.,
Catherine Otto, K.D., F.A.C.C., Carolyn Gardner,
R.D.K.S., Jeff Hanson, K.S., Hidetoshi Tsuboi, K.D.,
Yoshi.. Shoji, K.D., Gregory Kisbach, K.D., F.A.C.C.,
University of Washington, Seattle, Washington.
Peak rapid filling rate (PRFR) is often used to describe
diastolic LV function, yet its sensitivity to LA pressure
at lIitral opening (atrioventricular pressure crossover,
PCO) requires further clarification. To assess the rela-
tion of PRFR to PCO, we studied 5 open-chest dogs instru-
mented with LA and LV lIicrollanometer-tip pressure cathe-
ters and LV sonocrystals. Heart rate was maintained
constant by sinus node crushjRA pacing and CO was con-
trolled by a roller pump (input froll cavae, output to
RA). Sonocrystal-derived peak rate of change of LV vol-
ume (PRFR, ml/s) and PCO (mmHg) were measured on a beat-
to-beat basis during rapid flow reduction (analogous to a
vena caval occlusion). The results of linear regression
analysis are shown for each dog (PRFR-dependent variable,
.-slope of regression equation):
~g 1 2 3 4 5
Correlation (r) .95 .96 .84 .94 .98
a (1I1/s/lIIIHg) 27.230.3 40.9 7.6 25.6
S.E.E. (al/s) 26.3 22.5 29.6 9.9 15.1
P value <.001 <.001 <.001 <.001 <.001
Conclusions: 1) There is a steep linear relation between
PRFR and PCO; 2) if alterations in PRFR are to be used as
a I18rker of LV diastolic function, knowledge of concolli-
tant atrial loading conditions is I18ndatory.
EFFECfOFEARLYDIASTOUC LOADING ON MYOCARDIAL
RElAXATION IN THE INTACf CANINE LEFT VENTRICLE.
Srdjan Nikolic M.S., Edward L Yellin Ph.D., Koichi Tamura
M.D., Takako Tamura M.D., Robert W.M. Frater M.D., F.AC.C.
Albert Einstein College of Medicine, Bronx, NY
Early transmitral flow (MiF) patterns depend strongly on the rate
of fall of LVP: determined by both the active decay of pressure
(Pa) due to myocardial relaxation (MyoR), and the increase in
pressure due to stretch of passive elem~nts during fiI~ing. (P~).
This study was designed to uncouple fIlling from deactIVatIon m
order to reveal the instantaneous rate and duration of MyoR by
assuming a parallel combination of passive and active elements:
LVP(t) = Pa(t)+Pp(t); and without ~uming ~ny form of P~(t).
Pp(V) was determined ~y a retrospectIve analysIs of dat~ obta.med
in 8 anesthetized dogs mstrumented for volume c1ampmg with a
remote controlled Mi valve, with lA and LV micromanometers,
and with a MiF probe. The passive P-V relation (both positive
and negative portions) was determined by. c1a~ping ~t ESV or
after various filling volumes, and fit to loganthmlc functIons. Pp(t)
was then calculated from Pp(V) and Vet) (integral of MiF). Time
to end relaxation (Ter) was measured as time from Mi valve
opening (MiVO) to LVPmin during isovolumic relaxation. dP(dt
at the moment of MiVO when dPp/dt=O, gave the max relaxatIOn
rate dPa/dtmax. RESULTS, (n = 51 runs): In completelyisov~lumic relaxations, asymptote ~= -5 ±.. 4mmHg, (thus, Pa is
5mmHg>Pm at MiVO) and Ter z 38 ±.. 13ms. During normal
filling, Ter '" 120:t.. 32ms. At any time, dPa/dl during isovolumic
relaxation was always greater during filling, indicating a delay in
end relaxation. Pa increased with LV volume and dPa/dtrt'Jax
decreased with LVPmin. CONCLUSIONS: Internal restoring
forces and diastolic loading in the intact LV exert a profound
effect on the rau and durationof myocardial deactivation.
ENHANCED RECOVERY OF DIASTOLIC FUNCTION AFTER GLOBAL
MYOCARDIAL ISCHEMIA IN THE INTACT ANIMAL.
Kevin Tveter, M.D., John St.Cyr, M.D., Joseph Schneider,
M.D., Richard Bianco, B.A., John Foker, M.D., Ph.D.,
University of Minnesota, Minneapolis, MN.
The relationship of myocardial ATP levels and postis-
chemic dysfunction remains controversial. In an intact
animal model of global ischemia (Isc) and recovery, we
have found ribose (R) or adenine (A) and R accelerated the
return of ATP levels (84% and 80% recovery by 24 hrs).
The purpose of this study was to determine the effects of
enhancing ATP recovery on postlsc function. Following
20 min of lsc on cardiopulmonary bypass, dogs received
either R (80mM)(n-5), A (20mM) and R (80mM)(n-5) or saline
(NS)(n-6) for 24 hrs. The end-systolic pressure-volume
ratio (Emax' mmHg/ml), dP/dt (mmHg/sec~ and diastolic cir-
cumferential stress (a, dynes x 103/cm )-strain (£) rela-
tionships were determined from sonomicrometry and micro-
manometry data during transient vena caval occlusions.
The results (mean~SEK. *p<0.05 vs Prelsc, **p<0.05 vs NS):
Prelsc 4 hrs 24 hrs
dP/dt NS 2235~59 2212~145 2277~174
R 2680~169 2459~199 2879~237
AIR 2452~250 2212~173 2277~146
Emax NS 3.12t0.30 2.74~0.70 3.03~0.73
R 2.46~0.43 3.02~0.25 2.27~0.26
A/R 2.33~0.31 2.05~0.28 2.47~0.57
£ at a -20 NS 0.213~0.02 0.100~0.02* 0.128~0.01
R 0.282~0.03 0.164~0.02* 0.266tO.02**
AIR 0.278tO.04 0.17110.03* 0.242~0.04**
We conclude: (1) recovery of systolic function is essen-
tially complete by 4 hrs. (2) Return of diastolic func-
tion is enhanced similarly to ATP recovery by R or AIR.
(3) Because A did not further enhance ATP recovery, R
appears to be the rate limiting ATP precursor.
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REGIONAL DIASTOLIC MECHANICS OF ISCHEMIC AND NONISCHEMIC
AREAS IN THE PIG HEART
Toshiyuki Takahashi M D Marc J. Levine, M.D., William
Grossman, M.D., F.A.C.C., Harvard-Thorndike Laboratory,
Beth Israel Hospital, Boston, MA
Diastolic dysfunction has often been observed during
ischemia(IS), but differences between ischemic(IA) and
nonischemic(NA) areas, and between demand(D) and primary
(P) IS remain to be elucidated. We created regional D and
P in the pig heart(chest and pericardium open). D was
made by creating a 75-90% luminal stenosis on left
anterior descending artery(LAD) plus rapid pacing(1.8x
resting rate) for 3-5 min(n-7). P was made by a total LAD
occlusion for 1.5 min(n-6). LVP, LV segment lengths (SL),
time constant of LVP fall(T) and systolic shortening of
SL(%~L) were obtained. ~:*p<.Ol, **p<.05, mean±SEM.
LVEDP(nunl!g) I.!.mu.£l %ALCt> IA NA
pre post pre post pre post pre post
U 7±1 l5±1* 34±3 46±6** 20±2 l4±2* l5±3 l4±2
~ 7±1 ll±l* 32±3 38±3* l7±2 -4±1* l4±3 l6±2
During D, dynamic diastolic LVP-SL relation shifted
upward and rightward in lA, but mainly rightward in NA.
During P, LVP-SL shifted more rightward in IA(Figure).
During D, peak +dSL/dt(mm/sec) increased in NA(22±3 to
35±4*) without changes in IA(33±5 to 34±4). Conclusions:
Regional IS causes differences in both diastolic and
systolic behavior between IA and NA. Regional mechanics
of IA varies with the types of IS.
H!~[(l~~J~.~1~:
SL Cr.)
DILTIAZEM IMPROVES DIASTOLIC FUNCTION DURING HYPOXIA IN
HYPERTROPHIED RAT HEARTS
Ellen 0 Weinberg BS, WMark Vogel PhD, Carl S Apstein
MD FAcf, Boston Univ. School of Medicine, Boston, MA
This study examines the effect of diltiazem on the
exaggerated rise of diastolic stiffnesss during hypoxia
that we previously observed in hearts with LV hypertro-
phy (LVH). we used 8 weeks of deoxycorticosterone-salt
treatment to cause hypertensive LVH in rats. Hearts
were perfused for 20 min with oxygenated buffer follow-
ed by 5 min hypoxic perfusion, paced at 4 Hz through-
out. Treated hearts received 150 oM diltiazem 10 min
before and during hypoxia. LV volLJne was held constant
with a balloon adjusted to produce an initial LVEDP of
10 llIllIIg~ thus, increases of LVEDP indicate increases of
chamber stiffness. Results were tested by 2-way factor-
ial analysis of variance. LV mass was 1.0 + 0.03 g in
13 normal hearts and 1.3 + 0.04 g in 13 hearts with LVH
(p < .001). Initial aerobic LV developed pressure was
122 + 5 rrmHg in normal hearts and 156 + 4 rrmHg wi th LVH
(p <-.001). During aerobic perfusion~hearts with LVH
were more sensitive to diltiazem, which decreased
+dP/dt by 13 + 2 % in 6 normal hearts and by 20 + 1 %
in 7 hearts with LVH (p < .005 normal vs LVH), whYle 02
conslmlption decreased by 7 + 2 % in normals and by 12 +
2 % with LVH (p < .007 normal vs LVH). Systolic func::
tion during hypoxia was similar in all groups. Without
diltiazem LVEDP after 5 min hypoxia increased to 30 + 3
rrmHg in normals and to 60 :!: 7 rrmHg with LVH (p < .001'>.
With diltiazem LVEDP increased to 26 :!: 4 in normals (p
= NS vs untreated normal) and to 34 + 5 with LVH (p <
.001 vs untreated LVH, p = NS vs either normal group).
COM:LUSION: A modest negative inotropic dose of
diltiazem normalized the exaggerated increase of LVEDP
during brief hypoxia in hypertrophied hearts.
VENTRICULAR DIASTOLIC INTERACTION IN INTACT DOGS
ASSESSED BY CONDUCTANCE CATHETER
Chester M. Boltwood, Jr" M.D., F.A.C.C., Stanton A.
Glantz, Ph.D., Wadsworth VA/UCLA, Los Angeles and UCSF,
San Francisco, CA
Previous studies of ventricular interaction have re-
quired surgical instrumentation, which may cause pericar-
dial artifacts. The purpose of this study was to analyze
ventricular diastolic interaction using the conductance
catheter, which may provide a useful measure of relative
LV volume without surgical instrumentation. In 7 closed
chest dogs we recorded LV conductance.volume (CV) and
LV, RV pressures during control, and balloon occlusions
of inferior vena cava (IVCO), aorta (AD), and pulmonary
artery (PAD). We fit LVDP from single diastoles (ie.
LVDP nadir to LVEDP at 200 Hz) to:
LVDP = ag + a1 CV + a2 CV2 + a3 CV3 + k RVDP.
In theory, if pericardial constraint pressure (PP) < RVDP
then k < 1; if PP ~ RVDP then k , 1; and if PP > RVDP
then k > 1.
Results: In each experimental episode this regression
model showed high correlation (R2 0.88-0.96). Combining
all episodes, k = 1.09 ± 0.10 during control, but changed
from control by -0.30 ± 0.11 during IVCO (p<0.05), by
0.40 ± 0.11 during AO (p<O.OOl), and by -0.41 ± 0.12
during PAD (p<O.OOl). To validate this application of
the conductance catheter, we derived k from simultaneous
angiographic LV volume and CV over multiple control and
intervention episodes, and obtained similar results.
Conclusions: Our findings support the PP , RVDP ap-
proximation during control in the intact state. However,
our data suggest that PP > RVDP during AO, and PP < RVDP
during PAO. Thus, as suggested by recent experimental
literature, there are significant deviations from the
PP ~ RVDP approximation during asymmetric loading of
the LV or RV.
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Coronary Artery Stenosis and Vasomotor Tone
INCREASED FWW VELOCITY IN THE HUMAN CORONARY STENOSIS;
A SIMPLE ASSESSMENT OF STENOSIS SEVERITY.
Alan C YeJwg W. Joseph A Vita ID, Peter Ganz W Face,
Aodrew selwyn W FACC, Kathleen Reagan W, and -John A
Bittl ID FACC, Brigham and Wcrnen' s Hospital, Boston, MA.
Coronary stenoses are characterized by corrplex gearetry,
particularly after angioplasty, making angiographic
assessment difficult. Since blood flow velocity
increases at sites of arterial narrowing, we evaluated a
flow velocity~pendent, nonangiographic method to as-
sess stenosis severity. Validating the method, we
perfused 14 segrrents of 3.2-mn polyethylene tubing with
whole blood at 80 ml/min at an average pressure of
130/80 and found excellent correlation (y = 1.01x +
0.23; r 2 = 0.95; p = 0.001) between the absolute values
for luminal diarreter reduction (%) and the flow
velocity-dependent value measured with a No. 2.5 Fr
Doppler catheter using the continuity equation: As =
An'Vn/Vs, where A = the cross-sectional area and V = flow
velocity in normal (n) and stenosed (s) segrrents. The
Doppler catheter is easily used in Pts. During
aogioplasty, we advanced the tip of the catheter to the
stenosis and measured the value for Vn/Va while
estimated flow remained constant. Low noise, high
quality signals denonstrated as much as a 20-fold
increase in flow velocity in the stenosis conpared to
the normal segrrent, pennitting a measurement of stenosis
severity that is independent of angiography. In
conclusion: 1) In vitro studies show excellent corre-
lation between -absolute and Dowler-derived values for
stenosis severity; 2) This technique already exists for
awlication in pts, thus providing a sinple cOllPlerrent
to angiography, particularly when angioplasty produces
cOllPlex luminal geanetry but irrmedi.ate assessrent of
dilation is inpc,.:tant.
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EFFECTS OF ADENOSINE ON THE CORONARY
CIRCULATION IN HUMANS Robert F Wilson MD. Betsy
Christensen BSN, Stevan Zimmer MD, David Laxson MD, and Carl
W.White M.D.,FACC. University of Minnesota, Minneapolis, MN
Although adenosine(ADN) has been used widely in studies of the
coronary circulation in animals. its safety and dose response
characteristics have not been defined in humans. To do so, we
measured coronary blood flow velocity(CBFV) in a normal left
coronary artery in 10 patients using a 3F Doppler catheter. CBFV,
mean arterial pressure(AP), heart rate(HR), and the ECG
(PR,QRS,and QT intervals) were recorded after intracoronary(IC)
papaverine(P, 8-12mg boluses). IC ADN (4-l4~g boluses) and
intravenous(N) ADN infusions.
Results: Intracoronary Adenosine
(MEAN±SEMl 4 ug 8 ug 12 ug 14 ug P
6CBFV 3.9±.3 4.3±'2 4.6±.3 4.7±'4 4.8±3
MP(mmHg) -3±1 -4±1 -5±1 -3±1 -7±1
6HR(bpm) Ofl O±l Ofl Ofl +3±1
The duration of maximal hyperemia (l4~g ADN: lOOs; P 29±4s) and
the time for CBFV to normalize (ADN:37+2s;P: l18±5s) were shorter
after ADN than P (p<.OI). The ECG intervals were unchanged after
ADN. but P increased the QT (mean 6 +96±18 msec).
Intravenous Adenosine
Dose 70uglkglmin lOOuglkglmjn l4Quglkglmjn
6CBFV 2.9±.6 4.5±.7 4.4±.5
MP(mmHg) -5±2 -9±4 -ll±3
6HR(bpm) +7±3 +13±6 +18±3
CBFV increased maximally l23±25s after infusion onset and returned
to basal levels l13±13s after discontinuation. At submaximal doses.
CBFV fluctuated markedly. I patient had submaximal 6CBFV at
140~g/kg/min.TheECG was unchanged at any dose.
Conclusion: Maximal coronary hyperemia. equivalent in magnitude
to IC P but of ultra-short duration, can be safely produced with either
IC or IV ADN. Its brief duration of action and lack of effect on the
ECG should facilitate studies of the coronary circulation in humans.
THE COMPARISON OF ACETYLCHOLINE AND ERGONOVINE IN THE
PROVOCATION OF CORONARY VASOSPASM.
Nitaro Shibata M.D., Hiroki Mizobe, M.D., Yoshihiro
Miyazaki, M.D., Masaetsu Miura, M.D., Yuji Miyazawa, M.D.,
Yukio Komatsu, M.D.
Cardiovascular Center of Sendai, Sendai, Miyagi, Japan.
Provocative testing of coronary spasm is required for the
diagnosis of vasospastic angina (VSA) in chest pain
patients. In order to evaluate the provocating methods
of coronary spasm, we performed coronary arteriograms by
Judkins tecnique after the injection of acetylcholine
(ACH method) and ergonovine (EM method) in 8 VSA patients
and 12 patients with atypical chest pain (ACP). In ACH
method, acetylcholine (ACH) was injected with incremental
dose of 20. 50, and 100 micro gram to the left coronary
artery, 20 and 50 micro gram to the right coronary artery,
until coronary spasm was introduced. In EM method,
ergonovine meleate (EM) was injected up to 0.4 mG intra-
venously until coronary spasm was provocated. Coronary
spasm was defined as spasm of more than 90 \ or total
occulusion associated with an attack of chest pain and/or
ischemic ST segment changes on the ECG. In VSA patients
with ACH method, coronary spasm was induced 88\ to the
left coronary artery and 100 \ to the right coronary
artery. In VSA patients with EM method, coronary spasm
was induced in 57%. In ACP cases with ACH method, vaso-
spasm was induced in 17\ only in the right coronary
artery but with EM method. vasospasm was not induced.
With both ACH and EM methods no major complication was
observed. Spontaneous regression of the vasospasm was
observed within 5 minutes in all cases with ACH method in
which coronary spasms were observed but not withEM
method. In conclusion, ACH method is easier and more·
sensitive however less specific than EM method in the
induction of coronary vasospasm.
PRESERVED FLOW-MEDIATED VASODILATION DESPITE
ACElYLCHOLINE.INDUCED VASOCONSTRICI'ION IN
ATHEROSCLEROTIC CORONARY ARTERIES IN MAN
Andreas M. Zeihet MD, Helmut Drexler, MD, Helmut
Wollschlager, MD, Hanjor~ Just, MD. Medical Clinic, Dpt.of
Cardiology, University of Frelburg, F.R.G.
Recent experimental studies have demonstrated different mecha·
nisms of vasodilation in response to nitric oxide, believed to be
EDRF, and acetylcholine(ACh). We compared the vasomotor re-
sponse of human coronary arteries to increased coronary blood
flow and to the endothelium-dependent dilator ACh in 7 patients
with normal coronary aneries(normal CAl and in 9 patients with
coronary atherosclerosis (lesions < 30%, CAD). Flow-mediated
coronary dilation was evaluated before and 80 sec after selective
injection of 7 mg papaverin into the midportion of the LAD via a
Doppler catheter. CA diameter measurements(automated quanti-
tation of digitized cine-frames) were obtained at the proximal
LAD se~ent e1'POsed to increased flow, but not to papaverin.
ACh (10 M, lo-'M, l()'6M) was infused into the proximal LAD via
the Doppler catheter. LAD blood flow velocity was continuously
measured and CA diameters of identical LAD segments were
obtained at the end of each 3 min infusion period.
~: Flow-mediated vasodilation was observed in all patients,
although somewhat reduced in patients with CAD. In contrast,
ACh caused dilation in all normal 'patients, but profound vasocon-
striction in all patients with CAD (* P<0.001 vs flow-mediated).
% change normal CA patients with CAD
flow-mediated ACh. flow-mediated ACh
flow velocity 340.±.116 89.±.25 211.±.69 l40.±.74 •
CAdiameter +9.l.±.4.3 +9.8.±.4.6 +5.7.±.2.9 -21.2.±.4.9
Thus, flow-mediated dilation of atherosclerotic human CA is pre-
served despite acetylcholine-induced vasoconstriction. These
results suggest that, 10 contrast to (lure BDRF-mediated flow-
dependent coronary dilation, additIOnal mechanisms may be






00I0iARY IIfJIDY!WIIC EFFBCTS OF ATRIAL NA'l'RIURE'l'IC PEPrIIE
Andrew D. Rosenthal, M.D .. Carol A. Davis. R.N .. Mark Moran.
M.D .. Howard C. Herrmann. M. D°.
Universi ty of Pennsylvania. Philadelphia. PA
To determine if atrial natriuretic peptide (ANF) is a
direct coronary vasodilator, we compared the effects of
synthetic ANP (rat 103-126) and nitroglycerin (NTG) on
coronary hemodynamics in 8 pts with coronary artery
disease. Increasing doses of ANP (0.125 to 100 megs) or
~TG (0.5 to 200 megs) were administered directly into the
left coronary artery and peak. total coronary sinus blood
flow (CBF, mljrnin) was measured by continuous thermodilu-
t ion technique us ing a Webster catheter. Coronary
~ascular resistance (CVR, mmHg-min/ffil) was calculated as
nean arterial pressure/CBF. All pts received both ANP and
~TG in randan sequence with repeat baseline measurements
:>etween the drugs. No untoward effects were d>served with
~ither agent. CBF and CVR at the two baselines (differ-
mces not significant) and at the largest dose of ANP and
ITG given are shown (mean-+SEM; *p<0.05 drug vs baseline):
Baseline ANP (100 iik:g) Baseline NTG (200 meg)
:BF 129+9 155+9* 131+7 167+12*
:vR 1.00+.10 0.84+.07* 1.00+.08 0.79+.08*
The maxiinal effects-of ANP and N'IG on CBF were-similar
(+20* vs +27*, p=NS), and CVR
fell slightly more with NTG
(-16* vs -21*, p<0.05). The CBF
dose-effect curve for ANP is
shown. Conclusions: 1) ANP is a
potent direct coronary vasodila-
tor, whose maximal coronary
hemodynamic effects are similar
to those of NTG. 2) The adnini-
stration of ANP to pts with
coronary disease is safe and
well tolerated.
JACC Vol. 13, No.2
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CONTRASTING EFFEcrs OF ACET -YLCHOLINE ON
CORONARY CONDUCTANCE AND RESISTANCE VESSELS
IN PATIENTS WITH CORONARY ARTERY DISEASE
Helmut Drexler. MD. Andreas M. Zeiher, MD, Helmut
Wollschlager, MD, Thomas Meinertz, MD, Hanjorg Just, MD.
Medical Clinic, University of Freiburg, F.R.O.
Acet .ylcholine (Ach) has been shown to induce paradoxical vaso-
constriction of epicardial atherosclerotic coronary arteries,
however its effects on coronary resistance vessels in this setting
remains to be elucidated. Therefore, we evaluated the hyperemic
response to contrast medium during an~iography before and after
intracoronary Ach infusion (10"' M, 10 M), given into the lAD
via an intracoronary Doppler catheter. Coronary flow reserve was
assessed as the ratio of pre-injection intracoronary blood flow
velocity to contrast-induced peak hyperemic flow velocity.
Intracoronary injection of contrast medium was used as a mean
for coronary arteriolar dilatation and estimation of coronary
reserve. For determination of the epicardial response, lAD
diameters were measured by an automatic contour detection
system. Contrast mediated hyperemic response (coron~ reserve)
decreased from 2.9.±.0.5 durin~ control to 1.7.±.0.8 (10" M) and
0.8.±.OA (l~ M) during Ach Infusion in all 12 patlents (NL =
normal coronary arteries, n =6; CAD = corona!}' artery disease
with non flow-limiting stenoses, n =6). Ach slightly mcreased
epicardial lAD diameters in NL (7.±.4%), however significantly
reduced lAD diameters in CAD (-20.±.8%). Ach mediated
intracoronary flow velocity was somewhat more pronounced in
CAD (140.±.73%) compared to NL (81.±.33%), due to
simultaneous epicardial vasoconstriction.
Thus, hyperemic response to contrast was blunted during Ach
infusion both in NL and CAD indicating substantial Ach induced
dilatation of resistance vessels. These results suggest, that
paradoxical vasoconstriction in CAD was confined to epicardial
conductance vessels.
CLIMATOLOGICAL VARIABLES A!ID ACUTE MYOCARDIAL
INFARCTION: A TIMK COURSK SrooT.
Barry A. Franklin, Ph.D., Susan Wetherbee, R.D., Donovan
Bakalyar, Ph.D., William O'Neill,M.D., William Beaumont
Hospital, Royal Oak, Michigan.
Exposure to cold or heat stress has been shown to produce
transient increases in platelet and red cell counts, and
blood viscosity levels. Such findings seem to reinforce
the notion that fluctuations in selected climatological
variables (CV) may be involved in the precipitation of
acute myocardial infarction (AMI). To further clarify the
effects of temperature, wind chill, heat index, relative
humidity and barometric pressure on the incidence of AMI,
we retrospectively surveyed 9 Detroit hospitals to
determine if these hospitals simultaneously experienced an
influx of documented AMis on given admission dates over a
2-year period (1986-1987). Four hospitals prOVided a daiiy
listing of the number of AMIs, yielding an extensive data
base (n • 3,924 AMIs):
AMls/Day
Year Mean SO Range Total/Year
1986 5.38 2.36 0-15 1963
1987 5.37 2.41 0-13 1961
The incidence rates for 1986 vs 1987 were remarkably
similar. Moreover, the frequency of AMI was character-
ized by a Poisson distribution, suggesting that a small
number of days would, by chance, have a significantly
higher number of AMis. Over the 2-years, 14 days were
identified in which 11 or more AMis occurred (> 2 SO).
These nonconsecutive days showed no consistent relation to
the aforementioned CV. In addition, there was no appar-
ent seasonal or daily variation in the incidence of AMI.
Conclusion: These findings, although regionally specific,
suggeat that AMIs occur randomly over time, irrespective
of common CV, seasonal change, or day of the week.
INCREASED MORNING INCIDENCE OF MYOCARDIAL INFARCTION:
EXPERIENCE IN THE ISIS-2 TRIAL
Stefan N. Willich. M.D., Rory Collins, M.D., Richard
Peto, Thomas Linderer, M.D., Rolf Schroder, M.D., and
the ISIS-2 StUdy Group. Klinikum Steglitz, Free













UK I Ireland 1098 1684· 1319
Australia/N Zealand 455 605· SOB
Scandinavia 595 946· B09
USA I Canada 196 277· 251
West Germany 225 325· 250
To investigate the circadian pattern in the incidence
of acute myocardial infarction (MI), time of day of MI
was prospectively determined in 12,160 patients, who
were consecutively randomized for the ISIS-2 trial
(International Study of Infarct Survival). Local time
of randomization, interval between onset of clinical
MI symptoms and randomization, and information on
aspirin therapy in the 7 days prior to MI were
recorded by the randomization centers.
Tim e 0 fDa y (0-24 hrs)
Country 0-6 6-12 12-1 8
Total 2569 3837· 3137 2617 12160
• p < 0.001 vs. other times of day
In the subgroup of 1693 patients (l4'L of total) who
reportedly used aspirin in the 7 days prior to MI, the
circadian pattern in the incidence of MI was similar
to that observed for the total study population,
suggesting that aspirin does not blunt the morning
surge in the incidence of MI.
Conclusion: Prospective Investigation of time of MI
confl rmed the fi ndl ng of Increased morn Ing i ncl dence
of MI In a large inte~national study population.
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Epidemiology of Coronary Disease
Several recent studies have reported an
increased incidence of AMI during the morning
hours. These stUdies, however, failed to
determine the relationship between AMI onset and
time after awakening in relation to occurrence
of AMI. We examined this association in 148 pts
with AMI admitted to four Worcester, MA,
teaching hospitals during the past year. There
was a marked association of time of onset of
first AMI symptoms and time after awakening.
Forty-one percent of hospitalized pts had their
initial AMI symptoms within the first four hours
after awakening with 63\ of these pts having
their initial AMI symptoms within 2 hours after
awakening. This percentage declined to 21 \ of
pts having their first MI symptoms within five
to eight hours of awakening, 16 \ between nine
and twelve hours after awakening, 13\ between
thirteen and sixteen hours, and 9\ 17 hours or
greater after awakening. Further studies of the
mechanisms responsible for this observation are
needed and to assist in the development of
prevention strategies.
Time Of Onset Of Acute Myocardial Infarction
(AMI) After Awakening. Robert Goldberg, Ph.D.,
Priscilla Brady, R.N., Zuoyao Chen, M.D., Joel
Gore, M.D., Athan Flessas, M.D., Josh
Greenberg, M.D., George Theodosiou, M.D., James
Dalen, M.D., James MUller, M.D. Univ of MA
Medical School, Worcester, MA, Harvard Medical
School, Boston, MA
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TELEPHONE-MAIL MEDIATED DIETARY INTERVENTION FOR
HYPERCHOLESTEROLEMIA
Mia Clark. R.D., Mark Johannsson, M.P.H., David Hyman,
M.D., Candace Corsetto, B.S., Jane Borchers, R.D., Robert
DeBusk, M.D., F.A.C.C., Stanford University School of
Medicine, Stanford, California.
Multiple face~to-face counseling sessions for hypercholes~
terolemia are often impractical. To test a more convenient
method for individualized dietary counseling, 229 middle~
aged (49+10 years) men and women with total plasma choles~·
terol (TC) exceeding 200 mg/dl were randomized in a 4-
month-long worksite-based trial of dietary intervention
(INT, n-114) or a control condition (n-115). INT
consisted of: 1) a baseline food frequency questionnaire
requiring 10 minutes for completion, 2) a 40-minute
counseling session with a registered dietitian (RD) to set
individual dietary goals, 3) a food manual presenting
behavioral goals and tips, 4) RD's written revision of
dietary goals based on 2 followup questionnaires completed
at 4 and 9 weeks and 5) RD-initiated telephone contacts of
approximately 10 minutes at 5 and 10 weeks to review
revised dietary goals. Duplicate measurements of TC on
fingerstick blood obtained at baseline and 4 months were
corroborated by indirect beta quantification of venous
blood. After 4 months, TC values for the INT group fell
from 238+25 to 223+33 mg/dl compared to 237+24 to 235+30
in controls (p<0.002 for intergroup difference); the -
median decrease in INT was 15 mg/dl. CONCLUSION;
Telephone and mail-mediated followup of initial face~to~
face dietary counseling facilitates reduction of
hypercholesterolemia through. dietary change. The system,
which enhances the convenience of dietary counseling and
requires as little ss 1 hour of RD time, csn be widely
implemented in worksites.
CARDIOVASCULAR RISK REDUCTION THROUGH WORKSITE HEALTH
PROMOTION.
B. Barzl1ai, M.D., F.A.C.C., E. Fisher, Jr., Ph.D., K.
Rost, Ph.D., K. Schechtman, ph.D., D. Haire-Joshu, Ph.D.,
D. Bishop, Ph.D., W. Jaffe, R.N., B. Gaponoff, M.P.H., J.
Heins, R.D., P. Watkins, Ph.D., S. Levy, B.A., C.
Houston, R.D., Washington University, St. Louis, MO.
Worksite health promotion has been proposed as a means to
reach and motivate individuals for cardiovascular risk
reduction. To test this proposition, we developed an
experfmental program to include: a) screening for
lipoproteins, blood pressure, Obesity, smoking, and
behavioral risk factors b) individual counseling c)
4-hour overview of cardiovascular risk reduction d) group
programs for smoking cessation, weight loss, and stress
management and e) 21-month sequence of workshops and
activities to promote risk reduction. 1004 employees
from 17 sites of a large communication company enrolled
in the program. 322 participants (83' of eligible) have
completed two-year follow-up in 7 sites to date. Among
smokers, 32.4' quit. For hypertension, 72.7' of those
with BP over 140 and/or 90 reduced below 140/90 (mean
reduction for those at risk 12.4 sbp and 9.1 dbp). For
cholesterol, 54.9' of those over 200 mg/dl (or 180 if
under 3D yrs), reduced at least 5 mg/dl (mean reduction
for those at risk s 9.9 mg/dl). Among those at least
11~ ideal body weight at baseline, 25.1' lost at least 5
lb. Among those over the 75th percentile on the JAS
measure of T~pe Abehavior pattern, 38.2' were below the
75 'ile at t e end of the program (means for those at
risk: pre· 85.5 'ile, post· 75.3 'ile). Among those at
risk on at least one factor at screening, 54.8' reduced
at least one factor by the criteria indicated. Greatest
public health benefits may rest in moderate reductions by
large numbers at moderate risk. Worksite programs can
instigate such reductions.
SMOKING CESSATION POST MYOCARDIAL INFARCTION; EFFECTS OF
A NURSE-DIRECTED INTERVENTION
Nancy H. Miller, R.N., Mary Adornato, R.N., Nancy Fitch,
R.N., Robert F. DeBusk, M.D., F.A.C.C., C. Barr Taylor,
M.D., Stanford University Medical Center, Stanford,
California and Kaiser-Permanente Medical Centers.
Mortality in patients continuing to smoke after a
myocardial infarction (MI) is twice that of those who
stop. The efficacy of a relapse prevention program was
evaluated in 173 patients treated for MI ·in 4 Kaiser-
Permanente Medical Centers: 86 were randomized to a
nurse-directed intervention (ND) consisting of 2 face-to-
face counseling sessions beginning 5 days post-MI focusing
on avoidance of high-risk situations, a relapse prevention
manual and audiotapes and nurse-initiated telephone
followup in the 6 months post-MI, or to usual care (UC).
Nicotine gum (n-5) and mild aversive smoking (n-3) were
provided for patients continuing to smoke. UC (n-87)
consisted of standard messages about cessation by health
care professionals. Patient refusal rate was 21% (47 of
220). Smoking status, confirmed by expired carbon
monoxide and serum thiocyanate and psychological measures,
intention to quit and self-efficacy were assessed at 3,
26 and 52 weeks. At 26 weeks the dropout rate was 9% (15
of 173); mortality was 3% (6 of 173) and nonsmoking rates
in ND and UC groups were 71% (55 of 77) and 52% (39 of 75)
respectively (p<0.03). This trend continued at 12 months.
Predictors of smoking at 6 months included smoking at 3
weeks, alcohol intake ~2l oz/wk, and low self-efficacy and
lack of stated intention to quit measured at baseline.
CONCLUSION: A nurse-directed intervention commencing in
hospital significantly increased smoking cessation in the
6 months after acute MI, primarily by preventing early
relapse during the transition from hospital to home care.
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LINEAR GROWTH IN PEDIATRIC CARDIAC TRANSPLANT PATIENTS.
Liocla I AddoAizio. MD fACe. DaphAe T.Ibu. M.D.• Eric A. RollO. M.D.•
YeitoA M. Genony. MD. fACC. Coluabia University. NeY Yort. NY.
Do children usiA, steroid iaaunosuppnss1on It'01f &flor cardiac
traIlSpllA&WOA? 17 childreA (11 cardioayopathy.6 cOA,eAitaJ heart
cl.iseue) ages 3 ao. to 18 yrs. "ere Collo"ed Cor linear It'OYt.Il Croa6
to ~1 aos. post-traIlspllAt. The patieAts "ere divided into 4 groups
accordiA, to their ,roYtll potential at the tiee oC traIlspllA&Won. In
Groups I (childrea (~yn.) &Ad II (YOUA, adolescents) are patieAts
with a noru,roYtll poteAtial at the tiee oC traIls,lIAt. In Group
IJ( are adolesceAts whOle Ill"OYth poteAtial eight be iaJllired be-
cause oC pre-traIlspllAt high-close steroid adaiAisttation. cheao-
therapy or irradiatioA. 14 Group IV are you4,ldults who hid achi-
eved nOll' lIlUiJD&I,t'OYt.Il pre-traIlspllAt.The patient data is sua-
lDarized belo,,:
Group ·pts. Mean Ale Followup (ao.) Hat
__. (y.DJ____ uy [lOge (IWU
I 4 1.8!. 1.8 23 6-:U .,-~
11 6 13.1!. 0.8 24 1~ - 32 ~ - 75
III 3 14.9 !. 1.3 ~ 17 - 33 ., - 10
IV .( 18.0.!. O..f 17 13 - 18 10 ··50
In Group J(youn, children) &Ad Group ll(adoJoscents) 9 of 10 patieats
hid norullt'OYlh rates Corage &Ad lII&iAtaiAed their preop height
perceAti1es<h,t'ltile). One pwet hid too short a ColloYup to __
IlroYtll rate. In Group lII(adolescents"ith ,reop Ilt'OYtIl iapainDent)
2 patients did not ,roY &Ad 1patieat hid a Aot'lll&1lt'OYt.1l rate &Ad
lII&iAtaiAed his preop h,t'lti1e. In Group IV(youn,ldults) no sipifi'
C&At Ilt'OYtIl occurted. In sulUll&l'Y. not'lll&1llt'OYlh rates C&A be
achieftd in aost youn, children &Ad adolescents 04 steroid iaauno-
suppt'Olsion Collowin, cardiac traIlsp1aA~a. JIOYeYer. pre-tnu-
pIlAt noncardiac ris.t Cacton Cor IJ"OYlh 4'Jilure may co4uue to
affect their potential Cor lroYtll.
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CARDIOPULMONARY EXERCISE RESPONSE IN
ADOLESCENTS FOLLOWING CARDIAC TRANSPLANTATION.
Lee A Pyles M 0 , Marcus J. Mianulli M.S., Maria T. Olivari M.D.,
Elizabeth Braunlin M.D. (FACC) University of Minnesota,
Minneapolis, MN
EBSTEIN'S ANOMALY OF THE FETUS AND NEONATE;
ANATOMIC DETAILS OF PROONOSTIC IMPORTANCE
David A Roberson M 0 and Nonnan H. Silvennan M.D.
University of California, San Francisco;San Francisco CA.
Ebstein's anomaly (EA) presenting in the newborn period has a high
mortality. The purpose of this study was to detennine which anatomic
features ofEA are predictive of death at less than 3 months old. We
examined complete echocardiograms (ECHO) and medical records of
16 Pts with EA who were diagnosed at UCSF as a fetus or neonate.
EA was diagnosed when the ECHO demonstrated distal displacement
of the proximal attachments of the tricuspid valve from the AV groove
and valvar dysplasia. Cardiac cath data and angiograms in 5 Pts,
pathology specimens in 3 Pts, and intraoperative inspection in 3 Pts
confirmed the ECHO findings in each case. 6 Ptswere diagnosed in
utero, five of these died. 7 Pts died between 36 weeks gestation and 3
months old. Statistical differences (P.sO.05) in the incidence of
anatomic features between the early mortality group and the surviving
group were determined by the Fisher's exact test. Anatomic features
which correlated with early death included bound-down distal
attachments of the anterosuperior tricuspid valve leaflet (86%vsll%)~V wall thi,!-nin~ anddyskinesis (86%vsO%), LV compression by ,
nght heart dilatatlon (71%vsll%), and the combined area of the RA
and atrialized RV being greater than the combined area of the
functional RV, LA, and LV (57%vsO%) measured in the apical 4-
chamber view. The amount of valve leaflet dysplasia, number of
leaflets displaced, the distance the proximal valve attachments were
displaced from the AV groove, and the incidence of associated cardiac
lesions was not different between the 2 groups. 86% of Pts with
bound-down distal attachments had RV thinning and dyskinesis. 86%
of Pts with RV thinning and dyskinesis had bound-down distal
attachments. CONCLUSION: Death of the fetus or neonate with EA is
likely in the presence of bound-down distal attachments of the
anterosuperior tricuspid valve leaflet and RV thinning and dyskinesis.
These features commonly coexist LV compression and marked RA













Six adolescents (14-16 years,4M, 2F) have undergone cardiac
transplantation (CT) in the past 2 years for end stage cardi-
omyopathy. Cardiopulmonary exercise testing (Bruce protocol)
and right ventricular endomyocardial biopsy were performed 6
months after CT. Right heart catheterization was performed 6
to 12 months after CT. Parameters (mean ± SEM) at rest and
during maximal exercise (EX) are compared to 6 healthy
age,sex and weight matched controls (NL):
HR V02 02 PULSE
beat/min ml 02Jkg-min ml O2lbeat
96 ± 6 * 5.9 ±1.6 3.6 ±1.1
59 ± 5 4.2 ±0.4 2.0 ±0.8
134 ±8* 24.3 ±1.9* 11.7 ±1.4*
192 ±14 56.2 ±3.0 19.4 ±1.4
* p < 0.001 # P < 0.05
HR=heartrate, V02=02 consumption,02 Pulse=V02lHR
During EX, CT pts achieved no increase in mean BP, with only
70% HR,43% V02, and 60% 02 pulse increase compared to
controls. EX duration was 8.5 (CT) vs. 15.2 (NL) min (p<O.OO1).
Anaerobic threshold occurred at similar fractions of maximum
V02 (CT: 74%, NL: 69%). HR 5 min post EX remained elevated
in CT (85% max) vs. NL (51% max). Same day heart biopsy
showed no rejection. CT resting hemodynamics were normal
except elevated HR. EX response in adolescents 6 months
after CT is abnormal with attenuated BP, HR and V02 Max
consistent with the denervated state and previous adult
experience.
PATTERNS AND DETERMINANTS OF EXERCISE PERFORMANCE IN
FONTAN PATIENTS
Marc Gewillig, Ulla Lundstrom, Kate Bull, Richard Wyse,
John Deanfield
Hospital for Sick Children, Great Ormond Street, London,
UK
46 patients (age 12.5 : 5.2 years) underwent graded supine
bicycle exercise tests at levels equivalent to normal
daily activity (maximum 1.5 watts/kg), 4.5 : 3.5 years
after a Fontan (F) repair. Results were compared to 28
age matched controls. Cardiac output was assessed by
doppler echocardiography. At rest, cardiac index, stroke
index and systolic blood pressure were comparable in both
groups but increases with exercise were smaller in the
Fontan patients (p <0.01). The resting heart rate was
higher in the Fontan group but this difference disappeared
as soon as exercise commenced. To determine whether there
are limitations intrinsic to the F circulation we compared
the 10 best performances against age matched controls and
found no differences in cardiac index, stroke index, heart
rate or blood pressure at any exercise level. At the
other end of the spectrum, poor performance did not result
from inadequate levels of heart rate but from an inability
to increase stroke volume. Multivariate analysis (using
morphologic, clinical, haemodynamic, surgical and resting
echocardiographic variables) demonstrated that exercise
performance was limited by ventricular contractility only
when it was severely impaired (ejection fraction <25%).
In the majority, ventricular filling, which is determined
by the properties of the pulmonary vascular bed, appeared
to be the major determinant of functional result after F
repair. Thus, patients after Fontan can perform normally
at exercise levels equivalent to everyday activities
despite the absence of a biventricular circulation.
EVIDENCE OF ENHANCED CONTRACTILITY IN NORMAL
INFANTS COMPARED TO OLDER CHILDREN AND ADULTS
~ n.~ HD ~, Stephen P. Sanders MD,
Ira A. Parness MD, Philip J. Spevak MD,
Childrens Hospital, Boston, MA
Noninvasive stress-velocity and stress-
shortening analysis was used to investigate
potential age-related change in LV contractile
state. In 200 normal children age 7 days to 18
years (23 <6 months of age), M-mode and 2D echos
were obtained with simultaneous phono and pulse
tracings and peripheral blood pressure. In
154/200, long-axis dimension of the LV could be
obtained from apical views for calculation of
circumferential stress. Tracings were computer
digitized to obtain ventricular dimension, wall
thickness, and pressure throughout ejection.
From these data, fractional shortening (FS),
rate-corrected velocity of shortening (VCFc),
and end-systolic circumferential (ESSc) and
meridional (ESSm) wall stress were obtained.
FS and VCFc were inversely linearly related
to ESSm as has been previously reported in older
patients. ESSc was similarly related to FS and
VCFc in a linear fashion, with a constant
proportional relationship between the orthogonal
stresses at all ages. When subjects less than 6
months of age were analyzed separately, the
slopes of the ESSm-VCFc and ESSm-FS relations
were not significantly different from older
SUbjects, indicating a similar sensitivity to
afterload in the two groups. However, the
stress-adjusted FS and VCFc were higher in the
younger group (p = 0.01 by analysis of
variance), findings consistent with an enhanced
contractile state.






OCCURRENCE OF CONGENITAL HEART OEFECTS IN OFFSPRING OF
PATIENTS WITH VENTRICULAR SEPTAL DEFECT, AORTIC
STENOSIS, OR PULMONARY STENOSIS: RESULTS OF THE SECOND
NATURAL HISTORY STUDY OF CONGENITAL HEART DEFECTS.
David J. Driscoll, M.D., F.A.C.C., V. Michels, M.D., W.
M. Gersony, M.D., C. J. Hayes, M.O., J. F. Keane, M.O.,
B. S. L. Kidd, M.D., W. M. O'Fallon, Ph.D., D. R.
Pieroni, M.D., R. R. Wolfe, M.D., W. H. Weidman, M.D.,
Rochester, Minnesota (Coordinating Center).
To determine the occurrence rate of CHO (congenital
heart defects) in children of pts with VSO (ventricular
septal defect, AS (aortic stenosis), or PS (pulmonary
stenosis), we surveyed 341, 158, and 198 probands with
VSD, AS, and PS respectively who had children.
Of probands with VSD, 151 males and 190 females had
318 and 382 children respectively. CHD occurred in 10
(3.14%) of the 318 children of males and in 11 (2.88%)
of the 382 children of females. Of probands with AS,
123 males and 35 females had 227 and 66 children respec-
tively. CHO occurred in 3 (1.32%) of the 227 children
of males and 0 (0%) of the 66 children of females. Of
probands with PS, 92 males and 106 females had 169 and
204 children respectively. CHO occurred in 3 (1.78%)
of the 169 children of males and 8 (3.92%) of the 204
children of females.
The occurrence of CHO in siblings of probands with
VSO, AS and PS, were, respectively, 0.6% (15 of 2326),
1.7% (14 of 821), and 1.1% (14 of 1328).
The miscarriage rates for all females in NHS-2 were
28.6%, 14.1% and 13.8% for VSO, AS and PS respectively.
Based upon the results of NHS-2, occurrence rates of
CHO in children of probands with VSO, AS, and PS are
3%, 1.02%, and 2.95% respectively; considerably lower
than recently reported rates.
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VASOPRESSIN (AVP) IS ELEVATED TO PRESSOR LEVELS AND
UNOPPOSED BY ATRIAL NATRIURETIC FACTOR (ANF) FOLLOWING
REPAIR OF COARCTATION OF THE AORTA (CoA).
Julian M. Stewart MD,Ph.D.,FACC, Michael H. Gewitz MD,
FACC, Paul K. Woolf MD, Faustino Niguidula MD,FACC,
Bernard G. Fish MD,FACC, Guillermo A. Zeballos,Ph.D.,
New York Medical College, Valhalla, New York.
Systemic hypertension post CoA may result from changes
in renin-angiotensin and sympathetic nervous control of
BP. Since these systems interact with AVP and ANF we
studied AVP and ANY related to CoA repair. 6'patients,age
7 months to 12 years (m-7 yrs) undergoing CoA repair had
plasma AVP and ANF measured by RIA. All were hypertensive
postop requiring Nitroprusside (NP). BP and plasma AVP
and ANF were measured preop, immediately postop, pre NP,
post NP,at 24 hrs.postop and at 48 to 72 hrs.postop.(Table)
There was no relation of AVP and ANF to HR, CVP or osmo-
larity. ANF levels were normal and not significantly
changed by surgery. AVP levels were elevated preop, in-
creased with surgery (p<.OS), and peaked pre NP (p<.OS).
NP resulted in a sot decrease in mean AVP. AVP fell by
48-72 hours but remained elevated despite antihypertensive
therapy. We conclude. l)Plasma AVP is elevated in CoA to
levels sufficient to cause systemic pressor effects;
2)increases in AVP occur after CoA repair and are tempor-
ally related to postop BP; 3)NP is related to a sot de-
crease in AVP; 4)ANF levels may be inappropriately low
after CoA repair. Increased AVP unopposed by ANF may be
in part responsible for post CoA hypertension.
Preop Poatop PreMP PoatMP PODI POD2-3
139+9 138+9 lSl+6 139+9 134+7 121+2
18+S 86+1S* 138+30* 68+24* 24+7 20+3
24!8 6<J±16 7l±30 6<J±20 40:!16 27±2
LONG TERM PREVENTION OF BIOPROSTHETIC HEART YALVB
CALCIFICATION: AI+++ PRETREATMENT.
Catherine Wehb M p, Frederick Schoen M.D., Ph.D., Robert
Levy M.D., F.A.C.C. University of Michigan Medical Center,
Ann Arbor, MI
Calcification causes failure of glutaraldehyde pretreated
bioprosthetic hean valves (BPY) fabricated from porcine
aortic valves or bovine pericardium. Young age has been
shown to be an imponant risk factor for accelerated BPV
calcification in the pediatric population. BPY
preincubation in Al +++ inhibits BPY calcification in the
21 day rat subdermal model. This study was designed to
assess the long term ability of Al+++ to inhibit
calcification after 21 and 60 day rat subdermal implants.
Glutaraldehyde pretreated BPY specimens were
preincubated in O.OlM AIC13 or O.OSM HEPES (24 hrs, 2SC),
then implanted subdermally in weanling male rats (CD,
Sprague-Dawley, SO-60 gm) for 21 and 60 days. Results
showed that BPY Ca++ was profoundly inhibited in the
Al +++ pretreated groups after 21 day
(Ca++=2.33±.0.17ug/mg) and 60 day (Ca++=11.S7±.4.S8ug/mg)
implants compared to controls (Ca++=76.88±.9.S4ug/mg at
21 days vs 11O.04±.9.28 at 60 days). No adverse effects were
noted on rat growth or bone morphology. We conclude
that AI+++ preincubation effectively inhibits BPY
calcification after both shon and long term subdermal
implants in the rat. We speculate that A1+++ may prolong
the clinical usefulness of BPY's, especially in the pediatric
population.
HODULATION OF THE FETAL LEFT VENTRICULAR FUNCTION CURVE
BY THE THORACIC TISSUES.
Daniel A. Grant, H.Sc., John E. Haloney, Ph.D., John V.
Tyberg, H.D., Ph.D., F.A.C.C., and Adrian H. Yalker,
Ph.D., University of Calgary, Calgary, Canada.
To define the role that external ventricular restraint
plays in determining the shape and magnitude of the LV
function curve before birth, 6 fetal lambs (142-144 days
gestation) were studied. Lambs were partially delivered
by caesarean section under halothane anesthesia. Ye
measured LV stroke volume (SV) using a flow probe on the
ascending aorta, LV end-diastolic pressure (Plved) using
a transducer-tipped catheter passed through the LV free
wall, and intra-pericardial pressure (Pp) using a flat,
liquid containing balloon transducer. LV function curves
were generated after autono~ic blockade (0.2 mg/kg
atropine and 1.0 mglkg propranolol) by altering fetal
blood volume. Two conditions were studied: "A", the
chest and pericardium closed, and "B", the lungs and
pericardium widely retracted fro~ the heart. In "A", LV
function curves (SV'versus Plved) displayed an initial
ascending limb followed by a plateau in which the SV
changed little with further increases in Plved. Yhen LV
transmural pressure (Plved*=Plved-Pp) was used as the
index of preload, the plateau phase was absent. In "B",
LV function curves revealed much larger stroke volumes
at any given Plved (p<0.OO2). These data show that the
thoracic tissues significantly influence the LV function
curve in the fetal lamb. In "A", the plateau of the
function curve using Plved as preload results largely
from elevations in Pp which limit increases in Plved* as
Plved is raised. Consequently, Plved* is a more ac-
curate index of LV preload. The fetal LV has the ability
to increase its output but is limited in the intact
animal by the surrounding tissues.
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POS1NATAL DEVELOPHENl'AL QlANGES IN MYOCARDIAL
Ml'l'<XHlIDRIAL CALCIUM TRANSPORT.
~ Wot~ M.DUihFACC, Karen Rex, M.S., Louis Sordahl,
• , FA, versity of Texas Medical Branch,
Galveston, Texas
The newborn heart has a spBrse sarcoplasmic reticulun
and T-tubule syst:en, yet it's an active contractile
organ early in gestation. Sirce mitochondria are a
significant membrane fraction in the newborn heart, are
the principal source of ATP and actively transport Ca++,
we hypothesized that newborn heart mitochoMria play a
greater role in maintaining intracellular Ca++
haneostasis. Heart mitochoMria (HH) were isolated fran
1,3,7,14,30,40 day old and adult (control) rabbits.
Yields of HH protein, respiratory and Ca++ transport
activity were measured. HH protein content was similar
in all age groups. The Vmax of succinate-supported Ca++
uptake was significantly higher in 1, 3 and 7 day HH
groups (p < .(01) canpered to controls. Vmax decreased
steadily with maturation and reached adult levels by age
40 days. Apparent KIn's for Ca++ uptake were leas in 1
day old HH (KnP24.9 j.tl) ~ed to all other age groups
(t<m-35.7 j.tl in adults). Succinate-linked respiratory
rates (State 3) were the SSDe in 3,7 day and adult HH
(392-419 natam>/min/~), but were slightly lower at
1,14,30 and 40 days. The high rate of Ca++ uptake
suggest newborn HH may play a greater role in
maintaining intracellular Ca++ homeostasis during early
myocardial developuent. These maturation changes in
Ca++ uptake do not appear to relate to un:ierlying
alterations in substrate utilization.
VALIDATION OF DOPPLER EOIOCARDIOORAPIDC
CALaJLATION OF DESCENDING AORTIC AND UMBILICAL
FLOW IN FETAL LAMBS
Klaus G. Schmidt. MD: Mariarosaria Di Tommaso, MD; Norman H.
Silverman, MD, FACC; Abraham M. Rudolph, MD, FACC.
University of California, San Francisco; San Francisco, CA.
In order to substantiate the accuracy of flow (Q) calculations derived
from cross-sectional echocardiography (CSE) and pulsed Doppler
ultraSOUnd in the descending aorta (QoA> and wnbilical vein (Quv) of
human fetuses, we studied 6 fetal lambs (gestational age 125±3 d,
weight 3±O.8 kg). In these animals we placed hind limb catheters,
an electromagnetic flowtransducer on the descending aorta just above
the iliac bifurcation as well as on the common wnbilical artery, and
an occluder around the wnbilical cord After closure of all incisions,
CSE and Doppler study was performed. The lower descending aorta
and the common wnbilical vein within the liver were imaged and
pulsed Doppler intenogation was performed at these sites. Mean
velocity, velocity time integra\, and bean rate were calculated from
Doppler tracings; vessel diameter and an~le of incidence were mea-
sured from CSE. Actual flow in each animal was varied by gradual
occlusion of the wnbilical cord; QoA ranged from 150 to 950, Quv
from 150 to 850 mlImin. Continuous flowtransducer readings were
calibrated against the radiolabeled microspbere technique. Using
linear regression analysis we compared 74 QoA and 25 Quv flow-
transducer measurements (x-axis) with calculated values obtained
from CSE and PD at the same time (y-axis). We found a good
correlation both for QoA (y=77+1.04x; r=O.95; SEE±71 ml/min;
p<o.OOI) and for Quv (y=54+ l.1x; r=O.93; SEE±75 mlImin;
p<O.OOI). We conclude that calculation of fetal QoA and Quv using
CSE and Doppler ultrasound is feasible and may provide useful
measurements in the human fetus. The combined CSE and Doppler
method may slightly overestimate the actual flow.
EXPERIMENTAL ANIMAL INVESTIGATIONS OF THE POTENTIAL FOR
NEW APPROACHES TO DIAGNOSTIC CARDIAC IMAGING IN INFANTS
AND SMALL PREMATURE INFANTS FROM INTRACARDIAC AND
TRANSESOPIlAGEAL APPROACHES USING A 20MHz REAL TIME
ULTRASOUND IMAGING CATHETER. Lilliam Valdes-Cruz, M.D. ,
FACC, David J. Sahn, M.D., FACC, Paul Yock, M.D., FACe,
lain Simpson, M.D., Renate Schmidt, James Arenson, David
Linker, Hira Thapliyal. Univ Calif, San Diego, CA.
We performed imaging studies on small open and closed
chest animals with a 20KHz real time ultrasonic imaging
catheter designed for intracoronary and intraarterial
studies to assess its applicability for providing imag-
ing of the heart from either an intracardiac or trans-
esophageal site. In 2, 10Kg dogs, intracardiac catheter
placement in the LA allowed imaging and measurement of
AO and mitral valve orifices and LV wall, and we·veri-
fied location and size of surgically placed 7mm atrial
septal defects. Detailed visualization of jugular veins
and carotid arteries and their walls was obtained during
catheter transit. High resolution coronary artery imag-
ing was also obtained with catheter placement in the AO
root. In 3 rabbits (3Kg) and 2 rats (6-800 gros), trans-
esophageal placement of the catheter allowed imaging of
AO valve, LA, mitral and tricuspid valves and the entire
AO arch and PA. A significant potential exists for using
these high frequency catheters as a guide to localiza-
tion of defects or for imaging from inside the heart
during balloon valvuloplasty in children and neonates.
Likewise, since no devices exist currently which allow
intraesophageal ultrasound studies in small premature
newborns and infants, this technology has potential for
allowing transesophageal studies for intraoperative
monitoring of congenital heart repairs and for imaging
premature babies with chest deformities, pneumomedia-
stinum or poor quality, non-diagnostic precordial
imaging studies.
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NONINVASIVE DISCRIMINATION OF RIGHT ATRIAL
ECTOPIC FROM SINUS TACHYCARDIA IN DILATED.
"CARDIOMYOPATHIC" HEARTS
BOIce D Gelb M D , Arthur Qarso.o., Jr., M.D.• F.A.C.C.
Baylor College of Medici.a.e, Housto.o.. Taas.
When. a patie.a.t with an enlarged, poorly fiulctionillg heart presents
with a rapid right atrial rhythm, the diag.o.ostic possibilities include
primacy dilated cardiomyopathy (CMP) with sinus tachycardia and
right atrial ectopic tachycardia (RAET) with seco.o.dacy cardiac
dysfu.o.ctio.o.. Because RAET may be overlooked and requires a.a.
intracardiac elecaophysio1ogic study for COJlf1ClllatiOll, we auempted to
identify distiJlguishiJlg features from .o.o.o.-invasive studies. We
reviewed restin& surface ECG, 24 hour ambulatory ECG (Holter).
a.a.d echocardiograms (echo) of patie.o.ts with the retrospective
diag.o.oses of RAET (.0.=34) and CMP (.0.=33) seen. at Texas Childre.o.'s
Hospital from I 980-prese.o.t. Age at ol1Set and sex were .o.ot
significal1tly different. Atrial rates 0.0. routine ECG were higher for the
RAETs (p<. 003) with 21~ of RAETs greater tha.a. 180 bpm; .0.0
CMPs had a rate over 180. Muimum Holter rates while awalte and
asleep, corrected for age, were sig.a.ifica.a.tly faster with RAET
(p<.OOS and <.02 respectively). The mea.a. P wave axis in the
horizollta1 pla.a.e was more posterior in RAET (p<. 01) with the
horizollta1 axis < O· (.o.egative in lead V2) in 8/29 AETs versus 1/31
CMPs (p<.03). I.a. RAET. P wave duratio.o. in lead VI was longer
(p... 03). I.o.verted, .o.otched P waves in VI were see.o. in 6/27 RAETs
but 0/32 CMPs (p<.02). PR interval was 10ngel' with RAET (p=.01);
2" AV block. was observed 011 ECG and/or Holter in 12/33 AETs but
0/33 CMPs (p<.OOI). Amongst patients with abllormally increased
LV elld-diastolic dimel1Sioll (for weight), AETs had a better
shortening fractioll (SF) than CMPs (26~ versus lS~, p<.Ol).
Severe dysfullctioll with SF~10~ was fOlll1d in 13/33 CMPs but only
1/27 AETs (p=.003). Conclysions: As compared to CMP. RAET
presented with faster atrial rates, with P waves of different orientatioll,
duratioll and morphology, with more AV block, and with better LV
flll1caoll in the preseJ1ce of LV dilatiOlL




CHARACTERIZATION OF THE PHASIC RESPONSES OF THE NEONATAL
SINUS AND ATRIOVENTRICULAR NODE TO BRIEF VAGAL STIMULATION
Arthur S. Piekoff, M.D., Adrienne Stolfi, Tulane Univer-
sity School of Medicine, New Orleans, Louisiana.
Responses of the sinus node and atrioventricular (AV) node
to single, brief trains of vagal stimuli were studied in
10 very young (3-12 days) neonatal canines. Neonates were
pretreated with 1 mg/kg propranolol IV, both cervical vago-
sympathetic trunks divided, and the proximal ends prepared
for stimulation. Single, brief trains of stimuli (143 Hz,
5 stimuli) were delivered at constant current to either the
right or left vagus (RVS, LVS) and were programmed to scan
the cardiac cycle. Intracardiac electrogramswere recorded
from catheters placed in the high right atrium and region
of the His bundle. Maximal prolongation of the sinus cycle
(SCL) was always observed when stimuli were delivered 10
to 20 msec after atrial depolarization, and the maximal in-
crease in SCL was greater during RVS (144±115 msec RVS,
106±97 mseC LVS, p <.05). SCL could not be prolonged when
stimuli were delivered later than 181±39 msec after atrial
depolarization for RVS and 178:t36 msec for LVS. A "double
inhibitory wave", reported frequently in adults, was ob-
served in only one neonate. A single peak of inhibition
occurred in most, returning to control SCL over '" 15 car-
diac cycles. During sinus rhythm, RVS and LVS most common-
ly resulted in only very small (7-10 msec) increases or
decreases in AV nodal conduction time (AH interval) while
during constant atrial pacing small, transient increases
in AH (5-22 msec, spanning cardiac cycle 3 through 6) were
most often observed. AV block was only observed in two
neonates. Developmental differences in the magnitude and
time course of the responses of the neonatal sinus and AV
node to brief vagal stimulation provides further evidence
for functional immaturity of the parasympathetic nervous
system at birth.
IMPACT OF COEXISTING HEART DISEASE ON OUTCOME OF SURGERY
FOR THE WOLFF-PARKINSON-WHITE SYNDROME IN CHILDREN
Ronald J.Kanter M.D., Joyce C. Pressley M.P.H., Douglas
L. Packer M.D., F.A.C.C., Eric N.Prystowsky M.D., F.A.C.C.
Duke University Medical Center, Durham, N.C.
The effect of coexisting heart disease (HD) on the out-
come of surgery for Wolff-Parkinson-White syndrome was
evaluated in 53 operated pts (age 12 ± 4 years, 0.8-16)
with 68 accessory pathways (AP) undergoing AP division.
Nineteen pts had coexisting HD: Ebstein's (Ebs)-7,
cardiomyopathy-6 (2 dilated, 2 hypertrophic, 2 tachycardia
induced), corrected transposition (1-TGA)-3, ventricular
septal defect (VSD)-2, and aortic stenosis-I. Of those 13
with congenital defects, surgery was performed primarily
due to arrhythmias in 7, defects in 3, and both in 3. In
those with HD, septal APs were more prevalent (14/26 vs
14/42), and left freewall APs less prevalent (4/26 vs
22/42) than in those without HD. Nine septal APs occurred
in Ebs or I-TGA. Anesthesia, bypass, intubation, and
intensive care unit times were longer for those with, than
those without HD (p(.05). APs from 48/49 pts were success-
fully ablated, requiring 2 reoperations in each group.
All 34 pts without and 15/19 with HD survived. Two pts
with Ebs, 1 with hypertrophic cardiomyopathy, and 1 with
VSD and pulmonary artery band died. Three of these had HD
as their primary indication for surgery, and required
extensive structural repair. Of 9 pta with acquired heart
block, 8 had septal APs and the ninth had I-TGA and under-
went tricuspid valve replacement. Only 2 of these 9 occur-
red since posteroseptal AP dissection modification. From
these data, we conclude that AP ablation in children is
highly successful. Our experience suggests that the
increased risk observed in those with other HD is related
to surgery for structural defects and not to AP ablation.
Tuesday, March 21, 1989
Poster Displayed: 2:00PM-5:00PM
Author Present: 3:00PM-4:00PM
Pacific Room, Anaheim Convention Center
Pharmacology of Antiarrhythmic Drugs
EFFECTS OF BRB-I-28 UPON LONGITUDINAL AND TRANSVERSE
CONDUCTION IN CANINE MYOCARDIUM
Eu&ene Patterson, Ph D , K, Darrell Berlin, Ph,D" Benjamin
J, Scherlag, Ph.D,. F,A.C,C, University of Oklahoma Health
Sciences Center and VA Medical Center, Oklahoma City,
Oklahoma
BRB-I-28, an experimental bicyclononane antiarrhythmic
drug, was evaluated in superfused canine epicardial tissue.
Before drug administration, conduction was more rapid
longitudinal (L) vs. transverse (T) to fiber orientation
(0.94±.06 vs. 0.44±0.4 M/sec, LfT velocity ratio- 2.2±0,2;
p<O.Ol). Vmax was larger for T vs, L stimulation (189±11
vs. 133±10 V/sec; p<O.Ol). With rapid pacing (250 and 500
msec cycle lengths). the L/T velocity ratio was increased
(2,3±0.2 and 2,4±0.2, respectively; p<0.05). BRB-I-28
administration (3.2, 10 mg/L) produced rate-dependent
decreases in Vmax at 500 and 250 msec cycle lengths for
both L (19±4, 30±6%; 24±5, 49±6%) and T (25±5, 30±5%;3l±5.
52 ±6%, respectively) (p-NS) stimulation. L conduction was
slowed to a greater extent than T conduction at 500 msec
(18±5 vs, 10±3%;25±6 vs. 20±3%) and 250 msec (29±6 vs. l8±
5%;35±5 vs, 2l±35) cycle lengths (p<O.Ol). Conduction and
Vmax at cycle lengths 1000 msec or longer were not altpred
by drug. Action potential duration was unchanged at 70'
(144±7 and 151 ± 9 vs. 142 ± 9 msec) and 90% (19l±7 and 200
± 8 vs. 188 ± 9 msec) of repolarization (p-NS). The slope
of the linear relationship between the square of conduction
velocity and Vmax was greater for T (1l45±128; R- 0.89)
than L (267±38 Vsec/HZ; R-D,94)(10 mg/L) conduction. The
data demonstrate a rate-dependent depression of T and L
conduction with BRB-I-28. L conduction is depressed more
than T conduction despite equivalent changes in Vmax. "BRB-
1-28 may independently delay sodium channel recovery and
decrease junctional resistivity.
QUINIDINE MYOCARDIAL PHARMACOKINETICS AND PHARMACO-
DYNAMICS: INFLUENCE OF HYPOXIA,
Anne M, Gillis. M.D., Rae Keashly, M.Sc" University of
Calgary, Calgary, Alberta, Canada
Enhanced electrophysiologic effects of some anti-
arrhythmic drugs have been observed during hypoxia (H),
To determine whether pharmacokinetic and/or pharmaco-
dynamic mechanisms are responsible for these changes,
the time course of accumulation of qUinidine (QD) and
changes in electrophysiologic effects were studied in
isolated rabbit hearts. The QRS duration, ventricular
effective refractory period (VERP) and monophasic action
potential duration (MAP) were measured during control
(95% O2 - 5% CO2) or H (95% ~ - 5% CO2) prior to andduring QD (31JM) perfusion. 11Ie steady state QD myo-
cardial concentration was significantly reduced during H
( 14. 5 ± 3, 6 ~g/g vs 22.8 ± 5, 2 ~g/g, p < . 02) . The
linear QD myocardial concentration-effect relationships
were enhanced by H. The slopes of these relationships
are shown (msec/~g/g):
QRS VERP MAP
.45 ± .17 3.02 ± 1.48 2.13 ± 1,07
.66 ± .18 4,66 ± 1.24 4.19 ± 0.69
p = ,08 p < .1 p < .025
QD significantly prolonged ventricular conduction time
during H compared to the control, nonhypoxic state
(~QRS = 7 ± 6 msec, p < .01). QD reVersed the hypoxia-
induced shortening of MAP and VERP. However, prolonga-
tion of MAP and VERP compared to the control, nonhypoxic
state was not observed.
Conclusions: Hypoxia alters QD myocardial pharmaco-
kinetics and pharmacodynamics. Although QD myocardial
concentration is reduced by hypoxia, QD myocardial
concentration - effect relationships are enhanced.
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a: p <0.05 respect to control
b: p<0.05 respect to transverse propagation
The lack of depression of 9 during T propagation associa-
ted with a marked depression of Vmax either during Land
T propagations suggest that together with the Na+ channel
blocking properties, AMI would induced a decrease in the
effective axial resistivity, which will be far more
apparent in the T propagation. This may account for the
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DIFFERENTIAL EFFECTS OF AMIOOARONE ON ~max AND CONDUCTION
VELOCITY IN ANISOTROPIC MYOCARDIUM.
Ricardo Quinteiro M.O .. Marcelo Biagetti B.Sc., Eduardo de
Forteza E.Eng., Teaching and Research Department, Favaloro
Foundation, Buenos Aires, Argentina.
Despite its widespread clinical uae, the precise mechanism
of action of Amiodarone (AMI) has not been completely
defined. We examine the effects of the Na+ channel blo-
cking properties of AMI (20 ugr/ml) on Vaax and conduction
velocity (9) during longitudinal (L) and transverse (T)
propagation to fiber orientation in 10 canine ventricular
epicardial strips. Heaned values t standard deviations are
referred to as normalized fraction (beat 48/beat 1) at two
different basic cycle lengths (BCL):
BCL 9L 9T
mse~ CONTROL AMI CONTROL
A single or combined application of the class la and Ib
antiarrhythmic agents are frequently employed in clinical
practice, although their precise mechanism of actions
and the rationale for the combined use have not been
clarified. Therefore, effects of a single or combined
application of disopyramide (Dis), as class la, and lido-
caine (Lid), as class Ib, on Vmax of action potentials
in guinea pig papillary muscles were examined using the
conventional microelectrode technique. Dis (100 uM)
suppressed Vmax at frequency between 0.1 and 3.3 Hz,
while Lid (100 uM) did it at higher frequency than 1.0 Hz.
The onset of the block was best fitted by two exponentials
(fast and slow component) in both Dis and Lid. The time
constants of the fast and slow component in Dis were
0.962 and 0.020 per beat, respectively, and they became
3.541 and 0.037 per beat in Dis + Lid. In Lid, the fast
and slow component had time constants of 2.853 and 0.060
per beat, respectively, and they became 2.496 and 0.043
per beat. The results indicate two different processes
or states for drug-receptor interactions. The use
dependent block (UDB) significantly increased at 1.0 Hz
or the higher frequency, when the application of Dis was
changed to Dis + Lid, whereas UDS became more prominent
at all frequencies except 3.3 Hz when Lid was followed
by Lid + Dis. The application of Lid + Dis to Dis only
did not change the degree of UDS. These results indicate
that the combined application of Dis and Lid increases
the block of vmax of action potentials compared to those
of a single use of either drug.
SYNERGISTIC ACTIONS OF DISOPYRAMIDE AND LIDOCAINE ON Vmax
OF ACTION POTENTIALS IN GUINEA PIG PAPILLARY MUSCLES
Masayasu Hiraoka, M.D., FACC, Akihiko Sunami
Dept. Cardiovasc. Dis., Tokyo Ked. & Dent. Univ., Tokyo,
JAPAN
ANTI-ADRENERGIC ACTION OF ADENOSINE IN A CANINE
MODEL OF CHRONIC MYOCARDIAL INFARCTION.
AkjhjkQ Mjyaiawa M.D., Amir Pelleg Ph.D., Carl Hurt BS, Leonard
S. Dreifus M.D. F.A.C.C., Eric L. Michelson M.D., F.A.C.C.,
Lankenau Medical Research Center, Philadelphia, Pennsylvania.
PREVENTION OF HALOTHANE-EPINEPRRINE-INDUCED CARDIAC
ARRHYTHMIAS WITH FRUCTOSE 1-6 DIPHOSPHATE.
Lorenzo A. Farias, MD, Cheng-Bin Xu, MD, Patrick H. Lehan,
MO, FACC, and Angel K. Markov, MD, FACC, Department of
Medicine, University of Mississippi, Jackson, MS.
mean ± SEM; p * < 0.02; • < 0.05
SummlllY: 1. Local myocardial adenosine shortened VRPs in both
normal and infarct zones without affecting ETs or HR. 2. Systemic
ISO increased HR and shortened VRPs more markedly than
adenosine. 3. Adenosine had a site specific action in attenuating
the effect of ISO on VRPs. Conclusion: Adenosine exerts an anti-
adrenergic action in vivo, which may play a role in its
antiarrhythmic and putative cardioprotective effects.
The antiarrhythmic effect of adenosine has been attributed to an
indirect, anti-adrenergic action. However, this action has not been
conclusively shown in vivo. To test this hypothesis, ventricular
refractory periods (VRP) at twice threshold stimulus intensity and
excitability thresholds (ET) were determined in normal (n=29 sites)
and infarct (n=25) zones, in the distribution of the left anterior
descending coronary artery (LAD), in 16 anesthetized dogs with
chronic myocardial infarction during continuous intra-LAD infusion
of either saline (control) or adenosine (ADN; 5 I!moVmin), before











0.10±.01 0.50±.17 135±5 ~
0.11±'01 0.48±.18 ~ 137±6*
0.10±.01 0.39±.14 *169±4
0.11±'01 0.36±.13 l68±5
Halothane (Hal) sensitizes the heart to arrhythmogenic
effects of Epinephrine (Epi). Fructose 1-6 diphosphate
(FOP) reduces occurrence of ventriculsr arrhythmias (VA)
in AMI in animals and man, and in digitalis intoxication.
Thus, we assessed whether FOP will prevent the occurrence
of VA in Hal (1.5%) anesthetized rabbits (n-14). The ar-
rhythmogenic dose of Epi to produce 4 or more PVC in 5 sec
for all rabbits was 6.05~.76!g/kg. Then, randomly half of
the rabbits received an IV bolus of 15Omg/kg and a con-
stant infusion of IOmg/kg/min of FDP lOX, while the rest
received the same amount of glucose 10%. Thirty min fol-
lowing treatment, Epi infusion was given every 15 min for
the next two hours. In the glucose treated rabbits, VA
occurred within 0.93+0.08 min for the same dose 5.67+0.48
~g/kg every time, whereas no VA were noted in the the FDP
group for the 3 min testing period, although the dose of
Epi was increased to 233.93~59.24~g/kg (p<O.OOOl). After
the two hour experimental period, some FOP-treated rabbits
received Epi from 500 up to 1600~g/kg over 10 min and no
VA could be induced. No differences in systolic or diasto-
lic arterial pressure were observed, however, the UR in
rhe FDP group did not incresse as it did in the glucose
controls (NS). Arterial pH was lower in the FOP group and
lactate higher (p<0.005 and p<O.Ol, respectively). Arte-
rial pe02 was higher in the FDP group (NS), whereas p02
was no different. FOP prevented Hal-Epi induced VA at .
doses up to 383 times greater of Epi than those admini-
stered in the rabbits treated with glucose. The mechanism
by which FOP prevented Ual-Epi induced VA is not known at
present but, it is thought to be metabolically mediated.
140A ABSTRACTS JACC Vol. 13, No.2
February 1989: 140A
PRODYSRHYTHHIA OF O-DEHETHYL ENCAINIDE: SUPPRESSION BY
COHBINATION WITH HEXILETINE
H.;. Duff, H.D., H. Rahmberg, Univ. of Calgary, Canada
The prodysrhythmia of Class Ic agents remains a major
limitation to their widespread clinical use. The pur-
pose of the present study was to develop a model to
study this prodysrhythmia and to define methods to
suppress it. Six chronically instrumented dogs were
studied late following occlusion-reperfusion (HI). One
week following HI all dogs had sustained ventricular
tachyarrhythmias (VT) induced by programmed electrical
stimulation (PES). Over 6 weeks, loss of ability to
induce VT occurred in all 6 dogs. O-demethyl encainide
(ODHE) was then infused as a series of loading and
maintenance infusions. While non-inducible prior to
ODHE, all had inducible sustained VT on DOME requiring
repeated cardioversions and one animal died. Hexiletine
(H) was then added to DOME infusion and PES was repeated
in 5 dogs. Combination therapy with ODHE plus H sup-
pressed inducible VT in 3 of 5 (p<0.05). Electrogram QRS
duration as an index of local conduction time (CT),
refractoriness (VERP) and pacing threshold (thresh) were
measured, in the normal, and infarct (IFZ) zones.
Results: mA, msec, x±SD, *p<0.05 from bas line
Baseline ODHE ODME + Mexiletine
Inducible VT 0/6 ~ 2/5*
IFZ QRS 61±21 71±16* 59±15
IFZ VERP 151±50 165±47 180t55*
IFZ Thresh 2.1±1.7 3.1±2.1 3.8t1.5*
Relatively low concentrations of ODHE alone (156-
360ng/mL) prolonged IFZ electrogram QRS associated with
prodysrhythmia. Co-administration of M suppressed
prodysrhythmia associated with shortening of IFZ
electrogram QRS, and prolongation of IFZ VERP. In con-
clusion, combination of mexiletine with ODHE alters the
balance between CT and VERP required for induction of
sustained VT and suppresses DOME prodysrhythmia.
INTRAVENOUS PROPAFENONE FOR CONVERSION OF ATRIAL
FLUTTER OR FIBRILLATION OF RECENT ONSET.
Leopolda Bianconi, Augusto Pappalardo, Roberto
Boccadamo, Rossella Broglia, Michele Pistolese.
Division of Cardiology, S. Filippo Neri,
Hospital, Rome, Italy.
The efficacy and safety of i.v. Propafenone (p)
in the treatment of atrial fibrillation (a£) or
flutter (AP) of recent onset were evaluated. P
(2 mg/kg) was administered to 70 pts. (mean age
62 ± 11.9): 57 with af and 13 with AF. 36 pts.
(51.41) reverted to sinus rhythm within 95 min
(mean 28.2 ± 25.6): 32/57 (56.11) with af and
4/13 (30.71) with AF. The efficacy of the drug
was influenced by the arrhythmia duration: 31/46
(67.31) pts in whom the onset of the arrhythmia
was < 48 hrs and only 5/24 (20.81) in whom the
arrhythmia lasted more than 48 hrs, were
converted (p < 0.001). In non converters the
mean ventricular rate was reduced from 141.7 ±
28.5 to 106.5 ± 2l.4/min. (p < 0.001). A mean
171 QRS lenghthening was observed (from 76.6 ±
31.9 to 89.5 ± 36.8 msec) (p < 0.001). QTc
interval showed no significant change. No
untoward effects were observed except for two
reversible low output syndromes.
Conclusions: i.v. Propafenone is a safe and
effective drug in restoring sinus rhythm in the
majority of pts with af of short duration and in
controlling the ventricular rate in the
refractory cases.
SHORT TERM VARIABILITY OF VENTRICULAR ARRHYTHMIA AND RAPID
ASSESSMENT OF DRUG EFFICACY.
Ernst A. Raeder, M.D., F.A.C.C., Stefan H. Hohnloser,M.D.,
Stephen C. Vlay,M.D., F.A.C.C., Thomas Meinertz, M.D.,
Linda Olson, R.N. SUNY Health Sciences Center, Stony Brook
New York and Cardiology Division, University of Freiburg,
(Germany).
Acute drug testing (ADT) has been proposed to abbreviate
the search for safe and effective antiarrhythmic agents.
Since spontaneous variability (SV) may invalidate the re-
sults we developed statistical criteria for arrhythmia
suppression and aggravation in 24 pts with high-grade ven-
triculararrhythmia (VA). To quantify SV 24 to 48-hourHol-
ter recordings were obtained at least 4 half-lives after
discontinuation of antiarrhythmic therapy. Two-tailed 95%
confidence limits were computed for each pt by linear re-
gression analysis of log-transformed ectopy counts where
each hour served as the independent variable and its suc-
cessor as the dependent variable. A single oral dose of
disopyramide 300mg, flecainide 200mg, or propafenone 450
mg was given after baseline studies. Lidocaine was infused
in doses up to 4 mg/min. A test was considered positive
when VA fell outside the calculated limits during at least
one of four hours following drug administration. In 50
ADTs the minimum decrease in VA consistent with a true
antiarrhythmic effect averaged 90.9%(interquartile range:
87.7-95.2) while a proarrhythmic response required an in-
crease of hourly VA by 947%(713-1412). Analysis of VA
using individual confidence limits resulted in 34/50 pos-
itive ADTs with 1.4+1.2 hours below the calculated thres-
hold. By contrast, ;hen a 70% reduction was required,43/50
ADTs were positive showing arrhythmia suppression during
2.2+1.2 hours. Thus, a threshold of 70% overestimated'ef-
ficacy in 9/50 ADTs when compared to individual regression
analysis. We conclude that individualized assessment of
SV may enhance the reliability of ADT.
EFFECTS OF FlECAINIDE ON ACTION POTENTIAL DURATION OF
HUMAN ATRIAL FIBERS.
Bruno le Grand Ph.D., Jean-Yves le Heuzey.M.D., Patrick
P~r1er M.D.. Thomas lavergne M.D., Sylvain Chauvaud
M.D., Pierre P~ronneau, Ph.D. and louis Guize M.D.,
INSERM U. 256 and Department of Cardiovascular Surgery,
Broussais Hospital, Paris, France.
In_7"rder to evaluate the effects of Flecainide (5 x
10 M) on cellular electrophysiologic properties of
human atrium, we studied by the micro-electrode technique
10 preparations obtained from patients undergoing cardiac
surgery. We measured action potential durations at 50
(APD 50) and 90 % (APD 90) of repolarization and cellular
refractory periods (CRP) at 4 cycle lengths (Cl) of
1600, 1200, 800 and 400 msec. The micro-electrode was
located in a space < 1 mm from the stimulating electrode.
The results were related to action potential (AP)
morphologies : group A (n = 5, mean age 12 + 2) with
triangular AP, group B (n = 5, mean age 52 '+ 2) with
AP exhibiting a plateau and an initial notch.- In group
A, we observed after Flecainide no significant increase
of APD 50, APD 90 and CRP at all CL. In contrast, in
group B, ADP 50 were increased at 1600 (24 %, p < .05),
1200 (31 %, p < .05) and 800 msec (34 %, p < .02).
Similarly ADP 90 were increased at 1600 (22 %, p < .01),
1200 (25 %, p < .001), 800 (26 %, P < .01) and 400 msec
(23 %, p < .01). Finally CRP were increased at 1600
(18 %, p < .01), 1200 (20 S, p < .01), 800 (24 %, p
< .001) and 400 msec (33 S, p < • 01).
In conclusion, at this concentration, atrial effects
of Flecainide depend on the morphology of AP. The increase
of APD observed in "plateau cellsI' could suggest an
effect of Flecainide on transient outward currents.
lACC Vol. 13, No.2
February 1989:141A
ABSTRACTS 141A
COMBINED THERAPY WITH TYPE Ie AND IB AGENTS:
IS IT EFFECTIVE FOR VENTRICULAR TACHYCARDIA?
1. Mawu; Wharton MIl. Douglas L. Packer, MD, Jodie L. Hurwitz,
MD, Katherine A. Thompson, MD, Edward L. C. Pritchett, ~1D,
Eric N. Prystowsky, MD. Duke Univ Med Ctr, Durham, NC.
To determine the efficacy of combining a Type IB antiarrhythmic
agent with a Type IC agent in patients with sustained ventricular
tachycardia (VT) refractory to a IC agent alone, we studied 18
patients (mean age 59±12 years; 16 males; 13 with ischemic heart
disease) with VT unsuccessfully treated with 3.9±1.1 prior antiar-
rhythmic agents. Mean LV ejection fraction was 3:J±J:3%. After
baseline electrophysiologic study (EPS) and unsuccessful treatment
:-vith a IC agent (10 encainide, 4 propafenone, 4 flecainide), the max-
Imum tolerated dose of a IB agent (17 mexiletine, 1 tocainide) was
added to the IC agent. Almost one fourth of the patients could not
tolerate IC+IB because of side effects at the lowest possible dose of
IB (3 pts) or spontaneous proarrhythmia (1 pt). Of the 18 patients,
12 (67%) had EPS off antiarrhythmic therapy, on a IC alone, and
with a IC+IB combination. The addition of IB to IC did not
significantly alter the PR, QRS, or QT intervals or the effective or
functional refractory periods comparea to IC alone. The mean
number of premature stimuli for VT initiation was not significantly
different at baseline (3.2±.9), with IC (3.0±.8) or IC+IB (3.0±.9).
Only 1 patient (8%) was not inducible on IC+IB. Greater difficulty
inducing VT (increase of 2 premature stimuli) occurred in only 1
patient (8%) compared to IC alone (or baseline). Greater ease of VT
induction (decrease by 2 premature stimuli) occurred in 1 patient
(8%) compared to IC (in 2 pts compared to baseline). Mean VT
cycle length at baseline (233±53 ms) was significantly (p <0.005) pro-
longed by either IC (365±97 ms) or IC+IB (376±75 ms), but the
means were not significantly different between treatment groups.
IC+IB increased the VT cycle length by 50 msec in 7 patients (58%)
and decreased it by 50 msec n 4 (33%) compared to IC alone. Thus.
in patients who have failed a lC agent, the addition of a IB agents
rarely prohibits VT induction and often causes adverse reactions
necessitating its discontinuation.
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DIRECf CORONARY VASODILATION INDUCED BY
INTRACORONARY VASOACfIVE INTESTINAL PEPTIDE
IN HUMAN CORONARY ARTERIES
Jeffrey J. Popma, M.D., Thomas e. Smitherman, M.D., F.A.e.e.,
John B. Bedotto. M.D., Eric J. Eichhorn, M.D., FAe.e., Sami 1.
Said, M.D. and Gregory J. Dehmer, M.D., FAe.e. VA Medical
Center and Univ. of Texas Southwestern, Dallas, TX.
Vasoactive intestinal peptide (VIP) is a neuro transmitter with
wide distribution including epicardial coronary arteries. When
given intravenously, VIP causes an increase In coronary blood
flow, but this effect may not be due to direct coronary
vasodilation since there are simultaneous systemic effects. To
evaluate its direct coronary effects, graded doses of VIP (0.03, 0.1
and 0.3 ug/min.) were infused, into the normal left coronary artery
of 6 pts. Coronary sinus VIP concentrations rose progressively at
eac!.\.. infusion (lo±2 [mean±SD] pwml at baseline (BL) to
llQ.I17 pwml at 0.3 ug/min; p<0.(5), but arterial VIP was
elevated (25±S pg/ml) only at the maximal dose of 0.3 ug/min.
During all dosages of VIP, heart rate, LVEDP, RA pressure and
myocardial O2 consumption did not change. Coronary sinus
blo<f flow (oy therI¥0dilution) progressively increased from
127-57 (BL) to 191.:I:.60 ml/min at 0.3 ug/min (p<0.05) and
coronary vascular resistance progressively decreased. Myocardial
arteriovenous O2 differen~e and ~ercent 02 eXlractionpr~ressively decreased (1l8I12 to 63-25 milL and 64X-5% to
36I15%, respectively; both p<0.05 from BL to 0.3 ug/min).
Neither mean AO pressure nor LV dP/dt changed significantly at
doses < 0.3 -rg/min, but at 0.3ug/min, mean AO pressure
decreased (97-~ to 92±15 rmHg, p<O.OOl) and LV dP/dt
increased (1648I220 to 1809I226 mmHg/sec, p<0.OO2). We
conclude that VIP has a direct coronary vasodilating action and,
thus may playa role in the regulation of coronary resistance in
man.
DISOPYRAMIDE INDUCES UTERINE CONTRACTIONS IN PREGNANCY
Andre Keren H.D,. Ofer Tadmor H.D., Daniel Rosenak H.D.,
HichaelGal H.D., Hichael Shaia H.D., EI iezer Horenstein
H.D., Yoram Diamant H.D., Shlomo Stern H.D., F.A.C.C.
Bikur Cholim Hospital, Jerusalem, Israel.
At time of delivery maternal and newborn 0 serum
levels were O.93±0.4mg/l and 0,33±0.2 mg/l, respectively
(umbilical cord/maternal level ratio 0.36; r-0.73,
p<O.005), IhY.l: 1) 0 induces regular UC and labor.
Therefore its antiarrhythmic use should be avoided
during pregnancy 2) 0 should be further evaluated as an
alternative therapy for induction of labor.
EXCIMER LASER IRRADIATION INDUCES ENDOTHELIUM-
INDEPENDENT RELAXATION OF VASCULAR SMOOTH MUSCLE
P Gabrjel Stegr M D , Anthony J. Ronqione B.A., Dov
Gal D.V.M., Stephen T. DeJesus B.A., Richard H. ·Clarke
Ph.D., Jeffrey M. Isner M.D., F.A.C.C., St. Elizabeth's
Hospital, Tufts School of Medicine, Boston, MA.
Recent studies have demonstrated that continuous wave
laser (L) irradiation (I) induces contraction of
vascular smooth muscle (VSM) except at powers «0.1 W)
far below threshold for tissue ablation. To determine
the corresponding effects of pulsed LIon VSM tone,
rings (n-33) of rabbit aorta were mounted isometrically
with 1 g of tension in Krebs-bicarbonate buffer and
irradiated with 308 or 351 nm from an excimer L via a
400-um fiber. A total of 250 exposures were performed
using 1-7 mJ/pulse (fluence - 0.8-5.5 J/cm2 ), 10-100
Hz, and cumulative exposures of 10-120 sec. Excimer L
irradiation, in various combinations of pulse energy
(PE), repetition rate (RR) , and cumulative exposure
below, at, or above threshold for tissue ablation,
produced relaxation unaccompanied by contraction in
everyone of 250 exposures. Magnitude of relaxation
(reduction in recorded tension, Rmax,)-55±4% (~SEM) of
maximum vasomotor reactivity observed in response to 5-
HT. Rmax increased as a function of both I?E and RR:
increase in PE from 1 to 5 mJ/pulse (n-13) increased
Rmax from 57±19 to 80±19% (p<O. 0001); increase in RR
from 10-50 Hz (n-10) increased Rmax from 27±8 to 46±8
(p<O.OOOl). Rmax was unaffected by status of
endothelium or wavelength (308 vs 351 nm).
Simultaneously recorded time-temperature profiles
disclosed that during pulsed LI, tissue temperature
rise was never >SoC. Thus, in contrast to continuous
wave LI, pulsed LI does not cause contraction of VSM,
but instead induces a relaxation response. The fact
that the excimer LI does not produce contraction of VSM
could represent an important advantage for attempts to








We evaluated the effect of disopyramide (D) on uterine
contractions (UC) in late pregnancy using a double-blind
placebo controlled protocol. Included were 20 consecu-
tive healthy women, referred for induction of labor af-
ter the 38th week of pregnancy. Ten randomly assigned
pts received 0 150 mg TID and 10 pts received placebo.
If regular UC were not achieved within 48 h, conventio-
nal methods of labor induction were used. Clinical/ob-
stetric features, maternal ECG, fetal heart rate monito-
ring and estimated fetal weight were similar in the
groups. There were no maternal or fetal complications,
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During ct, local electrograms showed delay and fractionation resulting In
Increased total activation time from 62±20 msec during C to 117;1:50 msec In
IZ (p<0.05). Followtng G, local activation times significantly (p<o.ol) Improved
to 76;1:22 msec In IZ. We conclude that Ischemia-induced Increase In K+ 8nd
associated eIeclrophyslologlcal changes were ameliorated by a drug that
speclllcally blocks the cardiac ATP-sensltlve K+ channel. This provtde8 a
novel approach for management of malignant arrtlythmlas associated wtlh
early phase of acute Ischemia.
INDEPENDENT EFFECTS OF HYPOXIA AND GLUCOSE DEPRIVATION
ON THE B-ADRENOCEPTOR-ADENYLATE CYCLASE SYSTEM IN
CULTURED NEONATAL RAT VENTRlCllAR MYOCYTES
Krishna Rocha-Singh M D , Norman Honbo M.S., Joel S.Karliner
M.D., F.A.C.C. Department of Medicine, V.A.M.C. and CVRI
University of California, San Francisco, CA.
We explored the effects of two components of ischemia,
hypoxia and glucose deprivation. on the B·adrenerglc
receptor(BAR)-adenylate cyclase system in a model of sublethal,
reversible injury in cultured neonatal' rat ventricular myocytes.
Buffered glucose containing medIum was gassed with a 95% N2/
5% C02 mixture 10 a average p02 48 Torr, pH 7.35, at 37° C.
After 2 hrs. of hypoxia cell surface BAR density (3H CGP-
12177) decreased from 54.8 ± 16.8 (SO) to 39.0 ± 12.5
fmoVmg protein (n-l0, p<.05) while cytosolic B-AR density
(125,·CYP) in creased 49% (n-3, p<.05). Upon re·exposure to
02 for 2hrs.(reox) medium p02 and cell surface BAR density
returned toward control levels(n-5). Cells exposed to hypoxia and
reox without glucose exhibited similar alterations In BAR density.
In hypoxic cells incubated with 5 mM glucose, 1 11M (-)-
norepinephrine (NE)·stimulated cAMP generation increased from
29.3 ± 23.8 to 54.2 ± 36.7 pmoVwell (n-5, p<.025); upon reox
cAMP levels remained elevated above control levels (n-5, p<.05).
In contrast, NE·stimulated cAMP content In glucose deprived
hypoxic myocytes fell by 31% (n-5, poe.05) and did not return to
cc:lntroiievela with reox. ATP levels in cells Incubated In glucose·
free hypoxic medium dropped from 2.58 ± 0.54 to 1.54 ± 0.36
nmoV30 mm plate (n-7, p-.02); levels were unchanged from
control In cells exposed to glucose-containing hypoxic medium
(n-7). BAR-agonist affinity, 1·100 11M forskolln-stlmulated
cAMP generation and GI as assessed by pertussis toxin catalyzed
ADP·rlbosylatlon using SDS PAGE were unchanged In hypoxic
cells regardless of glucose content. We conclude that 02 and
glucose deprivation Independently regulate BAR density and













EFFECTS OF GLYBURIDE ON ISCHEMIA-INDUCED CHANGES IN
EXTRACELLULAR POTASSIUM AND LOCAL MYOCARDIAL ACTIVATION:
A NOVEL ANTIARRHYTHMIC MECHANISM
Soad Bekhelt MD FACC, Mark Restivo PhD, Raphael Henkin MS, Mohamed
Boutjdlr PhD, Kaveh Gooyandeh MS, Robert Jean-Bart MD, Celvln Williams
MD, William B Gough PhD, Nabll EI-Sherif MD FACC. SUNY Health Science
and VA Medical Centers, BroOklyn, NY.
Increased extracenular K+ (K+) has been Implicated In depression of
membrane properties, conduction disorders and malignant ventricular
arrtlythmlas dUring the early phase of acute Ischemia. It has been recently
suggested that Ischemia-Induced Increase in K+ Is due to activation of an
ATP-dependent K+ channel. Glyburlde (0) Is an oral hypoglycemic known to
block this channel. We investigated the effects of G on Ischemia-Induced
Increase of K+ and local myocardial activation In 9 dogs. Continuous
recordings of K+ by K+-sensitive electrodes and local bipolar electrograms
were obtained from normal (N), border (B) and Ischemic (I) zones during
control (C), followtng 10 minutes of reversible OCClusion of the LAO coronary




THERAPEUTIC LEVELS OF TOCAINIIX PRODUCE
DELETERIOUS I-£MODYNAMIC AND CLINICAL EFFECTS IN
SEVERE HEART FAILURE. Stephen S. Gottlieb MD, Marrick L.
Kukin MD, Norma Medina RN, Madeline Yushok RN; Milton
Packer, MD, FACC. MtSinai School of Medicine, New York, NY
Tocainide (TOC) exerts minimal cardiodepressant effects in
pts with normal LV function, but the hemodynamic response to
TOC in heart fail.ure (CHF) has not been assessed. We evaluated
fhe effe:ts of a single dose of TOC (600 mg orally) in 22 pts with
severe CHF (LV ejection fraction<40%) who were clinically
sfable at the time of right heart catheterization. Cardiac index
(CI, l/min/m2), stroke work index (SI,\~, g_m/m2 ), meon arterial,
LV fitling and mean right atrial pressures (MAP, LVFP, & RAP,
mm Hg), heart rate (HR, bpm), systemic vascular resistance
(SVR, d-s<) ard serum TOC levels (ng/mll were measured before
(pre) ard I.S to 2.5 hr after TOC; YkIere * =p <.05 (pre vs TOC)
CI SWI MAp LVFP RAP HR SVR
Pre 2.2 26 85 19 7 77 1836
TOC 1.8* 18* 84 24* 10* 81 * 2098*
LV function deteriorated significantly after Toc, as reflected by
.. in CI ard SWf ard t in LVFP and RAP. TOC also t HR and
SVR, probably due to reflex activation of neurohormonal
systems. No pretreatment hemodynamic or clinical variable
predicted the hemodynamic response to TOC in these pts.
Following TOC, 8 of the 22 pts (36%) developed new-onset
dyspnea at rest coincident with the deterioration in LV function.
These 8 pis experienced a greater" in SWI after TOC than the
14 pts who remained asymptomatic at rest (39% vs 22%, p <.05).
Serum TOC levels ranged from 2.2 to 9.2 ng/ml (mean
5.3 ± 0.4) and were all within or below the therapeutic range.
There was no relation between TOC levels ard the change in SWI
following TOC (r = 0.06). The mean TOC level in the 8 pts who
deteriorated clinically was similer to that in the 14 pts who
remained stable (5.6 vs 5.2 ng/mll, p = NS.
In conclusion, therapeutic levels of TOC can cause important
deleterious hemodynamic ard clinical effe:ts in severe CHF.
THE MECHANISM RESPONSIBLE FOR LASER-INDUCED
PHOTORELAXATION OF VASCULAR SMOOTH MUSCLE IS LIMITED TO
ULTRAVIOLET AND VISIBLE WAVELENGTHS.
Anthony J. Rongione, B.A., Dov Gal, D.V.M., Stephen T.
DeJesus, B.A., Saurabh Chokshi, M.D., Richard H.
Clarke, Ph.D., Jeffrey M. Isner, M.D., F.A.C.C., St.
Elizabeth's Hospital, Tufts Medical School, Boston, MA
It has previously been shown that laser (L) irradiation
(I) of vascular smooth muscle (VSM) with a pulsed L at
any fluence, or a continuous wave (CW) L at powers
sufficiently low to avoid significant rise in tissue
temperature (T) may induce reproducible reduction in
vascular tone, i. e. photo-relaxation (PR). The
mechanism responsible for PR, however, remains
enigmatic. Accordingly, we investigated the hypothesis
that PR of VSM is wavelength-dependent. Segments of
normal rabbit aorta were mounted in Krebs bicarbonate
buffer with resting tension-1-2 g. Isometric tension
and tissue T were then recorded during LI with
ultraviOlet (UV), visible (Vis), or infrared (IR) L
light. LI with both 308 and 351 nm from a UV pulsed L
consistently (n-58) produced endothelium-independent
(endo-indpt) PR (280±18mg) (l!\±SEM) at fluences from 1-
5J/cm2 . LI with 488 and 514 nm from a Vis CW L at
powers <0.1 watt consistently produced endo-indpt PR
(128.tllmg). In contrast,LI both in the near IR (1060
nm) from a CW L, and mid IR (2.1um) from a pulsed L
failed to produce PRo At 1060nm, powers as low as .02
watts with exposures (n-65) of 20 sec produced only a
1 0 C rise in tissue T; yet vasomotor reactivity was
limited to contraction or no response. At 2.1 um
(n-80), pulse energies of 5 to 300 mJ/pulse with
repetition rates of 5-10 Hz again produced tissue T
elevations limited to <10 oC, but in no case produced PR
of VSM. These findings were true for segments in which
the endo was intact or purposely denuded. Thus, PR of
VSM is a wavelength-dependent, endo-indpt phenomenon
limited to UV and Vis wavelengths I














ENDOTHELIUM-MEDIATED VASCULAR RESPONSE TO
LEUKOTRIENE 04 AND ACETYLCHOLINE.
pan Lawson. B.S.. Jawahar Mehta. M.D.• F.A.C.C., Wilmer
Nichols. Ph.D., F.A.C.C., Paulette Mehta, M.D., University of
Florida. Gainesville. Florida.
Entry of leukocytes during coronary reperfusion relates to
myocardial 'reperfusion injury' mediated via release of
superoxide radicals and leukotrienes (LTs). To examine the
effect of reperfusion on coronary vascular responses to LTD4.
8 dogs were subjected to circumflex (Cx) occlusion for 1 hr.
followed by reperfusion for 1 hr., while LAD was kept patent.
Following reperfusion. Cx (distal to occluder) and LAD
coronary arterial rings were precontracted with serotonin and
then exposed to LTD4 (10-9 to 2x10-SM) and ACh (1o-6M) in
an organ bath at 37°C. LTD4 caused a concentration-
dependent relaxation of precontracted LAD coronary rings.
ACh also relaxed these rings indicating intact endothelium and
release of endothelium-derived relaxing factor (EDRF). In
contrast, LTD4. as well as ACh. failed to induce relaxation of
coronary rings from the reperfused ex. suggesting loss of
EDRF. Since superoxide radical release causes breakdown of
EDRF. 3 other dogs were treated with superoxide dismutase
(SOD) prior to Cx reperfusion. In these animals, relaxation of
arterial rings from the reperfused ex was preserved. These
data suggest that coronary reperfusion results in loss of
vasorelaxant effect of LTD4 on precontracted vessels.
Administration of SOD prior to reperfusion protects against loss
of EDRF and thus maintains the vasorelaxant effect of LTD4.
"UP-REGULATION" OF GTP BINDING PROTEINS FOLLOWING CARDIAC
PARASYMPATHECTOHY - QUANTITATION BY IHHDNOBLOT METHOD.
Timothy Hodges, Ph.D., John Bailey, M.D., F.A.C.C.,
~~~ F.A.C.C., Krannert Institute of
Cardiology, Indiana Univ. Sch. of Med., Indianapolis, IN
Functional parasympathetic denervation of the myocardium
is produced by several disease processes in man. In a
canine model of selective cardiac parasympathectomy, we
have preViously demonstrated an increase in the membrane
density of the pertussis toxin substrates Gi and Go, but
used the indirect method of ADP ribosylation to quanti-
tate these proteins. The purpose of this study was to
directly quantitate the membrane density of the a subunit
of these GTP binding proteins using a specific antibody.
Sarcolemmal vesicles were prepared from normally inner-
vated canine ventricle (NI), and from ventricle 5 days
following selective cardiac parasympathectomy (PS)
(Method of Randall). U-49 antiserum (gift of A. Gilman)
was used to quantitate the density of a SUbunit in these
membranes. Sarcolemmal membrane proteins were separated
on SDS-PAGE and transferred to nitrocellulose. The anti-
serum reacted specifically with a single protein band




.significantly different from NI p=.009.
Increases in the density of the a subunit quantitated by
illllDUnoblot parallel the increases determined by ADP ribo-
sylation. These data confirm that membrane density of
GTP binding proteins is increased following PS, Go has
been shown to directly regulate sarcolemmal Ca channels.
Increases in the density of GTP binding proteins could




Gilbert MD, Michael R. Bristow MD PhD,
Salt Lake City, Utah
During heart fail ure the B-adrenergic receptor
pathways are markedly down-regulated and subsensitive to
B-agonist stimulation. In this stUdy we used isolated RV
trabeculae to compare isoproterenol, a nonselective full
agonist; zinterol, a 82 selective partial agonist;
dopamine, a direct partial agonist with indirect actions
(releases norepinephrine, (NE»; and dopexamine, a
dopamine derivative that also blocks NE reuptake.
Nonfail i ng hearts were obta ined from organ donors whose
hearts were not used for cardiac transpl ant. Fail i ng
hearts were from patients with either idiopathic dilated
cardiomyopathy or ischemic heart disease undergoing
transplant. Transplanted (TX) hearts were from patients
undergoing retransplantation due to graft
atherosclerosis. Contractile responses to these agonists
and tissue NE levels were:
Net Max mg Tension and Tissue NE. nglg
Agonist . Nonfail ing Transplant
Isoproterenol 1935 ± 417 2178 ± 839
Zinterol 1112 ± 173 894 ± 463
11Dopamine 1450 ± 600 443 ± 208
Dopexamine 1260 ± 320 454 ± 11011
Tissue NE 1799 ± 299 16 ± 16*
*p<0.05, IIp<.10 compared to nonfailing
Conclysions; Although there was reduced efficacy for all
agonists but zinterol in failing vs nonfailing hearts,
the reduct ions were greatest for dopamine and
dopexami ne. The responses to these two agonists were
also reduced in TX hearts, indicating that denervationl
1ack of rel easabl e NE may contri bute to the reduced
efficacy of indirect acting amines in heart failure.
Ia-HC MECHANISMS UNDERLYING POOITIVE alRCNOrROPlC E:F'F'ECl'S
OF HISTAMINE 00 THE RABBIT ATRIOVEm'RlCULAR NODE.
Hideo Tanaka M.D., Masao Nishimura M.D., Yoshizumi
Habuchi M.D., Takeshi Noda M.D., Nobuo Homma M.D., Yoshio
Watanabe M.D.,F.A.C.C., cardiovascular Institute, Fujita
Gakuen Health University, Toyoake, Aichi, Japan.
To elucidate the ionic mechanisms underlying positive
chronotropic effects of histamine (HST), microelectrode
and voltage clamp experiments were conducted in small
preparations (0.2 x 0.2 x 0.2mm) of the rabbit atrio-
ventrigular node. HST at concentrations ranging from 10-7
to 10- M caused a sigmoidal increase in the sff'ntaneous
firing frequency with a Kd of 3 x 10- M. HST
significantly increased the action potential amplitude,
maximal rate of depolarization and rate of diastolic
depolarizatio~The action potential duration remained
unchanged probably due to the increased spontaneous
firi~g rate. These effects of HST were antagonized by
10- M cimetidine. Voltage clamp experiments us~ng
double microelectrode method revealed that HST at 10- M
increased the slow inward current (IBj ) activated on
depolarization from -40 to -10mV by Il ± 18% (p<0.05,
n=6) without significantly changing the kinetics of its
recovery from inactivation. The same concentration of HST
increased the outward K current (lK) tail obtained on
repolarization from +10 to -40 mV by 21 ± 2% (p<0.05,
n:6). The hyperpolarization-activated inwa~ current (lh )
was similarly increased by HST. HST at 10- M frequently
imuced a transient inward current en depolarization from
-40 mV to potentials more positive to -20 mY. 2-pyridyl-
ethylamine, an H1 agonist, increased lsi in the presenoe
of cimetidine, but required higher concentrations than
HST. These results suggest that HST enhances automaticity
of the rabbit atrioventricular node mainly by increasing
lsi' and this action appears to be predominantly mediated
bY H2 receptor activatien by HST.
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CARDIOVASCULAR EFFECI'S OF PLAlELET-ACTIVATING
FACTOR IN CONSCIOUS DOGS
David W Mathias. MD. Timothy W. Behrens, M.D., James S.
Goodwin, M.D., H. Sidney Klopfenstein, M.D., F.A.C.C.,
Veterans Administration Medical Centel', Milwaukee, Wisconsin and
Bowman Gray School of Medicine, Winston-Salem, North Carolina.
Platelet-activating factor (PAP) is an endogenous membrane
phospbolipid, implicated as a mediator of anaphylaxis and
endotoxemia. We examined the effects of systemically administered
PAP (.4 uglkg as an IV bolus) in 5 unanesthetized mongrel dogs.
Results:
Time RAP HR AoBP CO
(Min) (mmHg) (B/min) (mmHg) CUmin)
Base 4.2 ± 0.8 112 ± 12 86 ± 2 3.9 ± 0.4
1 0.9 ± 2.0# 115 ± 20 64 ± 5# 1.8 ± 0.3#
5 -0.4±l.S# U6±18 73±5# 2.1±0.3#
10 0.4 ± 1.4# 113 ± 19 87 ± 3 2.5 ± 0.3#
20 1.0 ± 1.2# 117 ± 17 85 ± 2 2.6 ± 0.3#
(Mean ± SE; # P < .05 versus baseline)
PAF produced striking declines in intravascular volume and cardiac
filling p':Cssures, sys.temic hypotension, peripheral vasoconstriction,
and persIStent elevations of pulmonary vascular resistance.
Pretreatment.with SRI 63-675, a selective PAP receptor inhibitor (10
mglkg), aboltshed all of these hemodynamic and cardiovascular
derangements associated with PAP injection. We conclude that PAF
has profou~ c~oyascular effects, in conscious dogs, which mimic
well~ clinical shock states. Further, selective PAP receptor
antagomsts such as SRI 63-675 offer promise in attenuating the
hemodynamic deran$ements associated with endotoxemia and
anaphylaxis in the clinical setting.
EFFECT OF a-TOCOPHEROL (\'ITA~m.; E) 0\ REGIO:'.:.-\l.
Fl);CTIO;>.; I).; STC;>.;:'.:EO ,!YOCAROIC.I
--"rnd Buch\rald \1.0., Hermann H. Klein ,1.0 .• Stefanie
Lindert, Sybille Pich. Klaus );ebendahl ~I.D .. Chrisrlna
lnrerberg ,1.0., Heinrich Kreuzer ,1.0., Dept. of C:lI'diology.
l'ninrsity of Giirringen. FRG.
Ox~'gen free radicals ha,'e b.!en slJggest~d ~o cause 10"0-
c3rdial damage resulting in prolonged ~on[ractile dep~es­
sion follo\l'ing brief periods of regilmal rn~'ucar~!ai isch"mia.
In pigs ;lie infused either rile natural ant:o:ddant a-toco-
pherol (TOC) as its \\ater soluble acetate (0.:) g kg i,'.
n=6) or saline (n=6) three times during one .;:"ck. There-
after. thoracotomy \ras performed and the distal left an-
terior descending coronar~' artery occluded for 8 min, fol-
lowed by 90 min reperfusion (REP), Hearts weJ'2 paced at a
rate of 100 min. Regional segment shortening (55) was
measured by ultrasonic crystals in ischemic-r·,perfused (1-
REP) and control zones. Plasma level of TOC (HPl.C) was
1-l8.9i+~I.-l7 ~gml in the treatment group (T) and 0.51+
0.1.1 j.Jg/ml in the control group (C). ~Irocardial tissu,) level
of TOC was ele,'ated to 9:3.15+1-1.78 ~g'g in T. compared to
-1.08+0.60 ~g/g in C. \Ialondialdeh~'de concentration i,n 1-
REP myocardium was lower In T (-1-<1.9+59.6 vs 500.9+7:!.i
nmolesig). Systolic l.VP and LV dP'dt max remained stable
throughout the protocol in both groups. 5S in the I-REP
zone was negati,'e during occlusion and rapidly normalized
within one minute of REP in both groups. During the fol-
lowing 10 min, SS decreased to 52 +6 '!O of preischemlc
control In T and to 5.1 + 7 " in C (n.s.). 5S remained at
these depressed values throughout 90 min REP. Conclusion:
Pretreatment with the natural antioxidant TOC reduces
llpid peroxidation in I-REP myocardium, but fails to pre-.
vent the development of myocardial contractile depression
arter a short period of ischemia.
PLASMA AND HEART TISSUE LEVELS OF FLECAINIDE AFTER SINGLE
VERSUS MULTIPLE DOSES: IS THERE A Ro\TIONALE FOR
INTERMITTENT USE?
Hans W LoUWerenburg MD, J. Herre Kingma ,MD , Roy L.
Mcquinn,PhD, Shaw F. Chang, PhD , Aldora L. Miller,PhD,
Department of Cardiology, St. Antonius Hospital.
Nieuwegein, the Netherlands.
Flecainide acetate(F), a class Ic antiarrhythmic drug,
is used for chronic prophylactic treatment of various
arrhydulias(A) , but may also convert recent onset atrial
fibrillation. To investigate the rationale for episodic
versus chronic treatment with F we studied the tissue/
plasma level ratio after single and multiple dose use of
F. We studied plasma levels (PL) and right atrial tissue
levels (TL) in 13 pts, with normal left ventricular
ejection fraction, undergoing elective coronary artery
bypass grafting(CAllG). Silt pts(group A) received 100 mg
oral F prior to start of extracorporal circulation(ECC), 7
pts(group B) received 100 mg oral F b.i.d. during two days
before CABG, the last dose was given as in group A. Also
ECG conduction parameters( PR-interval, QRS duration and
JTc-interval, written at 100 lIIIl/sec) were obtained at
baseline and together with PL and TL of F, prior to start
of ECC., In group A mean PLITL ratio was 28.8(median 20.1,
SD 26.1), in group B mean PL/TL ratio was l8.9(median
17.8, SD 7.0); p-NS. Correlation c06fficient(R) of PL and
TL was 0.64(A:0.6l, B:0.66). R of PL and changes in PR-
interval, QRS duration and JTC-interval were 0.34, 0.50
and 0.31 respectively(resp). R of TL and changes in PR-
interval, QRS duration and JTc-interval were 0.60, 0.36
and 0.20 resp .
Conclusipns' Plasma/tissue level ratio of F did not differ
in group A and B. This supports a theoretical rationale
for intermittent oral use in exacerbations of A. further-
more R of PL and changes in cardiac ~onduction parameters
is poor and does not improve when applying TL of F.
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INCREASED CONTRACTILITY· INDUCED BY ALPHA ADRENERGIC
STIMULATION IN SEPTIC RAT HEARTS
Craig Goldstein, M.D., Eric Rackow, M.D., FACC, Mark Astiz,
M.D., Paul Karlinsky, Dave McKee, Max Weil, M.D., Ph.D.,
FACC, The Chicago Medical School, North Chicago, IL
Decreased myocardial responsiveness to B agonists during
sepsis has been reported, but a adrenergic response has
not been studied. We used a Langendorf preparation to
study the inotropic response to a agonist phenylephrine
(PE) in septic rats (SE). Sepsis was induced by cecal per-
foration. Sham operated rats (SH) served as controls.
Three hours after surgery, the hearts of 5 SE and 5 SH
were excis!1 and perfused with oxygenated buffer contain-
ing 5 x 10 M propranolol. An additional 5 seE~ic rat
hearts were perfused with propranolol plus 10 M prasozin
(SEP). A latex balloon was placed in the left ventricle to
measure max dP/dt at a standard preload. Mearts wgre in-
crementally bolus dosed with PE from 10-1 to 10- to moles.
Baseline max dP/dt was 2140 t 127 mmHg/sec in SH, 1731 t
127 mmHg/sec in SE and 1384 t 75 mmHg/sec in SEP (P< 0.05
SH vs SE, SEP). The percent increase in max dP/dt from
baseline (efficacy) at higher doses was greater in SE.
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These data suggest that alpha adrenergic agonists may be
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Thrombosis and Thrombolysis
AHTITHIlOIlllOTIC THERAPY: IS THI COIUlUIATIOII OF ASPIRIII
ABO IIITROGLYCERIII BEIIEFICIALf
Kichael Johnstone. K.D., Jules Y.T. La1a, K.D.,
F.A.C.C., Chantal Lachapelle, Jean-Cilles Latour,
Ph.D., David Waters, K.D., F.A.C.C., Kontreal Heart.
Institute, Kontreal, Canada.
Aspirin and nit.roSlycerin are frequently used tosether
and each possesses potent plat.elet inhibitor properties
which may be mediated throush different mechanisms. To
assess their potent.ial antiplatelet interaction, va
studied platelet deposition ex vivo onto exposed aortic
media prepared from normal piss and placed in well cha-
racterized cylindrical flow chambers of 1 _ di8llleter.
By means of a peristaltic pump, non-anticoagulated ar-
t.erial blood was drawn into t.he flow chambers from con-
trol pigs and pigs pre-treated wit.h aspirin (40 III&/day
for 3 days), IITG or both druss, at 20 ml/min for 5
min., fo£' a calculated shea£' £'ate of 1690 see-I. IITG
was infused to p£'oduce a 10j:4'J. fall in _an a£'terial
p£'essu£'e. Platelet deposition (PD X 106 per media)
was quantit.ated usins aut.olosous IIIIndium labeled
platelets injected 18-24 hrs before the experiment, and
are show:
n ~
Cont£'ol 8 55.5~ .6
Aspirin 8 26.2t5.3
IITC 8 37.7d.5
Aspirin plus IITG 8 11.0j:4.7
IITG vs Aspirin plus IITG, p<0.03
Thus, both aspi£'in and IITG deereas. platelet deposit.ion
onto exposed aortic media, and the antit.hrombotic pro-
perty of t.he combination may be additive and benefi-
cial. Cyclo-oxysenase inhibition may not attenuate the
anti-platelet effects of IITG.
N-ACETYLCYSTEINE POTENTIATES IV NITROGLYCERIN IN
INHIBITING PERIODIC PLATELET THROMBUS FORMATION IN
STENOSED DOG CORONARY ARTERIES.
John D. Folts, Ph.D., F.A,C,C" Jonathan Stamler, M.D.,
Joseph Loscalzo, M.D., Ph.D., F.A.C.C., Univ. of
Wisconsin Medical School, Cardiology Section, Madison, WI
and Dept. of Medicine, Harvard Medical School, Boston, MA
The antianginal effects of IV nitroglycerin (NTG) in
Pts with coronary disease are usually attributed to a de-
crease in preload and coronary vasodilation, although
high doses of NTG inhibit platelet aggregation in vitro.
We have shown that IV NTG 10-17 IIg/kg/min for 24 min
inhibits acute platelet thrombua formation (APTF) in our
dog model of stenosed coronary arteries. We studied the
effects of combining N-acetylcysteine (Nac) with NTG on
APTF in 10 open chest dogs with mechanical coronary
artery stenosis and intimal damage. As periodic APTF
occurs coronary blood flow is reduced (measured with EMF
probe) producing cyclical reductions in coronary flow
(CFRs). A low dose of NTG, 5 lIS/kg/min given IV for 30
minutes decreased arterial blood pressure (ARP) 9t4 mm
Hg, but diminished the size and frequency of CFRs in only
one dog. Nac 100 mg/kg was then infused IV over 30
minutes with no effect on ARP, heart rate or CFR's. When
the NTG infusion 5 lIS/kg was repeated after Nac, for 30
minutes ABP decreased 14t5 mm Hg and the CFRs were
abolished in 7 dogs and diminished in 3 dogs, after 26t4
min of infusion. We and others have shown that aspirin
and other platelet inhibitors abolish CFRs in this model
within 3-4 minutes, thus continuous IV NTG appears to
work by a different, time dependent mechanism. We
postulate that Nac potentiates the antithrombotic effects
of NTG possibly by inducing the formation of S-nitroso-
chiols that may activate platelet guanylate cyclase. This
combination, given to man may, in part, account for the
antianginal effect.
ABSTRACTS
'1'HRa'IBIN INHIBITIoo BY HIRUDIN DECREASES PlATELET
'1'IIRa'IBUS GlOmi 00 AREAS OF SEVERE VESSEL WALL INJURY.
Lina Badimon Ph.D, Juan Badimon Ph.D., Riitta Lassila
1'1.0., Magda Heras 1'1.0., James H. Chesebro 1'1.0, Valentin
Fuster M.D., Mount Sinai Medical Center, New York , New
York and Mayo Clinic, Rochester, Minnesota.
The role of Hirudin (H) (Sigma 2OU;m!) in platelet ves-
sel wall interaction and thrombus growth on three bio-
logical vascular surfaces was studied under controlled
flow conditions and compared to heparinized blood (HP)
(APTT x 1.5). The vascular materials, isolated colla-
gen type I fibrils (ICF), mildly damaged vessel wall
(~) and severely damaged vessel wall (SDV) were per-
fused by flowing blood at shear rates typical of patept
arteries (2l2s- 1 ) and of stenosed arteries (1690s- )
for 5 minutes. Platelet deposition (PO) was lIll!asured
by Indium-Ill-labeled platelets (x 106/cm2):
Shear rate 2l2s- 1 l690s- 1
H HP H HP
IeF 4.3 + 0.7 7 ± 0.3 6.6 ± 1.0 6 ± 1.0
~ 5 ±0.6 5 ± 0.3 9.2 ± 115 10 ± l.p
SDV 7.4 + 1.4 10.7 + 1.8 40 + 7 87 + 12
The perfusion of ICF and ~ induced the deposi tion of
1-2 layers of platelets (platelet-vessel wall inter-
action) that was not affected by hirudin. The perfu-
sion of SDV induced significant throabls growth mainly
at high shear rate. Thrombus growth was significantly
(* p < 0.05) reduced by hirudin (direct thrOlllbin in-
hibitor) as coopl.red to heparin (indirect thrOlllbin
inhibition). Therefore, throatJus growth is dependent
on local thram,in production and hirudin seems to be
more effective than heparin in preventing thra-bus
growth.
PtATELET DEPOSITIoo IN AREAS OF STENOSIS IS STIMUlATED
BY HIGH PIASMA CHOLESTEIlOL LEVELS.
Juan J. Badimon Ph.D, Lina Badimon Ph.D., Vincent
Turitto Sc.D., valentin Fuster M.D., Mount Sinai School
of Medicine, New York, N.Y.
The effect of lipids in platelet deposition and throm-
bosis, a cammon complication of advanced atherosclero-
sis, remains unknown. Our aim has been to study the
effects of hypercholesterolemia on platelet deposition
under controlled flow conditions mi~cking shear rates
typical of stenotic vttr:ls (2600 s- ). Platelet depo-
sition, lIll!asured by In-platelets and morphometry,
was studied in the rabbit using the BaUllllJllrtner's
perfusion chaD:ler. Hypercholesterolemia was induced by
a 0.5' cholesterol diet for 8 weeks. This diet signi-
ficantly increased plasma cholesterol levels (1496±109
vs 66±4 mg/dl; X± lSEM), and platelet IIll!Dtlrane fluidity
(0.201 ± 0.01 vs 0.217 ± 0.01 steady-state fluorescence
anisotropy; X±lSEM). Whole blood aggregation in hyper-
cholesterolema was siailar to that in normal blood
(ADP and collagen). Platelet deposition on deendothe-
lialized normal rabbit vessel wall was significantly
increased in hypercholesteroltyaia blood COlIIplIred to
normal blood (plateletsx10'/ea: 2.9t1.5 vs 0.8±O.2,
p<0.001, at 5 min; and, 2.3±0.6 vs 0.9t0.1, p<0.001, at
20 min perfusion). By morphollletry, we observed that
both platelet adhesion and thrc.tli formation (>5p11)
were increased in hypercholesteroleaia blood but only
adhesion was statistically significant. Although in
vitro platelet aggregation was not modified, severe
hypercholesterolemia increases platelet deposition at
high shear rate conditions.
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AOOIQS(X)PY - M:RE sm6ITIVE I'm IIE'fl'IF'iIlC
'IHR:MIllS, DISTAL EJm)LI, AND SUBIN1'IMAL DISSECl'ICN.
dlristopher Jciulsal, M.D., D. Dennis HlInsen, M.D.,
Rudolf Vnlckc, M.D., James Ritchie, M.D.,F.A.C.C.,
university of~ and VA Medical center,
seattle, washingtal.
Anqiosoc:py was ClCIIp!red to oaltrast argi<:gr:aply (cine)
for the detectiat of thrarbIs, distal EIlixlli, and
subiirt:imal dissectiat in a canine m::xIel of
t:hraIi:lolysis. 'lbraltlosis was created by foroeps crush
injmy, teqxlrary occlusim, and thraIbin injectiat in
15 arteries. Mecnanical (rotatialal thraltlectaDy-R1')
an:l enzymatic (tI'A) t:hraIi:lolysis were seq.leI'Iti.al.ly
awlied. AnqiOSClCP.{ and cine were perfoDllEld after R1'
an:l after tpA. later histologic ..ssessnent shclwed
subintilnal flaps or thratbi in all cases. In 27
arterial ooeervatiCKlS, subintimal dissectiat (seen as
flaps) was present 26 times by argiosoc:py. cine did
not de!II:lnst.rate flaps in aIrf art:exy (p<.001). '11lrarbJs
(li.niJ'g,p~ or occlusive) was present in 30/30
argiosoc.pic observatiCKlS, wereas ally 11/30 had
stenoses by cine (P<.001). Distal eai:loli were seen 6
times by argiosoc:py, versus twice by cine (p<.06).
OD:lusial: An;Ji.ClBClqlY is a IIDr8 sensitive means of
detectin:.J subintimal dissectial, thraIi:Jus and possibly
distal eai:loli follClWin; intravascular interventiCKlS,
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ENHANCED BETA ADRENERGIC RECEPTOR FUNCTION IN
SYMPTOMATIC MITRAL VALVE PROlAPSE. AZM Anwar MD,
Michael S. Katz, MD, Sarah R. Kohn, SA, Tazuko K. Hymer,
SA, Gemma T. Kennedy, RN, MSN, James F. Dunn, MD,
Michael H. Crawford, MD, FACC, Robert A. O'Rourke. MD,
FACC. Univ of TX Health Sc Ctr & VAH, San Antonio, TX.
Mitral valve prolapse (MVP) subjects may have a hyperad.
renergic state, but the mechanism of enhanced adrenergic
tone is unclear. Thus, we measured catecholamines,
lymphocyte beta adrenergic receptor ({JAR) characteris·
tics ([12SIJ iodopindolol radioli§and binding), and
isoproterenol (.ISO) stilllUlated (10' H ISO, 10 minutes)
lymphocyte cyclic ,AMP production in 12 symptomatic
female MVP subjects and 14 controls (C). Subsequently,
physiologic responses to infusion with three increasing
doses of ISO were measured in eight subjects from each
group. The \ of {JAR which binds ISO with high affinity
was greater in MVP than in C (61±7\ vs 4S±2\. p <.05).
Cyclic AMP (pmol) response to ISO was higher in MVP
(46±S vs 27±S, p<.02). Catecholamines and {JAR density
were similar in both groups. In HVP but not C, ISO
infusion caused arrhythmias (5/8 vs 0/8, p<.OI) and
reproduced symptoms (5/8 vs 0/8, p<.01). ISO also
caused a greater tachycardia [~J in MVP:
ISO (mcg/min) O. 5 1.0 2.0
C [~J (bpm) 16±3 22±2 38±S
MVP [~J (bpa) 37±7 3S±2 69±12
p <.005 <.002 <.008
Our studies show that in symptomatic HVP subjects {JAR-
catecholamine interaction and {JAR-linked responses are
increased, independent of catecholamine levels, and ISO
infusion often reproduces SymptOIllS. Therefore, the
hyperadrenergic state of some subjects with symptomatic
mitral valve prolapse may be secondary to enhanced beta
adrenergic receptor function.
DOES MYOCARDIAL INVOLVEMENT IN CHILDREN WITH SEVERE MIT-
RAL REGURGITATION (MR) DUE TO ACTIVE RHEUMATIC CARDITIS
(ARC) INFLUENCE THE OUTCOME OF MITRAL VALVE REPLACEMENT
(MVR)?
Rafigue Essop MD, Richard Marcus MD, Gillian Tweedie RN,
Michael Kenyon MD, Pierre Marais MD, Pinhas Sareli MD.
Baragwanath Hospital, Johannesburg, South Africa.
The role of primary myocardial involvement in LV dilata-
tion occurring in children with severe MR due to ARC is
undefined. We compared cardiac dimensions and systolic LV
function echocardiographically pre and 3 months post-op-
eratively in 32 children (mean age 13+3 yrs, mean body
surface area l,2m') with hemodynamically compromising MR
and ARC referred for MVR. 17 pts had MYR only while 15
required aortic valve replacement as well (35 St Judes
medical and 12 Medtronic Hall prostheses). The follOWing
table summarise the results: (mean+SD,*p<0.05 vs pre-op)
PRE-OP POST OP
Functional class (FC)(NYHA) 3,5+0,5 1,1+0,4*
Cardiothoracic ratio (CTR)(%) 65~6 54~5*
End diastolic diameter (EDD)mm 55~7 45~8*
End systolic diameter (ESD)mm 35~6 30;9
Fractional shortening (FS)(%) 35~7 33~10
The early mortality was 3.1% (1/32).-Rheumatic-activity
subsided completely in all pts post operatively. Conclu-
sions: 1, MVR in pts with severe MR and ARC carries-an-
acceptable operative mortality and is associated with si-
gnificant improvement in FC; 2, Restoration of MY compe-
tence in this group of pts results in a significant redu-
ction in CTR and EDD with no reduction in FS. This is
accompanied by a rapid decline in rheumatic activity; 3,
The results suggest that LV dilatation seen in our pts
was largely related to volume overload rather than to ;i-
gnificant myocardial involvement by the rheumatic process.
THE USE OF PULMONARY CAPILLARY WEDGE PRESSURE TO ASSESS
THE SEVERITY OF MITRAL STENOSIS: IS A TRUE LEFT ATRIAL
PRESSURE NEEDED IN THESE PATIENTS?
Richard A. Lange, ~, Donald M. Moore, Jr, MD, Ricardo G.
Cigarroa, MD, L. David Hillis, MD, FACC, U of Texas
Southwestern Medical Center, Dallas, TX.
There is disagreement concerning the use of the pulmonary
capillary wedge (PCW) pressure (in lieu of left atrial
[LA] pressure) in assessing the presence and severity of
mitral valve disease. This study was done to assess the
accuracy and reliability of an oximetrically confirmed
PCW pressure in measuring the transvalvular pressure
gradient and valve area in patients with mitral stenosis.
In 9 patients (I man, 8 women, aged 47 ± 8 [mean ± SD]
years) with mitral stenosis, PCW pressure was measured
through an 8 Fr Goodale-Lubin catheter with its wedge
position confirmed by oximetry (oxygen saturation ~ 95%);
a transseptal LA pressure was measured throU9h a Brocken-
brough catheter; and left ventricular pressure was
measured through a pigtail catheter. The mean and phasic
LA and PCW pressures were similar (mean LA, 19 ± 7 mmHg;
mean PCW, 19 ± 7 mmHg; NS). When the PCW pressure was
used but was not adjusted for time delay, the transvalvu-
lar pressure gradient (10.1 ± 3.3 mmHg) and valve area
(1.5 ± 0.5 cm') were significantly different (p < 0.05)
than the values obtained using the LA pressure (7.5 ± 2.8
mmHg and 1.7 ± 0.7 cm2 , respectively). In contrast, when
the PCW pressure was adjusted for the time delay through
the pulmonary vasculature, the difference in gradients
averaged only 1.6 mmH~, and the mitral valve areas were
similar (1.7 ± 0.7 em using LA, 1.6 ± 0.6 em2 using
time-adjusted PCW; NS). Thus, in patients with mitral
stenosis, a properly obtained, confirmed, and time-
adjusted PCW pressure accurately reflects LA pressure;
transseptal catheterization is not needed in these pts.
JACC Vol. 13. No.2
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EVIDENCE AGAINST A "MYOCARDIAL FACTOR" IN
RHEUMATIC MITRAL STENOSIS
Thomas Wisenbaugh MD, FACC and Kevin Sublett MD. VA and U of
Kentucky Med Centers, Lexington, KY.
We tested the hypothesis that low EF in rheumatic mitral stenosis
(MS) is due to chronic myocardial disease. Contractile function was
assessed using frame-by-frame stress(a) and volume (V) analysis from
simultaneous LV cine and micromanometty in 19 patients with
isolated MS and 23 normals (NL). Mean EF was reduced in MS
(.5H.1O) vs NL (.64±.07). MS patients were grouped by EF into
MSI (EF<.60, n=11) and MS2 (EF~.60, n=8). Afterload (aes) tended
to be higher than NL in MSI (p=.07 by ANOVA) but preloads (aed)
were similar. 1p<.05:
Group SF EDVl aed ESVI <Jes peak LVP
mVm2 kdyn m1/m2 kdyn mmHg
MSI .50±.07]~ 86±I7 46±25 44±14] 234±79 130±2I
MS2 .65±.03] 93±17 58±12 32± 4 175±32 llUll
NL .64±.07 85±17 49±19 30±7 192±54 123±14
An inverse relation (r=-.90) was observed between EFc (EF
determined from a common preload) and aes (afterload) in the NL
group. All but one patient with MS fell within the 95% prediction
band of the normal EFc-aes relation. Followup 20 echo in a subgroup
of MSI showed improvement in EF from .50±.04 before to .59±.04
one year after mitral valve replacement (n=3) or balloon valvotomy
(n=3), but in MS2 EF did not change (n=4). Conclusion: Normal EFc-
afterload relations and normaIization of EF after correction of mitral
stenosis argue against a myocardial factor as an important cause of low
ejection fraction in mitral stenosis.
'mE NA'lURAL HIsroRY OF !\IX.JLTS WI'lH ASYMl"I'<M'.TIC, SEVERE
JlDRl'IC STENOSIS
Patricia A. Pellikka, M.D., Kent R. Bailey, Ph.D., Rick A.
Nishinura, M.D., catherine L. Taylor, and A. Jamil
Tajik, M.D.: Mayo Clinic, Rochester, Minnesota
The natural history of asymptatatic, severe valvular
aortic steoosis (AS) has not been well doctmlented. Fran
anong 472 pts with AS by Doppler (peak systolic velocity
> 4 M/sec) at the Mayo clinic fran Jan. 1984-Aug. 1987,
144 were asymptaratic and had isolated valVUlar AS. The
30 pts who remained asymptaratic bJ.t underwent aortic
valve intervention (AVI), including aortic valve surgery
or balloon valVUloplasty within 3 IIOS were excluded. The
renaining 114 pts who formed the study popllation ranged
in age fran 40-90 years (mean 70 yrs). The mean velocity
was 4.3 M/sec (range 4.0-6.0 M/sec). The nean ejection
fraction was 64% (range 37-78%). Follo..-up was available
for all patients, nean period 20 IIOS (range 6 llCS-4 yrs).
The actuarial probability of renaining free of syrrpt:£::rlEI of
angina, dyspnea, or syncope was 88% at 1 yr am 72% at 2
yrs. The l-and 2-year probabilities of remaining free of
cardiac events (CE), including AVI or cardiac death were
93% and 74%, respectively. Of all clinical am echo-
cardiographic variables, only Doppler velocity (p=(l.004)
and ejection fraction (p=(l.013) were independent predic-
tors of subsequent CE. Ancng the 29 pts with velocity
>4.5 M/sec, the relative risk of sustaining a CE by Cox
regression was 2.5. There were 3 pts who sustained a car-
diac death presumed to be a result of the aortic steoosis:
all developed symptans at least 3 IIOS prior to death.
Ccnclusions: 1) Pts with asynptal8tic, severe AS are at
significant risk for CE within 2 yrs. 2) The developnent
of synptcltB precedes cardiac IlOrtality. Thus, the




IS THERE AN IMPROVEMENT IN CORONARY VASODILATOR CAPACITY
AFTER AORTIC VALVE REPLACEMENT?
Coronary sinus blood flow (CSBF;ml!min) was measured by
thermodilution in 6 controls (C), 30 patients (pts) with
aortic valve disease before (pre) and 17 pts 29 (12-52)
months after (post) aortic valve replacement (AVR) at
rest (R) and after 0.5 mg!kg Dipyridamole (D) given i.v.
over 15 min. Left ventricular muscle mass (LMMI;g!m2)
was measured by angiography. In the pts with AVR LV
biopsies had been taken preoperatively and muscle fiber
diameter (MFD;~), interstitial fibrosis (IF;%) and
fibrous content (FC;g!m2) were determined in the
subgroup with normal (n-8) and abnormal (n=9) coronary
flow reserve (CFR-CSBF D!R).
CSBF-R CSBF-D CFR CRR LMMI MAP
pre 246-'::1 414 1.7, l 0.611l 162'] :l 90-':l
post 1683*1 355 2.2t 0.4B.J 989' I 105~* I
C 149.J 445 2.8..3* 0.35...3* 82~ 102 J
Resistance ratio (CRR) - CR D!R;MAP • mean aortic
pressure (mmHg);*P<0.05;**P<0.01. MFD, IF and FC did not
differ in pts with normal and abnormal postoperative CFR.
Conclusions: Regression of left ventricular
hypertrophy after aortic valve replacement is accompanied
by a decrease of resting coronary blood flow. Because
maximal coronary blood flow after Dipyridamole was
unchanged coronary flow reserve improved. Similarly
coronary vasodilator capacity was enhanced. Preoperative
morphometric structure had no predictive value for the
degree of postoperative vasodilator capacity.
MECHANICAL RESISTANCE IN AORTIC STENOSIS: AN INDEX OF
FUNCTIONAL CHANGE AFTER VALWLOPlASTY.
Ted Feldman MD FACC, Lincoln E. Ford MD, Y. Christopher
Chiu MD, John D. Carroll MD, University of Chicago,
Chicago, n.
Balloon valvuloplasty results in small changes in
valve area with great symptomatic improvement in some
patients, while others have little relief with greater
increases in valve area. To assess functional changes
in mechanical valve obstruction, we compared Gorlin
valve area with mechanical resistance in 30 aortic
valvuloplasty patients. Resistance was computed as
mean gradient~systoliC flow, expressed as
dynes/sec/em' , as is peripheral resistance.
PRE POST
Mean Gradient(mmHg) 52±19 30±13*
Cardiac Output(L/min) 4.3±1.4 4.7±1.5*
Area (cm2) .57±.2 .92±.3*
Valve Resistance 453±258 207±123*
Peripheral Resistance 1660±522 1492±439
(dynes sec em'S) *p<.OOl
Area correlated with log resistance (r-0.93)(Fig).
Small increases in valve area were associated with
clinical improvement when fall ~ ....
in resistance was large, but I''''
there was not improvement with 1... l
a small drop in resistance. i ~
With large increases in valve ! "" .0
area, pts with little fall in ~ ,.. ~oo 0'-
valve resistance were not ~. •.• L' ...
likely to improve clinically. •.• V"-\IE""EA(,m',
Conclusions: 1) Mechanical resistance is useful to
characterize dynamic changes in valve obstruction
because it is a functional index of opposition to flow.
2) Resistance is easily measured from clinical data and
does not require an empirical constant.
~F~r~an~z~E~b~e~rului~M~.~D~.~,Manfred Ritter
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DETERMINANTS OF LEFT VENTRICULAR SIZE AND FUNCTION
FOLLOWING MITRAL VALVE REPLACEMENT. Michael H
Crawford MD FACC, Charles Oprian, PhD, D. Craig
Miller, MD, FACC, Shahbudin Rahimtoola, MS, FACC, John
C. Giacomini, MD, Gulshan Sethi, MD, Karl E.
Hammermeister, MD, FACC and Participants in VA Coop
Study on Valvular Heart Disease, San Antonio, TK.
To determine factors predictive of LV size and function
post-mitral valve replacement (MVR) we evaluated 104 pts
with isolated MVR before and 6 mos post-surgery by
cardiac catheterization. In the 48 pts with mitral
regurgitation (MR) the ejection fraction (EF) decreased
post-surgery from .S6±.lS (SD) to .4S±.13 (p<.OOl). The
best predictor by multivariate analysis of post-opera-
tive EF was pre-operative EF. All but one pt with a
pre-op EF ~.SO had a post-op EF ~.SO (90' sensitivity, p
<.03). A pre-op LV systolic pressure >120 mmHg was also
predictive of a post-op EF ~. SO (87' sensitivity, p
<.OS). LV end-diastolic volume index (EDVI) decreased
post-op from l17±Sl to 89±27 ml/m2 (p <.001) in MR pts.
The best predictor of post-op LV EDVI was pre-op end
systolic volume index (ESVI). Only one pt with at?re-op
ESVI <SO ml/m2 had a post-op EDVI >101 ml/m (95'
specificity, p<.OOl). Pre-op systolic pulmonary artery
pressure <20 mmHg was also predictive of a post-op EDVI
~101 ml/mZ (100' specificity, p <.004). The 23 pts with
MR and mitral stenosis (MS) responded similar to the MR
pts. The 33 pts with MS exhibited little change in LV
size and function post-op. We conclude that preser-
vation of LV performance following MVR for MR or MRIMS
is most likely if pre-op EF is >.50, LVSP is <120 mmHg,
ESVI is <50 ml/m2 and systolic PA pressure is <20 mmHg.
Thus these measures are important considerations in the
timing of surgical intervention in MR or MR/MS pts.
PERSISTENCE OF INCREASED DIASTOLIC STIFFNESS LATE
FOLLOWING AORTIC VALVE REPLACEMENT
E. Scott Monrad M.D., Otto M. Hess M.D., Tomoyuki
Murakami M.D., Hiroshi Nonogi M.D., William J. Corin
M.D., Hans P. Krayenbuehl M.D., University Hospital,
Zurich, Switzerland.
Patients with aortic stenosis have been shown to have an
increase in passive diastolic stiffness at 1 to 2 years
following aortic valve replacement (AVR), but the
regression of myocardial hypertrophy has been shown to be
incomplete at that time. To study the effect of further
regression of myocardial hypertrophy after AVR on the
passive diastolic properties of the left ventricle, we
performed LV micromanometry, frame-by-frame biplane
contrast ventriculography and LV endomyocardial biopsy in
15 patients before (PRE) and late (7ltls months) after
(POST) AVR (8 for aortic stenosis, 7 for aortic
insufficiency); the hemodynamic studies were also made in
10 controls (CON). Passive diastolic properties of the LV
were assessed using the viscoelastic stress (ST) - strain
(S, Lagrangian) model, where: ST _ aeBS+ dS/dt.
WT MMI %FIB B
CON 0.82tO.07 88t14 10.6t 2.4
PRE 1.1ItO.18* 181t36* 18.2t 6.7 19.7tll.0*
POST 0.90tO.ll*+ 107t31*+ 21.0tl0.4 20.7t 8.9*
- WT - LV wall thickness (cm); MMI • LV muscle mass index
(g/M2); %FIB • % myocardial fibrosis by light microscopy;
B • dimensionless factor of myocardial stiffness as
above; * • p<O.Os vs CON; + • p<O.Os PRE vs POST.
Conclusion: Despite the marked regression of myocardial
hypertrophy late follOWing AVR, there was a persistence
of the elevated myocardial stiffness present
preoperatively, paralleling the persistence of myocardial
fibrosis.
HEMODYNAMIC RESULTS AND CLINICAl FOLLOW-UP
IN PATIENTS UNDERGOING REPEAT BAlLOON
AORTIC VAlVULOPLASTY
BrW!ev M. leonard M.p., llndll l. McKey R.N., Bernard J. Roll M.D.,
Daniel J. DiYlll' M.D., Robert D. Sefien M.D., end Raymond a. McKey M.D.,
Hervard-Thorndike lllboratory, Beth Israel Hospital, Boston,
Messechusetts
We 8X8lII1ned the hemlXtynemlc results SId clinical follow-up In 22
patients (pts) undergoing repeat balloon mrtic velvuloplasty (BAY) for
mrttc vslve restenosls (mean Interval between procedUres 10 months).
In each cess, repeet BAY was safely performed with no significant
difference between the compllcatton rate followIng the second (BAY2) as
compered with the first (BAY I) prtlC8lllre. The mrtic velve eree (AYA),
mrttc vslve !redlent (Aye), cerdtllC output (CO), mean pUlmonary
cepillery wedge pressure, end mean pulmonary artery pressure before
end sfter each prcx:edure, as well as the llbsolute SId percent ch8nge In
these fectors, were _Jyzed in order to determine the efficacy of repeat
valvuloplasty. Overall, there was no sl!J)tftcent d1fference between BAY I
end BAY2 with respect to I!I'tfof these hemlD/nllmic variables. The pts
were then dlVtdell tnto two !rOUp$: Group A( 10 pts)- - tncrease tn AYA
after BAY2 ( increese in AYA efter BAY I; Group B(12 pts)- - increese
In AYA after BAY2 ~ Increase In AYA after BAY I. MUlttple linear
r81'8SSion _lysis identified four predictive fllCtors which si!J)ificantly
effected outcome (p<.OOO I): pts with a lower initial CO, hiltler initial
Aya, hi~ Aya post BAY I , end larger AYA post BAY I were more likely
to be in Group A. Clinical follow-up demonstrated Ih8t 8/10 pts in Group
A have either died or have required a third BAY or mrUc velve
replllCement (AYR) (llY8rllll8 time to cil8th, BAY3, or AYR 4 months). In
contrast, 8/' 2 pts in Group Bere alive, end 7/8 are without symptoms;
4112 have died (llY8rlIlI8 time to cil8th 7 months) roNClUSIONS: I.
Repeat BAY can be SlIfely performed in 38lected pts end results in similar
hemlD/nllmic improvement when compared to the rtrst proceWre. 2. Pts-
with en illCl'llllSll in AYA after repeat BAY which is not lIS !J'eat lIS that
achieved c1Iring the first procedure have a poor clin1calaJUrse.
DUAL BALLOON AORTIC VALVULOPLASTY, DESPITE AUGMENTING
ACUTE HEMODYNAMIC IMPROVEMENT, FAILS TO PREVENT POST-
VALVULOPLASTY RESTENOSIS
Constance D Fields M D , Alexandra Lucas, M.D., Mark
Desnoyers, M.D., Kenneth Rosenfield, M.D., Marjorie
Caldiera, R.N., Natesa Pandian, M.D., F.A.C.C., Deeb
Salem, M.D., F.A.C.C., Jeffrey M. Isner, M.D.,
F.A.C.C., St. Elizabeth's Hospital and New England
Medical Center, Tufts Medical School, Boston, MA.
Balloon aortic valuloplasty (BV) performed with 1 or a
series of single balloon catheters (lBV) has been
compromised by a high incidence of restenosis. Having
previously shown that use of a dual balloon technique
(2BV) could augment hemodynamic improvement achieved
using IBV, we sought to determine whether such
supplemental improvement would produce a more sustained
result. We therefore followed (up to 15 mo post-BV) 26
pts in whom IBV decreased peak gradient (PGr, mmHg)
from 77±'6 to 56±.5* and increased aortic valve (AV) area
(A, cm2) from .43±.03 to .57±.04* (m,±SEM; *-p<.OOOl);
and in whom 2BV, performed immediately following lBV,
further decreased PGr to 34±3* and increased AVA to
.76±..05*. Whereas 21/26 (81%) were NYHA Cl III-IV pre-
BV, 14/15 (93%) were NYHA Cl I-II at 6-mo follow-up and
10/10 were Cl I-II at 12-mo follow-up . Nevertheless,
non-invasive hemodynamic follow-up showed that despite
initial improvement in Doppler-derived AVA (. 51±.. 05
pr:-2BV to .71±.06* post-2BV), Doppler-derived AVA
I Ip decreased to •63±. 05* at mean
~ ., follow-up of 7.9 mo, including
~ .. 10 pts in whom AVA returned to
i (jIco.clO'l .cCLOOtI pre-BV (baseline) value.
S.. Mortality included 3 pts who
.. _.. ....... ...... died 24 hrs,and 3 & 4 me post-
BV; 1 pt underwent AV replacement. Conclusion: although
2BV may augment hemodynamic improvement acutely, the
incidence of restenosis observed post-BV using the 2BV
technique remains high.
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COIIPARISOIl OF EXERCISE TES'rIMG, DIPYRIDAIIOLE THALLIUM
IMAGING AlII) GATED BLOOD POOL SCANNlHG J10R 'lIIK PREDICTION
OF CARDIAC COMPLICATIONS FOLLOlfIHG VASCULAR SURGERY
Terrence Ruddy, MD, FACC, Neil McPhail, MD, James
Calvin, MD, FACC, Michel Sauve, MD, Ross Davies, MD,
FACC, Karen Gulenchyn, MD, Lyne Vigus, RN, Graeme
Barber, MD, Clarence Cole, MD, University of ottawa
Heart Institute, Ottawa, Canada.
The value of exercise ECG testing (EX), LV ejection
fraction (EF) by gated blood pool scanning and
dipyridamole thallium imaging (THAL) for prediction of
cardiac complications, was prospectively studied in 75
consecutive pts scheduled for vascular surgery. Ten pts
with markedly abnormal tests (>2 mm ST+, EF <20\, or
THAL multivessel ischemia) were excluded, resulting in a
final group of 65 pts. The attending clinicians were
blinded to the noninvasive results. Complications
occurred in 26 pts and included 2 deaths. EX was
positive (>1 mm ST+) in 8/65 pts. EF was <50\ in 13/65
pts. THAL-showed myocardial ischemia in 35/65 pts.
TEST SENSITIVITY SPECIFICITY LIKELIHOOD RATIO
Positive Negative
0.19** 0.89* 1.9 0.90
0.31** 0.87* 2.4 0.35
o.88 0 . 69 2. 9 O. 17
(*=p<0.05, **=p<O.OOOl vs THAL)
THAL had greater sensitivity for predicting cardiac
complications compared to EX and EF. The specificity of
THAL was less than EX and EF but reasonable. THAL had
the largest positive and smallest negative likelihood
ratios. Stepwise logistic regression showed THAL to be
the most powerful predictor (improvement X2=22.9,
p<O.OOOl). EF had small but significant additional
predictive value (X2=3.9, p<0.05). Thus, THAL, with the
greatest sensitivity and predictive power, is the
optimal initial test for identifying high risk pts.
ARTERIAL COLOR FLOW DUPLEX SONOGRAPHY OF THE LOWER
EXTREMITIES BEFORE AND AFTER EXCIMER LASER ANGIOPLASTY
Ann Hickey, MD, Frank Litvack, MD, FACC, Warren
Grundfest, MD, Louis Adler, MD, Jean Ellison, RVT, David
Cossman, MD, Lisa Hestrin, MPH, James Forrester, MD,
FACC, Cedars-Sinai Medical Center, Los Angeles, CA.
Nineteen patients studied by angiography prior to excimer
laser angioplasty of the lower extremities were also
imaged with color flow duplex sonography (CFDS). Angio-
graphy and CFDS obtained prior to angioplasty were
compared for location of stenosis/occlusion and length of
occlusion. In two patients with stenotic disease, 5 of 6
angiographic stenoses of >50% were correctly identified
by CFDS. The remaining stenosis was identified as <50% by
CFDS. The location of one stenosis was misidentified. Of
17 vessels occluded on angiography, 16 were accurately
identified by CFDS. Occlusion location by CFOS was
correct in all 16. In the one artery misidentified as
patent, there was a >90% stenosis by CFDS. In vessels
identified sonographically as occluded, estimation of
occlusion length by CFDS was within 3 cm of angiographic
appearance in all cases. In one. patient CFDS showed a
prOXimal occlusion of the superficial femoral artery not
seen angiographically. The occlusion, confirmed at
surgery, was found to be fresh thrombus. In 3 patients
who experienced restenosis or reocclusion 2-4 months
following laser angioplasty, the color flow duplex scan
accurately diagnosed one total occlusion, and two
stenoses. One restenosis was unsuspected by clinical
history and both restenoses were successfully dilated.
CONCLUSION: 1. Color flow duplex sonography of the lower
extremities correlates highly with angiographic
appearance. 2. Color flow duplex sonography provides a
simple, noninvasive method for following patients after
laser angioplasty, allowing early detection of restenosis
and therefore early treatment.
INCIDENCE AND PROGNOSTIC SIGNIFICANCE OF EARLY
FOO'IOPERATIVE. SIUiNl' ISCm1«A IN PERIPHERAL VASCIJIAR
SUFCERY PATIENrS
Pamela 0Uyam. M.D., F,A,C.C., Gary Gerstenblith, M.D.,
F.A.C.C., William R. Funnan, M.D., Peter J. Golueke,
M.D., Sidney O. Gottlieb, M.D., F.A.C.C. Jdlns Hq)ki.ns
Medical Institutions, Baltimore, MOo
Most periq:>erative OCIlplications in pta havin;r
peri~ vascular (PIlD) surgery result fran ooronaJ:Y
disease (CAD). 'lb see if peri-ope>rative ST c:han:Jes
:in:ii.cative of ischemia (STI) identifies higher risk pts,
we studied 24 pta with stable CAD us~ 4-1ead calibrated
anb.1latory ElCG IOOlli.tors (AElCG) on the day before PIlD
surgery, intra-qleratively, am for 29±10 hrs post-
qleratively (post-ql). 'Ihere were 17 JreI'I am 7 wc.men,
age 64±9 yrs; 17 pta had prior -myocardial infarction
(MI), U had prior alJlina, c'ld 3 had prior coronary
bypass surgery. General anesthes '.a was used in 19/24 pts.
On blin::led readin:Js of AElCG, 15/24 pta (63%) had
asynptanatic STI periq:>eratively. All 15 had STI post-q>
(2.8±O.7 episodes/24 hrs, 3ot7 miIVepi~), only 5 of
these pta had intra- am only 3 ~tive STI. pts
with am withoot STI did not differ a.<il to anesthetic
agent used, duration of vascular clanp time or of
~, periq:>erative hyper- or hypotension, or peri-
qlerative anti-ischemic medications. c.f the 15 STI pta,
8 (53%) had inhcspital i.sdlelnic events ;:' MI, 2 new OIF,
4 new rest angina) cc:arpared to only 1 1IIX'g the 9 pta
withoot STI who had post-ql alJlina (lU, i'<.05).
'!hus, early post-q> STI is cxmnon i., pta with ClIO
havin;r PIlD surgery am a~ to predict subsequent
inhcspital clinical i.sctIemi.c events. '!he iJmnediate post-
op period may be the optimJm time when AElCG can identify
tho$e pta who may benefit fran continued close 11¥Xlitorin;r
am additional. anti-ischemic interventioo.
Histological evaluatlon of "Vessel-5icpsies" obtained
with the Si~pson atherecto~y cat~eter
h.-_·(Q!L.E2ln.H.Ltl._h, D. Backa 5.5., G. nehrlich H.D.,
B. Hefling!. D., Med. Klinik I, Klinikum Gro~hadern,
Ludwiq-M3xi~ilians- UniV2rsit~t. ~unich, V. Geroany
Tjs Si~pscn 1there~t0~Y C~:h~t2: ena~18s the
~2rrutanE~US re~ov31 of p:~que ~at2rial, ~hus ,r0v~iing
:~2 o~pcrtunity to study t~~ prcc~ss of !e-st~oosis. ~e
~~.·all1-1t2d 305 spcl:i~ens f.to~ 32 pri:::ary stenc::~s
1ST) ar.d 9 re-s,,,noses ~RE-S) of peripher."l ·:<?ssels.
Pri~!'.,lry lesions (n= 52): ~ thickened, fibre::': ir..':2..-:'.a
~!S pr~s~~t in 100\ of stenoses. ~~dl~ in 5S% and
1djcn~iti1 ~272r. :~1~ :ells, infla~~~~:~l In::ltrlte
and :~~l~st~rih ~lefts w~re 5~~.~ i~ 34.E%,
211cificlti~n i~ ~5.~% ~r.d ~~~8~bi(f~~~~ ~: ::;ani2~i)
i:l 75%.
Re-st~r.soses (n=9, 5.4 z 2.5 mo post-~therec:a~y): All
showed a thickened inti~a with ~arked cellular
proliferation; thro=b~ were fo~nd in 8, while fo!z
cells and fibrosis in 7. Calcification was seen in 2
~edia was present in 111 cases, !dventitia never.
~or.clusion: .Obstructive tissue consists mainly of a
fibrous thickened inti~a, although the 2ntire spectru~
of atherosclerosis could be identified; aft~r
atherectomY,the true plaque ~ay sometimes re~ain de~per
~ithin the inti~a. Re-stenoses are characterized by
~arked cellular proliferation, fibrosis and the
presence of foam cells. Therapy to prevent restenosis
should be guided by th2se findings.
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Myocardial Ischemia with Normal Coronaries
HISTOLOGICAL EVIDENCE OF CORONARY ARTERIOLOSCLEROSIS AS A
CAUSE OF MYOCARDIAL ISCHEMIA IN PATIENTS WITH NORMAL
CORONARY ARTERIOGRAHS
Masayoshi Mishima H.D.! Kazuhisa Kodama M.D., Atsushi
Hirayama M.D.! Tomoki Ohara M.D., Masahiko Tsuj imoto M.D.
Hiroshi Sa to M.D., Kunimitsu Iwai H.D.
Osaka Police Hospital, Osaka, Japan
To test the hypothesis that small-vessel disease can be a
cause of clinically-defined myocardial ischemia, 20 pts
with angina-like symptom and normal large coronary
arteries were studied (8 men and 12 women, mean age: 55±7
years). Endomyocardia1 biopsy specimens were obtained
from the left ventricle with a Cordis biotome introduced
percutaneously through the femoral artery puncture. Three
to five specimens from different sites were taken. Rapid
atrial pacing resulted in ischemic ST depression associ-
ated with angina-like chest discomfort in all pts. Histo-
logic examination of an endomyocardia1 biopsy specimen
revealed slight to moderate interstitial fibrosis (17 of
20 pts), suggesting ischemic injury, and marked medial
thickening of coronary arterioles about 30 to 100 micro-
meter outer diameter. The thickening was observed to be
caused by proliferation of smooth muscle cells, hyaline
degeneration, and an increase in collagen in the media,
suggesting reduced vasodi1atory reserve. Electron micro-
scopic studies for evaluation of metabolic alterations
revealed secondary 1ysosomes, cytoplasmic deposition of
glycogen granule and intramitochondrial glycogen in
viable myocytes. These might be ultrastructural responses
to ischemic injury and myocardial ischemia.
These results suggest that in patients with angina-like
symptoms and normal large coronary arteries, (1) there
exists ultrastructural evidences of myocardial ischemia,
and (2) coronary arteriolosclerosis can be one of the
major mechanisms for reduced coronary flow reserve.
LONG-TERM FOLLOW-UP AND VARIABILITY OF
MARKERS OF MYOCARDIAL ISCHEMIA IN SYNDROME X
Gi~ppe Pupita M.D., Juan C. Kaski M.D., Alfredo R. .Galassi
M.D., Margarita Vejar JM.D., Attilio Maseri M.D. FACC. RPMS,
Hammersmith Hospital, London U.K.
To evaluate the long-term course of myocardial ischemia in
patients (pts) vith syMrome X (typical angina pectoris, positive
exercise test, no evidence of coronary spasm or left ventricular
hypertrophy am angiographically normal coronary arteries), ve
sb.l1ied 13 pts, 10 f am 3 m, mean age 49*7 years. Clinical and
ECG paramlters as veIl as exercise test am Holter monitoring (H)
vere assessed both vhen the di88JlOSis vas first established (A) am
after amean follov-up (F) of 6.3 years (raJl88 3-9). Mean number
of aD8inal episodes am NTG consumptionlveek vere similar at A
am F am only 2 of the pts tm pain-free periods of at least 1
month. In nore of the pts serious coronary events, left ventricular
failure or bundle brmrh block developed during F. Exercise time
(T), heart rate (HR) am rate-pressure produ:t (RPP) at 1nun of
ST depression at Aam Fvere similar:
+ve test Angina T HR RPP
A 13 13 594*178 134:1:20 20363:t:5264
P 13 13 631:1:202 139:t:17 21648*6173
24-b:>ur Hat Aam F shoved similar results regarding number of
episodes of ST depression ~ 0.1 mV (31 vs 25), proportion of
painful episodes (39 vs 36%) m1 of episodes preceded by an
iruease in HR (39 vs 32%). Thus, although syrxirome X seems to
have a benign prognosis, angina am ECGgraphic signs of iscMrnia
tml to persist UJXbanged during long periods m1 ~versi1y affect
lifestyle inasizable proportion ofpts.
ROLE OP It-ADRENERGIC RECEPTORS IN SYNDROME X
Alfredo R. Galassi M.D., Juan C. Kaski M.D., Giuseppe Pupita
M.D., Margarita Vejar J M.D., Attilio Maseri M.D. FACC RPMS,
HammersmithHospital, London, U.K.
Patients (pts) vith syndrome X (typical angina pectoris, positive
exercise test, no coronary spasm ani aD8iographically normal
coronary arteries) have a redu:ed coronary flov reserve dl.ll to
irmequate dilatation of small resistive vessels. To assess if It-
mrergic receptors play a role in the geresis of ST ischemic
changes in syndrome X, 10 su:h pts mean age 5O:t:8 years
undervent exercise testing (E) m124-hour Holter monitoring (H)
off treatment (OFF), am fol1oving tt-bloc~ vith prazosin (P)
2mg 12 hrly am clonidine (C) 0.20 mg 8hrlyon separate veats.
During clonidire therapy, 4 pts dropped out early, dl.ll to drug
side-effects. Comparative E results regarding exercise time (T),
double produ:t (RPP) at 0.1 mV ST depression am number of pts
vith positive tests as veIl as Hresults, vere:
$ Exercise testini Holter monitorina'
Positive(n) T(secs) RPP(rmnHgIbpm) episodes(n) tHR·
OFF 10 10 617:1:203 23857:t:6125 23 4
P 10 10 663:1:201 22098:t:4816 22 1
C 6 6 668:t:76 23547:1:2530 13 2
•• preceded byan imease of heart rate.
Seven patients also undervent a pbenylephrire test vhich did not
imu:e ST ischemic chaDBes in anyof the 1pts althoUBh 21m chest
pain. These fm1iD8s suggest that It-mnergic receptor media!ed
mechanisms do not play adetectable role in the genesis of transient
iscMmic episodes inpts vithsyn1rome X.
BETA-BLOCKERS IN SYNDROME X. R.Bugiardini,M.D.,F.A.C.C.,
A.Borghi.M.D., L.Biagetti,M.D., F.A.Nicolini,M.D.,
P.Puddu,M.D.
Institute of Patologia Medica, Univ. of Bologna, Italy.
pts with angina pectoris and normal coronary angiograms
(syndrome X: SX) have been found to have an inadequate va
sodilatory capacity of the coronary microcirculation. Ho;
ever the mechanisms of ischemia, thus the therapeutic man
agement of these pts, remain to be determined. We compar-
ed the effects of oral verapamil (V: 320 mg/day), propra
nolol (P: 160 mg/day) and placebo in 16 pts presenting
with the above set of findings and documented transient
myocardial ischemia during their daily life. Testing was
done according to a randomized double-blind crossover,pla
cebo-controlled trial consisting of 3 consecutive 7 day -
treatment periods. Pts underwent continuous 48 hour elec
trocardiographic monitoring during the last 2 days of-
each period. A total of 391 episodes of diagnostic ST +
was recorded during the trial. Of these, 23 were sympto-
matic. None of the episodes occurred while asleep, 25%
during exercise, 35% during minimal physical activity and
40% at physical rest. The latter occurred more during
activities demanding mental arousal (conversation,reading
or watching TV). Heart rate at the onset of ST ~ was hi-
gher l'> 10 bpm) than that observed in the 5 minutes preced
ing ischemia in 95% of the episodes. In the group as a-
whole, the average number of ischemic episodes per 24
hours was significantly reduced during P, ae compared to
placebo (0.7~0.6 vs 3.9~1.8,p~.OO5). Conversely, no si&
nificant differences were seen during V treatment. We con
clude that transient myocardial ischemia in pts with SX-
as well as reduced coronary flow reserve is mostly preci2
itated by an increase in oxygen demand.due to a heighten
ed sympathetic activity. Accordingl~, beta-blockers may-
represent the first line of treatment.
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Although there was no significant difference in left
ventricular mass al!long the three groups, cellular
hypertrophy and myocardial fibrosis were frequently
observed in left ventricle in chronic cor pulmonale. In
both ventricles cellular diameter was significantly
correlated with percent area of fibrosis. Percent area of
fibrosis of left ventricle was significantly correlated
with that of right ventricle. Thus, we conclude that the
left ventricle is also involved pathologically in chronic
cor pulmonale and that left ventricular function can be
impaired due to not only functional factors as hypoxemia
and deformity of left ventricle but also organic factors
as cellular hypertrophy and myocardial fibrosis in left
ventricle. .
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Pulmonary Hypertension




Jun Tanouchi, Ken Ishihara, l~satsugu Hori,
Akira Rita atake, Takenobu Kamada, Osaka University
School of Medicine, Osaka, Japan. -
To determine whether the left ventricle is involved in
chronic cor pulmonale, we studied 24 autopsied hearts :
10 of chronic lung disease with right ventricular
hypertrophy (RVH) in their electrocardiograms (A), 8 of
chronic lung disease without RVH (B) and 6 of extra-
cardiopulmonary disease (C). In each case other
cardiovascular diseases were not complicated. In both
right ventricle and left ventricle, ventricular weight,
wall thickness, myocyte diameter and percent area of
fibrosis (%F) were measured in the preparations. After
taking photographs of Azan-Hallory stained histological
sections of both ventricles, we traced the covering
transparent films at the site of blue portions (collagen
fiber) on the photographs. We cut off the tracing
portions from the copied papers of the films and weighed
the papers, then calculated the percent weight of








ECHO/DOPPLER AND CATHETERIZATION CORRELATES OF SURVIVAL IN
PRIMARY PULMONARY HYPERTENSION
Susan B. Eysmann, M.D., Harold I. Palevsky, M.D. Nathaniel
Relcfiek, M.D., F.A.C.C., Keith Haciney, Pamela S. Douglas,
M.D., F.A.C.C. University of Pennsylvania, Philadelphia,
Pennsylvania.
Prognosis in primary pulmonary hypertension (PPH) is high-
ly variable and difficult to predict. To determine corre-
lates of survival in PPH, we compared 50 echo/Doppler and
catheterization variables with outcome in 26 patients.
Mean follow-up was 20 months (2-52) in 10 survivors, mean
survival was 5 months (0-34) in 16 nonsurvivors. Univari-
ate Cox lifetable analysis correlated 8 variables with
early death (p < .05) and the data distribution was exa-
mined to select-critical values: severity of pericardial
effusion, heart rate (HR; > 87bpm) , pulmonic flow accele-
ration time (~~2ms), tricuspid early flow deceleration
(TOec; < -300cm lsI, mitral early to atrial flow velocity
ratio (R-E/A; < 1.0), cath cardiac index (CI; < 2.3
1/min/m2), mean and diastolic pulmonary pressures (> 61, >
43 mmHg). Multivariate analysis showed TDec, M-E/A, CI to
be independently related to death (p ~ .0014). Mortality
increased with the number of critical values reached: if
0(0% mortality), 1(50%), 2(75%), 3(100%). Analysis of in-
vasive variables alone related only CI to death (p =
.0140), while analysis of echo variables alone related
TOec, M-E/A, HR to poor survival (p : .0016); mortality
increased with the number of echo/Doppler critical values
reache4: 0(20%), 1(37%), 2(88%), 3(100%).
Thus, both echo/Doppler and hemodynamic variables yield
valuable information regarding outcome in PPH. The prog-





GRANULOCYTE ACTIVATION AUGMENTS HYPOXIA-INDUCED
PULMONARY HYPERTENSION IN VIVO.
Nancy J. Davenport M.D.,Ph.D., Linda M. Bradley M.D.,
F.A.C.C., Robert E. Goldstein M.D., F.A.C.C.,
U.S.U.H.S., Bethesda, MD.
Clinical and experimental data suggest that granulocyte
activation may be a major mediator of pulmonary
hypertension accompanying inflammatory lung disorders,
such as adult respiratory distress syndrome. Hypoxia
can also contribute significantly to pulmonary hyper-
tension. Although granulocyte activation and hypoxia
are both likely to occur in diseased lungs, the results
of their interaction in vivo are unknown. We studied
the effects of phorbor-myristate acetate (PHA), a known
potent granulocyte activator, on pulmonary hemodynamics
during normoxia (systemic arterial p02 80-150 mm Hg)
and during hypoxia (p02 30-50 mm Hg). Eight pigs had
closed-chest measurement of pulmonary artery pressure
(PAP) and pulmonary vascular resistance (PVR) before
and after P~50.1 \lg/kg Lv. Mean PAP (1IlD Hg) and PVR




*p <0.05 vs. pre-PHA
OUr results show that PHA added significantly and
independently to the actions of hypoxia in raising PAP
and PVR. Reversal of hypoxia promptly reduced PAP and
PVR to,pre-hypoxic baselines in the presence or absence
of PHA. The data suggest that suppression of granulo-
cyte activation may substantially enhance hemodynamic
benefits of reversing hypoxia when treating pulmonary
hypertension caused by an inflammatory lung disorder.
IS DIGITAL VASOCONSTRICTION A MARKER FOR
REVERSBLE PLLMONARY VASOCONSTRICTION IN
PATIENTS WITH PLLMONARY HYPERTENSION? Peter B.
Wilson MD, David J. Pinsky MD, Gerold W. Neuberg MD, Marrick
L. Kukln MD, Norma Medina RN, Madeline Yushd< RN, Milton
Pocker MD, FACC. Mt. Sinai School of Medicine, New York, NY
Previous investigators hove St.9gested that ph with pulmonary
hypertension (PH) who have digital vasoconstriction (RayllOJd's
phenomenon) are likely to hove pulmonary vasoconstriction os
the couse of thei r PH. To test this hypothesis, we evoluoted the
responsiveness of the pulmonary vasculature 10 the vasodilator,
nifedipire (N/F, 20 mg orally), in 20 pts with PH, of whom 10 had
Roynoud's phenomenon (+Royn) and 10 did not (-Rayn). Stroke
vohme index (SVI, ml/mz), heart rate (HR, bpm), mean sntemic
arterial, mean pulmonary arterial and right atrial pressures
(MAP, PA & RA, mm Hg), and systemic vosculcr and total pulm-
onary resistances (SVR and TPR, d-s-c) were measured before
(pre) and ))-60 min after NIF in both~oups~=p <0.05.
+ Rayn Pre 23 88 93 53 8 2491 1106
NIF 25 101* 73* 44* 10 1525* 1160*
- Royn Pre 23 83 90 63 Is 1925 1665
NIF 23 87 67* 52* 17 1232* 1339*
Pts with RaynOJds did nat show more favorable hemOdynamic
responses 10 NIF than pts without RoynOJd's. Both ~Olps
showed similcr .. in PA pressure, but SVI foiled to t significontly
in either grolp, despite the .. in RV afterlood. Bath ~olps
showed similcr .. in TPR, but the mean" in SVR exceeded the
mean +,in TPR In pts with ond without RaynaJd's. Individlally,
only 5 of 20 pts (3 +Rayn and 2 -Rayn) demonstrated a selective
pulmonary vasodilator effect with NIF (%+,in TPR >%+ in SVR),
and only 2 of 20 pts (I +Rayn and I -Rayn) improved clinically.
In conclusion, PH pts with RaYnaJd's do not respond more
favorably to vasodilator therapy than PH pts without RaynOJd's.
These data suggest that digital vasoconstriction does not reflect
the presence of reversible pulmonary vasoconstriction in PH pts.
152A ABSTRACTS lACC Vol. 13. No.2
February 1989: 152A
group A: uneventful clinical course; group B: non
.uccessful TT; group C: early thrombotic reocclusion
Thrombolytic therapy (TT) in a subset of patients leads
to increased thrombin release. measureable as increased
thrombin-antithrombin III- blood levels. This might be
related to early reocclusioDs after successful TT in
acute MI. In 55 consecutive patients (pts) undergoing TT
for MI we tested whether increased TAT-levels may predict
early reocclusion. Patency was assessed by angiography 60
min and 24-36h after onset of TT.
Results: TAT pg/l
2hPTCA 18-48 h PTCA NoPTCA P
M...=...QL Ii..=...ill N = 132
Days Hospitalized 11.3 9.5 10.2 .06
PTCA Performed 60% 55% 20% .001
CABG Performed 17% 17% 14% .74
Total Hospital Charges $20,301 $18,982 $16,076 .01
Employed at 1 year/
employed at entry 78%(21/27) 89%(50/56) 92%(46/50) .17
Unchanged income
at 1 year 60%(26/43) 73%(63/86) 80%(64/80) .07
Group A pts were seperated at 120 min from group Band C
pts by TAT values ~ 6 pg/l (p < 0.001; sensitivity 96.2\;
specificity 93.1\). In the 39 pts with primary patent
infarct related coronary artery (group A+C) reocclusion
was predicted by TAT levels ) 6 pg/l (p < 0.001; sensiti-
vity 96.2'; specificity 100 \). We conclude that TAT
level. ) 6·pg/l 2h after onset of thrombolysi. are sensi-
tiv and specific .arlcer for an unfavourable outcome of
throabolysis while TAT levels < 6 pg/l indicate a un-
eventful clinical course.
PREHOSPITAL THROMBOLYTIC THERAPY - MITI PROJECT
REPORT ON PHASE I: FEASIBILITY, CHARACTER-
ISTICS OF PATIENTS
W. Douglas Weaver MD. FACC, Jenny MartinRN,
Paul Litwin MS, Mickey Eisenberg MD, Mary Ho
MD, Peter Kudenchuk MD, for the MITI Project
Investigators, university of Washington,
Seattle, WA.
During Phase I of the Myocardial Infarction,
Triage and Intervention Project, pts are
evaluated by paramedics and remote physiican
for potential treatment with t-PA. Of the first
1871 chest pain pts, 35% were ~75 yrs, 16% had
pain >6 hrs, 16% had hypertension, 13% history
of stroke/altered mental status. The time from
onset of pain to medic evaluation was 52±60
(median=27) min; 17±10 min were required for
evaluation and transmission of a 12-lead
cellular ECG to the physician. Seventy-nine of
the chest pain pts (4%), or 30% of those with
acute myocardial infarction (AMI), were
prehospital t-PA candidates. Initiation of t-PA
by paramedics would have saved 21±9 min of
transportation time plus 56±39 min from
hospital admission until treatment. Of the AMI
pts that medics excluded, 21% received t-PA at
hospital. Mortality for the paramedic
included/excluded AMI pts were 2% and 14%,
respectively. Treatment in the excluded group
began 76±74 min after hospital arrival;
significantly later than in pts receiving
prehospital ECGs (p<O.Ol). Conclusion:
Paramedics with a remote physician can screen'
pts for t-PA using 12-lead cellular ECGs,
saving 1-1.5 hours and allowing treatment 76±62
min after the onset of AMI.
EARLY REPERFUSIOO AFTER 'IRE'.MMFlfI' WI'IH :I1'lmAVENOOS PR>-
UROKINASE WHm CXK'ARED 'ro :I1'lmAvnuJS S'mEPIOKINASE.
F.Venneer. J.Meyer, F.W.Biir, R.EI:bel, D.Mathey, R.uebis,
M.E! Deeb, J.P.M::II1asSier, P.westerl1of, H.Boss, H.Giilker,
B.01arl::lonnier, R.seabra-Q:mes, P.Prd:lst, J.Heikkilii,
G.struw, u.Sdlmi.tz-Huetr1er, H.J•TraIlpisch, I.Massberg,
H.Barth. Dept. of cardiology, University of Lilnturg,
University Hospital Maastridlt, '!he Netherlaros.
In a ran:ianized, dooble bl.in:l study (ImMI trial) 80 ng
of intravenous pro-urokinase (rscu-PA, 198 pta) was
ClCIIpCU'ed with 1.5 Mio IU of Lv. streptokinase (Sk, 203
pta). Treatment was given within four boors after onset
of synptans in pta with a first myocardial infarction.
ooronazy angiograpty was perfoI1lled at 60 min, at 90 min,
an:i 24 to 36 boors after the start of the infusion.
Patency rates at 60 min were 71% after rscu-PA an:i 48%
after Sk (p < 0.001). Patency at 90 min after rscu-PA
was 72% vs. 64% after Sk (p = 0.09). An]iograI:hically
documented reooclusion (within 24 boors) was seen in 6
pta treated with rscu-PA vs. 5 pta in the Sk graIp. In-
hospital mortality was low in both groops: 7 pta died in
the rscu-PA graIp (4%) vs. 10 pta in the Sk graIp (5%).
Four cerebravascul.ar accidents were reported, two in
eadl graIp (1%). Reinfarctions were seen in 4% after
rscu-PA vs. 3% after Sk. significant bleeciin; was lower
after rscu-PA (26 pta) than after Sk (49 pta; P = 0.005).
Blood transfusioo was required in 9 pta after rscu-PA vs
23 pta after Sk (p = 0.02). Decrease in fibrinogen was
less prcI'DlI1Cled after Lv. rscu-PA (mean 20% of baseline
value) than after Sk (6% of baseline value; p < 0.001).
cx:NCIIlSIOOS: After intravenous administratioo of pro-
urokinase in a direct eatparlsan to i.v. streptokinase
1) patency. rates are higher and r:epe,rfusioo is readled
at an earlier stage, and 2) bleed.jrq oc:aplications are
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Thrombolytic Therapy in Acute Myocardial
Infarction: I
ECONOMIC ADVANTAGES OF A CONSERVATIVE STRATEGY
FOR AMI MANAGEMENT: rt-PA WITIIOUT OBLIGATORY PTCA.
Edgar D. Charles, PhD, William J. Rogers MD, FACC, Guy S.
Reeder MD, FACC, James H. Chesebro MD, FACC, Silvio E.
Papapietro MD, FACC, Larry Maske RN, Alfred A. Bartolucci PhD.
UAB Med. Center, Birmingham, AL & Mayo Clinic, Rochester, MN.
In order to assess the economic impact of PTCA following rt-
PA for acute myocardial infarction (AMI), we collected total
hospital charges (including professional fees) in 329 patients with
AMI treated within 4 h onset of symptoms in the TIMI Phase II
study at Birmingham, AL, and Rochester, MN. Included were
patients from the TIMI II-A and II-B sub-protocols who were
randomized to receive PTCA within 2 h if feasible (II-A only),
PTCA at 18·48 h if feasible, or no angiography/PTCA unless
mandated by uncontrollable clinical ischemia. Employment and






Thus, the more conservative strategy without PTCA or CABG
unless dictated by uncontrollable ischemia resulted in savings of
15-21% in total hospital charges while yielding similar 1 year
employment and income profiles. The conservative strategy saved
approximately $2900.$4200/patient, and, if utilized in the 0.25-1:0
million US patients with AMI each year eligible for thrombolytic
therapy, would save 0.7 to 4.2 billion dollars, compared to the
more aggressive obligatory PTCA strategies.
EARLY THROMBOTIC REOCCLUSION AFTER SUCCESSFUL CORONARY
THROMBOLYSIS IS PREDICTABLE FROM AN INCREASED THROMBIN
RELEASE TWO HOURS AFTER ONSET OF THERAPY
Dietrich C. Gulba, M.D., H.Sc.; Gert-H. Reil. M.D.;
Monilca Barthels, M.D.; Wolf Rafflenbeul. M.D.; Wilhelm
MOller. M.D.; Paul R. Lichtlen, M.D., F.A.C.C.
Hannover Medical School. Hannover, FRG
lACC Vol. 13, No.2
February 1989: 153A
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RISK FACTORS FOR HEMORRHAGIC AND ISCHEMIC
STROKE IN MYOCARDIAL INFARCT PATIENTS
TREATED WITH TISSUE PLASMINOGEN ACTIVATOR
Ralph Althouse MD MPH. Charles Maynard PhD, Michele Olsutka
RN and I.Ward Kennedy MD, FACC U. of Washington, Seattle. WA.
We prospectively studied: risk factors for stroke in 1028 cons~utive
MI pts admitted to 8 hC?spltals In 1988. Pts ~ ~S yrs old Wlt~ ST
elevation and chest pam for ~ 6 hrs were ebglble for our tissue
Plasminogen Activator (tPA) study: those with a contraindication to tPA
treatment, sustained diastolic blood pressure (DBP) ~ 120 mmHg or
history of stroke were excluded. 160 pts (16%) were treated with tPA
and 868 were not Ten received ISO mg tPA and the remainder 100 mg
over 6 hrs; all received IV heparin. 19/868 pts (2%) were treated with
thrombolytic drugs outside of the study. Strokes were classified as
inttacerebral hemorrhage (lCH) or inttaeerebral infarction (lCI).
ICI occurred in 21160 tPA pts (1.3%) and in 111868 pts not given
tPA (1.3%). ICH occurred in 3/160 tPA pts (1.9%) and 0/868 pts not
given tPA (p=0.004). The incidence of ICH was 2112 (17%) in pts
with "transient" systolic blood pressure (SBP) ~ 180 mmHg (whl~h
resolved rapidly prior to tPA treatment) compared to 11147 (0.6%) With
lower SBP (odds ratio=24, p=O.OIS Fisher exact two-tailed). In pts
with transient DBP ~120 mmHg, the ICH rate was 2/9 (22%),
compared to 11147 (0.6%) with lower DBP (odds ratio=33, p=O.OO9).
ICH occurred in 2118 pts (11%) taking aspirin on admission, compared
to 1/142 (0.7%) not on aspirin (odds ratio=<16, p=O.03). Known risk
factors for spontaneous lCH including male sex, age, black race,
history of hypertension (HTN), and cigarette smoking were not as-
sociated with ICH following tPA. Known risk factors for spontaneous
ICI including male sex, age, history of HTN and transient HTN were
not associated with ICI in pts not treated with tPA.
We conclude that tPA treatment was associated with an excess of
ICH without changing the incidence of ICI. Furthermore, risk factors
for spontaneous ICH were not associated with ICH in pts treated with
tPA. Pts with "transient" HTN immediately prior to tPA infusion, or
who were taking aspirin were at increased risk of ICH during tPA
treatment
TOMOGRAPHIC ASSESSMENT OF MYOCARDIAL REPERFUSION DURING
ACUTE MYOCARDIAL INFARCTION USING Tc-99m METHOXY ISOBUTYL
ISONITRILE (MIBI)
Ratmond J. Gibbons, M.D., FACC, Mario S. Verani. M,D ••
FA C. Patricia A. Pellikka. M.D., Thomas Behrenbeck.
M.D., John J. Mahmarian. M.D •• James H. Chesebro. M.D ••
FACC. Frans J. Wackers. M.D .• FACC
Tc-99m MIBI was injected intravenously in 15 p~tients
during acute myocardial infarction (EARLY) and 6 to 14
days later (LATE). Ten patients were treated with intra-
venous thromblytic therapy after EARLY Tc-MIBI; 8 of 10
had patent arteries on subsequent angiography. Five
control patients did not receive thrombolytic therapy,
and had documented arterial occlusion. The absence of
myocardial redistribution of Tc-MIBI permitted tomograph-
ic imaging up to 8 hours after intravenous injection to
determine the extent of hypoperfused myocardium (%LVHYPO)
at the time of injection. %LVHYPO was quantitated using
a technique validated in phantoms (r·O.99 between true
defect and measured defect). tLVHYPO measured EARLY
varied from 9~ to 68%. indicating a wide range of myocar-
dium at risk. tLVHYPO measured LATE correlated signifi-
cantly (r=-O.83. p=.OOO2) with LATE resting ejection
fraction and with LATE regional wall motion score in the
infarct segment (r=-0.94, p·.D06 for anterior Infarcts;
r=-O.90. p=.02 for inferior infarcts). indicating its
validity as a measure of infarct size. There was a
significant decrease in %LVHYPO between the EARLY and
LATE studies In the treated patients (-12~ t 12~. p=.OI).
suggesting myocardial salvage due to reperfusion. There
was an insignificant increase in %LVHYPO in the control
patients (4% t 6%). Conclusion: The change in %LVHYPO
determined by tomographic Tc-MIBI EARLY and LATE is a
promising measurement tool for the assessment of the
efficacy of interventions in acute myocardial infarction.
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Phannacology of Calcium Channel Antagonists
EFFECTS OF LOW DOSE NIFEDlPINE ADKINISnED THROUGH THE
CORONARY SINUS IN ISCHEMIC HEART DISEASE.
Jacques Berland M.D., Jean-Christian Farcot M.D., FACC.
Thierry Savin M.D •• Alain Cribier M.D., FACC. Brice Letac
M.D •• FACC. ROUEN, FRANCE.
To determine the potential of coronary venous retroinfu-
sion (Rlnf) to selectively deliver drugs in the myocar-
dium, we assessed the effects of coronary sinus (CS) Rlnf
low dose of Nitedipine (NIF, 200 meg) on global and
regional left ventricular (LV) function in 11 patients
(Pts). After standard RAO LV angiogram and coronary
arteriography, a special three lumens balloon catheter
was inserted through an antecubital vein in the CS and
its tip placed in the great cardiac vein. CS was occluded
for one minute and 10 ml 5% glucose (control Pts, n-3) or
10 ml 5% glucose + NIF (n-8 Pts) were infused in the
great cardiac vein under continuous CS pressure (P)
monitoring. During Rlnf mean CSP increased from 7 ~ 5 to
30 + 10 1lIIIlIIg p<O.OOl. Then a second LV angiogram was
perfOrmed. Heart rate (HR). ejection fraction (En) and
anterior wall motion shortening (AWM) before and after CS
Rlnf were compared. In control Pts, as well as in 4 Pts
without coronary disease in whoa NIF was retroinfused. no
changes in hemodynamic or contractility occured. On the
opposite in 4 Pts with significant LAD stenosis DR
increased by 21% and EF dropped by 13% which was due to a
decrease in AWM by 31%.
Conclusions : 1) short term CS occlusion and 10 ml Rlnf
of 5% glucose does not carry out adverse effects.
2) Rlnf of low dose NIF induces regional wall motion
abnormalities only in Pts with LAD stenosis. This effect,
which mimicks intracoronary NIF injection. suggests that
NIF reaches the LV anterior wall and therefore that in
ischemic heart disease Rlnf have a potential for selecti-
ve delivery of drugs in this area.
A !fEW INTRACELLULAR CALCIUM ANTAGONIST, HA-I077, AM
I~NE DERIVATIVE, INHIBITS WIESCENT BOVINE
ARTERIAL SKlO'l1I MUSCLE CELL PROLIFERATION.
Manabu Shirotani M.D •• Yoshiki Yui M.D., Mamoru
Takahashi M.D., Takeshi Aoyama M.D., Yoshiharu Murohara
M.D., Hiroshi Morishita M.D., Kazushige Kadota M.D.,
Yoshiki Takatsu M.D., and Chuichi Kawai M.D. F.A.C.C.,
Third Division, Department of Internal Medicine, Faculty
of Medicine, Kyoto University, Kyoto, Japan.
The effect of HA-I077 (HA), isoquinoline-sulfonyl
homopiperazine, a new intracellular calcium antagonist,
was examined on growth of cultured bovine vascular smooth
muscl~ cells (BVSMC). Growth-arrested BVSMC were plated
(4xl0 cells/dish) and stimulated with 5% fetal calf serum
(FCSl. Cell numbers were counted on the following days.
(xl0 cells, M+SEM) *p<O.Ol vs. control(O~ of HA)
- Concentration of HA (~)
DAY 0 10* 30* 50* 100*
1 6.1+0.4 6.1+0.4 5.6+0.3 4.2+0.2 4.1+0.2
2 17.9+1.6 13.1+0.5 8.4+0.5 6.5+0.3 5.2+0.3
3 23.7+0.9 22.3+0.7 17.2+0.3 14.5+0.5 6.7+0.4
4 36.3+0.9 34.8+1.5 28.9+1.4 19.~1.1 9.8+0.8
HA (10, 30, 50, and l00uM) inhibited H-thymidine uptake
stimulated by 5% FCs by 2~3%*. 36t2%*. 5~1%*. and
70+1%* (*p<O.OI) • HA, 10 and 30~. also inhibited 3H_
thymidine uptake stimulated by I-hour exposure to
platelet-derived growth factor(IOng/ml) and subsequent
23-hour incubation with 10ug/ml bovine insulin by 22±3%*
and 29+3%* respectively (*p<O.OI). This inhibition was
observed when HA was present at the time of the initial
exposure. Conclusions: In cultured quiescent BVSMC, HA
inhibits cell proliferation and DNA synthesis dose-
dependently. Since platelet-derived growth factor here
worked as a competent factor, it is suggested that HA
suppresses at least GO-G1 transition.
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MODIFICATION OF MYOCARDIAL ISCHEMIA AND DYSFUNCTION BY
NIFEDIPINE AND NITROGLYCERIN DURING CORONARY OCCLUSION
Iva Amende M.D., F.A.C.C., Gunhild Herrmann M.D.,
RUdiger Simon M.D., F.A.C.C., Paul R. Lichtlen M.D.,
F.A.C.C.,· Hannover Medical School, Hannover, FRG
We evaluated whether pretreatment with nitroglycerin (NTG)
and nifedipine (NIF) protects the myocardium against
ischemia induced by coronary occlusion during angioplasty.
We studied the effects of 0.1 mq intracoronary (ic) NIF
in 18 Pts and of 0.2 mq ic/iv NTG in 20 Pts during
60 sec occlusion on the ic epicardial ECG and pulmonary
wedge pressure (PWP). NTG produced a significant fall in
PWP before (10 to 7 mmIIg) and a.t 60 sec occlusion (19 to
14 IlIIlBg) and delayed the appearance of the rise in PWP
"> 5 mmIIg from 16 to 26 sec. NTG had no effects on maxi-
mal ST segment shifts of the ic-ECG (1.8 to 1.8 mV) and
did not delay the onset of ischemic ST segment elevation
>0.5 mV (14 to 15 sec). In contrast, NIF significantly
reduced maximal ST segment shifts during occlusion (2.2
to 1.5 mV) and delayed the onset of ischemic ST segment
elevation (11 to 21 sec). NIF significantly delayed the
appearance of the rise in PWP (23 to 38 sec) but had no
effects on PWP before (9 to 11 mmHg) and at·60 sec oc-
clusion (23 to 22 mmIIg). In conclusion, NTG delays the
rise in filling pressure and limits its extent but has
little effect on ischemic ic~ECG changes during occlu-
sion. NIF delays the rise tn· filling pressure but does
not affect its magnitude. NIF, however, delays the onset
of ischemia in the ic-ECG and reduces its extent indica-
ting protection of regional ischemic myocardium.
NIFEDIPINE DOES NOT ALTER THE VENODILATORY RESPONSE TO
NITROGLYCERIN.
Wllllam P. Apollo B.S., Robert Zells M.D. F.A.C.C.,
Joseph A. Gascho M.D. F.A.C.C., Penn State Unlve~slty
School of Medicine, Hershey, Pennsylvania.
Although many patients with coronary artery disease
take both calcium channel blockers and nitrates, it is
not known if the calcium channel blockers alter the
venodilatory response to nitroglycerin (TNG). We there-
fore measured the venodilatory effect of TNG (0.8 mg
lingual spray) 35 minutes after placebo on one day and
after the calcium channel blocker nifedipine (10 mg p.o.)
on another day in 12 healthy fasting supine male volun-
teers, age 25±1 (SEM) yrs, on no medications. StUdies
were performed in a warm quiet room. In 7 of 12 SUbjects
placebo was given on day 1 and nifedipine on day 2; in
the other 5 the order was reversed. The equilibration
technique was used to measure the venodilatory effect of
TNG. The Change in forearm volume at 30 mmHg above
baseline venous distending pressure (VV[30], ccllOO cc
arm) induced by TNG was considered to be the venodilatory
effect of TNG.
Compared to placebo, nifedipine caused a SignifIcant
fall in diastolic pressure (-3±1 mmHg) and rIse in heart
rate (+7±2 b/min), but did not venodilate (4.23±0;23,
nifedipine; 4.03±0.34 cc/IOO cc arm, Placebo, p-NS).
Effects Of TNG on Hemodynamics and VV[30]
HR Systolic BP Diastolic BP VV[30]
Placebo +6t1 -2±1 -7±2 +0~13
Nitedieine +8±2 -1±1 -6±2 +0;70±O.09
n-12; x±SEM; *p<0.05 vs Placebo
Conclusions: (1) Nifedipine dilates arterioles but
not veins; (2) Nifedipine neither attenuates nor
accentuates the arteriolar dilatory or venodilatory
response to TNG.
It is concluded lhat inlracoronary Vp improves the
ischemic tolerance during PTCA; this is probably due to
a local protective effecl whereas the peripheral vascular
actions of Vp, as assessed by unchanged systemic blood
pre:;sure and heart rate during I.e. and Lv. administra-
lion. did not conlribute to this effect.
VERAPAMIL AS A POTENT CARDIOPROTECTIVE AGENT FOR
CORONARY ANGIOPLASTY: FIRST CLI~ICAL EXPERIENCE.
Gerald S. Wern~ M.D.. Michael Schmid, Hermann H.
Klein. M.D .• Volker Wiegand, M.D .. Heinrich Kreuzer. M.D..
Ulrich Tebbe, M.D. Dept. of Cardiology, Univer"ity of
Gottingen. F.R.G.
The cardioprotective effect of verapamil (Vp) was studied
in 30 pts (3 groups ii 10) with proximal LAD stenosis un-
dergoing coronary angioplasty (PTCA). After one initial
occlusion (')c) the groups received either Vp img/2m.n
Lc .. or Vp 5mg/2min Lv.. or an equivalent volume of NaCI
0.9% (5ml/2min) Lc. as control. ST segment and T wave
alterations were analyzed from chest lead ECG, duration
of oC and onset of angina. pectoris were registered.
Coronary sinus lactate, pyruvate and pH were taken
before and after each oc. We Dbserved a significantly
lmpt'oved ischemic tolerance after Le. Vp as compared
with Lv. and control (see Tab:x±sem;. p<0.05;u p<O.Oll.
Coronary sinus lactate rise after oc was reduced lo 48%
of control (p<0.05). This effect persisted also during lhe
third oc 5-7 min. after injection.
------ oc 1 ------- oc 2 -----
duration(s) ST (mV) duration(s) ST (mV)
EFFECT OF DILTIAZEM ON CORONARY FLOW RESERVE IN MAN.
James D. Rossen. M.D .• Ignazio Simonetti, M.D., Craig A.
Stark, M.D., Melvin L. Marcus, M.D., FACC, Michael D.
Winniford, M.D., FACC, Dept. of Medicine, University of
Iowa, Iowa City, IA.
Coronary flow reserve (CFR) is substantially diminished
by IV calcium channel antagonists (CCA) in conscious dogs.
This attenuation of coronary dilation has been postulated
as one of the mechanisms responsible for the anti-anginal
effects of CCA. Furthermore, use of CCA in patients could
alter assessment of CFR. To determine if observations in
dogs could be extended to patients, we examined the effect
on CFR of diltiazem (DT) given by the IV (n=9, 125 or 250
meg/kg bolus then 5 meg/kg min infusion) or intracoronary
(IC) (n=9, 150-600 meg bolus) routes in p~tients without
coronary obstruction. CFR was measured wlth a 3F coronary
Doppler catheter as the ratio of peak to resting coronary
blood flow velocity (CBFV) after a maximally dilating dose
of intracoronary papaverine. CFR was measured after DT
infusion when the transient increase in CBFV (IV 24:37%
m+SD IC 102%+74 of control) had returned to baseline.
Resuits: following IV DT, the DT plasma levels (263:89
ng/ml) were higher than commonly achieved during oral
therapy. MAP decreased by 12%* (*p<.05) from 96:11 mmHg
and HR decreased by 7% from 76:17 bpm. With ~V DT, CFR
fell from 3.9+1.2 to 3.6+1.1*. After IC infuslon of the
largest DT dose, MAP was-unchanged (99:12 vs DT 97:13
mnHg) and HR was held constant by atrial pacing. CFR with
IC DT was unchanged (3.8!O.9 vs DT 3.9:1.0) despite a
larger transient increase in peak CBFV. Thus, in contrast
to dog studies, DT given to patients in doses larger than
used clinically had no or minimal effects on CFR. There-
fore DT use should not confound interpretation of CFRmeas~rements. Attentuation of coronary dilation by DT is
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Autoperfusion CathetersNalvuloplasty
PROLONGED AUTOPERYOSION ANGIOPLASTY: IKKEDIATE CLINICAL
OUTCOME AND ANciOGRAPHIC FOLLOW-UP.
Peter J Quigley MD. Dean J. Kereiakes M.D .• F.A.C.C .•
Charles W. Abbottsmith H.D .• F.A.C.C .• Robert P. Bauman
M.D .• James E. Tcheng M.D., Joseph B. Muhlestein H.D.,
Harry R. Phillips H.D .• F.A.C.C .• Richard S. Stack M.D .•
F.A.C.C .• Duke Medical Center. Durham. North Carolina.
To assess the efficacy of prolonged angioplasty using
a new autoperfusion balloon catheter (P8C) (Advanced
Cardiovascular Systems. Inc.>, the combined results in
the first 122 patients (pts) (86 males; mean age 58 yrs)
undergoing elective coronary angioplasty (LAD 50%; RCA
44%; CIRC 6%) from two medical centers were analyzed.
The PBC is a 4.5F polyethylene catheter with multiple
sideholes before and after the balloon to allow blood to
flow through the central lumen during balloon inflation.
P8C use Was preceded by a short dilatation (60 sees)
using a small (2.0 mm) balloon in 58 pts (48%). Mean
P8C inflation duration was 13.8 + 5.8 min. to a maximum
of 6.5 ± .7 atmospheres. Angioplasty was successful
(~ 50% residual diameter stenosis) in 120/122 pts (98%).
Mean diameter stenosis was 85 ± 11% pre- and 17 ± 14%·
post-angioplasty. Emergency bypass surgery was
performed in one patient and one patient had late in-
hospital reocclusion.
So far. 63 out of 67 pts (94%) eligible for 6 month
follow-up angiography have been restudied. of whom 30%
(19/63 pts) have restenosis (> 50% luminal diameter
narrOWing).
In conclusion. prolonged balloon dilatation can be
safely and effectively performed using the PBC. The
acute success rate is high and in-hospital complications
are low compared to previously reported rates for
standard PTCA. Tha restenosis rate is similar to that

















Peak CPK (Units) 880±699 1593±1362 1589±69
Peak CPK-HB (Units) 73±93 148±129 IS2±113
Q.wave infarction (MI) 1/11 -p<.02- 12/16 3/4
Death 1/11 0/16 0/4
Internal _ary graft 5/11 2/16 0/4
~2 distal grafts 11/11 11/16 3/4
Time to CP8(minutes) 219±86 171±39 182!71
In conclUSion. despite comparable time to cardiopulmonary
bypass (CPB) , patients undergoing emergency CABG with 8
demonstrated consistent relief of angina, reduced ECG
ischemia, lower CPK. fewer Q-wave HI's, and greater use
of internal mammary artery grafts than patients supported
with IABP alone.
Benefit of the "Bailout" Catheter for F.aergency Bypass
Surgery after Failed PTCA.
POnnambalag Sundram H.D., John R. Harvey H.D .• Julian H.
Aroesty H.D., Beverly H. Lorell H.D., Raymond G. McKay
H.D., Daniel J. Diver H.D .• Robert D. Safian H.D., Donald
S. Baim H.D. Harvard-Thorndike Laboratory. Beth Israel
Hospital. Boston. MA.
Of 2102 consecutive coronary angioplasty (PTCA)
procedures, 31 patients (1.5%) were sent for emergency
bypass surgery (CABG). The 11 patients (36%) who had a
"bailout" (8) perfusion catheter. [including 2 who also
had an intraaortic balloon (IABP)], were compared to 16
patients (52%) who had only an IASP. and 4 patients (13%)
with neither B nor IABP. as regards control of ischemia
and surgical outcome.
15E (li' mE ICS STKK PmF15ION DILATATION CAmETER IN PTO\
10 A\OID ([JJ)NARY IIRTFRY BYPASS Sl)R;FRY
Zachary I. Hodes, M.D.. Ph.D•• Donald A. RothbaLDII, M.D.,
F.A.C.C•• ThOlllls J. Linnemeler. M.D •• F.A.C.C., Ronald J.
Landin. M.D.. F.A.C.C.. Michael W. Ball, M.D•• and Ruth A.
Giebel, R.N•• B.S.N. Indiana Heart Institute.
Indianapolis, Indiana
The success of conventional coronary angloplasty (<X:'.) can
be severely (imi ted by acute reclosure post <X:'. or i~ch­
emia during balloon inflation. The N::S Stacie Perfus Ion
Di latatlon Cl:Itheter (ICS-SPDC) allows for cont inuous per-
fusion of blood during prolonged balloon inflation. This
catheter ~s used In 22 stenoses in 21 Pts who experienced
dissection and repeated subtotal or total vessel occlusion
with a:::A (17 PU) or who developed profound Ischemia with
cont>romised left wntricular function with a:::A (left noin
stenosis, 1 Pt; right coronary ostial stenosis. 2 Pts; and
hypotension with LAD <X:'.. 1 Pt). The lesion ~s success-
fully crossed with the dilatation catheter In 19 of 21 Pts
(90'lf,). ()te to four inf lat ions (mean 1. 4) at 3-10 atlOO-
spheres pressure (mean 6.7) ~re performed. Inflation
time ~s Intended to be 20 min unless the patient dewl-
oped significant Ischemia earlier. The mean inflation
time 'olI1S 15 min (range 1-21 min) with 6 pts requiring
de(lat ion of the balloon before 20 min. The mean pre-
dilatation stenosis~s 88% (range 50-100'lf,) reduced to a
mean of 15'1(, (range 0-40'10). Four Pts developed renarrowing
at the angioplasty site. although only 2 experienced total
occlusionof the wssel. ()te Pt died In the
catheterization laboratory due to failure to maintain
patency of both a totallyoccluded LAD and subtotally
occluded EO!. (not o.a:; candidate). Three Pts required
emergency ('AR;, ~ver none of them experienced "l)'Ocar-
dial infarction by either BOG or CPK criteria. Therefore.
15 of 21 Pts (71'1(,), who otherwise llOuld haw required
('AR;, had successfUl ~ using the ACS-SPDC.
EFFECfS OF NITRAlES ON CORONARY HEMODYNAMICS AND
ANGINAL THRESHOLD IN SYNDROME X.
Raffaele BuKiardini M 0 FA C C ,Andrea Pozzati M.D., FilippoOttani
M.D., GianLuigi Morgagni M.D., Paolo Puddu M.D. Institute of
PalOlogia Medica and C.C.U.• University of Bologna, Italy.
Patients (pIS) with anginapectoris. found tohave angiographically nonna!
coronary arteries and no evidence of coronary spasm or ventricular
hypertrophy (syndrome X). offer a management dilemma to the clinician.
This study was undenaken to investigate the hemodynamic effects of s.1.
isosorbide dinitrate (10 mg; ill) in 10 pts presenting with the above set of
findings as well as spontaneous episodes oftransient myocardial ischemia
(anginal pain and~O.l5mV Sn). In these PIS, we measU1'Cd great cardiac
vein blood flow (GCVBF; ml/min) and mean aomc pressure (AoP;
mmHg) at rest and peak pacing (10 bpm increments every 2 min). both off
drugs and 5 min following ill. In all pts GCVBF increased by less than
50% or even decreased during pacing. This occurred both off drugs and
with 10. Administration of 10 caused a significant reduction (paired t-
test: p<.05)inAoP(x±SD: 94±16vs 104±15 atrest,and95±18 vs 105±20
at peak pacing) and GCVBF (94±54 vs 116±60 at rest, and 83±33 vs
121±52 at peak pacing). Angina and significant ST l (~O.l mY) during
pacing occurred after 582±1 10 sec off drugs and 492±93 sec (p < .02)
following ID. We conclude that: (1) pts with syndrome X exhibit a
reduced coronary flow response to pacing; (2) in such pIS. ID inay funher
reduce blood flow, thus increasing discrepancy between myocardial 0%
demand and supply; (3) a failure of the autoregulatory mechanisms to
adequately maintain coronary blood flow during decreased AoP is
suggested.
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IS BALLOON VALVULOPLASTY BENEFICIAL IN PATIENTS WITH
CALCULATED CRITICAL AORTIC STENOSIS BUT LOW EJECTION
FRACTION AND PRESSURE GRADIENT?
·P.S. Reddy H.D. FACC, Barry F. Uretsky H.D. FACC, Alfredo
Trento H.D., Karen Gallis-Davis R.N., University of
Pittsburgh, PA
Wednesday, March 22, 1989
8:30AM-IO:OOAM, California Room D
Anaheim Convention Center
Echo Doppler: Ischemic Heart Disease
To determine if pts with critical aortic stenosis (AS)
and severe symptoms (NYHA Class IV) have sustained
improvement and survival post aortic valvuloplasty, the
results of 53 pts were analyzed. Ejection fraction (EF)
was ~35% in 33 (Group A) and less than 35% in 20, of whom
13 had a mean pressure gradient >35 mmHg (Group B) and 7
had a mean pressure gradient ~35 mmHg (Group C).
Comparative data in 3 groups were as follows:
Group ABC
Age 77±,7 78±,8 7l±,8
EF 57±,14 27±,4 0 22+9 a t
Gradient 7Z±,19 54±,12 a 27±,6 a t
CO 3.8+0.9 3.6±,1.0 2.9±,1.0
AVA Before 0.44+0.2 0.47±,0.2 0.53±0.2
After 0.63~0.2 * 0.66±,0.3 * 0.64+0.1 *
H % 15 31 86 a t
CV H % 9 15 86 a t
p<.05 *-post vs. pre valvuloplasty;p<.05 a-A vs B, A vs C.
p<.05 t-B vs C. AVA-aortic valve area (cmZ);CO=cardiac
output (l/min); CV-cardiovascular;H-6month mortality (%)
All deaths in Group C but only one in Group B were from
terminal heart failure. Other deaths were noncardiac. None
of the 7 Group C pts had a clinical improvement post
procedure, whereas 75% in Group A and 53% in Group B
improved clinically (p<.05. C vs A, C vs B).
Therefore, in pts with low EF and low gradient. balloon
dilatation of apparent critical AS appears to be of little
clinical benefit.
ECHOCARDIOCRAPHIC EVAWATION OF SEGMENTAL WALL MOTION
EARLY AND LATE AFTER THROMBOLYTIC THERAPY IN ACUTE
MYOCARDIAL INFARCTION.
Catherine tL. Qll2... tLJL..... F.A C C , John R. Stratton,
M.D., F.A.C.C;, Charles Haynard, Ph.D .• Karl-Arne Johann-
essen, M.D., Ralph Althouse, M.D., .1. Ward Kennedy, M.D.,
F.A.C.C., University of Washington, Seattle, Washington.
In 92 acute myocardial infarction (AMI) patients treated
with tissue plasminogen activator (tPA) 2.3±1.2 hrs after
the onset of chest pain. 2D echocardiography (2DE) was
performed at 11±14 hrs (early) and, in 49 pts, again at
13±7 weeks (late). Infarct location and the LV wall
motion score index (WHSI) •• the average score (normal -
I, hypokinetic -2, akinetic - 3, dyskinetic - 4) for 20
segments -- were determined by 2 blinded observers.
Concordance between 2DE infarct location (anterior, in-
ferior or lateral) and infarct related artery at angio-
graphy 4±2 days later (n-8S) was 83'. compared to 7S' for
ECG vs angiography (both p<O.OOOl). The early WHSI was
worse for anterior (1. 7±O.4) vs inferior (1. 3±O.1) or
lateral (1.S±O.2) infarcts (both p<O.OOOl) , but was not
related to time to tPA or TIMI reperfusion grade. Over-
all, the WHSI improved froll early to late 2DE (n-49.
1.S±O.3 to 1.3±O.3. p-o.004). However. improvellent was
confined to those with time to tPA ~2 hrs (n-22 , 1.S±Q.3
to 1.2±O.2, p-o.002) vs >2 hrs (1.5±O.3 to 1.4±0.4,
p-NS), TIMI reperfusion grade ~l (n-38, 1.5±0.3 to
1.2±O.3, p-D.002) vs TIMI grade 0 (1.5±O.2 to 1.S±O.4,
p-NS). and anterior (n-17. 1.6±O.3 to 1.4±O.4, p-D.03) vs
inferior infarcts (1.3±O.3 to 1.2±O.2, p-NS).
ConclusioN: 2DE early after AMI identifies infarct
location and usefully defines the extent of aryocardiUII
for potential salvage. Improvement in the WHSI is seen
in anterior infarcts with early, successful reperfusion.
DIRECT IMAGING OF TBB PAPILLARY IIUSCLES DUltDlG ISCBBKIAr
IKPLICATIONS FOR ISCBBKIC MITRAL REGURGITATION. Dale
Touchstone H.D., William Glasheen H.E., Sanjiv Kaul M.D,
r.A.C.C. University of Virginia, Charlottesville, VA
Although papillary muscle (PH) dysfunction is thought
to cause mitral regurgitation (HR), the behavior of the
PHs during ischemia has never been directly observed.
Accordingly, we cannulated the left main coronary artery
(LHCA) in 10 open-chest anesthetized dogs and perfused
it with arterial blood. Reversible occluders were placed
on the proximal left anterior descending (LAD) and left
circumflex (Le) coronary arteries. 20 echo images of
the LV and PHs were obtained using short axis views at a
depth of 8 CIIS. Sonicated lIicrobubbles were injected
through the apex of the LV to assess severity of HR (0
to 4) in the 4-chamber view. Ao, LV, and LA pressures
were recorded. Each anillal was studied at baseline,
following separate occlusions of the LAD and Le, and
during global ischemia caused by reduction of flow to
the LHCA. Hean end-disto1ic thicknesses of the antero-
lateral and
2
Posterolledial PHs at baseline were 0.98 cm2
and 0.86 em , respectively. Percentage systolic thicken-
ing of the two PHs was 0.36 and 0.33, respectively which
was similar to the regions of the LV where the PHs were
attached. During ischeaia thickening of the PMs paral-
leled that of the corresponding region of the LV. How-
ever, the presence or severity of HR did not correlate
with the degree of either PH or regional LV dysfunction.
Instead it correlated best wi!h global dysfunction (r -
-0.86 with % systolic thickening, r • -0.76 with % glo-
bal systolic change in LV volume, and r _ -0.67 with LV
dp/dt). Incomplete lIitral leaflet closure was seen in
all instances of HR; prolapse of the mitral leaflets was
never noted.
We conclude that the PHs behave similar to the region
of the LV where they are attacted. However, PH dysfunc-
tion is not the cause of ischemic HR. The severity of HR
is related to degree of global LV dysfunction.
PREDICTIVE FACTORS FOR SUCCESS OF PERCUTANEOUS HITRAL
VALVULOPLASTY.
Antonio Serra. H.D •• Raoul Bonan. H.D., F.A.C.C., Angel
Cequier, H.D., Thierry Huller. H.D., Jacques Crepeau.
H.D., lhor Dyrda, H.D., F.A.C.C., Robert Petitclerc,
H.D., David Waters, H.D., F.A.C.C., Hontreal Heart
Institute, Hontreal. Canada.
To determine Whether early success of percutaneous
mitral valvuloplasty (PKV) can be predicted, 76 conse-
cutive pts were classified into 3 groups: optimal suc-
cess (area >1.S cm2 and sain >2Sll.): S3 pts (701.),
suboptimal success (area 'l.S eaa and/or sain
USll.): IS pts (201.) and failure (no effective infla-
tions): 8 pts (101.). Univariate and multivariate analy-
ses of 11 clinical. 20 hemodyn8lllic, 7 procedural and 6
echocarc1iosraphic variables revealed that the strongest
independent predictors of failure were LA diameter
(p-.004) (61.S*8 vs Sl.S*9 ms) followed by team inexpe-
rience (p-.OOl). Compared to optimal success, univari-
ate analysis showed the followinr; variables measured









Hitral valve area (mm2)
Total pulmonary vasc. rea.
Left atrial diameter (mm)
Leaflet thickness score >2
Leaflet mobility score >2
**_ p<.OOl; *= p<.OOS
By stepwise 10Sistlc resreaaion analysis, only total
pulmonary vascular resistance (p-.OOOl) and LA diameter
(p-.Ol) were selected aa independent predictors.
In conclusion, the results of percutaneous mitral val-
VUloplasty are more likely to be suboptimal in ph with
higher pulmonary vascular resistance and larser left
atria.















ACUTE MYOCARDIAL INFARCTION AND CHANGES
DURING EARLY RECOVERY.
Brian 0 Williamson M.D., Michael 1. Lim, Rita C. Pinton M.D.,
Andrew J. Buda M.D. FACC., University of Michigan, Ann Arbor,
MI.
Changes in LV filling during and following acute myocardial
infarction (AMI) are largely unknown. To examine this, pulsed
wave Doppler echo was used to evaluate LV diastolic filling in 60
pts within 24 hrs of AMI; 41 (68%) of whom had successful
reperfusion. A subgroup of 13 pts had repeat Doppler at 7 days. A
coronary disease (CAD) control group consisted of IS age and sex
matched pts without previous MI. Significant results are
summarized below (mean±SD):
CAD(n-IS) AMHn-6Q) 7day(n-13)
VTITotal (m) .120±.033 .098±.031*** .121±.04S**
VTI E (m) .068±.020 .OS8±.021 ** .073±.023**
VTI .33 (m) .061±.020 .040±..018** .OS4±.023**
VTI=Velocity Time Integral; *:p<.OS **:p<.Ol ***:p<.ool;
significance values for AMI vs. CAD, and 7 day vs.AMI.
Although peak E and E/A ratios were abnormal in AMI pts., they
were not different among the 3 study groups. However, AMI pts
had abnormal diastolic VTI compared to CAD controls which
improved by 7 days. On further subgroup analysis, significant
improvement in VTI occurred in pts with initial ejection fractions <
40% (p<.OS) and in pts with anterior AMI (p<.OS), but not in pts
with inferior AMI. We conclude that pts with AMI have impaired
diastolic filling in the initial 24 hrs which improves by 7 days post-
MI. This improvement is greatest in pts with anterior AMI and
impaired ejection fraction. Our data suggest that diastolic filling
dynamics may have greater potential for recovery following AMI
than systolic dysfunction.
SERIAL CHANGES IN LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC
FUNCTION FOLLOWING SUCCESSFUL THROMBOLYTIC THERAPY OF
MYOCARDIAL INFARCTION: ASSESSMENT BY DOPPLER
ECHOCARDIOGRAPHY
Gong Yuan Xie, M.D., Oi Ling Kwan, B.S., and Anthony N.
DeMarla, M.D., F.A.C.C.; University of Kentucky,
Lexington, Kentucky
Few data exist regarding serial changes in LV systolic
and diastolic function following successful thrombolytic
therapy of acute MI. Therefore we performed Doppler-
echocardiography(ECHO) in 17 pts in whom coronary
reperfusion was achieved within 120 minutes. Initial
studies were performed within 24 hrs, and repeated at 3,
5, and 7 days. All ECHO were performed in standard
fashion from usual windows. Systolic function was
evaluated by: an echo wall motion index(WMI) graded from
l(normal) to 4(dyskinetic); mean acceleration(ACL) in LV
outflow tract(OT), and LVOT velocity integral(FVI).
Diastolic function was assessed as mitral early(E) and
atrial(A) velocity integrals Ei/Ai ratio, and pressure
1/2 time (Pl/2t) at mitral annulus. Results:
Initial 6Day 3 6Day 5
EHcm) 5.1+3.2 -.4+2.4 1.1+2.6
Ai(cm) 4.2+1.9 -.9+1.7* -.7+.8**
Ei/Ai 1.4+0.6 .3+0.5* .8+.5**
pl/2t(ms) 46.4+11.6 3.7+15.0 6.9+15.1
FVI(cm)2 13.2+3.6 1.5+2.2* 2.0+3.0*
AC(cm/s) 7.0+2.2 1.0+2.0 1.6+1.4**
WMI 1.34+0.16 -.09+.09** -.12+.09**
*p<0.05, **p<0701 versus initial
Thus, shortly after reperfusion LV systolic function is
depressed and diastolic function reveals diminished E
filling. During the first week ECHO documents a
significant return toward normal of LV systolic and
diastolic abnormalities in reperfused HI pts.
LOW MAXIMUM ACCELERATION MEASURED USING AORTIC
DOPPLER IDENTIFIES PATIENTS AT RISK OF CARDIAC DEATH
FOLLOWING ACUTE MYOCARDIAL INFARCTION.
Susan Gilmour BSc, Dayjd Bennett FRGP Tim Cripps MRCP,
St George's Hospital Medical School, London, England.
Doppler ultrasound was used to obtain maximum acceleration (mls/s)
(MA) from the ascending aorta using the suprasternal approach in 95
patients (pts) with acute myocardial infarction (MI). The incidence of
cardiac deaths before exercise testing (within 1 month), and within 1
year were recorded:
Total Non-Survivors
Group Survivors 1 month 1 year
n 88 74 9 5
mean MA 15.8 16.4 12.9 11.0
SE 0.5 0.6 1.3 1.5
Both non-survivor groups had significantly lower MAthan the
survivors (pSO.05). Exercise treadmill-testing (Bruce protocol) was
carried out on 125 post MI pts including 46 of the above group. The pts
were assessed in terms of negative (neg) or positive (pos) exercise test, a
positive test being ~1mm ST depression on exercise. The incidence of
cardiac deaths (up to 18 months) were recorded. The results were
assessed in terms of MA on peak exercise (peak MAl.
Total Survivors Non-survivors
Group Neg Pos Neg Pos
mean 28.9 31.5 27.8 23 16.3
SE 1.1 1.6 1.6 2.1
n 1~ 55 45 1 7
The non-survivors had a significantly lower peak MA than the
survivors (ANOVA pSO.05). There was a mortality of 16% in patients
with a peak MA S23 mls/s, no deaths have occurred in patients with
peak MA>23.
MA measured acutely identifies the group at risk from early cardiac
death. Similarly those with a low peak MA and positive test are at risk
of cardiac death, however a positive exercise test when combined with
high peak MA is not associated with cardiac death.
Can Hemodynamically Sicnificant BY Infarction be
Identified by Two·Dimensional Echocardiocrapby?
Ronald B. Himelman M.D., Jeffrey Goldberger M.D., Peter Hui
M.D., Christopher L. Wolfe M.D., F.A.C.C., Nelson B. Schiller
M.D., F.A.C.C. University of California, San Francisco, CA.
To assess 20 echocardiograpby (2DE) in acute RV infarction
(RVMI), 19 patients with RVMI (defined by ECG and clinical
criteria) were evaluated by 2DE and hemodynamics. Of 19 patients,
7 had significant hemodynamic abnormalities (Hemodyn Sig, RA
pressure ~ 13 mm Hg, ratio of RA to PCW pressure> 0.65). 2DE
measurements were made in patients and 20 normal controls: systolic
descent of the RV base (Descent of Base, cm), ratio of RV to LV size
by single-plane area-length method in the apical four chamber view
(RV/LV), and respiratory response of inferior vena cava in the
subcostal view (IVC Response, fractional decrease in vena cava
diameter after inspiration).
~were (* p < 0.05 vs Hemodyn Sig):
~ Descent of Base RV I LV IVC Response
7 0.6 ± 0.2 1.12 ± 0.66 0.20 ± 0.17
12 1.3± 0.4* 0.63 ± 0.37 0.52 ± 0.08*
20 2.0 ± 0.3* 0.48±0.19* 0.64± 0.19*
RV wall motion abnormalities were found in 10 of 19 patients with
RVMI (3 with Hemodyn Sig RVMI) and 0 controls. An IVC
Response of S 0.50 was 100% sensitive for Hemodyn Sig RVMI and
56% specific, Descent of Base < 1.0 cm was 86% sensitive and 92%
specific, and RV/LV > 0.80 was 57% sensitive and 67% specific.
Conclusion: 2DE signs may help predict abnormal
hemodynamics in acute RVMI. Plethora of the inferior vena cava with
blunted respiratory response is a sensitive marker for elevated central
venous pressure, while poor descent of the RV base is specific for
Hemodyn Sig RVMI. Abnormal RV wall motion and size may be
diagnostic of RVMI, but do not predict hemodynamic compromise.
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Exercise and Nonexercise: Stress
Echocardiography
PHYSIOLOGIC SIGNIFICANCE OF CORONARY LESIONS ASSESSED BY
EXERCISE ECHOCARDIOGRAPHY AND QUANTITATIVE CORONARY
ANGIOGRAPHY
Khalid H. Sheikh. MP, James R. Bengtson, MD, MPH, Sherif
Helmy, MD, David S. Rendall, PA-C, Robert Burgess, BS,
Thomas M. Bashore, MD, FACC, Richard S. Stack, MD, FACC,
Joseph Kisslo, MD, FACC. Duke University Medical Center,
Durham, NC.
To determine the geometric features of coronary
lesions which relate to the development of exercise-
induced wall motion abnonnallties, 19 consecutive
patients with single vessel, proximal coronary lesions
were studied by exercise echocardiography (EE) and same-
day quantitative angiography (QA). All patients had
normal resting wall motion and were able to reach target
heart rate or developed positive ECG changes during
exercise.
Mlni.al luminal diameter (MLD), .inimu. cross-
sectional area (MeSA), I diameter stenosis (IDS), Ind I
area stenosis (I AS) assessed by QA were ca.pared between
patients developing wall motion abnormalities during
exercise (positive) and those with normal wall motion
(negative) .
Negative (N-9) positive (N-I0) --JL.-
MLD (1lIII) 1. 7 ± 0.4 1.0 ± 0.4 .007
MeSA (m) 2.4 ± 1.1 1.0 ± 0.7 .0001
IDS 47.8±8.0 66.9±13.1 .0001
'AS 72.1 ± 9.0 87.5 ± 7.4 .0001
MLD ~ 1.5 mI or MeSA ~ 1.9 mm identified all patients
with positive EE.
In patients with limited coronary atherosclerosis,
quantitative assess~nt of both absolute and relative
coronary dimensions is related to wall MOtion
abnormalities detected by exercise echocardiography.
BCBOCARDIOGRAPBIC ASSBSSMENT OP. MENTAL STRBSS
INDUCD WALL MOTION ABNORMALlTlBS: COMPARISON
WITH EXERCISE.
John S. Gottdiener. M.D.. F.A.C.C., David S. Krant~, Ph.D,
Adrian McGee, M.D., Marvin Oleshansky, M.D., James Myerhoff,
M.D., Shera E. Raisen, B.S., Alan Rozanski, M.D., F.A.C.C., VA
Medical Center, Washinaton DC, USURS, Bethesda, Md and
University of Maryland, Baltimore, Md.
In CAD, mental stress has been associated with transient
myocardial ischemia. Therefore, we u.ed 2D echo to
continuou.ly analyze LV wall motion (WM) in 14 men with CAD
(av aae 53 ± 0.6, yrs, av 1.7 ± 0.6 diseased vessels) and 6
normal men (av aae 56 ±10 YJ"S, pNS) durina mental arithmetic
(math), public speakina and upriaht bicycle exercise (EX).
Heart rate, blood pressure, and WM abnormality (A) were
assessed and compared for each stress intervention after echo
diaitization and display in continuous loop format. In CAD pt.,
av WMA increased from rest value of 1.13+0.20 to 1.37+0.41
with math, 1.31±Q.42 with speech and 1.63±Q:52 with EX (p<.05,
math, speech and EX VII re.t). Plasma epinephrine, (re.t 101 ±
50 pa/ml, math 172 ± 91 pa/mI, .peech 144 ± 53 pc/ml) and
double product (rest 9.5 ± 1.9 x 100, math 15.2 ± 4.4 x loa,
speech 14.6±3.6x100, EX 21.9±6.5) showed IlUb.tantialincre....
with mental .tres.. New or wo.rsened WMA occurred rapidly
durinc mental stress in 8/14 pta (57") vs 0/6 nor_Is, while
WMA durina EX occurred in 11/14 (79") pt., althouah at hiaher
double product than with mental stress. ST "ament depre.sion
with mental stress occurred in 4 of the 8 pt. with WMA, in
the absence of cheat pain. CONCLUSION: 1) mental arousal
can produce painlesll ischemia, probably by decrease in
myocardial oxyaen .upply; 2) the .table body po.ition, lower
heart rata and minimal re.piratory artifact with mental i1tre..
permitted ea.ier as....ment of WMA directly from the real time
2DE than polI.ible with EX.
EXERCISE ECHOCARDIOGRAPHIC DETECTION OF CORONARY
ARTERY DISEASE IN WOMEN.
Stephen Sawada, MD, Paul L. McHenry, MD, FACC, William
F. Armstrong, MD, FACC, Thomas Ryan, MD, Harvey
Feigenbaua, MD, FACC, Krannert Institute of Cardiology
and Indiana University Hospital, Indianapolis, IN.
The utility of exercise echocardiography (EE) for
the diagnosis of coronary artery disease (CAD) has been
evaluated in populations comprised largely of men who
have a high prevalence of disease. To determine the
diagnostic value of EE in women, 57 women who presented
for evaluation of chest psin were studied with coronary
angiography and EE utili&ing either treadmill (n-38) or
bicycle exercise (n-19). Twenty-eight of 57 patients
(49%) had significant CAD (>50% reduction in luminal
diameter), including 16 of 19 (84%) who had typical
angina and 12 of 38 (32%) who had atypical chest pain
(p<O.001). The overall sensitivity and specificity of
EE were both 86%. There were no significant
differences in the sensitivity and specificity of
bicycle EE vs treadmill EE. Three of 4 pts with fslse
positive EE had non-atherosclerotic cardiac disordera.
EE correctly determined the presence or absence of CAD
in 32 of 38 (84%) who had atypical chest psin and in 17
of 19 (89%) who had typical angina (p-ns). The
exerciae ECG wss non-diagnostic in 17 pts (30%) who had
resting ST segment depression or ST depression that
could be induced by hyperventilation or chsnges in
position. The· correct diagnosis was made by EE in 14
of 17 pts (82%) who hsd non-diagnoatic ECG. In
conclusion, EE has good sensitivity and specificity for
the detection of CAD in women. EE has diagnostic value
in women who have atypical chest pain and in those who
have non-diagnostic ECG.
HIGH DOSE DIPYRIDAMOLE·ECHOCARDOORAPHY TEST: l.A~E
SCALE CLINICAL TRIAL.
Eugenio Plcano MD Fabio Lallanzl MD, Michele Masini MD,
Artonlo L'Abbate, MD, FAC.C. C.N.R. Clinical Physlologf InstiIte,
Universly (J Pisa, taly.
Nine hurd'ed My-tw:> higlKlose dWidam<>lHchocardiogaphy test
(Del) were peI1'ormed in 771 pis wIh hiSOOfY (J chest pain and/or
myocardial irtarction. The dWidam<>1e irtuslon protocol was: 0.56
~g over 4', followed by 4' (J no dose, and , still fle9ative, 0.28
~g over 2'. The only <:rterion (J DETpostivly was the detection (J
a regional translelt ~n«<1I, abselt or (J a I&sser deg"ee in the
baseline examination. Irte1'preIable echo mages dll1ng DET were
OOlained in all pis. The average dll"ation (J a DET was less than 30
mimes. There were no death, myocardial Irfarction, malignalt
arrhyttmlas, severe twotenslon. Olot (J the 711 study pis, aslbset (J
580 was studied wtholot therapy, and ul'lderw9lt coronary
arteriogaphy; on this slbstt, the seostivly and spedlcl)' were
calculate<J. PIs were considered to have coronary artMy disQse ,
they had at least one sl9not1c lesion wit! 70X or~ diameter
reduction in the coronary anglog'am.Tht overall senstivl)' (J DET
was 75%; twas lower in single than inmu~1 disQse (54% YS
86%). The senstivl)' was 94% In pis wit! a resting vtrDicular
asynergy and 67% In pis wit! normal resting tunctlon. The overall
spedicl)' was 95", wit! smllar values In hypertensives and
I'lOI'IllOtensives (92 YS 97%, p.os), males and remaIes (96 YS 93%,
p.os).Thus, high dose DET is reasble and sate, wit! high spedlcl)',
and acceptlble senstIYl)' • especially In pis wit! mullvtsstl disease
and/or resting asynergy - for non InyasiYe detection (J
angiogaphlcally assessed coronary artery~.
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DIPYRIDAMOLE-DOPPLER ECHOCARDIOGRAPHY:
COMPARISON TO THALLIUM-201 IMAGING AND
QUANTITATIVE CORONARY ARTERIOGRAPHY.
Paul A Gnu'burn M.D., Jeffrey J. Popma M.D., Susan L Pryor
M.D., Brandy S. Walker M.D., Theodore R. Simon M.D., and
Thomas C. Smitherman M.D. VA Medical Center, DalIas, TX.
This study was undertaken to assess the ability of Doppler
parameters of aortic and mitral blood flow velocity to detect left
ventricular functional impairment due to ischemia during intra-
venous dipyridamole thalIium-201 imaging. In addition, we
evaluated the ability of Doppler measurements to detect the
presence of significant coronary artery stenoses as assessed ~y
quantitative coronary arteriography (QCA). The study conSIsted of
10 normal controls and 23 patients WIth coronary artery disease
(CAD) in whom QCA was performed (study interval 7.5:!:6.81~Ys).
A flow-limiting coronary artery stenosis was defined as <2mm m
cross-sectional area by QCA. Doppler estimates ofpeak aortic .
velocity (AoV) and acceleration (Ace) were determmed at baselIne
and post-dipyridamole as indexes of LV systolic performance.
Mitral flow velocity was measured at early filling (E) and atrial
systole (A) and the E/A ratio used as an index of Lv diastolic
function. The change from baseline to post-dipyridamole was:
AoV (m/s) Acc(rn/s2) E/A ratio
Normal controls 0.07:!:0.07 2.1:!:2.0 -0.18:!:0.68
CAD-thallium neg. 0.1l:!:0.12 2.9:!:2.3 -0.15:!:0.55
CAD-thallium pos. 0.02:!:0.17 0.5:!:2.9 -0.04:!:0.36
Differences between groups were not significant by analysis of
variance. Moreover, AoVand Ace decreased abnormally in only 3
of 14 pts with thallium-201 evidence of ischemia. E/A ratio did not
change abnormally in any pt. Similarly, no difference in Doppler
parameters existed for pts with and WIthout significant coronary
artery stenoses by QCA Thus, intravenous dipyridamole Doppler
echocardiography cannot reliably detect ischemia or significant
coronary artery stenoses and is of limited value in the evaluation of
ischemic heart disease.
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Cardiopulmonary Bypass Support for
Coronary Angioplasty and Shock
SlJFKRTHI) ANGIOPLASTY: INITIAL BXPERIENCB WITH HIGH
RISK PATIEtrnl
carl L. TOIIIIlBSO, M.D., F .A.C.C., Steven R. Gundry,
M.D., F.A.C.C., Albert R. Zoda, M.D., J. Lawrence
Stafford, M.D., F .A.C.C.. Rodney A. Johnson, M.D.,
F.A.C.C. Robert A. Vogel, M.D., F.A.C.C., University of
Maryland SChool of Medicine, Baltimore, Maryland
We used supported angioplasty to protect against
hemodynamic collapse in high risk patients undergoing
percutaneous transluminal coronary angioplasty (PI'CA).
Supported angioplasty is the performing of PI'CA while
the patient has been placed on cardiopulmonary bypass
in the catheterization lab. Ten male patients (mean
age-57.7 + 11.6 years) were placed on cardiopulmonary
bypass p-;::ior to PI'CA using right atrial to femoral
artery bypass via cannulae placed semi-percutnaeously
in a femoral artery and vein. Patients are given
Heparin 400 U/kg. Six patients had unstable and 4
severe stable angina. Indication for supported
angioplasty included marked reduction in left
ventricular ejection fraction ( <25%) in 2 patients;
significant jeopardized myocardil.lll (single coronary
vessel supplying distribution of two native vessels) in
4; and both (low EF, jeoparidized myocarditlll) in 4.
Cardiopulmonary bypass was initiated just before PI'CA;
flow ranged from 3.5 to 5 lImin. Balloon inflation
times were 1.5 to 5 mins/inflation. We attempted 13
lesions with 12 successes. Mean EF for all patients
was 25 + 14.7%; seven had EF <30%. Complications
included ;;ubsequent arterial repair in 1; late venous
thrombosis in 1; and recurrent femoral hematoma in 1.
One patient died because of celiac obstruction.
Restenosis has occurred in two patients.
Thus, supported angioplasty perm!ts PI'CA to be
performed safely in high risk patients who otherwise
would not be considered candidates for PI'CA.
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TVO-DIMENSIONAL ECHOCARDIOGRAPHY CAN REDUCE HOSPITAL
ADMISSIONS FOR ACUTE MYOCARDIAL INFARCTION BY MORE THAN
ONE-TRIRD: RESULTS OF A PROSPECTIVE STUDY PERPORHED IN
THE EMERGENCY ROOM. Peter Sabia H.D., Ali Atrookteh M.D.,
Dale Touchstone H.D., Mark Keller H.D, Sanjiv Kaul H.D.,
F.A.C.C. University of Virginia, Charlottesville, VA
Nationwide, less than 30% of patients admitted to the
hospital from the emergency room (ER) with suspected
acute myocardial infarction (AHI) actually have this
diagnosis. Because regional wall motion abnormality
(RYMA) is the sine qua non of AHI, we hypothesized that
using 20 echo in the ER could substantially reduce hospi-
tal admissions for suspected AMI. To test this hypothesis
we analyzed data from 180 pts who presented to the ER for
chest pain. AHI was documented in all pts by serial car-
diac enzymes. The results of the echo studies were not
divulged to the physicians who admitted or discharged the
pts based upon conventional criteria. Of the 40 pts dis-
charged, 2 had AMI; of the 57 admitted to non-coronary
care unit beds, 3 had AMI; while 25 of the 81 admitted to
the coronary care unit (CCU) had AMI. Average cost for
no admits was $247, for those admitted to non-CCU beds
was $4255, and for those admitted to the CCU beds was
$7605. The total cost for the 180 pts was $888,673 re-
sulting in cost/infarct of $29,622. Of the 30 AMI pts,
29 had technically adequate studies: 27 had RYMA and 2
had normal echos neither of whom had any complications;
none had diffuse global dysfunction of the LV. Of the 150
non-AMI pts, 140 had technically adequate echos, 58 were
normal, 60 had RYHA and 22 had diffuse global hypokine-
sia. If only pts with RYMAs had been admitted, total hos-
pital admissions would have decreased from 140 to 87 (de-
crease of 38%). No additional AHIs would have been dis-
charged and hospital cost (including $300 per echo) would
have been reduced to $61,1141 (decrease of 31%). We con-
clude that 20E performed in the ER is a cost effective
way to determine hospital admission for suspected AMI.
PERQJTANEXlUS INSTITUTION OF CAROIOPULMJNARY (BYPASS)
SUPPORT: TECiNIQUE ANO COMPLICATIONS.
FaylZ A.Shawl MD,FACC,Michael J.Domanski MD,FACC,Sudhakar
Punja, MD, FACC, Tomas J. Hernandez, MD, Washington Adventist
Hospital, Takoma Park, MD.
Cardiopulmonary bypass support(CPS) of pta undergoing
hi~ risk PTCA may be more effective than intraaortic
balloon, but has required surgical placement. We report
the safety and efficacy or CPS established percutaneoUBly
in 43 pts. 8 were emergenc1es(group-1). 35 hi~ risk
PTCA(group-2), and 2 higll risk valvul oplasty (V)(group-3) •
Group 1(ages 40-80 yrs) were in oardiogenic shock due to
myocardial infarction(MI) with 2 in cardiac arrest(A).
pts in groups 2(ages 41-78 yrs) and 3(ages 81-82 yrs)had
iliofemoral arteriography prior to CPS with iliofemoral
angioplasty in 2. 20F arterial and veooUB cannulae were
placed in the ri~t(8) or left(35)femoral vessels.
Cannulae were inserted after sequential dilatation using
8-14F dilators over a stiff .038· guidewire. CPS was then
instituted using· the Bard CPS system. FlOlis ranged frtlll
2.8-6L1min(mean 3.8) and pulmonary wedge pressures were
0-41D111 Hg. '!be 2 pta with A regained consciousness. PTCA
was successful in 15 of 16 lesions attempted in group 1
and 85 of 86 lesions attempted in group 2. Both pts in
group 3 had successful V with 4 coronary lesions dilated
in one. Hemostasis was achieved in 41 by an external
clamp applied for 6-18 hours(mean 12). Complications
include hospital death in one, acute occlusion in one, HI
in one, repair of femoral arteries in two, venous
thrtlllbolSis in one, infection at tbe entry lSi te in four,
flllloral nerve weakness in two, pseudoaneury811 in two.
Mean transfusion requirllllents were 9 units(U) per pt in
group 1, 0.5 U/pt in group 2 and 2.5 U/pt in group 3. In
conclusion, CPS can be llIt'ely and effectively instituted
percutaneously in selected patients witb an acoeptable
complication rate.
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PERaJTAN!:XlUS CARDIOPULI«lNARY BYPASS TO SUPPORT HIGH RISK
ELECTIVE OORONARY ANGIOPLASTY
Fayaz A. Shawl. MD. FACe, Mi chael J. Domanski, MD, FA CC;
Sudhakar Punja, MD, FACC; Tomas J. Hernandez, MD;
Wa8bington Adventist Hospital, Takoma Park, MD.
PTCA in ptll 'with lat ejeotion fraotion(EF) and/or a large
area of rEll1aining viable myocardil.lll served by the target
vessel can cause hemodynamio oollapse in case of aoute
clollure. We report 35 pts in whan peroutaneous
cardiopulmonary bypaSll support (PCPS) was instituted to
enhanoe the safety of PTCA. All pta had severe or
unstable angina associated with lat EF and/or a large
amount of myocardil.lll(H) perfused by the target artery. 22
males and 13 fEll1ales, ages III to 78 yrs(mean62), with
CalBdian Cardiovasoular Society(CCS) Class III (11) or IV
(211) ang:l.na and EF ranging fran 11 to 53J(mean-32) were
lltudied. A total of 86 leaionll were present(mean-2.II/pt).
Severe left main and 3 vessel disealle was present in II
and 33 ptll rellpeotively. One pt had severe 2 vessel
disease and one had single vesllel disease. 29 had a
previoUll myocardial infarotion and 10 had bypaSll surgery.
PCPS was inlltituted ulling 20 French cannulae. Flat ranged
fran 2.8-6 Llmin(mean-3.7). Pulmonary capillary wedge
prellsures were 0 to II IDlD Hg. PTCA was suooessful in 85 of
86 lesions attempted. No pt had ang:l.na at the maximl.lll
flat rate with balloon inflations up to 5 min. PCPS was
discontinlllld without oomplication after an average bypass
time of 37 min (range 10-73). HEII10stasiS was achieved by
external clamp compression in all but one pt who required
surgical repair of the fEll10ral artery. There was 1
hospital death. pt follatUP at 1 to 111 weeks(mean 6)
disclosed 4 in CCS Class II and 30 in Class O. We
conclude that PCPS can be used safely in seleoted higl:l
risk PTCA pts and therefore mq expand the application of
PTCA.
IMPROVED HEMODYNAMIC AND LEFT VENTRICULAR UNLOADING
DURING ACUTE ISCHEMIA USING THE HEMOPUMP LEFT VENTRICULAR
ASSIST DEVICE COMPARED TO INTRA AORTIC BALLOON COUNTER
PULSATION.
R. W. Smallin~. M.D., Ph.D., F.A.C.C., D. B. Cassidy.
M.D., M. Merhlge. M.D., P. R. Felli. B.S •• G M. Wise.
M.S•• R. L. Barrett, M.D., R. D. Wampler, M.D.
Thirteen conditioned dogs were subjected to a 2 hour mid
left anterior descending (LAD) occlusion followed by a 1
hour period of reperfusion. In 7 dogs hemodynamic support
was maintained by the Hemopump (HP). a 7 mm diameter
axial flow pumping cannula capable of pumping 3
liters/minute from left ventricle (LV) to aorta (Ao)
which was placed retrograde across the aortic valve. A
conventional intra aortic balloon pump (IABP) was
inserted in 6 dogs. Regional function was measured using
sonomi~ crometers in the control state. during LAD
occlusion and with reperfusion (R) on and off left
ventricular support. Left ventricular and aortic pressure
(P) measurements were made simultaneously with functional
measurements. Two hours after LAD occlusion during HP
support the LV systolic pressure fell from 97 to 45 mmHg
(P=.003) while the mean AoP rose from 79 to 87 mmHg. The
LV diastolic P fell from 6 to 0 mmHg (P=.05). The LAD
endiastolic diameter decreased from 17 to 13.9 mm and
paradoxical systolic bulging in the LAD region decreased.
During AIBP counter pulsation there was no change in any
of the apove parameters with LV systolic pressure
maintained at 100 mmHg, mean Ao pressure maintained at 89
mmHg and LAD diastolic diameter at 16.45 mm. Conclusion:
The Hemopump appears to be superior to IABP in terms of
LV unloading and support of aortic pressure during
interventions in acute regional myocardial ischemia.
EMERGENCY USE OF PORTABLE CARDIOPULMONARY BYPASS IN
PATIENTS WITH CARDIAC ARREST.
Paul A. Overlie, M.D., FACC. Robert T. Reichman, M.D.,
Sidney C. Smith, M.D., Walter Dembitsky, M.D., Robert
M. Adamson, M.D., Brian E. Jaski, M.D., David G. Marsh,
M.D., Pat O. DaEy, M.D. Sharp Memorial Hospital, San
Diego, CA.
A portable cardiopulmonary bypass system, (PCPB) was
placed in 25 patients (PTS) who had sustained cardio-
pulmonary arrest and had not responded to the usual
advanced cardiac life support (ACLS) measures. 25/25
had successful initiation of PCPB with flows in excess
of 3.5 l/min obtained in all pts. 12 survived short
term, 6 were discharged improved. 8 treated pts
arrested in the cath lab, either after attempted PTCA
(N=5) or prior to angiography (N=3). 4 survived short
term, 3 were discharged. all PTCA failures. One PTCA
failure, a Jehovah's Witness, survived CABG. but no
blood products could be given and pt expired. 13 pts
had PCPB placed after arrest in the ICU. 5 after cardiac
surgery (4/5 short term survivors, 2 pts discharged); 3
with m~ssive pulmonary emboli (0 survivors); 2 as a
"bridge" to ventricular arrest device or total artificial
heart (2 short term, 0/2 long term survivors); after
ven..:,icular rupture (sllccessful return of neurologic
function with surgeon/family deciding not to proceed
with cardiac surgery. 4 pts had PCPB placed on ward or
in ER; 1 survived. 2 morbidly obese pts had bleeding
secondary to cannula side-holes being extravascular.
Neither survived. Application of PCPB can salvage pts
after arrest, particularly if applied early either in the
cath lab percutaneously or in the surgical ICU setting.
Improvements in vascular cannulae have allowed for
greater success with our later experience.
EMERGENCY PERaJTAN!:XlUS CARDIOPULI«lNARY (BYPASS) SUPPORT
IN CARDIOGanC SHOCK.
FaYaz A. Shawl MD. FACC, Michael J. Domanski MD. FACC, Sudhakar
Punj a, MD, FACC, Tomas J. Hernandez, MD, Wa8bington Adventist
Hospi tal, Takoma Park, MD.
Support of pta in cardiogeni0 shock(CS) with an
intraaortic balloon mq not provide hEll10dynamic stability
during acute intervention. We report emergency
percutaneous cardiopulmonary bypasll support (PCPS)
instituted in 8 pts (ages 112-80 yrs) with CS and acute
myocardial infarotion(HI). PCPS was instituted 30-180
min(mean 106) after onset of symptClllll. 4 had previous HI
&. 2 were in cardiac arrest(A). 6 without A had a mean
blood pressure(BP) range 43-55 and pulmonary wedge
pressures(PWP) ~O DID Hg. 20F oannulae were inserted into
the fEll10ral artery and vein peroutaneoUllly. Flat rates of
3.2-5.2 Llmin (mean 11.0) were achieved with mean BP 63-76
and PWP of 0-11 mm Hg. 2 pta in A regained conscioUllness
while stUl in asystole or ventrioular fibrillation.
Angiography performed after hemodynamio stabUity
revealed lat ejeotion fraction, range 17-1I0J(mean 30),
critical stenosill involving left main in 1;3 vessels in
2;2 vessels in 2 and 1 vessel in 1I.0ne had anatany
unsuitable for either PTCA or bypass surgery, oould not
be weaned fran PCPS, and expired. The remaining 7
underwent suooessful PTCA in 15 of the 16 leaions
attempted and were weaned fran PCPS. Total bypass time
was 411-120 min(mean 66). HEII10stasis was achieved by
external clamp oompression in all but one pt who required
surgical repair of the femoral artery. There were no late
MI's or vascular complications. At 1-3 month(mean 2.2)
follatup all pta were asymptClllatio and 4 had a negative
strells test. In oonclusion, PCPS can:(1) be safely
instituted peroutaneously; (2)be lifesaving in pts with
CS; (3)hEll1odynamically stabilize pts in A; (lI)facil1tate
emergency complex PTCA even in pta in CS.







Superiority of Tomographic Thallium Imaging for the
Detection of Restenosis After Percutaneous Transluminal
Coronary Angioplasty
Charles A Lefkowitz MD. Bette L. Ross MSc. Leonard Schwartz MD
FACC. Harold E. Aldridge MD FACC, Mark A. Henderson MD
FACC, Peter P. Liu MD FACC. Sylvain Houle MD PhD, Peter R.
McLaughlin MD FACC, Toronto General Hospital, Toronto, Canada.
The accurate detection of restenosis following percutaneous
transluminal coronary angioplasty (PTCA) continues to be a common
and difficult problem. In order to address this issue. we studied 32
patients with serial tomographic and planar thallium scintigraphy
performed prior to, 1 month after and 6 months after successful single
vessel PTCA. Tomographic and planar imaging were performed at each
study timepoint (in a randomly determined sequence) and were analyzed
quantitatively for evidence of stress or washout abnormalities.· All
patients underwent repeat angiography at 6 months and restenosis was
present in 15 (incidence of 47%). Non-invasive detection of restenosis
was evaluated by comparing angiographic results to anginal symptoms,
exercise electrocardiography (GXT) and tomographic and planar
thallium analysis. Results (in %) are tabulated below (pY = predictive
value):
AnKina GXT ToroomPhy Planar
Sensitivity 36 53 92 87
Specificity 94 58 77 50
Positive PY 83 62 80 62
Ne&Atiye PV 64 63 93 80
Of those with restenosis, the specific vascular territory was correctly
localized to the territory of the PTCA vessel in 77% of the tomographic
studies as compared to only 33% of the planar studies.
These results demonstrate that tomographic thallium imaging is an
accurate method for detecting and localizing restenosis in patients 6
months post-PTCA and is superior to clinical assessment, GXT and
planar thallium studies in evaluating this problem.
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SAFETY AND INITIAL RESULTS IN MAN.
Richard A. Staudacher M.D., John J. Mahmarian M.D., Judy
B. R1XSOn R.N., Terri M. Boyce B.S., Antonio "Pacifico
M.D., FACC, Kiyotaka Kugiyama M.D., Mario S. Verani
M.D., FACC, Baylor College of Medicine, Houston, Texas.
Adenosine is a potent coronary vasodilator with a short
half-life (10 sec), which makes it an ideal drug to use
in combination with thallium-201 scintigraphy for the
diagnosis of coronary artery disease (CAD). To test the
feasibility and safety of adenosine-thallium scinti-
graphy, we studied 33 pts with suspected CAD. Adenosine
was infused intravenously at 50, 75, 100 and 140
ug/kg/min. Thallium-201 (3mCi) was injected at the
highest tolerable dose of adenosine, which was then
continued for 3 additional minutes. Single photon
tomography was performed immediately after the adenosine
infusion and 4 hours later. Side effects occurred in
76% (25/33 pts) but were usually mild, did not require
therapy, and ceased instantly after discontinuing the
adenosine infusion. Chest pain occurred in 53%, head-
ache in 34% and cutaneous flushing in 15%. Systolic
blood pressure (SBP) and heart rate (HR) changes (mean ±
SO) from baseline were:
Adenos ine dose~ 50 75 100
SBP (mmHg) 1.1±5.6 .03±6.9 -4.6±9*
HR (bpm) 2.5±5.5* 2.4±6.3* 8.1±7.6t
~ug/kg/min; *p < .05; tp < .001
CAD was documented in 15 pts, all of whom had thallium
defects after adenosine, which were reversible in 9
(sensitivity = 100%). Of 18 pts with either normal
coronaries (n=8) or at low risk for CAD (n=10), 16 had
normal scintigraphy (specificity 89%). Thus,
adenosine-induced coronary vasodilation is a safe, con-
venient, and potent intervention to uncover perfusion
defects during thallium scintigraphy in pts with CAD.
THE ROLE OF INTRAVENOUS DIPYRIDAMOLE THALLIUM IMAGING
IN PREOPERATIVE CARDIAC RISK ASSESSMENT BEFORE RENAL
TRANSPLANTATION.
Alan Camp, M.D., Judy Hoff, R.N., Leslee Shaw, M.A.,
Sheila Byers, R.N., Paul Garvin, M.D., Bernard
Chaitman, M.D., F.A.C.C., St. Louis University Medical
Center, St. Louis, MO.
Thus, diabetic pts awaiting renal transplant can be
safely and accurately risk stratified with OPT.
Routine coronary angiography is not necessary to risk
stratify this high risk clinical patient subset.
The effectiveness of dipyridamole thallium imaging
(OPT) in predicting cardiac events was assessed in 40
diabetic (20+6 years duration) renal transplant
candidates. -Of the 40 pts, whose average age was 42
(27-64) years, 34 (85%) were hypertensive and 21 (53%)
were cigarette smokers. Prior cardiac history included
chest pain in 6 pts and myocardial infarction (MI) in 3
pts. Cardiac events (CE), defined as cardiac death,
MI, or unstable angina occurred in 6/40 (15%) pts over
a mean follow-up of 17 (1-25) months. On OPT, 9 pts
had reversible defects, 8 pts had fixed defects, and 23
pts had normal scans. Only pts with reversible defects
had CE 6/9 (67%). Of the 6 pts with CE, 3 occurred in
pts awaiting transplantation (1 sudden cardiac death, 2
MI). Of the 21 pts that had renal transplants, 3 had
CE, all within 6 weeks after transplantation.














EXPERIENCE WITH THE INTRACORONARY DOPPLER CATHETER IN
PATIENTS WITH CLINICAL ISCIIl!MIC HEART DISEASE BUT NORMAL
OR TRIVIALLY DISEASED CORONARIES.
Jan L. Houghton M.D., F.A.C.C., Martin J. Frank M.D.,
F .A.C.C., Albert A. Carr M.D., Thomas W. von Dohlen
M.D., L. Michael Prisant M.D., F.A.C.C., Medical College
of Georgia, Augusta, Georgia.
Forty-two Pts referred for cardiac catheterization because
of suspicion of coronary disease and subsequently found
to have normal coronaries (36) or insignificant disease
in another coronary (6) underwent intracoronary (left
anterior descending or circumflex) doppler measurements
of flow reserve (FR) using intravenous dipyridamole
(DIP). DIP thallium scans and 2D echocardiography were
also performed for evaluation of myocardial ischemia
and mass. Twenty-three Pts (55%) had LV hypertrophy
from hypertension by echocardiography. Twenty of the
42 Pts had normal FR (augmented divided by baseline
flow velocity.? 3:1, range 3.2 to 7). The remaining
22 Pts had abnormal FR (range 1. 4 to 2.84) including
14 with markedly impaired FR « 2:1). Thallium scans
were positive in 12 of 42 (29%)-:- In spite of the fact
that obstruction was absent in the instrumented coronary,
FR was significantly lower in the group with positive
as compared to negative DIP thallium scans (1. 97 + .79
vs 3.6 + 1.3, p = .0002). In 11 of the 12 positives,
FR was abnormal (p = .002). Neither LVEDP nor LV mass
were predictive of a positive thallium scan in the low
FR group. Conclusions: 1. In a population with a' high
incidence of hypertensive heart disease, provocative
coronary vasodilator reserve testing using DIP frequently
results in low measured FR and positive thallium scans
in the absence of significant coronary obstruction.
2. Abnormally low FR is an important mechaniam for
positive thallium scans in pts without significant
coronary disease.
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THE COST-BENEFIT ADVANTAGE OF PRIMARY SCINTIGRAPHIC
EVALUATION AFTER UNCOHPLICATED ACUTE INFERIOR VALL
HYOCARDIAL INFARCTION.
David C. Reed, H.D., Lorene N. Shaw, BSN, Donald-L.
Kaiser, DPH and Robert S. Gibson, H.D., FACC, University
of Virginia, Charlottesville, Virginia
Host evaluations of cost-effectiveness utilize only
initial gains and outlays and do not take into account
outcome based on prospectively obtained population
specific natural history data. To fully assess the
cost-benefit of various risk stratification strategies
after uncomplicated inferior infarction (IHI) we tested
4 diagnostic and management algorithms (AI z cath
defined, A2 = TL-201 directed, A3 • cath followed by
TL-201, A4 = subgroup directed:Q-wave HI TL-201, Non-Q-
wave HI cath) and compared the results with those of our
natural history post-IHI population (62% multivessel
disease, 36% LAD disease, 31% cardiac event rate during
39 mos follow-up). A2 is the least expensive diagnostic
method (13-31% less) but leads to the highest initial
treatment costs (19-30% more) due to more CABG surgery
or PTCA. In contrast, its secondary costs are least
because of fewer required subsequent interventions (up
to 30%) and more moderate follow-up expense. Al is
least desirable, despite lower costs, due to the
increased number of unprevented deaths and iatrogenic
HIs. A2, A3, A4 decreased future HIs but only A2 and A4
lead to net positive lives saved with A2 saving 18
lives/1000 patients over 3 years at the lowest rate:
$659.221/1ife saved. Conclusion: Patients with uncom-
plicated IHI should undergo InItial TL-201 scintigraphy
as the functional detection of ischemia leads to a more
favorable cost-benefit ratio. However, identification
of additional high risk variables is required to reduce
the high cost of even this method.
RELATIVE CORONARY FLOW RESERVE REFLECTS STENOSIS SEVERITY
MORE ACCURATELY THAN ABSOLUTE FLOW RESERVE DURING
CHANGING AORTIC PRESSURE AND CARDIAC WORKLOAD.
K. Lance Gould, M.D., FACC, Richard L. Kirkeeide, Ph.D.,
Martin Buchi, M.D., University of Texas Medical School
at Houston, Houston, TX.
Coronary flow reserve (CFR) indicates functional stenosis
severity but is altered by conditions unrelated to sten-
osis geometry. To assess their effects on CFR, aortic
pressure (AP) and pressure rate product (PRP) were
altered by Phenylephrine (P) and Nitroprusside (N) in 11
acute dogs with 340 stenoses of the left circumflex by a
calibrated stenoser providing % area stenosis (%S) with
CFR measured by flowmeter after intracoronary adenosine.
Absolute CFR (max/rest flow) with no stenosis (CFRn)
was 5.9+2.5 (ISD) ranging from 2.0 to 12.1 depending on
AP/PRP.- However, relative CFR (CFR/CFRn) was independent
of AP/PRP since their affects on both numerator and de-
nominator cancel. The size of one standard deviation
(SD) expressed as % of mean absolute CFR was !43%
without S and for each category of stenosis severity
from 0 to 100% S averaged +45% compared to +17% for
relative CFR. For example: for a 65% S, absolute CFR
was 5.2+1.7, a +33% variation whereas relative CFR was
0.9+0.09, a +10% variation over the same range of AP/PRP.
Conclusions:-Absolute CFR by flowmeter is highly variable
for fixed stenoses depending AP/PRP whereas relative CFR,
as by PET perfusion imaging, is better suited for assess-
ing stenoses severity independent of physiologic
conditions.
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Antiarrhythmic Drugs/Ventricular Arrhythmias
THE SAFETY, EFFICACY AND PREDICTIVE VALUE OF
DRUG TERMINATION OF VENTRICULAR TACHYCARDIA.
Michael Griffith MRCP, Nicholas Linker MRCP, David Ward MD
FACC, John Camm MD FACe. St. George's Hospital, London, UK
Drug termination is frequently used in the acute management of
VT. The relative merits or significance of the effects of the drugs
available is not known. In this study drugs were given
intravenously as bolus doses (adenosine (A) and lignocaine (L» or
infusions (disopyramide (D), f1ecainide (F) and sotalol (S» during
induced, sustained haemodynamically stable VT in serial trials
over aperiod of a week. VT was tcrminated by pacing if it
continued 10 minutes after end of drug administration. Re-
induction of VT was attempted 15 mins after the infusions to
assess suppression, defined as no inducible VT, or re-induction
requiring either more extrastimuli or a faster (>20bpm) drive rate.,
Twenty four pts underwent 105 trials with termination of VT in
35 trials by the drug, In six pts no drug terminated VT.
Adenosine did not tcrminate VT in any pt (so acted as a control).
The number of pts whose VT was terminatcd by each drug are
listed.
Drug A L D F S
Termination 0/23 7/23 12/24 11/20 5/15
Suppression+Termination 6/12 6/11 3/5
Suppression-Termination 1/12 0/9 4/10
The association of tcrmination by D and F with suppression was
significant (p<0.05) but not specific. Serious adverse cffects
during VT were scen in 5/20 paticnts with F (4 proarrhythmic, I
haemodynamic), in 2/15 patients with 50talol (both
haemodynamic) and in 1/24 patients with D (proarrhythmic) but
were not seen with L or A.
Conclusion F was the most effective but had the most adverse
effects, while L was both significantly safcr and less effective
(p<0.05). Drug termination by D and F but not S were prcdictors
of suppression of VT re-induction.
SELECTIVITY OF A NOVEL CLASS III ANTIARRHYTHMIC AGENT
John R. Onufer, M.D., Steven M. Pogwizd. M.D., Peter B.
Corr, ph.D., Washington Universitj, St. Louis, MO
UK-66914 is a novel class III antiarrhythmic agent
which blocks competitively outward K+ conductance and
increases the refractory period in atrial and ventricu-
lar tissue. Since other class III agents also decrease
conduction velocity (CV) in ischemic or periinfarct re-
gions potentially modifying their antiarrhythmic
efficacy, the present stu<tt was performed to evaluate
whether UK-66914 altered CV in dog hearts in vivo with
a previous anterior infarct of greater than6!iiOdura-
tion. CV was determined on a beat to beat basis using
a 3-dimensional mapping system and recording from 240
simultaneous transmural sites. Treatment with UK-66914
(50 ~g/kg) resulted in a mean increase in the ventricu-
lar refractory period of 20.8 t 12.8 ms, p<.OOl. Total
activation time for sinus beats as well as Sl and S2
stimulated beats were unchanged between the control
interval and after treatment with UK-66914. Mean CV of
Sl beats (250 ms) in regions with normal CV was 76 t
2.5 cm/s before and 75 t 2.5 em/s after UK-66914 (p >
.6). In regions of slowed conduction « 50 cm/s). CV
for Sl was 26 cm/s and was unchanged after treatment (p
> .39). S2 at 140 ms resulted in a CV of 80 t 2.3 cm/s
before and 80 t 2.5 cm/s after UK-66914 (p > .60). In
regions of slowed conduction. CV for S2 was 36 t 1.9
cm/s before and increased to 50 t 7.4 cm/s after treat-
ment. Premature stimuli at 180 ms also resulted in no
si9nificant changes in CV between the control and
treatment intervals. In conclusion, UK-66914 does not
adversely alter CV or activation time in vivo in normal
or peri infarct regions although the agent-sTgnificant1y
prolongs the refractory period indicating a specific
antiarrhythmic effect not shared by other class III
agents.
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COMPARISON OF ANTIARRHYTHMIC EFFICACY AND SAFETY OF CLASS
lA, IB, AND lC AGENTS IN SYMPTOMATIC AND POTENTIALLY
MALIGNANT VENTRICULAR ARRHYTHMIA
Prakash Oeedwania. M.D" F,A,C,C" Peter Pool, M,D"
F,A,C,C" Robert Zob1e, M,D" F,A,C.C., and the Encainide
Study Group, VAMC/UCSF School of Medicine, Fresno, CA
Recently several new class I agents with varying spectrum
of e1ectrophysio1ogic actions have been approved for
clinical use, However, little data is available
regarding their comparative efficacy and safety, In this
multicenter, placebo (p1) controlled, randomized,
parallel study, procainamide (P), mexi1etine (M) and
encainide (E) were compared in 141 pts with chronic
frequent (~30/hr) and repet i t i ve PVCs wi th symptoms or
organic heart disease, All antiarrhythmic drugs were
discontinued and after 7-10 days pl, pts were randomized
to E, Mor P given in titrated doses (for 90% PVC~) up to
50 mg TID, 400 mg TID and 1000 mg QID, respectively, for
6 wks, Efficacy was assessed by 24 hr Holter monitorings,
Only tapes with ~ 18 hrs of data were analyzed blindly at
a central facility for uniformity. The interim analysis
of 69 pts revealed the baseline total and repetitive PVC
rates to be comparable in the 3 groups, During therapy,
the median % reduction in log transformed total PVC rate
was 95% with E, 55% with Mand 42% with P,encainide being
significantly more effective than M (p-0,004) or P
(p-O,OOI), Using 90% PVC ~ as a criterion, 59% of E, 25%
of Mand 29% of P pts achieved adequate response, The
median % ~ in repetitive PVCs was 100% for E, 96% for M
and 74% for P (p-ns). An overall test for adequate
response (90% ~ in total and repetitive PVCs) revealed E
to be superior to M(p=O.OI) and P (p=0.02), Four %of E
versus 37% of Mand 33% of P pts prematurely withdrew due
to adverse experiences, Conclusion: E is more effective
and better tolerated than Mor P in pts with symptomatic
and potentially malignant ventricular arrhythmia.
DYNAMIC RESPONSE OF CONDUCTION VELOCITY TO QUINIDINE
DURING PULSE TRAIN STIMULATION IN CANINE PURKINJE FIBERS.
Douglas L, Packer M,D" F.A,~~, Augustus O. Grant M,D"
F,A,C,C" Harold C, Strauss M.D" C. F. Starmer M,D., Duke
University Medical Center, Durham, North Carolina,
To determine if the relationship between squared con-
duction velocity (~) and Vmax remains linear during
repetitive stimulation in the presence of quinidine (4-8
mg/l) , 11 canine Purkinje fibers were studied with a
double microelect~ode technique, Conduction time was
determined using Vmax as a fiducial point, With abrupt
onset repetitive stimulation, a frequency-dependent
monoexponential decline in &2 was observed which
paralleled changes in net membrane currents as reflected
by Vmax, The uptake rates and steady-state change in e2
were both use and concentration-dependent. Quinidine ap-
parent binding7and unbinding rates derived from e
2 were
1.2 f ,24 x 10
3
/Msec and 63 f 12/sec for the activated and
1.5 f 1,0 x 10 /Msec and .16 f ,06/sec for the resting
membrane states. The steady-state relationship between 82
and Vmax was linear (r-.98f,02) with a 1:1 relationship in
7 fibers (mean slope- 1,02 f ,13), A concentration-inde-
pendent, 1:1 relationship persisted dynamically over the
course of 20 sec pulse trains (mean slope- 1.1 f 0.3) with
no deviation from linearity at any stimulation frequency.
These data suggest that the linear relationship between 82
and net membrane currents seen at steady state is
maintained under the dynamic conditions of repetitive
stimulation, and indirectly suggests that quinidine does
not appreciably alter passive membrane properties over the
course of a pulse train,
ELECTROPHYSIOLOGIC AND HEMODYNAMIC EFFECTS OF SUN-1l65:
A NEW ANTIARRHYTHMIC DRUG
Takeshi Ino. M,D., Hirotsugu Atarashi, M.D •• Hirokazu
Hayakawa. M.D., Shin-ichi Kuroki, M.D .• Takeo Onodera.
M,D., Hirokazu Saitoh. M.D .. 1st Department of Internal
Medicine, Nippon Medical School, Tokyo, Japan
SUN-1165 [N-(2.6-dimethy1pheny1)-8-pyrro1izidineacetamide
hydrochloride hemihydrate] (S) is a new antiarrhythmic
drug with class Ic properties in vitro, We assessed
acute e1ectrophysio10gic (EP) and hemodynamic (HD) ef-
fects of S in 18 pts with supraventricular tachycardia
(SVT) (6 pts with AV nodal reentrant tachycardia (AVNRT).
and 12 pts with AV reentrant tachycardia (AVRT», All
pts were free from organic heart disease, EP and HD
studies were performed before and 60 min after a single
oral administration of S (150 or 200 mg). S significantly
shortened sinus cycle length (798f172 to 727±106 msec,
M±SD, p<O.Ol); lengthened sinoatrial conduction time
(98±21 to ll2±21. p<O,Ol), AH interval (83±1l to 100±15,
p<O.Ol). HV interval (42±8 to 63±17, p<O,OOl), and RV
effective refractory period (220±28 to 231±27, p<0,05).
Anterograde conduction via accessory pathway (AP) was
abo1; shed in 5/7 pts. Retrograde conduct ion vi a AP and
AV node was abolished in 9/12 and 2/6 pts respectively.
Induction of SVT was completely suppressed in 9/13 pts
(3/5 pts with AVNRT, and 6/8 pts with AVRT). By HD stud-
ies (10 pts), decrease of stroke volume index (47±7
to 40±7; p<O,05). and increase of mean pulmonary arterial
pressure (16±2 to 19±3 mmHg. p<0.05) were demonstrated.
Plasma level of S at the time of these studies was ranged
0,19 to 1.88 (1,00±0.60) mcg/m1. No adverse effects
were observed. In conclusion •. oral S has potent EP ef-
fects on impulse propagation through AV node and AP
resulting in cessation of reentry. And it will be safe
and useful drug in preventing SVT. Cautions. however.
may have to be paid on its negative inotropic action.
ELECTROPHYSIOLOGIC EFFECTS OF ADENOSINE
FOLLOWING ORTHOTOPIC CARDIAC TRANSPLANTATION:
EVIDENCE OF SUPERSENSITIVITY. Kenneth A.
Ellenbogen. M.D., FACC. Marc D. Thames, M.D.,
FACC, John P. DiMarco, M.D., FACC, Helen
Sheehan, R.N., Bruce B. Lerman, M.D., FACC,
McGuire VAMC, Med ColI of VA, Richmond, VA and
U. of Virginia, Charlottesville, VA.
Adenosine (ADO) and acetylcholine (ACH) have
similar electrophysiologic effects thought to
be mediated by a common transduction process.
Denervated sinus and AV nodes are supersensi-
tive to ACH. We hypothesized that after
cardiac transplantation (CT) the donor sinus
node (Denervated, DSN) has greater responses to
ADO than the recipient sinus node (Innervated,
ISN). We measured changes in sinus cycle
length (~SCL), time to peak effect, and
duration of effect for DSN and ISN with
boluses of ADO (25-112 ug/kg) in 21 pts with CT
and 10 controls (data for 75 ug/kg dose in
table; * p < 0.05).
SCL '~SCL Peak Onset Duration
(ms) (sec) (sec)
Control (n=lO) 828±88 4±2 9±2 4±1
ISN (n-21) 877±64 21±6 17±1* 4±1
DSN (n-21) 706±23 85±20* 6±1* 23±1*
DSN is markedly more sensitive to ADO than
ISN. These effects are not due to hypoperfu-
sion or surgical trauma to the ISN since re-
sponses of ISN and control are similar. Effects
of ADO on ISN and DSN were not attenuated by
autonomic blockade in 5 pts. The exaggerated
response to ADO may be attributable to a shared
messenger and may explain the bradycardia
noted during episodes of CT rejection.
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Antiarrhythmic Drugs in Supraventricular
Tachyarrhythmias
FLECAINIDE ACETATE FOR THE TREATMENT OF
POSTOPERATIVE ATRIAL ARRHYTHMIAS.
Samjr Wafa MB ChB. David Ward MD. FACC. John Parker MD.
John Camm MD, FACC. St. George's Hospital. London. UK.
The antiarrhythmic efficacy of intravenous f1ecainide (F) and
intravenous digoxin (D) was assessed in 30 pts (27 males). aged 43
to 73 (63.2 ± 6.7) years who developed atrial arrhythmias in the
first 96 hours after open heart surgery. Twenty eight had AF and
2 had atrial flutter. Pts were entered into the study if the
arrhythmia had persisted for at least IS minutes with a
ventricular rate> 120 beats/minute. Pts were randomised to F
(group I. n - IS) or digoxin (group 2. n - IS). F was given as a
bolus of I mg/kg over 10 minutes followed by an infusion of 1.5
mg/kg/hour for I hour and then by an infusion of 0.25
mg/kg/hour for the rest of the 24 hour study period. D was given
as a bolus dose of 0.5 mg followed after 6 and 12 hours by 0.25
mg bolus doses. In both groups. intravenous verapamil 10 mg was
given after 45 minutes if AF or flutter persisted with a mean
ventricular rate of >100 beats/minute. The antiarrhythmic
efficacy was assessed by 24 hour Holter monitoring and frequent
IS second rhythm strips. Within 45 minutes F alone achieved
control of arrhythmia which was maintained for the rest of the
24 hour study period in 10/15 (9/15 reverted to sinus rhythm and
1/15 remained in arrhythmia with a controlled ventricular
response rate - CVRR) compared to 2/15 achieved by D alone
(both remained in arrhythmia but with CVRR) (p<O.OI). Within
one hour F either alone or combined with verapamil controlled
arrhythmia in 12/15 (10/15 reverted to sinus rhythm and 2/15
remained in arrhythmia with CVRR) compared to 3/15 controlled
by D either alone or combined with verapamil (all remained in
arrhythmia with CVRR) (p<O.OI). There were no serious adverse
effects in both groups. Conclusion: Intravenous F was safe and
more effective than conventional pharmacological therapy for
recent onset postoperative atrial arrhythmias.
fLECAINIDE fOR PREVENTION Of PAROXYSMAL ATRIAL fIBRILLA-
TION AND fLUTTER. A "ULTICENTER, DOUBLE-BLIND, PLACEBO-
CONTROLLED CROSSOVER STUDY.
~~~~~01'lr~:~:~I~h~nor=~~la~en~f~~a~~t~:ma~~I~i~ent~~
studY group, Rigshospitalet, University hospital, Copen-
hagen, Denmark.
Purpose: To evaluate flecalnlde (f) In prevention of at-
tacks of paroxysaal atrial (A) fibrillation and flutter.
Method: Inclusion criteria were at least 3 attacks In the
preceding 3 aonths, on 3 different days, each attack
lasting not aore than 3 days. Forty-three pts (23 aales),
aean age 53 t 13 (1 SO) (range 21-73) fulfilled these
criteria and were randomized to either F 300 mo/day (pts
( 60 kg, 200 mg/day) or aatchlng placebo for 3 month In
each period. With Intolerable symptoms It was allowed to
stop the treatment and cross-over. before the end of a
3 months period. pts kept a diary for recording attacks.
At least 2 of these should, In each period, be verified
objectivelY by a mlnl-ECG-eventrecorder.
Results: All 43 pts were treated at least I week In each
period (group (G) I), of these 39 pts were treated for at
least one month (G II), While 24 pts went through all 3
aonths in each period (G III). For statistical reaSOnS
each group were evaluated separately:
G III week G 11/1 month G 111/3 month
l'=..U.IJU.!l.t 1.l.act.Q..o F Pll.tt~F Plnebo F
Sample sf:e rr 43 39 H 24
Attack rate
Median 0 6 0 10 0
Range 0-30 0-37 0-124 0-60 0-324 0-35
,,"~....~llt.__l :.t_-I!.:.~__HL_Q.:.4 4-2L_0-7
vlfTirence
(Wilcnon/t'n~s) te.. 0 Q03 --te.. 0.00Q.L-2p • O.OQ.l
5-rConce n r a ron-were"""ittei""Tw ee k-Of-frea titilfTii-.ean
1.24 t 0.49 uaol/l (range 0.51-2.30) and after 3 aonths
in aean 1.03 t 0.47 uaol/l (range 0.26-2.(2). In 32 of
the 43 pts a total of 51 side effects were reported:
Gastrointestinal in 12 Pts, dizziness II, eye trouble 11,
tiredness 3, amenorrhea 1, others 7. Cardiovascular coa-
plaints were exercise dyspnea and weight gain In 1 Pt and
bradycardia In 1. Two pts had increase in attack rate.
One developed a sustained attack of A flutter with inter-
alttent 1:1 conduction.
Conclusion: flecalnlde significantly suppresses the nua-
ber of attacks In paroxysaal A fibrillation and flutter.
'Side effects are frequent but aostlY tolerable wlt~ only
2 withdrawals.
FLECAINIDE FOR HEART RATE CONTROL IN ATRIAL FIBRILLATION
T. Craig Timm. M.D., Anne A. Knowlton. M.D. Nancy J.
Battinelli, Rodney H. Falk, M.D., FACC. Boston City
Hospital, Boston, MA.
Digoxin (Dig) may be inadequate for control of heart rate
(HR) during exercise testing (ETT) in patients (pt) with
atrial fibrillat ion (AF). To' assess the efficacy of
flecainide (FL) we studied 12 pt in a double blinded
trial of Dig, Dig+ FL 100 bid, and FL 100 bid. FL 150
bid + Dig was giv?n to 5 pt with inadequate HR control
in blinded periods. Co~pared to Dig, HR was d~creased by
Dig+FL during ETT. Resting HR w~s unchanged with Dig+FL
but was increased with FL alone. Peak HR WoS inversely
correlated with FL level in patient also recei7ing Dig
(r=-.61, p=.02).
HR Data for Modified Bruce ETT:
~ FL Dig+FL Diq+150bidFL
Rest 81 92* '16 17
3 min 132 124 109* 100*
6 min 145 142 123* 120* *p<.05
9 ~in 160 152 139* 111* cf Dig alone
Peak 192 181 115* 160*
Dig+FL also reduced peak HR on Holter monitoring but not
~ean HR. Noncardiac side effects were rare but sustained
VT occurred in 1 pt and VF in 1 pt at peak exercise.
CONCLUSIONS: Digoxin is superior to flecainide for heart
rate control in AF but digoxin + f1ecainide is superior
to either alone. Significant exercise induced arrhythmia
may occur with flecainide even in the absence of
proarrhythmia on Holter monitoring.
AHPLIFICATIOH OF DILTIAZEM'S EFFECTS OH THE AV HODE BY
RAPID ATRIAL IHPUT LEADS TO SELECTIVE ACTIOHS DURING
ATRIAL FIBRILLATION.
Mario Talaiic, MD. Monsen Nayebpour, PharmD. Wuhua
Jing. MD, Stanley Hattel, MD, FACC. Montreal Heart
Institute. Montreal, Canada.
Diltiazem (D) reduces the mean ventricular response
(Il) in pts with atrial fibrillation (AF) at doses that
have little effect on AV conduction during sinus
rhythm. This could be a consequence of use-dependent
enhancement of calcium channel blockade by 0 resulting
from rapid atrial input into the AV node. To evaluate
this possibility, we studied the rate-dependent effects
of 0 on the 2 detet"lllinants of 11: concealed AV nodal
conduction and AV node functional refractory period
(FRP). These were evaluated at I1Ultiple cycle lengths
(CLl and during Ar (using RR histogram analysis) before
and after 0 in autonomically blocked dogs. 0 produced
small increases in FRP at long CL (means 10.18,31~ for
dose 1,2,3 respectively), larger increases at short CL
(11 ,50,81~) and maximal increases during AF
(39,86, 154~). The rate-dependence of FRP after 0 was
opposite to the decrease in rRP at shorter CL observed
under control. Moreover, increased AV refractoriness
caused by 0 also enlarged the zone of concealment (ZOC.
measured using SlS2S3 protocol) in a frequency-dependent
manner (88:t48 lIISec at CL 1 sec, 183:tS6 lIISec CL 500
me.c, p<O,OOl). The combfnation of rate-dependent
increases in rRP and ZOC resulted in an effect on D
(increases of B8, 197. and 3001, doses 1.2,3) which ~s
B-10 fold greater than that on rRP at CL comparable to
sinus rhythlll in man. We conclude that rate-dependent
amplification of D's effects on FRP and AV nodal con-
cealment leads to highly selective depression of AV node
function during AF. This constitutes sn important anti-
arrhythlllic consequence of modulated receptor mechanisms.
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INTRAVENOUS FLECAINIDE VERSUS INTRAVENOUS
DISOPYRAMIDE IN THE REVERSION OF ATRIAL
FIBRILLATION
Martin N Wiseman MB, Anthony W Nathan FACC, St Bartholomew's
Hospital, LONDON, UK..
Drug reversion of atrial fibrillation (AF) to sinus rhythm avoids
the need for direct current cardioversion under general
anesthesia. Both disopyramide (D) and the newer agent flecainide
acetate (F) have been used intravenously for this purpose. 2S pts
with spontaneous AF were allocated randomly to double blind
treatment with D (12 pts) or F (13 pts), 2mg/kg over 10 minutes.
Duration of AF was 132 ± 233 days (F pts 141 ± 269 days, D pts
124 ±200 days, paNS). Seven pts treated with F reverted compared
with only one treated with D (p<.OS). All pts who reverted had AF
present for 26 hrs or less, and reviewing all pts with AF present
for 2 days or less there was no significant difference in the
rates of reversion (F 7/8, D 1/3). In 2 pts in each 8rOUP adverse
events were recorded: one F pt reported a slight headache,
another developed ventricular bigemini in the 2 minutes post
reversion; one D pt developed a few short runs of ventricular
tachycardia after injection, and another had the injection
terminated after 8 minutes with the onset of ventricular
tachycardia (>15 beats). DC cardioversion was immediately
performed in IS pts who had not reverted, and was successful in
all cases.
Conclusions: I) F is an effective and safe agent in the reversion
of acute AF; 2) pts with AF present for less than 2 days may be
candidates for drug reversion; 3) pts with AF present for longer
than 2 days should be considered for elective DC cardioversion,
although there may be a role for pretreatment with an intravenous
antiarrhythmic.
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EVALUATICN CE ENXIl'HELIAL DEPEIDENl' RELAXATION IN !llJoIAN
SAPIlEN)US VEINS
Gerald H. Lawrie,Kl, FOCC, Philip D. Henry,Kl, FACe,
Donald G. weilbaecher,M)
Baylor College of Medicine, Houston, Texas
Endothelial deperdent relaxation factor (EDW) activity
has been observed in veins, but little is known about it.
In order to evaluate its magnitude and the influence of
various factors upon it strips of ~ from 78 pts were
contracted with phenylephrine and exposed to
nitroglycerin (NTG) a non-EDW dependent agent and
ionophore A23187, an EDW dependent agent. Interventions
were coopared. with control strips stored in Kreb's
solution: I-i.Imediately after harvesting; II-storage in
0.9% saline (22oC) for 1 hr; III-storage in Plasmalyte
(22oC) for 1 hr; without (IlIa) and with (IIIb)
inflation to 400 Il1IlIlg; IV-storage in Plasmalyte for 1 hr
and inflation without (IVa) or with (!Vb) NTG; V- as in
IV either without (Va) or with (\1» verapamil instead of
Nl'G. Relaxation with NTG was well preserved in all groups
(68-91%). EDW dependent relaxation was 36+4% in group
I am ranged from 19 to 34% of baseline in- groups II-V
with the highest level in group IlIa (34 + 4%). These
resUlts were correlated with electron micrOSccpy, Early
graft patency at autqJSy in 11 pts fran a series of pts
subsequently operated upon using group III techniques was
97% (29/30). Light microsccpy showed marked reduction in
~ endothelial and inflaJlm'ltory changes coopared to age,
sex and tine matched controls which had used the group II
method. Thus although venous EDW activity is weaker than
arterial EDW, it is reproducibly present and is
adversely affected by CatlllOll methods of ~ preservation.
Because EDW is a potent inhibitor of platelet adhesion
and aggregation and is a vasodilator, EDRF may be
iJTIlortant for good early am late ~ function.
cx:MI?ARISCN OF FIECAINIIlE VS PROCAINAMIIlE m DEPRESSmG
RE:'lmGIWlE ex:tlIXlCl'ICN m AnUovmmu:aJIAR NODlU. REENIRY
TAaiYCl\RDIA
Althciu;lh both drugs depressed VA con:iuction
significantly 0I:II'pared to baseline (p<.OOS),
Flecainide I s effect was greater than Procainamide 's (p
<.04). SUstained AVNRl' remained inducible in 3 pta with
Proc:ainamicle, hIt none with Flecainide; AVNRl' terminated
in the retrograde limb when ren:iered non-sustained (1 pt
Proc:ainamicle, 3 pts Flecainide). D.lrin} a 14 ± 7 me
follow-up a'll~ Flecainide, there was no
recurrent AVNRl'. Conclusions: 1) Flecainide is more
effective than Procainamide in depressin} retrograde
cxnitia'l in pta with AVNRl'. 2) Flecainide represents a
favorable altemative to Class IA agents as first line
c:tlraIic therapy in pta with AVNRl'.
Russell T. steinman M.D., Alan olivenstein M.D., Claudio
D. SChuger M.D., Michael H. LehInann M.D., F.A.C.C.,
Wayne state University and Harper Hospital, Detroit, MI
Class IA antiarrtlythmic agents are usefUl in the
treat3llent of atrioventricular nodal reentry tachycardia
(AVNRl') by depressin} ventriculoatrial (VA) oomuction.
Class IC agents also depress VA oomuction in AVNRl' pts,
i:Alt the relative efficacies are not well established.
We 0I:II'pared the actions of Procainami.de (10DgJl<g, IV) VB
Flecainide (mean 28811g/d, p.o.) on VA con:iuction in 8
pta with sustained AVNRl'. '!he shortest ventricular




291 ± 67 IllS
391 ± 43 ms
492 ± 76 IllS
all values
mean ± SD
PREOPERATIVE ASPIRIN IS NOT NECESSARY TO ACHIEVE
I"PROVED VEIN GRAFT PATENCY AFTER CORONARY ARTERY
BYPASS SURGERY, VA COOPERATIVE STUDY '297.
Report prep.r.d by Steven Golda.n, ".D.,F.A.C.C., J.ck
Copeland, ".D., F.A.C.C., Tho••s "oritz, ".S., Willi.a
Henderson, Ph.D., K.ren Z.din., R.N., ".A. and VA
Cooper.tive Study on Antipl.tel.t Th.rapy, Tucson VA"C
and University of Arizona, Tucson AZ, and VA CSPCC,
Hines, Illinois.
To deteraine if preoperative do.ing with ••pirin is
nec.ssary to .chieve iaproved graft patency at one
week after coronary .rtery byp••s gr.fting CCABG), we
co.pared aspirin C325 ag), giv.n as on. dose 12 hours
before surgery, with pl.cebo. Following surg.ry, all
patients rec.ived .spirin C325 ag qd), with the fir.t
dose adaini.tered 6 hours postop.ratively through the
n••ogastric tube. Gr.ft p.tency dat., det.rained by
angiography, were obtained .arly Caedian of 8 d.y.)
after oper.tion. In 292 p.tient. with 954 gr.fts
there w•• no difference in the .arly graft occlusion
r.te C6.3X with ••pirin coap.red to 7.6X with
placebo). Both the r.quirea.nt for red blood cell
r.pl.ceaent Clooo al with ••pirin coapared to 750 al
with placebo, P<O.Ol) and the reoperation r.t. C7.9X
with .spirin coapar.d to 2.7X with pl.cebo, P<O.03)
were gre.t.r in the p.tients tr••ted preoper.tively
with ••pirin. In conclUsion, .arly v.in gr.ft p.t.ncy
i. not diff.rent when .spirin i. st.rted before
operation coap.r.d to b.ginning .spirin 6 hour••fter
surg.ry. "oreover, the adainistr.tion of ••pirin
b.fore CABG incr..... the rate of reoperation.
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THE ENDOTHELIUM PROTECTS AGAINST CONTRACTIONS INDUCED BY
HISTAMINE AND SEROTONIN IN ARTERIAL, BUT NOT IN VENOUS
CORONARY BYPASS GRAFTS.
Zhihong Yang M.D., Dennis Diederich M.D., Kurt Schneider
M.D., Robert Siebenmann M.D., Peter Stu1z M.D., Ludwig
von Segesser M.D., Fritz R. Bahler M.D., Thomas F. LO-
scher M.D., Division of Cardiology, Dept. of Research and
Surgery, University Hospital Basel and Dept. of Cardio-
vascular Surgery, University Hospital ZQrich, Switzer-
land.
Internal mammary artery grafts (IMA) have a higher
patency rate and lower patient mortality than saphenous
vein grafts (SV). Release of endothelium-derived relaxing
factor (EDRF) in response to platelet-derived products
and histamine may be important for graft function. IMA
and SV rings with and without endothelium obtained
intraoperatively were suspended in organ chambers filled
with physiological salt solution (37°C;9S\O/S\C02);
isometric tension was _lfcorde.1> In IMA rings with endo-
thelium, histamine (10 -3x10 M) induced potent endothe-
lium-dependent re1axa~!ons (70tS\;ICSO 6.StO.2) inhibitedby methylene b!ge (10 M; to block guanylate cyc~~e) or
hemoglobin (10 M), but not by mec10fenamate (10 MI to
inhibit prostacyc1in) delineating EDRF as the mediator.
The histaminergic receptor releasing EDRF HI-hista-
minergic in nature, since ch10rphenramine but not cimeti-
dine inhibited the response. In contrast, in SV with
endothelium histamine did not cause endothelium-dependent
relaxations but endothelium-dependent contractions at
higher concentrations. The endothelium inhibited contrac-
tions to serotonin in IMA, but not SV. In SV, contrac-
tions were enhanced as compared to IMA (n=6,p<0.00S).
Thus, EDRF protects against contractions to histamine and
serotonin in IMA, but not SV. This may be important for
improved arterial graft function and patency.
RISK OF DUTIl AFTER NONFATAL MYOCARDIAL INFARCTION IN
THE VA COOPERATIVE STUDY OF CORONARY ARTERY BYPASS
SURGERY.
Peter Pednut Ph D., lfarvin Hurphy H.D., Katherine Detre
H.D. Dr.P.H., James Thoasen H.D., Herbert Hultgren H.D.,
Timothy Takaro H.D., CSPCC VA Hedical Center, West Haven,
Connecticut.
The 10-year incidence of nonfatal (NF) myocardial
infarction (HI) was evaluated in 686 patients (pts) who
were randomly assigned to medical (H) or surgical (S)
treatment. An infarction was classified as not fatal if
the pt survived 4 weeks after the event. HI was defined
as the development of new persistent Q-waves. The
incidence of NFKI was 22.1% S vs 16.7% H (p-O.09). The
higher rate in S pts was due to perioperative NFKI (7.7%)
and acceleration of NFKIs after 5 years.
The risk of mortality after NFKI was 59% lower is S than
in H pts (relative risk - 0.41, 95% confidence interval
0.24 to 0.71; p<0.001). In pts without HI, the RR was
nearly 1.0. The reduction in post-HI mortality was most
striking, in the angiographic high risk subgroup (J-vessel
disease with LV dysfunction) where the relative risk of
mortality (RR) was 0.08 (99% CI, 0.01 to 0.62; p-O.002).
We conclude that although S therapy does not reduce the
overall incidence of NFKI, it does reduce the risk of
death after HI, particularly in high risk pts who have a
poor prognosis with H therapy.
MYOCARDIAL INFARCTION COMPLICATING ELECTIVE CORONARY
BYPASS SURGERY
Robert J. Burns, M.D., F.A.C.C., Peter J. Gladstone,
M.D., ChrlStopher M. Felndel, M.D., David R. Salter,
M.D., Irving H. Lipton, M.D., Tirone E. David, M.D.,
F.A.C.C., Toronto Western Hospital, Toronto, Canada.
Standard diagnostic criteria for myocardial
infarction (MI) are unreliable early after coronary
bypass surgery (ACB). We employed illll1ediate pre- and
4B-hour postoperative technetium-99m pyrophosphate
single photon tomography (PPi-SPECT) to detect periACB
MI in 12 of 58 elective, stable angina patients (21%)
and 1ogi sti c regressi on to determi ne pre- and
intraoperative predictive variables. Serial CK-MB's
were higher in MI patients (p=0.0003); only 1/12 had
new Q waves. Preoperative symptom class (NYHA 3.3 vs
2.B (MI vs no MI), p=0.04) and smallest grafted distal
vessel lumen calibre (1.3 vs 1.51l111, p=0.03) were
multivariate predictors of perioperative MI. Five MI's
occurred in segments revascularized using sequential
vei n grafts, and 7 in segments perfused by si gnif-
icantly stenosed epicardial vessels with distal lumen
diameter and perfusion territory considered too small
to warrant bypass. At 6 month follow-up LV ejection
fraction had increased in negative PPi-SPECT patients
(0.61 to 0.65, p=O.Oll but not in perioperative HI
patients.
Thus, MI is frequently detected by PPi -SPECT
following successful, elective ACB for stable angina
and is associated with severe preoperative angina. Our
data imp1i cate a mechani sm of poor di sta1 coronary
run-off in both revascularized and nonrevascularited
myocardial segments supplied by small, stenosed
epicardial coronary arteries. These MI's limit
postoperative recovery of LV ejection fraction.
LATE FOLLOW-UP OF 781 PATIENTS UNDERGOING PERCUTANEOUS
TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) OR OPEN HEART
SURGERY (OHS) FOR AN ISOLATED OBSTRUCTION IN THE LEFT
ANTERIOR DESCENDING (LAD) CORONARY ARTERY.
J Kramer M.D., WProudfit M.D., F Loop M.D. F.A.C.C., M
Goormastic M.P.H, K Zimmerman B.A, G Horner R.N.
Cleveland Clinic Foundation, Cleveland, Ohio.
Between 1-1-80 and 12-31-84, 781 pts at the Cleveland
Clinic who had either PTCA or OHS for an isolated
obstruction in the LAD were followed retrospectively for
survival and events. 413 pts had PTCA while 368 pts had
OHS with an internal mammary artery (71.5%) or saphenous
vein bypass graft (28.5%). In hospital, there were no
surgical deaths and one perioperative MI while one PTCA
pt died and 9 (2.2%) had MI. Six OHS pts needed
reoperation while 32 PTCA pts (7.7%) needed OHS before
discharge. 776 pts (99.7%) were followed 56 + 18.4
months. At 5 years, survival was 95.3% for PTCA pts and
97.7% for OHS pts (p-0.03). Post-discharge events
included recatheterization (OHS-67 pt., PTCA-229 pts, p
less than 0.0001); PTCA (OHS-8 pts, PTCA-72 pts, pless
than 0.001); OHS (OHS-7 pts, PTCA-24 pts, p less than
0.01) • Overall, PTCA pta had lower survival and more
events than OHS pts.
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ACTIVATION PATTERN DURING INDUCTION AND MAINTENANCE OF
VENTRICULAR TACHYCARDIA IN PATIENTS WITH CORONARY
ARTERY DISEASE.
Wil he 1m Ka ltenbrunner, M.D., Pierre L. Page, M.D.,
FAcc, Ren~ cardinal, Ph.D., Dominique Lacroix, M.D.,
Mohammad Shenasa, M.D., Ph.D., FACC. Sacre-Coeur Hosp.
Universite de Montreal, Montreal, Canada.
In 16 pts with remote myocardial infarction,
endocardial (ENDO) and epicardial (EPI) activation
mapping was performed intraoperatively during 31
morphologically distinct ventricular tachycardia (VT)
induced by programmed stimulation (PS). Isochronal maps
of selected cardiac cycles during induction and
established VT were generated by a computerized system
using 64 unipolar electrograms recorded simultaneously
from both a sock electrode array (EPI) and a balloon
electrode array (ENDO). In 26 VT (Group I, 14 pts) the
earliest ENOO activation was detected 26 + 23 ms (mean
+ SO) before the onset of EPI activatTon, in 5 VT
TGroup II, 4 pts) it was 45 + 34 ms after. Evi dence
for reentry was found subendocardial1y in 6 VT (6 pts,
all group I) and subepicardially in 2 VT (2 pts, all
group I I). The reentrant wavefront showed an ENDO
figure-of-eight activation pattern in 4 VT and a
circular movement in 4 VT (2 ENDO, 2 EPI). During
initiation of VT, unidirectional block and a slow
conduction pathway were estab1 ished progressively
during PS in 6 VT (5 ENOO, 1 EPI) and during the
initial ventricular repetitive responses following PS
in 2 VT (1 ENOO, 1 EPI). We conclude that 1) reentrant
wavefront can be mapped throughout the entire VT cycle
in 50% of pts and 26% of VT, 2) subepicardial as well
as subendocardial layers participate in the mechanism
of VT.
ENDOCARDIAL ISOCHRONAL PATTERNS NEAR THE
VENTRICULAR TACHYCARDIA SITE OF ORIGIN WITH
ORTHOGONAL ELECTRODE CATHETER ARRAY
Jawahar Desai M D , Htay Nyo. Ph.D., Zak Vera, MD.
University of California, Davis.
Recent work using balloon electrode array or electrode catheters
have shown that majority of ventricular tachycardia (VT)
originates from 'focal' origin with monoregional spread. We used
an 8F 5 pole orthogonal electrode (E) catheter (4 peripheral. I
central electrode, interelectrode distance 0.5 cm. I sq cm
surface area) to study the 2-D isochronal patterns (IP) near VT
site of origin. In 7 mongrel dogs. 3 to 5 plunge electrodes (PE)
were randomly placed in LV. PEs paced (~ 180 bpm) in double
blind manner to simulate VT with focal origin. LV divided
arbitrarily into 4 quadrants and unipolar and bipolar recordings
made for each quadrant, identifying the quadrant with the
earliest arrival time. PE site identified by early arrival of
wavefront at one or more unipolar electrodes (~-35 msec with
ref. to earliest surface ECG). At this site radio .frequency
ablation was performed (all 5 E to backplate 600 KHz, 10 sec.
25 W.) All 7 dogs PE was within ablation area. IPs for area
covered by 5 E were "drawn for both ablation and remote sites
($.·35 msec with ref. Jto earliest surface ECG) from wavefront
arrival times at 5 FA IP was elliptical when PE was close to
central E (2), semielliptical when PE was" close to one or more
of peripheral Es (5). Earliest arrival time at the peripheral or
central E and direction of wavefront indicates position of
source. IPs remote from paced VT sites were farther apart,
straighter and nonelliptical. Occasionally transverse or
longitudinal velocities were identifiable by comparing unipolar
electrograms to IPs. Conclusions: I) Direction of wavefront
indicated by isochronal patterns and earliest arrival times from
unipolar electrograms can guide the operator to localize the site
of paced ventricular tachycardia origin with orthogonal electrode
catheter, 2) Elliptical and semielliptical isochrones are observed
near the 'focal' site of paced ventricular tachycardia.
TRANSMURAL VENTRICULAR ACTIVATION DURING CONSECUTIVE
CYCLES OF SUSTAINED VENTRICULAR TACHYCARDIA.
Nanc~ A. Branyas M.D., Michael E. Cain, M.D., F.A.C.C.,
Denn s M. cassidY M.D., F.A.C.C., Washington University,
St. Louis, Missouri.
Although computerized mapping has enabled intraoperative
delineation of ventricular activation from a single
complex of ventricular tachycardia (VT), beat-to-beat
reproducibility of Isochronic maps has not been defined.
To determine the reliability of single beat analysis,
epicardial, intramural and endocardial ventricular
e1ectrograms during 6 consecutive VT cycles were analyzed
in each of 10 patients during intraoperative mapping of
sustained monomorphic VT. Bipolar electrograms were
recorded simultaneously using sock and needle electrodes
from up to 96 epicardial and 160 transmural sites. In
each patient, at each electrode site, local activation
time, electrogram duration, and morphology were compared
over 6 consecutive beats. A total of 9816 electrograms
were analyzed. For each patient, the isochronic
activation map during VT was reproducible with a mean
beat-to-beat variation in local activation time of only
1.8+1.9 msec (p=ns). Moreover, electrogram duration did
not- vary significantly (1.6+3.4 IIsec). Epicardial
electrograms, however, were significantly longer when
compared to intramural and endocardial electrograms
(35+22 msec vs 26+19 msec, p <.001). There were only
two"lnstances of 2:T conduction failure, both occurred
intramurally and adjacent to a site of VT origin. Thus,
transmural ventricular activation during sustained
monomorphic VT is reproducible regardless of electrode
site or electrogram duration. These results demonstrate
that single beat analysis is a reliable and expedient
method to del ineate ventricul ar activation during
intraoperative mapping.
FACILITATION OF VENTRICULAR TACHYCARDIA INDUCTION BY
STIMULATION AT ITS SITE OF ORIGIN.
Mohammad Shenasa, M.D .• Ph.D .• F.A.C.C., Ren~ Cardinal.
Ph.D., Wilhelm Kaltenbrunner, M.D., Dominique Lacroix,
M. D., Marc Dubuc, M.D., Pierre Pag~, M.D., F.A.C.C.,
Sacr~-Coeur Hospital, University of Montreal, Montreal,
Canada.
To determine if stimulation at the site of origin of
ventricular tachycardia (VT) enhances induction of the
tachycardia. we studied 16 Pts with sustained monomor-
phic VT during arrhythmia surgery. Induction of VT was
attempted at the right and left ventricles as well as at
the site of origin of VT. The site of origin of VT was
determined using a computer-assisted acquisition of 63
unipolar epicardial and 63 or 32 unipolar endocardial
electrograms from a sock and balloon electrode array.
Stimulation at the site of origin of VT was done via the
balloon electrode array. Stimulation protocol consisted
of the introduction of up to 3 extrastimul1 at three
ventricular drive cycles. Induction of VT at the right
or the left ventricular sites required stimulation at
shorter cycles with up to 3 extrastimuli. Induction of
VT at the site of origin was achieved during long cycles
with one or two extrastimuli only. In 5 Pts. right
ventricular stimulation induced only nonsustained VT
while pacing at the site of origin with identical
stimulation protocol induced sustained tachycardia. In
4 Pts, stimulation at the right or the left ventricle
with 3 extrastimul1 induced ventricular fibrillation,
while stimulation at the si te of origin did not. The
resul ts suggest that stimulation at the site of origin
of VT facilitates the induction of sustained VT and
avoids induction of nonspecific arrhythmias.
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PHASE IMAGE TRIANGULATION OF ACCESSORY PATHWAYS IN
PATIENTS UNDERGOING CATHETER ABLATION OF POSTEROSEPTAL
PATHWAYS
Michael Oeff M 0 Joseph A. Abbott, M.D., F.A.C.C., Jerry C.
Griffin, M.D.• F.A.C.C., Melvin M. Scheinman. M.D,. F.A.C.C.,Elias
H. Botvinlck, M.D., F.A.C.C.,
University of Califomia, San Francisco, CA
We sought to relate findings on scintigraphic phase analysis
(PhA) to electrophysiologic (EP) findings in pts prior to catheter
ablation (ABL) of a posteroseptal accessory pathway (PS AP) and
to prognosis after ABL. To this end, a new method was developed to
triangulate on the AV valve plane, the site of earliest phase angle.
The method was applied blindly to 42 preexcited pts. Among these
were 21 pts with EP study indicating a PS AP, who underwent
ABL. Here, we report PhA for AP localization compared to EP lo-
calization and to clinical outcome in only those having ABL.
The pre-ABL PhA localized a middle or PS AP in 16 pts, 2 with
additional non-dominant right AP. In 4 other pts with a second
right or left AP, PM identified the non-PS AP correctly. PM lo-
calization erred in 1 pt with single PS AP. The surface ECG local-
ization of dual AP was unreliable.
Among those 15 pts with a single AP, all of 3 pts with a concen-
tric activation of both ventricles in PhA had successful ABL, but
only 6/11 pts with eccentric activation.
VA conduction time during reciprocating tachycardia failed to
predict ABL outcome.
CONCLUSIONS' PhA closely Iocelized 14/15 single PS AP. The PhA
localization of a non-septal focus suggested dual AP with the non·
PS AP at the site of earliest activation in PhA. In pts with single
AP, a concentric activation of both ventricles in PhA suggested
success of ABL
DIRECT ENTRAINMENT GUIDED ABLATION OF THE SLOW
CONDUCTION ZONE (SCZ) IN HUMAN TYPE I ATRIAL
FLUTTER (AF).
Nadir Saoudi M.D., Georges Atallah M.D., Gilbert Kirkorian
M.D., Paul Touboul M.D. HOpital Cardiologique, Lyon, France.
In order to avoid His bundle ablation with the subsequent
creation of a pacemaker dependency state, we attempted
to directly fulgurate the critical area of slow conduction
of the reentrant circuit in 8 patients (pts) referred for drug
resistant repetitive type I AF and His bundle ablation. Pts
1-6 had a history of symptomatic sustained AF which proved
to be resistant to at least 4 antiarrhythmic agents. Pt 7 had
recurrent episodes of pulmonary oedema due to AF, and pt
8 had poorly tolerated 1/1 AF. In all cases AF was induced
during programmed atrial stimulation. In 7/8 pts, careful
right atrial mapping during tachycardia revealed the presence
of a zone of prolonged (80-130 ms) and fragmented
electrograms in the low posterior right atrial septum • Other
areas of fragmentation were excluded because they exhibited
second degree local block either spontaneously or during
fixed rate overdrive atrial pacing while entrainment criterion
nOI was fulfilled. In one patient tachycardia termination was
accompanied by second degree local block within the SCZ,
followed by narrow local electrograms with shorter conduction
time. 1 to Z fulguration shocks (Zj/kg body weight) were
delivered in this area, with neither immediate nor late
complications. Patients were discharged without drug therapy
and AF was no more inducible in 7/8 pta immediately after
the procedure, and in 4/7 pts at late control (I and 3 months).
After a mean follow up of 3S,6 weeks, 3 pts experienced
early (DS) and late (D80) recurrences and underwent a second
ablation session which was unsuccessful in 1 pt.
In conclusion, direct entrainment guided catheter fulguration
of the SCZ of human type I AF is a feasible procedure, with
apparent good results, and deserves further study.
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CATHETER MODIFICATION OF THE ATRIOVENTRICULAR
NODE: A POTENTIAL CURE FOR ATRIOVENTRICULAR
NODAL REENTRANT TACHYCARDIA.
Laurence M Epstein MOO' Jonathan J Langberg M.D., John M
Herre M.D. F.A.C.C., Jerry C Griffin M.D.• FAC.C., Melvin M
Scheinman' M.D., FAC.C., Univ of Califomia. San Francisco
Recently, surgical ablati.on of atriove.ntricular nodal reen!rant
tachycardia (AVNRT) wl!h preservation of antegn:~de atrio-
ventricular (AV) conduction has been reported. SIX patients
(age 27·66) with disablinQ AVNRT (1/week· >25/day, for 1/2-
20 years) who failed mUltiple drugs (3-10), underwent a
catheter procedure to " modify "cAV conducti~n. Earliest .
retrograde atrial activation durin9 supra~entnc~lar tachyc~rdla
(SVT) was localized to the antenor low nght atnal septum In all
patients and dual AV nodal pathways were demonstrated in 4
of 6. The area between the His bundle electrode and coronary
sinus os was divided into 3 zones and perinodaJ direct current
shocks (1-7) of 100-300 joules were delivered in one (n=2) or
each zone (n=4) without complications. The end points were
induction of first degree AV block (1 ° AVB) and failure to induce
SVT. At early restudy (1-3 days), antegrade conduction was
preserved in all patients, with 1°AVB in 3 of 6. Retrograde
conduction perSisted in 4 of 6 patients and dual AV nodal
pathways persisted in 2. No patient had inducible SVT with or
without atropine and isoproterenol. Symptomatic AVNRT •
recurred in one patient at 3 months and required His bundle
ablation. The remaining 5 patients have had no recurrences
after a mean follow-up of 5.5 months (range1-10) and, of the 3
who underwent late restudy (2-6 months), 1 had inducible atrial
tachycardia and ~VNRT and 2 had n? inducibl~. arrhythmias.
Possible mechamsms appear to be either abolition of
retrograde conduction or modification of AV node function such
that SVT cannot be sustained. Percutaneous catheter "AV
nodal modification" appears to be a safe and potentially
effective approach to the management of refractory AVNRT.
ATI'!J1P'l'ED ABLATION or LU'l' SIDD> ACCESSORY PATHfAYS BY
RADIOrRlQUINCY CURRENT
Karl-Heinz Kuck n D • Ilaus-Peter Iunze, n.D., nantred
Geiger, n.D. anUlichael Schluter. Ph.D. UniversityHo~pi­
tal lppendort. Haaburg, f.R.G.
In 8 patients (5 aen. 3 woaen, 38:t10 years) ablation ot a
lett sided (LS) acces~ory atrioventricular pathvay (AP)
was atteapted with radiofrequency current (RfC). All ph
had drug refractory ~upraventricular arrhythaia~ and a
short «250 a~) anteqrade refractory period ot the AP. 3
pts had episode~ ot syncope due to docuaented atrial fib-
rillation. The AP vas preci~ely localized by direct
recordinJ~ of AP potentials and by the retroqrade atrial
activation sequence during supraventricular tachycardia.
In all pts, a doai.nant coronary artery close to the AP Vll~
excluded by coronary anqioqraphy. RrC vas delivered 2-9
tiaes for 10-30 seconds between an (epicardial) electrode
in the coronary llinUS (CS) and the tip electrode of a cath-
eter in the LV (endocardial). directly below the aitral
annulus and opposite the CS electrode. Preset voltage vas
30 to 50 Vwith a aeasured current of 69:t391lA. The LS AP Vllll
located lateral in 3 ph. posterolateral in 2 pts. poste-
rior in 2 pts and posteroseptal in 1 pt. PeIMnent AP block
vall achieved in 2 ptll. prololX1ation of the anteqrade effec-
tive refractory period of the AP in 2 pts (215->i70 as). In
i ph. AP conduction rellained uncbaDoed. DurinJ tollow-up
(6:t3 aonths) 5 ph beca.ae asyaptOllatic without drugs, 1 pt
beca.ae asyaptollatic under sotalol. 4 of these 6 ph had a
nOIllaI surface leG. 2 pts underwent ~urqery. Conclusion'
RfC application with a bipolar epicardial-endocardial
electrode configuration seeas to ,be feasible in selected
pts with a LS AP.
lACC Vol. 13, No.2
February 1989:l69A
ABSTRACTS 169A
CATHETER ABLATION OF A POSTEROSEPTAl ACCESSORY
ATRIOVENTRICULAR CONNECTION IN FORTY-TWO PATIENTS.
Horady F, Scheinman MM, Kou WH, Griffin JC, Dick H,
Herre J, Kadish AH, Langberg J.
Forty-two patients (pts) with a posteroseptal
accessory atrioventricular connection (AAVC) and
symptomatic tachycardias underwent catheter ablation of
the AAVC using 200-400 joule shocks delivered by a
standard defibrillator. Cathodal shocks were delivered
through the proximal pair of electrodes of a 6 French
quadripolar electrode catheter positioned at the os of
the coronary sinus. A 16 cm patch electrode positioned
on the back or anterior chest served as the anode. Two
to 4 shocks were delivered (total joules 636 ± 19, mean
± SO). The ablation procedure was successful in
eliminating symptomatic tachycardias in 31/42 pts (74%)
over a follow-up of 29 ± 19 mos. A long-term follow-up
electrophysiology study in 24 of these pts demonstrated
that conduction through the AAVC was completely absent
in 22 pts and present but impaired in 2 pts. The
success rate was signi ficantly higher in pts wi th a
concealed AAVC (12/12, 100%) than in pts with manifest
preexcitation (19/30, 63% p<O.OOI). Complications
included cardiac tamponade requiring needle peri-
cardiocentesis, AV block requiring a permanent pace-
maker, and a transient atrial tachycardia in 1 pt each.
In conclusion, with the catheter ablation technique
described in this study, a successful clinical outcome
may be achieved in approximately 75% of pts who have a
posteroseptal AAVC, with a low risk of serious compli-
cations. This technique is particularly well-suited to
pts wi th a concealed posterosepta1 AAVC, in whom the
success rate is higher than in pts with manifest
preexcitation,
CATHETER ABLATION OF THE ATRIOVENTRICULAR
JUNCTION USING RADIOFREQUENCY ENERGY
Jonathan J Langberg, M.D., Michael C Chin, B.S., John M Herre,
M.D., F.A.C.C., Jerry C. Griffin, M.D., F.A.C.C.,Navneet Dullet,
M.D., Melvin MScheinman, M.D., F.A.C.C. Univ of California,
San Francisco
Catheter ablation of the atrioventricular junction (AVJ) using
direct current shock requires general anesthesia and may have
serious side effects. Ten patients with drug-refractory
supraventricular tachycardia underwent catheter ablation of the
AVJ using radiofrequency (RF) ener\lY. A standard 7Fr
quadripolar electrode catheter was positioned to record the
largest unipolar His potential from the distal electrode. An
electrocoagulator (Microvaisive 4005) delivered continuous
unmodulated RF energy at 550kHz. One to 14 applications of RF
were applied between the distal electrode and a large chest wall
electrode. RF of 17±4 Watts was applied for 13.5 to 120
seconds. None of the patients had pain, significant arrhythmias
or blood pressure changes during RF.Five of10 patients (Group
1) had persistent complete AV block (3°AVB) induced by RF. All
of these had stable junctional escape rhythms at 46±3 BPM. His
electrograms could be recorded alter RF in the remaining 5
patients (Group 2), all of whom had successful His ablation with
DC shock at the same session. There was no difference in
unipolar His electrogram size, atrial electrogram size, atrial
injury current, or energy delivery parameters (power, duration,
total energy, impedance) between the two groups. The HV
interval was longer in Group 1 (56t4msec) than Group 2
(42±8msec, p=.Of4), suggesting that a more proximal catheter
position increases the Iiklihood of successful ablation.
CONCLUSIONS: 1. Catheter ablation of the His bundle using RF
appears to be safe and painless. 2. 50% of patients had 3°AVB
induced with RF, associated with a stable junctional escape
rhythm. 3. All patients not ablated with RF had 3°AVB induced
with DC shock.
ELECTROPHYSIOLOGIC EFFECTS OF ARGON LASER
IRRADlATION DURING INTRAOPERATIVE ATRIOVENTRICULAR
NODE OR ACCESSORY PATHWAY ABLATION IN MAN.
Sanjeev Saksena M.D., FAC.C., Isaac Gielchinsky M.D., Nicholas G. Tullo
M.D. Newark Beth Israel Med Ctr - NJ Medical School, Newark, NJ.
We examined the immediate and delayed electrophysiologic (EP) effects of
pulsed argon laser energy alone or combined with mechanical resection (MR)
in 11 pts with refractory supraventricular tachycardia (SVT). Intraoperative
map-guided laser AV nodal ablation (3 pts) or accessory bypass tract (ACB)
ablation (8 pts) was performed. A 15W argon laser was coupled to a 300p opti-
cal fiber with or without a metallic tip encasing a sapphire lens and a partial
beam transmission window. Direct EP effects of laser energy alone could be
examined in normothermic pts on the AV node or right/posterior septal ACB
(6 pts), with MR in 2 pts with posterior septal ACB, while left-sided ACB (3
pts) required laser ablation and MR during hypothermic cardioplegic arrest.
RESULTS: Laser ablation alone of the AV node acutely resulted in 3° AV
block (AVB) preceded by 1° AVB (3 pts), and associated with accelerated
junctional rhythm (1 pt). Recovery of 1:1 AV conduction occurred in 2 pts (10
AVB- 1 pt; normal PR interval- 1 pt). HV interval and QRS morphology were
unchanged from preoperative studies. Normothermic laser ablation alone of
right-sided ACB produced immediate antegrade and retrograde ACB
conduction block in all pts accompanied by transient 3° AVB in 2 pts with
septal ACE. Orthodromic SVT termination with disappearance of antegrade
and retrograde preexcitation during laser ablation was documented in 1 pt.
Spontaneous intermittent ACB conduction occurred in 2 pts postop which
became persistent (1 pt) and disappeared (1 pt). Postop EP study occasionally
demonstrated slow antegrade ACB conduction during close coupled atrial
extrastimulation despite elimination of delta wave (7 of 8 pts) and AV reentry
(all pts). Delta wave reappeared after discharge in 2 pts with septal ACE with
SVT recurrence controlled on preoperative ineffective drugs in 1 pt.
CONCLUSIONS: 1) Argon laser energy is effective in producing immediate
and permanent interruption or modification of antegrade and retrograde AV
nodal and ACB conduction and refractoriness in man. 2) Lens-tipped optical
fibers with metallic probes should be considered for percutaneous catheter
ablation systems.
TEMPERATURE-GUIDED RADIOFREQUENCY COAGULATION OF
MYOCARDIAL TISSUE
Wilhelm Haverkamp.~ Gerhard Hindricks, Ulrich Risse!, Thomas Budde,
MD, Wmfried Pfennigs, Hartmut Gillker, MD, GOOter Breithardt, MD, FESC.
University Hospital, Department of Cardiology, Miinster, Germany (FR)
The size of lesions induced by radiofrequency energy strongly depends on the
extend of tissue heating. Therefore we investigated the applicability of a new
temperature-guided RF-generator (HAT 200, Osypka, FRG). The
microprocessor controlled device delivers energy as a function of the preselected
catheter tip temperature (TI) which is continuously monitored via an ablation
catheter with a built-in tip thermistor. Energies (unipolar mode, duration: 10 - 30
s) were applied to isolated specimans (n=15) of porcine hearts which were
placed in a saline bath at room temperature (24 °C).Temperature rise to
preselected levels (SO - 90 0C) was paralleled by a maximum of delivered power
(10.3 - 29.5 W). When IT-levels were reached delivered power decreased by
approximately (wI (OCI
70-80% (seep 25 90 I
graph). Total 0 p 110 E
delivered energy: 70 =
ranged from 74 - II llO
286 J. Lesions 15 ~
volume (range: '0
3.8 - 51 mm~ 30
significantly 20
correlated with 10
the integral 0' , , I , I ; I .' • I , , I , t .10~s)
of the temperature curve (r = .86). Lesions revealed smooth coagulation
necrosis; no crater formation, rise in impedance or catheter damage was
observed. Thus,. the temperature guided approach seems to improve the
feasibility of RF-ab/ation and needs further investigation.
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Positive lAS > 15 msec correlated highly with EPS
sustained or nonsustained VT (Fisher exact p - 0.0005).
Similarly. posicive RMS < 70 uV was concordant with EPS
(p - 0.012). This study suggests (1) SAECG is an
accurate method to identify pts in whom VT is found by
EPS, (2) Appropriate cutoffs for interpretation of SAECG
in this pt group are 15 msec lAS and 70 uV RMS, (3) SAECG
could screen asymptomatic pts at risk for VT after
surgery for CHD. and help select pts for EPS.
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lATE POTENTIALS AND INDUCIBLE VENTRICULAR TACHYCARDIA IN
SURGICALLY REPAIRED CONGENITAL HEART DISEASE.
David A. Danford. M D , Jonathan A. Stelling, John R.
Windle, M.D .• F.A.C.C., John D. Kugler, M.D., F.A.C.C.,
University of Nebraska Medical Center. Omaha, Nebraska
LONG-TERM FOLLOWUP OF 109 PEDIATRIC PATIENTS TREATED
FOR THE WOLFF-PARKINSON-WHITE SYNDROME
Joyce C. Pres~ley, M.P.H •• Eric N. Prystowsky. M.D ••
F.A.C.C •• Ronald J. Kanter. M.D., James E. Lowe. M.D ••
Douglas L. Packer. M.D •• F.A.C.C •• J. Marcus Wharton.
M.D •• Duke University Medical Center. Durham. NC.
Interference with normal childhood activities and the
prospect of lifelong antiarrhythmic medications are
factors affecting selection of therapy for pediatric
patients (pts) with Wolff-Parkinson-White Syndrome (WPW).
This study examined the long-term outcome of 109 consecu-
tive pts with WPW (age 0.5-16 years) treated with surgical
ablation of the accessory pathway (n-7l) or with pharmaco-
logical therapy alone (n-3B). Followup data were obtained
in 89% by questionnaire (mean 6.0±3.8 years). At baseline.
surgically treated pts had failed more antiarrhythmic
drugs (2.6 vs 1.5. p-.Ol). had more years of arrhythmia
(6.1 vs 4.1. p-.OOl) and had more cardiac arrests (19%
vs 8%. p=.12). The distribution of accessory pathway
locations. clinical arrhythmias and associated diseases
were not different in the two groups. At followup. the
overall mortality was not significantly different in the
surgical vs medical pts (12% vs 5%) with 10/11 deaths
occurring in pts with associated heart disease. Both
groups reported significant improvement in the frequency
(94% vs 97%) and severity (98% vs 67%) of arrhythmias
post-therapy. Although 37% of pts reported palpitations
and arrhythmias post-surgery, none of the surgical group
required antiarrhythmic therapy. Post-therapy WPW-
related hospitalizations were reduced in both groups
(98% vs 93%). Surgery pts reported no post-therapy activity
limitations vs 19% for pharmacologically treated. pts
(p*.Ol). In conclusion, although both groups improve
significantly over baseline. surgery is superior in
reducing WPW-related sctivity limitations and generally


















Episodic ventricular tachycardia (VT) appears in some pts
after repair of congenital heart disease (CHD). The
signal averaged electrocardiogram (SAECG) has correlated
wich VT by electrophysiologic study (EPS) in pts with
coronary artery disease. This study compares SAECG and
EPS in pts with repaired congenital heart disease to (1)
select appropriate criteria for positive SAECG in this pt
group, and (2) determine the accuracy of SAECG to
identify pts wich inducible VT by EPS. 21 pts (age 3-40,
~years) with surgically repaired CHD who had EPS were
studied with SAECG. Pts were classified by EPS as no VT,
nonsustained VT, and sustained VT. SAECG's were examined
for the duration of low amplitude (~ 25 uV) terminal QRS
signal (lAS) and the root mean square voltage in the
terminal 40 msec of the QRS (RMS).
lAS (msec)
LATE ELECTRO PHYSIOLOGIC SEQUELAE Of EXPERIMENTAL RIGHT
VENTRICULOTOMY WITH RIGHT VENTRICULAR HYPERTENSION.
Jeffrey P. Moak. MO~ fACC; Arthur Garson, Jr., MO, fACC;
Kathleen Sprague, .
Texas Children's Hospital, Houston, Texas.
Right ventriculotomy (Vent) has been implicated as a
substrate for conduction disturbanqes and ventricular
arrhythmias. In a previous report lPediatr Res 23:433,
19BB), we observed that experimental Vent perfo~me~
during low RV pressure had few electrophysiologic lEP)
effects on cellular action potential (AP) characteristics
or conduc tion on a macroscopic level. In the present
study we addressed the late EP effects of Vent performed
in a cyanotic model of RV hypertension. Ten animals were
studiea: 6 beagles served as controls. four beagle
puppies formed the study group: 3 had a PA-LA shunt and
PA band, 1 had a VSD created and PA band at age 6 weeks'
all had surgical Vent performed 12 months later, the pA
band was left intact. All doqs had RV pressure >50 mrnHg.
Electrophysiologic assessmenc 12 months after Vent
included ECG, 24 hour Holter, clinical EP and
microelectrode study using standard techniques.
~: 1) Marked abnormalities in AP
~eristics were noted in the Vent dogs. Ph~se 0
upstroke velocity (543 +1- 4B vs 333 +1- 70 V/sec) , AP
amplitude (119 +1- 3 vs 114 +1-3 mv) and maximum
diastolic potential (B6 +1- 2 vs B3 +1- 1 my) were
significantly depressed in the Vent group compared with
controls p<U.05. X+SD. Post- Vent AP durstion (APO)
was signlficantl~proTonged, p<O.Ol. for eXi-ple, in the
outflow septum APO 50 increased from 125 +/- 11 to 149
+/- 7 msec and APO 90 increased from 173 + .:. 12 to 199
+/- 6 msec. However, lengthening of APO ~as less in the
Vent region (APO 50= 121 +/- 16 vs 127 +/- 15 maecl APO
90= 173 +1- lB vs IB4 +1- 15 msec). 2) Delared
afterdepolarizations occurred durin~ rapid ventricu ar
pacing in 1 post-Vent dog. 3) rn tile Vent region,
localIzed areas of conduction delay and block were
demonstrated. We ~lude that an abnormal
electrophysiologic substFi4e develops when a Vent is
healed under high RV pres~ure (abnormalities in
conduction and refractoriness) • These detrimental
electrophysiologic consequences may predispose to late
reentrant or trIggered arrhythmias.
DETERMINANTS AND OUTCOME Of EARLY AND LATE ARRHYTHMIA
AFTER FONTAN OPERATION
Marc Gewillig. Ulla Lundstrom, Dick Wyse. John Deanfield
Hospital for Sick Children, Great Ormond Street, London,UK
The incidence and clinical significance of arrhythmia was
studied in 104 consecutive patients (pts) undergoing
fontan (F) repair from 1975-l9BB. 11 pts developed
perioperative arrhythmia (B atrial flutter, 3 junctional
tachycardia). On multivariate analysis elevated mean
perioperative pulmonary artery pressure (PAP) (p <0.005)
and low aortic saturation (p <0.05) were significant risk
factors,but not underlying morphology or surgical
technique. Despite aggressive medical treatment 10 of 11
died. Clinical and annual ECG follow-up was available in
all 7B hospital survivors (mean age 11.4 ! 5.4 years.
interval from F 3.7 ! 3.3 years) and 63 underwent
ambulatory ECG monitoring (AECG) 3.5 ! 3 years after F.
55 of 63 (B7%) were in stable sinus rhythm on AECG with
2 pts in atrial flutter. 5 pts in junctional rhythm and 1
pt paced. None had significant bradycardia or ventricular
arrhythmia. Actuarial survival free of supraventricular
arrhythmia (SVA) B years after F was B2%. 11 pts had
late SVA (7 atrial flutter. 1 atrial fibrillation. 3 SVT).
In 9 the onset occurred early «4 m) after surgery during
weaning from diuretics and was associated with
haemodynamic upset. Multivariate analysis identified
enlarged right atrium on echo- (p< 0.05) and elevated
pre-operative PAP,> 20 mmHg (p <.0.01) as risk factors for
late SVA. All pts responded to medical treatment except 1
who died at redo F. Thus, arrhythmia after f is
associated with adverse haemodynamics, both early and late
after surgery, rather than with underlying morphology.
Medical and surgical modifications to.improve the
haemodynamic disturbance associate~with arrhythmia are
indicated.






LONG-TERM FOLLOWUP OF AMIODAR()IlE IN THE YOUNG: CONTINUED
EFFICACY, UNIMPAIRED GROWTH, MODERATE SIDE EFFECTS
Paolo Guccione, M.D., Thanas Paul, M.D., Arthur Garson
Jr., M.D., F.A.C.C., Baylor College of Medicine, Texas
Children's Hospital, Houston, Texas
Long-tenn follcwup on young pts receiving amlodarone (A)
Is lacking, especially In tenns of growth and late side
effects (SE). We reviewed the records of 95 young pts,
mean age 12.4 yrs (3 wks-31.5 yrs), who received A.
Mlnlnun follcwup for those cont Inulng to take A was 1. 5
yrs; mean duration of therapy was 2.3 (max. 6.5) yrs.
Mean maintenance dose was 7.7 (1.5-25) mg/kg/d. Initial
success (syrrptans and 24 hr-ECG) was achieved In 23/34
pts with ventricular tachycardia (VT) (9/11 pts with VT
and A failure had ventricular tumor or congestive
cardlanyopathy), In 32/33 pts with atrial flutter (AFL)
(In 7/33 pts, AFL returned 6 me after start of A), and
In 21/28 pts with SVT. Growth cont Inued along pre-A
percentiles In all but 8, Improving In 6 and worsening In
2 with severe underlying disease. Proarrhythmla occurred
In 3: 1 had torsade de polntes that disappeared when A
was stopped; 2 with severe anatanlc heart disease died
suddenly during loading period of A (l AFL, 1 VT). SE
occurred In 28/95 (29%) pts: keratopathy (11), abnormal
thyroid function tests (6), chemical hepatitis (3), rash
(D, peripheral neuropathy (2), behavioral changes (2),
blue skin discoloration (2), headaches (2), hypertension
(1), vanltlng (1). All SE disappeared when A was
discontinued or the dose was reduced. Conclusions: 1) A
was an effective drug for young pts with tachyarrhyth-
mlas. 2). Growth was unimpaired. 3) SE were relatively
canron but not severe (no pulmonary SE). Therefore, we
recarmend A only for young pts with life-threatening
arrhythmias that are resistant to conventional drugs.
EFFECTS OF POSITION AND EXERCISE ON THE QT INTERVAL
IN CHILDREN
James J O'Brien M.D., Gerald Barber, M.D., Charles T. Heise,
Carol S. Tanner, and Victoria L. Vetter, M.D., F.A.C.C.
The Children's Hospital of Phiiadelphia,Phiiadelphia, PA.
Exercise and postural change may affect autonomic· tone, with
reflection of these changes in the corrected QT interval (QTc). The
effects of position and exercise on the QTc were evaluated in 40
patients (pts) without known cardiac disease, and in 14 pts with
congenital long QT syndrome (LQTS), none on beta blockers. The
groups were not significantly different in age. LQTS was defined as
QTc ~.45 (age< 12) or ~.44 (age~12) with ventricular arrhythmias or
family history of LQTS. QTc's (Bazett's formula) were determined
supine, standing, seated at rest, at peak exercise (PE), immediately
post exercise, and at 3, 5, and 10 minutes of recovery. QTc's did not
significantly change at PE in either group, nor were there significant
differences between groups at PE or during recovery. QTc
significantly increased with change in position from supine to
standing in normals but not in pts with LQTS.
OTc Values (Mean ± S.D.)
Supine * S1Rlliti.!!.& ~
!&IS (14) .451+.021 .457+.036 0
normals (40) .418±.020*# .439±.032# 4.7
*p<O.OOI t-test; #p<O.OOl paired t-test.
We conclude from these data that: I) change in QTc during
exercise testing is of limited value in discriminating between normals
and patients with LQTS, since the QTc varied little in either grouP.
2) a moderate increase in QTc occurs with change from supine to
standing position in normal individuals, 3) the postural change of
QTc is not present in patients with LQTS. These findings are
consistent with high tonic level of left stellate ganglion input in
patients with LQTS, versus more reactive fluctuations in sympathetic
tone in normals.
Wednesday, March 22,1989
8:30AM-I0:00AM, California Room A
Anaheim Convention Center
Neurohormones and Cardiovascular Function
DOES ANY INFLUENCE VENOUS RETURN?
David L. Rutlen M.D., Geir Christensen M.D., Knut
Helgesen M.D., Arnfinn Ilebekk, M.D. Dr.Med.,
University of Oslo, Oslo, Norway.
Whether atrial natriuretic factor (ANT) acts on
intravascular volume in the capacitance vasculature to
change venous return is unknown. Furthermore, whether
ANT causes transport of volume between the peripheral
capacitance circulation and the central circulation is
unknown. Thus, in 8 anesthetized pigs undergoing
carotid denervation and cervical vagotomy, blood was
drained at a constant CVP from the vena cavae to an
extracorporeal reservoir and returned to the right
atrium at a constant rate so that changes in venous
return could be recorded as changes in reservoir
volume. Transudation was measured by determining
total intravascular volume from Tc labeling of erythro-
cytes and determining changes in hematocrit. ANT (0.1
Ug/kg min) for 15 minutes to increase plasma ANT from
85±9 (SEM) to 4l9l±3l0 pg/ml (P<.05) was associated
with a total volume displacement from the reservoir to
the animal of 63±13 ml (P<.05). Increased urine pro-
duction accounted for only an inconsequential portion
of this displacement, since ureteral flow increased
only from .044±.016 to .124±.016 ml/min. Since
200±26 ml (P<.05) of transudation to the animal's
extravascular space occurred, the total peripheral
capacitance vasculature acted to displace l37±33 ml (P<
.05) from the intracorporeal circulation to the extra-
corporeal reservoir. Thus, ANT's net effect on intra-
vascular volume acts to decrease venous return. This
decrease is due almost entirely to transudation of
volume out of the intravascular space; however, a
tendency to displace volume from the peripheral capaci-
tance circulation to the central circulation attenuates
the transudative influence on venous return.
ENDOCRINE CONVERSION OF VENTRICULAR CARDIOCYTES IN
VENTRICULAR ANEURYSM
Jiang Gu, M.D., Ph.D.,
Lynn McGrath, M.D., F.A.C.C., Michael D'Andrea,
B.A., Debra Graf, R.N., Sally Cull, A.A.S. Deborah
Research Institute, Browns Mills, NJ 08015-1799
Normal adult ventricular myocardiocytes do not have
endocrine function and contain only minute amounts of the
peptide hormone, atrial natriuretic peptide (ANP). To
study the effects of physical stretch on the ventricular
cardiocytes, we investigated human ventricular tissues
from 5 adult ventricular aneurysm patients with normal
blood pressure. In these patients, the viable
ventricular cardiocytes in and around the aneurysm were
paradoxically over-distended during heart contractions.
The tissues were collected during aneurysmectomy. The
occurrence and distribution of ANP and a
neuroendocrine-element marker, neuron-specific enolase
(NSE), were studied with light and electron microscopic
immunocytochemistry. ANP gene expression was examined
with RNA-RNA tissue in situ hybridization. Large amounts
of ANP-containing electron-dense granules, NSE
immunoreactivity and ANP mRNA were detected in the
cytoplasm of the over-stretched cardiocytes in and around
the aneurysm. The scar tissues and the normal ventricles
were devoid of any ANP, NSE or ANP mRNA positivities.
These findings suggest that physical over-distention of
the ventricular wall may be a triggering factor for the
activation of ANP and NSE synthesis by the ventricular
cardiocytes and the ventricles may become an important
endocrine entity during over-distension, such as
ventricular aneurysm, congestive heart failure and
hypertension.
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EFFECT OF ATRIAL NATRIURETIC FACTOR ON UFT VENTRICULAR
DIASTOLIC FUNCTION IN BUKANS VITH HEART FAILURE
Harc J. Semigran HD, Constantine N. Aroney HBBS, Howard
c:-Herrmann HD, G. Villiam Dec HD FACC, Charles A;
Boucher HD FACC and Hichael A. Fifer HD FACC.
Hassachusetts General Hospital and Harvard Hedical
School, Boston, HA
To assess the effect of atrial natriuretic factor
(ANF) on LV diastolic function in heart failure, we
administered nitroprusside (NTP) and ANF to 9 pts (NYHA
class II-IV, LV ejection fraction 14±1%) with coronary
artery disease (n=5) or idiopathic dilated
cardiomyopathy (n=4) undergoing cardiac catheterization.
LV micromanometer pressure and simultaneous LV volume
(gated scan) were obtained at baseline, on NTP, during a
second baseline, and on ANF. Hean arterial pressure
fell by an average of 18 mmHg on NTP and 9 mmHg on ANF.
LVEDP (mmHg) and LV end diastolic volume (LVEDV, ml),
time constant of isovolumic relaxation (T, ms), and peak
filling rate (dV/dt, mIls) were (mean±SEH, *p<0.05 vs.
baseline) :
LVEDP LVEDV T dV/dt
Baseline ~ 320t29 61t7 !!4±I9
NTP 14±3* 284±26* 54±8* 210±20
Baseline 26±2 3l4±26 65±7 233±12
ANF 18±3* 302±27* 58±8* 241±13
T decreased similarly on ANF and NTP; this may be
related to the load dependence of relaxation. The LV
diastolic pressure-volume (P-V) relation was shifted
downward on ANF in 3 pts and on NTP in 3 pts. These
effects were eliminated when the transmural P-V relation
was constructed by subtracting RA pressure from LV
pressure. Conclusions: (1) ANF has no direct effect on
LV diastolic properties in humans with heart failure.
(2) Some indices of LV diastolic function improve on
both ANF and NTP, probably due to changes in loading
conditions.
EFFECT OF INHIBITION OF ARGININE VASOPRESSIN ON SYSTEHIC
AND CORONARY HEMODYNAMICS.
James J. Glazier H.D., Haralambos Gavras H.D., Roger H.
Mills Jr., H.D., F,A.C.C., Nicholas A. Ruocco Jr., M.D.
F.A.C.C., Hargaret Bresnahan DSc, Thomas J. Ryan H.D.,
F.A.C.C., David P. Faxon H.D., F.A.C.C. Boston
University Hedical Center, Boston, HA.
Arginine vasopressin (AVP) is a potent vasoconstrictor
of isolated arterial sements in vito but its effect on
systemic and coronary vasomotor tone in man are
disputed. To determine the effects of AVP, we measured
blood pressure (HAP), systemic resistance (SVR) ,
coronary sinus blood flow (CSBF) and resistance (CVR) in
6 patients (pts) with severe coronary disease (CAD) at
the time of angiography. Cardiac pressures and serum
osmolality (Osm), AVP, catecholamines and renin levels
were measured before and after administration of
hypertonic contrast dye (HC), then following intravenous
injection of 0.5mg of an analogue inhibitor of
vasopressin (AVPI). Results (mean+ S.D.):
Before HC After He After AVPI
HAP(mm.Hg)_5 106+12 115+19 114+13
SVR(d.s.cm) 1429+152 1419+110 1453+138
CSBF(cc/mi~~ 196+49 206+51 191+67
CVR(d.s.cm) 41.5+75 39.7+7.4 44.9+10.2
OSH(HOSM/kg) 295+12 306+7 297+10
AVP(pg/HL) .61+0.28 3.84+36 36.1+16.3
5 of 6 patients had a-rise in AVP above physiologic
levels. No change in hemodynamic parameters were noted
in these patients. No changes were seen in
catecholamines or renin levels.
Ve conclude that, in pts with coronary artery disease,
endogenous AVP does not contribute to systemic nor
coronary vasomotor tone.
ANP 490±109 885±252 1171±3051431±360 1638±438 1846±482
LANP 6.1 ± 0.2 6.6 ±0.3 6.9 ± 0.2 7.1 ± 0.2 7.3 ± 0.2 7.4 ±0.2
RAP 4.4±0.9 7.0±2.1 6.8±2.0 7.0±2.1 7.0±2.1 7.0±2.1
There was a marked, statistically significant increase in ANP during every
minute of induced T (p < .001, ANOVA). The increase in RAP from 4.4 ±
0.9 to 7.0 ± 2.1 mm Hg was not statistically significant. Heart rate
increased from 75 ± 5 at baseline to 186 ± 13 beats/min (p <
0.001 )during T. There was a significant correlation (r = 0.89, P < .05)
between the increase in ANP and the increase in heart rate, while no
relationship was found between the increase in ANP and the increase in
RAP from baseline to 5 minutes of T (r =0.38, p. ns). These data show
that there is an immediate and significant increase in ANP in plasma from
the coronary sinus during induced T. Furthermore, the increase in ANP is
related to the increase in heart rate but is apparently not related to an
increase in mean right atrial pressure.
ATRIAL NATRIURETIC PEPTIDE FROM THE CORONARY SINUS IS
ACUTELY INCREASED FOLLOWING INDUCTION OF PAROXYSMAL
TACHYCARDIA.
Berli! Kjell "je Mp., Per Ivar Hoff M.D., Brill Skadberg M.D., Arve
Tronstad M.D., Ole Myking M.D., AsbjlJm Aakvaag M.D., Ole-JlIrgen Ohm
M.D., F.A.C.C., University School of Medicine, Bergen, Norway.
We evaluated concentrations of atrial natriurietic peptide (ANP) in plasma
from the coronary sinus in 5 patients following paroxysmal tachycardia (T)
induced by programmed stimulation. Coronary sinus plasma samples and
mean right atrial pressure (RAP) measurements were made before (B)
and every minute (min) after initiating the T. Logarithmic transformation of
ANP (LANP) was done to obtain normal distribution for statistical








DIRECT SUPPRESSION OF ALDOSTERONE SECRETION BY ENDO-
GENOUS ATRIAL NATRIURETIC PEPTIDE IN HEMODYNAMICALLY
NORMAL MAN: EVIDENCE FOR PHYSIOLOGIC ROLE OF ANP
Rudolph Canepa-Anson M D., Gordon W. Moe M.D .• FACC,
and Paul W. Armstrong M.D., FACC, St Michael's Hospital
and University of Toronto, Ontario, Canada
Atrial natriuretic peptide (ANP) has been shown in
vivo to reduce plasma aldosterone (ALOO) in association
with reduced plasma renin activity (PRA) and in vitro
to directly inhibit ALDO secretion by the adrenal
cortex. It is unclear whether direct suppression of
ALOO by endogenous ANP occurs in vivo. Accordingly we
measured hemodynamics, pulmonary artery plasma ANP
(ANPPA), PRA and plasma norepinephrine (NE) and ALOO
at control, after i-v saline 750 ml over 30 min
("peak") and again 30 min later (post) in 11 Pt with
normal LV function. Results are given as mean ± SD
(RAP and PCWP-right atrial and pulmonary capillary
wedge pressures [mm Hg], BP-blood pressure, HR-heart








p vs. control are*<0.05, #<0.01, (ANOVA).
RAP, PCWP and ANPpA increased with volume
expansion. HR and BP were unchanged, as were NE and
PRA, but ALDO was reduced at "peak" (-26%) and at 30
min post-infusion (-26%).
These data support the hypothesis that the response
of endogenous ANP to increases) in atrial pressures
within the normal range may directly modulate ALOO
secretion and, hence, sodium homeostasis.
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ooro::ME OF EMPIRICAL ANl'IARRH'i'llIC [JU; 'lHERAP'i
IN MM"OIED CXHlR1'S OF PATmnS wrm VEN1'RIaJIAR
AmlY'llMIAS AF1'ER MYco.RDIlIL INFARCl'ICN.
lllz-Haria Rcdri.guez. M.P•. Pedro Brogada, M.P.,
AIxir8 waleffe, M.P., E>:iuardo Back sternick,
M.D., Pelayo Tomer, M.D., Anne Deharen;J, M.P.,
Rcdulfo 0yarzIm, M.P., Hein J.J. wellens, M.P.,
F.A.C.C., Henri E. Mbertus, M.D., F.A.C.C.,
.l\cademic Hospital, Maastricht, '!be Netherlan:ls
am Liege, BelgiUIll.
serial test:in::J (ST) has been prc:p:lSEld as the
best awroadl to select antiarrhythmic drugs
(AD) in pt with ventricular tadlycard.la (Vl') or
fibrillation (VF) after myocardial infarction
(MI). '!be pll'pOSE! of ror study was to determine
ootcane of in::I.i.vidualized eapirical treatment
with antiarrhythmic drugs (AD) as an alternative
to ST. roorty-two pt treated in Liege were
oc:q:lared (matched for aqe, INEF, location of MI,
NYHA class for dysp1ea, n.miler of diseased
vessels am an:hythmi.a type) to 42 pt in::llXled
in the "Parallel stooy" in Maastricht. AlIli.~
ne alone or in CCl\i)ination with a class I AD was
given to lID6t pt. Total llDrtality ('IM), S\d:Ien
death (SP), cardiac death (CD) am rec::urren::es
(Ree) of vr dur:in::J a nean 24 m::nths follaMJp
are sbqwn below:
I.J:EGE MMSTRIOfl' P value
1M 9 (21%) 10 (24%) NS
SP 4 (10%) 5 (12%) NS
CD 4 ClO%) 5 cutl NS
1M, SD am CD were similar to reported series
us:in::J ST. Treatment us:in::J potent AD based on
clinical krlc:7;.rledge am e>q:lerien::e results in
survival rates similar to ST.
AV NODAL REENTRY INCORPORATING HIS BUNDLE: VERAPAMIL
SENSITIVITY IN RETROGRADE FAST PATHWAY CONDUCTION
Warren MJackman.MD.FACC, John AF Yeung-Lai-Wah, MBChB,
FACC, Karen J Frlday MD,FACC, David MFitzgerald MD,
Carlos Roman MD, Ralph Lazzara MD,FACC, Univ. of Oklahoma
Health Sciences Center and VAMC,Ok1ahoma City, OK
In AV nodal reentrant tachycardia, an indirect method
has been used to evaluate if the ventricular (distal) end
of the retrograde fast pathway (RFP) arises from the His
bundle (H) or AV node and correlate site of origin of RFP
with pharmacologic sensitivity. This method compares the H
to atrial interval during tachycardia (H-At) and during
ventricular pacing at the same cycle length (H-A ).H-At is
measured from onset of the H potential. H-Ap is ~easured
from the end of the H potential, since H is activated
retrogradely during ventricular pacing. End of retrograde
H was identified by pacing at RV sites which prevented
overlap of H and ventricular potentials. It is proposed
that if RFP originates within the AV node, then H-At<H-A
as the reentrant impulse has entered the RFP before H isP'
activated. If.th~ RFP originates from H, H-A~H-Ap since
the tachycardla lmpu1se must travel to H before engaging
RFP. Of 33 Pts,H-At<H-A in only 18. In the other 15 pts
(45\), H-At=H-Ap (5 Pts~ or H-At>H-Ap (10 pts).Decremental
ventricular paclng was performed immediately before and
after verapamil (10 mg iv) in 22 pts. Shortest ventricular
pacing cycle length maintaining 1:1 VA conduction (1:1 VA)
was 323 ! 3~ msec in 9 pts with H-At<H-Ap vs 299 ! 57 msec
in 13 pts wlth H-At ~ H-Ap (p=0.07). Verapami1 increased
the median 1:1 VA by only 40 msec in H-At<H-Ap pts
compared to 200 msec in H-A~ H-A pts (p<O.OI) ..
We conclude: 1) RFP may origina~e from H in a large
number of pts (45%); 2) conduction in RFP originating from
H may be capable of conduction at faster rates, and 3)
verapami1 depresses RFP conduction to a greater extent in
this group, but the reason for this response is unknown.
ANTEGRADE AND RETROGRADE CONDUCTION OCCURRING OVER
SEPARATE, ADJACENT ACCESSORY AV PATHWAYS
Warren MJackman MD.FACC, Karen J Friday MD,FACC, David M
Fitzgerald MD, John AF Yeung-Lai-Wah, MBChB, FACC, Carlos
Roman MD, Ralph Lazzara MD,FACC, Univ of Oklahoma Health
Sciences Center and VA Medical Center, Oklahoma City OK
Catheter recordings of accessory pathway (AP) acti~ation
suggest that left free-wall APs have an oblique course
with ventricular insertion distal (anterior) to the atrial
insertion. Identification of separate AP potentials can
distinguish activation of 2 close APs. In 69 patients
(pts) with B5 septal and left free-wall APs, AP potentials
were recorded from 67/85 APs. Antegrade and retrograde
conduction occurred over two separate, but close APs in 7
pts (10%).
In 4 pts, 2 parallel left free-wall APs had opposite
unidirectional conduction, antegrade in proximal (poster-
ior) AP and retrograde in distal (anterior) AP (figure).
Atrium
Venlrtcl.
At surgery, earliest epicardial atrial and ventricular
activation were within 1 cm, simulating a single, vertical
pathway. Pressure over the coronary sinus (CS) catheter
electrode recording activation of 1 AP resulted in
unidirectional conduction block in 3 of 4 pts.
In 3 pts, retrograde conduction occurred over a
concealed left posterosepta1 AP, wi~h AP potentials
recorded from CS at least 7 mm distal to the ostium.
During antegrade conduction, AP potentials were recorded
across the tricuspid annulus, just anterior (1 pt) or
posterior (2 pts) to the CS ostium.
We conclude that antegrade and retrograde conduction can
occur over separate, unidirectional pathways (10%).
MECHANISM OF COMPENSATORY PAUSE IN ATRIAL FIBRILLATION
Fred Wittkampf M.Sc., Mike de Jongste M.D., Frits
Meijler M.D.,F.A.C.C., University Hospital of Utrecht,
The Netherlands.
The compensatory pause after premature ventricular
contractions in pts with atrial fibrillation (AF) is
classically explained by interception of atrial impul-
ses and prolongation of atrioventricular nodal (AVNJ
refractoriness. On the other hand, retrograde conduc-
tion may also facilitate anterograde conduction. We
studied the underlying mechanism of compensatory pau-
ses in 15 pts with AF in whom single premature ventri-
cular extrastimuli were delivered at a fixed coupling
interval (RS) after each 8th spontaneous R wave. In
each pt an average of 375 extrastimuli were applied.
The histogram of compensatory pauses (SR) was compared
with that of the other spontaneous RR intervals. In
6/7 pts in whom RS was more than 200 ms shorter than
the shortest spontaneous RR interval, the SR intervals
were 240±70 ms longer than the RR intervals but the
shape of both histograms was not significantly diffe-
rent. However, in 5/8 pts in whom RS was relatively
longer, the SR histogram was broader than, and signi-
ficantly different from the spontaneous RR histogram.
Conclusions: 1, These results suggest that during AF,
early retrograde penetration can reset the AVN- 2
later penetration results in a mixed pattern of AVN
resetting and interception of anterograde conduction,
dependent on the timing of retrograde conduction rela-
tive to the spontaneous anterograde impulses; 3, the
ability to reset the AVN during AF, challenges the
classical concept that the AVN merely acts as a
"passive" structure transmitting atrial impulses.
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INCIDENCE AND SUBSTRATE OF SUSTAINED BUNDLE BRANCH
REENTRY AS A MECHANISM OF VENTRICULAR TACHYCARDIA.
Jose Caceres, M.D., Patrick Tchou, M.D., Mohammad
Jazayeri, M.D., James McKinnie, M.D., Boaz Avitall,
M.D., Masood Akhtar, M.D., F.A.C.C., Sinai-Samaritan
Medical Center, Milwaukee, Wisconsin.
Identification of bundle branch reentry (BBR) as a
mechanism of clinical and/or induced sustained
monomorphic ventricular tachycardia (SHVT) is of crucial
importance since nonpharmacologic therapy is curative.
The typical substrate, however, seems to be unrecognized
and its incidence is not clearly defined.
Of 285 pts with inducible SHVT studied in our laboratory
(1980-1987), 17 were diagnosed as BBR (67. incidence). A
detailed analysis of intramyocardial and His Purkinje
System (HPS) conduction was performed to identify the
substrate. Nonspecific intraventricular conduction
delay (IVCD) was observed in 1007. of Pts with BBR and
637. of those with non-BBR. Nonspecific IVCD and
prolonged HV (>60 ms) was seen in all Pts (1007.) with
BBR and in 117.-with non-BBR (p<O.Ol). Of the Pts who
had the trio of IVCD, prolonged HV and left bundle
branch block (LBBB) configuration SHVT, BBR was the
mechanism in 737..
Conclusions: (1) BBR is not an uncommon mechanism of
clinical SHVT and occurs in about 67. of cases. (2) The
typical substrate appears to be abnormal HPS conduction.
(3) The combination of IVCD, prolonged HV, and LBBB-SHVT
strongly suggests BBR as the mechanism of tachycardia.
EFFECT OF MYOCARDIAL REVASCULARIZATION ON INDUCIBLE
VENTRICULAR ARRHYTHMIAS. Patricia A. Kelly, M.D., Charles
S. Freeman, R.N., Jeremy N. Ruskin, M.D., F.A.C.C., Hasan
Garan, M.D., F.A.C.C., Massachusetts General Hospital,
Boston, MA. In some pts with out-of-hospital ventricular
fibrillation (VF) or sustained ventricular tachycardia
(SUVT) and inducible ventricular arrhythmias, surgical
myocardial revascularization (CABG) suppresses arrhythmia
induction. To determine what factors can be used to
identify those pts in whom CARG is most likely to suppress
ventricular arrhythmia induction, we analyzed data from
33 pts with >70% stenosis of >1 major coronary artery.
All pts had a history of VF (0-23) or SUVT (n=10) and
inducible VF or SUVT at electrophysiologic study. All pts
had CABG and repeat electrophysiologic study off anti-
arrhythmic drugs post-CARGo Thirteen variables of
potential predictive value were chosen and analyzed.
Stepwise regression analysis identified left ventricular
ejection fraction (p=0.015) and the type of ventricular
arrhythmia induced at pre-CARG electrophysiologic study
(p<O.OOl) as the only variables significantly predictive
of arrhythmia suppression at post-CABG electrophysiologic
study. The mean LV ejection fraction was 43+10% in pts
with no inducible ventricular arrhythmia post-CABG (n=13)
versus 33+11% in pts with persistently inducible
arrhythmias (n=20). Of 24 pts with inducible SUVT pre-
CARG, 19 had SUVT and 1 had VF at post-CABG electrophys-
iologic study. Nine of 9 pts with VF at pre-CABG electro-
physiologic study had no inducible ventricular arrhythmia
post-CARGo Thus, in pts with coronary artery disease
and inducible ventricular arrhythmias, SUVT induction is
unlikely to be suppressed by CABG alone. VF induction is
frequently suppressed by CABG alone.
MECHANISM OF INDUCIBLE VENTRICULAR TACHYCARDIA IN
fATIENTS VITH IDIOfATHIC DILATED CARDIOMYOPATHY
Patrick Tchou. M.D .. Zalman Blanck, M.D., James
Mckinnie, H.D., Boaz Avitall, M.D., Ph.D., Keith
Atassi, M.D., Mohammad Jazayeri. M.D., Hasood Akhtar,
M.D., F.A.C.C. Sinai Samaritan Medical Center.
Milwaukee, VI.
Sustained ventricular tachycardia (VT) is often seen
in patients with idiopathic dilated
cardiomyopathies. There is little data. however, on
the mechanisms of tachycardia in this pathologic
entity.
Over a 51 month period, 58 patients with dilated
myopathies underwent electrophysiologic studies at
our institution for suspected or documented VT. Of
these, 17 had inducible sustained monomorphic VT. In
7 of the 17 (41'), the mechanism of tachycardia was
bundle branch reentry. The 7 patients with bundle
branch reentry had documented clinical VT (N-5).
syncope (7) or sudden death (1).
Conclusions: 1) Bundle branch reentrant VT is a
clinically important causa of sustained VT in
patients with idiopathic dilated cardiomyopathies.
2) Since therapy of this entity can be apporoached
with right bundle ablation, one should consider the
possibility of bundle branch reentry mechanism in all
patients with idiopathic dilated cardiomyopathies in
whom sustained monomorphic VTs are induced at
electrophysiologic studias.
DOES RESPONSE TO IA AGENTS PREDICT RESPONSE TO IC·AGENTS
IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYCARDIA?
Jodie L. Hurwitz, M.D., Eric N. Prystowsky, M.D.,
F.A.C.C., J. Marcus Wharton, M.D., Douglas L. Packer,
M.D., F.A.C.C., Duke University, Durham, NC.
In an effort to facilitate the management of patients
(Pts) with sustained ventricular tachycardia (VT), we
prospectively evaluated whether the response to programmed
ventricular stimulation performed during treatment with
with IA antiarrhythmic agents can predict response to
subsequent treatment with IC antiarrhythmic agents. Each
of 33 Pts (mean age • 57tll) had sustained VT at baseline
electrophysiologic study (EPS) (mean VT cycle length
[VTCL] • 275t88 ms) and during treatment with IA agents
(mean VTCL • 3l7t64 ms). EPS was also performed during
treatment with IC agents (mean VTCL - 333tl06 ms). VT
was inducible in 30/33 (91%) Pts on IC agents. The MOl
of the VT induced in Pts on IC agents when compared to
the MOl of the· VT induced in pts on IA agents was harder
[increased extrastimuli (ES)] in 7/30 (23%), the Same in
11/30 (37%) and easier (decreaaed ES) in 12/30 (40%).
The MOl of VT 1n Pts on IA agents did not predict the
MOl of VT in Pts on IC agents. The VTCL in Pts on IC
agents was compared to the VTCL in Pts on IA agents and
found to be increased by 50 ms in 9/30 (30%), to be
decreased by 50 rns in 5/30 (1]%) and have < 50 ms change
1n 16/30 (53%). Prolongation of the VTCL 1n Pts on IA
agents tended to suggest a similar VTCL response in Pts
on IC agents.
Conclusions: Inducibility of VT in Pts on IA agents
predicts continued inducibility on Ie agents. The VTCL in
Pts on IC agents is not significanbly different from
the VTCL in Pts on IA agents.
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Huanlin An M.D., Sanjeev Saksena M.D., FACC Newark Beth Israel Med Ctr
- NJ Medical School, Newark, NJ.
COMPARATIVE EFFECT'S OF RADIOFREQUENCY AND LASER












We compared the effectiveness & safety of radiofrequency (RF) energy & laser
energy for ablation of normal ventricle (NY) & diseased human ventricle (OV).
RF ablation in NV was performed in the unipolar mode using a 500 kHz RF
generator coupled to a 6Fr USCI quadripolar ring electrode catheter (RF1) or
5Fr screw-in electrode (RF2). Laser ablation employed a 15W argon laser
coupled to a 300p core optical fiber alone (Ll) or 2.5mm metal probe encasing
a sapphire lens-tipped 600p core fiber with 80% beam transmission window
(L2). In DV, RF2 & Ll catheter delivery systems (CDS) were used. Lesion
dimensions were obtained by microscopic examination & correlated with
delivered energy using regression analysis. The ratio of lesion depth to diameter
(DID) was examined.







.p <.05; ••p <.001 as compared to L2
In each catheter, DID ratio did not change with increasing delivered energy.
Correlation between lesion size & delivered energy was good for RF2 & L2 at
all energies, but deteriorated for RFI & Ll at high power/energy outputs. RF2
failed to produce lesions in DV at energies <500J, while Ll induced lesions in
DV with mean diameter of 3.4mm & depth of 2.4mm at mean energy of 195J.
RF2 lesion dimensions in DV were comparable at mean energies of >8001.
Perforation was only observed in NV with Ll at energies >3001, but was not
observed with any other laser or RF CDS in NV or DV.
CONCLUSIONS: 1) Laser ablation is more effective in DV. 2) RF energy
produces shallower lesions & may be safer for ablation in thin-walled structures.
3) Metal probe-tipped optical fibers & screw-in electrodes are preferable for
ventricular ablation with laser & RF energy respectively.
Retrograde Pathway in Atrioventricular Nodal
Tachycardias: Nodal Tissue or Extranodal Accessory
Pathway?
James McKinnie M.D .. Boaz Avitall M.D., Ph.D., Jose
Caceres M.D., Mohammad Jazayeri M.D., Sergio
Kershenovich, M.D., Patrick Tchou, M.D., Masood
Akhtar M.D., F.A.C.C., Sinai-Samaritan Medical
Center, Milwaukee, WI.
The introduction of surgical techniques in the
management of patients with atrioventricular nodal
(AVN) reentrant tachycardia (AVNRT) has resulted in
renewed interest in the anatomic boundaries and
electrophysiological properties of the reentrant
circuit. Specifically, the nature of retrograde
(ReT) fast pathway (FP) in Pts with AVNRT remains
unclear. Fixed ReT AVN conduction (H2A2) using
ventricular extrastimulus technique during a single
and relatively long basic cycle length (BCL range
600-800 ms) has been interpreted as implying AVN
bypass tract conduction. ReT AVN input (V1H2)
remains fixed at a given BCL due to ReT His
Purkinje system (HPS) refractoriness and must be
shortened to appreciate AVN response. Shorter BCL
(range 350-500) were therefore scanned in 17 Pts
with AVNRT and H2A2 intervals at long and
progressively shorter BCL were compared. RESULTS:
At the long BCL the H2A2 ranged 25 to 50 ms. The
H2A2 progressively increased by 25' to 83' of the
baseline value as the V1H2 decreased at shorter
BCL; behavior typical of AVN conduction. It is
concluded that decremental properties of ReT FP
conduction can be unmasked using short BCL. These
new findings suggest that conduction via AVN bypass
tract need not be involved to explain short and
"fixed" H2A2 intervals in Pts with AVNRT.
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JUNCl'ICNAL TACHYC1\RDIA - ANATCMIC SUBSTRATE AND ITS
SIGNIFICANCE IN ABIATIVE POOCEDURES.
Saroja Bharati, M.D., F .A.C.C., Melvin SCheiflllal1, M.D.,
F.A.C.C., Mark Estes, M.D., F.A.C.C., William ~itz,
M.D., F.A.C.C., Maurice fJiN, M.D., F.A.C.C. Con:Jenital
Heart and Conduction System center, The Heart Institute
for Children of Christ Hospital, Palos Heights, Illinois.
HIS BUNDLE CRYOSURGICAL ABLATION USING A CLOSED HEART
EPICARDIAL APPROACH. Gerard M. Guiraudon, M.D. ,
F.R.C.S.(C), F.A.C.C.
University Hospital, London, Ontario, Canada.
We report our experience with His bundle cryosurgical
ablation using a closed heart epicardial approach in S
patients. The His bundle region was exposed via the right
coronary fossa (anterior septal region). The
atrio-ventricular fat pad was mobilized and the tricuspid
valve annulus exposed. The aortic annulus, and the
subjacent atrial membranous septum were exposed. The His
bundle is located at the tip of the exposed trihedron
(aorta and membranous septum, right ventricle ~n right
atrium). A cryoprobe Smm in diameter with a 4S oblique
tip (custom made by Frigitronics) is applied onto the
membranous septum and cooled at -SoC (ice mapping).
Cryosurgical ablation (_bOoC, 2min) is carried out at the
site where ante grade heart block is readily obtained.
There were 4 men and 1 woman, age 35 to 73 (median
62). The His bundle ablation was indicated for chronic
atrial fibrillation (4 pts) and multifocal atrial
tachycardias (1 pt) resistant to antiarrhythmia therapy.
One pt had associated congestive heart failure. All pts
had attempted catheter ablation. Permanent complete heart
block was obtained in all pts (mean follow-up 13 months).
There were no complications.
Closed heart epicardial His bundle cryosurgical
ablation is an effective surgical alternative to catheter
ablation avoiding cardiopulmonary bypass and/or
intracardiac manoeuvers.
we stOOied the Conduction System (CS) by serial section
in three cases of intractable junctional tachycardia
(JT) who died suddenly. Case One was a six IlOnth old
female, Case '1\;0 a five IlOnth old male, and Case Three
a twenty-two year old female nurse. The latter had a
pacanaker followin:J surgical ablation of the atrio-
ventricular (AV) node. All hearts were hypertrophied
and enlarged. In Case one, the beginning of the AV node
lay within the central fibrous body (CFB) and there was
a left-sided bundle of His. Acute necrosis was present
in the sunmit of the ventricular septum adjacent to the
AV node and bundle. In Case '1\;0, the COronary sinus
was displaced cranially close to the CFB, resultin:J in
abnonnality of the latter and entrapnent, distortion and
division of the AV node within the CFB. In Case Three,
there was a left AV node connected to the atrial septum,
and the right AV node fonned the peripheral CS. The
right AV node was eatpletely interrupted by sutures and
the penetratin:J and branching bundle was fibrosed.
In conclusion, (1) in all cases abnormalities in the
coronary sinus and/or the CFB and/or the AV node are
related to JT; (2) before ablative procedures are
undertaken, it might be useful to study clinically
the anatany of the atrial septum, and the coronary sinus.
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EFFECTS OF LOW ENERGY DIRECT CURRENT COUNTERSHOCK ON
ATRIOVENTRICULAR NODAL JUNCTION IN DOG USING
SUCTION-ABLATION CATHETER.
Igor Singer. M.D., Douglas Ackerman, M.D., Fred Collatz,
M.D., Claudio Maldonado, M.S., Christopher Zee-Cheng,
M.D., F.A.C.C., Joel Kupersmith, M.D., F.A.C.C.,
University of Louisville, Louisville, Kentucky.
The effects of low energy direct current (DC)
countershock on AV nodal conduction were studied using a
Cordis suction-ablation catheter in 6 dogs. DC shocks
in increments of 10 joules (J) were delivered until
either a partial or complete AV block occurred. A mean
of 36 ± 34 J was delivered. Complete AV block occurred
in 2/6 dogs. Partial AV block occurred in 4/6 dogs,
defined as > 50% increase in AH, or PR interval. The
dogs were sacrificed at 1 (n=2), 3, 8, 14 and 42 days.
The lesions were 3-22 (11 ± 6) mm in diameter and 1-4
(2.5 ± 1) mm in depth and involved the AV node, the His
bundle, and adjacent atrial tissue. Immediate changes
were focal coagulative necrosis and edema. At 3 days,
neutrophilic infiltrate, contraction bands and
interstitial edema were present. Chronic inflammatory
infiltrate was seen at 8 days. Granulation tissue was
seen at 2 weeks, progressing to scar at 6 weeks.
Conclusions: 1) With this catheter, partial or complete
AV nodal injury is possible using graded DC shocks. 2)
Pathologic changes are localized to the AV node and
adjacent tissue. 3) Suction-ablation catheter has a
potential clinical value for partial AV nodal ablation.
RADIOlREQUDf:Y OR DIRECT CURRENT fOR ABLATION Of
VEHTRICULAR TACHYCARDIA?
Klaus-Peter KJmZe It D. Karl-Heinz luck. It. D.. aoo
ltichael Schluter. Ph.D. University Hospital Eppeoo.orf.
Huburq, f.R.G.
Tre.navenous catheter ablation (TCA) using radiofrequency
current (RfC) was attellpted in 7 patients (pts) with
ventricular tachycardia (YT). 6 pts had coronary artery
disease (CAD). 1 had YT froa RV outflow tract. YT was
incessant (inc) in 4 pts am paroxysMl (pxl) in 3. In CAD
pts the site of TCA was deterained by deaonstration of an
isolated aid-diastolic potential preceding the onset of
the YT QRS coaplex by 80-140 as aM by pacing this site to
achieve a QRS coaplex identical to that during spontaneous
VT, but with a aarked delay between stiaulus am onset of
stiaulated QRS coaplex. 'lhese criteria were fulfilled in 3
pts at the proxiaal LV septua. in 2 pta at the posterobasal
and in 1 pt at the anterolateral LV. RfC (30-40 volts for
10-30 sees) was applied in 5 pts between the LV catheter am
a back paddle. In 2 pts with septal origin of VT, RfC 1l'Il.S
applied transseptally. In all 4 pts with inc VT. YT could
not be terainated and VT cycle lengthdid not change. In all
3 pts With pXl VT, VT was still imucible after RfC. After
unsuccessful RfC application all pts underwent direct
current (DC) TCA at the sue sites. 2-3 DC shocks of 100-300
joules caused teBination aM noniooucibllity of vr in all
pts. During follow-up (6t3 aonths) sustained aonoaorphic
VT did not recur. but 2 pts required antiarrhythaic therapy
because of sYJIPtoaatic ventricular preaature beats.
Conclusion: DC TCA at the site of slow cooouction
effectively terainated and suppressed vr. whereas RfC 1IIIl.S
ineffective at the sue catheter position.
SUCCESSFUL RADIOFREQUENCY CATHETER ABLATION OF RIGHT
ANTEROSEPTAL ACCESSORY ATRIOVENTRICULAR CONNECTIONS.
Gerald V. Naccarelli, M.D., F.A.C.C., Robert L.
Rinkenberger, M.D., Anne H. Dougherty, M.D., F.A.C.C.,
David M. Fitzgerald, M.D., Alex Zinner, Karl-Heinz Kuck,
M.D., Warren M. Jackman, M.D., F.A.C.C.
University of Texas Medical School at Houston, Houston,
Accessory atrioventricular connections (AAVCs) occur
least commonly (about 10%) in the right anteroseptal
(RAS) area. Surgical cure rates are not as high as free
wall locations and there is a high incidence of complete
AV block due to the AAVCs proximity to the AV node. We
successfully ablated RAS AAVCs in two patients using 625
KHz continuous wave radiofrequency current (RFC). A
custom device triggered the electrosurgical unit
synchronous with the QRS complex, controlled pulse
duration and measured RMS voltage, current, resistance,
power and energy. In both patients RFC was delivered,
without general anesthesia, between a 6F catheter and an
anterior indifferent chest patch electrode. Patient I,
a 15 year-old male, had drug refractory orthodromic SVT
and patient 2, a 31-year-old male, had symptomatic
paroxysmal atrial fibrillation with a rapid antidromic
response requiring DC cardioversion. In patient one, 15
seconds of RFC (14 W, 210) successfully ablated both
antegrade and retrograde AAVC conduction. In patient
two, eight seconds of RFC (14 W, 112 J) delivered over
an area where a Kent potential was recorded resulted in
transient loss of AAVC conduction. A second pulse of
RFC (12 W, 180 J) for 15 seconds permanently ablated
AAVC conduction. Neither patient had any alteration in
AV nodal or His-~rkinje conduction. Both patients have
been asymptomatic with no overt preexcitation noted u~
to one month after the procedure. We conclude that
unipolar catheter-delivered RFC can safely and
successfully ablate AAVCs in selected patients.
CATHETER MODIFICATION OF AV NODAL CONDUCTION
IN DRUG RESISTANT AV NODAL REENTRANT
TACHYCARDIA (AVNRT).
Nadir Saoudi M.D., Gilbert Kirkorian M.D., Georges Atallah
M.D., Jean C. Chevalier M.D., Paul Touboul M.D. HOpital
Cardiologique, Lyon, France.
Patients with drug resistant AVNRT are frequently referred
for His bundle ablation with subsequent pacemaker
implantation. Recent studies suggest the possibility of surgical
cure of this tachycardia with preservation of normal antegrade
conduction when selective destruction of atrial areas in the
vicinity of the AV node is performed. We therefore attempted
to "modify" AV nodal conduction by means of catheter ablation
shocks in 4 patients with long lasting (12. to 2.7 years) drug
resistant (4-7 antiarrhythmics drugs) AVNRT. During induced
AVRNT all patients underwent careful mapping of the perinodal
region by means of a standard bipolar catheter that was
pretested for fulguration. The latter was positioned close
to the His bundle recording catheter and then slightly
manipulated in order to map the AV nodal region. In all cases
the retrograde atrial activation was found to be synchronous
with (pt 1-3), or earlier than (pt 4) that recorded in the His
bundle lead, despite the lack of H wave recording. 1 to 13
cathodal shocks (mean energy 175 J) were delivered under
general anesthesia in 1 to 4 sessions and were followed by
a brief period of complete AV nodal block. 30 min after the
shock antegrade AV nodal His Purkinje system conduction
was normal in all cases, whereas retrograde conduction was
abolished (3 cases) or severely impaired (1 case). AVNRT
was no more inducible in 3/4 cases. At late control evaluation
(day 30) AVNRT remained inducible in 1/20 pt. During a mean
follow up of 5,5 months (1-10) AVNRT did not recur in 3/4
pts despite drug withdrawal.
In conclusion : catheter modification of AV nodal conduction
is a feasible procedure with preservation of normal antegrade
conduction. This procedure deserves further study.
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RELATIONSHIP BETWEEN STIMULATION THRESHOLD VARIABILITY OF
ISOLATED CARDIOMYOCYTES AND SEPARATED DEFIBRILLATION
SHOCKS DELIVERED IN ORTHOGONAL DIRECTIONS.
Alain Bardou PhD. Jean Degonde PhD. Michel Chesnais M.S.
INSERM U256. Hopital Broussais. Paris. France.
A marked improvement has recently been obtained in defi-
brillation by use of separated pulses delivered in ortho-
gonal directions. These results suggested the possible
dependence of cardiac fibres stimulation threshold on
their orientation with respect to the stimulus electric
axis. The aim of this work was to evidence such a varia-
bility on isolated rat ventricular myocytes. These isola-
ted myocytes were placed in a culture box were they appe-
ared spontaneously arranged along multiple directions. A
2ms. 1.5Hz stimulation was then delivered between two pa-
rallel electrodes. Stimulus intensity was progressively
increased from zero to a given value until obtention of
cells contraction. For a 2cm inter-electrodes distance.
contraction has always been obtained with a 8 to 10 volts
stimulus intensity for the'most longitudinally disposated
myocytes. A progressive recruitment was then observed by
increasing the stimulus intensity up to a 18 to 20 volts
value required to obtain the contraction of the most per-
pendicular myocytes. Conclusions: 1. These results show
that the dependence of stimulation threshold on longitu-
dinal or transversal application of atimulus appears to
be a fundamental property of ventricular fibres. This th-
reshold can vary in a ratio 1 to 2. 2. Considering that
fibres are distributed along different directions in the
heart. these results clearly show that after delivery of
2 orthogonal shocks. the cells undepolarized by the first
one are quite easily depolarized by the second one. In
these circumstances. cardiac fibres are totally depolari-
zed using the lowest energy required which leads to an
important decrease in energy required to defibrillste.
AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN
PATIENTS ON CHRONIC AMIODARONE: EFFECTS ON THE
DEFIBRILLATION THRESHOLD AND THE RATE OF SHOCKS.
S.K. Stephen Huang, M.D., F.A.C.C., Wilson Tan-DeGuzman,
M.D•• John Chenarides, M.D., Charles I. Haffajee, M.D.,
F.A.C.C., University of Massachusetts Medical Center,
Worcester, MA.
The role of chronic amiodarone (AM) in patients who
received AICD for ventricular fibrillation (VF) (n-22) or
sustained intractable tachycardia (VT) (n-16) was
evaluated in 38 patients. There were 31 males and 7
females with a mean age of 56 +12 years (range 21-74).
Twenty-eight patients had coronary artery disease. The
mean LV ejection fraction was 40 +13%. Twenty patients
had been taking AM prior to AICD Implant (mean 3.6 +1.5
months). These patients were unresponsive or intolerable
to a mean of 3.8 +1.6 antiarrhythmic agents before
receiving AM. The average dose of AM was 360 +24 mg/day
(200-400 mg). The defibrillation threshold at-AICD
implant in patients on AM was 13.5 +6.2 joules, which was
not significantly different from that (12.3 +4.4 joules)
in patients (n=18) who were not on AM. At mean follow-up
of 18 +14 months, 5 of 20 patients (25%) receiving
chronic AM had a total of 71 appropriate shocks in the
presence of symptoms or documented VT/VF. Subsequently,
2 of these 5 patients died suddenly presumably due to
generator failure (>28 months old). None of the 20
patients on AM have experienced major side effects. Of
18 patients not on AM, 4 (22%) had a total of 88
appropriate shocks. In conclusion, 1) chronic amiodarone
therapy does not appear to increase the defibrillation
threshold, and 2) a significant number of patients
receiving chronic amiodarone continue to suffer from
VT/VF requiring repeated shocks from the AICD.
NCt'l-INVASIVE ASSESSMENl' OF IMPROVEMENl' OF REXiIOOAL LEf'l'
VENl'RIaJLAR cx:NmACI'ILITY AFI'ER PERarrANEXXlS TRANSLUMINAL
<XRCWlRY ANGIOPIJ\STY BY QRST ISOAREA MAP IN PATIENrS WITH
ANGINA PEC'IUUS.
Yoshihiko sakai M.D., Makoto Hirai M.D., Hitoshi Ishihara
M.D., Yoshio Ichihara M.D., Shinya Takahama M.D.,
Kazumasa Korrlo M.D., Makoto Nagasal<a M.D., Jun Tsunekawa
M.D., Hiroshi Hayashi M.D., Nagoya University, Japan.
The purpose is to examine whether (JlST isoarea maps can
detect the improvement of the regional LV contractility
after percutaneous trans luminal coronary angioplasty
(PrCA). Left ventriculography (LVG) and ax mapping were
performed before and 6 months after PrCA in 16 angina
pectoris pts with a stenosis (>75%) of LAD. None had the
prior myocardial infarction. QRST isoareamap was
constructed fran data recorded with 87 body surface
unipolar electrodes at a sampling interval of 1 msec.
The improvement of the segmental LV contractility was
evaluated with the centerline rrethod by analyZing LVGs
before aOO after PTCA. In 7 pts (44%), LVG showed
asynergy before PrCA (Group A). LVG had no asynergy in
other 9 Pts (Group N). In 5 Pts (71%) of Group A,
asynergy disappeared after PrCA. In ORST isoarea maps of
all these 5 pts, after PrCA, the positive area recovered
over the upper left anterior chest where the negative
area was located before PrCA. However,~ isoarea maps
revealed no changes after PrCA in 10 pts out of 11 pts
whose LV contractility showed no changes after PrCA.
The recovery of the positive area over the upper left
anterior chest demonstrated the improvement of the
regional LV contractility after PrCA with a sensitivity
of 100% aOO a specificity of 91%. These findings
strongly suggested that QRST isoarea maps was useful to
detect the improvement of the local contractility of the
left ventricle after FOCA.
ABSENCE OF LATE POTENTIALS IN PATIENTS WITH REPETITIVE
MONOMORPHIC AND EXERCISE-FACILITATED VENTRICULAR
TACHYCARDIA AND NO APPARENT HEART DISEASE
Luis Constantin, M.D., Chien-Suu Kuo, M.D •• FACC, Lin-
Sheng tao, M.D .• UnIversity of Kentucky Medical Center,
Lexington. Kentucky.
Ventricular tachycardia occurring in the absence of heart
disease may be due to mechanisms other than reentry. If
so, late potentials should be absent from signal-averaged
ECG's performed in patients with ventricular tachycardia
and no heart disease. We examined signal-averaged ECG's
(bandpass 25-250 Hz. bidirectional filter, 300 beats,
noise ~1.0 ~v, sinus rhythm, QRS <0.10 sec, no
antiarrhythmics) from 6 patients,-ages 7 to 45 years,
with repetitive monomorphic (5) and/or exercise-
facilitated (4) ventricular tachycardia. and no
symptomatic (excluding palpitations). electro-
cardiographic. or echocardiographic evidence of heart
disease. Criteria for the presence of late potentials
were signal-averaged QRS duration ~120 rosec. root mean
square voltage of the terminal 40 msec ~25 ~v, or a
terminal low amplitUde signal «40 ~v) ~38 msec in
duration. Results: signal-averaged QRS duration, 82-110
msec; root mean square voltage, 32-148 ~v; duration of
low amplitude signal, 11-25 msec. Conclusion: Late
potentials were absent in this group of patIents with
repetitive monomorphic or exercise-facilitated
ventricular tachycardia and no apparent heart disease.
This ~inding is consistent with the hypothesis that such
ventrIcular tachycardia is due to a mechanism(s) other
than reentry.
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Effect of Thrombolysis on Late Potentials Incidence af-
ter Acute Myocardial Infarction.
Etienne Aliot MD, FACC, Fran90is Brunotte MD, Christian
de Chillou MD,Nicolas Sadoul MD, Jean Marie GILGENKRANTZ
MD. Department of Cardiology, Nancy, France.
In order to study the effects of thrombolysis on inci-
dence of late potentials (LPs) after acute myocardial in-
farction (AMI) the signal averaged ECG (SA ECG) was re-
corded in 202 consecutive patients (pts) during the
first six weeks after an AMI (mean 21 days). In 52 pts,
the AMI was treated by Streptokinase, the remaining 150
pts did not receive Streptokinase. The presence of LPs
was defined as root mean square voltage during the last
40 msec of the fil tered QRS (V40) l. 25 pV and fil tered
QRS >1 120 msec. LPs were recorded in 31 pts (15,3%); 22
of the 150 pts in the non thrombolysis group had LPs
(14.7%) and, 9 of the 52 pts in the thrombolysis group
had LPs (17.3%) (NS). The thrombolysis group was subse-
quently divided in 2 groups according to reperfusion
status : myocardial reperfusion (MR) with opened infarct
related artery (36 pts) 69.1%) and non MR with closed
infarct related artery (16 pts, 30.8%). LPs were recor-
ded in 5 of 36 pts in the MR group, (13.8%) and, in 4 of
16 pts in the non MR group (25%) (NS).
In contrast with previous works, our study suggests
that effective thrombolysis does not change significant-
ly the incidence of LPs in pts after AMI, but these re-
sults need to be further assessed by larger series.
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NEGATIVE INOTROPIC EFFECT OF NICARDIPINE IN PATIENTS VITH
BEART FAILURE: DEIlONSTRATION BY LEFT VENTRICULAR
END-SYSTOLIC PRESSURE-VOLUHE ANALYSIS
Constantine N. Aroney MBBS, Marc J. Semigran MD,
G. WIllIam Dec MD FACC, Charles A. Boucher MD FACC,
Michael A. Fifer MD FACC. Massachusetts General Hospital
and Harvard Medical School, Boston, MA.
Nicardipine, a dihydropyridine calcium antagonist, has
been shown to have minimal negative inotropic effect in
animal studies. To assess the inotropic effect of this
agent in humans independent of its vasodilator effect, we
administered equihypotensive doses of intravenous
nitroprusside (NTP) and nicardipine to 15 patients with
severe heart failure (NYHA class II-IV, LV ejection
fraction (EF) IS±2%). LV micromanometer pressure and
simultaneous LV volume (gated scan) were obtained at
baseline, during NTP infusion, during a second baseline,
and during nicardipine infusion. Heart rate (HR,
beats/mi2)' mean arterial pressure (HAP, mmHg) , CI
(L/min/m )~ systemic vascular resistance (SVR,
dynes-s/cm ) and EF (%) were:
HR HAP LVEDP CI SVR EF
Baseline 84t3 94t4!it! 1.utO.1 2l3ItISO 15±2
NTP 82±3 73±3' l4±2' 2.l±0.1' l486±130' l6±1
Baseline 80±3 9l±4 27±2 1.7±0.1 2l30±129 lS±l
Nicardipine 80±3 72±2' 23±3t* 2.4±0.1.* 1170±66.* 19±1,*
('p<O.OS vs baseline, *p<O.OS vs NTP)
Left ventricular pressure-volu~ loops were constructed in
14 patients. The LV end-systolic pressure-volume relation
was shifted rightward on nicardipine, indicating a
negative inotropic effect, in 12 of l4.patients.
Conclusions: (1) Nicardipine has a negative inotropic
effect in most patients with heart failure. (2) Despite
this effect, EF and eI increase on nicardipine because of
afterload reduction with minimal change in preload.
ORAL ISOSORBIDE DINITRATE IN CHRONIC HEART FAILURE:,
TOLERANCE DEVELOPMENT TO QID VS TID REGIMEN.
Uri Elkayam, M.D., F.A.C.C., Michael Jamison, M.D.,
Arie Roth, M.D., Daniel Kulick, M.D., Janet Vasquez,
R.N., Shahbudin H. Rahimtoola, M.D., F.A.C.C., LAC-USC
Medical Center, Los Angeles, CA.
Questions have been raised recently regarding the
optimal regimen of isosorbide dinitrate (ISDN) in pts
with heart failure (CHF). We therefore evaluated
continuoualy hemodynamic effect of the counnonly used
regimen of ISDN given every 6 hours (h) in 22 pts with
CHF. 11 pts received 5 consecutive doses of ISDN (qid)
and 11 pts received 4 doses at 0, 6, 12 and 24 hrs
(tid), allOWing a 12h nitrate-poor interval between the
3rd and last dose.
RESULTS: Effect on mean pulmonary artery wedge pressure
(PAW) waa markedly attenuated in magnitude and duration
in both groups already after 2nd dose. PAW in mmHg at
baseline (BL) and after 1st and last dose was (*p(O.OS
vs BLI):
1st Dose & 2 h 4 h 6 h
qid 28:!:8 19:!:7* 22:!:9* 22:!:7*
tid 24:!:6 IS:!:b* 17:!:S* 21:!:7
Last Dose ~ 2 h 4 h 6 h
qid 24:!:7 21:!:7* 2S:!:9 2S:!:7
tid 22:!:4 16:!:7* 16:!:~* 21:!:S
CONCLUSION: 1) Cotmnonly used regimen of ISDN given
every 6h results in early development of tolerance with
attenuation and shortening of effect on PAW; 2)
efficacy of ISDN can be fully restored by nitrate-poor
interval of 12h; 3) these findings suggest that ISoDN
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MEX:H1INIfHl OF IMPAIRED V1\SODIIATICft IN '!HE~
MICXJVASC1JIA'IUR OF PATIENlS wrm DIIATED CARDICMYOPMHY
Charles B. Treasyre MD, JOElE!Pl A. vita MD, R. ))wid Fish
MD, JciIn B. Golden MD, ))wid A. Q:lx MD, Gilbert H.~
MD FNX, Wllsal S. Colucci MD FNX, R. wayne Alexander
~ FNX, Arr::lreiI7 ·P. selwyn MD FNX, Peter Ganz MD FNX,
Brigham am WaDen's Hospital, Bostal, MA
Dilator reserve of the ooram:y microvasculature is
ilIpaired in myocardi.al hyperttqily. Dilated
cardi<:'lll}'qlathy (OC) is also asscx::iated with marked
ventricular growth. we tested the hypothesis that a)
dilator reserve is inpaired in OC am b) al:Dmnal.
erd:lthelial vasodilator furx:ticn could be a contril:lut:in;r
lIleCbanism. we.infUsed into the left anterior clesoenii.n;J
oorcrvu:y artezy (IAO) the erd:ltheliUIII deperdent
vasodilator acetyldloline (lIaf) (10-8 to lC1-6 M) am the
SIIXlOth llIlSCle vasodilator adenosine (AD) (10-6 to 10-4 M)
in 7 OC patients (mean EF 27%) am 5 ccntrols (C)
(atypical dIest pain). small vessel resistance was
assessed by measuri.JY;J IAO flcY (CBF) at CXI'IStant arterial
pressure with a OCg)ler velocity catheter (corrected for
cross-sec:ticnal area by an:Ji~). With lIaf, C
patients increased CBF 254 ± 37% while OC patients cnly
increased CBF 32 ± 26% (p<.01). With AD, C patients
increased CBF 405 ± 90% am OC patients 276 ± 50% (p=R;).
Microvascular vasodilaticn to AD in dilated
cardi<:'III}'qlthy patients was 68.1% (276/405) of the
vasodilaticn seen in ccntrols art: vasodilaticn to lIaf was
cnly 12.6% (32/254) of that seen in ccntrols. '11UIs,
small vessel dilaticn is ilIpaired in patients with
dilated cantianyqli!lthy, especially to an ermtheliUIII
cleperIQent vasodilator. Defective vasodilator fUlx:ti.cn of
the microvascular endoI:hel.iUIII~ to be ale of the
pathogenetic mec::hanisIls involved in this atnmDal.
oorcrvu:y flcY regulaticn faun in dilated cardianyt:pl.thy.
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ALTERATIONS IN THE CATALYST OF ADENYlATE CYClASE AND THE
INHIBITORY GUANINE NUCLEOTIDE REGULATORY PROTEIN IN
EXPERIMENTAL HEART FAILURE.
Martin J Frev M D , David Manning Ph.D., John R. Wilson
M.D., Perry B. Molinoff M.D., University of Pennsylvania,
Philadelphia, Pennsylvania.
Diminished contractile responses in heart failure (HF) to
beta stimulation may in part be due to abnormalities in
either the guanine nucleotide proteins (Gs and Gi) or the
catalyst of adenylate cyclase. We utilized a canine
model of HF produced by rapid ventricular pacing at 260
bpm for 4 weeks to characterize the adenylate cyclase/G
protein system. Adenylate cyclase activity was deter-
mined in membranes ffom the left ventricular free wall.
Basal, Gpp(NH)p (10- M) and forskolin-stimulated (30 ~M)
adenylate cyclase were reduced 24\, 56\, and 49\, respec-
tively (all p<0.05). The functional integrity of the
catalyst was determined by direct stimulation with puri-
fied GTP1S.Gs (0.1-0.8 ~g/ml); maximal stimulation by pu-
rified Gs was reduced in HF (C: 110±25; HF: 42±6
pmol/mg/min; p<O.Ol). Inactivation of Gi by pertussis
toxin resulted in normalization of basal (C: 6.3±0.8;
HF: 5.0±0.8 pmol/mg/min) and forskolin (C: 35.7±2.7;
HF: 27.0±2.8 pmol/mg/min) stimulated cyclase activity.
The level of oCi, aGo, and the p·subunit common to all G
proteins were assessed by enzyme· linked immunotransfer
blotting. By densitometric analysis, the level of aGi
was increased in HF 34±5\ compared to control tissue
(p<0.05), while there was no change in either aGo or the
p-subunit. In canine HF produced by rapid pacing: 1)
the catalytic component of adenylate cyclase is altered
and fails to respond to purified Gs and 2) the guanine
regulatory protein oCi is increased and inactivation of
Gi partially restores adenylate cyclase activity.
ENDOTHELIN CONSTRICTS THE SYSTEMIC AND CORONARY
CIRCULATIONS AND DEPRESSES VENTRICULAR FUNCTION IN VIVO.
Wayne L. Miller, M.D., Lawrence L. Aarhus, Denise M.
HeUblein, John C. Burnett, Jr., M.D., Mayo Clinic,
ROChester, Minnesota
Endothelin, an endothelium-derived peptide, demon-
strates calcium-dependent contractile properties in vitro
and may function in pathophysiologic states to elevate
systemic vascular resistance by antagonizing the vaso-
dilating and renin inhibitory actions of endothelin-
derived relaxing factor(s). The integrated in vivo
actions of endothelin on cardiac and systemic hemo-
dynamics and cardiorenal hormones, however, have not
been determined. This study was designed., therefore, to
test the hypothesis in anesthetized dogs that endothelin
increases mean systemic blood pressure (MAP) and resis-
tance (SVR), decreases cardiac output (CO) and coronary
blood flow (CBF) and elevates the cardiorenal hormones,
atrial natriuretic factor (ANF) and renin (PRA) in vivo.
Control Endothelin Washoutt
(50 ng/kglain,iv)
MAP, mmHg 98±7 123±7* 101 ±5
CO, Llmin 3.3±0.2 1.1±0.1* 2.3±O.2*
SVR, mmHg/ml/min 0.03±.002 0.13±.017* 0.04±.005*
caF, mllmin 60±15 41±13 55±15
CVR, mmHg/ml/min 2.16±0.05 6.48±3.76* 2.48±0.65
(L) AP, mmHg 2.5±0.4 9.1±3.4* 4.7±1.5*
ANF, pg/ml 39±6 180±53* 74±10*
PRA, ng/rol 3.7±1.0 6.9±1.7* 5.6±1.6
*p<.05; x±SEM; n-6 t1-hr post-infusion
We conclude that endothelin has potent systemic and
coronary vasoconstrictor activity associated with a
significant depression of cardiac inotropic function.
Further, despite increases in atrial natriuretic factor,
an inhibitor of renin, endothelin stimulates renin
release by the kidney.
VENTllIClll.A1l TACHYCAlUlIA IS NOT THE PUDOMINANT CAUSE OF
MONITORED SUDDEN DEATH IN HEAllT FAILURE. Michael Luu
1L..Il...., Willilll G. Stevenson M.D, F.A.C.C., Lynne Warner
Stevenson M.D.,F.A.C.C., Keesag Baron M.D., Julie Walden,
R.N. UCLA Medical Center, Los Angeles, CA
Sudden death in pts with heart failure is usually
attributed to a ventricular tachyarrhythmia (VT) but the
initial rhythm at cardiac arrest (CA) is rarely known.
Therefore 21 consecutive unexpected CA occurring in stable
pts hospitalized for cardiac transplant evaluation (mean
LVEF .20 ±.10) were reviewed. In only 8 patients (38%)
was the initial rhythm VT (7 pts) or VF (1 pt). In 13
(62%) pts the initial rhythm was bradycardia (BA) (11 pts)
or pulseless sinus rhythm (EKD) (2 pts). Pts with VT/VF
did not differ from pts with BA/EKD in mean LVEF, history
of nonsustained VT (3/8 vs 6/13), antiarrhythmic drug
therapy (6/8 vs 8/13), serUlll K', or success of
resuscitation (3/8 vs 5113). Non-ischemic cardiomyopathy
and hyponatremia were more common in pts with BA/EKD.
Coronary
Rb:t.thm .1L ~ ~ ~ Na'
VT/VF 8 8 1 0 l33±4 meqll
BA/EKD 13 5 2 1 l28±4 meq/l
p <0.005 <0.02
12 autopsies revealed recent infarction in 5 (1 from a
coronary artery embolus) and no acute structural cause of
CA in 7.
Conclusions: CA in heart failure frequently occurs with
bradyarrhythmias even in pts with a ventricular arrhythmia
history. This is likely to limit the efficacy of
antiarrhythmic drugs for prevention of sudden death in
heart failure.
RAPID-ONSET PULMONARY EDEMA IN PATIENTS WITH
LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: A SYNDROME
RELATED TO RIGHT VENTRICULAR FUNCTION
Dayid M Brill MD, Marvin A Konstam MD FACC, Paul G
Vivino MD, Susan Kelly RN, Noreen Dolan RN, Cindy Lane RN,
Jeanne Metherall CNMT, Deeb N Salem MD FACC. Tufts
University-New England Medical Center, Boston, MA
Patients with depressed LV ejection fraction (EF), may
manifest rapid-onset pulmonary edema (ROPE), regardless
of the presence of active ischemia. We studied determinants
of ROPE, postulating that a failed RV serves as a capacitor,
buffering pulmonary venous pressure and preventing ROPE.
We analyzed 48 variables in 105 consecutive pts with
congestive heart failure and LVEF < 0.40 (mean ± SE: 0.20 ±
0.01). ROPE «3 hr progression from asymptomatic to
pulmonary edema, without myocardial infarction) occurred
in 17 pts (16%). A similar proportion with (59%) and
without (57%) ROPE had coronary artery disease. Stepwise
logistic regression showed RVEF to be the strongest
independent correlate of ROPE, averaging 0.51 ±. 0.04 in pts
with ROPE [nonnal RVEF (a 0.45) in 65%] and 0.33 ± 0.02 in
those without ROPE ~ 0.45 in 23%) (p<O.OOOI). Pts with
ROPE also had higher serum Na (141 ±. 1 v. 137 ±. I meqlL;
p<O.OI). higher pulse pressures (54 ±. 4 v. 43 ±. 2 mmHg;
p<O.OS), and were older (64 ±. 1 v. 60 ±. 1 years; p<0.05).
Smoking was present in 67% of pts without ROPE but in all
pts with ROPE (p<O.02). Conclusions: In patients with low
LVEF. ROPE correlates with RVEF, serum Na, pulse pressure,
age, and smoking. We speculate that the failed RV prevents
ROPE by serving as a capacitor, buffering changes in
intravascular volume and in pulmonary venous pressure.
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GrQwing evidence suggests that the sympathetic nerVQUS
system can regulate the functiQn Qf the immune system. We
asked whether the chrQnically elevated sympathetic nerVQUS
activity in patients with cQngestive heart failure (CHF) is
associated with altered subsets of circulating mononuclear
leukocytes (MNL). We measured number and subset
distribution of MNL by flow cytometry using specific
monoclonal antibodies, and determined plasma levels of
epinephrine and nQrepinephrine by a radioenzymatic assay,
at rest in 35 patients with CHF (NYHA I-IV) and 31 age-
matched CQntrQls (C). CHF compared to C had lower
relative (18±1.4% vs 29±1.5~ of WBC, p<O.OOI) and absQlute
MNL numbers (1447±98/mm vs 1953±116/mm3, p<O.OI). The
numbers of suppressQr (CD8+) and natural killer (NK; Leu
7+, 7/2+, 11+, 19+) cells was reduced by 40-50% in CHF, but
the number of helper cells (CD4+) did not differ. Thus, the
helper/suppressor cell ratio (CD4+/CD8+) was increased in
CHF (2.3:1:0.2 vs 1.2±0.1, p<0.05). These alterations in
suppressor and NK cells were more pronQunced in NYHA
III-IV than I-II patients but were similar whether CHF was
of idiopathic or ischemic etiQlogy. Similarly, plasma levels
of epinephrine and norepinephrine were higher in NYHA
III-IV than I-II patients but did not differ between
etiologies. We conclude that alterations Qf both circulating
MNL and plasma catecholamines in CHF are a secondary
rather than a primary event. Since MNL have B-adreJ\ergic
receptors that can inhibit MNL function in vitro, we
hypothesize that the increased sympathetic activity may
both reduce MNL numbers and alter MNL function in CHF.
ALTERATIONS IN LYMPHOCYTE SUBSETS AND
CATECHOLAMINES IN CONGESTIVE H£ART FAILURE.
Kirk U KnQwltQn M.D , Ann ReardQn M.D., Martin C.
Michel M.D., Paul A. Insel M.D., Alan S. Maisel M.D.,
F.A.C.C. VAMC and University Qf CalifQrnia, San Diego, CA
EF>.5 O.9± 7 3± -174± 216± -16±
0.5 119 85 17 14*
EF<.3 1. 4± no± -116± 263± -20±
1. 21 155[ 108*[ 3Q[ 22*
COMPARISON OF ELECTROPHYSIOLOGIC RESPONSES TO ISO-
PROTERENOL IN THE FAILING AND NONFAILING HEART
Michael G. Kienzle M.D.• F.A.C.C., Ann Aschoff R.N.,
Sheldon L. Brownstein M.D., Rosanne Hopson R.N.,
Department of Medicine, University of Iowa and VA
Hospitals, Iowa City, Iowa
Inotropic and chronotropic responses to beta-adrenergic
stimulation are impaired in heart failure. We tested
the hypothesis that the right ventricular effective
refractory period (ERP) response to infused isopro-
terenol (ISO) would also be altered. We retrospectively
examined the sinus cycle length (SCL) and ERP (constant
pacing) before and during an infusion of ISO corrected
for body size (~gm/min body surface area) in II patients
(pts) with radionuclide LVEF<.30 and 27 pts with
LVEF>.50 studied electrophysiologically off antiarrhyth-
mic drugs for evaluation of known or suspected cardiac
arrhythmias. Pts on beta blockers or with sinus
dysfunction (abnormal sinus node studies) were excluded.
RESULTS
·p<.05 vs pre-ISO, [p<.05 vs LVEF>.50; data are mean±SD~
statistics are t-test. Group mean ages did not differ.
Conclusions: Ventricular effective refractory period
responses to beta-adrenergic stimulation are preserved
in the failing heart while chronotropic responses are
reduced. Thus, responses to beta-adrenergic influence
that likely modulate ventricular arrhythmias are
operative in heart failure,patients and may playa role
in their occurrence.
IMPAIRED MYOCARDIAL RESERVE AND CALCIUM INTOLERANCE
OCCURS PRIOR TO THE CONGESTIVE HEART FAILURE STAGE IN THE
CARDIOMYOPATHIC HAMSTER.
Osamu Han0L,M.D., Edward Kasper, M.D., Harlan F. Weisman,
M.D., Edwana G. Lakatta, M.D., Laboratory of Cardiovascu-
lar Science, Gerontology Research Center, NIA, NIH,
Balt imore, Maryl and.
While the cardiomyopathic hamster (CMH) , BIO 14.6 strain,
develops congestive heart failure with aging, the evolu-
tion of compromised myocardial reserve (MR) and' calcium
tolerance prior to overt failure remains to be undefined.
We compared MR in hearts (isovolumic via LV balloon, AV-
blocked, perfused with Hepes buffer at constant pressure
and st imul ated at 2 Hz at 37°C) isol ated from 35-60 day
CMH (n = 6) and from 6 age-
matched FIB strai n control s 160
(C). The maximum developed 3[
pressure (DP) ~~th increases in r 'Ie
perfusate rCa ] was approxi~ 120 ' 'J:
mately 150% greater in C T
(p<.OOI) than in CMH (Fig.). TL ~
Maximum DP occurr!l- in CMH CI ,'J:~~occurs at lower rCa ] than in:Z:: 80
C (Fig.). End diastolic pres- e
sure (EDP) was significantly e , CMH 20!
(p< .001) el evated ~v. CMH Q", I e
especially at high rCa ] 8_10 0 40~. 10 e
mM; however, coronary flow did _*;i( l5
not var~+ between groups nor C llJ
with rCa ]. Thus, a deficit '
in MR and calcium intolerance 0~2~4~""'6~8~10-::l
can be well demonstrated in CMH
before the d11 ated congest ive [Ca-t+J mM
heart failure stage.
PROGNOSIS OF CONGESTIVE HEART FAILURE (CHF) EVALUATED BY
1-123 11ETA-IODOBENZYLGUANIDINE (MIBG) MYOCARDIAL IMAGING
Pascal Herlet M.D., Hichel BQurguignon ~r.D., Heric Valette
!1.D., Denis AgQstini !I.D., Bri!litte JQuve, David Lellouche
M.D., Anne-Marie Duval H.D., Jean-Luc DubQis Rande M.D.,
Alain Castaigne M.D., Andre SyrQta M.D. ; S.H.F. JQliot,
CllA, Orsay, C.lr.U. Hondor, Creteil, France.
Previous studies have demonstrated the ability of cardiac
~lIBG scintir,raphy to assess the depletion of
norepinephrine stores of the failing myQcardium. The
orQznQsis value Qf MlnG imaging was prospectively
investigated in 40 patients (age 51+11) with CHF of
variQus etiolQgies treated only with digitalis, diuretics
and vasodilatQrs. InclusiQn criterias were : NYHA class
II-IV and radiQnuclide left ventricular ejection fraction
(LVEF) <40 %. ~IBG myocardial uptake was quantified as a
cardiac to mediastinum ratio (R) computed on anterior view
image recorded 4 hours after IV injectiQn of 1-123 MIBG. R
values (1.11+.16) were correlated with LVEF (r=.58,
p=.OOl) but -not related with NYHA class. Seventeen
patients poorly responded tQ medical therapy during a 1-16
months fQllow up period (6m+3) 7 died, 5 had heart
transplantation and 5 are waiting for transplantation.
These 17 patients showed a lower R value (1.04+.1, p<.03)
and LVEF (12+3 %, p<.OI) when compared to the patients who
presented a- sustained clinical imprQvement with medical
therapy (R=1.22+.15, LVEF=20+6 %). For the calculation of
positive (+) and negative -(-) predictive values (P),
threshold values R=I.11 and LVEF=14 %were choosen as
the median values of the overlap of the 2 groups :
P+(EF)=68 %, P-(EF)=81 %, P+(R)=68 %, P-(R)=81 %. When the
2 tests were combined, P+ and P- values were 84 %and 9S %
respectively. Therefore, in this sel~cted population, MIBG
scintigraphy prOVided additiQnrtal information for an
accurate assessment of the prognosis in CHF.
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ABNORMAL TRIIODOTBYllONINE IS THE STRONGEST SBORT-TElUI
PROG~STIC FACTOR IDENTIFIED IN ADVANCED HEART FAILURE.
IUchele Hamilton H D , Lynne W. Stevenson. M.D:.
F,A.S.C" Michael Luu, H.D., William G. Stevenson,
H,D., F.A.C,C., Julie Walden, R.N .. UCLA Hedical











To assess the prevalence and significance of altered
thyroid metabolism in advanced heart failure,
thyrOXine, triiodothyronine (T3), reverse T3 (rT3) , and
thyrotrophin (TSH) levels were obtained in 85 pts
hospitalized for heart transplant evaluation (7 pts on
Amiodarone and 4 with clinical hypothyroidism were
excluded). 43/85 pts (51%) had normal thyroid tests,
37/85 (44%) ~T3 and/or trT3. 4 tTSH, and 1 tT3. The
strongest univariate predictor of poor outcome (death
within six weeks (13pts) or
placement on urgent
transplant list (6pts» was
the T3/rT3 ratio (p <.0001).
T3/rT3 <4.0 was associated
with lower serum sodium (133
vs. 138, p<,Ol), ejection
fraction (16 vs. 19%, p<.Ol),
and CI (1.8 vs. 2,1 L/min.
p<.05). and higher RA (17. vs,
lOmm, p<.Ol), mean pulmonary
artery (39 vs. 33 mm, p<.05»
and wedge (29 vs. 23 Mm,
p<.Ol) pressures. However.
in multivariate analysis of these factors, T3/rT3 was
the only independent predictor of prognosis.
The ratio T3/rT3 is the strongest predictor yet




P (week 0) 11.1 (1.6) 30.9 (6.4) 1.30 (0.4)
P (week 8) 10.9 (1.4) 30.6 (6.9) 1.28 (0.4)
F (week 0) 10.9 (1.9) 31.4 (7.1) 1.44 (0.6)
F (week 8) 9.5 (2.2) • 26.2 (6.8) • 1.06 (0.4)·
EFFECTS OF FLOSEQUINAN ON METABOLIC AND VENTILATORY
PARAMETERS DURING SUBMAXlMAL EXERCISE IN CARDIAC FAILURE
Stuart Elborn M.B., Marshall Riley M.B.,
Frederick Stanford M.D., Paul Nicholls M.D.,
Royal Victoria Hospital, Belfast, Northern Ireland.
• P(0.05 vs placebo
F increased PV02 by 2.4 (1.5) ml/min/kg (P(O.Ol vs P),
and V02 at anaerobic threshold from 13.2 (2.8) to 15.8
(3.7) ml/min/kg (P(O.Ol). F therefore improves ventilatory
and metabolic responses during both submaximal and maxi-
mal exercise, and hence is likely to benefit patients with
CCF during everyday activity as well as at peak exercise.
Patients with chronic cardiac failure (CCF) demonstrate
abnormal metabolic and ventilatory responses to exercise.
We studied the effects of flosequinan (F), a vasodilator,
and placebo (P) in 20 patients with NYHA grade III - IV
CCF, aged 63 (7) years, mean (SO), and LVEF 26 (7)'.
All were symptomatically stable on 92 (19) mg furosemide/
day. After 3 preliminary cardiopulmonary exercise tests,
patients ~ere randomly allocated to F 100 mg daily or P,
double-blind, and the test repeated after 8 weeks. In
each subject the exercise stage approximating to 60. of
peak achieved oxygen consumption (PV02) was identified
before drug intervention (week 0), and the ventilatory
and metabolic responses observed during the last minute
of that stage compared at weeks 0 and 8:
Isoproterenol stimulated AC was reduced in the dogs with
HF from 144±15 pmol/mg/min to 86±8 pmol/mg/mln (p<O,05),
While the density of P-2 receptors was unchanged. P-2
specific stimulation of AC was also reduced in HF (C:
76±7; HF: 46±10 pmol/mg/min; p<O,05), These data sug-
gest that the canine model of HF produced by pacing re-
sults in selective down-regulation of the pol adrenergic
receptor and subsensitivity of AC to both pol and P-2
stimulation, Since these changes parallel those in human
HF, this model could potentially be used to study drug
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EFFEC"l'S OF EXERCISE-INDUCED IscmMIA IN PRESSURB-
VOLUME RELATIONS AND FILLING DYNAMICS IN 1lfE CONSCIOOS
OOG
Shunichi Miyazaki M.D" Brian D. Outh Ph.D., Rainer
Schulz M.S., Ciro Indolfi M.D., Erik Thaulow M.D.,
Toshiro Miura M.D., John Ross Jr M,D. ,F.A.C.C. Univ.
of California San Dieao, La Jolla, California
The effects of exercise(EX) induced ischearia on the
diastolic (D) properties of the left ventricle(LV) were
examined in 8 conscious dogs instrunented with a
micI'Olll8l'lOllleter and ~craDeters(LVpressure,P, LV
dimensions). After recording a steady state of EX.
ischemia(I) was created, durilli EX, by a pteuoatic
occltrler located on the left ciI'CUllflex coronary artery
so that %ischemic wall thickenini showed leas than 10%.
From EX to I, minimal DP('P[D) increased from 2.7+3.21
to 8.7±.4 . 4 1IIIiIg* (values are mean±,SD, * indicates-
p<0.05.), voltne at P!lIIl(VDD) from 72±.12 to 9O±.10..l*,
peak filling rate decreased fI'Olll 771±.223 to
625+228ml/sec* and ejection fraction froa 51+9 to
37±,~, Durinal EX induced I, disturbed ejection and
reduced relaxation increased VIA and ~, which
resulted in a right and upward shift of the diastolic
P-V relation (Fiaure). The vo11.llle increaent fI'Olll mitral
valve opening(MI durilli EX, M2 durinal I) up to the vn.
durinal I (point A2) was 23%
of that frail MI to Al ( the
voll.llll! at equivalent
pressure to P!lIIl of I during
EX)(MI to Al VB. M2 to A2,
*). Thus, markedly
disturbed filling dynamics
8CCOIIIp8llied the shift of the
early diastolic P-V relation












SELECTIVE pol ADRENERGIC RECEPTOR DOWN-REGULATION IN
EXPERIMENTAL CANINE HEART FAIUJRE.
Hartin J Frey H,D., Perry R, Holinoff H.D.,
John R, Wilson H.D,. University of Pennsylvania,
Philadelphia, Pennsylvania,
Prior animal models of heart failure (HF) do not result
in down-regulation of beta adrenergic receptors (PAR), as
has been reported for humans. In a canine model of HF
produced by rapid ventricular pacing at 260 bpm for 4
weeks, we measured the density of PAR, dihydropyridine
receptors (DH) , and adenylate cyclase activity (AC) in 6
dogs with HF and 7 control (C) animals. The density of
pAR determined by Scatchard analysis of ICYP binding was
reduced from 46±8 fmol/mg in C to 24 fmol/mg in HF
(p<O,05). whereas the density and Kd of DH receptors mea-
sured by 3HPN-200-ll0 was unchanged (C: 145±20 fmol/mg,
0.06 nK; HF: l45±40 fmol/mg. 0.08 nK), Competition
binding of ICYP with ICI 89,406 was fitted to a computer
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CATECHOLAMINE METABOLIC PATHWAYS AND EXERCISE TRAINING:
PLASMA AND URINE CATECHOLAMINES, METABOLIC ENZYMES, AND
CHROMOGRANIN A. Paul J. Rogers. M.D., G.·M. Tyee, Ph.D..
R. M. Weinshilboum, M.D., D. T. O'Connor, M.D., and
A. A. Bove, M.D., Ph.D., Mayo Clinic and Foundation,
Rochester, MN 55905.
The significant release of catecholamines during
exercise training may alter the basal release and metab-
olism of catecholamines. Ten well-trained male subjects
and nine minimally-trained male subjects (maximal oxygen
uptake 55.2 and 42.5, respectively) were examined at
rest, at submaximal and at maximal exercise to determine
plasma levels of norepinephrine, epinephrine, dopamine,
the sulfoconjugates of each, and chromogranin-A, a
marker of exocytotic catecholamine release. Activity of
catechol-O-methyltransferase (COMT) in red blood cells
and monoamine oxidase (MAO) and phenolsulfotransferase
(PST) in platelets was determined at rest and at maximal
exercise. Urine for catecholamines was collected for
24 hours during sedentary activity. There were
increased plasma levels of sulfoconjugated norepi-
nephrine and sulfoconjugated dopamine at rest and with
exercise in the well-trained subjects. Plasma levels of
chromogranin-A did not change with exercise or differ
between groups. There was no difference in activity of
COMT, MAO, or PST between groups with exercise. There
were increased urine concentrations of sulfoconjugated
epinephrine and dopamine products in the well-trained
group. Urine indices comparing activity of COMT, MAO,
and PST showed similar activity in both groups. These
results demonstrate that in well-trained individuals
there is greater inactivation of plasma catecholamines
by sulfoconjugation, with no difference in daily release
of catecholamines, in activity of catecholamine meta-
bolic enzymes, or in daily production of most
catecholamine metabolites.
DIAGNOSTIC STRATEGIES BASED ON CLINICAL AND EXERCISE
VARIABLES: LIBERATION FROM BAYES'S THEOREMA?
Jaap W Deckers M.D. , Benno J Rensing M.D., Jan GP
Tijssen Ph.D., Maarten L. Simoons M.D..Thoraxcenter,
Department of Cardiology, Erasmus University and
Academic Hospital Rotterdam "Dijkzigt", Rotterdam,
The Netherlands.
The relationship between the diagnostic properties of
clinical and exercise variables was studied with logis-
tic regression analysis. The study population comprised
295 consecutive symptomatic patients without a previous
myocardial infarction, who underwent exercise testing
and coronary angiography to establish the presence of
coronary artery disease. All had a normal ECG at rest.
Prevalence of coronary disease was 77% in males and 51%
in females. Clinical variables included sex, age, risk
profile and symptom classification. Exercise variables
comprised achieved workload, angina during exercise and
heart rate (HR) corrected ST segment amplitude changes.
Logistic regression analysis revealed the mutual depen-
dance of various clinical and exercise variables. The
final diagnostic model only included age, (severe) an-
gina, high cholesterol, cigarette smoking, HR adjusted
ST segment changes and angina during exercise in males.
Results obtained with this model proved to be superior
to those based on Bayesian analysis. Correct diagnostic
classification was substantially improved by exercise
testing in males but not in females. It is concluded
that logistic regression analysis is more suited to
establish a diagnostic function than the Bayesian ap-
proach.
COMPARISON OF EFFECTS OF PROLONGED EXERCISE ON THE RIGHT
AND LEFT VENTRICLES
Pamela S. oou1las, MD, FACC, Mary L. O'Toole, PhD, W.
Douglas B. Hi ler, MD, Robert Morrow, Keith Hackney,
Nathaniel Reichek, MD, FACC. Univ. of PA, Phila., PA,
Since exercise increases right ventricular (RV) work more
than left (LV), we compared the effects of prolonged exer-
cise on RV and LV in 41 athletes before, at the finish (13
min) and after recovery (25 hr) from the Hawaii Ironman
Triathlon (2.4 mi swim, 112 mi bike, 26.2 mi run). 20
echoes were digitized for LA, RA, LV and RV areas at end-
diastole and end-systole; emptying fractions and total
diastolic area (TAd=LA~LV~RA~RV) were calculated. Twenty-
one athletes had Doppler assessment of mitral and tricus-
pid regurgitation (MR, TR)and RV and LV inflow velocities
(E/A). Results were (*p<.05, **p<.Ol vs pre and recovery):
RAs LAs LVd LVs RVd RVs TAd M-E/A T-E/A
Pre 20 19 38 26 21 16 84 1.5 1.6
Finish 18** 17** 36** 25** 24** 18** 84 1.3* 1.2**
Recovery 20 20 38 26 22 17 83 1.8 1. 9
RAs, LAs and LVd all decreased while RVd increased at race
finish; the emptying fractions of all chambers were un-
changed. RV and LV filling patterns were similarly altered
at race finish, although the decrease in T-E/A was greater
than in M-E/A. Both the prevalences of MR (76 to O~) and
TR (86 to 52~) were decreased at finish (both p<.Ol), but
neither their presence nor severity correlated with cham-
ber sizes, emptying fractions or heart rate.
Thus, prolonged exercise redistributed intracardiac vo-
lume, while ventricular filling and valvular regurgitation
were substantially altered. The increase in RVd at race
finish cannot be attributed to increased preload alone
since RAs was decreased. Exercise may result in changes in
RV diastolic shape, compliance or function.
INSENSITIVITY OF THALLIUM 201 IMAGING AFTER ORAL
DIPYRIDAMOLE FOR DETECTION OF REVERSIBLE MYOCARDIAL
ISCfIEMIA
Sakina Khan, M.D., Jashvant Thakkar, M.D., David
Bushnell, M.D. and Henry S. Loeb, M.D., F.A.C.C., Hines
V.A. Hospital, Hines, Illinois.
Patients (pts) with known or suspected coronary disease
who may be at high risk during non-cardiac surgery may
be identified by stress testing. However, for pts un-
able to exercise sufficiently Thallium 201 imaging (TI)
following intravenous dipyridamole (D), and recently,
oral 0 has been used in place of exercise. Since demon-
stration of reversible myocardial ischemia (RMI) is
important in planning further workup and/or treatment
we investigated the sensitivity of TI following oral 0
for detection of RMI in 21 stable pts selected on the
basis of angiographically proven coronary disease (>
70% diameter narrowing of a major coronary artery) and
RMI (> 1 mm ST depression during standard treadmill
testing). Images (planar and SPECT) were obtained 45
minutes following oral D (300 mg suspension) at which
time serum 0 levels were 4.7+2.1 Ug/ml. Aminophylline
(125 mg IV) was given and delayed images were obtained
at 3 hours. RESULTS: Reversible defects by TI were
present in 11 of 21 pts (52%). Five pts (24%) had only
fixed defects and 5 pts (24%) had neither reversible
nor fixed defects. Mean serum 0 was {5.4+2.1 ug/ml in
11 pts with reversible defects vs 3.9+2.8-ug/ml in the
9 pts without (p - O.2-NS). CONCLUSION: Since almost
50% of pts with coronary disease and RMI by treadmill
did not have reversible defects on TI the use of TI
after oral 0 appears not to be a sati.sfactory substi-
tute for stress testing in detecti?g high risk pts
prior to non-cardiac surgery.
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INCREASED EXERCISE CAPACITY IN HEART FAILURE
PATIENTS FOLLOWING DIGOXIN ADMINISTRATION.
Michael Sullivan M.D., J. Edwin Atwood M.D., Joshua Feuer M.D..
Barbara Kellerman R.N., Jonathan Myers M.A., Susan Forbes R.N.,
Victor Froelicher M.D., F.A.C.C., Long Beach VA Medical Center,
Long Beach, California.
There Is controversy regarding whether digoxin should be included in
the treatment of patients with chronic congestive heart failure.
Prior studies have not consistently demonstrated improvements in
hemodynamics or exercise capacity in such patients due to digoxin. In
order to resolve this controversy, we investigated the effect of
digoxin on respiratory gas exchange variables in 11 patients with
congestive heart failure. Systolic dysfunction was documented by
clinical evaluation and noninvasive testing. They had a mean age of
59 <.±. 8 years) and a mean ejection fraction of 24% <.±. 9). They were
tested during chronic digoxin administration and then two weeks after
discontinuation. Symptoms and weight were stabilized while off
digoxin by diuretics.
Results: There was no significant increase in treadmill time or
workload. However, there were significant increases in maximal oxygen
uptake (mean of 2.6 mllkglmin; p < .01) and the gas exchange anaerobic
threshold (mean of 2.2 mllkglmin; p < .02) during chronic digoxin
administration. In addition, there was a significant decrease in
submaximal VDNT (mean of .03; p < .02).
Conclusions: There is an improvement in exercise performance in heart
failure patients during digoxin administration most likely due to
improved matching of ventilation and perfusion. Since there was no
significant change in treadmill time or workload achieved, these
findings also demonstrate the need for respiratory gas analysis to
measure changes in the cardiopulmonary response to exercise in
patients with chronic heart failure.
THE USE OF THE EXERCISE TEST TO PREDICT PROGNOSIS AFTER
CORONARY ARTERY BYPASS SURGERY.
Paul Dubach M.D., Victor Froelicher M.D. F.A.C.C., Jacob Klein M.D.,
Robert Detrano M.D., Long Beach VA Medical Center, Long Beach,
California.
Predicting prognosis of patients who become symptomatic after coronary
artery bypass surgery is an important issue since more than 200,000
patients undergo this surgical procedure annually in the USA.
Evaluation Is often difficult after coronary artery bypass surgery,
since symptoms are often atypical and resting ECGs are often abnormal.
The objective of this study was to predict the prognosis of patients
who became symptomatic after having undergone coronary artery bypass
surgery using clinical and exercise test responses. A retrospective
analysis was performed of all veterans referred for clinical
indications to a Veterans Administration Medical Center for a
treadmill test after having undergone coronary artery bypass surgery.
Out of 2044 patients who were exercise tested from April 1984 to Ma~
1987,296 had previously undergone coronary artery bypass surgery.
Clinical data considered included age, sex, medication and symptom
status, history of myocardial infarction and myocardial infarction
type, and the time from coronary artery bypass surgery. The following
exercise test responses were considered: MET level, maximal heart
rate, maximal systolic blood pressure, chest pain pattern, and ST
segment response. During a two year follow-up after exercise testing,
there were 15 deaths, 11 non fatal myocardial Infarctions, 6 repeat
coronary artery bypass surgeries, and 3 coronary artery dilations.
Though MET level and maximal heart rate were significantly related to
prognosis and no patient who exceeded 8 METs died, the predictive
power of these exercise test responses was low and ST segment
depression was not predictive at all.
Conclusions: The inability of the exercise ECG to predict cardiac
events In patients after coronary artery bypass surgery requires that
other methods of testing be utilized to identify those who need
invasive studies and intervention.
TRAINING LEVEL COMPARISON STUDY: FACTORS INFLUENCING
EXERCISE COMPLIANCE.
Julie Sulentic, M.A., Laura Dunnam, M.A., John Thiel,
M.Ed., Barbara Fletcher, M.N., Albert Oberman, M.D.,
F.A.C.C., Gerald Fletcher, M.D., F.A.C.C., Thomas
Sheffield, M.D., F.A.C.C., Jeannette Lee, Ph.D.
University of Alabama at Birmingham, Birmingham, Alabama.
Forty men with stable coronary heart disease were
randomly assigned to a low intensity (L) level (50% VOZ)
or to a high intensity (H) exercise level (85% VOZ)'
Characteristics at entry were assessed to determine
factors predictive of compliance to the exercise
routine. Each group exercised in an identical mode by
walking, walk-jogging, cycling, and calisthenics for 45
to 60 minutes, 3 times per week. Compliance was
defined as the percent of exercise sessions attended
during the initial six months of this two-year
rehabilitation study. Compliance for those randomized
to L levels (n • ZI) was 66.3% compared to 70.4% for
those at the H level (n • 19). Regardless of
randomization assignment compliance was greater for
those with some college education, 70.4% compared to
ZZ.5% for those without (p < .05). Smokers attended
less regularly, 35.6%, than the non-smokers, 70.4%.
Compliance related to time since the cardiac event
qualifying patients for the study; 70.4% « 6 mo.);
67.0% (7 to lZ mo.); and 6Z.9% (13 to 18 mo.).
Compliance varied by previous exercise habits - 70.4%
(some physical activity) compared to 41.7% (little or
none). We concluded that the intensity of the exercise
program had little effect on compliance, whereas
educational level significantly related to attendance at
sessions. Other important factors include smoking
habits, tim~ since qualifying cardiac event; and
previous exercise habits.
REDUCED EXERCISE CAPACITY OF CHRONIC OBSTRUCTIVE
PULMONARY DISEASE PATIENTS EXERCISING WITH
NOSECLIP/MOUTHPIECE: DECREASED RIGHT HEART PRELOAD?
Douglass A. Morrison, M.D., F.A.C.C., Michael Collins,
M.D., James R. Stovall, CNMT, Geoffrey Freifeld, M.D.
Denver Veterans Administration Medical Center and the
University of Colorado Health Sciences Center, Denver,
Colorado.
A noseclip and low resistance mouthpiece are used to
monitor exhaled gases. Because the otolaryngologic
literature suggests that 50% of airway resistance is in
the nose and mouth, we hypothesized that patients with
advanced chronic obstructive pulmonary disease (COPD)
might be artifactually limited by exercise testing with
exhaled gas measurement. Accordingly, 12 patients with
stable COPD performed 2 symptom-limited exercise tests
with simultaneous right heart hemodynamic measurements,
radionuclide ventriculography, and arterial and mixed
venous gas sampling. Exhaled gases were analyzed on the
noseclip/mouthpiece exercise.
Comparing noseclip to room air exercises, there were
significant reductions in exercise duration (397 + 270
sec vs 300 ~ 230 sec p < 0.01), exercise oxygen -
consumption (780 ~ 279 vs 638 ~ 200 ml p < 0.01), and
exercise cardiac output (8.4 + 2.7 vs 7.3 + 2.0 L/min p
< 0.05), an increase in right-ventricular ejection
fraction (RVEF) (.39 + .08 vs .43 + .08 P < 0.01) and no
change in exercise heart rate (106-+ 14 vs 106 + 14),
right heart pressures, or arterial and mixed venous
blood gases,
These data suggest that a noseclip/mouthpiece can
limit exercise tolerance in advanced COPD patients. The
cardiac output, heart rate, and RVEF data suggest that
this ventilatory maneuver is associated with decreased
right ventricular end-diastolic volume or decreased
right heart preload (venous return).
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DEVELOPMENT OF PHYSIOLOGIC EXERCISE
HEART RATE RESPONSES AFTER CAR D I A C
TRANSPLANTATION
Blair J. O'Neill, MD, peter W. pflugfelder, MD, Alan H. Menkis,
MD, F. Neil McKenzie, MD, William J. Kostuk, MD, FACC,
University Hospital, London, Ontario, Canada.
The chronotropic responses of the denervated heart during
and after exertion are blunted, but adaptations to exercise late
following transplantation have not been documented.
Therefore, the cardiovascular responses of 40 age-matched
normal volunteers (N) during treadmill (TM) exercise testing
(Bruce protOCOl) were compared to 49 cardiac transplant (Tx)
recipients studied serially at 3 mo and 1 yr and in a further 20
patients at 3 yr. Results:
Ex wr Rest 2 Min Peak Rae HR
'sees) HR Ex HR ExHR 4 njl
N 66S±126 74±11 107±1S 167±13 110±14
3m S87±170 101±12' 104±13 141±18' 142±16'
1y 621±189 103±11' 113±13 1SS±1S' 141±16'
3yr S96±182 92±12' 10S±1S 149±24' 114±14
means±SD; 'p<.01vs N; Ex durztreadmill exercise duration, HR=hearl rate,
Rec-recovery .
Although resting heart rates were similar, after 3 mo, Tx heart
rate rose more rapidly with the initiation of exercise and a
higher peak heart rate was acheived (p<.01). Deceleration of
heart rate post exercise was most pronounced 3 yr post
transplant. Thus, the heart rate responses during upright
exercif:e post cardiac Tx differ significantly from normal, but do
evolve toward normal with time. In the absence of cardiac
reinnervation, these data imply the development of an intrinsic
cardiac mechanism responding to the onset and termination of
exercise.
RISK ASSESSMENT AFTER MYOCARDIAL INFARCTION RULED OUT
Charles Dennis, M,D" FACC, Patricia Goins, R,N" Cheryl
Leong, B,S" Haim Hammerman, M.D. Stanford University,
Stanford, California
The purpose of this study was to evaluate a management
strategy after myocardial infarction was ruled out in
patients hospitalized with chest pain, Sixty men, mean
age 60 + 10 years, underwent symptom-limited treadmill
testing-(ETT) soon after chest pain was stabilized on
medical therapy and myocardial infarction was ruled out,
Patients with a normal ETT (peak workload > 7 METS) were
managed medically. Patients with an abnor;al ETT (> 2 mm
ST depression, workload < 7 METS) were referred for-
coronary angiography. Patients with an equivocal ETT « 2
mm ST depression, workload < 7 METS) underwent rest and
exercise radionuclide ventriculography (RVG). RVG was
classified as abnormal if ejection fraction fell and nor-
mal if it rose. Patients were followed for cardiac events
(death, non-fatal myocardial infarction, coronary sur-
gery) for a mean of 181 + 137 days.
ETT Results Normal Equivocal Equivocal Abnormal
RVG Resul ts Normal Abnormal
EVENT 0 3 5
NO EVENT 16 22 8 5
Only 1 of 39 patients with a negative non-invasive
evaluation had a cardiac event (sudden death at 106 days).
Of the 21 patients with a positive non-invasive evaluation
8 underwent coronary surgery (p < 0,01) because of severe
coronary disease on angiography.
CONCLUSION: A management strategy using ETT and RVG
accurately separates patients at high risk for severe
coronary disease requiring coronary surgery from patJents
with an extremely low risk of cardiac events while
treated medically after myocardial infarction ruled out.
A NEW QUANTITATIVE METHOD OF SINOATRIAL NODAL CELLS
IN SICK SINUS SYNDROME,
Yuji Ito, M.D., Shin-ichiro Ohkawa, M.D" Chizuko
Watanabe, M.D., Masaya Sugiura, M,D" Tokyo
Metropolitan Institute of Gerontology, Tokyo, Japan.
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Electrophysiology, Drugs and Arrhythmias
We have reported that pathological process either in
sinoatrial node (SAN) or perinodal regions is pre-
dominantly responsible for sick sinus syndrome(SSS). To
quantify the degree of cellular degeneration in SAN, we
compared the percentage of sinoatrial nodal cells(%SAN)
and sinoatrial nodal size(S-SAN) in histopathological
sections stained with xylidine ponceau and light green,
from 23 cases with SSS(age 69-94 yr;8 males, 15 females)
and from 23 cases with normal sinus rhythm(age; 16-100
yrs,10 males,13 females), using computer-assisted color
image analyzer at 672x magnification. %SAN was defined
as mean value of different three points determined by
dividing the area of nodal cells by the area of nodal
cells plus fibrosis. S-SAN was measured by tracing the
outlines of SAN on digitizer, Results were as follow.
Control(n-23) SSS(n-23) P Value
EFFECT OF COLD UPON ISCHEKIC THRESHOLD IN PATIENTS WITH
STABLE ANGINA: MAGNITUDE AND KECHAHISK.
Kartin Juneau, K.D., Kichael Johnstone, K.D.,_ Lucie
Larivee, R.N., Kyriam Brien, R.N., Jean Perrault,
K.Sc., David Waters, K.D., F.A.C.C., Kontreal Heart
Institute, Kontreal, Canada.
To investigate the influence of cold upon ishemic
threshold, we performed treadmill exercise tests off
antianginal medication at -8·C and 20·C in 24 pts. All
had stable angina and exercise-induced ST depression
(J.ST). Standardized light clothing was worn in a cold
chamber for the tests at -8·C. An angina questionnaire
completed before study entry identified a subgroup of 8
pts with worse angina in cold weather. Their clinical
features did not differ from the other pts.
All pts Cold SUbgroup
_8· 20· _8· 20·
Exercise duration (sees) 396 381 420 413
Time to angina (sees) 306 313 292 346
Time to 1 nun J.ST 222 252 169* 244
RPP at 1 nun J.ST (xIO-3) 22.0 23.0 19.8t 22.0
Kaximum J.ST (nun) 2.1 2.1 2.9 2.7
RPP=rate-pressure product; *=p<0.01; t=p<0.05 vs 20·.
For the entire group, none of the exercise parameters
differed significantly between cold and normal tempera-
tures. However, cold-sensitive pts developed J.ST
75±40 sees (3~) sooner at _8· compared to 20·C. At the
onset of ischemia, RPP was significantly lower in the
cold.
Thus, as assessed by exercise testing, cold does not
worsen ischemic threshold in most stable angina pts.
However, in a subset identifiable by history, ischemic
threshold is lower in the cold. This difference appears













A linear correlation was found between age and %SAN(r-
-O.64,P<0,01) but not between age and S-SAN.
Con~lusions:1)It was the %SAN, not the S-SAN, which was
statistically related to age. 2)%$AN was significantly
lower in SSS, compared with that of control cases.
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SIMULTANEOUS DElIONSTllATION or EAIlLY- AND DELAYED
AFTUD!POLARIZATIONS IN CAZ+ LOADED CARDIAC CELLS
Bela Szabo H.D .. Ph.D., Stefano Harchi, H.D., Benjamin J.
Scherlag, Ph.D., F.A.C.C., Ralph Lazzara, H.D., F.A.C.C.,
University of Oklahoma Health Sciences Center and Veterans
Administration Kedical Center, Oklahoma City, OK
Early afterdepolarizations (EAD) have been induced by
various interventions in cardiac Purkinje fibers, but not
in myocardial cells. .In our studies increased [CaZ+] i
enhanced Cs+·induced EAD in Purkinje fibers. We examined
the effects of high [CaZ+) i in 31 disaggregated canine
subepicardial ventricular myocytes pretreated in low [Na+'
(115 mH + 60 mH sucrose) solutions with 5 mH [CaZ+) for 15
minutes. Eight cells exhibited both EAD and delayed after
depolarizations (DAD) upon the readJDinistration of 145 mH
[Na'] and 1. 8 mH [CaZ+]. EAD manifested only at slow pacing
rates «0.5 Hz). DAD also were observed at slow rates, but
their amplitudes increased with increasing rate. Both EAD
and DAD induced triggered action potentials. Seven cells
which did not produce EAD following low [Na+)o and high
[CaZ+)o pretreatment developed EAD immediately in [Cs+)o 3-
7 mHo Both EAD and DAD were inhibited by acetylcholine or
carbachol (1 uK) but only DAD were enhanced by 10-100 uK
epinephrine. EAD but not DAD were immediately and
reversibly inhibited by sudden increases in [CaZ+]. (by 1-
3 mK) or decreases in [Na+]9 (by 30 mH). We conclude that:
1) EAD can be induced in cells of working myocardium loaded
with CaZ+ and are enhanced by Cs'; 2) Both EAD and DAD can
be induced with Caz+ loading but they respond differently to
changes in rate, [Na+] , or [CaZ+]o suggesting that Caz+
loading can generate di~ferent arrhythJDogenic mechanisms.
KECIIAJIISH AHD SIGIIIFICAHCE or CYCLE LENGTH ALURNAHS
DURING SUPRAVENTRICULAR TACHYCARDIA.
Hario Talaiic. H.D., Demetrios Papadatos, Christine
villemaira, B.Sc., Stanley Nattel, H.D., F.A.C.C.,
Hontreal Heart Institute, Hontreal, Canada.
Cycle length altemans (CLA) ill c01llllOnly observed du-
ring onset and termination of supraventricular tachy-
cardia (SVT). Although IlUltiple mechanislllll have been
proposed to explain its occurrence, experimental con-
firmation has been lacking. To test the hypothesia that
CLA is due to feedback between tachycardia cycle length
and intrinsic AV node recovery properties during AV re-
entrant tachycardia. (AVRT) , we developed computer si-
IlUlations to predict sequential AM and RR intervals af-
ter onset of orthodromic AVRT baaed on recovery curves
(AM vs 1.142) meaaured in 5 autonomically blocked 'dogs.
Simulated AVRT (sAVRT) was compared to experimantal
AVRT (eAVRT) created by a sensing and pacing circuit
mimicking a retrograde accessory pathway with a pro-
grBllll\lble VA conduction time. Results: No evidence of
dual pathways was found. Steady stata rate of sAVRT
correlated closely with that of eAVRT (r-o.99,
p<O.OOOI). CLA appeared consistently at the onset of
both sAVRT and eAVRt et shorter VAs. Duration of CLA
was always less than 10 beats and was inversely ralated
to VA. Peak CIA amplitude was exponentially related to
VA ·under both sillUlated and experiJDental conditions,
with si.ilar exponential coefficients for each. Abrupt
accelerations in atrial pacing leading to siailar rate.
as AVRT did not result in CLA. Wa conclUde: 1) CLA is
an expected phenomenon based on normal AV nodal eon-
duction properties, and does not require chanses in au-
tonomic tone or dual AV pathwaya. 2) CLA occurranee,
amplitude, and duration depend on VA during AVRT.
3) Presence of CLA suggests that the AV node is an
integral part of an SVT reentrant circuit.
FREQUENCY RESPONSE OF ACTION POTENTIALS FROK HUKAN
MYOCARDIUM.
Hara T Slawsky H D Ph D. G. Haurice Briggs, Ph.D.,
James P. Horgan, H.D., Ph.D., F.A.C.C., Judith K.
GwathJDey, V.H.D., Ph.D.; Harvard-Thorndike Laboratory,
the Beth Israel Hospital, Boston, Hass.
SURFACE ECG AND INTRACARDIAC FINDINGS WITH THE ONSET OF
ENTRAINMENT IN A PACING MODEL OF PSEUDOREENTRY VENTRICULAR
TACHYCARDIA.
Mark Kremers. M,p,. F.A.C,C., Peter Wells, M.D., William
Black, M.D., Robin Eckels, Anne Taylor, M.D., F.A.C.C., U
T Southwestern Medical Center, Dallas, TX.
Ventricular (V) pacing (P) in the VAT mode with both
"atrial" sensing (AS) and VP electrodes on the V was used
to create a pseudoreentrant V tachycardia (T) circuit in 5
dogs with cycle lengths (Cl) of 290-400 msec (mean
347±33). Entrainment from 1-4 other V sites at 2-4 PCl
20-90 msec 1ess than VT Cl was performed to investigate
the effects of PCl, conduction time (CT) to the circuit,
and the relationship of entraining site to circuit
entrance and exi t poi nts on the surface ECG and
intracardiac findings of entrainment. CT to circuit was
estimated from CT to AS and VP sites measured during P at
comparable Cl during sinus rhythm. Entrainment sites were
distal (D) if CT VP less than CT AS, proximal (PR) if CT
AS less than CT VP and within (W) if between AS and VP.
In 106 entrainments (450, 57PR, 4W), we found: 1) the
number of cycles to achieve, an stable QRS and intracardiac
circuit entrainment was directly related to PCl and CT to
circuit. 2) A stable QRS and intracardiac circuit
entrainment occurred on the same cycle in only 42/106
(40%). 3) At 0 sites, stable QRS proceeded or occurred on
the same cycle as intracardiac entrainment in 38/45 (84%)
but at PR and W sites stable QRS occurred after
intracardhc entrainment in 46/61 (75%) (p<0.05). 4) AS
site was always entrained before or on same cycle as VI>
site regardless of entrainment site. Conclusions: 1)
stable QRS is a poor marker of reentrant circuit
entrainment; 2) onset of entrainment may provide insight








Previous experiments have suggested that a calcium
overload state exists in myopathic human myocardium. We
tested the hypothesis that calcium overload would affect
electrophysiological parameters and associated isometric
muscle tension in human heart muscle. Action potentials
(AP) were studied in ventricular trabeculae from control
and myopachic human hearts. Resting potential (RP) and
time to 50' ang 80' repolarization (APD50,. APD80,) wererecorded at 30 C. Huscles from control hearts displayed
a decrease in APD as stimulus frequency was increased
from 0.1 Hz to 1 Hz. This was associated with a decrease
in isometric twitch duration. However, there was an
increase in peak tension (PT) (positive treppe effect).
Hyopathic heart muscles displayed a greater reduction in
APD when the stimulus frequency was increased to 1 Hz.
This was . associated with a decrease in PT (negative
treppe effect). These results ere consistent with the
hypothesis that an intracellular calcium overload state
exists in myopathic tissue. Intracellular calcium over·
load could cause a greater reduction in ~+duration a~
higher stimulus frequency by increasing Ca ·JDIdiated K
efflux and/or by reducing driving force for I i' ~.
J12D: These findings may explain in part why !achycardia
is poorly tolerated in patients with cardiomyopathy.
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IS THE PROARRIIYTBHIC EFFECT OF QUINIDINE A CHAOTIC
PHENOMENON? Alan Garfinkel, Ph.D, Hrayr S. Xaragueuzian,
Ph.D, FACC, Steven Khan, K.D., George A. Diamond, M.D.,
FACC. Cedars-Sinai Medical Center, Los Angeles, CA
We used dynamic markers based on recent mathematical
developments in chaos theory to predict the onset of
ventricular fibrillation (VF) during progessive
quinidine intoxication. Three closed-chest anesthetized
dogs were infused with quinidine (up to 10Omg/kg over S
hours). RV endocardial bipolar electrogram. were
recorded and analyzed by frequency spectra, phase plane
plots, Poincare section return maps and Lyapunov
exponents. In the control state and at therapeutic doses
the phase plane plots were unifo~y thick and showed no
gaps, indicating that cycle-to-cycle variation was due
to normal biological ·noise·. But as the quinidine dose
was increased to intermediate levels (40-S0 mg/kg) ,
phase plane plata showed clear non-uniform thickening,
(indicating sensitive dependence on initial conditions),
and also showed marked banding (densely filled regions
separated by divisions or gaps). Both these phenomena
are strong indicators of deterministic chaos as opposed
to random noise. At these intermediate doses, Lyapunov
exponents became positive and poincare return maps also
indicated non-random chaos. At still higher dales, phase
plane plots became more complex. In the two dogs that
did exhibit VP (and not in the other) there was a
significant change in the phase plane plot at the last
pre-fibrillatory dose: the development of a 'funnel', a
classic mechanism of chaos. The frequency spectra at all
pre-fibrillatory doses were discrete, with peaks at a
fundamental frequency and multiple harmonics. We
conclude that chaos does in fact occur during progessive
quinidine intoxication, and that phase plane plots are
better indicators of chaos than frequency spectra.
FECAL ELIMINATION OF AMIODARONE AND DESETHYL AMIODARONE
Suriya Sastri, MD, David Bull, MD, Nelson Mostow, MD.
University of Missouri, Columbia. MO & Cleve Metro Gen
Hosp. Cleveland, OH.
The importance of the fecal excretory pathway in
amiodarone (AMD) metabolism is not well defined. 24 hr
fecal excretion of AMD and desethyl AMD (dAMn) was
measured by HPLC in 7 pts receiving chronic AMD therapy
with mean cumulative dose (CD 370 gms) and in 6 pts who
discontinued AMD therapy (CD 244 gms). 7 pts on AMD had
mean 24 hr fecal excretion of AMD(12.5 mg) and dAMn
(33.1 mg) compared to AMD(2.1 mg) and dAMn(48.4 mg) in 6
pts within 2 months of AMD withdrawal. 3 further pts had
24 hr fecal drug levels performed at 14,21 and 28 days
after AMD withdrawal. While AMD levels were all <1 mg/24
hr, dAMn 24 hr excretion values were 19.5, 13.9 and 16.2
mg respectively for the 3 study days. Daily fecal excre-
tion of AMD and dAMn in pts on AMD remained constant at
approximately S' of the ingested drug during chronic AMD
therapy. Interpatient variability was more marked in pts
withdrawn from AMD than in pts on AMD. CONCLUSIONS: 1)
In pts on chronic AMD therapy, about S' of the ingested
drug is excreted daily in feces. 2) Fecal excretion of
the metabolite dAMn was higher than that of AMD both in
pts on and off AMD. 3) 1 month after withdrawal, major
fecal excretion of the 'metabolite dAMn continued, with
minimal excretion of AMD. 4) There was no correlation
between cumulative dose and fecal excretion. SPECULA-
TIONS: The biliary pathway is the maj or route of AMD
excretion. Therefore, the relatively low fecal excretion
of ingested AMD(5') suggests a much higher rate of ab-
sorption of AMD than previously reported and a major
enterohepatic circulation of AMD. Thus, resin binding
drugs such as cholestyramine may have a role in treating
AHD side effects by enhancing fecal elimination of AHD.
ABLATION OF CANINE VENTRICULAR MYOCARDIUM WITH A CRYQ.
GENIC CATHETER: A NEW CLOSED-CHEST ABLATIVE TECHNIQUE ?
Thomas Lavergne M.D., Jacques Verdier Ph.D., Patrick
Bruneval M.D., Louis Guize M.D., Dominique Von Euw,
JeanYves Le Heuzey M.D., Thierry Beard M.D., Pierre
Peronneau Ph.D. INSERM U 256/28 & CEA/CENG Paris, France.
Cryothermal techniques can be used to cure refractory ar-
rhythmias, but the currently available cryoprobes imply
a surgical approach. In order to achieve closed-chest
cryoablation of myocardial tissue we have developed a
cryogenic catheter (CC), with a 2.6 mm diameter tip elec·
trode (E) cooled by expanding nitrous oxide. In a saline
bath at 37°C, the E temperature was reduced to -30°C. The
efficacy of the CC was assessed in 9 dogs. In each dog,
4 consecutive 60 sec duration cooling sequences (CS) were
delivered to a single site of the right ventricle. Aortic
pressure and ECG were monitored. An electrophysiologic
study was performed before and after ablation.
Twenty-four hour Holter recordings (H) were obtained in
all doga immediatly after ablation (HI), and in S dogs
one day before the sacrifice (H2), 2 to 5 weeks later.
The ablated site pacing threshold significantly increased
after cooling 0.9 ±1.3 vs 1.1 ±O.4 mA, p<O.OOl). No
hemodynamic impairment was noted. Spontaneously termina-
ting ventricular tachycardias (VT) occurred shortly after
CS in 3 dogs. Non-sustained VT were present on 8/9 HI but
none on H2. One dog died suddenly at day 4. Anatomic
study identified endomyocardial lesions in 7/9 dogs, (4
transmural). The histologic lesions consisted in well
circumscribed areas of fibrotic tissue with a depth of
2.9 ±1.0 mm and a diameter of 4.0 ±O.9 Mm. In conclusion:
transcatheter cryoablation of ventricular myocardium can
induce well delineated injury. This technique has poten-
tial for being a new closed-chest ablative method.
Nevertheless further experimental data are required in
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Basic Regulatory Mechanisms in the Coronary
Circulation
IS ATRIAL NATRIURETIC FACTOR INVOLVED IN THE
MODULATION OF CORONARY TONE IN MAN ?
Helmut Drexler M.D., And~eas M. Zeiher M.D., Helmut
Wollschlager M.D., Thomas Munzel M.D., Jurgen Holtz
M.D., Thomas Meinertz M.D., Hanjor9 Just M.D., Medizi-
niscne K~.nik Ill, University of Freiburg, F.R.G.
To test, whether atrial natriuretic factor (ANF) may be
involved in the modulation of coronary vasomotor tone,
we injected 1-28 ANF into the left coronary artery in 17
patients wi th an9io9raphically normal coronary arteries.
Measurement of epicardial diameters of the A.circumflexa
(Cx) and left anterior descending (LAD) were made from
biplane an9iography by an automatic contour detection
system. Bolus injection of ANF (0.07 ~g/k9, diluted in
1 ml O.~ NaCl, n=7) increased dIameter of proximal se9-
ments of LAD (11±4r.) and Cx (10±4r.) (p(0.02 each versus
control) without alterin9 heart rate and mean arterial
pressure (MAP). Intracoronary nitro91ycerin (NTG, 0.3m9)
increased identical LAD and Cx segments by 18±3r. and
20±4r. while MAP declined. Intracoronary ANF infusion
(0.02 ~glkglmin over 5 min followed by 0.1 ~glkg/min,
n=10) exerted dose-dependent increases in diameters of
LAD and Cx (low dose: +5:2r., hi9h dose: +13±~4 versus
control, p(0.02 each versus control). ANF-infusion
increased arterial plasma ANF_levels from 280:80 pglml
during control to 894±B2 pglml (low dose) and to
2290:228 pglml (hi9h dose). Severe ischemia in patients
undergoing angioplasty exerted a 4-5 fold increase ion
arterial ANF levels, similar to the increase elicited by
low-dose infusion of ANF, Thus, ANF caused dose-dependent
coronary vasodilatation in man. Althou9h intracoronary
ANF levels during infusion were estim~ted to exceed by
far peripheral ANF levels, ventricular release of ANF
(e.g during severe ischemia) may lead to comparable co-
ronary ANF-levels thereby contributin9 to the modulation
of coronary vasomotor tone.
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OXYGEN CONSUMPTION DURING EXERCISE IN THE PRESSURE-
OVERLOADED HYPERTROPHIED HEART.
Xue-Zheng Dai. M.D., Eugene Sublett, B.A., Paul
Lindstrom, Robert J. Bache, M.D., F.A.C.C. University
of Mi nnesota, Mi nneapol is, Mi nnesota.
EFFECTS OF SHORT- AND LONG-TERM HYPERTENSIVE CARDIAC
HYPERTROPHY ON THE STRUCTURAL PROPERTIES OF THE
CORONARY RESISTANCE VESSELS.
John Vittu10 Ph D., Bernadine Healy M.D., F.A.C.C.,
Mark Penn, Pierre Wicker M.D., The Research Institute,
The Cleveland Clinic Foundation, Cleveland, Ohio.
Depression of coronary reserve in hypertensive cardiac
hypertrophy is in part due to structural alterations of
coronary arteries. But, it has been suggested that
long term hypertrophy is associated with arterial
vascular expansion and an improvement in coronary
reserve. There are no studies however that have
systematically examined the arterial vasculature both
in short- and long-term hypertensive cardiac
hypertrophy in the same model. We therefore determined
the structural characteristics of the coronary
arteriolar bed relevant to flow resistance: arteriolar
density (AD) and wall thickness to lumen ratio (WLR) in
a total of 43 hypertensive (SHR) and normotensive (WKY)
rats of 1. 5', 4, 11, 16 and 22 months of age. Using
standard histometric techniques, a total of 8521
arterioles (WKY: n-4914; SHR: n-3607) were sampled from
the LV and read blindly. The WLR was not significantly
affected by the strain or duration of hypertrophy (WKY:
.14 to .19, SHR: .12 to .17 pip, p-ns) , but AD was
significantly lower by 6' to 27' in SHR at all ages
(4.41 to 5.9 in WKY, 3.3 to 5.1 art/mm2 in SHR, p<.05 by
2 WAY-ANOVA).
The data show that arteriolar growth lags behind
cardiac growth during all phases of development of
hypertensive cardiac hypertrophy. Since no significant
arteriolar growth occurs during long-term hypertrophy
in SHR, these abnormalities may contribute to the
decrement in coronary reserve observed in this model of
genetic hypertension.
REDUCED MYOCARDIAL BLOOD R.OW WITH PERSISTENT
VASODILATOR RESERVE: ROLE OF ADRENERGIC
ACTIVAnON Barry Sharar. M D , Frank A. Fedele, M.D., Albert
S. Most, M.D., FACC, Henry Gewirtz, M.D., RI Hospital,
Providence, RI
This study tested the hypothesis that alpha adrenergic tone
contributes to reduced myocardial blood flow in the face of persistent
vasodilator reserve. Seven closed chest, domestic swine were
instrumented with an artifical coronary arterial stenosis (CAS) which
reduced luminal diameter 80%. Measurements of hemodynamics and
regional myocardial blood flow were made at; I) Control (C); 2) S min
after completion of regional alpha receptor blockade with
phenoxybenzamine (PBX) (0.2S mglKg distal to the CAS); 3) after 10
min of adenosine infusion (800 lLg/min) distal to the CAS and; 4) late
PBX, 1 hour post drug. At C distal endocardial (EN) flow (0.94±O.16
ml/min/g; mean ± SD) was reduced vs circumflex (CX) zone EN flow
(1.69±O.39, p<.Ol). Five min after PBX, distal zone EN and
epicardial (EP) flow (1.23±O.27) were unchanged vs C. Infusion of
adenosine reduced distal EP and EN resistance (Sl±ll to 23±7
mmHg/ml/ming/g; and 49±16 to 39±11; EP and EN, respectively; both
p <.OS vs C) and increased (p<.OS) distal zone EP flow (1.23±O.27 to
1.86±O.4S, ml/min/g). Distal zone EN flow did not change
significantly vs C during adenosine (0.94±O.16 to O.77±O.lS). Distal
zone EP flow (1.39±0.29) increased and resistance decreased (41±11)
late after PBX (both p<.OS vs C) without change in EN flow or in the
EN:EP flow ratio. EN resistance (41±13) also declined vs C in sn
animals (O.OS<p< 0.10). PBX (late) reduced distal EN resistance to a
similar extent vis-a-vis adenosine (49±11 at C to 41±13 with PBX vs
39±11with adenosine). In contrast, the decline in distal EP resistance
induced by PBX (late) was only a third that caused by adenosine
(Sl±l1 at C to 41±l1with PBX vs 23±7 with adenosine). Thus, the
data confirm the presence of residual EN vasodilator reserve despite
reduced resting blood flow in the setting of a severe CAS. Alpha
adrenergic tone accounts for much of the available EN reserve but only
1/3 of EP reserve.
IMPLANTATION OF THE INTERNAL MAMMARY ARTERY AS
A MEANS OF MYOCARDIAL REVASCULARIZATION IN A
CANINE MODEL OF MYOCARDIAL ISCHEMIA: A REASSESSMENT
Ellis F Unger. M.D , Cedric D. Sheffield, M.D.,
Matie Shou, M.D., and Stephen E. Epstein, M.D., F.A.C.C.
NHLBI, Bethesda, Maryland
It has been demonstrated that myocardial angiogenesis can
occur between an implanted internal mammary artery (IMA)
and the coronary circulation; however, these implants af-
ford limited flow to ischemic myocardium. The purpose of
this study was to attempt to enhance this flow by infusing
heparin and basic fibroblast growth factor directly into
the implant, and to assess the functional importance of
the collateral flow provided by the IMA. Ameroids were
placed on the proximal left anterior descending coronary
artery (LAD) of 23 dogs. The IMA was implanted in the lAD
zone. After 8 weeks, regional myocardial blood flow was
assessed in the conscious state with microspheres during
chromonar induced vasodilatation, and regional LV function
was assessed with ultrasonic crystals. Regional flow
(m1/min/g ± SEM) and segmental shortening ('61ength of
control ± SEM) were determined with the IMA and circumflex
patent (CONTROL), the IMA occluded (IMA) , the circumflex
occluded (CIRCUMFLEX), and both occluded (BOTH).
~ l!f6 I CIRCUMFLEX JlQllI
FLQq 2.42±0.21 *1.94±O.11 I 1.71±0.23 **1.11±0.19
'ALENGTH 100+0' 98+2' I 105+7' **90+7'
*p<0. 01, CONTROL vs. IMA; **p<0. 01 CIRCUMFLEX vs. BOTH
Thus IMA occlusion alone decreased maximal LAD zone flow
by 20', without affecting regional function. Occlusion
of the IMA during circumflex occlusion decreased LAD ter-
ritory flow by an additional 35' and caused systoliC dys-
function. We conclude that the implanted IMA is capalJ1e
of providing nutritive perfusion to ischemic myocardium,
and this flow has significant functional import.
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lIYPEUD!SITIVI'l'Y OF COaQNAllY AllT!llIES TO IllTRACOaQNAllY
11lGONOVINE FOLLOWING OllTBOTOl'lC CAllDUC 'lUNSPLA!lTATION.
Sudhir lCu.hwaha Kltep, David LythaU KltCP, Att1Uo
Ma.eri Kltep, Andraw Mitchell Kltep, Maldl Yacoub nes,
FACe., Bar.fi.ld eo.pital, Middla.aa, !nIland.
I
Tha in vivo bahaviour of coronary art.ri.. in dan.tvat.d
tranaplant.d h.art. i. notknowa. Ravinl docum.ntad
••~.r. coronary .pa.. In 4 .uch p.ti.nt. (pt.) we .tudl.d
ch. r ••pon.a of th. coronary artlri.. to incracoronary
.rlonovln. mal.at. (EH) in 10 othar patiant. who hael
und.rlonl orthotopic cardiac tran.plantatlon and .hown
to hav. normal coronary art.ria. at anlloaraphy. EH in
do••• of 1, 5 and 10~a wa. inj.ct.d into th. l.ft coron-
ary art.ry followad by 2 51" ot i.o.orbid. dinitrat.
(IDN), The proximal l.ft ant.rio~·d'lc.ndin8 (LAD), mid
LAD .nd mid circumflaa art.ri.. .bow.d a d.cr.... in
maa.ur.d diamet.r in re.ponl' to 1~8 of 1M (m.an t 5E,
12.3 t 3.4, 10.3 t 6.1, 4.9 t 6.' r ••p.ctlv.ly). lurth.r
incramant. produced no .ilnificant r ••pon.. anel contract·
ion w•• rav,r••d by IDN in all v.",l.. !h. dOl'
r••pona. curv. of EM wa. di.plac.d to th. l.fc by n.arly
a 101 cycl. co-par.d with pr.viou. .tueli.. on normal
v••••1., inelicatina hYPlr••n.itivity to th. drul. Row-
.v.r, th••aanitud. of th. r.ductton 1n di...t.r WI'
.1milar to that of normal v••••l. r.thlr than that
el••crib.d praviou.ly in patt.nt. with variant ansina.
Thl••ull••t. th.t denarv.t.d coronary art.ri•••r.
hyparnndtiva to EH.
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Technical Considerations of
Electrocardiography
LATE POTENTIAL AND NOISE LEVEL VARIABILITY CAUSED BY
BANDPASS VERSUS HIGH-PASS FILTERING, AND TYPE OF
SIGNAL-AVERAGING EQUIPMENT.
James Vacek, M.D' I F.A.C.C., Scott Smith, M.D., Tim
Boyer, M.D., Marvln Dunn, M.D., F.A.C.C., University
of Kansas Medical Center, Kansas City, Kansas.
Late potentials (LP) detected by signal-averaged
electrocardiography (SAECG) are predictive of
ventricular arrhythmia indJction and sudden death.
Prior studies have used a variety of equipment and
filtering parameters. The correlation between data
from two commercially available SAECG units and the
effects of bandpass (BP) opposed to high-pass (HP)
filtering was studied in 18 hospitalized patients.
C40Hz HP C40- 25 OHz BP A40- 25 OHz BP
QRS 109 + 15 (0.141) 107 + 15 (0.003) 102 + 14
RMS 32 + 26 (0.023) 31 + 25 (0.021) 36 + 25
LAS 34.+ 14 (0.135) 35 + 14 (0.287) 33 + 11
Values are mean + SO. A = ART 1200 EPX, C= Corazonic
Predictor, LAS =-duration of LP < 40 uV, QRS =
filtered QRS duration, RMS = root mean square
amplitude of last 40 ms of QRS. () = p values. Final
noise levels were lower for A (O.2B + 0.06) than for ~
(0.33 + 0.07) (p < 0.05) in spite of-fewer beats
averaged (123.:t 50 for A, 300 + 114 for C, p <
0.001). We conclude: (1) BP filtering does not
effect time domain LP variables in a clinically
relevant fashion. Requiring two of three parameters
to be abnormal for an abnormal study, no patient was
miscatagorized by HP versus BP filtering. (2)
Significant data differences between the two machines
existed, causing miscatagorization of three of 18
patients. (3) Significant differences in noise levels
and cycle aquisition number exist between units
powered by AC line (C) versus batteries (A).
Conclusions: 1) CVR In dilated and nonstenotlc neighboring arteries
of Gmup I pts appear 10 be lower than normal (Group II).
2) After successful coronary angloplasty. LAD CVR Is improved and
approaches that of normal CX In the same subject.
3) The measurement of CVR In nondilated, nonstenotlc neighboring
artery may provide a reference for assessing the success of comnary
angloplasty in Individual pts.
COMPARISON OF REGIONAL CORONARY VASODILATORY RESERVE
BETWEEN NORMAL AND POST ANGIOPLASTY ARTERIES IN THE SAME
PATIENT
Chalapathlrao Gydjpatj M p, Ubeydullah Deligonul, M.D.,Morton
Kern, M.D., F.A.C.C., Frank Aguirre, M.D., Harvey Serota, M.D.,
Brian Lew, M.D., Michel Vandormael, M.D., F.A.C.C., SI. Louis
University, SI. louis, Missouri
The Importance of regional differences in coronary vasodilatory
reserve (CVR) in the same human subject is not well known. We
assessed CVR by Intracoronary Doppler flowmetry in anlerlor
descending (LAD) and circumflex (CX) coronary arteries of 10 pts
without LV hypertrophy or myocardial infarction. Mean flow
velocity (mVel) was measured at rest and after peak hyperemia
Induced by Intracoronary injection of 10 mg. of papaverine. CVR.
mVel at hyperemlalmVel at rest. 5110 pIs (Group I) had successful
single vessel LAD dilation with decrease in stenosis from 82±S% to
16±.3% as measured by electronic calipers. All Shad
angiographically normal CX arteries. In the remaining S pts (Group
II), LAD and CX were angiographlcally normal. The results were:
Mean;,SEM.
Group I
Pre PICA Post PTCA ex
M 2.2.:1:.0.8 2.6S±.0.S 2.91±.0.S
LADICX 0.7S±.0.2 0.94±.0.2





A MICROPROCESSOR BASED ECG ANALYZER AND TONE
GENERATOR WHICH PERMITS IMMEDIATE RECOGNITION
AND CATEGORIZATION OF ECTOPIC RHYTHMS BY SOUND
Lloyd Marks M.D.. F.A.C.C., Scott Smith, Timothy Brophy, Roben
Grane, Thomas Moore Ph.D., Temple University Department of
Pediatrics, SI. Christopher's Hospital for Children, Pltila., PA
A conventional ECG monitor produces identical short, high
pi.tched tones with each QRS complex. As these tones do not vary
with QRS morphology, the ECG trace must be visually inspected
to determine the specific nature of the cardiac rhythm. When
performing certain tasks, it would be advantageous if ectopic
rhythms .could ~e .re~ognize~ and c~tegori~ed with. purely auditory
information as It IS Impractical or Impossible to Inspect the ECG
trace continuously. Such tasks include cardiac catheterization,
trans telephonic evaluation of cardiac rhythms, and monitoring
patients during surgery. We have developed and evaluated a new
cardiac monitor which allows the physician to recognize and
categorize ectopic rhythms with purely aUditory information.
The ECG and its first derivative are input to a dedicated
microprocessor system. Tones are generated with each QRS
complex such that~ QRS complexes produce short, clipped.
h!gh pitched tones and wide QRS complexes produce long. low
pitched tones. Wide QRS complexes which are different from one
another produce different long, low pitched tones:--
T~e system wa~ evaluated by playing t~e tone~ generated from
? different cardiac rhythms (normal SinUS, SinUS tachycardia,
Iso.lated uniform premall~re ventr~cular beats, uniform bigeminy,
Uniform couplets, multiform tnplets, and runs of uniform
vent~i~ular tachycardia) ~ach. for 15-20 s~conds to a group of 14
phySICIans (5 staff cardIologists. 2 cardiology fellows, 3 cardio-
thoracic surgeons, 3 residents, 1 anesthesiologist) after presenting
them with a brief written description of the system and a 30
second videotape demonstration. Thus, there were a total of 7 x
14 = 98 trials. None of the teaching material was used during the
trials. The rhythms were correctly identified in 47/49 trials (96%)
by the 7 cardiologists and in 45/49 (92%) by the other 7 physi-
cians. The difficulties in identification resultin$ in the few errors
appeared to be remediable with minimal edditlOnal teaching.
We conclude that this device provides audio information which
allows physicians to identify and categorize a wide variety of
ectopic rhythms with purely auditory cues. This may be useful
when a physician can not continuously inspect an ECG tracing.
















168.:!:1 BO 9B.:!:70lUfl-i pV 11 9.:!:57
Ratio of RKS-i to
RKS Total <0.31 0 2 8. 4
lUfl=root mean square; RKS-i=1Ufl of initial 40ms; LAS=IQl
amplitude signal; .p=0.05 •••=p<0.025 ••••=p<0.005. com-
pared to LVH Pts;.::p<0.02 oompared to non-induoible Pta.
COnoluaioD 1) high total QRS RKS values. or a IQl ratio of
IUfl (initial 40ms):total QRS RKS. suggests that the etiol-
Of!3 of the LVH is hypertroP1io oardiauyopathy and 2) find-
ing of abnormal QRS (>112ms). terminal IUfl «20),lV) and LAS




Veotor Integral >15 2
SIGNAL-AVERAGED ELEcrROCARDIClGRAmIC DIFFERWCES BElWEW
PATIENTS WITH NOO-MYOPATHIC LEFT VENTR"Irot1R HYPERTROmy
AND PATIENTS WITH HYPERTROmIC CARDIOMYOPATHY.
Lameh Fananapaz ir. M. D.. Anne Danforth. B. S. N.. Judi th B.
Winkler. B. S•• NHLBI•• Bethesda. Maryland.
Differentiation of ~pertroP1io oardiauyopathy frOID other
causes of left ventrioular hypertrophy (LVH) has thera-
peutio and prognostio implications. This stuelY' compares
signal-averaged ECIl results in 3 groups of Pts - A: 37 Pts
with hypertroP1io cardiauyopathy (20 Pts with and 17 Pts
without inducible ventrioular tachycardias at programmed
eleotrical stimulation). B: 15 Pts with ECIl and echo evi-
denoe of LVH -13 Pta with AO valve disease. 2 Pta with hy-
pertension and C:16 normal subjeots. All Pts had normal
ooronaries. The total. ini tial and terminal 40ms of the
QRS were evaluated: B:rpertl'opb10 CBrdiQ!Q'opatbl
Par_eter .00000al LVa Bon-Inducible Inducible
QRS width >112 ms 0 4 9 9
(T_1ual 40 u)
DOES THREE CHANNEL AMBULATORY ELECTROCARDIOGRAPHIC
MONITORING INCREASE DETECTION OF ISCHEMIA?
Bijoy Khandheria. M.D •• Stephen Hammill. M.D ••
F.A.C.C •• Carolyn O'Connor. Addie Muri. R.N •• and
Gerald Gau. M.D .• F.A.C.C .• Mayo Clinic. Rochester. MN
Silent ischemia (SI) is a relevant clinical problem
that is being intensively investigated. One o! the
commonly utilized methods for diagnosis of SI IS ST
segment analysis on 2 channel ambulatory el~ctrocardio­
graphic monitoring (AECG). However. analYSIS of 2
channels alone may not be adequate for detection of
SI. We evaluated the usefulness of 3 channel AECG
versus 2 channel AECG using a newly developed 3 channel
AECG monitoring device (Clinical Data. Boston) in 47
consecutive Pt undergoing treadmill exercise testing
(TMET). There were 36 males. 11 females. mean age
51 yrs (range 25-67 yrs) who had simultaneous.AECG
with leads piggybacked to 12 lead electrocardIogram.
Leads utilized for AECG were aVF. V3 and V5. All Pt
exercised to stage II or more of the Bruce proto~ol.
TMET was positive in 18 Pt. while AECG was positIve
in 17 Pt. Results:
TMET AECG
only AVF 4 3
only V5 2 2
on ly V3 1 1
combination (2 channel) 11 11
The sensitivity of AECG for detection of ischemia was
94% while the specificity was 100%. Analysis of 2
leads improved detection of ischemia than 1 lead in
33% (6/18) Pt with positive TMET. Addition of a
third lead (aVF) improved ischemia detection in 17%
(3/18) Pt. Conclusion: Three channel AECG monitoring
improved detection of ischemia in 17% more Pt in
comparison to 2 channel AECG.
ST Analysis: Intragroup Versus Intrapatient
Variability of Holter Results
Peter Nikutta, Dirk Hausmann, Paul Wenzlaff,
Hannover Medical School. Hannover. FRG.
The evaluation of the efficacy of antiischemic
interventions by Holter ECG causes difficulties
due to the variability (VAR) of ischemic acti-
vity during daily life. We compared intragr~up
and intrapatient VAR in 38 patients (PTS) WIth
proven CAD (stenoses > 70%) and 417 ischemic
episodes (IE) during Holter monitoring on 3
consecutive days. Mean values of the total study
group for day 1. 2 and 3 as well as the mean
intrapatient VAR from day to day were analyzed
for incidence (INC) of IE, mean duration (D),
total duration per day (Old), max. ST-depres-
sion (max. STD) and max. heart rate (HR) of IE:
dll 1 dll 2 ill 3 .I!. illill
INC -3.8- -3.8- 3.4- n.s. 52.3
D (min) 11.8 13.5 12.6 n.s. 113.3
Old (min) 54.1 54.9 48.0 n.s 186.6
max. STD (mV) 0.20 0.21 0.21 n.s. 20.6
max. HR (b/min) 111.5 109.6 110.1 n.s. 11.7
The peek INC resp. peek Old. observed during any
of the 3 days recorded, occured during the first
2 days of monitoring in 86.9% resp. 84.2% of
PTS. Conclusion: The intragroup VAR shows no
significant differences at 3 consecutive days in
38 PTS; in contrast, a marked intrapatient VAR
of INC. 0 and Old from day to day is present.
I. e., for the evaluation of group effects to
interventions 24 hour Holter ECG is sufficient.
The classification of each PT as responder
or non-responder requires a prolonged recording.
HOLTER MONITORING IN THE DIAGNOSIS OF SLEEP APNEA
SYNDROME
Jean-Yves Le Heuzey M.D •• Philippe Romejko M.D •• Bernard
Fleury M.D.. Pierre-Jean Scala M.D., Jean-Philippe
Derenne M.D •• Louis Guize M.D., Thomas Lavergne M.D. and
Jean Valty M.D. Departments of Cardiology and Pneumology.
Saint Antoine and Broussais Hospitals. Paris. France.
In order to assess the ability of Holter monitoring (HM)
to contribute to the diagnosis of sleep apnea syndrome
(SAS). we studied 39 patients (pts) clinically suspected
of SAS. Polygraphic recordings during sleep and 24 hour
HM were performed in all pts. Polygraphic recordings
comprised electrocardiogram. electroencephalogram.
electrooculogram, electromyogram of the chin muscles.
measurement of naso-buccal airflow. measurement of
thoracic and abdominal movements and oxymetry. It were
positive (> 10 episodes of apnea/h. duration > 10 sec) in
32 pts, negative in 7. The analysis of HM showed, in SAS
(+) pts. the occurrence during the nocturnal period
(midnight to 5 AM) of sino-atrial blocks (n-6) and/or RR
interval pauses> 2.5 sec (n-lO). Such abnormalities did
not occur in SAS (-) pts. The mean number of
supraventricular and ventricular premature beats, during
this nocturnal period, was higher in SAS (+) pts : 89.9
± 28.6 and 34.1 ± 14.1 versus 9.6 ± 5.2 and 2.8 ± 0.8.
respectively. The analysis of nocturnal heart rate
showed. in SAS (+) pts. a significantly higher
discrepancy between minimal and maximal heart rate (63.1
± 3.6 versus 45.4 ± 3.9 beats/mn. p <.05). due to
successive episodes of apneas inducing bradycardia and
ventilatory resumptions inducing tachycardia.
In conclusion, this discrepancy between maximal snd
minimal heart rate being a discriminant parameter. HM can
contribute to the diagnosis of SAS and is easier to
perform in routine than polygraphic recordings.
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The Signal Averaged ECG
COMPLEMENTARY ROLE OF SIGNAL-AVERAGED ECG AND
EXERCISE TESTING IN PREDIcrING CARDIAC EVENTS AFTER
MYOCARDIAL INFARCTION.
D Kuchar MD • J Freund MB. M Yeates MB. C Thorburn 'MB. N
Sammel MB FACC. St Vincent's Hospital. Sydney. Australia.
Recent studies have shown that serious cardiac events
occurring after myocardial infarction (MI) can be
predicted by results of exercise testing and by identification
of late potentials on the signal-averaged electrocardiogram
(SAECG). In order to assess the interrelationship of these
tests in predicting these events. we performed SAECG and
submaximal exercise testing in 150 consecutive patients
(pts) who were able to exercise after recovery from MI.
prior to hospital discharge. SAECG was performed with a
commercially-available instrument. and was defined as
abnormal if QRS duration >120ms or terminal voltage <20uV
using a 40 Hz filter. Exercise testing was performed using
radionuclide ventriculography and was abnormal if there
were ECG or hemodynamic changes. or a fall in ejection
fraction or new wall motion abnormality. SAECG was
abnormal in 62 pts (41 %) and exercise testing was abnormal
in 81 pts (54%). During a median follow-up of 14 months.
there were 20 events: 12 pts had recurrent MI. 5 had
symptomatic ventricular tachycardia (VT) and 3 died
suddenly. An abnormal SAECG was recorded in 33/81 pts
with an abnormal exercise test (X2=0.p=NS). SAECG was
abnormal in 3/12 pts with MI. 5/5 pts with VT. and in 2/3 pts
with sudden death. Exercise testing was abnormal in 9/12
pts with MI. 3/5 pts with VT and in 213 sudden deaths. An
abnormality of either test predicted 17/20 (85%) of all
events. Conclusions: SAECG and exercise testing are
independent predictors and probably identify different
pathophysiologic substrates. Evaluation of both parameters
enhances detection of patients prone to life-threatening
events after recovery from MI.
REPRODUCIBILITY OF THE SIGNAL-AVERAGED ECG IN THE ACUTE
PHASE OF MYOCARDIAL INFARCTION AND AT LONG TERM FOLLOW-UP.
Ma Hong. MD, Eli S. Gang, MD, FACC, Fang Z. Wang, MD,
Carol Siebert, RN, Yu Xiu Xu, MD, Thomas Peter, MD, FACC.
Cedars-Sinai Medical Center, Los Angeles, California.
We assessed the variability of sequential recordings of
the signal-averaged ECG (SAECG) in 283 consecutive
patients (pts) with acute myocardial infarction (AMI).
During the in-hospital phase, each pt had 4±1 recordings
(at 2-3 day intervals). Follow-up SAECG recordings were
obtained at 3 months (146 pts), at 6 months (113 pts), and
at 1 year (103 pts). Abnormal (Abnl) results were defined
as terminal voltage ~25 uV and a filtered QRS duration
~IIO msec. Pts with bundle-branch block were excluded.
~: (a) During hospitalization, 8~ of pts retained
their initial SAECG pattern, i.e., remained normal (Nl) or
Abnl. Specifically, 226 of 249 (9I~) initially Nl
remained Nl, while 25 of 34 (74~) of Abnl retained this
pattern. (b) At 3 months, 9~ of Nls remained Nl; in
contrast, 67~ (20 of 30) Abnls changed to Nl. (c) At 6
months, 1001 concordance with the 3 months tracings was
found. (d) At 1 year, a 9~ concordance with the 6 months'
tracings was seen; the 2~ discordance being due to Abnl
tracings changing to Nl.
Conclusion: The initially Nl SAECG rarely becomes Abnl
during AMI and at long term follow-up. In contrast, a
sizable number of Abnl tracings normalize within the first
3 months. These changes may reflect infarct healing and
parallel the well-known decreasing risk for sudden cardiac
death following AMI.
THE SIGNAL-AVERAGED ELECTROCARDIOGRAM PREDICTS ARRYTHHIC
EVENTS IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK. Pierce
Vatterott. H.D.; Stephen Hammill, H.D., F.A.C.C.; .Kenr--
Bailey, Ph.D. Hayo Clinic, Rochester, HN.
The signal-averaged ECG is believed to be less predictive
of sustained monomorphic ventricular tachycardia (SHVT)
at electrophysiologic testing or spontaneous SHVT in
patients with left bundle branch block. We evaluated if
signal-averaging can predict arrythmic events (AE)
(AE=sudden death or clinical SHVT or SHVT at electrophy·
siologic testing) in 41 left bundle branch block patients
~ith complex ectopy (13), syncope (14), clinical SHVT (5)
and other (9) prior to electrophysiology testing.
Patients were followed for a median of 11.3 months during
which 18 AE (12 sudden deaths, 6 SHVT) occurred. Seven
additional patients had SHVT only at electrophysiology
testing. The parameters of QRS duration, root mean
square voltage of the QRS terminal 40 msec (RHSV) , and
duration of low-amplitude signal at the terminal QRS <40
uV after 25, 40, and 80 Hz filtering and 5 clinical
variables were subjected to stepwise logistic regression
to create a model for predicting AE. This model consisted
of 4 variables: ejection fraction, 25 Hz and 80 Hz &~SV
and 40 Hz low-amplitude signal. Results of selected stan-
dard late potential criteria and the model were:
Standard Criteria Sensitivity % Specificity %
25 Hz RHSV <25 uV 68 (17/25) 75 (12/16)
40 Hz R.~SV <20 uV or 84 (21/25) 38 (6/16)
low amplitude signal
>38 msec
Hodel 96 (24/25) 62 (10/16)
CONCLUSIONS: Signal averaging predicts arrythmic events
in left bundle branch block patients. The described'
model should improve the clinician's ability to predict
arrythmic events in this patient group.
SmHAL-AVIlIJlJED BLIC'l'ROCABDIOG1lJ.RIIC ABJlOIIMILITIBS III
R(JJ-AFFIC'l'ED FIlST DIlDIIII JlI!LATlVllS OF PATIIRt8 WITH
BIPIJI'1'IOHlIC CABDIOMtOPA'lBY.
Deborah J. Barbour, M.D., Judith B. Winkler, B.S., Barry
Maron. M. D•• F. A. C. C•• LlIDeh Fananapazir, M. D•• NHLBI.
Beth esda. Mary land.
Signal-averaged ECG detection of late potentials is an
indicetor of arrhythmogenic LV in pts with hypertroP1ic
cerdiCIDYopathy (HCM). We compared the incidence of late
potentials in 3 groups of subjects:1) 15 Pte with echo-
cardiograP1ically proven HCM. 2) 31 first degree relat.-
ives of these Pts with normal echocardiogrllDs and 3) 16
normals. Signal-averaged ECG was performed with a 40 Hz
bidirectional filter. to a noise level of <0.3uV. Late
potential indices studied were: 11 QRS duration. 2) Root
Mean SCI uere (RMS) in terminal 40ms of Q RS, and 3) Leii'
amplitude signal (LAS). The results were:
Abaol'llal Abaorwal Sipal-Av8I'aged laJ
SUbjects 12-1ead laJ QRS>112u JUIS<20u LAS>351111
Normal s 0 0 1 (6J) 1 (6J)
HCM Pte 12 (75J) 2 (13J) 3 (2OJ) 5 (33J)
Relatives 8 (26J)*' 1 (3J) 4 (13J) 10 (32J)"
*=p<O.05. "=p<0.005. compared with normals; , =p<0.005
compared with HCM Pts.
OoaoluaiClll: The finding of abnormal 12-lead ECG and
SA ECG in first degree relatives of HCM Pts suggests
that a significant nl.lllber of these individuals bave
el ectrically abnormal hearts despi te the Dega tive echo-
cardiograP1ic appearanoes. The progndstic significanoe
of this observation rlquires furth$r stu<IY.
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EFFECT OF ANTIARRHYTHMIC DRUGS ON FREQUENCY-DOMAIN
PARAMETERS OF SIGNAL-AVERAGED ECG Roger A Freedman MD
~, Marc S. Fuller PhD, Jonathan S. Steinberg MD, for
the ESVEM investigators. University of Utah Medical
Center, Salt Lake City, UT.
Frequency-domain analysis of signal-averaged ECG
(SAECG) can identify pts with sustained VT. The effect
of antiarrhythmic drugs on frequency-domain parameters
was examined in 26 pts with spontaneous and inducible VT
undergoing total of 60 drug trials (7 quinidine, 8
procainamide, 11 imipramine, 10 mexiletine, 8 propaf-
enone, 16 sotalol). FFT area ratio (O-25Hz)/(25-50Hz)
was computed for 100 msec segments of SAECG QRS-ST,
multiplied by Blackman-Harris window, starting 40 msec
(AR40) and 100 msec (ARlOO) after QRS onset. High-
frequency (>40 Hz) QRS duration (fQRS) was derived from
time-domain analysis. Results:
- - - - _. _. -AR40- - - - - - - - - - - - -- - --ARlOO· - - - - - --
Drug Baseline Drug p Baseline Drug p
all l3.9±7.7 l6.l±8.8 .004 2l3±223 104±106 .0002
quin l3.7±9.5 l3.9±6.5 NS 207±142 l28±136 .14
proc l3.0±8.5 l7.0±8.0 .02 276±26l l30±122 .16
imip l4.l±8.4 l4.9±7.0 NS 230±262 102±122 .14
mexil l2.5±6.l l4.8±7.2 NS l20±86 113+103 NS
propaf l4.2±7.8 2l.5±14 .06 258±306 47±23 .08
sotal l5.0±7.8 l5.7±8.9 NS 208±229 108±103 .06
Drug effect on ARIOO, but not AR40, showed significant
correlation with drug effect on fQRS (r--0.48;p<0.001).
Conclusions: (1) Drugs decrease high-frequency relative
to low-frequency signal in mid-QRS, reflected in tAR40.
(2) Drugs increase high-frequency relative to low-
frequency signal in late QRS-ST, reflected in ~ARlOO,
and this correlates with tfQRS. (3) These effects are
caused by wide range of drugs, with propafenone showing
greatest effect. (4) Studies are warranted to examine
relation between these effects and drug efficacy.
EFFECTS OF EXERCISE INDUCED ISCHEMIA ON THE SIGNAL
AVERAGED ELECTROCARDIOGRAM.
Charles Gottlieb M.D., Nancy Britton R.N., Howard Eisen
M.D., Mark Rosenthal, M.D., F.A.C.C., John Hiller, M.D.,
F.A.C.C., Michael Lesh, M.D., Hark E. Josephson M.D.,
F.A.C.C., Michael Simson M.D., F.A.C.C.
To determine the effect of exercise-induced ischemia on
the signal averaged electrocardiogram (SAE), 51 pts had
SAE prior to and immediately after thallium stress
testing. Four subgroups were defined based on thallium
scintigraphy by the presence (+) or absence (-) of
ischemia (ISCH) or infarction (INF). The change in SAE
QRS duration and root mean square voltage in the last
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Summary: (1) In pts without prior infarction or ischemia,
exercise produces a small (3', p=.03) decrease in SAE QRS
duration and a modest (16'.1\, p=.07) increase in RMS 40.
(2) Ischemia is associated with SAE QRS prolongation and
a decrease in RMS 40 voltage. The change in RMS 40 with
ischemia was more marked in pts with prior infarctions,
3' vs 15'. (3) In some pts with prior infarction,
ischemia may complete the substrate for ventricular
arrhythmias since the changes in SAE are similar to those
seen in pts with chronic ventricular arrhythmias.
PERIOOICITY OF TRANSMURAL AND EPICARDIAL ELECTROGRAMS
DURING SINUS RHYTHM IN PATIENTS WITH VENTRICULAR
TACHYCARDIA.
Nancy A. Branyas M.D., Dennis M. Cassidy M.D., F.A.C.C.,
Michael E. Cain M.D., F.A.C.C., Washington University,
St. Louis, Missouri.
Despite widespread reliance on signal-averaged ECGs for
detecting patients prone to sustained ventrfcul ar
tachycardia (VT), the periodicity of global ventricular
activation during sinus rhythm has not been defined.
Accordingly, transmural and epicardial ventricular
electrograms during 6 consecutive sinus beats were
evaluated in 10 patients with abnormal signal-averaged
rCGs undergoing surgery for sustained VT. For each
patient, bipolar electrograms were recorded simultan-
eously using sock and needle electrodes from up to 96
epicardial and 160 transmural sites. Electrogram morpho-
logy, duration, and activation were compared on a
beat-by-beat basis. A total of 9816 electrograms were
analyzed. Mean durations of epicardial and transmural
electrograms were 33+16 msec (range 6-199 msec) and
23+10 msec (range 6-7~ msec) respectively, with beat-
to:beat variation of 1.9+1.4 msec per site. Similarly,
local activation times dTd not vary significantly during
the 6 cardiac cycles (mean variation 1.7+2.0 msec).
Local conduction failure was not observea. Although
electrograms during the terminal 40 msec of the QRS were
significantly longer (36+20 msec vs 26+12 msec, p <0.001)
when compared to those occurring earTler, beat-to-beat
variation in duration (2.1+1.6 msec) and activation
(1.7+2.3 msec) were not significant. Results demon-
strate that epicardial and transmural electrograms during
sinus rhythm from patients with sustained VT are periodic
signals and thus establish a physiologic basis for




Thrombolytic Therapy in Acute Myocardial
Infarction II
TISSUE PLASMINOGEN ACTIVATOR FOR UNSTABLE ANGINA
PECTORIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED TRIAL.
EJ Topol MD, FACC, NS Kleiman MD, JM Joelson MD, SG
Ellis MD, FACC, T Wahl MD, RM Califf MD, FACC, M
O'Brien, A Hopkins, R Roberts MD, FACC, DO Williams HD,
FACC, University of Michigan, Ann Arbor, Michigan.
To determine the role and appropriate dose regimen
of thrombolytic therapy for unstable angina, 66 pts
were enrolled in a 4 center randomized, double-blind,
placebo-controlled trial. pts with chest pain at rest
and a culprit vessel stenosis ?:I01o were randomized to
high dose iv t-PA (100 mg/6 hrs), low dose t-PA (60
mg/1 hr) or placebo. All pts received aspirin 325
mgld, 1.v. heparin 1,000 Ulhr, and underwent baseline
and repeat coronary angiography at 12-48 hrs. The
primary endpoint was change in 10 diameter stenosis
established by computer edge detection in a blinded
fashion at a core lab. The 3 groups were similar with
respect to age, sex, weight, duration of symptoms, and
presence of intraluminal thrombus at baseline.
Negative outcomes were defined as MI or emergency need
for PTCA or CABG. No deaths occurred in the study.
t-PA




1 (MI) 1 (PTCA) 3 (MI)
523
·p=0.07 ··p=0.03 ···p=0.19
In conclusion, these results indicate that using a
quantitative angiographic endpoint, heparin and aspirin
therapy for unstable angina is equally effective as low
or high dose t-PA.






PREDICTION AND PREVENTION OF MYOCARDIAL INFARCTION
DURING THE ACUTE PHASE OF UNSTABLE ANGINA.
Pierre Theroux. H.D.• F.A.C.C., Helene ouimet, H.D.,
Jean-Gilles Latour, Ph.D., John HcCans, H.D., F.A.C.C.,
Guy B. Pelletier, H.D., F.A.C.C., Hartin Juneau, H.D.,
David Waters, H.D., F.A.C.C., Hontreal Heart Institute,
Hontreal, Canada.
Hyocardial infarction (HI) occurred in 21 of 479 pts
enrolled in a double-blind, placebo-controlled, rando-
mized, factorial-design trial testing aspirin (A), he-
parin (H), and both (A+H) during the acute hospitaliza-
tion phase of unstable angina. HI occurred in 1210 of
the 118 placebo pts, significantly more frequently than
in A (3.310 of 121 pts, p~.Ol), H (0.810 of 118, p<.OOl)
and A+H (1.610 of 122, p~.OOl). New Q waves developed in
12 of the 14 placebo HI's (8610) compared to 2 of the 7
HI's (2910) in the active treatment groups (p<.Ol); peak
CK elevations were 2639:1:1932 IU and 1555:1:2275 IU re-
spectively (p~NS). No mortality occurred except for 2
deaths in the placebo group.
In addition to treatment, other predictors of HI were
age, (63:1:7 vs 58:1:10 years, p~.02), recurrent angina
during hospitalization (8110 of HI pts VB 3210 of others,
p<.OOl), number (0.8:1:1.2 vs 0.2:1:0.6 per pt, p#.002) and
duration (17:1:32 vs 2.6:1:9.5 min, p<.OOl) of chest pain
episodes during the first 24 hours. The clinical pre-
sentation of unstable angina. the presence of risk fac-
tors, concomitant medications and involvement of the
left anterior descending coronary artery were not pre-
dictive of HI.
Thus, aspirin and heparin protect against HI in the
acute phase of unstable angina. HI's that do occur on
these drugs are more likely to be non-Q than in un-
treated pts. Persistent ischemia early during hospita-
lization warrant aggressive intervention.
FATE OF ACUTE MYOCARDIAL INFARCTION PATIENTS WITH SUCCESS-
FUL MECHANICAL (RESCUE) VS. CHEMICAL PATENCY OF THE
INFARCT VESSEL AT EMERGENCY CATHETERIZATION.
Charles W. Abbottsmith, M.D.C.M., F.A.C.C., Eric J. Topol,
M.D., F.A.C.C., Dean J. Kereiakes, M.D., F.A.C.C., Barry
S. George, M.D., Linda Martin, R.N., Linda Anderson, R.N.,
Lynn Harrelson, Richard Candela, M.D., F.A.C.C., Richard
S. Stack, M.D., Robert M. Califf, M.D., and the Thrombo-
lysis in Acute Myocardial Infarction (TAMI) Study Group.
Rescue percutaneous coronary angioplasty (PTCA) after
failed thromholytic therapy has not been associated with
a uniformly good outcome. We analyzed the data of 773
patients with patent infarct vessels at the end of emer-
gency catheterization studied in the course of five TAMI
trials. All 773 patients received emergency catheteriza-
tion and 199 patients with occluded vessels at 90 minutes
had rescue PTCA (success in 168, 88%). Baseline demo-
graphics were similar with respect to age, sex, infarct
vessel, and multivessel disease.
Chemical Rescue P
No. Patients with Patency 605 168
Baseline Ejection Fraction 51.4% 48.3% .003
Reocclusion 67(11%) 37(22%) L.OOI
7-Day /j. Ejection Fraction 1.0 -.02 .008
7-Day /). in Regional Function +.45 +.2 .001
(SD/Chord)
Deaths (in-hospital) 28(5%) 10(6%) .36
Conclusion: Chemical patency is preferrable with better
baseline ejection fraction, ventricular functional
recovery, and less reocclusion. Despite this, the low
in-hospital mortality is the same in both groups, suggest-
ing the pivotal importance of an open infarct vessel
acutely, no matter how it is achieved.
IS DEUVERY OF rt-PA BY HEUCOPTER TRANSPORT TEAMS
SAFE AND TIME-EFFECI1VE? Daniel E. Spangler, Jr, MD.
William A. MacLean MD, FACC, William J. Rogers MD, FACC,
Joel Gore MD, Larry E. Maske RN, Terry E. Morgan RN, Jeanne
Corrao RN, Mickie Griffith RN. Carraway Methodist, UAB, and
U. Mass. Med. Centers, Birmingham, AL and Worcester, MA.
In order to assess the safety and feasibility of rt-PA delivery
by specially trained physician/nurse helicopter transport teams
to rural community hospitals and the subsequent transport of
patients to tertiary care facilities, we recorded transport and
treatment times and complications frequencies in 193 patients
(pts) treated with rt-PA within 4 hr onset AMI (myocardial
infarction) symptoms in the TIMI IT protocol at Birmingham, A.L,
and Worcester, MA. Of the 193 pts, 84 were treated post-flight,
whereas 109 were treated pre- and during flight by the
transport team. Time from onset of AMI symptoms to rt-PA
bolus was 201.±.34 min in post-flight treated pts vs 165.±.38 min in
pre-flight treated pts (p=.OOOl). Pts treated pre-flight received
rt-PA 28.±.9 min after team arrival, whereas pts transported
without rt-PA to tertiary care facilities received rt-PA 41,±,18
min after arrival there (p =.0001). There were no in-flight deaths
or CPR in either group. Frequency of in·flight arrhythmias was
similar between groups and, overall, averaged: V fib 0.7%, V
tach 3.6%, 3rd degree AV block 1.5%, bradycardia <60/min 13.9%.
Hypotension was significantly more common during transport in
the pre-flight treated group (19.2% vs 3.1%, p=.004), and this
group also received atropine in-flight more frequently for
symptomatic bradycardia (6.5% vs 0, p=.025). Hemorrhagic
complications over the first 24 hr after starting rt-PA were
lower in the pre-flight treated pts (42% vs 60%. p=.046). MI was
confirmed prior to hospital discharge in all patients.
Thus, skilled helicopter transport teams can appropriately
evaluate AMI pts and, on arriva~ can administer rt-PA 1TI0re
rapidly than tertiary hospital emergency staff. Symptomatic
bradycardia and hypotension are the most frequent in-flight
complications of rt-PA therapy and can be managed effectively.
DEMONSTRATION OF VIABLE MYOCARDIUM AFTER AN AClJI'E
INFARcrION SUBMITTED TO THROMBOLYSIS : COMPARISON BETWEEN
POSITRON EMISSION TOMOGRAPHY AND OOBl.JI'AMINE
ECHOCARDIOGRAPHY
Luc A. Pierard M.D., Christian M. De Landsheere M.D.,
Christian Berthe M.D., Pierre Rigo M.D., Henri E.
Kulbertus M.D., F .A.C.C., University of Liege, Belgium.
'Ib limti.fy~ victlility in a:ute~~
infarctim (AMI) t.reat:e::I within 3 tx:urs bt intrave.n::us~,
17 pati.alts (pta) ut:Erw;nt~ (am) at rest an
d.lriJ'g cl:i:utanire (D::iu) infusim at 10 PJ/1<g/min. 7 + 4 days afta:
AMI. 'lh¥ \\ere st:I.dierl with pmtlm ardssim~ (mr),
9 + 5 days afta: AMI. Q:ra1ary a'lata1y \\05 Mira:! in all pta.
Fo1J.a.H.p a:ro an mr I'm'e prla1red 9 + 7 nmths later'. Six segrarts,
~ic of the taritay of the left crittri.cr cm:a-diIg artery \\ere
crB1yarl with I:oth te:ln:i.cpas. An a:ro axr:e in:eK \\05 c:aJ..a.l1.a1:a,
I::asa:i en the 6 segrarts. SEgraJta1 prt'usi.cn (p) (with N-13 ammia
cr 1<38) an ghxrse qlta<e (G) (with 2~-1B-2~) \\ere
rreas.n:e:i an a ratio of G eNer: P \\05 caJ.aI1at:a:l in ea:h segrB1t.
~ victlility \\05 cEte::ta:l with mr in 11 pta : 5 ha:i rarral P
in the area at riB< (gmp lA) an 6 ha:i a hitjl G/P ratio (gmp 18).
N:> viaJility \\05 cEte::ta:l in 6 pta (gmp 2).
E1::txl axr:e in:eK lEst *** D::iu
~ lA 12 +2 *** 7.8 +1.3
~ 18 14.8 +2.2 * 12 +-2.1 *"
~ 2 14.6 +1.4 14.1+ 1.6 *"
P * =O.C5 *" < O"':"C5 ***< O.a:6
0:n:x:I:tirt int:eq:retaticn with the 2 ta:tn:iq.Bs \\05 farrl in 79 %of
affa:tB:i segrarts fer I:oth a:ute an fol.l.c:w..q:l st1dies. 'l1us, d::b1
a:ro is a !='f1i.sirg rretlxrl to 1.I'I'I'fl9t vicb1.e, sl1.rIlBJ~ in AMI.
Nxmll P of the area at riB< is asax:i.atB:i with g:cd fI.n::tialal
cutcare, WReas hitjl G/P ratio in:ii.cBtes ja:pmfurrl~ Wri.dl
frEq.mtl.y 1cses viaJility. '
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CORONARY THROHBOLYSIS WITH UROKINASE PREACTIVATED INTRA-
VENOUS PRO-UROKINASE
Dietrich C. Gulba, H.D., II.Sc.; Christoph Bode, 11.0.;
Semi Sen, II.D.; Jurgen Topp, 11.0.; Klaus Fischer, 11.0.;
Werner G. Daniel, H.D. Hannover lIedical School, Univerity
of Heidelberg. University of Homburg, and St. Urban
Hospital Berlin, FRG
In two consecutive dose finding studies (A: non rando-
mized; B: randomized) a total of 78 patients (pts) with
acute Q-wave myocardial infarctions were treated with a
combination of 250 000 IU of urokinase (UK) as an i v
bolus (for preactivation) and 4.5 or 6. 5 mega U of
natural pro-urokinase (nPUK). All pts concomitantly
received a 5000 IU iv heparin (hep) bolus and a conti-
nuous hep infusion (1250 IU/h). The patency rate (PR) was
assessed at 60 min after onset of thrombolytic therapy by
angiography.
Results:
group n U nPUK PR sign. fib PLG AP
Al 15 4.5 mega 33'1 - 9' -29' -59'
A2 16 6.5 mega 75' p< 0.05 -13'1 -34% -63'
Bl 23 4.5 mega 30% + 7' -31' -63%
B2 24 6.5 mega 71% p< 0.01 -18' -3S' -73'1
fib: fibrinogen; PLG: plasminogen; AP: a-2-antiplasmin
Bleeding complications were mainly related to arterial
puncture sites (30% hematomas). No other major haemorrha-
ge was observed. We conclude that thrombolysis with low
dose UK preactivated nPUK is highly effective and almost
completely fibrin specific. For further studies the com-
bination of 250 000 IU UK and 6.5 mega U nPUK should be
used.
Wednesday, March 22, 1989
4:00PM-5:00PM, Anaheim Room
Anaheim Convention Center
Coronary Angioplasty in Acute Myocardial
Infarction
EARLY HISTOPATHOLOGY OF REPERFUSION THERAPY FOR MYOCARDIAL
ISCHEMIA: STUDY OF 29 AUTOPSIED CASES.
Lyle J. Olson M.D., Thomas W. McGovern B.S., William D.
Edwards M.D., F.A.C.C., Rassul S. Saber M.D., Robert L.
Frye M.D., F.A.C.C., David R. Holmes, Jr. M.D., F.A.C.C.,
Mayo Clinic, Rochester, Minnesota.
The purpose of this study was to describe early pathologic
lesions associated with percutaneous trans luminal coronary
angioplasty (PTCA) or thrombolysis for the treatment of
myocardial ischemia. Of 2,235 Pts undergoing coronary
reperfusion therapy (RT) at our institution between Janu-
ary 1982 and July 1988, 138 have died. Hearts were avail-
able from 29 (ages 28-88 years; mean, 62 years; 18 were
men) who died within 3 weeks of RT; 32 treated and 58 non-
treated epicardial coronary arteries and myocardium were
studied systematically. For each Pt, clinical and angio-
graphic data were reviewed and recorded; 27 were treated
for acute ischemia. Treatment groups included PTCA alone
(17), thrombolysis alone (5), and PTCA and thrombolysis
(7). At autopsy, intimal fissures were observed in 28
treated arteries and extended into the media in 2.
Dissection was observed in 15 arteries, all treated by
PTCA. One coronary artery treated by PTCA and thromboly-
sis ruptured. Plaque extrusion was observed in 14 treated
arteries (13 by PTCA) and was associated with atheroembo-
lization in 2. Occlusive or nearly occlusive thrombi were
seen in 15 treated arteries. In nontreated arteries,
intimal fissures were seen in 11, plaque extrusion in 4,
occlusive thrombi in 7, and dissection in none. Hemor-
rhagic infarction was observed in 18 of the 29 Pts and was
moderate or severe in 10. Cardiac rupture occurred in 5
pts (3 with hemorrhage). Clinical failure of RT with
death may have diverse causes including coronary and
myocardial rupture, hemorrhagic infarction, and coronary
occlusion due to thromhosis, dissection, or embolization.
TWO- YEAR POST-DISCHARGE SURVIVAL AFTER EMERGENCY
CORONARY ANGIOPlASTY FOR MYOCARDIAL INFARCTION:
IMPORTANCE OF THE TIMING AND SUCCESS OF ANGIOPlASTY.
NH Kander, WW O'Neill, R Mileski, EJ Topol, SG Ellis.
University of Michigan Hospital, Ann Arbor, MI.
long term follow-up of large numbers of patients
wi th acute myocardiali nfarct i on (AMI) treated wi th
angioplasty (PTCA) is limited. Therefore, we analyzed
336 consecutive patients who underwent PTCA for AMI.
Two-hundred ninety-nine patients survived hospital-
ization, of whom, 293 (98%) were followed a median of
24 months. In this group, mean age a 55±11 years, 49%
had adjunctive thrombolytic therapy, 53% had multi-
vessel disease, baseline ejection fraction (lVEF) a
48+10% and median time to PTCA a 4.5 hours. Actuarial
survival was 96.1% at one year and 93.6% at 2 years.
Survival was independently predicted (logrank analysis)
by no prior AMI (96.9% vs. 87.3% 2 year survival;
p<.OOI), predischarge ejection fraction ~ 40% (98.1% vs
85.8% 2 year survival; p-.Ol), infarct artery patency
at hospital discharge (97.4% vs. 93.4% I year survival
but 94.2% vs. 93.4% 2 year survival; overall pa.02),
and successful PTCA ~ 4 hours after AMI onset (97.1%
vs. 91. 7% 2 year survi va1; PD. 04) . Survi va1 was not
dependent on prior thrombolytic therapy or 14 other
variables.
Conclysions: I) overall post-discharge survival
after treatment of AMI with PTCA was 93% at 2 years, 2)
2 year survival of 97% was achieved in patients with
successful PTCA ~ 4 hours from symptom onset, or
without prior infarction, or with pre-discharge lVEF >
40, 3) the improved post-discharge survival with early
treatment that has not been noted after thrombolytic
therapy alone suggests a long-term benefit from early
complete revascularization of the infarct artery.
"RESCUE" PERCUTANEOUS TRANSlUMINAl CORONARY ANGIOPLASTY
AFTER FAILED THROMBOLYTIC THERAPY--4 YEAR FOLLOW-UP
David R. Holmes Jr. M.D., F.A.C.C., Bernard J. Gersh
M.D., F.A.C.C., Kent R. Bailey Ph.D., GUy S. Reeder
M.D., F.A.C.C., John F. Bresnahan M.D., F.A.C.C., Dennis
R. Bresnahan M.D., F.A.C.C., Ronald E. Vlietstra M.D.,
F.A.C.C., Mayo Clinic, Rochester, Minnesota.
Four year (yr) outcome in 34 pts undergoing "rescue"
coronary angioplasty (PTCA) after failed lytic therapy
for treatment of persistent occlusion for acute
infarction (Group 1) (Gr 1) was compared to 29 pts
undergoing PTCA for residual subtotal stenosis after
successful lytic therapy (Group 2) (Gr 2). After PTCA,
patency was present in 71% Gr 1 and 90% Gr 2. There was
single vessel disease in 56% Gr 1 and 52% Gr 2 of pts.
Initi a1 and fi na 1 infarct artery stenos is (IRA-S) and
left ventricular function (EF) were:
Initial Mean Final Mean Initial Dismissal
IRA-S IRA-S EF EF
Gr 1 100% 61% 47% 36%
Gr 2 98% 54% 58% 50%
In-hospital mortality was 3% in Gr 1 and 0% in Gr 2;
in-hospital CABG was 29% in Gr 1 and 14% in Gr 2. After
discharge at mean follow-up of 4 yrs, survival free of
events was as follows:
Death Death/MI Death/MI/CABG
Gr 1 89% 81% 75%
Gr 2 97% 93% 90%
Pts with rescue PTCA have lower EF at dismissal as well
as increased late mortality/morbidity. Late survival
was less in Gr 1 than in Gr 2 but the relatively good
overall survival of 89% in pts with significantly
decreased EF (36%) at the time of discharge is
encouraging and raises the issue whether reperfusion
could improve mortality by mechanisms other than
myocardial salvage.
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'!'HE TIMI II A S'l'UDY OF PTCA TIMING AFTER RT-PA
TIIROMIlOLYSIS FOR ACUTE MYOCARDIAL INFARCTION (AMI)
Donald S. Bairn MD FACC, William J. Rogers MD FACC, Joel
M. Gore MD, Genell L. Knatterud PhD, Eugene Passamani MD
FACC, and the TIMI II A Investigators. Beth Israel
Hospital and Harvard Medical School, Boston, MA.
MEDIA THINNING OF SEVERELY DISEASED CORONARY ARTERIES:
GUIDEUNES FOR NEW INTERVENTIONAL PROCEDURES
varon AlmaQo[ M0 Martin B. Leon M. D., F.A.C.C., Antonio L.
Bartorelli M.D., Steven D. Lenhard, Michael W. Perlman B.A., Dean A.
Follmann Ph.D., William C. Roberts M.D.. F.A.C.C., Robert F. Bonner
Ph.D. NHLBI, Bethesda, MD.
Seven clinical centers in TIMI II A randomized 586 pts
with AMI (symptom duration < 4 hrs, mean 2.9 hrs) to one
of three treatments following rt-PA thrombolysis: 1)
acute (2 fir) cath, and PTCA if possible, 2) delayed (18-
48 hr) cath and "TCA if possible or 3) no cath/PTCA
unless prompted by clinical ischemia. Findings at
discharge cath (*) and 6 week follow-up (**) included the
following:
.L.AI2.(n-95) .wa(n-52) ~(n-131) .L..M.(n a 9)
123±38 133±38 167±48 247±49
63 72 85 99.4




Since many new catheter-based laser and mechanical devices have been
designed for definitive atheroma removal, safe and successful clinical
procedures in small, tortuous coronary arteries (CA) may be
critically dependent on the strength and Integrity of the underlying
media (M). To examine M dimensions of diseased CA, we studied 287
transverse histologic sections from 21 patients (66±10 yrs) dying
after myocardial infarction, and measured 1) cross sectional areas of
lumen, plaque, and media and 2) M thickness at 36 circumferential
points. From these data, we calculated average thickeness of the media
(ATM), % lumen cross-sectional narrowing (CSN). and % M points
>100 lUll.
Compared to normal patients without antemortem cardiac Illness
(n-l03 sites), the ATM was 27% thinner in diseased CA (195±63 vs
147±49jl.m, p<.OOl). Both ATM and % M points >100 jl.m decreased
significantly (p<.OOl) with Increasing stenosis (%CSN).
Furthermore, for diseased CA sections, plaques were significantly
thicker where the media was thinnest (p<.OOl). Thus, in diseased CA:
1) ATM is thlnnner than In normal pts and M Is thinnest In regions of
greatest plaque accumulation, and 2) ATM and % M points >100 lUll
decrease with increasing stenosis. These data suggest Jhat
preservation of M integrity will require precise ablative techniques
and that complete atheroma removal ("debulklng*) without
transmural perforation may be an unrealistic goal in some patients.
18-48 HR PTCA~
194 197
121 (62%) 55 (28%)
107 (55%) 35 (17%)
5 (3%) 5 (3%)
14 (7%) 20 (10%)
11 (6%) 17 (9%)
8 (4%) 12 (6%)
48/53 50/52
121/151(80%) 142/168(85%)























In conclusion, 1) Despite significantly less (p<.OOl),
utilization of mechanical revascularization, the strategy
of NO PTCA unless ischemia had a comparable outcome to
routine cath and PTCA, and 2) Of the two routine PTCA
strategies, 2 HR PTCA after rt-PA offered no additional
benefit, and carried a greater risk of complications
(transfusion (p<.OOl), CABG after PTCA (p<.Ol) than
either the 18-48 HR PTCA or NO PTCA strategies.
Wednesday, March 22, 1989
2:00PM-3:30PM, Marriott Hall North
Anaheim Marriott Hotel
Coronary Angioplasty: Experimental and
Pathologic Observations
CORONARY SPASM INDUCED BY STENT IMPLANTATION
George Rodgers MD, Albert Raizner MD FACC, Douglas
Cromeens DVM, Kenneth Wright PhD, C1 ifton Stevens DVM,
Gary Roubin MD FACC, Steven Minor MD. Baylor College of
Medicine, Houston, Texas
A feature of the swine model which is shared with humans
is their propensity for coronary artery spasm. We im-
planted the Gianturco-Roubin balloon expandable stent in
the left anterior descending or circumflex coronary
artery of 28 6-month old Hanford miniature swine
(25-35kg). Atherosclerosis had been induced in 9 of
these animals. All were treated with di1tiazem 2-4mg/kg
3 times daily for 3 days prior to stenting. All received
intracoronary nitroglycerin (NTG) 200-300mcg and all
received nifedipine 10mg bucca11y prior to stent imp1an-
tati on. Stents were selected such that they were 20%
greater than or equal to the vessel diameter. Coronary
arteriograms were performed immediately following and 15
minutes after stenting. Coronary spasm (a transient
focal narrowing) distal to the stent was observed in 15
animals (53%); 7/9 (78%) atherosclerotic pigs developed
spasm and 8/19 (42%) of the normal pi gs. In a11 but 1
case spasm was re1 ieved by additional doses of intra-
coronary NTG and/or buccal nifedipine 10mg. One animal
died of intractable coronary spasm during the stenting
procedure. Two other pigs who had transient coronary
spasm after stenting died approximately 8 hours later.
At necropsy both had patent stents, but 1 had thrombus
distal to the stent at the site of the previously
observed spasm. We conclude: 1) Swine appear to be a
sensitive model for coronary artery spasm; 2) Stent
induced spasm is a major problem in this experimental
model and may have similar importance in man.
I~lPEDANCE NEASURENENT OF ABSOLUTE BLOOD FLOW
USING AN ANGIOPLASTY GUIDEWIRE.
Lisa W. Hartin, N.D., F.A.C.C., Robert A. Vogel N.D.,
F.A.C.C., Rodne~' A. Johnson, N.D., F.A.C.C., Nark Englehardt
N.D., Helen Scott N.T., University of I'laryland, Baltimore,
Naryland.
The impact of a coronary stenosis on blood flow has been
difficult to assess, particularly during angioplasty. We have
previously developed an impedance angioplasty catheter
able to measure absolute blood flow. Impedance changes
induced by a 5% dextrose indicator solution (DsW) and
indicator dilution techniquea are used. One half ml of DsW
is infused upstream over five seconds through a side port
located just proximal to the angioplasty balloon. Blood
impedance is measured downstream at the catheter tip at a
frequency of 50 kHz, using two electrode sets spaced 2 mm
apat·t. (Small currents (10 uA) are used to eliminate cardiac
stimulation.) Flow is calculated using the area under the
first pass transit curve. In order to reduce the size of the
impedance instrument and thus prevent interference with
intrinsic blood flow, the electrodes are now on a .016 inch
standard guidewire. The angioplasty catheter containing the
guidewire may now be positioned proximal to the stenosia for
injection of the indicator, with the electrode system distal to
the stenosis. A 2 mm teflon electrode gap is located on the
guidewire 3 em from the tip to allow a bipolar eleetrode
system. We have validated this guidewire system in plastic
arterial phantoms with 2 to 4 mm diameter using one half
normal saline (with impedance similar to blood) injected at
known flow rates. An excellent correlation was found over a
flow range of 10 to 300 mllminute (Y = .95X + 10.8, R = .98,
N = 24) between calculated and known flow rates. These
results suggest that it may be feasible to measure absolute
blood flow in arteriea with stenoaes using an angioplasty
guidewire system.
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In Vivo Recanalization of Total Atherosclerotic
Arterial Occlusions: Combined Use of an Ultrasonic
Probe and Balloon Angioplasty System .
Robert J, Sjegel M,D" FACC, T, Anthony DonMichael,
M,D" FACC Eugene DeCastro A,A,S., Michael C, Fishbein,
M,D" FACC, Zia Hashemi M,D" Louis Adler M,D" Joseph
Bookstein M,D, James S, Forrester M,D" FACC Cedars-
Sinai Medical Center, Los Angeles, California
Arterial recanalization using a prototype ultrasound
probe with subsequent balloon angioplasty was studied.
Totally occluded human atherosclerotic arterial
xenografts (n-7) were surgically implanted in canine
aorta or iliac arteries, Arterial occlusions were 2 to
5 cm in length and 6 vessels were calcified. Attempts
at passage of conventional guide wires failed to open a
channel in the occluded vessels. Ultrasonic energy was
applied (47 watts/cm2 at a frequency of 20 kHz) with a
0,020 inch wire probe in a 7-9 Fr catheter. After 15
sec to 2 min of ultrasound, a lumen was generated
permitting passage of a gUide wire and balloon
angioplasty system, Subsequent balloon angioplasty was
readily accomplished in all vessels, The angiographic
residual stenosis was 24±10%, AnQioscopy after
ultrasound ablation and balloon dilatatlon revealed an
endothelial surface comparable to that produced by
balloon angioplasty alone, Perforation occurred in 1
vessel at the sutured anastomosis site. Histologic
sections of the arteries demonstrated findings similar
to those of balloon angioplasty alone, cracking of
calcific and fibrotic plaques and focal separation of
intimal plaques from underlying media, Potential
limitations of the prototype system include arterial
perforation due to the stiffness of the ultrasonic wire
probe as well as the generation of embolic debris,
Combined use of this ultrasonic probe and balloon
angiop1asty permit in vivo recanalization and
dilatation of atherosclerotic arteries, with ca1cfied,
long, complete occlusions,
INTRACORONARY DILTIAZEM LIMITS INFARCT SIZE DURING
PROLONGED ANGIOPLASTY BALLOON INFLATION
G.C. Rose, M,D., J,C. Jordan, and S.R. Jolly, Ph.D., East
Carolina University School of Medicine, Greenville, NC
The effect of intracoronary diltiazem (D) through a
balloon catheter lumen was examined on regional ischemia
and degree of necrosis during prolonged balloon inflation
followed by reperfusion, Ischemia (I) was produced in
closed -chest, pentobarbital anesthetized, male mongrel
dogs by inflation of 2.5-3,0 rom diameter balloons
introduced under fluoroscopy into the left anterior
descending or left circumflex coronary arteries. Animals
were randomly assigned to control (C) or D, administered
at the time of balloon inflation, D was titrated to
obtain significant systemic hemodynamic effects: 27±6 rom
Hg reduction in mean arterial pressure achieved with a
median dose of 900 ug/kg, An equivalent volume of saline
was without effects, After 50 min of I, a left
thoracotomy was performed and the left atrium was
cannulated for injection of radiolabelled microspheres at
70 mins, The animal was then reperfused by deflating and
removing the balloon. At 4 hr, animals were sacrificed
and the heart removed for measurement of area at risk
(AR) and infarct size (IS), using a dual staining
technique, Regional subendocardial blood flow did not
differ in the I area between groups: 12.0+2,6 vrs
13,8+2.8 ml/min/lOO g in C and D respectiv~ly, AR did
not differ between groups 38±4 vrs 39±3 percent of left
ventricle, IS was significantly reduced as percent of
AR: 22 + 5 vrs 9 + 2 in C and D respectively.
Therefor~, intracoronary D produced significant reduction
in myocardial injury attributable to reduction of 02
demand plus potential direct effects on the myocardium,
This intervention may be useful to delay cell death in
the setting of failed coronary angioplasty.
PERSISTENI' moornELIAL DYSFUNCI'IOO" FOIJ..CMIOO EXPEIUMENl'AL
ANGIOPIAS'IY. Franz weidin:Jer, MD, James M::I.enadJan. Me,
Peter Ganz, MD, FACC, JctIn COOke, MD, RlD, FACC, Brigham
& Wcmen's Hospital and HaIvard Medical SChool, BcSta1, MA
Endothelium (E) can inhibit vascular SID:lOth nuscle tone
and growth, To examine the late effects of vascular
injuxy on E vasodilator function, an;Jioplasty was
perfonned in the left iliac artery (inj) of 3 groops of
New Zealand rabbits, the right iliac seIVm;, as control
(ctl). A Iroderate and a severe injuxy were oc:rtpU"ed (2.5
and 3.onm balloons, respectively); both resulted in
OCIlplete E dernxlation, 1::A.rt: ally the latter caused
substantial intiJnal proliferation of SID:lOth DUSCle.
Vascular reactivity was studied at 2 and 4 weeks after
injuxy in arterial rin;Js in organ d1antlers.E~
relaxations were tested to acetylcholine (ACH) 110-9 to
10-5 M) and calcium iorqlhore A23187 (10-8 to 10-6 H) and
E-iJPeperx:lent: relaxation to ni1:Iqlrosside (NP) (10-9 to
10-4 M) after preconstriction with norepineplrine.
~ (relaxation expressed as % of maxiltum; all values
~;*p<0.05;**p<O,01;***p<0.001vs control):
ACH A23187 NP
ctl inj ctl inj ctl inj
2wk IOOderate(n=6) 99;t1 69;t15 98±2 66j;17 100 98±2
2wk severe (n=6) 95;t5 61±9** 95;t4 42±14** 100 100
4wk severe (n=6) 94±4 36j;10*** 91±5 45;t14* 97±3 100
E regrowth was confinned histologically. 'lhere was a good
correlation (r--.65, p<0.005) between the i.npainnent of
E~ relaxation and the degree of intiJnal
proliferation. nrus, followin:] an;Jioplasty, there is
progressive i.npainnent of emot:helial vaso:lilator
function despite erxiothelial regeneration. Persistent
dysfunction of erxiothelium could oontri1::A.rt:e to altered
vasalDtor tale after an;Jioplasty, and if generaliZed,
could be a cause of restenosis.
Wednesday, March 22, 1989
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Modification and Delineation of Coronary
Atherosclerosis: New Aspects
DIETARY SUPPLEKENTATION WITH FISH OIL PREVENTS CORONARY
OCCLUSION BY THROMBUS FORMATION,
Claude Benedict MD. FACC. Wen L Sheng MS, Gerald ~ Todd,
Unlverslty of Texas Medlca1 Branch, Galveston. Texas,
In Eskimos, intake of fish oils is associated with low
incidence of coronary artery disease. Whether dietary
supplementation with fish oil leads to a decreased inci-
dence of coronary occlusion by thrombus formation was
investigated in a chronically instrumented dog model of
coronary thrombosis, In this model in vivo platelet ag-
gregation (PA) correlates with elevated coronary sinus
serotonin (5HT) levels measured by a radioenzymatic
method, 16 dogs fed on a diet supplemented with menhaden
fish oil (total omega-3 fatty acid intake 400mg/kg/day)
for 12wks were subjected to thrombus formation, Thrombo-
sis is initiated by applying 150~A of current to the
circumflex coronary artery until a 50% decrease in
cross-sectional area (stenosis) develops, At this point
current is stopped and occlusion develops spontaneously
due to ongoing thrombus formation. Vessel closure was
determined by absence of flow (doppler) and impairment
in myocardial contractility. Vasoconstriction was moni-
tered by dimension crystals sewn to the arterial wall,
Controls Fish Oil
Number 10 16
Time for occlusion (min) 85,OtI6.0 >180*
Episodes of vasospasm (per hr) 6.0t 2,3 < 1 *
Peak 5HT levels (ng/m1) 45,OtI7,0 3.2+1.7*
Values are mean t ISD; *p < 0,01 compared to controls,
The data shows a marked attenuation of in vivo PA and
vasospasm in fish oil supp1imented dogs, This suggests
that inhibition in vivo PA and attenuation of coronary
vasospasm are some of the mechanisms by which omega-3
fatty acids may prevent coronary occlusion by thrombus
formation,
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REGRESSION OF ATHEROSCLEROSIS IN CHOLESTEROL FED RABBITS:
EFFECTS OF FISH OIL AND VERAPAMIL
Bo-Qing Zhu, M.D., Richard E. Sievers, B.S., William M.
Isenberg, Ph.D., Donald L. Smith, Ph.D., William W.
Parmley, M.D., University of California, San Francisco.
We have previously shown that either fish oil or verapamil
could attenuate the development of atherosclerosis in the
lipid fed rabbit. The present study was designed to
evaluate the individual and combined effects of these two
interventions on regression. 50 New Zealand rabbits (5
groups) were fed a .3% cholesterol diet for 10 weeks.
Group C10 was then sacrificed. Group C20 was fed a .3%
cholesterol diet and the other groups were fed a normal
diet for an additional 10 weeks. Group F received 2m1/day
of fish oil (EPA 180mg + DHA 120 mg/ml). Group V received
2g/100Om1-water of verapami1 and group FV received both
fish oil and verapamil. Serum cholesterol at 10 weeks
was similar in all groups (average 1033 mg/d1). After
converting to a normal diet the serum cholesterol in
group F was lower than levels in other groups (P (.01).
Groups
%Lesions C10 C20 F V FV
Aorta 40H5 57t22 15t17* 16t12* 26t24*
Pu1. Art. 20t7 37t11 11t9* 12t9* 17t14*
*Significant1y different from control groups.
Our previous study showed that a normal diet was
ineffective in causing regression of atherosclerosis over
a second 10 weeks. Thus, along with diet, fish oil or
verapamil significantly reduced lesions in the aorta and
pulmonary artery. These data demonstrate that either fish
oil or verapami1 can regress atherosclerosis in
cholesterol-fed rabbits put on a normal diet. However,
there was no additive effect of fish oil and verapami1.
Although not statistically significant, there was a
suggestive antagonistic effect between these two.
COMPENSATORY CORONARY DILATATION AND MEDIA THINNING:
ADAPTIVE RESf'aIlSESTO PR:)GRESSIVE ATI£AQSCl.ERCSS
varQn AlmagQr M 0 Martin B. LeQn M.D., F.A.C.C., ~ntonlo L.
Bartorelli M.D., Steven D. Lenhard, Michael W. Perlman B.A., Dean A.
Follmann Ph.D., Robert F. Bonner Ph.D. NHLBI, Bethesda, MD
Since clinical manifestations of myocardial Ischemia are dependent Qn
coronary lumen area (A), pathophysiologic responses to maintain
lumen A during progressive atherosclerotic plaque deposition are
critically Important. Using computerized video planimetry of
transverse histologic sections, we compared the coronary architecture
from 21 patients (313 sections) with severe atherosclerosis dying
after myocardial infarction (Group I) to 9 control patients (103
sections) with minimal atherosclerosis and no cardiac symptoms
(Group II). After measuring 1) cross-sectional (CS) A of lumen,
plaque, and media and 2) thickness of the media (TM) at 36
circumferential points in each section, we compared (mean±SD)
average TM, lumen A, plaque A, media A, CSA, and % CS narrowing for
both groups.
Averlge Medii P18que lumen CSA %CS
TMfllm)~~~~ Nmowlng
I 147±49 1.6±.8 3.9±2.S 1.9±1.7 S.8±3.6 67±20
II 19S±63 1.7±.7 1.1±0.6 2.1±0.9 3.1±1.4 33±11
p<.0001 N.S. p<.0001 N.S. p<.OO01 p<.OO01
Although Group I patients had 4X greater plaque A than Group II
controls, compensatory dilatation (tCSA) maintained normal lumen A.
Group I vessel enlargement was associated with significant thinning of
the media (p<.OOO1) without reduction in media mass. Moreover, for
Individual vessels, plaque was thickest over regions of thinnest media
(p<.0003). These findings suggest that the mechanism of
compensatory coronary enlargement during progressive plaque
accumulation is local vasodilation (and thinning) of the underlying
media. Thus, In patients with coronary disease, adaptive media
responses to enlarge CSA preserve the lumen A which may delay the
onset of clinical ischemia.
THE IIlPACT OF COIll'ENSATORY EIllAR6E1lENT OF ATHEROSClEROTIC COROllARY AIlTERIEI 011
THE A116106Ro\fIHIC A5SESSIlENT OF CORONARY ARTERY DISEASE
~!1!:g_~,_§!t!ll_~h_@~l lUdlilh 5,6. Sli.l, M, B", Joth.n Schoftr, "0,
O.U.f 6, "ath.y, "D. Dopartlfnt 01 Cardioloqy, Univffsity Hospital Epp.ndorl,
Haaburq, Wut Sfrlilly.
To d.hr.in. Ih.thtr COlp!1lutory enhrg'lfnt 01 athroscltrotic cot'oftlry
arhri'i occurs and to what drgret! it a//octs th. anqioqraphic u.uuent of
cot'oouy arhry diSl!ast, "' perloroed postoortft coronary angiography in 30
huaan hearh and lorpholftric leasurft!1lh 01 SO disusfd irtorial '1fJ1.nh 01
th.S! hurts. For this purpoSl, th. coronuy artfl'iu Ill!ff fillfd at i prllsuff
01 100 u Hg lith an acrylic radiopaque rllin and clostly ftbfdd.d in acrylic
ruin by th. us. 01 Ihich shrinhg. and lethaniul utihcts could be ivoidfd.
Th. angioqraphic and corruponding aorphONtric dlfJrH 01 shnoii. In aUH"d.
Th. iru circulscribed by th. intffnal .lastic hlina IIEl Area) Iii taken .. a
loalUff 01 th. area 01 th. uterial IUI.n if no phqu. had bun prllinto The
corr.lalion bellnn th. lEl Area and th. aru 01 thl plaque lltlion Aru) i.
hiqhly .ignificant (r=0.85, p t O.OOOll, Iuqgtlting thit coronary arhrill
enlarge as lesion Area increaus, With an incrull of the IDfphOHtric degree of
St!1l0Sil, th. noraal autolicil diainution 01 the coronary irtffY (.Iprtll.d ..
ratio of IEl Area dishl to IEl Aru proxilall ...1 incrulingly ibolishH dUI to
the cOlp.nsdot'y enluqfMnt in atheroKlfl'otic stgl.nt IroO.79, p i O.OOOll.
The angiographically assllsed dlfJru 01 steftolil las undfflltilatfd.
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und.mtiution lIhich In 3.50-1.37 laid up to ill allljioqriphic deqrH of SOl
MU and 301 diaNttr Ihnosil, rtlp. At high., degrtts 01 stonolil,
anqioqraphic under"tiaatiOll r"ult.d aainly froa dluast lith c.-pfllutot'y
f/lhrqftfllt in the pffstenotic reltrfllce SIll-t, lith an undfl'lItiutiOi helot'
of 1.37.
~!!'.!~lY!I~n'..J. I, Coapenutory Inhrgeltnt in Itenotic cot'onary ultry 119...11
occurs and 2, rnulll in a significant anqiographic und'ffltiution of coroniry
atheroschrolil durinq the urly stag. 01 coronary artory diseAse.
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Echocardiography: Assessment of Diastolic
Function
DIFFERENTIAL EFFECTS OF RIGHT VENTRICUIAR PRESSURE AND
VOLUKE WADING ON LEFT VENTRICUIAR FILLING ASSESSED BY
DOPPLER ECHOCARDIOGRAPHY
Eric Louie. K D . F.A,C.C , Stuart Rich, M.D., F.A.C.C.,
Sidney Levitsky. M.D., F.A.C.C., Bruce Brundage, K.D,
F.A.C.C., Loyola U., Maywood lL &U of IL, Chicago lL.
The effects of severe RV pressure overload (RVPO) and
severe RV volume overload (RVVO) were studied in 11 pts
with primary pulmonary hypertension (PA pressure 53±14
mmHg, RA pressure 5±5 mmHg) who had minimal or no TR by
Doppler and 11 age matched pts who had undergone
tricuspid valvu1ectomy for endocarditis (RA pressure
14±4 mmHg) who had severe TR but no pulmonary
hypertension (peak TR velocities < 2m/s). LV
eccentricity (E-minor axis parallel to the ventricular
septum/axis perpendicular to septum - 1.0 normally in
the absence of leftward septal shift) was measured by 2D
echo and transmitra1 filling fraction was measured by PW
Doppler. In RVPO leftward ventricular septal shift was
most marked at end-systole (E-1.64±.48) and improved at
mid-diastole (E-l.32±.22) and end-diastole (E-1.33±.33 p
< .01 v. end systole). By contrast in RVVO E was
relatively normal at end-systole (1.07±.09) and
increased at mid-diastole (E-1.30±.22) and end diastole
(E-1.35±.13 p < .001 v. end systole) as the ventricular
septum shifted leftward. The transmitra1 late diastolic
filling fraction in RVPO (0.48±0.16) was significantly
greater than in RVVO (0.22±0.11, p < .001) and the
transmitra1 early filling fraction in RVPO (.52±.16) was
significantly less that in RVVO (.78±.11 p < .001). RVPO
results in maximal geometric distortion of the LV in
early diastole resulting in preferential late LV
diastolic filling whereas RVVO results in maximal
leftward ventricular shift in late diastole resulting in
preferential early LV diastolic fit1ing.
lACC Vol. 13, No.2
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STUNNED MYOCARDIUM: EVIDENCE THAT DIASTOUC
VENTRICULAR DYSFUNCTION PERSISTS EVEN AFTER
RESOLUTION OF SYSTOUC DYSFUNCTION - EXPERIMENTAL
DOPPLER ECHOCARDIOORAPHIC STUDIES.
Shan Shen Wang MD Steven Schwartz, MD, Natesa Pandian, MD.
FACC. Tufts·New England Medical Center, Boston, Massachusetts.
While systolic abnormalities in stunned myocardium have been
well characterized. knowledge on changes in diastolic function Is
limited. We used Doppler analysis of mitral now 10 study diastolic
LV function In stunned myocardium. In 7 dogs a state of stunned
myocardium was created by multiple brief occlusions of LAD
coronary artery. With 20 echo we analysed regional systolic LV
function. From mitral flow velocity recordings, we measured the
lsovolumlc relaxation time (time from the end of aortic flow to the
onset of mitral flow, IRT) and also early diastolic (E), and late
diastolic velocity (A). Data were obtained in the control state. 15
min after reperfuslon following cessation of multiple brief
occlusions, and hourly thereafter. Results (mean±SD): In all dogs
there was dysynergy of the anterior LV wall at 15 min after
reperfuslon. The dysynergy remained abnormal at 1 hour but
resolved at 2 hours onwards. (%Systolic wall thickening was 40%
in control, 8"!o at 15 min, 24% at 1 hr. (1)<0.01); At 2 hrs "IoSWT
was 37% (p.NS). While systolic function retumed to normal range
2 hrs onwards, prolongation of IRT and diminution of E velocity
were abnormal not only at 15 min but remained abnormal for 4
more hours. IRT (miliisec) was 90 In control, and after
reperfuslon, It was 146 at 15 min, 149 at 1 hr, 147 at 2 hrs, 147
at 3 hrs, 140 at 4 hrs (All p<0.05 vs contrOl). 'Although ElA ratio
was not significantly altered. E velocity showed significant and
persistent decrease. E velocity (em/s) was 44 in control; After
reperfuslon, it was 27 at 15 min, 20 at 1 hr, 23 at 2 hrs, 25 at 3
hrs. 23 at 4 hrs (all p<0.05 vs contrOl). These data indicate that
diastolic ventricular dysfunction persists longer than systolic
dysfunction In the post·ischemlc period.
REDUCTION OF LEFT VENTRICULAR PRELOAD PRODUCED BY LOWER
BODY NEGATIVE PRESSURE AlTERS DOPPLER TRANSMITRAl FILLING
PATTERNS
Martin R Berk, MD, Patrick McGinnis, MD, Paula Taylor, RN,
Charles Knapp, PhD, Joyce Evans, MS, Theodore Kotchen, MD,
Anthony N DeMaria, MD, FACC, University of Kentucky,
Lexington, Kentucky.
Although transmitral filling velocities have been used to
assess LV diastolic function, few data are available
regarding the influence of changes in preload upon mitral
filling patterns. Therefore, we studied the effect of
variable preload induced by lower body negative pressure
(LBNP) upon transmitral flow velocities: eight normal
males (age 30-32) had graded LBNP applied (0, -20, &-50
mm Hg). Pulsed wave Doppler was obtained with the sample
volume at tips and annulus of the mitral valve. LV
dimensions were measured with 2-D guided M-mode.
RESULTS(annulus): statistics indicate overall LBNP effect
LBNP HR E A E/A DVI Ph LVDD
(mm Hg) (b~m) (c~'h (di'~) ratio (cm) (sec) (cm)
Rest 6 60 39 1.56 12.9 .063 5.0
-20 67 48 35 1.45 11.9 .079 4.6
-50 80 38 37 1.05 10.5 .094 4.3
p<.Ol p<.OI NS p<.02 p<.03 p<.03 p<.Ol
Thus, LBNP produced graded reductions in preload (+LVDD)
and in stroke volume (+DVI). The decreased transmitral
flow induced by the lowered preload was confined to early
passive filling (+Evel )' while late active atrial filling(Avel ) was maintainea. The net effect was a decreased E,increased pressure halftime (Pit), and unchanged A, a
pattern similar to that previously associated with
impaired diastolic properties. Thus, reduction of preload
may profoundly affect transmitral filling patterns,
compromising early passive filling but not active atrial
flow, and must be considered when interpreting Doppler
studies.
DOPPLER LEFT VENTRICULAR FILLING PATTERN IS CLOSELY
RELATED TO VENTRICULAR RELAXATION ABNORMALITIES.
William R. Davidson, Jr. M.D., FACC, Michael J. Pasquale
M.D., Robert D. Aronoff M.D., Pennsylvania State
University College of Medicine, Hershey, Pennsylvania.
Alterations in Doppler-measured left ventricular filling
(LVF) are commonly observed in coronary disease (CAD).
To determine the importance of abnormal ventricular
relaxation in producing these patterns 12 pts with
suspected CAD (7M, 5F; age 56+7 years, mean+SD) were
studied simultaneously with- Doppler/Echo and a
micromanometer-tipped LV catheter before and after left
ventriCUlography (LVgram). Doppler LV isovolumic
relaxation time (IVRT), peak early LVF velocity (E) and
the ratio of early to late LVF (E/A ratio) were compared
to pulmonary wedge pressure (PWP) and the time constant
of ventricular relaxation (Tau).
Results: In all pts ejection fraction was >40S (63+8S)
and normalized chamber stiffness was normal 13+0.8).- At
baseline PWP was 10+3 mm Hg, LVEDP 16+5 mm Hg, and LVEDV
129+35 cc rising-to 15+3 mm Hg**-; 23+5 mm Hg** and
143+30 cc. respectively after LVgram. -E/A rose from
.94+.50 to 1.04+.41 (P-O.06) and E from 44+12 to 53+12
cm/s••• Tau shortened from 50+20 to 43+16-msec*, and
IVRT fell from 94+26 to 82+22msec•• (.p<0.05, .·p<O.OOl).
IVRT was closely correlated with Tau (r.95, P<O.OO1)
but not PWP (r-.22, p-0.11). E and E/A were moderately
associated with Tau (r.73 and .64, both p<O.OOl). E,
but not E/A, correlated modestly with PWP (r.45,p<0.05).
Conclusions: In CAD patients with near normal LV
systolic function, Doppler LV filling pattern (IVRT and
E/A ratio) is closely related to ventricular relaxation
rate and less so to preload. In defined subgroups of
patients, Doppler techniques should be useful in
predicting abnormalities of ventricular relaxation.
ARE DOPPLER INDICES MORE LOAD SENSITIVE THAN OTHER
MEASURES OF DIASTOLIC LEFT VENTRICULAR FUNCTION?
Pamela S. Douglas, MD, FACC, Barbara A. Berko, MD, FACC,
Cynthla Parr, Alfred loll, Nathaniel Reichek, MD, FACC.
University of Pennsylvania, Philadelphia, Pennsylvania.
Doppler indices of left ventricular filling are sensitive
to changes in loading conditions, but comparison of this
sensitivity with that of hemodynamic and dimensional indi-
ces of diastolic function has not been performed. There-
fore, we studied 12 open-chest normal dogs during paired
baseline (B), nitroprusside (N; 10 meg/kg/min) and phenyl-
ephrine (P; 4mcg/kg/min) interventions. Data included Dop-
pler early (E; cm/s), atrial (A) LV inflow velocities,
their ratio (E/A) and atrial filling fraction (AFF); sono-
micrometry derived normalized peak rates of LV filling
(dV; cm/s2) and wall thinning (-dh), micromanometer LV
pressure decay (-dP/dt, Tau) and LA-LV pressure crossover
(PCO, mmHg). Results were (*p<.05 vs paired B):
HR LVP -dP/dt Tau pca dV -dh E A E/A AFF
B-N 112 116 -2289 32 15 g.O -2.7 46 30 1.67 31
N 121* 103* -2019* 30 15 9.2 -2.4 56* 33 1.84 29
B-P 115 105 -2186 28 15 9.2 -2.4 49 31 1.63 30
P 117 155* -2587 33 15 5.2* -2.0 39* 35 1.28 43*
Changes In E (~E) correlated with changes in ~dV (r--.51.
p<.03), while changes in E/A did not correlate closely
with other variables.
Thus. Doppler indices appear more sensitive to loading
conditions than were hemodynamics or wall thinning. This
sensitivity may limit the clinical usefulness of Doppler
measurements.
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NET LEFT ATRIAL AND VENTRICULAR COMPLIANCE CAN BE DERIVED
FROM TRANSMITRAL VELOCITY CURVES: A HYDRODYNAMIC IN
VITRO STUDY
James D. Thomas. MD, Frank A. Flachskampf, MD, J. Luis
Guerrero John P. O'Shea, MB BS, Arthur E. Weyman, MD,
FACC. M~ssachusetts General Hospital, Boston, MA.
The direct assessment of left atrial and ventricular
compliance by Doppler echocardiography remains an impor-
tant goal. Using a previously described mathematical
model of 1eft ventri cul ar fi 11 ing, we predi ct that, for
flow restricted by the mitral valve (mitral stenosis),
net atrioventricular compliance will be inversely propor-
tiona1 to the observed rate of change in transmi tra1
velocity (i.e., the slope of the Doppler velocity curve):
-MVA
Cn ~ pdv/dt' .
where MVA is effective mitral v.alve area, v 1S trans-
mitral velocity, p is blood density, and Cn is net
compliance, combining atrial (Ca > an~ ventri~ular. (Cx>compliance as (l/C ,. 1/C.)-I. Th1S relat10nsh1p 1S
val id both for ~onstant and continuously variable
compliance. We tested this hypothesis in an in vitro
model of mitral flow where net compliance could be
independently and continuously varied between 8 and 28
cmJ/mmHg throughout "diastole". RESULTS: Distinc-
tive Doppler velocity curves were observed: concave
upward when compliance increased during diastole, concave
downward when compliance decreased, and linear when
compl i ance was constant. The aboveequati on correctly
predicted net compliance throughout ventricular filling
for rising, falling, and constant compliance: r • 0.96,
p<O.OOl. CONCLUSION: Using the readily obtainable
noninvasive parameters of planimetered mitral valve area
and transmitral velocity curve, it appears possible to
derive atrioventricular compliance throughout diastole.
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Thrombolysis: Clinical Studies of Efficacy
DOSE RESPONSE RELATIONSHIP OF RT-PA INFUSION TO
INDUCTION OF SYSTEMIC FIBRIN(OGEN)OLYSIS IN THE NHLBI
THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI-II) TRIAL.
E. Bovill. 0 Stump. R Tracy. D. Collen T. Robertson.
M. Terrin J Cheseboro. F Feit. C Lambrew K. Mann
for the TIMI investigators. University of Vermont,
Burlington, VT.
Patients presenting with early acute myocardial
infarction were treated with a 5,000 IU IV bolus heparin
and a 6 hour intravenous infusion of rt-PA at either a
150 mg or 100 mg total dose. Plasma fibrinogen,
fibrin(ogen) degradation products (FOP) and rt-PA levels
were monitored in samples collected in sodium citrate
(0.01 M) and the protease inhibitor phenylalanyl-l-
prolyl-arginine chloromethylketone-2-HCL (PPACK; 20 ~).
Time 100 mg 150 mg
Awct .Lm1n1. IIlWl inl mun inl
Fibrinogen 0 312 (1389) 324 (85)
(clotting 50 257 (1353) 159 (88)
rate) 300 196 (1468) 87 (91)
mg/d1 480 192 (1358) 85 (91)
Peak rt-PA and FOP levels at the 100 mg dose were lower
by about half in comparison with the 150 mg dose.
Coronary artery patency rates observed at 2 hours were
75' after 100 mg rt-PA vs. 76' on 150 mg rt-PA, and at
18-48 hours were 85' after 100 mg rt-PA vs. 86, after
150 mg rt-PA. Clinic reported intracranial hemorrhage
occurred among 1.6' of patients treated with 150 mg rt-
PA vs. 0.6' of patients treated with 100 mg (JACC,
10: 970) . These data suggest that fibrin(ogen)olysis is
frequent and dose related. Furthermore, although 150
and 100 mg rt-PA doses are associated with similar
infarct-related artery patency at both 2 and 18-48
hours, 150 mg rt-PA is sssociated with greater frequency
of hemorrhage.
HEPARIN POTENTIATES THE THROMBOLYTIC EFFICACY OF NATURAL
PRO-UROKINASE
Dietrich C. Gulba. M.D •• M.Sc.; Klaus Fischer. M.D.;
Gert-H. Reil. M.D.; Werner G. Daniel. M.D.; Stefan Jost.
M.D.; Ingrid Wagenbreth, M.D.; Reinhold Frolllbach. H.D.:
Paul R. Lichtlen, H.D., F.A.C.C. Hannover Medical School,
Hannover. FRG
Natural Pro-Urokinase (nPUK) is inactivated by throlllbin.
If this effect is of illlportance for throlllbolysis (T) in
vivo. heparin (hep) should overcollle this problelll. In a
non randomized study. we treated 18 patients (pts) with
acute lIlyocardial infarctions with a 250 000 IU urokinase
bolus and a 4.5 Mio U nPUK infusion given within 40 min
i.v •• Nine pts (group I) were treated without hep while 9
pts (group II) received a 5000 IU hep bolus and a 1250
IUth continuous hep infusion starting before T. Angio-
grams were recorded at 60 min after onset of T. In group
I, only one pt (11') demonstrated an open infarct vessel:
however, after a 5000 IU hep bolus reperfusion was
achieved by a second 4.5 Mio U nPUK infusion in 7 of the
8 remaining pts (87.5'). In contrast. in 7 out of 9 group
II pts (77.8') primary patency was demonstrated by the
first angiogram. The difference between both groups is
highly significant (p<O.Ol). We conclude: 1) Thrombin
related nPUK inactivation is of significant importance
for T in vivo. 2) Hep can overcome this effect. 3) There
is synergism between hep and nPUK. 4) nPUK should only be
given together with high dose hep.
OVERVIEW OF BLEEDING RISK FROM THE TAMI TRIALS:
TWO AGENTS ARE BETTER THAN ONE
RM Califf M Dn FACC, D Stump, M.D., E1 Topol, M.D., FACC, TC
Wall M.D., E Kline, DJ Kereiakes, M.D., FACC, B George, M.D., S
Mantell, K Sigmon, RS Stack, M.D., FACC, Duke University Medical
Center, Durham, North Carolina
In order to evaluate factors associated with bleeding during
thrombolytic therapy of acute myocardial infarction (MIl 810 con-
secutive patients (pts) with acute myocardial infarction entered into
the TAMI trials were evaluated. Pts were treated with t-PA at
doses of 100-ISO mg (S61 pts), urokinase (UK) at a dose of 3 million
units (102 pts) or the combination at doses of I mglkg of t-PA and
0.S-2 million units of UK (147 pts). All pts underwent immediate
angiography shortly after initiation of therapy; adjunctive therapy
included heparin and aspirin in all pts. The majority of bleeding
occurred in peri-access sites, although gastrointestinal bleeding oc-
curred in IS% and intracranial bleeding in 0.7%. The median drop
in hematocrit from admission to nadir value in nonsurgical pts was
10.S% with t-PA, 11% with UK and 9.2% with the combination.
When clinical factors associated with bleeding were examined, the
same factors were important regardless of thrombolytic regimen.
Coronary bypass surgery was most important (p<.OI). In pts treated
without bypass surgery use of intraaortic balloon pumping
(p•.OOOI), older age (p<.OI), female sex (p•.03), lighter weight
(p<.OI) and history of prior cerebrovascular disease (p<.OI) were the
most important factors related to bleeding risk. When the throm-
bolytic regimens were evaluated, combination therapy was associa-
ted with significantly less bleeding (p..004), even when the other
important factors were taken into account. Thus, in prs treated
with thrombolytic therapy and aggressive pharmacologic and me-
chanical methods to maintain patency, invasive procedures and
demographic factors are more important than the thrombolytic
regimen used in predicting bleeding complications. A brief (60
min) combination thrombolytic regimen was, however, associated
with the least bleeding risk.
lACC Vol. 13, No.2
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EFFECT OF LOW DOSE-ASPIRIN ON THE INCIDENCE AND
HEMATOLOGICAL ACTIVITY OF LEFT VENTRICULAR THROMBOSIS IN
PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION
~"h Funke Kupper M.D •• Freek W.A. Verheugt M.D.,
F.A.C.C. Free University Hospital, Amsterdam, The
Netherlands.
Serial echocardiography (2DE) was used to identify left
ventricular thrombosis (LVT) in 100 consecutive pts with
first acute anterior myocardial infarction (MI). Pts
were randomised to aspirin (ASA) 100 mg qd or placebo
(P) < 12 hours after onset of symptoms. Heparin s.c.
50 mg b.i.d. was given 3-4 days. 2DE was done: < 24
hours, 48-72 hours, 1,2, and 12 weeks after MI. In pts
with LVT at the second week 2DE indium-Ill platelet
scintigraphy (IND) was performed.
LVT was detected by 2DE in 30 of the 92 evaluable pts
(15 ASA, 15 P). IND performed in 17 pts was positive in
9 pts (4 ASA, 5 P) and negative in 8 pts (3 ASA, 5 P).
Of the 30 pts with LVT, 6 pts died, one pt was lost for
follow up and in one pt LVT was found only at 12 weeks.
The remaining 22 pts showed LVT before or at the 2nd
week 2DE and were follwoed for 12 weeks. Oral
anticoagulants started in week 3 in 15/22 LVT pts
resulted in LVT resolution in 8/15 pts, similar to the
non-anticoagulated pts: 4/7. Thrombus resolution was
noted in 3/9 IND positive and in 5/8 IND negative pts
(p-ns) and in 7/10 of the ASA treated pts and 5/12 of
the placebo treated pts (p-ns). Arterial embolism
occurred in 2 pts with LVT both on ASA.
Thus, low dose ASA had no effect on the incidence,
hematolo~ical activity and embolic potential of LVT in
acute anterior MI.
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IN VIVO 31 P SPECTROSCOPY FROM TURTLE HEART
DURING ANOXIA AND RECOVERY.
YQseph RQzenman M.D.. Xueming ZQU, Jeremy Wasser
Ph.D., TimQthy R. Wu M.D., Bernard Hitzig Ph.D.,HQward L.
KantQr M.D.,Ph.D.,F.A.C.C, Mass. General HQsp., BQstQn ,MA.
The turtle can survive during extended periQds Qf anQxia, and
therefQre prQvides an QPPQrtunity tQ examine physiQIQgical
adaptatiQns tQ anQxia. This study is an NMR 31 Pin vivQ
examinatiQn at 4.7T Qf 5 turtle hearts during cQntrQI(C), 2h Qf
anoxia(A), and 1h of recovery(R). Spectra were obtained at
rQom temperature using a surface coil within the shell belQw
the heart. For each spectrum 400 aquisitiQns were Qbtained
with a relaxation delay Qf 1 sec. Control reSQnances Qbserved
were: sugar phQsphate, inorganic phosphate(Pi), creatine
phosphate(PCr), adenosine triphosphate(ATP), and a peak at
2.7 ppm which IS currently unidentified(Px). The contrQI values
Qf PCr/Pi, PCr/ATP, PCr/Px from fUlly relaxed spectra were
1.47±0.07, 1.62±0.21, and 1.32±0.31 respectively. PH values
were estimated from Pi chemical shift(C·PH was 7.68±0.22).
Results are presented as percentages of C concentrations.
TIME(hl EQr Ei ATP & E.!::!.
O.SA 70.63;3.8' 142.4±19.8 82.8±4.6# 92.7± 3.1# 7.44±.OS
1.0A SS.3±7.S' 141.6±24.S 77.S±4.2$ 80.6±11.6# 7.16±.02#
1.SA 40.S±6.0' 138.6±14.9# 69.6±3.S$ 76.3± 4.7$ 7.0S±.02#
2.0A 43.7±8.0' 144.7±19.6# 7S.0±6.8$ 82.8±11.5# 6.98±.03#
O.SA 79.6±6.9$ 128.6±13.S 87.2±4.0 97.9±10.6 7.S6±.16
1.0A 91.4±6.9 112.7±20.6 98.3±7.0 101.1±13.7 7.S4±.04
#-p<O.OS, $-p<O.Ol, '-p<O.OOl
PCr evolution was fit with an exponential, with half life of
38.4±10.6 min (p<0.005) and 10.7±3.9 min (p<0.05) for A and
R respectively, and an asymptote at 26.4±9.9% (p<0.05).
ConclusIons: 1. Myocardial turtle spectra are similar tQ those
obtained from mammals with an additional peak at 2.7 ppm.
2.The response to anQxia is slow, and stabilizes fQr the final
0.5h of a 2h period of anoxia.
31p.Maanetlc Re.onance Spectro.copy and Cine lH Magnetic
R..onance Im8lItnll ofDIlated CUdlomyopathy In Human8
Wolfgang Auffermann, MD, William M Chew, PhD, Nuno JTavares,
MD, Thomas Donneny, MD, Wllliam W Parmley, MD, Kanu
Chatterjee, MD, Christopher Wolfe, MD, R~ar!e!! B HigginS. MD.
University of California, San Francisco, Ca ornla
Comprehensive evaluation of cardiac structure, function and
metabolism was achieved by combining 31P-magnetlc resonance
spectroscopy (MRS) and cine IH-magnetlc resonance imaging (MRl)
at 1.5 Tesla. Five patients with dilated cardiomyopathy and 7
normal volunteers were studied using a one dimensional
spectroscopic imaging sequence and a gradient refocussed echo
sequence In a cinematographic mode. A homebuilt 9 cm circular
double-tuned (lH_31PI surface coil was used to both transmit and
recleve radiofrequency Signals. Cardiac volumes, contractility
patterns, muscle mass and wall stress were determined by cine MRl.
The peaks of adenosinetrlphosphate (ATP), phosphocreatine (PCr),
phosphodlesters (POE) and peaks attributable to 2,3
dlphosphoglycerate, InorganiC phosphate and phosphomonoesters
were Identified and the areas under each peak numerically Integrated
after baseline correctIon of the spectra.
Prominent peaks in the phosphodiester and
phosphomonoester regions were observed in cardiomyopathic
patients. PCr/.6-ATP was not significantly lower (1.49±0.08 vs
1.53±O.041. but POE/Per (l.l±O.02 va O.6±O.08) (pSO.Oll and PDE/.6·
ATP 1l.5O±O.04 va O.96±O.15) (pSO.05) were significantly higher In
patients with dilated cardiomyopathy (EF: 24±4%) compared to
normal volunteers (EF: 62±3%).
Thus,localized. gated 31p_MRS combined with cine IH-MRl
Identifies abnormal myocardial phosphate metabolism related to
abnormal contractility which might be useful In characterizing
patients with d1lated cardiomyopathy.
TRANSMURALLY LQCALIZED 31P MRS: METABOLIC HETEROGENEITY
DURING REGIONAL ISCHEMIA.
Barry Massie MD, FACC, Joel Gober PhD, Saul Schaefer MD,
S. Albert Camacho MD, Eli Botvinick MD, FACC, Michael
Weiner MD VAMC and Univ. of CA, San Francisco, CA.
Myocardial blood flow is often heterogeneous across the
LV wall, but corresponding metabolic differences have
not been sought under steady-state conditions. 31P-MRS
can provide serial assessments of myocardial metabolism,
with the potential for transmural localization.
Therefore, we attempted to obtain spectra predominantly
localized to the subepicardium (EPI) and subendocardium
ENDO). Initial experiments with a 3 compartment bar
phantom demonstrated >95% pure signal from each chamber.
Using a plane phantom, uncontaminated spectra could be
obtained from the EPI chamber, and although some
contamination was present in the ENDO spectrum,
improvement compared to non-localized techniques was
substantial. Studies were then conducted on open-chest
swine during partial coronary stenosis with the coil
overlying the ischemic zone. 12 min spectra were
derived from the ENDO and EPI. The PCr/Pi ratio was
related to microsphere measurements of ENDO and EPI
blood flow. In 3 animals, pre-stenosis ENDO and EPI
spectra were similar. With partial stenosis, a greater
decline in ENDO blood flow was noted, and this was
associated with significantly greater decl\~~1U.....
PCr/Pi in the ENDO layer (see ,UD__
figure). Thus, transmurally '-~
localized 31P spectra can be -
obtained in vivo, and these _ _
reveal metabolic heterogeneity =-. -
consistent with transmural -
differences in myocardial - -
blood flow during ischemia. • .... ~
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NMR LIPID IMAGING: A NEW STRATEGY FOR
ASSESSING THE MYOCARDIAL ISCHEMIC INSULT
Alain Bouchard, M.D., F.A.C.C., Randall Wil~on,
M.D., Mark Doyle, Ph.D., Russell C. Reeves, M.D.,
F.A.C.C., Sanford P. Bishop, D.V.M., Ph.D.,
Gerald M. POhost, M.D., F.A.C.C. University of
Alabama, Birmingham, AI.
Proton NMR methods can monitor changes in
mobile lipids (e.g.,triglycerides) in myocardium.
In a canine model of myocardial infarction (MI),
I H NMR spectroscopy has demonstrated increases. in
lipid resonances in zones of decreased mYocard~al
blood flow (MBF), 24hra after coronary occlusion
(Occl) • To evaluate 1H NMR imaging of lipid
accumulation in MI and peri infarct (PI) regions,
we studied 10 dogs, 24 hrs after Occl.(LAD - 6,
Cx - 4) using ex vivo lipid imaging and compared
the findings to MBF, gross infarct location and
Oil Red 0 histology. At 24 hr post Occl.,
microspheres were given and the heart excised.
Lipid imaging was done using a Philips 1.5T
imager and the Dixon technique (repetition time
s 1 sec, echo time - 30 msec, slice thickness -
10 rom field of view -20 cm, matrix -128 x 128).
The lipid image revealed enhanced signal (12-70',
mean -45') in regions corresponding to the post
mortem identified PI zone. Histologically, a
sharp border between neorotic and viable tissue
in the subepicardial region corresponded to a MBF
reduction of 74' (60-89') in the peripheral HI
and 48 , (30-60') in the PI viable tissue.
Viable PI myocardium stained intensely with Oil
Red 0, while MI tissue stained minimally.
Thus, 1H NMR lipid imaging identified viable
tissue with moderately reduced MBF in the
periin!a~eq~o~
MYOCARDIAL PROT£CTlON WI1lf VERAPAMIL DURING ISCHEMIA
AND REPERFUSION: ASSESSMENT BY MAGNETIC RESONANCE
SPECTROSCOPY
Chrjstopber l wane MD FACe Thomas Donnelly, MD, Richard
Sievers, BS, William Parmley. MD, FACC Univ.of Calnomla, S.F.
To test the hypothesis that verapamil is protective during myocardial
ischemia and reperfusion,~ 31 P magnetic resonance spectroscopy
was performed on rats pretreated wfth verapamll (5mgJ1<g, n-1 1) and
controls (n-1 1) during 45 min of LAD occlusion and 60 min reflow.
Myocardial phosphocreatine (PCr) and adenosine trfphosphate (ATP)
were reduced in both verapamil and control animals by similar amounts
after 45 min ischemia (57.4±3.7% vs 64.9±2.4%; 67.6±2.4% vs 70.5±3.4%;
mean±SE; % of baseline value) After 60 min reflow, there was signnlcant
recovery of PCr (91.1 ±.4.2%; P<0.05; % of baseline value) in the
verapamil group but no significant PCr recovery in controls. Infarct size
was signnicantly reduced in the verapamll group compared to controls
(7.6±2.4%, n-9. vs 29.6±5.4%. n-10; Infarct %of LV mass). The LV
systolic pressure, HR, RPP, and LV dP/dT were similar prior to ischemia,
and during ischemia in both groups (VerapamiVControl, n-14 in each
group. p.NS): Ba&IJm 40' Ischemia
HR 363f:18/391 ±17 291±221326±15
Syst BP 100l:9/121±12 85l:7/94±6
RPPx103 37.3±4.3/49.0±6.0 26.4±3.6/31.1±2.9
dP/dTx103 5.1±.6/5.6±.6 3.6±.5/4.1±.4
Thus, pretreatment with verapamil extends the time of myocardial
ischemia alter which reperfusion resufts in myocardial salvage. This
resufted in reduced infarct size and enhanced high energy phosphate
recovery In this model of ischemialreperfuslon. This protective effect
appears to be independent of factors that determine myocardial oxygen
demand durfng the Ischemic period.
SIlIDLTADOUS CARDIAC MIlCIIAIIICS AIlD UOCAm)!AL PBOSPIIORlJS~l
tom DERGETICS DUUlIG GLOBAL I8CIIDIIA & UPDFUSIOII II '11m
CLOSED-CHEST CORSClOUS DOG. D. Douglas Miller, MO, FACC,
Felix Salinas III,BS, Mark Canales,MD, Danny B~cobedo,
Richard Walsh,MD, FACC. U. of Texas HSC, San Antonio, TX.
To investigate the cardiac mechanical correlates of
myocardial high-energy phosphate metabolism during onset
and recovery from global ischemia in the conscious state,
7 pre-instrumented dogs had phosphorus P-31 NMR spectro-
scopy(NMR-S) during 5min. of bilateral coronary occlusion±
pacing(O) and reperfusion(R). ECC-gated spectra acquired
q5min. at 2Tesla[128 averages,TR-200Oms,pulsewidth-65us]
with a 6cm. 2-turn RF surface coil had signal(8ATP).noise
-10.1. Myocardial phosphocreatine(PCr). inorganic P(Pi).
sdenosine triP(ATP) and pH were correlated with continuous
micromanometer LV dP!dtmax. LVEDP and on-line sonomicro-
meter derived ejection fraction(EF);[*-p<0.05].
+dP/dt(!!III/s) LVlDP(-aa) LVEJ'(X) Per/Pi
Control 2396±5781 8.5:1:4 1. .32%. 071" 2.8±.8}'1
o 2051%906 * 19.3%14-' .10±.14.i *l 1.8±.5 **
R lSain. 2185±478 J 9.2:1:6 .08±.06 JJ 2.1%.5 JJ
R 30.in. 2462±467 8.7:1:5 .26±.09 2.2±.5
Myocardial pH remained depreased(·0.22±.23unita;p<O.0~
until R 3Omin. Myocardial ATP content was unchanged. PCr/Pi
and dP!dtmax were significantly correlated at control(y-558x
+862;r-O. 75;p<0.0l), with an insignificant trend in R(p-O.O?).
We conclude that. l)simultaneous hemodynamic measure-
ments are feasible during NHR-S without degrading P-3ldata
2) the extent and time course of functional and P-3lmetab-
olic changes during global ischemia and recovery are sig-
nificantly correlated. and 3) post-ischemic LV dysfunction
is associated with profound hydrogen ion accumulation'and
PCr depletion in the intact conscious dog.
Wednesday, March 22, 1989
4:00PM-5:00PM, Garden Grove Room
Anaheim Convention Center
Magnetic Resonance Imaging
MAGNETIC RESONANCE IMAGING IN ISCHEMIC INJURY
FOLLOWING CARDIAC TRANSPLANT IN RATS
Marvin A Konstam MD FACC, Mark J Aronoyit2'. Val M Runge
MD, Dean M Kaufman, Anhur R Dresdale MD, James T Diehl
MD, Nicholas A Katzen MD, Elliot Kaplan MD, Douglas D
Payne MD FACC, Richard J Cleveland MD FACC, Tufts
University·New England Medical Center, Boston, MA.
Magnetic resonance imaging (MRI) with and without
gadolinium (Gd)·DTPA has been shown to detect a)
coronary Occlusive ischemic injury and b) cardiac transplant
(CT) rejection. To examine the ability of MRI to detect
ischemic injury post·CT in the absence of rejection, we
performed MRI in 18 rats with isogeneic [Lewis graft; Lewis
host] heterotopic CT. Rats underwent MRI (1 Tesla) followed
by sacrifice 1·90 days post-CT. Ischemic injury.
characterized histologically by cellular infiltration andlor
necrosis. was present in 5/5 rats sacrificed at 1·2 days. 3/4
rats at 12-14 days, and 0/9 rats at 30·90 days. On MRI, rats
with histologic ischemic injury had increased T2·weighted
image intensity (TR 2.3s; TE 90ms) and focal areas of
intense enhancement post Gd-DTPA (0.5 mmol/kg) on Tl·
weighted images (TR 0.5s; TE 25ms) (·:p<O.05):
Hjsto!oiY I2 intensity % of aoimals with
(mean ± SE) Gd·DTPA enhancement
Ischemia absent 104 ± 17 10 %
Ischemia present 173 ± 27 • 75 % •
Conclusions; Post·CT ischemia causes increased T2 and Gd·
DTPA·induced T1 enhancement. findings similar to those
described in coronary occlusive ischemia and in CT rejection.
MRI abnormalities in the first J2 weeks post-CT may
represent ischemic injury rather than rejection.






MAGNETIC RESONANCE IMAGING WITH GADOLINIUM-DTPA IN MAN
FOR DETECTION OF ACUTE MYOCARDIAL INFARCTION WITH
OCCLUDED AND REPERFUSED VESSELS.
Albert C. van Rossum M.D., Frans C. Visser M.D., Jaap
Valk M.D., Jan P. Roos M.D., Free University Hospital,
Amsterdam, The Netherlands.
Canine studies have shown enhanced contrast between
infarcted (I) and normal (N) myocardium by magnetic
resonance imaging (MRI) using Gadolinium-DTPA (Gd).
This was more distinct in reperfused compared to
nonreperfused hearts. In this study we evaluated the
use of Gd in 18 pts with acute myocardial infarction
treated with intravenous streptokinase. Catheterization
was performed at 35 ± 24 hrs after infarction. Fo~r pts
had occluded infarct related vessels w1thout
collaterals. Cardiac gated Tl-weighted spin echo MRI
was obtained at 58 + 9 hrs after infarction. Based on
the ECG and ventriculogram the imaging plane was
selected as to encomprise I and N myocardium. Imaging
was performed before and serially up to 35 minutes after
injection of 0.1 romol/kg Gd. Two healthy volunteers
underwent the same protocol, assigning half of their
myocardium as pseudo-infarct. Images were analyzed
using a circumferential signal profile. In this pr~file
I myocardium could be identified by its increased s1gnal
intensity (SI).~ are expressed as SI ratios.
pts controls
1. I/N pre Gd 1.06 + 0.16 NS 0.96 ± 0.06
post Gd 1.39 + 0.13 p(O.OOI 1.03 ± 0.08
2. N post Gd/N pre Gd 1.28 +0.10 NS 1.23 ± 0.12
3. I post Gd/I pre Gd 1.56 +0.21 p.O.08 1.29 ± 0.09
4. I/N occlusion vS reperfusion: 1.37±Q.09 vs 1.3~.14
Conclusion: 1. Gd-DTPA improves Mil detection of acute
myocardial infarction in man. 2. No difference was
noted for myocardium supplied by occluded and reperfused
vessels.
T2 REIAXATIaf TIME AS A PREDlcroR OF CARDIAC TRANSPIANT
~Qfm!UWlS.
Tereasa siltawal, B.A., O!lVid W. mmt;.er. M.D., Eliza1:leth
Braunlin, M.D., F.A.C.C., Maria Teresa Olivari, M.D.,
university of Minnesota Hospital and Clinic,
Minneapolis, MilulIlSOta
Magnetic re&aIlm08 (MR) is a non-invasive iJragirq
lI'Cldality loiUch can characterize tissue water oorrtent
t:hrcutJ. measurement of T2 relaxatim time measurements.
cardiac rejectim has been shawn to be associated with a
significant ircrease in tissue water Caltent,~
MR as a possible Dethod far evaluatin;J transplant
rejection. To assess the diagnostic potential of MR in
det:ectin; card1ac allograft rejection, 99~ T2
relaxation meawrements were perfarmed on 27 transplant
patients at;Jl!d 6 lIa1ths to 64 years who had un:iergone
cardiac transplantation arn carrelated with ClClI"lOCni.tant
~ biqlsy speciJDens. Patients un:!erwent imaqirq
at variable tiIaes l::ietween ale to 150 weeks post
transplant far an avenge total of 3.7 tiInes per
patient.~ biqlsies were d:lt:ained within
24 halrs of i:aIaqirq in IIaIt cases. However, three of
the 18 rejectin;J biopeies were obtained within 72 b:lurs
of i:maqin;J arn 14 of the 81 negative biopeies were
~ within ale week of imaqirq in stable, non-
rejecti1q patients. Eighteen. MR OOservations with
biopsy OCXlfirmBd rejec:tim had a mean myocardial T2 of
51 ± 10 lilli,~ was significantly higher than the 43 ±
7 lIlII found in the 81 MR obeervations loiUch were biopsy
negatiw far rejectim. Usi.n:} the criterion of T2 mean
greater than ar equal to 50 in at least ale area of one
axial slice of the lett ventricle as evidence of
rejection, sensitivity was calauated to be 78' am
specificity 7M. A negative predictive valUEI of 93%
suggesta HR T2 relaxation measureaents my be an
etfectiw screen:In1 test to rule cut rejectial.
EVALUATIOII OF AOKUC II.I!GURGIUUOII B1 CIRE IfAGNETIC
llESOlIAIICE IMAGlllG COMPAIUBG CIMEAllGIOGKAPHl.
Fumiaki Nishimura M.D .• Yasushi Yoshino M.D., Junji Mihara
M.D., Hideki Kamiya M.D., Toshihiro Oouchi M.D., Masahiro
Umeda, Kameda General Hospital, Kamogawa, Japan.
It is well known that regurgitant blood flow of valvular
disease shows signal loss (SL) in cine magnetic resonance
imaging (cMRI). The purpose of this study is to define the
significance of cMRI in evaluating aortic regurgitation
(AR). Oblique cMRl showing the true long axis slice of
the LV was performed in 32 patients assessed AR by cine-
angiography (ANGlO). They did not have mitral stenosis
or severe mitral regurgitation, because they also induced
SL aimilar to that of AR. Each ANGlO was graded as none
(8 cases), mild (9 cases), moderate (9 cases) or severe
(7 cases). RESULTS: All of 25 cases with AR showed their
AR as diastolic SL extending from the aortic valve into
LV. On the other hand none of 8 cases without AR had SL.
Shape of SL was jet like in all of the mild and moderate
cases, but.in all of the severe cases it was diffuse within
LV. Length of SL (SLL) and area of SL (SLA) of AR planime-
tered in any view with the largest area, and the ratio to
length of LV (LVL) and area of LV (LVA) of the same view
calculated. Each index of SL excluding SLL moderate to
severe was significantly high (p<O.005) according to the
degree of AR by ANGlO. By comparing the ratio SLA/LVA (%)
of cMRI to grading of ANGlO, with SLA/LVA ~25% as mild,
26~50% moderate, 51~lOO% severe AR. cMRI classification
was identical to severity of ANGlO in 24/25.
SLL (cm) SLA (cm2 ) SLL/LVL(%) SLA!LVA (%)
4.2:t1.2]* 3.7:t2.0 j * 49:!:l3] * l2:t 7]*
7.8:t1.2]NS 17.4:tS.l]* 78:t 4]* 37:t 6]*
8.8t1.3 29.8t6.3 94 t 8 70tH
(mean:t ISO, *p<O.005)
We conclude that cMRI is a clinically useful method for
documentating and grading AR by analysis of SL.
Wednesday, March 22, 1989
4:00PM-5:00PM, California Room C
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Myocardial Ischemia with Normal Arteries
EFFECfSOFNlTRATES ON CORONARYHEMODYNAMICS AND
ANGINAL 1HRESHOID IN SYNDROME X.
Raffaele Buiiardjnj M D. F ACe, Andrea Pozzati MD.• FilippoOttani
M.D., GianLuigi Morgagni M.D.. Paolo Puddu M.D. Institute of
Patologia Medica and C.C.U., University of Bologna, Italy.
Patients (pts) with anginapectoris. foundtohave angiographically normal
coronary arteries and no evidence of coronary spasm or ventricular
hypertrophy (syndrome X). offeramanagementdilemma to the clinician.
This study was undertaken to investigate the hemodynamic effects of s.l.
isosorbide dinitrate (10mg; ID) in 10 pts presenting with the above set of
fmdings as well as spontaneousepisodes oftransientmyocardialischemia
(anginal pain and~ 0.15 mV STl). In these pts. we measuredgreatcardiac
vein blood flow (GCYBF; mlImin) and mean aortic pressure (AoP;
mmHg) at rest and peak pacing (l0 bpmincrements every 2 min). bothoff
drugs and 5 min following ID. In all pts GCVBF increased by less than
50% or even decreasedduring pacing. This occlllTCd both offdrugs and
with ID. Administration of ID caused a significant reduction (paired t-
test: p< .05) in AoP (x±SD: 94±16vs 104±15atrest, and95±18vs 105±20
at peak pacing) and GCYBF (94±S4 vs 116:f:60 at rest, and 83±33 VI
121±S2 at peak pacing). Angina and significant ST. ~ 0.1 mV) during
pacing occuired after 582±110 sec off drugs and 492±93 sec (p < .02)
following ID. We conclude that: (1) pts with syndrome X exhibit a
reduced coronary flow response to pacing; (2) in such pts. ID may further
reduce blood flow, thus increasing discrepancy between myocardial O2
demand and supply; (3) a failure of the autoregulatory mechanisms to
adequately maintain coronary blood flow during decreased AoP is
suggested.
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EXERCISE CAPACITY AFTER ACUTE AMINOPHYLLINE
ADMINISTRATION IN PATIENTS WITH SYNDROME X.
Michele Emdln M0 Eugenio Plcano M.D., Fabio Lattanzi M.D.,
Antonio L' Abbate M.D. FA.C.C., C.N.R. Clinical Physiology InsttIte,
Universly (/ Pisa , Pisa, bly.
It has~n shown that aminophylline (A) irtuslon increases exercise
capacly in anginal pIS with coronary artery disease, possbly through
adenosine receptors blockade which prevents transrmral steal
phenomena due to excessive arteriolardilatlon dlling exercise. As a
mechanism or myocardial ischemia, atransrmral steal has also~n
hypOthesized in pIS with syn<torne X, in whom there Is a coronary
now reserve reduction allrblted to increased reslslance at the sit (/
small coronary arteries. In this 'NOl'k the eIrect (/ the adenosine
receptor blod<er A on eIl'ort ischemia In pts with syndrome X has
~n tested. Seven pIS were selected on the basis (/: chest pain on
eIl'ort; e!eCtrocardlog'aphlcally postlve (>.1 mV ST-segnent
depression) exercise slress test and dipyridamole slress test; normal
coronary arterlog'aphy and LV runctJon; negatIVe ergonovine test.
Following dolble blind, randomIZed imavenous infusion (/ A (6
rr9Kg over 151 or piacebo (P), the pis underwent t¥igtt bIcyCle
exercise slress test on 2 consecutIVe days. Wlh A, there was an
increase In 'NOl'k tolerance (A: 8t.8 min (/ exercise vs P: 5.7t.9,
p<.01) paralleled by an increase (/ the ischemic threshold, evaluated
through the Rate Pressure Product(rrm Hg xbeatsl min x 11100) at.1
mV (/ ST-segnent depression or at peak exercise, when negatIVe (A:
289:t47 VS P:230t21, p<.01). Thus, at dosage which should
ell'ectively inhbl: adenosine receptors, aminophylline Irtuslon exerts
benenclal eIl'ecls on exercise induced ischemia in syndrome X,
possbly ttrough the prevention (/ now maldislrbLtion ellcted by
inappropriate adenosine release dlling elTort.
SYNDROME X: A PRIMARY METABOLIC DISEASE?
PlXllo Comlc1 M0 FA CC, PlXllo MarrOC:Cinl M.D., Roberto Lorenzonl M.D.•
Giuseppe BUZ21~11. Armm PerIsslnotto, Eleuterio Ferrann!nl M.D.,
Antonio L'Abbate M.D .F A.C.C., Merlo Marzlll1 M.D
C.N.R. Institute of Cl1nlcal Physlollqf, University of Plse. Italy.
Syndrome X( angina pectorIs assocIated WIth posItIve exercIse stress test •
anglographlcal1y normal coronary arteries and no evidence of spasm) Is a
challengtng pathophysiological model. In this stl»( we investigated. at rest
in the postllbsorptive state. coronary hem~namlcs and mvocardtal
metabollsm. by simultaneous arterial (art) and great card1~ vein (GCV)
catheterization. In 6 Pts with Syndrome X(PX) and In 6 Pts with a chest
pain syndrome, no evidence of Ischemia and normal coronary arteries (PN).
GCV flow (thermodilution) and coronary resistance were similar In PN and
PX (S2:t9vs49:tS ml/mln; 1.9:t.2vs2.t:t.2mmHg/ml/mm;p-N.S.l.PN
and PX h~ comparable arterial levels (6.4:t.2 vs S.9:t.2 mM; p=N.S).
myocardial extr~tlon fr~lon (art-GCV/art) (1.4t 1.6~ vs 2.3t 1.1~;
p·N.S,) and myocardial uptake [(art-(lCV)GCVflow] (1.6tS.8 vs
4.6:t2.lI.1mol/mln; paN.S.) of glucose. Free fatty ~tds arterlal levels,
myocardial extrectlon llnd uptake were also camper-able in PN end PX
(1.lt.3 vs .9t.9 mM; 30.4t4.8~ vs 2S.6:t3.4~; IO.Ot2.S vs 6.9t.8
umollmln; paN.S.). By contrast artertall~tate (.64t.69 vs 1.21 t.IS mM;
p<.O 1) and myocardial t~tate uptek.e (6.8t 1.2 vs 19.0tS.O umollmln;
p<.05) were lower In PX than In PN whilst the extr~ion fr~tton was
similar (31t6~ vs 36tS~; p=N.S.l. Pyruvate arterial content (46t4 vs
87t II mM; p<.05), myocardial extr~tlon ( 1tt 14~ vs 49t4~; P<.OS)
8nd uptake (.2t.2 vs 1.86t.S4 umol/m1n; p<.OS) were also lower tn PX
than In PN. Apositive uptake of alantne wes found in PX Whilst the substrate
was released tn PN (.8t.7 vs -1.2t.S umol/min, p<.OS). In CllIlC)ysllK! Pts
wtth Syndrome Xshow multiple metabol1c abnormal1t1es at rest (r8WCell
lactete end pyruvate and Increased alanine myocardllli utIlization) m the
absence of err; evldet"ict of myocardial ischemia This suggests that II primary
metllbOl1c alteration might pIll'( a role in the pathogenesis of this disease.
ENDOTHELIAL FUNCflON INFLUENCES TIlE
CORONARY VASOMOTOR RESPONSE TO
SYMPATHETIC STIMULATION IN MAN
Andreas M. Zejher. MD, Helmut Wollschlager, MD, Helmut
Drexler, MD, Bemward Saurbier. MSc, Hanjorg Just, MD.
Medical Clinic, University of Freiburg, ER.G.
Sympathetic stimulation by cold pressor test(CPT)has been shown
to dilate normal, but paradoxically constrict atherosclerotic coro-
nary arteries(CA)in man.To test the hypothesis that endothelium-
dependent dilation plays a role in this response, we compared the
effects of CPT and the endothelium-dependent dilator acetyl-
choline(ACh) in 9 normal subjects and in 10 patients with coro-
nary atherosclerosis (minimal disease with lesions < 30%, CAD).
Blood flow velocity within the lAD was continuously assessed by
intracoronary Doppler catheter, lAD diameters were measured
by automated quantitation of digitized cine-frames. ACh(l<r'lM,
1O·7M,10-6M) was infused into the lAD via the Doppler catheter.
~ (mean % change from baseline.±. 1SD): In all normal
subjects, CPT increased lAD blood flow velocity by 38.3.±.8.5%
and lAD diameter by 7.5.±.3.1%. Similarly, there was a dose-
dependent increase in lAD blood flow velocity (+94.2.±.19.1%)
and lAD diameter (+9.8.±.3.6%) at ACh concentration of 1()-6M
in all normal subjects. In contrast, in all patients with CAD, CPT
increased lAD blood flow velocity by 44.1.±.26.5%, but decreased
lAD diameter by -8.6.±.3.9%. Identically, there was a dose-depen-
dent increase in lAD blood flow velOCity by 121.7.±.54.6%, but a
decrease in lAD diameter by -17.2.±.5.9% at ACh concentration
of 1()-6M in all patients with CAD. There was complete agreement
in the direction of the response to CPT and ACh. Intracoronary
nitroglycerin (endothelium-independent) caused lAD dilation by
17.1.±.4.5% in all subjects.
Thus, the dilation of normal CA and the constriction of
atherosclerotic CA with CPT exactly mirror the response tO'1he
endothelium-dependent dilator ACh. These results suggest that
endothelial function may play an important role in the coronary
vasomotor response to sympathetic stimulation by CPT in man.
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Ischemia and The Ambulatory
Electrocardiogram
SILENT ISCHEMIA ON AMBUlATORY ECG DITORING PROVIDES
AIJl)ITIONAL PROGNOSTIC INFORMATION IN PATIENTS IIITH STABLE
ANGINA AND A POSITIVE EXERCISE TREADMILL TEST
Prakash Deedwania, H.D., F.A.C.C., John Nelson, H.D.,
Enrique Carbajal, H.D., VAMC/UCSF, Fresno, California
Patients (pts) with chronic stable angina (CSA) and
diagnostic ST depression (ST~ ) on exercise testing (ET)
have frequent silent ischemic events (SIEs) during
ambulatory ECG monitoring (AEH). However, it is unknown
whether SIE on AEH provides prognostic stratification in
addition to that of ET in pts with CSA. In this study, we
prospectively evaluated 76 consecutive male pts with CSA,
proved CAD, ST f on ET who underwent 24 hr AEH with a FH
system. All pts were followed every 3-4 months and
continued their antianginal drugs. Clinicians were
blinded to the AEH data. A SIE on AEH was defined as ST~
~ lnun l80 msec from J), lasting ~ Imin, and without
symptoms in the diary. Based on AEH and ET data, the pts
were divided into 2 groups (Gr); Gr-l, 31 pts with >40
min/d of SIE and time to Inrn ST ~ on ET of s,6min (6minET)
and Gr-2, 4S pts with s,40min/d of SIE and s,6minET. During
the mean follow-up period of 23±8 mos, Kaplan-Heier
actuari al analysi s was performed for the time-dependent
probability of cardiac events includ-
ing death, HI and unstable angina. As
shown in Fig, the GrI pts had signif-
cantly (P.0.036) worse prognosis. The
stepwise Cox hazard analysis of 9
variables including ET data revealed 1 , ••
presence of SIE on AEH as the most ~
powerful predictor of mortality.
(p-0.007). Thus, SIE on AEH is ~n
independent marker of poor prognosis --'.~--M
in pts with CSA and a positive ET.
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These data indicate that (1) maintained glucose activity
despite the presence of severe left ventricular asynergy
may contribute to exercise-induced ST elevation, and (2)
exercise-induced ischemia detected by N-1J ammonia PET
mayor may not cause ST elevation.
THE IMPORTANCE OF ASSESSING ST ELEVATION BY HOLTER
MONITORING IN UNSTABLE ANGINA.
Anatol! Langer M.P., Michael R. Freeman M.P., FACC. Paul
V. Armstrong M.P., FACC. Toronto. Canada.
Tha clinical significance of ST elevation (ST-E) on
Holtar monitoring (HH) in pts with unstable angina iii
uncertain since previous studies have grouped ST-E
together with ST depression (ST-P) in assessing progno-
sis. Ve studied 135 pts with 24 hr HH and continuous
intra-arterial BP monitoring on admission to CCU.
Coronary angiography (CA) was performed at 4.2±2.6 days.
There was ST shift in 89 pts: 20\ had ST-E (~l mm at
J), 62\ had SToP (~l mm. 80 msec after J). and 18\ had
both. Pts with ST-E were similar to those with SToP or
both with respect to clinical characteristics. previous
infarction (MI) , frequency of symptoms with ST shift.
and severity of coronary artery disease (CAD). The
incidence of cardiac events (death. MI, urgent revascu-
larization) was also similar: ST-E 50\, SToP 46%. and
both 62%. Compared to pts without ST shift. pts with
ST-E had more vessals with ~50\ stenosis (2.3±.9 vs
1.6±1.2, p<.05) and more in-hospital cardiac events (50\
vs 22\. p<.05). A total of 593 episodes of ST shift were
detected, of which 33\ were ST-E and 67% SToP; there was
no difference in duration of ST shift (16±30 vs 18±30
min) or rate-pressure product ~ssociated with ST shift
(9.0± 2.7 vs 9.4±2.8 BPxHRxlO) but the magnitude of
ST shift was slightly greater with ST-E (1.5±.9 vs
1.3±.5 mm. p<.Ol).
Ve conclude that patients with unstable angina and ST-E
on Holter monitor have more severe CAD and more frequent
cardiac events than pts without ST shift. Even though
ST-E is less frequent than SToP. it implies a similarly
poor outcome and. therefore. should be considered
together with SToP for prognostic stratification.
EXercise Increased
Regional Asynergy -Induced FOG
EF (%) Ischemia Uptake
LVEF
(%)
To evaluate the significance of exercise-induced ST-
segment elevation, we utilized positron emission
tomography (PET) with F-18 deoxyglucose (FOG) and N-1J
ammonia to characterize regional myocardial blood flow
and glucose metabolism in 27 patients with Q wave
anterior myocardial infarction. PET was performed with
N-1J ammonia at rest and after ergometer exercise, and
with FOG at rest with fasting. Thirteen patients
developed ST-segment elevation during exercise, and the







SIGNIFICANCE OF EXERCISE-INDUCED ST-SEGMENT ELEVATION IN
PATIENTS WITH Q WAVE ANTERIOR MYOCARDIAL INFARCTION:
EVALUATION BY POSITRON EMISSION TOMOGRAPHY.
Tetsuro Fudo M.D., Hirofumi Kambara M.D" F.A.C.C.,
Masataka Hayashi M.D., Tetsuo Hashimoto M.D., Ryuji
Nohara M.D., Nagara Tamaki M.D., Keiji Yamashita M.D.,










LEFl' VEtmUaJLAR FmCl'ICN AT REST AND THE PREIlALmcE OF
A/oBULAroRY SILENT lSOfOOA IN <D1alARY AR'reRY DISEASE
Arshed A. Ouyyumi{ M.D., Julio A. Panza, M.D., Kevin E.
McCarthy, M. D., T1IOOthy S. callahan, R:>bert O. BallOW,
M. D., FACC., stephen E. Epltein, M. D., FACC, NHU3I,
Bethesda,MD
LV function at rest and during exercise (ex) have
inp>rtant progoostic inplications in coronary disease
(CAD). 'lb! relation between LV function and the
prevalence and frequency of silent ischemia during daily
activities is unknown. We studied 80 CAD pts free of
cardiac drugs with ex radionuclide angiography and 48 hr
ambulatory sr monitoring. 'lt1e incidence and duration
(min/48hr) of anbulatory ischemic episodes (IE) in 51 pts
with normal resting ejection fraction (EF) ()45%) and in
29 pts with sutnormal resting EF «45%) was ENaluated. IE
in the subgroups of pts manifesting an ischemic response
to exercise «2% increase or a decrease in ex EF) was also
evaluated: -
~ Sb1oa.! BP
pts with IE 41%
Duration (m) 70+29
%of silent IE 8li
o Wave HI 45%
pta with _ BPJ. 17
pta with IE 47%
Duration (m) 81+39
*. p<.05, **a p<.oI mean ± SE
pts with sutnormal rest EF had lower prevalence of IE.
Qlce IE occured, the ci1ration of silent or painful IE was
similar in both groups. '!bus, IE are less frequent in pta
with resting LV dysfunction even in the subgroup
developing more severe dysfunction with ex, compatible
with ex-indJ.ced ischemia. J\i'ltlulatory sr BeCJIIerlt
electrocardiography may rot be a sensitive indicator of
silent ischemia in pts with resting LV dysfunction.
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THE MECHANISM OF THE ONSET OF ATRIAL FIBRILLATION IN THE
WOLFF·PARKINSON-WHITE SYNDROME: HOW IMPORTANT IS THE
ACCESSORY PATHWAY?
Osamy Fyiimura M0 George Klein M.D., F.A.C.C., A~un Sharma M.D..
F.A.C.C., Raymond Yee M.D.• F.A.C.C., University Hospital, London,
Ontario, Canada.
It has been suggested that reentry In branching networks of accessory
pathways (AP) may be implicated in the high incidence of atrial fibrillation (AF)
observed in the WoIfI-Parkinson-White (WPW) syndrome. To evaluate this,
we studied the mode of onset of 98 episodes of AF lasting at least 30
seconds in 78 patients during diagnostic electrophysiolgical study. No
patient had organic heart disease and 31 had clinical AF prior to stUdy. AF
occurred during routine pacing and extrastimulus testing for 71 episodes and
occurred in the absence of stimulation in 27. Electrograms were recorded
from the high right atrium. His bundle position and coronary sinus (LA). AF
patients were then compared to a control group of 53 WPW patients in whom
atrial fibrillation could only be sustained with rapid atrial pacing.
Ninety·two of 98 episodes were technically suitable for analysis. AF
Invariably began with a rapid atrial tachycardia which became progressively
disorganized within 10 to 20 cycles. It was Initiated during RA stimJlation (n-
57), RV stimUlation (n.11 l, during reciprocating taChycardia (n-22) and
apparently spontaneously during sirlls rhythm (n-2). Earliest atrial activation
during the initiating rapid tachycardia OCQJrred at a right atrial site in 73
epiSodes and at a LA site in 19 epiSodes. Most episodes started at a high
right atrial site regardless of AP location with only 20% of episodes starting at
the electrode closest to the AP. However. AF started at the AP site In 12 of
22 episodes occurring spontaneously during reciprocating tachycardia.
Patients with AF had longer PA intervals (54.:t. 14 vs 42.:t.12. p.cO.001) shorter
atrial functional refractory period (226.:t. 38 vs 240;t.30, p.0.49) and shorter
effective refractory period of the AP (279.:t. 26 vs 304.:t. 75 msec , p.0.03).
These data suggest that multiple factors may explain the high incidence of
AF in WPW with intrinsic atrial factors and accessory pathway factors probably
both playing a role. Onset of AF close to the AP site supports the theory of
AP involvement In the genesis of AF in some patients.
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We conclude that the ability of procainamide to predict SRR ~ 250 by loss of
preexcitation In sinus rhythm Is dose dependent. Specificity declines
markedly after cumulative doses >550 mg.
SUSTAINED PREEXC!TED TACHYCARDIA: AV NODAL RATHER
THAN TRUE ANTIDROMIC REENTRY AS THE MAIN MECHANISM.
Mohammad Jazayeri M.D., Galen Van Wyhe M.D .• James
McKinnie M.D., Boaz Avitall M.D., Sergio Kershenovich
M.D., Patrick Tchou M.D., Masood Akhtar M.D.,
F.A.C.C., Sinai Samaritan Medical Center. Milw. WI.
Determination of underlying mechanism of preexcited
tachycardia (PRET) has important clinical implications
especially when surgical ablation of accessory pathway
is considered. During electrophysiologic evaluation
of 94 consecutive pts with manifest ventricular (V)
preexcitation, 11 pts had PRET. Pts with PRET due to
atrial (A) flutter/fibrillation were excluded. Three
mechanisms were identified: 1) AV nodal tachycardia
(6 pts) by meeting the following criteria: a) His
bundle-right bundle activation interval similar to
that during narrow QRS tachycardia. b) Retrograde
conduction delay in the His-Purkinje system during
introduction of premature ventricular complex without
affecting the corresponding A-A interval. c) Abrupt
A-A interval prolongation followed by V-V interval
lengthening of the same degree. In 4 pts who
underwent surgery, intraoperative mapping confirmed
the diagnosis. 2) Antidromic reentry utilizing 2
accessory pathways (4 pts). No pt had true antidromic
reentry using normal pathway as the retrograde limb.
3) Atrial tachycardia (1 pt). Conclusion; Our data
indicate that AV nodal tachycardia is not an uncommon
mechanism of PRET. A thorough electrophysiologic
evaluation is necessary to separate AV nodal
tachycardia from other mechanisms of PRET (e.g. true
antidromic reentry). This information is particularly
useful for pts undergoing surgical ablation of
accessory pathway, since AV nodal tachycardia is also



































THE RELIABILITY OF PROCAINAMIDE IN PREDICTING THE SHORTEST
PREEXCITED R-R INTERVAL DURING ATRIAL FIBRILLATION IS DOSE
DEPENDENT
K Ana Boahene M P George J.Klein M.D., FAC.C., Arjun D.Shanna M.D.,
FAC.C., Raymond Yee M.D., FAC.C., Osamu Fujimura M.D., University
Hospital, London, Ontario, Canada.
A shortest R-R interval (SRR) during atrial fibrillation (AF) ~ 250 msec Identifies
pafienfs (pfS) with preexcltation potentially at risk for ventricular fibrillation.
Loss of preexcitation with procainamide infusion during sinus rhythm has been
suggested as a means to Identify pts with long effective refractory periods
(ERP) and hence low risk dUring AF. These findings have been questioned.
We hypothesized that the conflicting results are related to different
methodologies and dosages, and proceeded to test procainamide, in a rigidly,
standardized fashion, With the goal of predicting SRR ~ 250 by loss of
preexcitation ("true positive"). Thirty·two consecutive pts with preexcitation
referred for electrophysiologic testing were studied. After control data were
obtained, AF was Induced by rapid atrial pacing and SRR during AF was
detennlned. After termination of AF, we gave procainamlde in incremental
doses of 50, 100,200,400 and 250 mg every 10 minutes up to a cumulative
dose of 1 gm or to loss of preexcitation. These doses were given over 1-2
minutes in the supine position. except for the 400 mg dose given over 3-4
minutes. During the control period and after each dose. accessory pathway




AGE-RELATED DIFFERENCES IN THE ELECTROPHYSIOLOGIC
PROPERTIES OF ACCESSORY PATHWAYS IN PATIENTS WITH THE
WOLFF-PARKINSON-w~ITE SYNDROME.
Doug1as_1. Packer M.D .. F.A.C.C., Jodie L. Hurwitz M.D ..
Michael J. Barber M.D, Ronald J. Kantor M.D., Eric N.
Prystowsky M.D., F.A.C.C., Duke University, Durham, NC.
In order to assess the relationship between age and
electrophysiologic characteristics of accessory path-
ways, 102 pts under 16 years of age (mean age 13 t 4
yrs) (PEDS) and 503 pts older than 16 yrs (mean age 36 t
14 years) were studied. The prevalence of other heart
disease and sudden death were similar in both groups.
Right freewall and multiple accessory pathways were
significantly more common in PEDS than adults (28% vs.
18% and 25% vs. 15%). The accessory pathway anterograde
effective refractory period (APERP), the shortest RR
interval between 2 preexcited complexes and average RR
intervals during atrial fibrillation, and the recipro-
cating tachycardia cycle length (RTCL) were compared as
shown:
APERP Shortest RR Average RR RTCL
Peds 257 t 56 213 t 50 300 t 71 283 t 45
Adult 284 t 91 240 t 66 346 t 81 323 t 51
p. .025 .0014 .0001 .0001
The APERP and shortest and average RR intervals were
significantly shorter in PEDS than adults. The RTCL
difference was due to a shorter A-H interval in the
former group (113 t 43 vs. 133 t 52/p·.0065), with no
difference in the ventriculo-atrial interval (113 t 39
vs. 115 t 37) despite expected differences in cardiac
size. These data indicate an increased prevalence of
right and multiple pathways in symptomatic PEDS, more
rapid atrial fibrillation and RT rates in younger pts,
and suggest that the change in RTCL with age is due to
AH and not VA interval prolongation.
SAFETY AND EFFICACY OF ORAL FLECAINIDE THERAPY
IN PATIENTS WITH THE WOLFF·PARKINSON-WHITE
SYNDROME
James L CQckrell. MD, Christina Titus, MS. RN, Ibrahim
Helmy, MD, Jonathan J. Langberg. MD, Jerry C. Griffin, MD,
FACC, Michael A. Lee, MD, Melvin M. Scheinman, MD.
FACC. University Qf CalifQrnia. San FranciscQ, California.
A tQtal Qf 59 pts with the WQlff·ParkinSQn-White (WPW)
syndrome underwent electrophysiologic studies (EPS) befQre
and after Qral f1ecainide (F) therapy. Flecainide therapy
prevented inductiQn of sustained supraventricular tachycardia
(SVT) in 41 pts (69%) and these pts were treated chronically
with F. Of the remaining 18 pts, the drug was discontinued in
5 during in-hQspital monitQring (spontaneQus life-threatening
atrial fibriliatiQn -2 pts, breakthrQ~9!! parQxysmal
supraventricular tachycardia (PSVT) -1, and incessant SVT
-2), and 13 (22%) had F discQntinued after repeat EPS
(inducible sustained SVT -11, new atrial arrhythmias -1, and
severe sUPfreSSiQn Qf sinus nQde functiQn ·1). Over a
follQw-up 0 18±10 mQnths (range, 3-31), 32 Qf the 41 pts
(78%) treated with F have cQntinued tQ do well with no
significant symptoms Qr adverse reactiQns. F was
discQntinued in 9 (22%) because of sudden death (1), central
nervous system side effects (3), recurrent PSVT (3) or pt
preference for surgery (2). Six Qf the 59 pts had Significant
proarrhythmic effects, including SUdden death, incessant SVT,
new atrial arrhythmias or prQlonge9 sinus pauses. These pts
had more organic heart disease (4 Of 6 had OHD, vs 0/53 pts
without proarrhytmic effects), and were older (45±17. range
22·82 vs 36±12, range 9-73). CQnclusiQn: (1) Flecainide
cQnstitutes effective fong-term therapy fQr the majority of pts
with WPW. (2) Pre·discharge EPS and in·hQspital mQnitQring
detected mQst pts with seriQus proarrhythmic effects. (3)
PrQarrhythmic effects occurred predQminately in Qlder
subjects with organic cardiac disease.
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EFFECTS OF UPRIGHT POSTURE ON ATRIOYENTRICULAR
ACCESSORY PATHWAY CONDUCTION
David E Mann MD" F,A C C. and Michael J. Reiter, MD., Ph.D.,
F.A.C.C. University of Colorado Health Sciences Center, Denver,
Colorado,
Electrophysiologic testing of patients with atrioventricular (A V)
accessory pathways (AP) is usually performed in the supine
position. To study the effects of upright posture (UP) we
measured anterograde (ante) and retrograde (retro) AP block (B)
cycle length (CL) and effective refractory periods (ERP) in 19
patients (mean age 28 years) while supine and with 450 UP. UP
enhanced ante and retro AP conduction:
supine (ms) ~ Q
ante AP BCL 374 ± 52 303 ± 33 <.05
ante AP ERP 286 ± 17 249 ± 10 <,01
retro AP BCL 320 ± 33 285 ± 31 <.05
retro AP ERP 312 ± 26 274 ± 15 .06
During induced atrial fibrillation (AFB) the mean RR interval
shortened with UP (377 ± 13 to 325 ± II ms, p <.01) and the
shortest RR shortened, but not significantly (259 ± 16 to 234 ±
14 ms, p NS). The percentage of preexcited bealS during AFB
did not change (70 ± 14% supine. 61 ± 15% during UP, p NS).
Sustained orthodromic reciprocating tachycardia (RT) was
induced in II patients. RT CL shortened with UP (357 ± 26 to
304 ± 21 ms, p <.01). primarily due to a decrease in ante AV
nodal conduction time (198 ± 25 to 162 ± 14 ms, p <.05).
Retrograde AP conduction time during RT shortened slightly
(130 ± 17 to 123 ± 16 ms, p < .05). In patients with RT or AFB,
both supine and UP testing overestimated the spontaneous
tachycardia CL. but UP testing did so to a lesser degree (24 ± 25
ms overestimation with UP vs 69 ± 25 ms supine. p <.05). Thus
UP I) enhances ante and retro AP conduction, 2) shortens thc
mean RR interval during AFB, 3) shortens RT CL, 4) more
closely reproduces the CL of spontaneous RT and AFB, and 5)
may be useful in the assessment of patients with AP.
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Pediatric Cardiac Imaging
USPIRATORY IDLUBJICB 011 RV AlII) LV DIASTOLIC
rILLIIIG III 1I0RMAL CBILDUlf.
Thomas W, Riggs, M.p" F,A,C,C, and A, Rebecca
Snider, M.D., F.A.C.C., wm. Beaumont Hosp, and
C.S, Mott Hosp" Royal Oak and Ann Arbor, MI,
Our objective was to examine the effects of
respiration on RV and LV diastolic fillinq in
normal children. Twenty children (aqes 1-11)
had Doppler examinations of the RV and LV
inflow, recorded with respiration and ECG. We
measured the peak E and A velocities (em/sec)
and the E and A areas, and then computed the
ratios: peak E/A velocity , E/A area, and the
1/3 area fraction. Inspiration siqnificantly
auqmented both the early and the late phases of
RV fillinq in a similar fashion; thus the peak
E/A, E/A area and 1/3 area were unaffected by
respiration, Inspiration selectively lowered
early LV fillinq; thus the peak E, peak E/A,
E/A area and 1/3 area were each decreased,
Inspiration lXpiration p-ya1ue
RV peak B 62.1 ± 12.8 49,3 ± 12,0 < 0.0001
RV peak B/A 1.61 ± 0.51 1,48 ± 0.46 NS
RV B/A area 2,56 ± 1.29 2,48 ± 1.34 NS
RV 1/3 area 0,40 ± 0.06 0.41 ± 0,07 NS
RV peak A 41,7 ± 11,5 35,2 ± 9.3 < 0.0001
LV peak B 84.8 ± 11.0 92.1 ± 14.1 < 0.0001
LV peak B/A 1,72 ± 0.42 2.00 ± 0.64 < 0,005
LV B/A area 2,72 ± 1,04 3,09 ± 1,34 < 0.001
LV 1/3 area 0,44 ± 0,09 0,50 ± 0.09 < 0.001
LV peak A 52.1 ± 12,1 50.0 ± 13,1 NS
Conclusion: Inspiration enhances RV venous re-
turn, while the LV response to inspiration is a
complex interplay amonq LV preload, LV
atterload and ventricular interdependence.
Respiration siqnificantly alters variables of
RV and LV diastolic tillinq. Any pediatric
assessment of RV or LV diastolic function
should be standardized for respiration.
THE POOR PROGNOSIS FOR FETUSES WITH PRENATALLY DIAGNOSED
TRICUSPID VALVE ABNORMALITIES. Lisa K. Hornberger, B.A.,
David J. Sahn, M.D., FACC, Charles Kleinman, M.D., FACC
Kathryn Reed, M.D., Univ Calif, San Diego, CA and Univ
Ariz, Tucson, AZ and Yale University.
Tricuspid valve disease (TVD) in newborns and children
is often well tolerated, but studies suggest a worse
prognosis for TVD detected in-utero. We reviewed 27
fetuses with TVD and significant tricuspid insufficiency
(TI) diagnosed in utero (19-35 wks gestation), after
referral because their obstetrical ultrasounds showed an
abnormal atrioventricular valve or an asymmetric four-
chamber view. One fetus had Trisomy 13. None of the
others had any non-cardiac defects. Seventeen fetuses
had ·Ebstein's malformation, 7 had TV dysplasia with
poorly developed, normally inserting leaflets, and 3 had
an unguarded orifice without significant TV tissue and
low velocity, non-turbulent Doppler TI. Four fetuses
initially had normal forward PA flow but on subsequent
studies had retrograde ductal PA flow in association
with the development of critical pulmonary stenosis (PS)
[1] or pulmonary atresia (ATR) [3]. Four other fetuses
had PS and 3 had ATR on their initial exam. Serially
studied fetuses had progressive right-sided cardiomegaly
including 3 fetuses who had normal RV size when initial-
ly referred. Twelve fetuses died in utero and 11/15 who
were liveborn died despite vigorous medical and, when
indicated, surgical management. Confirmation of anatomic
diagnosis was obtained by autopsy for 19 fetuses and by
cath or at surgery in all but 3 of the others. Ten
autopsies documented pulmonary hypoplasia, total lung
weight < ! of expected. The prognosis for fetuses with
in-utero diagnosed TVD is extremely poor and their pre-
natal course includes progressive right heart dilata-
tion, lung hypoplasia and in some, development of
pulmonary stenosis or pulmonary ATR.
A NEW METHOD FOR NONINVASIVE ESTIMATION OF VENTRICULAR
SEPTAL DEFECT (VSD) SHUNT FLOW BY COLOR DOPPLER, IMAGING
OF THE LAMINAR FLOW CONVERGENCE REGION ON THE LEFT SEP-
TAL SURFACE. Valdir A. Moises, M.D" Lisa Hornberger,
Benedito Maciel, M.D., Azucena Murillo, M.D., David J.
Sahn, M.D., FACC, Univ Calif, San Diego, CA,
Flow cORvergence (FC) on the left septal side of a
VSD is commonly imaged by color flow Doppler (CFD) as a
region of aliased velocities going into the VSD orifice.
If the first aliasing region represents a hemispherical
isovelocity boundary of FC going into the VSD, volume
flow can be estimated using the radius (R) of the first
alias from the VSD orifice and the Nyquist limit (NL)
velocity. R should increase as a function both of VSD
size and trans-VSD flow velocity. We measured R (nor-
malized for body surface area [BSA) and calculated R x
NL, the BSA normalized planimetered area (A) inside R (x
NL), the hemisphere volume (HV) of radius R (2/3 w R'),
and the hemisphere surface (HS) area (2 w R2) as esti-
mates of VSD flow from CFD studies in 18 children aged 2
to 84 months with single perimembranous VSD using a
Toshiba SSH 65A, 3.75 MHz 4 kHz. These measurements
were compared to catheterization determined shunt flow
through the VSD (Qp-Qs) and pUlmonary/systemic flow
ratio (Qp/Qs), For simple indices, R (r20.80), R x NL
(r-0,84) A (r=0.97) and A x NL (r-0.94) had the closest
correlation with Qp-Qs for the 10 Pts who showed good Fe
in four-chamber views and A (raO.90) and A x NL (raO.92)
correlated well with Qp/Qs. For Fe on long-axis images
of 15 Pts, A (r=0.85) HV (r-0.80) HV x NL (r-0.89) and
HS x NL (raO.88) showed good correlation to Qp-Qs, and A
x NL (r-0,79) HV x NL (r-O.80) and HS x NL (raO.82)
correlated well with Qp/Qs, Indices derived from the FeR
proximal to a VSD allow calculation of trans-VSD shunt
flow and may serve as simple and clinically useful
estimates of VSD shunting.
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DOES COLOR DOPPLER ECHOCARDIOGRAPHY DETECT
ADDITIONAL SMALL MUSCULAR DEFECTS IN INFANTS WITH
A LARGE VENTRICULAR SEPTAL DEFECT?
Alvin Chin. MJ1., Ernerio Alboliras, M.O., Gerald Barber, M.O.,
John Murphy, M.O., Gregg Helton, M.O., John Pigott, M.O., William
Norwood, M.O.,Ph.O., F.A.C.C.
Children's Hospital of Philadelphia, Philadelphia, PA
Although color Doppler (CO) can clearly detect one or more
small ventricular septal defects (VSO's), whether it can do so in the
setting of a known large (non-restrictive) VSO is unknown. In the
presence of a large (low-resistance) pathway through the septum, the
amount and velocity of blood shunting through additional small
muscular VSO's (ASM VSO's) may be low. In the face of the trend
toward neonatal reparative surgery of many congenital heart
malformations, one of the only mitigating factors is the identification
of ASM VSO's; for example, a neonate with transposition, a large
malalignment-type VSO, and ASM VSO's might more easily undergo
arterial switch repair 3 months later when the A5M VSO's may have
closed spontaneously.
We evaluated with CO and angiography (angio) 129 pIS under
2 years who subsequently underwent surgical closure of a large VSD:
tetralogy of Fallot 49, transposition II, perimembranous VSO with
normal great arteries (NL GA's) 27, aortic arch anomaly 13,
atrioventricular canal IS, other lesions 14. Only 4 had ASM VSO's at
repair. The ASM VSO's were detected by both angio and CO in 2,
by angio only in I, and were missed by both techniques in I. The
negative predictive values of CO and angio in the detection of ASM
VSO's is 0.98 and 0.99, respectively. Of those 67 pts who were over
6 mos old, only I had an ASM VSO.
Conclusions: I) CO does not appear to completely eliminate,
false-negative diagnosis of ASM VSO's in the presence of known
large VSO; 2) The prevalence of ASM VSO's, estimated by previous
reports to be as high as IS'lb in infants less than 12 mos, falls to J.S'lb
by age 6 mos; 3) The vast majority of ASM VSO's close in the first
few mos.
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Left Atrium/Atrial Fibrillation/Pericardium
LEFT ATRIAL ENLARGEMENT AS A CONSEQUENCE OF ATRIAL
FIBRILLATION: A PROSPECTIVE ECHOCARDIOGRAPHIC STUDY.
AnthQny J Sanfi] toDQ MD, Vivian M Abasca1 MD, Mary
Sheehan RH, Pamela Harrigan ROMS, Lynn B Oertel RH,
RQbert A Hughes MD, Arthur E Weyman MD FACC.
Massachusetts General HQspita1, BQston.
Left atrial enlargement (LAE) is cQmmQn1y Qbserved in
patients presenting with atrial fibrillatiQn (AF). It is
nQt clear, hQwever, whether the LAE is the cause Qr CQn-
sequence Qf the AF. This issue is Qf clinical impQrtance
since LAE is knQwn tQ increase risk fQr thrQmbus fQrma-
tiQn and embQlizatiQn. Its pQtentia1 prevention by
CQrrect i Qn Qf the AF wou1 d sUPPQrt aggress ive treatment
Qf the arrhythmia in even asymptQmatic patients.
TQ address this question, 14 pts (age 48-78 yrs, mean
-68.3 yrs) with non-rheumatic AF prQspective1y underwent
serial echQcardiQgraphic (echo) studies separated by 11-
28 mQS (mean-20.4 mQs). The patients were selected on the
basis of the fQllQwing findings at their inita1 echQ: 1)
nQ significant mitral valve or LV pathology, 2) no or
minimal mitral regurgitatiQn (MR), 3) nQrma1 or only
mildly increased LA size. LA measurements were carried
out in the anterQ-posterior (AP), mediQ-1atera1 (ML) and
superQ-inferiQr (S1) dimensiQns. Volume (VOL) was
calculated using an e11ipsQid fQrmu1a.
RESULTS: (all values given ± standard deviatiQns)
AU.!!!ml MU.!!ml ~ LA VOL (cm~.-l
Study II 38.6 ± 4.9 40.6 ± 3.7 54.6 ± 7.8 45.2 ± 11.0
Study 12 42.4 ± 4.6 46.1 ± 5.2 62.4 ± 6.2 64.1 ± 13.5
p value <0.008 <0.005 <0.002 <0.0001
CONCLUSIONS: LA size increases in patients with AF even
in the absence Qf significant MR, mitral valve patho1Qgy,
Qr LV disease. Thus, AF appears tQ induce LAE. CQrrection
Qf the AF may therefQre prevent LAE and pQtentia1ly
reduce risk fQr t~rQmbus formatiQn and stroke.
CHANGES IN LEFT ATRIAL SIZE DUE TO CHRONIC ATRIAL
FIBRILLATION. Guillermo Sosa-Suarec, Steven Lampert,
Thoma. B. Graboy., Shmuel Ravid, Bernard Lown, Brigham
and Women'. Hospital and Harvard School of Public
Health, Bo.ton, HA 0211$
Unsettled is the question of whether left atrial (LA)
enlargement (E) in patients with atrial fibrillation
(AF) is a consequence of left ventricular (LV) function
or whether the AF alone causes LAB. We reviewed 436
patients (PTs) with AF and selected 22 with lone AF who
were free of any structural heart disease based on the
normal phy.ical exam and doppler-echocardiography
study. AF was chronic (CAF) in 10 PT. (agel 64 yr•• )
and paroxysmal (PAF) in 12 PT. (agel 63 yrs). All PT.
were followed for an average of 6,2 yr. (1.1 - 13 yr.),
there wa. no difference in average follow-up in the 2
group.. Baseline measurement. of LA .ice, LV .ize,
fractional .hortening (FS) and heart rate (RR) were
similar in the CAr and PAF groups. LA .ize increa.ed
an average of .6 cm (-0,1-1.$) in all patients. In CAr
PT. it increased .81 cm compared to .38 em in PAP PT.
(p - ,0$). LV dimension. and FS did not change .ign-
ificantly during the observation period. HR tended to
increa.e in the CAF group (II! 27 bps) and decrea.ed
alightly in the PAP group (-4 ! 17 bps) (NS). Tha
change in LA .ice wa. most clo.ely related to duration
of follow-up and whether AP wa. chroniC or paroxy.mal.
The LA increase. 0.12 cm/yr in patient. with CAr. LAE
did not correlate with either baseline mea.urement. of
LV function or with change. in LV .ice or function. We
conclude that the LA can increa.e in .ize aa a con.e-
quence of CAr alone, independent of any change. in LV'
.ice or function. The mechani.m for this effect needa
to be explored.
THE EFFECT OF ATRIAL CONTRACTION AND SYNCHRONEITY OF
CARDIAC CONTRACTION ON VENTRICULO-ARTERIAL COUPLING.
Kazuhiro Yamamoto M.D.. Kazuhisa Kodama M.D., Atsushi
Hirayama M.D., Tomoki Ohara M.D., Masaaki Uematsu M.D.,
Akira Kitabatake M.D., Takenobu Kamada M.D.,
Cardiovascular Div., Osaka Police Hospital, Osaka, Japan
We investigated the effect of the atrial contraction and
synchroneity of cardiac contraction on ventriculo-
arterial coupling in 6 patients with sick sinus syndrome.
Pacing leads were placed in right atrium (A) and right
ventricle (V), then we obtained left ventricular
pressure-volume data by conductance catheter inserted
into left ventricle during A pacing, AV sequential
pacing, and V pacing. In V peeing, VA sequential peeing
was performed to neglect atrial contraction. In AV
sequential pacing, Atrioventricular delay was kept at 150
msec. The slope of the end-systolic pressure-volume
relationship (Ees) was determined by inferior vena caval
occlusion. The effective arterial elastance (Ea) was
expressed by the ratio of end-systolic pressure to stroke
volume. Because heart rate was controlled at a constant
rate (90bpm), we used Ea as an index of afterload. The
mechanical energy efficiency (Eff) was determined by the
ratio of external work to pressure volume area. In AV
sequential pacing, compared with A pecing, Ees and Eff
were reduced, (-15!,12%, -8!,6%, p<0.05), but Ea didn't
change significantly. In V pacing, compared with AV
sequential pacing, Ees, Eff, and Ea altered
significently (-24!,11%, -16!,14%, +16!,15%, p<0.05).
Conclusions: 1), Synchroneity of cardiac contraction
enhances contractility of left ventricle; 2), Atrial
contraction enhances contractility of left ventricle,
and reduces afterload; 3). Atrial contraction and
synchroneity of cardiac contraction are important factors
on ventriculo-arterial coupling.








LEFT VENTRICULAR FUNCTION IN ATRIAL FIBRILLATION:
A COMPARISON BEFORE AND AFTER CARDIOVERSION.
Harry Crijns M.D., Isabel van Gelder M.D. ,Paul Blanksma MD
Nico Knop, Kong Lie M.D., Dept.of Cardiology, Thoraxcenter
University Hospital Groningen, The Netherlands.
LV function is difficult to establish in atrial fibrilla-
tion(AF) because of the variable preload.To compare it be-
fore and after electrical cardioversion(CV) we developed a
computerized system for on line beat-to beat measurement
of RR-interval, filling time, filling volume and ejection
fraction(EF). For EF and filling volume measurement we
used a nuclear probe(Nuclear Stethoscope) connected to a
microcomputer via an AID converter. With the help of this
system we looked after the influence of the duration of
the preceding RR intervals on diastolic and systolic LV
function. In 10 pts with AF we found a linear relationship
between filling time and RR-interval. The regression line
crossed the RR-axis at 369t13 ms. This may be considered
as the minimal duration of the electromechanical systole.
Filling time was relatively increased when the precedinR
RR-interval was less then 500 ms.This curvilinear relation
ship may be considered as a measure of diastolic function.
EF was dependent on at least two preceding RR-intervals in
a curvilinear relationship.Mean EF during AF was 37±10%,
found at a mean RR of 647±40 ms.EF during AF,using only
the RR-intervals with the duration found after CV, was
4l±11% t8p 0.05),whereas EF after CV(sinus rhythm with a
mean RR-interval of 853t83 ms) was 40tll% (N.S.,compared
to EF before cardioversion). Conclusions: 1. LV function
in AF is influenced by at least the two preceding RR-
intervals. 2. After CV EF can be predicted from the ob-
tained relationship of EF and RR-interval during AF. 3. EF
does not change after CV.
INFLUENCE OF THE PERICARDIUM ON DYNAMIC RIGHT AND LEFT
VENTRICULAR FILLING
8rian D. Hoit. M.D .• F.A.C.C., Valmik 8hargava, Ph.D.,
Nancy Dalton, R.D.M.S., Ralph Shabetai, M.D., F.A.C.C.
University of Cincinnati, Cincinnati, OH
To evaluate pericardial restraint of ventricular
filling, we performed Doppler echo of right (RV) and
left (LV) ventricular inflow in 10 open chest dogs at
three levels of LV end-diastolic pressure (EDP) before
and immediately after pericardiectomy (P). Dextran
infusion and P caused a significant increase in the
transmitral early filling velocity (Em) and tended to
increase the ratio of early to late filling velocity
(Em/Am, p=.079). For RV inflow, increasing preload
with the pericardium intact resulted in significant
increases in early (Et) and late transtricuspid
velocity (At), but no change in Et/At. In contrast, P
greatly increased At, but not Et, causing a significant
decrease in Et/At:
EDP (mmHg) 7:':2 13:':2
beforeP .fterP b.fo,..P .fte,.p be'o,.., afte,.p
Em 43:':6 60:':10& 63:':11 b 73:':12& 71:':13b *91:':13&
Am 30:,:9 34~10 32:,:9 39:':21 40:':16 42:':17
Em/Am 1.4:,:.4 1.9:':.5 2+.7 2.1:,:.8 1.3:':.5 2.5:,:1.1&'
Et 27:':8 27:':12 29:':8 31:,:7 39:': 6b ,c 36:': 8
At 24+8 40+10& 29:':13 43:':11& 31:':12b 51:':15&
Et/At 1.2+.4 .8±.3 1.3:,:.9 .8:':.2& 1.5:,:.6 .8+.2&
a=before vs. after P, b=compared to EDP 6, c=compared
to EDP 12, P (0.05 *P=0.058
We conclude that filling of the two ventricles is
strongly affected by the pericardium over a wide range
of volumes and pressures, and that there are important
differences in pericardial influences on RV vs. LV
filling. The effect of the pericardium on inflow
velocities must be considered when assessing
interventions that alter pericardial restraint.
SHIFT OF THE LEFT VENTRICULAR DIASTOLIC PRESSURE-
VOLUME CURVE WITH ISCHEMIA: IMPORTANCE OF
VOLUME AND THE PERICARDIUM
Robert I ApPlegate M D, Iakob Vinten-Iohansen, Ph.D., William
E. Johnston, M.D., William C. Little. M.D., F.A.C.C. Bowman
Gray School of Medicine. Wake Forest University, Winston-Salem,
N.C.
Acute coronary artery occlusion has been variably reported
to produce upward or rightward shifts of the left ventricular (LV)
end-diastolic (D) pressure (P)-volume (V) relation. These variable
responses may be due to several factors including the effect of the
initial LV V and a pericardial effect. The purpose of this study
was to evaluate the effect of LV size and the pericardium (PER) on
the LVDPV relation during coronary occlusion. LV end-diastolic
pressure (EDP) and LVV (impedance catheter) were monitored
during intraluminal baUoon occlusion of the left circumflex
coronary artery in 7 anesthetized closed chested mongrel dogs.
Balloon occlusion was evaluated at 2 different LV V before and
after removal of the PER. From the initial baseline LVEDP
(S±4mmHg) and low LVV (64j;16ml) in the presence of an intact
PER, the LVDPV curve shifted to the right during coronary
occlusion. This shift was unchanged by removal of the
pericardium. After volume loading (LVEDP 23j;8mmHg, LVEDV
9Sj;22ml), the LVDPV curve shifted upwards in the presence of the
pericardium. Following removal of the pericardium similar
coronary occlusion produced a rightward shift.
Conclusions: Coronary occlusion at low LVV causes a rightward
shift of the left ventricular diastolic pressure-volume curve which is
independent of the presence of the pericardium. At high LVV
during coronary occlusion, the curve shifts to the right in the
absence of the pericardium, but shifts upwards when it is present.
Thus, the response of the LVDPV curve during coronary occlusion
is modulated by the initial LVV and the pericardium.
Wednesday, March 22,1989
4:00PM-5:00PM, California Room A
Anaheim Convention Center
Cardiac Function: Basic Cellular and
Molecular Studies
Reversible Cardiac Depression Caused by The Supernatant
of Lymphocytes Cultured with Interleukin-2. P. A.
Sobotka, J. McMannis, R. 1. Fisher, S. W. Orlow, J. X.
Thomas, Jr. Loyola Univ. Medical Center, Maywood, .IL
Lymphocytes in acute cardiac allograft rejection and
acute myocarditis have been suggested to participate in
the heart failure seen in these conditions. Also cancer
immunotherapy protocols including recombinant inter-
leukin-2 (rIL-2), a potent activator of lymphocytes has
been associated with severe cardiovascular depression.
To investigate the relationship between lymphocytes,
rIL-2 and cardiac function we evaluated the direct ef-
fect of rIL-2. and the supernatant from either cultured
lymphocytes (LYM) or lymphocytes cultured with rIL-2
(Lymphocyte Activated Killer Cells; LAX) on cardiac
output in the isolated, perfused working rat heart. The
cardiac outputs (ml/min/am wet wt) as measured after 60
min with perfusion with rIL-2 (n-ll), LYM (n-8) , and LAX
(n-9) were (mean ± SEM):
o min 20 min 40 min
rIL-2 70±3 66±4 64±4
LYM 70±4 70±4 68±3
LAX 62±2 42±2tt 35±3tt
t p<O.OOl with 0 min; p<O.OOl with rIL-2 & LYM
Another group (n-6) perfused with LAX for 20 min fol-
lowed by washout, indicated that LAX induced myocardial
depression was reversible. The depression was not as-
sociated with a decrease in coronary flow. Thus, LAX
produced soluble factor(s) that caused a reversible
depression of cardiac function. The depression of car-
diac function seen in acute allograft rejection or myo-
carditis could conceivably be a consequence of a soluble
product(s) of lymphocytes. Similarly, immunotherepy
with rIL-2/LAX can be associated with a direct depres-
sion of myocardial performance due to this product.












(arl B. (onz KD, Kichael Baap SRA, (ri.tina I. Bill PBD,
Raymond r. Burk KD, Richard A. Val.h MD", Dept. of Med.,
V U, Na.hville, TI 37232 and "OTBSC, San Antonio TI
78284.
Seleniua deficiency hal been thought to cau.e (e.han
di.ea.e. Glutathione peroxida.e (GSB-Px) a .elenoenzyme,
detoxifies peroxide.. Vitamin I i. known to prevent
lipid peroxidation. The effect of ,the.e nutrient. was
.tudied u.ing doubly-deficient (OSI 01) and control
pig•• OSe '01 pig. were devided into tho.e that died and
tho.e that .urvived. Biplane cineangiography and high
fidelity micromanoaetery were done. At necrop.y, ti••ue
.ample. were taken for GSB-Px and total glutathione
(GSB).Beart rate LV pre••ure, Ind dp/dt••• were .imilar
in all group.. LV dia.tolic function however wa.
dimini.hed a. .hown by impaired relaxation (Tau a. time
con.tant of i.ovoluaic relaxation P-Po'e- t /,) and
.ub.tantial elevation of LV end-dia.tolic pre••ure in
OSe 01 aniaal. that died. LV aa•• wa. increa.ed 20' in
OSe 01. Relative organ weiht. (organ/bw) indicate left
and right .ided heart failure. Beart GSB-Px activity was






OSe 01 16:1:7" 43:1:10" 3.2:1:.3 11.3:1:3"
(.urvived,n-7)
Control 14:1:6" 49:1:18* 2.7:1:.8" 10.5:1:2"
(n-6)
"p<0.05 OSI 01 (died) v. control or OSe 01
Ve conclude that OSe 01 mini pig.
hypertrophy, iapaired LV dia.tolic
biventricular conge.tive heart failure.
PRELIMINARY BIOCHEMICAL CHARACTERIZATION OF THE CANINE
CARDIAC SODIUM CHANNEL.
Sidnet A. Cohen, MD, PhD and Robert L. Barchi, MD, PhD,Hospi al of the University of Pennsylvania, Phila., PA.
Electrophysiologic studies have indicated that two sub-
types of sodium channel exist in the heart, a toxin in-
sensitive form responsible for the upstroke of the action
potential and a toxin sensitive form which may contribute
to action potential duration. In these studies, tritiated
saxitoxin (3 H-STX) waa uaed in binding studies to iden-
tify the two subtypea in dog heart ventricular membranea.
Under conditions of 100 mM choline chloride, 50 mM KHPD4,
and pH 7.4 at OOC., Kd's of 11.5 and 1.0 and Bmax's of 151
and 45 fmoles/mg were obtained for the toxin inaenaitive
and toxin aenaitive forms, reapectively. These values were
confirmed by kinetic determination of on and off rates.
Unlabeled STX and tetrodotoxin were equally able to dis-
place 3H-STX from both channel subtypes. Channel protein
could be solubilized by several non-ionic detergenta
(including Tween-20 and Nonidet P-40) in a form which
maintained toxin binding ability. The channel waa demon-
strated to be an anionic glycoprotein aa evidenced by spe-
cific binding to lectin affinity and ion exchange columns.
Further biochemical manipulation caused the loss of toxin
binding ability; therefore, alternate probes for the solu-
bilized channel were sought. Several anti-skeletal muscle
monoclonal antibodies and eel-aequence specific polyclonal
antibodies were able to identify partially purified chan-
nel protein in dot-blot assays. Iodinated Tttyas gamma
toxin also bound to the channel protein in in ~ng assays.
Conclusions: 1, Two subtypes of cardiac sodium channels
have been identified in binding assays using 3H-STX; 2,
canine ventricular muscle sodium channels share biochem-
ical and biophysical characteristica with sodium channels
in other tissues.
ALTERATIONS IN COLLAGEN CROSS·LINKING IMPAIR
MYOCARDIAL CONTRACTILITY IN VITRO OF THE Movbr
MOUSE HEART
Joseph M Canasso Ph D.. Emily Puntillo, Giorgio
Olivetti M.D., Giancarlo Guideri Ph.D., Piero Anversa
MD. New York Medical College, Valhalla, NY
A number of genetic disorders in humans arc
associated with defects in the synthesis and metabolism
of collagen which arc accompanied by multiple
cardiovascular disease processes. To determine whether
genetically determined cross-linking abnormalities of
collagen may alter cardiac function, left ventricular
papillary muscles of Movbr mice were studied in ili.r.Jl..
With respect to controls (N: NIH[Sn, increases in time
to peak tension, from 102 ± 1.4 to 12S ± SA ms
(p<O.OOO, and time to one half relaxation, from 76 ± S
to 98 ± 9 ms (p<O.OS) were measured. Moreover, resting
tension was elevated, from II.I ± 1.7 to 19.3 ± 1.1
mN/mm2 (p<O.OOO, while developed tension, peak rate of
tension rise and decay, and time to peak rate of
tension rise and fall remained substantially constant.
Alterations of the isotonic phase of contraction
consisted of a decrease in the magnitude of peak
shortening, from 4 ± O.S to 2 ± 0.2 % (p<0.04), and a
reduced muscle length at which peak isotonic shortening
occurred, from 1.8 ± 0.2 to 1.0 ± 0.1 % (p<0.02). In
conclusion, the inability to cross-link collagen
increases muscle stiffness and alters cardiac mechanics
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Coronary Angioplasty Technique II
THE EFFECT OF LARGER BALLOON SIZE ON RECURRENCE AFTER
REPEAT CORONARY ANGIOPLASTY DUE TO RESTENOSIS.
Brian Lew, M,D" Morton Kern, M.D., F.A.C.C., Ubeydullah
Deligonul, M.D., Michel Vandormael, M.D., F.A.C.C., St.
Louis University Hospital, St. Loui., MO.
The use of a larger balloon during repeat percutaneous
transluminal coronary angioplasty(PTCA) for restenosis
is controversial. To assess whether a larger balloon
during repeat PTCA influences recurrence, a retro·
spective analysis of 58 single vessel lesions requiring
repeat PTCA for restenosis aftei initial successful PTCA
was performed. Recurrence was determined by restenosis
on repeat angiograms defined as )-50% average diameter
stenosis at the previous dilatation site (8 restenosis
out of 10) and/or recurrence of severe anginal symptoms
within 6 months after repeat PTCA. Angiographic balloon
and artery diameters were measured by digital calipers.
Analysi. was performed according to whether the measured
balloon size used during the repeat PTCA was (B1) or was
not (BO) 0.5mm greater than that used during the initial
PTCA, There was no significant differences between the
groups with respect to sex, tobacco use, hypercho-
lesterolemia, or diabetes. Values listed are for the
second PTCA. mean (S.D.). (VES - Vessel, BAL - Balloon).
% Stenosis VES 5AL Percent Recurrence
N I!.!!!. post gg SIZE at 6 months
BO 40 83 21 3,0 2.9 28
(13) (11) (0,3) (0.4) paNS
B1 18 78 25 3.2 3.3 33
(11) (16) (0.6) (0.3)
It is therefore concluded that use of a larger balloon
for repeat PTCA for restenosis does not influence
recurrence.
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Echo Doppler: General V
EVALUATION OF VENTRICUlAR SEPTAL DEFECT COMPLICATING
ACUTE MYOCARDIAL INFARCTION: IDENTIFICATION.
LOCALIZATION AND DIFFERENTIATION FRl»4 MITRAL
REGURGITATION BY COLOR DOPPLER FLl7I/ IMAGING
Michael R Harrison, MD, FACC, Edward A Harlamert, MD,
John CGurley, MD, BlaIr MacPhail, MD, Mikel D Smith, MD,
FACC, Anthony N DeMaria, MD, FACC. University of
Kentucky Medical Center, Lexington, Kentucky.
Although color Doppler flow imaging (CFI) has been
demonstrated to be useful in assessing congenital
ventricular septal defects (VSD), few data exist
regarding the accuracy of CFI in evaluating VSD's
complicating acute myocardial infarction (MI). Similarly,
the ability of CFI to differentiate VSD from acute mitral
regurgitation (MR) is uknown. Thus, we analyzed the
results of CFI, cardiac catheterization and surgery in 15
patients (mean age 71.6) with MI referred for evaluation
of hemodynamic instability associated with a new systolic
murmur, CFI was performed using standard echocardio-
graphic windows and VSD was identified as systolic
turbulence traversing the interventricular septum. For
purposes of VSD localization, the interventricular septum
was divided into anterior, posterior, and apical regions.
Results: CFI correctly identified 8 of 8 ventriculo-
septal defects. The remaining 7 patients had acute MR as
demonstrated by large areas of turbulent systolic flow in
the left atrium by both CFI and cineventriculography. CFI
located the VSD as anterior (3), posterior (3), or apical
(2), and was 100% concordant for location compared to
cine and surgery. In this series, CFI was accurate in
identifying the presence and location of acute VSD
complicating MI, and accurately differentiated VSD from
MR. CFI provides easy, safe and rapid diagnosis of acute
VSD complicating MI, and may alleviate the need for
preoperative cineventriculography.
ARE DOPPLER INDICES OF DIASTOLIC FILLING AFFECTED BY LEFT
VENTRICULAR HYPERTROPHY?
John W Cooper, Mahmoud M. Awad M.D., Vinod K, Shah
M,D" Hirday K, Chopra, M.D" Dinyar Daruwala M.D"
Navin C. Nanda M,D, F.A.C.C" Albert Oberman M,D., Neal
Zilllbaldi, University of Alabama at Bimingh8lll, AL,
Doppler studies were performed on 373 mildly
hypertensive (HTN) Pts (diastolic blood pressure (BP)
90-100 =mRg, age-54). The ratio of atrial systolic
velocity (A), to mitral inflow velocity (E), ratio of
time-velocity integrals, and A velocity correlated well
with age (in ~intiles) and fairly well with baseline
systolic and BP (r-,74,r-,71). A velocity increased by
3,8 cm/sec/quintile (r- ,97, p<,05) and AlE by
8,2\/quintile (r-,94, p<0,5), In the two oldest
quintiles (50-65 yr), A>E in 69\ of subjects, while A>E
frequency in the remaining quintiles was 28\, Of 26
Pts with heart rates (HR) ~ 90, 24 (92,4\) showed
increased A and A/E, and decreased E-F slope (r-,99,
p-<,Ol). In subjects with A>E (43\), E velocity varied
inversely with LV mass septile (-2,5 cm/sec/septile,
r-,9I, p<.05). This was not seen in subjects with E>A.
No significant differences were seen with sex, race, or
previous medication. Calculated LV mass (M) by echo in
septiles (LVK-222±58 gm), and LVH corrected for body
surface area, height, weight, and LV cavity volume did
not correlate with any Doppler par8llleter (range r-.09-
.46). A separate group of 25 Pts with hypertrophic
cardiomyopathy (HCK) (ill-52, (VK-39Q±157gm) was
studied similarly, and showed poor correlation of LVH
with Doppler indices (range r-.04-.43). Our study
suggests that unlike age, BP, and HR, calculated LV
mass in Pts with mild HTN or HCM has no relation to
Doppler diastolic filling parameters.
PULSED DOPPLER ECHOCARDIOGRAPHIC MITRAL VALVE FLOW
PATTERNS AND LEFT VENTRICULAR CHAMBER PROPERTIES IN
PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
Shinji Miki M.D., Tomoyuki Murakami M.D., Tomoyuki Iwase
M.D., Yukizono Suzuki M.D., Chuichi Kawai M.D.,F.A.C.C.
Kyoto University Hospital, Kyoto, Japan
Using pulsed Doppler echocardiography and frame-by-frame
biplane cineangiocardiography with simultaneous micro-
mamonetry, left ventricular(LV) filling patterns were
assessed in 25 patients(pts) with previous myocardial
infarction(HI): 5 with normal ejection fraction(EF>55%)
and end-diastolic pressure(EDP~14 mmHg)(MIl): 10 with an
EF <55% and EDP<14 mmHg(MI2); and 10 with an EF <55% and
EDP>14mmHg(MI3): Peak E and A waves(E,A;cm/s), the ra2ioof A to E wave(A/E), end-systolic volume (ESV; ml/m ),
the time constant of LVP decay(T;ms), mitral valve open-
ing pressure(MVOP;mmHg) defined as the LVP at the begin-
ning of E wave, and the 'b~stant of LV chamber
stiffness(b;1/ml/m2) from P= ae +C were determined.
(*:p<0.05 vs MIl, #;p<0.05 vs MI2 ;ANOVA)
EF EDP ESV T MVOP b E A A/E
MIl 59 12 43 56 12 .045 41 49 1.27
MI2 45* 11 76* 63 13 .048 35 52 L50
MI3 42* 21*# 78* 78* 21*# .085* 54*# 47 0.89#
The A/E ratio of <1 was observed in 1/5, 0/10 and 7/10
pts in the MIl,MI2-and HI3 groups, respectively.
CONCLUSIONS: Decreased E wave along with increased A/E
ratio indicates an impairment of early diastolic filling
in pts with MI and normal EDP (compliant LV). In con-
trast, elevated atrial driving P (MVOP+) may increase E
wave and reduce A/E ratio in pts with MI and high
EDP(reduced LV compliance). Thus, in pts with prior MI,
Doppler echocardiographic A/E ratio of <1 is a sensitive
indicator of reduced LV compliance (EDP +) associated
with depressed systolic function (EF.j.).
ACCURACY OF MODIFIED PRESSURE-HALF-TIME METHOD FOR
EVALUATION OF STENOTIC MITRAL VALVE AREA
Rainer Jacksch M.D.,Beate Einsele,Wolfram Volker M.D.,
Karl-R. Karsch M.D"Ludger Seipel M.D" Department of
Cardiology, University of Tubingen, West-Germany
In previous studies the Doppler velocity profile of mitral
stenosis was defined as a linear curve during diastole.
The problems to quantify an exponential curve of the ve-
locity profile has yet not been addressed, although in a
considerable number of patients with mitral stenosis this
downslope appeared non linear. Aim of this stUdy was to
investigate the frequency of an exponential slope and to
develope a method for quantification. In 23 of 60 patients
with isolated mitral valve stenosis the CW-Dopplerspectrum
was characterized by an exponential slope. The quantita-
tive analysis of this downslope was performed according
to 3 different methods. A sufficient correlation between
the pressure-half-time method (PHT) and mitral valve area
(MVA) evaluated by 2-dimensional echocardiography (2d)
and Gorlin-method (Go) was found when using. the PHT after
definition of a meso-to enddiastolic tangent (PHTED), The
best correlation was found by quantitative analysis of
the slope using an exponential function (PHTe). These
both methods were superior to a two point (2P) method
(early to enddiastolic linear slope).
MVA(PHT2P) 0,65' MVA2d + O,4B ; r=O,70, p'0,OOl
MVA(PHTED) = 0,83. MVA2d + 0,21 ; r=0,B7, p<O,OOl
MVA(PHTe) = 1,2 • MVA2d + 0,01 ; r=O,92, p<O,OOl
MVA(PHTe) = 1,41- MVAGo + 0,09 ; r s O,84, p<O,OOl
The invasive and noninvasive study was performed simul-
taneously. Conclusion: In 30% of pat. with mitral stenosis
CW-Dopplerspectrum shows an exponential slope. In these
patients the MVA can be determined with high accuracy
by a quantitative analysis pf the exponential slope,
2lOA ABSTRACTS JACC Vol. 13, No.2
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VAI1JE AND LIMlTATICHl OF 'mANSD3OPfIl\GFAL OOUR DOPPIER
ECHXARDIOGRAPHY FOR '!HE Rl!XDGNITIOO OF 'IRANSVALVUIAR
RmUAnTATIOO IN '!HE l«RWLY FUNCl'IaIDC sr. JUIE VALVE
He1:gI1t W. Iame MD, Jeanne Olsen RDlS, Maureen Kane MD,
James A. Daniel MD, FAa::, Irvin F. Goldenberg MD, FAa::.
Minneapolis Heart Institute, Minneapolis, MN
'!he distinctioo bebieen notmal transvalvular am.
abnorlIlal paravalvular regurqitatioo (regurq) in the
bileaflet st. JUde valve by transthoracic color DewIer
edlocard.iCJ9l'llP1Y (Tl'E) is difficult. 'lO assess~
transesq:t1agea edIocardiCJ9l'llP1Y (TEE) offers greater
accuracy in imaqin;J transvalvular regurq, Io'e studied 30
st. JUde valves (15 aortic valves [AV), 15 mitral valves
[MV) in 28 pta withcut clinical evidence of valvular
dysfurx:t:ioo. ~: ADaq 15 pta with AY prosthesis,
Tl'E identified aortic regurqitatioo (AR) in 11 pta
(73t). By TEE, AR was present in all 15 pta (lOOt).
'!he total I'llIIliler of AR jets was 15 by Tl'E am. 25 by TEE
(p < .05). A transvalvular jet origin was seen in a'lly
3 of 15 AR jets (20t) by Tl'E, am. 4 of 25 jets (16t) by
TEE. AnaJ;J 15 pta with MY prosthesis, Tl'E identified
mitral regurq (MR) in 3 pta, of whan all had a'lly 1
jet. By TEE, MR was present in allIS pta (total number
of jets - 52). By Tl'E, the origin of the 3 MR jets
could not be seen. By Ca'ltrast, in 48 of 52 MR jets
(92t) by TEE, the jet origin was clearly identified as
bein;J the central orifice (27 jets) or the side orifice
(21 jets). TEE M-mode color DewIer identified all 4 MR
jets of urxleteI1nined origin as transvalvular by shclIiirr;
early systolic closure back flow am. holcsystolic leak-
age back flow. C'onclusiqlS: TEE identifies transval-
vular AR with higher sensitivity than Tl'E. However, due
to the pexpeniieular imaqin;J an;le of TEE, both tecn-
niques have similar liJnitaticns in localizin;J the origin
of AR jets. TEE is clearly superior to T1'E in iclentify-
in;J the preseooe am. jet origin of transvalvular MR.
ATTENUATION OF EARLY MITRAL FLOW VELOCITY BY ACUTE AORTIC
INSUFFICIENCY.
Peter S. Rahko, M.D., F.A.C.C., Larry F. Whitesell, B.S.,
Stephen H. Nellis, Ph.D., University of Wisconsin,
Madison, WI.
The purpose of this study was to evaluate changes in
mitral flow patterns produced by graded levels of acute
aortic insufficiency (AI). In 13, open-chested, mongrel
dogs who were continuously paced from the RA, acute AI
was created at graded levels of severity with a basket
catheter. Measurements made were: LV end diastolic
pressure (LVEDP) and mean LA pressure (LAP) by microman-
ometer catheters; aortic valve stroke volume (AVSV),
regurgitant volume (RV) and regurgitant fraction (RV/AVSV)
by aortic flow probe; peak early mitral flow velocity
(E), peak atrial flow velocity (A), E/A ratio, early
(EVI) and atrial (AVI) velocity integrals and the early
filling fraction (EFF) EVI/(EVI + AVI) by pulsed Doppler.
Results: (mean + standard error, *-p cO.05 by analysis of
variance) -
RV/AVSV 0% 1-20% 21-40% 40X
n 13 9 9 8
*E (cm/s) 39t3 32t2 33t3 27:!:2
A (cm/s) 31t2 30tl 28t3 31t2
*E/A 1.3tO.l1.1tO.l 1.3tO.2 0.9tO.l
EFF (X) 66t2 68t2 65t4 56t5
*RV (ml) 0 13t3 25t4 32t11
LVEDP (mm Hg) 4t 1 7:!: 1 7t 1 6:!:l
LAP (mm Hg) 10tl 10:!:l 11t2 14:!:l
Conclusions: In normal dogs, acute progressive levels of
AI attenuates peak early mitral flow velocity but does
not change peak atrial filling velocity. This causes a
significant decline in E/A but not EFF. These changes
are not due to changes in filling pressures but are
probably a consequence of progressively greater
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TREATMENT OF CARDIAC ALLOGRAFT REJECTION WITH PULSED
STEROIDS: ATHREE YEAR EXPERIENCE
Leslie W Mjller, M pEA C C Lawrence R. McBride, M.D., 0,
Glenn Pennington, M.D.• St. Louis University, 51. Louis. Missouri
Between January, 1985 and December, 1987, 42 pts underwent
cardiac transplantation (CTx) and survived > 6 months. Thlrty-
seven pts were managed with Cyclosporlne (CyA), Azathioprine (Al)
and Prednisone (P) alone and 5 received CyA '" Palone.
Antilymphocyte sera was not given except for refractory rejection
(n-4). Pts were biopsied at a predetermined frequency and graded 0-
4. Only grade ~ 2.0 was treated. Rejection treatment consisted of
Solumedrol (SOL) (1 gm IV/dX3 d). There were a total of 38
rejections during the 620 months of pt follow-up (0.06/pt month).
There were 25 (66%) rejections graded as mild, 10 (26%)
moderate and 3 (8%) severe. Seventeen pts (44%) have had no
rejection. Twenty-eight (74%) responded to the single course of
SOL. 6 (15%) were treated with a second course of SOL within 2
weeks of the initial course for unresolved rejection and 4 (11 %)
required the use of antllymphoblast globlulln (ALG). There were no
Infections during or within 2 weeks of the rejection therapy with
steroids, and only 1 with ALG therapy. Eight of 11 pts with a biopsy
rejection grade ~ 2.5 required either a second course of steroids or
ALG for resolution. Most mild rejections can be successfully treated
with SOL, but pts with more than mild reje6tlon should be treated









LOAD DEPENDENCE OF REDUCED EARLY DIASTOLIC FILLING IN
LEFT VENTRICULAR HYPERTROPHY. Thomas R. Downes, MD,
Abdel-Mohsen Nomeir, MD, William C. Little, MD, Bowman
Gray School of Medicine, Wake Forest University,-
Winston-Salem, NC.
Patients with left ventricular hypertrophy (LVH)
frequently have Doppler evidence of decreased early
diastolic mitral flow thought to indicate diastolic LV
dysfunction. We hypothesized that changes in loading
conditions might further alter the pattern of early
diastolic filling in patients with LVA. Accordingly,
we evaluated 9 patients with concentric LVA (LV wall
thickness > 12 mm) and decreased early diastolic
mitral flow (ratio of peak early (E) to late (A)
diastolic flow velocity < 1.1). Doppler mitral flow
velocities were measured at rest (supine) and
immediately following tilt to the upright and head
down positions. Mitral flow velocities were
determined prior to a change in heart rate with each
maneuver. Early diastolic flow velocity integral (Er )
total diastolic flow velocity integral (Tr), and the
ratio Er/Tr were also measured.
HR E A
Control 70+11 67+18 88+18
Upright 72+11 54+14* 81+19
Head Down 70+13 84+24* 87+23
mean+SD, *;<0~05 vs control-
Conclusion: In patients with LVA, upright tilt
further decreases early diastolic filling, while head
down tilt augments early filling without altering late
diastolic filling. Thus, the Doppler pattern of LV
diastolic filling in patients with LVA is load
dependent. An increase in LV preload may mask Doppler
evidence of diastolic dysfunction while diminished
preload may result in overestimation of filling
abnormalities.
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VENTRICULAR ARRHYTHMIAS FOLLOWING ORTHOTOPIC
CARDIAC TRANSPLANTATION: RELATIONSHIP TO ACUTE
REJECTION AND SUDDEN DEATH
Randall E. Little MP, G. Neal Kay MD, Robert C.
Bourqe MD FACC, Vance J. Plumb MD FACC, James K.
Kirklin MD FACC, Andrew E. Epstein MD FACC.
University of Alabama, Birminqham, AL
The relationship of ventricular arrhythmias (VA)
to acute rejection (AR) or sudden death (SO) after
cardiac transplantation is unknown. We analyzed
.telemetry data from 2311 monitored days (November
1981 to July 1987) in 33 cardiac transplants (TX)
in 29 consecutive pts to determine if premature
ventricular complexes (PVCs), accelerated
.idioventricular rhythm (AIVR) , ventricular
,tachycardia (VT), VT duration, VT rate, or Lown
Class were markers for AR or SO. Hypokalemia
,and/or catecholamine therapy were exclusion
criteria. PVCs were recorded durinq 359 days in
26 of 33 TX (79') and were Lown Class I(60t),
II(9'), III(2'), and IV(29'). AIVR (25 episodes)
occurred in 9 of 33 TX (27') •.VT (76 episodes)
occurred in 18 of 33 TX (54t) with a mean duration
of 6 beats (ranqe 3-41) and a mean rate of 158
beats per minute (ranqe 100-250). The presence of
PVCs, AIVR, VT, VT duration, VT rate, and Lown
Class did not predict AR (36 episodes in 22 TX)
before or after controllinq for differences in
immunosuppressive therapy (p-NS). 4 pts died
suddenly, 2 with no prior VA and 2 with prior VA
(monitorinq at the time of SO in the latter 2 pts
revealed acute sinus bradycardia leadinq to
asystole). Inferences; after orthotopic cardiac
transplantation, hiqh qrade VA are common, do not
predict acute rejection, and are not a marker for
sudden death from ventricular arrhythmias.
EFFEX:'I'S OF aR:'fiARY REVASaJIARIZATIell ell RmIctlAL WAIL
M:7l'Iell: AN mIWC~ ECB) S'lUDl(
Harold L. lazar. M.p•• nee. JCIlathan Plehn, M.D., Fdqar
Sdrlck, M.D., D.Isan Da:nick, M.D., Ric:ha!:d J. Shemin,
M.D., FAlX, Bostal university Medical center, Bostal, MA.
Al~ Q:m:I'lary ArtaIy~ Graftirq (CAro)
effectively reduces the syJIpt:aI8 of myocardial i.sc:nem1a,
its imnedi.ate effect en reqiCllal wall mctien is nJt well
defined. 'Ibis i.nt:rac.pmltive ectlo study was uniertaksn
to determine whether CAro inpraves reqiCllal wall mcticn
in areas of preqlerIltive isdlemi.c dysfunctien. In 17
patients umergoinq CAro, short axis epen-ebested
ectloca1'I:ilognms Vlere d:Jtained 30 mimtes prior to and
follow!nq cardicp1lJlr.rlary bypass. ()Iantitative reqicnal
wall lIXJtien (1Mf) was calculated as the , in::rease in
segmental wall thick8ni.nq ch1rinq systole Vlere ~ 40%
thickeninq was defined as isctlemic dysfUnctien.
~itative 1M( was evaluated by visual dIan;Jes in
endocardial wall mcticn usinq a gnIded score (00n0rJDal to
~is). In the 136 segDIlI1ts st:ul1ied, 44 (32') had
evidence of pre-CAOO isdlemic dysfl.lncticn. tb!n post-CAOO
1M( was analyzed in all 136 SEIlJIlI!I1t&, there was no
siqnificant c:tlanr;JB in either cpmtitative 1M( (62 ± 7
pre-CAOO VB 58 ± 6t post-CAOO) or cpalitative 1M( (.19 ±
.06 VB .17 ± .06). HoweYer, in theBe S8lJIlI!I1t& with
u.e:t-ic dysfUnctien pre-CAOO, there _ a siqnificant
increase in cpmtitative 1M( post-CAOO (24 ± 2 VB 50 ± 5t
P< .02): 1otb.Ue cpalitative~ of 1M( failed to shew
any siqnificant~ (1.3 ±.l VII 1.05 ±.2). 118
ocncl\de that CAro resultll in an u.-tiate~ in
systolic thickeninq in thc&e segDBlts with pre-existinq
isdlemic dysfUnctien. '1bese dIan;Jes can be difficult to
detect with visual cpalitative methcda and are best
analyzed by ClaJP.It8r deriva1 indiCllll of cpmtitative
reqicnal wall thickeninq.
IS LUNG TRANSPLANTATION FEASIBLE IN PATIENTS WITH
PULMONARY HYPERTENSION?
Gregory J. Mlshkel MD., Chla-Mlng Hsieh. G. Alexander
Patterson M.D., Joel Cooper M.D., Stephen C. Dunn M.D.,
Crls Gresser. Jagdlsh Butany M.D., Richard D. Weisel
M.D., Harry Rakowski M.D. Toronto General Hospital,
Toronto, Canada.
To assess the role of lung transplantation alone as a
treatment for pulmonary hypertension we developed a
canine model of chronic reversible RV pressure overload
and right heart failure (RHF). PA banding was performed
In 23 dogs to produce RHF (158 +- 72 days). Dogs were
then randomized to Immediate unbandlng (UNB, n-ll) or
maintained (MRHF) In RHF for a further 3 months (n-12).
Clinical, hemodynamic, and echo-doppler studies were
done at control (C), onset RHF (ORHF), MRHF, and 1
(UNB1) and 4 months (UNB4) post-UNB. Pathology was
obtained at ORHF, post· UNa, and In 8 additional
controls.
C Pc.OS ORHF MRHF UNBl UNB4
RVSP 24 • 93 108 48 40
RVEDA 5.4 • 13.4 14.1 8.5 8.5
"FS 43 • 21 24 28 38
TR(1-4) 0 • 2.8 2.5 0.2 0.1
RV(gm) 30 • 71 70 55 58
With onset of RHF there was a marked Increase In RV
systolic pressure (RVSP), tricuspid regurgitation (TR),
RV end-diastolic area (RVEDA), and RV weight (gm), and a
decrease In RV fractional shortening area ("FS). No
worsening occurred with maintaining RHF. At 4 months
post UNB values normalized except for RV weight.
In patients with pulmonary hypertension, removal of
pressure overload by lung transplantation alone might
lead to dramatic Improvements In RV size and function.
REPAIR OF COMPLEX CONGENITAL HEART DISEASE WITH THE
USE OF THE VALVED CONDUIT.
Jeffrey Pearl. M.D., Hillel Laks, M.D •• Davis Drinkwater,
M.D •• Barbara George. M.D •• Thomas Santulli. M.D ••
Roberta Williams. M.D •• UCLA Medical Center. Los Angeles.
CA.
Repair of complex cardiac lesions has been facilitated
by the availability of valved conduits to reestablish
right ventricular to pulmonary artery continuity. From
1977 to 1988. 88 patients underwent repair with insertion
of a conduit for transposition (TGA) with ventricular
septal defect (VSD) in 46, pulmonary atresia (PAtr) with
VSD in 22, truncus arteriosus is 16. PAtr with intact
ventricular septum in 3. and atrio-ventricular canal with
PAtr in one. The mean age was 6.8 years (11 days to 45
years). Dacron porcine valved conduits were used in 37,
homografts in 47. and non-valved conduits in 4. There
were 10 early deaths overall (11%); 8 received dacron
grafts (22%) and 2 received homografts (4%). Among
dacron grafts there was one late death (3.7%) in 27 pts.
followed for a mean of 4.9 years. and six patients have
required reoperation for conduit obstruction. In 40
homograft recipients there was one late death (2.5%).
No homografts have required replacement for stenosis
during a mean follow-up of 19 months. The use of a
valved homograft has been associated with a reduced early
mortality and excellent long-term results for repair of
complex right heart lesions.
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=~t (2) Fi.rate
A turbid concentrate of stable abumln MBa In the size range 4-32 mlcrons
(suspended in albumin) were used to lest the filtration effICiency (FE). 2.5
MHz CW Doppler was used as a bubble detector (CW). Bubbles passing
through the CW targetlng area produce a charaderistlc sound and a sharp
spike on the visual display. By monitoring the pre- and post- AF CW, an
assessment of FE was made. Inactivated, the AF had no effect on the FE
(at baseline, or after albumin MB injection). Activated, the AF provided
total or near total clearing of the post-AF CW signats. When the albumin
MBa were Introduced into the pre-AF Input line. the pre·AF CW was •
Immediately saturated, whereas the post-AF CW signal remained clear,
indicating effective filtration. The effect was the same in water or blood.
CONCLUSION: The AF may provide more effective arterial fmration of
small gas MBa than currenly available mechanlcaf bypass flners.
ACOUSTIC FILTRATION OF GAS MICROEMBOU IN BLOOD.
Karl a Schwarz, MD, Charles C Ct.Jrch, PhD, Richard SMeltzer, MD,
PhD, FACC. University of Rochester, Rochester, NY.
Post-cardiopulmol18lY bypass encephalopathy Is thought to be due In large
part to continuous micfoembollzatlon of the brain wMh gaseous
microbubb18s (MBa: slze <40 microns) while on pump. Current mechanical
fmer technology cannot effectively remove MBa below 40 microns In
'ragile" fluids such as blood. We developed a non-mechanlcaf uhrasound
based fluid filtration system (acoustic f1her·AF) capable of fillering small
MBa «40 microns) from fluid using acoustic radiation force. Traveling
uhrasonlc waves, directed along the length 01 an acrylic tube, "sweep" the
fluid clean as • entelS the fihrate ed port. Asheet of mylar seals the tube
at both ends, anowlng for water-tight integrity and transparent passage of
the unrasound wnhout reflection. Three fluid ports are provided: (1) Fluid
entry; (2) Fihrate; (3) Waste ex•.
(3) Waste (1) Input
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FATAL AND NON FATAL RECURRENCES AFTER
ENDOCARDIAL RESECTION: ROLE OF THE
UNDERLYING ETIOLOGY
Hans-Joachim Trappe M.D., Helmut Klein H.O.,
Guenter Frank H.D., Paul Wenzlaff Ph.D.,
Paul Lichtlen M.D., F.A.C.C., University
Hospital Hannover, West Germany
We studied the follow up of lOS patients
(pts) who underwent mapping guided surgery
(MGS) due to drug refractory sustained
monomorphic ventricular tachycardia (VT).
There were 97 pts with an old myocardial
infarction (MI) (Group G I) and 11 pts with
arrhythmogenic right or left ventricular
dysplasia (Group GIl). Hean follow up was
2S+27 months in G I and 35+27 months in G
II~ Results: There were no significant
differences in total mortality (TH),
incidence of sudden (SD) or cardiac death
(COl between G I and G II. However, non
fatal recurrences (REC) occurred more
frequently in G II than in G I (p<.Ol):
G I (97) G II (11) p
TM 29 (30') 2 (lS') ns
SO 7 (7') 1 ( 9') ns
CD 20 (21') 1 ( 9') ns
REC 7 (7') 5 (45') <.01
Conclusions: The risk of fatal (SO) or non
fatal REC is rather low in pts with an old
HI (7') after MGS. Although the incidence of
non fatal REC is high in pts with non HI (G







PREDNISONE WITHDRAWAL IN "HIGH RISK" CARDIAC
TRANSPLANT RECIPIENTS.
David O. Taylor M.D., James A. Thompson M.D., Sheelah Rider
Katz R.N., Barbara McClung RN, Glenn Barnhart M.D., Andrea
Hastlllo M.D. F.A.C.C., Richard R. Lower M.D., and Michael
Hess M.D. F.A.C.C. Medical College of Virginia, Richmond,
Virginia 23298.
Prednillone has long been a significant part of
immunosuppressive protocols for clinical cardiac
transplantation. We have shown transplantation without
maintenance steroids ill both feasible and safe for many
patients. We hypothesized that most patients, including "high
risk" ones (those with 3 or more treated rejections requiring
maintenance prednisone) could be eventually weaned from
prednisone with careful surveillance. Thus we attempted to
wean prednisone from 15 "high risk" patients and 12 "low rillk"
patients (2 or less treated rejections) who required prednisone
for reasons other than rejection. Prednisone tapering schedules
were dictated by ease of follow up, biopsy results, duration of
prednisone usage, and a<renal function as evidenced by ACTH
stimulation tests. Eleven of 15 "high risk" patients and five of
twelve "low risk" patients were successfully weaned from
prednisone, p--ns. Acute rejection occurred during or after
prednisone withdrawl in 3 "high rillk" patients and 2 "low rlsk"
patients, p=ns. Five of 12 patients weaned in less than 12
months had acute rejection compared to none of the 9 patients
weaned over 12 or more months. There were no signficant
ditterences between the 5 patients who acutely rejected and
those who did not in terms ot cyclosporine doses or levels,
serum creatinines, WBC, or number of rejections prior to
prednisone tapering. We conclude that 1) predisone can be
safely weaned from many patients, including "high rillk" and
long-term users, but only with trequent surveillance biopsies
and close follow up, and 2) longer tapering schedules appear
superior in thill patient population.
SERIAL EVALUATION OF CARDIAC TRANSPLANT FUNCTION:
RELATIONSHIP TO DONOR HEART ISCHEMIC TIME, DONOR HEART
AGE AND SEVERE REJECTION EPISODES.
Peter S. Rahko, M.D., F.A.C.C., Barry L. Fields, M.D.,
Herbert A. Berkoff, M.D., David C. Wilson, R.N.
University of Wisconsin, Madison, WI.
Using echocardiography, we evaluated serial changes in
LV size, .mass and systolic function for 28 pts during the
first yeart following cardiac transplantation. Para-
meters measured were: % fractional shortening (%FS);
mean velocity of circumferential fiber shortening (mVcf);
LV end diastolic dimension (LVEDD) and LV mass (LVH).
Results: (mean:standard deviation, p values for analysis
of variance).
Week post mVef LVEDD LVH
Transplant %FS (eire/s) (em) (g)
1 41%7 1. 71%0.25 4.8±0.5 197±30
4 40±6 1.62:0.31 4.8±0.4 207143
13 3S16 1.52:0.23 5.010.4 183144
26 3615 1.5210.23 4.910.5 180142
52 (n-22) 3518 1.39:0.31 4.910.6 164±35
p 0.004 0.001 NS 0.002
Correlations between donor heart ischemic time (mean 154,
range 61-257 minutes) and donor age (mean 25. range
15-41 years) were determined. Neither ischemic time nor
donor age correlated with %FS, mVcf, LVEDD or LVH. At 52
weeks post transplant, 12 pts had experienced 1 or more
grade 3 rejection episodes, to pts had none. Comparing
those having rejection to those not having rejection
there was no significant difference in %FS (36±7 vs
3419), mVcf (1.4710.26 vs 1.3410.34 circ/s), LVEDD
(4.810.5 vs 5.0±0.6 cm) or LV mass (158139 vs 169134 g).
Conclusions: There is a mild but significant decline in
LV function and LV mass over the firs~ year follOWing
cardiac transplantation. This is opt related to donor
heart ischemic time, age or episodes of severe rejection.
lACC Vol. 13. No.2
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CARDIAC tlAKSl'LAR'£ATIOlf roJ. nUPdTIJK CAlUlIOKYOPA'lTl.
Dall uavot !CD, AlINr Khalhall:l. FlCS, IUchola. Banller
MaCl', X11:I...a P:l.tlIllta14 HII, IS. AZldt.. HUchll1 MlCP,
Mald:l. Yacoull nes, rACC.
Iarlf:l.lld BOlp:l.tal. H:l.ddlllax. ElIllIlId.
Plr:l.partwa car410.yopathy :l.a a rllae1vlly IIlIco.-an tora
of haart failurl attlct1111 vaaln ill thl:l.r la.e mollth of
prllllallcy or thl tir.e .1K mAnth••ftar dllivlry. Thl
It1010lY 1. :l.nkDovn an4 cou14 1nvo1vI diftlrlnt ~chan­
:I.... vbln comparld eo othlr fatal of COllallt:l.vl cardio-
-.yopathy. Sinel 1983. 6 VIlalll al14 U to 35 yurl (.un
30) haVI undlrlonl card1ae eranlplantation (CTX) tor
plriparewa cardiomyoplthy. '0••:1.1111 r:l.lk flctor.
include4 1'1 (4 ebovl 30 Ylarl). h"lrtln.ioll al.oc:l.lt.d
With ptllllancy :l.n Z at whoa 1 .1.0 hac! ltayaaud· ••yndro..
and ehe oth.r had .elro:l.d dlplndane I.thma. Prl.llltina
Iymptaml Wlrl dYlpnoll, lltharlY and ankll 0141.. :l.n all.
pllp:l.cec:l.on :l.n 3. pneumon:l.a :1.11 Z and pulmonary :l.nfaret :l.n
2. All del:l.verl4 notall 1I.b:l.... 1'Wo reqv.:l.rad a.rly
illduction of labour dUI Co 'IVlrl clrd1ac dacampln.ac:l.on.
The t:!..111 :l.lltarval 'betwaall onllt of 17.lIPtau and CTx
rllliad baeVlIII Z walk. eo 2 Yllr. (ma4:1.an-Z .cnCha). ~our
CTx wlrl p.rfotal4 on a..rsallcy ba.:I..; 1 patilnt rlquir.d
:l.nCra-lortic lIa1100n pvapin. pr:l.or co CTx an4 1 wa. puC on
l..r,lncy cardiopulmonary lIypa•• for 1 hour wh:l.11 a.aie1111
the donor h.art. onl p.Cilllt had cytotoxic Inti1l0d:l.a. all4
Itronlly poaitiva lyaphocytl croa.-sttch. Th.rl wlrl 2
larly 411thl, 1 from hyplracuel rljlct:l.on Ind 1 fram
.er.ptocoeeal ••pt:l.caam:l.l 2 and 18 day. followin. CTx.
~our pt. 1%1 currently a1:1.vI lS mDlIch. to S t.ar.
tol1ow:l.ll& CTx.
It :I.. conclud.d ehae p.riplrcwa clrdiomyopaehy cln tl'u1t
:1.11 a Vlry rap:l.d dltlr:!.orae1on raqu:l.r:l.lII urllnt CTx Vh:l.ch
l:l.vl. ICClptab1Irl.u1tl. l'rltormad IDt1bod:l.al rllult:l.na
:l.n hyplrlCv.tl rljlct:l.on cln occur.
CYTOMEGALOVIRUS INFECTION IN CARDIAC TRANSPLANT
RECIPIENTS PREDICTS THE INCIDENCE OF ALLOGRAFT
ATHEROSCLEROSIS
Ken McDonald. M.R.C.P.I •• Thomas Rector. Ph.D.,
Elizabeth Braunlin, M.D., Maria Teresa Olivari, M.D.,
University of Minnesota, Minneapolis
Allograft atherosclerosis now represents the major limi-
tation to long term survival after heart transplant
(Tx). Its etiology remains obscure. The possible role
of viral infection in the genesis of coronary artery
disease (C.A.D.) stimulated the review of 102 heart Tx
performed since the introduction of triple drug immuno-
suppression (cyc10sporine, azathioprine, cor-
ticosteroids) to assess the relevance of post Tx.
cytomegalovirus (C.M.V.) infection to C.A.D. C.M.V.
infection was defined as a 4-fo1d increase in immunoglo-
bulin Gtitre (complement fixation) occurring in asso-
ciation with a positive culture. C.A.D. occurred in 16
Pts. (15.6$) with 11 Pts. having C.A.D. at one year
after Tx. Recipient age, sex, pre-Tx diagnosis, fre-
quency of acute rejection episodes, cyc10sporine,
triglyceride or cholesterol levels did not differ bet-
ween those with or without C.A.D. Pts. with C.A.D.
received hearts from older donors (31±8 yrs. vs. 26±9
yrs.) but this difference did not attain statistical
significance (p = 0.067). C.M.V. infection, occurring
in 62$ of Pts. with C.A.D. and in only 25$ of those
without C.A.D., did independently predict the occurrence
of C.A.D. (p =0.007). This data supports the existence
of a strong relationship between post Tx C.M.V. infec-
tion and allograft atherosclerosis. It is possible that
the virus contributes to the initial injury to the coro-
nary endothelium.
THE ROLE OF RADIONUCLIDE ANGIOGRAPHY IN SELECTING
PATIENTS FOR CORONARY BYPASS SURGERY
Kerry L Lee, PhD, Karen S Pieper, MS, Frank E Harrell Jr,
PhD, Robert MCaliff, MD, FACC, Daniel B Mark, MD, Mark A
H1atky, MD, FACC, R Edward Coleman, MD, Frederick R Cobb,
MD, David B Pryor, MD, FACC. Robert HJones. MD, FACC,
Duke University Medical Center, Durham, NC
To determine the usefulness of exercise radionuc1ide
angiography (RNA) in selecting patients for coronary
artery bypass surgery (SURG), we studied 873 pts with
significant coronary artery disease (CAD) (~75' stenosis
who had rest and exercise RNA within three months of car-
diac catheterization (Cath). Pts with significant left
main disease and severe mitral regurgitation were ex-
cluded. 342 pts underwent SURG within 6 months folloWing
Cath and RNA, while 531 were medically treated (MED).
Median fo11owup was 6 years. To date 87 medical pts and
44 CABG pts have died from cardiovascular causes. At 5
years, Kaplan-Meier survival rates were 93' for SURG and
87' for MED. Using the Cox proportional hazards model,
exercise ejection fraction (EF) was the most prognostic
RNA variable. It contributed significant independent in-
formation (p<.OOOI) in both treatment groups to estab-
lished clinical and Cath prognostic factors. The rela-
tive benefit of surgery did not change (p>.50) for dif-
ferent levels of exercise EF, rest EF, or the change frOM
rest to exercise (AEF). However, the absolute dif-
ference in survival between SURG and MED was greatest in
pts with he lowest exercise EF (5 yr. survival 62S MED,
78' SURG where exercise EF <35) and least in pts with
high exercise EF (5 yr. survival 95' MED, 97' SURG where
exercise EF ~50)
Exercise EF may be useful in selecting pts for SURG,
and defines treatment benefit more clearly than toEF.
AUGMENTATION OF MYOCARDIAL FUNCTION WITH DYNAMIC
CARDIOMYOPLASTY IN A CHRONIC CANINE MODEL.
Mark Soberman M,D" Alexander Justicz M.D.,
Naomi A1azraki M.D., Garth Austin M.D., Ph.D.,
John Coleman III M.D., Charles Hatcher, Jr.
M.D., F.A.C.C., James Sink M.D., F.A.C.C., Emory
University and V.A. Medical Center, Atlanta,
Georgia.
This study was undertaken to determine the
ability of the latissimus dorsi muscle (LDM) to
function as a partial myocardial replacement. In
5 hounds, a full thickness RV cardiomyp1asty was
successfully performed. A defect was created in
the RV and repaired with a right LDM flap
sutured over a pericardia1 patch. A Medtronic
Cardiomyostimu1ator was used to provide
stimulation. After training, LDM pacing
eventually utilized 30 Hz bursts with each
native R-wave. 14 weeks after cardiomyop1asty,
ECG, RV pressure and dP/dt were recorded. MUGA
ejection fractions (RVEF) were determined in 2
dogs.
Unstimulated Stimulated
RV 23.2 ± 0.95 25.1 ± 1.5*
dP/dt 225.7 ± 13.0 308.9 ± 12.1*
RVEF 51.5 ± 13.5 66.5 ± 14.5*
(RV=RV peak systOlic pressure in rom Hg; dP/dt=RV
dP/dt in rom Hg/sec; Stimulated 7. 5V, 30 Hz,
185msec; * denotes p~0.05) .
These data indicate for the first time that
cardiomyop1asty augments ventricular function in
a chronic canine model, and suggest that
cardiomyop1asty may be a suitable technique for
repair of ventricular aneurysm.
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HIGH FREQUENCY (ULTRASONIC) MECHANICAL
DEBRIDEMENT IN THE TREATMENT OF CALCIFIC AORTIC
STENOSIS: AN ECHOCARDIOGRAPHIC STUDY
Matthew Schwinger, M.D., Stephen Colvin, M.D.,
Susan Harty, R.N.,Itzhak kronzon, M.D., F.A.C.C.
New York University Medical Center, NY, NY.
Repair of aortic stenosis may lead to
hemodynamic and clinical improvement without
the problems inherent to prosthetic valves. The
use of a high frequency (ultrasonic) device
(Cavitron) for the debridement of calcium from
the aortic valve is currently undergo~ng
evaluation as an adjunct to standard mechanical
debridement. Nine pts ( 5 female, 4 male; ages
63 83) were stUdied by m-mode, two-
dimensional, and Doppler echocardiography before
and an average of 28 days after this procedure.
The degree of calcification of the valve cusps
was markedly reduced. The maximal cusp excursion
increased from 0.7 Z 0.1 cm. pre-op to 1.5 Z
0.4 cm post-op (p=0.006). The peak aortic
gradient fell from 80 Z 39 mmHg to 27 Z 10 mmHg
(p=0.002). The mean aortic gradient fell from 52
+ 22 mmHg to 16 + 5 mmHg (p~O.OOOl). Aortic
valve area calculated by the continuity equation
increased from 0.6 + 0.2 cm2 to 1.4 + 0.4 cm2
(p~0.0008). The degree of aortic insufficiency
detected by color decreased in 1 pt, remained
the same in 4 pts and increased in 4 pts.
Conclusion: High frequency mechanical
debridement of the aortic valve results in a
significant increase in the mobility of the
valve cusps with a decrease in the amount of
calcium. There is a marked increase of the
aortic valve area with a concomitant reduction
of the aortic valve gradient. However, aortic
insufficiency may worsen after the procedure.
AN IMPLANTABLE AND EXTRACTABLE SENSOR FOR
INTRA AND POSTOPERATIVE MONITORING OF BLOOD
FLOW IN MAN. R!l2.hael S. RabinQyitz Ph.D., Craig J.
Hartley Ph.D., UQ:rd H:Michael Ph.D., P~ L. Jackson, Gary
L. Liedtke, Geral W. Parker D.V.M., George P. Noon M.D.,
F.A.C.C., BaylQr CQllege Qf Medicine, HQuston, Texas.
CQntinuQus mQnitQring Qf blQQd flQW during and after
vascular recQnstructive operatiQns can prQvide immediate
infQrmatiQn abQut heart functiQn, vascular patency, and
effectiveness Qf drug administratiQn. TQ dQ this, we have
developed a miniature implantable 10 Qr 20 MHz pulsed
ultrasonic DQppler blood flQW sensQr. The senSQr is made
frQm silicQne rubber and during surgery can be wrapped
around a blood vessel and securei:l in place with a releasable
tie. NQ tissue puncturing techniques are required. The wire
leads and a release cable are slleathed in 2mrn diameter
silicQne rubber tubing and are exteriQrized thrQu$h the skin.
TWQ to six days postoperatively when mQnitQring 1S nQ IQnger
needed, the tie 1S externally released by pulling the release
cable, and the sensor is extracted frQm the closed patient by
pulling Qn the tubing. We have tested 29 sensors Qn 6 carQtid
and 13 corQnary arteries (25-4mm diameter) and 10 ascending
aortas (16-25mm diameter) in 16 chronically instrumented
dogs fQr up tQ 12 days. Each sensor was extracted from the
awake dQgs with no visible behaviQral reaction. PQstmQrtem
exams shQwed that none of the vessels were damaged Qr
thrQmbQsed. In-vivo and in-vitro calibrations showed high
linear correlations (r>O.88) with electromagnetic flQwmeters
and timed blQQd collections. Three sensors have been
successfully applied to and released from coronary grafts of
patients during surgery. The measured flow velocity signals
were similar to slmultaneous electroma~netic flowml!ter
tracings. Thus, the new sensor is a prom1sing method for
continuous monitoring of blood flow in vessels 2.5-25mm
diameter during surgery and the early postoperative period.
DIFFERENCES IN SURGICAL OUTCOME FOR VENTRICULAR
TACHYCARDIA AND FIBRILU.TION.
Jeanne E Poole. M.D , Melinda L. Marks, M.D., Judy L.
Powell, R.N., Charles Maynard, Ph.D., Alexandra P.
Kruse, R.N., Gust H. Bardy, M.D., F.A.C.C., Tom D.
Ivey, M.D., F.A.C.C., H. Leon Greene, M.D., F.A.C.C.,
University of Washington. Seattle, Washington.
EVIIBa: OF IATISSDIB IXR>I KJSCU: ADAP1M'IQl BEFalE
CARD!CIM>PUS'IY•
F'reQerik van der Veen 81.0, Miek Hawnith M.D., Pierre
GraR!j8llll FbD, carolina !lR' M.p., Willem 0!lSsen 81.0.,
Olaf P8nn M.D. and Hein wellens M.D., DepartmIlnt of




We evaluated 182 pts with a history of primary
ventricular fibrillation (VF) , sustained ventricular
tachycardia (VT) or both (VTfVF) who underwent cardiac
arrhythmia surgery. There were no differences in age.
presence of coronary artery disease or remote
myocardial infarction among these 3 groups
Q::.rJtinDls electrical st.imJlatioo of the latiss1mJs
dorsi (ID) lIUSC1e to c:btain a fatigue resistant slcB1eta1
llUIIC1e is recpired for clinical use of caIdianyqllasty.
'!he effect of tm'st stiDulatioo 00 both ID llUIIC1e enzyme
activity and 1IUSC1. fUsicxt~ was studied Wrin;J
3 IDOIlths of trainiJ'q. In dogs, the lett ID was stiDu1a-
ted 24 ha.lrs a day with l:lursts of stiDu1i (30 Hz) cl1-
rirq 0.25 secxn:ls. 'Ihe time interval between b;o~
was dec:reued every b;o -a resultirq initially 30 and
at the end 80 ccntraetialS per mirI.lte. Biopsies (1'1"6)
were obtAined frca the stiJILllated and centralateral
llUIIC1e fIN8r'J 4 weIaI. Similar to the fiber type dIarKJe
within 2 IIQ'Iths frca 35% to DW:ire than 70t type I fibers,
the Ulf-iso&'lzyIE& c::har9ld frca pncbIinantl.y ~ to
I1Jfl' LlJf2 and I1Jf3' 'Ihe :i.nc:nlue in total mitochcrdrial
voluma was net reflectecl in c:!larqE8 in 1&T isoenzymes
(54 :t 6t III'"'ASAT after 3 1DOIlths). !bIcle fUsioo fnq.Blcy
(n-4) _ IIIIlaSUred in vivo with a foroa displ.acllment
tranIcb:ler (2 up to 256 Hz). At 10 Hz the riwle decrea-
sed gracl1ally fraR loot (urwtiJIUlated) to at (3 1IQ'Iths),
~ alSapt:at.i.a1 to a predaD1nant slCllf fibE type.
'!he fatigue test (100 ccntraetic:nI/lIIin; 85 Hz) _
significantly better tolerated after 8 weeks of trai-
nirq. In CCIlClusim llUIIC1e fusioo frecplncy, lILIIIC1e
fat1gl»-test, and I1Jf-isoenzyme activity~ to be
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Conclusions: 1. Operative and long-term mortality is
lowest in pts with VF only. 2. VTfVF pts are at
greateat riak for
recurrent arrhythmia
and death. 3. Poor
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Cardiac Pacing and Defibrillation
IMPAIRED ACTIVITY RATE RESPONSIVENESS OF ATRIAL
ACTIVITRAX II PACEMAKERS.
Adrian H Shandling MD, Mark J. Castellanet MD, FACC,
John C. Messenger MD, Myrvin H. Ellestad MD, FACC,
University of California, Irvine; Orange, California.
The physiological benefit of rate-response (RR)
during single chamber cardiac pacing is well docu-
mented. Post-implantation testing is important to
ensure adequate actiVity-mediated RR. We studied the
activity response of 7 (3 bipolar) atria11y placed
Activitrax II pacemakers. Six were noted to have
inadequate RR with maximal pacing rates of 85 to 101
bpm, despite maximally sensitive activity settings, and
upper rate limit (URL) of 150. Marker channel analysis
revealed that the URL was reset by far-field R-wave
sensing, even when sensed in the atrial refractory
period. These 7, and 2 pacemakers with identical
sensing circuits (Pasys) were tested by P-wave
sensitivity adjustment for ability to exclude far-R
sensing while preserving P-wave sensing. Implantation
data were then examined for predictors of differential
Rand P sensing. Results; differential sensing
occurred in 5/9 (4/5 bipolar; 4/9 unipolar). An index
of unipolar peak P amplitude x P slew rate divided by
peak R amplitude x R slew rate rest indicated future
differential P and R sensing. A value of > 8
discriminated outcomes for 8/9 pacemakers (p<.02).
Conclusions: 1, The RR of atrial Activitrax II
pacemakers is limited by far-field R-wave sensing even
during atrial refractoriness; 2, reprogramming atrial
sensitivity to differentially sense P and R-waves may
restore appropriate RR in some unipolar and many
bipolar units; 3, although an implant discriminant
index correctly identifies future RR in most cases, the
atrial application of the Activitrax II pacemaker is
cautioned until further validation is forthcoming.
DIRECT EXCITATION OF RELATIVELY REFRACTORY
TISSUE BY MONOPHASIC AND BIPHASIC SHOCKS
.Tames P Daubert M D David W. Frazier M.D., Wanda M.
Krassowska Ph.D., 5eitaro Yabe M.D., William M. 5mith Ph.D.,
Raymond E. Ideker M.D.,Ph.D., Duke Univ. Med. Ctr., Durham, NC
The mechanism for the greater efficacy of biphasic over monophasic
defibrillation shocks is unknown, but could be due to differing effects
on relatively refractory tissue, which is thought to be present during
fibrillation. Using a 117 electrode epicardial recording grid over a
32x30 mm region of RV, we studied the response of pa.rtially refract-
ory tissue to 3 ms monophasic and 2-1 ms biphasic shocks in 6 dogs.
51 pacing and 52 shocks were both delivered from electrodes along
the same side of the grid to create parallel 51 activation fronts and
52 isogradient lines. The parallel 51 activation sequence resulted in
nearly parallel isorefractory lines with refractoriness increasing away
from the 51 and 52 electrodes. Premature 52 shocks ranging from
40V to 1IOV generated potential gradients that progressively de-
creased with distance away from the 51 and 52 electrodes. At long
51-52 coupling intervals the 52 shock directly excited (DE) tissue
under the grid extending away from the 51 and 52 electrodes. The
DE region was always smaller for biphasic than monophasic shocks of
equal leading edge voltage and timing. After the shock for both bi-
phasic and monophasic waveforms, conduction propagated away from
the border of the DE region at long 51-52 intervals. At shorter cou-
pling intervals for both biphasic and monophasic shocks, the tissue
was more refractory so that the border of the DE region occurred in
regions of greater refractoriness nearer the 52.electrode; where the
gradient was more than 2.5 to 6 VIcm,. conduction block o?curred ~t
the border of the DE region. ConclUSIons: For monophasiC and bl-
phasic shocks of equal leading edge voltage, duration and coupling in-
terval, similar responses of either conduction or block. occ.ur at the DE
border of relatively refractory tissue, but the DE regIOn IS .s~aller for
biphasic thaD monophasic shocks. This suggests. tha.t additional fac-
tors besides excitation are important for defibrillation, such as re-
initiation of fibrillation by stimulation of relatively refractory myocar-
dium.
CLINICAL EVALUATION OF AN IMPLANTABLE CARDIOVERTER/
DEFIBRILLATOR WITH NONEPICARDIAL LEADS IN PATIENTS
WITH REFRACTORY VENTRICULAR TACHYARRHYTHMIAS.
Sanjeev Saksena M.D., FAC.C., Nicholas G. lUl10 M.D., Ryszard B. Krol M.D.,
Victor Parsonnet M.D., Isaac Gielchinsky M.D.• Ravindra Karanam M.D.
Newark Beth Israel Med Ctr - NJ Medical School, Newark NJ.
We evaluated an implantable cardioverter/defibrillator (CD) with a
nonepicardial lead system in pts with refractory ventricular tachycardia!
fibrillation (VTNF). 7 pts. mean age 67 yrs, mean LV ejection fraction 32%,
refractory to 5;t2 drugs having prior cardiac surgery (4 pts). severe lung disease
(2 pts), and renal failure (l pt) were studied. A tripolar electrode catheter with
1 sensing electrode and 2 defibrillating electrodes was placed in the RV apex
and a submuscular patch (SP) electrode was used in an epicostal location.
Defibrillation threshold (OF!) was determined using 2 to 4 dual or triple
electrode configurations. Optimal SP location was determined after temporary
use of cutaneous R2 patch prior to CD implant.Electrophysiologic studies
(EPS) were performed predischarge and after 3 mos.
RESULTS: Percutaneous insertion and placement of the electrode catheter
were achieved in all pts. OFf testing was done using 1 to 4 (mean 2.4) electrode
configurations and required 6 to 21 (mean 12) VF inductions and 8 to 56 (mean
20) shocks per patient. In all pts, lowest reliable OFf was obtained with a triple
electrode configuration and bidirectional shocks (mean OFf = 16;t6J).
Cutaneous patch "mapping" preceding SP implant could be performed in 6 pts
and all 6 pts had CD implant. CD implanted had sensing rates of 142 to 158
bpm, with (4 pts) or without (2 pts) morphology sensing, and initial shock
energy of 28 to 321. VF termination with the first CD shock was documented in
all pts. Device charge times ranged from 5.3 to 6.7 and total time to
defibrillation was 10.5 to 17.1 sec. There was no mortality in CD implanted pts.
Postop EPS predischarge (6 pts) and at 3 mos (2 pts) continued to demonstrate
successful defibrillation by first CD shock. During followup (2 to 6 mos) there
was no sudden or cardiac death and spontaneous CD discharges occurred in 3
pts. Successful VTNF termination occurred in 2 pts and 1 pt had a lead
fracture with inappropriate shocks requiring lead replacement. Antiarrhythmic
drug therapy could be withdrawn in 4 pts and reduced in 2 pts.
CONCLUSIONS: 1) CD can be used clinically with nonepicardial lead systems.
2) Optimal OFf determination requires use of temporary patch electrode
mapping and evaluation of bidirectional shocks. 3) OFf with this lead system
are acceptable for use with the rorrent CD in most pts. 4) Nonepicardial lead
systems should be initially considered for CD implants.
RESPONSE OF RATE-ADAPTIVE PACEMAKERS TO PHYSIOLOGICAL
STIMULI OTHER THAN ISOTONIC EXERCISE: COMPARISON OF SIX
DIFFERENT SENSORS .
C,J Garratt MBCP, V.E.Pau1 MRCP, D.E.Ward MD FACC,
A.J.Camm MD FACC.
St. George's Hospital Medical School, London, UK.
An ideal rate-adaptive pacemaker is one that responds to
all stimuli in a physiological manner. Most comparative
studies have evaluated rate response to isotonic exercise
We assessed the response of 20 patients with rate-
adaptive pacemakers to the following stimuli: head-up
tilt from the supine position, isometric exercise (one
third maximum hand grip), standardised mental activity
test and mild emotional stress. 5 patients had pacemakers
using activity as the sensor (3 Activitrax, 2 Senso1og),
5 using minute ventilation (Meta MV), 4 using stimu1us-
T wave interval (Vitatron 919), 4 using the integral of
the paced evoked depo1arisation (Prism), one using right
ventricular temperature (Nova MR) and one using dP/dT
(De1tatrax). No response was seen in the patients with
actiVity-sensing pacemakers to any of the manoeuvres. One
patient with a Meta MV had a 10' increase in rate with
isometric exercise. All patients with Vitatron 919
pacemakers had an increase in rate (mean 19'*3.4) to all
of the manoeuvres. All patients with Prism pacemakers
and the patient with the De1tatrax had an increase in
rate (mean 15'±2.8 and 19' respectively) to isometric
exercise, mental activity and emotional stress but none
had any increase in rate in response to tilt.
The patient with the Nova MR showed a 7' increase
to isometric exercise and a 6' response to tilt.
Conclusion: Pts with pacemakers using stimu1us-T wave
measurement were the only group to increase their pacing
rate to all the stimuli tested and therefore most closely
mimic the physiological response of the normal heart.
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REIATIaanP OF INmRPU[SE SEPARATIal AND lEFIBRILIATIal
EFFICACY FCR BIPHlISIC WAVEfCRt).
Ranjan K. 'JhIkur M.D., JOIlElI;il Souza, Peter D. Chapnan
M.D., F.A.C.C., JW.e N. wethel:bee M.D., Paul J. TJ:oup
M.D., F .A.C.C., Medical College of Wiscxmsin, Milwaukee,
Wiscxmsin.
Biphasic pulse (B) defibrillation has been s1'x:lwn to be
superior to ~ic (M) defibrillation. 'l11e opt.ima1
P1-P2 separation for B defibrillation over a single
pathway has not been defined. Five pentobarbital
anesthetized mongrel doqs (19.3 ± 1.3 Kq) underwent
plaammt of 4 c:m2 right ventricular catheter electnxle
(cathode) ani an apical subcutaneous patch electnxle
(13.9 c:m2, an:xie). Variable tilt B pUBes with a 5 IlIleC
positive phase (Pl) ani a 5 IlIleC trailing negative phase
(P2) were studied at Pl-P2 separations of 0, 1, 3, 5, 7,
and 10 msec. Capacitance was 150 p.F. Leading edge
voltages for Pl were 200, 300, 400, 500, And 600 volts
And for P2=O.5 x Plo Four trials were conducted at each
voltage level for each Pl-P2 separation and
defibrillation efficacy curves constructed using loqiatic
regression. Enerqies associated with 80% successful
defibrillation (E80) were ClCDplD.'eCi1
PI - P2 SEPARATICIf
o IlIleC 1 msec 3 msec 5 IlIleC 7 msec 10 IlIleC
E80 18.1 J 17.8 J 19.7 J 23.8 J 23.9 J 27.1 J
L..--------.C---:!PeO.Ol'L'=:J-r---------J
CpncluaiQIU For a 10 msec biphasic sing1e-caplK:itor sl¥:x:lc
dellveted. over a single pathway, Pl-P2 separations of
0-3 nwec are superior to Pl-P2 separations of 5-10 msec.
OPTIMAL CAnIETER ELECTRODE DIMENSIONS FOR NON·
nIORACOTOMY CARDIOVERSIONIDEFIBRILLATION LEAD
SYSTEMS.
Huanlin An M.D., Sanjeev Saksena M.D., FAe.e. Newark Beth Israel Med Ctr
. NJ Medical School, Newark, NJ.
We evaluated the efficacy of 2 different nonepicardial electrode systems for
cardioversion of polymorphic ventricular tachycardia (VI') or ventricular
fibrillation (VF) in 23 pts. mean age 65~8 yrs. mean LV ejection fraction
35~15%, undergoing electrophysiologic study (EPS). 2 different tripolar
transvenous cardioversion·defibrillation electrode catheters (CDC) were zused
in conjunction with a cutaneous R2 patch electrode (surace area = 50 cm ) on
the anterior left thorax. The distal defibrillation electrode was located in the
RVapex and the proximal electrode at the SVC/RA junction for both systems.
Defibrillation catheter electrode surface area was diffe~ent for each catheter
systsm (CDC 1· distal = 125 ~mz & proximal = 125 mm ; CDC 2· distal =400
mm & proximal = 800 mm ). Sustained VT or VF was induced at EPS. 1
asynchronous 25J bidirectional shock was delivered using an RV catheter
electrode as a common cathode and SVC catheter and cutaneous patch
electrodes as dual anodes.
RESULTS: 29 polymorphic VTNF episodes were analyzed. CDC 1 (11 pts)
and CDC 2 (12 pis) were comparable for mean LV ejection fraction (CDC 1·
38%; CDC 2· 34%; P >.4) and concomitant antiarrhythmic drug therapy (CDC
1· 53%; CDC 2· 33%; p >.2).
~ ~ p(CDC1vsCDC2l
Polymorphic VT (n=9)
Efficacy 67% 100% >.6
Yf(n=20)
Efficacy 33% 91% <.03
I2!a1 (n=29)
Efficacy 47% 93% <.03
10 Group 1, a second 25J bidirectional shock terminated all remaining
polymorphic VT episodes but did not defibrillate VF.
CONCLUSIONS: 1) 25J bidirectional shocks can cardiovert polymorphic VT
and VF with a triple nonepicardial lead system. 2) Large surface area catheter
electrodes are more effective for VF defibrillation for this triple nonepicardial
electrode configuration.
VENTRICULAR FIBRILLATION WAVEFORM CHARACTERISTICS
ASSOCIATED WITH SUCCESSFUL DEFIBRILLATION USING FIXED LOW
ENERGY DC SHOCK
Peng-Wie E. Hsia. Ph.D., Kenneth W. Hellman, B.S.
Rehan Mahmud, M.D., F.A.C.C., East Carolina University
School of Medicine. Greenville. NC
Low energy DC shocks (DCS) are often observed to
successfully defibrillate at one attempt but not at
another. even when energy, hardware. and duration of
ventricular fibrillation (VF) are kept constant.
Methods: In order to identify factors associated with VF
waveform which may determine success or failure. a fixed
capacitor discharge (successful at the approximate 50%
level) was used in a canine VF model. In addition, patch
size and location. energy and duration of VF were kept
rigidly constant. VF waveform was digitized at 500 Hz
sampling rate and following parameters were examined for
each successful (N-46) as well as unsuccessful (N-70)
DCS. 1) Instantaneous transmyocardial resistance (THR).
2) delivered energy • 3) degree of concordance of
polarity (COP) of DCS pulse with VF waveform 2 msec prior
to DCS (max COP score = 3) and 4) absolute VF waveform
voltage (V) 2 msec prior to DCS.
Results (+ SD) THR Energy COP VFV
- ohms joules
Successful DCS 73.4+8.2 7.8+6.6 2.3+0.5 0.4+0.2
Unsuccessful DeS 72.9±8.4 7.9±6.7 1.8+0.3 0.3+0.1
P value NS NS <.01 <.01
Conclusions: Successful defibrillation appears to be
associated with both degree of concordance of VF waveform
with DCS pulse as well as absolute VF voltage at time.of
DCS. THR and delivered energy are the same for
successful and unsuccessful DCS. These findings may
explain why a fixed energy DC shock is successful at
certain times but not at others.
SEQUENTIAL PULSE DEFIBRILLATION IN HAN: EFFECTS OF
LIDOCAINE AND VERAPAHIL. Doug L. Jones, Ph.D .• George J.
Klein, M.D., F.A.C.C., Gerard M. Guiraudon, M.D .. Raymond
Yee, M.D., F.A.C.C., Arjun D. Sharma, M.D., F.A.C.C.
University of Western Ontario and University Hospital,
London, Ontario.
Patients with automatic defibrillators frequently require
antiarrhythmic drug therapy or receive acute therapy with
the onset of symptoms. Many of these drugs have not been
evaluated for their effects on defibrillation. We examined
the effects of lidocaine and verapamil on sequential pulse
defibrillation in 19 patients during corrective arrhythmia
surgery. The minimum energy requirements for ventricular
defibrillation before and 5 min after the intravenous
administration of l50mg of lidocaine (n-8) or 10 min after
10 mg of verapamil (n-ll) were determined. Patients were
studied intraoperatively after routine epicardial mapping.
Three mesh coil defibrillating electrodes (Medtronic 6891,
6892) were attached to the epicardium of the right and left
ventricles. Each patient was assigned to receive either
verapamil or lidocaine. Ventricular fibrillation was
induced using AC current and after a minimum of 10 sec of
fibrillation the minimum energy for defibrillation was
established. The drug was then infused a~d a 5 or 10 min
circulation time was allowed. Lidocaine did not alter the
minimum energy for defibrillation (3.0 ± 1.4 J vs 3.0 ± 1.8
J, mean ± SD), despite levels averaging 13.2 ± 1.9 ~/L.
However, verapamil significantLy increased (3.9 ± 2.2 J vs
6.5 ± 2.9 J) the energy necessary for defibrillation. These
data indicate the necessity for determining the efficacy of
defibrillation before medication changes are instituted in
patients. They also point out the desirability for program-
mability of delivered energy in automatic devices. Further
they indicate the need for caution in nbe use of verapamil
in patients with automatic defibrillators and marginal
defibrillation thresholds.
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AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
IMPLANTATION BY A NON-TII0RACOTOHY APPROACH
Ronald McCowan MD, J8lIles 0 Maloney MD FACC, Dirar Khoury
BS, Tony WSillllons MD, FACC, Bruce L Wilkoff MD, FACC,
Hugh McAlister MB, Victor A Morant MD, Dave WMullis
PHD, Rits Thsis RN, Lon WCastle MD, FACC
The Cleveland Clinic Foundstion; Cleveland, Ohio
Implantstion of the VENTAK AXCD iaplantable cardioverter
defibrillator (device) by a non-thoracotomy (NT)
approach is desirable. Nine men had defibrillation
threshold (OFT) assessment for device implantation.
Implant indications were sudden cardiac death (3) and
drug refractory ventricular tachycardia (6). Mean
ejection fraction was 25+10%. The implanted device
comprises an endocardial lead with proximal and distal
springs, a subcutaneous patch lead, and pulse
generator. DFTs were assessed using different lead
configurations. The implanted configurations were: A)
distal spring as cathode with proximal spring and patch
as anodes; B) proximal and distal springs as cathodes
ad patch as anode.
Configuration A Configuration B
~ >10 < 15 joules(2pts) <30 joules(lpt)
>15 ..; 20 joules (2pta) >20"; 25 joules(lpt)
QO joules (lpt) >15 ..; 20 joules(lpt)
One system was not iaplanted due to OFT :>40J at NT
implant and at thoracotomy. Days in hospital post
iaplant were a mean 6+2 days excluding 1 pt (36 days
urosepsis). No implant or post operative complications
occurred. During pre-discharge device assessment all
episodes of induced ventricular fibrillation were
terminated with 1-2 shocks.
CONCLUSION: VENTAK AICD implantation using a NT approach
shortens post-operative hospital stay, has a low
complication rate, and has acceptable DFTs.
THE EFFECT OF CARDIAC PACING MODE ON THE LONG-TERM
DEVELOPMENT OF ATRIAL FIBRILLATION.
Adrian H Shandling MD, Joshua M. Feuer MD, J. Edwin
Atwood MD, FACC, Roger L. Ong, Craig D. Castellanet,
John C. Messenger MD, Mark J. Castellanet MD, FACC,
University of California, Irvine; Orange, California.
PROHORMONE ATRIAL NATRIURETIC PEPTIDES 1-30, 31-67, AND
99-126 INCREASE IN PROPORTION TO RIGHT VENTRICULAR PACING
RATE.
Lam !!s2. M.D., Richard P. Wyeth M.A., Joe K. Bissett M.D.,
F.A.C.C., Mary Teresa Newton B.S., Wes L. Hester B.S.,
Alan L. Sallman M.D., Chris J. Winters M.D., David L.
Vesely M.D. Ph.D. University of Arkansas for Medical
Sciences and Veterans Medical Center, Little Rock.
To determine if heart rate influences the release of
three new cardiac peptides (amino acids 1-30, 31-67, and
99-126 of the 126 amino acid prohormone of strial
natriuretic factor) their circulating concentrations
were measured by radioimmunoassays in 6 dogs before and
after pacing. Right atrial blood samples were obtained
immediately prior and just after pacing at 100, 125, ISO,
and 180 beats/min (bpm) and every 30 min for 2 hours
poat-pacing. At pacing rates of 125 bpm and above,
proANFs 1-30, 31-67 and ANF plasma concentrations
increased two to threefold from their pre-paced levels of
885+118 pg/ml, 857+118 pg/ml, and 59+3 pg/m! respectively
(p<:OO2). Mean al:rial pressure decreased significantly
with pacing at ISO and 180 bpm while mean systemic blood
pressure decreased when paced at 180 bps. The plasma
levels of these three peptides correlated better with
heart rate (r-o.68; p<O.ool) than with mesn right atrial
pressure (r-Q.48; p<O.OOl). Within 30 min of pacing
cessation ANF's concentration returned to its pre-pacing
level while proANFs 1-30 and 31-67 remained elevated for
2 hours. Conclusions: 1. All 3 of these peptides hormones
are simultaneously released from the heart at heart rates
of 125 bpm and above. 2. ProANFs 1-30 and 31-67 remained
elevated for at least 2 hours post-pacing which may help
explain the prolonged diuresis observed after rapid
pacing or tachycardia,
EFFECTS OF DIFFERENT PACING MODES ON RIGHT ATRIAL
PRESSURE AND ATRIAL NATRIURETIC PEPTIDE IN PATIENTS
WITH ATRIOVENTRICULAR BWCK.
Benil Kjel! 0je M D Arve Tronstad M.D., Britt Skadberg M.D., Ole
Myking M.D., Ole-J"rgen Ohm, M.D., F.A.C.C., University SChool of
Medicine, Bergen, Norway.
•- p • ns; .. - p < .002; t - p < .001
The 10 minute period of WI pacing did not aher RAP or ANP compared to
the inllial 15 minute period of WI pacing. During the 10 minutes of the AV
pacing period, RAP and ANP decreased significantly compared to the
preceding WI stimulation period while the VA pacing period induced an
increase in both RAP and ANP. The mors physiological findings with AV
pacing (substanlial reduction of ANP and RAP) suggest that this mode
offers the most favorable hemodynamic response of the three modes
evaluated.
We examined mean right amal prsssure (RAP) and amal natriuretic peptide
(ANP) in plasma from the femoral artery In 9 patients with high-degres
atrioventricular (AV) block prior to pacemaksr l/llliantation. Pacing was
performed for 10 minute periods in random order with (1)AV pacing to
simulate normal sinus rtlythm, (2) ventriculoatrial (VA) pacing to simulate
spontaneous VA conduction or (3) ventricular (VVI) pacing. Each study
period was preceded by 1~ minutes of WI pacing. The stirrolation rate was
80 beatslminule during all Ihree pacing modes, and Ihe delay between
stimulation of the atria and ventricles was +175 InS and -175 ms during AV
and VA pacing, respectively. RAP was recorded and blood samples were
drawn just before and at the end of the 10 minute periods of investigation.
Dillerences between ANP (A ANP) and RAP (A RAP) alter the 10 minute
pacing period and the end of the preceding VVI period were (mean ± sem):
WI Ay VA
The maintenance of sinus rhythm (SR) is important to
ensure optimal cardiac performance and reduce
potential for systemic thromboembolism. In patients
with cardiac pacemakers, the mode of pacing determines
atrioventricular synchrony, and might impact on the
future development of atrial fibrillation (AF). To
test this hypothesis. we compared the most current
rhythm of 110 consecutive patients in the WI mode,
FlU 47.6 months ±34, to that of 110 patients in DOD
mode, FlU 40.2 months ±20 (p-NS). All patients were
in SR at implant. In the WI group, 20 patients (18%)
developed AF versus 9 (8%) in the DOD group (p<.05).
In those with sick sinus syndrome (S5S), 15/61 in WI
versus 8/70 in DOD developed AF (p-NS). When these
results were pooled and compared to patients with
atrioventricular block, AF occurred more frequently in
SSS (p<.02). Examination of pre-implantation
characteristics demonstrated that only paroxysmal
atrial tachyarrhythmias (PATA) on electrocardiogram
or Holter monitor predicted AF in WI (16/33,
p<.0001), but not in DOD mode (4/38, p-NS). There were
significant intermodal differences (p<.002).
Conclusions: 1. the incidence of AF is signifi-
cantly higher in those patients with WI versus DOD
pacemakers; 2, the development of AF predominates in
SSS; 3. pre- implantation PATA is strongly associated
with future AF in the WI group only, suggesting that
DOD pacing. in comparison to WI, may reduce the
incidence of AF in the subgroup with PATA.
A ANP (pmoVl):
A RAP (mmHg):
-8.5 ± 3.0' -57.8 ± 3.9" +40.3 ± 2.4t
0.1 ±0.03' -2.6 ±0.1t +1.5 ±0.1t
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'lRIHfASIC WAVEFORMS INCREASE DEFIBRILIATION EFFICACY
OVER BIHlASIC WAVEroIlMS Wl'IH CA'IHETER/SUBaJrANEXXJS PATO:I
E!ECIroDES
Janice Jones Ph.D., John SWartz M.D., Barbara Temeck
M.D., Ronald Jones M.S.E.E., Ross Fletcher M.D.,
F.A.C.C., AIde Notargi.acxm:> M.S., Georgeta.m University
aM VA Medical center, wasl'1i.n3ton, D. C.
To determine whether triphasic waveforms (T) improve
defibrillation efficacy, CCIIplred to bi~ic waveforms
(B), percent success was determined for bi- and
tri~ic shocks in a paired study with a total of 232
episodes in 5 dogs (3 acute aM 2 chronic) usin;J a right
ventricular catheter/subcutaneous patch electrode
system. Initial shocks followed ISs fibrillation and
backup shocks 308 fibrillation. B had 60% undershoot
aM T was similar to B but with a third pulse having
OITershoots of 20-40%. Percent tilt was 50-80%. Dogs
with thresholds <60OV shaNed no significant difference
in V : however, T decreased curve width making the V9
bed for T than B. For dogs with threshold >600V, 1:1
decreased. VSo.b'f 7OV. BaM T pairs delivered at each
voltage SllI:lIiIeQ 20 episodes where B only aM 38 episodes
where T only defibrillated (P<0.02). Results were
subdivided into high and low voltage groups. For
V-30o-500, B only episode~10 and T only-13 (NS): for
v=50o-700, B only episode~10 and T only-25 (P<0.02).
'1hese results suggest that specifically shaped tri~ic
waveforms increase the probability for success





NORMALIZATION OF CORONARY FLOW RESERVE AFTER SUCCESSFUL
ANGIOPLASTY ASSESSED WITH POSITRON EMISSION TOMOGRAPHY
AND H2150
Mary N. Walsh, M.D., Edward M. Geltman, M.D., F.A.C.C.,
Robert L. Steele, M.D., Joseph L. Kenzora, M.D., Carla J.
Weinheimer, B.S., Burton E. Sobel, M.D., F.A.C.C., and
Steven R. Bergmann, M.D., Ph.D. Washington University,
St. Loui s, MD
We have previously demonstrated that myocardial blood
flow (MBF) and coronary flow reserve (CFR) can be measured
quantitatively by positron emission tomography (PET) with
H2150. To assess changes in MBF and CFR in absolute terms
in patients undergoing percutaneous transluminal coron.ary
angioplasty (PTCA), we characterized MBF at rest and after
dipyridamole induced hyperemia (0.14 mg/kg/mln for 4 min)
in 7 patients before and after angiographically successful
PTCA. Minimum luminal area, assessed by ~uantitative angi-
ography prior to PTCA was 0.8 ± 0.7 mm and increased to
3.56 ± 1.16 mm 3 after angiopl asty (p < 0.01). Prior to
angioplasty, MBF at rest was not different between regions
distal to stenoses (1.54 ± 0.5 ml/g/min) compared with
regions supplied by arteries without significant stenoses
(1.46 ± 0.42 ml/g/min). In contrast, after dipyrldClllole,
regions distal to stenoses had flow of only 64 ± 15% of
normal (1.98 ± 1.05 compared with 3.24 ± 2.07 ml/g/min, p
< 0.025). After PTCA, hyperemic flow distal to the steno-
sis site increased to 115 ± 59% of flow in normal regions
and averaged 104 ± 23% at a fo Ilow-up PET study> 4 months
after PTCA (absolute flows after dipyridClllole of 3.07 ±
1.05 ml/g/min in regions supplied by the angioplasty ves-
sel compared with 3.04 ± 1.12 ml/g/min in normal regions).
Thus, PET and H2150 document noninvasively augmentation of
CFR after successful PTCA and should permit objective
comparison of therapies designed to augment flow.
INCREMENTAL CRITICAL CORONARY STENOSIS CONTRACTS
RATHER THAN EXPANDS MYOCARDIAL VASCULAR VOLUME Andrew
J Feirinq MD fACe, Ray Grenier MS, Carl Christensen
PhD, Donald Schmidt MD. Univ of Wisconsin, Sinai
Samaritan MEdical Center, Milwaukee WI.
Pressure gradient-flow dependent coronary stenosis
(PG-FDCS) may abolish vasodilator reserve (VORl. This
is thought to be secondarv to near maximal dilatation
of the distal coronary vasculature (i.e. exhausted
reserve). We evaluated the relationship between
change. in myocardial vascular volume (V) as a function
of d@cremental changes in coronary blood flow (F) using
a previously validated method for determining V. Four
dogs were instrumented with carotid to LAD shunts, and
in-line flow probes •. Myocardial vascular transit times
(T) were measured using a multicrystal camera after
intrashunt injection of O.lml. 99m Technetium-DTPA
(3mCi). Mean diltal coronary pressure (P) was varied
fro. 90-30 mm Hg by screw clamp yielding flows between
60-2 ml/min. (N=45). Since V-FT, and F and Tare
measured, V can be determined.
~yi1l: For each animal the inverse of T varied
linearly with F (rang@ r=0.96-0.99). As expected, P vs
F was linear (range r=0.94-0.97). However, V decreased
a. a linear function of P (range r= 0.91-0.98). When P
was between 30 and 50 mm Hg, the mean value for V
decreased by 3~lO% of the resting V (P~.05).
Conclusion: Previously we have shown that a normal
5-fold VDR is associated with a 2- fold increase in V.
Contrary to previous beliefs, progressive PG-FDS
engenders a linearly dependent reduction in V from
resUng valuel and not a "compensatory" increale in V.
These findings seriously question the concept that
PG-FDCS yields maximal downstrea. valodilatation as a
relult of ischemia.
IN VIVO MEASUREMENf OF SEGMENfAL ARTERIAL WALL
STIFFNESS IN PIGS USING A REAL-TIME ULTRASONIC
SECTOR IMAGING CAllIETER
Dayid T Linker, M,D.. Erling Johansen, M.S., Stig Sloerdal, M.D.,
Paul G. Yock, M.D., F,A.C.C., Aage Groenningsaeter, M.S., Hroar
Piene, M,D., Ph,D., Bjoem A.J. Angelsen, Dr. Techn., University of
Trondheim, Trondheim, Norway
The local elastic properties of the arterial wall influence the complex
impedance, and thereby the propagation of the pressure wave and the
systolic load on the ventricle. In order to measure these local
properties. we used an ultrasound system consisting of a custom,
highly flexible, 8 french intra-arterial catheter probe with a 20 MHz
transducer, and a custom ultrasound instrument, capable of generating
360 degree sector images in a plane perpendicular to the catheter. Three
anesthetized pigs were studies by passing the ultrasound catheter into
the aorta through an arteriotomy in the carotid or femoral artery, and a
pressUre catheter to the same position through a separate artenotomy.
Each measurement consisted of twenty nine frames of digital image
data which were collected in real time at 30 frames per second and
transferred to a computer for further analysis. Blood pressure was
digitized and stored with the corresponding image data. The collected
data was analyzed by manually identifying the borders on each frame,
and calculating an equivalent radius (ER) from the area, circumferential
wall stress (WS) based on pressure and equivalent radius, and wall
stiffness (Ep, in dyneslcm2 x 1()6) based on the slope of the linear
regression line of WS as a function of ER. A total of fifteen
measurements were perfonned at different sites in the aorta. The values
of Ep ranged from 0.47 to 2.04, with a mean of 0.89±O.49. The
graphs of WS versus ER also demonstrated the known hysteresis of
the stress-strain relationship of the arterial wall. We conclude that the
ultrasonic intra-arterial imaging catheter provides a new method for
measuring segmental arterial wall stiffness~.









TDIB-AVllUGml PIIOSPBOI.DS-3l IDOl SPECDOIICOPY OF TIlE
MKTAIOLIC US~SJ: 10 IIEIOlYIWIICALLY BQOIVALDT PACDIG-
llIDUCED A10l I'LOW-LDII'mD ISCIIEMIA D TIlE cnlSClOUS DOG.
D. Douglas Miller,KO, FACC, Mark Csnales,KO, Felix Salinas,
as, Dsnny Escobedo, Richard A. Walsh,KO, FACC.
Univ. of Texas Health Science Center. San Antonio, TX.
To compare the myocardial high-energy phosphate metab-
olic response to equivalently severe pacing-induced(demand)
and flow-limited(supply) ischemia in the conscious dog,
serial phosphorus P-3l NHR apectra(NHR-S) were acquired at
2Tesla using an RF surfsce coil during and after partial
coronary occlusion+pacing(220/min.) x5min.[n-51 or bilat.
total occlusion xlmin.ln-51. Comparability of demand and
supply ischemia was confirmed by continuous on-line record
of micromanometer LV dP/dtmax(2124:1:1132 vs 1978:1:745IJ111l1!g/s),
LVEDP(l2:1:l3 vs l8:1:lOlJlllll!g) and sonomicrometer-derived eject-
ion fractionIEF](.10:l:.15vs .11:1:.16); all p-NS. Myocardial
P-3l NHR-S phosphocreatine(PCr), inorganic P(Pi), B peak
adenosine triP(B-ATP) and pH were measured at control, peak
ischemia and recoveryl*-p<0.05;#-p<0.05 between groupsi.
Per/Pi Ratio 8 -ATP
J)ew!nd ~ J)ew!nd ~
Control 2.6:1:.7]. 2.9:1:.7111 12.9:1:2.2 14.3:1:2.1"
Iache.ta 1.7:1:.4.1.8:1:.5.Jj* 13.4:1:2.1111.2:1:1.4;
hcovery 15' 2.l:l:.6.J 2.0:1:.5 j 14.2:1:2.6 13.7:1:1.4.J
hcoYery 30' 2.2:1:.5 2.1:1:.5 13.7:1:1.9 15.0:1:2.6
Ischemic myocardial pH(7.06:1:.l4 vs 7.l4:1:.20units;p-NS)
and all hemodynamic parameters normalized by 30 min. of
recovery, except LYEF which remained depressed in the
'supply' tachemia group( .23:1:.06 vs .33:1:.04;p<.05 vs control).
We conclude that. 1)p-3l NHR-S demonstrates significant
discordance in the metabolic response to equivalent demand
vs supply ischemia, and 2)prolonged depression of global LV
function is associated with pr~found ATP depletion in the
conscious dog.
REGIONAL DEFORMATION OF THE PERICARDIUM DURING THE CAR-
DIAC CYCLE.
Voichi Goto, M.D., Martin M. LeWinter, M.D., F.A.C.C.
University of Vermont, Burlington, VT.
We hypothesized that contact forces between the peri-
cardium and the heart csuse regional variation in peri-
cardial deformation during the cardiac cycle, reflecting
changes in volume of the individual chambers. To test
this, we measured regional pericardial area (PA) over
the right atrium (RA) and ventricle (RV) with orthogonal
pairs of sonomicrometers in 6 open-chest dogs. At left
ventricular end-diastolic pressure (LVEDP) of 5 mmUg,
RV PA paralleled RV volume, i.e., shrinkage during ejec-
tion (Sel) by 8±8(SD)X and expanaion during filling.
RA PA wa1l reciprocally related to RV PA, with average
expansion during ventricular ejection of 3±4X, thus para-
lleling RA volume during RV ejection. With volume load-
ing (LVEDP 11 mmHg), RV S increased to 14±6X, but RA
PA no longer was reciProcaf j (0±3X change during RV ejec-
tion). Elimination of contact forces by cardiac tampo-
nade resulted in both marked attenuation of RV PA changes
and synchronization of the RV and RA PA pattern, 1.e ••
both shrank during RV ejection (RV by 3±21. RA by l±lX).
In 2 additional dogs, measureaent of PA over LV and left
atrium showed similar results. We conclude that dynamic
Pllricardial contact forces cause regional variation in
pericardia1 deformation which reflects volume changes
of the underlying chambers. Theae findings imply that
the influence of the pericardium on filling is more com-
plex than previously recognized, varying both by chamber
and dynamically over the course of the cardiac cycle.
PERCENT WALL THICKENING IS PRELOAD DEPENDENT AT LOW BUT
NOT AT HIGH LEVELS OF AFTERLOAD. Joao A. C. Lima, Thomas
Aversano, David Kass, W. Lowell Maughan. Johns Hopkins
Hospital, Baltimore, Md.
Percent systolic thickening (%ST) is often used as an
index of regional myocardial function. Although its
dependence on loading conditions is recognized, the
precise magnitude of its preload and afterload
dependencies, as well as the extent of their interaction
have not been well characterized. In order to define %ST
preload dependence at different levels of afterload and
vice-versa, 6 isolated cross-perfused canine left
ventricles were instrumented with sonomicrometers and
made to eject into a simulated arterial system. %ST was
measured at 4 levels of preload (EDPI • 1 ± 1, EDP2 • 6 ±
1, EDP3 • 13 ± 2, EDP4 • 25 ± 2 mmHg) for each of 3
levels of afterload resistance (AR • 1.5, 3 and 6
mmHg.sec/ml).
m 11 increasing fIlf.:i W:.iWllfill 2f AR
EDP1 EDP2 EDP3 EDP4 ANOVA
15 ± 3 16 ± 4 19 ± 4 21 ± 4 < 0.01
13 ± 4 13 ± 4 14 ± 4 15 ± 4 NS
9±4 7±4 8±4 9±3 NS
< 0.001 < 0.001 < 0.001 < 0.001
Repeated measures ANOVA showed that only at the lowest
level of AR %ST increased with increasing preload, while
at all four preload levels it decreased with increasing
AR's. Preload versus afterload interaction was
statistically significant by ANOVA (p < 0.02). In
conclusion, %ST is altered by preload at low but not at
high levels of afterload. This load interdependence lIay
be important in interpret i ng th ickeni ng changes in
patients with varying arterial resistance.
DOES ACUTE PHARMACOLOGIC STIMULATION OF STUNNED
MYOCARDIUM HAVE CHRONIC DELETERIOUS EFFECTS?
Karin Przyklenk PhD. Sharon L. Hale BS. and Robert A. Kloner MD
PhD FACC, Harper Hospital/Wayne State Univenity. Detroit MI &
Hospital of the Good Samaritan, Los Angeles CA.
Pharmacologic agents can 'force' stunned myocardium to contract,
but this acute inotropic recruitment may have deleterious effects on
adenosine triphosphate (ATP) stores and later recovery of contrac-
tile function. To study this issue, 12 dogs underwent IS min of
coronary occlusion (CO) and 30 hours of reperfusion (R). At 30 min
postR (Le. when stunned), 6 dogs were randomized to receive a
bolus of hydralazine (OOS7 mg/kl), while 6 received saline. '1& Wal1
thickening (WT) in the center of the ischemic region and '1& ch~lIge
in LV cavity area ('1& A A) were meuured from short axis 2-D
echocardiograms obtained at frequent intervals throughout the
protocol: Durinl Stunned: Posttreat
fmCQ ~ ~iil ~ i
33;t4'1& -1:t.4'1& I:t.S'I& 7±7'1& 1S:t.1I'1&
4O:t.S'I& -8:t.3'1& 6:t.S'I& S4:t.7'1&·· 7:t.S'I&
'l&AA: Saline 41%,6'1& 26:t.S'I& 3S%,6'1& 36:t,4'1& 4117'1&
'l&AA: Hydralazine 4813'1& 19:t.S'I& 34;t4'1& 71:t.3'1&·· 44±2'1&
In addition, myocardial biopsies were obtained at 2 houn and 30
houn posttreatment. Mean ATP content in the previously ischemic
epicardium (expressed u a '1& of nonischemic values) was:
ATP: Saline 93%,6'1& 83:t.1'I&
ATP: Hydralazine 178:104'1&. 8S%,6'1& I
Hydralazine acutely enhanced contractile function ("P<O.OOI vs.
saline) and~ epicardial ATP levels (·p<O.OS vs. saline) at 2
houn posttreat. However, by 30 houn posttreat, 'l&WT, 'l&A.A and
epicardial ATP valueS did not differ between the hydralazine-
treated and saline control groups. Thus, acute inotropic stimulation
of stunned myocardium with hydralazine did not impair later
recovery of contractile function or ATP stores in this canine model.
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CARDIAC RESUSCITATION BY EXTRACORPOREAL PUMP OXYGENATOR
(ECPO) APTER FAILURE OF PRECORDIAL COMPRESSION.
Raul J. Gazmuri M.D., Max Harry Weil M.D. Ph.D., Martin
von Planta M.D., Joe Bisera MSEE, Sandra Erickson RH,
Eric C. Rackow M.D., Division of Cardiology, UHS/The
Chicago Medical School, North Chicago, Illinois.
After cardiac arrest, cardiac resuscitability is contin-
gent on prompt restoration of effective myocardial per-
fuaion. We investigated ECPO, utilizing jugular vein and
femoral artery access for rapid restoration of coronary
blood flow. Ventricular fibrillation was electrically
induced in 26 pigs with the aid of an electrode catheter
impinged on the endocardium of the right ventricle.
After 10 minutea, two maximal DC countershocks failed to
restore viable rhythm. After an additional 5 min of pre-
cordial compression, ventricular fibrillations unrespon-
sive to countershock (n-13) or electromechanical dissoci-
ation (n-13) were observed. Of 5 control animals (sham
ECPO), continued precordial compression and maximal doses
of epinephrine failed to increase coronary perfusion
pressure to more than 12 mmHg and none of these animals
were resuscitated. ECPO, however, increased coronary
perfusion pressure to 22 mm Hg or greater in each
instance. This exceeds the threshold value previously
identified as predictive of successful resuscitation.
ECPO restored spontaneous cireulation in 19/21 pigs and
12/21 animals survived for 24 hours or more. With con-
current administration of epinephrine (3ug/kg/min) in the
last 13 animals, all ..intained spontaneous cireulation
after only 17 + 13 min of ECPO. Of 4 animals observed
for> 48 hr, 3-were fUlly responsive and fed themselves.
ECPO- is therefore a strikingly effeetive intervention
after 15 min of "elinieal death" and failure of conven-
tional CPR.
INSIGNIFICANCE OF "LOAD DEPENDENCE" ON LEFI'
VENTRICULAR RELAXATION AND FILLING.
Srdjan Nikolic M.s., Steven Solomon B.S., Guangfu Gong M.D.,
Robert W.M. Frater M.D., FAC.C., Edward L Yellin Ph.D.
Albert Einstein Col/ege ofMedicine, Bronx, N. Y.
To investigate the effects of systolic loading on LV relaxation and
filling, we instrumented six anesthetized dogs to measure LVP,
lAP, mitral (Mi) and aortic (Ao) flows. A computer driven mitral
valve occluder and aortic clamp accurately controlled the timing
of aortic and mitral occlusions (AoOc, MiOc) during a single
cycle. We performed perturbations of outflow and the subsequent
inflow to create: I) AoOc and MiOc, i.e., completely isovolumic
cycles (IV); 2) AoOc, i.e., isovolumic contractions, with normal
filling (IVC-NF); 3) AoOc close to end-systole and MiOc to give
complete relaxation, (AoOc-CR); and 4) AoOcwith normal filling
(AoOc-NF).~ (at constant HR): in AoOc-CR and AoOc-
NF vs IV, time of the onset of relaxation (time of peak LVP in
isovolumetric contraction) increased (p<.OI); in AoOc-CR vs IV
the time to end relaxation (minimum LVP in MiOc) increased
(p<.01); filling volume in IVC-NF vs control decreased (p<.ool)
due to decrease in filling time (p<.OI). In AoOc-NF vs. control:
rate of relaxation increased (p<.OI); time to LVP minimum in
early diastole, LVPmin, LVEDP and filling volume were
unchanged. In summary, the computer controlled aortic and mitral
occluders allowed us to precisely control ventricular ejection and
filling, and to distinguish the individual effects of passive and
active properties, thereby revealing the complete time course of
myocardial relaxation in the intact ventricle. We conclude: in the
intact LV, the "load dependence" of ventricular relaxation has an
insignificant effect on diastolic filling.
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Outcome of Coronary Angioplasty
Histopathologic phenomena at the site of percutaneous
transluminal coronary angioplasty. Michael B. Gravanis,
M.D., Gary S. Roubin, M.D., PhD., Atlanta, Georgia.
Eighteen post-angioplasty cases were morphologically
studied at postmortem. Eight out of nine early cases
(few hours post-PTCA) exhibited intimal disruptions,
which with the exception of two were superficial and
of limited extent. All intimal cracks, in eccentric
plaques, occurred at the junction of the atheromatous
plaque with the atheroma-free segment of the arterial
wall. All early cases showed an aneurysmal dilatation
of the plaque-free segment of the arterial wall, in
eccentric plaques. This was interpreted as the result
of uneven distribution of the dilating force (circum-
ferential stress) on the arterial wall, apparently
contributing in the primary success of this procedure.
Late cases (survival over one month post-PTCA) revealed
characteristic medial and intimal lesions of the
atheroma-free segment of the wall indicative of dila-
tation injury. Those lesions (media destruction with
myofibroblastic replacement and intimal thickening)
were present regardless of the degree of luminal
stenosis. It is hypothesized that intrinsic arterial
wall changes (media disruption) at the plaque-free
segment and the resulting altered arterial geometry •
have significant effect on the vascular conduit and
may enhance and sustain the myoproliferative intimal
response resulting in restenosis.
EARLY AND LATE CLINICAL OUTCOME FOLLOWING
SUCCESSFUL CORONARY ANGIOPLASTY OF TOTAL
CORONARY OCCLUSIONS.
Edward S. Thomas. M,D , David O. Williams, M.D., F.A.C.C.,
Robert J. Mich, M.D., Albert S. Most, M.D., F.A.C.C., Rhode
Island Hospital, Brown University, Providence, RI.
To assess the long-term efficacy of coronary angioplasty (PTCA)
for total coronary occlusion (TCO), we reviewed the outcome of94
consecutive non-acute myocardial infarction patients (pts) with TCO
in whom PTCA was attempted and follow-up was obtained. In
addition, outcome was compared to a group of patients without TCO
in whom PTCA was successful with single vessel disease OVD,
n=189) or multivessel disease (MVD, n=92). PTCA was successful
(suc) in 62 and unsuccessful (unsuc) in 32 TCO pts. Prior to
PTCA, each pI. had disabling angina pectoris. Follow-up exercise
treadmill tests were performed at a mean of 2.8 ±4.5 mos. in 56/62
(90%) suc pts. The incidence of ischemia and/or angina during
exercise testing was more common in suc TCO pts than in 1VD pts
(27% vs. 13%, p<.Ol) but similar to MVD pts (33%, p>.05). After
a mean follow-up of 21 ± 11 mos, more suc pts. noted clinical
improvement (89% vs. 69%, p<.04) than unsuc pts. Furthermore,
fewer suc TCO pts had subsequent hospitalization for chest pain
(21% vs. 50%, p<.Ol) or coronary bypass surgery (3% vs. 28%,
p <.001) than unsuc. Repeat PTCA (16%), non-fatal MI (2%) and
death (0%) occurred infrequently in suc TCO pts. TCO pts were
more likely to experience late recUITent angina pectoris or have
repeat PTCA or CABG than 1VD pts. Thus, successful PTCA in
symptomatic patients with TCO results in both acute and late clinical
improvement but not to the degree achieved by pts with subtotal
1VD.
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PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF INTERNAL
MAMMARY ARTERY BYPASS GRAFTS
David M. Hill, M.D., Bruce J. McAuley, M.D., F.A.C.C.,
Dennis J. Sheehan, M.D., John B. Simpson, M.D.,
F.A.C.C., Matthew R. Selmon, M.D., Edward T. Anderson,
M.D., F.A.C.C., Sequoia Hospital, Redwood
City, California
Internal mammary artery (IMA) bypass grafts offer
superior patency rates when compared to saphenous vein
grafts I however, stenosis of the IMA graft may occur in
the early post-operative period. We reviewed our
experience with PTCA in 11 patients who underwent IMA
bypass graft dilatation.
Eight of the 11 patients had left IMA grafts placed to
the LAD. Three patients had right IMA grafts-one to
the LAD and two to the RCA. All patients developed
recurrent angina within 4 months of coronary bypass
surgery. In 10 of 11 patients, there was severe
stenosis of the IMA at the distal anastomosis. In one
patient there was stenosis of the proximal IMA.
Nine of 11 patients had successful PTCA of the IMA
graft without complication. Extreme angulation of the
anastomosis with the LAD prevented passage of a
guidewire in one patient. Failure secondary to
imcomplete balloon expansion was encountered in one
patient. At re-operation, a marked fibrotic reaction of
the IMA pedicle with extrinsic compression was found.
At a mean follow-up of 13 months post-PTCA, 8 of 9
patients successfully dilated were asymptomatic. Two
patients developed restenosis and were successfully
dilated.
CONCLUSION, PTCA can be successfully performed in IMA
bypass grafts with a high success rate and a low
restenosis rate. Significant stenosis at the distal lMA
anastomotic site occurs early post-CABG and in one case
was secondary to fibrosis with extrinsic compression.
INTERNAL HAHKARY ARTERY GRAFT ANGIOPLASTY: CLINICAL AND
ANGIOGaAPHIC FOLLOW-UP
Michael H Sketch Jr MD, Jose A. Perez MD, Peter J.
Quigley MD, James Herndon Ph.D, Christopher M. O'Connor
MD, James E. Tcheng MD, Joseph B. Muhlestein MD, Richard
S. Stack MD, FACC. Duke Medical Center. Durham, NC
With improved graft patency rates of internal mammary
artery (IMA) conduits, little data has accumulated
regarding outcome following PTCA of IMA stenoses. Over
a 48 month period, 13 consecutive pts (11 males) with a
mean age of 57.9 yrs underwent PTCA of IMA stenoses.
The lesion sites were 11 distal, 1 proximal and 1 body,
with a mean graft age of 7.4 months. The procedural
success rate was 92% (12 of 13 grafts) with a reduction
in the mean IMA luminal narrowing from 88% to 18%. The
one acute failure was due to the inability to cross the
lesion (100% stenosis pre-PTCA). No in-hospital
reocclusions occurred.
Of the 12 initially successful angioplasties, there
was 92% angiographic and 100% clinical follow-up (mean -
7.5 months). Angiographic restenosis (> 50% occlusion)
occurred in one patient (9%).
In comparing these results to 84 saphenous vein (SV)
graft angioplasties performed during the same time
period, initial success and in·hospital reocclusions
rates were similar. However. the restenosis rate was
38% for SV grafts vs. the 9' for IMA grafts (p-0.08).
In conclusion, PTCA of IMA grafts appears to be both
safe and effective with an excellent short and long. term
outcome.
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF LEFT INTERNAL
MAMMARY ARTERY GRAFTS USING A FEMORAL APPROACH.
Malcolm R. BellL-M.B.,B.S., Ronald E. Vlietstra, M.B.,
Ch.B., F.A.C.C., Dennis R. Bresnahan, M.D., F.A.C.C.,
David R. Holmes, Jr., M.D., F.A.C.C., Mayo Clinic,
Rochester, MN.
Use of the internal mammary artery (IMA) as a conduit
for coronary artery bypass grafting is increasing.
Despite excellent long term patency rates, stenosis of
the IMA graft and the distal native vessel can occur.
Experience with percutaneous trans luminal angioplasty
(PTA) in treating these stenoses has been limited and
there have been technical concerns regarding the use of
a femoral approach.
We have performed PTA through IMA grafts on 11 pts,
mean age 58 + 11 yrs. Standard PTA techniques were used
employing low-profile balloons with a standard IMA guide
catheter positioned via the femoral artery. There were
7 stenoses at the distal anastomotic site and 4 in the
distal native coronary artery. The median interval from
surgery to PTA was 6 mos (range 5 days to 6 yrs). PTA
was successful (>40% improvement in stenosis) in 10 pts
(91%), including 1 pt with a totally occluded distal
graft and 1 pt treated at the time of an acute myocar-
dial infarction. There were no major complications
related to PTA although 1 pt had a transient occlusion
at the site of PTA. Clinical improvement was noted in
10 pts during follow-up of 10 ! 8 mos; 1 late death
occurred in a pt with a history of "sudden death". No
clinical or angiographic restenoses have occurred.
These results suggest that PTA via the femoral artery
is both safe and effective for IMA graft and distal
coronary artery stenoses. This has important thera-
peutic implications for the expected increase in the
number of pts presenting with IMA graft stenoses.
~ AOOIOPIAS'IY DISSl!X:I'IQr: m-IDSPlTAL cxm:am.
JanEs p. M!!di!jqt MD, Flla;, Jodi Fishman M:xlrley RN MS,
Michael R. M:xlrley MD, Ir:vin F. Goldenberg MD, FAlX.
MiJmeapolis Heart Institute, MiJmeapolis, MH.
To deteJ:mine the effect of the type of coronary
an;riqllasty (CA) -associated dissec:tiat upon in-hospital
canl.iac events and success rates at hospital disdlarge,
_ reviewed our last 104 NHI.BI type B-F dissectiai
cases. 'Ihe type of dissectia'l was defined
an;ri~cally. Type B~ as a rad10clense
intraluminal parallel tract durin; contrast injectia'l,
withalt oontrast persisteooe, C as the persisteooe of
oontrast ootside the lumen follCJWin; injection, 0 as a
spiral defect withalt delay in antegrade flow, E as a
new, persistent fillin; defect durin; injectia'l, and F
as a total coronary ooclusia'l. 'Ihe 104 cases were
evaluated for incidence of each dissec:tia'l type, for
in-hospital carplicatia'lS by dissec:tiat type, and for
an;ri~c and clinical suooess at the time of
disc:harge. In-hospital OCIIplicatia'lS evaluated incllDld
acute closure, EIIlelT:JeIlt bypass surgery (Em-S),
myocardial infarction, elective bypass surgery (El-S),
and repeat CA durin; the same hospitalization. '!here
were no deaths in the series.
Successful Ao.lte Myocardial Repeat
CA Closure Em-S Infarctiat El-S CA
Type '" , "B (N-75) 92 1 0 0 7 3
C=F CN-29) 41 28 41 14 10 3
P value <.001 <.001 <.001 <.005 (NS) (NS)
'lhus, pta with type B dissec:tia'l have an excellent
in-hospital Q1toane. In oontrast, pta with type C-F
dissec:tia'lS CXJlIIIOrl1y have adverse in-hospital events.
'1tlese data suggest that new inter:ventiCllal devices may
play a role in the fub.Ire treatment of pta with Type C-F
dissec:tia'lS.
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CORONARY ANGIOPLASTY IN PATIENTS WITH SEVERE DEPRESSION
OF LEFT VENTRICULAR FUNCTION
RS Kohli. H D, OW Vetrovec, MD, FACC, G DiSciascio, MD.,
FACC, SA Lewis, MD, FACC, A Nath, H D, HJ COWley, MD,
FACC, Hedical College ot Virginia, Richmond, Va.
H1gh risk salvage coronary angioplasty (CA)
trequently includes patients (pts) with severe lett
ventrioular dysfunotion. We report here the aoute and
chronio outcome ot CA in 63 pts with lett ventrioular
ejeotion traotion (LVEr) i 35', who underwent CA between
1985 and 1987 beoause they were deemed high risk or poor
candidates tor bypass surgery as a primary treatment.
There were 49 males (H) and 14 temales (F) with a mean
age ot 59 :!:. 15 (80) years. Hean LVEF was 28 :!:. 7' (SD).
(Range 9-35'). One had an aoute myooardial intarotion
(HI), 13 had previous HI and 24 had reoent HI «15 days)
while 42 had unstable angina. Twelve pts had previous
bypass surgery. Single vessel CA was pertormed in 45
pts and mUltiple vessels in 18. Suooessful CA was
pertormed in 116 ot 123 lesions (94,). Clinioal
improvement was seen in 56 (90" pts. Major
oomplioations (HI, death, urgent bypass surgery) were
seen in 8 (12.5') pts. Two (3') pts died during the
prooedure, both were H With LVEF ot 15' and 23'. One pt
was sent tor emergenoy revasoularization. Five (7') pts
developed HI during CA (inoluding a non-Q wave HI). All
pts had tOllow-up tor greater than 6 months; 45 (71')
remained olinioally improved. Nine (14') had
restenosis, 2 (3') had new disease and 7 (11') pts died.
This data indioates that CA 18 an aooeptable method ot
ooronary revasoularization in seleoted, potentially high
risk aurgioal pts, although oomplioationa are higher
oompared to CA in pta with normal oardiao function.
Furthermore, auoh pta require oloae tollow-up in order
to deteot early olinioal reourrenoe whioh may have an
impaot on the higher inoidenoe ot late morbid events.
Wednesday, March 22, 1989
3:00PM-4:00PM, Pacific Room
Anaheim Convention Center
Coronary Atherectomy and Imaging Catheters
INTRAVASCULAR ULTRASOUND VISUALIZATION OF ATHEROMA PLAQUE
REMOVAL BY ATHERECTOMY
~onathan H. Tobis. H.D .. FACCi John A. Mallery, H.D.; Don
Hahon, H.D.; James Griffith, Ph.D.; James Gessert; lach-
lan Hacleay, H.D.; Hichael Hcrae, H.D.; Hatthew Bessen,
H.D.; Walter l. Henry, H.D., FACC;
University of California, Irvine, CA
Although atherectomy methods are designed to remove
atheroma mass, present angiographic methods do not permit
an adequate analysis of either the amount of mass removed
or the residual wall thickness. Because it may be impor-
tant to assess these parameters, a technique to visualize
the atheroma mass and arterial wall in cross section dur-
ing interventional procedures could have significant
benefit. Toward this purpose, a 1.2 mm diameter 20 HHz
intravascular ultrasound imaging catheter was used to
obtain cross-sectional arterial images in vitro in 12
atherosclerotic human peripheral and coronary artery seg-
ments. Each arterial segment was imaged with the intra-
luminal ultrasound probe at 1 mm increments. lumen
dimensions were measured on multiple cross-sectional
ultrasound images before and after a portion of the
atheroma was removed with a Simpson atherectomy catheter.
In each arterial segment, the cross-sectional ultrasound
images demonstrated a significant decrease in fibrocal-
cific plaque. The mean values of the lumen before and
after atherectomy were:
Diameter (rom) Area (rom2) Perimeter (rom)
Pre: 2.7x3.2 6.6±4.2 9.7±5.3
Pest: 4.2x4.8 16. 1±7.4 14.3±6.1
This preliminary experience in vitro suggests that an
intravascular ultrasound imaging catheter may provide
information of considerable value to the interventional
cardiologist.
O'1'ILIft or AB IftMVASCOLAR OLTIIABOORD IIIAGIRG
DBVICB rOR ARTERIAL WALL DBrIRITIOR ABO
ATBBRBCmMY GOIDUCB.
Susan P. Graham H.D., David Brands, Adam
Savakus M.S., John McB. Hodgson H.D.,
F.A.C.C., McGuire VAMC and Medical College of
Virginia, Richmond, VA.
We have used a percutaneous S.SF, phased
array 20 MHz ultrasound imaging catheter to
examine arterial wall characteristics before
and after atherectomy in isolated human
ileofemoral arteries (ART) and in intact
anesthetized dogs. The catheter produces 2-D
cross-sectional images in ART up to l6mm in
diameter. Ultrasound images were compared to
histologic sections. Normal ART walls appear
as a single layer < 1.Omm thick. Diseased ART
have wall thickness proportionate to the
medial thickening and subintimal pI aque seen
on histology. Diseased ART also have 3
distinct layers. With increasing disease and
especially with calcium, the seyaration of
layers may be lost. Penetrat on of the
innermost layer (plaque) by atherectomy is
easily visualized. Progression through the
echo-lucent media cannot be exactly
determined. The outer border echos remain
visible until the adventitia is completely
penetrated (in vitro). Potential limitations
included the need to position the catheter
coaxially, lateral spread of the echo beam and
·shadowing· effects from calcified regions.
Conclusion: Intravascular ultrasound imaginq
allows differentiation of normal from abnormal
ART walls. Plaque removal by atherectomy can
can be easily assessed using this catheter.
COMPLICATIONS: EARLY EXPERIENCES OF PERCUTANEOUS
CORONARY A"mERECTOMY
~ Robertson, MD; TOllOaki Hinohara, MO, FACC;
Ma tthew Se lmon, MO; Michael Rowe, MO; Ne i1 White, MO;
John Simpson, MD, FACC; Sequoia Hospital, Redwood
City, CA.
Percutaneous Coronary Atherectomy (PCA) was developed
to achieve predictable re1lJ)va1 of coronary atheroma
with low complications. Since October 1986, PCA was
attempted in 93 lesions in 83 patients (pt) at Sequoia
Hospital. Overall success rate «50% residual
stenosis) was 72%. Complications during the procedure
and ho sp i ta lizat ion we re as fo llows.
Major Complications n-3 (4%)
Coronary occ 1usion requir ing surgery 1
Trans ien t co rona ry occ 1us ion requ ir ing PTeA 1
Distal embolization 1
Q Wave infarct 1
~ath 0
La te coronary occ 1usion 0
Major dissection not requiring surgery 0
Vessel perforation 0
Minor Complications n-6 (7%)
Small side bral1Ch occlusion 2
Air embolization without sequ1ae 1
Non- Q Wave In fare t 1
Surgical repair of access site 2
Transient thrombus forma tion 1
Distal embolization occured during PCA of a 12 year
old bypass graft resulting in a Q wave infarct and 1
pt with small side branch occlusion had a non-Q wave
infarct. In conclusion, our preliminary experiel1Ce
suggests that significant complications are infrequent
and PCA is s relatively safe procedure with
experiel1Ced operators using current equipment.
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ANGIOGRAPHIC APPEARANCES FOLLOWING PERCUTANEOUS
CORONARY ATHERECTOMY
Tom:>aki Hinohara, ~ FACC; Matthew Selmon, MO;
Gregory Robertson, MD; Neil White, MO; Michael RoWil,
MO; John Simpson, MD, FACC; Sequoia Ilospita1, RedloiOod
City, CA.
Percutaneous coronary atherectomy (PCA) was developed
to achieve a wider lumen and smoother surface
removing tissue from the coronary artery. The purpose
of this study was to analyze angiographic appearances
following successful PeA. Between April and August
1988, PCA was attempted in 62 lesions in 54 patients.
Seventy-nine % of these lesions were in native
coronary arteries and 21 % in vein grafts. Fifty
lesions were successfully treated with PCA alone with
reduction of stenosis from median of 90% to 10%.
Adjunctive coronary angiop1asty (PTCA) W:lS performed
in remaining 12 lesions because of failure to place
the PeA catheter (9 lesions) or significant residual
stenosis following PCA (3 lesions). Angiographic
appearance following failed PCA prior to adjunctive
PTCA did not show new dissection, intimal flap or
thrombosis. Angiographic appearances of post
successful PeA site (n=50) Wilre as follows: irregular
rough appea ra nc e 6 %; fi lling defec t suggest ive of
thrombus 2%; intraluminal linear radio1uceny 8%; minor
dissection 6%; major dissection 0%; hazy appearance
4%. In conclusion, our study dellDnstrates that PeA
typically creates a sm:>oth angiographic surface
without the major dissections commonly seen after
PTCA.
INITIAL EXPERIENCE WITH A FLEXIBLE ROTATIONAL ATHRECTOMY
SYSTEM DESIGNED FOR REMOVAL OF CORONARY AND SMALL
PERIPHERAL ARTERY ATHEROMAS.
Richard W. smallina, M.D., Ph.D., F.A.C.C.,David B.Cassidy, M.D., Wal emar A. Schmidt, M.D., Ph.D., Glenda
M. Wise, M.S., Patricia R.Felli, B.S., Robert L. Barrett,
M.D. and Gary L. Boseck, Ph.D., University of Texas
Medical School at Houston, Houston, Texas.
A 4.5 French flexible rotational athrectomy system (RAS)
capable of being introduced through a guiding catheter
over a standard coronary angioplasty guide wire has been
developed by BARD. The RAS uses an auger device which is
placed into atheroma and effectively captures debris as
the flexible cutting shaft is advanced over it. After
initial studies in canine peripheral, renal and coronary
arteries demonstrated its ability to negotiate tortuous
vessels it was used to remove atheromas in 4 human below
knee amputation specimens. Quantitative arteriography of
diseased segments before and after athrectomy
demonstrated improvement in lumen diameter from .49-.83
to 1.17-1.31 mm. Histologic examination of normal
arteries showed no structural abnormalities after
treatment with the RAS. The RAS seemed to preferentially
track the "true" lumen in diseased vessels removing
atheromatous material while leaving a smooth border and
sparing the muscularis. The RAS successfully recanalized
long segments of totally occluded vessel without per-
foration. Conclusion: The RAS is capable of removing
atheromatous leslons in severely diseased, tortuous
vessels using co-axial, wire-guided techniques.
BARD ROrARY ATHEROCIU1Y SYSTEM (BRAS) IN raMAL CANINE
CDRalARY ARTERIES
Alexamer Battler, M.D., F.A.C.C., Mickey SCheinowitz,
M.Sc., samuel Rath, M.D., Gary Boseck, Ph.D., Michael
Eldar, M.D., Research Laboratory for Laser Application
in cardiology, Sheba Medical ctr, Tel Aviv University,
Tel Hashaner, Israel.
A new mechanical atherectcxny device, the BRAS system,
was evaluated in 10 coronary arteries of 5 normal dogs.
The device canprises a non rotating guidewire with a
spiral shaped distal end arrl a 5F rotary catheter
equipped with a hollow blade. This system is designed
to remove and collect atherosclerotic occlusive material
using conventional coronary catheterization techniques.
The BRAS was advanced into the distal coronary vessel
through a 8F guiding catheter over .014" exchangeable
guidewire using the percutaneous femoral approach. This
procedure was performed twice in each dog, initially in
either the left anterior descending or circumflex
coronary artery and 1-3 days later in the other coronary
artery. The do;Js were maintained on aspirin 25Orrg/day
arrl were sacrificed after the second procedure arrl the
errlarterectany sites underwent pathological and
histological examination. Angiography performed i.nme-
diately after errlarterectcxny arrl 1-3 days later
demonstrated patent coronary vessels without perforation
or thranbosis in all cases. Macroscopic examination of
the excised hearts, demonstrated the presence of minimal
perivascular hemorrhage in 5 of the arteries,
irrespective of the time and site of errlarterectcxny. It
is concluded that percutaneous coronary errlarterectany
with the BRAS system is feasible without acute or
chronic angiographic evidence for perforation or
tlu.anbosis.
EVALUATION OF AORTIC IMPLANTATION AND REDILATION OF
BALLOON EXPANDABLE INTRAVASCULAR STENTS IN
JUVENILE MINIPIGS.
G Wesley. Viek III MD ,Martin O'Laughlin MD, Tim Myers RRT,
Takeshi Nakatani MD, Julio Palmaz MD, Richard Schatz MD FACC,
W. Robert Morrow MD, Charles Mu!!ins MD FACC. The Lillie Frank
Abercrombie Section of Cardiology, Department of Pediatrics, Baylor
Co!!ege of Medicine, Houston, TX
Ba!!oon expandable intravascular stents (BEIS) are potentia!!y an
efficacious catheter treatment for pediatric patients with congenital and
acquired vascular stenoses. More information is needed, however,
regarding the feasibility of redilation of BEIS and implantation of
BEIS in series as a possible treatment for long segment stenoses. Nine
BEIS were placed in the abdominal aortas of 6 juvenile minipigs
(weight 14.7 ± 1.2 kg, age 90 ± 12 d) under general anesthesia. In
three cases, stents were implanted in series (ie, overlapping each
other). Initial implantation of stents was successful in 8 of 9 instances.
Series implantation of BEIS was successful in each of 3 attempts.
Five animals were evaluated by repeat catheterization and aortography
at 196 d ± 17 d after placement. Weight at redilation was 43.5 ± 2.1
kgs. Stents were patent in each instance, but mild constriction with
growth relative to the normal proximal aortic diameter was noted.
There were no pressure gradients at the site of the stents at the
subsequent examination, however. RediJation was successful in 4 of
4 attempts (1 after series implantation), and the mild constriction of the
aorta at the BEIS site was relieved. Redilation increased the diameter
of the aorta at the BEIS site by an average of 35%. One animal died
due to unexplained ventricular fibrillation at the fo!!ow-up
catheterization before redilation could be attempted. No evidence of
perforation or other technical problems were noted at autopsy.
Pathological examination of the BEIS taken from this animal and the
aorta at the stent site revealed no evidence of thrombosis. The BEIS
was covered with a thin layer of neointima. We conclude: 1) stents do
not interfere with normal growth in animals, 2) implantation of stents
in series is feasible, and 3) redilation of stents is possible subsequent
to growth.
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ADDITIONAL IMPROVEMENT IN VESSEL LUMEN IN THE FIRST 24 HOURS
AFTER STENT IMPLANTATION DUE TO RADIAL DILATING FORCE
Kevin J Bean M.R C P Michel Bertrand M.D., Jaques Puel M.D., Tony
Rickards M.D., F.A.C.C., Patrick W. Serruys M.D., FAC.C., and Ulrich
Slgwart M.D., FAC.C.
Core laboratory lor quantltatJve angiography: on behalf at the working group
for endolumlnal coronary artery prostheses.
Thoraxcentre, Erasmua Unlverslty Rotterdam, The Netherlands.
Quantitative coronary angiography was performed In 18 patients pre-PTeA,
post-PTCA, post-stent Implantation, and at 24 hours followtng Implantation.
The minimal lumen diameter (MLD), the reference diameter (RD) at the
stented coronary artery segments, the percentage diameter stenosis (OS)
and the mean diameter at the stented segment (STN MD) were determined.
Results:
MLD RD OS STNMD
Pre-PTCA 1.31.±.O.56 2.97.±.O.65 52.±.16
Post-PTCA 1.64.±.O.47.., 2.91.±.O.68.., 36.±.15.,
* ** *
Post-stent 2.38.±.O.38-1 3.O9.±.O.55 -l 22.±. 9 -I 2.62.±.O.51..,
* ** * **
24 hour F\U 2.79.±.O.51 .... 3.39.±.O.78-J 17.±. 9-1 3.08.±.O.59~
* p<O.OOl. ** p<O.02.
Immediatelyfollowing slent Implantation there was a slgnlllcant improvement
In the MLD, the OS and the STN MD with a further s1gnlllcant Increase over
the next 24 hours. The radlallorce at the self expanding prosthesis has the
eIIect at Improvtng the caliber at the entire stented segment, creating an
optimal hemodynamic proIIe, and this affect continues lor at least the first
24 hours. The eIIect wi! tend to raduce the sIgnlllcance at any subsequent
InIImII hyperplasia, and may be Important In determining the long term
outcome at this device.
PATHOLOGIC FINDINGS AFTER IN VIVO PLACEMENT OF
PERCUTANEOUS BALLOON EXPANDABLE TANTALUM STENTS.
Christopher White, M.D., F.A.C.C.,Saurabh K. Chokshi,
M.D., Jeffrey M. Isner, M.D., F.A.C.C., Ochsner Clinic,
New Orleans, LA, and St. Elizabeth's Hospital, Tufts
University School of Medicine, Boston, MA
Balloon expandable endovascular stents represent a
potential solution to certain complications of balloon
angioplasty, namely restenosis and abrupt closure. We
examined pathologic findings evaluating tissue reaction
and biocompatibility of balloon mounted Wiktor stents
placed percutaneously in peripheral and coronary
arteries of normal Yucatan swine. These stents are
constructed of tantalum designed to enhance
radiographic visualization. A total of 20 stents, 15 mm
in length, were placed in 12 external iliac, 1 internal
iliac, 1 caudal, 1 left circumflex coronary and 5 left
anterior descending coronary arteries.No chronic anti-
platelet agents or anticoagulants were
employed. Sequential angiography performed at 1 day in 6
arteries, 1 wk in 2 arteries, 2 wks in 2 arter~es, 4
wks in 6 arteries and 6 wks in 4 arteries, showed 100%
patency of stented segments. Light microscopy of the
stents at 1 day post-placement revealed an irregular
intimal surface with thrombus covering the struts of
the stent. Over the next 3 wks, complete covering of
the stent wire with neointima resulted in "smoothing"
of the intimal surface. The neointimal growth was
asymmetric; foci of maximal thickness were observed
adjacent to the stent "struts". The thickness of the
neointima varied from 108-436 urn; peak neointimal
growth developed at 4 wks post-implantation;by 6 wks,
maximum neointimal thickness measured ~48 um. In all
segments examined at 4 wks or more post-stent-
implantation, the media underlying the stent was
severely attenuated. These findings document the
biocompatibility of a tantalum stent, designed to
enhance radiographic visualization, which in this
animal model was associated with 100% patency.




ECHOCARDIOGRAPHIC COMPUTED TOMOGRAPHY OF THE HEART:
PRELIMINARY RESULTS. Riccardo Pini M 0 , Elisabetta
Monnini, D.El.Eng., Leonardo Masotti, D.El.Eng., Barbara
Greppi, M.D., Marino Cerofolini, M.D., Richard B.
Devereux, M.D., FACC. Cornell Medical College, New York,
N.Y.
To perform three-dimensional reconstruction of the
heart by ultrasound, we developed a new echocardiographic
transducer that allowed acquisition of 60 standard fan
shaped two-dimensional (2-D) views at 3 degree increments
of rotation about its central axis from any acoustical
window, terminating at l80Q with a mirror image of the
starting echocardiographic view. Acquisition time is 72
to 120 seconds in sinus rhythm. Comparing the 0 to 180
degree images provides an immediate check of stability of
the axis of rotation during the recording. A PDP 11/44
digital computer with a 512 x 512 pixel x 256 grey level
frame grabber digitized the 60 videotaped images with
electrocardiographic gating and converted the original
2-D images acquired in cylindrical coordinates to recon-
struct a three-dimensional cone of information including
the heart, with enhancement by a scan converter, from
which 2-D images in any plane at specified times or
throughout the cardiac cycle can be derived. Tubes and
wires in a standard ultrasound phantom were accurately
reconstructed, as were planes Visualizing the aortic
valve cusps and proximal left coronary artery when the
transducer's axis of rotation was at mitral tip leve~ in
clinical studies. In conclusion: 1) a novel rotating
echocardiographic transducer images a solid cone encom-
passing the heart from the chest surface; 2) short
imaging time (~120 seconds) does not prolong the
echocardiographic examination and allows stability of the
axis of rotation; and 3) this system permits computed
tomography of the heart without cumbersome external
reference systems, expensive immobile equipment, or
radiation exposure.
DETECTION OF PULMONARY ARTERY THROMBI BY
TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN PATIENTS
WITH SUSPECTED PULMONARY EMBOLISM
Norbert Wittlich M.D., Raimund Erbel M.D.,
F.A.C.C., Michael Todt M.D., Susanne Mohr-Kahaly
M.D., Michael Drexler M.D., Jurgen Meyer M.D.
II. Medical Clinic, University of Mainz, FRG
Transesophageal echocardiography (TEE) allows a
visualization of the pulmonary artery (PAl.
Especially the right PA (RPA) can be depicted at
a length of 3-6 em. We examined 23 patients
(pts) with suspected pulmonary embolism (PE) by
TEE in order to evaluate the capability of this
approach to detect pulmonary artery thrombi
(PAT). In 7 pts with the age of 52.29 ± 18.07
years, 4 female, 3 male, we observed thrombi in
the RPA, filling more than half of the lumen of
the vessel, in two cases nearly occluding. These
2 pts went to surgery after confirmation of the
TEE findings by angiography (ANG). The emboli
were removed. In another pt the thrombus was not
seen by ANG but could be visualized by computed
tomography. In 2 other pts the TEE findings were
confirmed by ANG. In all pts PA pressure was
elevated: systolic 73±27.68 mmHg, diastolic
32.4±9.34 mmHg, mean 48,4±15,77 mmHg. With the
exception of one pt (surgery case) all pts had
repeated PE; in all venous thrombosis was
detected as source of embolism.
Conclusion: The detection of PAT in pts with PE
is possible by TEE. The clinical value of this
tool, its sensitivity and specificity is still
to be evaluated.
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SAFETY OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN AWAKE
PATIENTS: EXPERIENCE WITH 400 PROCEDURES.
BijObKhandheria, M.D., James Seward, M.D., F.A.C.C.,Jae h, M.D., F.A.c.c., William Freeman, M.D., L. J.
Sinak, M.D., Barbara Nichols, R.N., and A. Jamil
Tajik, M.D., F.A.C.C., Mayo Clinic, Rochester, MN
Transesophageal echocardiography (TEE) is being used
with increasing frequency in the awake Pt. We report
our initial experience with 400 procedures in 387 Pt.
207 males; age range 12-88 yrs (mean=61 yrs), TEE
studies represented 2.7' of all transthoracic echo ex-
aminations (14.881), Indications included: suspected
malfunctioning prosthesis (90) or native valve (55),
thromboembolic event (56). endocarditis (47), aortic
pathology (40). critically ill (40), congenital heart
disease (20), and miscellaneous (39), An echoscope was
introduced following left lateral positioning (90'),
pharyngeal anesthetic (100'), intravenous drying agent
[0.2 mg glycopyrollate] (100'), and Midazolam sedation
(73') [mean dose 3.5 mg, range 1-7 mg], There were 29
critically ill patients studied with endotracheal tube
in place. TEE was unsuccessful in 2/400 (0.5') [cervi-
cal spondylosis (1). uncooperative (1)], aborted 1/400
procedures (0.25'). Examination time ranged 5-45 min-
utes (mean=I6 minutes). Minor complications occurred
in 2/400 procedures (0.5') [supraventricular tachy-
cardia (2)], Minor sore throat was reported in 71' Pt.
In response to a questionnaire, 99' Pt reported they
would undergo a repeat examination if indicated. Su-
perior TEE information was found in Pt with mitral
prosthesis. aortic dissection, thromboembolic episodes,
endocarditis, cardiac masses, and critically ill Pt.
Conclusion: TEE is a feasible examination in the awake
Pt and can be performed safely and expediently, and







NON-INVASIVE COMPUTER. RECONSTRUCTION OF THE
PULMONARY ARTERY PRESSURE WAVEFORM USING
DOPPLER ECHOCARDIOGRAPHY
Karl Isaaz M.D., S. Albert Camacho M.D., John Webb, M.D., Kanu
Chatterjee M.D., FACC, Nelson B. Schiller M.D., FACC. Unive~ity
ofCalifornia, San Francisco, CA.
We developed a method for non-invasive reconstruction of the PA
pressure wavefortD using continuous wave Doppler. RV systolic
pressure wavefortD was digitized from tricuspid regurgitant jet velocity
using the modified Bernoulli equation and estimation of RA pressure
from inferior vena cava dynamics. The systolic portion of the PA
pressure wavefortD was derived from the RV pressure curve between
the opening and the closing of the pulmonary valve (PV). The diastolic
portion of the the PA pressure wavefortD was derived from a straight
line interpolation between the RV pressure at the time of PV closing
and PV opening. The time of PV opening and closing was measured
from doppler at the right ventricular outflow tract. The timing of
tricuspid regurgitation and RVoutflow signals were referenced to the
onset of the QRS to allow determination of the RV pressure at the time
of PV opening and closing. We compared simultaneous doppler and
catheter PA pressure measurements in 12 CCU patients.
(y-doppler; x=catheter) R SEIi 12
systole y=0.74x+I2 0.84 5 0.0006
diastole y=0.99x+ 0.6 0.87 4 0.0003
mean y=0.87x+4 0.83 4 0.0008
.1 .. ;..·.'.· ;...
-~;~:i··Ii.:.:
-i.~ : ..' I....·
:~ .. : i: '
. I I r~h' .-~ -1-·t··;v<'I' C'- :
'0+ I I Jo : ,·r-r·-j-·. .
We conclude that both PA pressures and the PA pressure wavefortD
can be computer generated from noninvasive Doppler tracings.
TIHE COURSE OF PULHONARY ARTERIAL PRESSURE CHANGE IN
THB BARLY POSTNATAL PBRIOD - NONINVASIVE COLOR DOPPLBR
AND CONTINUOUS WAVE DOPPLER BCHOCARDIOGRAPHIC STUDY
Kai-Sheng Hsieh H.D., Be-Tau Hwang H.D., Kwan-Shan Yeh
H.D., Laura Heng H.D., Veterans General Hospital and
National Defense Hedical Center, Taipei, Taiwan.
It is well known that pUlmonary arterial pressure
drops after birth. However, the exact time course of
this change ramains unclear. We prospectively studied
the blood flow characteristics across the patent duc-
tus arteriosus (PDA) among 42 full term newborns using
non-invasive color Doppler flow mapping (CDF) and CDF-
guided continuous wave Doppler echocardiography. The
closure rate of PDA was 2.4\, 53.2\, 18.6\, 88.1\,
92.9\, 95.2\ and 91.1\ from day I through day 1. COF
revealed bidirectional shunt, with systolic right to
left and diastolic left to right shunt ocurred in
45.2\ of the neonates during the first 12 hours of
life. At 24 hour of life, only 2.4\ showed bidirectio-
nal shunt. Pure left to right shunt prevails over the
days afterwards. The maximal pressure difference
between the pulmonary artery and descending aorta was
14.4+0.5, 3l.4±1.S, 29.2±0.4 and 33.6±1.0.aRg at 12,
36 and 60 hours of life. Our data suggest that the
pUlmonary arterial pressure drop occurs .-jorly within
24 hours of life. By the age of 36 hours ~st of the
newborns (34/42) had stable pul.onary artery pressure
without further change of the pressure difference
between the 2 great arteries. We conclude that the
pUlmonary arterial pressure drop occurs SUbstantially
over the first 12-24 hours of life instead of abrupt
change imlediately after establishment of spontaneous
aspiration. Right to left ductal shunt (a variant
form of fetal circulation ) is common during the first
12-24 hours of life.
DOPPLER COLOR FLOW MAPPING OF THE "PROXIMAL ISOVELOCITY
SURFACE AREA": A NEW METHOD FOR MEASURING VOLUME BLOOD
FLOW ACROSS AN ORIFICE.
Toshinori Utsynomjya, MD; Toshio Ogawa. Hoang A. Tang.
Walter L. Henry, MD. FAeC; Julius M. Gardin. HD. FACe;
University of California, Irvine, CA.
Flow through a narrowing is characterized by the conver-
gence of radial stream1 ines .proxima1 to the orifice. If
a proximal isove10city surface area (PISA) can be identi-
fied and quantified, then volume flow rate can be calcu-
lated as PISA X isove10city (V). Using Doppler color
flow mapping. it might be possible to visualize an 1so-
velocity region as a red-blue interface proximal to the
orifice. Because the aliasing V is known. volume flow
can be calculated. To evaluate this possibility, we used
a Hitachi-Biosound cve 151 color flow mapping (CFM)
machine to attempt to visualize a PISA proximal to circu-
lar orifices in both constant and pulsatile flow models
in vitro. Over a range of orifice diameters from 3 to
16 mm, and flow rates of 0.5 to 18 L/min. a PISA could be
visualized and was best described by an elliptical model
with two different radii measured from long axis and
short axis views. Actual volume flow was measured simul-
taneously using a cylinder and stopwatch. In the constant
flow model, volume flow calculated from Doppler PISA cor-
related well with actual flow (r-0.g97, P<O.OOI. SEE-0.42
l/min). In the pulsatile flow model, with jet velocities
ranging from 2.5 to 7.6 m/sec. calculated volume flow
also demonstrated an excellent correlation with actual
flow (r-0.g86. P<O.OOI. SEE-0.33 L/min). In conclusion.
color flow mapping identification of the proximal iso-
velocity surface area appears to be a promising technique
for estimating volume flow across an orifice.
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a.INICAL APPLICATICH OF UIlrRASCHIC·BAa<SCl\1'lER IN
~ EX:H) '1'0 t'E'1!rl' rsalD«C Ml/OCAR-
DItJ{.
Annie KArpati MS, Stephen COrdAy MO, FAce,
Mi.c:hM1 Jaffe MS, QJstavo Ve1a!IqUeZ MO, JUlian
Gold MO, Joe Areeda, OIdar8-Sinai Medical center,
Ul8 AngBlee ,CA.
we utilized the cyclic varlatien in ultrascnic
I:lacIaIcatter to detect isdlemia in patients UI'W:2r-
go1J'q~~ Mlo were m::n!tored by
~ two-dimensialal ec:tlocardiogra.
Ten patients, Mlo were judged by en inleperxlent
anesthesiologist to 1:leoalle ischaDic by wall mo-
tien criteria dUr1J'q the surgical procedure, loIere
selected.
In each patient, a bue1ine(base) bnaqe end en
bnaqe at time of greatest isdIemia (hypo) were
idsntitied by en irxSep8ndent c:'ibserVer.
we IIlBUUX'ed CNer the SllIII8 area of myocardi1.Dll the
cyclic c::haJ13es in 1:lackBcattered power , skewness
end kurtosis between end~iastolic and end-
syBtolic myocardi1.Dll as shown below ( * p<0.001):
CYclic Chames
Mean Gray Skewness IOJrtosis
Base 21.16+9.56* -.204+2.28 -2.96+3.64
Itjpo 6.32±5.72* -2.4S±5.80 -.624±2.64
Q;n;;1Y1icn: we ccn::l\Di tnat tissua d1arllcteriza-
tion techniques an easily applied to tren-
~ 20 echocaxdiogrllll& dI.le to their supe-
riar iJDage e,ality. 'lbese 1IlllUU%'8IB1ts allow us
to clearly separate isdlsmic trail I'lCI1isdlemic
lI'jtlC8J:dial II8gIIIII1ts by dwqes in cyclic bac:laI-
catter. 'Ibis tedlnique shcWII great pranise far
future clinical lll=Pllcatia'lS to allow ciljective
det:acticn of isdlsmic myocardi1.Dll.
CYCLIC VARIATION OF ULTRASOUND BACKSCATTER IN NORMAL
MYOCARDIUM IS VIEW DEPENDENT: CLINICAL STUDIES USING A
REAL-TIME BACKSCATTER IMAGING SYSTEM
Byron F. Vandenberg, M.D., F.A.C.C., Linda Rath. Thomas
A. Shoup, Ph.D., Richsrd E. Kerber, M.D.,F.A.C.C., Steve
M. Collins, Ph.D., David J. Skorton, M.D., F.A.C.C.,
University of Iowa, Iowa City, Iowa
Open chest animal experiments suggest that the cyclic
variation in integrated backscatter noted in normal myo-
cardium may be independent of the angle between the
ultrasound interrogation beam and myocardial fiber ori.n-
tation. Such angle independence is very desirable in
the clinical setting. A new 2D real-time backscatter
imaging system allows transthoracic clinical evaluation
of cyclic backscatter variation, but has only been test-
ed in limited regions of the normal human left ventricle
imaged from a single view. We evaluated possible angle
dependence of cycliC variation in backscatter in the
clinical setting by imaging multiple regions of the left
ventricle from four standard .cho views. Parasternal
long (PSLAX) and short (PSSAX) axis viewa, and apical (2
and 4 chamber) views w.re obtained in 20 normal male
subjects (mean age-28t5 [SD).
Results (cyclic change in backscatter [dB, meantSD):
View Se~tum n Posterior n Lateral n
PSLAX 2. t3.[* 20 4.6tl.6* [9
PSSAX 1.2t2.6 18 2.812.2* 17 -1.ltl.4 9
Apical -l.6tl.8 19 -o.2t2.5 11 O.ltl.) 6
*p<O.O[, diastole vs. systole.
Conclusion: (1) 2D resl-time int.grated backscatter
imaging d.monstrates that cyclic variation of backscat-
t.r is view dependent in normal posterior and septal
myocardium. (2) View dependence of cyclic variation in
backscatt.r may be related to the att.nuation of ultra-
sound by intervening chest wall or·myocardium, or to the
ori.ntation of myocardial fibers to the ultrasound b.....
DO DOPPLER FLOW ALGORITHMS FOR MAPPING DISTURBED FLOW
MAKE SENSE?
Juliys M. Gardin. MD; Slawomir Lobodzinski, Ph.O~ Univer-
sity of California, Irvine, CA
It has been suggested that a major advantage of Doppler
color flow mapping (CFM) is its ability to localize areas
of disturbed flow--e.g., in stenosis, regurgitation, or
shunts. To investigate the ability of CFM to display
disturbed flow, we employed custom programs to evaluate
the CFM algorithms of 7 commercially available ultrasound
machines. In these algorithms, green is reportedly used
to map disturbed flow areas. We calculated the %green
added to each pixel along the red and blue portions of
the velocity reference color bar for each machine. Velo-
cities (V) ranged from ±46 to ±64 cmVsec, depending on
the Nyquist limit. The Table shows mean %green added to
the red color bar at a mean Vof 25cmVsec. This V is
below velocity threshold at which turbulence is expected
(Reynolds' <2000) in an adult aorta.
Mach jne , 1 2 3 4 5 6
Mean %green 25% 38% 38% 31% 12% 18%
In Machine 7, the reference color bar did not correspond
to colors in the images because green is not blended with
red and blue; rather, its intensity is a direct marker of
degree of disturbed flow defined as turbulence, noise
or aliasing. Although most machines displayed increased
%green with increasing +1- V, two demonstrated different
gradients for adding green to the primary colors. At 25
cmlsec on the blue scale, Machine 6 displayed green vary-
ing from 12 to 89%. We conclude that CFM machines add
green according to markedly different algorithms and at
velocities not producing turbulence. If color flow map-
ping is to be useful quantitatively, detailed information
regarding mapping algorithms must be provided.
TWO TO FIVE YEAR ECHOCARDIOGRAPHIC FOLLOW-UP OF PATIENTS
WITH MITRAL VALVE PROLAPSE: IS APICAL FOUR-CHAMBER VIEW
DISPLACEMENT A PRECURSOR OF ABNORMALITY?
Anthony J Sanfiljppo MD, Aleksandar 0 Popovic MO, Pamela
Harrigan ROMS, Mark 0 Handschumacher BA, Arthur E Weyman
MO FACC, Robert A Levine MO FACC. Massachusetts General
Hospital, Boston MA.
Recent studies in over 400 patients from this laboratory
have suggested that superior mitral leaflet displacement
(MLO) limited to the 20 echocardiographic (20E) apical
four-chamber (A4C) view is within the normal range
because it is not associated with independent markers of
mitral valve (MV) disease. However, the question has
been raised as to whether A4C view MLO might be a
precursQr of subsequent abnormality, such as progressive
MLO or the development of MLO in the parasternal long-
axis view (PLA). In order to explore this possibility,
we reviewed our echo database to select patients having
two 20E examinations separated by at least 2 years, with
superior systol ic MLO noted on the initial study. Pts
with intrinsic MV disease other than MVP were excluded.
We studied 53 consecutive pts satisfying these criteria
(mean follow-up 41 mos). MLO was initially 1imited to
the A4C view in 28. The PLA was also involved in 25.
RESULTS: 1) Of the 28 pts who had MLO limited to the A4C
view initially none showed evidence of progression
while in 8 the MLO was no longer evident, 2) 25 pts had
MLO in the PLA and MC views initially; of these 24
continued to have these findings in follow-up. In 1 pt.
the PLA MLO resolved in association with new severe LV
dysfunction. CONCLUSIONS: Patients with MLO limited to
the A4C view did not show evidence of progression in a
follow-up period of up to 5 years. These results support
the normality of MLO limited to the A4C view.
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A NEW THREE-DIMENSIONAL ECHOCARDIOGRAPHIC METHOD FOR QUAN-
TITATING MITRAL VALVE PROLAPSE
Mark D Handschumacher. BS. Anthony J Sanfilippo, MD,
Pamela Harrigan RDMS, Arthur E Weyman, MD, FACC, Robert A.
Levine, MD, FACC. Massachusetts General Hospital, Boston,
Massachusetts
Mitral valve prolapse (MYP) represents systolic leaflet
displacement (ML DIS) above the mitral annulus (MA). We
have previously shown that the MA is nonplanar in systole,
so that no 2-dimensional echo (2DE) view fully reflects
the degree of DIS and a 3D measure of volumetric (VOL) DIS
is required. We therefore developed a technique for non-
invasive 3D reconstruction of the MLs and MA from inter-
secting systolic 2DE scans localized by spark gaps. This
method has been applied to 10 normal subjects and 5 pts
with MVP, providing for each: 1) a topographic ML surface;
2) a 3D annulus, and 3) a least squares plane of fit (LSP)
to the MA to provide a frame of reference. VOL ML DIS was
measured as: 1) DIS above a plane parallel to the LSP at
the level of the highest point of the MA or ;.l~ll_b~e
the LSP.
RESULTS: A coherent ML surface
cases. VOL DIS was:
DIS above MA DIS above ISP
NORMALS (na 10) 0 3 0.5 + .3cm3
MVP (n- 5) 1.1 ± .5cm 1.6:± .7cm3
CONCLUSIONS: 1) We have developed a technique to recon-
struct a topographic ML surface and measure its 3D volume-
tric DIS above the MA. 2) Measures of VOL DIS can be de-
rive1 and their normal range established. This can be used
to relate VOL DIS to DIS in routine 2DE views and to cli-
nical and echo measures of MY disease.
ESTIMATION OF EFFECTIVE MITRAL TISSUE PROSTHETIC AREA
US ING THE CONTINUITY EQUATION.
Kanwal K Kapur M D PoHoey Fan M.D., Hirday K. Chopra
M.D., Raj Ballal M.D., Navin C. Nanda M.D. F.A.C.C.
University of AlabAlllA at BirllinghaDI, Alabama.
We evaluated the use of the continuity equation (CE) at
the mitral orifice, in the estimation of effective
mitral tissue prosthetic area (EA) in 9 Pts with no or
Grade I mitral regurgitation who were catheterized
within 0·14 days (mean 3.7 days) of the color Doppler
study. The previously validated method of color pixel
intensity was used to estimate maximal proximal veloci·
ty in LA close to the prosthesis. The inner diameter
of the prosthetic annulus was measured using the pros·
thetic stents (apical view) and crossectional area
(CSA) estimated assuming a circular configuration of
the prosthetic annulus. Peak velocity across mitral
prosthesis was estimated by aligning the continuous
wave cursor parallel to the antegrade mitral flow sig·
nals using the apical plane. The EA was computed using
CEo
EA - CSA prosthetic annulus X proximal yelocity
Peak mitral velocity
The EA by CE (0.6·2.01 cma mean l.18±Q.52cma) correlated
very well with Gorlin's EA at cath. (0.5·2.6 cma mean
1.32±O.74 cma) r-Q.92. In 5 Pts with EA by CE of 0.6-
1.03 cma (mean 0.79 cm2) prosthetic obstruction (thick·
ened i..obile leaflets) was noted at surgery, while in
the remaining 4 with clinically normal prostheses the
EA was 1.3-2.01 c.a (mean 1.67 cm2 , p-.002). Thus CE at
mitral orifice provides another method by Doppler for
the estimation of prosthetic mitral EA.
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New Devices for Intraarterial Angioplasty and
Imaging
TREATMENT OF PEllIPIIERAL VASC1JLA1I. DISEASE WITH THE
TRANSLU!lINAL EXTRACTION CATHETER: RESULTS OF A
MULTICENTER STUDY
Richard S, Stack HD FACC, Jose A. Perez MD, Glenn E.
Newman MD, Richard L, McCann MD, Mark H. Wholey MD,
Frank E. Cummins MD, Joseph T. Galichia MD, Patricia U.
Hoffman, James E. Tcheng MD, Michael H. Sketch Jr. MD,
Myoung M. Lee MD, Harry R, Phillips MD, FACC. Duke
Medical Center. Durham NC
The transluminal extraction catheter (TEC) is a new
rotary cutting device that is advanced over an .014 inch
PTCA gUidewire. When the conical cutting head enters a
lesion, rotation begins (750 RPM) and material is
continuously extracted from the vessel via suction.
Seventy·one atherosclerotic lesions were treated
during 41 procedures in 41 extremities of 36 patients
(mean age - 62; 72' males) at 4 medical centers. TEC
was used exclusively in 49 lesions and in conjunction
with angioplasty in 8 lesions. In addition, 14 lesions
remote from the TEC site were treated with angioplasty
alone. Mean ankle/arm index went from .60 ± .12 to .72
± .19 (p < 0.0003) and mean luminal diameter stenosis
went from 72' ± 17' to 29' ± 16' (p < 0,0001). The TEC
procedural success rate (~ 50' residual stenosis in all
lesions) was 98' (40/41) and the patient success rate
was 97' (35/36). There was no evidence of distal
embolization arteriographically or clinically and no
vessel perforations. Two pts had temporary thrombotic
occlusions during the hospitalization at sites where
angioplasty only was used (successfully recannulated
with urokinase) and 2 pts required vascular repair at
the sheath insertion sites.
These results suggest that the TEC procedure is safe
and effective for reducing stenosis and improving flow
in patients with peripheral vascular disease.
MEClWfICAL TRANSLUMIRAL COIlOIWI.Y EIIIWlTBREC'IOIIY: IlIITUL
CLINICAL EXPERIENCE WITH THE AlmI MECIWIlCAL IOTAl.Y
CATHETBIt.
William W. O'Neill, M.D., Eric R. Bates, M.D., Marvin
Kirsh, M.D., Joseph Bassett, M.D., Mark Sakwa, M.D.,
Mark Elliott, M.D., Dennis Doppke, William Beaumont
Hospital, Royal Oak, Michigan.
We have performed intra-operative transluminal coronary
endarterectomy with the Auth mechanical rotary catheter
to assess safety and efficacy in patients prior to
percutaneous usage. Nine patients have had 11 segments
treated. Only lesions above the arteriotomy site were
treated. Since all vessels treated also underwent
bypass, a flow limiting stenosis was required to exist
in the proximal vessel to avoid competitive flow. During
surgery, a sizing probe was advanced to the lesion
before and after trans luminal coronary endarterectomy to
assess efficacy. Angiography was performed one week
after tranaluminal coronary endarterectomy to assess
vessel patency and allow computerized lesion
quantitation. Transluminal coronary endarectomy was
initially succeasful in 10/11 segments, 1 vessel
perforation (of an extremely angulated segment)
occurred. Angiography documented sustained patency in
9/10 vessels. Stenosis diameter decreased (72+4% to
51!9%, p <203) and minim21 cross sectional area improved
(0.7+0.1.. to 1.4+0.2.. , p <.02). We conclude that
intra-operative transluminal coronary endarterectomy
safely and effectively ameliorates human coronary
stenoses. These reaults allow for cautious application
of mechanical rotary catheter to the catheterization
laboratory setting.
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HUMAN PERCUTANEOUS CORONARY ROTATIONAL
ATHERECTOMY : RESULTS AND SHORT FOLLOW UP.
Jean L. Fourrier M.D., David Auth Ph.D.,Jean M.
Lablanche M.D., Jean M. Brunetaud M.D., Antoine
Gommeaux M.D., Michel E. Bertrand M.D. F.A.C.C.
University of Lille - FRANCE.
Percutaneous coronary rotational atherectomy
(PCRA) was performed in 10 patients (pts). The
device (ROTABLATOR, USA) consist of a flexible
rotating shaft 120.000 rpm with an abrasive tip
of various diameter (1.25 to 1.75 mm) and a
central guide wire (GW). The 10 pts (mean age:
57) presented a stenosis (ST) of LAD. (3) or
RCA (7). Through a 9F catheter, the GW crossed
ST under fluoroscopy. The abrasive tip was
slowly advanced over the GW and several passes
across the ST were made after which the device
was removed, and the residual ST measured. In
case of residual ST>50% a balloon dilatation
(PTCA) was done.
Results : The ST was significantly enlarged
from 0.58 mmi:O.:35 to 1.18 mm::!:O.25.The outline
of vessel appeared smooth and regular.5 pts had
PCRA alone and 5 PCRA + PTCA. No acute compli-
cation occured and the pts were discharged 2.2
days after PCRA. 1 pt dead because of a mesen-
teric infarction unrelated to the PCRA. 9 pts
were functionnally improved and 4 pts had a new
angiograms :3 months after PCRA. All the arte-
ries were patent and only 1 pt presented a
restenosis.
Conclusion : PCRA is a safe and effective
method of angioplasty but long term assessment
requires further investigations.
PERCUTANEOUS TRANSLUMINAL CORONARY ROTABLATION
DURING HEART CATHETERIZATrON
Raimund Erbel, M.D. FACC, Ulrich Dietz, M.D.,
David Auth, Ph.D., Michael Haude, M.D., Uwe
Nixdorf, M.D.,Jurgen Meyer, M.D.
rr. Medical Clinic, University Mainz, F.R.G.
After promising results in peripheral arteries,
percutaneous trans luminal coronary rotablation
(PTCR) was used for atherectomy in coronary
arteries during heart catheterization. The de-
vice consisted of a diamond-coated brass burr
rotating with up to 190.000 rpm along a coaxial
guide wire with a flexible tip. The burr size
ranged from 1.25 - 2.0 mm. It was advanced
during rotation avoiding drop of speed> 10 %.
10 patients (pts) with single vessel disease
underwent PTCR instead of balloon angioplasty
(PTCA) PTCR was started with small burr sizes.
The final burr size measured 1.5 mm in 3 pts,
1.75 mm in 6 pts and 2.0 mm in 1. pt. PTCA was
successful (increase of luminal narrowing > 20~;;)
in 9 of 10 pts with a decrease of coronary
stenosis from 75.B ! 28.3 % to 33.3 ! 3% (p<
0.001). The most effective PTCR occurred in
the pts with stable angina and no previous in-
farction. Because of residual luminal narrowing
additional PTCA was necessary in3 of 9 pts de-
creasing the narrowing further to 14.8 ~ 13.5%.
Vessel perforation was not observed. With PTCR
a dissection of a proximal LAD lesion occurred
using a 2.0 mm burr. Bypass surgery was per-
formed successfully.
Conclusion: PTCR seems to be an effective method
for atherectomy in coronary arteries, particu-
larly in hard lesions.
VASCULAR REPAIR AND REM:DELI~ US~ RADIOrnmuEN:Y
~ AN:;IOPLASTY'.
Benjillllin 1. Lee, M.D., F.A.C.C.; Gary J. Becker, M.D.;
Bruce F. Waller, M.D., F.A.C.C.; Kevin J. Barry, M.S.;
Jonathan Kaplan, M.D.; Rayroond J. Connolly, Ph.D.; Paul
Nardella, B.S. VA and Georgetown Medical Centers,
Washington, D.C.
The combination of balloon pressure and controlled thermal
energy delivery may effectively repair intimal tears (IT)
and rerodel atherosclerotic vessels. To test the potential
for radiofrequency energy (RF) fusion of IT, 5 atIrospheres
(atm) pressure were ilpplied and 200 J RF delivered fran
block-mounted bipolar electrodes to 24 segments of post-
rrortem human atherosclerotic aorta which had been manually
separated along the intima-media and media-adventitial
plane. Stronger tissue fusion resulted with pressure and
RF (28.5 + 3.3 gm) than with pressure alone (4.8 + .26 gm;
p<: .001) .-To study the feasibility of RF balloon angio-
plasty (RFBA), a 4 lTItl x 2 em bipolar RF balloon angio -
plasty catheter was used to dilate segments of postn-ortem
human atherosclerotic arteries of similar diameter. The
balloon was inflated to 3 atm pressure for 1 min and
vessels additionally treated with ZOO J RF or with balloon
pressure alone. 10/10 RF treated vessels had significant
enlargement of their luminal diameter with stretching and
thermal rrolding of the vessel walls and histological
evidence of medial myocyte injury. 10/10 control vessels
de!lonstrated recoil to their pre-dilatation gecmetry with-
out histological evidence of myocyte injury. Thus, RFBA
results in 1) strong tissue fusion of intima-media flaps,
Z) thermal rrolding of atherosclerotic vessels and 3)injury
to cells in'plicated in the fibroproliferative response.
These observations lMy have i.nt>licaticns for reducinq
acute and chrooic restenosis following balloon angioplasty.
QUANTITATIVE ANALYSIS OF CORONARY ARTERY MORPHOLOGY USING
INTRACORONARY HIGH FREQUENCY ULTRASOUND: VALIDATION BY
HISTOLOGY AND QUANTITATIVE CORONARY ARTERIOGRAPHY.
Charles McKay MD FACC, Bruce Waller MD FACC, James
Gessert BSEE, Steve Collins PhD, Michelle Catellier MD
Steven Fleagle BSEE, Melvin L. Marcus MD FACC, University
of Iowa, Iowa City, Iowa.
Intracoronary high frequency (20 mHz) ultrasound (ECHO)
is ~ ne~ techno.logy. Before it can be used clinically,
valIdatIon studIes are essential. We placed a 1.5 rnm di-
ameter probe in the coronary artery lumen and rotated it
to image the arterial wall and lumen. We performed ECHO
mea~urements on 25 pressure perfusion fixed coronary ar-
ternl segments from cadaver bovine and porcine hearts.
~e vaI idated m~asurements of Iumen area (LA, ins ide the
Int~rnal elastIC lamina), and total arterial area (area
insl~e external el~sti~ lamina) using histologic (HIS)
sectIons and quantItatIVe coronary arteriography (QCA).
The HIS measurements of LA ranged from 2.4 to 28.3 rrmz
a~d of total arteri a1 area ranged from 2.9 to 33.9 rrmz.
01 rect measurements of arteri a1 wall di ameters by ECHO
were limited in some specimens due to non-circular lumen
shape or eccentric ECHO probe position. Measurements by
ECHO were highly correlated with HIS and QCA:
LUMEN (n s 251 r SEE(mm2) Slope Intercept (mm2)
AREA (HIS vs ECHO) .96 1.86 .91 - .49
AREA (QCA vs ECHO) .94 2.07 .85 1.31
TOTAL ARTERIAL
AREA (HIS vs ECHO) .97 2.11 .89 -.33
We concl ude that coronary artery lumen area and tota1
arterial area can be measured accurately with high fre-
quency intracoronary ultrasound. This technique may per-
mit evaluation of the arterial .wall and lumen during
cardiac catheterization.
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Clinical Outcome of Coronary Angioplasty
DOES THE DISADVANTAGE OF INCOMPLETE REVASCULARIZATION BY
CORONARY ANGIOPLASTY INCREASE WITH TIME?
David R. Holmes Jr. M.D., F.A.C.C., Ronald E. Vlietstra
M.D., F.A.C.C., [aVon N. Hammes, GUy S. Reeder M.D.,
F.A.C.C., Michael B. Mock M.D., F.A.C.C., Mayo Clinic,
Rochester, Minnesota.
The importance of achieving complete revascularization
(CR) vs incomplete revascularization (IR) by
percutaneous transluminal coronary angioplasty (PTCA)
remains controversial. Of 1,183 pts (474 with single,
709 with multi vessel disease) followed up for successful
PTCA performed between 1979 and 1987, there was CR (no
residual visual assessment stenosis >70%) in 718 (61%)
and IR in 465 (39%). CR was achievea in 41% of
multivessel and 89% of sin9le vessel cases. During 6-97
months follow-up (mean 30 months), CR and IR event
totals were as follows: death 25 (3%) and 26 (6%)
(p=.09), bypass surgery 68 (9%) and 77 (17%) (p=.006),
repeat PTCA 124 (17%) and 73 (16%), and myocardial
infarction 24 (3%) and 31 (7%) (p=.Ol), respectively.
At last follow-up, 80% of CR had no an9ina vs 73% of IR
pts. The probability (standard error) of survivin9 free
of death, bypass graftin9, angina Class III or IV, or
myocardial infarction was:
1 Year 2 Years 3 Years 5 Years
CR (n=718) 0.84(.01) 0.7B(.01) 0.72(.02) 0.62(.03)
IR (n=465) 0.70(.02) 0.58(.03) 0.49(.03) 0.37(.04)
The event-free survival probabilities for IR were
significantly lower (p<O.OOl) at each time interval. In
addition, the discrepancy in outcome between CR and IR
increased with time. This progressive disparity in
outcome with time underscores the need for longer-term
follow-up in studies comparing different degrees of
revascularization.
CONSEQUENCES OF EARLY RESTENOSIS AFTER CORONARY
ANGIOPLASTY.
Ronald E. Vlietstra M.B.,Ch.B., F.A.C.C., David R.
Holmes, Jr. M.D., F.A.C.C., Richard J. Rodeheffer M.D.,
F.A.C.C., LaVon N. Hammes, Kent R. Bailey Ph.D., Mayo
Clinic, Rochester, Minnesota.
Early restenosis is an unresolved problem whose impact on
long-term outcome has not been quantitated. We evaluated
all 466 successful Mayo Clinic patients (1979-1987) who
had reangiography at 3 to 12 months to detect the pres-
ence (P) or absence (A) of restenosis. Restenosis was
defined as a loss of 501 of the initial gain or more than
301 worsening in percentage stenosis. P and A groups
were similar with respect to age, sex, number of vessels
diseased, ejection fraction, and prior MI or CABGj 341 of
P but only 211 of A (P < 0.005) had >1 segment dilated
initially. Their 5-year probability of events (standard
error) was as follows:
Group P Group A RR· (951 confi-
Event (n = 236) (n = 230) dence interval)
Repeat PTCA 0.48 (0.04) 0.23 (0.05) 4.26 (2.80-6.51)
CABG alone 0.29 (0.04) 0.11 (0.03) 3.68 (2.16-6.28)
MI 0.11 (0.04) 0.06 (0.02) 1.07 (0.44-2.64)
Death 0.10 (0.04) 0.06 (0.02) 1.07 (0.39-2.96)
.Relative risk, from proportional hazards model.
The 5-year probability was 0.38 for P and 0.03 for A
for PTCA of previously dilated segments only, 0.04 and
0.17 for new segments, and 0.06 and 0.03 for both types
of segments. We conclude that the occurrence of early
restenosis markedly increases the risk of revasculariza-
tion events during 5-year follow-up but has little effect
on infarction or mortality. Even when early restenosis
is absent, there is a significant 5-year probability of
further revascularization procedures, predominantly for
disease at other sites.
DETERHlIWITS OF ARTERIAL DISSECTIOII DUKIJIG PTC&:
LESION TYPE VEasUS IHFLArION RATE.
Ani1 Bansal, M.D., Nishit A. Choksi, M.D., Arlene
Bradley Levine, M.D., V. Gangadharan, M.D., F.A.C.C.,
Gerald C. Timmis, M.D., F.A.C.C., William O'Neill, M.D.,
William Beaumont Hospital, Royal Oak, Michigan.
Gradual balloon inflation has recently been suggested to
reduce the frequency of coronary dissection (DIS) post
PTCA. We hypothesized that lesion characteristics may
additionally affect DIS risk. We randomized 142 lesions
(120 patients) to either a gradual increase to peak
inflation pressure of 8 atmospheres over 30 sec or to a
rapid inflation protocol (increase of pressure to 8
atmospheres in < 5 sec). Seventy-one lesions had
gradual and 71 lesions rapid inflations. Lesions were
classified by level of complexity as Type A (low), B
(medium), and C (high) (ACC/AHA task force on PTCA; Circ
1988; 78:486). Post PTCA angiograms were assessed for
DIS and lesion type.
Frequency of DIS:
Frequency of DIS:
Gradual Ra~id P Value
I;fffl 48 71 NS
Type of Lesion
ABC
8/24 57/91 26/27 p. <0.00001
EVALUATION OF LEFT VENTRICULAR FUNCTION IMMEDIATELY
AFTER SUCCESSFUL BALLOON RECANALIZATION OF CHRONIC
TOTAL CORONARY OCCLUSIONS.
Leo Flnel MD. Bernhard MeIer M.D.• Bernard de Bruyne M.D..
PIerre-Andre Dorsaz Ph.D.• Pierre-Andre Doriot Ph.D.. Wilhelm
Rutishauser. M.D.. FAC.C.• Cardiology Center. University Hospital.
Geneva. Switzerland.
To evaluate changes In left ventrtcular (LV) function after successful
balloon recanalization of chronic total coronary occlusions. hIgh
fidel1ty LV pressure measurements using tip-manometers and
bIplane left ventrtculograms for regional wall motion analysis were
performed immedIately «5 sec) after right ventricular pacing at
1nCremenls of 20 beats per mtn every 2 mtn up to 160 beals per mtn or
onset of chest pain. Ten patients were studIed before and after
successful balloon recanalization of 6 left anterior descendIng. 2
right. and 2 left circumflex coronary arteries. All pertinent
terrItories had VisIble collaterals and abnormal regIonal wall
motion at rest. In addition. synchronism of regional wall motion was
analyzed by contraction-relaxation fitted. curves obtaIned by
biharmonic Fourier transformation of each of 128 shorlenlng l1nes
created between end-dtastol1c and end-systol1c points of the realigned
LV silhouettes. This allowed to determtne the time to peak relaxatlon
(TPR) for each shorleDlng l1ne. Balloon recanalization led to better
LV synchrOnism after pacIng as expressed bY a reduction In the
standard devlatlon ofTPR of the 128 shortening I1nes It also resulted

















Standard devlatlon ofTPR (0) 43±13










Conclusion: The balloon inflation rate appears to have
no significant effect on DIS risk. In contrast, DIS
occurrence post PTCA is affected by lesion type and
occurs most commonly with more complex lesion morphology
(B and C).
ConclusIons: After successful balloon recanalization of chronlc total
coronary occlusions. immediate Improvement of LV function after
pacing can be demonstrated.
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CONSEQUENCES OF OCCLUSION DURING PTCA:
THE 1985-86 NHLBI PTCA REGISTRY
Katherine M Detre MD DrPH, David R. Holmes Jr, MD,
FACC, Richard Holubkov, MS, and Registry Investigators,
University of Pittsburgh, Pittsburgh, PA
Of 1,801 pts with revascularization by PTCA, 122 (6.8%)
had occlusion during PTCA or as an abrupt closure
during post-PTCA hospitalization. The occlusion rate
was 6.0% in pts with single-vessel and 7.5% in pts with
multivessel disease. Of these 122 pts, 60 (49%) were
successfully redilated by PTCA (Group I), 43 (35%) were
not redilated and had bypass surgery (CABG) (Group 2),
and 19 (16%) were treated medically (Group 3). Event
rates in-hospital and during one-year post-hospital
follow.up are evaluated below and compared to those of
the 93% of all pts without occlusion. (Pts with PTCA
for acute myocardial infarction (MI) or with prior PTCA
are not included in this analysis.)
Pt Subgroup In-Hospital(%) Post-Hospital(%)
Occlusion n Death MI CABG Death MI CABG PTC2*
Group 1 60 5 27 10 3 2 10 17
Group 2 43 5 56 100 5 5 2 2
Group 3 19 5 47 0 5 0 16 5
N~ Occlusion 1679 1 2 3 2 3 8 19
( PTC2 denotes post-hospital repeat PTCA)
Combining all untoward events by one yr, 19% of all
deaths, 38% of all MIs, and 25% of all CABGs occurred
in the 7% of pts with first PTCA complicated by
occlusion. Pts with occlusion related to or soon after
PTCA have a high in-hospital complication rate
irrespective of whether PTCA or CABG is performed.
However, following discharge, the course of Group 1 pts
closely resembles that of pts without occlusion.
A COMPARISON OF SOCIO-ECONOMICS AND OUTCOME AFTER
MULTIVESSEL CORONARY ANGIOPLASTY OR BYPASS SURGERY.
Ben D. McCallister, M.D., F.A.C.C., Robert Ligon, M.A.,
Martin Stack, B.S., Michael Borkon, M.D., F.A.C.C.,
Geoffrey O. Hartzler, M.D., F.A.C.C. Mid America Heart
Institute, Kansas City, Missouri
The purpose of this study was to compare all medical
costs, complications, and the effectiveness of therapy
in a consecutive series of pts. undergoing PTCA or CABG
during 1986 & 1987. All pts. had an angiogram and CV
evaluation during the initial hospitalization. Comparing
the PTCA vs CABG groups, resp.: avo age a 64 vs 65 yrs.;
males· 69 vs 71%; LVEF • 58 vs 62%; class III or IV
angina· 75 vs 74%; 3 vessel disease· 47 vs 88% (P aL
.001); no. of lesions dilated vs no. of grafts placed
= 322 vs 378; % with total revascularization = 50 vs
77% (P -< .001); length of initial hosp. stay· 8.6 vs
16.2 16.2 days (P .t.. .001); CVA post-op - 0 vs 3%; in
hosp. death· 2 vs 5%. No PTCA pt. required emergency
CABG. AT F.U. comparing the PTCA vs CABG groups, resp.;
Class I or II angina· 88 vs 96%; late deaths in 1st
yr•• 3 vs 1%; nonfatal MI • 3 vs 2%; total 1 yr. mortal-
ity - 5 vs 6%; late need for CABG • 5 vs 0%; late need
for PTCA • 22 vs 3%; % who felt they were liVing a normal
life = 82 vs 89%. Cost analyses including all physician
and hosp. charges during the initial hosp. stay and for
1 yr. resp.: PTCA· 13,807 & 17,732, CABG - 31,075 &
33,673 (P -t., .00l). Conclusions: 1) The initial and
total 1 yr. medical costs for PTCA were 56 & 47%, resp.,
less than CABG. 2) A subsequent procedure (PTCA or CABG)
was required in 24% of PTCA pts. vs 3% of CABG pts.
3) Although the PTCA procedural mortality was lower in
this study, the 1 yr. mortality was similar in both
groups. 4) At 1 yr. fewer CABG pts. had angina, possibly
reflecting more complete revascularization, but pt. life
satisfaction & activity was similar in the two groups.
Thursday, March 23, 1989
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Pharmacology of Nitroglycerin
BIPHASIC RESPONSE OF CORONARY BLOOD FLOW TO INTRACORONARY
NITROGLYCERIN IN NORMAL SUBJECTS.
Ignazio Simonetti, M.D., James D. Rossen, M.D., Melvin L.
Marcus, M.D., FACC, Michael D. Winniford, M.D., FACC,
University of Iowa, Iowa City, IA
Coronary flow (CF) responses to intracoronary nitro-
glycerin in patients have been reported to be extremely
variable. In dogs, intracoronary (IC) nitroglycerin has
a striking biphasic effect on CF (increment/decrement).
To determine if nitroglycerin had a similar effect on CF
in normal humans (NLS), we injected nitroglycerin IC (50
and 300 mg) in 9 NLS and compared its effect on coronary
flow velocity (CFV: 3Fr IC Doppler catheter) to that of
IC papaverine (PAP: 6,8,10, and 12 mg). Peak increase
and duration (OUR, sec) of CFV response were evaluated.
Results (mean+SE):
- Papaverine (mg) Nitroglycerin (meg)
6 8 10 12 50 300
CFR 2. 7 3. 4@ 3. 6@ 3. 9*@ 2.1 3. 1
SEM 0.1 0.2 0.2 0.2 0.2 0.2
OUR 77*@ 101*@ 115*@ 132*@ 26 42
SEM 7 6 6 9 2 3
(*=p<0.01 vs nitroglycerin 300 meg; @=p<0.05 vs
nitroglycerin 50 meg). At 3 min after nitroglycerin 300
meg, resting CFV was 21~3% lower (p<O.Ol), mean blood-
pressure was 14~2% lower (p<O.Ol) and Quantitative
proximal coronary diameter (Brown/Dodge method) 15~3%
larger (0<0.01) than control. ThUS, the human coronary
circulation exhibits a striking biphasic response to
nitroglycerin - marked increase promptly followed by a
mild decrease in CFV. Failure to appreciate the biphasic
nature of coronary flow response to IC nitroglycerin may
explain many conflicting results reported in previous
studies.
MmHIaIINE REVERSES 'roIER1lNCE 'ro 'mANS~
Nl'IRlGLYCEUN
warren S, Levy. M.p., Ridlard J. Katz, M.D., F.A.C.C.,
Alan G. wassexman, M.D., F.A.C.C.
George washin:Jtal university, washingtat, D.C.
Depletial of sulfh}'dtyl groops (SH) may ocntr1b1te to
nitroglycerin (N'ro) tolerance followiIg' chra'Iic exposure.
we stutied the ability of met:h1aUne (Math), a SH dalor,
to potentiate the vasodilatory effects of Nro ani reverse
tolerance. '!he equilibriUIII tedlnicpe of forearm plethys-
mograpty was used to IIlBlISUre \IeI'lCQI tale (Vl') pre ani
post a 0.4 IIIJ sublirgual N'ro bolus in 13 pts 1) at
baseline (base); 2) 2 hrs post 10 IIIJ Nro patch (NI'P-2h)
ani 3) 74 hrs after CXII'1tiJulaIs patch exposure (NI'P-74h).
Repeat measures IoIer8 made followiIg' 5 gIllS IV Math at base
(M-base) ani 74 hrs (M-74h). Foreazm volumes IoIer8
measured at 30 DID H;J above cuff zero with results
expressed as vr (oe/100 oc ann; mean ± S.D.):
~ M:@R' N1'P=2h Nl'P=74h..lt:Z4h..
Pre-NTG 2.58±.9 2.5~.8 2.8Q±1 2.58±.9 2.67±.9
Post-NIG 3.37± 1* 3.45:t.9* 3.6Q±1* 3.0l,±.9* 3.53± 1*
, c:tlar¥Je 32±13 37±15+ 3l,±13** 1~10 35:t14**
*lX.001 vs. pre-N1G. +0<.02 vs. &".**0<.001 VB N1'P=74h
MethiaUne alme had no intrinsic vasodilatory acticn.
vr c:han}es in respalSe to Nro bolus were att:er1.lated at 74
hrs (p<.001 vs. 2hrs). Math patentiat.ed the effect of
Nro nme so at 74 hrs than at base (17.4' vs. 5.4',
P<.OOl)~ greater sulfh}'dtyl dalor effect in the
attEn.lated state. Plasma volUlll8 expansiat was suggested
at 74 hrs vs. 2hrs by a 3' fall in hematocrit (p<.01) ani
inc:rease in llIeight (157 vs 155 1J:ls, p<.01).
OXlc1usialS: 1) Heth potentiates the vasocW.atory effects
of N'ro ani reverses attermatiat, foll~ chra'Iic
transdenDal N'ro exposure; 2) Plasma volUlll8 8llplIlISiat
after prolal;led N'ro exposure may ccntdh1te to attenaticn.
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A NEWLY DEVELOPED NITROGLYCERIN PATCH WITH
'PHASED RELEASE'
Sigmund Silber, M,D Ph 0.. F.A,C,C" Astrid C. Vogler, M,D"
Margot Vogel, R.N., Karl Theisen, M,D.. University of Munich,
West Germany.
As we have shown in previous studies, constant plasma levels
of isosorbide dinitrate (ISDN) and its metabolites induce the
development of tolerance, whereas daily three-fold fluctuations
of the plasma levels circumvent it, To test the hypothesis that the
same concept can be extrapolated to nitroglycerin (NTG), we
studied 12 pts with proven coronary artery disease, angina
pectoris and abnormal exercise test in a placebo controlled,
double-blind, randomized and cross-over protocol. To establish
fluctuating plasma levels, a new NTG patch containing 20 mg
NTG with 'phased release' was developed. Exercise tests were
performed before as well as 2 & 10 hrs after the 1st & next day
(2nd) application, The decisive parameter for unbiased
assessment of the anti-ischemic effect was the exercise-induced
ST-segment depression at identical work loads.
~ NTG plasma levels 2, 10 &24 hrs after the 1st applica-
tion were 544±402, 261 ±183 &176±129 pg/ml and 2 &10 hrs
after the 2nd application 521 ±210 & 307±310 pg/ml. The corre-
sponding exercise-induced ST-segment depression at identical
work-loads the 1st day were 2.9±0,9 (baseline), 1.0±0,8*, 2.4±
0.7 & 2.8±0.7 mm; 2nd day 2.0±1.3 & 2.8±1.1 mm (* = signifi-
cant as compared to placebo).
Conclusions; The newly developed NTG patch with 'phased
release' lost its effect within 2 days. Even the concept of three-
fold fluctuations in NTG plasma levels did not prevent the devel-
opment of tolerance. Perhaps a short term removal (e,g. 90
minutes) of this 'phased release' patch will be sufficient to
prevent tolerance development.
TIll AllTITHROMBOTIC ACTION OF NITROGLYCERIN: CYCLIC GKP
AS A POTENTIAL KEDIATOR.
Kichael Johnstone, K.D., Jules Y.T. Lam, K.D., F.A.C.C.,
Oavid Wate~s, K.D., F.A.C.C., Kont~eal Hea~t Institute,
Kont~eal, Canada,
To investigate whethe~ cyclic GKP may be involved in
the antith~ombotic action of nit~oglyce~in (BTG) we
studied platelet deposition (PO, xl06) onto normal
po~cine ao~tic media in an ex vivo flow chambe~ of 1 rom
diamete~. A~tedal blood f~om cont~ol and drog t~eated
pigs was d~awn by a pe~istaltic pump th~ough the cham-
be~ at 20 ml/min fo~ 5 mins. PO was quantitated using
autologous 111Indium-labeled platelets injected 18-24
h~s befo~ehand. Baseline PO was 55.5:1:6.6. A NTG infu-
sion tit~ated to p~oduce a 1~ fall in mean a~te~ial
p~essure dec~eased PO to 37.7:1:8.5 (n-8, p<O.Ol). with
aspidn p~et~eatment (1 mg/kg fo~ 3 days), PO was low
26.2:1:5.3 (p<0.005) and dec~eased fu~the~ with a NTG in-
fusion to 17.0:1:4.7 (n=8, p<0.005). Kethylene blue (KB,
5x10-3 K) given as a 10 ml 1. v. bolus +. pe~fusion of
3 ml/min did not change PO compa~ed to cont~ol:
34.0:1:6.8 vs 25.1:1:5.8 (n=8, p=NS) and a subsequent per-
fusion of ftG caused no dec~ease in PO: 31.3:1:8.0 (p=
NS). NTG given pdo~ to the KB infusion decreased PO;
this dec~ease was attenuated by KB and enhanced by sub-
sequent cyclic GKP infusion (chambe~ cone 7.4x10-6 K).
! PD Ql * SI) P vs control
control 5 117. 4t18. 7
ftG 5 47.1*14.4 0.04
NTG + KB 5 54.6t7.0 0.07 }0.02
KB + cyclic GKP 5 18.4*3.8 0.006
Thus, unde~ cont~olled flow conditions, cyclooxygenase
inhibition with aspidn does not attenuate the anH-
thrombotic effect of IITG. Guanylate cyclase inhibition
with methylene blue abolishes the effect of RTG, but it
is restored by a cyclic GKP infusion.
BRACHIAL ARlERY PRESSURE MEASUREMENTS
UNDERESTIMAlE BENEFICIAL EFFEcrs OF
NITROOLYCERIN ON LEFr VENTRICULAR AFlERLOAD.
Raymond Kelly M B. Hany Gibbs M.B, John Morgan M.B,
F.A.C,C, Julie Daley R.N, Kem Mang BSc, Albeno Avolio PhD,
Michael O'Rourke M.D, F.A.C.C. St. Vincent's Hospital, Sydney,
Australia.
In normal doses sublingual nitroglycerin (NTG) not only reduces LV
preload but also dilates peripheral and coronary arteries. Anerial
dilation decreases wave reflection leading to reduced ascending aortic
systolic pressure. Under clinical conditions, however, a change in
sphygmomanometric pressure is not consistently seen despite
symptom improvement with NTG. This study examines why
beneficial effects of NTG on LV afterload are not always apparent
from pressure measurements in peripheral arteries. Sublingual NTG
(0.3 mg) was administered to 14 pts undergoing diagnostic catdiac
catheterisation. Recordings were taken in the ascending Ao and
brachial artery (BA) with a Millar micromanometer catheter before
and 5-8 minutes after sublingual NTG. Ao systolic pressure always
fell after NTG (- 6 to - 44, avo 22.1 mm Hg), In contrast, BA
pressure change was much less: + 2 to - 33, avo 11.8 mm Hg. In
some patients a marked Ao fall was accompanied by little or no BA
change, Integrated mean pressure fell to a variable degree in all but 2
pts (- I to - 25, av, 7.5 mm Hg) with no significant change in
diastolic pressure. Comparison of Ao and BA pressure wave
contours explains this discrepancy, The systolic pressure peak in the
Ao is normally formed by a reflected wave whereas in the BA this
wave occurs after the systolic peak, on the downstroke of the wave.
Thus, reduction in wave reflection by NTG does not alter the systolic
peak in the BA but reduces the Ao peak pressure. Conclusion: BA
pressure measurements underestimate beneficial effects of NTG on
central pressure levels due to transmission changes in wave contour
between Ao and BA sites as a result of different timing of wave
reflection.
EVIDENCE FOR ANTITHROMBOTIC PROPERTIES OF !IIITRATE-
VASODILATORS IN VIVO BUT NOT IN VITRO
C, Drummer, U. Valta-Seufzer, J.-M. Helm. R, Gerzer
Med. Kllnik Innenstadt, University of Munich, FRG
The NOa-contalnlng organic nitrates and the NO-containing
vasodilators llke sodium nitroprusside (SNP) or SIN-I (the
bloactive metabollte of molsldomlne) exert their effects
through activation of soluble guanylate cyclase (sGC), While
NO-compounds can directly activate sGC, the nitrates need
to be metabollzed to release nitric oxide prior to activation
of the enzyme, a mechanism that exists In vascular smooth
muscle, Its exhaustion seems to be the reason of nitrate
tolerance. Nitric oxide also activates sGC In platelets, We
have recently shown that in vitro only NO-containing
agents, but not nitrates, can stimulate sGC In platelets and
potently Inhibit aggregation. To Investigate this difference
In vivo, we conducted a double-blind study to compare the
effectlveness of each a single oral dose of molsldomlne
(4mg), Isosorblde-5-mononltrate (ISMO,20mg) or placebo on
platelet function. Twelve healthy young subjects received
their medications within 6 consecutive days In a randomized
order, After a 30 min resting period measurements were
done before and 30 and 60 min after appllcation (days
1,3,5) as well as during the wash-out period (days 2.4,6).
RESULTS: The minimal dose of platelet activating factor
(PAF) required to induce Irreversible aggregation was In-
creased slgnlflcantly (pSO.005) within 30 min after appli-
cation of ISMO from about 50 to 120 nM, This threshold
dose was Increased in a similar manner for molsldomlne,
whereas In the control period It was only sllghtly elevated
from 50 to 80 nM PAF. There was also a prolongation of the
bleeding time In both Intervention periods (4,5 min to 6
min) that was still detectable after 24 hours, CONCLUSION;
The elevated threshold doses and prolonged bleeding times
Indicate antithrombotic properties of organic nitrates In
vivo, These results also demonstrate that In vivo, In
contrast to In vitro, not only NO-compounds, but also orga-
nic nitrates Inhibit platelet function.
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THB BFFBCT OF BPICARDIAL ACCBSSORY PATHWAY ABLATION OR
ENDOCARDIAL DISSBCTION Foa AV NODAL REENTRANT TACHYCARDIA
ON VAGAL INNERVATION TO THB AV NODB.
Willi!l!!l JL. Mil.u..... M.D .. FACC, Raymond B. Dusman, M.D.,
Lawrence S. Klein, M.D., FACC, James J. Heger, M.D., FACC,
Yousuf MahOllled, M.D., Robert D. King, M.D., Douglas P.
Zipes, M.D., FACC, Indians Univ. Med. Ctr., Krannert Inst.
of Cardiology, VAKC, Indianapolis, IN
The effect of surgery for supraventricular tachycardia
on vagal innervation to the AV node in humans is unknown;
our canine data suggest that posteroseptal epicardial AV
dissection interrupts vagal innervation to the AV node.
Therefore, we examined reflex changes in AV nodal conduc-
tion following phenylephrine (P) in 31 patients (pts)
(mean age 33 yrs) after epicardial dissection and cryo-
ablation of accessory pathways (AP) and in 5 pts (mean age
38 yrs) after endocardial dissection of the AV node for AV
nodal reentrant tachycardia (AVNR) while preserving AV
nodal conduction. Boluses of P (200-1000 mcg IV) were
titrated 4-19 (mean 7) days after surgery to increase BP >
20 mm Hg and sinus cycle length (CL) > 50 msec. The same
dose of P was then given during atrial and ventricular
pacing at constant CL (400-600 me). Of the 31 pts with
APs, P prolonged both AV and VA conduction in 16 pts, AV
conduction only in 8 pts, VA conduction only in 1 pt, and
AV conduction in 3 pts with no VA conduction; P failed to
prolong (~ 10 ms) AV or VA conduction in 3 pts (2 with
right and 1 with left free wall APs). Of the 5 pt. with
surgery for AVNR, P prolonged either AV or VA conduction
in only 2 pta; all 5 pta had preoperative evidence of
vagal innervation of the AV node and no pt had recurrent
AVNR postoperatively. Thus, epicardial diasection and
cryoablation for WPW does not interrupt vagal innervation
to the AV node in most pta, but endocardial surgical
dissection for AV nodal reentry usually, but not
consistently interrupts vagal innervation to the AV node.
FUR1HER SlJPJ:an' OF 'lllE A1RIo-VEmRIaJIAR
LOCALIZATICN OF SQ-CJ\IUD ''MAIlAIM FIBERS".
JacOO Ati.e, M.D. , Peclro Brogada, M.D., Jeep
L.R.M. smeets, M.D., F'etnan:3o E.S. CI:UZ, M.D.,
Olaf e.K.M. Penn, M.D., Hein J.J. Wellens, M.D.,
F.A.e.e., Depts. of cardiology an:!. cardiotho-
ra7ic 5Urgery, university of LiJIbJrq, Maas-tr~cht, 'lhe Netherlan:1s.
To characterize the type of pathway (P) of
awarent!y noclo-ventricular (NV) accessory (A)
pathWays, data of 4 pt were retLOlSptCtively an:!.
of 2 pt prospectively analyzed. In 5 pt a
right-sided an:!. in one pt left-sided NV AP was
diagnosed. In 1 pt, ventricular activation oc:W.d
be advanced dur.in:J tachycardia (T) by a right
atrial premature beat, given sinultaneously with
the onset of retrograde atrial activatia1
suggest.in:J a direct AV connection of the AP. In
another pt epicardial dissectia1 of the right
lateral AV groove .int:errupt:ed ant:eroqrade pre-
excitation an:!. T, thereby deIII:I1strat.in:J a direct
AV connection of the AP. In the other 4 pt
careful analysis of the electrqilysioloqi~
studies suggested a classic NV AP. However, an
AV AP with anterograde decremental oorxllctia1
prqlert:ies oc:W.d oot be excllX1ed. In CXXlC1usia1
in ~ 6 pt with an electrqilysioloqicaUy
typical NV AP, 2 had an AV AP with dec:t:emtliJtal
oorxllction. In the remaini.n1' 4 pt a t:roe AV
localization of the AP oc:W.d oot be excllX1ed.
activity coupled with a fast rate; these support an in vitro






THE DURATION OF SINUS NODE DEPOLARIZATION CAN INDICATE
THE DEGREE OF SINUS NODE DYSFUNCTION.
James A. Reiffel, M.D., F.A.C.C., Gail Zimmerman, M.D.,
Columbia University, New York.
SND DUR: 138 95-190
We have shown that the duration (DUR) of sinus node (SN)
depolarization (D) as seen on SN electrograms is longer in
patients with SN dysfunction than in normala. A reduced
rate of rise and/or prolonged refractoriness of SN cells
as well as delayed intranodal conduction could each pro-
long the SND, and might be additive. Thus, we hypothe-
sized that the SND DUR would be longeat in patients with
the most extensive SN dysfunction. To test this hypoth-
esis we determined the SND DUR in 10 patients with normal
SN function and in 20 patients with 1 or more of the
following SN abnormalities: prolongation of sinoatrial
conduction time, prolongation of cbrrected SN recovery
time, prolongation of peak paced cycle length (PCLp), or
SN dysfunction by ECG. All results are in msec (mean/
range).
(Carotid massage was necessary for visualization in 5
normals). SND' DUR was> 150 in only 2/10 normals but in
4/8 and 9/12 with 1 or ~ 2 SN abnormalities respectively •
In 2 patients with all of the listed abnormalities the
SND DUR was 230/200-260. We conclude the SND DUR, an
easily obtained measurement, correlates with SN function.
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BEATS PER "'INUTE
AUTONOMIC INFLUENCE ON VENTRICULAR SUBSIDIARY
PACEMAKERS: A STUDY OF PATIENTS POST AV NODAL
ABLATION.
KpD.plawee Nademapee MOE ACe H. Elizabet.h Noll, M.D.,
WIlham G. Stevenson, M.D., F.A.C.C., James N. WeISS, M.D.,
F.A.C.C., Clara M. Pruitt, R.N., VAMC, Los Angeles, California.
To study the autonomic effects on subsidiary ventricular pace-
makers, we studied 8 patients {all male' 54 years) who had complete
AV block post AV nodal ablation for the treatment of recalcitrant
supraventricular tachyarrhythmias. The study included ventricular
pacing for 30 seconds (70-180 bpm) during baseline, isoproterenol
(2-3 micrograms/minute), and after I mg atropine infusion. The study
was performed 4 to 48 hours after the ablation procedure. The basic
cycle length (BCL) of the spontaneous activity and the cycle length
from the last paced beat to the first spontaneous ventricular escape
beat, the ventricular recovery time, were obtained in all conditions.
Results: There are two types of overdrive pacemaker responses
durin~ control: I) overdrive suppression (OS) which occurred in the
majonty of patients. 2) overdrive acceleration (OA) which occurred in
2 patients. Isoproterenol significantly shortened the BCL 22% (p <
O.OJ) and abolished OS in all patients. Also, isoproterenol induced OA
at a fast rate (150-180 bpm) in 6 of the 8 patients. Atropine had no
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CHRONIC EFFECTS OF A-V NODAL ARTERY EMBOLIZATION
Paul J, Wang, M.D., Frederick Schoen, M.D., Kathleen
Reagan, M.D., Hussein Rizk, M.D., Hong Sheng Guo, M.D.,
Peter L. Friedman, M.D., Ph.D. Harvard Medical School,
Boston, MA.
Catheter ablation of A-V conduction to treat
refractory supraventricular tachycardia causes advanced
A-V block and requires permanent pacemaker
implantation. A new method for modifying A-V
conduction (AVC) by selective A-V nodal artery
catheterization and embolization (EMB) of the A-V nodal
artery was tested in closed chest dogs. Autonomic
blockade was first achieved by administration of
atropine and propranolol. A-V nodal refractory period
(AVNRP) and Wenckebach cycle length (WCL) in ms were
then measured in a control state (PRE-EMB), acutely
after EMB and a, mean of 37 days after EMB. Results for
AVNRP/WCL were:
DOG PRE-EMB ACUTE EMB CHRONIC EMB
T 2IWm 310/350 <200/260
2 <130/220 230/280 230/280
3 <180/230 <195/230 <2001<200
4 <190/210 <260/300 <205/230
5 <200/250 <190/240 <220/250
6 240/290 270/320 240/280
Advanced A-V block did not occur' acutely after EMB, nor
did it appear later after EMB. EMB acutely caused an
increase in AVNRP and WCL. Subsequently, AVNRP and WCL
returned to normal in all but one animal, even though
all animals had histologic evidence of localized
infarction within or near the A-V node and His bundle.
In dogs, A-V nodal artery EMB alone does not yield
long-term changes in AVC. Administration of cytotoxic
ablative agents via the A-V nodal artery in addition to
or instead of EMB of the A-V artery may be required to
achieve clinically relevant chronic changes in AVC.
ORAL PROPAFENONE FOR PREVENTION OF RECURRENT PRIMARY ATRIAL
FIBRILLATION: PREDICTIVE VALUE OF THE RESPONSE TO TRANSESO=
PHAGEAL ATRIAL STIMULATION.
Fulvio Bellocci M.D., Antonio Nobile M.D., Andrea Spampina=
to M.D., Simonetta Nava M.D., Sandro Montenero M.D., Paolo
Zecchi M.D., Catholic University Sacred Heart, Rome, Italy.
We studied 34 pts(18 men,16 women,mean age 45 years)who had
multiple episodes of primary paroxismal atrial fibrillation
(PAF). Transesophageal atrial stimulation(TAS) was perfor=
med after all antiarrhythmic drugs had been stopped for at
least 5 half-lives before testing, using a moderately ag=
gressive protocol:single and double extrastimuli during si=
nus rhythm and during 600 and 400 msec cycle length pacing
and 8" atrial bursts at incremental rates from 180 to 300
bpm. All pts had inducible,sustained(a>30" duration) PAF
at the time of basal TAS. All pts received oral propafenone
(P) in escalating dosages of 150 mg every 8 h, 300 mg every
12 hand 300 mg every 8 h. The dosage was based on pts to:
lerance and ECG evidence of QRS interval prolongation~50~
from control. All pts underwent a second TAS after at least
12 days of oral P therapy. Twenty pts were considered reSa
ponders(sustained PAF no more inducible) and 14 non respon=
ders(sustained PAF still inducible). There was no differen=
ce between responders and non responders in regard to age,
sex,left atrial dimension,duration of PAF,electrophysiolo:
glc parameters before and after ~ and olasma level of P.
During a follow-up of 13 ± 5 months,2 ~esponders(10~) and
8 non responders(57~) had recurrences of sustained PAF
(p<0.05). We conclude that oral P Is effective and safe
for treating pts with PAF. TAS is a rapid, simple and not
expensive method in predicting the response to oral P.
Thursday, March 23, 1989
8:30AM-I0:00AM, California Room D
Anaheim Convention Center
Valvular
EVALUATION OF PROSTHETIC VALVE PERFORMANCE BY ASSESSING
THE RESPONSE TO EXERCISE USING DOPPLER ECHOCARDIOGRAPHY
Hossam I. Kandil, MB BC.h., Ms.C; Claudine Moffett; Oi
Ling Kwan, B.S.; Michael R. Harrison, M.D., FACC; Yahya
S. Mikhael, M.D., FACC; Galal M. El-Said, M.D., FACC;
Mohamed M. Ibrahim, M.D., FACC; Sherif El Tobgy, M.D.;
Anthony N. DeMaria, M.D., FACC; University of Kentucky,
LeXington, Kentucky
Although considerable data exist regarding the function
of prosthetic heart valves(PROS} at rest, few data exist
regarding the response to exercise(EX}. Thus, we per-
formed continuous wave Doppler(DOP) in 46 Pts with normal
LV function (EF>55%) with 50 PROS (27 mitral (M), 23 aor-
tic (Ao}) of varying ~ype before and after symptom limi-
ted supine bicycle exercise. Gradient(GRAD) increased
with Ex in all PROS: 4.4"8.5 mmHg for mean M, 1I.5~17.8
mean Ao, and 24.2~39.0 mmHg for max Ao (all p<.OOl), and
the percent increase was similar for both (51% (M) vs 64%
(AO}). Linear regression failed to demonstrate a rela-
tionship between the change in gradient and indices of
exercise effort including heart rate and Ex duration: (r
- 0.1 and r • 0.2 respectively for all PROS). The change
in GRAD with exercise was similar for tissue, tilting
disc, caged, ball and bileaflet valves. No relation was
observed between ~GRAD and valve size for all PROS, or
for 17 Pts with Bjork-Shiley; however an inverse relation
existed for 20 Pts with St. Jude (r- .61). Importantly,
the largest GRAD with EX was predicted by the resting
GRAD: r • 0.93, r • 0.79, and r - 0.94, for mean GRAD of
AO, Mand both. Thus, Ex DOP provides a good method to
assess PROS function. In asymptomatic pts with normal
LV, GRAD response is not related to duration or HR. The
response to EX of bileaflet valve tends to be favorable
to other PROS. Of significance, the maximu. GRAD produced
by EX is related to and predicted by the rest GRAD.
THE PROGRESSION OF AORTIC STENOSIS AS ASSESSED BY
ECHOCARDIOGRAPHY.
Anthony J Sanfi] iopo Mo, Mark S Adams BS, Leonardo
Rodriguez MD, Al eksandar 0 Popovic Mo, Arthur E Weyman
MD FACC. Massachusetts General Hospital, Boston MA.
Two-dimensional and Doppler echocardiography (echo)
are now the major tools used in follOWing patients with
aortic stenosis (AS). Despite this, little is known
about how echo-derived aort ic val ve areas (AVA) change
with time, or how the severity of AS may effect such
change. Such data would allow more rational planning of
follow-up and interpretation of results. In order to
clarify this we reviewed our echo database to select
patients who had AS found on serial echo examinations
separated by at least 2 years and in whom the examina-
tion included all data reqUired for calculation of AVA
by the continuity equation. Fifty-seven such patients
have been reviewed to date (30M:27F; mean age 57.5
years). Mean follow-up (FU) was 32.7 mos.
RESULTS: AVA decreased from 1.45 +.72 to 1.17 +.51 cmz.
(p<.OOOI). The change in AVA (CHG) was then calculated
on the basis of severity of AVA at initial study (AVA1):
AVA1 (caH !l2... ~l mm FU (mos)
~ 1.0 18 [.09+.10] 12.5+13.6 34.6+11.8
1.0-2.0 27' .21±.23]· 14.2±I6.3 31.1± 8.4
> 2.0 11 .74±.57· 26.2±16.8f 33.6±10.6
(*.p<0.03; '-p<O.OS compared with both other groups)
CONCLUSIONS: The change in both absol ute and %AVA were
greater when initial AVA was in the mild or moderate
range as compared with severe AS over an average of 32.7
mos of follow-up. These results suggest that valve area
decreases less rapidly as the severity of aortic
stenosis increases.
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VENTRICULAR AND ATRIAL COMPLIANCE CHANGES AFFECT PRESSURE
HALF TIME: EXPERIMENTAL EVIDENCE
Frank A. Flachskampf, MD, James D. Thomas, MD, J. Luis
Guerrero, and Arthur E, Weyman, MD, FACC; Massachusetts
General Hospital, Boston, Massachusetts
Pressure half time (T%) from Doppler tracings is widely
used to estimate valve area. We have shown previously in
theory and ina flow model that ita1so depends on net
atrial and ventricular compliance. To investigate the
behavior of n in the more physiologic situation where
instantaneous compl iance varies throughout diastole, we
used an in vitro model of mitral filling where net
compl iance could increase or decrease up to the three-
fold during diastole. RESULTS: 1. When compliance was
constant (middle curve of figure), T% was 31±1.7%
(mean±SD) of the diastolic filling period (DFP). 2.
A steadily increasing compliance, but with the same
average value, resulted in a T% of 22±2% of DFP (bottom).
3. A steadily decreasing compliance, average value again
identical, yielded a n of 41±2% of DFP (top). These
changes were observed with pressure, flow, and Doppler
recordings.
.~_-L--I.......I=::':::'==-_----==:::3!lJ
Q D.' 0.4 D., 0.'
DIASTOLIC FILLING TIME (He)
CONCLUSION: T% is affected not only by mean net complian-
ce, but also reflects the temporal variation in complian-
ce during diastole.
SYSTEKATIC ERROIlS IN THE DOPPLER PRESSURE HALF-TIHE
FOIlMIJLA FOR KITRAL onrrCE AREA.
Donovan M. Bakalyar Ph.D., Gerald C. Timmis M.D.,
F.A.C.C., Andrew M. Hauser M.D., F.A.C.C. William
Beaumont Hospital, Royal Oak, Michigan
The pressure half-time (T
I/2
) formula for the Doppler
calc~lation of the m tral valve area (A),
A(cm )a220/TI/2' has enjoyed widespread clinical
application despite the absence of theoretical
justification. The potential for large systematic
errors exist because in addition to the mitral valve
area, TI/2 depends strongly on muscle properties such aschamber compliance (C), the ventricular relaxation time
(R), and degree of relaxation (D). We have developed a
computer model employing these muscle properties and
Euler's equation for fluid flow with which the Doppler
curve can be reproduced by adjusting C,R,D, and A. We
have used this model to produce a family of Doppler
curves in which C,R, and D were held fixed while A was
varied. The area A estimated from these curves using
the half-time formul~ was compared to the area A used in
generating these curves. As is shown in the graph, Aabegins2to deviate strongly from A for areas larger than1.5 cm •
CONCLUSION: We have shown, using
the principles of fluid dynamics
and ventricular mechanics, that the
validity of the pressure half-time
formula depends on severe
constraints that may often be
violated in a clinical setting.
CAN THE MODIFIED BERNOULLI EQUATION ACCURATELY
ESTIMATE INSTANTANEOUS TRANSMITRAL PRESSURE
GRADIENTS IN PATIENTS WITH CARDIAC PATHOLOGY?
Daniel David, M.D., F.A,C.C" Alex Neumann, B.S., Roberto M.
Lang, M.D., F.A.C.C., Pinhas Sareli, M.D., Richard Marcus, M.D.,
Kenneth M. Borow, M.D., F.A.C.C., University of Chicago, IL
The modified Bernoulli equation (MBE) is widely used to
calculate instantaneous pressure gradients (PG) from Doppler
velocities. These velocities are dependent upon valve area (VA)
and flow. During cath, we studied the Impact of these two
factors on the reliability of MBE in assessing instantaneous
transmi¥.al PG In 14 pts: 4 with mitral stenosis (MS; MVA = 1.1 ±
0.5 cm ) and normal transmitral flow and 10 with dilated
cardiomyopathy (C~), normal MVA and + transmitral flow (Cl =
2.0 ± 0.5 Llminlm ). Simultaneous PG from LA and LV microtip
catheters and transmitral Doppler data using MBE were obtained
at 5 points during diastole: early (E) and late (A) peak velocities,
velocity nadir (N) and identical velocities on the upslope (U) and
downslope (D) of early filling. Percent differences between PG-
CATH and PG-MBE are shown (*p < 0.01; PG-CATH vs PG-MBE).
TIMING MS CM E
--- 96 Diff r 96 Diff r ~..
U - 2 .98 -71* .30 U D •
E + 4 .96 -34* .10 I I ";\\
o -11* .75 -52* .09 ~,.
N -24* .42 -37* .06 ,.. I.:. . .
A -21* .56 -57* .08 ,..
In MS pts with +MVA, PG-MBE correlated well with PG-CATH at
points U and E but underestimated PG-CATH at D, Nand A. This
was true despite similar mean PG for MBE vs CATH (14 ± 4 vs 15
± 2 mmHg). In CM pts with + transmitral blood flow, PG-MBE
correlated poorly with PG-CATH (r ~ 0.30) at all measured
points. Thus, the accuracy of the MBE for estimating
instantaneous transmitral PG is affected by both the MVA and the
magnitude of transvalvular flow.
VALVE RESISTANCE IN AORTIC STENOSIS: AN ALTERNATIVE
METHOD FOR ASSESSING THE HEMODYNAMIC SIGNIFICANCE
OF FLOW OBSTRUCTION.
Alex Neumann, B.S., Ted Feldman, M.D., F.A.C.C., Kenneth M.
Borow, M.D., F.A.C.C., Roberto M. Lang, M.D., F.A.C.C., Lincoln
E. Ford, M.D., The University of Chicago, Chicago, Illinois.
The accuracy of echo-Doppler (E-D) data for estimating valve
area in patients with aortic stenosis (AS) has been well
documented. These calculations are based on Gorlin's formula
which relates transvalvular flow to the square root of the LV-Ao
mean pressure gradient (PG). However, recent studies have
suggested that flow and PG in AS vary as a linear rather than
exponential function. In an attempt to develop a hemodynamic
index of flow obstruction which incorporaSes this concept, we
calculated valve resistance (VR; d-s-cm- ) as PG/CO in 12
patients with tS and ~ mild aort\!; regurgitation (AR) (valve area
= 0.6 ± 0.2 cm ; range 0.4-1.0 cm ). .,..--------.1
During cath, PG and Fick CO -
were simUltaneously obtained with l'I ra.tS
E-D data. An excellent :1-
correIation between echo-Doppler Iii
and cath determined valve PI_
resistance was obtained (r = I
0.95). In 11/12 patients, the j!;
difference between E-D and cath ~­
values were < 1096. In most cases,
E-D determined LV outputs were
slightly higher than Fick CO
probably reflecting the failure of
Fick CO measurements to include AR flow. Thus, echo-Doppler
techniques are capable of accurately quantitating aortic valve
resistance in AS. This capability should allow a more
physiologically appropriate measure of "alvular obstruction,
especially when the magnitUde of LV ., Ao flow is altered by
Valvuloplasty, exercise or pharmacologic interventions.
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The Pericardium
LEFT VENTRICULAR PSEUDO HYPERTROPHY IN PERICARDIAL
EFFUSION: A SIGN OF CARDIAC TAMPONADE.
Elio Di Segni M.D., Yoel Arbel M.D., Avinoam Bakst
M.D., Bruno Beker M.D., Hadassah Dean M.D., Alexander
Levi M.D., Osnat Sharon, Herman O. Klein M.D.
Meir General Hospital, Kfar-Saba and Tel-Aviv
University, Israel.
Reversible increase in left ventricular wall thickness
(pseudo hypertrophy) resulting from cardiac tamponade
has not been previously described. We reviewed the
echocardiograms recorded immediately before and after
pericardiocentesis in 19 Pts with cardiac tamponade.
In 4 pts the interventricular septum and the left
ventricular posterior wall were thickened during tampo-
nade, returning to normal after pericardiocentesis
together with expansion of the ventricles. Interventri-
cular septal diastolic dimension ranged between 14-17
mm in diastole before and returned to 9-11 mm after
pericardiocentesis; in systole it was 16-22 mm and 10-
13 mm respectively. Left ventricular posterior wall
thickness decreased from 10-16 mm to 8-10 mm in dias-
tole and from 16-21 mm to 11-13 mm in systole. Right
ventricular collapse was present in one case only.
Pseudo hypertrophy is a reversible phenomenon, not
infrequent in cardiac tamponade. This increase in wall
thickness was observed both in systole and diastole,
suggesting that myocardial engorgement and congestion
rather than impairment of diastolic expansion may be
the underlying mechanism. Its detection is helpful in
making the diagnosis of tamponade, especially in cases
without right ventricular Or right atrial diastolic
collapse.
DIAGNOSIS OF PERICARDIAL ABNORMALITIES BY
TWO·DIMENSIONAL ECHO: A PATHOLOGY·ECHO
CORRELATION IN 85 PATIENTS.
Spencer W Hinds MD. Antonio F Amico, MD, Richard SMeltzer,
MD, PhD, FACC. University of Rochester, Rochester, NY.
Though pericardial thickening, nodules, and masses are often
diagnosed by echocardiography, there is no series of two-dimensional
echocardiography - pathology correlations in the literature. We
therefore retrospectively reviewed the echocardiograms of 68 patients
who died and had autopsies within six months of the echocardiogram,
and 17 patientsts who had echocardiograms within six months of
pericardiectomy. The echocardiograms were re-read in random order by
an observer (AFA) blinded to the diagnosis and whether the
echocardiogram carne from the autopsy or pericardiectomy population.
Pathology reports were reviewed and graded by another observer
(SWH) for pericardial abnormalities (thickening or increased fibrosis,
nodules, malignancy, fibrin strands or clots, and size of effusion).
Pericardial abnormalities were coded separately for both
echocardiographic and pathology reviews. RESULTS: There were 85
patients who met the inclusion criteria (aged 53 ± 25 years, mean ± I
SD). The time between echocardiography and pathology was 34 ± 47
days for the autopsy group and 14 ± 17 days for the pericardiectomy
group. Of the 37 patients with pathological abnormalities, 13 had
echocardiographic abnormalities and 24 did not; of the 48 patients with
a normal pericardium pathologically, 44 were normal by
echocardiography and 4 were abnormal. In the following pathological
states, echocardiographic abnormalities were noted as follows:
pericardial tumors 3/6, thickening 9/12, fibrosis 8/19, postoperative
adhesions In, fibrin in pericardial space 6116, late post myocardial
infarction (MI) pericarditis ~ 21 days between MI and pathology): 4/9,
early post MI pericarditis « 21 days between MI and pathology): 0/4.
CONCLUSION: Two-dimensional echocardiography is fairly specific
(92%) for pericardial abnormalities (exclusive of effusion) detected
pathologically, but not sensitive (35%).
EFFECTIVENESS OF PERICARDIOSCOPY FOR ETIOLOGICAL
DIAGNOSIS IN 18 PATIENTS WITH SUSPECTED MALIGNANT
PERICARDIAL EFFUSION.
Alain Millaire M.D., Alain Wurtz M.D., Eric Tison M.D.,
Gerard Ducloux M.D. Department of Cardiology University
of Lille, France.
In cases of malignancy with pericardial effusion (PE),
conventional biopsy (CB) from subxyphold pericardial win-
dow has proved to be inadequate to assess the metastatic
involvement of the pericardium (P). To improve the diag-
nostic yield of pericardial biopsy, we performed peri-
cardioscopy (PCS) in 18 patients (pts) who had evidence of
large PE on echocardiography. Twelve pts had an history of
malignancy (neoplasm : 9 pts with radiotherapy in 5 out of
9 ; non Hodgkin lymphoma: 3 pts), 4 pts had metastases of
unknown origin and 2 pts had severe biological inflam-
mation. Performed under general anesthesia, with a rigid
mediastinoscope introduced through a surgical subxyphold
approach, PCS allowed cytological studies (C) on the
fluid, CB and guided biopsies (GB) selected by direct
inspection on suspect areas. No complication occured. In
6 out of 18 pts (33%) neoplastic PE was proved : with GB
in 4 pts even when CB was negative in 3 out of 4 and C in
2 out of 4 ; with C in 1 pt ; in the last pt, C, CB, GB
were negative in spite of metastasis on the lateral P
(diagnosed with autopsy). In 12 out of 18 pts (66%) no
metastasis was discovered : C, CB, and GB were negative
and PCS showed alterations of the P, specific of other
etiologies : post-radiation PE in 3 pts ; pyogenic PE in
2 pts ; haemopericardium in 2 pts ; idiopathic PE in 5 pts.
Conclusion : without own morbidity, PCS improves the
diagnosis yield of pericardial biopsy especially by
allowing guided biopsies.
RIGHT VENTRICULAR INFARCTION DECREASES LEFT VENTRICULAR
COMPLIANCE AND PERFORMANCE BY A PERICARDIAL MECHANISM.
Mouhieddin Traboulsi M.D., Nairne Scott-Douglas, Israel
Belenkie M.D. FACC, John Tyberg M.D. FACC. Eldon Smith
M.D., University of Calgary, Alberta, Canada.
The mechanism of the impaired LV function following RV
infarction (RVI) is poorly understood. We instrumented 7
dogs (sonomicrometers) to measure LV anteroposterior
(Dlvap) and LV and RV septal to free wall diameters
(Dlvsfw, Drvsfw). Pressures (Plv. PrY) were recorded
with micromanometers and pericardial pressure with a
ba 11 oon transducer. RVI was induced by right coronary
ligation or Hg injection. Stroke work (SW) was
calculated from the pressure-diameter loop area.
Ventricular function curves were generated (venocaval
occlusion/volume infusion) before and after RVI. All
data were normalized to their values at Prved = 5 I11l1Hg;
data (control versus post RVI) obtained at Prved ; 5 and
; 20 mmHg were compared.
Prved Plved Plvtm LV area% Dlvsfw/TCD SWlv%
; 5"""tOiitro1 DIr ~ IDO .70±.02 TOO
RVI 4±1* hI 95±3* .66±.02* 53±33*
; 20 Control 23±2 3±1 I06±4 .68±.03 135±32
RVI 20±2* h2* 101±4* .64±.03* 68±31*
TCD =Dlvsfw + Drvsfw; * p < 0.05 versus Control;
tm = transmural = Plved - pericardial pressure
Thus, RVI caused leftward septal shift, increased
pericardial pressure, reduced LV volume and SW. The
increased pericardial pressure (resulting in decreased LV
transmural pressure) caused the apparent decrease in LV
compliance.
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PERICARDms IN THE FACE OF THROMBOLYTIC INTERVEN-
TION DENOTES SEVERE MYOCARDIAL DAMAGE
TC Wall M D, EJ Topol, M.D., FACC, L Harrelson, M Honan, M.D.,
CW Abbottsmith, M.D.• FACC, DJ Kereiakes. M.D., FACC, S
Mantell, HR Phillips, M.D., FACC, RM Califf, M.D., FACC. Duke
University Medical Center. Durham, North Carolina
To determine the significance of pericarditis (PC) in acute
myocardial infarction (MI) patients treated with thrombolytic
therapy, we prospectively evaluated 810 consecutive patients treated
with t-PA, urokinase, or both in the TAMI Trials. Forty patients
(4.8%) had clinical evidence of acute PC by clinical evaluation.
There was no significant difference between patients with or
without PC in regards to Ige, sex, weight, race, history of hyperten-
sion, diabetes mellitus, hypertension. or number of diseased vessels.
Significant factors associated with PC were lower baseline ejection
fraction (44.3 +/- 13.9 vs. 50.9 +/- 11.3). worse infarct zone quantita-
tive left ventricular function (-2.96 +/- 0.91 SD/chord vs -2.53 +/-
1.09 SD/chord) and higher in-hospital mortality (15% versus 6%).
Of the 6 deaths in the pts with PC, 5 were due to power failure and
I was sudden. Patients with PC had a greater prevalence of left
anterior descending as the infarct-related artery (51% versus 38%).
Thrombolytic therapy resulted in TIMI Grade 3 perfusion within 90
min in 83% of pts without PC and in 74% of pts with PC. PC oc-
curred in the majority of patients (n-23) within the first 48 hours
after treatment with thrombolytic therapy. Of note pericardial
tamponade did not occur.
PC in patients treated with thrombolytic therapy for acute
myocardial infarction is a marker of more extensive myocardial
damage and is associated with a higher in-hospital mortality rate.
Despite the occurrence of PC, tamponade was not observed.
Thursday, March 23, 1989
8:30AM-IO:OOAM, Garden Grove Room
Anaheim Convention Center
Diagnostic and Prognostic Value of Exercise
Testing
POST-EXERCISE ST SEGMENT DEPRESSION IN RELATION TO
HEART RATE: IMPROVED IDENTIFICATION OF CORONARY
ARTERY DISEASE BY THE RATE-RECOVERY LOOP
Peter M Okin M P F A C C Olivier Ameisen M.D., Paul
Kligfield M.D., F.A.C.C. Cornell Medical Center. New York, NY.
Although the time course of ST segment recovery after exercise
has been related to the pr~sence and severity of coronary artery
disease (CAD), recovery phase patterns of ST segment depression
(STD) with reference to changing heart rate (HR) have not been
quantified. We have found distinct recovery loop patterns that
separate subjects without CAD from pts with CAD when STD is
examined in the HR domain. Continuous plots of STD and HR
were constructed throughout treadmill exercise and recovery in
100 clinically normal subjects (Nls) and in 124 pts with
catheterization proven CAD. In 95% (95/100) of NIs, STD was
less at early recovery HR than at corresponding exercise HR
(negative (clockwise) rate-recovery loop]. Conversely, in 93%
(115/124) of pts with CAD, STD was greater at early recovery
HR than at corresponding exercise HR (positive
(counterclockwise) rate-recovery loop]. Standard test criteria
(positive test- ~O.I mV horizontal or downsloping STD or ~O.J5
mY upsloping STD) were similarly specific in Nls (93% (93/100)1,
but had a sensitivity of only 74% (92/124, p<.OOI vs the
rate-recovery loop) for the detection of CAD. We conclude that
the pattern of STD as a function of HR during exercise and
recovery can markedly enhance the accuracy of the exercise ECG




PLEURAL EFFUSION AS A CAUSE OF RIGHT
VENTRICULAR DIASTOUC COLLAPSE AND CARDIAC
TAMPONADE
Kevin J. Vaska, M.D., L. Samuel Wann, M.D., FACC, Kiran
Sagar, M.D., FACC., H Sidney KlQpfenstein. M D, Ph.D,
Medical CQllege Qf WisCQnsin, Milwaukee, W.I. and The
Bowman Gray School of Medicine, Winston-Salem, N.C.
Right ventricular diastolic cQllapse (RVDC) is a sensitive
and specific marker for cardiac tamponade (CT), and is
presumed to occur when intrapericardial pressure (IPP) finally
exceeds right ventricular diastolic pressure (i.e. negative
transmural pressure=TMP). Intrathoracic pressure is also
influenced by pleural and intraesophageal pressures. To test
the hypothesis that a pleural effusiQn in the presence of an
otherwise insignificant amount of intrapericardial fluid could
produce RVDC, we created CT 5 times and pleural effusion 5
times in 4 conscious dogs by intrapericardial (10 ml/min) and
intrapleural (100 ml/min) infusion of warm saline, respectively.
Before pleural effusion, an amount of intrapericardlal saline
60.±16ml was instilled equal to half of the vQlume required to
cause the Qnset Qf RVDC in the preceding CT run. We
measured aortic, intrapericardial, IOtrapleural, right atrial
pressures (fluid-filled catheters) and shQrt axis 2D
echocardiQgrams (2 observers) at 2mmHg increments in IPP
until the Qnset of RVDC. At the onset of RVDC, IPP was
7.5.±0.4mmHg in CT vs. 7.7.±0.2mmHg in pleural effusion (p
NS). Intrapleural pressure (IPI P) tended to reflect IPP during
pleural effusion only (IPI P=8.0.±O.4mmHg, p NS vs. IPP).
Calculated TMP at RVDC was -O.~O.OmmHg in CT vs.
-0.4.±O.lmmHg in PI E (p NS). Thus, a pleural effusiQn in the
presence of an otherwise hemodynamically unimportant
pericardial effusion may increase IPP enough to produce
RVDC, perhaps leading to misdirected therapy of the
intrapericardial effusion rather than the pleural effuSIOn
DETECTION OF RESTENOSIS AFTER ELECTIVE CORONARY
ANGIOPLASTY USING THE EXERCISE TREADMILL TEST
James R. Bengtson. Mp.MpH, Daniel B. Mark, MD, MPH,
Michael B. Honan, MD, Robert M. Califf, MD, FACC, David
S. Rendall, PA-C, Tomoaki Hinohara, MD. Mark A. Hlatky,
MD, FACC, David B. Pryor. MD, FACC. Duke University
Medical Center, Durham, NC.
To determine the value of a 6-lOnth treadmill test
(ETT) for detecting restenosis (RST) after elective
coronary angioplasty (PTCA), we studied 235 consecutive
successful PTCA pts without a recent myocardial infarc-
tion and without interval cardiac events or contraindica-
tion to cath or Ell. 205 pts (87~) had both follow-up
cath and ETT. RST (~75~ diameter stenosis) occurred in 51
pts (25~). Five variables were associated with a higher
risk of RST: recurrent angina (p-.0002), exercise-induced
angina (p-.0001), a positive ElT (p-.008), more exercise
ST deviation (p-.04), and a lower maximum exercise heart
rate (p-.05). However, only exercise-induced angina
(p•. 002), recurrent angina (p-.01), and a positive ElT
(p·.04) were independent risk factors for RST. RST rates
in selected subgroups were:
Angina At Follow-up No Angina
IRestenosis / Nll~l IRestenosis/Nll%1
Ell Angina 15/26 (~) 6/15 (4~)
+ Ell 5/7 (71~) 4/8 (5~)
- ETT 10/18 (56~) 2/7 (29\)
No ETT Angina 15/48 (31~) 15/116 (13~)
+ ElT 4/11 (36%) 5/25 (2~)
- ElT 9/33 127~1 10/89 111~1
Total 30/74 (41~) 21/131 (16~)
We conclude that the exercise treadmill test stratifies
the risk of RST better than symptoms. Nevertheless, 2~
of pts with RST had neither recurrent angina nor exercise
induced ischemia. For more accurate qetection of RST. the
ETT must be supple~nted by a lOre/definitive test.
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ISCHEMIC THRESHOLD VARIES IN RESPONSE TO
DIFFERENT TYPES OF EXERCISE IN PATIENTS WITH
CHRONIC STABLE ANGINA
Giuseppe Pupita M.D., Juan C. Kaski M.D., Alfredo R. Galassi
M.D., Filippo Cm M.D., Margarita Vejar J M.D., Attilio Maseri
M.D. FACC. RPMS, Hammersmith Hospital, Lomon, U.K.
It is still controversial v~ther ischemic threshold, in patients (pts)
vith chronic stable angina, can vary depeming upon exercise
intensity. To ehridate this, 14 pts vith chronic stable angina,
documented coronary artery disease and reprodlrible positive
exercise tests vere stII1ied off antianginal therapy. Tvo types of
exercise - carried out randomly - vere compared regarding time
(T) and rate-pressure prodoct (RPP) at I mmST of ST depression:
a baseline exercise teston the modified Broce protocol (ME) and a
ME preceded by avarm-up period of 10 minutes at I mph and 0%
grMe (W). On a separate day all pts performed a ME before and
lSfter .5 mg of sublingual NTG. On average, isc~mic ST segment
changes developed at a significantly bigblr RPP and T during W
compared to ME (20297:1:4782 vs 18802:1:4000 mmHgxbpm;
412:1:198 vs 30lz149 sees respectively, p<0.05). Furthermore, the
improvement of RPP vith W vas higblr than 2000 in 7 pts
(20129:1:4732 vs 23211z4583): all these pts shoved a similar
improvement vith NTG (251 O2z5733) vhereas in the remaining 7
little or no changes in RPP vere seen during W (17476:1:2855 vs
17382:2955) and only I of them improved vith NTG. Thus,
isc~mic threshold can vary in response to exercise of different
intensity; the f~ that these pts also la1 a significant improvement
vith nitrates suggests that a decreased coronary tone may be
responsible for this p~nomenon.
EXERCISE-INDUCED SILENT ISCHEMIA: EFFECT OF
TYPE A BEHAVIOR ON FREQUENCY AND PROGNOSIS
William Siegel MD, Daniel Mark MD, Mark Hlatky
MD,FACC, David B. Pryor, MD,FACC, John Barefoot
PhD, Redford Williams MD. Duke University Medi-
cal Center, Durham NC.
Type A pts (A's) tend to ignore or underreport
symptoms while performing achievement-oriented
tasks such as the exercise treadmill test
(ETT). To determine whether A's with coronary
disease might be more likely than Type B pts
(B's) to have silent ischemia on the ETT and
consequently a worse prognosis, we studied 419
patients with documented coronary disease, a
positive Bruce ETT and a structured interview
to assess Type A behavior. A's and B's did
not differ in baseline demographic and clinical
characteristics, except that A's were less
likely than B's to report a history of typical
angina (76% vs 85%, p=.04). In addition, A's
were more likely than B's to experience silent
ischemia during the ETT (35% vs 24%, p=.02).
However, using the Cox model, there were no
significant differences in survival between A's
with silent or symptomatic ischemia (4 year
survival 86% vs 80%, respectively), or between
B's with silent or symptomatic ischemia (4 year
survival 79% vs 84%, respectively). Similar
results were found for non-fatal myocardial in-
farction.
We conclUde that A's are more likely to have
silent ischemia during exercise than B's, but
that they are not at uniquely increased long-
term risk because of this.
WAPJ1ING UP PHENOI{ENON CANNOT BE EXPLAINED BY THE INCREASE
IN CORONARY FLOW RESERVE
Yasushi Okazaki M.D., Hiroshi Sato M.D., Atsushi Hirayama
M.D., Shinji Asada M.D., Yasushi 11atsumura M.D., Kazuhisa
Kodama M.D.
Osaka Police Hospital, Osaka, Japan
To investigate the mechanism of warming up phenomenon,two
serial identical tests of supine ergometer exercise by 15
minutes recovery period in 9 patients with stable effort
angina and with angiographic evidence of left anterior
descending artery (LAD) stenosis were performed.
Patients with multivessel disease were excluded.
Hemodynamic parameters were recorded at everyone minute
during exercise and coronary angiogram was performed at
the onset of angina. Great cardiac vein (GCV) flow and
oxygen content in aorta and in GCV were measured before
and during exercise. Results: Exercise time to angina
increased from 362±110sec. at the first exercise to
424±118sec. at the second exercise (p<O.05). Diameter of
LAD at the first exercise was not significantly different
from that of the second exercise. Regional myocardial
oxygen consumption (MV02: 16.4±3.4/ min) and pressure
rate products (PRP: 19600±780) during the first test were
not significantly different from those of the second test
(MV02: 14.6±4.0ml/min, PRP: 19100±850). We conclude that
(1) significant variations in coronary blood flow do not
occur and that (2) inappropriate vasoconstriction does
not account for this phenomenon.
COMPARISON OF EXERCISE ELECTROCAROIOGRAHY AND
RADIONUCLIDE ANGIOGRAPHY IN THE IDENTIFICATION OF SEVERE
CORONARY ARTERY DISEASE
Raymond J. Gibbons, M,D., FACC, Alan R. Zinsmeister,
Pn.D., Todd D. M,ller, M.D., Ian P. Clements, M.D., FACC
Exercise electrocardiography (EXECG) and exercise radio-
nuclide angiography (EXRNA) are both utilized to non-
invasively identify patients with 3-vessel and left main
coronary artery disease (SEVCAD). The purpose of this
study was to compare these two modalities in 363 patients
with a normal resting ECG who underwent supine bicycle
exercise and coronary angiography within 3 months. No
patient was taking digoxin. Separate logistic regression
models were developed for the EXECG and EXRNA to predict
SEVCAD. The EXECG model, consisting of mm ST depression,
exercise heart rate-blood pressure prOduct, patient
gender, and METS of exercise, was statistically powerful
(x2=92, p<.OOOl) and could classify most patients into
high-risk or low-risk groups (see below). The addition
of EXRNA parameters (ejection fraction and ventricular
volumes) improved the predictive power of the model
slightly (x2=99), but had little effect on its ability to
classify patients (pts) into high- and low-risk groups:
EXECG EXRNA
Risk Group Pts---YSEVCAD Pts---YSEVCAD
Low 174 5% 177 6%
Intermediate 100 26% 91 24%
High 89 60% 95 58%
Conclusions: 1) In patients with a normal resting ECG,
who are not taking digoxin, EXECG can noninvasively clas-
sify most patients with respect to their risk of SEVCAD.
2) Compared to the EXECG, EXRNA provides little
additional advantage for the identification of SEVCAD in
such patients.
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The drug-efficacy analysis will alsQ be preaented.
S.TAI. (STUDY OF TICLOPIDINE IN UNSTABLE ANGINA)
F, VIQII Mp D. ScrutlniQ MD, C. Cimmlniello MD, G. Gamba MD, G. Rudelll
MD, S.M. Chlerichettl MD, P. RizzQn MD and F. BalsanQ MD Qn the bahalf
Qf Italian S.TAI. study grQup.
Treating pta with unstable angina (UA) with antlplatelet druga Is a the-
rapeutic approach that has prQvided Interesting reaults. Pts given aspI-
rin, which Inhibits the cycloQxygenase pathway, have ahQwn a signifI-
cant reductlQn Qf cardlQvascular eventa. Surprisingly sulflnplrazQne,
which possesses a similar mechanism Qf actlQn tQ aspirin, has nQt Influ-
enced cardiQvaacular cQmpllcatlQns of UA pta. TQ further investigate the
rQle Qf plateleta In UA pta, _ studied if tlclQpidlne (T), which Inhibits
platelet functiQn by blQcking fibrlnQgen binding tQ plateleta, Influences
the clinical CQurse Qf UA. The trial was multicenter (53 centers), contrQI-
led, centrally randQmlzed, with blind valldatlQn Qf both pta eligibility
and primary eventa by an Independent committee. Pta of both sexes with
UA were randQmly allQcated tQ conventlQnal therapy (en (beta-bIQck-
ers, Ca-antagQnlsts, nitrates etc.) Qr CT+T. T, 250 mg b.l.d., was started
within 48 h Qf hQspltalizatlQn. Pts were mQnltQred mQnthly up tQ 6 mQ.
NQnfatal AMI and cardiQvascular death cQnstituted the primary end PQ-
ints. 2438 pts were screened, 652 (338 Qn CT, 314 Qn CT+T) were rando-
mized; 599 pts (309 Qn CT, 290 Qn CT+T) were eligible. The results Qf the
IntentIQn-tQ-treat analysis are shQwn In the table.
PRIMARY EVENTS
CT n=338 T+CT n=314 Risk reduct. p value
29(8.6%) 15 (4.8%) 44.2% 0.0531
15 (4.4%) 6 (1.9%)












The relative value of both non-invasive and invasive
predictors of outcome following medically stabilized
unstable angina (UA) has not been adequately assessed.
Accordingly, we prospectively compared 24 hour
Ho1ter(HOL) monitoring, qua28itative exercise(EX)
thallium tomography (T1) and cardiac
catheterization in predicting 6 month outcome in 54
such pts. Unfavorable outcome (UO) was defined as
recurrent UA(n-11), myocardial infarction (n-2) , and
death (n-1). Results (x±SD) for ST shift ~1 mm on HOL
in min during first 24 hr after admission, EX duration
(DUR) in min bY20rruce protocol, reversible perfusion
defect by EX T1 as X of total myocardium, # of
vessels (VES) with ~50X stenosis and contrast ejection
fraction(EF, X, n-30) are shown i8 the table:
EVENT HOL EXDUR EXTl2 1 VES EF
UO 37±43 7.9±3.1 17±18 2.1±1.0 69±15
NO UO 52±119 8.0±3.6 6±11 1.1±1.2 70±10
p NS NS <0.05 <0.05 NS
Age, sex, pain or presence of ST shift on EX were not
associated ~brh UO. On multiple regression analysis,
exercise T1 (F-7.50) was of similar value as number
of VES(F-6.97) in predicting UO.
These results suggest that in unst~Bie angina after
medical stabilization, exercise T1 has greater
value for risk stratification than early Holter ST
monitoring and is as good a predictor of unfavourable 6
month outcome as extent of angiographic disease.
Thursday, March 23, 1989
10:30AM-12:00NOON, Garden Grove Room
Anaheim Convention Center
Prognostic Indicators in Unstable Angina
PREDICTING LONGTERK OUTCOME IN MEDICALLY STABILIZED
UNSTABLE ANGINA: EARLY HOLTER ST SEGMENT MONITORING,
PREDISCHARGE EXERCISE THALLIUM TOMOGRAPHY AND CORONARY
ANGIOGRAPHY .
Jonathan D Marmur, M.D., Michael R. Freeman, M.D.,
FACC, Anato1y Langer, M.D., Paul W. Armstrong M.D.,
FACC. University of Toronto, Toronto, Ontario, Canada.
SERIAL URINARY FIBRINOPEPTIDE A LEVELS IN UNSTABLE
ISCHEMIC HEART DISEASE
Robert L. Wilensky, MD, Jack A. Zeller, MD, Marc H.
Wish, MD, Mark Tulchinsky, MD, The Krannert Institute
of Cardiology, Indianapolis, IN, VA Medical Center,
Washington, DC.
Since acute intracoronary thrombosis can lead to
unstable angina (UA) and myocardial infarction (MI)
urinary Fibrinopeptide A (uFpA) was evaluated as a non-
invasive marker of thrombus. We measured spot uFpA
normalized for urinary cr.eatinine (Cr), in consecutive
CCU pts with UA (n-21) and MI (n-13) 0,2,8 hrs sfter
admission. Consecutive pts with stable angins (SA
n-20) and without known CAD (n-13) had urine obtained
at 0 and 2 hrs. The SA and no CAD pts had similar ad-
mission levels (3.2+1.1, 3.3+1.4 ng/mg Cr). The mean
admission uFpA value of UA pts was 5.7+2.6 ng/mg Cr
(p(O.OOl, p-0.008 compared to SA and nO CAD). The mean
admission value of MI pts was 8.4 +10.0 ng/mg Cr
(p(O.OOI, p-0.005 compared to 'SA a~d nO CAD groups).
There was no difference between UA and MI admission
levels. UA peak values (7.6+5.9 ng/mg Cr) were in-
creased over SA (4.0+1.0 ng/mg Cr p-0.04) but not
control (4.5+1.9 ng/ig Cr p-0.056) pts. Mean peak MI
values (44.5+60.0 ng/mg Cr) were higher than no CAD
(p(O.OOI); SA (p-0.002) and UA pts (p.0.03). The UA
pts with highest values (11.6,.29.2 ng/mg Cr) suffered
MIs 2 and 4 days later. Using 6.1 ng/mg Cr as a cutoff
value (no CAD mean +2 SD) 48X of UA admission and 53X
of peak values were increased. For MI, 50X of admis-
sion and 91% of peak values were increased. We
conclude: 1) Spot uFpA levels are elevated in-Unstable
ischemic heart disease implying active thrombosis, 2)
changes in uFpA levels in MI reflect the dynamic nature
of coronary thrombosis, 3) high uFpA levels in UA may
indicate impending MI.
ANALYSIS OF TIlE ISCHEMIA RELATED CORONARY ARTERY
AND ITS PREDICTIVE VALUE IN UNSTABLE ANGINA.
Andrea Pozzatj M D., Raffaele Bugiardini M.D. F.A.C.C., Filippo Ollani
M.D., Gianluigi Morgagni M.D., Paolo Puddu M.D. Institute ofPatologia
Medica and C.C.U., University of Bologna, Italy.
To assess the factors predictive ofan adverse clinical outcome in unstable
angina, we related the 6 month follow-up of 50 patients (pts) with rest or
crescendo angina, to their coronary angiograms obtained within 2 weeks
from admillance in C.C.U. Quantitative (% stenosis) and qualitative
(Ambrose criteria) analysis of the ischemia related coronary artery (IRA)
was perfonned in all pts. Twentyfive of the 50 pts showed complicated
(type II eccentric lesion) IRA stenosis; of these, 16 (64%) had an adverse
clinical outcome (3 myocardial infarction, 4 sudden death and 9 need for
urgent coronary revascularization). Severe stenosis (~ 90% lumen
narrowing) ofIRA was present in 28/50 pts; of these, 17 (61 %) had an
unfavourable clinical course (4 myocardial infarction. 3 death, 10
revascularization). The occurrence of both complicated and severe IRA
stenosis was observed in 20/50 pts, 16 of whom (80%) presented an
adverse clinical outcome (4 myocardial infarction, 3 death, 8
revascularization). Only 6 of the remaining 30 pts (20% vs 80%; X':
p<.OOOI) had major coronary events (I myocardial infarction, I death, 4
revascularization). In conclusion, association between complicated
morphology and severity of IRA stenosis is closely related to an adverse
clinical outcome in pts with unstable angina; thus, an aggressive
management of this subset of pIS is recommended.
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VENTRICULAR VOLUME AND FUNCTION IN INFANT ORTHOTOPIC
HEART TRANSPLANTATION
Thursday, March 23, 1989
8:30AM-I0:00AM, California Room C
Anaheim Convention Center
Pediatric Cardiology Follow-Up Studies and
Methods
Mohammad S. Kanakriyeh, MD, Charles E. Mullins, MD,
FACC, Marcos Cordoba MD, Leonard L. Bailey. MD, FACC
Loma Linda University, Loma Linda, CA
To study the growth and function of transplanted
hearts donated from young infants and neonates. angio-
graphic volume parameters were measured in the first
five recipients who underwent cardiac catherization 17 ;
5.6 months post transplantation. Mean donor age was 0.8
(range 0.1 - 2.3) months. Mean recipient age was 1.4
(range 0.1 - 3.5) months. Angiographic ventricular end-
diastolic volumes (An9EDV) were compared with donors'
predicted EDV (DPrEDV) derived from previously pub-
lished formulas according to body surface area.
Volume increase from DPrEDV (L1V) was used to evaluate
ventricular growth. Ejection fraction (EEl and cardiac
index (CI) were used to evaluate cardiac function.
IHPACT OF ABNOlUlAL HYOCARDIAL PER.F11SION ON VENTRICULAR
FUNCTION IN PATIENTS WITH UNSTABLE ANGINA.
Anatoly Langer M.D., Michael a. Freeman M.D. FACC,
aobert J. Howard M.D. FACC, Paul W. Ar.strong M.D. FACC,
Toronto, Canada.
To assess the impact of myocardial perfusion on left
ventricular funct~8Y in unstable angina ve performed
resting thallium myocardial perfusion scans (Tl,
anterior, lateral, and 450 LAO vievs) on admission and
biplane left ventricular angiography (LVA, &AO 300 and
LAO 600 vievs) 4±3 days folloving admission in 161
pts. The presence of a defect (D) in either anterior
(apical, anterolateral, septal, and anteroseptal
aegments) or posterior (inferior and posterolateral
segments) territories vas assessed by quantitative
analysis (> 2.5 S.D. belov normal). Tvo independent
observers, blinded to Tl results, assessed anterior and
posterior vall motion abnormality (VMA) by LVA.
Myocardial infarction (MI) on admission vas ruled out by
enzymes and in pts vith previous MI, territories associ-
ated vith infarction vere not analyzed. The association
of VMA vith perfusion according to territory is shown in
the uble: ANTERIOR POSTERIOR
no D(n-81) ~ no D(n-82) ~
27(33\) 33(69\)* 20(24\) 16(55\)*
54(67\) 15(31\)* 62(76\) 13(45\)*
*p<.005 vs no D
Ve then correlated D size vith VMA score (for each
segment: I-normal, 2-hypokinetic, 3..kinetic, 4-dys-
kinetic) combining anterior and posterior territories:
r-.60, p<.005.
We conclude that resting thallium defects in unstable
angina are evident early after presentation, potentially
defining territory at risk, and have significant impact




























IIIRDIPDlE 1M tIMSTABLE ANGDIAI B1IRD'ICw. IFrBCTS 1M TIlE
ILDEllLY AND 1M PATIBNTS vrm JlIOOCEI) LOT VJlNTJUCIlLAR
FUNCTION. Sidney O. Gottlieb l H.D., FACC, Pamela Quyang,
H.D., FACC, E. David Hellits, Sc.D., Gary Gerstenblith,
H.D., FACC. The Johns Hopkins Hedical Institutions,
Baltimore, Haryland.
The beneficial effects of nifedipine therapy has
previously been described for the broad spectrum of
unstable angina pts. Recent reports, however, have raised
concern about the safety of some calcium antagonists in
subsets of pts with acute ischemic syndromes who have
reduced LV function. There is also concern for the
potential for adverse effects with combination therapy in
elderly pts due to previously noted age-related changes
in electrophysiological and beta-adrenergic
responsiveness. In the Johns Hopkins Nifedipine Unstable
Angina trial, 138 pts treated with beta blockers and
nitrates were randomized to receive either nifedipine 80
mg/day (N) or placebo (PI). Of these, 45 pts (21N, 24 PI)
had an initial LV ejection fraction < 55% (~35% n-11,
36-40% n-7, 41-45% n-7, 46-50% n-10, 51-54% n-10). After
18 months 15 PI pts and only 10 N pts experienced a
clinical outcome (death, myocardial infarction, or
requirement for bypass surgery for recurrent angina), and
Kaplan-Heier analysis revealed a beneficial effect of N
on the incidence and time dependence of these combined
outcomes (p<.03). In the same trial, 42 pts (19 N, 23 PI)
were > 65 years of age (range 65-87 years). Over 18
months~ 15 PI and only 7 N pts experienced one of the
above clinical outcomes, and Kaplan-Heier analysis also
revealed a beneficial effect of nifedipine (p<.04). No
adverse electrophysiologic or hemodynamic effects
occurred in either of these subgroups. Thus, nifedipine
in combination with nitrates and beta blockers is well
tolerated and beneficial in subsets of unstable angina
pts who are elderly and who have reduced LV function.
This is the first angiographic study to document
growth and normal function after infant orthotopic
heart transplantation.
RIGHT VENTRICULAR GROWTH AND FUNCTION FOLLOWING FONTAN
PROCEDURE FOR TRICUSPID ATRESIA.
Edwin McGOUth, MD, FACC, Kent Thorne, MD. Mark Boucek. MD.
Primary Chi dren's Medical Center. Salt Lake City, Utah.
It has been shown that significant right ventricular (RV)
growth can occur in patients with tricuspid atresia (TA)
and ventricu1o-arteria1 concordance. However, growth of
the RV has been related to preoperative size, and problems
with conduit obstruction have limited use of the RV. We
have used preoperative selective RV angios to demonstrate
the unique morphology of the RV in TA; usually not well
visualized. Based on this information, we have evolved
an operative approach to promote RV growth and minimize
conduit obstruction. Operative technique includes en-
larging the OS infundibulum to incorporate the trabecular
portion of the RV. The trabecu1ations are excised and the
VSD is closed. The right atrial to RV connection is ac-
complished with a homograft inserted in a manner to avoid
obstruction of the conduit from compression of the sternum
secondary to RV growth. Eight consecutive patients with
an average age of 2.9 years (range 2.1- 5.9 years) have
been operated on using this approach. All patients have
survived and six have been studied more than one year after
operation. RV diastolic volume increased from 14.4+9.5
cc to 45.4+24 cc p 0.05 or 40+22% to 106+43% of pre-
dicted nonna1. The increase in the RV volume was not re-
lated to preoperative size. The postoperative RVejection
fraction was 52.:!: 3.9%.
We conclude that an operative approach directed toward
inclusion of both portions of the RV and specific tailoring
of the conduit will promote RV growth. systolic function
and avoid conduit obstruction.
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REMODELING OF THE AORTA FOLLOWING SUCCESSFUL BALLOON
COARCTAllCl'J ANGIOPLAS1Y
P Syamasyndar Rao M D , F.A.C.C., Patrick Carey, M.S., University
of Wisconsin, School of Medicine, Madison, Wisconsin.
The purpose of this study was to examine if remodeling of aorta
takes place following succeSSful balloon angioplasty of aortic
coarctation. During the 35-month period ending December 1987,
30 children, aged 14 days to 13 years underwent balloon angioplasty
of unoperated aortic coarctation with resultant reduction in
coarctation gradient from 44 ;l;. 20 to 10;l;. 8 moo Hg (p<0.001). On
the basis of results of six to 30 months follow-up catheterization
data in 20 children, they were divided into group A with good results
(gradient oS. 20 moo Hg and no recoarctation on angiography), 13
patients and group B with fair and poor results (gradient >20 moo Hg
with or without recoarctation on angiography), 7 patients.
Measurements of the aorta at five sites, namely ascending aorta,
isthmus, coarctation segment and descending aorta distal to
coarctation and at the level of diaphram were made in two
angiographic views, corrected for magnification and averaged. A
standardized variance of the diameter of the aorta at the five locations
measured was calculated for each case prior to angioplasty and at
follow-up. The variance between groups was compared with the use
of Mann-Whitney U statistic and the effect of angioplasty was tested
by Wilcoxon's signed rank test.. The variance of standardized aortic
measures (0.233 vs 0.287) was similar (p>0.05) in both groups
prior to angioplasty while at follow-up (0.057 vs 0.129) they were
different (p-0.01). There was a significant improvement at follow-
up (0.233 vs 0.057) in group A with good results (p=0.002) while
there was a marginal improvement (p-0.04) in group B (0.287 vs
0.129). Anderberg's cluster analysis was also indicative of
remodeling of the aorta in the group with good results. These data
indicate a greater normalization of the aorta following successful
balloon angioplasty of aortic coarctation suggesting that normalized
flow across the dilated coarctation allows optimal growth of the aortic
segments.
RIGHT VENTRICULAR SIZE AND PULMONARY FLOW IN P~TIENTS
~R FIRST ST~GE SURGERY FOR PULMONARY ATRESIA: COM-
BINED ASSESSMENT BY CINE MAGNETIC RESONANCE IMAGING AND
COLOR DOPPLER FLOW MAPPING. Frederick Sherman, M.D. ,
FACC, lain Simpson, M.D., Jack Powell, M.D., Azucena
Murillo, Richard Swensson, M.D., FACC, Lilliam Valdes-
Cruz, M.D., FACC, David J. Sahn, M.D., F~CC, Kyung
Chung, M.D., FACC. Univ Calif, San Diego, CA
We used the combination of cine magnetic resonance
imaging (MRI) and color Doppler flow mapping (COFM) to
assess RV and PA morphology and the derivation of PA
flow in 9 Pts, ages 4 weeks to 2.5 yrs, with pulmonary
atresia (POL ATR) with intact ventricular septum (IVS)
studied after pulmonary valvotomy and AO to PA shunts.
Cine MRI was performed using a GE Signa system (1.5
Tesla). High resolution cine MRI images were obtained in
all 9 pts and accurately delineated RV and PA anatomy
compared to observations by angiography in 8 Pts and at
subsequent surgery in 1 Pt. The RV wall thickness (mm)
and the area ejection fraction derived from diasto-
lic and systolic RV areas (em·) on saggital and axial
views by cine MRI also provided an assessment of RV size
and function comparable to angio, including 1 Pt with RV
cavity obliteration. CDFM delineated the shunt flow pat-
terns in the PA in 7 pts and the area of variance
encoded shunt flow correlated well with the arterial
oxygen tension. Forward RV-to-PA flow identified by
acceleration proximal to the pulmonary valve was seen in
6 Pts with continuing valve patency, but the severity of
residual stenosis was better assessed using CW Doppler
of TV insufficiency (TI) velocities. The degree of TI
and PI was similar on COFM and MRI. combined use of cine
MRI and COFM provides a comprehensive assessment of RV
growth, PA size and hemodynamic results in Pts with PUL
ATR and IVS after initial surgery and aids planning
subsequent medical or surgical managment.
FATE OF THE NEOAORTIC VALVE AFTER ARTERIAL REPAIR OF
TRANSPOSITION OF THE GREAT VESSELS
Frank Smith M.D., Rae-Ellen Kavey M.D" Craig Byrum M.D.,
Bonnie Salisbury R.N., R.D.M.S., and John Dadario.
SUNY Health Science Center, Syracuse, New York.
It remains unresolved whether neoaortic valve incompetence
occurs late after arterial repair of transposition of the
great vessels. To address this question we reviewed the
most recent color doppler echocardiograms (CDE) and com-
pared them to previous two dimensional studies in 17 Pts
with this diagnosis. The patients were most recently
studied at 7 mos-7lyrs of age (mean 2.4 yrs), 6 mos-6 yrs
after repair (mean 2.3 yrs). All were asymptomatic and on
no medications. Neoaortic incompetence (AI) was detected
by CDE in 5/17 Pts, but was judged to be trace in 4 and
only mild in 1. The latter Pt was the only 1/17 with Al
by auscultation. Maximum neoaortic root diameter (AOD)
could be measured on early postoperative studies (mean 5
months postop) as well as on later postoperative studies
(mean 27 months postop) in 14/17 Pts. On the early
studies the AOD averaged 1.16 x 95%ile for age and exceed-
ed 95%ile in 11/14 Pts. On the recent studies the AOD
averaged 1.18 x 95%ile for age and exceeded 95%ile in 9/14
Pts. Although AOD averaged large for age on early and
late studies, the size relative to upper limits of normal
for respective patient age did not change significantly
over the interval. Although neoaortic incompetence re-
mains uncommon, neoaortic root dilatation has persisted
for up to 6 years after arterial repair of transposition
of the great vessels. Progressive aortic root dilatation
relative to patient age, however, did not occur. Further
long term follow-up is needed to determine the signifi.
cance of neoaortic root dilatation in this patient group.
PREVALENCE OF CONGENITAL HEART DISEASE IN OFFSPRING OF
PARENTS WITH FALLOT'S TETRALOGY.
Thomas M. Zellers, M.D., David J. Driscoll, M.D.,
F.A.C.C., Virginia V. Michels, M.D., Section of Pediatric
Cardiology, Mayo Clinic, Rochester, Minnesota.
Patients with Fallot's tetralogy (TOF) can be offered
physiologic operative repair with low operative and late
mortality. Because many of these patients marry and have
children of their own, we conducted this study to deter-
mine the prevalence of significant congenital heart
disease (CHD) in liveborn offspring of patients with TOF.
We contacted 230 consecutive patients (mean age = 38 + 10
years, range 24-78) with TOF who were evaluated at the
Mayo Clinic between 1945-1968. Of these 230, 163 were
married and 129 (63F; 66M) had 256 children (126F; 130M).
Three (all F) of the 256 (1.2%) children had congenital
heart disease (1 TOF, 1 VSD, 1 truncus). The occurrence
rate between probands was similar in males (1.5%) and
females (O.93%). The occurrence rate per family was 3 of
129 (2.3%). Neither the probands nor their spouses in the
3 involved families had additional first degree relatives
with CHD.
The 63 women had 135 pregnancies; 20 of these women had
25 spontaneous abs and 3 therapeutic abs (maternal
health). The 230 patients had 595 siblin9s, 15 (2.5%) of
whom had congenital heart disease.
These data sU9gest that th~ occurrence rate of signifi-
cant congenital heart disease in liveborn offsprin9 of
parents with TOF is low (1.2%) and consistent with the
theory of multifactorial etiology.




Noo-Osc 2.2 * 26 13 9.5 323 321
Osc pts hod a lower CI than No;;osc pts - suggesting that Osc
(like CSR) could be related to delayed chemoreceptor signalling.
Values for 6minW, Tmax andV02mox were similar in Osc andNon-Osc ph. In Non-Osc pts, there was a close relation between
VO max and Tmax (r=O.S5) aro between VO,max aro 6minW
(r=&S3). In contrast, in Osc ph, V0.1max aid not correlate
significantly with Tmaxor 6minW (r=0.3rand r=0.21).
In conclusion, cyclical changes in ventilatioo occur dJring
exercise in some CI-F pts with a very low CI aro may distort the
expected relation between VO, aro workload. Tros, V02max
may not accurately reflect exercise tolerance in such pts.
OSCILLATORY SHIFTS IN OXYC£N LPTAKE DIMINISH
THE FU'JCTIONAL RELEVANCE OF GAS EXCHANGE
MEASUREMENTS DrnlNG EXERCISE IN CHRONIC f-EART
FAILURE. Rochelle L. Goldsmith MS, Gerald W. Neuberg MD,
Morrick L Kukin MD, Stephen S. Gottlieb MD, Milton Packer
MD, FACC. Mount Sinai School of Medicine, New York, NY
Although oxygen Lptake (VO,) normally increases as workload
+, we we observed pts with Chronic heart failure (CHF) whose
VO (measured breath-by-breath) increases and decreases
cyaicolly dJring exercise. Such shifts recurred every 1-2 min
and resulted in on oscillatory (Osc) pattern of VO" which
varied> 100% even when workload 'MlS constant. Oscilrations of
VO in these pts appeared to be related to cyclical chonges inmi~uteventilation (Cheyne-Stokes respiratory pattern, CSR).
To determine the significance of Osc, we evaluated IS pts
with CHF, of whom 9 had Osc oro 9 did not (Non-Osc). In both
groLps, we measured: (I) cardia: iroex (CI, I/min/m2), LV filling
aro mean right atrial pressures (LVFP and RA, mm Hg) at rest;
(2) slbmaximal exercise capacity by the distance a:hieved during
06 min walk (6minW, m); and (3) maximal exercise capacity by
the dJration (Tmax, s) oro maximal oxygen Lptoke (VO,!"ox,
m Ilk min) achieved on an incremental bi cle test· * = <;uS.
I max max 6minW
In order to determine the effect of age on central cardiovascular
function. we studied 82 healthy volunteers from a wide age range
(S4 men age 20-73 and 28 women age 21-67). All subjects had
negative exercise electrocardiograms during a familiarization
test. Subjects underwent maximal (MAX) bicycle exercise with
simultaneous right heart and brachial artery catheterization,
expired gas analysis, and radionuclide angiography for serial
measuremen~of 02 consumption (V02' ml/kg/min), cardiac index
(CI. I/f.lin/m ) by direct Fick. stroke volume index (SVI.
ml/m ). LVEF, end diastolic volume index (EDVI. ml/m2)
calculated from SVI and LVEF, mean arterial pressure (MAP,mmHg)
and pulmonary wedge pressure (PWP. mmHg). The correlation
coefficients for the regression equations of these variables versus
age at ufright rest, 300 kpm/min. 600 kpm/min and MAX are displayed
below ( p<O.O I, ·p<o.OO I):
REST 300 600 MAX
V02 -.27 -.36' -.37' -.S6'
HR -.19 -.IS -.18 -.72'
CI -.24 -.38' -.40' -.S4·
SVl -.17 _.34a -.2~ _.28a
LVEF -.03 .01 -.04 _.26a
EDVI -.IS _.30a _.30a -.IS
MAP .46' .4S· .46' .3Sa
PCWP.l4 .06 .OS .06
Thus, in normal subjects, aging is accompanied by significant
alterations in central cardiovascular function during exercise.
including reduced heart rate, cardiac output, and LVEF. EDVI and
SVI do not compensate for the age related decline in maximal heart
rate. and PWP is not age related.
Thursday, March 23, 1989
10:30AM-12:00AM, California Room C
Anaheim Convention Center
Physiologic Effects of Exercise
EXERCISE CARDIAC OUTPUT DECLINES WITH
ADVANCING AGE IN NORMAL SUBJECTS
~LKmmanMJ2.. Martin J. Sullivan M.D.• Frederick R. Cobb
M.D., Michael B. Higginbotham M.B., Duke University and V.A.
Medical Centers, Durham, North Carolina.
• •••Un.
8llseline meen:l:ld OIL PLA PR:>
Total cholesterol , DBt33 183U3 1DO±28
LOL cholo''''ol 131±25 111l±35 118±21
HOL chol"'.,.. 38±07 36±11 36±OD





EXERCISE TRAINING VERSUS EXERCISE TRAINING WllH DILTIAZEM OR
PROPRANOLOL: EFFECTS ON MAXIMAL OXYGEN UPTAKE AND EXERCISE
DURATION IN MEN WITH MILD HYPERTENSION.
MlchaelH KelemenM D FA C C, MarkS. Effron M.D.. FAC.C..Stephen
A. Valenti M.D..FAC.C.. and Kerry J. Stewart Ed.D. Johns Hopkins SChool
of Medicine. Baltimore. Maryland.
Beta blockers may Impair exercise-induced Increases In endurance
capacity whereas calcium channel blockers have not been studied
wtlen combined with exercise training. 52 sedentary men. ages 2&-59.
with a D8P c:A 90 to 105 ott drugs. and negative stress tests were
randomized In a double blind fashion to dUtlazem SR (OIl). propranolol
(PRO). or placebo (PlA). Maxtmal oxygen uptake (MVO~and exercise
duration were assessed on a Bruce treadmUI test atter a 4 week single
blind plocebo boseJine. atter2 weeks c:Adrug run-in. and atter 10weeks
of exercise trainlng. Dally rurHn doses were Increosed to 240 mg of PRO
and 360 mg c:ADIL 51 men (DIL n= 17. PLA 0-19. PRO D=15)completed the




••••lIn. Run-In T,.lnod 8...lIn. Run·ln T,.ln.d
PRO decreosed MV02 atter run-In (p<.05). Exercise increased MVO(p<.~)trom run-In values In aU groups. However. MV02 attertTainlog wa;
not different from boseline in the PRO group. Exercise increased duration
In ali groups (p<.05). This increose from boseline was 22% for DIL. 19% for
PLA. and 10% for PRO . While exercise with PRO produced a training
effect. the reduction In MVO consequent to PRO therapy limited the
overall benefits of exercise. DfL did not Interfere with exercise capacity
and provides an advantage over PRO during exercise training when
patients require drug therapy.
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EXCESSIVE VENTILATORY RESPONSES TO CARBON DIOXIDE
PRODUCTION DURING EXERCISE IN PATIENTS WITH CONGESTIVE
HEART FAILURE
Kazushi Itoh M.D., Hiroshi Yamabe M.D., Hisashi Fukuzaki
M.D., Kobe University, Kobe, Japan
To elucidate the mechanisms causing excessive
ventilatory responses to carbon dioxide production
(VC02) during exercise (Ex), ventilatory and hemodynamicresponses were assessed in thirty-five Pts with chronic
congestive heart failure (CHF). Minute ventilation (VE)
increased proportionally with VCO during Ex and
individual linear regression analYSi~ showed excellent
correlations in all Pts (r ~ 0.95). VE at any given level
of VCO during Ex was significantly higher in Pts with
more a~vanced CHF. Significant correlation was noted
between excessive ventilation and dead space ratio
(VD/VT)(rz O.77). Increased VD/VT was mainly due to
abnormally widened arterial-end tidal CO tension
(P(a-ET)C02), indicating increased alveolar aead spacewith high ventilation/ perfusion ratio (V/Q). Calculated
anatomical dead space was not different. There was
virtually no difference in theoretical effective
alveolar ventilation (=VE(l-VD/VT» needed to eliminate
CO2, suggesting preserved neurochemical ventilatorydnve to maintain normal arterial CO2 tension despiteincreased dead space. Excessive ventilation also
correlated with pulmonary capillary wedge pressure
(r=0.42) and pulmonary vascular resistance (r=0.41).
Conclusion: Abnormal lung units with high V/Q ratio
which are associated with impaired pulmonary circulation
account for increased VD/VT and wasted ventilation
resulting in compensatory excessive ventilation in Pts
with CHF. Excessive ventilatory response to VC02 is afrequent abnormal finding and may be an objective marker
of altered ventilatory function in Pts with CHF.
<XK>ARISCN OF EXERCISE IKIDXOIS: E.VAWATICJf OF OXYGm
tJPmI(E KINEl'ICS IN HEARl' F?IIllRE
Ileana L. Pina M.O" F.A.C.C., Dean G. Karalis M.D.,
Radlel zack R.N., WilliaJn S. Frankl M.D., F.A.C.C.,
Likeff cardiovasa.l1ar Institute, HahneIoann university,
Rl.ilade1pUa, Pennsylvania.
'!be pnpcse of this study was to detenDine whid1 tread-
mill protocol 1oQ1ld best assess aerd:lic capacity in pts
with Class III heart failure (HF). six pts were tested
[mean age 65±!l;mean ejecticn fracticn(EF)22%] usi.n;J 4
protocols [Bruce (B) ,Naughton in 2' am in 3' stages am a
Rallp(15 wattjmin)] with breath by breath ~ upt:alte0-'02) •
Medicaticns were at steady state. Testin;J was da1e at a
mean of 3 ha.Irs post dose, to dysplea/fatigue, am to a
respiratory exd1an;Je ratio of >1.1. Mean hemodynamics
were: [heart rate(fIR); ~lic pressure (SBP) 1IIIfi3';
cbJble product (OP) x 10 ; VO:!cc,lm.i.nl)cq; ti:me(mins).
I!!!M.Jlr peak s!:p~~ ~
lll:lg 126:±15 154±36 19.4±5 11.2±3 4.0±1.2
~ 122±16 160±27 19.3±3 8.7±3.6 4.4±1.3
1miD 128±10 152±19 19.4±3 7.8±1.7 9.~5.5
zmiD 12~15 162±37 20.4±6 8.3±3.2 7.8±2.7
AnaerdJic threshold (AT) was reproducible in eadl pt
regardless of protocol within a margin of 6.5-9%. All
pts adlleved the highest VO:! with the B. 'Ihere was no
significant correlaticn betWeen EF am exercise ti:me or
betWeen the protocol and the max OP in eadl pt. '!be slq:e
of VO:! kinetics prior to AT ('lVOV~ ti:me) was highest in
the B. 'lhus, in pts with HF, the fIR reserve is relatively
fixed and a ctlallaqi.n;J test will give a better
awrarimaticn of maxi.Dun VO:! b.It a less~ ale
will allOlol a greater duraticn. Peak V02 is effort and
protocol dependent. AT, hcMM!r,may be a better parameter
to measure therapy respa1SI! due to its reproducibility.
Its prognostic capabilities are yet to be determined.
Thursday, March 23, 1989
8:30AM-IO:OOAM, Santa Ana Room I
Anaheim Convention Center
Cardiac Transplantation: New Insights
IS YEARLY CORONARY ARTERIOGRAPHY SUFFICIENT FOR
DETECTION OF CORONARY ARTERY DISEASE IN HEART
TRANSPLANT RECIPIENTS? Milena J. Heoz!ova. MD. Hrudaya
Nath, MD, James K. Kirklin, MD, FAce, Robert C. Bourge, MD,
FAce, Connie L White, RN, William J. Rogers, MD, FACC.
University of Alabama at Birmingham, Birmingham, AL
In order to determine whether routine yearly coronary
angiography post-cardiac transplantation is adequate for detection
of coronary artery disease (CAD), we reviewed the clinical
course, serial coronary angiograms, and autopsy data from 73
transplanted patients who survived until the first yearly
angiogram or later. AngiogralOS (n • 138) were read by 2
observers, projecting serial angiogralOS simultaneously for side-
by-side comparison and assessment of interval change. CAD was
detected in 7.1% (5/70) at 1 yr, in 14.3% (6/42) at 2 yr, in 36.8%
(7/19) at 3 yr, in 66.7% (2/3) at 4 yr, and 75% (3/4) at 5 yr
post-transplantation. Patients with CAD were longer post-
transplant than patients without CAD (34 .±. 17 mos vs 22 .±. 11
mos, p<0.OO3). Of the 15 patients with CAD, 53% had lesions
involving only 1 vessel, 40% 2 vessels and 7% 3 vessels. Only 2
patients had lesions comprising >50% luminal narrowing. Of the 13
patients having <50% luminal narrowing, CAD had been missed on
previous "clinical" (non-simultaneous side-by-side) reading of the
angiograms in 8 (62%). Among 7 patients who died 2-11 mos
following coronary angiography, severe underestimation (or rapid
progression) of CAD was noted in 2 patients (29%) and likely was
the proximate cause of death. Not predictive of CAD development
were other clinical variables including recipient's and donor's age,
sex, race, primary disease, ischemic time, and number and
severity of rejection episodes.
Thus, CAD becomes increasingly prevalent as survival post-
transplantation lengthens; transplant CAD in its earliest stages is
subtle and best detected by side.by-side angiogram analysis.
However, even 1 yr serial coronary angiogralOS are inadequate to
detect rapidly progressive transplant CAD in some patients.
Alternate non-invasive detection methods are needed.
POSITRON EMISSION TOMOGRAPHY REVEALS DECREASED
CORONARY FLOW RESPONSE TO EXERCISE AFTER
CARDIAC TRANSPLANTATION
Janine KriyQkapich M 0 F A e.c., Jon Kobashigawa
M.D., Lynne W. Stevenson M.D., F.A.C.C., Sung-Cheng
Huang O. Sc., Heinrich R. Schelbert M.D., F.A.C.C.
UCLA School of Medicine, Los Angeles, CA
The maximal exercise capacity for some pts after
cardiac transplantation (CTx) is decreased compared to
normals. To determine if a limitation in coronary flow
reserve contributes to this problem, we measured
coronary blood flow in 9 pts with CTx at rest and at
peak supine exercise using dynamic positron emission
tomography. Ejection fraction for CTx pts was 55±15%
and recent coronary angiography showed no evidence of
atherosclerosis except in 1 pt with distal 2-vessel
disease. The flow tracer nitrogen-13 ammonia (NH3) was
injected at rest and at 1 min prior to the end of
supine exercise. A 2 compartment model was applied to
the initial 90 sec of PET data to obtain average flow
values. The average flow at rest was 1.16±.38
ml/min/g, 45% higher than n6rmals (.80±.43 ml/min/g).
The double product (OP) for CTx pts at rest was also
49% higher than the OP for normals. Despite an 80%
increase in OP in CTx pts with exercise, the flow only
increased 10% (1.28±.83ml/min/g, N.S.). In normals,
with an identical peak DP, the flow increased 100%
(1.53±.69 ml/min/g, p<.OOl). In conclusion, elevated
resting flow rates were observed in CTx pts which may
have resulted from their higher resting OPs. The
cardiac flow response to exercise was decreased. These
findings may result from cyclosporin-induced
hypertension, the effects of denervation on heart rate
and coronary vasomotion, and/or the effects of
accelerated atherosclerosis on the microvasculature.
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CORONARY ARTERY TO RIGHT VENTRICLE FISTULAE IN
HEART TRANSPLANT RECIPIENTS: A COMPUCAnON OF
ENDOMYOCARDIAL BIOPSY?
MUena J. Henzlova. M.D., Hrudaya Nath, M.D., R. Pat Bucy, M.D.,
Ph.D., James K. Kirklin, M.D., FAC.C., William J. Rogers, M.D.,
FAC.C., University of Alabama at Birmingham, Birmingham, AL.
Coronary artery fIStula is a very rare congenital anomaly with
an incidence of 0.1-0.2% (Hobbs, 1982; Gillebert, 1986). However,
in a series of 74 cardiac transplant recipients undergoing annual
follow-up coronary angiography, we observed a coronary artery to
right ventricle fistula in 4 patients (incidence = 5.4%, C.L. 2.7%
to 8.1%). In order to investigate an endomyocardial biopsy-
related etiology of these fIStulae, the clinical records and biopsy
histopathological data of these patients were reviewed and
compared with those of patients without fistulae. All fistulae
were detected at the time of the first yearly coronary angiogram.
Patients with fistula underwent more biopsies during the first
year post-transplant than patients without fistula (20 .±. 11 vs 14
.±. 6, P < .05). However, during the entire observation period (25 .±.
14 months) the total number of biopsies in patients with fistula
(20 .±. 11) was no different from that of patients without fistula
(19 .±. 7)(P > .05).
Histopathologically, at least one "large" arteriole (circumference
> 0.5 mm) was found in the biopsy specimens of all patients with
fIStula (100%) but in only 2 of 12 randomly selected patients
without fistula (16.7%, p < .01). All fistulae were located in the
biopsy sampling area; in 2 patients fIStulae involved the left
anterior descending (LAD), in 1 patient the right coronary artery
(RCA), and in 1 patient both LAD and RCA. Right heart pressures
and cardiac index were normal in all 4 patients with fistula at
the time of diagnosis.
Thus, more frequent endomyocardial biopsies during the first
year post-cardiac transplant may predispose to fIStula formation
between right ventricle and a coronary artery, an apparently
benign condition.
ABSTRACTS
PRESERVED ATRIAL NATRIURETIC PEPTIDE SECRETORY FUNCTIDN
IN DENERVATED CARDIAC TRANSPLANT RECIPIENTS.
Randall C. Starling, M.D., Thomas M. O'Dorisio, M.D., P.
David Myerowitz, M.D., F.A.C.C., Timothy A. Galbraith,
M.D., Robert A. DeVol, Ohio State University, Columbus,
Ohio.
The secretion of atrial natriuretic peptide (ANP) is
regulated by atrial pressure and stretch and influenced
by the autonomic nervous system via cardiac innerva-
tion. The purpose of this investigation was to deter-
mine if ANP secretory function is preserved in denervat-
ed, orthotopic cardiac transplant recipients (CTR). Ten
cyclosporine treated patients performed supine bicycle
exercise with simultaneous hemodynamic monitoring. The
mean baseline ANP level (pg/ml) was 140±15 and the mean
peak level was 430±37 (p< .001). Significant differenc-
es (p<.OOl) between hemodynamic measurements obtained at
rest and peak exercise were observed: mean right atrial
pressure (RAM) 5±1 and 12±1; pulmonary artery mean pres-
sure (PAM) 19±2 and 35±3; pulmonary capillary wedge mean
(PCW) 10±1 and 22±2. ANP levels correlate with the RAM
r=.66, PAM r=.63, and PCW r=.62 (all p<.005). No corre-
lation exists between mean arterial pressure and ANP
levels (r=.226). All patients had therapeutic
cyclosporine levels and the mean blood urea nitrogen was
28±7.7 mg/dl and serum creatinine 1.3±.23 mg/dl. In
conclusion basal ANP levels are markedly elevated (nor-
mal< 20) in successful CTR. ANP levels increase with
exercis~associatedwith increased PCW indicating that
despite denervation, ANP secretory function is preserved
in CTR.
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ECHOCARDIOGRAPHIC FEATURES OF THE TRANSPLANTED HEART IN
WELL PATIENTS ONE YEAR POST TRANSPLANTATION.
John Gorcsan, M.D., Frank R. Snow, M.D., Walter J.
Paulsen, M.D., FACC, James A. Thompson, M.D., FACC,
Richard R. Lower, M.D., FACC, J. V. Nixon, M.D., FACC,
Medical College of Virginia, Richmond, Virginia
*1><0.005
At one year post Tx, clinically well recipients are
characterized by increased LV mass but normal LV volumes
and ejection fraction, increased RV wall thickness and
cavity size but normal RV systolic function, and markedly
dilated atria. These unique echocardiographic features
of well orthotopic Tx recipients should provide a normal
baseline from which recognition of pathologic states may
be made in their long term follow-up.
The echocardiographic features of well orthotopic cardiac
transplantation (Tx) recipients have not been previously
characterized. Accordingly, echocardiography was perform-
ed on 28 Pts(aged 23-60 yrs) who were clinically well 12±
2 months post Tx. All had normal stress thallium scinti-
graphy, normal radionuclide left ventriculography, and no
endomyocardial biopsy evidence of rejection within 48 hrs
of the time of study. The following 2-dimensional and
M-mode echocardiographic parameters were measured and
compared to those of a group of 10 similarly aged (22-59
yrs) normal subjects (N): LV end-diastolic (D) volume
(Simpson's Rule), LV ejection fraction, LV mass (Penn
method), RV end-diastolic area and RV fractional area
change during systole (FAC), RV wall thickness, and LA
and RA areas. Values are mean ± standard deviation.
Tx N Tx N
ONE HEART, TWO BODIES: INSIGHTS FROM THE
TRANSPLANTED HEART'S NEW ELECTROCARDIOGRAM.
Samuel M Butman M D, F.A.C.C., Brendan Phibbs, M. D., FAC.C.,
Joan Wild, A.R.T.C., and Jack G. Copeland, M. D., F.A.C.C.
University Medical Center, Tucson, Arizona
Cardiac transplantation provides a unique opportunity for the study of
the human heart in 2 hosts. To evaluate the significance of common
accepted findings in the scalar electrocardiogram (ECG), 35 donor
and recipient ECGs were coded and compared a mean of 57 (17)
days after successful transplantation. There was no difference in
height (173 (2.1) vs 171 (2.2) em, pNS), but recipient weight 71 (2.5)
vs 63 (2.2) kg, p<0.025) and body surface area (1.84 vs 1.72 M2,
p<0.05) were higher. The mean recipient age was also higher (44.2
vs 31.3 years, p<0.05). The ECG findings were as follows:
()=SEM QQ!12r ~ g
Rate (bpm) 107(3.7) 104(4.4) NS
PR interval (msec) 146(2.9) 138(3.0) <0.025
QRS(msec) 107(3.0) 868(3.0) NS
QT(msec) 350(8.0) 320(11) <0.05
QRS Axis +62(4.0) +54(5.9) NS
Transition (mean) V3 V4 <0.0005
SV1+RV5(mm) 21.5(1.5) 24.1(2.2) NS
Eight pts had new incomplete RBBB and 2 had new complete RBBB.
Mean ischemic time for the new RBBB pts was 150.3 (14.6) min
versus 150.0 (13.1) min for the pts with a normal QRS (pNS). Mean
PA pressure and PVR were not significantly different. Conclusions:
1. Clockwise rotation detected on ECG has a true anatomic basis, 2.
An acute increase in age or body mass does not result in a decrease
in frontal plane voltage, 3. The PR, QRS. and QT intervals are
shortened after denervation, and 4. New BBBs do not appear to be
related to pUlmonary hypertension prior to or preservation injury at
the time of orthotopic cardiac transplantation.
LV IIlIISS g
LV Vol.... (D) cc
LV Ejection Fraction \
Area ",,2
197!49* 12S!44 RV Thickness "" D.6!.1* D.'!!.1
109!28 1D3!28 RV Area (0) ",,2 23!4* 16!3
63!3 63:t4 RV FAC \ 33!l2 35!l1
Z1!4* 5!4 Area 1 3
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Arterial and Ventricular Compliance in HTN
COOCURRENT CCM'LIANCE REDlX.'TIOO AND INCREASED RESISTANCE
IN THE MANIFESTATION OF ISOLATED SYS'IOLIC HYPERTENSIOO.
John K-J. Li, Ph.D., David S. Berger, B. S., cardiovas-
cular Research Lab, Bianedical Engineering, Ialtgers
university. Piscataway, New Jersey
Reduced carpliance (C) of blood vessels has been
suggested as a causative factor of the occurrence of
isolated systolic hypertension (ISH). No consistent
theoretical or experimental model has been proposed
for the production of ISH. To investigate this, experi-
ments were perfonned on open chested anesthetized dogs
(n=6). SilTultaneous measurements of ECG, aortic pressure
(AOP). and flCM (llOQ) were recorded. Increased systolic
pressure (Ps) alone with insignificant change in diastolic
blood pressure (Pd) was successfully produced in a modi-
fied windkessel model of the aterial system with llOQ
as the input and AOP the output, as shown belCM. A
reduction of C alone increases Ps, but also decreases
Pd (A). A C decrease of 50% and a silTultaneous smaller
increase in peripheral resistance (~25%) are necessary
for the successful production of ISH fran a nonnal dog
(B). This finding suggests that a decrease in CCIlpliance
alone is not responsible for ISH.
B
ANTIHYPERTENSIVE THERAPY IS IMPROVED BY
CENTRAL EFFECTS OF ARTERIAL DILATION AND
REDUCED WAVE REFLECTION.
Raymond Kelly M.B.. Julie Daley R.N., Alberto Avolio PhD, Michael
O'Rourke M.D., F.A.C.C. St. Vincent's Hospital, Sydney, Australia.
Systolic blood pressure is an important risk factor for cardiovascular
morbidity and mortality. Its determinants include arterial distensibility
and pulse wave reflection. The purpose of this study was to examine
how these detenninants of systolic pressure are affected by different
types of antihypertensive therapy. We compared dilevalol (an isomer of
labetolol), 200-400 mg daily, against atenolol, 50-100 mg, in a double-
blind, cross-over, placebo-controlled trial with respect to effects on
arterial distensibility (measured as pulse wave velocity, PWV) and
wave reflection (assessed from carotid pressure wave contour). 12 pts
(44-73 yrs) with essential hypertension (supine diastolic BP 95-114
mm Hg) took active therapy for 12 weeks, separated by a 2-4 week
placebo period. Carotid pressure waveforms were recorded non-
invasively by applanation tonometry using a Millar micromanometer-
tipped probe. PWV was measured between carotid and femoral
arteries (aortic PWV), carotid and radial (arm PWV), femoral and pedal
pulses (leg PWV). Early wave reflection was calculated from the ratio
of the height of the peak of the carotid wave above its shoulder to the
pulse pressure and expressed as an index of augmentation (lA). Both
drugs were equally effective in reducing brachial sphygmomanometric
pressure and PWV in all 3 regions (active vs placebo p < 0.001) but
there was no significant difference between the two active therapies.
However, IA (averaged over the period of treatment) was significantly
lower with dilevalol (19%) than atenolol (28%), p < 0.01,
corresponding to a greater fall of 5-8 mm Hg in carotid systolic
pressure compared to the brachial artery. While both drugs were
equally effective in reducing arterial distensibility, the vasodilating
action of dilevalol gave added benefit in reducing wave reflection. In
conclusion: dilevalol is better than atenolol in reducing central systolic
pressure and left ventricular load due to its effect on wave reflection.
NONINVASIVE ASSESSMENT OF ARTERIAL COMPLIANCE IN
PATIENTS WITH SYSTEMIC HYPERTENSION.
Gary McCray, M.D., Roberto M. Lang, M.D., F.A.C.C., Michael
Murphy, M.D., Kirk Spencer, B.S., Earl Barnes, Ph.D., Jim
Bednarz, B.S., Lynn Weinert, B.S., Daniel David, M.D., Claudia
Korcarz, D.V.M., Alex Neumann, B.S., Kenneth M. Borow, M.D.,
F.A.C.C., The University of Chicago, Chicago, Illinois.
Arterial compliance (AC) is often abnormal in pts with
systemic hypertension (HTN) resulting in a greater than normal +
in arterial pressure for any change in AO volume. Traditional
approaches to measuring AC have required cardiac cath.
Accordingly, we developed a noninvasive method (analogous to
the invasive method of Yin et a1) which is based on the Windkessel
model of the arterial system. This assumes that AO diastolic
pressure decays exponentially with time. In 12 normals and 18
untreated HTN pts, continuous wave Doppler was used to measure
instantaneous AO flow while simultaneously recorded calibrated
carotid pulse tracings were used to determine the rate of Ao
pressure decay. Sustained HTN was confirmed by ambulatory 24
hr BP monitoring. The HTN pts were divided into those with
normal (n = 9) vs low (n = 9) arterial compliance.
NORMALS HTN (NL AC) HTN (+AC)
Age (years) 48 ± 16 47 ± 12 47 ± 20
Mean 24 hr
2
BP 89 ± 10 112 ± 5* 116 ± 9*
CI (L/m/m ~ 2.9 ± 0.4 3.6 ± 0.7* 2.8 ± 0.5:;
SVR (ds/cm ) 1445 ± 281 1316 ± 313 1990 ± 487*:;
AC (ml/mmHg) 1.8 ± 0.5 1.8 ± 0.3 1.2 ± 0.3*:;
*p < 0.01 vs NL, :;p < 0.01 vs HTN (NL AC)
The HTN patients with +AC had lower AO flow and higher SVR
than HTN pts with normal AC. This was true despite similar
mean 24 hr BP and age. Thus, this easily performed noninvasive
method for determining arterial compliance can identify
differences in LV-peripheral vascular coupling that are not
evident from BP measurements alone. This may have important"
therapeutic implications for a physiologically based approach to
treatment of systemic hypertension.
RELATIONSHIP BETWEEN LEFT VENTRICULAR MASS
REGRESSION AND IMPROVED LEFT VENTRICULAR FILLING
IN SEVERE HYPERTENSION. Robert A Phillips MD PhD,
Maria Ardeljan RN, Martin E Goldman MD FACC, Lawrence R
Krakoff MD. Mount Sinai Medical Center, NY, NY
The relationship between LV mass regression and
improved LV diastolic performance in severe
hypertensives remains uncertain. We treated II severe
hypertensives (age 58±4, mean±s.e.m.) with long-term
monotherapy using Nifedipine-GITS (Nif-GITS), a
sustained release preparation. Serial measurements by
echo/Doppler to assess LV mass index (LVMI) and LV
filling were made at entry (E) and after two months
(2M) of blood pressure (BP) control (diastolic BP ~95
mm Hg). The ratio of atrial to early LV filling
velocity (A/E ratio) was used as an index of LV
filling. AtE, 55% had elevated LVMI and 60% had an
elevated A/E ratio. Systolic (SBP) and Diastolic (DBP)
BP were well controlled at 2M on Nif-GITS. LV mass
regression (8%) was significant and there was a trend
toward normalization of LV filling with a fall (18%) in
the A/E ratio. There was no correlation between LV mass
regression and improvement of LV filling. 2
Phase SBP DBP LVMI(gm/m ) A/E ratio
E 198±1O 117±3 I24±1I 1.6±O.2
2M 141±8 87±2 114±11 1.3±O.1
p<.OOO I p<.OOO I p<.05 ns
Conclusion: Sustained BP reduction by Nif-GITS for 2M
leads to regression of LV hypertrophy. LV regression
precedes and is not correlated with improved LV
filling. This suggests that LV mass regression and
improved LV filling may be dissociated in severe
hypertensives who -are treated long-term with
nifedipine-GITS.
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Neurohumoral Activation in Congestive Heart
Failure
RV Biopsy ~ L..L. k...L..
, Receptor Density
58l±67 -.60* +.66* -.26 -.30
Group II: CSNE PWP C. I. E. F. IIAP
--!nl-- Pre Post Pre Post Pre Post Pre Post~
IIa (6): 936 *357 19 *11 2.0 2.3 .25 .28 88 90
±30l ±106 ±4 ±l ±.2 ±.2 ±.03 ±.04 ±4 ±4
IIb(14): 830 465 16 15 2.2 2.2 .23 .25 85 86
±3l0 ±154 ±3 ±4 ±.l ±.2 ±.02 ±.02 ±2 ±3
IIc (9): 275 *1136 10 *18 2.4 2.3 .23 .25 83 87
± 74 ±483 ±2 ±ll ±.2 ±.2 ±.03 ±.03 ±4 ±3
Conclusion: Change in left ventricular filling pressure
(PWP) is the best correlate of changes in ADc. One
possible mechanism for the increased ADc is therefore
increased ventricular volume and/or pressure, with the
subsequent inhibition of inhibitory adrenergic reflexes
mediated by either stretch or pressure receptors located
in the ventricles, atria, or central veins.
HEMODYNAMIC CORRELATES OF INCREASED CARDIAC ADRENERGIC
DRIVE IN THE INTACT FAILING HUMAN HEART. ~nthon[aB,
Sandoval M D" Edward M. Gilbert, M.D. ,attirrabee,
B.S. Randy Rasmussen, B.S., Kirk Volkman, R.N., Michael
R. Bristow. University of Utah, Salt Lake City, Utah
Cardiac adrenergic drive (ADc) is increased in heart
failure. Little is known about the hemodynamic or
cardiac functional abnormalities that trigger the
increase in ADc. To investigate possible afferent
signals for an increase in ADc, we measured coronary
sinus norepinephrine (CSNE) and hemodynamic variables in
60 subjects (group 1) with idiopathic dilated
cardiomyopathy. In a separate group of 29 subjects
(group II) we serially measured ADc with respect to
hemodynamic changes: subgroup IIa, decrease in CSNE;




CONCENTRIC REMODELING OF THE LEn VENTRICLE IN HYPERTEN-
SIVE PATIENTS WITH NORMAL VENTRICULAR MASS.
Antonello Ganau M D , Richard B. Devereux, M.D., FACC,
Mary J. Roman, M.D., Peter Schnall, M.D., Thomas G.
Pickering, M.D., Ph.D., John H. Laragh, M.D. Cornell
Medical College, New York, N.Y.
To investigate whether modifications of LV geometry
and inotropism play a role in LV adaptation to the
pressure-overload in hypertensive pts (H) without LV
hypertrophy, we studied by echocardiography 50 normal
subjects (N) and 38 untreated mild H with LV mass index
(LVMI) within sex-specific normal limits. Relative wall
thickness (RWT) was increased more than 2 standard
deviations above the normal mean (>.44) in 11/38 H,
providing evidence of a su~tle change in LV geometry.
Cardiac index (CI:_~/min/m ), total peripheral resistance
(T~R: dynes2sec.cm ), peak wall stress (PWS:10 dynes/cm )7 end-syssolic stress/volume index ratio
(ESS/ESVi: 10 dynes/cm ), and 2-dimensional LV short/long
axis ratio (S/L) were compared in N and in H with in-
creased (HI) or normal (H2) RWT. Systolic blood pressure
was higher in HI (142±11 mmHg; p<.Ol) and H2 (134±10;
p<.05) tha~ in N (128±9), whereas LVMI was similar in N
(79±19 glm ), HI (89±13) and H2 (85±15).
RWT CI TPR ESS/ESVi SIL
(50) .34±.0 2.7±.6 1480±357 3.2±.7 .59±.06
(11) .45±.0* 2.3±.5* 1877±368* 3.6±.6 .52±.04*
(27) .35±.0 2.7±.6 l6l0±457+ 3.2±.5 .57±.04
+ - p<.05 and * - p<.01 vs N.
Thus, increased RWT and more elliptic LV shape ( SILl
suggest that concentric remodeling of LV occurs in a
number of H with normal LV mass. Low CI, high TPR and a
trend toward increased inotropism are associated with
this anatomic pattern. Since PWS is lower in this group
(173±23; p<.05) than in N (207±36) or in H2 (221±29), LV
concentric remodeling seems to eliminate the stimulus to
increase of LV mass due to mild hypertensive overload.
SPONTANEOUS PROGRESSION AND REGRESSION OF CONCENTRIC
HYPERTROPHY IN PATIENTS WITH BORDERLINE(BOH) OR MILD
HYPERTENSION(MIH).
Nobutaka Doba M.D., Hiroshi Tomiyama, M.D., Toshio Kushiro
M.D. ,Nagao Kajiwara,M.D.,FACC,Shigeaki Hinohara,M.D.,FACC.
Teikyo Univ. ,Nihon Uni v. ,Life Planning Center, Tc1,)'0, Japan.
BOH and MIH have been well known to reveal increased rela-
tive diastolic wall thickness (RDWT). In this study, we
will demonstrate changes in RDWT for 44 :I: 10 months and
will discuss the possibility of prediction of its progres-
sion (PROG) or regression(REG). Of ISS male patients with
BOH or MIH whose echocardiograms were eligible for routine
measurements, 56 subjects (average age of 44 :I: 5 years)
who completed the second check-up after 3.7 years were
selected for the study. Maximal treadmill stress testing
was performed on all subjects. Subjects were divided into
3 groups based on changes in RDWT; progressive(6RDWT ~
0.1), less progressive (0.1 >6RDWT ~ 0) and regressive (~
RDWT < 0). Comparisons were made between 14 PROG and 13
REG subjects with regard to blood pressure (BP) levels at
rest and maximal exertional stress, and echocardiographic
parameters. While no significant differences were noted at
the entry between the two groups with regard to rest BP,
CI, EF, mVcf, TPRI, LVDd, LVDs or PWTd, significant dif-
f('rences were noted in maximal exertional systolic pres-
sure, IVSTd and several echocardiographic diastolic func-
tions. For 3.7 years, increased ROWT in PROG was associ-
ated with significantly increased IVSTd, PWTd, TPRI and
decreased LDVd and LVDs without changes in BP levels. On
the other hand, decreased ROWT in REG was characterized
not by changes in BP levels, but by increased LVDd and de-
creased IVSTd and TPRI. Conclusions: (1) TPRI and diastol-
ic functions at rest and BP response to maximal exertional
stress were different between PROG and REG groups. Thus,
(2) Progression or regression of concentric hypertrophy
could be predicable at the entry to the program.
RELATIONSHIP OF VENTRICULO-ARTERIAL COUPLING TO
NEUROHUMORAL MECHANISMS IN HEART FAILURE.
Tomoki Kameyama ~' Hidetsugu Asanoi M.D., Shinji
Ishizaka M.D., Shigetake Sasayama M.D.F.A.C.C .. Toyama
Medical & Pharmaceutical University, Toyama, Japan.
Circulatory adjustments to heart failure were evaluated
by ventriculo-arterial coupling in relation to
sympathetic nervous activity, as measured by plasma
norepinephrine levels, and baroreflex sensitivity.
Direct arterial pressure and LV echocardiogram were
recorded simultaneously as the pressure was changed by
phenylephrine and nitroprusside in 10 normals and 23 pts
with chronic heart failure. Ventriculo-arterial coupling
was defined by the relationship between the slope of the
end-systolic pressure-volume relation (Ees) and the
slope (Ea) of the end-systolic pressure-stroke volume
relation; Ea/Ees. Ea/Ees was 0.5±0.2 in normal subjects
and markedly increase in pts with heart failure
(1.7±1.l,p<0.OS). Baroreflex sensitivity substantially
fell with the increase in Ea/Ees. Pts with Ea/Ees
greater than 1.0 had 2.4±1.7msec/mmHg of baroreflex
sensitivity, while pts with Ea/Ees of 1.0 or less had
7.7±6.Omsec/mmHg (p<0.05). Plasma norepinephrine was
elevated more in pts with Ea/Ees of 2.0 or more
(439±223pg/ml) than in pts with Ea/Ees less than 2.0
(22l±73pg/ml,p<0.05) Thus, these results suggest that in
the course of heart failure, circulatory adjustments
result in three phases according to Ea/Ees; phase I with
normal baroreflex and sympathetic activity (Ea/EesSl.O).
phase II with depressed baroreflex and normal
sympathetic activity (1<Ea/Ees<2) and phase III with
depressed baroreflex and enhanced sympathetic activity
(Ea/Ees~2).
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CARDIOVASCULAR HORMONES IN RELATION TO MORTALITY IN SEVERE
HEART FAILURE
Karl Swedberg M.D., FACC., Peter Eneroth M.D., John Kjeks-
hus M.D., Steve Snapinn Ph.D., Lars W.iJhelmsep M.D., astra
Hospital, Gothenburg, Sweden.
EVIDENCE FOR AN EARLY INCREASE IN CARDIAC SYMPATHETIC
STIMULATION IN PATIENTS WITH DIASTOLIC DYSFUNCTION.
Michel F. Rousseau M.D., F.A.C.C., Jean Etienne, Henri
Van Meche1en, Hubert Pou1eur M.D., F.A.C.C., University
of Louvain, Brussels, Belgium.
The relation between left ventricular (LV) function
and cardiac sympathetic drive at rest was studied in 19
patients with ischemic heart disease (Ejection Fraction
ranging from 26 to 60 %, mean 45±13). No patient had
clinical signs of congestive heart failure and all
cardioactive drugs were stopped for 3 days before
measuring arterial and Coronary Sinus (CS)
norepinephrine (NE) and the indices of LV function
(Millar + Angiography). CS NE concentrations ranged
from 0.62 to 5.78 pmo1/m1 (mean 1.98±1.65 pmo1/m1) and
correlated slightly with the ejection fraction
(r=-0.76*) but not with LV dP/dt Max (r=0.04). The best
correlations, however, were found between CS NE and the
indices of diastolic function such as LVEDP (r=0.91**)
or the time-constant T of isovo1umic relaxation
(r=0.86**). Arterial NE levels (mean values 1.84±1.19
pmol/m1) were slightly lower than in the CS and the
correlation of arterial NE with LV function indices
were significantly weaker than with CS NE. Thus, CS NE
is increased in the presence of diastolic dysfunction
suggesting an activation of cardiac sympathetic drive
before any signs of overt congestive heart failure.
These data also indicate that systemic plasma levels of
NE underestimate cardiac sympathetic stimulation in the
presence of LV dysfunction and may explain the moderate
p-adrenoceptor down-regulation reported in such










<23 23-25 25-27 ~30
P 11 32 30 36
E 42 24 18 19
P vs E:0.003. Primarily death due to progressive heart
failure was prediC'ted.
ConC'lusion: The C'ombined aC'tivation of the sympathet.iC'
nervous system and the reninangiotensin system is strongly
C'orrelated to mortality in patients with severe heart fai-
lure not treated with ACE-inhibitors. This relationship
was not observed among patients treated with enalapril
where mortality was muC'h lower.
In the CONSENSUS TRIAL 253 patients with severe heart
failure were randomised to plaC'ebo (P,n:127) or enalapr.il
(E,n:126). Blood levels of noradrenaline, adrenaline,
angiotensin II and atrial natriuretiC' peptide were deter-
mined at baseline. In the plaC'ebo group there was a signi-
fiC'ant rf'lationship between eaC'h of these hormones and
mortality. We used a stepwise linear disC'riminant analysis
to evaluate how the C'ombined interaction of these hormones
C'ould prediC't mortality. A prediC'tion score was C'alC'ula-
ted. A higher sC'ore indiC'ates high hormonal levels over-
all.
Results: There were 217 pat ients with all hormones deter-
mined.74 patients died within 6 months (primary ct:>jeC'tive).
6-month Mort ali ty (~D) by PrediC't ion SC'ore at Baseline
DIFFERENCES IN NEUROHUMORAL ACTIVATION IN
PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION WITH
AND WITHOUT HEART FAILURE.
Gary Francis. MD. FACC, Claude Benedict, MD,
PhD, FACC, David Johnstone, MD, Philip Kirlin,
MD, FACC, Gerald Neuberg, MD, Spencer Kubo, MD,
FACC, James Hosking, PhD, Chang-seng Liang, MD,
PhD, FACC, Salim Yusuf, MD; Investigators for
Studies of Left Ventrioular Dysfunotion. Min-
neapolis, MH.
Patients (pts) with oongestive heart failure
(CHF) are known to have neurohumoral activa-
tion. Comparative data in asymptomatio pts
with left ventrioular (LV) dysfunotion are not
available. We measured baseline plasma
norepinephrine (PNE) and plasma renin ectivity
(PRA) in pts with LV dysfunction (ejection
fraotion {EF} ~O.35) with and without CHF. The
mean EF was O.29t5 (SD) in asymptomatic pts and
O.25t6 in symptomatio pts (p<O.0003). Although
PHE was significantly (p<O.02) lower in the 87
asymptomatio pts (_78t218 pg/ml) oompared to
the 56 pts with CBF (596t3-0 pg/ml), this dif-
ference was modest with oonsiderable overlap.
By contrast, the differenoes in PRA between the
two groups were striking (1.16±1.13 ng/ml/hr in
the asymptomatic group vs 2.58t2.95 in the CHF
group, p<O.0005) with no asymptomatio pt (n=87)
shOWing PRA elevation. Therefore, asymptomatic
pts with LV dysfunotion have lower PHE and PRA
than pts with CHF, but have higher values of
PHE than previously reported for non-age
matohed oontrols. Sympathetio activation may
preoede renin-angiotensin activation in pts
with CBF.
Pre 24 87 26 13 83 1760 5.0 703
FEN 29 73* 22 II 91* 1160* 14.5* 984*
Although FEN + MAP and 5vR; the drug did not improve LV
function (as assessed by SVI, py,p or RA). This may explain why
FEN produced little clinical improvement in these ph. There
was no + in maximum 02 consumption (bicycle) (9.7 to 10.1
ml/kg/min) or in distance walked in 6 min (308 to 2B4 m). Only 5
of 19 pts (26%) showed +CHF symptoms; 14 did not.
Changes in neurohormonal activity paralleled the clinical
response to FEN. The 5 responders hod low values for PRA and
PNE before FEN and showed no change in PRA 0.2 to 1.4
ng/ml/hr) or PI\E (541 to 615 pg.7ml) during FEN. In contrast, in
the 14 nonresponders. pretreatment values for PRA and PNE
were elevated, and both PRA (6.7 to 20.4 ng/ml/hr, p<.05) and
PI\E (821 to 1177 pg/ml, p <.05) + further ooring FEN.
In conclusion, FEN does not produce hemodynamic or clinical
benefits in mast pts with severe CHF. This may be related to the
ability of FEN to stimulate neurohormones, particularly in pts
whose neurohormonal systems are actiV0ted before treatment.
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Inotropic Agents in Congestive Heart Failure
ACCELERATED ARTERIAL WAVE REFLECTION WITH DOPAMINE BUT
NOT DOBUT~lINE IN CONGESTIVE HEART FAILURE
Philip F. Binkley H.D., F.A.C.C., Douglas B. VanFossen
M.D., F.A.c.c., Enrico Nunzlatta H.S.b.M.E., Carl V.
Leier H.D., F.A.C.C. The Ohio State University, Colum-
bus, Ohio
Reflected pressure and flow waves may significantly
alter ventricular performance since reflected pressure
adds to afterload ano reflected flow subtracts from
forward stroke volume. The effect of the positive
inotropic agents dopamine (DOP) anddobutamine (DOB) on
peripheral wave reflection was analyzed in 12 patients
with congestive heart failure to determine whether these
agents beneficially alter afterload by influencing re-
flected waves. Deconvolution of signal-averaged central
aortic pressure and flow wave forms was performid using
Fourier analysis to geuerate forward and reflected pres-
sure and flow waves. The backward wave ar~ival time
(BWAT) and BwAT normalized for left ventricular (lv)
ejection time (BWATN) were determined at baseline and
with infusion of DOP at 2, 4, and. 8 ug/kg/min and DOB at
3, 6, and 12 ug/kg/min. DOP resulted in a progressive
decrease in BWAT from 208+72 to 117+21 msec and in BWATN
from 1,0251314 to 579t175-(both p<.05). However, DOB
was associated with no change in BWAT (164±25 to 168±33
msec) and an increase in BWATN (.723±.124 to .8?1±.173;
p=.09). Therefore, DOP administration is associated
with'earlier arrival of reflected arterial waves during
lv ejection thus augmenting afterload and ~ubtracting
from fo~rd flow. In contrast, DOB is associated with
a later arrival of reflected waves relative to Iv ejec-
tion.thus ~eneficially influencing systolic loading
condit ions.
ABSENCE OF TACHYPHYLAXIS FOLLOWING CHRONIC THERAPY WITH
XAMOTEROL IN HEART FAILURE.
S.Virk, N.Anfi10goff, N.Lawson, A.Sadler, S.Smith,
A.Nuttall, R.Murray, W.Littler, M.Davies, Department of
Cardiology, University of Birmingham, Birmingham, U.K.
The chronic use of Bl-receptor agonists as inotropes in
heart failure is limlted by tachyphylaxis, possibly
mediated by B-receptor down-regulation. Xamoterol~) is a
novel Bl-agonist with 43% of the intrinsic sympathomimetic
activity of the full agonist isoprenaline. Its properties
enable it to act as a Bl-agonist when sympathetic tone is
low and as an antagonist when sympathetic tone is high.
This modulstion of sympsthetic tone may be beneficial in
preserVing B-receptor function and maintaining therapeutic
response to inotropes. Haemodynamic variables (Swan-Ganz
catheter, intra-arterial blood pressure and radio~clide
ejection fraction) were assessed at rest and on exercise
before and after intravenous (IV)X (0.2mg/Kg), in 30
patients with heart failure NYHA 11(13), III (17) due to
ischaemic heart disease or congestive cardiomyopathy. The
patients then entered a 3 month double blind crossover
study comparing oral X with placebo and the haemodynamic
response to IV X reassessed at the end of the study. At
rest, initi~11Y2X increased cardiac index (CI) (2.5~O.2 to
2.8~O.1 l/mln/m , P<O.~Ol) and stroke volume index (SVI)
(33+2 to 40+3 mls/bt/m , P<O.OOl), with a small fall in
heart rate (78~3 to 74~2, P<O.05). At peak exercise, X
mai~tained CI at significantly lower heart rates (112+4
to 97+3, P<O.OOl) and double product (18640+920 to 15990+
760 m~g/min, ~<0.01) due to an improvement in SVI(42~3 to
48~4 mls/bt/m , P<O.OOl). Following chronic oral therapy
the haemodynamic responses to IV X both at rest and on
exercise were preserved and showed no attenuation.
Conclusion. In this study there was no evidence of tachyp-
hylaxis to either the agonist effect at rest or antagonist
effect on exercise after chronic therapy with Xamoterol.
ENOXlOO!\'E INPRO\'ES MAXIMAL AIIlD SlJB.'lA.XlMAL EXERTIO:-<
IN PATIB'TS WlTIl CIlOOl\IC HEART FAILURE: A DCXJ'BLE-BLI:>'1l,
PLACEBO ro:>''TROlLED TRIAL.
Mariell Jessup, M.D., F.A.C.C., Susan C. Brozena, M.D.,
Arthur Jenkins III, Judianne Samaha, R.N. Temple













9±2 11+4 13±4 14+3 505+183
8±2 11±3 13±~ 14+3 534!lii
8+1 9+2 11.:!:3' 12+3' 608+248'
(11'<'01: + 1'<.08 ,'s-baseline)
C'O~CLUSIO~: Enoximone, added to digi talis and diuretics,
significantly improves Vo,max, exercise time and
percei ved exertion at subnaximal loads in patients with
chronic CHF.
An important goal in the treatment of patients ~ith
chronic heart failure (CHf) is to improve tolerance to
the exertion of daily living. Accordingly, 14 patients
~i th C!{F, aged 58 ± 8 years, LV ejection fraction of 21 +
9%, optimally treated with digitalis and diuretics, -
underwent 2 or more baseline maximal exercise tests with
respiratory gas exchange to measure a reproducible
baseline exercise duration (base) (seconds) and maximal
oxygen uptake (Vo,ma.'d (mIlke/min). At each stage of
exercise, patients indicated a Borg Perceived E.xertion
score. Patients were then randomized, double blind to
enoximone (enox) , (n:i) at 1 m&/kg TID or placebo (plac),
(o=i) for 12 weeks. All exercise testing and thE, Borg
scale scores were repeated at the end of this time.
RESL'LTS-".
TACHYPHYLAXIS ASSOCIATED WITH DOPEXAKINE ADMINISTRATION
IN SEVERE HEART FAILURE.
ig~!~i, MR~,p~e§ich~e~ R. K~~\s~~~~a~:D~'~n'i:eart:A': ~f
Utah chool of Medicine. Salt Lake City, Utah
Dopexamine (DPX) is reportedly a dopaminergic and &2
agonist with combined inotropic and vasodilator effects.
In isolated hUllan heart DPX appears to also possess
"indirect" action related to release of neuronal
norepinephrine. In 7 patients (pts) with severe heart
failure, hemodynamics were measured at baseline and with
i.v. infusion of DPX at 1 to 8 pg/kgfmin. DPX was then
infused to maintain cardiac index 20·40' above baseline
for 72 hours or until loss of efficacy or adverse events
occurred. Infusion was prematurely discontinued in 3 pts
with tachyarrhythmia and 3 pts with loss of efficacy. In
5 pts, DPX dose-response could be remeasured after
27.919.7 hrs of DPX infusion. For these 5 pts cardiac
index (L/min/m2) response was: '
DPX Dose Initial Poat-infusion
No DPX 1. 7 1 O. 3 1. 6 1 O. 6
1 pg/kgfmin 2.3 1 0.4 1.9 1 0.5
2 pg/kgfmin 2.6 1 0.4 2.2 1 0.7
4 pg,lkg/min 3.1 to. 4 1. 9 1 0.6
6 pg/kgfmin 3.6 ± 0.6 2.5 ± 0.8
8 pg/kg/min 3.6 ± 0.9 1.9 ± 0.4
The post-infusion dose response was significantly
downward and right-shifted (p-O.013). Control pts
receiving a 43±5 hr dobutamine (DBT) infusion exhibited
no shift in DBT dose - response curve, CONCLUSION;
Although DPX initially improves cardiac output, efficacy
is rapidly lost during long-term DPX infusion, In
contrast, early tachyphylaxis is not observed in DBT-
treated pts, The mechanism of tachyphylaxis may be
related to the indirect action of DPX,
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USE OF EN::lXIKlNE IN CARDIAC 7RANSPLAN'l' CANDIDATES;
!Fll'I!'L'T Cfi a ADRENERGIC RFL:EP'roRS
HaoIard R. Lee, M.D. ,Ph.D., John B. O'CcIlnell, M.D.,
F.A.C.C., Dale G. Renlund, M.D., F.A.C.C., EdNard M.
Gilbert, M.D., Patrice C. MI!laley, R.N., Kirk VolJcman,
R.N., Patricia A. Larrabee, B.S., Michael R. BristQ<l,
M.D. ,Ph.D., lII'Id the UTAH cardiac Trllnsplant Program,
sal t Lake City, Utah
We have used Enoximone (E), a phospIodiesterase
inhibitor with pasitive inotropic and vasodilator
effects, for stabilizing cardiac function in patients
aeiting cardiac transplantatien ('!'X). 72 patients have
been treated withE (58 transplanted with 84ll; 1 year
survival; 6 died while aeiting '!'X; 8 alive not '!'X). In
10 patients aeitir9 '!'X, the effect of E (mean treatment
25.5 days; range 4-64) en ventricular myccardial a
adreIlergic receptors (AR) _ studied. The mean age _
46±4 (~SE) years and 7 were male. Five patients hid
dilated cardic:mycpathy, 4 hid coronary artery disease,
and 1 had lIdriamycin cardiomyopathy. The explanted
hearts (LV & RV) of patients treated with E alane, and
hearts not requiring E or a agonists were analyzed for
total .BAR density (Stat)' al/~ AR density (al/~)'
dissociatien constants (Kc:!), and norepinePu'ine (HE)
ccntent: (*p < 0.01)
Group Stat al (ll; al ) ~ (ll;~)
fIDol1m protein
(+)E (n=20) 51.7±2.8 24.~2.5* (46)* 25.4±2.5* (51)*
(-)E (n=106) 52.~1.9 34.4±1.6 (63) 18.8±Q.9 (36)
There _ no significant difference in Xci or HE levels
(+E=377±69 rq/g tissue; -E=557±58). ccnclusion: E is
not associated with further down-regulation of the atot
in heart failure, bIt is associated with a decrease in
al arid an increase in ~ AR.
LACK OF CORRELATION OF OUABAIN BINDING SITES AND INO-
TROPIC RESPONSE TO DIGITALIS IN EXPERIMENTAL HEART
FAILURE. Tai-Hwang!h Fan, Ph.p'., Susumu Sakamoto, H.D.,
John Thompson Sullebarger, H.D., Chang-seng Liang, H.D.,
Ph.D., F.A.C.C., University of Roohester Hedioal Center,
Roohester, New York.
Hyocardial digitalis receptor numbers (DR) have been
shown to be reduoed in several pathologio oonditions
including congestive heart failure secondary to dilated
cardiomyopathy. To stUdy whether this reduotion in DR
causes a blunted inotropic response to digitalis, we
measured DR and hemodynamio response to aoetylstrophan-
thidin (AS, 50 ~g/kg) in 8 dogs with right heart failure
(RHF) induced by tricuspid avulsion and pulmonary artery
oonstriotion and 10 sham-operated dogs. Compare to sham
dogs, RHF dogs exhibited a lower (p<0.05) baseline RV
dP/dt (492~34 vs. 730~27 mmHg/sec), LV dP/dt (1950~115
vs. 3002+128 mmHg/seo) and CO (2.69+0.18 vs. 3.24+0.14
L/min). -Ventrioular DR was quantitated by radiollgand
binding assay with [3H]-ouabain whioh bound oardiao
membranes with high affinity (Kd~13 nM) and Soatchard
analysis showed a homogeneous POPUlation of binding sites
in both RHF and sham dogs. Results (mean+SE) of DR
(pmol/mg). and maximum AS-induced increases in dP/dt and
CO are: P<0.05 vs. sham.
RV DR LV DR RV dP/dt LV dP/dt CO
Sham 4.7~0.2. 5.8~0.3. 247+25 1312+107 1.13+0.12
RHF 3.2+0.3 3.9+0.3 282~55 1491~232 0.93~0.10
HR responses to AS did not differ between the 2 groups.
The results indioate that the reduction of DR is not
specific to the failing myooardium, as it also oocurs in
the non-failing LV. Furthermore, since the ventricular
dP/dt and CO responses to AS did not differ between the
sham and RHF dogs, we oonolude that DR can be reduoed by
as much as 30J without causing a demonstratable deorease
in the inotropic response to digitalis.
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EFFECTS OF COMBINED LOW DOSES OF QUINIDINE AND METOPROLOL
ON INDUCIBLE VENTRICULAR ARRHYTHMIAS IN A CHRONIC CANINE
INFARCT MODEL
William P. Schafer M.D., E. Neil Moore D.V.M., Ph. D.,
F.A.C.C., Joseph F. Spear Ph. D., F.A.C.C., University of
Pennsylvania, Philadelphia, Pennsylvania
Quinidine (Q) and metoprolol (M) are given to treat
ventricular arrhythmias (VA) and ilnprove survival after
myocardial infarction (MI) , however, full dose therapy is
frequently limited by intolerable side effects, toxicity
or treatment failure. Thus, using the chronic canine
occlusion-reperfusion model of inducible VA, we studied
the ability of combined sub-therapeutic doses of Q+M to
suppress inducible VA. Of 34 dogs, no VA were inducible
in 9, sustained ventricular tachycardia (VT) was repro-
ducibly initiated in 14 and ventricular fibrillation (VF)
in 11. Alternating sub-therapeutic intravenous doses of Q
(3.75_15 mg/kg) and M (0.1-1.0 mg/kg) were given until VA
were suppressed. 2 VT dogs could not tolerate even low
doses of Q hemodynamically and were eliminated from fur-
ther study. Low dose Q alone suppressed VT in one dog.
Low dose M alone suppressed VT in 2 dogs. Combined low
dose Q+M suppressed VT in 8 of the remaining 9 dogs. Q
slowed VT rates, M did not. Q alone suppressed VF in 3
cases. Prior studies demonstrated remarkably small doses
of M to be completely effective at suppressing VF. It re-
mained so here in the one case when it was given first.
Low dose M remained effective against VF in the seven
cases when low dose Q given first was ineffective.
Conclusion, Combined low doses of Q+M are extremely
successful at suppressing VT after experimental MI, with
only rare treatment failure and no proarrhythmia. Neither'
drug alone suppressed VT. Low dose M remains effective
against VF, even in the presence of Q.
COMBINATION OF CLASS IA AND IB ANTIARRHYTHMIC DRUGS MAR-
KEDLY DEPRESSES Vmax WITH LITTLE CHANGE IN THE ACTION PO-
TENTIAL DURATION IN CANINE PURKINJE FIBERS
Yoshio Watanabe H.D •• F.A.C.C., Hideo Tanaka H.D., Nobuo
Homma H.D., Hiroko Uchida H.D., Cardiovascular Institute.
Fujita Gakuen Health University. Toyoake. Aichi. Japan
Cellular electrophysiologic mechanisms for the beneficial
effects of combined class IA and 18 antiarrhythmic drugs
in the treatment of ventricular tachyarrhythmias were stu-
died by recording transmembrane potentials of canine Pur-
kinje fibers driven at 1 Hz. Drugs tested were (1) 5mg/L
disopyramide (D) + lOmg/L lidocaine (L), and (2) D + 5mg/L
mexiletine (H), with the perfusion sequence switched in
both groups. In group 1. initial perfusion with D signi-
ficantly (P < 0.05) decreased Vmax and prolonged the action
potential duration at 90% repolarization (APD90), and sub-
sequent addition of L further reduced Vmax and restored
APD90 to normal (n-5). L alone significantly decreased
Vmax and APDgO' .and addition of D further reduced Vmax and
prolonged APDgO to the control level (n~5). In group 2,
H showed exactly similar interactions with D, whether the
perfusion sequence was D followed by D+M (n-B) or H fol-
lowed by M+D (n=B). Shortening of APD90 at shorter cycle
lengths of stimulation (600 and 400 ms) as compared with
1,000 ms was less marked when D and H were combined. sug-
gesting relative prolongation of APD during tachycardia.
Use-dependent depression of ~max on sudden shortening of
the cycle length from 1.000 to 400-500 ms showed fast ki-
netics with L or M and slow kinetics with D, and their
combination produced an intermediate response. These re-
sults suggest that combination of class IA and IB drugs
are additive in depressing conduction and antagonistic in
modifying refractoriness, and such interactions may cause
an increased efficacy against ventritular tachyarrhythmias
with less untoward effects on ventricular repolarization.
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TERMINATION OF EPINEPHRINE-INDUCED VENTRICULAR TACHYCAR-
DIA BY ADENOSINE IN HALOTHANE-ANESTHETIZED DOGS
W. Jerry Merrell M.D., William Rush B.S., Menno ter Riet,
David G. Bjoraker M.D., Luiz Belardinelli M.D., Univer-
sity of Florida College of Medicine, Gainesville, Florida
Halothane sensitizes the heart to the effects of epineph-
rine and may lead to life-threatening ventricular ar-
rhythmias, properties not shared by other commonly em-
ployed inhalational anesthetics. Thia catecholamine-
induced arrhythmia is blocked by adrenergic blockers or
adenosine triphosphate (ATP) but exacerbated by theophyl-
line, an adenosine antagonist. Therefore, we sought to
determine whether this arrhythmia is suppreased by adeno-
sine, which has been shown to terminate isoproterenol-
induced ventricular tachycardia (VT) in humans. In 8
dogs anesthetized with halothane, arterial pressure was
measured and arrhythmias monitored by lead-2 ECG, RA, RV,
and/or His-Bundle electrograms. Under stable anesthetic
conditions, progressively larger doses of epinephrine
were administered sequentially by constant intravenous
(IV) infusion until VT occurred. Epinephrine, at a mean
dose of 46.8 + 13.1 ~/min (SEM), induced sustained VT in
all dogs. In-every case, IV administration of adenosine,
105 + 65 \.1M/min (mean + SEM) , rapidly restored normal
sinus rhythm. When "ildenosine was discontinued, VT
promptly recurred. In 2 dogs, dipyridamole (250 \.Ig/kg
IV), an adenosine uptake blocker that increases myocar-
dial adenosine levels, also restored normal sinus rhythm;
this effect was reversed by the adenosine antagonist 8-
sulpho-phenyltheophylline (5 mg/kg IV). Conclusions:
Epinephrine-induced VT during halothane anesthesia: Ca)
can be terminated effectively and rapidly by exogenous
adenosine and (b) is modulated by endogenous adenosine.
Adenosine or agents with adenosine-like effects may be
valuable in the treatment of catecholamine-induced VT.
DISPARATE EFFECTS OF ACUTE AND CHRONIC AMIODARONE
ON VENTRICULAR FIBRILLATION THRESHOLD IN DOGS.
MariOD Gonzalez M D.•Jaime J. Grin.M.D.•EduardoD. Venturini. M.S.E.E.
College of Medicine. National University of Rosario. Argentina.
Chronic oral amiOdarone (A) Odminlstratlon is effective In suppressing
ventricular antlyfhmias In patients at high risk forsudden death. However.
Intravenous administration of A Is often less effective. The purpose of this
study was to compare the effect of Intravenous A with lidocaine on the
ventriculor fibriliotion threshold (\1FT) In anesthetized closed-chest dogs.
In addition. serial studies during long-term oral A administration were per-
formed to determine the time-course of VFT changes. VFT was deter-
mined byscanning the ventricular vunerable period with single RVendo-
cardial stimuli of Increasing current strength. Following intravenous
administration of lidocaine (2 mg/kg followed by 20I1g/kg/min. n=10)VFT
Increased significantly from 46.5±6.3 to 8O±15.3 mA (mean±SEM. p <
0.025). In contrast•Intravenous A (3.6 mg/kg over5 min.n=13) decreased
the VFT from 35±5.5 to 27±3.6 mA (p < 0.025). The VFT was not modified
after the administration of either saline solution (30±2 vs 31±2 mAo NS:
n=10) or solvent of A ( 40±2 vs 45±8 mAo NS; n=5). Repeated measure-
ments (at 2 to 8week intervals) during chronic studies were analyzed by
flfting a straiQht line to the data ofeach animal. The mean slope2f these
regressions (b) was subjected to trend analysis (I- statistic. 1 = b -In /s.).
In the control group. the VFT remained stable over a mean of 5.1±O.4
months (5 = -o.9±O.6. not significantly dlfferentfrom zero). Prolonged oral
A administration (17 mg/kg/day for 4.6±0.7 months. n=7) resulted In a
progressive Increase In the VFT (b = 12.712.18. P<O.CXXl5). A 50% Increase
in the VFT was observed after 65±16days of A. In conclusion: The
intravenous Infusion of amiodarone. unlike lidocaine. Increased the vu~
nerability of the ventricle to electrically Induced ventricular fibrillation.
Conversely. chronic amiadarone administration was required to pro-
duce an Increase In the VFT. These data emphasize the disparate effects
of ocute and chronic amiOdarone therapy.
AMIODARONE ON SUPPRESSION OF BARIUM-INDUCED TRIGGERED
AUTOMATICITY AND EARLY AFTERREPOLARIZATIONS IN PURKINJE
FIBERS RELATIVE TO EFFECTS OF VERAPAMIL AND CLASS I
AGENTS.
Chiei Takanaka M.D., Bramah N. Singh M.D., Ph.D.,
F.A.C.C., Wadaworth VA Medical Center Los Angeles, CA.
Triggered automaticity (TA) and early afterdepolari-
zations (EADs) are implicated in the genesis of torsades.
The effects on EADs of amiodarone (Am) which rarely
causes torsades is unknown. TA and EADs were produced
in isolated canine Purkinje fibers with 5 mM barium (Ba).
Such action P2tentials (AP) were abolished in Tyrode
devoid of rCa I and by 10 \.1M verapamil. Effects of Am
(50 \.1M) on maximil diastolic potential (MOP), AP
amplitude (APA), Vmax, spontaneous frequency (SF)
are shown as means ± SE (*p<O.OI):
MOP AMP Vmax SF
(mV) (mV) (V/sec) (mV)
Control 55.1 78.8 13.2 62.3
±l.l ±2.9 ±l.l ±4.0
Am 55.4 60.0* 7.3* 35.5*
±1.2 ±2.7 ±0.8 ±2.8
Lidocaine (40\.lM) had no effect. Quinidine (IO\.lM)
decreased APA 6.9% (p<0.05) and Vmax 15.7% (p<O.OI) but
increased APD (p<0.05) and produced EADs. Am had no
effect on APD but abolished EADs. Conclusions: (i) Slow
Ca- but not fast-Na channel activity appears to mediate
Ba- triggered APs and EADs; (ii) low incidence of
torsades on Am may be due to associated inhibitory
effects on Ca-channels.
'TORSADES DE POINTES' WITH QUINIDINE AND
PROPRANOLOL IN CONSCIOUS DOGS WITH A-V BLOCK .
.J.""C'q\l.El? ~El.is.s.Elll1:>\l~.~Elr. M.D., Frederique
Chezalviel, Jean-Marc Davy M.D., Antoine Ferry
M.D., Gilbert Motte M.D. and Georges Cheymol
M.D. Faculte St-Antoine, 75012-Paris (France).
Quinidine (Q)-induced 'Torsades de pointes'
(TdP) are known to be facilitated by hypo-
kaliemia (HK) and bradycardia and prevented by
isoproterenol infusion. In a recent model of
conscious dog with permanent A-V block, non-
toxic doses of i. v. Q have been shown to pro-
voke frequent complex ventricular (V) arrhyth-
mias mostly when chronic diuretic-induced HK
was present. But TdP never occured.
In order to obtain TdP in this model, we admi-
nistered propranolol (PPL, 0.5 mg/Kg i.v.)
prior to Q (10 mg/Kg i .v.) in 7 dogs with
normokaliemia (NK) and in 6 dogs with HK
(3.l±0.lmMol/1). At baseline V cycle length
were similar in both groups (RR: l520±l09ms).
After Q and PPL, RR increased to 2325±76ms in
NK and to 1965±190ms in HK, and QT intervals at
V driven-rate (60/min) reached 382±16ms (NK)
and 374±17ms (HK). TdP occured in 4 out of the
7 dogs in NK (with 2 V fibrillations) and in 2
out of 6 dogs in HK (all with V fibrillations).
Other V arrhythmias (non-sustained tachycardia
or couplets) occured in 4 dogs (1 in NK and 3
in HK dogs). QC?!!:C',lll.s.:iC?lls: In dogs wi th A-V
block, PPL pre-treatment is required to observe
TdP after non-toxic i. v dose of Q. Enhanced
degree of bradycardia and/or direct adrenergic
interactions could here be involved.










At pH 7.3 tonic and use dependent block were equivalent in adults and
neonates, but 'on' rate was shaner and 'l' off longer In adults (both
P<.05). Acidosis Increased use-dependent block and 'l'o/[ in both groups
(P<.05) and eliminated the differences between adult and neonate In 'Qn'
rate and loff- TQ attain this required a greater prolongation of 'on' rate
and To/[ in the neonate. These results suggest that the interactions
between lidocaine and the developing cell membrane are influenced by
pH such that at neutral pH ionized lidocaine is more effective In Induclnj;l
local anesthetic action In the adult.
DEVELOPMENTAL CHANGES IN UDOCAINE ACTION OCCUR AT
NEUTRAL BUT NOT ACIDIC pH.
Mary Hamra, Ph.D. & Michael R. Rosen, M.D., FACC
CQlumbla University, New York NY
Previous studies have shown that lidocaine Induces use-dependent
depression of t'max In adult canine Purklnje fibers (PF) to a greater extent
than in neonates, and thai acidosis augments IIdocaine's use dependent
actions. We studied the Interactions of lidocaine (5 mglL) and pH {7.3
and 6.8) on ~max ol adult and neonatal PF, to determine if acidosis
altered the developmental differences previQusly seen. PF were driven at
stimulus cycle lengths = 1300 and 300 ms. Control maximal diastolic
potential (MOP) and t'max = -83t1mV and 623.16V1sec, respectively
(adUlts); and -83t1mV and 550.36 Vlsec (neonates) (p>.05). We studied
the effects ol lidocaine on tonic block (% reduction of t'max from contrQQ;
use-dependent block (% reduction of t'max from tonic); the 'on' rate
(number of stimuli tQ establish steady state use dependent block); and
the off rate representing recovery from use-dependent block ('l' off)'

















Sodium channel blocking agents decrease the slope of
phase 0 of the action potential, thereby decreasing
myocardial conduction velocity (CV). This blockade is
rate dependent (RD), which may occur as a result of
mechanisms postulated by the modulated receptor hypo-
thesis. This study was performed to examine this pheno-
menon in man, by determining if procainamide causes RD
slowing of intraventricular conduction, and if this
phenomenon can be accurately measured by catheter record-
ings. At EP study, 11 patients were paced at 650-250 ms
paced cycle length from electrode pair 1 of a catheter in
the RV apex, and conduction time was measured from pairs
2 to 5 (33 mm apart) before and after 15 mg/kg IV procain-
amide (PA), 1evel-9.7:2 ~g/m1. The standard deviation of
5 measurements averaged: 1.2 ms. Assuming linear
conduction, mean baseline CV was 0.73 M/sec, and did not
vary with rate. Mean CV on PA slowed with decreasing
paced cycle length by 2.6xl0-4 M/sec/ms, from 0.64 to
0.53 M/sec. The graph shows mean CV : standard errors
with linear regression lines and 95% confidence limits
for baseline and PA. Thus: ••• -....
1) Ventricular CV can be
reproducibly measured by
this method and is similar
to reported ventricular CV
measured in vitro; 2) CV in
the absence of drugs is not
RD; 3) PA slows CV in a linear,
RD fashion; 4) this method may
be useful to quantify RD effects
of antiarrhythmic drugs in man.
RATE-DEPENDENT SLOWING OF INTRAVENTRICULAR CONDUCTION BY
PROCAINAMIDE: DIRECT MEASUREMENT IN THE HUMAN HEART
E. Wayne Grogan, Jr., M.D., F.A.C.C. University of
Wisconsin, Madison, Wisconsin
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ELECTROPHYSIOLOGIC EFFECTS OF A CHEMICAL DEFIBRILlATORY
AGENT: DIBENZEPIN
GiQra Amllzyr phD. William B. GQugh PhD, Nabll EI-Sherlf MD,FACC,
SUNY, Health Science and VA Medical Centers, Brooklyn, NY
We studied the effects Qf dlbenzepln (D), a tricyclicantidepressant,
which spQntaneQusly terminates electrically Induced ventricular
fl/brlllatlQn. Its deflbrlllatQry actlQn Is enhanced by elevated
catecholamlnes. Using standard mlcroelectrode techniques the
following measurements were made In vltrQ In canine papillary
muscle: action potential amplitude and duratlQn, effective refractQry
period, maximum dlastQlic potential, overahQot, Vmax (V/sec) and
conduction time (CT) between 2 electrode sites spaced 1-2mm apart
(mseclmm). Measurements were made at 3 cycle lengths both befQre
(C) and after dlbenzepln. A cycle length of of 200 msec was studied In
order tQ approach cycles that may occur during flbrlllatlQn.
Cycle length ymax( Cl ~..QILQl. QILP1
1000(msec) 195%.29 187%.25 1.85%..45 1.54%..45'
400(msec) 182%.26 166%.27' 1.92%..48 1.61%..48'
200(msec) 163±,2 5 136±,27' 2.08%..44 1.70%..51'
Significant reductlQns occurred In Vmax and CT (n-8;·p<.05) even at
the very short cycle length. The paradoxical shortening of CT with a
decreased Vmax may be due to Indirect effects of dlbenzepln. It
Inhibits reuptake Qf catecholamlnes. Therefore, prQpranQIQI (P)
(200 nanoM) was used. (n=6).
Cycle length YIIwLm ymaxlP*PI m:Lm Q.ILD..±El
1000(msec) 192%.30 167%.27' 1.59%..22 1.79%..28'
400(msec) 177%.27 158%.26' 1.64%..26 1.85%..35'
200(msec) 165%.24 145%.26' 1.69:1:..28 2.03%..35'
Propanolol alone caused no significant changes In any measurment.
When combined with d1benzepln Vmax was stili slgnlflcantly reduced
but CT was Increased. Therefore, the paredoxlcal effect ofdlbenzlpln
alone to decrease Vmax but Inprove conduction may be mediated by the
ability of catecholamlnes tQ Increase Intercellular coupling. Thus, the
defibrillatory effects of d1benzepln seem to be due tQ Its ability to
Improve conductlQn during fibrillation and thereby decrease the
critical number of asynchrQnQus flbrillatQry wavelets.
anouc .1lMIODARJNE ArMINISTRATIOO Pro:t!X:TS AGAINST GLOBAL
MYOCARDIAL ISOIm!IA IN 'ltlE RAT
James A. Karlson, M.D., M.M.SC., }Obert W. Hopkins, M.D.,
JOM M. ~ran, M.D., F .A.C.C., Karl E. Karlson, M.D.,
Ph.D., F.A.C.C., Brown University, Providence, ROOde
Island.
Patients w!xl have had therapy for arrhytlTnia with 1\mi.oda-
rene (A) frequently require cardiac surgery.
To evaluate the effect of chronic administration of A on
cardiac function after surgery with global ischemia,
oonrotensive (n=6) ani spontaneously hypertensive (n=6)
rats were administered A intraperitoneally for 4 weeks.
An equal number of oonrotensive ani hypertensive controls
were injected with sterile saline solution on the same
schedule.
NoIIlDtensive rats received a total dose of 240 ng/kg of
A crver 4 weeks, at which time the~l concentra-
tion of A was 3.73 1: 1.98 Alg!gm wet weight. Hypertensive
rats received 500 mg/kg of A crver 4 weeks, at which time
myocardial A was 1. 74 oU;/!gm wet weight. The hearts fran
these rats were excised ani perfused in a Lan:l'ermrff
apparatus for 30 min, then subjected to 15 min global
ischemia followed by 45 min reperfusion, all at oomo-
thenni.a. Heart rate ani LV developed pressure were
measured usin:J an LV ballcon ani LV work was calculated
before ani after ischemia. Durin:] the reperfusion
period, A treated hearts had significantly better LV
function than controls, and treated hearts had recovered
97 ± 13% of preischemic work after 45 min, cmpared to
76 ± 17% for control hearts (p<0.005).
There was 00 difference in the post-ischemic functional
recovery of oonrot:ensive ani hypertensive hearts.
Chronic A administration protects against functional de-
terioration after global ischemia un:ief these conditions.
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EPICARDIAL KAPPIHG OF RATE-DEPEHDEHT VEHTRICULAR
COHDUCTIOH SLOWIHG BY PROCAIHAKIDE.
StanleY Hattel. M.D .• F.A.C.C .• Wuhua Jing. M.D.,
Montreal Heart Institute, Montreal, Quebec.
While antiarrhythmic drugs are mown to produce rate-
dependent sodilllll channel blockade, littla quantitative
work has been done to evaluate the consequenees for
drug effects on conduetion. The purpose of these exper-
iments vas to study interval-dependent effects of pro-
cainamide on epicardial activation in anesthetized
dogs. Fonaalin-induced AV block vas used to study the
effects of 3 stable procainamide concentrations over a
vide range of coupling intervals. Computer-based map-
ping vas perfol'llll!d using data frOlll 56 aillUltaneously
acquired epicardial electrogrBmS. Results: Overall con-
duction pattern and time were constant over a vide
range of test intervals (SlS2) under control con-
ditions. Procainamide produced a concentration and in-
terval-related sloving in conduction velocity (8).
Quantitative analysis of conduction pettern showed it
to be unchanged by procainamide, even in the presence
of substantial drug-induced conduction slowing. Hathe-
matical modelling of conduction slowing caused by pro-
cainamide showed it to be more consistent with an un-
derlying proportional relationship between Vmax and
82 (least sum of squares of curve fits •• 8±O.9*10-3)
than with a lineal' relationship between Ymax and 8
(least sum of squares 7.2±1.7*10-3, p<.05). Drug-in-
duced epicardial conduction time changes correlated
closely with changes in QRS duration (raO.95, peOOl),
indicating that QRS is a valid index of drug effects on
ventrieular conduction. Conclusions: 1) Procainamide
causes rate-related conduction slowing suggesting that
Ymax Q 82, without altering overall epicardial
activation pattern; 2) QRS is a valid noninvasive index
of drug effects on ventricular conduction.
RETROGRADE COIIDUCTIOR PROPERTIES DETERHlRE RATE-
DEPEHDEHT EFFICACY OF DILTIAZEH FOR AV REERTRAHT
TACHYCARDIA.
Demetrios Papadatos, Mario Talaj ic, HD, Christine
Villemaire, BSc, Mohsen Rayebpour, PharmD, stanley
Hattel, MD, FACC, Montreal Heart Institute, Montreal,
Canada.
Moleeular models predict rate-dependent effects of dil-
tiazem (D) on AV nodal conduction. This study vas
designed to evaluate the potential clinical signifi-
cance of this property in treating orthodrOlllic AV reen-
trant tachycardia (AVRT). Sensing and pacing eircuits
were used to mimic a retrograde accessory pathway in 10
auton01llieally-bloeked do&s. In each dog, AVRT vas in-
duced over a range of retrograde intervals (VA) between
300 and 10 msec. Under control conditions, the rate of
AVRT increased as VA decreased, and sustained AVRT
(sAVRT) vas observed until atrial refractoriness limited
induction at V"31±8 lIIlIec. In the pr..ence of 0, de-
creases in VA resulted in rate-dependent AV conduction
slowing, manifesting as a secondary phase of AM pro-
longation after tachycardia onset which prevented or
slowed sAVRT. This phase had a time eonstant averaging
2. beats, similar to that of 0 effeets on lsi in vitro,
and a magnitude determined by VA and AVRT rate
(p<.OOl). Consequently, the ability of 0 to prevent
sAVRT depended on VA, vith an efficacy of 0,37, and 81~
(low dose) and 29,86, and 10Of. (high dose) at VA's of
200, 100, and 50 uec reapectively. The rate-related
secondary phase of AM prolongation depended on D dose,
and vas absent under control conditions. we conelude
that retrograde conduction properties determine D's ef-
ficacy in AVRT by controlling rate-dependent slow chan-
nel blockade. This confirms predictions based on phar-
macologie models suggesting seleetive depression of ta-
ehycardias by drugs with use-dependent bloeking actions.
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Cellular Metabolism and Cardiac Injury
IN VIVO NEAR INFRARED MONITORING OF MYOCARDIAL
OXYGENATION DURING ISCHEMIA AND REPERFUSION.
William J. Parsons, MD, Judi th C. Rembert, PhD,
Robert P. Bauman, MD, Jack A. Griebel, MD, Claude A.
Piantadosi, MD, Duke and VA Medical Centers, Durham, NC.
The use of near infrared (NIR) sp~ctroscopy to assess
cardiac oxidative metabolIsm in vivo is reported for th?
first time. NIR spectroscopydeteCts changes in redox
state of the copper complex of mitochondrial cytoohrome
~'~3 and oxygenation of tissue hemoglobin (Hb) and
myoglobIn (Mb). We employed the NIR method in open
chest dogs (n-6) to assess oxidative metabolism in
normally contracting, ischemi c, and reperfused
myocardium. Complete occlusion of the LAD artery for 1
min was associated with an abrupt drop in myocardial O2stores (tissue Hb02 + Mb02) and tissue Hb volume,
reaching a nadir in -30 sec. The cyt ~'~3 oxidation
level decreased in parallel, due to an imbalance between
electron flClx and O2 sClpply in ischemia. Upon
reperfusion. reactive hyperemia was reflected in
increases in tissue Hb volume and myocardial 0
stores. Reoxidation of cyt ~'~3 was observed wIthin 3S
sec to above preocclClsion levels, followed by return to
baseline within 1 mIn. Reperfusion after 15 min of LAD
occlusion led to mor~ prominent optically detected
hyperemic changes. Of note, cyt ~'~3 remained at an
elevated state of oxidation for up 1;0 one hour post
occlusion. Thus, in contrast to isolated mitochondria
~~' cyt ~'~3 is not f'-llly oxidized in contracting
myocardi urn. Also, reperfusion after prolonged coronary
occlusIon is associated with a persistent hyperoxidized
state in terms of enhanced O2 availabilIty relative to
electron flux at the oxidase. The NIR method provid(>s
important and unique information· regarding changes in
myocardial oxidative metabolism associated with ischemia
and reperfusion.
BSTIMATION OP THE CONCENTRATION AND PUNCTION
OP THB ADP/ATP CARRIBR IN THB MYOCARDIUM OF
PATIENTS WITH DILATED CARDIOMYOPATHY (DCM)
G. Ulrich, H.-P. Schultheiss, and B. ~emke.
Med. ~linik I. University of Munich, PRG
Recent studies from our group described the
ADP/ATP carrier (ADP/ATP c.) of the inner
mitochondrial membrane a. an autoantigen in
DCM. After i.olation of mitochondria from
explanted heart. the adenine nucleotide ex-
change was monitored u.ing an inhibitor .top
method coabined with back exchange. In 14 out
of 27 DCM the ATP-transport rate wa. signifi-
cantly lower than in coronary heart di.ease
(CHD) (after 40 .ec.: 44.2±3.5 vS. 61.7±3.6
'I. Although the transport capacity of the
ADP/ATP carrier was decreased. its concentra-
tion in DCM wa. .arkedly increased as measured
with a dot immunobinding as.ay (DCM 72.5±10.6;
CHD 51.0±3.7 pg/mg protein). In these 14
patients autoantibody (AB) deposition in car-
diac myocytes wa. clearly visible in direct
immunofluorescence (CHD negative). To substan-
tiate these findings, myocardial biopsies from
patients with DCM (n-40) and CHD (n-10) w.re
examined for ADP/ATP c. concentration and for
deposition of AB in the tissue. In DCM the
ADP/ATP C. concentration was significantly
higher than in CHD (70.5±16.6 vS. 50.2±3.5
pg/mg protein). In 67' the elevated ADP/ATP c.
titer was paralleled by a deposition of AB in
cardiac myocytes. The.e data suggest that as a
con.equence of the autoimmune reaction against
the ADP/ATP C. and its functional impairment
the concentration of the carrier protein i.
up-regulated.
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SARCOLEMMAL PHOSPHOLIPID TURNOVER: A CRITICAL MEDIATOR
OF MYOCARDIAL INJURY
Yutaka Miyazaki. M.D .• Ph.D .• Richard W. Gross, M.D.,
Ph.D., Burton E. Sobel, M.D., F.A.C.C., and Jeffrey E.
Saffitz, M.D., Ph.D., F.A.C.C., Washington University,
St. Louis, MO
The biochemical events responsible for the transition
from reversible to irreversible myocardial ischemic
injury are not yet well understood. Increased turnover
of membrane phospholipids with release of arachidonic
acid (AA) and toxic, amphiphilic metabolites has been
implicated. To delineate specific subcellular loci of
augmented AA turnover in order to determine whether this
process occurs in particularly vulnerable sites such as
the sarcolemma, we characterized the subcellular distri-
bution of 3H-AA in neonatal rat myocytes (n = 24 pre-
parations) incubated with 5 nM 3H-AA for 24 hr before
(pre1abe1ed) or during (concomitantly labeled) exposure
to iodoacetate to simulate either reversible (3 hr) or
irreversible (5 hr) ischemic injury. Reversibly injured
prelabe1ed cells released only minimal amounts of 3H-AA
and resumed contracting in control media. Irreversibly
injured pre1abe1ed cells released massive amounts of
3H-AA and lactate dehydrogenase and did not recover.
TLC did not identify marked changes in the percentage of
3H-AA in specific lipid pools despite injury. Quan-
titative ultrastructural autoradiography showed that the
specific radioactivity of sarcolemma in pre1abe1ed cells
increased by B% with reversible and by 56% with irre-
versible injury. The percentage of total 3H-AA in
sarcolemma of concomitantly labeled cells increased from
0.2% in controls to 4.0% in reversibly injured and 19.2%
in irreversibly injured cells. Thus, markedly augmented
turnover of sarcolemmal phospholipids presages and
appears likely to contribute to irreversible hypoxic
injury of cardic myocytes.
HYPOXIA AND GLUCOSE DEPRIVATION INDEPENDENTLY INDUCE
UNCOUPLING OF al-ADRENERGIC SIGNAL TRANSDUCTION IN
CULTURED MYOCARDIALCEUS
Tgshjfumj Kag;ya MD, Krishna Rocha-Singh M.D., Norman Honbo
M.S. and Joel S. Karliner M.D., F.A.C.C. VA Medical Center and
Cardiovascular Research Institute, University of California, San
Francisco, CA
Supplement of glucose could be of critical importance in supporting
ischemic myocardium. And it is still unclear how altered adrenergic
receptor regulation during myocardial ischemia influences the
second messenger system. We investigated the effects of hypoxia
and/or deprivation of glucose on myocardial al-receptors and
phosphatidylinositol(PI) hydrolysis in single-cell cultures from
neonatal rat myocardium. Cells were incubated under normoxic
(95% 02+5% C02) or hypoxic (95% N2+5% C02) conditions in
combination with glucose deprivation in media at 37°C for 2 hr.
Inositol phosphates(IPs) were measured using anion exchange
chromatography. Hypoxia increased the number of al-receptors
(1B.1±2.5 (SE) to 26.9±3.4 fmoVmg protein; n-12, p<.001) and
the basal level of inositol trisphosphate (4B.1±6.9 to 6B.5±14.8
fmol/mg protein; n-5, p<.05), but norepinephrine (NE)-
stimulated PI hydrolysis was not enhanced (72.7±14.7 to
77.5±16.6 fmol/mg protein; n-5). Glucose deprivation without
hypoxia increased al-receptor density (12.5±3.0 to 23.0±4.1
fmollmg protein; n-4, p<.05) and hypoxia produced further
increase (27.2±2.7 fmollmg protein; n-5). During glucose
deprivation, NE-stimulated PI hydrolysis was also not enhanced
either with or without hypoxia. Hypoxia resulted in a shift of NE
competition curve for 1251-HEAT binding to the right, the Ki
Increasing significantly 2.97 fold (n-3, p<O.01). These results
suggest that hypoxia increased the number of al-receptors but
decreased agonist affinity, and that both hypoxia and glucose
deprivation independently result in uncoupling of al-receplor
mediated signal transduction.
LOW DOSE OF ANTITUMOR AGENTS PREVENTS SMOOTH MUSCLE CELL
PROLIFERATION AFTER ENDOTHELIAL INJURY
Peter Barath. M.D., Ko Arakawa, M.D., Jin Cao, M.D.,
Michael Fishbein, M.D., FACC, James Fagin, M.D., A1don
Lusis, M.D., James Forrester, M.D. FACC, Cedars-Sinai
Medical Center, Los Angeles, CA
The cellular basis of restenosis after balloon
angiop1asty (BA) is dedifferentiation of smooth muscle
cells (SMC) (shift from the contractile to synthetic
phenotype) followed by proliferation accompanied by and
production of connective tissue. We hypothesize that
early administration of low dose cytostatic agents could
prevent restenosis by selectively damaging the active and
proliferating SMCs. We gave mitosis phase specific
Vincristine (0.075 mg/kg) and transcription inhibitor
Actinomycin 0 (0.015 mg/kg) i.v. during balloon
denudation of rabbit aorta. Control (C), denuded (D),
treated (Rx) and denuded + treated (D-Rx) animals were
sacrificed at 3d. The number of subintimal SMCs after
intervention was compared with the that of control and
the proportion of mitotic figures in 2,000 SMCs was
expressed in percentage in semi-thin sections. Electron
microscopic signs of cell ,activity (euchromatinization of
nucl ei , pronounced endop1asmi c ret i cul um) , cell u1 ar
damage and the presence or absence of myofibri1s were
scored on a 4 point ordinal scale.
C(n=9) D(n=9) Rx(n=9) D-Rx(n=9)
#SMC (% of control) - 223% 100% 155%
Mitotic figures 0.15% 17% 24% 34%
Activity +++
Cell Damage +++
Myofi bril s +++ +++ ++
CONCLUSION: Cytostatic agents in .s~ng1e low doses
administered at the time of the lnJury preven~SMC
proliferation without damaging normal SMCs. Therefore,
these drugs may prevent post-angiop1asty restenosis.
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ENHANCED PHOSPHOINOSITIDE METABOLISM DURING REPERFUSION
OF ISCHEMIC RAT HEART: A NOVEL MECHANISM OF REPERFUSION
INJURY.
Hajime Otani, M.D., Ph.D., M. Renuka Prasad, Ph.D.,
Richard M. Engelman, M.D., Hitomi Otani, Ph.D., Dipak K.
Das, Ph.D., Kansai Medical University, Moriguchi City,
Osaka, Japan.
We examined phosphoinositide (PI) metabolism in ischemic
and reperfused rat heart. The incorporation of [3H]-
inositol into PI increased significantly during re-
perfusion after 30 min of ischemia compared to that
observed durin~ nonischemic perfusion. In the heart pre-
labeled with [ H]inositol, 30 min of ischemia did not
increase accumulations of [3H]inositol phosphates (IP),
but reperfusion caused a several-fold increase in [3H]IP
accumulations. Reperfusion of the ischemic heart pre-
labeled with [I4C]arachidonate increased [I4C]diacyl-
glycerol (DAG) and [I4C]phosphatidic acid. The enhanced
accumulations of [3H]IP during reperfusion were not
affected by either prazosin plus atropine or indomethacin,
but were inhibited by hypoxic reperfusion, reperfusion
with Ca2+-free buffer, or by mepacrine.
Conclusions: I, myocardial reperfusion enhances PI meta-
bolism via stimulation of Ca2+-dependent, PI-specific
phospholipase C activity; 2, the second messenger roles
of IP3 and DAG in elevating intracellular Ca2+ suggestthat enhanced PI metabolism may represent a novel mecha-
nism of reperfusion injury. !
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INSE1'lSITIVI'I'Y OF RIGHI' VENmICllIAR mIX:MYOCARDIAL BIOPSY
m 'llIE DIJ'lI:X:SIS OF MYOCARDITIS: tiHI'lHER 'llIE GOLD S'I7IN-
lYIRD? lawrence H. Opw. MD, 'lhcmas D. sears, MD, F'ACX:, &
Bruce M. McMarals, MD, BlO, FACe. university of Nebraska
Medical center, ClIIaha, NE.
Clinical suspiciQ'l of myocarditis relies heavily Q'l the
en:lanyocardi.a bic.p;y for oc:nfizmatiQ'l, yet the sensitiv-
ity of the procedure in this settinJ has not been clearly
defined. 'lbi.s un::ert:ainty has assumed greater iJrport:aooe
in the face of decisiCllS about therapy for recent-onset,
rapidly progressive heart failure of unknown cause. Bi-
c.p;y sensitivity was detem.i.ned in the present study in
14 hearts with histologically proven myocarditis investi-
gated ex vivo, includi..Iq 12 au1:qlSies and 2 native hearts
of allograft recipients. An average of 4-5 RV enianyo-
cardial biq:sies was obtained fran the apical ventricular
sepb.nn of eadl heart, usiJr:1 bath the Cordis'IM and stan-
ford bi~, and sanpliJr:1 was repeated at 3-5 specific
RV sites in the rest of the septum. Con:espondin;J diag-
nostic sensitivities, ccnsidered casewise for each biq>-
tate, either inside or outside the apical area,~
fran 43-57%. By 0ClIi:liniJr:1 the results of bath bi~
in each septal regiQ'l (a mean of 8-9 biq:siesjregion),
sensitivity inproved to 64%. Only by canbiniJr:1 all avail-
able sanples in each heart did sensitivity reach 79%, b.It
this required an average of 17.2 pieoesjheart, a number
clinically unattainable. F\lrtheznm"e, disease severity
was urDerestiJnated in alJncst Cl'le-third of cases, and the
nature of the inflaJllllatozy infiltrate was inaccurately
represented in an equivalent proportion. Clearly, contin-
uiIx:J revision of ideas about the diagnosis of myocarditis
IlUSt include careful attentiQ'l to the sufficient number
of biq:sies to be obtained, as well as further approaches
to examine the tissue to make this I"AlIIi:ler clinically ap-
plicable.
EFFECT OF CARDIAC TRANSPLANTATION ON ANTI-BETA-RECEPTOR
AUTOANTI BOD IES
Constantinos Limas, M.D., Catherine Limas, M.D., Irvin
Goldenberg, M.D., University of Minnesota and
Minneapolis Heart Institute, Minneapolis, Minnesota
Patients with idiopathic dilated cardiomyopathy (IDC)
have serum autoantibodies directed against cardiac
aI-receptors, as determined by ligand binding inhibi-
tion, immunoprecipitation, and immunoblotting assays.
Fourteen of forty-two IDC patients (30%) evaluated for
heart transplantation were positive for anti-a-receptor
autoantibodies (more than 20% inhibition of
[3H]dihydroalprenolol binding to cardiac membranes at
100-fold serum dilution). Following cardiac transplan-
tation, eleven ·of the fourteen patients showed a decline
in the degree of ligand binding inhibition (from 40±5%
before, to 12±3% after, transplantation).
Immunoblotting of a-receptors on cardiac membranes
showed a quantitative decline in the titer of autoan-
tibodies following transplantation. In addition, two of
the three patients in whom autoantibodies against
a-receptor persisted following transplantation had
rejection episodes compared to two of the eleven
patients with declining titer. These results suggest
that removal of the immunogen (diseased heart) and/or
immunosuppressive therapy effectively lowers the inci-
dence and titers of anti a-receptor antibodies with
possibly positive functional consequences on the reci-
pient heart.
PORCINE MODEL OF MYOCARDITIS LEADING TO DILATED CARDIO-
MYOPATHY. Mara T Slawsky MD. Ph',D. Judith K.
Gwathmey, V.M.D., Ph.D., Patricia C. Come, M.D.,
F.A.C.C., Walter H. Abelmann, M.D., F.A.C.C., Beth
Israel Hospital, Harvard Medical School, Boston, Mass.
We have developed a large animal model of myocarditisj
cardiomyopathy using outbred pigs infected with encepha-
lomyocarditis virus. Twenty-five pigs were studied over
a thirty day period following infection. Cumulative mor-
tality post infection was 39%; the majority of deaths
occurred within one week post infection. Histopathologi-
cal findings in seven animals which died during this
period and in six of seven animals sacrificed between
two and three weeks after infection, revealed active
myocarditis as defined by the Dallas criteria. In the
four animals sacrificed at the end of thirty days,
histopathological examination revealed no active myocar-
ditis and little to no fibrosis. M-mode echocardiography
was used to measure end-diastolic and end-systolic left
ventricular diameters (EDD and ESD). Fractional shor-
tening (FS) was then calculated as a measure of systolic
function. Each animal served as its own control. Left
ventricular dilatation occurred in infected pigs:
EDDijEDDc-l.2±O.04 (mean ± SE; n-24; p<O.OOl); i-infec-
ted and c-control. There was no significant difference
between EDD in animals which died following infection
and those which survived (1.1 ± 0.09 vs 1.3 ± 0.06;
p-0.12). However, animals which succumbed showed a
significant decrease in FS (FSijFSc-0.4 ± 0.06) compared
with animals which survived (FSijFSc-0.9 ± 0.08);
p<O.Ol. In conclusion, these data suggest that animals
surviving acute myocarditis showed recovery of resting
ventricular function but persistent left ventricular
dilatation. These changes occurred despite the absence
of significant fibrosis on histopathological examination.
SHARING OF ANTIGENIC DETERMINANTS BETWEEN COXSACKIE B3
VIRUS AND AUTOANTIGENS IN VIRAL MYOCARDITIS AND DILATIVE
CARDIOMYOPATHY.
Peter L. Schwimmbeck M.D., Heinz-Peter Schultheiss M.D.,
Bodo E. Strauer M.D., Michael B.A. Oldstone M.D.,
Dept. of Internal Medicine/Cardiology, University of
Duesseldorf, Duesseldorf, F.R.G.
Both myocarditis (MC) and dilative cardiomyopathy (DCM)
are characterized by an autoimmune response against
specific autoantigens. We studied if these
autoantibodies may be due to molecular mimicry, i.e. the
sharing of antigenic determinants between a host and an
invading microbe, such as a virus. As coxsackie B3
virus (CB3) has been shown to induce myocarditis in mice
and man, we searched for homologous determinants shared
between the recently determined sequence of CB3 and
proteins identified as the main autoantigens in viral
heart disease. Utilizing the Dayhoff Data Bank,
computer search and computer predictions of the
secondary structure of proteins, the best homologies are
as follows:
-CB3, res. 1895-1905, and myosin, res. 400-410
-CB3, res. 1220-1227, and adenine nucleotide carrier,
res. 28-35
-CB3, res. 1311-1320, and connexon, res. 168-177
Subsequently, we synthesized peptides of up to 25 amino
acids covering the homologous regions by the "tea-bag"
method and raised antibodies against them. By
immunochemical analysis we could demonstrate that
homology also translated into immunological cross-
reactivity. Conclusion: These results show that the
sharing of cross-reacting antigenic determinants between
CB3 and known autoantigens in KC and DCM occurs and may
play a role in the pathogenesis of KC and DCM.
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CYCLOSPORINE IN AVIREMIC COXSACKIEVIRUS B3 MYOCARDITIS
IN MICE.
Chiharu Kishimoto, M.D., Walter H. Abelmann, M.D., F.A.e.C.
Beth Israel Hospital and Harvard Medical School, Boston,
Massachusetts.
To investigate the effects of cyclosporine (CS) upon
postviremic myocarditis, we analysed myocardial lymphocyte
subsets (LS) in BALB/c mice inoculated with coxsackievirus
B3 (eB3). CS, 25 mg/kg, was administered sc daily, start-
ing on day 10 (Exp I) or 30 (Exp II) for 3 weeks. LSs
(Thy 1.2x pan T, Lyt I-effector T, Lyt 2x suppressor T,
L3T4-activated T, M7/20-interleukin-2 receptor (IL-2R))
were examined by an immunoperoxidase method. Mortality
appeared high in Exp I (15/25 vs 24/25, p<0.05) and Exp II
(32/34 vs 34/34, NS). There was no decrease in cardiac
pathOlogy (infiltration, necrosis and calcification) com-
pared to infected controls (C) in either Exp.
Days 15-18 ~
LS(%,±SD) C (n-5) CS (n-5) C (n-4) CS (n-4)
Thyl.2+ 21.5±7.3 18.8±12.0 8.9±4.3 9.0±0.4
Lyt 1+ 17.1±8.9 13.0±5.5 8.1±2.3 7.4±2.7
Lyt 2+ 5.5±1.1 5.3±1.7 2.7±0.1 2.0±0.6
L3T4+ 3.3±1.0 3.8±1.0 1.7±1.6 1.3±1.0
IL-2R+ 1.4±2.1 0.8±0.9 0.2+0.2 ·0.2±0.4
Histologically, cellular depletion was evident in the
thymus, not in the spleen, of CS groups. The failure of
es to ameliorate aviremic myocarditis may be due to the
paucity of CS-sensitive cells (Lyt 2+, L3T4+, IL-2R+) in
the diseased myocardium. Significant depression of thymus
may account for the high mortality in es groups. In con-
clusion, the use of CS in clinical CB3 myocarditis may be
ineffective if not deleterious.
MYOCARDIAL IGA DEPOSITION: A POSSIBLE MARKER FOR ALCOHOL
RELATED MYOCARDIAL DISEASE.
John Cleland M.R.C.P., Manjit Shahi M.R.C.P., Rashid
Shahrabani M.R.e.p., Robert Goldin M.R.C.P., Rodney Foale
F.A.e.C., St Mary's Hospital, London, England.
The contributmn of chronic alcohol consumption to left
ventricular dysfunction in patients with idiopathic
dilated cardiomyopathy (IDCM) and coronary artery dis-
ease (CAD) has been difficult to assess. One difficulty
is the lack of a pathological marker for alcohol related
myocardial disease. Recent immunological studies sug-
gest that in alcohol related liver disease IgA may be
such a marker.
We examined right ventricular endomyocardial biopsies
from 50 patients; age 27-65 years. The indication for
biopsy was IDeM (20),ventricular dysfunction dispro-
portionate to the extent of CAD (24) and ventricular
arrhythmias in (6). In addition to the routine histo-
logy, sections were stained using an indirect immuno-
peroxidase technique for the presence of immunoglobulins
(IgG, IgM and IgA). These were then examined by an
observer with no prior knOWledge of the patients
clinical details. 14 patients were heavy drinkers
(>30u/week), 8 were moderate (15-30u/week), 9 were
light (1-15u/week) and 19 drank occasionally «lu/week).
12 patients had evidence of IgA deposition on myocardial
cell membranes. The diagnoses in these patients were
IDeM in 5 and coronary heart disease in 7. Of these, 9
admitted to heavy and 3 to moderate alcohol consumption.
IgA deposition on myocardial cell membranes is a highly
specific and moderately sensitive marker of alcohol
related myocardial dysfunction and may also have a role
in the pathogenesis of this condition.
